PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Boffito, M; Venter, F				Boffito, Marta; Venter, Francois			The triumph of HIV treatment: another new antiretroviral	LANCET			English	Editorial Material									[Boffito, Marta] Chelsea & Westminster Hosp, St Stephens AIDS Trust, London SW10 9NH, England; [Boffito, Marta] Imperial Coll London, Div Med, London, England; [Venter, Francois] Univ Witwatersrand, WITS Reprod Hlth & HIV Inst, Johannesburg, South Africa	Imperial College London; Imperial College London; University of Witwatersrand	Boffito, M (corresponding author), Chelsea & Westminster Hosp, St Stephens AIDS Trust, London SW10 9NH, England.; Boffito, M (corresponding author), Imperial Coll London, Div Med, London, England.	marta.boffito@chelwest.nhs.uk		Venter, Willem/0000-0002-4157-732X	Gilead; ViiV; Mylan; Janssen; Merck; Teva; Bristol-Myers Squibb; Cipla; USAID; UNITAID	Gilead(Gilead Sciences); ViiV; Mylan; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Teva(Teva Pharmaceutical Industries); Bristol-Myers Squibb(Bristol-Myers Squibb); Cipla; USAID(United States Agency for International Development (USAID)); UNITAID	MB reports grants and personal fees from Gilead, ViiV, Mylan, Janssen, Merck, and Teva; grants from Bristol-Myers Squibb; and personal fees from Cipla. MB has also discussed the results of the studies by Gallant et al and Sax et al with one of the coauthors, Anton Pozniak. FV reports personal fees and non-financial support from Gilead and ViiV and grants from USAID and UNITAID.	Clinton Health Access Initiative, 2017, CHAI HIV MID YEAR MA; Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Elliot E, 2017, CURR OPIN INFECT DIS, V30, P58, DOI 10.1097/QCO.0000000000000327; Gallant J, 2017, LANCET; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Sax PE, 2017, LANCET; Thorne C, 9 IAS C HIV SCI JUL; van den Berk G, C RETR OPP INF FEB 2; World Health Organisation (WHO), 2017, GUID PUBL HLTH RESP; World Health Organization, 2017, GUID HIV; Zash R, 9 IAS C HIV SCI JUL; Zhang H, C RETR OPP INF FEB 2	12	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2019	2021		10.1016/S0140-6736(17)32297-3	http://dx.doi.org/10.1016/S0140-6736(17)32297-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FL5DD	28867498				2022-12-28	WOS:000414250800006
J	Chamberlain, JJ; Kalyani, RR; Leal, S; Rhinehart, AS; Shubrook, JH; Skolnik, N; Herman, WH				Chamberlain, James J.; Kalyani, Rita Rastogi; Leal, Sandra; Rhinehart, Andrew S.; Shubrook, Jay H.; Skolnik, Neil; Herman, William H.			Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							EXCHANGE CLINIC REGISTRY; BLOOD-GLUCOSE; INTENSIVE TREATMENT; INSULIN-TREATMENT; COMPLICATIONS; THERAPY; MELLITUS; FAT; PROGRESSION; RETINOPATHY	Description: The American Diabetes Association (ADA) annually updates Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2017 Standards of Care, the ADA Professional Practice Committee did MEDLINE searches from 1 January 2016 to November 2016 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C, depending on the quality of evidence, or E for expert consensus or clinical experience. The Standards of Care were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendation: This synopsis focuses on recommendations from the 2017 Standards of Care about monitoring and pharmacologic approaches to glycemic management for type 1 diabetes.	[Chamberlain, James J.] St Marks Hosp, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA; [Chamberlain, James J.] St Marks Diabet Ctr, Internal Med St Marks, 1160 East 3900 South,Suite 1200, Salt Lake City, UT USA; [Kalyani, Rita Rastogi] Johns Hopkins Univ, Div Endocrinol Diabet & Metab, 1830 East Monument St,Suite 333, Baltimore, MD 21287 USA; [Leal, Sandra] SinfoniaRx, 1 East Toole, Tucson, AZ 85701 USA; [Rhinehart, Andrew S.] Glytec, 231 Seahorse Court, Marco Isl, FL 34145 USA; [Shubrook, Jay H.] Touro Univ, Coll Osteopath Med, 1310 Club Dr,Admin & Fac 1,Room 117, Vallejo, CA 94592 USA; [Skolnik, Neil] Abington Family Med, Abington Mem Hosp, 500 Old York Rd,Suite 108, Jenkintown, PA 19046 USA; [Herman, William H.] Univ Michigan, 1000 Wall St,Room 6108 SPC 5714, Ann Arbor, MI 48105 USA	Johns Hopkins University; Touro University California; Abington Memorial Hospital; University of Michigan System; University of Michigan	Chamberlain, JJ (corresponding author), St Marks Hosp, 1160 East 3900 South,Suite 1200, Salt Lake City, UT 84124 USA.; Chamberlain, JJ (corresponding author), St Marks Diabet Ctr, Internal Med St Marks, 1160 East 3900 South,Suite 1200, Salt Lake City, UT USA.	jimchammd@yahoo.com			Merck; Sanofi-Aventis; Janssen; Novo Nordisk	Merck(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novo Nordisk(Novo Nordisk)	Dr. Chamberlain reports personal fees from Merck, Sanofi-Aventis, Janssen, and Novo Nordisk during the conduct of the study. Dr. Rhinehart reports personal fees from Sanofi, Janssen, Boehringer Ingelheim, Novo Nordisk, Eli Lilly, Forest Pharmaceuticals, and AstraZeneca and employment with and stock in Glytec outside the submitted work. Dr. Shubrook reports being on advisory boards for Lilly Diabetes, Novo Nordisk, and Intarcia Therapeutics. Dr. Skolnik reports personal fees and nonfinancial support from AstraZeneca and Sanofi outside the submitted work; personal fees from Boehringer Ingelheim, Lilly, Teva, Janssen, and Intarcia outside the submitted work; and serving on the Primary Care Advisory Committee of the American Diabetes Association. Dr. Herman reports being on data monitoring committees for Lexicon Pharmaceuticals and Merck Sharp & Dohme outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-1259.	Albers JW, 2010, DIABETES CARE, V33, P1090, DOI 10.2337/dc09-1941; American Diabetes Association, 2017, Diabetes Care, V40, pS6; Battelino T, 2011, DIABETES CARE, V34, P795, DOI 10.2337/dc10-1989; Beck RW, 2009, DIABETES CARE, V32, P2047, DOI 10.2337/dc09-0846; Beck RW, 2009, DIABETES CARE, V32, P1378, DOI 10.2337/dc09-0108; Bell KJ, 2016, DIABETES CARE, V39, P1631, DOI 10.2337/dc15-2855; Bell KJ, 2015, DIABETES CARE, V38, P1008, DOI 10.2337/dc15-0100; Bode BW, 2015, DIABETES CARE, V38, P2266, DOI 10.2337/dc15-0075; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; Endocrine Society, 5 THINGS PHYS PAT SH; Gellad WF, 2015, JAMA INTERN MED, V175, P26, DOI 10.1001/jamainternmed.2014.5405; Grant RW, 2015, AM J MANAG CARE, V21, pE119; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5154; Lachin JM, 2016, DIABETES CARE, V39, P1378, DOI 10.2337/dc15-2399; Lachin JM, 2015, DIABETES, V64, P631, DOI 10.2337/db14-0930; Mathieu C, 2016, DIABETES CARE, V39, P1702, DOI 10.2337/dc16-0691; Miller KM, 2013, DIABETES CARE, V36, P2009, DOI 10.2337/dc12-1770; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Novo Nordisk, 2016, HIGHL PRESCR INF TRE; O'Connell MA, 2009, DIABETOLOGIA, V52, P1250, DOI 10.1007/s00125-009-1365-0; Orchard TJ, 2015, JAMA-J AM MED ASSOC, V313, P45, DOI 10.1001/jama.2014.16107; Phillip M, 2013, NEW ENGL J MED, V368, P824, DOI 10.1056/NEJMoa1206881; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Sanofi, 2015, HIGHL PRESCR INF TOU; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; U.S. Food and Drug Administration, SGLT2 INH DRUG SAF C; Vella S, 2010, DIABETOLOGIA, V53, P809, DOI 10.1007/s00125-009-1636-9; Wei N, 2014, DIABETES CARE, V37, P1048, DOI 10.2337/dc13-2173; Wolpert HA, 2013, DIABETES CARE, V36, P810, DOI 10.2337/dc12-0092; Wong JC, 2014, DIABETES CARE, V37, P2702, DOI 10.2337/dc14-0303; Wood JR, 2013, DIABETES CARE, V36, P2035, DOI 10.2337/dc12-1959; Yeh HC, 2012, ANN INTERN MED, V157, P336, DOI 10.7326/0003-4819-157-5-201209040-00508	38	41	48	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					493	+		10.7326/M17-1259	http://dx.doi.org/10.7326/M17-1259			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28892816				2022-12-28	WOS:000411988900010
J	Chen, FX; Xie, P; Collings, CK; Cao, KX; Aoi, YK; Marshall, SA; Rendleman, EJ; Ugarenko, M; Ozark, PA; Zhang, A; Shiekhattar, R; Smith, ER; Zhang, MQ; Shilatifard, A				Chen, Fei Xavier; Xie, Peng; Collings, Clayton K.; Cao, Kaixiang; Aoi, Yuki; Marshall, Stacy A.; Rendleman, Emily J.; Ugarenko, Michal; Ozark, Patrick A.; Zhang, Anda; Shiekhattar, Ramin; Smith, Edwin R.; Zhang, Michael Q.; Shilatifard, Ali			PAF1 regulation of promoter-proximal pause release via enhancer activation	SCIENCE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; COMPLEX; DISTINCT; GENOME; GENES; ROLES; TEFB	Gene expression in metazoans is regulated by RNA polymerase II (Pol II) promoter-proximal pausing and its release. Previously, we showed that Pol II-associated factor 1 (PAF1) modulates the release of paused Pol II into productive elongation. Here, we found that PAF1 occupies transcriptional enhancers and restrains hyperactivation of a subset of these enhancers. Enhancer activation as the result of PAF1 loss releases Pol II from paused promoters of nearby PAF1 target genes. Knockout of PAF1-regulated enhancers attenuates the release of paused Pol II on PAF1 target genes without major interference in the establishment of pausing at their cognate promoters. Thus, a subset of enhancers can primarily modulate gene expression by controlling the release of paused Pol II in a PAF1-dependent manner.	[Chen, Fei Xavier; Collings, Clayton K.; Cao, Kaixiang; Aoi, Yuki; Marshall, Stacy A.; Rendleman, Emily J.; Ugarenko, Michal; Ozark, Patrick A.; Smith, Edwin R.; Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA; [Xie, Peng; Zhang, Michael Q.] Univ Texas Dallas, Dept Biol Sci, Ctr Syst Biol, Richardson, TX 75080 USA; [Zhang, Anda; Shiekhattar, Ramin] Univ Miami, Miller Sch Med, Dept Human Genet, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Zhang, Michael Q.] Tsinghua Univ, Bioinformat Div, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Ctr Synthet & Syst Biol, TNLIST, Beijing 100084, Peoples R China; [Shilatifard, Ali] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Dallas; University of Miami; Tsinghua University; Tsinghua University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biochem & Mol Genet, Chicago, IL 60611 USA.; Shilatifard, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	ash@northwestern.edu	Aoi, Yuki/L-7948-2018; Smith, Edwin/N-4834-2015	Aoi, Yuki/0000-0002-0252-9536; Zhang Quintero, Anda/0000-0003-2498-4836; Collings, Clayton/0000-0002-3471-2132; Smith, Edwin/0000-0002-4125-6294; Ozark, Patrick/0000-0002-4047-5102; Cao, Kaixiang/0000-0001-9953-1503; CHEN, FEI/0000-0002-7827-7988	NIH [MH102616, CA211428, GM078455, GM105754]; Natural Science Foundation of China [31671384]; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center; JSPS; Eugene McDermott Graduate Fellowship; Robert H. Lurie Comprehensive Cancer Center-Lefkofsky Family Foundation/Liz and Eric Lefkofsky Innovation Research Award; National Cancer Institute [CA214035]; NATIONAL CANCER INSTITUTE [R50CA211428, R01CA214035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105754, R01GM078455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Eugene McDermott Graduate Fellowship; Robert H. Lurie Comprehensive Cancer Center-Lefkofsky Family Foundation/Liz and Eric Lefkofsky Innovation Research Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all the members of the Shilatifard laboratory, J. Yu, J. Crispino, J. Wang, and D. Taatjes for helpful discussions during the course of this work; I. Cheeseman for the gift of the OsTIR1-expressing DLD-1 cell line; M. Kanemaki for the gift of the pMK286 (mAID-Neo) and pMK287 (mAID-Hygro) plasmids; M. Mendillo and S. Takagishi for suggestions about CRISPR/Cas9; and L. Shilatifard for editorial assistance. ChIP-seq, RNA-seq, and 4C-seq data have been deposited at the Gene Expression Omnibus (GEO) under accession number GSE97527. Supported by NIH grant MH102616 and Natural Science Foundation of China grant 31671384 (M.Q.Z.); NIH grant CA211428 (E.R.S.); NIH grants GM078455 and GM105754 and the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center (R.S.); a JSPS Research Fellowship for Young Scientists (Y.A.); a Eugene McDermott Graduate Fellowship (P.X.); and a Robert H. Lurie Comprehensive Cancer Center-Lefkofsky Family Foundation/Liz and Eric Lefkofsky Innovation Research Award (A.S.). Transcriptional elongation studies in the Shilatifard laboratory are supported by National Cancer Institute grant CA214035 (A.S.).	Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fischl H, 2017, MOL CELL, V65, P685, DOI 10.1016/j.molcel.2017.01.006; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; McNamara RP, 2016, MOL CELL, V61, P39, DOI 10.1016/j.molcel.2015.11.004; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Yang Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005794; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338	22	59	59	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2017	357	6357					1294	1298		10.1126/science.aan3269	http://dx.doi.org/10.1126/science.aan3269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7BX	28860207	Green Accepted			2022-12-28	WOS:000411337700046
J	Kedziora, KM; Purvis, JE				Kedziora, Katarzyna M.; Purvis, Jeremy E.			The persistence of memory	NATURE			English	Editorial Material							PROLIFERATION-QUIESCENCE DECISION; DNA-DAMAGE; CELLS; P21		[Kedziora, Katarzyna M.; Purvis, Jeremy E.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Kedziora, KM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	kmkedz@email.unc.edu; jeremy_purvis@med.unc.edu		Kedziora, Katarzyna/0000-0001-6524-7731				Arora M, 2017, CELL REP, V19, P1351, DOI 10.1016/j.celrep.2017.04.055; Barr AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14728; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Karimian A, 2016, DNA REPAIR, V42, P63, DOI 10.1016/j.dnarep.2016.04.008; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; TEMIN HM, 1971, J CELL PHYSIOL, V78, P161, DOI 10.1002/jcp.1040780202; Yang HW, 2017, NATURE, V549, P404, DOI 10.1038/nature23880	10	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					343	344		10.1038/nature23549	http://dx.doi.org/10.1038/nature23549			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7PB	28869963				2022-12-28	WOS:000411381300026
J	Duffy, JE; Godwin, CM; Cardinale, BJ				Duffy, J. Emmett; Godwin, Casey M.; Cardinale, Bradley J.			Biodiversity effects in the wild are common and as strong as key drivers of productivity	NATURE			English	Article							ECOSYSTEM FUNCTION; TREE PRODUCTIVITY; SPECIES RICHNESS; DIVERSITY; CLIMATE; MULTIFUNCTIONALITY; INCREASES; BIOMASS	More than 500 controlled experiments have collectively suggested that biodiversity loss reduces ecosystem productivity and stability(1-3). Yet the importance of biodiversity in sustaining the world's ecosystems remains controversial(4-8), largely because of the lack of validation in nature, where strong abiotic forcing and complex interactions are assumed to swamp biodiversity effects(6-9). Here we test this assumption by analysing 133 estimates reported in 67 field studies that statistically separated the effects of biodiversity on biomass production from those of abiotic forcing. Contrary to the prevailing opinion of the previous two decades that biodiversity would have rare or weak effects in nature, we show that biomass production increases with species richness in a wide range of wild taxa and ecosystems. In fact, after controlling for environmental covariates, increases in biomass with biodiversity are stronger in nature than has previously been documented in experiments and comparable to or stronger than the effects of other well-known drivers of productivity, including climate and nutrient availability. These results are consistent with the collective experimental evidence that species richness increases community biomass production, and suggest that the role of biodiversity in maintaining productive ecosystems should figure prominently in global change science and policy.	[Duffy, J. Emmett] Smithsonian Inst, Tennenbaum Marine Observ Network, 647 Contees Wharf Rd, Edgewater, MD 21037 USA; [Godwin, Casey M.; Cardinale, Bradley J.] Univ Michigan, Sch Environm & Sustainabil, 440 Church St, Ann Arbor, MI 48109 USA	Smithsonian Institution; Smithsonian Environmental Research Center; University of Michigan System; University of Michigan	Duffy, JE (corresponding author), Smithsonian Inst, Tennenbaum Marine Observ Network, 647 Contees Wharf Rd, Edgewater, MD 21037 USA.	duffye@si.edu	Cardinale, Bradley J/I-7076-2013; Duffy, J. Emmett/ABF-9200-2020; Godwin, Casey/E-6892-2014	Duffy, J. Emmett/0000-0001-8595-6391; Godwin, Casey/0000-0002-4454-7521	US National Science Foundation [OCE-1336206]; Smithsonian Institution; University of Michigan's Energy Institute; US National Science Foundation's DIMENSIONS of Biodiversity program [DEB-1046121]; Division Of Ocean Sciences [1336206] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); University of Michigan's Energy Institute; US National Science Foundation's DIMENSIONS of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the authors of the original studies summarized here, which are cited in Fig. 1; without these papers this study would not have been possible. J.E.D. was supported by the US National Science Foundation (OCE-1336206) and the Smithsonian Institution. B.J.C. was supported by grants from the University of Michigan's Energy Institute and the US National Science Foundation's DIMENSIONS of Biodiversity program (DEB-1046121). S. Brandl contributed the artwork for Fig. 3. This is contribution number 17 from the Smithsonian's MarineGEO Network.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Duffy JE, 2016, P NATL ACAD SCI USA, V113, P6230, DOI 10.1073/pnas.1524465113; Duffy JE, 2015, ECOL LETT, V18, P696, DOI 10.1111/ele.12448; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gaitan JJ, 2014, J ECOL, V102, P1419, DOI 10.1111/1365-2745.12273; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Garcia-Comas C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2129; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jing X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9159; Leps J, 2004, BASIC APPL ECOL, V5, P529, DOI 10.1016/j.baae.2004.06.003; Liang JJ, 2016, SCIENCE, V354, DOI 10.1126/science.aaf8957; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Poorter L, 2015, GLOBAL ECOL BIOGEOGR, V24, P1314, DOI 10.1111/geb.12364; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Ruiz-Benito P, 2014, GLOBAL ECOL BIOGEOGR, V23, P311, DOI 10.1111/geb.12126; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; SCHULTZE ED, 1994, BIODIVERSITY ECOSYST; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Thompson PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117595; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; van der Plas F, 2016, P NATL ACAD SCI USA, V113, P3557, DOI 10.1073/pnas.1517903113; Vila M, 2003, OECOLOGIA, V135, P299, DOI 10.1007/s00442-003-1182-y; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Wardle DA, 2016, J VEG SCI, V27, P646, DOI 10.1111/jvs.12399; Watson JV, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0045-4; Wu JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep35649; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x; Zimmerman EK, 2014, OIKOS, V123, P267, DOI 10.1111/j.1600-0706.2013.00777.x	40	328	345	37	504	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					261	+		10.1038/nature23886	http://dx.doi.org/10.1038/nature23886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28869964				2022-12-28	WOS:000410555900043
J	Klose, CSN; Mahlakoiv, T; Moeller, JB; Rankin, LC; Flamar, AL; Kabata, H; Monticelli, LA; Moriyama, S; Putzel, GG; Rakhilin, N; Shen, XL; Kostenis, E; Konig, GM; Senda, T; Carpenter, D; Farber, DL; Artis, D				Klose, Christoph S. N.; Mahlakoiv, Tanel; Moeller, Jesper B.; Rankin, Lucille C.; Flamar, Anne-Laure; Kabata, Hiroki; Monticelli, Laurel A.; Moriyama, Saya; Putzel, Gregory Garbes; Rakhilin, Nikolai; Shen, Xiling; Kostenis, Evi; Koenig, Gabriele M.; Senda, Takashi; Carpenter, Dustin; Farber, Donna L.; Artis, David			The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation	NATURE			English	Article							IMMUNE INTERACTIONS; RECEPTORS; CYTOKINES; CRTH2	The type 2 cytokines interleukin (IL)-4, IL-5, IL-9 and IL-13 have important roles in stimulating innate and adaptive immune responses that are required for resistance to helminth infection, promotion of allergic inflammation, metabolic homeostasis and tissue repair(1-3). Group 2 innate lymphoid cells (ILC2s) produce type 2 cytokines, and although advances have been made in understanding the cytokine milieu that promotes ILC2 responses(4-9), how ILC2 responses are regulated by other stimuli remains poorly understood. Here we demonstrate that ILC2s in the mouse gastrointestinal tract co-localize with cholinergic neurons that express the neuropeptide neuromedin U (NMU)(10,11). In contrast to other haematopoietic cells, ILC2s selectively express the NMU receptor 1 (NMUR1). In vitro stimulation of ILC2s with NMU induced rapid cell activation, proliferation, and secretion of the type 2 cytokines IL-5, IL-9 and IL-13 that was dependent on cell-intrinsic expression of NMUR1 and G(alpha q) protein. In vivo administration of NMU triggered potent type 2 cytokine responses characterized by ILC2 activation, proliferation and eosinophil recruitment that was associated with accelerated expulsion of the gastrointestinal nematode Nippostrongylus brasiliensis or induction of lung inflammation. Conversely, worm burden was higher in Nmur1(-/-) mice than in control mice. Furthermore, use of genedeficient mice and adoptive cell transfer experiments revealed that ILC2s were necessary and sufficient to mount NMU-elicited type 2 cytokine responses. Together, these data indicate that the NMU-NMUR1 neuronal signalling circuit provides a selective mechanism through which the enteric nervous system and innate immune system integrate to promote rapid type 2 cytokine responses that can induce anti-microbial, inflammatory and tissue-protective type 2 responses at mucosal sites.	[Klose, Christoph S. N.; Mahlakoiv, Tanel; Moeller, Jesper B.; Rankin, Lucille C.; Flamar, Anne-Laure; Kabata, Hiroki; Monticelli, Laurel A.; Moriyama, Saya; Putzel, Gregory Garbes; Artis, David] Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA; [Moeller, Jesper B.] Univ Southern Denmark, Dept Mol Med, DK-5000 Odense, Denmark; [Rakhilin, Nikolai; Shen, Xiling] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Rakhilin, Nikolai; Shen, Xiling] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA; [Kostenis, Evi; Koenig, Gabriele M.] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Senda, Takashi; Carpenter, Dustin; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Senda, Takashi; Carpenter, Dustin; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Senda, Takashi; Carpenter, Dustin; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA	Cornell University; University of Southern Denmark; Duke University; Cornell University; University of Bonn; Columbia University; Columbia University; Columbia University	Artis, D (corresponding author), Cornell Univ, Jill Roberts Inst Res Inflammatory Bowel Dis, Joan & Sanford I Weill Dept Med, Dept Microbiol & Immunol,Weill Cornell Med, New York, NY 10021 USA.	dartis@med.cornell.edu	Klose, Christoph/ABE-6396-2020; Moeller, Jesper B/E-6377-2015	Moeller, Jesper B/0000-0001-8786-8037; Kabata, Hiroki/0000-0001-8853-6149; Rankin, Lucille/0000-0002-3699-1569; Mahlakoiv, Tanel/0000-0001-9059-0486; Farber, Donna/0000-0001-8236-9183; Artis, David/0000-0002-1753-4100	German Research Foundation (DFG) [KL 2963/1-1, FOR2372]; Australian National Health and Medical Research Comission (NHMRC) early career fellowship; Novo Nordic Foundation [14052]; Weill Cornell Department of Medicine Pre-Career Award; Naito Foundation; JSPS Overseas Research Fellowships; MSD Life Science Foundation; Jill Roberts Institute; Defense Advanced Research Projects Agency (DARPA) [HR0011-16-C-0138]; National Institutes of Health (NIH) [F32AI134018, AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI106697, AI097333, R01GM114254, OT2-OD023849]; Burroughs Wellcome Fund; Crohn's & Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106697, R21AI087990, R01AI061570, R01AI097333, R01AI102942, R21AI083480, R01AI074878, R01AI095466, U01AI095608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122465, R01GM114254] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [OT2OD023849] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF15OC0014052] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); Australian National Health and Medical Research Comission (NHMRC) early career fellowship(National Health and Medical Research Council (NHMRC) of Australia); Novo Nordic Foundation(Novo Nordisk Foundation); Weill Cornell Department of Medicine Pre-Career Award; Naito Foundation(Naito Memorial Foundation); JSPS Overseas Research Fellowships; MSD Life Science Foundation; Jill Roberts Institute; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Crohn's & Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank I. Gabanyi and D. Mucida for help with the muscularis isolation, H.-R. Rodewald for providing Cpa3<SUP>cre</SUP> and G. Eberl for Rorgt<SUP>GFP</SUP> mice. We thank the Epigenomics Core, the Imaging Core and the Mouse Genetics Core at Weill Cornell Medicine and MSKCC. Nmur1<SUP>LacZ/+</SUP> mice were generated by Velocigene and Nmu<SUP>GFP</SUP> by GENSAT and provided by the KOMP or MMRRC Repository at UC Davis. The work was supported by grants from the German Research Foundation (DFG; KL 2963/1-1 to C.S.N.K.; FOR2372 to E.K. and G.M.K.), the Australian National Health and Medical Research Comission (NHMRC) early career fellowship (to L.C.R.), the Novo Nordic Foundation (14052; to J.B.M.), the Weill Cornell Department of Medicine Pre-Career Award (to L.A.M.), the Naito Foundation (to S.M.), JSPS Overseas Research Fellowships (to S.M.), MSD Life Science Foundation (to H.K.), the Jill Roberts Institute (to G.G.P.), Defense Advanced Research Projects Agency (DARPA; HR0011-16-C-0138 to X.S.), the National Institutes of Health (NIH; F32AI134018 to L.A.M.; AI061570, AI087990, AI074878, AI083480, AI095466, AI095608, AI102942, AI106697 and AI097333 to D. A.; R01GM114254 and OT2-OD023849 to X.S.; AI106697 to D.L.F.), the Burroughs Wellcome Fund (to D.A.) and the Crohn's & Colitis Foundation of America (to T.M. and D.A.).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gautron L, 2013, J COMP NEUROL, V521, P3741, DOI 10.1002/cne.23376; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moriyama M, 2006, AM J PHYSIOL-LUNG C, V290, pL971, DOI 10.1152/ajplung.00345.2005; Moriyama M, 2005, J EXP MED, V202, P217, DOI 10.1084/jem.20050248; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	40	298	308	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					282	+		10.1038/nature23676	http://dx.doi.org/10.1038/nature23676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28869965	Green Accepted			2022-12-28	WOS:000410555900048
J	Sridhar, J; Chang, JS				Sridhar, Jayanth; Chang, Jonathan S.			Marfan's Syndrome with Ectopia Lentis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sridhar, Jayanth; Chang, Jonathan S.] Bascom Palmer Eye Inst, Miami, FL 33136 USA	Bascom Palmer Eye Institute	Sridhar, J (corresponding author), Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jsridhar@med.miami.edu		Chang, Jonathan/0000-0001-5693-5065					0	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2017	377	11					1076	1076		10.1056/NEJMicm1406002	http://dx.doi.org/10.1056/NEJMicm1406002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG6YC	28902582				2022-12-28	WOS:000410545200010
J	Wadman, M				Wadman, Meredith			ZAPPING COCAINE ADDICTION	SCIENCE			English	Editorial Material																			0	1	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		960	963		10.1126/science.357.6355.960	http://dx.doi.org/10.1126/science.357.6355.960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883057				2022-12-28	WOS:000409455700015
J	Pinheiro, HT; Bernardi, G; Simon, T; Joyeux, JC; Macieira, RM; Gasparini, JL; Rocha, C; Rocha, LA				Pinheiro, Hudson T.; Bernardi, Giacomo; Simon, Thiony; Joyeux, Jean-Christophe; Macieira, Raphael M.; Gasparini, Joao Luiz; Rocha, Claudia; Rocha, Luiz A.			Island biogeography of marine organisms	NATURE			English	Article							SEA-LEVEL FLUCTUATIONS; NEUTRAL-THEORY; REEF FISHES; BIODIVERSITY; SPECIATION; MODEL; SELECTION; EVOLUTION	Studies on the distribution and evolution of organisms on oceanic islands have advanced towards a dynamic perspective(1), where terrestrial endemicity results from island geographical aspects and geological history(2) intertwined with sea-level fluctuations(3,4). Diversification on these islands may follow neutral models(5), decreasing over time as niches are filled(6), or disequilibrium states(7) and progression rules(8), where richness and endemism rise with the age of the archipelago owing to the splitting of ancestral lineages (cladogenesis). However, marine organisms have received comparatively little scientific attention. Therefore, island and seamount evolutionary processes in the aquatic environment remain unclear(9). Here we analyse the evolutionary history of reef fishes that are endemic to a volcanic ridge of seamounts and islands to understand their relations to island evolution and sea-level fluctuations. We also test how this evolutionary history fits island biogeography theory. We found that most endemic species have evolved recently (Pleistocene epoch), during a period of recurrent sea-level changes and intermittent connectivity caused by repeated aerial exposure of seamounts, a finding that is consistent with an ephemeral ecological speciation process(10). Similar to findings for terrestrial biodiversity(7), our data suggest that the marine speciation rate on islands is negatively correlated with immigration rate. However, because marine species disperse better than terrestrial species, most niches are filled by immigration: speciation increases with the random accumulation of species with low dispersal ability, with few opportunities for in situ cladogenesis and adaptive radiation. Moreover, we confirm that sea-level fluctuations and seamount location play a critical role in marine evolution, mainly by intermittently providing stepping stones for island colonization.	[Pinheiro, Hudson T.; Rocha, Claudia; Rocha, Luiz A.] Calif Acad Sci, San Francisco, CA 94118 USA; [Pinheiro, Hudson T.; Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Pinheiro, Hudson T.; Simon, Thiony; Joyeux, Jean-Christophe; Macieira, Raphael M.; Gasparini, Joao Luiz] Univ Fed Espirito Santo, Dept Oceanog & Ecol, BR-29075910 Vitoria, ES, Brazil; [Macieira, Raphael M.] Univ Vila Velha, Complexo Biopraticas, BR-29102770 Vila Velha, ES, Brazil	California Academy of Sciences; University of California System; University of California Santa Cruz; Universidade Federal do Espirito Santo; Centro Universitario Vila Velha	Pinheiro, HT (corresponding author), Calif Acad Sci, San Francisco, CA 94118 USA.; Pinheiro, HT (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA.; Pinheiro, HT (corresponding author), Univ Fed Espirito Santo, Dept Oceanog & Ecol, BR-29075910 Vitoria, ES, Brazil.	htpinheiro@gmail.com	Macieira, Raphael/G-2808-2011; Rocha, Luiz/T-6326-2019; Bernardi, Giacomo/F-6346-2011; Pinheiro, Hudson/A-4065-2019	Macieira, Raphael/0000-0002-8871-8724; Bernardi, Giacomo/0000-0002-8249-4678; Pinheiro, Hudson/0000-0002-3143-1474; Rocha, Luiz/0000-0003-4011-569X	CNPq [470725/2009-5, 557043/2009-3, 405426/2012-7]; Fundacao O Boticario [0938_20121]; CNPq (Ciencia sem Fronteiras) [GDE 202475/2011-5]; EEB/UCSC department; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao O Boticario; CNPq (Ciencia sem Fronteiras)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); EEB/UCSC department; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank our colleagues that contributed to the studies on the VTC: E. Mazzei, J. B. Teixeira, L. B. Xavier, C. R. Pimentel, R. L. Moura, G. M. Amado-Filho, A. Carvalho-Filho, A. C. Braga, P. A. S. Costa, B. P. Ferreira, C. E. L. Ferreira, S. R. Floeter, R. B. Francini-Filho, A. S. Martins, G. Olavo, I. Sazima; J. B. Teixeira and S. Lacoste for helping with illustrations of Figs 1 and 4, respectively. CNPq (grant 470725/2009-5, 557043/2009-3 and 405426/2012-7) and Fundacao O Boticario (grant 0938_20121) provided funding for the research. We are grateful for the support of donors who endorsed the California Academy of Sciences' Hope for Reefs initiative and helped to make this publication possible. H.T.P. received a doctoral fellowship from CNPq (Ciencia sem Fronteiras; GDE 202475/2011-5) and support from the EEB/UCSC department; T.S. and R.M.M. were recipients of CAPES (http://capes.gov.br) fellowships.	Bernardi G, 2005, MOL ECOL, V14, P4085, DOI 10.1111/j.1365-294X.2005.02729.x; Borregaard MK, 2017, BIOL REV, V92, P830, DOI 10.1111/brv.12256; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Cutter AD, 2016, EVOLUTION, V70, P2171, DOI 10.1111/evo.13030; Dawson MN, 2016, GLOBAL ECOL BIOGEOGR, V25, P831, DOI 10.1111/geb.12314; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2015, MOL ECOL, V24, P1543, DOI 10.1111/mec.13129; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Hachich NF, 2015, J BIOGEOGR, V42, P1871, DOI 10.1111/jbi.12560; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Hubbell Stephen P., 2001, V32, pi; Kopp M, 2010, BIOESSAYS, V32, P564, DOI 10.1002/bies.201000023; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Ludt WB, 2015, J BIOGEOGR, V42, P25, DOI 10.1111/jbi.12416; Luiz OJ, 2013, P NATL ACAD SCI USA, V110, P16498, DOI 10.1073/pnas.1304074110; MAC ARTHUR ROBERT H., 1967; Macieira RM, 2015, ENVIRON BIOL FISH, V98, P385, DOI 10.1007/s10641-014-0269-0; Fernandez-Palacios JM, 2016, GLOBAL ECOL BIOGEOGR, V25, P817, DOI 10.1111/geb.12320; Fernandez-Palacios JM, 2016, NATURE, V532, P42, DOI 10.1038/nature17880; Motoki A, 2012, REV BRAS GEOMORFOL, V13, P151; Pinheiro HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118180; Robertson DR, 2006, MOL PHYLOGENET EVOL, V40, P795, DOI 10.1016/j.ympev.2006.04.011; Rocha LA, 2010, ZOOTAXA, P22; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Rosindell J, 2011, ECOL LETT, V14, P552, DOI 10.1111/j.1461-0248.2011.01617.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sandin SA, 2008, GLOBAL ECOL BIOGEOGR, V17, P770, DOI 10.1111/j.1466-8238.2008.00418.x; Shaw KL, 2016, P NATL ACAD SCI USA, V113, P7986, DOI 10.1073/pnas.1601078113; Swofford DL, 2003, PHYLOGENETIC ANAL US; TAJIMA F, 1983, GENETICS, V105, P437; Weigelt P, 2016, NATURE, V532, P99, DOI 10.1038/nature17443; Weigt LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041059; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x	35	86	96	1	149	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					82	+		10.1038/nature23680	http://dx.doi.org/10.1038/nature23680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28854164				2022-12-28	WOS:000409388700037
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Innovation without sufficient evidence is a disservice to all	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Donnolly L, 2017, DAILY TELEGRAPH; Enfield Clinical Commissioning Group, 2017, MILL LOND TEST NEW N; Haringey Clinical Commissioning Group, 2017, FREQ ASK QUEST NHS 1; Middleton K, SORTING OUT SYMPTOMS; Turner J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003451	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358								j3980	10.1136/bmj.j3980	http://dx.doi.org/10.1136/bmj.j3980			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874353	Green Published, Bronze			2022-12-28	WOS:000410575100016
J	Panda, S; Swaminathan, S; Hyder, KA; Christophel, EM; Pendse, RN; Sreenivas, AN; Laksono, SJ; Srivastava, R; Nair, GB; Aditama, TY; Singhasivanon, P; Thapa, AB; Sarkar, SK				Panda, Samiran; Swaminathan, Soumya; Hyder, Khurshid A.; Christophel, Eva-Maria; Pendse, Razia N.; Sreenivas, Achuthan N.; Laksono, Setiwan J.; Srivastava, Rahul; Nair, Gopinath B.; Aditama, Tjandra Y.; Singhasivanon, Pratap; Thapa, Arun B.; Sarkar, Swarup K.			Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Panda, Samiran] ICMR Natl Inst Cholera & Enter Dis, Kolkata, India; [Swaminathan, Soumya] Govt India, Indian Council Med Res, New Delhi, India; [Hyder, Khurshid A.; Christophel, Eva-Maria; Srivastava, Rahul; Nair, Gopinath B.; Aditama, Tjandra Y.; Thapa, Arun B.; Sarkar, Swarup K.] WHO, Reg Off South East Asia, New Delhi, India; [Pendse, Razia N.] World Hlth Org Country Off, Colombo, Sri Lanka; [Sreenivas, Achuthan N.] World Hlth Org Country Off, New Delhi, India; [Laksono, Setiwan J.] World Hlth Org Country Off, Jakarta, Indonesia; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); World Health Organization; World Health Organization; World Health Organization; World Health Organization; Mahidol University	Sarkar, SK (corresponding author), WHO, Reg Off South East Asia, New Delhi, India.	sarkarswa@who.int		Nair, Sreenivas/0000-0002-2586-6797	WHO SEARO	WHO SEARO(World Health Organization)	This article is one of a series commissioned by The BMJ based on an idea from WHO SEARO. The BMJ retained full editorial control over external peer review, editing, and publication. Open access fees are funded by the WHO SEARO.	Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Beyrer C, 2006, PLOS MED, V3, P1733, DOI 10.1371/journal.pmed.0030393; Bhatia R, 2010, INDIAN J MED RES, V132, P482; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; ELLIOTT AM, 1995, TUBERCLE LUNG DIS, V76, P463, DOI 10.1016/0962-8479(95)90016-0; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Koenderink JB, 2010, TRENDS PARASITOL, V26, P440, DOI 10.1016/j.pt.2010.05.002; Kumar M, 2014, AIDS RES HUM RETROV, V30, P294, DOI [10.1089/aid.2013.0222, 10.1089/AID.2013.0222]; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Mahendradhata Y, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25412; Nair N, 2010, B WORLD HEALTH ORGAN, V88, P164, DOI 10.2471/BLT.09.073874; Packard RM, 2014, NEW ENGL J MED, V371, P397, DOI 10.1056/NEJMp1403340; Panda S, 2016, INT J DRUG POLICY, V37, P115, DOI 10.1016/j.drugpo.2016.08.009; Sharma A, 2017, LANCET INFECT DIS, V17, P707, DOI 10.1016/S1473-3099(17)30247-5; Trotter AB, 2013, AIDS REV, V15, P162; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; World Health Organization, 2015, GLOB MAL REP 2015; World Health Organization, 2016, END SIGHT ACC END HI; World Health Organization, 2017, ART ART BAS COMB THE; World Health Organization, 2015, GLOB HLTH OBS REP PO; World Health Organization. Regional Office for South-East Asia, 2016, TUBERCULOSIS CONTROL; World Health Organization Regional Office for South-East Asia, 2016, MAL FREE MALD; World Health Organization Regional Office for South-East Asia, 2016, MAL FREER SRI LANK; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	26	16	16	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						67	70	j3545	10.1136/bmj.j3545	http://dx.doi.org/10.1136/bmj.j3545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874362	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000410575100009
J	Isaacman-Beck, J; Clandinin, TR				Isaacman-Beck, Jesse; Clandinin, Thomas R.			Glia put visual map in sync	SCIENCE			English	Editorial Material							DROSOPHILA; SPECIFICATION		[Isaacman-Beck, Jesse; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu		Isaacman-Beck, Jesse/0000-0002-0932-0962				Fernandes VM, 2017, SCIENCE, V357, P886, DOI 10.1126/science.aan3174; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Lanet E, 2013, CELL REP, V3, P587, DOI 10.1016/j.celrep.2013.02.006; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Ma ZG, 2016, NATURE, V539, P428, DOI 10.1038/nature20145; Okamoto N, 2015, DEV CELL, V35, P295, DOI 10.1016/j.devcel.2015.10.003; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Wernet MF, 2014, GENE DEV, V28, P2565, DOI 10.1101/gad.248245.114; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	12	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					867	868		10.1126/science.aao2991	http://dx.doi.org/10.1126/science.aao2991			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860369				2022-12-28	WOS:000408734900023
J	Pain, E				Pain, Elisabeth			Reports raise concerns about France's nuclear waste tomb	SCIENCE			English	News Item																			0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					858	858		10.1126/science.357.6354.858	http://dx.doi.org/10.1126/science.357.6354.858			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860365				2022-12-28	WOS:000408734900019
J	Reilley, B; Leston, J				Reilley, Brigg; Leston, Jessica			A Tale of Two Epidemics - HCV Treatment among Native Americans and Veterans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEPATITIS-C; UNITED-STATES		[Reilley, Brigg; Leston, Jessica] Northwest Portland Area Indian Hlth Board, Portland, OR 97201 USA		Reilley, B (corresponding author), Northwest Portland Area Indian Hlth Board, Portland, OR 97201 USA.							Centers for Disease Control and Prevention's (CDC), 2017, VIR HEP SURV US 2015; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Moon AM, 2017, ALIMENT PHARM THER, V45, P1201, DOI 10.1111/apt.14021	4	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					801	803		10.1056/NEJMp1705991	http://dx.doi.org/10.1056/NEJMp1705991			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854094				2022-12-28	WOS:000408626400001
J	Peddada, S				Peddada, Shyamal			Seasonal change in the gut	SCIENCE			English	Editorial Material									[Peddada, Shyamal] Natl Inst Environm Hlth Sci, Biostat & Computat Biol Branch, Durham, NC 27709 USA		Peddada, S (corresponding author), Natl Inst Environm Hlth Sci, Biostat & Computat Biol Branch, Durham, NC 27709 USA.	peddada@niehs.nih.gov		Peddada, Shyamal/0000-0002-5014-6513	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01 ES101744-04]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101744] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES101744-04).	Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; White RA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003042	8	3	3	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					754	755		10.1126/science.aao2997	http://dx.doi.org/10.1126/science.aao2997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839060				2022-12-28	WOS:000408327900024
J	Martinez-Zamudio, RI; Robinson, L; Roux, PF; Bischof, O				Martinez-Zamudio, Ricardo Ivan; Robinson, Lucas; Roux, Pierre-Francois; Bischof, Oliver			SnapShot: Cellular Senescence in Pathophysiology	CELL			English	Editorial Material									[Martinez-Zamudio, Ricardo Ivan] INSERM, U993, F-75015 Paris, France; Equipe Labellisee Fdn ARC Rech Canc, F-94803 Villejuif, France; Inst Pasteur, Mol & Cellular Biol Cellular Senescence & Age Rel, Nucl Org & Oncogenesis Unit, Dept Cell Biol & Infect, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Martinez-Zamudio, RI (corresponding author), INSERM, U993, F-75015 Paris, France.		Roux, Pierre-François/J-8875-2019; Bischof, Oliver/K-1548-2019	Roux, Pierre-François/0000-0002-0695-4206; Robinson, Lucas/0000-0003-1051-6011	ANR-BMFT; Fondation ARC pour la recherche sur le Cancer; Association La Ligue National Contre le Cancer LNCC; INSERM; National Cancer Institute of the National Institutes of Health [R01CA136533]	ANR-BMFT(French National Research Agency (ANR)); Fondation ARC pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association La Ligue National Contre le Cancer LNCC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from ANR-BMFT, Fondation ARC pour la recherche sur le Cancer, Association La Ligue National Contre le Cancer LNCC, INSERM, and the National Cancer Institute of the National Institutes of Health under Award Number R01CA136533. R.I.M.-Z. is a member of the Mexican National Investigator System (SNI). O.B. is a CNRS fellow.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	6	29	31	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					1044	+	1044.e1	10.1016/j.cell.2017.08.025	http://dx.doi.org/10.1016/j.cell.2017.08.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841411	Bronze			2022-12-28	WOS:000408372400020
J	Davies, R				Davies, Rachael			Jeroen Bax: inspiring the next generation of cardiologists	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					730	730		10.1016/S0140-6736(17)32094-9	http://dx.doi.org/10.1016/S0140-6736(17)32094-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD9RD	28831985				2022-12-28	WOS:000407858900010
J	Eikelboom, JW; Connolly, SJ; Bosch, J; Dagenais, GR; Hart, RG; Shestakovska, O; Diaz, R; Alings, M; Lonn, EM; Anand, SS; Widimsky, P; Hori, M; Avezum, A; Piegas, LS; Branch, KRH; Probstfield, J; Bhatt, DL; Zhu, J; Liang, Y; Maggioni, AP; Lopez-Jaramillo, P; O'Donnell, M; Kakkar, AK; Fox, KAA; Parkhomenko, AN; Ertl, G; Stork, S; Keltai, M; Ryden, L; Pogosova, N; Dans, AL; Lanas, F; Commerford, PJ; Torp-Pedersen, C; Guzik, TJ; Verhamme, PB; Vinereanu, D; Kim, JH; Tonkin, AM; Lewis, BS; Felix, C; Yusoff, K; Steg, PG; Metsarinne, KP; Bruns, NC; Misselwitz, F; Chen, E; Leong, D; Yusuf, S; Aboyans, V; Ha, J; Keltai, K; Lamy, A; Liu, L; Moayyedi, P; Piegas, L; Sharma, M; Varigos, J; Bhagirath, V; Bogaty, P; Botto, F; Catanese, L; Magno, JD; Fabbri, G; Gabizon, I; Gosselin, G; Halon, D; Heldmann, M; Lamelas, P; Lauw, M; Lutay, D; Maly, M; Mikulik, R; Nayar, S; Ng, K; Perera, K; Pirvu, O; Ronner, E; Sato, S; Smyth, A; Sokolova, E; Wiendl, M; Winkelmann, B; Yang, X; Yufereva, Y; Cairns, J; Sleight, P; DeMets, D; Momomura, SI; Prins, M; Ramsay, T; Goto, S; Rouleau, JL; Schumi, J; Thabane, L; Casanova, A; Bangdiwala, S; Deng, E; Dyal, L; Khatun, R; Marsden, T; Pogue, J; Tang, C; Wong, G; Yuan, F; Aman, S; Ariz, A; Ashton, H; Belanger, J; Belanger, M; Brettell, K; Chandra, J; Choppick, C; Cisternino, D; Cuncins-Hearn, A; Di Marino, M; Diao, L; Dwomoh, S; Dykstra, A; Galatsis, E; Gasic, T; Gutierrez, J; Hamilton, L; Irwin, L; Lapensee, C; Li, A; Lu, X; MacRae, L; Malik, S; Malvestiti, A; Mastrangelo, J; Maystrenko, A; O'Donnell, L; Reeh, K; Szymkow, P; Thomas, S; Thrasher, D; Tyrwhitt, J; White, L; Bastone, R; Berkowitz, S; Dias, A; Ho, K; Keller, L; Lanius, V; Lister, K; Merten, C; Muehlhofer, E; Schmidt, K; Tasto, C; Tsihlias, E; Woroniecka-Osio, A; Orlandini, A; Niemann, G; Pascual, A; Toscanelli, S; Cabezon, M; Debaveye, B; Meeusen, K; Luys, C; Broos, K; Vandenberghe, K; Luyten, A; Oliveira, GBF; Nova, DCV; Konishi, MYN; Lonn, E; Lonn, A; Turbide, G; Cayer, M; Rovito, C; Standen, D; Li, J; Pico, ML; Dusek, R; Buzalka, V; Larsen, J; Paucar, MJ; Saarinen, M; Simon, T; Bezault, M; Le Lay, M; Epstein, L; Fajardo-Moser, M; Roser, C; Putz-Todd, G; Scheidemantel, F; Poehler, D; Renner, J; Hargitai, A; Doherty, AO; Duffy, N; Roarty, C; Nolan, A; Power, A; Yuval, R; Ben Ari, M; Greenblatt, S; Marmor, Y; Lucci, D; Ceseri, M; Baldini, E; Cipressa, L; Miccoli, M; Goto, M; Yamasowa, H; Kajiwara, M; Takase, D; Ikeguchi, K; Matsumoto, M; Ishii, M; Asai, J; Nozaki, D; Akatsuka, T; Yoshida, T; Shahadan, S; Nasir, NM; Schut, A; Vinck, L; van Leeuwen, M; Sanchez, J; Aquino, MR; Mararac, T; Benedyk, K; Iordache, A; Ciobanu, A; Rimbas, R; Galrinho, RD; Magda, S; Mihaila, S; Mincu, R; Suran, B; Cotoban, A; Matei, L; Kursakov, A; Rusnak, P; Zakharova, A; Demidova, E; Commerford, A; Lee, S; Ju, I; Gunolf, M; Lorimer, A; Parkhomenko, L; Johnson, J; Anderson, J; Norby-Slycord, C; Sala, J; Sicer, M; Rasmussen, M; Luciani, C; Cartasegna, L; Beltrano, C; Medek, G; Vico, M; Lanchiotti, P; Martella, C; Hominal, M; Castoldi, M; Casali, W; Raimondi, S; Hasbani, E; Prado, A; Paterlini, G; Waisman, F; Leonard, M; Caccavo, A; Alarcon, V; Zaidman, C; Guerlloy, F; Vogel, D; Imposti, H; Dominguez, A; Hrabar, A; Fernandez, A; Schygiel, P; Sokn, F; Cuneo, C; Carrillo, NG; Martinez, G; Luquez, H; Costantino, M; Ruiz, M; Beccetti, N; Mackinnon, I; Cluigt, N; Guerrero, RA; Fanuele, M; Campisi, V; Costabel, J; Romanelli, M; Bartolacci, I; Echeverria, M; Pedrotti, M; Montana, O; Camino, A; Crespo, C; Barbieri, M; Santi, RL; Tonin, H; Heffes, R; Vilamajo, OG; Vanesio, F; Allegrini, E; Duran, RG; Garcia, C; Duran, LG; Schiavi, L; Mana, M; Bordonava, A; Rodriguez, M; Gutierrez, M; Garrido, M; Rodriguez, C; Ingaramo, A; Costamagna, O; Almagro, S; Gerbaudo, C; Pelagagge, M; Labarta, MB; Novaretto, L; Maldini, A; Lopez, L; Di Gennero, JA; Saggia, LI; Vilkas, AG; Alvarez, M; Stoermann, W; Vita, N; Vottero, E; Macin, S; Cocco, M; Onocko, M; Dran, R; Gimenez, C; Cardona, M; Guzman, L; Guzman, P; Martinez, D; Sarjanovich, R; Huerta, C; Scaro, G; Cuadrado, J; Nani, S; Guardiani, F; Bruno, ML; Ceconi, G; Chacon, C; Casado, M; Moutin, MF; Maffei, L; Sassone, S; Yantorno, M; Grinfeld, D; Vensentini, N; Rolandi, F; Fallabrino, L; Majul, C; Paez, O; Visser, M; Luciardi, H; Mansilla, V; Colaso, PG; Pacora, FF; Jure, H; Parody, M; Espeche, E; Whelan, A; Boyle, A; Collins, N; Roberts-Thomson, P; Rogers, J; Caroll, P; Colquhoun, D; Williams, L; Shaw, J; Blombery, P; Amerena, J; Lee, C; Hii, C; Royse, A; Royse, C; Singh, B; Selvanayagam, J; Jansen, S; Thompson, P; Lo, W; Hammett, C; Poulter, R; Graves, S; Narasimhan, S; Van Den Heuvel, P; Sinnaeve, P; Fourneau, I; Meuris, B; Vanassche, T; Ector, B; Debonnaire, P; Vandekerckhove, Y; Van de Borne, P; Wautrecht, J; Leroy, J; Schroe, H; Vrolix, M; Vranckx, P; Elegeert, I; Lerut, P; Hoffer, E; Borgoens, P; Dujardin, K; Brasil, CKOI; Del Monaco, MI; Uint, L; Pavanello, R; Precoma, DB; Vianna, HS; Abrantes, J; Morelli, J; Manenti, E; Reis, G; Giorgeto, FE; Franca, CCB; Saraiva, J; Costa, M; de Camargo, O; Lopes, MM; Maia, LN; Nakazone, MA; Mouco, OMCC; Lemos, MABT; Hernandes, ME; Pantano, GS; de Castro, JCM; Rossi, PRF; Guedes, AAM; dos Santos, FR; Vidotti, MH; Zimmermann, SL; Rech, R; Nunes, C; Abib, E; Leaes, PE; Botelho, RV; Navarro, ALC; Silva, RA; Arantes, FBB; Dutra, O; Vaz, R; Souza, WKSB; Souza, ASB; Queiroz, WCB; Braile, M; Ferreira, V; Izukawa, NM; Prakasan, AK; Nicolau, JC; Dalcoquio, TF; Tanajura, LFL; Serrano, CV; Minelli, C; Neto, FAB; Nasi, LA; Oliveira, LFA; Silva, MAV; Cantarelli, MJD; Tytus, R; Pasyk, E; Pandey, AS; Rowe, A; Anand, S; Cha, J; Vizel, S; Babapulle, M; Semelhago, L; Saunders, K; Haligowski, D; Berlingieri, J; Nisker, W; Kiaii, B; Romsa, J; Chu, M; Nagpal, D; Guo, R; Mckenzie, N; Quantz, M; Bhargava, R; Bhargava, M; Mehta, P; Hill, L; Heslop, W; Fell, D; Hess, A; Zadra, R; Zeman, P; Srivamadevan, M; Lam, A; Tai, S; Al-Qoofi, F; Spence, F; Anderson, T; Kieser, T; Kidd, W; Fedak, P; Smith, E; Har, B; Brown, C; Forgie, R; Hassan, A; Pelletier, M; Searles, G; Marr, D; Bessoudo, R; Douglas, G; Legare, J; Petrella, R; Pavlosky, W; Ricci, J; Galiwango, P; Janmohamed, A; Kassam, S; Mukherjee, A; Vijayaraghavan, R; Burstein, J; D'Mello, N; Glanz, A; Noiseux, N; Stevens, LM; Basile, F; Prieto, I; Normandin, L; Helou, J; Bainey, K; Tymchak, W; Welsh, R; Merali, F; Pandith, V; Heffernan, M; Orfi, J; Mcconachie, D; Jedrzkiewicz, S; Della Siega, A; Robinson, S; Nadra, I; Dagenais, G; Poirier, P; Dagenais, F; Voisine, P; Mohammadi, S; Doyle, D; Baillot, R; Charbonneau, E; Dumont, E; Kalavrouziotis, D; Perron, J; Jacques, F; Laflamme, M; Brulotte, S; Crete, M; Degrace, M; Delage, F; Grondin, F; Lemieux, A; Michaud, N; Saulnier, D; Ross, MK; Nguyen, M; Harvey, R; Daneault, B; Hartleib, M; Guzman, R; Nguyen, T; Singal, R; Bourgeois, R; Landry, D; Kamel, S; Rupka, D; Kuritzky, R; Khaykin, Y; Phaneuf, DC; Desjardins, V; Coll, X; Huynh, T; Pilon, C; Mansour, S; Lemire, F; Kokis, A; Campeau, J; Audet, M; Boulianne, M; Dupuis, R; Lauzon, C; Pruneau, G; Senay, B; Pichette, F; Cieza, T; Breton, R; Belisle, P; Barabas, M; Diaz, A; Costa, R; Absi, F; Garand, M; Rheault, A; Lemay, C; Gisbert, A; Raymond, A; Barrero, M; Gagne, C; Rheault, P; Johnston, J; Mundi, A; Cohen, G; Shukle, P; Baskett, R; Hirsch, G; Ali, I; Stewart, K; Fenton, J; Pudupakkam, S; Willoughby, R; Czarnecki, W; Roy, A; Montigny, M; Descarries, L; Mayrand, H; Comtois, H; Essiambre, R; Ringuette, G; Boutros, G; Gendreau, R; Pham, L; Nguyen, V; Nguyen-Thanh, HK; Nawaz, S; Fremes, S; Moussa, F; Shukla, D; Jano, G; Bobadilla, B; Saavedra, J; Bahamondes, J; Cobos, J; Grunberg, E; Corbalan, R; Verdejo, H; Medina, M; Vega, M; Nahuelpan, L; Castania, F; Raffo, C; Vargas, A; Reyes, T; Vargas, D; Arriagada, G; Potthoff, S; Godoy, J; Stockins, B; Larenas, G; Quininao, F; Sepulveda, P; Trucco, V; Pincetti, C; Saavedra, S; Silva, P; Vejar, M; Rodriguez, T; Tian, H; Zhang, J; Meng, Y; Wu, X; Wu, Q; Wang, Q; Mu, Y; Yang, J; Wang, F; Zhang, W; Ke, Y; Jiang, H; Yin, P; Jia, K; Chen, C; Wang, Z; Qi, B; Yu, L; Feng, G; Li, L; Jiang, L; Wu, S; Yu, H; Wu, Z; Ding, R; Liu, S; Xu, H; Cao, H; Bai, X; Zheng, Y; Liu, Z; Sun, H; Yang, P; Li, B; Feng, Z; Yang, Y; Xu, Z; Wu, W; Meng, Q; Ge, J; Dai, Y; Yang, H; Chen, X; Tian, X; Shi, Y; Hu, T; Zhang, R; Zhao, Q; Quan, W; Zhu, Y; Zheng, Z; Zhang, S; Zhao, Y; Zhao, C; Wang, R; Tao, L; Hu, D; Wang, Y; Fan, F; Huang, W; Xia, X; Fu, G; Jiang, D; Wang, M; Li, C; Xu, K; Dong, Y; Chen, Y; Wu, D; Wang, C; Sun, X; Lu, S; Zhou, X; Kong, Y; Zhang, B; Sotomayor, A; Suarez, M; Ripoll, D; Herrera, O; Mendoza, JA; Cure, CS; Reyes, M; Vidal, T; Beltran, PD; Jaimes, EH; Castillo, H; Rocha, C; Forero, L; Bernal, DZ; Gonzalez, LV; Triana, MU; Quintero, A; Ramirez, N; Mendoza, JB; Martinez, GA; Cotes, C; Mercado, A; Percy, XL; Mayorga, MP; Rodriguez, N; De Salazar, DM; Agudelo, JP; Villegas, LL; Ramos, LA; Polo, MM; Albornoz, AE; Gomez, JF; Vallejo, GS; Aristizabal, J; Gallego, A; Contreras, C; Yepez, J; Escobar, JA; Manzur, F; Cohen, L; Boneu, D; Lozada, HG; Barrios, L; Celemin, C; Diego, M; Ortiz, LG; Montoya, C; Ramirez, E; Palma, EA; Ceron, J; Acosta, G; Mesa, JG; Velasquez, J; Barreto, D; Dada, FT; Accini, FT; Cano, R; De La Cruz, KC; Maria, V; Palmera, J; Vesga, B; Hernandez, H; Silgado, GM; Vesga, SA; Martinez, EB; Villareal, GQ; Ayazo, FS; Zidkova, E; Krupicka, P; Bultas, J; Mandysova, E; Lubanda, J; Horak, J; Belohlavek, J; Kovarnik, T; Gorican, K; Rucka, D; Smid, O; Dostalova, G; Skalicka, H; Karetova, D; Pavlinak, V; Kuchynkova, S; Marek, J; Rob, D; Ravlykova, K; Prochazka, P; Siranec, M; Urbanec, T; Vareka, T; Nesvadbova, P; Kaletova, M; Indrakova, J; Kryza, R; Heczko, M; Hanak, P; Jancar, R; Kocurkova, L; Marcinek, G; Cermak, O; Drasnar, T; Richter, M; Kaspar, J; Spinar, J; Parenica, J; Parenicova, I; Schildberger, J; Toman, O; Ludka, O; Poloczek, M; Musil, V; Miklik, R; Labrova, R; Lokaj, P; Felsoci, M; Bocek, O; Kanovsky, J; Zatocil, T; Jerabek, P; Matuska, J; Jankovic, M; Jankovicova, H; Tesak, M; Sulc, D; Svacinova, H; Radvan, M; Bednar, J; Motovska, Z; Petr, R; Fischerova, M; Branny, M; Vodzinska, A; Cerny, J; Indrak, J; Sknouril, L; Maly, J; Vacek, T; Prazak, O; Broulikova, K; Hajsl, M; Jarkovsky, P; Kamenik, L; Kotik, I; Krcova, E; Sedlon, P; Skvaril, J; Cernohous, M; Kohoutek, J; Levcik, M; Holek, M; Hajdusek, P; Caisova, LF; Novak, V; Kladivkova, M; Slaby, J; Houra, M; Vojtisek, P; Novotny, V; Lazarak, T; Pliva, M; Pirk, J; Barciakova, L; Jandova, R; Adamkova, V; Galovcova, M; Peterkova, L; Turek, D; Prochazka, J; Belohoubek, J; Spinarova, L; Panovsky, R; Novotny, P; Krejci, J; Hude, P; Ozabalova, E; Godava, J; Honek, T; Kincl, V; Benesova, M; Buckova, J; Canadyova, J; Mokracek, A; Homza, M; Stverka, P; Florian, J; Lukac, B; Polasek, R; Kucera, P; Seiner, J; Karasek, J; Coufal, Z; Stastny, J; Cernicek, V; Skalnikova, V; Jiresova, E; Brat, R; Sieja, J; Gloger, J; Berger, P; Prochazkova, I; Samlik, J; Brtko, M; Tuna, M; Polansky, P; Omran, N; Myjavec, A; Hrdinova, M; Jansky, P; Kratochvilova, R; Burkert, J; Koubek, F; Fiala, R; Schwabova, JP; Lindner, J; Hlubocky, J; Spacek, M; Marcian, P; Hanak, V; Pozdisek, Z; Lonsky, V; Santavy, P; Troubil, M; Straka, Z; Budera, P; Fojt, R; Talavera, D; Tretina, M; Nemec, P; Orban, M; Bedanova, H; Wiggers, H; Tougaard, R; Larsen, A; Nielsen, H; Mattsson, N; Gunnar, G; Bruun, N; Folke, F; Soendergaard, K; Koeber, L; Frydland, M; Fuchs, A; Bang, L; Houlind, K; Olsen, M; Soerensen, V; Andersen, UO; Dixen, U; Refsgaard, J; Moeller, D; Zeuthen, E; Lund, J; Soegaard, P; Jensen, S; Duarte, Y; Duarte, W; Caceres, S; Long, FPC; Penaherrera, C; Anzules, N; Sanchez, M; Zuleta, I; Lopez, J; Villota, M; Sanchez, H; Perugachi, C; Gomez, S; Morejon, P; Marmol, R; Guaman, S; Trujillo, F; Escobar, M; Carrera, F; Ponce, F; Teran, P; Carrasco, S; Tuomilehto, J; Humaloja, K; Lindberg, L; Tuomilehto, H; Tuominen, ML; Kantola, I; Juliard, J; Feldman, L; Ducrocq, G; Boulogne, C; Petitalot, V; Leclercq, F; Roubille, F; Agullo, A; Ferrari, E; Chiche, O; Moceri, P; Boccara, F; Charbonnier, M; Azeddine, B; Ederhy, S; Dufour, LS; Cohen, A; Etienney, A; Messas, E; Calvalido, A; Galloula, A; Zarka, S; Courtois, MC; Mismetti, P; Accassat, S; Buchmuller, A; Moulin, N; Bertoletti, L; Seffert, B; Sevestre, M; Remond, SSM; Dupas, S; Mardyla, J; Le Gloan, S; Cayla, G; Cornillet, L; Schmutz, L; Motreff, P; Souteyrand, G; Amonchot, A; Barber-Charmoux, N; Combaret, N; Malcles, G; Brenner, S; Christa, M; Duengen, H; Krackhardt, F; Bobenko, A; Hashemi, D; Stellbrink, C; Stellbrink, E; Koster, C; Guerocak, O; Bourhaial, H; Tiam, SO; Kemala, E; Froemke, J; Kadel, C; Moellinger, H; Friedrich, K; Rafoud, K; Braun-Dullaeus, R; Herold, J; Ganzer, M; Jeserich, M; Kimmel, S; Haggenmiller, S; Schoengart, H; Voehringer, H; Opitz, C; Appel, K; Appel, S; Utech, A; Finger, C; Duersch, M; Dorsel, T; Wistorf, N; Grude, M; Nikol, S; Ueberschaer, D; Kast, P; Darius, H; Sommer, S; Girke, F; Oeztuerk, C; Ranft, J; Mikalo, A; Schellong, S; Voigts, B; Mueller, C; Jungmair, W; Davierwala, P; Misfeld, M; Bomke, K; Akhavuz, O; Haensig, M; Vorpahl, M; Blem, A; Langer, G; Nover, I; Koehler, T; Bajnok, L; Marton, Z; Laszlo, Z; Noori, E; Veress, G; Fogarassy, G; Aradi, D; Kelemen, B; Vertes, A; Davidovits, Z; Zsary, A; Kis, E; Hepp, T; Koranyi, L; Peterfai, E; Bezzegh, K; Bakai, J; Agardi, I; Boda, Z; Razso, K; Poor, F; Varallyay, Z; Jarai, Z; Sallai, L; Dudas, M; Barton, J; Mahmood, K; Makki, H; McAdam, B; Salim, T; Murphy, A; Crean, P; Liddy, AM; Mahon, N; Khan, I; Hassan, S; Curtin, R; McFadden, E; MacNeill, B; Kyvelou, S; Canavan, M; Veerasingam, D; Dinneen, S; Halabi, M; Rosenfeld, I; Levinas, T; Goldberg, A; Khateeb, A; Zimlichman, R; Ben-Aharon, J; Beniashvili, A; Betsalel, A; Zeltser, D; Rogowski, O; Mardi, T; Rozenbaum, Z; Turgeman, Y; Or, T; Rabkin, Y; Klainman, E; Halabi, S; Halon, DA; Katz, A; Plaev, T; Drogenikov, T; Atar, S; Kilimnik, M; Wishniak, A; Merei, M; Zvi, Y; Nikolsky, E; Zukermann, R; Petcherski, S; Bosi, S; Gaitani, S; Naldi, M; Barbieri, A; Faggiano, P; Guidetti, F; Adamo, M; D'Aloia, A; Magatelli, M; Robba, D; Mos, L; Vriz, O; Sinagra, G; Maras, P; Doimo, S; Cosmi, F; D'Orazio, S; Visconti, LO; Leonardi, S; Vullo, E; Sbaffi, A; Azzara, G; Mauri, S; Gianni, U; De Matteis, C; Campidonico, U; Di Pasquale, G; Di Niro, M; Riva, L; Filippini, E; Di Biase, M; Ieva, R; Martone, A; Mandorla, S; Regni, O; Capponi, EA; Martinelli, S; Bernardinangeli, M; Proietti, G; Piccinni, GC; Gualtieri, MR; Gulizia, MM; Francese, GM; Portale, A; Galvani, M; Ottani, F; Capatano, OG; Conficoni, E; Longhi, S; Bachetti, C; Venturi, F; Capati, E; Morocutti, G; Bisceglia, T; Fresco, C; Baldin, MG; Gamba, C; Olivieri, C; Perna, GP; Battistoni, I; Marini, M; Cirrincione, V; Ingrilli, F; Kanno, T; Ishii, Y; Kohmura, C; Igawa, T; Izawa, K; Daida, H; Miyauchi, K; Shimada, K; Ohmura, H; Ito, S; Okazaki, S; Konishi, H; Miyazaki, T; Hiki, M; Kurata, T; Suzuki, H; Morimoto, R; Yokoyama, M; Yamamoto, T; Okai, I; Isoda, K; Fujimoto, S; Dohi, T; Shimada, A; Ozaki, Y; Watanabe, E; Kawai, H; Naruse, H; Takada, K; Okuda, K; Okumura, M; Ishikawa, M; Ohtsuki, M; Ohta, M; Sarai, M; Koshikawa, M; Kawai, M; Miyagi, M; Motoyama, S; Matsui, S; Ichikawa, T; Kato, Y; Nagahara, Y; Muramatsu, T; Hashimoto, Y; Hoshino, N; Harada, M; Yamada, A; Yoshiki, Y; Motoike, Y; Nomura, Y; Miyajima, K; Takatsu, H; Nishimura, H; Nagasaka, R; Kawada, Y; Miyamoto, N; Seki, K; Inoue, A; Higashiue, S; Kojima, S; Kuroyanagi, S; Furuya, O; Komooka, M; Yamamoto, S; Wakabayashi, N; Domae, H; Ata, T; Hashidomi, H; Kawahara, R; Hosokawa, S; Hiasa, Y; Otani, R; Kishi, K; Takahashi, T; Yuba, K; Miyajima, H; Tobetto, Y; Yoneda, K; Ogura, R; Kobayashi, H; Takamura, T; Enkou, K; Ochi, Y; Yamada, D; Kuramochi, T; Misumi, K; Iiduka, D; Hirose, M; Tone, K; Taniguchi, Y; Ebihara, T; Makino, M; Yokota, M; Nitta, M; Udo, A; Shimizu, S; Fujii, K; Iwakura, K; Okamura, A; Inoue, K; Nagai, H; Hirao, Y; Tanaka, K; Tanaka, N; Yamasaki, T; Oka, T; Iwamoto, M; Tanaka, T; Nakamaru, R; Okada, M; Takayasu, K; Sumiyoshi, A; Inoue, H; Kitagaki, R; Ninomiya, Y; Mizutomi, K; Koizumi, I; Funada, A; Tagawa, S; Kamide, S; Saku, K; Ideishi, M; Ogawa, M; Uehara, Y; Iwata, A; Nishikawa, H; Ike, A; Sugihara, M; Imaizumi, S; Fujimi, K; Kawamura, A; Sako, H; Morito, N; Morii, J; Fukuda, Y; Yahiro, E; Matsunaga, A; Matsumoto, N; Noda, K; Shiga, Y; Nagata, Y; Kimura, K; Ebina, T; Hibi, K; Iwahashi, N; Maejima, N; Konishi, M; Matsushita, K; Minamimoto, Y; Kawashima, C; Nakahashi, H; Kimura, Y; Takahashi, H; Matsuzawa, Y; Kirigaya, J; Sato, R; Kikuchi, S; Ogino, Y; Kirigaya, H; Kashiwase, K; Hirata, A; Takeda, Y; Amiya, R; Higuchi, Y; Sakaguchi, T; Nakano, T; Matsusaki, N; Suzuki, S; Hayashi, T; Nakatani, S; Koide, M; Kobayashi, T; Hamanaka, Y; Makino, N; Sotomi, Y; Abe, M; Fujieda, H; Hashimoto, K; Teratani, Y; Abe, Y; Yokoyama, Y; Higashino, H; Okuda, H; Yamazato, M; Noda, T; Arai, M; Ono, K; Hirose, T; Iwama, M; Warita, S; Goto, Y; Abe, S; Kojima, T; Yoshizane, T; Tanihata, S; Fujii, T; Yagasaki, H; Miwa, H; Ishiguro, M; Kato, T; Watanabe, R; Horio, S; Mita, T; Hirayama, A; Watanabe, I; Hiro, T; Nakai, T; Takayama, T; Yoda, S; Yajima, Y; Okubo, K; Okumura, Y; Kato, M; Fukamachi, D; Aizawa, Y; Sonoda, K; Iida, K; Sasaki, N; Iso, K; Takahashi, K; Kougo, T; Haruta, H; Kurokawa, S; Mano, H; Nagashima, K; Onaka, H; Doi, H; Hirano, N; Okamoto, F; Mori, K; Ri, G; Zushi, R; Otsuka, K; Inoko, M; Haruna, T; Nakane, E; Miyamoto, S; Izumi, T; Honjo, S; Ikeda, H; Wada, Y; Funasako, M; Hayashi, H; Hamasaki, A; Sasaki, K; Seko, Y; Nakasone, K; Hanyu, M; Iwasaki, Y; Iwasaki, K; Ayano, S; Hirokami, M; Omoto, Y; Sasaki, H; Sato, H; Yuda, S; Okubo, M; Matsuo, H; Tsuchiya, K; Kawase, Y; Miyake, T; Kondo, H; Hattori, A; Kikuchi, J; Okamoto, S; Hirata, T; Kawamura, I; Ota, H; Omori, H; Tanigaki, T; Kamiya, H; Sobue, Y; Komoda, T; Akatsuka, Y; Yamamoto, M; Isegawa, K; Takanezawa, M; Kataoka, C; Imamaki, M; Shibata, Y; Yasuda, K; Shimano, M; Ozaki, R; Morishita, Y; Okabe, K; Kondo, K; Miura, A; Manita, M; Tabata, K; Asahi, T; Mashidori, T; Higa, N; Nakata, M; Himi, T; Matsudo, Y; Sekine, T; Hou, K; Tonoike, N; Hama, Y; Tanaka, S; Ge, B; Takahara, M; Ishimura, M; Shikada, T; Ueno, H; Amemiya, H; Hisamatsu, Y; Sada, K; Sato, T; Harada, K; Nakamura, T; Ako, J; Tojo, T; Shimohama, T; Kishihara, J; Ishii, S; Fukaya, H; Meguro, K; Nishino, Y; Inoue, M; Matsui, Y; Omura, Y; Kawakami, H; Matsuoka, H; Oshita, A; Seike, F; Kondo, N; Miyoshi, T; Yamada, Y; Uchiya, T; Kikuchi, Y; Koretsune, Y; Abe, H; Shinouchi, K; Nishida, H; Yasumura, K; Date, M; Ueda, Y; Iida, Y; Idemoto, A; Toriyama, C; Yokoi, K; Mishima, T; Yamada, T; Fukunami, M; Morita, T; Furukawa, Y; Kawasaki, M; Kikuchi, A; Tamaki, S; Seo, M; Shirakawa, Y; Ikeda, I; Fukuhara, E; Kawai, T; Kayama, K; Kawahira, M; Tanabe, K; Nakamura, J; Shimomura, H; Kudo, T; Morisaki, S; Ogura, Y; Chazono, N; Onoue, Y; Matsumuro, Y; Shirakawa, T; Nishi, M; Kinoshita, N; Nakamura, R; Miyai, N; Ohta, K; Sawanishi, T; Takahashi, A; Hada, T; Nakajima, S; Taniguchi, N; Mizuguchi, Y; Takahashi, Y; Hashimoto, S; Machida, M; Hirabayashi, K; Morimoto, S; Higashino, Y; Otsuji, S; Takiuchi, S; Yabuki, M; Hasegawa, K; Shishikura, D; Ibuki, M; Ishibuchi, K; Nagayama, S; Ishii, R; Tamaru, H; Yamamoto, W; Utsu, N; Miyakoshi, K; Nakashima, D; Tsukuda, K; Ueda, K; Nakano, A; Fukuda, T; Ikeda, S; Tsuchiya, H; Toshima, S; Tateno, R; Ishikubo, T; Suguta, M; Nakamura, S; Funatsu, A; Mizobuchi, M; Tanaka, M; Nagai, T; Hirano, S; Hashimoto, T; Doi, T; Shirasaka, A; Takeda, S; Sasaki, Y; Ohya, H; Hosokawa, A; Nishina, N; Koki, B; Ando, K; Hiramori, S; Soga, Y; Tomoi, Y; Tohoku, S; Shirai, S; Hyodo, M; Isotani, A; Domei, T; Kuramitsu, S; Morinaga, T; Hayashi, M; Hiromasa, T; Nagae, A; Yamaji, Y; Nakao, K; Sakamoto, T; Taguchi, E; Tsurugi, T; Tanaka, Y; Suzuyama, H; Koyama, J; Nagano, M; Okamatsu, H; Kodama, K; Nakamura, M; Horibata, Y; Sone, M; Tsunemori, M; Bando, M; Nakayama, T; Tanigaito, Y; Nomoto, M; Sawamura, T; Unoki, T; Lim, CW; Rashid, RZ; Khir, RN; Ibrahim, KS; Azman, WAW; Sridhar, GS; Watson, T; Abu Kassim, Z; Zuhdi, ASM; Hafidz, MIA; Abu Hassan, MR; Shah, WFWR; Karthikesan, D; Suan, MAM; Ali, SMM; Kasim, S; Arshad, MKM; Ismail, JR; Ibrahim, ZO; Chua, NYL; Rahim, AAA; Rusani, BI; Yap, LB; Zamrin, DM; Amir, MA; Ismail, NI; Razi, AAM; Prins, F; Bendermacher, P; Burg, M; Lok, D; Van der Sluis, A; Martens, F; Badings, E; Milhous, J; van Rossum, P; Viergever, E; van Hessen, M; Willems, F; Gin, RTJ; Swart, H; Oomen, A; Kromhout, S; Lauwerijssen, I; Daalmans, M; Breedveld, R; De Vries, K; FeenemaAardema, M; Hofma, S; Van Der Borgh, R; van Nes, E; Gobel, E; Oei, F; Dorman, H; Bos, R; Zoet-Nugteren, S; Emans, M; Kragten, H; Lenderink, T; Feld, R; Herrman, J; Van Bergen, P; Gosselink, M; Elvan, A; Hoekstra, E; The, S; de Vries, R; Zegers, E; Ophuis, TO; Remmen, J; Bech, J; Kooistra, J; Den Hartog, F; Oosterhof, T; Bartels, G; Posma, J; Nierop, P; Liem, A; Van Der Zwaan, C; Asselman, M; Van Eck, J; Gevers, R; Van Gorselen, E; van Hal, J; Terpstra, W; Groenemeijer, B; Jerzewski, A; Hoogslag, P; Geertman, J; De Groot, M; Dijkstra, B; Loyola, A; Dans, A; Sulit, D; Mercado, MJ; Rey, N; Evangelista, L; Abola, M; Padua, L; Morales, D; Palomares, E; Abat, M; Santos, R; Rogelio, G; Chua, P; Baello, R; Del Pilar, J; Alianza, M; Alcaraz, J; Alcaraz, L; Ebo, G; Guido-Saliot, I; Tirador, L; Estoce, E; Ygpuara, M; Cruz, J; Anonuevo, J; Pitargue, A; Janion, M; Guzik, TJ; Drewniak, Z; Guzik, B; Nowak, M; Nosal, M; Niewiara, L; Gajos, G; Bury, K; Czubek, U; Misztal, M; Grzybczak, R; Zalewski, J; Kruszelnicka-Kwiatkowska, O; Zabowka, M; Rynkiewicz, A; Grzybowski, A; Szalkowski, P; Broncel, M; Gorzelak, P; Mozdzan, M; Olszewska-Banaszczyk, M; Szuba, A; Tabin, M; Chachaj, A; Czarnecka, D; Terlecki, M; Klocek, M; Maga, P; Coman, I; Tarlea, M; Ghionea, M; Gavrila, C; Dimulescu, D; Popescu, A; Vinereanu, D; Stoicescu, C; Vintila, V; Mihaila, S; Florescu, M; Galrinho, RD; Cretu, DB; Mincu, R; Magda, S; Suran, M; Cotoban, A; Mihalcea, D; Juravle, LL; Cinteza, M; Rimbas, R; Calin, I; Bicescu, G; Vasile-Toma, N; Udroiu, C; Gherghinescu, C; Darabont, R; Patrascu, N; Constantinescu, C; Popescu, I; Sinescu, C; Andrei, C; Axente, L; Arsenescu, C; Statescu, C; Ardeleanu, I; Anghel, L; Benedek, I; Benedek, T; Kinga, P; Banga, DK; Bobescu, E; Doka, B; Dobreanu, D; Sirbu, V; Rudzik, R; Kantor, K; Sus, I; Gaita, D; Maximov, D; Brie, D; Mosteoru, S; Olariu, I; Iancu, A; Marc, M; Hagiu, R; Manole, V; Molnar, A; Dregoesc, I; Iliesiu, A; Armean, P; Parvu, I; Deleanu, A; Lighezan, D; Ciobotaru, V; Buzas, R; Petrescu, L; Nicola, R; Dan, R; Crisan, S; Pirvu, O; Trasca, L; Teodorescu, I; Zara, O; Tiron, T; Tesloianu, D; Spiridon, M; Vintila, M; Baluta, M; Chioncel, O; Stoica, E; Kulcsar, I; Antohi, L; Strazhesko, I; Tkacheva, O; Sharashkina, N; Pykhtina, V; Vasyuk, Y; Shkolnik, E; Khadzegova, A; Sadulaeva, I; Ivanova, S; Nesterova, E; Nesvetov, V; Shupenina, E; Shcherbak, M; Sizova, Z; Beloborodova, A; Pozdnyakov, Y; Tarasov, A; Shvedov, I; Zabashta, S; Ryzhikova, I; Barbarash, O; Pecherina, T; Vatutin, M; Inozemceva, A; Kazachek, Y; Mineeva, E; Kupriyanova, T; Voevoda, M; Gafarov, V; Gromova, E; Panov, D; Voevoda, E; Kovalkova, N; Ragino, Y; Poponina, T; Poponina, Y; Garganeeva, N; Repin, A; Vershinina, E; Borodina, E; Kalashnikova, T; Safyanova, O; Osipova, I; Antropova, O; Pyrikova, N; Polyakova, I; Efremushkina, A; Guryanova, N; Kiseleva, E; Lomteva, E; Shtyrova, T; Novikova, N; Parfenov, D; Volovchenko, A; Averkov, O; Pavlikova, E; Vaulina, L; Pletnikova, I; Mishchenko, L; Saranin, S; Tsupko, I; Kuznetsova, N; Zateyshchikov, D; Dankovtseva, E; Vlazneva, Y; Tolokonnikova, N; Zhurina, M; Zubova, E; Aseycheva, O; Sigalovich, E; Vertkin, A; Rodiukova, I; Komissarov, S; Sokolova, R; Ausheva, A; Salbieva, A; Yusubova, A; Isakova, S; Hranai, M; Obona, P; Cisar, P; Semetko, J; Vanova, P; Ferencikova, Z; Vykoukalova, T; Gaspar, L; Caprnda, M; Bendzala, M; Pella, D; Fedacko, J; Hatalova, K; Drozdakova, E; Peter, O; Commerford, P; Ntsekhe, M; De Andrade, M; Seedat, S; Gani, M; Van Zyl, L; Naude, M; Cronje, T; Van Zyl, F; Engelbrecht, J; Jansen, J; Roos, J; Makotoko, E; Pretorius, C; Mirna, S; Nell, H; Pretorius, M; Basson, M; Njovane, X; Mohamed, Z; Pillay, T; Dawood, S; Horak, A; Lloyd, E; Hitzeroth, J; Mabin, T; Abelson, M; Klug, E; Gebka, M; Hellig, F; Alison, M; Bae, J; Kim, C; Kim, D; Joo, S; Ha, J; Park, C; Kim, J; Kim, Y; Jarnert, C; Ryden, L; Mooe, T; Binsell-Gerdin, E; Dellborg, M; Torstensson, I; Albertsson, P; Hiller, M; Perers, E; Johansson, L; Jansson, JH; Al-Khalili, F; Almroth, H; Andersson, T; Ostman, ME; Pantev, E; Utter, F; Tengmark, BO; Olsson, A; Liu, B; Rasmanis, G; Wahlgren, CM; Thott, O; Moccetti, T; Rossi, MG; Crljenica, C; Parkhomenko, A; Dovgan, N; Skarzhevskyi, O; Kozhukhov, S; Tseluyko, V; Mishchuk, N; Kuznetsov, I; Semenikhin, S; Matviichuk, N; Matuzok, O; Yakovleva, L; Volkov, V; Zaprovalna, O; Serik, S; Riabukha, V; Koval, O; Kaplan, P; Ivanov, A; Romanenko, S; Skoromna, A; Kononenko, L; Saprychova, L; Lazareva, S; Prokhorov, O; Vdovychenko, V; Bychkov, M; Demydova, A; Kapustynska, O; Bazylevych, A; Dutka, R; Vlasyuk, Z; Shabat, M; Rudenko, L; Beregova, O; Fedtchouk, L; Gusak, I; Vizir, V; Sadomov, A; Shkolovoy, V; Nasonenko, O; Demidenko, O; Karpenko, O; Ponomarenko, K; Oryshych, G; Nevolina, I; Mitskevych, L; Bezuglova, S; Kizim, S; Todoriuk, L; Brodi, N; Karpenko, L; Malynovsky, Y; Fedotov, S; Malynovska, O; Goydenko, O; Miroshnykov, S; Rabota, I; Koval, V; Ohirko, O; Khaba, U; Storozhuk, B; Danylchuk, I; Danylchuk, A; Gutsuliak, R; Cotton, J; Luckraz, H; Wrigley, B; Venkataraman, A; Maher, A; Moriarty, A; McEneaney, D; Connolly, D; Davis, R; Banerjee, P; Davey, P; Elmahi, E; Senior, R; Ahmed, A; Birdi, I; Gedela, S; Singh, A; Calvert, J; Butler, M; Donnelly, P; Jasinka, A; Orr, C; Trevelyan, J; Routledge, H; Carter, J; Oxenham, H; Peace, A; McNeill, A; Austin, D; Jackson, M; Kukreja, N; Kotwinski, P; Hilton, T; Bilizarian, S; Srivastava, S; Walsh, R; Fields, R; Portnay, E; Gogia, H; Deits, R; Salacata, A; Hunter, J; Bacharach, J; Shammas, N; Suresh, D; Gurbel, P; Banerjee, S; Grena, P; Bedwell, N; Brown, C; Sloan, S; Lupovitch, S; Soni, A; Gibson, K; Pepper, D; Sangrigoli, R; Mehta, R; Patel, J; Tsai, PIH; Gillespie, E; Harrison, A; Dempsey, S; Phillips, R; Hamroff, G; Hametz, C; Black, R; Lader, E; Kostis, J; Bittner, V; Mcguinn, W; Branch, K; Cheng, R; Pal, J; Malhotra, V; Michaelson, S; Vacante, M; Mccormick, M; Arimie, R; Dukkipati, R; Camp, A; Dagher, G; Koshy, N; Culp, J; Thew, S; Ferraro, A; Costello, F; Heiman, M; Chilton, R; Moran, M; Adler, F; Balingit, P; Comerota, A; Seiwert, A; French, W; Vardi, G; Singh, T; Serota, H; Qayyum, U; Das, S; Harrison, R; Vora, A; Bakeen, F; Omer, S; Chandra, L; Casaccia, G; Tinto, J; Sighel, C; Giozzi, E; Morell, Y; Bianchini, M; Yossen, M; Hoyos, M; Venturini, C; Merkusa, C; Carrique, A; Carrique, P; Fracaro, V; Torres, M; Crunger, P; Espinosa, M; Passarello, A; Zaidman, M; Ledesma, M; Troncoso, C; Aviles, A; Vigil, SR; Vogel, M; Takla, M; Funosas, C; Ferreiro, M; Bruno, T; Buzzetti, C; Lozano, J; Damelio, AA; Bocanera, M; Vicente, D; Cenci, A; Deluca, C; Santana, R; Calvelo, AA; D'Amelio, AA; Calvelo, JA; Herrero, S; Robertson, M; Tapia, D; Escalante, M; Canas, M; Cendali, G; Esposito, L; Muniz, M; Montana, J; Di Vruno, M; Strevezza, M; Santi, ML; Massei, N; Garate, V; Perlo, D; Campora, F; Jakubowski, I; Moisello, MG; Actis, M; Schiavi, S; Aguirre, M; Ceirano, C; Zillo, M; Yunis, M; Berdini, A; Gerbaudo, R; Berdini, J; Palma, F; Pinero, S; Virulio, S; Vitale, A; Flores, GS; Saggia, CI; Saggia, DI; Roses, A; Martinelli, C; Vargas, L; Salazan, MG; Dran, P; Tinnirello, V; Pelayes, S; Bordoni, P; Navarro, A; Barilati, P; Serra, R; Nigro, A; Cleiman, S; Bianchi, M; Vallejo, M; Ingratta, M; Tonelli, L; Levantini, M; Bonifacio, M; Hansen, V; Chaieb, A; Majul, S; Medina, F; Gallinotti, P; Madariaga, T; Andrea, G; Blumberg, C; Volpe, M; Gandur, H; Benincasa, V; Barreto, M; Jure, D; Greenwell, D; Forrest, N; Nyman, E; Mcintosh, C; O'May, V; Grabek, T; Conway, B; O'Donoghue, M; Brady, L; Duroux, M; Ratcliffe, M; Shone, S; Connelly, A; Ferreira-Jardim, A; Vandernet, R; Downes, R; Davids, F; Teal, L; Knight, S; Soraghan, D; Spence, C; Smith, K; Tivendale, L; Williams, Z; O'Connor, M; Walker, I; Ferguson, L; Holiday, J; Griffin, R; Palethorpe, L; Hindom, L; Lilwall, L; Wadham, S; Narasimhan, K; Van Extergem, P; Joris, I; Oreglia, M; Jacobs, C; Leus, W; Robesyn, V; Vanheule, K; Van Den Bossche, K; Albertijn, S; Vissers, C; Badts, G; Vangenechten, K; Derycker, K; Dejaegher, K; De Grande, T; De Clippel, M; Gayet, F; Jorion, M; Jourdan, A; Tartaglia, K; Zwinnen, W; Roijakkers, I; Van Genechten, G; Schoonis, A; Bollen, J; Janssen, A; De Coninck, M; Ruell, S; Grimonprez, A; Bouckaert, N; Van Eeckhoutte, H; Malmendier, D; Massoz, M; Jacquet, S; Vanhalst, E; Casier, T; Barroso, SL; Tamashiro, N; Correa, CP; Sehnem, EAB; Precoma, CB; Pinheiro, L; Ruschel, KB; Dos Reis, AL; Santos, MS; De Oliveira, LOSP; De Carvalho, LMG; Dos Santos, MES; Reis, LLF; Da Cunha, GT; Franca, FF; Bessa, SK; Vicente, C; Ormundo, C; Trama, L; Pires, NF; Esteves, D; Sila, OL; Goes, NC; Amorin, RC; Faria, MO; Bucalon, EC; Marin, LP; Herek, L; Araujo, VL; Silva, AF; Lima, F; Gomes, CG; Pagnan, LG; Novelli, CM; Carvalho, JKC; Teodoro, AR; Zimmermann, EMB; Beiersdorf, JR; Machado, BG; Pedroso, FBV; De Vargas, T; Peres, CS; Dos Santos, TF; De Souza, SF; Luiz, RO; Ferreira, P; Souza, DF; Cunha, SMC; De Resende, IM; Furtado, CCF; Soprane, AA; Brum, AB; Zorzo, JAT; Dos Santos, JC; Queiroz, LB; Barros, FE; Vianna, CO; Zanateli, A; Konishi, MYN; Vieira, APZ; Melo, G; Zambonin, MAGEC; Paiva, P; Viana, RMM; Yagihara, MM; Takiuti, MM; Miyamoto, PB; Da Silva, MF; Borin, LA; Chiazzini, SML; Fleck, N; Batista, RF; Cardoso, DT; Camasmie, PM; Assompcao, RP; Marques, LL; Leung, S; Lewis, C; Tytus, A; Clarus, S; Juranics, S; Pandey, M; Frenette, L; Magi, A; Nowacki, B; Otis, J; Fox, B; Corke, R; Miller, B; Rizzo, A; Trombetta, L; Power, P; Richert, L; Haligowski, R; Macrae, C; Kooistra, L; Urso, C; Fox, S; Felbel, S; Stafford, C; Stata, C; Barnabe, B; Mehta, K; Faul, J; Gohel, J; Bhakta, S; Harwood, A; McPherson, C; Marucci, J; Manasterski, L; Veenhuyzen, J; Ramadan, D; Madden, B; Jetha, A; Pajevic, M; Dube, C; Rolfe, B; O'Blenis, G; Roy, L; Dihel, C; Butler, J; Simmavong, K; Bartol, C; Bozek, B; Hart, B; Shier, M; Coughlin, M; Lamantia, C; Lamantia, D; Vilag, C; Fecteau, J; Dionne, J; Peloquin, G; Hogg, N; Welsh, S; Weerasingam, S; Lantz, M; Lounsbury, N; Martin, E; Mitchell, L; Morgen, G; Nelson, S; Pelzer, E; Sorensen, S; LeBlanc, A; Bourlaud, AS; Premont, A; Leger, P; Lariviere, MM; Tremblay, H; Bergeron, A; Dumont, J; Keilani, S; Landry, P; Deneufbourg, I; Breton, C; Bilodeau, N; Cote, M; Dumont, F; Dufort, L; Marcoux, D; David, M; Otis, R; Parks, J; Cepidoza, C; Janz, W; Weighell, W; Yaworski, S; Boyd, K; Lambert, J; Shea-Landry, G; Reid, K; Thiessen, S; Nemtean, D; Futers, S; Drouin, K; Masson, C; Arseneault, MC; Lachance, N; Bergeron, C; Boudreault, C; Perkins, L; Barnett, A; Fortin, J; Duclos, R; Vallieres, C; Bouchard-Pilote, C; Ouimet, F; Roberge, B; Couture, ML; Deshaies, D; Bastien, A; Chartrand, MJ; Gagne, NL; Desbiens, K; Alarie, P; Cassan, J; Ducharme, Y; Roy, I; Tapps, D; Bolduc, H; Laliberte, J; Hickey, L; Spero, M; Bernstein, M; Clement, J; Pawluch, A; Ricci-Bonzey, M; Richer, J; Vaillancourt, J; Ward, B; Rad, PM; Oleski, L; Karkhanis, R; Hartleib, V; Poirier, R; Hidalgo, J; Hernandez, C; Obreque, C; Quilapi, D; Villa, F; Iturriaga, C; Ferrada, M; Navarrete, S; Becerra, E; Vargas, C; Roque, C; Alarcon, J; Diaz, D; Sepulveda, M; Villan, C; Garcia, N; Lara, C; Lezana, B; Basso, N; Torres, G; Pasmino, C; Gonzalez, S; Medina, D; Rodriguez, J; Guo, T; Chen, S; Han, W; Shi, D; Zhang, Q; Li, W; Cui, L; Huang, Z; Gong, X; Liu, D; Tan, S; Caicedo, L; Rodriguez, A; Mejia, I; Ruiz, JE; Ochoa, CC; Ortega, YC; Diaz, AA; Rodriguez, B; Lopez-Lopez, J; Di Stefano, K; Florez, L; Manco, T; Rodriguez, D; Urina, A; De La Hoz, L; Almendrales, L; Bello, O; Valencia, HU; Rivera, PC; Perdomo, I; Alzate, J; Rivera, E; Jimenez, D; Guzman, A; Betancourt, S; Marin, HM; Leyva, M; Ortiz, M; Moreno, N; Marin, E; Lorena, AA; Alvarez, Y; Hurtado, AC; Mendoza, AA; Accini, MT; Eguis, B; Del Portillo, C; Ortega, M; Delgado, P; Arciniegas, J; Rodriguez, L; Sanchez, SM; Chavera, I; Mendoza, MP; Quintero, AN; Zidek, M; Hajkova, D; Rozskowska, P; Opavska, I; Souckova, E; Matuskova, E; Kratochvilova, T; Pavelec, P; Zelenkova, V; Dolezalova, Z; Marquez, M; Moreira, D; Zuleta, M; Santana, G; Coello, A; Andrade, G; Salazar, J; Rivadeneira, J; Vaerma, J; Lappalainen, S; Silvennoinen, S; Haaraoja, A; Valimaki, S; Roine, E; Abergel, H; Msakni, W; Fuentes, A; Briday, G; David, A; Soltani, S; Decorps, A; Chettouh, M; Douillet, M; Zamiti-Smondel, A; Cuccu, L; Salhi, N; Helene, M; Martin, S; Merah, A; Daher, P; Laurie, S; Roussel, L; Leperchois, C; Delelo, E; Thalamy, A; Chazot, E; Tahirovic, E; Watson, S; Brettschneider, B; Maas, M; Euler, K; Rahn, G; Beissner, S; Anuschek, V; Tu, E; Buerger, M; Schemann, J; Klinger, C; Kurzidim, T; Sahbani, S; Laszig, S; Beilfuss, M; Foerster, A; Eichinger, G; Rupprecht, M; Kuehnert, J; Wendler-Huelse, I; Buelow-Johansen, B; Baierlein, A; Iselt, M; Sievert, B; Frommhold, R; Wolf, T; Hahn, M; Schoen, B; Acimic, C; Ludwig, M; Funkat, A; Wagner, I; Schink, M; Calvo-Sanchez, D; Feil, JF; Sumegi, TP; Miko-Pauer, R; Courcy, M; Kelly, C; Farrell, D; Kirrane, C; Hall, M; Gilroy, E; Kelsey, M; Andrew, G; Joyce, M; Conway, S; Omer, T; Duane, L; Zuker, S; Platner, N; Saranga, H; Kaufman, E; Livshitz, L; Genin, I; Klainman, M; Iunger, KU; Abitbul, A; Fishman, B; Greenshtein, I; Tubul, O; Lasri, E; Zvi, R; Yablonski, A; Levin, LH; Lunetto, ML; Savoldi, D; Fiorini, M; Ramani, F; Mariottoni, B; Rizzotti, D; Di Matteo, C; Musio, S; Minciaroli, SP; Serani, S; Aloisi, A; Attanasio, C; Tricoli, M; Giordano, V; Andrioli, V; Biundo, V; Schiff, D; Trovarelli, P; Chiodi, R; Sampaolesi, S; Cina, MT; Tullio, L; Abatello, M; De Tora, M; Pietrucci, F; Pezzetta, S; Chiminelli, E; Dall'Asta, A; Bennati, M; Elia, A; Bizzoco, M; Iaquaniello, A; Spigarelli, R; Cremonesi, C; Gagliardi, M; Torricelli, L; Ijichi, N; Shiraiwa, K; Murakami, M; Takeshita, K; Sato, M; Shiratori, A; Kinjo, K; Tomita, K; Mizuno, M; Kurihara, F; Tachibana, M; Nitta, Y; Unno, K; Hiramatsu, H; Sano, A; Nanatsumura, M; Tanikawa, I; Uesugi, K; Banno, S; Miyata, T; Kujuji, A; Kawai, K; Maegawa, A; Koseki, T; Watanabe, Y; Aoki, S; Maesawa, M; Suzuki, A; Itose, Y; Konishi, K; Fujieda, K; Nakade, S; Minami, M; Yoneda, J; Akiyama, R; Sakai, S; Nakatani, K; Yamazaki, A; Funama, M; Kaneko, E; Morii, S; Onishi, M; Sone, A; Sagawa, N; Iwai, F; Kawahara, A; Hasimoto, C; Ueki, M; Kamiji, M; Ando, M; Yokoo, M; Okada, Y; Yamada, H; Matsushige, N; Nagato, A; Matsumoto, R; Nishikawa, M; Oka, I; Kitou, S; Tachiuchi, M; Nakagawa, M; Yoneda, S; Iwasa, K; Matsuda, J; Oda, A; Tokudome, S; Kaneyuki, Y; Higaki, M; Yoneda, H; Kajita, C; Suwa, K; Sato, E; Nagata, T; Kubo, Y; Umesu, A; Ohashi, K; Takeuchi, M; Tanaka, I; Nobehara, T; Yamano, R; Yumiba, A; Hamada, M; Nishihata, T; Ohashi, Y; Morita, M; Endo, M; Matsugi, M; Tateishi, H; Nakamori, R; Yamashita, Y; Okabe, M; Matsuo, M; Ono, T; Shigeyama, Y; Ichiyanagi, M; Sugimori, K; Ohmura, C; Igarashi, M; Aotsuka, S; Komoda, N; Watanabe, M; Enomoto, Y; Suzuki, Y; Kawaguchi, A; Kasahara, A; Koide, A; Sakatani, T; Kurihara, T; Yokota, S; Futagi, R; Amemiya, Y; Ono, E; Maeda, A; Kadono, K; Ishiguchi, Y; Kikuchi, R; Kuramatsu, M; Nakamura, E; Chiba, S; Higa, A; Kitahashi, M; Tanaka, H; Ito, T; Oba, M; Tsubouchi, M; Toshima, M; Morishita, M; Miyano, A; Kondo, M; Watanabe, K; Shibata, R; Tosaki, Y; Ito, Y; Saoda, M; Yamasaki, E; Kadosaki, S; Motooka, S; Akiyoshi, H; Morio, S; Nemoto, H; Yoshizawa, S; Okabe, N; Semba, K; Yoshida, A; Lee, Y; Yoshida, M; Iwashita, Y; Takeda, A; Maezato, M; Kawahira, K; Yoshikawa, M; Okamoto, N; Nishimura, M; Matsuura, K; Fukunaga, M; Fukai, K; Osakabe, Y; Yamamura, K; Koike, M; Shibuya, S; Shiramata, M; Ono, Y; Tsujimoto, Y; Tadokoro, T; Morishita, N; Matsuo, Y; Yumoto, I; Sakazaki, S; Atarashi, A; Nabata, Y; Okuda, N; Fujita, A; Matsuo, A; Ishizawa, Y; Shibata, H; Ootsuka, M; Taimatsu, R; Takeuchi, A; Sumi, Y; Yamamoto, F; Araki, Y; Tanaka, A; Kuroda, S; Sakata, R; Okada, N; Sawada, Y; Miyata, M; Asayama, H; Koga, N; Miki, T; Yamaguchi, N; Hashimoto, A; Fukuike, C; Kubo, A; Yamasaki, M; Mori, Y; Nakayama, S; Kobayashi, Y; Takenaka, S; Mashima, M; Katsuta, H; Matsumura, T; Yanagida, S; Watanabe, N; Kodama, S; Kusano, M; Yamamoto, N; Kamada, R; Suzuki, K; Itami, K; Hasebe, Y; Fujita, N; Kubota, S; Usuki, A; Okamoto, M; Uno, S; Chikuma, A; Kishikawa, H; Yano, C; Nakano, K; Otaguro, M; Kayashima, Y; Shinoda, M; Jaafar, SM; Baharuddin, S; Gembor, J; Ahmad, H; Mansor, SMS; Abdullah, WM; Shafie, Z; Yunus, SM; Alwi, SM; Hussin, N; Basri, NA; Ling, LL; Naem, NS; Rutten, R; Rademaker, H; Van Buijsen, M; Scholten, M; Stuij, S; van Zeijst, M; van Houwelingen, K; Engelen, W; Kramer, H; Maassen, E; Verhoeven, P; Awater, J; van Scheltinga, CT; Meijlis, P; Blom, L; Bos, M; van der Wal, M; Van Laerhoven, G; Jacobs, T; Tan-Urgert, B; de Gaag, JV; Den Boer, P; Verlek, E; Lardinois, R; Coenjaerds, C; Hendrick, R; Schoep, J; Froma, E; van Nes, C; Beuving, D; Krikken, J; Drent, I; Geerlings, F; Buvelot, S; Wissenburg, A; Dijkshoorn, A; Van Der Meer, LV; Singerling, M; Van Wijk, D; Bor, A; Aukema-Wouda, Z; Hendriks-Van Woerden, M; Kort, I; Danse, I; van der Knaap, M; de Jong, C; Temminck, M; Schaefer, T; Van der Ven, N; Drost, I; Mulder, R; De Vos, A; de Hoop, M; Post, G; Wielandt, D; Edorot, N; De Castro, K; Flotildes, M; Mulingtapang, T; Vasquez, S; Facundo, S; Peralta, M; Jose, M; Bandiez, J; Sulit, P; Joaquin, F; Arbis, MG; Silva, C; Delgado, D; DeLeon, R; Maglasang, P; Sian, A; Alagban, C; Alcorano, J; Marcelo, MJ; Dela Pena, C; Hyra, I; Malkiewicz, B; Mosakowska, K; Cana, I; Dobrin, I; Lautaru, A; Manescu, G; Samoila, N; Lacatus, M; Apostoie, A; Prunoiu, M; Tilinca, M; Budeanu, A; Nedelcu, C; Dumitrache, N; Boeru, L; Zhuravleva, E; Gundova, M; Hoffmannova, J; Svitkova, M; Pekarova, T; Ujacka, K; Zsoriova, T; Kubincova, K; Jankovicova, Z; Talliard, C; Tyumbu, N; Mngoma, N; Kannemeyer, M; Mostert, J; Page, A; Krahenbuhl, C; Tredoux, C; Hendricks, L; Oliver, S; Le Grange, M; Naidoo, V; Bae, Y; Kim, H; Lee, J; Yu, N; An, S; Kim, E; Yang, K; Woo, J; Kim, S; Rasck, J; Smetana, S; Ajax, K; Bylander, L; Lindberg, A; Dellborg, H; Hultsberg-Olsson, G; Harsmar, K; Knutsson, A; Hakansson, L; Kaveryd-Holmstrom, M; Lundmark, LM; Norrfors, B; Lof, P; Skoglund, K; Torgersruud, M; Johansson, K; Mattsson, A; Quist, M; Haglund, P; Lundell, L; Gunvasdotter, S; Rangman, B; Liu, R; Shi, J; Forstedt, G; Nylund, L; Welin-Berger, B; Nilsson, O; Garcia-Varlid, A; Forlenza, R; Kaminska, K; Nagorna, T; Cottam, V; Harper, R; Gilchrist, M; Musanhu, R; Mackin, A; Turner, A; Willetts, S; Cadd, A; Evans, J; Young, G; Sevillano, A; Brodie, K; Eccles, A; Kelly, S; Doughty, A; Gray, J; Gibson, M; Finlayson, M; Domingo, D; Brazee, L; Renaud, K; Doman, A; Meyer, R; Beatty, J; Morgan, T; Rodas, E; Campbell, D; Mcquarrie, M; Battistelli, E; Eisenbraun, P; Farley, R; Park, H; Dwyer, J; Adams, K; Schneider, W; Barbour, C; Whyne, E; Budzinski, S; Craig, M; Elmore, JG; Scott, D; Bellini, S; Pepper, M; Gunderson, K; Stipek, I; Schwarz, L; Watkins, K; Moore, V; Palao, A; Keane-Richmond, P; Franklin, L; Ward, L; Kostedt, G; Bailey, S; Hollenweger, L; Solomon, A; Johnson, D; Gloer, K; Meyer, M; Boleyn, M; Nieters, D; Humphrey, K; Bohn, A; Mueller, G; Mckenzie, H; Edwards, T; Velky, J; Cole, C; Diederick, M; Burg, S; Coulson, T; Karunaratne, K; Gunasekera, R; Cook, S; Fisher, S; Garrison, K; Passey, L; Kuykendall, K; Luck, K; Ramia, L; Joan, H; Reynoso, F; Farley, M; Shuman, S; Santana-Fernandes, E; Ventimiglia, A; Steele, V; Gers, L; Brown, P; Wilson, J; Freebersyser, J; Reno, M; Buettner, N; Mcgovern, M; Hubbard, T; Elmore, H; Payne, D; Mccann, M; Decker, S; Sharp, A; Forgey, E; Broussard, E; Juett, U; Siddiqui, A				Eikelboom, J. W.; Connolly, S. J.; Bosch, J.; Dagenais, G. R.; Hart, R. G.; Shestakovska, O.; Diaz, R.; Alings, M.; Lonn, E. M.; Anand, S. S.; Widimsky, P.; Hori, M.; Avezum, A.; Piegas, L. S.; Branch, K. R. H.; Probstfield, J.; Bhatt, D. L.; Zhu, J.; Liang, Y.; Maggioni, A. P.; Lopez-Jaramillo, P.; O'Donnell, M.; Kakkar, A. K.; Fox, K. A. A.; Parkhomenko, A. N.; Ertl, G.; Stoerk, S.; Keltai, M.; Ryden, L.; Pogosova, N.; Dans, A. L.; Lanas, F.; Commerford, P. J.; Torp-Pedersen, C.; Guzik, T. J.; Verhamme, P. B.; Vinereanu, D.; Kim, J. -H.; Tonkin, A. M.; Lewis, B. S.; Felix, C.; Yusoff, K.; Steg, P. G.; Metsarinne, K. P.; Bruns, N. Cook; Misselwitz, F.; Chen, E.; Leong, D.; Yusuf, S.; Aboyans, V.; Ha, J.; Keltai, K.; Lamy, A.; Liu, L.; Moayyedi, P.; Piegas, L.; Sharma, M.; Varigos, J.; Bhagirath, V.; Bogaty, P.; Botto, F.; Catanese, L.; Magno, J. Donato; Fabbri, G.; Gabizon, I.; Gosselin, G.; Halon, D.; Heldmann, M.; Lamelas, P.; Lauw, M.; Lutay, D.; Maly, M.; Mikulik, R.; Nayar, S.; Ng, K.; Perera, K.; Pirvu, O.; Ronner, E.; Sato, S.; Smyth, A.; Sokolova, E.; Wiendl, M.; Winkelmann, B.; Yang, X.; Yufereva, Y.; Cairns, J.; Sleight, P.; DeMets, D.; Momomura, S. I.; Prins, M.; Ramsay, T.; Goto, S.; Rouleau, J. L.; Schumi, J.; Thabane, L.; Casanova, A.; Bangdiwala, S.; Deng, E.; Dyal, L.; Khatun, R.; Marsden, T.; Pogue, J.; Tang, C.; Wong, G.; Yuan, F.; Aman, S.; Ariz, A.; Ashton, H.; Belanger, J.; Belanger, M.; Brettell, K.; Chandra, J.; Choppick, C.; Cisternino, D.; Cuncins-Hearn, A.; Di Marino, M.; Diao, L.; Dwomoh, S.; Dykstra, A.; Galatsis, E.; Gasic, T.; Gutierrez, J.; Hamilton, L.; Irwin, L.; Lapensee, C.; Li, A.; Lu, X.; MacRae, L.; Malik, S.; Malvestiti, A.; Mastrangelo, J.; Maystrenko, A.; O'Donnell, L.; Reeh, K.; Szymkow, P.; Thomas, S.; Thrasher, D.; Tyrwhitt, J.; White, L.; Bastone, R.; Berkowitz, S.; Dias, A.; Ho, K.; Keller, L.; Lanius, V.; Lister, K.; Merten, C.; Muehlhofer, E.; Schmidt, K.; Tasto, C.; Tsihlias, E.; Woroniecka-Osio, A.; Orlandini, A.; Niemann, G.; Pascual, A.; Toscanelli, S.; Cabezon, M.; Debaveye, B.; Meeusen, K.; Luys, C.; Broos, K.; Vandenberghe, K.; Luyten, A.; Oliveira, G. B. F.; Vila Nova, D. C.; Konishi, M. Y. N.; Lonn, E.; Lonn, A.; Turbide, G.; Cayer, M.; Rovito, C.; Standen, D.; Li, J.; Pico, M. Lopez; Dusek, R.; Buzalka, V.; Larsen, J.; Paucar, M. J.; Saarinen, M.; Simon, T.; Bezault, M.; Le Lay, M.; Epstein, L.; Fajardo-Moser, M.; Roser, C.; Putz-Todd, G.; Scheidemantel, F.; Poehler, D.; Renner, J.; Hargitai, A.; Doherty, A. O.; Duffy, N.; Roarty, C.; Nolan, A.; Power, A.; Yuval, R.; Ben Ari, M.; Greenblatt, S.; Marmor, Y.; Lucci, D.; Ceseri, M.; Baldini, E.; Cipressa, L.; Miccoli, M.; Goto, M.; Yamasowa, H.; Kajiwara, M.; Takase, D.; Ikeguchi, K.; Matsumoto, M.; Ishii, M.; Asai, J.; Nozaki, D.; Akatsuka, T.; Yoshida, T.; Shahadan, S.; Nasir, N. Md; Schut, Astrid; Vinck, Leonie; van Leeuwen, Marjelle; Sanchez, J.; Aquino, M. R.; Mararac, T.; Benedyk, K.; Iordache, A.; Ciobanu, A.; Rimbas, R.; Galrinho, R. Dragoi; Magda, S.; Mihaila, S.; Mincu, R.; Suran, B.; Cotoban, A.; Matei, L.; Kursakov, A.; Rusnak, P.; Zakharova, A.; Demidova, E.; Commerford, A.; Lee, S.; Ju, I.; Gunolf, M.; Lorimer, A.; Parkhomenko, L.; Johnson, J.; Anderson, J.; Norby-Slycord, C.; Sala, J.; Sicer, M.; Rasmussen, M.; Luciani, C.; Cartasegna, L.; Beltrano, C.; Medek, G.; Vico, M.; Lanchiotti, P.; Martella, C.; Hominal, M.; Castoldi, M.; Casali, W.; Raimondi, S.; Hasbani, E.; Prado, A.; Paterlini, G.; Waisman, F.; Leonard, M.; Caccavo, A.; Alarcon, V.; Zaidman, C.; Guerlloy, F.; Vogel, D.; Imposti, H.; Dominguez, A.; Hrabar, A.; Fernandez, A.; Schygiel, P.; Sokn, F.; Cuneo, C.; Gutierrez Carrillo, N.; Martinez, G.; Luquez, H.; Costantino, M.; Ruiz, M.; Beccetti, N.; Mackinnon, I.; Cluigt, N.; Ahuad Guerrero, R.; Fanuele, M.; Campisi, V.; Costabel, J.; Romanelli, M.; Bartolacci, I.; Echeverria, M.; Pedrotti, M.; Montana, O.; Camino, A.; Crespo, C.; Barbieri, M.; Lopez Santi, R.; Tonin, H.; Heffes, R.; Gomez Vilamajo, O.; Vanesio, F.; Allegrini, E.; Garcia Duran, R.; Garcia, C.; Garcia Duran, L.; Schiavi, L.; Mana, M.; Bordonava, A.; Rodriguez, M.; Gutierrez, M.; Garrido, M.; Rodriguez, C.; Ingaramo, A.; Costamagna, O.; Almagro, S.; Gerbaudo, C.; Pelagagge, M.; Bustamante Labarta, M.; Novaretto, L.; Maldini, A.; Lopez, L.; Albisu Di Gennero, J.; Saggia, L. Ibanez; Vilkas, A. Garcia; Alvarez, M.; Stoermann, W.; Vita, N.; Vottero, E.; Macin, S.; Cocco, M.; Onocko, M.; Dran, R.; Gimenez, C.; Cardona, M.; Guzman, L.; Guzman, P.; Martinez, D.; Sarjanovich, R.; Huerta, C.; Scaro, G.; Cuadrado, J.; Nani, S.; Guardiani, F.; Litvak Bruno, M.; Ceconi, G.; Chacon, C.; Casado, M.; Fernandez Moutin, M.; Maffei, L.; Sassone, S.; Yantorno, M.; Grinfeld, D.; Vensentini, N.; Rolandi, F.; Fallabrino, L.; Majul, C.; Paez, O.; Visser, M.; Luciardi, H.; Mansilla, V.; Gonzalez Colaso, P.; Ferre Pacora, F.; Jure, H.; Parody, M.; Espeche, E.; Whelan, A.; Boyle, A.; Collins, N.; Roberts-Thomson, P.; Rogers, J.; Caroll, P.; Colquhoun, D.; Williams, L.; Shaw, J.; Blombery, P.; Amerena, J.; Lee, C.; Hii, C.; Royse, A.; Royse, C.; Singh, B.; Selvanayagam, J.; Jansen, S.; Thompson, P.; Lo, W.; Hammett, C.; Poulter, R.; Graves, S.; Narasimhan, S.; Van Den Heuvel, P.; Sinnaeve, P.; Fourneau, I.; Meuris, B.; Vanassche, T.; Ector, B.; Debonnaire, P.; Vandekerckhove, Y.; Van de Borne, P.; Wautrecht, J.; Leroy, J.; Schroe, H.; Vrolix, M.; Vranckx, P.; Elegeert, I.; Lerut, P.; Hoffer, E.; Borgoens, P.; Dujardin, K.; Brasil, C. K. O. I.; Del Monaco, M. I.; Uint, L.; Pavanello, R.; Precoma, D. B.; Vianna, H. S.; Abrantes, J.; Morelli, J.; Manenti, E.; Reis, G.; Giorgeto, F. E.; Franca, C. C. B.; Saraiva, J.; Costa, M.; de Camargo Junior, O.; Marson Lopes, M.; Maia, L. N.; Nakazone, M. A.; Mouco, O. M. C. C.; Lemos, M. A. B. T.; Hernandes, M. E.; Pantano, G. S.; de Castro, J. C. M.; Rossi, P. R. F.; Guedes, A. A. M.; dos Santos, F. R.; Vidotti, M. H.; Zimmermann, S. L.; Rech, R.; Nunes, C.; Abib Junior, E.; Leaes, P. E.; Botelho, R. V.; Navarro, A. L. C.; Silva, R. A.; Arantes, F. B. B.; Dutra, O.; Vaz, R.; Souza, W. K. S. B.; Souza, A. S. B.; Queiroz, W. C. B.; Braile, M.; Ferreira, V.; Izukawa, N. M.; Prakasan, A. K.; Nicolau, J. C.; Dalcoquio, T. F.; Tanajura, L. F. L.; Serrano Junior, C. V.; Minelli, C.; Borsetti Neto, F. A.; Nasi, L. A.; Oliveira, L. F. A.; Silva, M. A. V.; de Carvalho Cantarelli, M. J.; Tytus, R.; Pasyk, E.; Pandey, A. S.; Rowe, A.; Anand, S.; Cha, J.; Vizel, S.; Babapulle, M.; Semelhago, L.; Saunders, K.; Haligowski, D.; Berlingieri, J.; Nisker, W.; Kiaii, B.; Romsa, J.; Chu, M.; Nagpal, D.; Guo, R.; Mckenzie, N.; Quantz, M.; Bhargava, R.; Bhargava, M.; Mehta, P.; Hill, L.; Heslop, W.; Fell, D.; Hess, A.; Zadra, R.; Zeman, P.; Srivamadevan, M.; Lam, A.; Tai, S.; Al-Qoofi, F.; Spence, F.; Anderson, T.; Kieser, T.; Kidd, W.; Fedak, P.; Smith, E.; Har, B.; Brown, C.; Forgie, R.; Hassan, A.; Pelletier, M.; Searles, G.; Marr, D.; Bessoudo, R.; Douglas, G.; Legare, J.; Petrella, R.; Pavlosky, W.; Ricci, J.; Galiwango, P.; Janmohamed, A.; Kassam, S.; Mukherjee, A.; Vijayaraghavan, R.; Burstein, J.; D'Mello, N.; Glanz, A.; Noiseux, N.; Stevens, L. M.; Basile, F.; Prieto, I.; Normandin, L.; Helou, J.; Bainey, K.; Tymchak, W.; Welsh, R.; Merali, F.; Pandith, V.; Heffernan, M.; Orfi, J.; Mcconachie, D.; Jedrzkiewicz, S.; Della Siega, A.; Robinson, S.; Nadra, I.; Dagenais, G.; Poirier, P.; Dagenais, F.; Voisine, P.; Mohammadi, S.; Doyle, D.; Baillot, R.; Charbonneau, E.; Dumont, E.; Kalavrouziotis, D.; Perron, J.; Jacques, F.; Laflamme, M.; Brulotte, S.; Crete, M.; Degrace, M.; Delage, F.; Grondin, F.; Lemieux, A.; Michaud, N.; Saulnier, D.; Ross, M. K.; Nguyen, M.; Harvey, R.; Daneault, B.; Hartleib, M.; Guzman, R.; Nguyen, T.; Singal, R.; Bourgeois, R.; Landry, D.; Kamel, S.; Rupka, D.; Kuritzky, R.; Khaykin, Y.; Phaneuf, D. C.; Desjardins, V.; Coll, X.; Huynh, T.; Pilon, C.; Mansour, S.; Lemire, F.; Kokis, A.; Campeau, J.; Audet, M.; Boulianne, M.; Dupuis, R.; Lauzon, C.; Pruneau, G.; Senay, B.; Pichette, F.; Cieza, T.; Breton, R.; Belisle, P.; Barabas, M.; Diaz, A.; Costa, R.; Absi, F.; Garand, M.; Rheault, A.; Lemay, C.; Gisbert, A.; Raymond, A.; Barrero, M.; Gagne, CE.; Rheault, P.; Johnston, J.; Mundi, A.; Cohen, G.; Shukle, P.; Baskett, R.; Hirsch, G.; Ali, I.; Stewart, K.; Fenton, J.; Pudupakkam, S.; Willoughby, R.; Czarnecki, W.; Roy, A.; Montigny, M.; Descarries, L.; Mayrand, H.; Comtois, H.; Essiambre, R.; Ringuette, G.; Boutros, G.; Gendreau, R.; Pham, L.; Nguyen, V.; Nguyen-Thanh, H. K.; Nawaz, S.; Fremes, S.; Moussa, F.; Shukla, D.; Jano, G.; Bobadilla, B.; Saavedra, J.; Bahamondes, J.; Cobos, J.; Grunberg, E.; Corbalan, R.; Verdejo, H.; Medina, M.; Vega, M.; Nahuelpan, L.; Castania, F.; Raffo, C.; Vargas, A.; Reyes, T.; Vargas, D.; Arriagada, G.; Potthoff, S.; Godoy, J.; Stockins, B.; Larenas, G.; Quininao, F.; Sepulveda, P.; Trucco, V.; Pincetti, C.; Saavedra, S.; Silva, P.; Vejar, M.; Rodriguez, T.; Tian, H.; Zhang, J.; Meng, Y.; Wu, X.; Wu, Q.; Wang, Q.; Mu, Y.; Yang, J.; Wang, F.; Zhang, W.; Ke, Y.; Jiang, H.; Yin, P.; Jia, K.; Chen, C.; Wang, Z.; Qi, B.; Yu, L.; Feng, G.; Li, L.; Jiang, L.; Wu, S.; Yu, H.; Wu, Z.; Ding, R.; Liu, S.; Xu, H.; Cao, H.; Bai, X.; Zheng, Y.; Liu, Z.; Sun, H.; Yang, P.; Li, B.; Feng, Z.; Yang, Y.; Xu, Z.; Wu, W.; Meng, Q.; Ge, J.; Dai, Y.; Yang, H.; Chen, X.; Tian, X.; Shi, Y.; Hu, T.; Zhang, R.; Zhao, Q.; Quan, W.; Zhu, Y.; Zheng, Z.; Zhang, S.; Zhao, Y.; Zhao, C.; Wang, R.; Tao, L.; Hu, D.; Wang, Y.; Fan, F.; Huang, W.; Xia, X.; Fu, G.; Jiang, D.; Wang, M.; Li, C.; Xu, K.; Dong, Y.; Chen, Y.; Wu, D.; Wang, C.; Sun, X.; Lu, S.; Zhou, X.; Kong, Y.; Zhang, B.; Sotomayor, A.; Suarez, M.; Ripoll, D.; Herrera, O.; Mendoza, J. Accini; Cure, C. Saad; Reyes, M.; Vidal, T.; Beltran, P. Donado; Jaimes, E. Hernandez; Castillo, H.; Rocha, C.; Forero, L.; Bernal, D. Zarate; Gonzalez, L. Vanstrrahle; Triana, M. Urina; Quintero, A.; Ramirez, N.; Mendoza, J. Balaguera; Martinez, G. Aroca; Cotes, C.; Mercado, A.; Percy, X. Lastra; Mayorga, M. Perez; Rodriguez, N.; De Salazar, D. Molina; Agudelo, J. Perez; Villegas, L. Lopez; Ramos, L. Agudelo; Polo, M. Melo; Albornoz, A. Esparza; Gomez, J. Forero; Vallejo, G. Sanchez; Aristizabal, J.; Gallego, A.; Contreras, C.; Yepez, J.; Escobar, J. Angel; Manzur, F.; Cohen, L.; Boneu, D.; Lozada, H. Garcia; Barrios, L.; Celemin, C.; Diego, M.; Ortiz, L. Garcia; Montoya, C.; Ramirez, E.; Palma, E. Arcos; Ceron, J.; Acosta, G.; Mesa, J. Gomez; Velasquez, J.; Barreto, D.; Dada, F. Trujillo; Accini, F. Trujillo; Cano, R.; De La Cruz, K. Corredor; Maria, V.; Palmera, J.; Vesga, B.; Hernandez, H.; Silgado, G. Moreno; Vesga, S. Aruachan; Martinez, E. Burgos; Villareal, G. Quintero; Ayazo, F. Solano; Zidkova, E.; Krupicka, P.; Bultas, J.; Mandysova, E.; Lubanda, J.; Horak, J.; Belohlavek, J.; Kovarnik, T.; Gorican, K.; Rucka, D.; Smid, O.; Dostalova, G.; Skalicka, H.; Karetova, D.; Pavlinak, V.; Kuchynkova, S.; Marek, J.; Rob, D.; Ravlykova, K.; Prochazka, P.; Siranec, M.; Urbanec, T.; Vareka, T.; Nesvadbova, P.; Kaletova, M.; Indrakova, J.; Kryza, R.; Heczko, M.; Hanak, P.; Jancar, R.; Kocurkova, L.; Marcinek, G.; Cermak, O.; Drasnar, T.; Richter, M.; Kaspar, J.; Spinar, J.; Parenica, J.; Parenicova, I.; Schildberger, J.; Toman, O.; Ludka, O.; Poloczek, M.; Musil, V.; Miklik, R.; Labrova, R.; Lokaj, P.; Felsoci, M.; Bocek, O.; Kanovsky, J.; Zatocil, T.; Jerabek, P.; Matuska, J.; Jankovic, M.; Jankovicova, H.; Tesak, M.; Sulc, D.; Svacinova, H.; Radvan, M.; Bednar, J.; Motovska, Z.; Petr, R.; Fischerova, M.; Branny, M.; Vodzinska, A.; Cerny, J.; Indrak, J.; Sknouril, L.; Maly, J.; Vacek, T.; Prazak, O.; Broulikova, K.; Hajsl, M.; Jarkovsky, P.; Kamenik, L.; Kotik, I.; Krcova, E.; Sedlon, P.; Skvaril, J.; Cernohous, M.; Kohoutek, J.; Levcik, M.; Holek, M.; Hajdusek, P.; Caisova, L. Foltynova; Novak, V.; Kladivkova, M.; Slaby, J.; Houra, M.; Vojtisek, P.; Novotny, V.; Lazarak, T.; Pliva, M.; Pirk, J.; Barciakova, L.; Jandova, R.; Adamkova, V.; Galovcova, M.; Peterkova, L.; Turek, D.; Prochazka, J.; Belohoubek, J.; Spinarova, L.; Panovsky, R.; Novotny, P.; Krejci, J.; Hude, P.; Ozabalova, E.; Godava, J.; Honek, T.; Kincl, V.; Benesova, M.; Buckova, J.; Canadyova, J.; Mokracek, A.; Homza, M.; Stverka, P.; Florian, J.; Lukac, B.; Polasek, R.; Kucera, P.; Seiner, J.; Karasek, J.; Coufal, Z.; Stastny, J.; Cernicek, V.; Skalnikova, V.; Jiresova, E.; Brat, R.; Sieja, J.; Gloger, J.; Berger, P.; Prochazkova, I.; Samlik, J.; Brtko, M.; Tuna, M.; Polansky, P.; Omran, N.; Myjavec, A.; Hrdinova, M.; Jansky, P.; Kratochvilova, R.; Burkert, J.; Koubek, F.; Fiala, R.; Schwabova, J. Paulasova; Lindner, J.; Hlubocky, J.; Spacek, M.; Marcian, P.; Hanak, V.; Pozdisek, Z.; Lonsky, V.; Santavy, P.; Troubil, M.; Straka, Z.; Budera, P.; Fojt, R.; Talavera, D.; Tretina, M.; Nemec, P.; Orban, M.; Bedanova, H.; Wiggers, H.; Tougaard, R.; Larsen, A.; Nielsen, H.; Mattsson, N.; Gunnar, G.; Bruun, N.; Folke, F.; Soendergaard, K.; Koeber, L.; Frydland, M.; Fuchs, A.; Bang, L.; Houlind, K.; Olsen, M.; Soerensen, V.; Andersen, U. Overgaard; Dixen, U.; Refsgaard, J.; Moeller, D.; Zeuthen, E.; Lund, J.; Soegaard, P.; Jensen, S.; Duarte, Y.; Duarte, W.; Caceres, S.; Long, F. Pow Chon; Penaherrera, C.; Anzules, N.; Sanchez, M.; Zuleta, I.; Lopez, J.; Villota, M.; Sanchez, H.; Perugachi, C.; Gomez, S.; Morejon, P.; Marmol, R.; Guaman, S.; Trujillo, F.; Escobar, M.; Carrera, F.; Ponce, F.; Teran, P.; Carrasco, S.; Tuomilehto, J.; Humaloja, K.; Lindberg, L.; Tuomilehto, H.; Tuominen, M-L.; Kantola, I.; Juliard, J.; Feldman, L.; Ducrocq, G.; Boulogne, C.; Petitalot, V.; Leclercq, F.; Roubille, F.; Agullo, A.; Ferrari, E.; Chiche, O.; Moceri, P.; Boccara, F.; Charbonnier, M.; Azeddine, B.; Ederhy, S.; Dufour, L. Soulat; Cohen, A.; Etienney, A.; Messas, E.; Calvalido, A.; Galloula, A.; Zarka, S.; Courtois, M. C.; Mismetti, P.; Accassat, S.; Buchmuller, A.; Moulin, N.; Bertoletti, L.; Seffert, B.; Sevestre, M.; Remond, S. Samy Modeliar; Dupas, S.; Mardyla, J.; Le Gloan, S.; Cayla, G.; Cornillet, L.; Schmutz, L.; Motreff, P.; Souteyrand, G.; Amonchot, A.; Barber-Charmoux, N.; Combaret, N.; Malcles, G.; Brenner, S.; Christa, M.; Duengen, H.; Krackhardt, F.; Bobenko, A.; Hashemi, D.; Stellbrink, C.; Stellbrink, E.; Koester, C.; Guerocak, O.; Bourhaial, H.; Tiam, S. Oumbe; Kemala, E.; Froemke, J.; Kadel, C.; Moellinger, H.; Friedrich, K.; Rafoud, K.; Braun-Dullaeus, R.; Herold, J.; Ganzer, M.; Jeserich, M.; Kimmel, S.; Haggenmiller, S.; Schoengart, H.; Voehringer, H.; Opitz, C.; Appel, K.; Appel, S.; Utech, A.; Finger, C.; Duersch, M.; Dorsel, T.; Wistorf, N.; Grude, M.; Nikol, S.; Ueberschaer, D.; Kast, P.; Darius, H.; Sommer, S.; Girke, F.; Oeztuerk, C.; Ranft, J.; Mikalo, A.; Schellong, S.; Voigts, B.; Mueller, C.; Jungmair, W.; Davierwala, P.; Misfeld, M.; Bomke, K.; Akhavuz, O.; Haensig, M.; Vorpahl, M.; Blem, A.; Langer, G.; Nover, I.; Koehler, T.; Bajnok, L.; Marton, Z.; Laszlo, Z.; Noori, E.; Veress, G.; Fogarassy, G.; Aradi, D.; Kelemen, B.; Vertes, A.; Davidovits, Z.; Zsary, A.; Kis, E.; Hepp, T.; Koranyi, L.; Peterfai, E.; Bezzegh, K.; Bakai, J.; Agardi, I.; Boda, Z.; Razso, K.; Poor, F.; Varallyay, Z.; Jarai, Z.; Sallai, L.; Dudas, M.; Barton, J.; Mahmood, K.; Makki, H.; McAdam, B.; Salim, T.; Murphy, A.; Crean, P.; Liddy, A. M.; Mahon, N.; Khan, I.; Hassan, S.; Curtin, R.; McFadden, E.; MacNeill, B.; Kyvelou, S.; Canavan, M.; Veerasingam, D.; Dinneen, S.; Halabi, M.; Rosenfeld, I.; Levinas, T.; Goldberg, A.; Khateeb, A.; Zimlichman, R.; Ben-Aharon, J.; Beniashvili, A.; Betsalel, A.; Zeltser, D.; Rogowski, O.; Mardi, T.; Rozenbaum, Z.; Turgeman, Y.; Or, T.; Rabkin, Y.; Klainman, E.; Halabi, S.; Halon, D. A.; Katz, A.; Plaev, T.; Drogenikov, T.; Atar, S.; Kilimnik, M.; Wishniak, A.; Merei, M.; Zvi, Y.; Nikolsky, E.; Zukermann, R.; Petcherski, S.; Bosi, S.; Gaitani, S.; Naldi, M.; Barbieri, A.; Faggiano, P.; Guidetti, F.; Adamo, M.; D'Aloia, A.; Magatelli, M.; Robba, D.; Mos, L.; Vriz, O.; Sinagra, G.; Maras, P.; Doimo, S.; Cosmi, F.; D'Orazio, S.; Visconti, L. Oltrona; Leonardi, S.; Vullo, E.; Sbaffi, A.; Azzara, G.; Mauri, S.; Gianni, U.; De Matteis, C.; Campidonico, U.; Di Pasquale, G.; Di Niro, M.; Riva, L.; Filippini, E.; Di Biase, M.; Ieva, R.; Martone, A.; Mandorla, S.; Regni, O.; Capponi, E. A.; Martinelli, S.; Bernardinangeli, M.; Proietti, G.; Piccinni, G. C.; Gualtieri, M. R.; Gulizia, M. M.; Francese, G. M.; Portale, A.; Galvani, M.; Ottani, F.; Capatano, O. G.; Conficoni, E.; Longhi, S.; Bachetti, C.; Venturi, F.; Capati, E.; Morocutti, G.; Bisceglia, T.; Fresco, C.; Baldin, M. G.; Gamba, C.; Olivieri, C.; Perna, G. P.; Battistoni, I.; Marini, M.; Cirrincione, V.; Ingrilli, F.; Kanno, T.; Ishii, Y.; Kohmura, C.; Igawa, T.; Izawa, K.; Daida, H.; Miyauchi, K.; Shimada, K.; Ohmura, H.; Ito, S.; Okazaki, S.; Konishi, H.; Miyazaki, T.; Hiki, M.; Kurata, T.; Suzuki, H.; Morimoto, R.; Yokoyama, M.; Yamamoto, T.; Okai, I.; Isoda, K.; Fujimoto, S.; Dohi, T.; Shimada, A.; Ozaki, Y.; Watanabe, E.; Kawai, H.; Naruse, H.; Takada, K.; Okuda, K.; Okumura, M.; Ishikawa, M.; Ohtsuki, M.; Ohta, M.; Sarai, M.; Koshikawa, M.; Kawai, M.; Miyagi, M.; Motoyama, S.; Matsui, S.; Ichikawa, T.; Kato, Y.; Nagahara, Y.; Muramatsu, T.; Hashimoto, Y.; Hoshino, N.; Harada, M.; Yamada, A.; Yoshiki, Y.; Motoike, Y.; Nomura, Y.; Miyajima, K.; Takatsu, H.; Nishimura, H.; Nagasaka, R.; Kawada, Y.; Miyamoto, N.; Seki, K.; Inoue, A.; Higashiue, S.; Kojima, S.; Kuroyanagi, S.; Furuya, O.; Komooka, M.; Yamamoto, S.; Wakabayashi, N.; Domae, H.; Ata, T.; Hashidomi, H.; Kawahara, R.; Hosokawa, S.; Hiasa, Y.; Otani, R.; Kishi, K.; Takahashi, T.; Yuba, K.; Miyajima, H.; Tobetto, Y.; Yoneda, K.; Ogura, R.; Kobayashi, H.; Takamura, T.; Enkou, K.; Ochi, Y.; Yamada, D.; Kuramochi, T.; Misumi, K.; Iiduka, D.; Hirose, M.; Tone, K.; Taniguchi, Y.; Ebihara, T.; Makino, M.; Yokota, M.; Nitta, M.; Udo, A.; Shimizu, S.; Fujii, K.; Iwakura, K.; Okamura, A.; Inoue, K.; Nagai, H.; Hirao, Y.; Tanaka, K.; Tanaka, N.; Yamasaki, T.; Oka, T.; Iwamoto, M.; Tanaka, T.; Nakamaru, R.; Okada, M.; Takayasu, K.; Sumiyoshi, A.; Inoue, H.; Kitagaki, R.; Ninomiya, Y.; Mizutomi, K.; Koizumi, I.; Funada, A.; Tagawa, S.; Kamide, S.; Saku, K.; Ideishi, M.; Ogawa, M.; Uehara, Y.; Iwata, A.; Nishikawa, H.; Ike, A.; Sugihara, M.; Imaizumi, S.; Fujimi, K.; Kawamura, A.; Sako, H.; Morito, N.; Morii, J.; Fukuda, Y.; Yahiro, E.; Matsunaga, A.; Matsumoto, N.; Noda, K.; Shiga, Y.; Nagata, Y.; Kimura, K.; Ebina, T.; Hibi, K.; Iwahashi, N.; Maejima, N.; Konishi, M.; Matsushita, K.; Minamimoto, Y.; Kawashima, C.; Nakahashi, H.; Kimura, Y.; Takahashi, H.; Matsuzawa, Y.; Kirigaya, J.; Sato, R.; Kikuchi, S.; Ogino, Y.; Kirigaya, H.; Kashiwase, K.; Hirata, A.; Takeda, Y.; Amiya, R.; Higuchi, Y.; Sakaguchi, T.; Nakano, T.; Matsusaki, N.; Suzuki, S.; Hayashi, T.; Nakatani, S.; Koide, M.; Kobayashi, T.; Hamanaka, Y.; Makino, N.; Sotomi, Y.; Abe, M.; Fujieda, H.; Hashimoto, K.; Teratani, Y.; Abe, Y.; Yokoyama, Y.; Higashino, H.; Okuda, H.; Yamazato, M.; Noda, T.; Arai, M.; Ono, K.; Hirose, T.; Iwama, M.; Warita, S.; Goto, Y.; Abe, S.; Kojima, T.; Yoshizane, T.; Tanihata, S.; Fujii, T.; Yagasaki, H.; Miwa, H.; Ishiguro, M.; Kato, T.; Watanabe, R.; Horio, S.; Mita, T.; Hirayama, A.; Watanabe, I.; Hiro, T.; Nakai, T.; Takayama, T.; Yoda, S.; Yajima, Y.; Okubo, K.; Okumura, Y.; Kato, M.; Fukamachi, D.; Aizawa, Y.; Sonoda, K.; Iida, K.; Sasaki, N.; Iso, K.; Takahashi, K.; Kougo, T.; Haruta, H.; Kurokawa, S.; Mano, H.; Nagashima, K.; Onaka, H.; Doi, H.; Hirano, N.; Okamoto, F.; Mori, K.; Ri, G.; Zushi, R.; Otsuka, K.; Inoko, M.; Haruna, T.; Nakane, E.; Miyamoto, S.; Izumi, T.; Honjo, S.; Ikeda, H.; Wada, Y.; Funasako, M.; Hayashi, H.; Hamasaki, A.; Sasaki, K.; Seko, Y.; Nakasone, K.; Hanyu, M.; Iwasaki, Y.; Iwasaki, K.; Ayano, S.; Hirokami, M.; Omoto, Y.; Sasaki, H.; Sato, H.; Yuda, S.; Okubo, M.; Matsuo, H.; Tsuchiya, K.; Kawase, Y.; Miyake, T.; Kondo, H.; Hattori, A.; Kikuchi, J.; Okamoto, S.; Hirata, T.; Kawamura, I.; Ota, H.; Omori, H.; Tanigaki, T.; Kamiya, H.; Sobue, Y.; Komoda, T.; Akatsuka, Y.; Yamamoto, M.; Isegawa, K.; Takanezawa, M.; Kataoka, C.; Imamaki, M.; Shibata, Y.; Yasuda, K.; Shimano, M.; Ozaki, R.; Morishita, Y.; Okabe, K.; Kondo, K.; Miura, A.; Manita, M.; Tabata, K.; Asahi, T.; Mashidori, T.; Higa, N.; Nakata, M.; Himi, T.; Matsudo, Y.; Sekine, T.; Hou, K.; Tonoike, N.; Hama, Y.; Tanaka, S.; Ge, B.; Takahara, M.; Ishimura, M.; Shikada, T.; Ueno, H.; Amemiya, H.; Hisamatsu, Y.; Sada, K.; Sato, T.; Harada, K.; Nakamura, T.; Ako, J.; Tojo, T.; Shimohama, T.; Kishihara, J.; Ishii, S.; Fukaya, H.; Meguro, K.; Nishino, Y.; Inoue, M.; Matsui, Y.; Omura, Y.; Kawakami, H.; Matsuoka, H.; Oshita, A.; Seike, F.; Kondo, N.; Miyoshi, T.; Yamada, Y.; Uchiya, T.; Kikuchi, Y.; Koretsune, Y.; Abe, H.; Shinouchi, K.; Nishida, H.; Yasumura, K.; Date, M.; Ueda, Y.; Iida, Y.; Idemoto, A.; Toriyama, C.; Yokoi, K.; Mishima, T.; Yamada, T.; Fukunami, M.; Morita, T.; Furukawa, Y.; Kawasaki, M.; Kikuchi, A.; Tamaki, S.; Seo, M.; Shirakawa, Y.; Ikeda, I.; Fukuhara, E.; Kawai, T.; Kayama, K.; Kawahira, M.; Tanabe, K.; Nakamura, J.; Shimomura, H.; Kudo, T.; Morisaki, S.; Ogura, Y.; Chazono, N.; Onoue, Y.; Matsumuro, Y.; Shirakawa, T.; Nishi, M.; Kinoshita, N.; Nakamura, R.; Miyai, N.; Ohta, K.; Sawanishi, T.; Takahashi, A.; Hada, T.; Nakajima, S.; Taniguchi, N.; Mizuguchi, Y.; Takahashi, Y.; Hashimoto, S.; Machida, M.; Hirabayashi, K.; Morimoto, S.; Higashino, Y.; Otsuji, S.; Takiuchi, S.; Yabuki, M.; Hasegawa, K.; Shishikura, D.; Ibuki, M.; Ishibuchi, K.; Nagayama, S.; Ishii, R.; Tamaru, H.; Yamamoto, W.; Utsu, N.; Miyakoshi, K.; Nakashima, D.; Tsukuda, K.; Ueda, K.; Nakano, A.; Fukuda, T.; Ikeda, S.; Tsuchiya, H.; Toshima, S.; Tateno, R.; Ishikubo, T.; Suguta, M.; Nakamura, S.; Funatsu, A.; Mizobuchi, M.; Tanaka, M.; Nagai, T.; Hirano, S.; Hashimoto, T.; Doi, T.; Shirasaka, A.; Takeda, S.; Sasaki, Y.; Ohya, H.; Hosokawa, A.; Nishina, N.; Koki, B.; Ando, K.; Hiramori, S.; Soga, Y.; Tomoi, Y.; Tohoku, S.; Shirai, S.; Hyodo, M.; Isotani, A.; Domei, T.; Kuramitsu, S.; Morinaga, T.; Hayashi, M.; Hiromasa, T.; Nagae, A.; Yamaji, Y.; Nakao, K.; Sakamoto, T.; Taguchi, E.; Tsurugi, T.; Tanaka, Y.; Suzuyama, H.; Koyama, J.; Nagano, M.; Okamatsu, H.; Kodama, K.; Nakamura, M.; Horibata, Y.; Sone, M.; Tsunemori, M.; Bando, M.; Nakayama, T.; Tanigaito, Y.; Nomoto, M.; Sawamura, T.; Unoki, T.; Lim, C. W.; Rashid, R. Zainal; Khir, R. Najme; Ibrahim, K. S.; Azman, W. A. Wan; Sridhar, G. S.; Watson, T.; Abu Kassim, Z.; Zuhdi, A. S. Mahmood; Hafidz, M. I. Abdul; Abu Hassan, M. R.; Shah, W. F. Wan Rahimi; Karthikesan, D.; Suan, M. A. Mohd; Ali, S. M. Md; Kasim, S.; Arshad, M. K. Mohd; Ismail, J. R.; Ibrahim, Z. O.; Chua, N. Y. L.; Rahim, A. A. Abdul; Rusani, B. I.; Yap, L. B.; Zamrin, D. M.; Amir, M. A.; Ismail, N. I.; Razi, A. A. Mohammad; Prins, F.; Bendermacher, P.; Burg, M.; Lok, D.; Van der Sluis, A.; Martens, F.; Badings, E.; Milhous, J.; van Rossum, P.; Viergever, E.; van Hessen, M.; Willems, F.; Gin, R. Tjon Joe; Swart, H.; Oomen, A.; Kromhout, S.; Lauwerijssen, I.; Daalmans, M.; Breedveld, R.; De Vries, K.; FeenemaAardema, M.; Hofma, S.; Van Der Borgh, R.; van Nes, E.; Gobel, E.; Oei, F.; Dorman, H.; Bos, R.; Zoet-Nugteren, S.; Emans, M.; Kragten, H.; Lenderink, T.; Feld, R.; Herrman, J.; Van Bergen, P.; Gosselink, M.; Elvan, A.; Hoekstra, E.; The, S.; de Vries, R.; Zegers, E.; Ophuis, T. Oude; Remmen, J.; Bech, J.; Kooistra, J.; Den Hartog, F.; Oosterhof, T.; Bartels, G.; Posma, J.; Nierop, P.; Liem, A.; Van Der Zwaan, C.; Asselman, M.; Van Eck, J.; Gevers, R.; Van Gorselen, E.; van Hal, J.; Terpstra, W.; Groenemeijer, B.; Jerzewski, A.; Hoogslag, P.; Geertman, J.; De Groot, M.; Dijkstra, B.; Loyola, A.; Dans, A.; Sulit, D.; Mercado, M. J.; Rey, N.; Evangelista, L.; Abola, M.; Padua, L.; Morales, D.; Palomares, E.; Abat, M.; Santos, R.; Rogelio, G.; Chua, P.; Baello, R.; Del Pilar, J.; Alianza, M.; Alcaraz, J.; Alcaraz, L.; Ebo, G.; Guido-Saliot, I.; Tirador, L.; Estoce, E.; Ygpuara, M.; Cruz, J.; Anonuevo, J.; Pitargue, A.; Janion, M.; Guzik, T. J.; Drewniak, Z.; Guzik, B.; Nowak, M.; Nosal, M.; Niewiara, L.; Gajos, G.; Bury, K.; Czubek, U.; Misztal, M.; Grzybczak, R.; Zalewski, J.; Kruszelnicka-Kwiatkowska, O.; Zabowka, M.; Rynkiewicz, A.; Grzybowski, A.; Szalkowski, P.; Broncel, M.; Gorzelak, P.; Mozdzan, M.; Olszewska-Banaszczyk, M.; Szuba, A.; Tabin, M.; Chachaj, A.; Czarnecka, D.; Terlecki, M.; Klocek, M.; Maga, P.; Coman, I.; Tarlea, M.; Ghionea, M.; Gavrila, C.; Dimulescu, D.; Popescu, A.; Vinereanu, D.; Stoicescu, C.; Vintila, V.; Mihaila, S.; Florescu, M.; Galrinho, R. Dragoi; Cretu, D. Baghilovici; Mincu, R.; Magda, S.; Suran, M.; Cotoban, A.; Mihalcea, D.; Juravle, L. Lungeanu; Cinteza, M.; Rimbas, R.; Calin, I.; Bicescu, G.; Vasile-Toma, N.; Udroiu, C.; Gherghinescu, C.; Darabont, R.; Patrascu, N.; Constantinescu, C.; Popescu, I.; Sinescu, C.; Andrei, C.; Axente, L.; Arsenescu, C.; Statescu, C.; Ardeleanu, I.; Anghel, L.; Benedek, I.; Benedek, T.; Kinga, P.; Banga, D. K.; Bobescu, E.; Doka, B.; Dobreanu, D.; Sirbu, V.; Rudzik, R.; Kantor, K.; Sus, I.; Gaita, D.; Maximov, D.; Brie, D.; Mosteoru, S.; Olariu, I.; Iancu, A.; Marc, M.; Hagiu, R.; Manole, V.; Molnar, A.; Dregoesc, I.; Iliesiu, A.; Armean, P.; Parvu, I.; Deleanu, A.; Lighezan, D.; Ciobotaru, V.; Buzas, R.; Petrescu, L.; Nicola, R.; Dan, R.; Crisan, S.; Pirvu, O.; Trasca, L.; Teodorescu, I.; Zara, O.; Tiron, T.; Tesloianu, D.; Spiridon, M.; Vintila, M.; Baluta, M.; Chioncel, O.; Stoica, E.; Kulcsar, I.; Antohi, L.; Strazhesko, I.; Tkacheva, O.; Sharashkina, N.; Pykhtina, V.; Vasyuk, Y.; Shkolnik, E.; Khadzegova, A.; Sadulaeva, I.; Ivanova, S.; Nesterova, E.; Nesvetov, V.; Shupenina, E.; Shcherbak, M.; Sizova, Z.; Beloborodova, A.; Pozdnyakov, Y.; Tarasov, A.; Shvedov, I.; Zabashta, S.; Ryzhikova, I.; Barbarash, O.; Pecherina, T.; Vatutin, M.; Inozemceva, A.; Kazachek, Y.; Mineeva, E.; Kupriyanova, T.; Voevoda, M.; Gafarov, V.; Gromova, E.; Panov, D.; Voevoda, E.; Kovalkova, N.; Ragino, Y.; Poponina, T.; Poponina, Y.; Garganeeva, N.; Repin, A.; Vershinina, E.; Borodina, E.; Kalashnikova, T.; Safyanova, O.; Osipova, I.; Antropova, O.; Pyrikova, N.; Polyakova, I.; Efremushkina, A.; Guryanova, N.; Kiseleva, E.; Lomteva, E.; Shtyrova, T.; Novikova, N.; Parfenov, D.; Volovchenko, A.; Averkov, O.; Pavlikova, E.; Vaulina, L.; Pletnikova, I.; Mishchenko, L.; Saranin, S.; Tsupko, I.; Kuznetsova, N.; Zateyshchikov, D.; Dankovtseva, E.; Vlazneva, Y.; Tolokonnikova, N.; Zhurina, M.; Zubova, E.; Aseycheva, O.; Sigalovich, E.; Vertkin, A.; Rodiukova, I.; Komissarov, S.; Sokolova, R.; Ausheva, A.; Salbieva, A.; Yusubova, A.; Isakova, S.; Hranai, M.; Obona, P.; Cisar, P.; Semetko, J.; Vanova, P.; Ferencikova, Z.; Vykoukalova, T.; Gaspar, L.; Caprnda, M.; Bendzala, M.; Pella, D.; Fedacko, J.; Hatalova, K.; Drozdakova, E.; Peter, O.; Commerford, P.; Ntsekhe, M.; De Andrade, M.; Seedat, S.; Gani, M.; Van Zyl, L.; Naude, M.; Cronje, T.; Van Zyl, F.; Engelbrecht, J.; Jansen, J.; Roos, J.; Makotoko, E.; Pretorius, C.; Mirna, S.; Nell, H.; Pretorius, M.; Basson, M.; Njovane, X.; Mohamed, Z.; Pillay, T.; Dawood, S.; Horak, A.; Lloyd, E.; Hitzeroth, J.; Mabin, T.; Abelson, M.; Klug, E.; Gebka, M.; Hellig, F.; Alison, M.; Bae, J.; Kim, C.; Kim, D.; Joo, S.; Ha, J.; Park, C.; Kim, J.; Kim, Y.; Jarnert, C.; Ryden, L.; Mooe, T.; Binsell-Gerdin, E.; Dellborg, M.; Torstensson, I.; Albertsson, P.; Hiller, M.; Perers, E.; Johansson, L.; Jansson, J. H.; Al-Khalili, F.; Almroth, H.; Andersson, T.; Ostman, M. Eriksson; Pantev, E.; Utter, F.; Tengmark, B. O.; Olsson, A.; Liu, B.; Rasmanis, G.; Wahlgren, C. M.; Thott, O.; Moccetti, T.; Rossi, M. G.; Crljenica, C.; Parkhomenko, A.; Dovgan, N.; Skarzhevskyi, O.; Kozhukhov, S.; Tseluyko, V.; Mishchuk, N.; Kuznetsov, I.; Semenikhin, S.; Matviichuk, N.; Matuzok, O.; Yakovleva, L.; Volkov, V.; Zaprovalna, O.; Serik, S.; Riabukha, V.; Koval, O.; Kaplan, P.; Ivanov, A.; Romanenko, S.; Skoromna, A.; Kononenko, L.; Saprychova, L.; Lazareva, S.; Prokhorov, O.; Vdovychenko, V.; Bychkov, M.; Demydova, A.; Kapustynska, O.; Bazylevych, A.; Dutka, R.; Vlasyuk, Z.; Shabat, M.; Rudenko, L.; Beregova, O.; Fedtchouk, L.; Gusak, I.; Vizir, V.; Sadomov, A.; Shkolovoy, V.; Nasonenko, O.; Demidenko, O.; Karpenko, O.; Ponomarenko, K.; Oryshych, G.; Nevolina, I.; Mitskevych, L.; Bezuglova, S.; Kizim, S.; Todoriuk, L.; Brodi, N.; Karpenko, L.; Malynovsky, Y.; Fedotov, S.; Malynovska, O.; Goydenko, O.; Miroshnykov, S.; Rabota, I.; Koval, V.; Ohirko, O.; Khaba, U.; Storozhuk, B.; Danylchuk, I.; Danylchuk, A.; Gutsuliak, R.; Cotton, J.; Luckraz, H.; Wrigley, B.; Venkataraman, A.; Maher, A.; Moriarty, A.; McEneaney, D.; Connolly, D.; Davis, R.; Banerjee, P.; Davey, P.; Elmahi, E.; Senior, R.; Ahmed, A.; Birdi, I.; Gedela, S.; Singh, A.; Calvert, J.; Butler, M.; Donnelly, P.; Jasinka, A.; Orr, C.; Trevelyan, J.; Routledge, H.; Carter, J.; Oxenham, H.; Peace, A.; McNeill, A.; Austin, D.; Jackson, M.; Kukreja, N.; Kotwinski, P.; Hilton, T.; Bilizarian, S.; Srivastava, S.; Walsh, R.; Fields, R.; Portnay, E.; Gogia, H.; Deits, R.; Salacata, A.; Hunter, J.; Bacharach, J.; Shammas, N.; Suresh, D.; Gurbel, P.; Banerjee, S.; Grena, P.; Bedwell, N.; Brown, C.; Sloan, S.; Lupovitch, S.; Soni, A.; Gibson, K.; Pepper, D.; Sangrigoli, R.; Mehta, R.; Patel, J.; Tsai, P. I. Hsuan; Gillespie, E.; Harrison, A.; Dempsey, S.; Phillips, R.; Hamroff, G.; Hametz, C.; Black, R.; Lader, E.; Kostis, J.; Bittner, V.; Mcguinn, W.; Branch, K.; Cheng, R.; Pal, J.; Malhotra, V.; Michaelson, S.; Vacante, M.; Mccormick, M.; Arimie, R.; Dukkipati, R.; Camp, A.; Dagher, G.; Koshy, N.; Culp, J.; Thew, S.; Ferraro, A.; Costello, F.; Heiman, M.; Chilton, R.; Moran, M.; Adler, F.; Balingit, P.; Comerota, A.; Seiwert, A.; French, W.; Vardi, G.; Singh, T.; Serota, H.; Qayyum, U.; Das, S.; Harrison, R.; Vora, A.; Bakeen, F.; Omer, S.; Chandra, L.; Casaccia, G.; Tinto, J.; Sighel, C.; Giozzi, E.; Morell, Y.; Bianchini, M.; Yossen, M.; Hoyos, M.; Venturini, C.; Merkusa, C.; Carrique, A.; Carrique, P.; Fracaro, V.; Torres, M.; Crunger, P.; Espinosa, M.; Passarello, A.; Zaidman, M.; Ledesma, M.; Troncoso, C.; Aviles, A.; Rodera Vigil, S.; Vogel, M.; Takla, M.; Funosas, C.; Ferreiro, M.; Bruno, T.; Buzzetti, C.; Lozano, J.; Alvarez Damelio, A.; Bocanera, M.; Vicente, D.; Cenci, A.; Deluca, C.; Santana, R.; Ahuad Calvelo, A.; Alvarez D'Amelio, A.; Ahuad Calvelo, J.; Herrero, S.; Robertson, M.; Tapia, D.; Escalante, M.; Canas, M.; Cendali, G.; Esposito, L.; Muniz, M.; Montana, J.; Di Vruno, M.; Strevezza, M.; Lopez Santi, M.; Massei, N.; Garate, V.; Perlo, D.; Campora, F.; Jakubowski, I.; Gonzalez Moisello, M.; Actis, M.; Schiavi, S.; Aguirre, M.; Ceirano, C.; Zillo, M.; Yunis, M.; Berdini, A.; Gerbaudo, R.; Berdini, J.; Palma, F.; Pinero, S.; Virulio, S.; Vitale, A.; Sosa Flores, G.; Ibanez Saggia, C.; Ibanez Saggia, D.; Roses, A.; Martinelli, C.; Vargas, L.; Galarza Salazan, M.; Dran, P.; Tinnirello, V.; Pelayes, S.; Bordoni, P.; Navarro, A.; Barilati, P.; Serra, R.; Nigro, A.; Cleiman, S.; Bianchi, M.; Vallejo, M.; Ingratta, M.; Tonelli, L.; Levantini, M.; Bonifacio, M.; Hansen, V.; Chaieb, A.; Majul, S.; Medina, F.; Gallinotti, P.; Madariaga, T.; Andrea, G.; Blumberg, C.; Volpe, M.; Gandur, H.; Benincasa, V.; Barreto, M.; Jure, D.; Greenwell, D.; Forrest, N.; Nyman, E.; Mcintosh, C.; O'May, V.; Grabek, T.; Conway, B.; O'Donoghue, M.; Brady, L.; Duroux, M.; Ratcliffe, M.; Shone, S.; Connelly, A.; Ferreira-Jardim, A.; Vandernet, R.; Downes, R.; Davids, F.; Teal, L.; Knight, S.; Soraghan, D.; Spence, C.; Smith, K.; Tivendale, L.; Williams, Z.; O'Connor, M.; Walker, I.; Ferguson, L.; Holiday, J.; Griffin, R.; Palethorpe, L.; Hindom, L.; Lilwall, L.; Wadham, S.; Narasimhan, K.; Van Extergem, P.; Joris, I.; Oreglia, M.; Jacobs, C.; Leus, W.; Robesyn, V.; Vanheule, K.; Van Den Bossche, K.; Albertijn, S.; Vissers, C.; Badts, G.; Vangenechten, K.; Derycker, K.; Dejaegher, K.; De Grande, T.; De Clippel, M.; Gayet, F.; Jorion, M.; Jourdan, A.; Tartaglia, K.; Zwinnen, W.; Roijakkers, I.; Van Genechten, G.; Schoonis, A.; Bollen, J.; Janssen, A.; De Coninck, M.; Ruell, S.; Grimonprez, A.; Bouckaert, N.; Van Eeckhoutte, H.; Malmendier, D.; Massoz, M.; Jacquet, S.; Vanhalst, E.; Casier, T.; Barroso, S. L.; Tamashiro, N.; Correa, C. P.; Sehnem, E. A. B.; Precoma, C. B.; Pinheiro, L.; Ruschel, K. B.; Dos Reis, A. L.; Santos, M. S.; De Oliveira, L. O. S. P.; De Carvalho, L. M. G.; Dos Santos, M. E. S.; Reis, L. L. F.; Da Cunha, G. T.; Franca, F. F.; Bessa, S. K.; Vicente, C.; Ormundo, C.; Trama, L.; Pires, N. F.; Esteves, D.; Sila Junior, O. L.; Goes, N. C.; Amorin, R. C.; Faria, M. O.; Bucalon, E. C.; Marin, L. P.; Herek, L.; Araujo, V. L.; Silva, A. F.; Lima, F.; Gomes, C. G.; Pagnan, L. G.; Novelli, C. M.; Carvalho, J. K. C.; Teodoro, A. R.; Zimmermann, E. M. B.; Beiersdorf, J. R.; Machado, B. G.; Pedroso, F. B. V.; De Vargas, T.; Peres, C. S.; Dos Santos, T. F.; De Souza, S. F.; Luiz, R. O.; Ferreira, P.; Souza, D. F.; Cunha, S. M. C.; De Resende, I. M.; Furtado, C. C. F.; Soprane, A. A.; Brum, A. B.; Zorzo, J. A. T.; Dos Santos, J. C.; Queiroz, L. B.; Barros, F. E.; Vianna, C. O.; Zanateli, A.; Konishi, M. Y. N.; Vieira, A. P. Z.; Melo, G.; Zambonin, M. A. G. E. C.; Paiva, P.; Viana, R. M. M.; Yagihara, M. M.; Takiuti, M. M.; Miyamoto, P. B.; Da Silva, M. F.; Borin, L. A.; Chiazzini, S. M. L.; Fleck, N.; Batista, R. F.; Cardoso, D. T.; Camasmie, P. M.; Assompcao, R. P.; Marques, L. L.; Leung, S.; Lewis, C.; Tytus, A.; Clarus, S.; Juranics, S.; Pandey, M.; Frenette, L.; Magi, A.; Nowacki, B.; Otis, J.; Fox, B.; Corke, R.; Miller, B.; Rizzo, A.; Trombetta, L.; Power, P.; Richert, L.; Haligowski, R.; Macrae, C.; Kooistra, L.; Urso, C.; Fox, S.; Felbel, S.; Stafford, C.; Stata, C.; Barnabe, B.; Mehta, K.; Faul, J.; Gohel, J.; Bhakta, S.; Harwood, A.; McPherson, C.; Marucci, J.; Manasterski, L.; Veenhuyzen, J.; Ramadan, D.; Madden, B.; Jetha, A.; Pajevic, M.; Dube, C.; Rolfe, B.; O'Blenis, G.; Roy, L.; Dihel, C.; Butler, J.; Simmavong, K.; Bartol, C.; Bozek, B.; Hart, B.; Shier, M.; Coughlin, M.; Lamantia, C.; Lamantia, D.; Vilag, C.; Fecteau, J.; Dionne, J.; Peloquin, G.; Hogg, N.; Welsh, S.; Weerasingam, S.; Lantz, M.; Lounsbury, N.; Martin, E.; Mitchell, L.; Morgen, G.; Nelson, S.; Pelzer, E.; Sorensen, S.; LeBlanc, A.; Bourlaud, A. S.; Premont, A.; Leger, P.; Lariviere, M. M.; Tremblay, H.; Bergeron, A.; Dumont, J.; Keilani, S.; Landry, P.; Deneufbourg, I.; Breton, C.; Bilodeau, N.; Cote, M.; Dumont, F.; Dufort, L.; Marcoux, D.; David, M.; Otis, R.; Parks, J.; Cepidoza, C.; Janz, W.; Weighell, W.; Yaworski, S.; Boyd, K.; Lambert, J.; Shea-Landry, G.; Reid, K.; Thiessen, S.; Nemtean, D.; Futers, S.; Drouin, K.; Masson, C.; Arseneault, M. C.; Lachance, N.; Bergeron, C.; Boudreault, C.; Perkins, L.; Barnett, A.; Fortin, J.; Duclos, R.; Vallieres, C.; Bouchard-Pilote, C.; Ouimet, F.; Roberge, B.; Couture, M. L.; Deshaies, D.; Bastien, A.; Chartrand, M. J.; Gagne, N. L.; Desbiens, K.; Alarie, P.; Cassan, J.; Ducharme, Y.; Roy, I.; Tapps, D.; Bolduc, H.; Laliberte, J.; Hickey, L.; Spero, M.; Bernstein, M.; Clement, J.; Pawluch, A.; Ricci-Bonzey, M.; Richer, J.; Vaillancourt, J.; Ward, B.; Rad, P. Mostafai; Oleski, L.; Karkhanis, R.; Hartleib, V.; Poirier, R.; Hidalgo, J.; Hernandez, C.; Obreque, C.; Quilapi, D.; Villa, F.; Iturriaga, C.; Ferrada, M.; Navarrete, S.; Becerra, E.; Vargas, C.; Roque, C.; Alarcon, J.; Diaz, D.; Sepulveda, M.; Villan, C.; Garcia, N.; Lara, C.; Lezana, B.; Basso, N.; Torres, G.; Pasmino, C.; Gonzalez, S.; Medina, D.; Rodriguez, J.; Guo, T.; Chen, S.; Han, W.; Shi, D.; Zhang, Q.; Li, W.; Cui, L.; Huang, Z.; Gong, X.; Liu, D.; Tan, S.; Caicedo, L.; Rodriguez, A.; Mejia, I.; Escalante Ruiz, J.; Camera Ochoa, C.; Conrrado Ortega, Y.; Accini Diaz, A.; Rodriguez, B.; Lopez-Lopez, J.; Di Stefano, K.; Florez, L.; Manco, T.; Rodriguez, D.; Urina, A.; De La Hoz, L.; Almendrales, L.; Bello, O.; Urrea Valencia, H.; Correa Rivera, P.; Perdomo, I.; Alzate, J.; Rivera, E.; Jimenez, D.; Guzman, A.; Betancourt, S.; Mendoza Marin, H.; Leyva, M.; Ortiz, M.; Moreno, N.; Marin, E.; Angie Lorena, A.; Alvarez, Y.; Cervantes Hurtado, A.; Accini Mendoza, A.; Trujillo Accini, M.; Eguis, B.; Del Portillo, C.; Ortega, M.; Delgado, P.; Arciniegas, J.; Rodriguez, L.; Melo Sanchez, S.; Chavera, I.; Pastrana Mendoza, M.; Negrette Quintero, A.; Zidek, M.; Hajkova, D.; Rozskowska, P.; Opavska, I.; Souckova, E.; Matuskova, E.; Kratochvilova, T.; Pavelec, P.; Zelenkova, V.; Dolezalova, Z.; Marquez, M.; Moreira, D.; Zuleta, M.; Santana, G.; Coello, A.; Andrade, G.; Salazar, J.; Rivadeneira, J.; Vaerma, J.; Lappalainen, S.; Silvennoinen, S.; Haaraoja, A.; Valimaki, S.; Roine, E.; Abergel, H.; Msakni, W.; Fuentes, A.; Briday, G.; David, A.; Soltani, S.; Decorps, A.; Chettouh, M.; Douillet, M.; Zamiti-Smondel, A.; Cuccu, L.; Salhi, N.; Helene, M.; Martin, S.; Merah, A.; Daher, P.; Laurie, S.; Roussel, L.; Leperchois, C.; Delelo, E.; Thalamy, A.; Chazot, E.; Tahirovic, E.; Watson, S.; Brettschneider, B.; Maas, M.; Euler, K.; Rahn, G.; Beissner, S.; Anuschek, V.; Tu, E.; Buerger, M.; Schemann, J.; Klinger, C.; Kurzidim, T.; Sahbani, S.; Laszig, S.; Beilfuss, M.; Foerster, A.; Eichinger, G.; Rupprecht, M.; Kuehnert, J.; Wendler-Huelse, I.; Buelow-Johansen, B.; Baierlein, A.; Iselt, M.; Sievert, B.; Frommhold, R.; Wolf, T.; Hahn, M.; Schoen, B.; Acimic, C.; Ludwig, M.; Funkat, A.; Wagner, I.; Schink, M.; Calvo-Sanchez, D.; Feil, J. Felfoldine; Sumegi, T. Patakine; Miko-Pauer, R.; Courcy, M.; Kelly, C.; Farrell, D.; Kirrane, C.; Hall, M.; Gilroy, E.; Kelsey, M.; Andrew, G.; Joyce, M.; Conway, S.; Omer, T.; Duane, L.; Zuker, S.; Platner, N.; Saranga, H.; Kaufman, E.; Livshitz, L.; Genin, I.; Klainman, M.; Iunger, K. Uziel; Abitbul, A.; Fishman, B.; Greenshtein, I.; Tubul, O.; Lasri, E.; Zvi, R.; Yablonski, A.; Levin, L. Helmer; Lunetto, M. L.; Savoldi, D.; Fiorini, M.; Ramani, F.; Mariottoni, B.; Rizzotti, D.; Di Matteo, C.; Musio, S.; Minciaroli, S. Pieroni; Serani, S.; Aloisi, A.; Attanasio, C.; Tricoli, M.; Giordano, V.; Andrioli, V.; Biundo, V.; Schiff, D.; Trovarelli, P.; Chiodi, R.; Sampaolesi, S.; Cina, M. T.; Tullio, L.; Abatello, M.; De Tora, M.; Pietrucci, F.; Pezzetta, S.; Chiminelli, E.; Dall'Asta, A.; Bennati, M.; Elia, A.; Bizzoco, M.; Iaquaniello, A.; Spigarelli, R.; Cremonesi, C.; Gagliardi, M.; Torricelli, L.; Ijichi, N.; Shiraiwa, K.; Murakami, M.; Takeshita, K.; Sato, M.; Shiratori, A.; Kinjo, K.; Tomita, K.; Mizuno, M.; Kurihara, F.; Tachibana, M.; Nitta, Y.; Unno, K.; Hiramatsu, H.; Sano, A.; Nanatsumura, M.; Tanikawa, I.; Uesugi, K.; Banno, S.; Miyata, T.; Kujuji, A.; Kawai, K.; Maegawa, A.; Koseki, T.; Watanabe, Y.; Aoki, S.; Maesawa, M.; Suzuki, A.; Itose, Y.; Konishi, K.; Fujieda, K.; Nakade, S.; Minami, M.; Yoneda, J.; Akiyama, R.; Sakai, S.; Nakatani, K.; Yamazaki, A.; Funama, M.; Kaneko, E.; Morii, S.; Onishi, M.; Sone, A.; Sagawa, N.; Iwai, F.; Kawahara, A.; Hasimoto, C.; Ueki, M.; Kamiji, M.; Ando, M.; Yokoo, M.; Okada, Y.; Yamada, H.; Matsushige, N.; Nagato, A.; Matsumoto, R.; Nishikawa, M.; Oka, I.; Kitou, S.; Tachiuchi, M.; Nakagawa, M.; Yoneda, S.; Iwasa, K.; Matsuda, J.; Oda, A.; Tokudome, S.; Kaneyuki, Y.; Higaki, M.; Yoneda, H.; Kajita, C.; Suwa, K.; Sato, E.; Nagata, T.; Kubo, Y.; Umesu, A.; Ohashi, K.; Takeuchi, M.; Tanaka, I.; Nobehara, T.; Yamano, R.; Yumiba, A.; Hamada, M.; Nishihata, T.; Ohashi, Y.; Morita, M.; Endo, M.; Matsugi, M.; Tateishi, H.; Nakamori, R.; Yamashita, Y.; Okabe, M.; Matsuo, M.; Ono, T.; Shigeyama, Y.; Ichiyanagi, M.; Sugimori, K.; Ohmura, C.; Igarashi, M.; Aotsuka, S.; Komoda, N.; Watanabe, M.; Enomoto, Y.; Suzuki, Y.; Kawaguchi, A.; Kasahara, A.; Koide, A.; Sakatani, T.; Kurihara, T.; Yokota, S.; Futagi, R.; Amemiya, Y.; Ono, E.; Maeda, A.; Kadono, K.; Ishiguchi, Y.; Kikuchi, R.; Kuramatsu, M.; Nakamura, E.; Chiba, S.; Higa, A.; Kitahashi, M.; Tanaka, H.; Ito, T.; Oba, M.; Tsubouchi, M.; Toshima, M.; Morishita, M.; Miyano, A.; Kondo, M.; Watanabe, K.; Shibata, R.; Tosaki, Y.; Ito, Y.; Saoda, M.; Yamasaki, E.; Kadosaki, S.; Motooka, S.; Akiyoshi, H.; Morio, S.; Nemoto, H.; Yoshizawa, S.; Okabe, N.; Semba, K.; Yoshida, A.; Lee, Y.; Yoshida, M.; Iwashita, Y.; Takeda, A.; Maezato, M.; Kawahira, K.; Yoshikawa, M.; Okamoto, N.; Nishimura, M.; Matsuura, K.; Fukunaga, M.; Fukai, K.; Osakabe, Y.; Yamamura, K.; Koike, M.; Shibuya, S.; Shiramata, M.; Ono, Y.; Tsujimoto, Y.; Tadokoro, T.; Morishita, N.; Matsuo, Y.; Yumoto, I.; Sakazaki, S.; Atarashi, A.; Nabata, Y.; Okuda, N.; Fujita, A.; Matsuo, A.; Ishizawa, Y.; Shibata, H.; Ootsuka, M.; Taimatsu, R.; Takeuchi, A.; Sumi, Y.; Yamamoto, F.; Araki, Y.; Tanaka, A.; Kuroda, S.; Sakata, R.; Okada, N.; Sawada, Y.; Miyata, M.; Asayama, H.; Koga, N.; Miki, T.; Yamaguchi, N.; Hashimoto, A.; Fukuike, C.; Kubo, A.; Yamasaki, M.; Mori, Y.; Nakayama, S.; Kobayashi, Y.; Takenaka, S.; Mashima, M.; Katsuta, H.; Matsumura, T.; Yanagida, S.; Watanabe, N.; Kodama, S.; Kusano, M.; Yamamoto, N.; Kamada, R.; Suzuki, K.; Itami, K.; Hasebe, Y.; Fujita, N.; Kubota, S.; Usuki, A.; Okamoto, M.; Uno, S.; Chikuma, A.; Kishikawa, H.; Yano, C.; Nakano, K.; Otaguro, M.; Kayashima, Y.; Shinoda, M.; Jaafar, S. M.; Baharuddin, S.; Gembor, J.; Ahmad, H.; Mansor, S. M. Syed; Abdullah, W. M.; Shafie, Z.; Yunus, S. Muhamad; Alwi, S. M.; Hussin, N.; Basri, N. A.; Ling, L. Ling; Naem, N. S.; Rutten, R.; Rademaker, H.; Van Buijsen, M.; Scholten, M.; Stuij, S.; van Zeijst, M.; van Houwelingen, K.; Engelen, W.; Kramer, H.; Maassen, E.; Verhoeven, P.; Awater, J.; van Scheltinga, C. Terwisscha; Meijlis, P.; Blom, L.; Bos, M.; van der Wal, M.; Van Laerhoven, G.; Jacobs, T.; Tan-Urgert, B.; de Gaag, J. Van; Den Boer, P.; Verlek, E.; Lardinois, R.; Coenjaerds, C.; Hendrick, R.; Schoep, J.; Froma, E.; van Nes, C.; Beuving, D.; Krikken, J.; Drent, I.; Geerlings, F.; Buvelot, S.; Wissenburg, A.; Dijkshoorn, A.; Van Der Meer, L. Van Setten; Singerling, M.; Van Wijk, D.; Bor, A.; Aukema-Wouda, Z.; Hendriks-van Woerden, M.; Kort, I.; Danse, I.; van der Knaap, M.; de Jong, C.; Temminck, M.; Schaefer, T.; Van der Ven, N.; Drost, I.; Mulder, R.; De Vos, A.; de Hoop, M.; Post, G.; Wielandt, D.; Edorot, N.; De Castro, K.; Flotildes, M.; Mulingtapang, T.; Vasquez, S.; Facundo, S.; Peralta, M.; Jose, M.; Bandiez, J.; Sulit, P.; Joaquin, F.; Arbis, M. G.; Silva, C.; Delgado, D.; DeLeon, R.; Maglasang, P.; Sian, A.; Alagban, C.; Alcorano, J.; Marcelo, M. J.; Dela Pena, C.; Hyra, I.; Malkiewicz, B.; Mosakowska, K.; Cana, I.; Dobrin, I.; Lautaru, A.; Manescu, G.; Samoila, N.; Lacatus, M.; Apostoie, A.; Prunoiu, M.; Tilinca, M.; Budeanu, A.; Nedelcu, C.; Dumitrache, N.; Boeru, L.; Zhuravleva, E.; Gundova, M.; Hoffmannova, J.; Svitkova, M.; Pekarova, T.; Ujacka, K.; Zsoriova, T.; Kubincova, K.; Jankovicova, Z.; Talliard, C.; Tyumbu, N.; Mngoma, N.; Kannemeyer, M.; Mostert, J.; Page, A.; Krahenbuhl, C.; Tredoux, C.; Hendricks, L.; Oliver, S.; Le Grange, M.; Naidoo, V.; Bae, Y.; Kim, H.; Lee, J.; Yu, N.; An, S.; Kim, E.; Yang, K.; Woo, J.; Kim, S.; Rasck, J.; Smetana, S.; Ajax, K.; Bylander, L.; Lindberg, A.; Dellborg, H.; Hultsberg-Olsson, G.; Harsmar, K.; Knutsson, A.; Hakansson, L.; Kaveryd-Holmstrom, M.; Lundmark, L. M.; Norrfors, B.; Lof, P.; Skoglund, K.; Torgersruud, M.; Johansson, K.; Mattsson, A.; Quist, M.; Haglund, P.; Lundell, L.; Gunvasdotter, S.; Rangman, B.; Liu, R.; Shi, J.; Forstedt, G.; Nylund, L.; Welin-Berger, B.; Nilsson, O.; Garcia-Varlid, A.; Forlenza, R.; Kaminska, K.; Nagorna, T.; Cottam, V.; Harper, R.; Gilchrist, M.; Musanhu, R.; Mackin, A.; Turner, A.; Willetts, S.; Cadd, A.; Evans, J.; Young, G.; Sevillano, A.; Brodie, K.; Eccles, A.; Kelly, S.; Doughty, A.; Gray, J.; Gibson, M.; Finlayson, M.; Domingo, D.; Brazee, L.; Renaud, K.; Doman, A.; Meyer, R.; Beatty, J.; Morgan, T.; Rodas, E.; Campbell, D.; Mcquarrie, M.; Battistelli, E.; Eisenbraun, P.; Farley, R.; Park, H.; Dwyer, J.; Adams, K.; Schneider, W.; Barbour, C.; Whyne, E.; Budzinski, S.; Craig, M.; Elmore, J. Gilley; Scott, D.; Bellini, S.; Pepper, M.; Gunderson, K.; Stipek, I.; Schwarz, L.; Watkins, K.; Moore, V.; Palao, A.; Keane-Richmond, P.; Franklin, L.; Ward, L.; Kostedt, G.; Bailey, S.; Hollenweger, L.; Solomon, A.; Johnson, D.; Gloer, K.; Meyer, M.; Boleyn, M.; Nieters, D.; Humphrey, K.; Bohn, A.; Mueller, G.; Mckenzie, H.; Edwards, T.; Velky, J.; Cole, C.; Diederick, M.; Burg, S.; Coulson, T.; Karunaratne, K.; Gunasekera, R.; Cook, S.; Fisher, S.; Garrison, K.; Passey, L.; Kuykendall, K.; Luck, K.; Ramia, L.; Joan, H.; Reynoso, F.; Farley, M.; Shuman, S.; Santana-Fernandes, E.; Ventimiglia, A.; Steele, V.; Gers, L.; Brown, P.; Wilson, J.; Freebersyser, J.; Reno, M.; Buettner, N.; Mcgovern, M.; Hubbard, T.; Elmore, H.; Payne, D.; Mccann, M.; Decker, S.; Sharp, A.; Forgey, E.; Broussard, E.; Juett, U.; Siddiqui, A.		COMPASS Investigators	Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY PREVENTION; ORAL RIVAROXABAN; CLOPIDOGREL; TRIAL; RISK	BACKGROUND We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention. METHODS In this double-blind trial, we randomly assigned 27,395 participants with stable atherosclerotic vascular disease to receive rivaroxaban (2.5 mg twice daily) plus aspirin (100 mg once daily), rivaroxaban (5 mg twice daily), or aspirin (100 mg once daily). The primary outcome was a composite of cardiovascular death, stroke, or myocardial infarction. The study was stopped for superiority of the rivaroxaban-plus-aspirin group after a mean follow-up of 23 months. RESULTS The primary outcome occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (379 patients [4.1%] vs. 496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P< 0.001; z = -4.126), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (288 patients [3.1%] vs. 170 patients [1.9%]; hazard ratio, 1.70; 95% CI, 1.40 to 2.05; P< 0.001). There was no significant difference in intracranial or fatal bleeding between these two groups. There were 313 deaths (3.4%) in the rivaroxaban-plus-aspirin group as compared with 378 (4.1%) in the aspirin-alone group (hazard ratio, 0.82; 95% CI, 0.71 to 0.96; P = 0.01; threshold P value for significance, 0.0025). The primary outcome did not occur in significantly fewer patients in the rivaroxaban-alone group than in the aspirin-alone group, but major bleeding events occurred in more patients in the rivaroxaban- alone group. CONCLUSIONS Among patients with stable atherosclerotic vascular disease, those assigned to rivaroxaban (2.5 mg twice daily) plus aspirin had better cardiovascular outcomes and more major bleeding events than those assigned to aspirin alone. Rivaroxaban (5 mg twice daily) alone did not result in better cardiovascular outcomes than aspirin alone and resulted in more major bleeding events.	[Eikelboom, J. W.; Connolly, S. J.; Hart, R. G.; Shestakovska, O.; Lonn, E. M.; Anand, S. S.; Leong, D.; Yusuf, S.] McMaster Univ, Populat Hlth Res Inst, David Braley Res Bldg,237 Barton St E, Hamilton, ON L8L 2X2, Canada; [Eikelboom, J. W.; Connolly, S. J.; Bosch, J.; Hart, R. G.; Shestakovska, O.; Lonn, E. M.; Anand, S. S.; Leong, D.; Yusuf, S.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Dagenais, G. R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Diaz, R.] Estudios Clin Latino Amer, Rosario, Santa Fe, Argentina; [Diaz, R.] Inst Cardiovasc Rosario, Rosario, Santa Fe, Argentina; [Alings, M.] Amphia Ziekenhuis & Werkgroep Cardiol Ctr Nederla, Utrecht, Netherlands; [Widimsky, P.] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Cardioctr, Prague, Czech Republic; [Widimsky, P.] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Hori, M.] Osaka Int Canc Inst, Osaka, Japan; [Avezum, A.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Piegas, L. S.] Hosp Coracao, Sao Paulo, Brazil; [Branch, K. R. H.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Probstfield, J.] Univ Washington, Seattle, WA 98195 USA; [Bhatt, D. L.] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA; [Zhu, J.; Liang, Y.] FuWai Hosp, Beijing, Peoples R China; [Maggioni, A. P.] Natl Assoc Hosp Cardiologists Res Ctr ANMCO, Florence, Italy; [Lopez-Jaramillo, P.] Fdn Oftalmol Santander FOSCAL Bucaramanga, Res Inst, Bucaramanga, Colombia; [O'Donnell, M.] Natl Univ Ireland, Galway, Ireland; [Kakkar, A. K.] Thrombosis Res Inst, London, England; [Kakkar, A. K.] UCL, London, England; [Fox, K. A. A.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Guzik, T. J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Guzik, T. J.] Jagiellonian Univ, Coll Med, Krakow, Poland; [Parkhomenko, A. N.] Inst Cardiol, Kiev, Ukraine; [Ertl, G.; Stoerk, S.] Univ Wurzburg, Wurzburg, Germany; [Ertl, G.; Stoerk, S.] Univ Hosp, Wurzburg, Germany; [Bruns, N. Cook; Misselwitz, F.; Chen, E.] Bayer, Leverkusen, Germany; [Keltai, M.] Semmelweis Univ, Budapest, Hungary; [Ryden, L.] Karolinska Inst, Stockholm, Sweden; [Pogosova, N.] Natl Res Ctr Preventat Med, Moscow, Russia; [Dans, A. L.] Univ Philippines, Manila, Philippines; [Lanas, F.] Univ La Frontera, Temuco, Chile; [Commerford, P. J.] Univ Cape Town, Cape Town, South Africa; [Torp-Pedersen, C.] Aalborg Univ, Copenhagen, Denmark; [Verhamme, P. B.] Univ Leuven, Leuven, Belgium; [Vinereanu, D.] Carol Davila Univ & Emergency Hosp, Univ Med & Pharmacol, Bucharest, Romania; [Kim, J. -H.] Catholic Univ Korea, Seoul, South Korea; [Tonkin, A. M.] Monash Univ, Melbourne, Vic, Australia; [Lewis, B. S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Felix, C.] Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador; [Yusoff, K.] Univ Teknol Mara, Selangor, Malaysia; [Steg, P. G.] Univ Paris Diderot, Hop Bichat, AP HP, Paris, France; [Metsarinne, K. P.] Turku Univ Cent Hosp, Turku, Finland; [Metsarinne, K. P.] Turku Univ, Turku, Finland	McMaster University; Population Health Research Institute; McMaster University; Amphia Hospital; Charles University Prague; University Hospital Vinohrady; Charles University Prague; Instituto Dante Pazzanese de Cardiologia; Hospital do Coracao - HCor; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Ollscoil na Gaillimhe-University of Galway; Thrombosis Research Institute; University of London; University College London; University of Edinburgh; University of Glasgow; Jagiellonian University; Collegium Medicum Jagiellonian University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; University of Wurzburg; University of Wurzburg; Semmelweis University; Karolinska Institutet; National Medical Research Center for Therapy & Preventive Medicine; University of the Philippines System; University of the Philippines Manila; Universidad de La Frontera; University of Cape Town; Aalborg University; KU Leuven; Carol Davila University of Medicine & Pharmacy; Catholic University of Korea; Monash University; Clalit Health Services; Carmel Medical Center; Universiti Teknologi MARA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Turku; University of Turku	Eikelboom, JW (corresponding author), McMaster Univ, Populat Hlth Res Inst, David Braley Res Bldg,237 Barton St E, Hamilton, ON L8L 2X2, Canada.; Eikelboom, JW (corresponding author), Hamilton Gen Hosp, Hamilton Hlth Sci, David Braley Res Bldg,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	eikelbj@mcmaster.ca	Buzas, Roxana/ABF-1665-2021; Kratochvílová, Tereza/GXG-1344-2022; Iancu, Adrian Corneliu/ABI-4828-2020; Bobescu, Elena/AAC-6840-2021; Lokaj, Petr/AAG-4405-2020; Dregoesc, Mihaela Ioana/ABD-6765-2020; ANGHEL, LARISA/ABE-7401-2021; Zimmermann, Sérgio/AIE-5122-2022; Nesterova, Ekaterina/AAI-9317-2021; Klocek, Marek/O-8832-2014; Sinescu, Crina Julieta/AAA-8793-2021; Pogosova, Nana/G-7470-2016; Singh, Avinainder/AAJ-2920-2020; Popescu, Iulia/AAA-6427-2020; Padua, Luca/K-5398-2016; Kishihara, Jun/AAA-1489-2021; Sepúlveda, Pablo/GXF-5175-2022; Zateyshchikov, Dmitry/AGN-8590-2022; Panov, Dmitriy/E-7855-2017; Schwabová, Jaroslava Paulasová/ABE-8194-2021; ntsekhe, mpiko/AAI-8001-2021; Bosch, Jacqueline/AAP-6910-2021; Strazhesko, Irina/AAD-9390-2019; Avezum, Alvaro/AAP-7687-2020; Sadulaeva, Irina/C-6852-2018; Gaita, Dan/AGT-0656-2022; Maia, Lilia Nigro/AAV-6938-2021; Nakazone, Marcelo Arruda/H-2719-2012; Watson, Timothy J/E-5513-2014; Berkowitz, Scott Darrell/AAS-9397-2021; STEG, Philippe Gabriel/Z-1567-2019; Karetova, Debora/O-2411-2017; Yusoff, Khalid/I-7029-2019; Keltai, Katalin/V-4350-2019; Lanas, Fernando/AAE-8842-2022; Stork, Stefan/AAR-4182-2020; Marcián, Pavel/AAD-3284-2020; Zateyshchikov, Dmitry A/D-6575-2012; Luckraz, Heyman/AAV-7206-2020; Chioncel, Ovidiu/R-7556-2017; Jansen, Shirley/AAU-3889-2021; Sinagra, Gianfranco/AAE-3943-2020; Moayyedi, Paul/M-6178-2014; Furtado, Cassia/ABD-9529-2021; Voevoda, Elena/E-5478-2017; Hou, Kaijian/AFP-0275-2022; Lutay, Yaroslav/GLT-9262-2022; Hou, Kaijian/AAY-4716-2021; Repin, Alexey/AAB-9393-2019; Hou, Kaijian/GVU-1115-2022; Volpe, Massimo/K-5240-2016; Bazylevych, Andriy/G-2834-2019; Leonardi, Sergio/AAK-1490-2020; Novotny, Vojtech/L-7170-2018; Maggioni, Aldo Pietro/AAL-5334-2020; Špaček, MUDr./ABA-5193-2021; Hajšl, Martin/AAQ-6903-2020; Welsh, Robert/ABH-3526-2021; Meuris, Bart/AAH-1719-2019; Buzas, Roxana/AAB-4197-2020; Stellbrink, Christoph/AAX-7701-2021; Sepúlveda, Pablo Espicel/HCI-5123-2022; Nalesnik, Elena O/L-9929-2016; Dagher, Georges/AAC-1556-2020; Pogosova, Nana/ABG-1633-2021; Fresco, Claudio/M-5203-2015; O'Donnell, Martin/ABE-7459-2020; Bobescu, Elena/ABD-6951-2020; Folke, Fredrik/P-3601-2014; Abdelaleem, khadiga Gaafar/AAC-9612-2020; Cairns, John/AAI-8744-2021; Bertoletti, Laurent/X-1319-2019; Moceri, Pamela/D-3053-2014; Mincu, Raluca-Ileana/ABH-3141-2021; Urina-Triana, Miguel A/H-2605-2016; Fox, keith A A/I-3742-2013; Kozhukhov, Sergey/E-6498-2018; Widimsky, Petr/P-8088-2016; Rynkiewicz, Andrzej/AAW-8733-2021; Aroca, Gustavo/P-9173-2016; Ragino, Yulia I./E-9498-2015; Royse, Alistair/A-6046-2008; Malynovsky, Yaroslav/T-1898-2017; Guzik, BartÅomiej/AAP-4826-2020; Precoma, Dalton B/D-5674-2013; rozenbaum, zach/AAN-3130-2020; Fojt, Richard/AAD-5928-2019; Guzik, Tomasz Jan/AAM-5007-2020; Garganeeva, Natalia/R-3836-2016; Paucar, MJ/GSD-2205-2022; kasim, sazzli/G-4149-2012; ANGHEL, LARISA/Y-4048-2019; Voevoda, Mikhail/N-6713-2015; Eikelboom, John/AAG-6117-2019; Vanassche, Thomas/GQZ-9004-2022; Rizzotti, Diego/H-5610-2015; Opitz, Christian/L-3438-2019; Brat, Radim/G-7925-2019; Galrinho, Ruxandra Dragoi/B-1865-2019; Efremushkina, Anna/AAB-4871-2020; Bychkov, Mykola/G-2777-2019; Aboyans, Victor/AAN-8308-2020; Gafarov, Valeriy V/O-9502-2015; Brtko, Miroslav/ABE-3493-2020; Zaprovalna, Olga/AAT-1774-2021; Szuba, Andrzej/AAY-1162-2020; Petrella, Robert J/G-6557-2018; Rozenbaum, Zach/GQH-4884-2022; galvani, marcello/AAQ-3210-2020; Krackhardt, Florian/AAK-7561-2020; Gromova, Elena/Q-9879-2017; Barbarash, Olga/A-4834-2017; Spacek, Miroslav/I-4534-2017; Vasyuk, Yury/G-1772-2013; Serik, Serhii/T-3897-2018; Reis, Gilmar/I-4500-2013; Hlubocky, Jaroslav/I-4517-2017; Gajos, Grzegorz/None; Abdul Hafidz, Muhammad Imran/H-5933-2017; Repin, Alexey/J-6150-2017	Iancu, Adrian Corneliu/0000-0002-9764-1888; Dregoesc, Mihaela Ioana/0000-0003-0340-4476; Sinescu, Crina Julieta/0000-0001-5933-8549; Pogosova, Nana/0000-0002-4165-804X; Singh, Avinainder/0000-0003-1717-005X; Padua, Luca/0000-0003-2570-9326; Kishihara, Jun/0000-0002-5920-4417; Zateyshchikov, Dmitry/0000-0001-7065-2045; Schwabová, Jaroslava Paulasová/0000-0002-8465-8269; ntsekhe, mpiko/0000-0002-0851-7675; Bosch, Jacqueline/0000-0001-6292-4207; Sadulaeva, Irina/0000-0002-9278-2008; Nakazone, Marcelo Arruda/0000-0002-0449-7056; Watson, Timothy J/0000-0001-9260-4597; Berkowitz, Scott Darrell/0000-0002-9428-4408; Yusoff, Khalid/0000-0001-5669-5188; Keltai, Katalin/0000-0002-8294-9062; Stork, Stefan/0000-0002-1771-7249; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Luckraz, Heyman/0000-0003-1218-1243; Chioncel, Ovidiu/0000-0002-3197-3628; Jansen, Shirley/0000-0001-7781-4748; Moayyedi, Paul/0000-0002-3616-9292; Voevoda, Elena/0000-0002-5141-8074; Hou, Kaijian/0000-0003-1733-0068; Volpe, Massimo/0000-0002-9642-8380; Bazylevych, Andriy/0000-0001-5053-2548; Leonardi, Sergio/0000-0002-4800-6132; Novotny, Vojtech/0000-0003-3521-9945; Maggioni, Aldo Pietro/0000-0003-2764-6779; Hajšl, Martin/0000-0002-0684-092X; Buzas, Roxana/0000-0001-7476-6584; Nalesnik, Elena O/0000-0002-2665-9108; Fresco, Claudio/0000-0001-7123-8153; O'Donnell, Martin/0000-0002-7347-7761; Bobescu, Elena/0000-0002-0945-9067; Bertoletti, Laurent/0000-0001-8214-3010; Moceri, Pamela/0000-0002-0741-1609; Urina-Triana, Miguel A/0000-0001-6003-4622; Kozhukhov, Sergey/0000-0002-7973-7894; Widimsky, Petr/0000-0001-5686-7752; Aroca, Gustavo/0000-0002-9222-3257; Ragino, Yulia I./0000-0002-4936-8362; Royse, Alistair/0000-0002-4449-663X; Malynovsky, Yaroslav/0000-0002-9118-1104; Guzik, BartÅomiej/0000-0002-0630-8394; rozenbaum, zach/0000-0003-4953-7696; Garganeeva, Natalia/0000-0002-7353-7154; kasim, sazzli/0000-0003-4585-7713; Voevoda, Mikhail/0000-0001-9425-413X; Eikelboom, John/0000-0003-4126-1285; Vanassche, Thomas/0000-0002-7404-8918; Rizzotti, Diego/0000-0003-0641-8857; Brat, Radim/0000-0001-9381-9135; Bychkov, Mykola/0000-0001-6620-1751; Brtko, Miroslav/0000-0002-9577-9736; Zaprovalna, Olga/0000-0002-5066-0483; Rozenbaum, Zach/0000-0003-4953-7696; galvani, marcello/0000-0001-5897-667X; Krackhardt, Florian/0000-0001-5965-8817; Hueb, Whady/0000-0002-3166-6054; Meuris, Bart/0000-0001-9176-293X; Janion, Marianna/0000-0002-8811-4568; Houlind, Kim/0000-0002-1600-4415; Fedacko, Jan/0000-0002-4940-0393; Sinnaeve, Peter/0000-0003-4716-5892; Brenner, Susanne/0000-0003-3051-9498; Guzik, Tomasz/0000-0002-5039-7849; Gromova, Elena/0000-0001-8313-3893; Varallyay, Zoltan/0000-0002-8675-2005; McEneaney, David/0000-0002-1734-0736; Botto, Fernando/0000-0002-0572-8493; Fedak, Paul/0000-0003-0658-9381; Ibrahim, Khairul Shafiq/0000-0002-0507-8865; Cotton, James/0000-0001-6548-2723; DUARTE VERA, YAN CARLOS/0000-0003-4685-6907; Chachaj, Angelika/0000-0001-8087-8005; CELEMIN FLOREZ, CARLOS AUGUSTO/0000-0003-1147-5979; Branch, Kelley/0000-0003-2362-6498; Szuba, Andrzej/0000-0002-7555-6201; Mozdzan, Monika/0000-0002-1028-8314; Maga, Pawel/0000-0002-0944-0972; Murphy, Andrew/0000-0001-5549-8246; Mikulik, Robert/0000-0002-7458-5166; Gomez-Mesa, Juan Esteban/0000-0002-6635-6224; Lanas, Fernando/0000-0003-3595-9759; Felix, Camilo/0000-0003-0224-2321; Rynkiewicz, Andrzej/0000-0002-5284-9511; ederhy, stephane/0000-0002-0792-2521; Tesloianu, Nicolae-Dan/0000-0002-1007-3022; Bangdiwala, Shrikant/0000-0002-3111-0689; Kunz Sebba Barroso Souza, Weimar/0000-0002-1265-1930; Zimmermann, Sergio/0000-0002-9444-9209; Tytus, Richard/0000-0001-8247-8523; , jonathan/0000-0003-4451-1921; Vesga, Boris/0000-0001-6258-1195; Barbarash, Olga/0000-0002-4642-3610; Spacek, Miroslav/0000-0001-8742-8330; Mahon, Niall/0000-0002-2872-2297; Vasyuk, Yury/0000-0003-2913-9797; Katz, Amos/0000-0003-0422-934X; Yusuf, Salim/0000-0003-4776-5601; Sadomov, Anton/0000-0003-0298-7120; Kaplan, Pavel/0000-0003-0455-2630; Martens, Fabrice/0000-0002-0977-7276; Serik, Serhii/0000-0001-6257-3566; Cheng, Richard/0000-0001-5994-5998; Mishchenko, Larysa/0000-0001-5484-854X; Doimo, Sara/0000-0002-0885-4647; Sizova, Zhanna/0000-0002-1242-7074; Boulogne, Cyrille/0000-0001-5365-3492; Reis, Gilmar/0000-0002-4847-1034; Hlubocky, Jaroslav/0000-0003-4318-5490; Gajos, Grzegorz/0000-0002-7361-3559; Koranyi, Laszlo/0000-0002-5733-9350; Poulter, Rohan/0000-0002-9875-4374; Shestakovska, Olga/0000-0002-4175-4680; Canavan, Michelle/0000-0001-9445-0181; BARRETO, DHAYRA KAREM/0000-0001-6447-1854; Abdul Hafidz, Muhammad Imran/0000-0002-7444-9631; Halon, David/0000-0003-1865-7919; Parkhomenko, Liudmyla/0000-0002-4454-0979; Bury, Kamil/0000-0002-4689-3516; Barbieri, Andrea/0000-0002-7189-9602; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; AVEZUM, ALVARO/0000-0002-3073-6890; takahashi, akihiko/0000-0003-4906-2328; YEPEZ ALVARAN, JUAN PABLO/0000-0002-6907-4214; Fox, Keith/0000-0002-0140-2752; Turek, Daniel/0000-0003-3437-1275; Pella, Daniel/0000-0001-9999-6271; Ramsay, Tim/0000-0001-8478-8170; Welsh, Robert/0000-0003-2613-9142; Panov, Dmitriy/0000-0002-8101-6121; Folke, Fredrik/0000-0002-2284-7857; Repin, Alexey/0000-0001-7123-0645	Bayer	Bayer(Bayer AG)	Funded by Bayer; COMPASS ClinicalTrials.gov number, NCT01776424.	Anand S, 2007, NEW ENGL J MED, V357, P217; Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6; Anand SS, LANCET IN PRESS; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bosch J, 2017, CAN J CARDIOL, V33, P1027, DOI 10.1016/j.cjca.2017.06.001; Brechenmacher T, 2011, J BIOPHARM STAT, V21, P748, DOI 10.1080/10543406.2011.551334; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Connolly SJ, LANCET IN PRESS; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Turpie AGG, 2011, THROMB HAEMOSTASIS, V105, P444, DOI 10.1160/TH10-09-0601	19	1208	1258	22	256	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2017	377	14					1319	1330		10.1056/NEJMoa1709118	http://dx.doi.org/10.1056/NEJMoa1709118			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ0CB	28844192	Green Published, Bronze			2022-12-28	WOS:000412375000012
J	Manning, BD				Manning, Brendan D.			Game of TOR - The Target of Rapamycin Rules Four Kingdoms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MAMMALIAN PROTEIN; YEAST; COMPLEX		[Manning, Brendan D.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Manning, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.		Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721	8	19	23	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2017	377	13					1297	1299		10.1056/NEJMcibr1709384	http://dx.doi.org/10.1056/NEJMcibr1709384			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI3DU	28874074				2022-12-28	WOS:000411838100016
J	Yang, HW; Chung, M; Kudo, T; Meyer, T				Yang, Hee Won; Chung, Mingyu; Kudo, Takamasa; Meyer, Tobias			Competing memories of mitogen and p53 signalling control cell-cycle entry	NATURE			English	Article							PROLIFERATION-QUIESCENCE DECISION; DNA-DAMAGE RESPONSE; REPLICATION STRESS; D1; P21; INHIBITION; ACTIVATION; EXPRESSION; RADIATION; P21(CIP1)	Regulation of cell proliferation is necessary for immune responses, tissue repair, and upkeep of organ function to maintain human health(1). When proliferating cells complete mitosis, a fraction of newly born daughter cells immediately enter the next cell cycle, while the remaining cells in the same population exit to a transient or persistent quiescent state(2). Whether this choice between two cell-cycle pathways is due to natural variability in mitogen signalling or other underlying causes is unknown. Here we show that human cells make this fundamental cell-cycle entry or exit decision based on competing memories of variable mitogen and stress signals. Rather than erasing their signalling history at cell-cycle checkpoints before mitosis, mother cells transmit DNA damage-induced p53 protein and mitogen-induced cyclin D1 (CCND1) mRNA to newly born daughter cells. After mitosis, the transferred CCND1 mRNA and p53 protein induce variable expression of cyclin D1 and the CDK inhibitor p21 that almost exclusively determines cell-cycle commitment in daughter cells. We find that stoichiometric inhibition of cyclin D1-CDK4 activity by p21 controls the retinoblastoma (Rb) and E2F transcription program in an ultrasensitive manner. Thus, daughter cells control the proliferation-quiescence decision by converting the memories of variable mitogen and stress signals into a competition between cyclin D1 and p21 expression. We propose a cell-cycle control principle based on natural variation, memory and competition that maximizes the health of growing cell populations.	[Yang, Hee Won; Chung, Mingyu; Kudo, Takamasa; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA	Stanford University	Yang, HW; Meyer, T (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA.	heewony@stanford.edu; tobias1@stanford.edu		Chung, Mingyu/0000-0003-1718-6203; Meyer, Tobias/0000-0003-4339-3804; Yang, Hee Won/0000-0002-0000-8091	National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A6A3A03025832]; NIGMS [GM11837, GM063702, PGM107615]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063702, R01GM118377, P50GM107615] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Education; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Aoki and M. Matsuda for EKAR sensors, J. Stewart-Ornstein and G. Lahav for the p21-and p53-tagged MCF7 cell line, J. Ferrell, K. Cimprich, S. Collins, A. Hayer, S. Cappell, L. Pack, C. Liu, Y. Fan, L. Daigh, A. Jaimovich and S. Spencer for discussions, and the Stanford Shared FACS Facility for cell sorting. This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A6A3A03025832) and NIGMS R01 grants (GM11837, GM063702 and PGM107615).	Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Arora M, 2017, CELL REP, V19, P1351, DOI 10.1016/j.celrep.2017.04.055; Barr AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14728; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chen JY, 2013, MOL CELL, V52, P87, DOI 10.1016/j.molcel.2013.09.009; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P556, DOI 10.1016/j.tibs.2014.09.003; Grillo M, 2006, BREAST CANCER RES TR, V95, P185, DOI 10.1007/s10549-005-9066-y; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hitomi M, 1999, CURR BIOL, V9, P1075, DOI 10.1016/S0960-9822(99)80476-X; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Stewart-Ornstein J, 2016, CELL REP, V14, P1800, DOI 10.1016/j.celrep.2016.01.045; Sugimoto M, 2002, ONCOGENE, V21, P8067, DOI 10.1038/sj.onc.1206019; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	26	120	125	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					404	+		10.1038/nature23880	http://dx.doi.org/10.1038/nature23880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7PB	28869970	Green Accepted			2022-12-28	WOS:000411381300039
J	Mi, W; Li, YY; Yoon, SH; Ernst, RK; Walz, T; Liao, MF				Mi, Wei; Li, Yanyan; Yoon, Sung Hwan; Ernst, Robert K.; Walz, Thomas; Liao, Maofu			Structural basis of MsbA-mediated lipopolysaccharide transport	NATURE			English	Article							BINDING CASSETTE TRANSPORTER; ABC TRANSPORTER; MOLECULAR-MECHANISM; ALTERNATING ACCESS; BIOSYNTHESIS; RECOGNITION; DIVERSITY; RESONANCE; FLIPPASE; COMPLEX	Lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria is critical for the assembly of their cell envelopes. LPS synthesized in the cytoplasmic leaflet of the inner membrane is flipped to the periplasmic leaflet by MsbA, an ATP-binding cassette transporter. Despite substantial efforts, the structural mechanisms underlying MsbA-driven LPS flipping remain elusive. Here we use single-particle cryo-electron microscopy to elucidate the structures of lipid-nanodisc-embedded MsbA in three functional states. The 4.2 angstrom-resolution structure of the transmembrane domains of nucleotide-free MsbA reveals that LPS binds deep inside MsbA at the height of the periplasmic leaflet, establishing extensive hydrophilic and hydrophobic interactions with MsbA. Two sub-nanometre-resolution structures of MsbA with ADP-vanadate and ADP reveal an unprecedented closed and an inward-facing conformation, respectively. Our study uncovers the structural basis for LPS recognition, delineates the conformational transitions of MsbA to flip LPS, and paves the way for structural characterization of other lipid flippases.	[Mi, Wei; Liao, Maofu] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Li, Yanyan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Yoon, Sung Hwan; Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Walz, Thomas] Rockefeller Univ, Lab Mol Electron Microscopy, 1230 York Ave, New York, NY 10065 USA	Harvard University; Harvard Medical School; Jiangnan University; University System of Maryland; University of Maryland Baltimore; Rockefeller University	Liao, MF (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Walz, Thomas/0000-0003-2606-2835; Ernst, Robert/0000-0001-5016-8694; Yoon, Sung Hwan/0000-0001-5794-3286; Li, Yanyan/0000-0002-8109-7574	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122797] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM122797] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Buchaklian AH, 2005, BIOCHEMISTRY-US, V44, P5503, DOI 10.1021/bi047568v; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Doshi R, 2013, J BIOL CHEM, V288, P21638, DOI 10.1074/jbc.M113.485714; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gu RX, 2015, BIOCHEMISTRY-US, V54, P5989, DOI 10.1021/acs.biochem.5b00753; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; HASIN M, 1982, J BIOL CHEM, V257, P2475; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kaur H, 2015, BIOL CHEM, V396, P1135, DOI 10.1515/hsz-2015-0119; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Kim JM, 2015, NATURE, V517, P396, DOI 10.1038/nature13872; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Lin DYW, 2015, NATURE, V523, P425, DOI 10.1038/nature14623; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; May JM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0027; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Oldham ML, 2016, NATURE, V529, P537, DOI 10.1038/nature16506; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P3599, DOI 10.1021/bi101666p; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Sharom FJ, 2011, IUBMB LIFE, V63, P736, DOI 10.1002/iub.515; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Simpson BW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0029; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; van Meer G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004671; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zheng S., 2016, ANISOTROPIC CORRECTI; Zoghbi ME, 2016, J BIOL CHEM, V291, P4453, DOI 10.1074/jbc.M115.698498; Zou P, 2010, BIOPHYS J, V98, pL18, DOI 10.1016/j.bpj.2009.12.4193; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051	66	147	147	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					233	+		10.1038/nature23649	http://dx.doi.org/10.1038/nature23649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28869968	Green Accepted			2022-12-28	WOS:000410555900037
J	Rubin, R				Rubin, Rita			Alleged acoustic attack on US diplomats puzzling experts	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					E22	E22		10.1016/S0140-6736(17)32359-0	http://dx.doi.org/10.1016/S0140-6736(17)32359-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28870717				2022-12-28	WOS:000409528600001
J	Wiesner, DL; Klein, BS				Wiesner, Darin L.; Klein, Bruce S.			The balance between immunity and inflammation	SCIENCE			English	Editorial Material							DIVERSITY; OBESITY; ASTHMA		[Wiesner, Darin L.; Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA; [Wiesner, Darin L.; Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Internal Med, Madison, WI 53792 USA; [Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Klein, BS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA.; Klein, BS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Internal Med, Madison, WI 53792 USA.; Klein, BS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53792 USA.	bsklein@pediatrics.wisc.edu			NIAID NIH HHS [R37 AI035681, R01 AI035681, T32 AI055397, R01 AI040996] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035681, R01AI040996, T32AI055397] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2017, BURD FUNG DIS; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; CDC, 2013, CDC ASTHM FACTS CDCS; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Jhingran A, 2012, CELL REP, V2, P1762, DOI 10.1016/j.celrep.2012.10.026; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; Sharon A., 2009, MYCOTA; Sharon A, 2009, FEMS MICROBIOL REV, V33, P833, DOI 10.1111/j.1574-6976.2009.00180.x; Shlezinger N, 2017, SCIENCE, V357, P1037, DOI 10.1126/science.aan0365; Shlezinger N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002185; Sinclair C, 2017, SCIENCE, V357, P1014, DOI 10.1126/science.aaj2155	14	3	4	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		973	974		10.1126/science.aao3086	http://dx.doi.org/10.1126/science.aao3086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883060	Green Accepted			2022-12-28	WOS:000409455700026
J	Halamka, JD; Tripathi, M				Halamka, John D.; Tripathi, Micky			The HITECH Era in Retrospect	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Halamka, John D.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Halamka, John D.] Harvard Med Sch, Boston, MA 02115 USA; [Tripathi, Micky] Massachusetts eHlth Collaborat, Waltham, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Halamka, JD (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.; Halamka, JD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.								0	46	46	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					907	909		10.1056/NEJMp1709851	http://dx.doi.org/10.1056/NEJMp1709851			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF9XU	28877012				2022-12-28	WOS:000409373100004
J	Singh, P				Singh, Poonam			One Health approach to tackle antimicrobial resistance in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Singh, Poonam] WHO, South East Asia Reg, New Delhi, India	World Health Organization	Singh, P (corresponding author), WHO, South East Asia Reg, New Delhi, India.	singhpoonam@who.int			WHO SEARO	WHO SEARO(World Health Organization)	This article is one of a series commissioned by The BMJ based on an idea from WHO SEARO. The BMJ retained full editorial control over external peer review, editing, and publication. Open access fees are funded by the WHO SEARO.		0	15	16	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						1	1	j3625	10.1136/bmj.j3625	http://dx.doi.org/10.1136/bmj.j3625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874363	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000410575100010
J	Barnett, R				Barnett, Richard			Case histories Lung cancer	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	12	12	1	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					928	928		10.1016/S0140-6736(17)32243-2	http://dx.doi.org/10.1016/S0140-6736(17)32243-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28872022				2022-12-28	WOS:000408746300013
J	Sharma, DC				Sharma, Dinesh C.			Over 60 children die in a hospital in north India	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					926	926		10.1016/S0140-6736(17)32332-2	http://dx.doi.org/10.1016/S0140-6736(17)32332-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28872020				2022-12-28	WOS:000408746300011
J	Wright, IJ; Dong, N; Maire, V; Prentice, IC; Westoby, M; Diaz, S; Gallagher, RV; Jacobs, BF; Kooyman, R; Law, EA; Leishman, MR; Niinemets, U; Reich, PB; Sack, L; Villar, R; Wang, H; Wilf, P				Wright, Ian J.; Dong, Ning; Maire, Vincent; Prentice, I. Colin; Westoby, Mark; Diaz, Sandra; Gallagher, Rachael V.; Jacobs, Bonnie F.; Kooyman, Robert; Law, Elizabeth A.; Leishman, Michelle R.; Niinemets, Ulo; Reich, Peter B.; Sack, Lawren; Villar, Rafael; Wang, Han; Wilf, Peter			Global climatic drivers of leaf size	SCIENCE			English	Article							TEMPERATURES; ENERGY; PLANTS; MORPHOLOGY; PATTERNS; RAINFALL; TRAITS; LEAVES; COSTS; FROST	Leaf size varies by over a 100,000-fold among species worldwide. Although 19th-century plant geographers noted that the wet tropics harbor plants with exceptionally large leaves, the latitudinal gradient of leaf size has not been well quantified nor the key climatic drivers convincingly identified. Here, we characterize worldwide patterns in leaf size. Large-leaved species predominate in wet, hot, sunny environments; small-leaved species typify hot, sunny environments only in arid conditions; small leaves are also found in high latitudes and elevations. By modeling the balance of leaf energy inputs and outputs, we show that daytime and nighttime leaf-to-air temperature differences are key to geographic gradients in leaf size. This knowledge can enrich "next-generation" vegetation models in which leaf temperature and water use during photosynthesis play key roles.	[Wright, Ian J.; Dong, Ning; Maire, Vincent; Prentice, I. Colin; Westoby, Mark; Gallagher, Rachael V.; Kooyman, Robert; Law, Elizabeth A.; Leishman, Michelle R.; Wang, Han] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Dong, Ning] Univ Reading, Ctr Climate Change, Reading RG6 6AH, Berks, England; [Dong, Ning] Univ Reading, SAGES, Reading RG6 6AH, Berks, England; [Maire, Vincent] Univ Quebec Trois Rivieres, Trois Rivieres, PQ G9A 5H7, Canada; [Prentice, I. Colin] Imperial Coll London, Dept Life Sci, AXA Chair Biosphere & Climate Impacts, Silwood Pk Campus,Buckhurst Rd, Ascot SL5 7PY, Berks, England; [Diaz, Sandra] Univ Nacl Cordoba, Inst Multidisciplinario Biol Vegetal IMBIV, Consejo Nacl Invest Cient & Tecn, Casilla Correo 495, RA-5000 Cordoba, Argentina; [Diaz, Sandra] Univ Nacl Cordoba, Fac Ciencias Exactas Fis Nat, Casilla Correo 495, RA-5000 Cordoba, Argentina; [Jacobs, Bonnie F.] Southern Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA; [Law, Elizabeth A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Niinemets, Ulo] Estonian Univ Life Sci, Inst Agr & Environm Sci, Kreutzwaldi 1, EE-51014 Tartu, Estonia; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA 90095 USA; [Villar, Rafael] Univ Cordoba, Fac Ciencias, Area Ecol, Cordoba 14071, Spain; [Wang, Han] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess, Coll Forestry, Yangling 712100, Peoples R China; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Macquarie University; University of Reading; University of Reading; University of Quebec; University of Quebec Trois Rivieres; Imperial College London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Southern Methodist University; University of Queensland; Estonian University of Life Sciences; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of California System; University of California Los Angeles; Universidad de Cordoba; Northwest A&F University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wright, IJ (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	ian.wright@mq.edu.au	Wright, Ian J/G-4979-2012; Diaz, Sandra/Q-9804-2018; Kooyman, Robert M/H-3347-2017; Niinemets, Ülo/A-3816-2008; Leishman, Michelle M/G-9726-2012; Leishman, Michelle/AAU-4102-2020; Sack, Lawren/A-5492-2008; Díaz, Sandra/ABE-7349-2020; Villar, Rafael/F-7507-2010; Law, Elizabeth/C-8981-2015	Wright, Ian J/0000-0001-8338-9143; Kooyman, Robert M/0000-0003-1985-9547; Niinemets, Ülo/0000-0002-3078-2192; Leishman, Michelle M/0000-0003-4830-5797; Leishman, Michelle/0000-0003-4830-5797; Sack, Lawren/0000-0002-7009-7202; Díaz, Sandra/0000-0003-0012-4612; Villar, Rafael/0000-0002-3895-9984; Gallagher, Rachael/0000-0002-4680-8115; dong, ning/0000-0003-0793-8854; Reich, Peter/0000-0003-4424-662X; Maire, Vincent/0000-0002-3245-2568; Law, Elizabeth/0000-0003-4456-1259; Wang, Han/0000-0003-2482-1818; Prentice, Iain Colin/0000-0002-1296-6764; Westoby, Mark/0000-0001-7690-4530	Australian Research Council [RN0459908, DP0558411, FT100100910]; Macquarie University; Spanish Ministerio de Educacion y Ciencia project ECO-MEDIT [CGL2014-53236-R]; European Fondo Europeo de Desarrollo Regional funds; National Science Foundation (USA) [EAR-9510015]	Australian Research Council(Australian Research Council); Macquarie University; Spanish Ministerio de Educacion y Ciencia project ECO-MEDIT(German Research Foundation (DFG)); European Fondo Europeo de Desarrollo Regional funds; National Science Foundation (USA)(National Science Foundation (NSF))	We thank the following people who generously provided access to previously unpublished trait data or data otherwise unavailable from source publications: D. Ackerly, H. Cornelissen, W. Cornwell, D. Duncan, E. Garnier, L. Yulin, J. Lloyd, H. Morgan, T. Navarro, J. Oleksyn, J. Overton, O. Phillips, N. Pitman, H. Poorter, L. Poorter, C. Vriesendorp, J. Wright, and A. Zanne. J. Cooke, T. Lenz, A. Ordonez, and J. Suitch helped compile and error-check trait data. This research was funded by the Australian Research Council (grants RN0459908, DP0558411, and FT100100910) and by Macquarie University (Ph.D. scholarship supporting N. D.) and is a contribution to the AXA Chair Programme in Biosphere and Climate Impacts and the Imperial College initiative on Grand Challenges in Ecosystems and the Environment. R.V. was funded by the Spanish Ministerio de Educacion y Ciencia project ECO-MEDIT (CGL2014-53236-R) and European Fondo Europeo de Desarrollo Regional funds. B.F.J. acknowledges support from the National Science Foundation (USA), grant EAR-9510015. This work originated from a working group held at Macquarie University. The leaf trait data set was compiled by I. J. W., E. A. L., and R.V.G.,from literature data and data provided by S.D., R.V.G., B.F.J., R.K., M.R.L., U.N., P.B.R., R.V., M.W., P.W., and I. J. W. Geographic and climate data were compiled or calculated by I. J. W., E. A. L., V.M., and H. W. Statistical analyses were run by V.M. and I. J. W. The modeling component was conceived by I.C.P., N. D., and I. J. W. and run by N.D.L.S. initially suggested teaming empirical analysis with energy balance models. V.M., N. D., and R.V. created the figures. I. J. W. drafted the initial manuscript with assistance from I.C.P. All coauthors contributed to subsequent versions. The "global leaf size data set" is available as an Excel workbook in the supplementary materials.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Ackerly DD, 2002, OECOLOGIA, V130, P449, DOI 10.1007/s004420100805; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Chiariello N., 1984, Physiological ecology of plants in the wet tropics. Proceedings of an international symposium held in Oxatepec and Los Tuxtlas, Mexico, June 29 to July 6, 1983, P85; Curtis EM, 2014, OECOLOGIA, V175, P1051, DOI 10.1007/s00442-014-2988-5; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Dong N, 2017, GLOBAL ECOL BIOGEOGR, V26, P998, DOI 10.1111/geb.12614; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; GATES DM, 1965, ECOLOGY, V46, P1, DOI 10.2307/1935252; GATES DM, 1968, ANN REV PLANT PHYSIO, V19, P211, DOI 10.1146/annurev.pp.19.060168.001235; Givnish T. J., 1984, Physiological ecology of plants in the wet tropics. Proceedings of an international symposium held in Oxatepec and Los Tuxtlas, Mexico, June 29 to July 6, 1983, P51; GIVNISH TJ, 1976, AM NAT, V110, P743, DOI 10.1086/283101; GIVNISH TJ, 1987, NEW PHYTOL, V106, P131, DOI 10.1111/j.1469-8137.1987.tb04687.x; GREENWOOD DR, 1992, REV PALAEOBOT PALYNO, V71, P149, DOI 10.1016/0034-6667(92)90161-9; Halloy SRP, 1996, J ROY SOC NEW ZEAL, V26, P41, DOI 10.1080/03014223.1996.9517504; Hu ZH, 2005, PHOTOSYNTHETICA, V43, P529, DOI 10.1007/s11099-005-0085-z; Huntingford C, 1998, BOUND-LAY METEOROL, V88, P87, DOI 10.1023/A:1001110819090; Jacobs BF, 1999, PALAEOGEOGR PALAEOCL, V145, P231, DOI 10.1016/S0031-0182(98)00102-3; Jensen KH, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.018104; Jones HG, 2014, PLANTS AND MICROCLIMATE: A QUANTITATIVE APPROACH TO ENVIRONMENTAL PLANT PHYSIOLOGY, 3RD EDITION, P1; JORDAN DN, 1994, AGR FOREST METEOROL, V71, P359, DOI 10.1016/0168-1923(94)90020-5; KORNER C, 1989, FLORA, V182, P353; Larcher W, 2003, PHYSL PLANT ECOLOGY; Leigh A, 2017, PLANT CELL ENVIRON, V40, P237, DOI 10.1111/pce.12857; LEUNING R, 1988, AGR FOREST METEOROL, V42, P135, DOI 10.1016/0168-1923(88)90073-1; Michaletz ST, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.129, 10.1038/NPLANTS.2016.129]; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Moles AT, 2000, OIKOS, V90, P517, DOI 10.1034/j.1600-0706.2000.900310.x; Niinemets U, 2007, ANN BOT-LONDON, V100, P283, DOI 10.1093/aob/mcm107; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Pickup M, 2005, FUNCT ECOL, V19, P88, DOI 10.1111/j.0269-8463.2005.00927.x; Raupach MR, 2001, Q J ROY METEOR SOC, V127, P1149, DOI 10.1002/qj.49712757402; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; SMITH WK, 1978, SCIENCE, V201, P614, DOI 10.1126/science.201.4356.614; Taylor S. E., 1975, Perspectives of biophysical ecology., P73; Vitasse Y, 2014, J ECOL, V102, P981, DOI 10.1111/1365-2745.12251; Warming E, 1909, OECOLOGY OF PLANTS; Wilf P, 1998, GEOLOGY, V26, P203, DOI 10.1130/0091-7613(1998)026<0203:UFLAPI>2.3.CO;2; Wright IJ, 2006, PHYSIOL PLANTARUM, V127, P445, DOI 10.1111/j.1399-3054.2006.00699.x	42	393	421	69	480	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					917	+		10.1126/science.aal4760	http://dx.doi.org/10.1126/science.aal4760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860384	Green Submitted			2022-12-28	WOS:000408734900042
J	Upton, B				Upton, Ben			ARCHAEOLOGY Submarine mystery solved	NATURE			English	News Item																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					511	511		10.1038/nature.2017.22447	http://dx.doi.org/10.1038/nature.2017.22447			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858322	Bronze			2022-12-28	WOS:000408703100008
J	Leslie, M				Leslie, Mitch			Zebrafish larvae could help to personalize cancer treatments	SCIENCE			English	News Item																			0	8	8	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					745	745		10.1126/science.357.6353.745	http://dx.doi.org/10.1126/science.357.6353.745			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839055				2022-12-28	WOS:000408327900019
J	Stokstad, E				Stokstad, Erik			Surge in right whale deaths raises alarms	SCIENCE			English	News Item																			0	4	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					740	741		10.1126/science.357.6353.740	http://dx.doi.org/10.1126/science.357.6353.740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839051				2022-12-28	WOS:000408327900015
J	Su, XD; Ma, J; Wei, XP; Cao, P; Zhu, DJ; Chang, WR; Liu, ZF; Zhang, XZ; Li, M				Su, Xiaodong; Ma, Jun; Wei, Xuepeng; Cao, Peng; Zhu, Dongjie; Chang, Wenrui; Liu, Zhenfeng; Zhang, Xinzheng; Li, Mei			Structure and assembly mechanism of plant C2S2M2-type PSII-LHCII supercomplex	SCIENCE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II; CRYSTAL-STRUCTURE; GRANA MEMBRANES; PROTEIN; CP24; IDENTIFICATION; ORGANIZATION; PH	In plants, the photosynthetic machinery photosystem II (PSII) consists of a core complex associated with variable numbers of light-harvesting complexes II (LHCIIs). The supercomplex, comprising a dimeric core and two strongly bound and two moderately bound LHCIIs (C2S2M2), is the dominant form in plants acclimated to limited light. Here we report cryo-electron microscopy structures of two forms of C2S2M2 (termed stacked and unstacked) from Pisum sativum at 2.7- and 3.2-angstrom resolution, respectively. In each C2S2M2, the moderately bound LHCII assembles specifically with a peripheral antenna complex CP24-CP29 heterodimer and the strongly bound LHCII, to establish a pigment network that facilitates light harvesting at the periphery and energy transfer into the core. The high mobility of peripheral antennae, including the moderately bound LHCII and CP24, provides insights into functional regulation of plant PSII.	[Su, Xiaodong; Ma, Jun; Wei, Xuepeng; Cao, Peng; Zhu, Dongjie; Chang, Wenrui; Liu, Zhenfeng; Zhang, Xinzheng; Li, Mei] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhu, Dongjie] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Chang, Wenrui; Liu, Zhenfeng; Zhang, Xinzheng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Ctr Biol Imaging, Beijing 100101, Peoples R China; [Wei, Xuepeng] Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Wei, Xuepeng] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Liu, ZF; Zhang, XZ; Li, M (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Liu, ZF; Zhang, XZ (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Zhang, XZ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Ctr Biol Imaging, Beijing 100101, Peoples R China.	liuzf@ibp.ac.cn; xzzhang@ibp.ac.cn; meili@ibp.ac.cn	zhang, xinzheng/L-6254-2019	Zhang, Xinzheng/0000-0002-0114-0270; liu, zhen feng/0000-0001-5502-9474; Su, Xiaodong/0000-0001-6650-2327; Zhu, Dongjie/0000-0002-5052-1782; Ma, Jun/0000-0002-3823-8714; Wei, Xuepeng/0000-0002-6514-7076; Li, Mei/0000-0002-1742-2360; , Peng/0000-0002-2044-3074; Cao, Peng/0000-0002-4616-5914	Strategic Priority Research Program of CAS [XDB08020302, XDB08030204]; Key Research Program of Frontier Sciences of CAS [QYZDB-SSW-SMC005]; National Key R&D Program of China [2017YFA0503702, 2017YFA0504700]; National 973 project [2011CBA00900]; National Natural Science Foundation of China [31570724, 31270793]; National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China	Strategic Priority Research Program of CAS; Key Research Program of Frontier Sciences of CAS; National Key R&D Program of China; National 973 project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China	We thank J. Zhang and X. Zhao for their assistance in preparing thylakoid samples. Cryo-EM data collection was carried out at the Center for Biological Imaging, Core Facilities for Protein Science, at the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS). We thank X. Huang, G. Ji, Z. Guo, B. Zhu, D. Fan, F. Sun, and other staff members at the Center for Biological Imaging (IBP, CAS) for their support in data collection; L. Niu and X. Ding for mass spectrometry; J. Li for assistance in fluorescence measurement; L. Kong for cryo-EM data storage and backup; and K. Wang, Y. Yin, and C. Yang (Institute of Botany, CAS) for high-performance liquid chromatography analysis. The project was funded by the Strategic Priority Research Program of CAS (XDB08020302, XDB08030204), the Key Research Program of Frontier Sciences of CAS (QYZDB-SSW-SMC005), the National Key R&D Program of China (2017YFA0503702, 2017YFA0504700), National 973 project grant 2011CBA00900, and National Natural Science Foundation of China (31570724, 31270793). Z.L. and X.Z. received scholarships from the National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China. The atomic coordinates of the PSII-LHCII supercomplexes have been deposited in the Protein Data Bank with accession codes 5XNL (for stacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>), 5XNM (for unstacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>), 5XNN (for M-LHCII-CP24 from the stacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>), and 5XNO (for M-LHCII-CP24 from the unstacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>). The cryo-EM maps of these supercomplexes have been deposited in the Electron Microscopy Data Bank with accession codes EMD-6741, EMD-6742, EMD-6743, and EMD-6744 for the stacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>, unstacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>, and the M-LHCII-CP24 from the stacked and unstacked C<INF>2</INF>S<INF>2</INF>M<INF>2</INF>. W.C., Z.L., X.Z., and M.L. conceived the project; X.S., P.C., and X.W. prepared the samples; X.S. and X.W. collected the data; X.S., P.C., and M.L. performed the sample characterization; J.M., D.Z., and X.Z. processed the cryo-EM data and reconstructed the cryo-EM maps; P.C. and X.W. built and refined the structure models; P.C., Z.L., X.Z., and M.L. analyzed the structures; Z.L., X.Z., and M.L. wrote the manuscript; all authors discussed and commented on the results and the manuscript.	Albanese P, 2016, BBA-BIOENERGETICS, V1857, P1651, DOI 10.1016/j.bbabio.2016.06.011; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Anderson JM, 2008, PHOTOSYNTH RES, V98, P575, DOI 10.1007/s11120-008-9381-3; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bielczynski LW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00105; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; CHAPMAN DJ, 1989, BIOCHEM J, V258, P357, DOI 10.1042/bj2580357; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; De Las Rivas J, 2004, PHOTOSYNTH RES, V81, P329, DOI 10.1023/B:PRES.0000036889.44048.e4; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Ettinger WF, 1999, PLANT PHYSIOL, V119, P1379, DOI 10.1104/pp.119.4.1379; Jackowski G, 2001, BBA-BIOENERGETICS, V1504, P340, DOI 10.1016/S0005-2728(00)00262-0; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Pagliano C, 2014, BBA-BIOENERGETICS, V1837, P1454, DOI 10.1016/j.bbabio.2013.11.004; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Passarini F, 2009, J BIOL CHEM, V284, P29536, DOI 10.1074/jbc.M109.036376; PORTIS AR, 1976, BIOCHIM BIOPHYS ACTA, V449, P434, DOI 10.1016/0005-2728(76)90154-7; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Standfuss J, 2004, J BIOL CHEM, V279, P36884, DOI 10.1074/jbc.M402348200; Stoichev S, 2015, BIOPHYS J, V108, P844, DOI 10.1016/j.bpj.2014.12.042; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020	33	196	203	17	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					816	+		10.1126/science.aan0327	http://dx.doi.org/10.1126/science.aan0327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839073				2022-12-28	WOS:000408327900046
J	Venkataramani, AS; Tsai, AC				Venkataramani, Atheendar S.; Tsai, Alexander C.			Dreams Deferred - The Public Health Consequences of Rescinding DACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Venkataramani, Atheendar S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Venkataramani, Atheendar S.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Tsai, Alexander C.] Massachusetts Gen Hosp, Chester M Pierce MD Div Global Psychiat, Boston, MA 02114 USA; [Tsai, Alexander C.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Venkataramani, AS (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.		Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917				Chassamboulli A, 2015, REV ECON DYNAM, V18, P792, DOI 10.1016/j.red.2015.07.005; Hainmueller J, 2017, SCIENCE; Patler C, 2017, SOC SCI MED; Venkataramani AS, 2017, LANCET PUBLIC HEALTH, V2, pE175, DOI 10.1016/S2468-2667(17)30047-6; Williams DR, 2017, NEW ENGL J MED, V376, P2295, DOI 10.1056/NEJMms1702111	5	11	11	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 2	2017	377	18					1707	1709		10.1056/NEJMp1711416	http://dx.doi.org/10.1056/NEJMp1711416			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FL4ZB	28902574				2022-12-28	WOS:000414239100002
J	Galea, S; Keyes, KM				Galea, Sandro; Keyes, Katherine M.			Population Health Science and the Challenges of Prediction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Galea, Sandro] Boston Univ, Sch Publ Hlth, 715 Albany St, Boston, MA 02118 USA; [Keyes, Katherine M.] Columbia Univ, Mailman Sch Hlth, 722 West 168th St,724, New York, NY 10032 USA	Boston University; Columbia University	Galea, S (corresponding author), Boston Univ Publ Hlth, 715 Albany St, Boston, MA 02118 USA.	sgalea@bu.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945	NIAAA NIH HHS [K01 AA021511] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021511] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Dalton JE, 2017, ANN INTERN MED, V167, P456, DOI 10.7326/M16-2543; Galea, 2016, POPULATION HLTH SCI; Kaplan GA, 1999, ANN NY ACAD SCI, V896, P116, DOI 10.1111/j.1749-6632.1999.tb08109.x; Keyes KM, 2016, AM J PUBLIC HEALTH, V106, P633, DOI 10.2105/AJPH.2016.303101; Keyes KM, 2015, J EPIDEMIOL COMMUN H, V69, P574, DOI 10.1136/jech-2014-204983; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626	7	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					511	+		10.7326/M17-1733	http://dx.doi.org/10.7326/M17-1733			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI4ZI	28847011	Green Accepted			2022-12-28	WOS:000411988900015
J	Hofmann, R; James, SK; Jernberg, T; Lindahl, B; Erlinge, D; Witt, N; Arefalk, G; Frick, M; Alfredsson, J; Nilsson, L; Ravn-Fischer, A; Omerovic, E; Kellerth, T; Sparv, D; Ekelund, U; Linder, R; Ekstrom, M; Lauermann, J; Haaga, U; Pernow, J; Ostlund, O; Herlitz, J; Svensson, L				Hofmann, Robin; James, Stefan K.; Jernberg, Tomas; Lindahl, Bertil; Erlinge, David; Witt, Nils; Arefalk, Gabriel; Frick, Mats; Alfredsson, Joakim; Nilsson, Lennart; Ravn-Fischer, Annica; Omerovic, Elmir; Kellerth, Thomas; Sparv, David; Ekelund, Ulf; Linder, Rickard; Ekstrom, Mattias; Lauermann, Jorg; Haaga, Urban; Pernow, John; Ostlund, Ollie; Herlitz, Johan; Svensson, Leif		DETO2X-SWEDEHEART Investigators	Oxygen Therapy in Suspected Acute Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHEST-PAIN; INHALATION; SIZE	BACKGROUND The clinical effect of routine oxygen therapy in patients with suspected acute myocardial infarction who do not have hypoxemia at baseline is uncertain. METHODS In this registry-based randomized clinical trial, we used nationwide Swedish registries for patient enrollment and data collection. Patients with suspected myocardial infarction and an oxygen saturation of 90% or higher were randomly assigned to receive either supplemental oxygen (6 liters per minute for 6 to 12 hours, delivered through an open face mask) or ambient air. RESULTS A total of 6629 patients were enrolled. The median duration of oxygen therapy was 11.6 hours, and the median oxygen saturation at the end of the treatment period was 99% among patients assigned to oxygen and 97% among patients assigned to ambient air. Hypoxemia developed in 62 patients (1.9%) in the oxygen group, as compared with 254 patients (7.7%) in the ambient-air group. The median of the highest troponin level during hospitalization was 946.5 ng per liter in the oxygen group and 983.0 ng per liter in the ambient-air group. The primary end point of death from any cause within 1 year after randomization occurred in 5.0% of patients (166 of 3311) assigned to oxygen and in 5.1% of patients (168 of 3318) assigned to ambient air (hazard ratio, 0.97; 95% confidence interval [CI], 0.79 to 1.21; P = 0.80). Rehospitalization with myocardial infarction within 1 year occurred in 126 patients (3.8%) assigned to oxygen and in 111 patients (3.3%) assigned to ambient air (hazard ratio, 1.13; 95% CI, 0.88 to 1.46; P = 0.33). The results were consistent across all predefined subgroups. CONCLUSIONS Routine use of supplemental oxygen in patients with suspected myocardial infarction who did not have hypoxemia was not found to reduce 1-year all-cause mortality.	[Hofmann, Robin; Witt, Nils; Frick, Mats] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Div Cardiol, Sjukhusbacken 10, S-11883 Stockholm, Sweden; [Svensson, Leif] Soder Sjukhuset, Karolinska Inst, Ctr Resuscitat Sci, Stockholm, Sweden; [Jernberg, Tomas; Linder, Rickard; Ekstrom, Mattias] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Cardiol, Stockholm, Sweden; [James, Stefan K.; Lindahl, Bertil; Arefalk, Gabriel] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [James, Stefan K.; Ostlund, Ollie] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Erlinge, David; Sparv, David] Lund Univ, Dept Clin Sci, Cardiol, Lund, Sweden; [Ekelund, Ulf] Lund Univ, Dept Clin Sci, Emergency Med, Lund, Sweden; [Alfredsson, Joakim; Nilsson, Lennart] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Alfredsson, Joakim; Nilsson, Lennart] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Ravn-Fischer, Annica; Omerovic, Elmir; Herlitz, Johan] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Kellerth, Thomas] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Lauermann, Jorg] Ryhov Hosp, Dept Internal Med, Div Cardiol, Jonkoping, Sweden; [Haaga, Urban] Karlstad Cent Hosp, Dept Cardiol, Karlstad, Sweden; [Pernow, John] Karolinska Univ Hosp, Dept Cardiol, Solna, Sweden; [Pernow, John; Svensson, Leif] Karolinska Inst, Dept Med, Solna, Sweden; [Herlitz, Johan] Univ Boras, Dept Hlth Sci, Boras, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Danderyds Hospital; Karolinska Institutet; Uppsala University; Uppsala University; Lund University; Lund University; Linkoping University; Linkoping University; Sahlgrenska University Hospital; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Boras	Hofmann, R (corresponding author), Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, Div Cardiol, Sjukhusbacken 10, S-11883 Stockholm, Sweden.	robin.hofmann@sll.se	James, Stefan K/J-4554-2014; Hofmann, Robin/C-1138-2013; Ekström, Mattias/HGU-3873-2022	Hofmann, Robin/0000-0002-8907-895X; Ekström, Mattias/0000-0001-9448-8403; Pernow, John/0000-0003-4766-0922; Jernberg, Tomas/0000-0003-1695-379X; Ostlund, Ollie/0000-0001-8028-2308	Swedish Heart-Lung Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; AstraZeneca; Merck Sharp Dohme; Aspen; Roche; BioMerieux; Philips; Thermofisher; the Medicines Company	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); AstraZeneca(AstraZeneca); Merck Sharp Dohme(Merck & Company); Aspen; Roche(Roche Holding); BioMerieux; Philips; Thermofisher; the Medicines Company	Supported by the Swedish Heart-Lung Foundation, the Swedish Research Council, and the Swedish Foundation for Strategic Research.; Dr. Jernberg reports receiving lecture fees and consulting fees from AstraZeneca, consulting fees from Merck Sharp & Dohme, and lecture fees from Aspen; Dr. Lindahl, receiving fees for serving on a steering committee, paid to his university, from Roche, research support and advisory board fees, paid to his university, from BioMerieux, and advisory board fees, paid to his university, from Philips and Thermofisher; and Dr. Erlinge, receiving lecture fees and advisory board fees from AstraZeneca and the Medicines Company. No other potential conflict of interest relevant to this article was reported.	Cabello JB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007160.pub4; Hofmann R, 2014, AM HEART J, V167, P322, DOI 10.1016/j.ahj.2013.09.022; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; KELLY RF, 1995, AM HEART J, V130, P957, DOI 10.1016/0002-8703(95)90194-9; Khoshnood A, 2016, EUR J EMERG MED; MADIAS JE, 1976, CIRCULATION, V53, P411, DOI 10.1161/01.CIR.53.3.411; MAROKO PR, 1975, CIRCULATION, V52, P360, DOI 10.1161/01.CIR.52.3.360; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Moradkhan R, 2010, J AM COLL CARDIOL, V56, P1013, DOI 10.1016/j.jacc.2010.04.052; Thang ND, 2012, AM J EMERG MED, V30, P1788, DOI 10.1016/j.ajem.2012.02.014; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Sepehrvand N, 2016, JACC-HEART FAIL, V4, P783, DOI 10.1016/j.jchf.2016.03.026; Steele C., 1900, BMJ-BRIT MED J, V2, P1568; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Thang ND, 2013, INT J CARDIOL, V166, P141, DOI 10.1016/j.ijcard.2011.10.014; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	20	196	209	3	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2017	377	13					1240	1249		10.1056/NEJMoa1706222	http://dx.doi.org/10.1056/NEJMoa1706222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI3DU	28844200	Bronze, Green Published			2022-12-28	WOS:000411838100007
J	Boulay, G; Sandoval, GJ; Riggi, N; Iyer, S; Buisson, R; Naigles, B; Awad, ME; Rengarajan, S; Volorio, A; McBride, MJ; Broye, LC; Zou, L; Stamenkovic, I; Kadoch, C; Rivera, MN				Boulay, Gaylor; Sandoval, Gabriel J.; Riggi, Nicolo; Iyer, Sowmya; Buisson, Remi; Naigles, Beverly; Awad, Mary E.; Rengarajan, Shruthi; Volorio, Angela; McBride, Matthew J.; Broye, Liliane C.; Zou, Lee; Stamenkovic, Ivan; Kadoch, Cigall; Rivera, Miguel N.			Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain	CELL			English	Article							CELL-FREE FORMATION; ONCOGENIC FUSION; EWINGS-SARCOMA; GENOMIC LANDSCAPE; CHROMATIN; ELEMENTS; BINDING; EWSR1; TRANSCRIPTION; PROGRAM	Alterations in transcriptional regulators can orchestrate oncogenic gene expression programs in cancer. Here, we show that the BRG1/BRM-associated factor (BAF) chromatin remodeling complex, which is mutated in over 20% of human tumors, interacts with EWSR1, a member of a family of proteins with prion-like domains (PrLD) that are frequent partners in oncogenic fusions with transcription factors. In Ewing sarcoma, we find that the BAF complex is recruited by the EWS-FLI1 fusion protein to tumor-specific enhancers and contributes to target gene activation. This process is a neomorphic property of EWS-FLI1 compared to wild-type FLI1 and depends on tyrosine residues that are necessary for phase transitions of the EWSR1 prion-like domain. Furthermore, fusion of short fragments of EWSR1 to FLI1 is sufficient to recapitulate BAF complex retargeting and EWS-FLI1 activities. Our studies thus demonstrate that the physical properties of prion-like domains can retarget critical chromatin regulatory complexes to establish and maintain oncogenic gene expression programs.	[Boulay, Gaylor; Iyer, Sowmya; Naigles, Beverly; Awad, Mary E.; Rengarajan, Shruthi; Volorio, Angela; Rivera, Miguel N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Boulay, Gaylor; Iyer, Sowmya; Naigles, Beverly; Awad, Mary E.; Rengarajan, Shruthi; Volorio, Angela; Rivera, Miguel N.] Harvard Med Sch, Boston, MA 02114 USA; [Sandoval, Gabriel J.; McBride, Matthew J.; Kadoch, Cigall] Dana Farber Canc Inst, Boston, MA 02215 USA; [Sandoval, Gabriel J.; McBride, Matthew J.; Kadoch, Cigall] Harvard Med Sch, Boston, MA 02215 USA; [Boulay, Gaylor; Sandoval, Gabriel J.; McBride, Matthew J.; Kadoch, Cigall; Rivera, Miguel N.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Riggi, Nicolo; Volorio, Angela; Broye, Liliane C.; Stamenkovic, Ivan] Univ Lausanne, Inst Pathol, Fac Biol & Med, Ctr Hosp Univ Vaudois, CH-1011 Lausanne, Switzerland; [Boulay, Gaylor; Buisson, Remi; Naigles, Beverly; Awad, Mary E.; Rengarajan, Shruthi; Volorio, Angela; Zou, Lee; Rivera, Miguel N.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Boulay, Gaylor; Buisson, Remi; Naigles, Beverly; Awad, Mary E.; Rengarajan, Shruthi; Volorio, Angela; Zou, Lee; Rivera, Miguel N.] Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital	Rivera, MN (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Rivera, MN (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Kadoch, C (corresponding author), Dana Farber Canc Inst, Boston, MA 02215 USA.; Kadoch, C (corresponding author), Harvard Med Sch, Boston, MA 02215 USA.; Kadoch, C; Rivera, MN (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Rivera, MN (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Rivera, MN (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	cigall_kadoch@dfci.harvard.edu; mnrivera@mgh.harvard.edu	Buisson, Rémi/AAK-5208-2020	Buisson, Rémi/0000-0002-7196-8209; McBride, Matthew/0000-0001-9846-3385	Department of Defense Prostate Cancer Research Program Postdoctoral Training Award [W81XWH-15-1-0659]; Swiss National Science Foundation [PP00P3-157468/1]; MEDIC Foundation; NIH Pathway to Independence Award [1K99CA212154]; NIH DP2 New Innovator Award [1DP2CA195762-01]; American Cancer Society Research Scholar Award [RSG-14-051-01-DMC]; Pew-Stewart Scholars in Cancer Research Grant; Alex's Lemonade Stand Foundation Young Investigator Award; V Foundation for Cancer Research; Affymetrix; NATIONAL CANCER INSTITUTE [K99CA212154] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program Postdoctoral Training Award(United States Department of Defense); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MEDIC Foundation; NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH DP2 New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Award(American Cancer Society); Pew-Stewart Scholars in Cancer Research Grant; Alex's Lemonade Stand Foundation Young Investigator Award; V Foundation for Cancer Research; Affymetrix; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Gillepsie, M. Bobbin, M. Aryee, and N. Mashtalir as well as members of the Rivera, Kadoch, Bernstein, and Suva labs for valuable guidance and advice. We thank L. Nieman of the MGH Cancer Center/Molecular Pathology Confocal Core (MGH) and members of the Taplin Mass Spec Facility (HMS) for assistance with experiments and data analysis. We thank G.R. Crabtree and A. Kuo for kindly sharing the homemade BAF155 (SMARCC1) antibody used in ChIP-seq experiments. G.J.S. is supported by the Department of Defense Prostate Cancer Research Program Postdoctoral Training Award W81XWH-15-1-0659. N.R. is supported by the Swiss National Science Foundation Professorship grant (PP00P3-157468/1) and the MEDIC Foundation. R.B. is supported by a NIH Pathway to Independence Award (1K99CA212154). C.K. is supported by the NIH DP2 New Innovator Award 1DP2CA195762-01, the American Cancer Society Research Scholar Award RSG-14-051-01-DMC, and the Pew-Stewart Scholars in Cancer Research Grant. This work was also supported by the Alex's Lemonade Stand Foundation Young Investigator Award (C.K.). M.N.R. is supported by the V Foundation for Cancer Research. M. N. R. is a consultant for Loxo and receives research support from Affymetrix. C.K. is a scientific founder, shareholder, and consultant for Foghorn Therapeutics.	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Embree LJ, 2009, CANCER RES, V69, P4363, DOI 10.1158/0008-5472.CAN-08-3229; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gomez NC, 2016, CELL REP, V17, P1607, DOI 10.1016/j.celrep.2016.10.011; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herrero-Martin David, 2011, Sarcoma, V2011, P352580, DOI 10.1155/2011/352580; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kovar Heinrich, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/837474; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Mertens F, 2016, GENE CHROMOSOME CANC, V55, P291, DOI 10.1002/gcc.22335; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Patel M, 2012, GENOME RES, V22, P259, DOI 10.1101/gr.125666.111; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Pohl A, 2014, BIOINFORMATICS, V30, P1618, DOI 10.1093/bioinformatics/btu056; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Thomsen C, 2013, FASEB J, V27, P4965, DOI 10.1096/fj.13-234435; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	213	219	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					163	+		10.1016/j.cell.2017.07.036	http://dx.doi.org/10.1016/j.cell.2017.07.036			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28844694	Bronze, Green Accepted			2022-12-28	WOS:000411331800018
J	Lowy, DR; Schiller, JT				Lowy, Douglas R.; Schiller, John T.			Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection 2017 Lasker-DeBakey Clinical Research Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lowy, Douglas R.; Schiller, John T.] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lowy, DR (corresponding author), NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lowyd@mail.nih.gov	Schiller, John/ABK-8287-2022		Merck; GlaxoSmithKline; NATIONAL CANCER INSTITUTE [ZIABC010579] Funding Source: NIH RePORTER	Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lowy reported holding a patent for virus-like particle L1 human papillomavirus (HPV) vaccine licensed to Merck, GlaxoSmithKline, and Indian Immunologicals Ltd. Dr Schiller reported being an inventor on patents owned by the US government with royalties paid by Merck and GlaxoSmithKline.	Chow EPF, 2017, LANCET INFECT DIS, V17, P68, DOI 10.1016/S1473-3099(16)30116-5; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lowy DR, 2016, J CLIN INVEST, V126, P5, DOI 10.1172/JCI85446; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; Schiller JT, 1996, SEMIN CANCER BIOL, V7, P373, DOI 10.1006/scbi.1996.0046; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4; zur Hausen H, 2009, ANGEW CHEM INT EDIT, V48, P5798, DOI 10.1002/anie.200901917	7	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					901	902		10.1001/jama.2017.11706	http://dx.doi.org/10.1001/jama.2017.11706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28876435	Green Accepted			2022-12-28	WOS:000410487100005
J	Siemieniuk, RAC; Lytvyn, L; Ming, JM; Mullen, RM; Anam, F; Otieno, T; Guyatt, GH; Taylor, GP; Beltran-Arroyave, C; Okwen, PM; Nduati, R; Kinuthia, J; Luma, HN; Kirpalani, H; Merglen, A; Lesi, OA; Vandvik, PO; Agoritsas, T; Bewley, S				Siemieniuk, Reed A. C.; Lytvyn, Lyubov; Ming, Jinell Mah; Mullen, Rhonda Marama; Anam, Florence; Otieno, Teresia; Guyatt, Gordon H.; Taylor, Graham P.; Beltran-Arroyave, Claudia; Okwen, Patrick Mbah; Nduati, Ruth; Kinuthia, John; Luma, Henry Namme; Kirpalani, Haresh; Merglen, Arnaud; Lesi, Olufunmilayo A.; Vandvik, Per Olav; Agoritsas, Thomas; Bewley, Susan			Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TENOFOVIR DISOPROXIL FUMARATE; TO-CHILD TRANSMISSION; HEPATITIS-B-VIRUS; SAFETY; PHARMACOKINETICS; ASSOCIATION; INFECTION; INFANTS; AFRICA; GRADE		[Siemieniuk, Reed A. C.; Guyatt, Gordon H.; Agoritsas, Thomas] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Siemieniuk, Reed A. C.; Guyatt, Gordon H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lytvyn, Lyubov] Oslo Univ Hosp, Forskningsveien 2b, Oslo, Norway; [Ming, Jinell Mah] Southern Alberta HIV Clin, Calgary, AB, Canada; [Mullen, Rhonda Marama] HIV AIDS Fdn, INA Maori Indigenous & South Pacific, Tirau, New Zealand; [Anam, Florence] Int Community Women Living HIV ICW Global, Nairobi, Kenya; [Otieno, Teresia] ATHENA Network, Seattle, WA USA; [Taylor, Graham P.] Imperial Coll London, London, England; [Beltran-Arroyave, Claudia] Univ Antioquia, Medellin, Colombia; [Okwen, Patrick Mbah] Bali Dist Hosp, Yaounde, Cameroon; [Nduati, Ruth] Univ Nairobi, Nairobi, Kenya; [Kinuthia, John] Kenyatta Natl Hosp, Nairobi, Kenya; [Luma, Henry Namme] Univ Yaounde, Yaounde, Cameroon; [Kirpalani, Haresh] Univ Penn, Philadelphia, PA 19104 USA; [Merglen, Arnaud] Geneva Univ Hosp, Geneva, Switzerland; [Lesi, Olufunmilayo A.] Lagos Univ, Teaching Hosp, Lagos, Nigeria; [Lesi, Olufunmilayo A.] Univ Lagos, Coll Med, Lagos, Nigeria; [Vandvik, Per Olav] Univ Oslo, Fac Med, Inst Hlth & Soc, Oslo, Norway; [Vandvik, Per Olav] Innlandet Hosp Trust Div, Dept Med, Gjovik, Norway; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, CH-1211 Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva, Switzerland; [Bewley, Susan] Kings Coll London, Womens Hlth Acad Ctr, London, England	McMaster University; University of Toronto; University of Oslo; Imperial College London; Universidad de Antioquia; University of Nairobi; Kenyatta National Hospital; University of Yaounde I; University of Pennsylvania; University of Geneva; University of Lagos; University of Oslo; Innlandet Hospital Trust; University of Geneva; University of Geneva; University of London; King's College London	Siemieniuk, RAC (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Siemieniuk, RAC (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	reed.siemieniuk@medportal.ca	Agoritsas, Thomas/F-4321-2014	Agoritsas, Thomas/0000-0002-6182-9969; Beltran-Arroyave, Claudia Patricia/0000-0002-5372-8172; Okwen, Patrick/0000-0002-9017-7496; LESI, Olufunmilayo/0000-0002-6958-1531				Agoritsas T, 2017, JAMA-J AM MED ASSOC, V317, P2239, DOI 10.1001/jama.2017.4887; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Best BM, 2010, JAIDS-J ACQ IMM DEF, V54, P381, DOI 10.1097/QAI.0b013e3181d6c9ed; de Ruiter A, 2014, HIV MED, V15, P1, DOI 10.1111/hiv.12185; DEVJI T, 2017, BMJ OPEN, V7, DOI DOI 10.1136/BMJOPEN-2017-019023.; European AIDS Clinical Society, 2017, EACS GUIDE; Forbes JC, 2012, AIDS, V26, P757, DOI 10.1097/QAD.0b013e328350995c; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Habiyambere V, 2016, WHO GLOBAL ARVS DIAG; Health Service Executive, 2011, IR GUID ANT TREATM C; Keane E, 2016, ALIMENT PHARM THER, V44, P1005, DOI 10.1111/apt.13795; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Medecins Sans Frontieres Access Campaign, 2016, UNT WEB ANT PRIC RED; Mofenson LM, 2017, AIDS, V31, P213, DOI 10.1097/QAD.0000000000001313; MSELLATI P, 1995, J ACQ IMMUN DEF SYND, V8, P506; North American AIDS Cohort Collaboration on Research and Design, 2017, ART US INT EP DAT EV; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2016, REC US ANT DRUGS PRE; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Phanuphak N, 2010, THAILAND NATL GUIDEL; Poolman RW, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j576; Rochwerg B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017602; Salem AH, 2016, ANTIMICROB AGENTS CH, V60, P400, DOI 10.1128/AAC.01197-15; Schillie S, 2015, PEDIATRICS, V135, pE1141, DOI 10.1542/peds.2014-3213; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Siemieniuk RAC, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1982; UNAIDS, 2016, AIDSINFO DAT SHEETS; Vandvik PO, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5085; Wang HW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003187; WHO, 2013, CONSOLIDATED GUIDELI; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x	36	12	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2017	358								j3961	10.1136/bmj.j3961	http://dx.doi.org/10.1136/bmj.j3961			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH6MW	28893728	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000411292100001
J	Bittner, KC; Milstein, AD; Grienberger, C; Romani, S; Magee, JC				Bittner, Katie C.; Milstein, Aaron D.; Grienberger, Christine; Romani, Sandro; Magee, Jeffrey C.			Behavioral time scale synaptic plasticity underlies CA1 place fields	SCIENCE			English	Article							TIMING-DEPENDENT PLASTICITY; LONG-TERM POTENTIATION; HIPPOCAMPUS; NAVIGATION; NEURONS; MEMORY; CELLS; ACTIVATION; SYSTEMS; BRAIN	Learning is primarily mediated by activity-dependent modifications of synaptic strength within neuronal circuits. We discovered that place fields in hippocampal area CA1 are produced by a synaptic potentiation notably different from Hebbian plasticity. Place fields could be produced in vivo in a single trial by potentiation of input that arrived seconds before and after complex spiking. The potentiated synaptic input was not initially coincident with action potentials or depolarization. This rule, named behavioral timescale synaptic plasticity, abruptly modifies inputs that were neither causal nor close in time to postsynaptic activation. In slices, five pairings of subthreshold presynaptic activity and calcium (Ca2+) plateau potentials produced a large potentiation with an asymmetric seconds-long time course. This plasticity efficiently stores entire behavioral sequences within synaptic weights to produce predictive place cell activity.	[Bittner, Katie C.; Milstein, Aaron D.; Grienberger, Christine; Romani, Sandro; Magee, Jeffrey C.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Milstein, Aaron D.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Magee, JC (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	mageej@janelia.hhmi.org		Grienberger, Christine/0000-0002-7774-4062; Milstein, Aaron/0000-0002-7186-5779; Bittner, Katie/0000-0002-2554-2637; Romani, Sandro/0000-0002-4727-4207	HHMI; NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies) [NS090583]	HHMI(Howard Hughes Medical Institute); NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies)	We thank M. Tadross, G. Tervo, and I. Soltesz for discussions and N. Brunel, J. Dudman, R. Gutig, G. Rubin, and M. Tadross for comments on the manuscript. This work is supported by HHMI and NIH BRAIN (Brain Research through Advancing Innovative Neurotechnologies) grant NS090583. Data are archived on Janelia Research Campus servers and are available upon request.	Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Dayan P, 2001, COMPUTATIONAL NEUROS; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Eichenbaum H, 2014, NAT REV NEUROSCI, V15, P732, DOI 10.1038/nrn3827; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Foster DJ, 2012, CURR OPIN NEUROBIOL, V22, P294, DOI 10.1016/j.conb.2011.12.005; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Grienberger C, 2017, NAT NEUROSCI, V20, P417, DOI 10.1038/nn.4486; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hebb Donald O., 1949, ORG BEHAV; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Hull C., 1943, PRINCIPLES BEHAV; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; LAVOND DG, 1993, ANNU REV PSYCHOL, V44, P317, DOI 10.1146/annurev.ps.44.020193.001533; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Li BX, 2016, SCIENCE, V351, P863, DOI 10.1126/science.aad3647; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007	36	214	217	10	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1033	1036		10.1126/science.aan3846	http://dx.doi.org/10.1126/science.aan3846			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883072	Green Accepted			2022-12-28	WOS:000409455700043
J	Kaiser, J				Kaiser, Jocelyn			PRECISION MEDICINE NIH's massive health study is off to a slow start	SCIENCE			English	News Item																			0	2	2	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		955	955		10.1126/science.357.6355.955	http://dx.doi.org/10.1126/science.357.6355.955			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883052				2022-12-28	WOS:000409455700010
J	Cobey, K				Cobey, Kelly			Illegitimate journals scam even senior scientists	NATURE			English	Editorial Material									[Cobey, Kelly] Ottawa Hosp Res Inst Canada, Ottawa, ON, Canada		Cobey, K (corresponding author), Ottawa Hosp Res Inst Canada, Ottawa, ON, Canada.	kcobey@ohri.ca	Cobey, Kelly D/AAA-5463-2020	Cobey, Kelly D/0000-0003-2797-1686					0	21	22	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					7	7		10.1038/549007a	http://dx.doi.org/10.1038/549007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0DH	28880308	Green Submitted, Bronze			2022-12-28	WOS:000409388700005
J	Corren, J; Parnes, JR; Wang, LW; Mo, M; Roseti, SL; Griffiths, JM; van der Merwe, R				Corren, Jonathan; Parnes, Jane R.; Wang, Liangwei; Mo, May; Roseti, Stephanie L.; Griffiths, Janet M.; van der Merwe, Rene			Tezepelumab in Adults with Uncontrolled Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; OBSTRUCTIVE PULMONARY-DISEASE; CONTROLLED PHASE-3 TRIAL; HUMAN EPITHELIAL-CELLS; QUALITY-OF-LIFE; EOSINOPHILIC ASTHMA; DOUBLE-BLIND; EXPRESSION; TSLP; INFLAMMATION	BACKGROUND In some patients with moderate-to-severe asthma, particularly those with noneosinophilic inflammation, the disease remains uncontrolled. This trial evaluated the efficacy and safety of tezepelumab (AMG 157/MEDI9929), a human monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled despite treatment with long-acting beta-agonists and medium-to-high doses of inhaled glucocorticoids. METHODS In this phase 2, randomized, double-blind, placebo-controlled trial, we compared subcutaneous tezepelumab at three dose levels with placebo over a 52-week treatment period. The primary end point was the annualized rate of asthma exacerbations (events per patient-year) at week 52. RESULTS The use of tezepelumab at a dose of 70 mg every 4 weeks (low dose; 145 patients), 210 mg every 4 weeks (medium dose; 145 patients), or 280 mg every 2 weeks (high dose; 146 patients) resulted in annualized asthma exacerbation rates at week 52 of 0.26, 0.19, and 0.22, respectively, as compared with 0.67 in the placebo group (148 patients). Thus, exacerbation rates in the respective tezepelumab groups were lower by 61%, 71%, and 66% than the rate in the placebo group (P<0.001 for all comparisons). Similar results were observed in patients regardless of blood eosinophil counts at enrollment. The prebronchodilator forced expiratory volume in 1 second at week 52 was higher in all tezepelumab groups than in the placebo group (difference, 0.12 liters with the low dose [P = 0.01], 0.11 liters with the medium dose [P = 0.02], and 0.15 liters with the high dose [P = 0.002]). A total of 2 patients in the medium-dose group, 3 in the high-dose group, and 1 in the placebo group discontinued the trial regimen because of adverse events. CONCLUSIONS Among patients treated with long-acting beta-agonists and medium-to-high doses of inhaled glucocorticoids, those who received tezepelumab had lower rates of clinically significant asthma exacerbations than those who received placebo, independent of baseline blood eosinophil counts. (Funded by MedImmune [a member of the AstraZeneca Group] and Amgen; PATHWAY ClinicalTrials.gov number, NCT02054130.)	[Corren, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Parnes, Jane R.; Mo, May] Amgen Inc, Thousand Oaks, CA USA; [Wang, Liangwei; Roseti, Stephanie L.; Griffiths, Janet M.] MedImmune, Gaithersburg, MD USA; [van der Merwe, Rene] MedImmune, Cambridge, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Amgen; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Corren, J (corresponding author), 10780 Santa Monica Blvd,Suite 280, Los Angeles, CA 90025 USA.	jcorren@ucla.edu			MedImmune [a member of the AstraZeneca Group]; Amgen	MedImmune [a member of the AstraZeneca Group]; Amgen(Amgen)	Funded by MedImmune [a member of the AstraZeneca Group] and Amgen; PATHWAY ClinicalTrials.gov number, NCT02054130.	Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 2012, J ALLERGY CLIN IMMUN, V129, pS65; [Anonymous], 2017, GLOBAL STRATEGY ASTH; [Anonymous], 2012, GLOBAL STRATEGY ASTH; Bateman ED, 2008, ALLERGY, V63, P932, DOI 10.1111/j.1398-9995.2008.01724.x; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bleck B, 2008, J CLIN IMMUNOL, V28, P147, DOI 10.1007/s10875-007-9149-0; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Calven J, 2012, J INNATE IMMUN, V4, P86, DOI 10.1159/000329131; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Nagata Y, 2007, INT ARCH ALLERGY IMM, V144, P305, DOI 10.1159/000106319; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; West EE, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8471; Wilson SR, 2012, J ALLERGY CLIN IMMUN, V129, pS88, DOI 10.1016/j.jaci.2011.12.988; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790; Zeiger RS, 2014, J ALLER CL IMM-PRACT, V2, P741, DOI 10.1016/j.jaip.2014.06.005; Zhong J, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau007; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	40	425	437	4	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					936	946		10.1056/NEJMoa1704064	http://dx.doi.org/10.1056/NEJMoa1704064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF9XU	28877011	Bronze			2022-12-28	WOS:000409373100007
J	Grinberg-Bleyer, Y; Oh, H; Desrichard, A; Bhatt, DM; Caron, R; Chan, TA; Schmid, RM; Klein, U; Hayden, MS; Ghosh, S				Grinberg-Bleyer, Yenkel; Oh, Hyunju; Desrichard, Alexis; Bhatt, Dev M.; Caron, Rachel; Chan, Timothy A.; Schmid, Roland M.; Klein, Ulf; Hayden, Matthew S.; Ghosh, Sankar			NF-kappa B c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer	CELL			English	Article							TRANSCRIPTION FACTOR; TUMOR-IMMUNITY; NUCLEAR-FACTOR; MICE LACKING; PENTOXIFYLLINE; MELANOMA; EXPRESSION; ANTITUMOR; PD-1; INFLAMMATION	Regulatory T cells (Tregs) play a pivotal role in the inhibition of anti-tumor immune responses. Understanding the mechanisms governing Treg homeostasis may therefore be important for development of effective tumor immunotherapy. We have recently demonstrated a key role for the canonical nuclear factor kappa B (NF-kappa B) subunits, p65 and c-Rel, in Treg identity and function. In this report, we show that NF-kappa B c-Rel ablation specifically impairs the generation and maintenance of the activated Treg (aTreg) subset, which is known to be enriched at sites of tumors. Using mouse models, we demonstrate that melanoma growth is drastically reduced in mice lacking c-Rel, but not p65, in Tregs. Moreover, chemical inhibition of c-Rel function delayed melanoma growth by impairing aTreg-mediated immunosuppression and potentiated the effects of anti-PD-1 immunotherapy. Our studies therefore establish inhibition of NF-kappa B c-Rel as a viable therapeutic approach for enhancing checkpoint-targeting immunotherapy protocols.	[Grinberg-Bleyer, Yenkel; Oh, Hyunju; Bhatt, Dev M.; Caron, Rachel; Klein, Ulf; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Desrichard, Alexis; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Schmid, Roland M.] Tech Univ Munich, Med Klin 2, Klinikum Rechts Isar, Munich, Germany; [Klein, Ulf] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Klein, Ulf] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY 10032 USA; [Hayden, Matthew S.] Dartmouth Hitchcock Med Ctr, Sect Dermatol, Dept Surg, Lebanon, NH 03756 USA; [Klein, Ulf] Univ Leeds, Sect Expt Haematol, Leeds Inst Canc & Pathol, Leeds LS2 9JT, W Yorkshire, England	Columbia University; Memorial Sloan Kettering Cancer Center; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Columbia University; Columbia University; Dartmouth College; University of Leeds	Ghosh, S (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA.	sg2715@cumc.columbia.edu	Chan, Timothy A/ABD-5850-2021	Bhatt, Dev/0000-0003-3616-3701; Hayden, Matthew/0000-0003-1670-6430; Grinberg-Bleyer, Yenkel/0000-0002-3515-8305; Caron, Rachel/0000-0003-1421-4256	Cancer Research Institute; NIH [R01-AI068977]; Herbert Irving Cancer Center at Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herbert Irving Cancer Center at Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Lekha Nair, Alice Lepelley, Thomas S. Postler, John J. Seeley, Crystal Bussey, Gaelle H. Martin, Christian Schindler, Thomas M. Enzler, and Gary K. Schwartz for technical help and constructive discussions on the project. Y.G.B. was supported by a postdoctoral fellowship from the Cancer Research Institute. This work was supported by grants from the NIH (R01-AI068977) and the Herbert Irving Cancer Center at Columbia University and institutional support from Columbia University to S.G.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bertrand A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0455-8; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bravo-Cuellar A, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-13; Chen SH, 2015, CANCER IMMUNOL RES, V3, P149, DOI 10.1158/2326-6066.CIR-14-0118; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Darrasse-Jeze G, 2009, J CLIN INVEST, V119, P2648, DOI 10.1172/JCI36628; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Deree J, 2007, SURGERY, V142, P276, DOI 10.1016/j.surg.2007.04.008; Dias S, 2017, IMMUNITY, V46, P78, DOI 10.1016/j.immuni.2016.12.017; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; Dua P, 2007, INT J CANCER, V121, P1600, DOI 10.1002/ijc.22843; EDWARD M, 1991, INT J CANCER, V49, P711, DOI 10.1002/ijc.2910490514; FINGERT HJ, 1988, CANCER RES, V48, P4375; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Heise N, 2014, J EXP MED, V211, P2103, DOI 10.1084/jem.20132613; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jandus C, 2008, CANCER IMMUNOL IMMUN, V57, P1795, DOI 10.1007/s00262-008-0507-4; Jimenez JL, 2001, J PHARMACOL EXP THER, V299, P753; Kamran MZ, 2013, BIOMED PHARMACOTHER, V67, P399, DOI 10.1016/j.biopha.2013.03.020; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Messina N, 2016, J AUTOIMMUN, V70, P52, DOI 10.1016/j.jaut.2016.03.017; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Nakagawa H, 2016, P NATL ACAD SCI USA, V113, P6248, DOI 10.1073/pnas.1604765113; Neo WH, 2014, J BIOL CHEM, V289, P31693, DOI 10.1074/jbc.M114.574517; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang ZX, 2016, TUMOR BIOL, V37, P77, DOI 10.1007/s13277-015-4315-0; Pinzani M, 1996, BRIT J PHARMACOL, V119, P1117, DOI 10.1111/j.1476-5381.1996.tb16012.x; Ratheesh A, 2007, CANCER BIOL THER, V6, P1743, DOI 10.4161/cbt.6.11.4833; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shono Y, 2014, CANCER DISCOV, V4, P578, DOI 10.1158/2159-8290.CD-13-0585; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Suresh R, 2002, J IMMUNOL, V169, P4262, DOI 10.4049/jimmunol.169.8.4262; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012	53	171	175	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1096	1108		10.1016/j.cell.2017.08.004	http://dx.doi.org/10.1016/j.cell.2017.08.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886380	Green Accepted, Bronze			2022-12-28	WOS:000409536000008
J	Hornyak, T				Hornyak, Tim			Smarter, not harder	NATURE			English	Editorial Material																			0	5	9	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					S1	S3		10.1038/549S1a	http://dx.doi.org/10.1038/549S1a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0DH	28877160	Bronze			2022-12-28	WOS:000409388700001
J	Marris, E				Marris, Emma			Labs cope with Hurricane Harvey's historic flooding	NATURE			English	News Item																			0	0	0	0	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					13	14		10.1038/nature.2017.22542	http://dx.doi.org/10.1038/nature.2017.22542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880297				2022-12-28	WOS:000409388700006
J	Maskell, G				Maskell, Giles			The practice of radiology needs to change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gilesmaskell@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j4102	10.1136/bmj.j4102	http://dx.doi.org/10.1136/bmj.j4102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EM	28882983				2022-12-28	WOS:000410576200008
J	Dolan, SM; Goldwaser, TH; Jindal, SK				Dolan, Siobhan M.; Goldwaser, Tamar H.; Jindal, Sangita K.			Preimplantation Genetic Diagnosis for Mendelian Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dolan, Siobhan M.; Goldwaser, Tamar H.; Jindal, Sangita K.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Reprod & Med Genet, Dept Obstet & Gynecol & Womens Hlth, 1695 Eastchester Rd,Ste 301, Bronx, NY 10461 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Dolan, SM (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Div Reprod & Med Genet, Dept Obstet & Gynecol & Womens Hlth, 1695 Eastchester Rd,Ste 301, Bronx, NY 10461 USA.	sdolan@montefiore.org	Goldwaser, Tamar/AAB-4720-2020	Dolan, Siobhan/0000-0001-8890-8045				American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2016, Obstet Gynecol, V128, pe61, DOI 10.1097/AOG.0000000000001643; Centers for Disease Control and Prevention, 2016, 2014 ASS REPR TECHN, P5; Collins SC, 2017, J ASSIST REPROD GEN, V34, P1515, DOI 10.1007/s10815-017-1001-8; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Harton GL, 2011, HUM REPROD, V26, P33, DOI 10.1093/humrep/deq231; Rechitsky S, 2015, FERTIL STERIL, V103, P503, DOI 10.1016/j.fertnstert.2014.11.007; Soc Assisted Reprod Technology, 2008, FERTIL STERIL, V90, pS136, DOI 10.1016/j.fertnstert.2008.08.062; Wilton L, 2009, HUM REPROD, V24, P1221, DOI 10.1093/humrep/den488	8	5	8	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					859	860		10.1001/jama.2017.10892	http://dx.doi.org/10.1001/jama.2017.10892			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873149				2022-12-28	WOS:000409183700017
J	Horton, R				Horton, Richard			Offline: Terrorism and Syria-"a crisis of the world"	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					924	924		10.1016/S0140-6736(17)32347-4	http://dx.doi.org/10.1016/S0140-6736(17)32347-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28872019	Bronze			2022-12-28	WOS:000408746300009
J	Meissner, KJ; Bralower, TJ				Meissner, Katrin J.; Bralower, Timothy J.			PALAEOCLIMATE Volcanism caused ancient global warming	NATURE			English	Editorial Material							EOCENE THERMAL MAXIMUM; CARBON; CLIMATE; RELEASE		[Meissner, Katrin J.] Univ New South Wales Sydney, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Meissner, Katrin J.] Univ New South Wales Sydney, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Bralower, Timothy J.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Meissner, KJ (corresponding author), Univ New South Wales Sydney, Climate Change Res Ctr, Sydney, NSW 2052, Australia.; Meissner, KJ (corresponding author), Univ New South Wales Sydney, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia.	k.meissner@unsw.edu.au; tjb26@psu.edu		Meissner, Katrin/0000-0002-0716-7415				Cui Y, 2011, NAT GEOSCI, V4, P481, DOI [10.1038/ngeo1179, 10.1038/NGEO1179]; Dunkley Jones T, 2013, EARTH-SCI REV, V125, P123, DOI 10.1016/j.earscirev.2013.07.004; Frieling J, 2016, P NATL ACAD SCI USA, V113, P12059, DOI 10.1073/pnas.1603348113; Gibbs SJ, 2016, GEOLOGY, V44, P59, DOI 10.1130/G37273.1; Gutjahr M, 2017, NATURE, V548, P573, DOI 10.1038/nature23646; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Meissner KJ, 2014, PALEOCEANOGRAPHY, V29, P946, DOI 10.1002/2014PA002650; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Penman DE, 2014, PALEOCEANOGRAPHY, V29, P357, DOI 10.1002/2014PA002621; THOMAS E, 1990, GEOLOGICAL SOC AM SP, V247, P481; Valdes P, 2011, NAT GEOSCI, V4, P414, DOI 10.1038/ngeo1200; von der Heydt AS, 2016, CURR CLIM CHANGE REP, V2, P148, DOI 10.1007/s40641-016-0049-3	13	1	1	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					531	533		10.1038/548531a	http://dx.doi.org/10.1038/548531a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2BO	28858315				2022-12-28	WOS:000408703100025
J	Mohan, P; Selvan, KS				Mohan, Pazhanivel; Selvan, Kuppusamy Senthamizh			Double pathology in a woman with worsening dysphagia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mohan, Pazhanivel; Selvan, Kuppusamy Senthamizh] Jawaharlal Inst Postgrad Med Educ & Res, Dept Gastroenterol, Pondicherry, Tamil Nadu, India	Jawaharlal Institute of Postgraduate Medical Education & Research	Mohan, P (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Gastroenterol, Pondicherry, Tamil Nadu, India.	dr.pazhani@gmail.com		, Senthamizhselvan/0000-0002-7543-4052; Mohan, Pazhanivel/0000-0003-1473-4382				Anderson SR, 2007, AM J OTOLARYNG, V28, P22, DOI 10.1016/j.amjoto.2006.06.004; CHISHOLM M, 1974, POSTGRAD MED J, V50, P215, DOI 10.1136/pgmj.50.582.215; Messmann H, 2001, BEST PRACT RES CL GA, V15, P249, DOI 10.1053/bega.2000.0172; Novacek G, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-36	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3783	10.1136/bmj.j3783	http://dx.doi.org/10.1136/bmj.j3783			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CQ	28860182				2022-12-28	WOS:000409387000008
J	Mogessie, B; Schuh, M				Mogessie, Binyam; Schuh, Melina			Actin protects mammalian eggs against chromosome segregation errors	SCIENCE			English	Article							KINETOCHORE-MICROTUBULE INTERFACE; SPINDLE-ASSEMBLY CHECKPOINT; CRANE-FLY SPERMATOCYTES; MOUSE OOCYTES; HUMAN ANEUPLOIDY; MEIOTIC SPINDLE; CYTOCHALASIN-D; F-ACTIN; ANAPHASE; MITOSIS	Chromosome segregation is driven by a spindle that is made of microtubules but is generally thought to be independent of actin. Here, we report an unexpected actin-dependent mechanism that drives the accurate alignment and segregation of chromosomes in mammalian eggs. Prominent actin filaments permeated the microtubule spindle in eggs of several mammalian species, including humans. Disrupting actin in mouse eggs led to significantly increased numbers of misaligned chromosomes as well as lagging chromosomes during meiosis I and II. We found that actin drives accurate chromosome segregation by promoting the formation of functional kinetochore fibers, the microtubule bundles that align and segregate the chromosomes. Thus, actin is essential to prevent chromosome segregation errors in eggs, which are a leading cause of miscarriages, infertility, and Down syndrome.	[Mogessie, Binyam; Schuh, Melina] Max Planck Inst Biophys Chem, Dept Meiosis, Fassberg 11, D-37077 Gottingen, Germany	Max Planck Society	Schuh, M (corresponding author), Max Planck Inst Biophys Chem, Dept Meiosis, Fassberg 11, D-37077 Gottingen, Germany.	melina.schuh@mpibpc.mpg.de	Mogessie, Binyam/AAM-6147-2020	Mogessie, Binyam/0000-0002-0702-6356	European Research Council [337415]; Medical Research Council [MC_U105192711] Funding Source: researchfish; MRC [MC_U105192711] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of the Medical Research Council Laboratory of Molecular Biology's Animal, Genotyping and Microscopy Facilities for technical assistance, and members of the Schuh laboratory for discussions. We thank K. Scheffler for help with in vitro fertilization and mouse embryo imaging experiments. We are thankful to K. Elder and M. Blayney from Bourn Hall Clinic, Cambridge, for providing the human oocyte shown in fig. S1A. We thank H. Maiato for generously providing a plasmid-encoding human CLASP1. Research leading to these results has received financial support from the European Research Council under grant agreement no. 337415. Plasmids are available from M.S. under a materials transfer agreement with the Max Planck Society. B.M. and M.S. conceived the study and designed the experiments and methods for data analysis; B.M. performed all experiments, analyzed the data, and prepared figures; B.M. and M.S. wrote the manuscript; and M.S. supervised the study. The authors declare no competing financial interests.	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2011, DEVELOPMENT, V138, P2903, DOI 10.1242/dev.060269; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Forer A, 1998, CHROMOSOME RES, V6, P533, DOI 10.1023/A:1009224322399; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Gui LM, 2012, DEVELOPMENT, V139, P1941, DOI 10.1242/dev.078352; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Holubcova Z, 2015, SCIENCE, V348, P1143, DOI 10.1126/science.aaa9529; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kolano A, 2012, P NATL ACAD SCI USA, V109, pE1858, DOI 10.1073/pnas.1204686109; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Kuliev A, 2005, CYTOGENET GENOME RES, V111, P193, DOI 10.1159/000086889; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Lane SIR, 2012, DEVELOPMENT, V139, P1947, DOI 10.1242/dev.077040; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lopez MP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5778; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; Mogessie B, 2015, ELIFE, V4, DOI 10.7554/eLife.05697; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nagaoka SI, 2011, CURR BIOL, V21, P651, DOI 10.1016/j.cub.2011.03.003; Ning WX, 2016, DEV CELL, V39, P61, DOI 10.1016/j.devcel.2016.09.003; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rosenbusch BE, 2006, FERTIL STERIL, V85, P302, DOI 10.1016/j.fertnstert.2005.10.015; SALMON ED, 1980, J CELL BIOL, V85, P853, DOI 10.1083/jcb.85.3.853; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schmidt JC, 2012, DEV CELL, V23, P968, DOI 10.1016/j.devcel.2012.09.012; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Sebestova J, 2012, CELL CYCLE, V11, P3011, DOI 10.4161/cc.21398; Silverman-Gavrila RV, 2000, J CELL SCI, V113, P597; STAIGER CJ, 1991, PLANT CELL, V3, P637, DOI 10.1105/tpc.3.6.637; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011	61	81	83	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353							eaal1647	10.1126/science.aal1647	http://dx.doi.org/10.1126/science.aal1647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839045	Green Submitted			2022-12-28	WOS:000408327900035
J	Liu, X; Zhang, YY; Chen, Y; Li, MS; Zhou, F; Li, KL; Cao, H; Ni, M; Liu, YX; Gu, ZM; Dickerson, KE; Xie, SQ; Hon, GC; Xuan, ZY; Zhang, MQ; Shao, Z; Xu, J				Liu, Xin; Zhang, Yuannyu; Chen, Yong; Li, Mushan; Zhou, Feng; Li, Kailong; Cao, Hui; Ni, Min; Liu, Yuxuan; Gu, Zhimin; Dickerson, Kathryn E.; Xie, Shiqi; Hon, Gary C.; Xuan, Zhenyu; Zhang, Michael Q.; Shao, Zhen; Xu, Jian			In Situ Capture of Chromatin Interactions by Biotinylated dCas9	CELL			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; EMBRYONIC STEM-CELLS; HUMAN GENOME; CHROMOSOME CONFORMATION; GENE-EXPRESSION; TRANSGENIC MICE; DNA INTERACTIONS; IDENTITY GENES; TRANSCRIPTION	Cis-regulatory elements (CREs) are commonly recognized by correlative chromatin features, yet the molecular composition of the vast majority of CREs in chromatin remains unknown. Here, we describe a CRISPR affinity purification in situ of regulatory elements (CAPTURE) approach to unbiasedly identify locus-specific chromatin-regulating protein complexes and long-range DNA interactions. Using an in vivo biotinylated nuclease-deficient Cas9 protein and sequence-specific guide RNAs, we show high-resolution and selective isolation of chromatin interactions at a single-copy genomic locus. Purification of human telomeres using CAPTURE identifies known and new telomeric factors. In situ capture of individual constituents of the enhancer cluster controlling human beta-globin genes establishes evidence for composition-based hierarchical organization. Furthermore, unbiased analysis of chromatin interactions at disease-associated cis-elements and developmentally regulated super-enhancers reveals spatial features that causally control gene transcription. Thus, comprehensive and unbiased analysis of locus-specific regulatory composition provides mechanistic insight into genome structure and function in development and disease.	[Liu, Xin; Zhang, Yuannyu; Li, Kailong; Cao, Hui; Ni, Min; Liu, Yuxuan; Gu, Zhimin; Dickerson, Kathryn E.; Xu, Jian] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA; [Chen, Yong; Xuan, Zhenyu; Zhang, Michael Q.] Univ Texas Dallas, Dept Biol Sci, Ctr Syst Biol, Richardson, TX 75080 USA; [Li, Mushan; Shao, Zhen] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai 200031, Peoples R China; [Zhou, Feng] Fudan Univ, Minister Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai 200032, Peoples R China; [Zhou, Feng] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Xie, Shiqi; Hon, Gary C.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Zhang, Michael Q.] Tsinghua Univ, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Bioinformat Div, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Ctr Synthet & Syst Biol, TNLIST, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University; Fudan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Xu, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Med Ctr Res Inst, Dallas, TX 75390 USA.; Zhou, F (corresponding author), Fudan Univ, Minister Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai 200032, Peoples R China.; Zhou, F (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.	zhou_feng@fudan.edu.cn; jian.xu@utsouthwestern.edu	LIU, XIN/AAD-9918-2022; LIU, XIN/AFR-0503-2022; Li, Kailong/AFT-0331-2022	LIU, XIN/0000-0003-0847-182X; LIU, XIN/0000-0003-0847-182X; li, kailong/0000-0002-3311-5782; Xie, Shiqi/0000-0002-0516-3621; Xuan, Zhenyu/0000-0001-9344-8493; Shao, Zhen/0000-0002-4934-4360	NIH [R01MH102616]; Cecil H. and Ida Green Endowment; SKRDPC grant [2017YFA0505503]; NSFC [91519326, 31671384]; NSFC grant [31670836]; National Key R&D Program of China [2017YFA0505100]; Shanghai Institute of Higher Learning [TP2015003]; "100-Talent'' Program of Chinese Academy of Sciences [Y516C11851]; NIH grants [K01DK093543, R03DK101665, R01DK111430]; Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award [RR140025]; American Cancer Society award; Harold C. Simmons Comprehensive Cancer Center at UT Southwestern [IRG-02-196]; Welch Foundation grant [I-1942-20170325]; American Society of Hematology Scholar award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cecil H. and Ida Green Endowment; SKRDPC grant; NSFC(National Natural Science Foundation of China (NSFC)); NSFC grant(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Shanghai Institute of Higher Learning; "100-Talent'' Program of Chinese Academy of Sciences(Chinese Academy of Sciences); NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award; American Cancer Society award(American Cancer Society); Harold C. Simmons Comprehensive Cancer Center at UT Southwestern; Welch Foundation grant(The Welch Foundation); American Society of Hematology Scholar award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Chen and B. Huang at UCSF for the CRISPR imaging reagents and discussion; L. Wang, Y. Du, and D. Trudgian at UTSW BioHPC for assistance; and S.T. Smale at UCLA for critical reading of the manuscript and discussion. This work was supported by the NIH grant R01MH102616, the Cecil H. and Ida Green Endowment, the SKR&DPC grant (2017YFA0505503), and the NSFC grants (91519326, 31671384) to M.Q.Z.; the NSFC grant (31670836), the National Key R&D Program of China (2017YFA0505100), and Shanghai Institute of Higher Learning (TP2015003) to F.Z.; the "100-Talent'' Program of Chinese Academy of Sciences (Y516C11851) to Z.S.; the NIH grants K01DK093543, R03DK101665, and R01DK111430, a Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award (RR140025), the American Cancer Society award and the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern (IRG-02-196), the Welch Foundation grant I-1942-20170325, and an American Society of Hematology Scholar award to J.X.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Fujita T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03171; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Ibarra A, 2016, GENE DEV, V30, P2253, DOI 10.1101/gad.287417.116; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/NMETH.3205, 10.1038/nmeth.3205]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; Morley B. J., 1992, NATURE, V467, P430; MORLEY BJ, 1992, MOL CELL BIOL, V12, P2057, DOI 10.1128/MCB.12.5.2057; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Peterson KR, 1998, HUM MOL GENET, V7, P2079, DOI 10.1093/hmg/7.13.2079; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schwartzman O, 2016, NAT METHODS, V13, P685, DOI 10.1038/nmeth.3922; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Stonestrom AJ, 2015, BLOOD, V125, P2825, DOI 10.1182/blood-2014-10-607309; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Waldrip ZJ, 2014, EPIGENETICS-US, V9, P1207, DOI 10.4161/epi.29919; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhou F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3171	58	167	170	5	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					1028	+	1043.e19	10.1016/j.cell.2017.08.003	http://dx.doi.org/10.1016/j.cell.2017.08.003			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841410	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000408372400019
J	Courand, PY; Lantelme, P				Courand, Pierre-Yves; Lantelme, Pierre			Stretching the carotid sinus to treat resistant hypertension	LANCET			English	Editorial Material							LOWERS BLOOD-PRESSURE; RENAL DENERVATION; DOUBLE-BLIND; BAROREFLEX; PLACEBO		[Courand, Pierre-Yves; Lantelme, Pierre] Hosp Civils Lyon, Dept Cardiol, European Soc Hypertens Excellence Ctr, Hop Croix Rousse, F-69004 Lyon, France; [Courand, Pierre-Yves; Lantelme, Pierre] Hosp Civils Lyon, Hop Lyon Sud, F-69004 Lyon, France; [Courand, Pierre-Yves; Lantelme, Pierre] Lyon Univ Claude Bernard Lyon 1, Univ Lyon, CREATIS, CNRS UMR5220,INSERM U1044,INSA,Hosp Civils Lyon, Lyon, France	CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Courand, PY (corresponding author), Hosp Civils Lyon, Dept Cardiol, European Soc Hypertens Excellence Ctr, Hop Croix Rousse, F-69004 Lyon, France.; Courand, PY (corresponding author), Hosp Civils Lyon, Hop Lyon Sud, F-69004 Lyon, France.; Courand, PY (corresponding author), Lyon Univ Claude Bernard Lyon 1, Univ Lyon, CREATIS, CNRS UMR5220,INSERM U1044,INSA,Hosp Civils Lyon, Lyon, France.	pierre-yves.courand@chu-lyon.fr	Lantelme, Pierre/G-2708-2019; Courand, Pierre-Yves/O-1054-2016	Courand, Pierre-Yves/0000-0003-3199-7977	CVRX; Medtronic; Saint Jude Medical	CVRX; Medtronic(Medtronic); Saint Jude Medical	P-YC and PL have received personal fees from CVRX, Medtronic, and Saint Jude Medical for lectures in the field of hypertension.	Azizi M, 2016, CIRCULATION, V134, P847, DOI 10.1161/CIRCULATIONAHA.116.022922; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Courand PY, 2014, ARCH CARDIOVASC DIS, V107, P690, DOI 10.1016/j.acvd.2014.08.002; Hoppe UC, 2012, J AM SOC HYPERTENS, V6, P270, DOI 10.1016/j.jash.2012.04.004; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Lohmeier TE, 2015, PHYSIOLOGY, V30, P148, DOI 10.1152/physiol.00035.2014; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Spiering W., 2017, LANCET; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3	12	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2610	+		10.1016/S0140-6736(17)32298-5	http://dx.doi.org/10.1016/S0140-6736(17)32298-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FQ1FF	28870715				2022-12-28	WOS:000418101000009
J	Schuster, MA; Onorato, SE; Meltzer, DO				Schuster, Mark A.; Onorato, Sarah E.; Meltzer, David O.			Measuring the Cost of Quality Measurement A Missing Link in Quality Strategy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Schuster, Mark A.; Onorato, Sarah E.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA; [Schuster, Mark A.; Onorato, Sarah E.] Harvard Med Sch, Boston, MA USA; [Meltzer, David O.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Meltzer, David O.] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Chicago; University of Chicago	Schuster, MA (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	mark.schuster@childrens.harvard.edu						Amster A, 2015, J AM MED INFORM ASSN, V22, P409, DOI 10.1136/amiajnl-2014-002865; Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Lester HE, 2011, BMJ QUAL SAF, V20, P1057, DOI 10.1136/bmjqs.2010.048371; Meltzer DO, 2014, HEALTH AFFAIR, V33, P132, DOI 10.1377/hlthaff.2011.1283; Panzer RJ, 2013, JAMA-J AM MED ASSOC, V310, P1971, DOI 10.1001/jama.2013.282047	6	30	30	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2017	318	13					1219	1220		10.1001/jama.2017.11525	http://dx.doi.org/10.1001/jama.2017.11525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI8CW	28859200				2022-12-28	WOS:000412229600009
J	Brejc, K; Bian, Q; Uzawa, S; Wheeler, BS; Anderson, EC; King, DS; Kranzusch, PJ; Preston, CG; Meyer, BJ				Brejc, Katjusa; Bian, Qian; Uzawa, Satoru; Wheeler, Bayly S.; Anderson, Erika C.; King, David S.; Kranzusch, Philip J.; Preston, Christine G.; Meyer, Barbara J.			Dynamic Control of X Chromosome Conformation and Repression by a Histone H4K20 Demethylase	CELL			English	Article							ELEGANS DOSAGE COMPENSATION; CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-CYCLE; SEX DETERMINATION; COMPLEX; GENOME; METHYLATION; GENE; TRANSCRIPTION	Chromatin modification and higher-order chromosome structure play key roles in gene regulation, but their functional interplay in controlling gene expression is elusive. We have discovered the machinery and mechanism underlying the dynamic enrichment of histone modification H4K20me1 on hermaphrodite X chromosomes during C. elegans dosage compensation and demonstrated H4K20me1's pivotal role in regulating higher-order chromosome structure and X-chromosome-wide gene expression. The structure and the activity of the dosage compensation complex (DCC) subunit DPY-21 define a Jumonji demethylase subfamily that converts H4K20me2 to H4K20me1 in worms and mammals. Selective inactivation of demethylase activity eliminates H4K20me1 enrichment in somatic cells, elevates X-linked gene expression, reduces X chromosome compaction, and disrupts X chromosome conformation by diminishing the formation of topologically associating domains (TADs). Unexpectedly, DPY-21 also associates with autosomes of germ cells in a DCC-independent manner to enrichH4K20me1 and trigger chromosome compaction. Our findings demonstrate the direct link between chromatin modification and higher-order chromosome structure in long-range regulation of gene expression.	[Brejc, Katjusa; Bian, Qian; Uzawa, Satoru; Wheeler, Bayly S.; Anderson, Erika C.; Kranzusch, Philip J.; Preston, Christine G.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Brejc, Katjusa; Bian, Qian; Uzawa, Satoru; Wheeler, Bayly S.; Anderson, Erika C.; Kranzusch, Philip J.; Preston, Christine G.; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [King, David S.] Univ Calif Berkeley, HHMI Mass Spectrometry Lab, Berkeley, CA 94720 USA; [Wheeler, Bayly S.] Rhodes Coll, Dept Biol, Memphis, TN 38112 USA; [Kranzusch, Philip J.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Kranzusch, Philip J.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Preston, Christine G.] Invitae, San Francisco, CA 94107 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Meyer, BJ (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Meyer, Barbara/0000-0002-6530-4588; Anderson, Erika/0000-0002-0029-6230; Bian, Qian/0000-0001-7022-2213	NIH Instrumentation Grant [S10 OD018174]; Miller Institute funds; NIGMS grants [R01 GM030702, F32 GM100647]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100647, R01GM030702] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018174] Funding Source: NIH RePORTER	NIH Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miller Institute funds; NIGMS grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Fujimori, D. Minor, T. Cline, E. Ralston, and M. Marletta for general discussions; J. Dekker for Hi-C discussions; D. Stalford for figures; T. Cline, J. Berger, B. Farboud, and N. Fuda for manuscript comments; and J. Doudna for sharing equipment and expertise. We used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by an NIH Instrumentation Grant (S10 OD018174). X-ray data were collected at the Lawrence Berkeley National Laboratory Advanced Light Source (Beamline 8.3.1). Huygens software was licensed to the CNR Biological Imaging Facility at UC Berkeley. Research was supported, in part, by Miller Institute funds and NIGMS grants (R01 GM030702 to B.J.M.; F32 GM100647 to B.S.W.). B.J.M. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Blanchard DP, 2014, P NATL ACAD SCI USA, V111, pE4234, DOI 10.1073/pnas.1416321111; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; da Rocha ST, 2017, NAT STRUCT MOL BIOL, V24, P197, DOI 10.1038/nsmb.3370; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Delaney CE, 2017, DEVELOPMENT, V144, P1273, DOI 10.1242/dev.145722; Dumas KJ, 2013, GENETICS, V194, P619, DOI 10.1534/genetics.113.149948; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Giorgetti L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1081-2; Harrison MM, 2007, GENETICS, V176, P255, DOI 10.1534/genetics.106.069633; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kramer M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005698; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Kuroda MI, 2016, GENETICS, V204, P435, DOI 10.1534/genetics.115.185108; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lau AC, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-31; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Markolovic S, 2016, CURR OPIN STRUC BIOL, V41, P62, DOI 10.1016/j.sbi.2016.05.013; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; RHIND NR, 1995, CELL, V80, P71, DOI 10.1016/0092-8674(95)90452-2; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soshnev AA, 2016, MOL CELL, V62, P681, DOI 10.1016/j.molcel.2016.05.004; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Strome S., 2014, COLD SPRING HARB PER, V6; Takahashi T, 2004, BIOL REPROD, V70, P1485, DOI 10.1095/biolreprod.103.026096; Tan FJ, 2007, CELL DEATH DIFFER, V14, P1925, DOI 10.1038/sj.cdd.4402215; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; van Nuland R, 2016, MOL CELL PROTEOMICS, V15, P755, DOI 10.1074/mcp.R115.054742; Vielle A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002933; Wang JX, 2015, NAT NEUROSCI, V18, P1256, DOI 10.1038/nn.4069; Webster CM, 2013, DEVELOPMENT, V140, P3601, DOI 10.1242/dev.094292; Wells MB, 2012, MOL CELL BIOL, V32, P1710, DOI 10.1128/MCB.06546-11; Williamson I, 2012, DEVELOPMENT, V139, P3157, DOI 10.1242/dev.081174; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yonker SA, 2003, DEVELOPMENT, V130, P6519, DOI 10.1242/dev.00886; Zielinska DF, 2009, J PROTEOME RES, V8, P4039, DOI 10.1021/pr900384k	76	40	41	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					85	+		10.1016/j.cell.2017.07.041	http://dx.doi.org/10.1016/j.cell.2017.07.041			41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28867287	Green Accepted, Bronze			2022-12-28	WOS:000411331800013
J	Oetjen, LK; Mack, MR; Feng, J; Whelan, TM; Niu, HX; Guo, CXJ; Chen, SS; Trier, AM; Xu, AZ; Tripathi, SV; Luo, JL; Gao, XF; Yang, LH; Hamilton, SL; Wang, PL; Brestoff, JR; Council, ML; Brasington, R; Schaffer, A; Brombacher, F; Hsieh, CS; Gereau, RW; Miller, MJ; Chen, ZF; Hu, HZ; Davidson, S; Liu, Q; Kim, BS				Oetjen, Landon K.; Mack, Madison R.; Feng, Jing; Whelan, Timothy M.; Niu, Haixia; Guo, Changxiong J.; Chen, Sisi; Trier, Anna M.; Xu, Amy Z.; Tripathi, Shivani V.; Luo, Jialie; Gao, Xiaofei; Yang, Lihua; Hamilton, Samantha L.; Wang, Peter L.; Brestoff, Jonathan R.; Council, M. Laurin; Brasington, Richard; Schaffer, Andras; Brombacher, Frank; Hsieh, Chyi-Song; Gereau, Robert W.; Miller, Mark J.; Chen, Zhou-Feng; Hu, Hongzhen; Davidson, Steve; Liu, Qin; Kim, Brian S.			Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch	CELL			English	Article							INNATE LYMPHOID-CELLS; ATOPIC-DERMATITIS; DRY SKIN; T-CELLS; PRURITUS; EXPRESSION; INTERLEUKIN-13; SENSITIZATION; TOFACITINIB; DUPILUMAB	Mammals have evolved neurophysiologic reflexes, such as coughing and scratching, to expel invading pathogens and noxious environmental stimuli. It is well established that these responses are also associated with chronic inflammatory diseases, including asthma and atopic dermatitis. However, the mechanisms by which inflammatory pathways promote sensations such as itch remain poorly understood. Here, we show that type 2 cytokines directly activate sensory neurons in both mice and humans. Further, we demonstrate that chronic itch is dependent on neuronal IL-4Ra and JAK1 signaling. We also observe that patients with recalcitrant chronic itch that failed other immunosuppressive therapies markedly improve when treated with JAK inhibitors. Thus, signaling mechanisms previously ascribed to the immune system may represent novel therapeutic targets within the nervous system. Collectively, this study reveals an evolutionarily conserved paradigm in which the sensory nervous system employs classical immune signaling pathways to influence mammalian behavior.	[Oetjen, Landon K.; Mack, Madison R.; Feng, Jing; Whelan, Timothy M.; Niu, Haixia; Guo, Changxiong J.; Trier, Anna M.; Xu, Amy Z.; Tripathi, Shivani V.; Luo, Jialie; Gao, Xiaofei; Chen, Zhou-Feng; Hu, Hongzhen; Liu, Qin; Kim, Brian S.] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Oetjen, Landon K.; Mack, Madison R.; Whelan, Timothy M.; Niu, Haixia; Trier, Anna M.; Xu, Amy Z.; Tripathi, Shivani V.; Council, M. Laurin; Schaffer, Andras; Kim, Brian S.] Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA; [Feng, Jing; Guo, Changxiong J.; Luo, Jialie; Gao, Xiaofei; Gereau, Robert W.; Chen, Zhou-Feng; Hu, Hongzhen; Liu, Qin; Kim, Brian S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Chen, Sisi; Davidson, Steve] Univ Cincinnati, Coll Med, Dept Anesthesiol, Cincinnati, OH 45267 USA; [Yang, Lihua; Hamilton, Samantha L.; Miller, Mark J.] Washington Univ, Div Infect Dis, Dept Med, Sch Med, St Louis, MO 63110 USA; [Wang, Peter L.; Brestoff, Jonathan R.; Schaffer, Andras; Hsieh, Chyi-Song; Kim, Brian S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Brasington, Richard; Hsieh, Chyi-Song] Washington Univ, Div Rheumatol, Dept Med, Sch Med, St Louis, MO 63110 USA; [Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol, ZA-7700 Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, ZA-7700 Cape Town, South Africa	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University System of Ohio; University of Cincinnati; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town	Kim, BS (corresponding author), Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Kim, BS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.	briankim@wustl.edu	wang, peter/AAD-5851-2020; CHEN, SI/GZL-4800-2022; Brestoff, Jonathan R./I-7000-2019; Wang, Peizhong Peter/B-2447-2008; Kim, Brian/GZK-6649-2022	Brestoff, Jonathan R./0000-0002-7018-7400; Kim, Brian/0000-0002-8100-7161; Hu, Hongzhen/0000-0002-8967-7522; Davidson, Steve/0000-0003-2944-1144; Trier, Anna/0000-0001-7957-2180; Miller, Mark/0000-0001-5676-389X	LEO Pharma; WUSM Institute of Clinical and Translational Sciences (ICTS); NIH National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) [UL1TR000448]; NCI [P30CA91842]; ICTS CTSA grant from the National Center for Research Resources (NCRR) [UL1TR000448]; NCRR Shared Instrumentation grant [1S10RR027552]; NIDDK [P30DK052574, R01DK103901]; NINDS [R01NS042595]; NIAMS [R21AR068012, K08AR065577, R01AR070116]; NIGMS [R01GM101218]; American Skin Association; Doris Duke Charitable Foundation; NHLBI [T32HL007317]; Howard Hughes Medical Institute (HHMI) Medical Fellows Program; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR002345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027552] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY024704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125743, R01AI077600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR068012, R01AR070116, R56AR064294, K08AR065577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103901, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037261] Funding Source: NIH RePORTER	LEO Pharma(LEO Pharma); WUSM Institute of Clinical and Translational Sciences (ICTS); NIH National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS CTSA grant from the National Center for Research Resources (NCRR); NCRR Shared Instrumentation grant; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Skin Association; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute (HHMI) Medical Fellows Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all our collaborators at Washington University School of Medicine (WUSM) for their advice and discussion. We also thank members of the Division of Dermatology at WUSM for their assistance with patient sample collection. Specifically, we thank Ms. Mary Tabacchi, Ms. Nancy Bodet, and Dr. Lynn Cornelius for their support. This publication was supported, in part, by a grant from LEO Pharma and by the WUSM Institute of Clinical and Translational Sciences (ICTS), which is supported by the NIH National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) (UL1TR000448). We also thank the Genome Technology Access Center (GTAC) at WUSM for assistance with RNA sequencing. GTAC is partially supported by an NCI grant (P30CA91842) and by an ICTS CTSA grant (UL1TR000448) from the National Center for Research Resources (NCRR). We also thank the WUSM Alafi Neuroimaging Laboratory, supported by an NCRR Shared Instrumentation grant (1S10RR027552). We thank the WUSM Digestive Disease Research Core Center for histology assistance, supported by an NIDDK grant (P30DK052574). We also thank the Immunomonitoring Laboratory (IML) at the Bursky Center for Human Immunology & Immunotherapy Programs (ChiiPs) for flow cytometry support. Research using human DRG in the Gereau Lab is supported by an NINDS grant (R01NS042595). The Davidson Lab is supported by an NIAMS grant (R21AR068012). The Hu Lab is supported by an NIGMS grant (R01GM101218) and an NIDDK grant (R01DK103901). The Kim Lab is supported by NIAMS grants (K08AR065577 and R01AR070116), the American Skin Association, and the Doris Duke Charitable Foundation. L.K.O. is supported by an NHLBI grant (T32HL007317). A.Z.X. is supported by the Howard Hughes Medical Institute (HHMI) Medical Fellows Program. IL-4R alpha<SUP>flox</SUP> mice were kindly provided by Dr. Herbert (Skip) Virgin at WUSM and Dr. Ajay Chawla at University of California, San Francisco. We also thank Dr. Steven Saenz for critical discussions.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Andersen HH, 2017, PAIN, V158, P1780, DOI 10.1097/j.pain.0000000000000980; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Berger TG, 2011, SEMIN CUTAN MED SURG, V30, P113, DOI 10.1016/j.sder.2011.04.002; Bissonnette R, 2016, BRIT J DERMATOL, V175, P902, DOI 10.1111/bjd.14871; Cevikbas F, 2014, J ALLERGY CLIN IMMUN, V133, P448, DOI 10.1016/j.jaci.2013.10.048; Chan LS, 2001, J INVEST DERMATOL, V117, P977, DOI 10.1046/j.0022-202x.2001.01484.x; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Kaplan AP, 2004, J ALLERGY CLIN IMMUN, V114, P465, DOI 10.1016/j.jaci.2004.02.049; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kini SP, 2011, ARCH DERMATOL, V147, P1153, DOI 10.1001/archdermatol.2011.178; Levy LL, 2015, J AM ACAD DERMATOL, V73, P395, DOI 10.1016/j.jaad.2015.06.045; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Matterne U, 2011, ACTA DERM-VENEREOL, V91, P674, DOI 10.2340/00015555-1159; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; Mollanazar NK, 2016, J AM ACAD DERMATOL, V75, DOI 10.1016/j.jaad.2016.05.035; Morita T, 2015, NEURON, V87, P124, DOI 10.1016/j.neuron.2015.05.044; Oetjen LK, 2016, SEMIN IMMUNOPATHOL, V38, P549, DOI 10.1007/s00281-016-0567-z; Ordovas-Montanes J, 2015, TRENDS IMMUNOL, V36, P578, DOI 10.1016/j.it.2015.08.007; Patel Tejesh, 2010, Skin Therapy Lett, V15, P5; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Reich A, 2011, CLIN DERMATOL, V29, P15, DOI 10.1016/j.clindermatol.2010.07.002; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SH, 2016, SEMIN IMMUNOPATHOL, V38, P293, DOI 10.1007/s00281-015-0530-4; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Thaci D, 2016, LANCET, V387, P40, DOI 10.1016/S0140-6736(15)00388-8; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Valtcheva MV, 2016, NAT PROTOC, V11, P1877, DOI 10.1038/nprot.2016.111; Valtcheva MV, 2015, J PAIN, V16, P346, DOI 10.1016/j.jpain.2015.01.005; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Xu AZ, 2016, J AM ACAD DERMATOL, V74, P1017, DOI 10.1016/j.jaad.2015.11.029; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814; Zhao ZQ, 2013, J CLIN INVEST, V123, P4769, DOI 10.1172/JCI70528; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zheng T, 2009, J INVEST DERMATOL, V129, P742, DOI 10.1038/jid.2008.295	62	440	460	18	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					217	+		10.1016/j.cell.2017.08.006	http://dx.doi.org/10.1016/j.cell.2017.08.006			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28890086	Green Accepted, Bronze			2022-12-28	WOS:000411331800022
J	Holland, SM; Pierce, VM; Shailam, R; Glomski, K; Farmer, JR				Holland, Steven M.; Pierce, Virginia M.; Shailam, Randheer; Glomski, Krzysztof; Farmer, Jocelyn R.			Case 28-2017: A 13-Month-Old Girl with Pneumonia and a 33-Year-Old Woman with Hip Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-GENAVENSE INFECTION; RECIPIENT CASE-REPORT; IMMUNOSUPPRESSIVE THERAPY; AVIAN MYCOBACTERIOSIS; CLINICAL-FEATURES; IFN-GAMMA; INTERFERON; DOMINANT; PATIENT; SUSCEPTIBILITY		[Holland, Steven M.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Pierce, Virginia M.; Glomski, Krzysztof] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Farmer, Jocelyn R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Pierce, Virginia M.; Glomski, Krzysztof] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Shailam, Randheer] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Farmer, Jocelyn R.] Harvard Med Sch, Dept Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Holland, SM (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Pierce, Virginia/0000-0002-3723-1326; Farmer, Jocelyn/0000-0003-4901-9848	McNeely Case Records of the MGH Visiting Professor Series; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001069, ZIAAI000647] Funding Source: NIH RePORTER	McNeely Case Records of the MGH Visiting Professor Series; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the McNeely Case Records of the MGH Visiting Professor Series and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bogdan C, 1997, CLIN INFECT DIS, V24, P1245, DOI 10.1086/513634; BOTTGER EC, 1994, EUR J CLIN MICROBIOL, V13, P932, DOI 10.1007/BF02111494; BOTTGER EC, 1992, LANCET, V340, P76, DOI 10.1016/0140-6736(92)90397-L; BOTTGER EC, 1993, INT J SYST BACTERIOL, V43, P841, DOI 10.1099/00207713-43-4-841; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Charles P, 2011, MEDICINE, V90, P223, DOI 10.1097/MD.0b013e318225ab89; de Lastours V, 2008, EMERG INFECT DIS, V14, P346, DOI 10.3201/eid1402.070901; Doggett JS, 2011, TRANSPL INFECT DIS, V13, P38, DOI 10.1111/j.1399-3062.2010.00545.x; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Dumouchel-Champagne H, 2009, EUR RESPIR REV, V18, P299, DOI 10.1183/09059180.00002209; Ehlers S, 2000, INFECT IMMUN, V68, P3720, DOI 10.1128/IAI.68.6.3720-3723.2000; Glosli H, 2008, CLIN INFECT DIS, V46, pE23, DOI 10.1086/525855; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hoefsloot W, 2013, CLIN MICROBIOL INFEC, V19, P432, DOI 10.1111/j.1469-0691.2012.03817.x; HOOP RK, 1993, J CLIN MICROBIOL, V31, P990, DOI 10.1128/JCM.31.4.990-993.1993; Hoop RK, 1996, J CLIN MICROBIOL, V34, P991, DOI 10.1128/JCM.34.4.991-992.1996; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Kiehn TE, 1996, J CLIN MICROBIOL, V34, P1840, DOI 10.1128/JCM.34.7.1840-1842.1996; Kimberlin D. W., 2015, RED BOOK 2018 REP CO, V30th; Kong XF, 2013, HUM MOL GENET, V22, P769, DOI 10.1093/hmg/dds484; Krebs T, 2000, J INTERN MED, V248, P343, DOI 10.1046/j.1365-2796.2000.00730.x; Leautez S, 2000, EUR J CLIN MICROBIOL, V19, P51, DOI 10.1007/s100960050010; Lhuillier E, 2012, EXP CLIN TRANSPLANT, V10, P618, DOI 10.6002/ect.2012.0052; Lorenzen J, 2009, CLIN RHEUMATOL, V28, pS39, DOI 10.1007/s10067-009-1120-4; Lu KJ, 2009, TRANSPL INFECT DIS, V11, P534, DOI 10.1111/j.1399-3062.2009.00431.x; Manarolla G, 2009, VET MICROBIOL, V133, P323, DOI 10.1016/j.vetmic.2008.07.017; Matsiota-Bernard P, 2000, MICROBES INFECT, V2, P575, DOI 10.1016/S1286-4579(00)00369-5; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Nurmohamed S, 2007, AM J TRANSPLANT, V7, P722, DOI 10.1111/j.1600-6143.2006.01680.x; Ombelet S, 2016, TRANSPL INFECT DIS, V18, P125, DOI 10.1111/tid.12493; Palmieri C, 2013, J COMP PATHOL, V148, P126, DOI 10.1016/j.jcpa.2012.06.005; PECHERE M, 1995, ARCH INTERN MED, V155, P400, DOI 10.1001/archinte.155.4.400; Portaels F, 1996, J CLIN MICROBIOL, V34, P319, DOI 10.1128/JCM.34.2.319-323.1996; Potjewijd J, 2012, CLIN IMMUNOL, V144, P83, DOI 10.1016/j.clim.2012.05.007; Ramis A, 1996, AVIAN DIS, V40, P246, DOI 10.2307/1592398; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-311; Renoult E, 2013, TRANSPLANTATION, V96, pE64, DOI 10.1097/TP.0b013e3182a9026c; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Takeda K, 2014, CLIN IMMUNOL, V151, P25, DOI 10.1016/j.clim.2014.01.004; Tassone L, 2013, J ALLERGY CLIN IMMUN, V131, P607, DOI 10.1016/j.jaci.2012.05.041; Vinh DC, 2009, CLIN INFECT DIS, V49, pE62, DOI 10.1086/605532; Wu UI, 2015, LANCET INFECT DIS, V15, P968, DOI 10.1016/S1473-3099(15)00089-4; Zerbe CS, 2005, CLIN INFECT DIS, V41, pE38, DOI 10.1086/432120	46	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2017	377	11					1077	1091		10.1056/NEJMcpc1706097	http://dx.doi.org/10.1056/NEJMcpc1706097			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6YC	28902581				2022-12-28	WOS:000410545200012
J	Chokshi, DA				Chokshi, Dave A.			A Bipartisan "Moonshot" in Health: Improving Care for High-Need Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Chokshi, Dave A.] OneCity Hlth, New York, NY 10038 USA; [Chokshi, Dave A.] New York City Hlth Hosp, New York, NY 10035 USA; [Chokshi, Dave A.] Bellevue Hosp, New York, NY 10016 USA; [Chokshi, Dave A.] NYU, Sch Med, Populat Hlth & Med, New York, NY 10003 USA	Bellevue Hospital Center; New York University	Chokshi, DA (corresponding author), OneCity Hlth, New York, NY 10038 USA.; Chokshi, DA (corresponding author), Bellevue Hosp, New York, NY 10016 USA.; Chokshi, DA (corresponding author), NYU, Sch Med, Populat Hlth & Med, New York, NY 10003 USA.	dave.chokshi@alumni.duke.edu		Chokshi, Dave/0000-0001-7467-4591					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					788	789		10.1001/jama.2017.10801	http://dx.doi.org/10.1001/jama.2017.10801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873150				2022-12-28	WOS:000409183700003
J	Maddocks, M; Lovell, N; Booth, S; Man, WDC; Higginson, IJ				Maddocks, Matthew; Lovell, Natasha; Booth, Sara; Man, William D-C; Higginson, Irene J.			Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease	LANCET			English	Article							OF-LIFE CARE; REFRACTORY CHRONIC COUGH; END-STAGE COPD; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; LUNG-CANCER; DOUBLE-BLIND; RESPIRATORY-DISEASES; EXERCISE CAPACITY; SELF-MANAGEMENT	People with advanced chronic obstructive pulmonary disease (COPD) have distressing physical and psychological symptoms, often have limited understanding of their disease, and infrequently discuss end-of-life issues in routine clinical care. These are strong indicators for expert multidisciplinary palliative care, which incorporates assessment and management of symptoms and concerns, patient and caregiver education, and sensitive communication to elicit preferences for care towards the end of life. The unpredictable course of COPD and the difficulty of predicting survival are barriers to timely referral and receipt of palliative care. Early integration of palliative care with respiratory, primary care, and rehabilitation services, with referral on the basis of the complexity of symptoms and concerns, rather than prognosis, can improve patient and caregiver outcomes. Models of integrated working in COPD could include: services triggered by troublesome symptoms such as refractory breathlessness; short-term palliative care; and, in settings with limited access to palliative care, consultation only in specific circumstances or for the most complex patients.	[Maddocks, Matthew; Lovell, Natasha; Higginson, Irene J.] Kings Coll London, Cicely Saunders Inst Palliat Care Policy & Rehabi, London, England; [Booth, Sara] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Palliat Med, Cambridge, England; [Booth, Sara] Univ Cambridge, Dept Oncol, Cambridge, England; [Man, William D-C] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Harefield Pulm Rehabil & Muscle Res Lab, London, England	University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Higginson, IJ (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London SE5 9PJ, England.	irene.higginson@kcl.ac.uk	Harding, Richard/G-9729-2012; Lovell, Natasha/F-8536-2016; Higginson, Irene Julie/C-7309-2012	Lovell, Natasha/0000-0001-6594-799X; Man, William/0000-0002-3782-659X; Higginson, Irene Julie/0000-0002-3687-1313; Maddocks, Matthew/0000-0002-0189-0952	Cicely Saunders International; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLARHC) South London at King's College Hospital NHS Foundation Trust; NIHR Health Services & Delivery Research grant [NIHR HSDR 16/02/18]; NIHR CLARHC South London; NIHR CLAHRC for Northwest London Breathlessness Theme; MRC [G1002113] Funding Source: UKRI; Marie Curie [MCCC-RP-15-A18859] Funding Source: researchfish; Medical Research Council [G1002113] Funding Source: researchfish; National Institute for Health Research [CTF-01-12-04, 16/02/18, PB-PG-0213-30003, PDF-2011-04-048, ACF-2011-17-019, CDF-2017-10-009, NIHR-CTF-2013-02-009] Funding Source: researchfish	Cicely Saunders International; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLARHC) South London at King's College Hospital NHS Foundation Trust; NIHR Health Services & Delivery Research grant; NIHR CLARHC South London; NIHR CLAHRC for Northwest London Breathlessness Theme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Cicely Saunders International and the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLARHC) South London at King's College Hospital NHS Foundation Trust. Cicely Saunders International support NL and funded much of the work on breathlessness upon which text in this review is based. MM is supported by an NIHR Health Services & Delivery Research grant (NIHR HSDR 16/02/18) and NIHR CLARHC South London. WD-CM is part funded by NIHR CLAHRC for Northwest London Breathlessness Theme. IJH is an NIHR Emeritus Senior Investigator. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. We thank Surinder Birring (King's College Hospital) for feedback on text relating to cough.	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Ahmadi Z, 2016, INT J CHRONIC OBSTR, V11, P2651, DOI 10.2147/COPD.S112484; Albert RK, 2016, NEW ENGL J MED, V375, P1617, DOI 10.1056/NEJMoa1604344; Ali Zohal Mohammad, 2013, Glob J Health Sci, V5, P150, DOI 10.5539/gjhs.v5n3p150; Andreassen P, 2017, BMJ SUPPORT PALLIAT, V7, P335, DOI 10.1136/bmjspcare-2015-000886; [Anonymous], 2017, LANCET, V389, P574, DOI 10.1016/S0140-6736(17)30327-6; Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Back AL, 2006, J CLIN ONCOL, V24, P4209, DOI 10.1200/JCO.2006.06.007; Baltzan MA, 2011, CHRON RESP DIS, V8, P119, DOI 10.1177/1479972310396737; Barnes H, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011008.pub2; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bausewein C, 2010, J PALLIAT MED, V13, P1109, DOI 10.1089/jpm.2010.0068; Beernaert K, 2013, RESP MED, V107, P1731, DOI 10.1016/j.rmed.2013.06.003; Benzo RP, 2016, ANN AM THORAC SOC, V13, P10, DOI 10.1513/AnnalsATS.201508-490OC; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Birring SS, 2017, PULM PHARMACOL THER, V47, P84, DOI 10.1016/j.pupt.2017.04.001; Blinderman CD, 2009, J PAIN SYMPTOM MANAG, V38, P115, DOI 10.1016/j.jpainsymman.2008.07.006; Booth Sara, 2006, Palliat Support Care, V4, P287; Breslin E, 1998, CHEST, V114, P958, DOI 10.1378/chest.114.4.958; Brighton LJ, 2016, POSTGRAD MED J, V92, P466, DOI 10.1136/postgradmedj-2015-133368; Buckingham S, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.20; Budhiraja R, 2012, SLEEP, V35, P369, DOI 10.5665/sleep.1698; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cherny NI., 2015, OXFORD TXB PALLIATIV, V6; Chin C, 2016, POSTGRAD MED J, V92, P393, DOI 10.1136/postgradmedj-2015-133578; Chochinov HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147607; Chochinov HM, 2011, LANCET ONCOL, V12, P753, DOI 10.1016/S1470-2045(11)70153-X; Chochinov HM, 2002, LANCET, V360, P2026, DOI 10.1016/S0140-6736(02)12022-8; Claessens MT, 2000, J AM GERIATR SOC; Cohen J, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0017-y; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Coventry PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060532; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Curtis JR, 2008, J PALLIAT MED, V11, P610, DOI 10.1089/jpm.2007.0209; Curtis JR, 2004, EUR RESPIR J, V24, P200, DOI 10.1183/09031936.04.00010104; Disler RT, 2014, J PAIN SYMPTOM MANAG, V48, P1182, DOI 10.1016/j.jpainsymman.2014.03.009; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Donesky-Cuenco D, 2009, J ALTERN COMPLEM MED, V15, P225, DOI 10.1089/acm.2008.0389; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Edmonds P, 2001, PALLIATIVE MED, V15, P287, DOI 10.1191/026921601678320278; Ekstrom M, 2018, THORAX, V73, P88, DOI 10.1136/thoraxjnl-2016-209868; Farquhar M., 2016, PALLIATIVE CARE RESP; Farquhar M, 2017, CURR OPIN SUPPORT PA, V11, P165, DOI 10.1097/SPC.0000000000000281; Farquhar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177081; Farquhar MC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1304-6; Ferreira IM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000998.pub3; Fishman A, 2003, NEW ENGL J MED, V348, P2059; FLENLEY DC, 1981, LANCET, V1, P681; Furness S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008934.pub2; Galbraith S, 2010, J PAIN SYMPTOM MANAG, V39, P831, DOI 10.1016/j.jpainsymman.2009.09.024; Giacomini M, 2012, Ont Health Technol Assess Ser, V12, P1; Global Initiative for Chronic Obstructive Lung Disease, 2016, GLOBAL STRATEGY DIAG; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; Guidelines and audit implementation network (GAIN), 2011, GEN PALL CAR GUID MA; Gysels M H, 2009, Chron Respir Dis, V6, P133, DOI 10.1177/1479972309102810; Gysels M, 2008, J PAIN SYMPTOM MANAG, V36, P451, DOI 10.1016/j.jpainsymman.2007.11.008; Gysels Marjolein, 2007, Palliat Support Care, V5, P281; Gysels M, 2015, EUR RESPIR J, V46, P1515, DOI 10.1183/13993003.00751-2015; Habraken JM, 2008, BRIT J GEN PRACT, V58, P844, DOI 10.3399/bjgp08X376186; HajGhanbari B, 2012, RESP MED, V106, P998, DOI 10.1016/j.rmed.2012.03.004; Han MLK, 2016, LANCET RESP MED, V4, P473, DOI 10.1016/S2213-2600(16)00094-1; Hanania NA, 2011, AM J RESP CRIT CARE, V183, P604, DOI 10.1164/rccm.201003-0472OC; Harrington SE, 2017, CURR OPIN PULM MED, V23, P154, DOI 10.1097/MCP.0000000000000358; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; Heffner JE, 1996, AM J RESP CRIT CARE, V154, P1735, DOI 10.1164/ajrccm.154.6.8970363; Higginson IJ, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0776-2; Higginson IJ, 2014, LANCET RESP MED, V2, P979, DOI 10.1016/S2213-2600(14)70226-7; Holland AE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008250.pub2; Houben CHM, 2017, CHEST, V151, P1081, DOI 10.1016/j.chest.2016.12.003; Houben CHM, 2014, J AM MED DIR ASSOC, V15, P477, DOI 10.1016/j.jamda.2014.01.008; Howard C, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.76; Hui D, 2016, NAT REV CLIN ONCOL, V13, P159, DOI 10.1038/nrclinonc.2015.201; Hui D, 2015, ANN PALLIAT MED, V4, P89, DOI 10.3978/j.issn.2224-5820.2015.04.01; Hui D, 2015, ONCOLOGIST, V20, P77, DOI 10.1634/theoncologist.2014-0312; Jacobsen J, 2011, J PALLIAT MED, V14, P459, DOI 10.1089/jpm.2010.0382; Janssen DJA, 2012, J AM MED DIR ASSOC, V13, P394, DOI 10.1016/j.jamda.2011.04.017; Janssen DJA, 2011, CHEST, V139, P1081, DOI 10.1378/chest.10-1753; Janssen DJA, 2012, PATIENT EDUC COUNS, V86, P19, DOI 10.1016/j.pec.2011.01.007; Jones S, 2016, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD009419.PUB3; Kahraman H, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-66; Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Kendall M, 2015, J PAIN SYMPTOM MANAG, V50, P216, DOI 10.1016/j.jpainsymman.2015.02.017; Khakban A, 2017, AM J RESP CRIT CARE, V195, P287, DOI 10.1164/rccm.201606-1162PP; Knauft E, 2005, CHEST, V127, P2188, DOI 10.1378/chest.127.6.2188; Kunik ME, 2008, PSYCHOL MED, V38, P385, DOI 10.1017/S0033291707001687; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Laveneziana P, 2012, EUR RESPIR J, V40, P522, DOI 10.1183/09031936.00041212; Levack WM, 2013, N Z J PHYS, V42, P170; Levack WMM, 2015, COCHRANE DB SYST REV, V9; Lewko A, 2012, CURR RESPIR MED REV, V8, P370, DOI 10.2174/157339812803832476; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu XM, 2016, INT J CHRONIC OBSTR, V11, P675, DOI 10.2147/COPD.S98082; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Maddocks M, 2016, THORAX, V71, P988, DOI 10.1136/thoraxjnl-2016-208460; Maddocks M, 2016, LANCET RESP MED, V4, P27, DOI [10.1016/S2213-2600(15)00503-2, 10.1016/S2213-2600(16)00093-X]; Martinez M, 2017, PALLIATIVE MED, V31, P492, DOI 10.1177/0269216316665562; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; McGarvey L, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000148; Meharry R, 2016, EUROP RESP J; Mikkelsen RL, 2004, NORD J PSYCHIAT, V58, P65, DOI 10.1080/08039480310000824; Mitchell SAFC, 2017, THORAX, V72, P129, DOI 10.1136/thoraxjnl-2016-208843; Moens K, 2014, J PAIN SYMPTOM MANAG, V48, P660, DOI 10.1016/j.jpainsymman.2013.11.009; Momen N, 2012, THORAX, V67, P777, DOI 10.1136/thoraxjnl-2012-201835; Mucke M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006788.pub3; Mullerova H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085540; Murphy PB, 2017, JAMA-J AM MED ASSOC, V317, P2177, DOI 10.1001/jama.2017.4451; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nakken N, 2015, EUR RESPIR REV, V24, P498, DOI 10.1183/16000617.00010114; Ngai SPC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009953.pub2; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Norden J, 2015, EUR J CLIN NUTR, V69, P256, DOI 10.1038/ejcn.2014.76; Ospina MB, 2017, THORAX, V72, P31, DOI 10.1136/thoraxjnl-2016-208820; Patel K, 2012, RESPIROLOGY, V17, P72, DOI 10.1111/j.1440-1843.2011.02087.x; Payne C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008427.pub2; Philip J, 2018, PALLIAT SUPPORT CARE, V16, P452, DOI 10.1017/S147895151700044X; Pilling S, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4108; Pinnock Hilary, 2011, BMJ Support Palliat Care, V1, P174, DOI 10.1136/bmjspcare.d142rep; Puhan MA, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub4; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Rayner L, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.001002/14651858.CD14007503; Rea H, 2004, INTERN MED J, V34, P608, DOI 10.1111/j.1445-5994.2004.00672.x; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Rocker GM, 2013, CLIN INVEST MED, V36, pE114; Rush B, 2017, CHEST, V151, P41, DOI 10.1016/j.chest.2016.06.023; Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Simon ST, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub3; Simon ST, 2016, J PAIN SYMPTOM MANAG, V52, P228, DOI 10.1016/j.jpainsymman.2016.02.016; Singer AE, 2015, ANN INTERN MED, V162, P175, DOI 10.7326/M13-1609; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Slater G, 2012, J THORAC DIS, V4, P608, DOI 10.3978/j.issn.2072-1439.2012.10.07; Smith SMS, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000042; Solomon BK, 2016, J PAIN SYMPTOM MANAG, V51, P529, DOI 10.1016/j.jpainsymman.2015.11.007; Spathis A, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0024-z; Spruit MA, 2017, LANCET RESP MED, V5, P542, DOI 10.1016/S2213-2600(17)30158-3; Steiner MC, 2015, THORAX, V70, P805, DOI 10.1136/thoraxjnl-2015-206948; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinweg M, 2017, UNTIMELY MEDITATIONS, P1, DOI 10.1136/thoraxjnl-2016-209376; Struik FM, 2013, COCHRANE DB SYST REV, V6; Sullivan MD, 2010, PAIN, V149, P345, DOI 10.1016/j.pain.2010.02.037; Tawakol A, 2017, LANCET, V389, P834, DOI 10.1016/S0140-6736(16)31714-7; Teno JM, 2015, J PALLIAT MED, V18, P662, DOI 10.1089/jpm.2015.0039; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Twycross R, 2014, PALLIATIVE CARE FORM; Usmani ZA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010673.pub2; Usmani ZA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008483.pub2; van Dam van Isselt Eleonore F, 2014, BMJ Open, V4, pe005898, DOI 10.1136/bmjopen-2014-005898; Vanfleteren LEGW, 2016, LANCET RESP MED, V4, P911, DOI 10.1016/S2213-2600(16)00097-7; Verma JY, 2018, CHRON RESP DIS, V15, P5, DOI 10.1177/1479972317712720; Vertigan AE, 2016, CHEST, V149, P639, DOI 10.1378/chest.15-1271; Vozoris NT, 2016, EUR RESPIR J, V48, P683, DOI 10.1183/13993003.01967-2015; Wachterman MW, 2016, JAMA INTERN MED, V176, P1095, DOI 10.1001/jamainternmed.2016.1200; Weisberg J, 2002, CHEST, V121, P1070, DOI 10.1378/chest.121.4.1070; Wildman MJ, 2009, QJM-INT J MED, V102, P389, DOI 10.1093/qjmed/hcp036; Wildman MJ, 2007, BRIT MED J, V335, P1132, DOI 10.1136/bmj.39371.524271.55; Willgoss TG, 2013, RESP CARE, V58, P858, DOI 10.4187/respcare.01862; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wysham NG, 2015, ANN AM THORAC SOC, V12, P1294, DOI 10.1513/AnnalsATS.201503-180OC; Yin HL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006836; Yoong J, 2013, JAMA INTERN MED, V173, P283, DOI 10.1001/jamainternmed.2013.1874; Yorke J, 2015, SUPPORT CARE CANCER, V23, P3373, DOI 10.1007/s00520-015-2810-x; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	166	108	109	3	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					988	1002		10.1016/S0140-6736(17)32127-X	http://dx.doi.org/10.1016/S0140-6736(17)32127-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2SE	28872031	Green Submitted			2022-12-28	WOS:000408746300028
J	Gramling, C				Gramling, Carolyn			Toxic algae may be culprit in mysterious dinosaur deaths	SCIENCE			English	News Item																			0	2	2	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					857	857						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860363				2022-12-28	WOS:000408734900017
J	Wadman, M				Wadman, Meredith			Documents detail gender-related tensions at Salk	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					741	741		10.1126/science.357.6353.741	http://dx.doi.org/10.1126/science.357.6353.741			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839052				2022-12-28	WOS:000408327900016
J	Clarke, LE; Liddelow, SA				Clarke, Laura E.; Liddelow, Shane A.			NEUROBIOLOGY Diversity reaches the stars	NATURE			English	Editorial Material							ASTROCYTES; NEURONS	Cells called astrocytes promote and maintain neuronal function. The discovery that astrocytes vary in their gene expression, protein levels, cellular structure and function suggests that they are specialized to support distinct circuits.	[Clarke, Laura E.; Liddelow, Shane A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clarke, LE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	lclarke2@stanford.edu; liddelow@stanford.edu	Liddelow, Shane/ABE-6456-2020	Liddelow, Shane/0000-0002-0840-1437				Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Francelle L, 2015, HUM MOL GENET, V24, P1563, DOI 10.1093/hmg/ddu571; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Sloan SA, 2014, NEURON, V84, P1112, DOI 10.1016/j.neuron.2014.12.003; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	11	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					396	397		10.1038/548396a	http://dx.doi.org/10.1038/548396a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836597				2022-12-28	WOS:000408279000022
J	Takashima, Y; Guo, G; Loos, R; Nichols, J; Ficz, G; Krueger, F; Oxley, D; Santos, F; Clarke, J; Mansfield, W; Reik, W; Bertone, P; Smith, A				Takashima, Yasuhiro; Guo, Ge; Loos, Remco; Nichols, Jennifer; Ficz, Gabriella; Krueger, Felix; Oxley, David; Santos, Fatima; Clarke, James; Mansfield, William; Reik, Wolf; Bertone, Paul; Smith, Austin			Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human (vol 158, pg 1254, 2014)	CELL			English	Correction												bertone@ebi.ac.uk; austin.smith@cscr.cam.ac.uk	Reik, Wolf/I-6794-2012; Bertone, Paul/A-6600-2013; Ficz, Gabriella/HCH-3771-2022	Bertone, Paul/0000-0001-5059-4829; Ficz, Gabriella/0000-0001-9313-9578; Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388; Loos, Remco/0000-0002-9850-6821	Medical Research Council [G1100526] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029	1	25	26	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 16	2015	162	2					452	453		10.1016/j.cell.2015.06.052	http://dx.doi.org/10.1016/j.cell.2015.06.052			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CN0EU	28843285	Green Published, hybrid			2022-12-28	WOS:000358087700023
J	Zhang, G; Feenstra, B; Bacelis, J; Liu, X; Muglia, LM; Juodakis, J; Miller, DE; Litterman, N; Jiang, PP; Russell, L; Hinds, DA; Hu, Y; Weirauch, MT; Chen, X; Chavan, AR; Wagner, GP; Pavlicev, M; Nnamani, MC; Maziarz, J; Karjalainen, MK; Ramet, M; Sengpiel, V; Geller, F; Boyd, HA; Palotie, A; Momany, A; Bedell, B; Ryckman, KK; Huusko, JM; Forney, CR; Kottyan, LC; Hallman, M; Teramo, K; Nohr, EA; Smith, GD; Melbye, M; Jacobsson, B; Muglia, LJ				Zhang, G.; Feenstra, B.; Bacelis, J.; Liu, X.; Muglia, L. M.; Juodakis, J.; Miller, D. E.; Litterman, N.; Jiang, P. -P.; Russell, L.; Hinds, D. A.; Hu, Y.; Weirauch, M. T.; Chen, X.; Chavan, A. R.; Wagner, G. P.; Pavlicev, M.; Nnamani, M. C.; Maziarz, J.; Karjalainen, M. K.; Ramet, M.; Sengpiel, V.; Geller, F.; Boyd, H. A.; Palotie, A.; Momany, A.; Bedell, B.; Ryckman, K. K.; Huusko, J. M.; Forney, C. R.; Kottyan, L. C.; Hallman, M.; Teramo, K.; Nohr, E. A.; Smith, G. Davey; Melbye, M.; Jacobsson, B.; Muglia, L. J.			Genetic Associations with Gestational Duration and Spontaneous Preterm Birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; LOCI; AGE; WEIGHT; POLYMORPHISMS; EPIDEMIOLOGY; PREECLAMPSIA; PRESSURE; PATHWAYS	BACKGROUND Despite evidence that genetic factors contribute to the duration of gestation and the risk of preterm birth, robust associations with genetic variants have not been identified. We used large data sets that included the gestational duration to determine possible genetic associations. METHODS We performed a genomewide association study in a discovery set of samples obtained from 43,568 women of European ancestry using gestational duration as a continuous trait and term or preterm (< 37 weeks) birth as a dichotomous outcome. We used samples from three Nordic data sets (involving a total of 8643 women) to test for replication of genomic loci that had significant genomewide association (P< 5.0x10(-8)) or an association with suggestive significance (P< 1.0x10(-6)) in the discovery set. RESULTS In the discovery and replication data sets, four loci (EBF1, EEFSEC, AGTR2, and WNT4) were significantly associated with gestational duration. Functional analysis showed that an implicated variant in WNT4 alters the binding of the estrogen receptor. The association between variants in ADCY5 and RAP2C and gestational duration had suggestive significance in the discovery set and significant evidence of association in the replication sets; these variants also showed genomewide significance in a joint analysis. Common variants in EBF1, EEFSEC, and AGTR2 showed association with preterm birth with genomewide significance. An analysis of mother-infant dyads suggested that these variants act at the level of the maternal genome. CONCLUSIONS In this genomewide association study, we found that variants at the EBF1, EEFSEC, AGTR2, WNT4, ADCY5, and RAP2C loci were associated with gestational duration and variants at the EBF1, EEFSEC, and AGTR2 loci with preterm birth. Previously established roles of these genes in uterine development, maternal nutrition, and vascular control support their mechanistic involvement.	[Zhang, G.; Muglia, L. J.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Miller, D. E.; Weirauch, M. T.; Chen, X.; Forney, C. R.; Kottyan, L. C.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Weirauch, M. T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat & Dev Biol, Cincinnati, OH 45229 USA; [Zhang, G.; Muglia, L. M.; Pavlicev, M.; Huusko, J. M.; Muglia, L. J.] Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Perinatal Inst, Cincinnati, OH 45229 USA; [Zhang, G.; Muglia, L. M.; Pavlicev, M.; Huusko, J. M.; Muglia, L. J.] March Dimes Prematur Res Ctr Ohio Collaborat, Cincinnati, OH USA; [Feenstra, B.; Liu, X.; Geller, F.; Boyd, H. A.; Melbye, M.] Univ Copenhagen, Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Melbye, M.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Nohr, E. A.] Univ Southern Denmark, Inst Clin Res, Res Unit Gynecol & Obstet, Odense, Denmark; [Bacelis, J.; Sengpiel, V.] Univ Gothenburg, Sahlgrenska Univ Hosp Ostra, Dept Obstet & Gynecol, Gothenburg, Sweden; [Juodakis, J.] Univ Gothenburg, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, B.] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Litterman, N.; Jiang, P. -P.; Russell, L.; Hinds, D. A.; Hu, Y.] Stanford Univ, Sch Med, 23andMe Mt View, Stanford, CA 94305 USA; [Melbye, M.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Chavan, A. R.; Wagner, G. P.; Nnamani, M. C.; Maziarz, J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Wagner, G. P.] Yale Med Sch, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Chavan, A. R.; Wagner, G. P.; Nnamani, M. C.; Maziarz, J.] Yale Syst Biol Inst, West Haven, CT USA; [Wagner, G. P.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Karjalainen, M. K.; Ramet, M.; Huusko, J. M.; Hallman, M.] Univ Oulu, PEDEGO Res Unit, Oulu, Finland; [Karjalainen, M. K.; Ramet, M.; Huusko, J. M.; Hallman, M.] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Karjalainen, M. K.; Ramet, M.; Huusko, J. M.; Hallman, M.] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Palotie, A.] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Teramo, K.] Univ Helsinki, Obstet & Gynecol, Helsinki, Finland; [Teramo, K.] Helsinki Univ Hosp, Helsinki, Finland; [Palotie, A.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Psychiat & Neurodev Genet Unit,Dept Psychiat, Boston, MA 02114 USA; [Palotie, A.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Palotie, A.] Broad Inst Massachusetts Inst Technol & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Palotie, A.] Broad Inst Massachusetts Inst Technol & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Momany, A.; Bedell, B.; Ryckman, K. K.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Ryckman, K. K.] Univ Iowa, Dept Epidemiol, Carver Coll Med, Iowa City, IA USA; [Ryckman, K. K.] Univ Iowa, Coll Publ Hlth, Carver Coll Med, Iowa City, IA USA; [Smith, G. Davey] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Sch Social & Community Med, Bristol, Avon, England; [Jacobsson, B.] Norwegian Inst Publ Hlth, Dept Genet & Bioinformat, Area Hlth Data & Digitalizat, Oslo, Norway	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Statens Serum Institut; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; University of Gothenburg; Stanford University; Stanford University; Yale University; Yale University; Wayne State University; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iowa; University of Iowa; University of Iowa; University of Bristol; Norwegian Institute of Public Health (NIPH)	Muglia, LJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, MLC 7009,3333 Burnet Ave, Cincinnati, OH 45229 USA.	louis.muglia@cchmc.org	Davey Smith, George/A-7407-2013; Huusko, Johanna M/H-9448-2019; Weirauch, Matthew/M-5459-2019; Hallman, Niilo/AHD-9810-2022; Kottyan, Leah C./H-3050-2019; Jacobsson, Bo/O-8007-2014; Pavlicev, Mihaela/O-4460-2015	Davey Smith, George/0000-0002-1407-8314; Kottyan, Leah C./0000-0003-3979-2220; Jacobsson, Bo/0000-0001-5079-2374; Pavlicev, Mihaela/0000-0001-8439-9351; Palotie, Aarno/0000-0002-2527-5874; Bacelis, Jonas/0000-0002-2450-732X; Karjalainen, Minna K/0000-0003-3184-3775; Juodakis, Julius/0000-0001-5600-974X; Ryckman, Kelli/0000-0002-9496-4147; Boyd, Heather/0000-0001-6849-9985; melbye, mads/0000-0001-8264-6785; Geller, Frank/0000-0002-9238-3269; Venkatasubramanian, Siddharth/0000-0002-5860-0768	March of Dimes [22-FY15-003, 21-FY16-121]; National Institutes of Health; Cincinnati Children's Hospital Medical Center; Fifth Third Foundation; Bill and Melinda Gates Foundation [OPP1113966]; Jane and Aatos Erkko Foundation; Norwegian Research Council [FUGE 183220/S10, FRIMEDKLI-05 ES236011]; Jane Foundation; Dan Olsson Foundation; Swedish government [ALFGBG-507701]; FP7 from European Community's Seventh Framework Program [HEALTH-F4-2007-201413]; John Templeton Foundation [54860]; Oak Foundation fellowship; Nordic Center of Excellence in Health-Related e-Sciences; Norwegian Mother and Child Cohort Study; Norwegian Ministry of Health; Ministry of Education and Research; National Institute of Environmental Health Sciences [N01-ES-75558]; National Institute of Neurological Disorders and Stroke [UO1 NS 047537-01, UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10, FRI-MEDBIO 249779]; Swedish Research Council [2015-02559]; Academy of Finland; March of Dimes; Bill and Melinda Gates Foundation; John Templeton Foundation; National Institutes of Health Genes, Environment, and Health Initiative; Danish Council for Independent Research, Medical Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30 AR070549]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM108540] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI	March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital Medical Center; Fifth Third Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Jane and Aatos Erkko Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Jane Foundation; Dan Olsson Foundation; Swedish government; FP7 from European Community's Seventh Framework Program; John Templeton Foundation; Oak Foundation fellowship; Nordic Center of Excellence in Health-Related e-Sciences; Norwegian Mother and Child Cohort Study; Norwegian Ministry of Health; Ministry of Education and Research; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); Swedish Research Council(Swedish Research CouncilEuropean Commission); Academy of Finland(Academy of Finland); March of Dimes(March of Dimes); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); John Templeton Foundation; National Institutes of Health Genes, Environment, and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants (22-FY15-003, to Dr. Muglia; and 21-FY16-121) from the March of Dimes, grants from the National Institutes of Health, grants (to Drs. Jiang, Hu, Hinds, and Litterman and Ms. Russell) from the Cincinnati Children's Hospital Medical Center, a grant (to Dr. Muglia) from the Fifth Third Foundation, a grant (OPP1113966, to Dr. Muglia) from the Bill and Melinda Gates Foundation, a grant from the Jane and Aatos Erkko Foundation, grants (FUGE 183220/S10 and FRIMEDKLI-05 ES236011) from the Norwegian Research Council, a grant from the Jane and Dan Olsson Foundations, a grant (ALFGBG-507701) from the Swedish government to researchers in the public health service, and a grant (FP7/2007-2013) from the European Community's Seventh Framework Program (grant agreement HEALTH-F4-2007-201413). Dr. Wagner is supported by a grant (54860) from the John Templeton Foundation; Dr. Feenstra, by an Oak Foundation fellowship; Dr. Liu, by the Nordic Center of Excellence in Health-Related e-Sciences; the Norwegian Mother and Child Cohort Study, by the Norwegian Ministry of Health and the Ministry of Education and Research, by the National Institute of Environmental Health Sciences (contract no. N01-ES-75558), the National Institute of Neurological Disorders and Stroke (UO1 NS 047537-01 and UO1 NS 047537-06A1), by the Norwegian Research Council/FUGE (151918/S10 and FRI-MEDBIO 249779), and by the Swedish Research Council (2015-02559); Dr. Palotie, by the Academy of Finland; Dr. Ryckman, by the March of Dimes, Bill and Melinda Gates Foundation, and National Institutes of Health; Dr. Chavan and Ms. Maziarz, by the John Templeton Foundation; and Dr. Boyd, by the National Institutes of Health Genes, Environment, and Health Initiative and the Danish Council for Independent Research, Medical Sciences. Support from the Functional Genomics Core at Cincinnati Children's Hospital Medical Center was made possible through a grant (P30 AR070549) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Akbar SA, 2009, ACTA OBSTET GYN SCAN, V88, P606, DOI 10.1080/00016340902859307; Albertsen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058257; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2007, PRETERM BIRTH CAUSES; Bezold KY, 2013, GENOME MED, V5, DOI 10.1186/gm438; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Burnum KE, 2012, ENDOCRINOLOGY, V153, P4568, DOI 10.1210/en.2012-1335; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Durand EY., 2014, BIORXIV, DOI 10.1101/010512; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Geller F, 2014, NAT GENET, V46, P957, DOI 10.1038/ng.3063; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Griffon A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1280; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Howson C, 2012, BORN TOO SOON GLOBAL; Hurst R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01425; Kemp JP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004423; Kistka ZA, 2008, AM J OBSTET GYNECOL, V199, pe1, DOI DOI 10.1016/J.AJ0G.2007.12.014; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; LITTLE RE, 1986, AM J PUBLIC HEALTH, V76, P1350, DOI 10.2105/AJPH.76.11.1350; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MANGTANI P, 1993, J EPIDEMIOL COMMUN H, V47, P84, DOI 10.1136/jech.47.2.84; Martin Joyce A, 2015, NCHS Data Brief, P1; Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275; Monangi NK, 2015, SEMIN PERINATOL, V39, P574, DOI 10.1053/j.semperi.2015.09.005; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Myking S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061781; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Philibert P, 2011, FERTIL STERIL, V95, P2683, DOI 10.1016/j.fertnstert.2011.01.152; Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641; Rayman MP, 2011, CAN MED ASSOC J, V183, P549, DOI 10.1503/cmaj.101095; Singh A, 2015, EUR J HUM GENET, V23, P854, DOI 10.1038/ejhg.2014.189; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu W, 2013, F1000RESEARCH, V2, DOI 10.12688/f1000research.2-255.v1; Xie GQ, 2015, ATHEROSCLEROSIS, V243, P30, DOI 10.1016/j.atherosclerosis.2015.08.034; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029475; Zhang HP, 2015, GENET EPIDEMIOL, V39, P217, DOI 10.1002/gepi.21887; Zhou A, 2013, PLACENTA, V34, P75, DOI 10.1016/j.placenta.2012.10.007	57	183	190	3	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2017	377	12					1156	1167		10.1056/NEJMoa1612665	http://dx.doi.org/10.1056/NEJMoa1612665			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7FF	28877031	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000411348500009
J	Schlich, T				Schlich, Thomas			The history of anaesthesia and the patient-reduced to a body?	LANCET			English	Editorial Material									[Schlich, Thomas] McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada	McGill University	Schlich, T (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada.	thomas.schlich@mcgill.ca							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1020	1021		10.1016/S0140-6736(17)32362-0	http://dx.doi.org/10.1016/S0140-6736(17)32362-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28901928				2022-12-28	WOS:000409528600013
J	Kaser, A; Blumberg, RS				Kaser, Arthur; Blumberg, Richard S.			The road to Crohn's disease	SCIENCE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; LINKS ER STRESS; INTESTINAL INFLAMMATION; PANETH CELLS; ATG16L1; AUTOPHAGY; RISK		[Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge, England; [Blumberg, Richard S.] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kaser, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge, England.	ak729@cam.ac.uk; rblumberg@bwh.harvard.edu			Wellcome Trust [106260/Z/14/Z]; European Research Council [648889]; NIH [DK018839]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088199, R01DK044319] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors' laboratories are supported by a Wellcome Trust Senior Investigator Award 106260/Z/14/Z (A.K.), the European Research Council HORIZON2020/ERC grant no. 648889 (A.K.), and NIH grant DK018839 (R.S.B.).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bel S, 2017, SCIENCE, V357, P1047, DOI 10.1126/science.aal4677; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Deuring JJ, 2014, GUT, V63, P1081, DOI 10.1136/gutjnl-2012-303527; Diamanti MA, 2017, J EXP MED, V214, P423, DOI 10.1084/jem.20161867; Hosomi S, 2017, J EXP MED, V214, P2985, DOI 10.1084/jem.20162041; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Tschurtschenthaler M, 2017, J EXP MED, V214, P401, DOI 10.1084/jem.20160791; Zhang Q, 2015, NAT IMMUNOL, V16, P918, DOI 10.1038/ni.3233	15	4	5	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		976	977		10.1126/science.aao4158	http://dx.doi.org/10.1126/science.aao4158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883062	Green Accepted			2022-12-28	WOS:000409455700028
J	Ma, WJ				Ma, Wei Ji			The stories behind a CV	SCIENCE			English	Editorial Material								Based on my CV, you might think my path to becoming a tenured faculty member was pretty smooth: master's degree, Ph.D., two postdocs, faculty position. The true story, however, is much more twisted. During my graduate work in physics, I was so out of my depth that, as an escape, I spent more time on online chess, political activism, and volunteering than on work. After my Ph.D., I almost left science for business consulting or politics. I ended up staying, but I changed fields. I published zero papers with my first postdoc adviser. In my second postdoc, I constantly felt inferior to a fellow researcher who seemed to come up with all the good ideas. All that time, I often thought that I was the only one struggling, and that everyone else was sailing smoothly along.	[Ma, Wei Ji] NYU, Neurosci & Psychol, New York, NY 10003 USA	New York University	Ma, WJ (corresponding author), NYU, Neurosci & Psychol, New York, NY 10003 USA.								0	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					942	942		10.1126/science.357.6354.942	http://dx.doi.org/10.1126/science.357.6354.942			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860387				2022-12-28	WOS:000408734900047
J	Winters, J; Sridhar, D				Winters, Janelle; Sridhar, Devi			Earmarking for global health: benefits and perils of the World Bank's trust fund model	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Winters, Janelle; Sridhar, Devi] Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland	University of Edinburgh	Winters, J (corresponding author), Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland.	janelle.winters@ed.ac.uk		Winters, Janelle/0000-0002-3450-7673	Wellcome Trust [106635/Z/14/Z]	Wellcome Trust(Wellcome Trust)	We have read and understood BMJ policy on declaration of interests and declare that this work was supported by Wellcome Trust [106635/Z/14/Z]. A senior member of the World Bank is on our project's advisory board,	Atun RA, 2008, DO VERTICAL STAND AL; Bill & Melinda Gates Foundation, WHAT WE DO; Bretton Woods Project, 2015, WORLD BANK SUPP MIN; Browne S, 2015, VERTICAL FUNDS LESSO; Clinton C, 2017, GOVERNING GLOBAL HLT; Distler L., 2016, THESIS; Eichenauer V, 2016, 7731 WORLD BANK GROU; Fernandes G, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3395; Hafner T, 2013, HEALTH POLICY PLANN, V28, P41, DOI 10.1093/heapol/czs023; Huq W., 2010, CFP WORKING PAPER SE; Independent Evaluation Group, 2014, OPP CHALL WORK PARTN; Independent Evaluation Group, 2011, EV WORLD BANKS TRUST; Independent Evaluation Group, 2014, RESP GLOB PUBL BADS; International Development Association, 2009, PROJ APPR DOC PROP C; International Finance Corporation, 2008, BUS HLTH AFR PARTN P; International Finance Corporation, 2012, ACC INF POL; International Finance Corporation, 2010, IFC SUPP HLTH PUBL P; Organisation for Economic Co-operation and Development, 2015, MULT AID 2015 BETT P, DOI [10.1787/9789264235212-en, DOI 10.1787/9789264235212-EN]; Reinsberg B., 2016, POL EC INT ORG C 201; Reinsberg B, 2015, 7441 WORLD BANK; Reinsberg B, 2016, RETHINK INT DEV, P185, DOI 10.1057/978-1-137-55357-7_13; Shiffman J, 2014, INT J HEALTH POLICY, V3, P297, DOI 10.15171/ijhpm.2014.120; Smyth S, 2013, HEALTH HUM RIGHTS, V15, P58; Sridhar D, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3339; Sridhar D, 2013, GLOB POLICY, V4, P325, DOI 10.1111/1758-5899.12066; Stein F, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3397; Storeng KT, 2014, GLOB PUBLIC HEALTH, V9, P865, DOI 10.1080/17441692.2014.940362; Wagner L., 2016, 150 FERDI; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6; World Bank, 2012, FIN INT FUNDS M GLOB; World Bank, 2017, WORLD BANK ENV SOC F; World Bank, 2015, WORLD BANK OP MAN BA; World Bank, 2015, BANK DIR COST REC FR; World Bank, 2009, TRUST FUNDS WORLD BA; World Bank, WORLD BANK POL PROC; World Bank, 2015, COMMUNICATION; World Bank Concessional Finance and Global Partnerships, 2013, TRUST FUND REF PROGR; World Bank Group, 2017, FACT SHEET WORLD BAN; World Bank Group, 2011, 2011 TRUST FUND ANN; World Bank Group, 2016, WORLD BANK GROUP MOD; World Bank Group, 2013, 2013 TRUST FUND ANN; World Bank Group, 2016, FORW LOOK VIS WORLD; World Bank Group Finances, PAID CONTR IBRD IDA; World Bank. Oxford University, 2006, DIS CONTR PRIOR DEV	44	4	4	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3394	10.1136/bmj.j3394	http://dx.doi.org/10.1136/bmj.j3394			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CQ	28860310	Green Published, Green Submitted			2022-12-28	WOS:000409387000004
J	Tang, C; Hamilton, LS; Chang, EF				Tang, C.; Hamilton, L. S.; Chang, E. F.			Intonational speech prosody encoding in the human auditory cortex	SCIENCE			English	Article							COMPLEX TONES; NEURAL REPRESENTATION; SPEAKER RECOGNITION; LINGUISTIC PROSODY; VOICE PERCEPTION; PITCH SALIENCE; AWAKE MONKEY; HUMAN BRAIN; RESPONSES; LANGUAGE	Speakers of all human languages regularly use intonational pitch to convey linguistic meaning, such as to emphasize a particular word. Listeners extract pitch movements from speech and evaluate the shape of intonation contours independent of each speaker's pitch range. We used high-density electrocorticography to record neural population activity directly from the brain surface while participants listened to sentences that varied in intonational pitch contour, phonetic content, and speaker. Cortical activity at single electrodes over the human superior temporal gyrus selectively represented intonation contours. These electrodes were intermixed with, yet functionally distinct from, sites that encoded different information about phonetic features or speaker identity. Furthermore, the representation of intonation contours directly reflected the encoding of speaker-normalized relative pitch but not absolute pitch.	[Chang, E. F.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	edward.chang@ucsf.edu	Hamilton, Liberty/V-2542-2019	Hamilton, Liberty/0000-0003-0182-2500	NIH [R01-DC012379, F32 DC014192-01]; New York Stem Cell Foundation; Howard Hughes Medical Institute; McKnight Foundation; Shurl and Kay Curci Foundation; William K. Bowes Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC014192, R01DC012379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); McKnight Foundation; Shurl and Kay Curci Foundation; William K. Bowes Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Shattuck-Hufnagel, K. Johnson, C. Schreiner, M. Leonard, Y. Oganian, N. Fox, and B. Dichter for helpful comments on the manuscript. This work was supported by grants from the NIH (R01-DC012379 to E.F.C. and F32 DC014192-01 to L.S.H.). E.F.C. is a New York Stem Cell Foundation Robertson Investigator. This research was also supported by the New York Stem Cell Foundation, the Howard Hughes Medical Institute, the McKnight Foundation, The Shurl and Kay Curci Foundation, and The William K. Bowes Foundation. Raw data, analysis code, and supporting documentation for this project are accessible online at https://doi.org/10.5281/zenodo.826950.	Allen EJ, 2017, J NEUROSCI, V37, P1284, DOI 10.1523/JNEUROSCI.2336-16.2016; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bizley JK, 2013, CURR BIOL, V23, P620, DOI 10.1016/j.cub.2013.03.003; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Bizley JK, 2009, J NEUROSCI, V29, P2064, DOI 10.1523/JNEUROSCI.4755-08.2009; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Doherty CP, 2004, HUM BRAIN MAPP, V23, P85, DOI 10.1002/hbm.20042; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Fishman YI, 2013, J NEUROSCI, V33, P10312, DOI 10.1523/JNEUROSCI.0020-13.2013; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Garofalo J. S., 1993, INGUISTIC DATA CONSO; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Gussenhoven C, 1997, J ACOUST SOC AM, V102, P3009, DOI 10.1121/1.420355; HEILMAN KM, 1984, NEUROLOGY, V34, P917, DOI 10.1212/WNL.34.7.917; Jakobson R., 1951, PRELIMINARIES SPEECH; Kluender KR, 2003, SPEECH COMMUN, V41, P59, DOI 10.1016/S0167-6393(02)00093-6; Kreitewolf J, 2014, NEUROIMAGE, V102, P332, DOI 10.1016/j.neuroimage.2014.07.038; Ladd DR, 2008, CAMB STUD LINGUIST, V79, P1; Lee CY, 2009, J ACOUST SOC AM, V125, P1125, DOI 10.1121/1.3050322; LICKLIDER JCR, 1954, J ACOUST SOC AM, V26, P945, DOI 10.1121/1.1928005; McDermott JH, 2008, PSYCHOL SCI, V19, P1263, DOI 10.1111/j.1467-9280.2008.02235.x; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; PIERREHUMBERT J, 1979, J ACOUST SOC AM, V66, P363, DOI 10.1121/1.383670; Plack CJ, 2006, PITCH NEURAL CODING, V24; Plante E, 2002, NEUROIMAGE, V17, P401, DOI 10.1006/nimg.2002.1182; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; Schonwiesner M, 2008, EXP BRAIN RES, V187, P97, DOI 10.1007/s00221-008-1286-z; ShattuckHufnagel S, 1996, J PSYCHOLINGUIST RES, V25, P193, DOI 10.1007/BF01708572; Sonntag GP, 1998, COMPUT SPEECH LANG, V12, P437, DOI 10.1006/csla.1998.0107; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Tong YX, 2005, NEUROIMAGE, V28, P417, DOI 10.1016/j.neuroimage.2005.06.002; VANDOMMELEN WA, 1990, LANG SPEECH, V33, P259, DOI 10.1177/002383099003300302; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Witteman J, 2011, NEUROPSYCHOLOGIA, V49, P3722, DOI 10.1016/j.neuropsychologia.2011.09.028; Wong PCM, 2003, J SPEECH LANG HEAR R, V46, P413, DOI 10.1044/1092-4388(2003/034); Zatorre RJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00544	51	59	59	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					797	801		10.1126/science.aam8577	http://dx.doi.org/10.1126/science.aam8577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839071	Green Accepted			2022-12-28	WOS:000408327900042
J	Gazibegovic, S; Car, D; Zhang, H; Balk, SC; Logan, JA; de Moor, MWA; Cassidy, MC; Schmits, R; Xu, D; Wang, GZ; Krogstrup, P; Veld, RLMOH; Zuo, K; Vos, Y; Shen, J; Bouman, D; Hojaei, BS; Pennachio, D; Lee, JS; van Veldhoven, PJ; Koelling, S; Verheijen, MA; Kouwenhoven, LP; Palmstrom, CJ; Bakkers, EPAM				Gazibegovic, Sasa; Car, Diana; Zhang, Hao; Balk, Stijn C.; Logan, John A.; de Moor, Michiel W. A.; Cassidy, Maja C.; Schmits, Rudi; Xu, Di; Wang, Guanzhong; Krogstrup, Peter; Veld, Roy L. M. Op het; Zuo, Kun; Vos, Yoram; Shen, Jie; Bouman, Daniel; Hojaei, Borzoyeh S.; Pennachio, Daniel; Lee, Joon Sue; van Veldhoven, Petrus J.; Koelling, Sebastian; Verheijen, Marcel A.; Kouwenhoven, Leo P.; Palmstrom, Chris J.; Bakkers, Erik P. A. M.			RETRACTED: Epitaxy of advanced nanowire quantum devices (Retracted article. See vol. 604, pg. 786, 2022)	NATURE			English	Article; Retracted Publication							INAS; TRANSPORT; FIELD	Semiconductor nanowires are ideal for realizing various low-dimensional quantum devices. In particular, topological phases of matter hosting non-Abelian quasiparticles (such as anyons) can emerge when a semiconductor nanowire with strong spin-orbit coupling is brought into contact with a superconductor(1,2). To exploit the potential of non-Abelian anyons-which are key elements of topological quantum computing-fully, they need to be exchanged in a well-controlled braiding operation(3-8). Essential hardware for braiding is a network of crystalline nanowires coupled to superconducting islands. Here we demonstrate a technique for generic bottom-up synthesis of complex quantum devices with a special focus on nanowire networks with a predefined number of superconducting islands. Structural analysis confirms the high crystalline quality of the nanowire junctions, as well as an epitaxial superconductor-semiconductor interface. Quantum transport measurements of nanowire 'hashtags' reveal Aharonov-Bohm and weak-antilocalization effects, indicating a phase-coherent system with strong spin-orbit coupling. In addition, a proximity-induced hard superconducting gap (with vanishing sub-gap conductance) is demonstrated in these hybrid superconductor-semiconductor nanowires, highlighting the successful materials development necessary for a first braiding experiment. Our approach opens up new avenues for the realization of epitaxial three-dimensional quantum architectures which have the potential to become key components of various quantum devices.	[Gazibegovic, Sasa; Car, Diana; Zhang, Hao; Balk, Stijn C.; de Moor, Michiel W. A.; Cassidy, Maja C.; Xu, Di; Wang, Guanzhong; Veld, Roy L. M. Op het; Zuo, Kun; Vos, Yoram; Shen, Jie; Bouman, Daniel; Kouwenhoven, Leo P.; Bakkers, Erik P. A. M.] Delft Univ Technol, QuTech, NL-2600 GA Delft, Netherlands; [Gazibegovic, Sasa; Car, Diana; Zhang, Hao; Balk, Stijn C.; de Moor, Michiel W. A.; Cassidy, Maja C.; Xu, Di; Wang, Guanzhong; Veld, Roy L. M. Op het; Zuo, Kun; Vos, Yoram; Shen, Jie; Bouman, Daniel; Kouwenhoven, Leo P.; Bakkers, Erik P. A. M.] Delft Univ Technol, Kavli Inst NanoSci, NL-2600 GA Delft, Netherlands; [Gazibegovic, Sasa; Car, Diana; Veld, Roy L. M. Op het; van Veldhoven, Petrus J.; Koelling, Sebastian; Verheijen, Marcel A.; Bakkers, Erik P. A. M.] Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands; [Logan, John A.; Hojaei, Borzoyeh S.; Pennachio, Daniel; Palmstrom, Chris J.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Schmits, Rudi] TNO Tech Sci, Nanoinstrumentat Dept, NL-2600 AD Delft, Netherlands; [Krogstrup, Peter] Univ Copenhagen, Ctr Quantum Devices, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Krogstrup, Peter] Univ Copenhagen, Stn Q Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Lee, Joon Sue; Palmstrom, Chris J.] Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA; [Verheijen, Marcel A.] Philips Innovat Serv Eindhoven, High Tech Campus 11, NL-5656 AE Eindhoven, Netherlands; [Kouwenhoven, Leo P.] Delft Univ Technol, Microsoft Stn Q, NL-2600 GA Delft, Netherlands; [Palmstrom, Chris J.] Univ Calif Santa Barbara, Elect & Comp Engn, Santa Barbara, CA 93106 USA	Delft University of Technology; Delft University of Technology; Eindhoven University of Technology; University of California System; University of California Santa Barbara; Netherlands Organization Applied Science Research; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Niels Bohr Institute; University of California System; University of California Santa Barbara; Philips; Delft University of Technology; University of California System; University of California Santa Barbara	Bakkers, EPAM (corresponding author), Delft Univ Technol, QuTech, NL-2600 GA Delft, Netherlands.; Bakkers, EPAM (corresponding author), Delft Univ Technol, Kavli Inst NanoSci, NL-2600 GA Delft, Netherlands.; Bakkers, EPAM (corresponding author), Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands.	e.p.a.m.bakkers@tue.nl	Bouman, Daniël/AAE-1451-2020; Zhang, Hao/P-6220-2017; Verheijen, Marcel/AAT-3889-2021; Lee, Joon Sue/AAC-6295-2020; Pennachio, Daniel/GLR-1121-2022; Krogstrup, Peter/G-4323-2011	Zhang, Hao/0000-0003-1734-6051; Bouman, Daniel/0000-0002-8865-8493; Verheijen, Marcel/0000-0002-8749-7755; Lee, Joon Sue/0000-0002-1001-1462; Shen, Jie/0000-0002-7205-5081; Krogstrup, Peter/0000-0002-1930-8553; Palmstrom, Christopher/0000-0003-4884-4512; Cassidy, Maja/0000-0002-7780-1549; Op het Veld, Roy/0000-0001-9142-1422	European Research Council [ERC HELENA 617256]; Dutch Organization for Scientific Research [NWO-VICI 700.10.441]; Foundation for Fundamental Research on Matter (FOM); Microsoft Corporation Station-Q; Solliance, a solar energy R&D initiative of ECN; TNO; Holst; TU/e; imec; Forschungszentrum Julich; Dutch province of Noord-Brabant; Office of Naval Research (ONR); Microsoft Research	European Research Council(European Research Council (ERC)European Commission); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Microsoft Corporation Station-Q(Microsoft); Solliance, a solar energy R&D initiative of ECN; TNO; Holst; TU/e; imec; Forschungszentrum Julich(Helmholtz Association); Dutch province of Noord-Brabant; Office of Naval Research (ONR)(Office of Naval Research); Microsoft Research(Microsoft)	We acknowledge N. Wilson for the assistance at University of California, Santa Barbara. This work has been supported by the European Research Council (ERC HELENA 617256 and Synergy), the Dutch Organization for Scientific Research (NWO-VICI 700.10.441), the Foundation for Fundamental Research on Matter (FOM) and Microsoft Corporation Station-Q. We acknowledge Solliance, a solar energy R&D initiative of ECN, TNO, Holst, TU/e, imec and Forschungszentrum Julich, and the Dutch province of Noord-Brabant for funding the TEM facility. We thank the Office of Naval Research (ONR) for financial support. The work at University of California, Santa Barbara was supported in part by Microsoft Research. We also acknowledge the use of facilities within the National Science Foundation Materials Research and Science and Engineering Center (DMR 11-21053) at the University of California, Santa Barbara and the LeRoy Eyring Center for Solid State Science at Arizona State University.	Aasen D, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031016; ADACHI S, 1981, J ELECTROCHEM SOC, V128, P1342, DOI 10.1149/1.2127633; Albrecht SM, 2016, NATURE, V531, P206, DOI 10.1038/nature17162; Alicea J, 2011, NAT PHYS, V7, P412, DOI 10.1038/NPHYS1915; Car D, 2014, ADV MATER, V26, P4875, DOI 10.1002/adma.201400924; Caroff P, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495606; Conesa-Boj S, 2014, NANO LETT, V14, P326, DOI 10.1021/nl404085a; Dalacu D, 2013, NANO LETT, V13, P2676, DOI 10.1021/nl400820w; Dalacu D, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395602; Deng MT, 2016, SCIENCE, V354, P1557, DOI 10.1126/science.aaf3961; Fadaly E. M. T, 2017, NANO LETT; Gul O, 2017, NANO LETT, V17, P2690, DOI 10.1021/acs.nanolett.7b00540; Gul O, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/21/215202; Hansen AE, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.045327; Hyart T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035121; Kammhuber J, 2016, NANO LETT, V16, P3482, DOI 10.1021/acs.nanolett.6b00051; Kang JH, 2013, NANO LETT, V13, P5190, DOI 10.1021/nl402571s; Karzig T, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.235305; Krogstrup P, 2015, NAT MATER, V14, P400, DOI [10.1038/nmat4176, 10.1038/NMAT4176]; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Meijer FE, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035308; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Plissard SR, 2012, NANO LETT, V12, P1794, DOI 10.1021/nl203846g; Plugge S, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa54e1; Rieger T, 2016, NANO LETT, V16, P1933, DOI 10.1021/acs.nanolett.5b05157; Shabani J, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.155402; van Weperen I, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.201413; Vijay S, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.235446; Webb JL, 2015, NANO LETT, V15, P4865, DOI 10.1021/acs.nanolett.5b00282; WHITE LK, 1980, J ELECTROCHEM SOC, V127, P2687, DOI 10.1149/1.2129573; Zhang H, 2016, BALLISTIC MAJORANA N	33	208	210	7	222	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					434	+		10.1038/nature23468	http://dx.doi.org/10.1038/nature23468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28836603	Green Submitted			2022-12-28	WOS:000408279000034
J	Huang, ZH; Chen, HC				Huang, Zheng-Hao; Chen, Hsiang-Cheng			Sweet's Syndrome in a Patient with Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Zheng-Hao] Kaohsiung Armed Forces Gen Hosp, Kaohsiung, Taiwan; [Chen, Hsiang-Cheng] Triserv Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital	Chen, HC (corresponding author), Triserv Gen Hosp, Taipei, Taiwan.	hccheng@ndmctsgh.edu.tw	Chen, Hsiang-Cheng/CAG-3864-2022; Chen, Hsiang-Cheng/AGQ-6364-2022; Chen, Hsiang-Cheng/O-1312-2016	Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161; Chen, Hsiang-Cheng/0000-0002-0753-6161					0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					769	769		10.1056/NEJMicm1700945	http://dx.doi.org/10.1056/NEJMicm1700945			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28834481				2022-12-28	WOS:000413090000009
J	Tapper, EB; Lok, ASF				Tapper, Elliot B.; Lok, Anna S. -F.			Use of Liver Imaging and Biopsy in Clinical Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC HEPATITIS-C; CONTROLLED TRANSIENT ELASTOGRAPHY; MAGNETIC-RESONANCE ELASTOGRAPHY; NAFLD FIBROSIS SCORE; NONALCOHOLIC STEATOHEPATITIS; ALANINE AMINOTRANSFERASE; STIFFNESS MEASUREMENT; HEPATOCELLULAR-CARCINOMA; NONINVASIVE ASSESSMENT; DIAGNOSE FIBROSIS	Liver biopsies are traditionally performed to determine the cause and stage of liver disease, as well as to inform treatment decisions and determine prognosis. In 2001, Bravo et al. observed that "liver biopsy is usually the most specific test to assess the nature and severity of liver diseases." During the past 16 years, however, the clinical use of liver biopsies has undergone a profound transformation. Validated alternatives to liver biopsy have proliferated, spurred by concerns about the costs of biopsy and the risk of complications. Furthermore, research has brought a new understanding of the limitations of liver biopsy. In this review, we discuss the role of liver biopsy in the current era, as well as the accuracy of noninvasive evaluations and their use in clinical practice for determining the cause of liver disease and focal liver lesions and for detecting advanced fibrosis and cirrhosis.	[Tapper, Elliot B.; Lok, Anna S. -F.] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Tapper, Elliot B.; Lok, Anna S. -F.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Tapper, Elliot B.] Vet Affairs Hosp, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tapper, EB (corresponding author), 3912 Taubman Ctr,SPC 5362,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	etapper@umich.edu			AbbVie; Bristol-Myers Squibb; Idenix; Gilead; GlaxoSmithKline; MYR; Tekmira; Merck	AbbVie(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); Idenix; Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); MYR; Tekmira; Merck(Merck & Company)	Dr. Lok reports receiving grant support from AbbVie, Bristol-Myers Squibb, and Idenix, grant support and fees from Gilead for serving on an advisory panel, fees from GlaxoSmithKline, MYR, and Tekmira for serving on advisory panels, and grant support and consulting fees from Merck. No other potential conflict of interest relevant to this article was reported.	Adams LA, 2004, AM J GASTROENTEROL, V99, P1316, DOI 10.1111/j.1572-0241.2004.30444.x; Ajmera V, 2017, HEPATOLOGY, V65, P65, DOI 10.1002/hep.28776; Allan R, 2010, WORLD J GASTROENTERO, V16, P3510, DOI 10.3748/wjg.v16.i28.3510; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2001, AM J GASTROENTEROL, V96, P1553; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Chan HLY, 2009, J VIRAL HEPATITIS, V16, P36, DOI 10.1111/j.1365-2893.2008.01037.x; Chen J, 2017, RADIOLOGY, V283, P418, DOI 10.1148/radiol.2016160685; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Corpechot C, 2014, GASTROENTEROLOGY, V146, P970, DOI 10.1053/j.gastro.2013.12.030; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; de Bruyn G, 2001, BMC Med Inform Decis Mak, V1, P6, DOI 10.1186/1472-6947-1-6; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Ferraioli G, 2016, LIVER INT, V36, P1860, DOI 10.1111/liv.13207; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Foster GR, 1997, BRIT MED J, V315, P453, DOI 10.1136/bmj.315.7106.453; Freeman RB, 2006, LIVER TRANSPLANT, V12, P1504, DOI 10.1002/lt.20847; Grazioli L, 2012, RADIOLOGY, V262, P520, DOI 10.1148/radiol.11101742; Huang GT, 1996, J HEPATOL, V25, P334, DOI 10.1016/S0168-8278(96)80120-6; Imajo K, 2016, GASTROENTEROLOGY, V150, P626, DOI 10.1053/j.gastro.2015.11.048; Karlas T, 2016, COLLABORATION NOT CO; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Lackner C, 2017, J HEPATOL, V66, P610, DOI 10.1016/j.jhep.2016.11.011; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Marrero JA, 2014, AM J GASTROENTEROL, V109, P1328, DOI 10.1038/ajg.2014.213; Naugler WE, 2015, CLIN GASTROENTEROL H, V13, P827, DOI 10.1016/j.cgh.2014.03.038; Petta S, 2015, LIVER INT, V35, P1566, DOI 10.1111/liv.12584; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Pimentel CFMG, 2016, DIGEST DIS SCI, V61, P905, DOI 10.1007/s10620-015-3916-1; Poynard T, 2014, J HEPATOL, V61, P994, DOI 10.1016/j.jhep.2014.06.027; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Poynard T, 2012, CLIN GASTROENTEROL H, V10, P657, DOI 10.1016/j.cgh.2012.01.023; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Singh S, 2015, CLIN GASTROENTEROL H, V13, P440, DOI 10.1016/j.cgh.2014.09.046; Skelly MM, 2001, J HEPATOL, V35, P195, DOI 10.1016/S0168-8278(01)00094-0; Sorbi D, 2000, AM J GASTROENTEROL, V95, P3206; Sorbi D, 1999, AM J GASTROENTEROL, V94, P1018; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Tapper EB, 2017, J HEPATOL, V66, P313, DOI 10.1016/j.jhep.2016.09.017; Tapper EB, 2016, AM J GASTROENTEROL, V111, P677, DOI 10.1038/ajg.2016.49; Tapper EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147237; Tapper EB, 2015, AM J GASTROENTEROL, V110, P1298, DOI 10.1038/ajg.2015.241; Tapper EB, 2015, DIGEST DIS SCI, V60, P1589, DOI 10.1007/s10620-014-3490-y; Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P27, DOI 10.1016/j.cgh.2014.04.039; Tapper EB, 2013, AM J MED, V126, P926, DOI 10.1016/j.amjmed.2013.01.039; Tapper EB, 2013, J HEPATOL, V59, P889, DOI 10.1016/j.jhep.2013.03.040; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Udell JA, 2012, JAMA-J AM MED ASSOC, V307, P832, DOI 10.1001/jama.2012.186; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; VANNESS MM, 1989, ANN INTERN MED, V111, P473, DOI 10.7326/0003-4819-111-6-473; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Venkatesh SK, 2015, ABDOM IMAGING, V40, P766, DOI 10.1007/s00261-015-0347-6; Venkatesh SK, 2014, MAGN RESON IMAGING C, V22, P433, DOI 10.1016/j.mric.2014.05.001; Wagner M, 2017, RADIOLOGY, V284, P401, DOI 10.1148/radiol.2016160863; WHO, 2014, GUID SCREEN CAR TREA	79	178	190	9	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					756	768		10.1056/NEJMra1610570	http://dx.doi.org/10.1056/NEJMra1610570			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ9IS	28834467				2022-12-28	WOS:000413090000008
J	Watkins, DA; Johnson, CO; Colquhoun, SM; Karthikeyan, G; Beaton, A; Bukhman, G; Forouzanfar, MH; Longenecker, CT; Mayosi, BM; Mensah, GA; Nascimento, BR; Ribeiro, ALP; Sable, CA; Steer, AC; Naghavi, M; Mokdad, AH; Murray, CJL; Vos, T; Carapetis, JR; Roth, GA				Watkins, David A.; Johnson, Catherine O.; Colquhoun, Samantha M.; Karthikeyan, Ganesan; Beaton, Andrea; Bukhman, Gene; Forouzanfar, Mohammed H.; Longenecker, Christopher T.; Mayosi, Bongani M.; Mensah, George A.; Nascimento, Bruno R.; Ribeiro, Antonio L. P.; Sable, Craig A.; Steer, Andrew C.; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.; Vos, Theo; Carapetis, Jonathan R.; Roth, Gregory A.			Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; FOLLOW-UP; FEVER; CHILDREN; ADOLESCENTS; PREVENTION; PREVALENCE	BACKGROUND Rheumatic heart disease remains an important preventable cause of cardiovascular death and disability, particularly in low-income and middle-income countries. We estimated global, regional, and national trends in the prevalence of and mortality due to rheumatic heart disease as part of the 2015 Global Burden of Disease study. METHODS We systematically reviewed data on fatal and nonfatal rheumatic heart disease for the period from 1990 through 2015. Two Global Burden of Disease analytic tools, the Cause of Death Ensemble model and DisMod-MR 2.1, were used to produce estimates of mortality and prevalence, including estimates of uncertainty. RESULTS We estimated that there were 319,400 (95% uncertainty interval, 297,300 to 337,300) deaths due to rheumatic heart disease in 2015. Global age-standardized mortality due to rheumatic heart disease decreased by 47.8% (95% uncertainty interval, 44.7 to 50.9) from 1990 to 2015, but large differences were observed across regions. In 2015, the highest age-standardized mortality due to and prevalence of rheumatic heart disease were observed in Oceania, South Asia, and central sub-Saharan Africa. We estimated that in 2015 there were 33.4 million (95% uncertainty interval, 29.7 million to 43.1 million) cases of rheumatic heart disease and 10.5 million (95% uncertainty interval, 9.6 million to 11.5 million) disability-adjusted life-years due to rheumatic heart disease globally. CONCLUSIONS We estimated the global disease prevalence of and mortality due to rheumatic heart disease over a 25-year period. The health-related burden of rheumatic heart disease has declined worldwide, but high rates of disease persist in some of the poorest regions in the world. (Funded by the Bill and Melinda Gates Foundation and the Medtronic Foundation.)	[Watkins, David A.] Univ Washington, Dept Med, Div Gen Internal Med, 325 9th Ave,Box 359780, Seattle, WA 98104 USA; [Johnson, Catherine O.; Forouzanfar, Mohammed H.; Naghavi, Mohsen; Mokdad, Ali H.; Murray, Christopher J. L.; Vos, Theo; Roth, Gregory A.] Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98104 USA; [Roth, Gregory A.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98104 USA; [Watkins, David A.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, Cape Town, South Africa; [Watkins, David A.; Mayosi, Bongani M.] Univ Cape Town, Cape Town, South Africa; [Colquhoun, Samantha M.; Steer, Andrew C.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Colquhoun, Samantha M.; Steer, Andrew C.] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Carapetis, Jonathan R.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Carapetis, Jonathan R.] Princess Margaret Hosp Children, Perth, WA, Australia; [Karthikeyan, Ganesan] All India Inst Med Sci, Dept Cardiol, New Delhi, India; [Beaton, Andrea; Sable, Craig A.] Childrens Natl Hlth Syst, Washington, DC USA; [Bukhman, Gene] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global NCDs & Social Change, Boston, MA USA; [Bukhman, Gene] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA USA; [Longenecker, Christopher T.] Case Western Reserve Univ, Dept Med, Div Cardiol, Cleveland, OH 44106 USA; [Longenecker, Christopher T.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Mensah, George A.] NHLBI, Div Cardiovasc Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Nascimento, Bruno R.; Ribeiro, Antonio L. P.] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Nascimento, Bruno R.; Ribeiro, Antonio L. P.] Univ Fed Minas Gerais, Telehealth Ctr, Belo Horizonte, MG, Brazil	University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Telethon Kids Institute; University of Western Australia; University of Western Australia; All India Institute of Medical Sciences (AIIMS) New Delhi; Children's National Health System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Watkins, DA (corresponding author), Univ Washington, Dept Med, Div Gen Internal Med, 325 9th Ave,Box 359780, Seattle, WA 98104 USA.	davidaw@uw.edu	Carapetis, Jonathan R/H-8933-2014; Ribeiro, Ana Cristina/HHN-7466-2022; Ribeiro, Antonio L/C-2707-2009; Karthikeyan, Ganesan/D-5767-2012; Mokdad, Ali H./AAD-1232-2022; Nacimento, Bruno Ramos/F-8066-2013; Watkins, David/ABC-3783-2020	Carapetis, Jonathan R/0000-0002-1182-9792; Ribeiro, Ana Cristina/0000-0002-0493-8376; Ribeiro, Antonio L/0000-0002-2740-0042; Karthikeyan, Ganesan/0000-0002-2073-2917; Mokdad, Ali H./0000-0002-4994-3339; Nacimento, Bruno Ramos/0000-0002-5586-774X; Watkins, David/0000-0001-6341-9595; Colquhoun, Samantha/0000-0002-6750-1147	Bill and Melinda Gates Foundation; Medtronic Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medtronic Foundation	Supported by a grant from the Bill and Melinda Gates Foundation and by the Medtronic Foundation (to Dr. Watkins).	[Anonymous], 1954, WHO TECHN REP SER; [Anonymous], 2015, SOC DET HLTH VIS; Bach JF, 1996, LANCET, V347, P644, DOI 10.1016/S0140-6736(96)91202-7; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Beaton A, 2014, PEDIATR CARDIOL, V35, P1259, DOI 10.1007/s00246-014-0925-3; Colquhoun SM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001282; Doukky R, 2014, INT J CARDIOL, V175, P178, DOI 10.1016/j.ijcard.2014.04.207; GORDIS L, 1985, CIRCULATION, V72, P1155, DOI 10.1161/01.CIR.72.6.1155; Gunther G, 2006, LANCET, V367, P391, DOI 10.1016/S0140-6736(06)68128-2; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Longo-Mbenza B, 1998, INT J CARDIOL, V63, P287, DOI 10.1016/S0167-5273(97)00311-2; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; MASSELL BF, 1988, NEW ENGL J MED, V318, P280, DOI 10.1056/NEJM198802043180504; Maurice J, 2013, LANCET, V382, P1085, DOI 10.1016/S0140-6736(13)61972-8; Meira ZMA, 2005, HEART, V91, P1019, DOI 10.1136/hrt.2004.042762; Nascimento BR, 2016, INT J CARDIOL, V219, P439, DOI 10.1016/j.ijcard.2016.06.088; Nordet P, 2008, CARDIOVASC J AFR, V19, P135; Parks T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004033; Remenyi B, 2013, NAT REV CARDIOL, V10, P284, DOI 10.1038/nrcardio.2013.34; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Rheumatic fever and rheumatic heart disease, 2004, TECHN REP SER WHO; Roberts K, 2014, CIRCULATION, V129, P1953, DOI 10.1161/CIRCULATIONAHA.113.003495; Rothenbuhler M, 2014, LANCET GLOB HEALTH, V2, pE717, DOI 10.1016/S2214-109X(14)70310-9; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2013, GLOB ACT PLAN PREV C; Wyber R, 2014, B WORLD HEALTH ORGAN, V92, P768, DOI 10.2471/BLT.13.134486; Zuhlke L, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0225-3; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449; Zuhlke L, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0343-1	31	506	520	10	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					713	722		10.1056/NEJMoa1603693	http://dx.doi.org/10.1056/NEJMoa1603693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ9IS	28834488	Bronze			2022-12-28	WOS:000413090000004
J	Gostin, LO; Hodge, JG; Noe, SA				Gostin, Lawrence O.; Hodge, James G., Jr.; Noe, Sarah A.			Reframing the Opioid Epidemic as a National Emergency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Law Ctr, Washington, DC 20001 USA; [Hodge, James G., Jr.] Arizona State Univ, Ctr Publ Hlth Law & Policy, Sandra Day OConnor Coll Law, Phoenix, AZ USA; [Noe, Sarah A.] Univ Penn, Sch Law, Philadelphia, PA 19104 USA	Georgetown University; Arizona State University; Arizona State University-Downtown Phoenix; University of Pennsylvania	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				American Society of Addiction Medicine, 2016, OP ADD 2016 FACTS FI; Blau M, 2017, OPIOIDS COULD KILL N; Bonnie RJ, 2017, JAMA-J AM MED ASSOC, V318, P423, DOI 10.1001/jama.2017.10046; Murphy SM, 2016, PHARMACOECONOMICS, V34, P863, DOI 10.1007/s40273-016-0400-5; National Institutes of Health, OVERD DEATH RAT; President's Commission on Combating Drug Addiction and the Opioid Crisis, 2017, INT REP; US Centers for Disease Control and Prevention, 2016, HIV INJ DRUG US	7	152	154	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2017	318	16					1539	1540		10.1001/jama.2017.13358	http://dx.doi.org/10.1001/jama.2017.13358			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK6EX	28832871	Green Published			2022-12-28	WOS:000413597200015
J	Puri, P; Mills, M; Schneider, C; Simbotin, I; Montgomery, JA; Cote, R; Suits, AG; Hudson, ER				Puri, Prateek; Mills, Michael; Schneider, Christian; Simbotin, Ionel; Montgomery, John A., Jr.; Cote, Robin; Suits, Arthur G.; Hudson, Eric R.			Synthesis of mixed hypermetallic oxide BaOCa+ from laser-cooled reagents in an atom-ion hybrid trap	SCIENCE			English	Article							ELECTRONIC STATES; COLLISIONS; POTASSIUM; SPECTRUM	Hypermetallic alkaline earth (M) oxides of formula MOM have been studied under plasma conditions that preclude insight into their formation mechanism. We present here the application of emerging techniques in ultracold physics to the synthesis of a mixed hypermetallic oxide, BaOCa+. These methods, augmented by high- level electronic structure calculations, permit detailed investigation of the bonding and structure as well as the mechanism of its formation via the barrierless reaction of Ca (3PJ) with BaOCH3+. Further investigations of the reaction kinetics as a function of collision energy over the range 0.005 kelvin (K) to 30 K and of individual Ca fine-structure levels compare favorably with calculations based on long-range capture theory.	[Puri, Prateek; Mills, Michael; Schneider, Christian; Hudson, Eric R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Simbotin, Ionel; Montgomery, John A., Jr.; Cote, Robin] Univ Connecticut, Dept Phys, Storrs, CT 06269 USA; [Suits, Arthur G.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of California System; University of California Los Angeles; University of Connecticut; University of Missouri System; University of Missouri Columbia	Hudson, ER (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	eric.hudson@ucla.edu		Montgomery, John/0000-0002-2627-2317; Suits, Arthur/0000-0001-5405-8361	National Science Foundation [PHY-1205311, PHY-1415560, DGE-1650604]; Army Research Office [W911NF-15-1-0121, W911NF-14-1-0378, W911NF-13-1-0213]; Direct For Mathematical & Physical Scien [1415560] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Army Research Office; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank W. Campbell, S. Schowalter, A. Dunning, and E. West for insightful conversations. P.P. also thanks K. Purser for foundational discussions. This work was supported by the National Science Foundation (grants PHY-1205311, PHY-1415560, and DGE-1650604) and Army Research Office (grants W911NF-15-1-0121, W911NF-14-1-0378, and W911NF-13-1-0213).	Abe M, 2013, CHEM REV, V113, P7011, DOI 10.1021/cr400056a; Antonov IO, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3541255; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Boutou V, 1998, PHYS REV LETT, V80, P2817, DOI 10.1103/PhysRevLett.80.2817; Chang YP, 2013, SCIENCE, V342, P98, DOI 10.1126/science.1242271; DALGARNO A, 1958, PHILOS TR R SOC S-A, V250, P411, DOI 10.1098/rsta.1958.0002; DAVIS HF, 1993, J CHEM PHYS, V98, P9595, DOI 10.1063/1.464390; Derevianko A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.023002; Dulieu O, 2011, PHYS CHEM CHEM PHYS, V13, P18703, DOI 10.1039/c1cp90157e; Eberle P, 2015, J PHYS CONF SER, V635, DOI 10.1088/1742-6596/635/1/012012; Frisch M. J., 2016, GAUSSIAN 09; Green SP, 2007, SCIENCE, V318, P1754, DOI 10.1126/science.1150856; Gross RL, 2003, CHEM PHYS LETT, V376, P710, DOI 10.1016/S0009-2614(03)01063-7; Hall FHJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233202; Hudson ER, 2016, EPJ TECH INSTRUM, V3, DOI 10.1140/epjti/s40485-016-0035-0; Kirste M, 2012, SCIENCE, V338, P1060, DOI [10.1126/science.1229549, 10.1126/science.1227491]; Langevin P, 1905, ANN CHIM PHYS, V5, P245; Merawa M, 2001, CHEM PHYS LETT, V343, P397, DOI 10.1016/S0009-2614(01)00668-6; Merritt JM, 2009, J PHYS CHEM A, V113, P13300, DOI 10.1021/jp904653v; MIES FH, 1973, PHYS REV A, V7, P942, DOI 10.1103/PhysRevA.7.942; Mills M, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.033402; Mitroya J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841470; Nakano M, 2015, J PHYS CHEM LETT, V6, P3236, DOI 10.1021/acs.jpclett.5b00956; Noury S, 2002, INORG CHEM, V41, P2164, DOI 10.1021/ic011003v; Oates CW, 1999, EUR PHYS J D, V7, P449, DOI 10.1007/s100530050589; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Ostojic B, 2013, J PHYS CHEM A, V117, P9370, DOI 10.1021/jp310531s; Ostojic B, 2012, J MOL STRUCT, V1023, P101, DOI 10.1016/j.molstruc.2012.03.048; Ostojic B, 2011, PHYS CHEM CHEM PHYS, V13, P7546, DOI 10.1039/c0cp02996c; Rellergert WG, 2013, NATURE, V495, P490, DOI 10.1038/nature11937; Santra R, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042510; Schneider C, 2016, INT J MASS SPECTROM, V394, P1, DOI 10.1016/j.ijms.2015.10.006; Schneider C, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.034013; Schowalter SJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12448; Schowalter SJ, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3700216; SUGAR J, 1985, J PHYS CHEM REF DATA, V14, P1; Uyanik M, 2010, SCIENCE, V328, P1376, DOI 10.1126/science.1188217; Wang YJ, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4941380	38	48	48	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2017	357	6358					1370	+		10.1126/science.aan4701	http://dx.doi.org/10.1126/science.aan4701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI3QH	28882994	Green Submitted			2022-12-28	WOS:000411880800039
J	Wang, S; Xia, PY; Chen, Y; Qu, Y; Xiong, Z; Ye, BQ; Du, Y; Tian, Y; Yin, ZN; Xu, ZH; Fan, ZS				Wang, Shuo; Xia, Pengyan; Chen, Yi; Qu, Yuan; Xiong, Zhen; Ye, Buqing; Du, Ying; Tian, Yong; Yin, Zhinan; Xu, Zhiheng; Fan, Zusen			Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation	CELL			English	Article							FACTOR T-BET; TRANSCRIPTIONAL REGULATION; MOUSE MODEL; DIFFERENTIATION; LYMPHOCYTES; INTERLEUKIN-22; SUSCEPTIBILITY; PROGENITORS; ACTIVATION; RESOLUTION	An emerging family of innate lymphoid cells (termed ILCs) has an essential role in the initiation and regulation of inflammation. However, it is still unclear how ILCs are regulated in the duration of intestinal inflammation. Here, we identify a regulatory subpopulation of ILCs (called ILCregs) that exists in the gut and harbors a unique gene identity that is distinct from that of ILCs or regulatory T cells (Tregs). During inflammatory stimulation, ILCregs can be induced in the intestine and suppress the activation of ILC1s and ILC3s via secretion of IL-10, leading to protection against innate intestinal inflammation. Moreover, TGF-beta 1 is induced by ILCregs during the innate intestinal inflammation, and autocrine TGF-beta 1 sustains the maintenance and expansion of ILCregs. Therefore, ILCregs play an inhibitory role in the innate immune response, favoring the resolution of intestinal inflammation.	[Wang, Shuo; Xia, Pengyan; Qu, Yuan; Xiong, Zhen; Ye, Buqing; Du, Ying; Fan, Zusen] Chinese Acad Sci, CAS Key Lab Infect & Immun, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Tian, Yong; Fan, Zusen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chen, Yi] Sichuan Univ, Dept Gastrointestinal Surg, State Key Lab Biotherapy, West China Hosp, Chengdu 610041, Sichuan, Peoples R China; [Tian, Yong] Chinese Acad Sci, Key Lab RNA Biol CAS, Inst Biophys, Beijing 100101, Peoples R China; [Yin, Zhinan] Jinan Univ, Affiliated Hosp 1, Biomed Translat Res Inst, Guangzhou 510632, Guangdong, Peoples R China; [Yin, Zhinan] Jinan Univ, Guangdong Prov Key Lab Mol Immunol & Antibody Eng, Guangzhou 510632, Guangdong, Peoples R China; [Xu, Zhiheng] Chinese Acad Sci, State Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Jinan University; Jinan University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Wang, S; Fan, ZS (corresponding author), Chinese Acad Sci, CAS Key Lab Infect & Immun, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China.; Fan, ZS (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wangshuo@moon.ibp.ac.cn; fanz@moon.ibp.ac.cn	TIAN, YONG/L-2414-2019; TIAN, YONG/ABF-4406-2021	TIAN, YONG/0000-0002-8790-1148; Xu, Zhiheng/0000-0002-4809-2851; Chen, Yi/0000-0002-5180-3490	National Natural Science Foundation of China [91640203, 31530093, 81330047, 81601361, 31471386, 31570872, 31671531]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDB19030203, XDA12020219]; Youth Innovation Promotion Association of CAS [2015073]; China Postdoctoral Science Foundation [2015M571141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Programs of the Chinese Academy of Sciences; Youth Innovation Promotion Association of CAS; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Junying Jia, Lei Sun, Yan Teng, Shu Meng, Zhonglin Fu, Yapu Zhao, and Feng Zhang for technical support. We thank Drs. Flavell (Yale University), Yuan Zhuang (Duke University), and Chen Dong (Tsinghua University) for providing the genetic mouse stains. We thank Jing Li (Cnkingbio Company) for technical support. This work was supported by the National Natural Science Foundation of China (91640203, 31530093, 81330047, 81601361, 31471386, 31570872, and 31671531), the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDB19030203 and XDA12020219), the Youth Innovation Promotion Association of CAS (2015073) (to S.W.), and the China Postdoctoral Science Foundation (2015M571141) (to P.X.).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bedoui S, 2016, NAT IMMUNOL, V17, P490, DOI 10.1038/ni.3432; Brandenburg S, 2008, EUR J IMMUNOL, V38, P1643, DOI 10.1002/eji.200737791; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Ishizuka IE, 2016, ANNU REV IMMUNOL, V34, P299, DOI 10.1146/annurev-immunol-041015-055549; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Miyazaki M, 2014, NAT IMMUNOL, V15, P767, DOI 10.1038/ni.2928; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Spooner CJ, 2013, NAT IMMUNOL, V14, P1229, DOI 10.1038/ni.2743; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang S, 2016, IMMUNITY, V45, P131, DOI 10.1016/j.immuni.2016.06.019; Wang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11023; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356; Xia PY, 2014, J EXP MED, V211, P2119, DOI 10.1084/jem.20140169; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	66	215	232	11	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					201	+		10.1016/j.cell.2017.07.027	http://dx.doi.org/10.1016/j.cell.2017.07.027			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28844693	Bronze			2022-12-28	WOS:000411331800021
J	Gross, C; Bloch, I				Gross, Christian; Bloch, Immanuel			Quantum simulations with ultracold atoms in optical lattices	SCIENCE			English	Review							MANY-BODY LOCALIZATION; FERMI-HUBBARD MODEL; MOTT INSULATOR; ANTIFERROMAGNETIC CORRELATIONS; NEUTRAL ATOMS; TOPOLOGICAL INSULATORS; STATISTICAL-MECHANICS; INTERACTING FERMIONS; PHASE-TRANSITION; POLAR-MOLECULES	Quantum simulation, a subdiscipline of quantum computation, can provide valuable insight into difficult quantum problems in physics or chemistry. Ultracold atoms in optical lattices represent an ideal platform for simulations of quantum many-body problems. Within this setting, quantum gas microscopes enable single atom observation and manipulation in large samples. Ultracold atom-based quantum simulators have already been used to probe quantum magnetism, to realize and detect topological quantum matter, and to study quantum systems with controlled long-range interactions. Experiments on many-body systems out of equilibrium have also provided results in regimes unavailable to the most advanced supercomputers. We review recent experimental progress in this field and comment on future directions.	[Gross, Christian; Bloch, Immanuel] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Bloch, Immanuel] Ludwig Maximilians Univ Munchen, Germany Fak Phys, D-80799 Munich, Germany	Max Planck Society; University of Munich	Gross, C; Bloch, I (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.; Bloch, I (corresponding author), Ludwig Maximilians Univ Munchen, Germany Fak Phys, D-80799 Munich, Germany.	christian.gross@mpq.mpg.de; immanuel.bloch@mpq.mpg.de	Bloch, Immanuel/N-9169-2019; Gross, Christian/P-5475-2014; Bloch, Immanuel/G-3174-2010	Gross, Christian/0000-0003-2292-5234; Bloch, Immanuel/0000-0002-0679-4759				Abanin DA, 2017, ANN PHYS-BERLIN, V529, DOI 10.1002/andp.201700169; AHARONOV Y, 1959, PHYS REV, V115, P485, DOI 10.1103/PhysRev.115.485; Aidelsburger M, 2015, NAT PHYS, V11, P162, DOI 10.1038/NPHYS3171; Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Aidelsburger M., 2015, THESIS; Aikawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210401; Altman E, 2015, ANNU REV CONDEN MA P, V6, P383, DOI 10.1146/annurev-conmatphys-031214-014701; Aman JA, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.043425; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Azurenko AM, 2017, NATURE, V545, P462, DOI 10.1038/nature22362; Baier S, 2016, SCIENCE, V352, P201, DOI 10.1126/science.aac9812; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Balewski JB, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/063012; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Barredo D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.113002; Basko DM, 2006, ANN PHYS-NEW YORK, V321, P1126, DOI 10.1016/j.aop.2005.11.014; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Boll M, 2016, SCIENCE, V353, P1257, DOI 10.1126/science.aag1635; Bordia P, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.140401; Bouchoule I, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.041803; Brown P. T., 2016, ARXIV161207746; Brown RC, 2015, SCIENCE, V348, P540, DOI 10.1126/science.aaa1385; Celi A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043001; Cheuk LW, 2016, SCIENCE, V353, P1260, DOI 10.1126/science.aag3349; Cheuk LW, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.235301; Cheuk LW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.193001; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Choi JY, 2016, SCIENCE, V352, P1547, DOI 10.1126/science.aaf8834; D'Alessio L, 2016, ADV PHYS, V65, P239, DOI 10.1080/00018732.2016.1198134; Dalla Torre EG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.260401; Danzl JG, 2008, SCIENCE, V321, P1062, DOI 10.1126/science.1159909; de Paz A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185305; Deiglmayr J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.133004; Drewes JH, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.170401; Drewes JH, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.135301; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Duca L, 2015, SCIENCE, V347, P288, DOI 10.1126/science.1259052; Edge GJA, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063406; Endres M, 2011, SCIENCE, V334, P200, DOI [10.1126/science.1209284, 10.1126/science.1210268]; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Endres M, 2012, NATURE, V487, P454, DOI 10.1038/nature11255; Esslinger T, 2010, ANNU REV CONDEN MA P, V1, P129, DOI 10.1146/annurev-conmatphys-070909-104059; Flaschner N, 2016, SCIENCE, V352, P1091, DOI 10.1126/science.aad4568; Fukuhara T, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.035302; Fukuhara T, 2013, NATURE, V502, P76, DOI 10.1038/nature12541; Fukuhara T, 2013, NAT PHYS, V9, P235, DOI [10.1038/nphys2561, 10.1038/NPHYS2561]; Garcia-Ripoll JJ, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/376; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Gerbier F, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033007; Gericke T, 2008, NAT PHYS, V4, P949, DOI 10.1038/nphys1102; Girvin S., 1999, QUANTUM HALL EFFECT; Glaetzle AW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15813; Glaetzle AW, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041037; Glaetzle AW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.173002; Goldman N, 2016, NAT PHYS, V12, P639, DOI [10.1038/NPHYS3803, 10.1038/nphys3803]; Goldschmidt EA, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.113001; Greif D, 2016, SCIENCE, V351, P953, DOI 10.1126/science.aad9041; Greif D, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.260401; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Griesmaier A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160401; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Grunzweig T, 2010, NAT PHYS, V6, P951, DOI 10.1038/NPHYS1778; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; Haller E, 2015, NAT PHYS, V11, P738, DOI [10.1038/nphys3403, 10.1038/NPHYS3403]; Hart RA, 2015, NATURE, V519, P211, DOI 10.1038/nature14223; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hazzard KRA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063622; Henkel N, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195302; Hild S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.147205; Hilker TA, 2017, SCIENCE, V357, P484, DOI 10.1126/science.aam8990; Ho TL, 2009, P NATL ACAD SCI USA, V106, P6916, DOI 10.1073/pnas.0809862105; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; Honer J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160404; Jain A, 2017, NAT PHYS, V13, P633, DOI [10.1038/nphys4077, 10.1038/NPHYS4077]; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Jordens R, 2008, NATURE, V455, P204, DOI 10.1038/nature07244; Johnson JE, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.033412; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; Karski M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.053001; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Kondov SS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.083002; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; Langen T, 2015, SCIENCE, V348, P207, DOI 10.1126/science.1257026; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Leonard J., 2017, ARXIV170405803; Leonard J, 2017, NATURE, V543, P87, DOI 10.1038/nature21067; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lohse M, 2016, NAT PHYS, V12, P350, DOI 10.1038/NPHYS3584; Lu HI, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.200402; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Mancini M, 2015, SCIENCE, V349, P1510, DOI 10.1126/science.aaa8736; Meinert F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.053003; Meinert F, 2014, SCIENCE, V344, P1259, DOI 10.1126/science.1248402; Miranda M, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.063414; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Nakajima S, 2016, NAT PHYS, V12, P296, DOI 10.1038/NPHYS3622; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Nascimbene S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205301; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Nogrette F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021034; Oka T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.081406; Omran A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.263001; Parsons MF, 2016, SCIENCE, V353, P1253, DOI 10.1126/science.aag1430; Parsons MF, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.213002; Pekker D, 2015, ANNU REV CONDEN MA P, V6, P269, DOI 10.1146/annurev-conmatphys-031214-014350; Podolsky D, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.054508; Podolsky D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174522; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; Pollet L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.010401; Preiss PM, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.041602; Pupillo G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.223002; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Santos L, 2000, PHYS REV LETT, V85, P1791, DOI 10.1103/PhysRevLett.85.1791; Schauss P, 2015, SCIENCE, V347, P1455, DOI 10.1126/science.1258351; Schauss P, 2012, NATURE, V491, P87, DOI 10.1038/nature11596; Schlosser M, 2011, QUANTUM INF PROCESS, V10, P907, DOI 10.1007/s11128-011-0297-z; Schneider U, 2008, SCIENCE, V322, P1520, DOI 10.1126/science.1165449; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; Sherman D, 2015, NAT PHYS, V11, P188, DOI 10.1038/NPHYS3227; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Smith J, 2016, NAT PHYS, V12, P907, DOI [10.1038/nphys3783, 10.1038/NPHYS3783]; Struck J, 2013, NAT PHYS, V9, P738, DOI [10.1038/nphys2750, 10.1038/NPHYS2750]; Struck J, 2011, SCIENCE, V333, P996, DOI 10.1126/science.1207239; Stuhl BK, 2015, SCIENCE, V349, P1514, DOI 10.1126/science.aaa8515; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; THOULESS DJ, 1983, PHYS REV B, V27, P6083, DOI 10.1103/PhysRevB.27.6083; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; van Bijnen RMW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.243002; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wirth G, 2011, NAT PHYS, V7, P147, DOI [10.1038/nphys1857, 10.1038/NPHYS1857]; Xiao D, 2010, REV MOD PHYS, V82, P1959, DOI 10.1103/RevModPhys.82.1959; Yamamoto R, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/2/023016; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Zeiher J, 2017, ARXIV170508372; Zeiher J, 2016, NAT PHYS, V12, P1095, DOI [10.1038/NPHYS3835, 10.1038/nphys3835]; Zupancic P, 2016, OPT EXPRESS, V24, P13881, DOI 10.1364/OE.24.013881; Zwerger W, 2012, LECT NOTES PHYS	155	568	571	15	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		995	1001		10.1126/science.aal3837	http://dx.doi.org/10.1126/science.aal3837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883070				2022-12-28	WOS:000409455700037
J	Wade, L				Wade, Lizzie			SCIENCE FUNDING In Colombia, peace dividend for science proves elusive	SCIENCE			English	News Item																			0	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		958	958		10.1126/science.357.6355.958	http://dx.doi.org/10.1126/science.357.6355.958			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883055				2022-12-28	WOS:000409455700013
J	Abbott, A				Abbott, Alison			GERMANY'S SECRET TO SCIENTIFIC EXCELLENCE	NATURE			English	News Item													Figueiredo, Americo/H-5875-2019	Figueiredo, Americo/0000-0002-9105-9619					0	6	6	2	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					18	+		10.1038/549018a	http://dx.doi.org/10.1038/549018a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880310	Bronze			2022-12-28	WOS:000409388700011
J	Kastenhuber, ER; Lowe, SW				Kastenhuber, Edward R.; Lowe, Scott W.			Putting p53 in Context	CELL			English	Review							WILD-TYPE P53; ACUTE MYELOID-LEUKEMIA; COLORECTAL-CANCER PATIENTS; TUMOR-SUPPRESSOR P53; EMBRYONIC STEM-CELLS; LI-FRAUMENI-SYNDROME; GAIN-OF-FUNCTION; MUTANT P53; DNA-DAMAGE; IN-VIVO	TP53 is the most frequently mutated gene in human cancer. Functionally, p53 is activated by a host of stress stimuli and, in turn, governs an exquisitely complex anti-proliferative transcriptional program that touches upon a bewildering array of biological responses. Despite the many unveiled facets of the p53 network, a clear appreciation of how and in what contexts p53 exerts its diverse effects remains unclear. How can we interpret p53's disparate activities and the consequences of its dysfunction to understand how cell type, mutation profile, and epigenetic cell state dictate outcomes, and how might we restore its tumor-suppressive activities in cancer?	[Kastenhuber, Edward R.; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Sloan Kettering Inst, New York, NY 10065 USA; [Kastenhuber, Edward R.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, Sloan Kettering Inst, New York, NY 10065 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	lowes@mskcc.org		Kastenhuber, Edward/0000-0002-1872-212X	NCI/National Institutes of Health [F31CA192835]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA087497, F31CA192835] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Charles Sherr of HHMI at St. Jude Children's Research Hospital and all members of the Lowe lab for advice and critical discussions, especially Francisco Sanchez-Rivera, Shauna Houlihan, and John P. Morris, IV. E.R.K. is supported by an F31 NRSA predoctoral fellowship from the NCI/National Institutes of Health under award number F31CA192835. S.W.L. is an investigator of the Howard Hughes Medical Institute and the Geoffrey Beene Chair for Cancer Biology. We thank all of the investigators who have contributed to the p53 field and the many ideas presented herein. We apologize to the many investigators whose work could not be cited owing to space constraints.	Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Achatz M.I., 2016, COLD SPRING HARB PER, V6, P6; Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Andreeff M, 2016, CLIN CANCER RES, V22, P868, DOI 10.1158/1078-0432.CCR-15-0481; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Aschauer L, 2016, BIOCHEM SOC T, V44, P460, DOI 10.1042/BST20150261; Aylon Y., 2016, COLD SPRING HARB PER, V6, P6; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BAKER SJ, 1990, CANCER RES, V50, P7717; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Blanden AR, 2015, DRUG DISCOV TODAY, V20, P1391, DOI 10.1016/j.drudis.2015.07.006; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Burgess A, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00007; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Candeias MM, 2016, EMBO REP, V17, P1542, DOI 10.15252/embr.201541956; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Cha YJ, 2016, LUNG CANCER, V97, P73, DOI 10.1016/j.lungcan.2016.05.001; Chang NT, 2007, J BIOMED SCI, V14, P211, DOI 10.1007/s11373-006-9126-2; Charni M, 2017, CELL DEATH DIFFER, V24, P8, DOI 10.1038/cdd.2016.117; Checler F, 2014, PHARMACOL THERAPEUT, V142, P99, DOI 10.1016/j.pharmthera.2013.11.009; Cheok C.F., 2017, COLD SPRING HARB PER, V7, P7; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cooks T, 2014, CARCINOGENESIS, V35, P1680, DOI 10.1093/carcin/bgu134; Cortez MA, 2015, JNCI-J NATL CANCER I, V108, P108; CRAWFORD LV, 1982, INT J CANCER, V30, P403, DOI 10.1002/ijc.2910300404; Danilova N, 2008, MECH DEVELOP, V125, P919, DOI 10.1016/j.mod.2008.09.003; de Oliveira GAP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00097; Dejosez M, 2013, SCIENCE, V341, P1511, DOI 10.1126/science.1241628; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; Deneberg S, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.60; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Eischen C.M., 2016, COLD SPRING HARB PER, V6, P6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ellebaek E, 2012, CANCER IMMUNOL IMMUN, V61, P1791, DOI 10.1007/s00262-012-1242-4; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Feng ZH, 2011, FASEB J, V25, P2245, DOI 10.1096/fj.10-180166; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gomes NP, 2010, CELL CYCLE, V9, P3428, DOI 10.4161/cc.9.17.12998; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Hardwick N, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.958949; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horvath MM, 2007, PLOS GENET, V3, P1284, DOI 10.1371/journal.pgen.0030127; Houlihan SL, 2014, ELIFE, V3, DOI 10.7554/eLife.03297; Itahana Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep28112; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jiang DD, 2011, P NATL ACAD SCI USA, V108, P17123, DOI 10.1073/pnas.1111245108; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; KASTAN MB, 1991, CANCER RES, V51, P6304; Kaushansky A, 2013, CELL REP, V3, P630, DOI 10.1016/j.celrep.2013.02.010; Kim HR, 2013, BIOCHEM BIOPH RES CO, V437, P225, DOI 10.1016/j.bbrc.2013.06.043; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumari Rajni, 2014, Mol Cell Oncol, V1, pe969653, DOI 10.4161/23723548.2014.969653; Laberge RM, 2012, CANCER MICROENVIRON, V5, P39, DOI 10.1007/s12307-011-0069-4; Lane DP, 2011, CELL CYCLE, V10, P4272, DOI 10.4161/cc.10.24.18567; Lane DP, 2010, CELL CYCLE, V9, P748, DOI 10.4161/cc.9.4.10616; Lane DP, 2010, CELL CYCLE, V9, P540, DOI 10.4161/cc.9.3.10516; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Leijen S, 2016, J CLIN ONCOL, V34, P4354, DOI 10.1200/JCO.2016.67.5942; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Levine AJ, 2016, BIOESSAYS, V38, P508, DOI 10.1002/bies.201600031; Li HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep45821; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Liu Y, 2016, NATURE, V531, P471, DOI 10.1038/nature17157; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Menendez D, 2017, MOL CANCER RES, V15, P735, DOI 10.1158/1541-7786.MCR-17-0019; Menendez S, 2010, CELL CYCLE, V9, P3887, DOI 10.4161/cc.9.19.13301; Merkle FT, 2017, NATURE, V545, P229, DOI 10.1038/nature22312; Messina RL, 2012, INT J CANCER, V130, P2259, DOI 10.1002/ijc.26228; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Morandell S, 2012, PROG MOL BIOL TRANSL, V110, P289, DOI 10.1016/B978-0-12-387665-2.00011-0; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nieto M, 2004, ONCOGENE, V23, P735, DOI 10.1038/sj.onc.1207175; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Olivos DJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121982; Pappas K, 2017, MOL CANCER RES, V15, P1051, DOI 10.1158/1541-7786.MCR-17-0089; Parrales A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00288; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Pfister NT, 2015, GENE DEV, V29, P1298, DOI 10.1101/gad.263202.115; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116; Roth J, 1996, P NATL ACAD SCI USA, V93, P4781, DOI 10.1073/pnas.93.10.4781; Schuster C, 2011, BLOOD, V118, P4635, DOI 10.1182/blood-2010-10-313098; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Senturk S, 2014, P NATL ACAD SCI USA, V111, pE3287, DOI 10.1073/pnas.1321640111; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shatz M, 2012, CANCER RES, V72, P3948, DOI 10.1158/0008-5472.CAN-11-4134; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shinmura K, 2011, ANN SURG ONCOL, V18, P2084, DOI 10.1245/s10434-011-1568-8; Shirole NH, 2016, ELIFE, V5, DOI 10.7554/eLife.17929; Siegl C, 2014, CELL REP, V9, P918, DOI 10.1016/j.celrep.2014.10.004; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Soto M, 2017, CELL REP, V19, P2423, DOI 10.1016/j.celrep.2017.05.055; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Su D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004885; Sulak M, 2016, ELIFE, V5, DOI [10.7554/eLife.11994, 10.7554/eLife.24307]; Sullivan KD, 2015, CELL CYCLE, V14, P56, DOI 10.4161/15384101.2014.973330; Sullivan KD, 2012, BBA-REV CANCER, V1825, P229, DOI 10.1016/j.bbcan.2012.01.004; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Thorburn J, 2014, CELL REP, V7, P45, DOI 10.1016/j.celrep.2014.02.036; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tosoni D, 2015, J CELL BIOL, V211, P845, DOI 10.1083/jcb.201505037; Tovy A, 2017, GENE DEV, V31, P959, DOI 10.1101/gad.299198.117; Tschaharganeh DF, 2016, CANCER CELL, V29, P617, DOI 10.1016/j.ccell.2016.04.011; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; van der Burg SH, 2002, CLIN CANCER RES, V8, P1019; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venkatanarayan A, 2015, NATURE, V517, P626, DOI 10.1038/nature13910; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Welch JS, 2016, NEW ENGL J MED, V375, P2023, DOI 10.1056/NEJMoa1605949; Williams A.B., 2016, COLD SPRING HARB PER, V6, P6; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Wylie A, 2016, GENE DEV, V30, P64, DOI 10.1101/gad.266098.115; Wylie A, 2014, ELIFE, V3, DOI 10.7554/eLife.01530; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04223; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yun MH, 2013, P NATL ACAD SCI USA, V110, P17392, DOI 10.1073/pnas.1310519110; Zeestraten ECM, 2013, INT J CANCER, V132, P1581, DOI 10.1002/ijc.27819; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	180	881	900	15	261	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1062	1078		10.1016/j.cell.2017.08.028	http://dx.doi.org/10.1016/j.cell.2017.08.028			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886379	Green Accepted, Bronze			2022-12-28	WOS:000409536000006
J	Rush, RP; Saltman, AP; Prica, AA; Breiner, A; Detsky, AS				Rush, Raphael P.; Saltman, Alexandra P.; Prica, Anca A.; Breiner, Ari; Detsky, Allan S.			Connecting the Dots	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							B-CELL LYMPHOMA; HODGKIN; NEUROLYMPHOMATOSIS; TRIAL; RISK		[Rush, Raphael P.; Saltman, Alexandra P.; Prica, Anca A.; Breiner, Ari; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Prica, Anca A.; Breiner, Ari; Detsky, Allan S.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Prica, Anca A.; Breiner, Ari; Detsky, Allan S.] Mt Sinai Hosp, 600 Univ Ave,Rm 429, Toronto, ON M5G 1X5, Canada; [Breiner, Ari] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Ottawa	Detsky, AS (corresponding author), Mt Sinai Hosp, 600 Univ Ave,Rm 429, Toronto, ON M5G 1X5, Canada.	allan.detsky@sinaihealthsystem.ca			Grifols	Grifols	Dr. Breiner reports receiving grant support from Grifols. No other potential conflict of interest relevant to this article was reported.	Baehring JM, 2003, NEURO-ONCOLOGY, V5, P104; Boehme V, 2009, BLOOD, V113, P3896, DOI 10.1182/blood-2008-10-182253; El-Galaly TC, 2015, HEMATOL ONCOL, V33, P209; Graus F, 2014, BLOOD, V123, P3230, DOI 10.1182/blood-2014-03-537506; Grisariu S, 2010, BLOOD, V115, P5005, DOI 10.1182/blood-2009-12-258210; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Schmitz N, 2012, ANN ONCOL, V23, P1267, DOI 10.1093/annonc/mdr440; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Sehn LH, 2006, CLIN LYMPHOMA MYELOM, V7, pS14, DOI 10.3816/CLM.2006.s.003; Tomita N, 2010, BLOOD, V116, P3948; Vitolo U, 2016, ANN ONCOL, V27, pv91, DOI 10.1093/annonc/mdw175; YOUNG RC, 1979, AM J MED, V66, P435, DOI 10.1016/0002-9343(79)91065-9	12	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					978	984		10.1056/NEJMcps1613804	http://dx.doi.org/10.1056/NEJMcps1613804			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF9XU	28877025				2022-12-28	WOS:000409373100012
J	Umen, J; Goodenough, U; Heitman, J				Umen, James; Goodenough, Ursula; Heitman, Joseph			Eukaryotic Sexual Reproduction Evoked "with a Little Help from My Friends"	CELL			English	Editorial Material								Bacteria and eukaryotes interact in many ways-from the microbiome that educates the mammalian immune system and enhances nutrition to relationships that are commensal, symbiotic, or parasitic. Now in an unexpected twist, King and colleagues have expanded the repertoire of prokaryotic influence over eukaryotic physiology to include mating.	[Umen, James] Donald Danforth Plant Sci Ctr, 975 North Warson Rd, St Louis, MO 63132 USA; [Goodenough, Ursula] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Donald Danforth Plant Science Center; Washington University (WUSTL); Duke University	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@duke.edu	Heitman, Joseph/ABC-6006-2021; Umen, James G/K-9120-2013	Umen, James G/0000-0003-4094-9045	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050113, R37AI039115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078376] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI039115, R01 AI050113] Funding Source: Medline; NIGMS NIH HHS [R01 GM078376] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Levin TC, 2013, CURR BIOL, V23, P2176, DOI 10.1016/j.cub.2013.08.061; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014	9	1	1	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1059	1061		10.1016/j.cell.2017.08.038	http://dx.doi.org/10.1016/j.cell.2017.08.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886378	Bronze			2022-12-28	WOS:000409536000005
J	Liu, XQ; Agerbo, E; Ingstrup, KG; Musliner, K; Meltzer-Brody, S; Bergink, V; Munk-Olsen, T				Liu, Xiaoqin; Agerbo, Esben; Ingstrup, Katja G.; Musliner, Katherine; Meltzer-Brody, Samantha; Bergink, Veerle; Munk-Olsen, Trine			Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; AUTISM SPECTRUM DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EXPOSURE; RISK; DEPRESSION; ASSOCIATION; BEHAVIOR; BIRTH; LIFE	OBJECTIVE To investigate the association between in utero exposure to antidepressants and risk of psychiatric disorders. DESIGN Population based cohort study. SETTING Danish national registers. PARTICIPANTS 905 383 liveborn singletons born during 1998-2012 in Denmark and followed from birth until July 2014, death, emigration, or date of first psychiatric diagnosis, whichever came first. The children were followed for a maximum of 16.5 years and contributed 8.1x10(6) person years at risk. EXPOSURES FOR OBSERVATIONAL STUDIES Children were categorised into four groups according to maternal antidepressant use within two years before and during pregnancy: unexposed, antidepressant discontinuation (use before but not during pregnancy), antidepressant continuation (use both before and during pregnancy), and new user (use only during pregnancy). MAIN OUTCOME MEASURE First psychiatric diagnosis in children, defined as first day of inpatient or outpatient treatment for psychiatric disorders. Hazard ratios of psychiatric disorders were estimated using Cox regression models. RESULTS Overall, psychiatric disorders were diagnosed in 32 400 children. The adjusted 15 year cumulative incidence of psychiatric disorders was 8.0% (95% confidence interval 7.9% to 8.2%) in the unexposed group, 11.5% (10.3% to 12.9%) in the antidepressant discontinuation group, 13.6% (11.3% to 16.3%) in the continuation group, and 14.5% (10.5% to 19.8%) in the new user group. The antidepressant continuation group had an increased risk of psychiatric disorders (hazard ratio 1.27, 1.17 to 1.38), compared with the discontinuation group. CONCLUSIONS In utero exposure to antidepressants was associated with increased risk of psychiatric disorders. The association may be attributable to the severity of underlying maternal disorders in combination with antidepressant exposure in utero. The findings suggest that focusing solely on a single psychiatric disorder among offspring in studies of in utero antidepressant exposure may be too restrictive.	[Liu, Xiaoqin; Agerbo, Esben; Ingstrup, Katja G.; Musliner, Katherine; Bergink, Veerle; Munk-Olsen, Trine] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Agerbo, Esben] Aarhus Univ, CIRRAU Ctr Integrated Register Based Res, Aarhus, Denmark; [Agerbo, Esben; Musliner, Katherine] iPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Meltzer-Brody, Samantha] Univ North Carolina Chapel Hill, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Bergink, Veerle] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands	Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Erasmus University Rotterdam; Erasmus MC	Liu, XQ (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark.	lxq@econ.au.dk	Meltzer-Brody, Samantha/J-6926-2019; Munk-olsen, Trine/AAS-3546-2021; Liu, Xiaoqin/AAB-7509-2019; Agerbo, Esben/A-2645-2012	Meltzer-Brody, Samantha/0000-0002-8509-408X; Munk-olsen, Trine/0000-0002-0786-7147; Liu, Xiaoqin/0000-0003-4519-1536; Agerbo, Esben/0000-0002-2849-524X; Musliner, Katherine/0000-0001-6198-4953	National Institute of Mental Health (NIMH) [R01MH104468]; Danish Council for Independent Research [DFF-5053-00156B]; Sage Therapeutics; Janssen; iPSYCH; Lundbeck Foundation Initiative for Integrative Psychiatric Research [R155-2014-1724]; Danish National Research Foundation; Stanley Medical Research Institute; Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research (VENI); Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104468] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Sage Therapeutics; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); iPSYCH; Lundbeck Foundation Initiative for Integrative Psychiatric Research; Danish National Research Foundation(Danmarks Grundforskningsfond); Stanley Medical Research Institute; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (VENI)(Netherlands Organization for Scientific Research (NWO)); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	XL, SM, and TMO are supported by the National Institute of Mental Health (NIMH) (R01MH104468). XL is also supported by the Danish Council for Independent Research (DFF-5053-00156B). SMM has received research grant support from Sage Therapeutics and Janssen to the University of North Carolina. EA, KGI, KM, and TMO are supported by iPSYCH, the Lundbeck Foundation Initiative for Integrative Psychiatric Research (R155-2014-1724). EA is also supported by a Niels Bohr professorship grant from the Danish National Research Foundation and the Stanley Medical Research Institute. VB has received funding from the Netherlands Organization for Scientific Research (clinical fellow and VENI incentive). The investigators conducted the research independently. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Andersen TF, 1999, DAN MED BULL, V46, P263; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bonari L, 2004, CAN J PSYCHIAT, V49, P726, DOI 10.1177/070674370404901103; Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Brown AS, 2016, JAMA PSYCHIAT, V73, P1163, DOI 10.1001/jamapsychiatry.2016.2594; Brown HK, 2017, JAMA-J AM MED ASSOC, V317, P1544, DOI 10.1001/jama.2017.3415; Ciraulo DA, 2011, PHARMACOTHERAPY OF DEPRESSION, SECOND EDITION, P33, DOI 10.1007/978-1-60327-435-7_2; Clements CC, 2015, MOL PSYCHIATR, V20, P727, DOI 10.1038/mp.2014.90; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Dansk Selskab for Almen Medicin, 2010, KLIN VEJL ALM PRAKS; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; Figueroa R, 2010, J DEV BEHAV PEDIATR, V31, P641, DOI 10.1097/DBP.0b013e3181e5ac93; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Gidaya NB, 2014, J AUTISM DEV DISORD, V44, P2558, DOI 10.1007/s10803-014-2128-4; Glover ME, 2015, NEUROSCIENCE, V284, P775, DOI 10.1016/j.neuroscience.2014.10.044; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Huybrechts KF, 2013, GEN HOSP PSYCHIAT, V35, P265, DOI 10.1016/j.genhosppsych.2012.12.010; Hviid A, 2013, NEW ENGL J MED, V369, P2406, DOI 10.1056/NEJMoa1301449; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lahon K, 2011, J CLIN DIAGN RES, V5, P1069; Laugesen K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003507; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Malm H, 2016, J AM ACAD CHILD PSY, V55, P359, DOI 10.1016/j.jaac.2016.02.013; McLearn KT, 2006, ARCH PEDIAT ADOL MED, V160, P279, DOI 10.1001/archpedi.160.3.279; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nulman I, 2002, AM J PSYCHIAT, V159, P1889, DOI 10.1176/appi.ajp.159.11.1889; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Ornoy A., 2017, REPROD TOXICOL, P30135; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Petersson F, 2011, SCAND J PUBLIC HEALT, V39, P95, DOI 10.1177/1403494811408483; Rai D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2059; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Sorensen Merete Juul, 2013, Clin Epidemiol, V5, P449, DOI 10.2147/CLEP.S53009; Sprowles JLN, 2016, INT J DEV NEUROSCI, V54, P39, DOI 10.1016/j.ijdevneu.2016.08.007; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Sujan AC, 2017, JAMA-J AM MED ASSOC, V317, P1553, DOI 10.1001/jama.2017.3413; Videman M, 2017, CEREB CORTEX, V27, P3208, DOI 10.1093/cercor/bhw153; Vigod SN, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1547; Viktorin A, 2017, PSYCHOL MED, V47, P2787, DOI 10.1017/S0033291717001301; Viktorin A, 2016, INT J EPIDEMIOL, V45, P170, DOI 10.1093/ije/dyv351; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]; Zoega H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144474	51	42	43	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j3668	10.1136/bmj.j3668	http://dx.doi.org/10.1136/bmj.j3668			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG7EG	28877907	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000410575400003
J	Scrutton, NS				Scrutton, Nigel S.			Enzymes make light work of hydrocarbon production	SCIENCE			English	Editorial Material									[Scrutton, Nigel S.] Univ Manchester, Sch Chem, Ctr Synthet Biol Fine & Special Chem,Manchester I, Engn & Phys Sci Res Council,Biotechnol & Biol Sci, Manchester M1 7DN, Lancs, England	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Sch Chem, Ctr Synthet Biol Fine & Special Chem,Manchester I, Engn & Phys Sci Res Council,Biotechnol & Biol Sci, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk			BBSRC [BB/M017702/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M017702/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Conrad KS, 2014, NAT CHEM BIOL, V10, P801, DOI [10.1038/NCHEMBIO.1633, 10.1038/nchembio.1633]; Emmanuel MA, 2016, NATURE, V540, P414, DOI 10.1038/nature20569; Gahloth D, 2017, NAT CHEM BIOL, V13, P975, DOI [10.1038/nchembio.2434, 10.1038/NCHEMBIO.2434]; Heyes DJ, 2015, ANGEW CHEM INT EDIT, V54, P1512, DOI 10.1002/anie.201409881; Kallio P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5731; Lee SH, 2017, ANGEW CHEM INT EDIT, V56, P8681, DOI 10.1002/anie.201702461; Park JH, 2015, ANGEW CHEM INT EDIT, V54, P969, DOI 10.1002/anie.201410059; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Piano V, 2017, TRENDS BIOCHEM SCI, V42, P457, DOI 10.1016/j.tibs.2017.02.005; Sorigue D, 2017, SCIENCE, V357, P903, DOI 10.1126/science.aan6349; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/NCHEM.687, 10.1038/nchem.687]; Zhang M, 2016, SCIENCE, V354, P209, DOI 10.1126/science.aah6071	12	12	12	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					872	873		10.1126/science.aao4399	http://dx.doi.org/10.1126/science.aao4399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860372				2022-12-28	WOS:000408734900026
J	Sisti, DA				Sisti, Dominic A.			Nonvoluntary Psychiatric Treatment Is Distinct From Involuntary Psychiatric Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVANCE DIRECTIVES; AUTONOMY; COERCION		[Sisti, Dominic A.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Room 1409, Philadelphia, PA 19104 USA	University of Pennsylvania	Sisti, DA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 423 Guardian Dr,Blockley Hall,Room 1409, Philadelphia, PA 19104 USA.	sistid@upenn.edu		Sisti, Dominic/0000-0002-2282-9253	Thomas Scattergood Behavioral Health Foundation	Thomas Scattergood Behavioral Health Foundation	This study was supported by the Thomas Scattergood Behavioral Health Foundation.	Appelbaum P S, 1979, Bull Am Acad Psychiatry Law, V7, P306; Bonnie RJ, 2012, PSYCHIAT SERV, V63, P411, DOI 10.1176/appi.ps.20120p411; Caplan A, 2008, ADDICTION, V103, P1919, DOI 10.1111/j.1360-0443.2008.02369.x; Henderson C, 2008, PSYCHIAT SERV, V59, P63, DOI 10.1176/ps.2008.59.1.63; Nelson RM, 2011, AM J BIOETHICS, V11, P6, DOI 10.1080/15265161.2011.583318; SCHWARTZ HI, 1988, HOSP COMMUNITY PSYCH, V39, P1049; Swanson J, 2006, J AM ACAD PSYCHIATRY, V34, P43; WERTHEIMER A, 1993, BEHAV SCI LAW, V11, P239, DOI 10.1002/bsl.2370110303	8	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP	2017	318	11					999	1000		10.1001/jama.2017.10318	http://dx.doi.org/10.1001/jama.2017.10318			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7DP	28837717				2022-12-28	WOS:000411343400006
J	Petrenko, VV; Mith, AMS; Chaefer, HS; Riedel, K; Brook, E; Baggenstos, D; Harth, C; Hua, Q; Buizert, C; Schilt, A; Fain, X; Mitchell, L; Bauska, T; Orsi, A; Weiss, RF; Everinghaus, JPS				Petrenko, Vasilii V.; Mith, Andrew M. S.; Chaefer, Hinrich S.; Riedel, Katja; Brook, Edward; Baggenstos, Daniel; Harth, Christina; Hua, Quan; Buizert, Christo; Schilt, Adrian; Fain, Xavier; Mitchell, Logan; Bauska, Thomas; Orsi, Anais; Weiss, Ray F.; Everinghaus, Jeffrey P. S.			Minimal geological methane emissions during the Younger Dryas-Preboreal abrupt warming event	NATURE			English	Article							SITU COSMOGENIC (CH4)-C-14; ATMOSPHERIC CH4; TAYLOR GLACIER; FOSSIL-FUEL; ICE; C-14; (CO)-C-14; CLIMATE; RECORD; LAKES	Methane (CH4) is a powerful greenhouse gas and plays a key part in global atmospheric chemistry. Natural geological emissions (fossil methane vented naturally from marine and terrestrial seeps and mud volcanoes) are thought to contribute around 52 teragrams of methane per year to the global methane source, about 10 per cent of the total, but both bottom-up methods (measuring emissions)(1) and top-down approaches (measuring atmospheric mole fractions and isotopes)(2) for constraining these geological emissions have been associated with large uncertainties. Here we use ice core measurements to quantify the absolute amount of radiocarbon-containing methane ((CH4)-C-14) in the past atmosphere and show that geological methane emissions were no higher than 15.4 teragrams per year (95 per cent confidence), averaged over the abrupt warming event that occurred between the Younger Dryas and Preboreal intervals, approximately 11,600 years ago. Assuming that past geological methane emissions were no lower than today(3,4), our results indicate that current estimates of today's natural geological methane emissions (about 52 teragrams per year)(1,2) are too high and, by extension, that current estimates of anthropogenic fossil methane emissions(2) are too low. Our results also improve on and confirm earlier findings(5-7) that the rapid increase of about 50 per cent in mole fraction of atmospheric methane at the Younger Dryas-Preboreal event was driven by contemporaneous methane from sources such as wetlands; our findings constrain the contribution from old carbon reservoirs (marine methane hydrates(8), permafrost(9) and methane trapped under ice(10)) to 19 per cent or less (95 per cent confidence). To the extent that the characteristics of the most recent deglaciation and the Younger Dryas-Preboreal warming are comparable to those of the current anthropogenic warming, our measurements suggest that large future atmospheric releases of methane from old carbon sources are unlikely to occur.	[Petrenko, Vasilii V.] Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA; [Mith, Andrew M. S.; Hua, Quan] ANSTO, Locked Bag 2001, Kirrawee Dc, NSW 2232, Australia; [Chaefer, Hinrich S.; Riedel, Katja] Natl Inst Water & Atmospher Res NIWA, POB 14901,301 Evans Bay Parade, Wellington, New Zealand; [Brook, Edward; Buizert, Christo; Schilt, Adrian; Mitchell, Logan; Bauska, Thomas] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Baggenstos, Daniel; Harth, Christina; Orsi, Anais; Weiss, Ray F.; Everinghaus, Jeffrey P. S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Baggenstos, Daniel] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Fain, Xavier] Univ Grenoble Alpes, CNRS, LGGE, UMR 5183, F-38041 Grenoble, France; [Mitchell, Logan] Univ Utah, Dept Atmospher Sci, Salt Lake City, UT 84112 USA; [Bauska, Thomas] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Orsi, Anais] Univ Paris Saclay, Lab Sci Climat & Environm, LSCE IPSL, CEA CNRS UVSQ, F-91198 Gif Sur Yvette, France	University of Rochester; Australian Nuclear Science & Technology Organisation; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Oregon State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Bern; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Utah System of Higher Education; University of Utah; University of Cambridge; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Petrenko, VV (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	vpetrenk@ur.rochester.edu	Mitchell, Logan E/A-5481-2011; FAIN, Xavier/AAF-7985-2019; Baggenstos, Daniel/AAK-5751-2021; Brook, Edward/AAB-7807-2021; Hua, Quan/F-9593-2014	Mitchell, Logan E/0000-0002-8749-954X; FAIN, Xavier/0000-0002-4119-6025; Baggenstos, Daniel/0000-0001-9756-6884; Hua, Quan/0000-0003-0179-8539; Petrenko, Vasilii/0000-0002-0263-8759; Smith, Andrew/0000-0002-9193-2617; Bauska, Thomas/0000-0003-1901-0367; Schaefer, Hinrich/0000-0002-1163-2818	US National Science Foundation [0839031, 0838936, 1245659]; National Oceanic and Atmospheric Administration Climate and Global Change Postdoctoral Fellowship; Packard Fellowship for Science and Engineering; Marsden Fund Council from New Zealand Government; ANSTO Isotopes in Climate Change and Atmospheric Systems project; NIWA under Climate and Atmosphere Research Programme [CAAC1504 (2014/15 SCI)]; Australian Government for the Centre for Accelerator Science at ANSTO through the National Collaborative Research Infrastructure Strategy; Directorate For Geosciences [1245659, 1245821] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1246148] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration Climate and Global Change Postdoctoral Fellowship(National Oceanic Atmospheric Admin (NOAA) - USA); Packard Fellowship for Science and Engineering; Marsden Fund Council from New Zealand Government(Royal Society of New ZealandMarsden Fund (NZ)); ANSTO Isotopes in Climate Change and Atmospheric Systems project; NIWA under Climate and Atmosphere Research Programme; Australian Government for the Centre for Accelerator Science at ANSTO through the National Collaborative Research Infrastructure Strategy; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by US National Science Foundation Awards 0839031 (J.P.S.), 0838936 (E.B.) and 1245659 (V.V.P.), the National Oceanic and Atmospheric Administration Climate and Global Change Postdoctoral Fellowship (C.B.), the Packard Fellowship for Science and Engineering (V.V.P.), the Marsden Fund Council from New Zealand Government funding administered by the Royal Society of New Zealand (H.S.) and the ANSTO Isotopes in Climate Change and Atmospheric Systems project (A.M.S.). Further support came from NIWA under Climate and Atmosphere Research Programme CAAC1504 (2014/15 SCI). We acknowledge the financial support from the Australian Government for the Centre for Accelerator Science at ANSTO through the National Collaborative Research Infrastructure Strategy. We thank the US Antarctic Program for field support, US Ice Drilling and Development Office for ice drilling support, R. Beaudette for logistical assistance, the Institut Polaire Francais Paul-Emile Victor for supporting X.F.'s field participation, J. Shakun for providing deglacial ice volume and temperature data, and M. Dyonisius, H. Graven, J. Miller, E. Dlugokencky, L. Murray, T. Weber, B. Hmiel and S. Schwietzke for comments.	Anthony KMW, 2012, NAT GEOSCI, V5, P419, DOI [10.1038/ngeo1480, 10.1038/NGEO1480]; Archer D, 2009, P NATL ACAD SCI USA, V106, P20596, DOI 10.1073/pnas.0800885105; Buizert C, 2015, CLIM PAST, V11, P153, DOI 10.5194/cp-11-153-2015; Buizert C, 2014, P NATL ACAD SCI USA, V111, P6876, DOI 10.1073/pnas.1320329111; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Etiope G, 2008, GLOBAL PLANET CHANGE, V61, P79, DOI 10.1016/j.gloplacha.2007.08.008; Etiope G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033623; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Kennett JP, 2003, METHANE HYDRATES QUA; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Lassey KR, 2007, ATMOS CHEM PHYS, V7, P2141, DOI 10.5194/acp-7-2141-2007; Luyendyk B, 2005, MAR PETROL GEOL, V22, P591, DOI 10.1016/j.marpetgeo.2004.08.005; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Moller L, 2013, NAT GEOSCI, V6, P885, DOI [10.1038/ngeo1922, 10.1038/NGEO1922]; O'Connor FM, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000326; Petrenko VV, 2016, GEOCHIM COSMOCHIM AC, V177, P62, DOI 10.1016/j.gca.2016.01.004; Petrenko VV, 2013, EARTH PLANET SC LETT, V365, P190, DOI 10.1016/j.epsl.2013.01.032; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Schaefer H, 2006, SCIENCE, V313, P1109, DOI 10.1126/science.1126562; Schaefer H, 2016, SCIENCE, V352, P80, DOI 10.1126/science.aad2705; Schilt A, 2010, EARTH PLANET SC LETT, V300, P33, DOI 10.1016/j.epsl.2010.09.027; Schwietzke S, 2016, NATURE, V538, P88, DOI 10.1038/nature19797; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Wadham JL, 2012, NATURE, V488, P633, DOI 10.1038/nature11374; WAHLEN M, 1989, SCIENCE, V245, P286, DOI 10.1126/science.245.4915.286; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Walter KM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000569; Walter KM, 2007, PHILOS T R SOC A, V365, P1657, DOI 10.1098/rsta.2007.2036; Weitemeyer KA, 2006, GLOBAL PLANET CHANGE, V53, P176, DOI 10.1016/j.gloplacha.2006.03.014; Winckler G., 2002, GEOPHYS RES LETT, V29, P4	33	57	57	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					443	446		10.1038/nature23316	http://dx.doi.org/10.1038/nature23316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28836593	Green Published			2022-12-28	WOS:000408279000036
J	Byrne, RA; Stone, GW; Ormiston, J; Kastrati, A				Byrne, Robert A.; Stone, Gregg W.; Ormiston, John; Kastrati, Adnan			Coronary balloon angioplasty, stents, and scaffolds	LANCET			English	Article							EVEROLIMUS-ELUTING STENTS; BARE-METAL STENTS; DEDICATED BIFURCATION STENT; RESULTS TEST EFFICACY; LONG-TERM EFFICACY; 5-YEAR FOLLOW-UP; DURABLE-POLYMER; BIODEGRADABLE-POLYMER; ARTERY-DISEASE; RANDOMIZED-TRIAL	Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary intervention has become one of the most common medical procedures worldwide. Much of this progress has been due to the iteration and improvement of angioplasty technologies. Balloon angioplasty was limited by unpredictable procedural outcomes due to vessel dissection and recoil, and a high rate of restenosis. The introduction of stents resulted in more stable early results and lower rates of restenosis, although early stent thrombosis and neointimal hyperplasia causing vessel renarrowing were key limitations. Drug-eluting stents delivering antiproliferative agents significantly lowered the rates of restenosis, permitting widespread use of percutaneous coronary intervention in more advanced and complex disease. Although fully bioresorbable scaffolds have the potential to further improve long-term outcomes, they have not yet achieved results equivalent to those of conventional metallic drug-eluting stents in the early years after implantation. Progress in catheter technology did not occur in isolation, and the success of percutaneous coronary intervention is also due to important advances in intracoronary imaging, and adjunct pharmacotherapy-each of which is reviewed in other papers in this Series.	[Byrne, Robert A.; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Byrne, Robert A.; Kastrati, Adnan] German Ctr Cardiovasc Res, Munich, Germany; [Stone, Gregg W.] New York Presbyterian Hosp, New York, NY USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Ormiston, John] Mercy Angiog, Auckland, New Zealand	German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; NewYork-Presbyterian Hospital; Columbia University; Cardiovascular Research Foundation (CRF)	Byrne, RA (corresponding author), Deutsch Herzzentrum Munich, D-80636 Munich, Germany.	byrne@dhm.mhn.de	, Kastrati/Y-2389-2019; Byrne, Robert/C-3902-2016	Byrne, Robert/0000-0001-5224-6393	B Braun Melsungen AG; Biotronik; Boston Scientific; St Jude; Toray; Matrizyme; Ablative Solutions; Claret; Sirtex; V-wave; Vascular Dynamics; Miracor; Neovasc; Medical Development Technologies; BackBeat Medical; Valfix; TherOx; Reva	B Braun Melsungen AG; Biotronik; Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Toray(Toray Industries, Inc.); Matrizyme; Ablative Solutions; Claret; Sirtex; V-wave; Vascular Dynamics; Miracor; Neovasc; Medical Development Technologies; BackBeat Medical; Valfix; TherOx; Reva	RAB reports lecture fees from B Braun Melsungen AG, Biotronik, and Boston Scientific and research grants to the institution from Boston Scientific, and Heartflow. GWS reports personal fees from St Jude, Toray, Matrizyme, Ablative Solutions, Claret, Sirtex, V-wave, Vascular Dynamics, Miracor, Neovasc, Medical Development Technologies, BackBeat Medical, Valfix, TherOx, and Reva; equity in Qool Therapeutics, Caliber, Aria, Biostar family of funds, MedFocus family of funds, Guided Delivery Systems, Micardia, and Cagent; and royalties to his employer, Columbia University, from Abbott Vascular for the sale of the MitraClip. JO reports being a member of an advisory board and honoraria from Boston Scientific, and honoraria from Abbott Vascular. AK has a patent (EP1402849, stent with rough surface) licensed to Translumina Therapeutics LLP and B Braun Melsungen AG, a patent (EP2073856, coated implant) licensed to Translumina Therapeutics LLP, and a patent (EP1933893, implant with multiple coating) licensed to B Braun Melsungen AG.	Abizaid A, 2016, JACC-CARDIOVASC INTE, V9, P565, DOI 10.1016/j.jcin.2015.12.004; Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054; Alfonso F, 2015, J AM COLL CARDIOL, V66, P23, DOI 10.1016/j.jacc.2015.04.063; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 2015, CATHETER CARDIOVASC, V86, P400; Bonaa KH, 2016, NEW ENGL J MED, V375, P1242, DOI 10.1056/NEJMoa1607991; BONZEL T, 1986, BIOMED TECH, V31, P195, DOI 10.1515/bmte.1986.31.9.195; Byrne RA, 2015, EUR HEART J, V36, P2608, DOI 10.1093/eurheartj/ehv203; Byrne RA, 2014, NAT REV CARDIOL, V11, P13, DOI 10.1038/nrcardio.2013.165; Byrne RA, 2013, LANCET, V381, P461, DOI 10.1016/S0140-6736(12)61964-3; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Cassese S, 2018, EUROINTERVENTION, V13, P1565, DOI 10.4244/EIJ-D-17-00492; Cassese S, 2016, LANCET, V387, P537, DOI 10.1016/S0140-6736(15)00979-4; Cuisset T, 2017, LANCET, V390, P810, DOI 10.1016/S0140-6736(17)31936-0; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; DORROS G, 1983, CIRCULATION, V67, P723, DOI 10.1161/01.CIR.67.4.723; Ellis S., 2017, AM COLL CARD 2017 SC; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gao R., 2017, EUROPCR 2017; Garot P, 2017, J AM COLL CARDIOL, V69, P162, DOI 10.1016/j.jacc.2016.10.009; Genereux P, 2016, JACC-CARDIOVASC INTE, V9, P1338, DOI 10.1016/j.jcin.2016.03.042; Genereux P, 2015, J AM COLL CARDIOL, V65, P533, DOI 10.1016/j.jacc.2014.11.031; Giacoppo D, JAMA CARDIO IN PRESS; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; Haude M, 2016, LANCET, V387, P31, DOI 10.1016/S0140-6736(15)00447-X; Iqbal J, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002230; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kastrati A, 2001, CIRCULATION, V103, P2816; Kereiakes DJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002372; Kozuma K., 2017, EUROPCR 2017; Kufner S, 2017, JACC-CARDIOVASC INTE, V10, P1332, DOI 10.1016/j.jcin.2017.04.024; Kufner S, 2016, JACC-CARDIOVASC INTE, V9, P784, DOI 10.1016/j.jcin.2016.01.009; Kufner S, 2016, EUROINTERVENTION, V11, P1372, DOI 10.4244/EIJY14M11_02; Kufner S, 2015, JACC-CARDIOVASC INTE, V8, P877, DOI 10.1016/j.jcin.2015.01.031; Levin AD, 2004, P NATL ACAD SCI USA, V101, P9463, DOI 10.1073/pnas.0400918101; Massberg S, 2011, CIRCULATION, V124, P624, DOI 10.1161/CIRCULATIONAHA.111.026732; Mauri L, 2002, AM J CARDIOL, V90, P1079, DOI 10.1016/S0002-9149(02)02773-X; Mehilli J, 2008, EUR HEART J, V29, P1975, DOI 10.1093/eurheartj/ehn253; Meier B, 2017, EUROINTERVENTION, V13, P15, DOI 10.4244/EIJV13I1A2; Meredith IT, 2014, AM J CARDIOL, V113, P1117, DOI 10.1016/j.amjcard.2013.12.011; Mintz GS, 2017, LANCET, V390, P793, DOI 10.1016/S0140-6736(17)31957-8; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Natsuaki M, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002817; Otsuka F, 2015, EUR HEART J, V36, P2147, DOI 10.1093/eurheartj/ehv205; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Park KW, 2014, J AM COLL CARDIOL, V63, P2805, DOI 10.1016/j.jacc.2014.04.013; Puricel S., 2015, TANSCATHETER CARDIOV; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019; Raungaard B, 2017, JACC-CARDIOVASC INTE, V10, P255, DOI 10.1016/j.jcin.2016.11.007; Sabate M, 2016, LANCET, V387, P357, DOI 10.1016/S0140-6736(15)00548-6; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Scheller B, 2016, CATHETER CARDIO INTE, V88, P51, DOI 10.1002/ccd.26216; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Sen H, 2015, JACC-CARDIOVASC INTE, V8, P889, DOI 10.1016/j.jcin.2015.01.033; Serruys P., 1988, J AM HEART ASSOC, V77, P361; Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5; Serruys PW, 2016, J AM COLL CARDIOL, V67, P766, DOI 10.1016/j.jacc.2015.11.060; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; SIMPSON JB, 1982, AM J CARDIOL, V49, P1216, DOI 10.1016/0002-9149(82)90047-9; Siontis GCM, 2015, LANCET, V386, P655, DOI 10.1016/S0140-6736(15)60657-2; Sotomi Y, 2017, EUROINTERVENTION, V12, P1747, DOI 10.4244/EIJ-D-16-00471; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Steigerwald K, 2009, BIOMATERIALS, V30, P632, DOI 10.1016/j.biomaterials.2008.10.005; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2016, LANCET, V387, P1277, DOI 10.1016/S0140-6736(15)01039-9; Stone GW, 2012, J AM COLL CARDIOL, V60, P1975, DOI 10.1016/j.jacc.2012.09.004; Stone GW, 2011, JACC-CARDIOVASC INTE, V4, P300, DOI 10.1016/j.jcin.2010.11.013; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Vlachojannis GJ, 2017, JACC-CARDIOVASC INTE, V10, P1215, DOI 10.1016/j.jcin.2017.02.029; von Birgelen C, 2016, LANCET, V388, P2607, DOI 10.1016/S0140-6736(16)31920-1; von Birgelen C, 2014, LANCET, V383, P413, DOI 10.1016/S0140-6736(13)62037-1; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Windecker S., 2016, TANSCATHETER CARDIOV; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Wohrle J, 2012, J AM COLL CARDIOL, V60, P1733, DOI 10.1016/j.jacc.2012.07.040; Worthley SG, 2017, JACC-CARDIOVASC INTE, V10, P147, DOI 10.1016/j.jcin.2016.10.020; Wykrzykowska JJ, 2017, NEW ENGL J MED, V376, P2319, DOI 10.1056/NEJMoa1614954; Yamaji K, 2010, CIRC-CARDIOVASC INTE, V3, P468, DOI 10.1161/CIRCINTERVENTIONS.110.958249; Zbinden R, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003255	88	125	128	6	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					781	792		10.1016/S0140-6736(17)31927-X	http://dx.doi.org/10.1016/S0140-6736(17)31927-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28831994				2022-12-28	WOS:000407858900022
J	Antonia, SJ; Villegas, A; Daniel, D; Vicente, D; Murakami, S; Hui, R; Yokoi, T; Chiappori, A; Lee, KH; de Wit, M; Cho, BC; Bourhaba, M; Quantin, X; Tokito, T; Mekhail, T; Planchard, D; Kim, YC; Karapetis, CS; Hiret, S; Ostoros, G; Kubota, K; Gray, JE; Paz-Ares, L; Carpeno, JD; Wadsworth, C; Melillo, G; Jiang, H; Huang, Y; Dennis, PA; Ozguroglu, M				Antonia, S. J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Yokoi, T.; Chiappori, A.; Lee, K. H.; de Wit, M.; Cho, B. C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y. -C.; Karapetis, C. S.; Hiret, S.; Ostoros, G.; Kubota, K.; Gray, J. E.; Paz-Ares, L.; de Castro Carpeno, J.; Wadsworth, C.; Melillo, G.; Jiang, H.; Huang, Y.; Dennis, P. A.; Ozguroglu, M.		PACIFIC Investigators	Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED PHASE-III; CONCURRENT CHEMORADIOTHERAPY; CONSOLIDATION CHEMOTHERAPY; DOCETAXEL; TRIAL; RADIOTHERAPY; CARBOPLATIN; COMBINATION; TECEMOTIDE; PACLITAXEL	BACKGROUND Most patients with locally advanced, unresectable, non-small-cell lung cancer (NSCLC) have disease progression despite definitive chemoradiotherapy (chemotherapy plus concurrent radiation therapy). This phase 3 study compared the anti-programmed death ligand 1 antibody durvalumab as consolidation therapy with placebo in patients with stage III NSCLC who did not have disease progression after two or more cycles of platinum-based chemoradiotherapy. METHODS We randomly assigned patients, in a 2: 1 ratio, to receive durvalumab (at a dose of 10 mg per kilogram of body weight intravenously) or placebo every 2 weeks for up to 12 months. The study drug was administered 1 to 42 days after the patients had received chemoradiotherapy. The coprimary end points were progression-free survival (as assessed by means of blinded independent central review) and overall survival (unplanned for the interim analysis). Secondary end points included 12-month and 18-month progression-free survival rates, the objective response rate, the duration of response, the time to death or distant metastasis, and safety. RESULTS Of 713 patients who underwent randomization, 709 received consolidation therapy (473 received durvalumab and 236 received placebo). The median progression-free survival from randomization was 16.8 months (95% confidence interval [CI], 13.0 to 18.1) with durvalumab versus 5.6 months (95% CI, 4.6 to 7.8) with placebo (stratified hazard ratio for disease progression or death, 0.52; 95% CI, 0.42 to 0.65; P<0.001); the 12-month progression-free survival rate was 55.9% versus 35.3%, and the 18-month progression-free survival rate was 44.2% versus 27.0%. The response rate was higher with durvalumab than with placebo (28.4% vs. 16.0%; P<0.001), and the median duration of response was longer (72.8% vs. 46.8% of the patients had an ongoing response at 18 months). The median time to death or distant metastasis was longer with durvalumab than with placebo (23.2 months vs. 14.6 months; P<0.001). Grade 3 or 4 adverse events occurred in 29.9% of the patients who received durvalumab and 26.1% of those who received placebo; the most common adverse event of grade 3 or 4 was pneumonia (4.4% and 3.8%, respectively). A total of 15.4% of patients in the durvalumab group and 9.8% of those in the placebo group discontinued the study drug because of adverse events. CONCLUSIONS Progression-free survival was significantly longer with durvalumab than with placebo. The secondary end points also favored durvalumab, and safety was similar between the groups.	[Antonia, S. J.; Chiappori, A.; Gray, J. E.] H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,MRC 3-E, Tampa, FL 33612 USA; [Villegas, A.] Canc Specialists North Florida, Jacksonville, FL USA; [Mekhail, T.] Florida Hosp, Inst Canc, Orlando, FL USA; [Daniel, D.] Tennessee Oncol, Chattanooga, TN USA; [Daniel, D.] Sarah Cannon Res Inst, Nashville, TN USA; [Vicente, D.] Hosp Univ Virgen Macarena, Seville, Spain; [Paz-Ares, L.] Univ Complutense, Hosp Univ Octubre 12, Ctr Invest Biomed Red Canc, Madrid, Spain; [Paz-Ares, L.] Spanish Natl Canc Res Ctr, Madrid, Spain; [de Castro Carpeno, J.] Hosp Univ La Paz, Madrid, Spain; [Murakami, S.] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan; [Yokoi, T.] Kansai Med Univ Hosp, Hirakata, Osaka, Japan; [Tokito, T.] Kurume Univ Hosp, Kurume, Fukuoka, Japan; [Kubota, K.] Nippon Med Coll Hosp, Tokyo, Japan; [Hui, R.] Westmead Hosp, Sydney, NSW, Australia; [Hui, R.] Univ Sydney, Sydney, NSW, Australia; [Karapetis, C. S.] Flinders Univ S Australia, Bedford Pk, SA, Australia; [Karapetis, C. S.] Flinders Med Ctr, Bedford Pk, SA, Australia; [Lee, K. H.] Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Cheongju, South Africa; [Cho, B. C.] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Kim, Y. -C.] Chonnam Natl Univ, Med Sch, Hwasun Hosp, Gwangju, South Korea; [de Wit, M.] Vivantes Klinikum Neukolln, Berlin, Germany; [Bourhaba, M.] Ctr Hosp Univ Liege, Liege, Belgium; [Quantin, X.] CHU Montpellier, Montpellier, France; [Quantin, X.] Canc Inst Montpellier Val Aurelle, Montpellier, France; [Planchard, D.] Inst Gustave Roussy, Villejuif, France; [Hiret, S.] Inst Cancerol Ouest, Site Rene Gauducheau, St Herblain, France; [Ostoros, G.] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Wadsworth, C.] AstraZeneca, Alderley Pk, England; [Melillo, G.; Jiang, H.; Huang, Y.; Dennis, P. A.] AstraZeneca, Gaithersburg, MD USA; [Ozguroglu, M.] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey	H Lee Moffitt Cancer Center & Research Institute; Adventist Health Services; AdventHealth; Tennessee Oncology; Sarah Cannon Research Institute; Hospital Universitario Virgen Macarena; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario La Paz; Kanagawa Prefectural Cancer Center; Kansai Medical University; Kurume University; Nippon Medical School; University of Sydney; University of Sydney; Flinders University South Australia; Flinders Medical Centre; Chungbuk National University; Chungbuk National University Hospital; Yonsei University; Yonsei University Health System; Chonnam National University; VIivantes Klinikum Neukolln; University of Liege; Universite de Montpellier; CHU de Montpellier; UNICANCER; Gustave Roussy; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); AstraZeneca; Istanbul University; Istanbul University - Cerrahpasa	Antonia, SJ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,MRC 3-E, Tampa, FL 33612 USA.	scott.antonia@moffitt.org	Hui, Rina/L-6114-2019; Cortot, Alexis B/F-7006-2019; bearz, alessandra/ABE-2497-2020; van den Heuvel, Michel M/D-9491-2017; MUSTAFA, ÖZGÜROĞLU/A-8234-2016; Paz-Ares, Luis/AAH-2750-2019	Cortot, Alexis B/0000-0003-0098-2238; bearz, alessandra/0000-0003-1020-2338; van den Heuvel, Michel M/0000-0002-6372-2153; MUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628; Cho, Byoung Chul/0000-0002-5562-270X; De Castro, Javier/0000-0002-3622-6306; Gomez, Jorge/0000-0001-6859-363X; ALVAREZ, ROSA/0000-0003-0935-8298; Faivre-Finn, Corinne/0000-0001-5617-9781; Mandziuk, Slawomir/0000-0002-9812-0777; Kowalski, Dariusz/0000-0002-9452-3229; Blasco Cordellat, Ana/0000-0001-5889-0382; Juan, Oscar/0000-0002-7772-9030; Belda Iniesta, Cristobal/0000-0003-3254-7492; O'Byrne, Kenneth/0000-0002-6754-5633; SOTO PARRA, HECTOR/0000-0001-7966-4472; Haigentz, Missak/0000-0002-3610-2266; Karapetis, Christos/0000-0003-1741-996X; Lee, Ki Hyeong/0000-0002-7830-5950	AstraZeneca; Cancer Research UK [20465] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by AstraZeneca; PACIFIC ClinicalTrials.gov number, NCT02125461.	Ahn JS, 2015, J CLIN ONCOL, V33, P2660, DOI 10.1200/JCO.2014.60.0130; Antonia SJ, 41 EUR SOC MED ONC A; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Butts C, 2014, LANCET ONCOL, V15, P59, DOI 10.1016/S1470-2045(13)70510-2; Deng LF, 2014, J CLIN INVEST, V124, P687, DOI 10.1172/JCI67313; Dovedi SJ, 2014, CANCER RES, V74, P5458, DOI 10.1158/0008-5472.CAN-14-1258; Ettinger DS, 2017, J NATL COMPR CANC NE, V15, P504, DOI 10.6004/jnccn.2017.0050; Gandara David R, 2003, J Clin Oncol, V21, P2004, DOI 10.1200/JCO.2003.04.197; Goldstraw P, 2010, STAGING MANUAL THORA; Hanna N, 2008, J CLIN ONCOL, V26, P5755, DOI 10.1200/JCO.2008.17.7840; Hoang T, 2012, J CLIN ONCOL, V30, P616, DOI 10.1200/JCO.2011.36.9116; Kelly K, 2008, J CLIN ONCOL, V26, P2450, DOI 10.1200/JCO.2007.14.4824; Mitchell P, 2015, ANN ONCOL, V26, P1134, DOI 10.1093/annonc/mdv104; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Stewart R, 2015, CANCER IMMUNOL RES, V3, P1052, DOI 10.1158/2326-6066.CIR-14-0191; Tsujino K, 2013, J THORAC ONCOL, V8, P1181, DOI 10.1097/JTO.0b013e3182988348; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Vokes EE, 2007, J CLIN ONCOL, V25, P1698, DOI 10.1200/JCO.2006.07.3569; Wozniak AJ, 2015, CLIN LUNG CANCER, V16, P340, DOI 10.1016/j.cllc.2014.12.014; Yoon SM, 2017, WORLD J CLIN ONCOL, V8, P1, DOI 10.5306/wjco.v8.i1.1; Zhang P, 2008, MOL IMMUNOL, V45, P1470, DOI 10.1016/j.molimm.2007.08.013	23	2255	2341	6	239	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2017	377	20					1919	1929		10.1056/NEJMoa1709937	http://dx.doi.org/10.1056/NEJMoa1709937			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM7CU	28885881	Green Submitted			2022-12-28	WOS:000415228800005
J	Huh, WK; Joura, EA; Giuliano, AR; Iversen, OE; de Andrade, RP; Ault, KA; Bartholomew, D; Cestero, RM; Fedrizzi, EN; Hirschberg, AL; Mayrand, MH; Ruiz-Sternberg, AM; Stapleton, JT; Wiley, DJ; Ferenczy, A; Kurman, R; Ronnett, BM; Stoler, MH; Cuzick, J; Garland, SM; Kjaer, SK; Bautista, OM; Haupt, R; Moeller, E; Ritter, M; Roberts, CC; Shields, C; Luxembourg, A				Huh, Warner K.; Joura, Elmar A.; Giuliano, Anna R.; Iversen, Ole-Erik; de Andrade, Rosires Pereira; Ault, Kevin A.; Bartholomew, Deborah; Cestero, Ramon M.; Fedrizzi, Edison N.; Hirschberg, Angelica L.; Mayrand, Marie-Helene; Ruiz-Sternberg, Angela Maria; Stapleton, Jack T.; Wiley, Dorothy J.; Ferenczy, Alex; Kurman, Robert; Ronnett, Brigitte M.; Stoler, Mark H.; Cuzick, Jack; Garland, Suzanne M.; Kjaer, Susanne K.; Bautista, Oliver M.; Haupt, Richard; Moeller, Erin; Ritter, Michael; Roberts, Christine C.; Shields, Christine; Luxembourg, Alain			Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial	LANCET			English	Article							GENOTYPE ATTRIBUTION; PARTICLE VACCINE; INFECTION; IMPACT	Background Primary analyses of a study in young women aged 1626 years showed efficacy of the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58) vaccine against infections and disease related to HPV 31, 33, 45, 52, and 58, and non-inferior HPV 6, 11, 16, and 18 antibody responses when compared with quadrivalent HPV (qHPV; HPV 6, 11, 16, and 18) vaccine. We aimed to report efficacy of the 9vHPV vaccine for up to 6 years following first administration and antibody responses over 5 years. Methods We undertook this randomised, double-blind, efficacy, immunogenicity, and safety study of the 9vHPV vaccine study at 105 study sites in 18 countries. Women aged 1626 years old who were healthy, with no history of abnormal cervical cytology, no previous abnormal cervical biopsy results, and no more than four lifetime sexual partners were randomly assigned (1:1) by central randomisation and block sizes of 2 and 2 to receive three intramuscular injections over 6 months of 9vHPV or qHPV (control) vaccine. All participants, study investigators, and study site personnel, laboratory staff, members of the sponsor's study team, and members of the adjudication pathology panel were masked to vaccination groups. The primary outcomes were incidence of high-grade cervical disease (cervical intraepithelial neoplasia grade 2 or 3, adenocarcinoma in situ, invasive cervical carcinoma), vulvar disease (vulvar intraepithelial neoplasia grade 2/3, vulvar cancer), and vaginal disease (vaginal intraepithelial neoplasia grade 2/3, vaginal cancer) related to HPV 31, 33, 45, 52, and 58 and non-inferiority (excluding a decrease of 15 times) of anti-HPV 6, 11, 16, and 18 geometric mean titres (GMT). Tissue samples were adjudicated for histopathology diagnosis and tested for HPV DNA. Serum antibody responses were assessed by competitive Luminex immunoassay. The primary evaluation of efficacy was a superiority analysis in the per-protocol efficacy population, supportive efficacy was analysed in the modified intention-to-treat population, and the primary evaluation of immunogenicity was a non-inferiority analysis. The trial is registered with ClinicalTrials.gov, number NCT00543543. Findings Between Sept 26, 2007, and Dec 18, 2009, we recruited and randomly assigned 14 215 participants to receive 9vHPV (n=7106) or qHPV (n=7109) vaccine. In the per-protocol population, the incidence of high-grade cervical, vulvar and vaginal disease related to HPV 31, 33, 45, 52, and 58 was 05 cases per 10 000 person-years in the 9vHPV and 190 cases per 10 000 person-years in the qHPV groups, representing 974% efficacy (95% CI 850999). HPV 6, 11, 16, and 18 GMTs were non-inferior in the 9vHPV versus qHPV group from month 1 to 3 years after vaccination. No clinically meaningful differences in serious adverse events were noted between the study groups. 11 participants died during the study follow-up period (six in the 9vHPV vaccine group and five in the qHPV vaccine group); none of the deaths were considered vaccine-related. Interpretation The 9vHPV vaccine prevents infection, cytological abnormalities, high-grade lesions, and cervical procedures related to HPV 31, 33, 45, 52, and 58. Both the 9vHPV vaccine and qHPV vaccine had a similar immunogenicity profile with respect to HPV 6, 11, 16, and 18. Vaccine efficacy was sustained for up to 6 years. The 9vHPV vaccine could potentially provide broader coverage and prevent 90% of cervical cancer cases worldwide.	[Huh, Warner K.] Univ Alabama Birmingham, Div Gynecol Oncol, Birmingham, AL 35294 USA; [Joura, Elmar A.] Med Univ Vienna, Ctr Comprehens Canc, Dept Gynecol, Vienna, Austria; [Giuliano, Anna R.] H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL USA; [Iversen, Ole-Erik] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Iversen, Ole-Erik] Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway; [de Andrade, Rosires Pereira] Univ Fed Parana, CERHFAC, Dept Tocoginecol, Setor Ciencias Saude, Curitiba, Parana, Brazil; [Ault, Kevin A.] Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Kansas City, KS 66103 USA; [Bartholomew, Deborah] Ohio State Univ, Dept Obstet & Gynecol, Wexner Med Ctr, Columbus, OH 43210 USA; [Cestero, Ramon M.] Univ Calif Irvine, Sch Med, UC Irvine Hlth, Dept Obstet & Gynecol, Orange, CA 92668 USA; [Fedrizzi, Edison N.] Univ Fed Santa Catarina, Dept Obstet & Gynecol, Florianopolis, SC, Brazil; [Hirschberg, Angelica L.] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Hirschberg, Angelica L.] Dept Womens & Childrens Hlth, Stockholm, Sweden; [Mayrand, Marie-Helene] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Mayrand, Marie-Helene] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Ruiz-Sternberg, Angela Maria] Univ Rosario, Clin Res Grp, Bogota, Colombia; [Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Stapleton, Jack T.] Iowa City VA Med Ctr, Iowa City, IA USA; [Wiley, Dorothy J.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Ferenczy, Alex] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Kurman, Robert] Johns Hopkins Sch Med, Dept Gynecol & Obstet, Baltimore, MD USA; [Ronnett, Brigitte M.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Stoler, Mark H.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Cuzick, Jack] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England; [Garland, Suzanne M.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Womens Hosp, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Kjaer, Susanne K.] Univ Copenhagen, Danish Canc Soc, Unit Virus Lifestyle & Genes, Copenhagen, Denmark; [Kjaer, Susanne K.] Univ Copenhagen, Rigshosp, Dept Gynecol, Copenhagen, Denmark; [Bautista, Oliver M.; Haupt, Richard; Moeller, Erin; Ritter, Michael; Roberts, Christine C.; Shields, Christine; Luxembourg, Alain] Merck & Co Inc, Kenilworth, NJ USA	University of Alabama System; University of Alabama Birmingham; Medical University of Vienna; H Lee Moffitt Cancer Center & Research Institute; University of Bergen; University of Bergen; Haukeland University Hospital; Universidade Federal do Parana; University of Kansas; University of Kansas Medical Center; University System of Ohio; Ohio State University; University of California System; University of California Irvine; Universidade Federal de Santa Catarina (UFSC); Karolinska Institutet; Karolinska University Hospital; Universite de Montreal; Universite de Montreal; Universidad del Rosario; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of California System; University of California Los Angeles; McGill University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Virginia; University of London; Queen Mary University London; Murdoch Children's Research Institute; University of Melbourne; Danish Cancer Society; University of Copenhagen; Rigshospitalet; University of Copenhagen; Merck & Company	Huh, WK (corresponding author), Univ Alabama Birmingham, Div Gynecol Oncol, Birmingham, AL 35294 USA.	whuh@uabmc.edu	Hirschberg, Angelica/AAK-6693-2020; Mayrand, Marie-Hélène/ABB-7029-2020; Ruiz-Sternberg, Angela Maria/J-1073-2016	Roberts, Christine/0000-0003-4359-7946; Wiley, Dorothy/0000-0002-9416-473X; Ruiz-Sternberg, Angela Maria/0000-0002-4651-4635; Stapleton, Jack/0000-0002-2302-9055	Merck Co, Inc.; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; Cancer Research UK [16891] Funding Source: researchfish	Merck Co, Inc.(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	Merck & Co, Inc.	Alemany L, 2015, INT J CANCER, V136, P98, DOI 10.1002/ijc.28963; Ault KA, 2011, INT J CANCER, V128, P1344, DOI 10.1002/ijc.25723; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Brown D, 2014, VACCINE, V32, P5880, DOI 10.1016/j.vaccine.2014.08.004; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Chen YHJ, 2015, CLIN TRIALS, V12, P84, DOI 10.1177/1740774514552110; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Else EA, 2011, J CLIN MICROBIOL, V49, P1907, DOI 10.1128/JCM.00236-10; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Joura EA, 2014, CANCER EPIDEM BIOMAR, V23, P1997, DOI 10.1158/1055-9965.EPI-14-0410; Kjaer SK, 2015, LONG TERM EFFECTIVEN; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Luxembourg A, 2015, HUM VACC IMMUNOTHER, V11, P1313, DOI 10.1080/21645515.2015.1012010; Luxembourg A, 2015, CONTEMP CLIN TRIALS, V42, P18, DOI 10.1016/j.cct.2015.02.009; Majewski S, 2009, J EUR ACAD DERMATOL, V23, P1147, DOI 10.1111/j.1468-3083.2009.03266.x; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Moreira ED, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4387; Perez G, 2008, INT J CANCER, V122, P1311, DOI 10.1002/ijc.23260; Roberts C, 2014, HUM VACC IMMUNOTHER, V10, P2168, DOI 10.4161/hv.29205; Roberts CC, 2011, J CLIN MICROBIOL, V49, P1899, DOI 10.1128/JCM.00235-10; Safaeian M, 2009, CANCER RES, V69, P3262, DOI 10.1158/0008-5472.CAN-08-4192; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Serrano B, 2015, EUR J CANCER, V51, P1732, DOI 10.1016/j.ejca.2015.06.001; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Tay EH, 2008, INT J GYNECOL OBSTET, V102, P275, DOI 10.1016/j.ijgo.2008.03.021	30	215	230	8	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2017	390	10108					2143	2159		10.1016/S0140-6736(17)31821-4	http://dx.doi.org/10.1016/S0140-6736(17)31821-4			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN0CL	28886907	Green Submitted			2022-12-28	WOS:000415642200020
J	Bauerlein, FJB; Saha, I; Mishra, A; Kalemanov, M; Martinez-Sanchez, A; Klein, R; Dudanova, I; Hipp, MS; Hartl, FU; Baumeister, W; Fernandez-Busnadiego, R				Baeuerlein, Felix J. B.; Saha, Itika; Mishra, Archana; Kalemanov, Maria; Martinez-Sanchez, Antonio; Klein, Ruediger; Dudanova, Irina; Hipp, Mark S.; Hartl, F. Ulrich; Baumeister, Wolfgang; Fernandez-Busnadiego, Ruben			In Situ Architecture and Cellular Interactions of PolyQ Inclusions	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTIN EXON-1 FIBRILS; MUTANT HUNTINGTIN; ER STRESS; AMYLOID FIBRILS; TRINUCLEOTIDE REPEAT; PROTEIN AGGREGATION; ELECTRON TOMOGRAPHY; TRANSGENIC MICE	Expression of many disease-related aggregationprone proteins results in cytotoxicity and the formation of large intracellular inclusion bodies. To gain insight into the role of inclusions in pathology and the in situ structure of protein aggregates inside cells, we employ advanced cryo-electron tomography methods to analyze the structure of inclusions formed by polyglutamine (polyQ)-expanded huntingtin exon 1 within their intact cellular context. In primary mouse neurons and immortalized human cells, polyQ inclusions consist of amyloid-like fibrils that interact with cellular endomembranes, particularly of the endoplasmic reticulum (ER). Interactions with these fibrils lead to membrane deformation, the local impairment of ER organization, and profound alterations in ER membrane dynamics at the inclusion periphery. These results suggest that aberrant interactions between fibrils and endomembranes contribute to the deleterious cellular effects of protein aggregation.	[Baeuerlein, Felix J. B.; Kalemanov, Maria; Martinez-Sanchez, Antonio; Baumeister, Wolfgang; Fernandez-Busnadiego, Ruben] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Saha, Itika; Hipp, Mark S.; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Mishra, Archana; Klein, Ruediger; Dudanova, Irina] Max Planck Inst Biochem, Dept Mol Signaling & Dev, D-82152 Martinsried, Germany; [Kalemanov, Maria] Grad Sch Quantitat Biosci Munich, D-81337 Munich, Germany; [Klein, Ruediger; Hipp, Mark S.; Hartl, F. Ulrich] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Munich	Baumeister, W (corresponding author), Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany.; Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.; Hartl, FU (corresponding author), Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany.	uhartl@biochem.mpg.de; baumeist@biochem.mpg.de	Hipp, Mark/AAA-4238-2022; Hartl, F. Ulrich/Y-8206-2019; Bäuerlein, Felix JB/B-9909-2012; Dudanova, Irina/AAA-4725-2021; Martinez-Sanchez, Antonio/A-6968-2019; Klein, Ruediger/C-6147-2008	Bäuerlein, Felix JB/0000-0002-8889-7371; Dudanova, Irina/0000-0003-1052-8485; Martinez-Sanchez, Antonio/0000-0002-5865-2138; Klein, Ruediger/0000-0002-3109-0163; Salfer, Maria/0000-0002-7604-6617; Hipp, Mark/0000-0002-0497-3016; Fernandez-Busnadiego, Ruben/0000-0002-8366-7622	European Commission [FP7 GA ERC-2012-SyG_318987-ToPAG]; Munich Cluster for Systems Neurology [EXC 010 SyNergy]; Graduate School of Quantitative Biosciences Munich [GSC-1006]	European Commission(European CommissionEuropean Commission Joint Research Centre); Munich Cluster for Systems Neurology; Graduate School of Quantitative Biosciences Munich	This research has received funding from the European Commission (FP7 GA ERC-2012-SyG_318987-ToPAG) and the Munich Cluster for Systems Neurology (EXC 010 SyNergy). M.K. was supported by the Graduate School of Quantitative Biosciences Munich (GSC-1006). We thank Radostin Danev, Gunter Pfeifer, and Jurgen Plitzko for electron microscopy support; Tom Gaitanos and Tim Laugks for assistance with light microscopy; Stefan Pfeffer for advice in data analysis; and EriSakata for discussions and critically reading the manuscript.	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Burke KA, 2013, BBA-BIOMEMBRANES, V1828, P1953, DOI 10.1016/j.bbamem.2013.04.025; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Deo N., 2016, GRAPH THEORY APPL EN, V1st; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fukuda Y, 2015, J STRUCT BIOL, V190, P143, DOI 10.1016/j.jsb.2015.03.004; Gu XF, 2015, NEURON, V85, P726, DOI 10.1016/j.neuron.2015.01.008; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Higo T, 2010, NEURON, V68, P865, DOI 10.1016/j.neuron.2010.11.010; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hoop CL, 2016, P NATL ACAD SCI USA, V113, P1546, DOI 10.1073/pnas.1521933113; Hrabe T, 2012, J STRUCT BIOL, V178, P177, DOI 10.1016/j.jsb.2011.12.003; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Jiang YW, 2016, BRAIN RES, V1648, P650, DOI 10.1016/j.brainres.2016.03.034; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kegel-Gleason KB, 2013, J HUNTINGTONS DIS, V2, P239, DOI 10.3233/JHD-130068; Kirstein J, 2015, EMBO J, V34, P2334, DOI 10.15252/embj.201591711; KOENDERINK JJ, 1992, IMAGE VISION COMPUT, V10, P557, DOI 10.1016/0262-8856(92)90076-F; Kouroku Y, 2002, HUM MOL GENET, V11, P1505, DOI 10.1093/hmg/11.13.1505; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lajoie P, 2011, J CELL SCI, V124, P3332, DOI 10.1242/jcs.087510; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Leitman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090803; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Leitman J, 2013, DNA CELL BIOL, V32, P2, DOI 10.1089/dna.2012.1889; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin HK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15462; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; NAGASHIMA H, 1980, J MOL BIOL, V136, P169, DOI 10.1016/0022-2836(80)90311-3; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Page DL, 2002, GRAPH MODELS, V64, P199, DOI 10.1006/gmod.2002.0574; Pfeffer S, 2012, STRUCTURE, V20, P1508, DOI 10.1016/j.str.2012.06.010; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Ramdzan YM, 2017, CELL REP, V19, P919, DOI 10.1016/j.celrep.2017.04.029; Rigort A, 2012, J STRUCT BIOL, V177, P135, DOI 10.1016/j.jsb.2011.08.012; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roux A, 2013, SOFT MATTER, V9, P6726, DOI 10.1039/c3sm50514f; Saibil HR, 2012, P NATL ACAD SCI USA, V109, P14906, DOI 10.1073/pnas.1211976109; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang H, 2016, TRENDS CELL BIOL, V26, P934, DOI 10.1016/j.tcb.2016.06.002	73	162	164	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					179	+		10.1016/j.cell.2017.08.009	http://dx.doi.org/10.1016/j.cell.2017.08.009			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28890085	Green Submitted, Bronze			2022-12-28	WOS:000411331800019
J	He, BB; Hu, B; Yen, HW; Cheng, GJ; Wang, ZK; Luo, HW; Huang, MX				He, B. B.; Hu, B.; Yen, H. W.; Cheng, G. J.; Wang, Z. K.; Luo, H. W.; Huang, M. X.			High dislocation density-induced large ductility in deformed and partitioned steels	SCIENCE			English	Article							INDUCED PLASTICITY STEEL; TENSILE PROPERTIES; MECHANICAL-PROPERTIES; RETAINED AUSTENITE; MULTIPHASE STEELS; MAXIMUM STRENGTH; LATH MARTENSITE; TRANSFORMATION; MICROSTRUCTURE; METALS	A wide variety of industrial applications require materials with high strength and ductility. Unfortunately, the strategies for increasing material strength, such as processing to create line defects (dislocations), tend to decrease ductility. We developed a strategy to circumvent this in inexpensive, medium manganese steel. Cold rolling followed by low-temperature tempering developed steel with metastable austenite grains embedded in a highly dislocated martensite matrix. This deformed and partitioned (D and P) process produced dislocation hardening but retained high ductility, both through the glide of intensive mobile dislocations and by allowing us to control martensitic transformation. The D and P strategy should apply to any other alloy with deformation-induced martensitic transformation and provides a pathway for the development of high-strength, high-ductility materials.	[He, B. B.; Huang, M. X.] Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Hu, B.; Luo, H. W.] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Xue Yuan Lu 30, Beijing 100083, Peoples R China; [Yen, H. W.; Cheng, G. J.] Natl Taiwan Univ, Dept Mat Sci & Engn, Roosevelt Rd, Taipei 10617, Taiwan; [Wang, Z. K.] City Univ Hong Kong, Dept Mech & Biomed Engn, Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Science & Technology Beijing; National Taiwan University; City University of Hong Kong	Huang, MX (corresponding author), Univ Hong Kong, Dept Mech Engn, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.; Luo, HW (corresponding author), Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Xue Yuan Lu 30, Beijing 100083, Peoples R China.	luohaiwen@ustb.edu.cn; mxhuang@hku.hk	Wang, Zuankai/D-1555-2009; Luo, Haiwe/A-7029-2015; Huang, M.X./F-3348-2010; Luo, Haiwen/O-4596-2019; He, Binbin/AAG-7609-2020; He, Binbin/H-6605-2018	Wang, Zuankai/0000-0002-3510-1122; Luo, Haiwe/0000-0001-7205-476X; Huang, M.X./0000-0002-8038-431X; Luo, Haiwen/0000-0001-7205-476X; He, Binbin/0000-0002-5362-0954; Yen, Hung-Wei/0000-0002-7885-938X	Research Grants Council of Hong Kong [712713, 17203014, 17255016]; National Natural Science Foundation of China [U1560204, U1460203]; Ministry of Science and Technology of the Republic of China [MOST-104-2218-E-002-022-MY3]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors thank K. Lu for his insightful and constructive comments on this paper. M.X.H. is grateful for financial support from the Research Grants Council of Hong Kong (grant nos. 712713, 17203014, and 17255016) and the National Natural Science Foundation of China (grant no. U1560204). H.W.L. is grateful for financial support from the National Natural Science Foundation of China (grant no. U1460203). H.W.Y. acknowledges the Ministry of Science and Technology of the Republic of China for providing financial support under contract MOST-104-2218-E-002-022-MY3 and thanks the Instrumentation Center at National Taiwan University for technical support during use of the JSM 7800F PRIME high-resolution scanning electron microscope. The authors also acknowledge the Shanghai Synchrotron Radiation Facility for providing the synchrotron XRD facility at beamline no. 14 B. The present work has pending patents with application numbers 201610455155.3 and PCT/CN2016/096509 and another awarded patent, number 201410669029.9. M.X.H. supervised the study. M.X.H., B.B.H., and H.W.L. designed the study. B.B.H. and B.H. prepared the thermomechanical treatment and the mechanical tests. H.W.Y., G.J.C., and B. B.H. conducted the microstructure characterization. B. B.H., M.X.H., H.W.L., and Z.K.W. analyzed the data. B. B.H. and M.X.H. wrote the paper. The authors declare no competing financial interests. Data are available in the manuscript and supplementary materials.	Akama D, 2016, ISIJ INT, V56, P1675, DOI 10.2355/isijinternational.ISIJINT-2016-140; [Anonymous], 1934, P R SOC LOND A, DOI [10.1098/rspa.1934.0107, DOI 10.1098/RSPA.1934.0107, DOI 10.1098/RSPA.1934.0106]; Arlazarov A, 2013, ISIJ INT, V53, P1076, DOI 10.2355/isijinternational.53.1076; Boehlert CJ, 2006, METALL MATER TRANS A, V37A, P27, DOI 10.1007/s11661-006-0149-0; Bouaziz O, 2013, STEEL RES INT, V84, P937, DOI 10.1002/srin.201200288; Bouaziz O, 2012, ADV ENG MATER, V14, P49, DOI 10.1002/adem.201100164; Chatterjee S, 2006, MATER SCI TECH-LOND, V22, P641, DOI 10.1179/174328406X86128; Chen YS, 2017, SCIENCE, V355, P1196, DOI 10.1126/science.aal2418; COTTRELL AH, 1949, P PHYS SOC LOND A, V62, P49, DOI 10.1088/0370-1298/62/1/308; De Moor E, 2011, ISIJ INT, V51, P137, DOI 10.2355/isijinternational.51.137; Garcia-Mateo C, 2005, MATER TRANS, V46, P1839, DOI 10.2320/matertrans.46.1839; Hatem T., 2013, MAT SCI TECHNOL, V27, P1570; He JY, 2016, ACTA MATER, V102, P187, DOI 10.1016/j.actamat.2015.08.076; Hirth J. P., 1972, THEORY DISLOCATIONS; Jacques PJ, 2001, METALL MATER TRANS A, V32, P2759, DOI 10.1007/s11661-001-1027-4; Jiang SH, 2017, NATURE, V544, P460, DOI 10.1038/nature22032; Kawakami K, 2012, ISIJ INT, V52, P1693, DOI 10.2355/isijinternational.52.1693; Kim SH, 2015, NATURE, V518, P77, DOI 10.1038/nature14144; Koyama M, 2017, SCIENCE, V355, DOI 10.1126/science.aal2766; Lai MJ, 2015, ACTA MATER, V100, P290, DOI 10.1016/j.actamat.2015.08.047; Lani F, 2007, ACTA MATER, V55, P3695, DOI 10.1016/j.actamat.2007.02.015; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Li ZM, 2016, NATURE, V534, P227, DOI 10.1038/nature17981; Liu G, 2013, NAT MATER, V12, P344, DOI [10.1038/NMAT3544, 10.1038/nmat3544]; Lu K, 2009, SCIENCE, V324, P349, DOI 10.1126/science.1159610; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Morito S, 2006, ACTA MATER, V54, P5323, DOI 10.1016/j.actamat.2006.07.009; Nakamoto Y, 2008, SCRIPTA MATER, V58, P731, DOI 10.1016/j.scriptamat.2007.12.013; Neelakantan S, 2014, MAT SCI ENG A-STRUCT, V590, P140, DOI 10.1016/j.msea.2013.10.003; Nickel Development Institute, 1976, USITC PUBL, V4419; OLSON GB, 1975, METALL TRANS, VA  6, P791, DOI 10.1007/BF02672301; Raabe D, 2009, SCRIPTA MATER, V60, P1141, DOI 10.1016/j.scriptamat.2009.02.062; SANDVIK BPJ, 1983, METALL TRANS A, V14, P809, DOI 10.1007/BF02644284; Sauzay M, 2008, MAT SCI ENG A-STRUCT, V483-84, P410, DOI 10.1016/j.msea.2006.12.183; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Shintani T, 2011, ACTA MATER, V59, P4314, DOI 10.1016/j.actamat.2011.03.055; Speer J, 2003, ACTA MATER, V51, P2611, DOI 10.1016/S1359-6454(03)00059-4; Tsai CW, 2015, MATER SCI TECH-LOND, V31, P1178, DOI 10.1179/1743284714Y.0000000754; Ungar T, 2014, ACTA MATER, V66, P251, DOI 10.1016/j.actamat.2013.11.012; Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9; Victoria M, 2000, J NUCL MATER, V276, P114, DOI 10.1016/S0022-3115(99)00203-2; Wang HT, 2012, ACTA MATER, V60, P4027, DOI 10.1016/j.actamat.2012.03.035; Wang MM, 2015, ACTA MATER, V85, P216, DOI 10.1016/j.actamat.2014.11.010; Wang XG, 2017, ACTA MATER, V124, P17, DOI 10.1016/j.actamat.2016.10.069; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133; Wei Q, 2008, MAT SCI ENG A-STRUCT, V491, P62, DOI 10.1016/j.msea.2008.01.013; Wei YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4580; Wu XL, 2015, P NATL ACAD SCI USA, V112, P14501, DOI 10.1073/pnas.1517193112; Zhang M, 2006, MAT SCI ENG A-STRUCT, V438, P296, DOI 10.1016/j.msea.2006.01.128; Zhang XD, 2011, ACTA MATER, V59, P3422, DOI 10.1016/j.actamat.2011.02.017; Zhao JL, 2012, J IRON STEEL RES INT, V19, P57, DOI 10.1016/S1006-706X(12)60088-0	52	518	547	73	793	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1029	1032		10.1126/science.aan0177	http://dx.doi.org/10.1126/science.aan0177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28839008				2022-12-28	WOS:000409455700042
J	Kemfert, C				Kemfert, Claudia			Germany must go back to its low-carbon future	NATURE			English	Editorial Material									[Kemfert, Claudia] DIW Berlin, German Inst Econ Res, Environm Dept, Energy,Transportat, Berlin, Germany; [Kemfert, Claudia] Hertie Sch Governance, Energy Econ & Sustainabil, Berlin, Germany	DIW Berlin - Deutsches Institut fur Wirtschaftsforschung	Kemfert, C (corresponding author), DIW Berlin, German Inst Econ Res, Environm Dept, Energy,Transportat, Berlin, Germany.; Kemfert, C (corresponding author), Hertie Sch Governance, Energy Econ & Sustainabil, Berlin, Germany.	sekretariat-evu@diw.de		Kemfert, Claudia/0000-0002-6742-0478				Bundesministerium fur Wirtschaft und Technologie, 2010, EN BUND UMW ZUV BEZ; Bundesministerium fur Wirtschaft und Technologie, 2016, FUNFT MON BER EN ZUK; Bundesregierung, 2011, REG EL; Federal Ministry for Economic Affairs and Energy (BMWi), 2017, BUND EN 2017; Figueres C, 2017, NATURE, V546, P593, DOI 10.1038/546593a; Georgeson L, 2016, NATURE, V538, P27, DOI 10.1038/538027a; Kemfert C., 2013, BATTLE ELECT; Kemfert C., 2016, CESIFO DICE REPORT, V14, P65; Umweltbundesamt, 2016, UMW SUBV DEUTSCHL	9	12	12	4	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					26	27		10.1038/549026a	http://dx.doi.org/10.1038/549026a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0DH	28880299	Bronze			2022-12-28	WOS:000409388700016
J	Moher, D; Shamseer, L; Cobey, K				Moher, David; Shamseer, Larissa; Cobey, Kelly			Stop this waste of people, animals and money	NATURE			English	Editorial Material									[Moher, David] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Moher, D (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	dmoher@ohri.ca	Cobey, Kelly D/AAA-5463-2020; Shamseer, Larissa/E-9645-2017; Alabousi, Mostafa/AAE-5841-2021; Moher, David/I-3408-2019; Beck, Andrew/K-3382-2019; Wolfe, Dianna/ABA-4768-2020	Cobey, Kelly D/0000-0003-2797-1686; Shamseer, Larissa/0000-0003-3690-3378; Alabousi, Mostafa/0000-0003-4023-0559; Moher, David/0000-0003-2434-4206; Page, Matthew/0000-0002-4242-7526; Thavorn, Kednapa/0000-0003-4738-8447; McGrath, Trevor/0000-0001-8063-289X; Avey, Marc/0000-0002-8696-3232; Ghannad, Mona/0000-0002-5848-3477; Beck, Andrew/0000-0002-8308-2202; Wolfe, Dianna/0000-0003-1807-6647; Hutton, Brian/0000-0001-5662-8647; Hersi, Mona/0000-0003-1784-1167				Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Machacek V, 2017, PREDATORY J SCOPUS; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Shamseer L, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0785-9; Shen CY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0469-2; Taljaard M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2496; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; Xia JF, 2015, J ASSOC INF SCI TECH, V66, P1406, DOI 10.1002/asi.23265	9	133	134	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					23	25		10.1038/549023a	http://dx.doi.org/10.1038/549023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0DH	28880300	Bronze			2022-12-28	WOS:000409388700015
J	Delamater, PL; Leslie, TF; Yang, YT				Delamater, Paul L.; Leslie, Timothy F.; Yang, Y. Tony			Change in Medical Exemptions From Immunization in California After Elimination of Personal Belief Exemptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Delamater, Paul L.] Univ North Carolina Chapel Hill, Dept Geog, Chapel Hill, NC USA; [Leslie, Timothy F.] George Mason Univ, Dept Geog & Geoinformat Sci, Fairfax, VA 22030 USA; [Yang, Y. Tony] George Mason Univ, Dept Hlth Adm & Policy, Fairfax, VA 22030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; George Mason University; George Mason University	Delamater, PL (corresponding author), Univ North Carolina Chapel Hill, Carolina Populat Ctr, Dept Geog, 217 Carolina Hall,CB 3220, Chapel Hill, NC 27599 USA.	pld@email.unc.edu		Leslie, Timothy/0000-0002-4928-3705; Delamater, Paul/0000-0003-3627-9739	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NICHD NIH HHS [P2C HD050924] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Delamater PL, 2016, JAMA PEDIATR, V170, P619, DOI 10.1001/jamapediatrics.2015.4856; Mello MM, 2015, NEW ENGL J MED, V373, P785, DOI 10.1056/NEJMp1508701; Simon GR, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2145	3	35	36	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					863	864		10.1001/jama.2017.9242	http://dx.doi.org/10.1001/jama.2017.9242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873152	Green Published			2022-12-28	WOS:000409183700018
J	Voelker, R				Voelker, Rebecca			New Formulation of Lupus Drug	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					790	790		10.1001/jama.2017.10937	http://dx.doi.org/10.1001/jama.2017.10937			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NC	28873147				2022-12-28	WOS:000426800500002
J	van den Akker, T; Bloemenkamp, KWM; van Roosmalen, J; Knight, M				van den Akker, Thomas; Bloemenkamp, Kitty W. M.; van Roosmalen, Jos; Knight, Marian		Netherlands Audit Comm Maternal; UK Confidential Enquiry Maternal	Classification of maternal deaths: where does the chain of events start?	LANCET			English	Editorial Material									[van den Akker, Thomas; Knight, Marian] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [van den Akker, Thomas; van Roosmalen, Jos] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [Bloemenkamp, Kitty W. M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp Birth Ctr, Dept Obstet, Utrecht, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands	University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	van den Akker, T (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.; van den Akker, T (corresponding author), Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands.	t.h.van_den_akker@lumc.nl	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575				Maternal Mortality Committee, 2003, QUAL STAND PREV MAT; Maternal Newborn and Infant Clinical Outcome Review Programme MBRRACE-UK, 2016, MOTH BAB RED RISK AU; NHS Institute for Innovation and Improvement, 2015, CAES SECT PROM NORM; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; World Health Organization, 2016, VERB AUT STAND 2016; World Health Organization, 2012, WHO APPL ICD 10 DEAT	6	16	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					922	923		10.1016/S0140-6736(17)31633-1	http://dx.doi.org/10.1016/S0140-6736(17)31633-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28872018				2022-12-28	WOS:000408746300008
J	Fouqueau, T; Werner, F				Fouqueau, Thomas; Werner, Finn			The architecture of transcription elongation	SCIENCE			English	Editorial Material							RNA-POLYMERASE CLAMP; 3 DOMAINS; INITIATION; COMPLEX; LIFE; TFE		[Fouqueau, Thomas; Werner, Finn] UCL, Inst Struct & Mol Biol, Div Biosci, Gower St, London WC1E 6BT, England	University of London; Birkbeck University London; University College London	Werner, F (corresponding author), UCL, Inst Struct & Mol Biol, Div Biosci, Gower St, London WC1E 6BT, England.	f.werner@ucl.ac.uk		Fouqueau, Thomas/0000-0003-1539-093X; Werner, Finn/0000-0002-3930-3821				Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Ehara H, 2017, SCIENCE, V357, P921, DOI 10.1126/science.aan8552; Elmlund D., 2017, CURR OPIN STRUCT BIO, V46; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Schulz S, 2016, P NATL ACAD SCI USA, V113, pE1816, DOI 10.1073/pnas.1515817113; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507	13	3	3	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					871	872		10.1126/science.aao4754	http://dx.doi.org/10.1126/science.aao4754			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860371	Green Submitted			2022-12-28	WOS:000408734900025
J	Zenker, J; White, MD; Templin, RM; Parton, RG; Thorn-Seshold, O; Bissiere, S; Plachta, N				Zenker, J.; White, M. D.; Templin, R. M.; Parton, R. G.; Thorn-Seshold, O.; Bissiere, S.; Plachta, N.			A microtubule-organizing center directing intracellular transport in the early mouse embryo	SCIENCE			English	Article							ADHERENS JUNCTIONS; GOLGI NETWORK; E-CADHERIN; CENTROSOME; NUCLEATION; ENDOSOMES; BIOGENESIS; MECHANISMS; PROTEINS; POLARITY	The centrosome is the primary microtubule-organizing center (MTOC) of most animal cells; however, this organelle is absent during early mammalian development. Therefore, the mechanism by which the mammalian embryo organizes its microtubules (MTs) is unclear. We visualize MT bridges connecting pairs of cells and show that the cytokinetic bridge does not undergo stereotypical abscission after cell division. Instead, it serves as scaffold for the accumulation of the MT minus-end-stabilizing protein CAMSAP3 throughout interphase, thereby transforming this structure into a noncentrosomal MTOC. Transport of the cell adhesion molecule E-cadherin to the membrane is coordinated by this MTOC and is required to form the pluripotent inner mass. Our study reveals a noncentrosomal form of MT organization that directs intracellular transport and is essential for mammalian development.	[Zenker, J.; White, M. D.; Bissiere, S.; Plachta, N.] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Templin, R. M.; Parton, R. G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Templin, R. M.; Parton, R. G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Thorn-Seshold, O.] Ludwig Maximilians Univ Munchen, Dept Pharm, Ctr Drug Res, Munich, Germany; [Plachta, N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Queensland; University of Queensland; University of Munich; National University of Singapore	Plachta, N (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.; Plachta, N (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.	plachtan@imcb.a-star.edu.sg	Thorn-Seshold, Oliver/AAA-3382-2021; White, Melanie/J-5565-2019; Parton, Robert/C-5673-2009	Thorn-Seshold, Oliver/0000-0003-3981-651X; White, Melanie/0000-0002-7399-8348; Parton, Robert/0000-0002-7494-5248	Deutsche Forschungsgemeinschaft; Swiss National Foundation and Human Frontier Science Program; National Health and Medical Research Council; Australian Research Council Centre of Excellence; Centre for Nanoscience; A*STAR; European Molecular Biology Organization; Howard Hughes Medical Institute-Wellcome Trust	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Foundation and Human Frontier Science Program; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence(Australian Research Council); Centre for Nanoscience; A*STAR(Agency for Science Technology & Research (A*STAR)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Howard Hughes Medical Institute-Wellcome Trust	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to J.Z. and O.T.-S.); the Swiss National Foundation and Human Frontier Science Program (to J.Z.); the National Health and Medical Research Council and Australian Research Council Centre of Excellence (to R.G.P.); the Centre for Nanoscience (to O.T.-S.); and A*STAR, the European Molecular Biology Organization, and Howard Hughes Medical Institute-Wellcome Trust (to N.P.). O.T.-S. is an inventor on patent application WO2015166295 submitted by Ludwig-Maximilians-University Munich that covers the structure of PST-1.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2015, CURR BIOL, V25, pR162, DOI 10.1016/j.cub.2014.12.027; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Borowiak M, 2015, CELL, V162, P403, DOI 10.1016/j.cell.2015.06.049; Carter AP, 2016, CURR OPIN STRUC BIOL, V37, P62, DOI 10.1016/j.sbi.2015.12.003; Chatzimeletiou K, 2005, HUM REPROD, V20, P672, DOI 10.1093/humrep/deh652; Clift D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8217; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Feldman JL, 2012, CURR BIOL, V22, P575, DOI 10.1016/j.cub.2012.02.044; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Howe K, 2013, CELL CYCLE, V12, P1616, DOI 10.4161/cc.24755; JOHNSON MH, 1985, J EMBRYOL EXP MORPH, V90, P311; Khanal I, 2016, J CELL SCI, V129, P2651, DOI 10.1242/jcs.189076; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KIDDER GM, 1988, ROUX ARCH DEV BIOL, V197, P110, DOI 10.1007/BF00375933; Le Droguen PM, 2015, DEVELOPMENT, V142, P363, DOI 10.1242/dev.113472; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Roossien DH, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00252; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Sanchez Ariana D, 2017, Curr Opin Cell Biol, V44, P93, DOI 10.1016/j.ceb.2016.09.003; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stephenson RO, 2010, DEVELOPMENT, V137, P3383, DOI 10.1242/dev.050195; Wakida NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015462; Wieczorek M, 2015, NAT CELL BIOL, V17, P907, DOI 10.1038/ncb3188; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207	30	73	74	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					925	+		10.1126/science.aam9335	http://dx.doi.org/10.1126/science.aam9335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860385				2022-12-28	WOS:000408734900044
J	Dow, A; Thibault, G				Dow, Alan; Thibault, George			Interprofessional Education - A Foundation for a New Approach to Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dow, Alan] Virginia Commonwealth Univ, Hlth Sci, Richmond, VA 23284 USA; [Thibault, George] Josiah Macy Jr Fdn, New York, NY USA; [Thibault, George] Harvard Med Sch, Boston, MA USA	Virginia Commonwealth University; Harvard University; Harvard Medical School	Dow, A (corresponding author), Virginia Commonwealth Univ, Hlth Sci, Richmond, VA 23284 USA.			Dow, Alan/0000-0002-9004-7528				Cox M, 2013, TRANSFORMING PATIENT; Institute of Medicine, 2003, HLTH PROFESSIONS ED, DOI DOI 10.17226/10681; Lawlis TR, 2014, J INTERPROF CARE, V28, P305, DOI 10.3109/13561820.2014.895977; World Health Organization, 2010, FRAM ACT INT ED COLL; Zorek J, 2013, J INTERPROF CARE, V27, P123, DOI 10.3109/13561820.2012.718295	5	25	27	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					803	805		10.1056/NEJMp1705665	http://dx.doi.org/10.1056/NEJMp1705665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854090				2022-12-28	WOS:000408626400002
J	Garcia-Lopez, V; Chen, F; Nilewski, LG; Duret, G; Aliyan, A; Kolomeisky, AB; Robinson, JT; Wang, GF; Pal, R; Tour, JM				Garcia-Lopez, Victor; Chen, Fang; Nilewski, Lizanne G.; Duret, Guillaume; Aliyan, Amir; Kolomeisky, Anatoly B.; Robinson, Jacob T.; Wang, Gufeng; Pal, Robert; Tour, James M.			Molecular machines open cell membranes	NATURE			English	Article							PROSTATE-CANCER; OPTICAL CONTROL; IDENTIFICATION; APOPTOSIS; PORATION; DYNAMICS; VESICLES; BILAYERS; RUPTURE; FUSION	Beyond the more common chemical delivery strategies, several physical techniques are used to open the lipid bilayers of cellular membranes(1). These include using electric(2) and magnetic(3) fields, temperature(4), ultrasound(5) or light(6) to introduce compounds into cells, to release molecular species from cells or to selectively induce programmed cell death (apoptosis) or uncontrolled cell death (necrosis). More recently, molecular motors and switches that can change their conformation in a controlled manner in response to external stimuli have been used to produce mechanical actions on tissue for biomedical applications(7-9). Here we show that molecular machines can drill through cellular bilayers using their molecular-scale actuation, specifically nanomechanical action. Upon physical adsorption of the molecular motors onto lipid bilayers and subsequent activation of the motors using ultraviolet light, holes are drilled in the cell membranes. We designed molecular motors and complementary experimental protocols that use nanomechanical action to induce the diffusion of chemical species out of synthetic vesicles, to enhance the diffusion of traceable molecular machines into and within live cells, to induce necrosis and to introduce chemical species into live cells. We also show that, by using molecular machines that bear short peptide addends, nanomechanical action can selectively target specific cell-surface recognition sites. Beyond the in vitro applications demonstrated here, we expect that molecular machines could also be used in vivo, especially as their design progresses to allow two-photon, near-infrared and radio-frequency activation(10).	[Garcia-Lopez, Victor; Nilewski, Lizanne G.; Aliyan, Amir; Kolomeisky, Anatoly B.; Tour, James M.] Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA; [Garcia-Lopez, Victor; Nilewski, Lizanne G.; Tour, James M.] Rice Univ, Smalley Curl Inst & NanoCarbon Ctr, Houston, TX 77005 USA; [Chen, Fang; Wang, Gufeng] North Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Duret, Guillaume; Robinson, Jacob T.] Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA; [Pal, Robert] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England; [Tour, James M.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA	Rice University; Rice University; University of North Carolina; North Carolina State University; Rice University; Durham University; Rice University	Tour, JM (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.; Tour, JM (corresponding author), Rice Univ, Smalley Curl Inst & NanoCarbon Ctr, Houston, TX 77005 USA.; Wang, GF (corresponding author), North Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA.; Robinson, JT (corresponding author), Rice Univ, Dept Elect & Comp Engn, Houston, TX 77005 USA.; Pal, R (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.; Tour, JM (corresponding author), Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.	jtrobinson@rice.edu; gufeng_wang@ncsu.edu; robert.pal@dur.ac.uk; tour@rice.edu	García-López, Víctor/ABL-0304-2022; Pal, Robert/K-4316-2012; Kolomeisky, Anatoly B/A-9372-2011	Pal, Robert/0000-0002-0641-4218; Kolomeisky, Anatoly B/0000-0001-5677-6690; Garcia-Lopez, Victor/0000-0003-2915-4591	North Carolina State University; FRPD Award; Royal Society; BSI Durham; National Science Foundation [CHE-1007483]; Integrated Microscopy Core at Baylor College of Medicine; NIH [DK56338, CA125123]; CPRIT [RP150578]; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Engineering and Physical Sciences Research Council [EP/P025684/1] Funding Source: researchfish; EPSRC [EP/P025684/1] Funding Source: UKRI	North Carolina State University; FRPD Award; Royal Society(Royal Society of London); BSI Durham; National Science Foundation(National Science Foundation (NSF)); Integrated Microscopy Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	G.W. acknowledges North Carolina State University start-up funds and the FRPD Award. R.P. acknowledges support from the Royal Society and BSI Durham. J.M.T. acknowledges support from the National Science Foundation (CHE-1007483). Imaging for this project was supported by the Integrated Microscopy Core at Baylor College of Medicine with funding from NIH (DK56338 and CA125123), CPRIT (RP150578), the Dan L. Duncan Comprehensive Cancer Center and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. We thank R. S. Gunasekera for his assistance with imaging and A. Marti for the use of his high-performance liquid chromatography (HPLC) system for the separation of 7-10. W. Sikkema prepared Fig. 1a.	Barber DM, 2016, CHEM SCI, V7, P2347, DOI [10.1039/c5sc04084a, 10.1039/C5SC04084A]; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Bennett WFD, 2014, BIOPHYS J, V106, P210, DOI 10.1016/j.bpj.2013.11.4486; Broichhagen J, 2015, ANGEW CHEM INT EDIT, V54, P15565, DOI 10.1002/anie.201506384; Butler SJ, 2015, DALTON T, V44, P4791, DOI 10.1039/c4dt02785j; CHANG DC, 1989, BIOPHYS J, V56, P641, DOI 10.1016/S0006-3495(89)82711-0; Chen JW, 2014, J AM CHEM SOC, V136, P14924, DOI 10.1021/ja507711h; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; DUNN WA, 1980, J BIOL CHEM, V255, P5971; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evans E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095010; Garcia-Lopez V, 2015, NANO LETT, V15, P8229, DOI 10.1021/acs.nanolett.5b03764; HaywoodReid PL, 1997, PROSTATE, V31, P1, DOI 10.1002/(SICI)1097-0045(19970401)31:1<1::AID-PROS1>3.0.CO;2-S; Huang CW, 2011, J NUCL MED, V52, P1979, DOI 10.2967/jnumed.111.091256; Ivanov IT, 1999, INT J HYPERTHER, V15, P29, DOI 10.1080/026567399285837; Kessner S, 2001, BBA-BIOMEMBRANES, V1514, P177, DOI 10.1016/S0005-2736(01)00368-6; Lakshmanan S, 2014, ADV DRUG DELIVER REV, V71, P98, DOI 10.1016/j.addr.2013.05.010; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; Li FF, 2013, BIOPHYS J, V105, P872, DOI 10.1016/j.bpj.2013.06.045; Liu D, 2012, NANO LETT, V12, P5117, DOI 10.1021/nl301928z; Mandelin J, 2015, P NATL ACAD SCI USA, V112, P3776, DOI 10.1073/pnas.1500128112; Pal R, 2015, FARADAY DISCUSS, V177, P507, DOI 10.1039/c4fd00158c; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Shigematsu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15369; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Waleed M, 2013, BIOMED OPT EXPRESS, V4, P1533, DOI 10.1364/BOE.4.001533; Wang X, 2012, LANGMUIR, V28, P7417, DOI 10.1021/la300127m; Watson MA, 2016, CHEM SOC REV, V45, P6118, DOI 10.1039/c5cs00874c; Xu TL, 2017, ADV MATER, V29, DOI 10.1002/adma.201603250	30	164	166	18	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					567	572		10.1038/nature23657	http://dx.doi.org/10.1038/nature23657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858304	Green Accepted			2022-12-28	WOS:000408703100035
J	Tillmann, T; Vaucher, J; Okbay, A; Pikhart, H; Peasey, A; Kubinova, R; Pajak, A; Tamosiunas, A; Malyutina, S; Hartwig, FP; Fischer, K; Veronesi, G; Palmer, T; Bowden, J; Smith, GD; Bobak, M; Holmes, MV				Tillmann, Taavi; Vaucher, Julien; Okbay, Aysu; Pikhart, Hynek; Peasey, Anne; Kubinova, Ruzena; Pajak, Andrzej; Tamosiunas, Abdonas; Malyutina, Sofia; Hartwig, Fernando Pires; Fischer, Krista; Veronesi, Giovanni; Palmer, Tom; Bowden, Jack; Smith, George Davey; Bobak, Martin; Holmes, Michael V.			Education and coronary heart disease: mendelian randomisation study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; GENOME-WIDE ASSOCIATION; ADULT MORTALITY; SOCIOECONOMIC POSITION; RISK-FACTORS; 52 COUNTRIES; IMPACT; ARCHITECTURE; INTERHEART	OBJECTIVE To determine whether educational attainment is a causal risk factor in the development of coronary heart disease. DESIGN Mendelian randomisation study, using genetic data as proxies for education to minimise confounding. SETTING The main analysis used genetic data from two large consortia (CARDIoGRAMplusC4D and SSGAC), comprising 112 studies from predominantly high income countries. Findings from mendelian randomisation analyses were then compared against results from traditional observational studies (164 170 participants). Finally, genetic data from six additional consortia were analysed to investigate whether longer education can causally alter the common cardiovascular risk factors. PARTICIPANTS The main analysis was of 543 733 men and women (from CARDIoGRAMplusC4D and SSGAC), predominantly of European origin. EXPOSURE A one standard deviation increase in the genetic predisposition towards higher education (3.6 years of additional schooling), measured by 162 genetic variants that have been previously associated with education. MAIN OUTCOME MEASURE Combined fatal and non-fatal coronary heart disease (63 746 events in CARDIoGRAMplusC4D). RESULTS Genetic predisposition towards 3.6 years of additional education was associated with a one third lower risk of coronary heart disease (odds ratio 0.67, 95% confidence interval 0.59 to 0.77; P=3x10(-8)). This was comparable to findings from traditional observational studies (prevalence odds ratio 0.73, 0.68 to 0.78; incidence odds ratio 0.80, 0.76 to 0.83). Sensitivity analyses were consistent with a causal interpretation in which major bias from genetic pleiotropy was unlikely, although this remains an untestable possibility. Genetic predisposition towards longer education was additionally associated with less smoking, lower body mass index, and a favourable blood lipid profile. CONCLUSIONS This mendelian randomisation study found support for the hypothesis that low education is a causal risk factor in the development of coronary heart disease. Potential mechanisms could include smoking, body mass index, and blood lipids. In conjunction with the results from studies with other designs, these findings suggest that increasing education may result in substantial health benefits.	[Tillmann, Taavi; Pikhart, Hynek; Peasey, Anne; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England; [Vaucher, Julien] Lausanne Univ Hosp, Dept Internal Med, Lausanne, Switzerland; [Okbay, Aysu] Vrije Univ Amsterdam, Dept Complex Trait Genet, Amsterdam, Netherlands; [Kubinova, Ruzena] Natl Inst Publ Hlth, Ctr Environm Hlth Monitoring, Prague, Czech Republic; [Pajak, Andrzej] Jagiellonian Univ, Med Coll, Chair Epidemiol & Populat Studies, Inst Publ Hlth,Fac Hlth Sci, Krakow, Poland; [Tamosiunas, Abdonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Malyutina, Sofia] RAS, Branch Inst Cytol & Genet, Res Inst Internal & Prevent Med, SB, Novosibirsk, Russia; [Malyutina, Sofia] Novosibirsk State Med Univ, Novosibirsk, Russia; [Hartwig, Fernando Pires] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil; [Hartwig, Fernando Pires; Bowden, Jack; Smith, George Davey; Holmes, Michael V.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Fischer, Krista] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Veronesi, Giovanni] Univ Insubria, Res Ctr Epidemiol & Prevent Med, Varese, Italy; [Palmer, Tom] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Holmes, Michael V.] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Holmes, Michael V.] Univ Oxford, Big Data Inst, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Holmes, Michael V.] Univ Oxford, MRC, Populat Hlth Res Unit, Oxford, England; [Holmes, Michael V.] Oxford Univ Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr, Oxford, England	University of London; University College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Vrije Universiteit Amsterdam; National Institute of Public Health (SZU) - Czech Republic; Jagiellonian University; Collegium Medicum Jagiellonian University; Lithuanian University of Health Sciences; Russian Academy of Sciences; Novosibirsk State Medical University; Universidade Federal de Pelotas; University of Bristol; University of Tartu; University of Insubria; Lancaster University; University of Bristol; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Tillmann, T (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	t.tillmann@ucl.ac.uk; julien.vaucher@chuv.ch	Veronesi, Giovanni/E-3859-2010; Holmes, Michael/AAA-2208-2021; Hartwig, Fernando/AAG-5578-2020; Pikhart, Hynek/E-3074-2010; Veronesi, Giovanni/O-5678-2019; Bowden, Jack/AAF-2305-2019; Malyutina, Sofia/J-1651-2018; Davey Smith, George/A-7407-2013; Tamosiunas, Abdonas/AAD-4274-2021; Palmer, Tom Michael/X-6807-2019; Tillmann, Taavi/R-6026-2016	Veronesi, Giovanni/0000-0002-4119-6615; Pikhart, Hynek/0000-0001-5277-4049; Veronesi, Giovanni/0000-0002-4119-6615; Malyutina, Sofia/0000-0001-6539-0466; Davey Smith, George/0000-0002-1407-8314; Palmer, Tom Michael/0000-0003-4655-4511; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tillmann, Taavi/0000-0002-8428-3719; s, hema/0000-0002-3440-9475; Vaucher, Julien/0000-0002-3230-3693; Bobak, Martin/0000-0002-2633-6851; Okbay, Aysu/0000-0002-5170-7781	Wellcome Trust [106554/Z/14/Z, 064947/Z/01/Z, WT081081]; Swiss National Science Foundation [P2LAP3_155086]; US National Institute on Aging [1R01 AG23522]; MacArthur Foundation (Health and Social Upheaval network); Russian Science Foundation [14-45-00030]; European Union's Seventh Framework Programme [HEALTH-F3-2010-242244, HEALTH-F2-2011-278913]; Medical Research Council (MRC) methodology research fellowship [MR/N501906/1]; European Research Council [647648 EdGe]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; UK MRC; Medical Research Council Integrative Epidemiology Unit at the University of Bristol [MC_UU_12013/1]; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; Russian Science Foundation [17-45-00002] Funding Source: Russian Science Foundation; MRC [MC_UU_12013/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation (Health and Social Upheaval network); Russian Science Foundation(Russian Science Foundation (RSF)); European Union's Seventh Framework Programme(European Commission); Medical Research Council (MRC) methodology research fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Integrative Epidemiology Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Russian Science Foundation(Russian Science Foundation (RSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TT is funded by a Wellcome Trust fellowship (106554/Z/14/Z); JV is supported by the Swiss National Science Foundation (P2LAP3_155086); the HAPIEE study is supported by the Wellcome Trust (064947/Z/01/Z, WT081081), the US National Institute on Aging (1R01 AG23522), the MacArthur Foundation (Health and Social Upheaval network), and the Russian Science Foundation (14-45-00030); the MORGAM Project was supported by the European Union's Seventh Framework Programme (HEALTH-F3-2010-242244, HEALTH-F2-2011-278913); GDS works in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_12013/1); JB is supported by a Medical Research Council (MRC) methodology research fellowship (grant MR/N501906/1); AO is supported by a European Research Council consolidator grant (647648 EdGe); MVH is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and works in the MRC Population Health Research Unit at the University of Oxford that receives funding from the UK MRC. The funders had no role in the study design, data collection, analysis, interpretation, or writing, nor in the decision to submit the article for publication.	Arden R, 2016, INT J EPIDEMIOL, V45, P178, DOI 10.1093/ije/dyv112; Botero J, 2013, J LAW ECON, V56, P959, DOI 10.1086/674133; Bowden J, 2016, INT J EPIDEMIOL, V45, P1961, DOI 10.1093/ije/dyw220; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burgess S, 2015, AM J EPIDEMIOL, V181, P290, DOI 10.1093/aje/kwv017; Clark D, 2013, AM ECON REV, V103, P2087, DOI 10.1257/aer.103.6.2087; Cuellar-Partida G, 2016, GENET EPIDEMIOL, V40, P66, DOI 10.1002/gepi.21936; Davies NM, 2016, BIORXIV; de Walque D, 2007, J HEALTH ECON, V26, P877, DOI 10.1016/j.jhealeco.2006.12.005; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Fletcher JM, 2011, HEALTH ECON, V20, P889, DOI 10.1002/hec.1745; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Hartwig FP, 2017, INT J EPIDEMIOL, V46, P1985, DOI 10.1093/ije/dyx102; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; HINKLE LE, 1968, SCIENCE, V161, P238, DOI 10.1126/science.161.3838.238; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Kitagawa EM, 1973, DIFFERENTIAL MORTALI, DOI [10.4159/harvard.9780674188471, DOI 10.4159/HARVARD.9780674188471]; Kvaavik E, 2012, EUR J PUBLIC HEALTH, V22, P544, DOI 10.1093/eurpub/ckr106; Lager ACJ, 2012, P NATL ACAD SCI USA, V109, P8461, DOI 10.1073/pnas.1105839109; Lawlor DA, 2016, INT J EPIDEMIOL, V45, P1866, DOI 10.1093/ije/dyw314; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Lundborg P, 2016, DEMOGRAPHY, V53, P1135, DOI 10.1007/s13524-016-0489-3; Madsen M, 2014, SOC SCI MED, V118, P182, DOI 10.1016/j.socscimed.2014.04.016; Madsen M, 2010, AM J EPIDEMIOL, V172, P225, DOI 10.1093/aje/kwq072; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; Marioni RE, 2016, P NATL ACAD SCI USA, V113, P13366, DOI 10.1073/pnas.1605334113; Mazumder B., 2008, EC PERSPECTIVES, V33, P2; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Naess O, 2012, INT J EPIDEMIOL, V41, P1683, DOI 10.1093/ije/dys143; Nelson CP, 2015, NEW ENGL J MED, V372, P1608, DOI 10.1056/NEJMoa1404881; Nguyen TT, 2016, ANN EPIDEMIOL, V26, P71, DOI 10.1016/j.annepidem.2015.10.006; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Oreopoulos P, 2011, J ECON PERSPECT, V25, P159, DOI 10.1257/jep.25.1.159; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Richmond RC, 2016, HUM MOL GENET, V25, pR149, DOI 10.1093/hmg/ddw197; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Sondergaard G, 2012, AM J EPIDEMIOL, V176, P675, DOI 10.1093/aje/kws230; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; van Kippersluis H, 2011, J HUM RESOUR, V46, P695, DOI 10.1353/jhr.2011.0006; Varbo A, 2015, CIRC RES, V116, P665, DOI 10.1161/CIRCRESAHA.116.304846; Veronesi G, 2016, HEART, V102, P958, DOI 10.1136/heartjnl-2015-308909; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	55	90	91	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2017	358								j3542	10.1136/bmj.j3542	http://dx.doi.org/10.1136/bmj.j3542			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG0CN	28855160	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000409386700001
J	Topalian, SL				Topalian, Suzanne L.			Targeting Immune Checkpoints in Cancer Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PD-1 BLOCKADE		[Topalian, Suzanne L.] Johns Hopkins Univ, Sch Med, Dept Surg, 1550 Orleans St,CRB2,Room 508, Baltimore, MD 21287 USA; [Topalian, Suzanne L.] Johns Hopkins Bloomberg Kimmel Inst Canc Immunoth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Topalian, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, 1550 Orleans St,CRB2,Room 508, Baltimore, MD 21287 USA.	stopali1@jhmi.edu			Bristol-Myers Squibb; Potenza Therapeutics; Compugen	Bristol-Myers Squibb(Bristol-Myers Squibb); Potenza Therapeutics; Compugen	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Topalian receives research grants from Bristol-Myers Squibb, and is a consultant for and owns stock from Five Prime Therapeutics. An immediate family member is a consultant for Amgen, MedImmune/AstraZeneca, Merck, and Pfizer; receives research grants, consulting fees, and stock options from Potenza Therapeutics; receives stock options from Jounce Therapeutics; receives research grants and stock options from Compugen; and receives patent royalties through his institution from Bristol-Myers Squibb and Potenza.	Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	8	82	86	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2017	318	17					1647	1648		10.1001/jama.2017.14155	http://dx.doi.org/10.1001/jama.2017.14155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM0CW	28885639				2022-12-28	WOS:000414627500009
J	Ramsden, CE; Domenichiello, AF				Ramsden, Christopher E.; Domenichiello, Anthony F.			PURE study challenges the definition of a healthy diet: but key questions remain	LANCET			English	Editorial Material							PERSONALITY; CONSCIENTIOUSNESS		[Ramsden, Christopher E.; Domenichiello, Anthony F.] NIA, Lab Clin Investigat, NIH, Baltimore, MD 21224 USA; [Ramsden, Christopher E.] NIAAA, Intramural Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Ramsden, CE (corresponding author), NIA, Lab Clin Investigat, NIH, Baltimore, MD 21224 USA.; Ramsden, CE (corresponding author), NIAAA, Intramural Program, NIH, Bethesda, MD 20892 USA.	chris.ramsden@nih.gov	Ramsden, Christopher/AAW-9516-2021	Ramsden, Christopher/0000-0002-4058-7630	NATIONAL INSTITUTE ON AGING [ZIAAG000453] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AG999999] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Dehghan M., 2017, LANCET; Duggan KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090628; Hill PL, 2011, HEALTH PSYCHOL, V30, P797, DOI 10.1037/a0023860; Iwasa H, 2008, AM J GERIAT PSYCHIAT, V16, P399, DOI 10.1097/JGP.0b013e3181662ac9; Keller C, 2015, APPETITE, V84, P128, DOI 10.1016/j.appet.2014.10.003; Mente A, 2017, LANCET DIABETES ENDO; Miller V, 2017, LANCET; Nissen SE, 2016, ANN INTERN MED, V164, P558, DOI 10.7326/M16-0035; Sacks FM, 2017, CIRCULATION, V136, pE1, DOI 10.1161/CIR.0000000000000510; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID	12	19	20	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2018	2019		10.1016/S0140-6736(17)32241-9	http://dx.doi.org/10.1016/S0140-6736(17)32241-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FL5DD	28864330	Green Accepted			2022-12-28	WOS:000414250800005
J	Miller, PG; Ebert, BL				Miller, Peter G.; Ebert, Benjamin L.			Vitamin C regulates stem cells and cancer	NATURE			English	Editorial Material							CLONAL HEMATOPOIESIS; SELF-RENEWAL; TET2; 5-METHYLCYTOSINE; LEUKEMIA; DISEASE; DNA		[Miller, Peter G.; Ebert, Benjamin L.] Harvard Med Sch, Div Hematol, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Miller, Peter G.; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Miller, Peter G.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ebert, BL (corresponding author), Harvard Med Sch, Div Hematol, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	bebert@bwh.harvard.edu		Miller, Peter/0000-0002-6797-9335	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038627] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Lee B, 2015, KOREAN J FAM MED, V35, P278, DOI 10.4082/kjfm.2015.36.6.278; Loria CM, 2000, AM J CLIN NUTR, V72, P139; Mihaylova MM, 2014, CELL STEM CELL, V14, P292, DOI 10.1016/j.stem.2014.02.008; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Moser MA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081328; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346	18	6	7	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2017	549	7673					462	464		10.1038/nature23548	http://dx.doi.org/10.1038/nature23548			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI4GT	28869971				2022-12-28	WOS:000411930000036
J	Goldstein, JL				Goldstein, Joseph L.			Artists Create Puzzles, Scientists Solve Them	CELL			English	Editorial Material								The Spanish artist Diego Velazquez created a puzzle-painting 360 years ago that to this day remains unsolved, but still mystifies and intrigues. Unlike artists who get their thrills by creating puzzles that stimulate the imagination, scientists get their kicks by solving puzzles that advance biomedical research.	[Goldstein, Joseph L.] Univ Texas Southwestern Med Ctr Dallas, Lasker Awards Jury, Dallas, TX 75390 USA; [Goldstein, Joseph L.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Lasker Awards Jury, Dallas, TX 75390 USA.; Goldstein, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu						Alteveer I., 2016, KJ MARSHALL MASTRY; Carminati M., 2012, VELAZQUEZS LAS MENIN; Eliot T. S., 1985, SO REV, V21, P873; Ellmann Richard, 1982, J JOYCE, P521; Gopnik Blake, 2010, WASH POST; Rafart i Planas C., 2001, PICASSOS LAS MENINAS; STEINBERG L, 1981, OCTOBER, P45; Stork DG, 2009, PROC SPIE, V7238, DOI 10.1117/12.806264	8	0	0	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					5	9		10.1016/j.cell.2017.08.022	http://dx.doi.org/10.1016/j.cell.2017.08.022			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28888326	Bronze			2022-12-28	WOS:000411331800002
J	Cardoso, V; Chesne, J; Ribeiro, H; Garcia-Cassani, B; Carvalho, T; Bouchery, T; Shah, K; Barbosa-Morais, NL; Harris, N; Veiga-Fernandes, H				Cardoso, Vania; Chesne, Julie; Ribeiro, Helder; Garcia-Cassani, Bethania; Carvalho, Tania; Bouchery, Tiffany; Shah, Kathleen; Barbosa-Morais, Nuno L.; Harris, Nicola; Veiga-Fernandes, Henrique			Neuronal regulation of type 2 innate lymphoid cells via neuromedin U	NATURE			English	Article							IMMUNE INTERACTIONS; RECEPTOR RET; IDENTIFICATION; IMMUNOREACTIVITY; EXPRESSION; INTESTINE; TYROSINE; TRACT; BRAIN; GENE	Group 2 innate lymphoid cells (ILC2s) regulate inflammation, tissue repair and metabolic homeostasis(1), and are activated by host-derived cytokines and alarmins(1). Discrete subsets of immune cells integrate nervous system cues(2-4), but it remains unclear whether neuron-derived signals control ILC2s. Here we show that neuromedin U (NMU) in mice is a fast and potent regulator of type 2 innate immunity in the context of a functional neuron-ILC2 unit. We found that ILC2s selectively express neuromedin U receptor 1 (Nmur1), and mucosal neurons express NMU. Cell-autonomous activation of ILC2s with NMU resulted in immediate and strong NMUR1-dependent production of innate inflammatory and tissue repair cytokines. NMU controls ILC2s downstream of extracellular signal-regulated kinase and calcium-influx-dependent activation of both calcineurin and nuclear factor of activated T cells (NFAT). NMU treatment in vivo resulted in immediate protective type 2 responses. Accordingly, ILC2-autonomous ablation of Nmur1 led to impaired type 2 responses and poor control of worm infection. Notably, mucosal neurons were found adjacent to ILC2s, and these neurons directly sensed worm products and alarmins to induce NMU and to control innate type 2 cytokines. Our work reveals that neuron-ILC2 cell units confer immediate tissue protection through coordinated neuroimmune sensory responses.	[Cardoso, Vania; Chesne, Julie; Ribeiro, Helder; Garcia-Cassani, Bethania; Carvalho, Tania; Barbosa-Morais, Nuno L.; Veiga-Fernandes, Henrique] Univ Lisbon, Fac Med Lisboa, Inst Med Mol, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal; [Cardoso, Vania; Chesne, Julie; Ribeiro, Helder; Garcia-Cassani, Bethania; Veiga-Fernandes, Henrique] Champalimaud Res, Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal; [Bouchery, Tiffany; Shah, Kathleen; Harris, Nicola] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa; Fundacao Champalimaud; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Veiga-Fernandes, H (corresponding author), Univ Lisbon, Fac Med Lisboa, Inst Med Mol, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal.; Veiga-Fernandes, H (corresponding author), Champalimaud Res, Champalimaud Ctr Unknown, P-1400038 Lisbon, Portugal.	henrique.veigafernandes@research.fchampalimaud.org	Carvalho, Tânia/GNM-6203-2022; Carvalho, Tânia/X-2873-2019; harris, nicola/E-5342-2019; Barbosa-Morais, Nuno L/I-2743-2013	Carvalho, Tânia/0000-0002-5283-5013; harris, nicola/0000-0003-2922-0210; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Ribeiro, Helder/0000-0002-7090-9274; Cardoso, Vania/0000-0002-2330-7553; Veiga-Fernandes, Henrique/0000-0001-6216-1836; bouchery, tiffany/0000-0003-3743-7356	Fundacao para a Ciencia e Tecnologia (FCT), Portugal; Fondation pour la Recherche Medicale (FRM), France; Marie Sklodowska-Curie fellowship, EU [750030]; FP7, EU [289720]; FCT, Portugal; European Molecular Biology Organisation (EMBO); Swiss National Science Foundation [310030_156517]; ERC, EU [647274]; Kenneth Rainin Foundation, USA; Crohn's and Colitis Foundation of America, USA	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Fondation pour la Recherche Medicale (FRM), France(Fondation pour la Recherche Medicale); Marie Sklodowska-Curie fellowship, EU; FP7, EU; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC, EU; Kenneth Rainin Foundation, USA; Crohn's and Colitis Foundation of America, USA	We thank the Histology and Bioimaging services at iMM Lisboa. We thank the Vivarium and Flow Cytometry platforms at iMM Lisboa and at the Champalimaud Centre for the Unknown. We thank A. McKenzie for providing Il1rl1<SUP>-/-</SUP> and Il17rb<SUP>-/-</SUP> mice; D. Fonseca-Pereira, V. Fonseca, S. Xapelli and L. Lopes for helpful discussions; and M. Rendas for technical assistance. V.C was supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal. J.C. by Fondation pour la Recherche Medicale (FRM), France, and by Marie Sklodowska-Curie fellowship (750030), EU; B.G.-C. by FP7 (289720), EU. N.L.B.-M. is supported by FCT, Portugal, and European Molecular Biology Organisation (EMBO). N.H. by Swiss National Science Foundation (310030_156517). H.V.-F. by ERC (647274), EU; Kenneth Rainin Foundation, USA; Crohn's and Colitis Foundation of America, USA; and FCT, Portugal.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; AUGOOD SJ, 1988, REGUL PEPTIDES, V20, P281, DOI 10.1016/0167-0115(88)90063-8; BALLESTA J, 1988, NEUROSCIENCE, V25, P797, DOI 10.1016/0306-4522(88)90037-1; Bouchery T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7970; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cording S, 2016, NAT IMMUNOL, V17, P755, DOI 10.1038/ni.3448; Doherty TA, 2013, J ALLERGY CLIN IMMUN, V132, P205, DOI 10.1016/j.jaci.2013.03.048; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; HONZAWA M, 1990, NEUROPEPTIDES, V15, P1, DOI 10.1016/0143-4179(90)90153-P; Hoshi M, 2012, DEVELOPMENT, V139, P2405, DOI 10.1242/dev.078667; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Martinez VG, 2015, CLIN CHEM, V61, P471, DOI 10.1373/clinchem.2014.231753; Monticelli LA, 2016, NAT IMMUNOL, V17, P656, DOI 10.1038/ni.3421; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Raddatz R, 2000, J BIOL CHEM, V275, P32452, DOI 10.1074/jbc.M004613200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Veiga-Fernandes H, 2017, NAT IMMUNOL, V18, P116, DOI 10.1038/ni.3634; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Veldhoen M, 2015, NAT IMMUNOL, V16, P215, DOI 10.1038/ni.3100; Zhu JD, 1999, CELL RES, V9, P107, DOI 10.1038/sj.cr.7290010	43	308	314	3	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					277	+		10.1038/nature23469	http://dx.doi.org/10.1038/nature23469			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28869974	Green Accepted			2022-12-28	WOS:000410555900047
J	Richards, C				Richards, Cecile			A Century of Progressing and Advancing Reproductive Health Care The 2017 Lasker-Bloomberg Public Service Award	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Richards, Cecile] Planned Parenthood Federat Amer, 123 Williams St,10th Floor, New York, NY 10038 USA; [Richards, Cecile] Planned Parenthood Act Fund, 123 Williams St,10th Floor, New York, NY 10038 USA		Richards, C (corresponding author), Planned Parenthood Federat Amer, Planned Parenthood Act Fund, 123 Williams St,10th Floor, New York, NY 10038 USA.							Bailey MJ, 2012, 17922 NBER; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Glynn SJ., BREADWINNING MOTHERS; National Cancer Institute, CANC HLTH DISP; Planned Parenthood Federation of America, 2016, NAT SURV WOM KNOWL R; Planned Parenthood Federation of America and Planned Parenthood Action Fund, ANN REPORT; Soller K, 2014, BLOOMBERG BUSINESSWE; Sonfield A, SOCIAL EC BENEFITS W	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					903	904		10.1001/jama.2017.11957	http://dx.doi.org/10.1001/jama.2017.11957			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28876434				2022-12-28	WOS:000410487100006
J	[Anonymous]				[Anonymous]			Lax Infection Control Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					899	899		10.1001/jama.2017.11455	http://dx.doi.org/10.1001/jama.2017.11455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898384				2022-12-28	WOS:000410487100029
J	Diamond, DA; Chan, IHY; Holland, AJA; Kurtz, MP; Nelson, C; Estrada, CR; Bauer, S; Tam, PKH				Diamond, David A.; Chan, Ivy H. Y.; Holland, Andrew J. A.; Kurtz, Michael P.; Nelson, Caleb; Estrada, Carlos R., Jr.; Bauer, Stuart; Tam, Paul K. H.			Advances in paediatric urology	LANCET			English	Article							POSTERIOR URETHRAL VALVES; URINARY-TRACT-INFECTION; CONTINENCE SOCIETY RECOMMENDATIONS; CONGENITAL NEUROPATHIC BLADDER; VESICOURETERAL REFLUX; URETERAL REIMPLANTATION; AUGMENTATION CYSTOPLASTY; UNDESCENDED TESTIS; HYPOSPADIAS REPAIR; BOWEL DYSFUNCTION	Paediatric urological surgery is often required for managing congenital and acquired disorders of the genitourinary system. In this Series paper, we highlight advances in the surgical management of six paediatric urological disorders. The management of vesicoureteral reflux is evolving, with advocacy ranging from a less interventional assessment and antimicrobial prophylaxis to surgery including endoscopic injection of a bulking agent and minimally invasive ureteric reimplantation. Evidence supports early orchidopexy to improve fertility and reduce malignancy in boys with undescended testes. A variety of surgical techniques have been developed for hypospadias, with excellent outcomes for distal but not proximal hypospadias. Pelvi-ureteric junction obstruction is mostly detected prenatally; indications for surgery have been refined with evidence, and minimally invasive pyeloplasty is now standard. The outlook for patients with neurogenic bladder has been transformed by a combination of clean intermittent catheterisation, algorithms of diagnostic investigations, and innovative medical and surgical therapies. Posterior urethral valves are associated with considerable mortality; fetal diagnosis allows stratification of candidates for intervention, but ongoing bladder dysfunction in patients after valve ablation remains a cause of long-term morbidity.	[Diamond, David A.; Kurtz, Michael P.; Nelson, Caleb; Estrada, Carlos R., Jr.; Bauer, Stuart] Harvard Med Sch, Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Chan, Ivy H. Y.; Tam, Paul K. H.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Holland, Andrew J. A.] Childrens Hosp Westmead, Dept Paediat Surg, Westmead, NSW, Australia; [Holland, Andrew J. A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Hong Kong; University of Sydney; University of Sydney	Tam, PKH (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	paultam@hku.hk	Holland, Andrew J A/R-2937-2019; /C-4405-2009	Holland, Andrew J A/0000-0003-3745-8704; /0000-0001-6231-3035				Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Akhavan A, 2014, J PEDIATR UROL, V10, P864, DOI 10.1016/j.jpurol.2014.01.028; Arora S, 2015, J PEDIATR UROL, V11, DOI 10.1016/j.jpurol.2015.02.008; Asklund C, 2010, INT J ANDROL, V33, P80, DOI 10.1111/j.1365-2605.2009.00957.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Austin PF, 2015, PEDIATRIC INCONTINENCE: EVALUATION AND CLINICAL MANAGEMENT, P263; Babu R, 2015, J PEDIAT UROL, V11, p[63, e1], DOI DOI 10.1016/J.JPUR0L.2014.10.007; Baek M, 2013, INT UROL NEPHROL, V45, P703, DOI 10.1007/s11255-013-0423-1; Bauer SB, 2012, NEUROUROL URODYNAM, V31, P610, DOI 10.1002/nau.22247; Bergman JEH, 2015, WORLD J UROL, V33, P2159, DOI 10.1007/s00345-015-1507-6; Berrocal T, 2005, RADIOLOGY, V234, P235, DOI 10.1148/radiol.2341031503; Bi YL, 2011, J LAPAROENDOSC ADV S, V21, P969, DOI 10.1089/lap.2011.0103; Bonde JP, 2017, HUM REPROD UPDATE, V23, P104, DOI 10.1093/humupd/dmw036; Brandstrom P, 2010, J UROLOGY, V184, P286, DOI 10.1016/j.juro.2010.01.061; Brock JW, 2015, PEDIATRICS, V136, pE906, DOI 10.1542/peds.2015-2114; Chalmers DJ, 2016, J PEDIAT UROL, V12, pe1; Chan E, 2014, PEDIATR SURG INT, V30, P87, DOI 10.1007/s00383-013-3429-y; Chevalier RL, 2016, PEDIATR NEPHROL, V31, P1411, DOI 10.1007/s00467-015-3291-3; Chua ME, 2014, J PEDIATR SURG, V49, P1659, DOI 10.1016/j.jpedsurg.2014.06.013; Chung PHY, 2008, J PEDIATR SURG, V43, P2246, DOI 10.1016/j.jpedsurg.2008.08.057; DIAMOND DA, 1987, J UROLOGY, V137, P1209, DOI 10.1016/S0022-5347(17)44453-3; Dias CS, 2013, J UROLOGY, V190, P661, DOI 10.1016/j.juro.2013.02.014; Esposito C, 2016, TRANSL PEDIATR, V5, P256, DOI 10.21037/tp.2016.09.08; Feyles F, 2014, EUR J PEDIATR SURG, V24, P376, DOI 10.1055/s-0033-1349715; Finkelstein JB, 2015, J PEDIAT UROL, V11, P170, DOI DOI 10.1016/J.JPUR0L.2014.11.020; Frimberger D, 2016, J PEDIATR UROL, V12, P362, DOI 10.1016/j.jpurol.2016.11.001; Froehlich JW, 2016, MOL CELL PROTEOMICS, V15, P2607, DOI 10.1074/mcp.M116.059386; Gargollo PC, 2011, J UROLOGY, V185, P1425, DOI 10.1016/j.juro.2010.11.054; Gatti JM, 2017, J UROLOGY, V197, P792, DOI 10.1016/j.juro.2016.10.056; Grimsby GM, 2016, J UROLOGY, V195, P155, DOI 10.1016/j.juro.2015.06.103; Gupta RK, 2010, J PEDIATR UROL, V6, P32, DOI 10.1016/j.jpurol.2009.05.009; Hennus PML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085474; Hoag NA, 2014, J UROLOGY, V191, P1523, DOI 10.1016/j.juro.2013.09.062; Hoberman A, 2014, NEW ENGL J MED, V370, P2367, DOI 10.1056/NEJMoa1401811; Holland AJA, 2016, CURR OPIN PEDIATR, V28, P388, DOI 10.1097/MOP.0000000000000335; Horowitz M, 2006, BJU INT, V97, P593, DOI 10.1111/j.1464-410X.2006.06001.x; Hutson JM, 2015, CURR OPIN PEDIATR, V27, P520, DOI 10.1097/MOP.0000000000000237; Hutson JM, 2013, ENDOCR REV, V34, P725, DOI 10.1210/er.2012-1089; Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103; Khrichenko D, 2016, PEDIATR RADIOL, V46, P666, DOI 10.1007/s00247-015-3532-4; Kilby MD, 2014, NAT REV UROL, V11, P412, DOI 10.1038/nrurol.2014.132; Kim WJ, 2015, J UROLOGY, V194, P180, DOI 10.1016/j.juro.2015.03.002; Kirsch AJ, 2014, J PEDIATR UROL, V10, P1249, DOI 10.1016/j.jpurol.2014.06.019; Koff SA, 2002, J UROLOGY, V167, P291, DOI 10.1016/S0022-5347(05)65453-5; Kolon TF, 2014, J UROLOGY, V192, P337, DOI 10.1016/j.juro.2014.05.005; Kraft KH, 2012, J UROLOGY, V188, P1429, DOI 10.1016/j.juro.2012.04.025; Kurtz MP, 2016, PRENATAL DIAG, V36, P720, DOI 10.1002/pd.4850; Kurtz MP, 2016, J PEDIAT UROL, V12, P408; Juarez SL, 2014, J LAPAROENDOSC ADV S, V24, P422, DOI 10.1089/lap.2013.0290; Lau CT, 2017, J LAPAROENDOSC ADV S, V27, P203, DOI 10.1089/lap.2016.0236; Law J, 2016, CUAJ-CAN UROL ASSOC, V10, P83, DOI 10.5489/cuaj.3440; Leung L, 2016, J LAPAROENDOSC ADV S, V26, P318, DOI 10.1089/lap.2015.0095; Lip SZL, 2013, ARCH DIS CHILD, V98, P20, DOI 10.1136/archdischild-2012-302051; Lodwick D, 2017, UROLOGY, V100, P207, DOI 10.1016/j.urology.2016.08.003; Mandal S, 2013, J PEDIATR UROL, V9, P1093, DOI 10.1016/j.jpurol.2013.03.015; Menon P, 2015, J PEDIAT UROL, V11, DOI DOI 10.1016/J.JPUR0L.2014.10.014; Mitchell M., 1982, DIAL PEDIAT UROL, V5, P8; Morris RK, 2013, LANCET, V382, P1496, DOI 10.1016/S0140-6736(13)60992-7; MUREAU MAM, 1995, J UROLOGY, V154, P1351, DOI 10.1016/S0022-5347(01)66859-9; Nelson CP, 2016, ACAD PEDIATR, V16, P489, DOI 10.1016/j.acap.2015.11.003; Nelson CP, 2014, PEDIATRICS, V133, pE394, DOI 10.1542/peds.2013-2109; Nerli Rajendra Bapusaheb, 2013, Nephrourol Mon, V5, P801, DOI 10.5812/numonthly.9443; Nino F, 2016, CURR GENOMICS, V17, P70, DOI 10.2174/1389202916666151014223507; Ostlie DJ, 2015, J LAPAROENDOSC ADV S, V25, P536, DOI 10.1089/lap.2015.0183; Ozdemir T, 2013, TURK J UROL, V39, P232, DOI 10.5152/tud.2013.059; Pettersson A, 2007, NEW ENGL J MED, V356, P1835, DOI 10.1056/NEJMoa067588; Polzin WJ, 2017, FETAL DIAGN THER, V41, P51, DOI 10.1159/000445946; Priti K, 2004, PEDIATR SURG INT, V20, P136, DOI 10.1007/s00383-003-1107-1; Radmayr C, 2016, J PEDIATR UROL, V12, P335, DOI 10.1016/j.jpurol.2016.07.014; Rawashdeh YF, 2012, NEUROUROL URODYNAM, V31, P615, DOI 10.1002/nau.22248; Rickard M, 2017, J PEDIAT UROL, V13, pe1; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Routh JC, 2016, J UROLOGY, V196, P1728, DOI 10.1016/j.juro.2016.07.081; Ruano R, 2016, ULTRASOUND OBST GYN, V48, P476, DOI 10.1002/uog.15844; Rynja SP, 2011, J PEDIATR UROL, V7, P504, DOI 10.1016/j.jpurol.2011.02.008; Salle JLP, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2015.06.011; Sananes N, 2015, ULTRASOUND OBST GYN, V45, P183, DOI 10.1002/uog.13405; Scheepe JR, 2017, CURR OPIN UROL, V27, P14, DOI 10.1097/MOU.0000000000000352; Schneuer FJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2768; Schneuer FJ, 2015, ARCH DIS CHILD, V100, P1038, DOI 10.1136/archdischild-2015-308809; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; Skoog SJ, 2010, J UROLOGY, V184, P1145, DOI 10.1016/j.juro.2010.05.066; Smeulders N, 2011, J PEDIATR UROL, V7, P203, DOI 10.1016/j.jpurol.2010.04.011; Snodgrass W, 2016, UROL ANNALS, V8, P403, DOI 10.4103/0974-7796.192097; Snodgrass W, 2011, PEDIATRICS, V127, pE382, DOI 10.1542/peds.2010-1719; Springer A, 2016, J PEDIAT UROL, V12, DOI DOI 10.1016/J.JPUR0L.2015.12.002; Springer A, 2017, EUR UROL SUPPL, V16, P8, DOI 10.1016/j.eursup.2016.09.006; Sturm RM, 2016, CURR BLADDER DYSFUNC, V11, P225, DOI 10.1007/s11884-016-0371-6; Tullus K, 2015, LANCET, V385, P371, DOI 10.1016/S0140-6736(14)60383-4; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; Varda BK, 2014, J UROLOGY, V191, P1090, DOI 10.1016/j.juro.2013.10.077; Wang HHS, 2015, J UROLOGY, V193, P963, DOI 10.1016/j.juro.2014.08.112; Wayne C, 2015, PEDIATR SURG INT, V31, P327, DOI 10.1007/s00383-015-3676-1; Wilkinson DJ, 2012, J PEDIATR UROL, V8, P307, DOI 10.1016/j.jpurol.2010.11.008; Wozniak MM, 2016, EUR J RADIOL, V85, P1238, DOI 10.1016/j.ejrad.2015.11.006; Yap TL, 2016, J PEDIATR SURG, V51, P2015, DOI 10.1016/j.jpedsurg.2016.09.028	96	14	20	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1061	1071		10.1016/S0140-6736(17)32282-1	http://dx.doi.org/10.1016/S0140-6736(17)32282-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG1BW	28901936	Green Submitted			2022-12-28	WOS:000409528600024
J	DeSantis, ME; Cianfrocco, MA; Htet, ZM; Tran, PT; Reck-Peterson, SL; Leschziner, AE				DeSantis, Morgan E.; Cianfrocco, Michael A.; Htet, Zaw Min; Tran, Phuoc Tien; Reck-Peterson, Samara L.; Leschziner, Andres E.			Lis1 Has Two Opposing Modes of Regulating Cytoplasmic Dynein	CELL			English	Article							MICROTUBULE PLUS-ENDS; BEAM-INDUCED MOTION; SACCHAROMYCES-CEREVISIAE; AXONAL-TRANSPORT; MOTOR DOMAIN; MITOCHONDRIAL TRANSPORT; ELECTRON-MICROGRAPHS; ORGANELLE TRANSPORT; DIRECTED TRANSPORT; DISTINCT FUNCTIONS	Regulation is central to the functional versatility of cytoplasmic dynein, a motor involved in intracellular transport, cell division, and neurodevelopment. Previous work established that Lis1, a conserved regulator of dynein, binds to its motor domain and induces a tight microtubule-binding state in dynein. The work we present here-a combination of biochemistry, single-molecule assays, and cryoelectron microscopy-led to the surprising discovery that Lis1 has two opposing modes of regulating dynein, being capable of inducing both low and high affinity for the microtubule. We show that these opposing modes depend on the stoichiometry of Lis1 binding to dynein and that this stoichiometry is regulated by the nucleotide state of dynein's AAA3 domain. The low-affinity state requires Lis1 to also bind to dynein at a novel conserved site, mutation of which disrupts Lis1's function in vivo. We propose a new model for the regulation of dynein by Lis1.	[DeSantis, Morgan E.; Cianfrocco, Michael A.; Htet, Zaw Min; Tran, Phuoc Tien; Reck-Peterson, Samara L.; Leschziner, Andres E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Htet, Zaw Min] Harvard Univ, Biophys Grad Program, Boston, MA 92105 USA; [Reck-Peterson, Samara L.] Univ Calif San Diego, Sect Cellular & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Leschziner, Andres E.] Univ Calif San Diego, Sect Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Cianfrocco, Michael A.] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Reck-Peterson, SL; Leschziner, AE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Reck-Peterson, SL (corresponding author), Univ Calif San Diego, Sect Cellular & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA.; Leschziner, AE (corresponding author), Univ Calif San Diego, Sect Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	sreckpeterson@ucsd.edu; aleschziner@ucsd.edu		Tran, Tien Phuoc/0000-0003-3354-5907; Htet, Zaw/0000-0003-2914-7682; Leschziner, Andres/0000-0002-7732-7023	NSF [ACI-1548562, DGE1144152]; Jane Coffin Childs Memorial Fund [61-1552-T]; Damon Runyon Cancer Research Foundation [2171-13]; NIH [R01GM107214]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107214] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Kellog (University of California, Berkeley) for the distance comparison script; the University of California, San Diego (UCSD) Cryo-EM facility; A. Desai for access to a spinning disk microscope; the UCSD Physics IT group; and W. Lee (University of Massachusetts, Amherst) for yeast strains. We used the Extreme Science and Engineering Discovery Environment (XSEDE) for computing allocations (MCB160079 to Z.M.H. and MCB140257 to A.E.L.), supported by NSF grant ACI-1548562. M.E.D. is supported by the Jane Coffin Childs Memorial Fund (61-1552-T), M.A.C. by the Damon Runyon Cancer Research Foundation (2171-13), Z.M.H. by a NSF graduate research fellowship (DGE1144152), S.L.R.-P. and A.E.L. by NIH grant R01GM107214, and S.L.R.-P. is an HHMI-Simons Foundation Faculty Scholar.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Baumbach J, 2017, ELIFE, V6, DOI 10.7554/eLife.21768; Bhabha G, 2014, CELL, V159, P857, DOI 10.1016/j.cell.2014.10.018; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Caudron F, 2008, J CELL SCI, V121, P1506, DOI 10.1242/jcs.023374; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cianfrocco MA, 2015, ELIFE, V4, DOI 10.7554/eLife.06664; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; DeWitt MA, 2015, NAT STRUCT MOL BIOL, V22, P73, DOI 10.1038/nsmb.2930; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Dix CI, 2013, J CELL BIOL, V202, P479, DOI 10.1083/jcb.201211052; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Gleave ES, 2014, J STRUCT BIOL, V186, P367, DOI 10.1016/j.jsb.2014.03.019; Gutierrez PA, 2017, J BIOL CHEM, V292, P12245, DOI 10.1074/jbc.M117.790048; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Klinman E, 2015, CELL REP, V12, P462, DOI 10.1016/j.celrep.2015.06.032; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Markus SM, 2011, CYTOSKELETON, V68, P157, DOI 10.1002/cm.20502; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mogami T, 2007, J BIOL CHEM, V282, P21639, DOI 10.1074/jbc.M701914200; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Nicholas MP, 2015, P NATL ACAD SCI USA, V112, P6371, DOI 10.1073/pnas.1417422112; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reddy BJN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12259; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roberts AJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02641; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Shao CY, 2013, TRAFFIC, V14, P785, DOI 10.1111/tra.12070; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toropova K, 2014, ELIFE, V3, DOI 10.7554/eLife.03372; Twelvetrees AE, 2016, NEURON, V90, P1000, DOI 10.1016/j.neuron.2016.04.046; Vagnoni A, 2016, J CELL SCI, V129, P178, DOI 10.1242/jcs.179184; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	61	42	42	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1197	1208		10.1016/j.cell.2017.08.037	http://dx.doi.org/10.1016/j.cell.2017.08.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886386	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000409536000016
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, MJ; Davidson, KW; Doubeni, CA; Epling, JW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W., Jr.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Vision Screening in Children Aged 6 Months to 5 Years US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; EYE-DISEASE-STUDI; PRESCHOOL-CHILDREN; VISUAL IMPAIRMENT; RISK-FACTORS; AMBLYOPIA TREATMENT; OUTCOMES; PREVALENCE; MYOPIA; TERM	IMPORTANCE One of the most important causes of vision abnormalities in children is amblyopia (also known as "lazy eye"). Amblyopia is an alteration in the visual neural pathway in a child's developing brain that can lead to permanent vision loss in the affected eye. Among children younger than 6 years, 1% to 6% have amblyopia or its risk factors (strabismus, anisometropia, or both). Early identification of vision abnormalities could prevent the development of amblyopia. SUBPOPULATION CONSIDERATIONS Studies show that screening rates among children vary by race/ethnicity and family income. Data based on parent reports from 2009-2010 indicated identical screening rates among black non-Hispanic children and white non-Hispanic children (80.7%); however, Hispanic children were less likely than non-Hispanic children to report vision screening (69.8%). Children whose families earned 200% or more above the federal poverty level were more likely to report vision screening than families with lower incomes. OBJECTIVE To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for amblyopia and its risk factors in children. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy of vision screening tests and the benefits and harms of vision screening and treatment. Surgical interventions were considered to be out of scope for this review. FINDINGS Treatment of amblyopia is associated with moderate improvements in visual acuity in children aged 3 to 5 years, which are likely to result in permanent improvements in vision throughout life. The USPSTF concluded that the benefits are moderate because untreated amblyopia results in permanent, uncorrectable vision loss, and the benefits of screening and treatment potentially can be experienced over a child's lifetime. The USPSTF found adequate evidence to bound the potential harms of treatment (ie, higher false-positive rates in low-prevalence populations) as small. Therefore, the USPSTF concluded with moderate certainty that the overall net benefit is moderate for children aged 3 to 5 years. CONCLUSIONS AND RECOMMENDATIONS The USPSTF recommends vision screening at least once in all children aged 3 to 5 years to detect amblyopia or its risk factors. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of vision screening in children younger than 3 years. (I statement)	[Grossman, David C.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98112 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, John W., Jr.] Virginia Tech, Caril Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA 98112 USA.	chair@uspstf.net	Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, 2011, CLIN PREV SERV REC V; American Academy of Ophthalmology Pediatric Ophthalmology/Strabismus_Panel, 2012, PREF PRACT PATT GUID; American Optometric Association, 2002, OPT CLIN PRACT GUID; Awan M, 2005, INVEST OPHTH VIS SCI, V46, P1435, DOI 10.1167/iovs.04-0971; Barton M, 2011, PEDIATRICS, V127, P340, DOI 10.1542/peds.2010-3177; Bell AL, 2013, AM FAM PHYSICIAN, V88, P241; Borchert MS, 2011, OPHTHALMOLOGY, V118, P1966, DOI 10.1016/j.ophtha.2011.06.030; Carlton J, 2008, Health Technol Assess, V12, pxi; Carlton J, 2008, HEALTH TECHNOL ASSES, V12, pxi; Chua B, 2004, BRIT J OPHTHALMOL, V88, P1119, DOI 10.1136/bjo.2004.041863; Clarke MP, 2003, BMJ-BRIT MED J, V327, P1251, DOI 10.1136/bmj.327.7426.1251; Cogen M S, 1992, Ala Med, V62, P16; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; Donahue SP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3597; Doshi NR, 2007, AM FAM PHYSICIAN, V75, P361; EPELBAUM M, 1993, OPHTHALMOLOGY, V100, P323; Flynn J T, 1998, Trans Am Ophthalmol Soc, V96, P431; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Horwood J, 2005, INVEST OPHTH VIS SCI, V46, P1177, DOI 10.1167/iovs.04-0597; Hrisos S, 2004, OPHTHALMOLOGY, V111, P1550, DOI 10.1016/j.ophtha.2003.12.059; Hutchinson K., 2012, OPEN J OPHTHALMOL, V2, P9; Jonas DE, 2017, JAMA-J AM MED ASSOC, V318, P845, DOI 10.1001/jama.2017.9900; Jonas DE, 2017, AHRQ PUBLICATION, V14-05216-EF-1; Kemper Alex R, 2014, MMWR Suppl, V63, P43; Marsh-Tootle WL, 2010, OPTOMETRY VISION SCI, V87, P104, DOI 10.1097/OPX.0b013e3181cc8d7c; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; McKean-Cowdin R, 2011, OPHTHALMOLOGY, V118, P1974, DOI 10.1016/j.ophtha.2011.06.031; Miller JM, 2012, PEDIATRICS, V130, P983, DOI 10.1542/peds.2012-2548; Packwood EA, 1999, J AAPOS, V3, P15, DOI 10.1016/S1091-8531(99)70089-3; Quinn GE, 2013, J AAPOS, V17, P124, DOI 10.1016/j.jaapos.2012.10.025; Rahi JS, 2006, BRIT MED J, V332, P820, DOI 10.1136/bmj.38751.597963.AE; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Schmidt P, 2005, INVEST OPHTH VIS SCI, V46, P2639, DOI 10.1167/iovs.05-0141; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Tarczy-Hornoch K, 2011, OPHTHALMOLOGY, V118, P2262, DOI 10.1016/j.ophtha.2011.06.033; van Leeuwen R, 2007, BRIT J OPHTHALMOL, V91, P1450, DOI 10.1136/bjo.2006.113670; VANHOFVANDUIN J, 1989, EARLY HUM DEV, V20, P255, DOI 10.1016/0378-3782(89)90011-X; Varma R, 2009, OPHTHALMOLOGY, V116, P1990, DOI 10.1016/j.ophtha.2009.03.027; Wallace DK, 2006, OPHTHALMOLOGY, V113, P904, DOI 10.1016/j.ophtha.2006.01.069; Webber AL, 2008, OPTOMETRY VISION SCI, V85, P1074, DOI 10.1097/OPX.0b013e31818b9911; Webber Ann L, 2005, Clin Exp Optom, V88, P365; Williams C, 2002, BMJ-BRIT MED J, V324, P1549, DOI 10.1136/bmj.324.7353.1549; Williams C, 2001, Ophthalmic Epidemiol, V8, P279; Ying GS, 2014, OPHTHALMOLOGY, V121, P630, DOI 10.1016/j.ophtha.2013.09.036	44	65	66	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					836	844		10.1001/jama.2017.11260	http://dx.doi.org/10.1001/jama.2017.11260			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873168				2022-12-28	WOS:000409183700015
J	Oliver, D				Oliver, David			David Oliver: "Progressive dwindling," frailty, and realistic expectations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Age UK, 2015, DONT CALL ME FRAIL; Bowman C, 2014, J ROY SOC MED, V107, P95, DOI 10.1177/0141076813512298; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Lynn J, 2003, RAND HLTH; Oliver D., 2016, BMJ-BRIT MED J, V358, pi458; Oliver D, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5195; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9	7	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358								j3954	10.1136/bmj.j3954	http://dx.doi.org/10.1136/bmj.j3954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874343	Bronze, Green Published			2022-12-28	WOS:000410575100015
J	Kattel, S; Ramirez, PJ; Chen, JGG; Rodriguez, JA; Liu, P				Kattel, Shyam; Ramirez, Pedro J.; Chen, Jingguang G.; Rodriguez, Jose A.; Liu, Ping			Response to Comment on "Active sites for CO2 hydrogenation to methanol on Cu/ZnO catalysts"	SCIENCE			English	Editorial Material							OXIDE; ZNO	In their Comment on the our recent Report, Nakamura et al. argue that our x-ray photoelectron spectroscopy (XPS) analysis was affected by the presence of formate species on the catalyst surface. This argument is not valid because the reactant gases were evacuated at temperatures from 525 to 575 kelvin, conditions under which formate is not stable on the catalyst surface. An analysis of the XPS results obtained after exposing zinc oxide/copper (111) [ZnO/Cu(111)] surfaces to hydrogen (H-2) and mixtures of carbon dioxide (CO2)/H-2 show an absence of carbon (C) 1s signal, no asymmetries in the oxygen (O) 1s peak, and a Zn:O intensity close to 1:1. Thus, the most active phase of these catalysts contained a ZnO-Cu interface.	[Kattel, Shyam; Chen, Jingguang G.; Rodriguez, Jose A.; Liu, Ping] Brookhaven Natl Lab, Div Chem, Upton, NY 11973 USA; [Ramirez, Pedro J.] Cent Univ Venezuela, Fac Ciencias, Caracas 1020A, Venezuela; [Chen, Jingguang G.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Rodriguez, Jose A.; Liu, Ping] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11790 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; University of Central Venezuela; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, JGG; Rodriguez, JA; Liu, P (corresponding author), Brookhaven Natl Lab, Div Chem, Upton, NY 11973 USA.; Chen, JGG (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.; Rodriguez, JA; Liu, P (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11790 USA.	jgchen@columbia.edu; rodrigez@bnl.gov; pingliu3@bnl.gov	Kattel, Shyam/AAK-6985-2020	Rodriguez, Jose/0000-0002-5680-4214; Ramirez, Pedro/0000-0002-6236-5545				Graciani J, 2014, SCIENCE, V345, P546, DOI 10.1126/science.1253057; Kattel S, 2017, SCIENCE, V355, P1296, DOI 10.1126/science.aal3573; Li CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7538; LUDVIKSSON A, 1994, SURF SCI, V313, P64, DOI 10.1016/0039-6028(94)91157-6; Lunkenbein T, 2015, ANGEW CHEM INT EDIT, V54, P4544, DOI 10.1002/anie.201411581; Martin O, 2016, ANGEW CHEM INT EDIT, V55, P6261, DOI 10.1002/anie.201600943; Nakamura J, 1996, J CATAL, V160, P65, DOI 10.1006/jcat.1996.0124; Nakamura J, 1996, CATAL TODAY, V28, P223, DOI 10.1016/0920-5861(95)00240-5; Nakamura J, 2017, SCIENCE, V357, DOI 10.1126/science.aan8074; Schon G., 1973, Journal of Electron Spectroscopy and Related Phenomena, V2, P75, DOI 10.1016/0368-2048(73)80049-0; Senanayake SD, 2016, J PHYS CHEM C, V120, P1778, DOI 10.1021/acs.jpcc.5b12012	11	26	29	12	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354							eaan8210	10.1126/science.aan8210	http://dx.doi.org/10.1126/science.aan8210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860355	Green Submitted			2022-12-28	WOS:000408734900002
J	Liu, XD; Dalladay-Simpson, P; Howie, RT; Li, B; Gregoryanz, E				Liu, Xiao-Di; Dalladay-Simpson, Philip; Howie, Ross T.; Li, Bing; Gregoryanz, Eugene			Comment on "Observation of the Wigner-Huntington transition to metallic hydrogen"	SCIENCE			English	Editorial Material							DENSE HYDROGEN	Dias and Silvera (Research Article, 17 February 2017, p. 715) claim the observation of the Wigner-Huntington transition to metallic hydrogen at 495 gigapascals. We show that neither the claims of the record pressure nor the phase transition to a metallic state are supported by data and that the data contradict the authors' own unconfirmed previous results.	[Liu, Xiao-Di; Gregoryanz, Eugene] Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei, Anhui, Peoples R China; [Dalladay-Simpson, Philip; Howie, Ross T.; Li, Bing; Gregoryanz, Eugene] Ctr High Pressure Sci & Technol Adv Res, Shanghai, Peoples R China; [Li, Bing] Florida Int Univ, Ctr Study Matter Extreme Condit, Dept Mech & Mat Engn, Miami, FL 33199 USA; [Gregoryanz, Eugene] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh, Midlothian, Scotland; [Gregoryanz, Eugene] Univ Edinburgh, Sch Phys & Astron, Edinburgh, Midlothian, Scotland	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; State University System of Florida; Florida International University; University of Edinburgh; University of Edinburgh	Gregoryanz, E (corresponding author), Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei, Anhui, Peoples R China.; Gregoryanz, E (corresponding author), Ctr High Pressure Sci & Technol Adv Res, Shanghai, Peoples R China.; Gregoryanz, E (corresponding author), Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh, Midlothian, Scotland.; Gregoryanz, E (corresponding author), Univ Edinburgh, Sch Phys & Astron, Edinburgh, Midlothian, Scotland.	e.gregoryanz@ed.ac.uk		Liu, Xiao-Di/0000-0002-0067-7244; Gregoryanz, Eugene/0000-0001-9080-8756; Howie, Ross/0000-0002-7013-8211				Dalladay-Simpson P, 2016, NATURE, V529, P63, DOI 10.1038/nature16164; Dias R., 2016, ARXIV1603; Dias RP, 2017, SCIENCE, V355, P715, DOI 10.1126/science.aal1579; Dubrovinsky L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2160; Eremets M., 2017, ARXIV1702; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Goncharov A., 2017, ARXIV1702; Howie RT, 2015, NAT MATER, V14, P495, DOI [10.1038/NMAT4213, 10.1038/nmat4213]; Howie RT, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.175501; Howie RT, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818606; Howie RT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.214104; Howie RT, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.125501; Loubeyre P., 2017, ARXIV1702; Loubeyre P, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134101; Zha CS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217402	15	48	50	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353							eaan2286	10.1126/science.aan2286	http://dx.doi.org/10.1126/science.aan2286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839046	Green Submitted, Bronze			2022-12-28	WOS:000408327900003
J	Wheeler-Dubas, M				Wheeler-Dubas, Maria			How I found my outreach niche	SCIENCE			English	Editorial Material									[Wheeler-Dubas, Maria] Phipps Conservatory & Bot Gardens, Pittsburgh, PA 15213 USA		Wheeler-Dubas, M (corresponding author), Phipps Conservatory & Bot Gardens, Pittsburgh, PA 15213 USA.	SciCareerEditor@aaas.org							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					838	838		10.1126/science.357.6353.838	http://dx.doi.org/10.1126/science.357.6353.838			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839074				2022-12-28	WOS:000408327900047
J	Bress, AP; Bellows, BK; King, JB; Hess, R; Beddhu, S; Zhang, Z; Berlowitz, DR; Conroy, MB; Fine, L; Oparil, S; Morisky, DE; Kazis, LE; Ruiz-Negron, N; Powell, J; Tamariz, L; Whittle, J; Wright, JT; Supiano, MA; Cheung, AK; Weintraub, WS; Moran, AE				Bress, A. P.; Bellows, B. K.; King, J. B.; Hess, R.; Beddhu, S.; Zhang, Z.; Berlowitz, D. R.; Conroy, M. B.; Fine, L.; Oparil, S.; Morisky, D. E.; Kazis, L. E.; Ruiz-Negron, N.; Powell, J.; Tamariz, L.; Whittle, J.; Wright, J. T., Jr.; Supiano, M. A.; Cheung, A. K.; Weintraub, W. S.; Moran, A. E.		SPRINT Res Grp	Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASSOCIATION TASK-FORCE; CARDIOVASCULAR-DISEASE; AMERICAN-COLLEGE; HEART-FAILURE; ADHERENCE; HEALTH; RISK; RECOMMENDATIONS; HYPERTENSION; GUIDELINES	BACKGROUND In the Systolic Blood Pressure Intervention Trial (SPRINT), adults at high risk for cardiovascular disease who received intensive systolic blood-pressure control (target, <120 mm Hg) had significantly lower rates of death and cardiovascular disease events than did those who received standard control (target, <140 mm Hg). On the basis of these data, we wanted to determine the lifetime health benefits and health care costs associated with intensive control versus standard control. METHODS We used a microsimulation model to apply SPRINT treatment effects and health care costs from national sources to a hypothetical cohort of SPRINT-eligible adults. The model projected lifetime costs of treatment and monitoring in patients with hypertension, cardiovascular disease events and subsequent treatment costs, treatment-related risks of serious adverse events and subsequent costs, and quality-adjusted life-years (QALYs) for intensive control versus standard control of systolic blood pressure. RESULTS We determined that the mean number of QALYs would be 0.27 higher among patients who received intensive control than among those who received standard control and would cost approximately $47,000 more per QALY gained if there were a reduction in adherence and treatment effects after 5 years; the cost would be approximately $28,000 more per QALY gained if the treatment effects persisted for the remaining lifetime of the patient. Most simulation results indicated that intensive treatment would be cost-effective (51 to 79% below the willingness-to-pay threshold of $50,000 per QALY and 76 to 93% below the threshold of $100,000 per QALY), regardless of whether treatment effects were reduced after 5 years or persisted for the remaining lifetime. CONCLUSIONS In this simulation study, intensive systolic blood-pressure control prevented cardiovascular disease events and prolonged life and did so at levels below common willingness-to-pay thresholds per QALY, regardless of whether benefits were reduced after 5 years or persisted for the patient's remaining lifetime.	[Bress, A. P.; Hess, R.; Conroy, M. B.] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84112 USA; [Bellows, B. K.; Ruiz-Negron, N.] Univ Utah, Sch Med, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA; [Hess, R.; Conroy, M. B.] Univ Utah, Sch Med, Div Gen Internal Med, Salt Lake City, UT 84112 USA; [Beddhu, S.; Cheung, A. K.] Univ Utah, Sch Med, Div Nephrol & Hypertens, Salt Lake City, UT 84112 USA; [Supiano, M. A.] Univ Utah, Sch Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Beddhu, S.; Cheung, A. K.] Univ Utah, Sch Med, Dept Internal Med, Med Serv,Vet Affairs Salt Lake City Healthcare Sy, Salt Lake City, UT 84112 USA; [Supiano, M. A.] VA Salt Lake City Geriatr Res, Educ & Clin Ctr, Salt Lake City, UT USA; [Bellows, B. K.; Ruiz-Negron, N.] SelectHealth, Murray, UT USA; [King, J. B.] Kaiser Permanente Colorado, Dept Pharm, Aurora, CO USA; [Zhang, Z.; Weintraub, W. S.] Christiana Care Hlth Syst, Newark, DE USA; [Berlowitz, D. R.] Bedford VA Med Ctr, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Berlowitz, D. R.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Kazis, L. E.] Boston Univ, Sch Publ Hlth, Ctr Assessment Pharmaceut Practices, Dept Hlth Law Policy & Management, Boston, MA USA; [Fine, L.] NHLBI, Clin Applicat & Prevent Branch, Div Cardiovasc Sci, Bethesda, MD USA; [Oparil, S.] Univ Alabama Birmingham, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL USA; [Morisky, D. E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA; [Powell, J.] East Carolina Univ, Brody Sch Med, Div Gen Internal Med, Greenville, NC USA; [Tamariz, L.] Univ Miami & Geriatr Res, Div Populat Hlth & Computat Med, Educ & Clin Ctr, Miami, VA USA; [Whittle, J.] Clement J Zablocki VA Med Ctr, Milwaukee, WI USA; [Whittle, J.] Med Coll Wisconsin, Dept Med, Wauwatosa, WI USA; [Wright, J. T., Jr.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA; [Moran, A. E.] Columbia Univ, Med Ctr, Dept Med, Div Gen Med, New York, NY USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Kaiser Permanente; Christiana Care Health System; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of North Carolina; East Carolina University; Medical College of Wisconsin; Case Western Reserve University; Case Western Reserve University Hospital; Columbia University	Bress, AP (corresponding author), Univ Utah, Sch Med, 295 Chipeta Way, Salt Lake City, UT 84108 USA.	adam.bress@hsc.utah.edu	Morisky, Donald/AAU-4679-2021; King, Jordan/GSI-5222-2022	Whittle, Jeff/0000-0002-9544-838X; Supiano, Mark/0000-0002-5438-5087; Ruiz-Negron, Natalia/0000-0003-1775-8128; Berlowitz, Dan/0000-0002-8783-5611; Tamariz, Leonardo/0000-0003-1583-3534	National Heart, Lung, and Blood Institute [1K01HL133468-01, R01 HL130500-01A1]; National Institute of General Medical Sciences [U54-GM10494]; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Institute of Neurological Disorders and Stroke through the Department of Veterans Affairs [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; National Institute of Neurological Disorders and Stroke through Clinical and Translational Science Awards Programs [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; National Center for Advancing Translational Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130500, K01HL133468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke through the Department of Veterans Affairs; National Institute of Neurological Disorders and Stroke through Clinical and Translational Science Awards Programs; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants (1K01HL133468-01, to Dr. Bress; and R01 HL130500-01A1, to Drs. Moran and Bellows) from the National Heart, Lung, and Blood Institute and a grant (U54-GM10494, to Drs. Weintraub and Zhang) from the National Institute of General Medical Sciences. SPRINT is funded by the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke (contract numbers HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C, and Interagency Agreement Number A-HL-13-002-001), through the Department of Veterans Affairs, and through Clinical and Translational Science Awards Programs funded by the National Center for Advancing Translational Sciences.	Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; Anderson JL, 2014, J AM COLL CARDIOL, V63, P2304, DOI 10.1016/j.jacc.2014.03.016; [Anonymous], 2015, 2015 ANN DAT REP; Arias Elizabeth, 2013, Natl Vital Stat Rep, V61, P1; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Bress AP, 2017, CIRCULATION, V135, P1617, DOI 10.1161/CIRCULATIONAHA.116.025322; Bress AP, 2016, J AM COLL CARDIOL, V67, P463, DOI 10.1016/j.jacc.2015.10.037; Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421; Centers for Disease Control and Prevention, 2013, CHRON DIS COST CALC; Centers for Medicare & Medicaid Ser- vices, 2016, LAB FEE SCHED; Centers for Medicare & Medicaid Services, 2016, PHYS FEES SCHED; Cook NR, 2016, ANN INTERN MED, V165, P786, DOI 10.7326/M16-1739; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Gabb GM, 2016, MED J AUSTRALIA, V205, P85, DOI 10.5694/mja16.00526; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Haley WE, 2016, J AM SOC HYPERTENS, V10, P857, DOI 10.1016/j.jash.2016.08.009; Healthcare Cost and Utilization Project (HCUP), 2013, STAT HOSOP STAYS; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jones DE, 2012, PATIENT EDUC COUNS, V89, P57, DOI 10.1016/j.pec.2012.06.003; King JB, 2016, JACC-HEART FAIL, V4, P392, DOI 10.1016/j.jchf.2016.02.007; Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Moise N, 2016, HYPERTENSION, V68, P88, DOI 10.1161/HYPERTENSIONAHA.115.06814; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Richman IB, 2016, JAMA CARDIOL, V1, P872, DOI 10.1001/jamacardio.2016.3517; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Trogdon JG, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150131; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3; Xu KT, 2005, J HUM HYPERTENS, V19, P365, DOI 10.1038/sj.jhh.1001828; Yao GQ, 2008, PHARMACOECONOMICS, V26, P879, DOI 10.2165/00019053-200826100-00007	38	96	97	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					745	755		10.1056/NEJMsa1616035	http://dx.doi.org/10.1056/NEJMsa1616035			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ9IS	28834469	Green Accepted, Bronze			2022-12-28	WOS:000413090000007
J	Goodwin, CAP; Ortu, F; Reta, D; Chilton, NF; Mills, DP				Goodwin, Conrad A. P.; Ortu, Fabrizio; Reta, Daniel; Chilton, Nicholas F.; Mills, David P.			Molecular magnetic hysteresis at 60 kelvin in dysprosocenium	NATURE			English	Article							SINGLE-ION MAGNET; SPIN QUBITS; RELAXATION; ANISOTROPY; COMPLEXES; BLOCKING	Lanthanides have been investigated extensively for potential applications in quantum information processing and high-density data storage at the molecular and atomic scale. Experimental achievements include reading and manipulating single nuclear spins(1,2), exploiting atomic clock transitions for robust qubits(3) and, most recently, magnetic data storage in single atoms(4,5). Single-molecule magnets exhibit magnetic hysteresis of molecular origin(6)-a magnetic memory effect and a prerequisite of data storage-and so far lanthanide examples have exhibited this phenomenon at the highest temperatures. However, in the nearly 25 years since the discovery of single-molecule magnets(7), hysteresis temperatures have increased from 4 kelvin to only about 14 kelvin(8-10) using a consistent magnetic field sweep rate of about 20 oersted per second, although higher temperatures have been achieved by using very fast sweep rates(11,12) (for example, 30 kelvin with 200 oersted per second)(12). Here we report a hexa-tert-butyldysprosocenium complex-[Dy(Cp-ttt)(2)][B(C6F5)(4)], with Cp-ttt = {(C5H2Bu3)-Bu-t-1,2,4} and Bu-t = C(CH3)(3)-which exhibits magnetic hysteresis at temperatures of up to 60 kelvin at a sweep rate of 22 oersted per second. We observe a clear change in the relaxation dynamics at this temperature, which persists in magnetically diluted samples, suggesting that the origin of the hysteresis is the localized metal-ligand vibrational modes that are unique to dysprosocenium. Ab initio calculations of spin dynamics demonstrate that magnetic relaxation at high temperatures is due to local molecular vibrations. These results indicate that, with judicious molecular design, magnetic data storage in single molecules at temperatures above liquid nitrogen should be possible.	[Goodwin, Conrad A. P.; Ortu, Fabrizio; Reta, Daniel; Chilton, Nicholas F.; Mills, David P.] Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England	University of Manchester	Chilton, NF; Mills, DP (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	nicholas.chilton@manchester.ac.uk; david.mills@manchester.ac.uk	Ortu, Fabrizio/K-7128-2015; Goodwin, Conrad/GRS-3753-2022; Mills, David/A-4395-2013; Ortu, Fabrizio/R-9799-2019; Goodwin, Conrad/I-6094-2016; Mills, David/GXF-1821-2022; Goodwin, Conrad/AAZ-4103-2020; RETA, DANIEL/H-6853-2015	Ortu, Fabrizio/0000-0002-1743-8338; Goodwin, Conrad/0000-0002-4320-2548; Mills, David/0000-0003-1575-7754; Ortu, Fabrizio/0000-0002-1743-8338; Goodwin, Conrad/0000-0002-4320-2548; Goodwin, Conrad/0000-0002-4320-2548; RETA, DANIEL/0000-0003-0000-9892; Cador, Olivier/0000-0003-2064-6223	Engineering and Physical Sciences Research Council [EP/P002560/1]; Ramsay Memorial Fellowships Trust; University of Manchester; EPSRC [EP/P002560/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1329386] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ramsay Memorial Fellowships Trust; University of Manchester; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge funding from the Engineering and Physical Sciences Research Council (studentship to C.A.P.G. and EP/P002560/1 for F.O. and D.R.), the Ramsay Memorial Fellowships Trust (fellowship to N.F.C.) and the University of Manchester. We thank the University of Manchester for access to the SQUID magnetometer and Computational Shared Facility and R.E.P. Winpenny, E. J. L. McInnes and D. Collison for comments.	Abragam A., 1970, ELECTRON PARAMAGNETI; Berkefeld A, 2012, J AM CHEM SOC, V134, P10843, DOI 10.1021/ja300591v; Chen YC, 2016, J AM CHEM SOC, V138, P2829, DOI 10.1021/jacs.5b13584; Chilton NF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3551; Demir S, 2014, CHEM-EUR J, V20, P9524, DOI 10.1002/chem.201403751; Demir S, 2012, J AM CHEM SOC, V134, P18546, DOI 10.1021/ja308945d; Ding YS, 2016, ANGEW CHEM INT EDIT, V55, P16071, DOI 10.1002/anie.201609685; Donati F, 2016, SCIENCE, V352, P318, DOI 10.1126/science.aad9898; Escalera-Moreno L, 2017, J PHYS CHEM LETT, V8, P1695, DOI 10.1021/acs.jpclett.7b00479; Evans WJ, 2003, J AM CHEM SOC, V125, P5204, DOI 10.1021/ja020957x; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Gregson M, 2016, CHEM SCI, V7, P155, DOI 10.1039/c5sc03111g; Guo F.-S., 2017, ANGEW CHEM INT ED; Gupta SK, 2016, CHEM SCI, V7, P5181, DOI 10.1039/c6sc00279j; Jeletic M, 2011, J AM CHEM SOC, V133, P19286, DOI 10.1021/ja207891y; Jiang SD, 2012, INORG CHEM, V51, P3079, DOI 10.1021/ic202511n; Jiang SD, 2011, J AM CHEM SOC, V133, P4730, DOI 10.1021/ja200198v; Kaita S, 2003, MACROMOL RAPID COMM, V24, P180; Liu J, 2016, J AM CHEM SOC, V138, P5441, DOI 10.1021/jacs.6b02638; Lunghi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14620; Meng YS, 2016, CHEM-EUR J, V22, P12724, DOI 10.1002/chem.201601934; Natterer FD, 2017, NATURE, V543, P226, DOI 10.1038/nature21371; Rinehart JD, 2011, CHEM SCI, V2, P2078, DOI 10.1039/c1sc00513h; Rinehart JD, 2011, J AM CHEM SOC, V133, P14236, DOI 10.1021/ja206286h; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Shiddiq M, 2016, NATURE, V531, P348, DOI 10.1038/nature16984; SHRIVASTAVA KN, 1983, PHYS STATUS SOLIDI B, V117, P437, DOI 10.1002/pssb.2221170202; Stoyanov ES, 2008, CHEM-EUR J, V14, P7880, DOI 10.1002/chem.200800337; Thiele S, 2014, SCIENCE, V344, P1135, DOI 10.1126/science.1249802; Vincent R, 2012, NATURE, V488, P357, DOI 10.1038/nature11341; Zhang P, 2014, J AM CHEM SOC, V136, P4484, DOI 10.1021/ja500793x	31	1133	1139	19	358	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					439	442		10.1038/nature23447	http://dx.doi.org/10.1038/nature23447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28836589	Green Accepted			2022-12-28	WOS:000408279000035
J	Azizi, M				Azizi, Michel			Catheter-based renal denervation for treatment of hypertension	LANCET			English	Editorial Material							TRIAL; DESIGN		[Azizi, Michel] Univ Paris 05, Paris, France; [Azizi, Michel] Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, F-75015 Paris, France; [Azizi, Michel] Ctr Invest Clin, Inst Natl Sante & Rech Med, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Azizi, M (corresponding author), Univ Paris 05, Paris, France.; Azizi, M (corresponding author), Hop Europeen Georges Pompidou, AP HP, Hypertens Unit, F-75015 Paris, France.; Azizi, M (corresponding author), Ctr Invest Clin, Inst Natl Sante & Rech Med, Paris, France.	michel.azizi@aphp.fr	Azizi, Michel/Y-9580-2019		Recor; Actelion; CVRx; Quantum genomics	Recor; Actelion; CVRx; Quantum genomics	I have received grants and non-financial support from Recor and Actelion, personal fees from CVRx, and grants from Quantum genomics.	Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Kandzari DE, 2016, AM HEART J, V171, P82, DOI 10.1016/j.ahj.2015.08.021; Mahfoud F, 2017, EUR HEART J, V38, P3272, DOI 10.1093/eurheartj/ehx215; Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Persu A, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-015-0610-9; Persu A, 2014, J HYPERTENS, V32, P2101, DOI 10.1097/HJH.0000000000000323; Pocock SJ, 2015, J AM COLL CARDIOL, V66, P2886, DOI 10.1016/j.jacc.2015.10.051; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Townsend RR, 2017, LANCET; White WB, 2014, J AM SOC HYPERTENS, V8, P743, DOI 10.1016/j.jash.2014.06.005	12	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2017	390	10108					2124	2126		10.1016/S0140-6736(17)32293-6	http://dx.doi.org/10.1016/S0140-6736(17)32293-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0CL	28859945				2022-12-28	WOS:000415642200005
J	Saag, KG; Petersen, J; Brandi, ML; Karaplis, AC; Lorentzon, M; Thomas, T; Maddox, J; Fan, M; Meisner, PD; Grauer, A				Saag, Kenneth G.; Petersen, Jeffrey; Brandi, Maria Luisa; Karaplis, Andrew C.; Lorentzon, Mattias; Thomas, Thierry; Maddox, Judy; Fan, Michelle; Meisner, Paul D.; Grauer, Andreas			Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; STRENGTH; SCLEROSTEOSIS; METAANALYSIS; DISEASE; AORTA; RISK	BACKGROUND Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation, and decreases bone resorption. METHODS We enrolled 4093 postmenopausal women with osteoporosis and a fragility fracture and randomly assigned them in a 1: 1 ratio to receive monthly subcutaneous romosozumab (210 mg) or weekly oral alendronate (70 mg) in a blinded fashion for 12 months, followed by openlabel alendronate in both groups. The primary end points were the cumulative incidence of new vertebral fracture at 24 months and the cumulative incidence of clinical fracture (nonvertebral and symptomatic vertebral fracture) at the time of the primary analysis (after clinical fractures had been confirmed in >= 330 patients). Secondary end points included the incidences of nonvertebral and hip fracture at the time of the primary analysis. Serious cardiovascular adverse events, osteonecrosis of the jaw, and atypical femoral fractures were adjudicated. RESULTS Over a period of 24 months, a 48% lower risk of new vertebral fractures was observed in the romosozumab-to-alendronate group (6.2% [127 of 2046 patients]) than in the alendronateto-alendronate group (11.9% [ 243 of 2047 patients]) (P< 0.001). Clinical fractures occurred in 198 of 2046 patients (9.7%) in the romosozumab-to-alendronate group versus 266 of 2047 patients (13.0%) in the alendronate-to-alendronate group, representing a 27% lower risk with romosozumab (P< 0.001). The risk of nonvertebral fractures was lower by 19% in the romosozumab-to-alendronate group than in the alendronate-to-alendronate group (178 of 2046 patients [8.7%] vs. 217 of 2047 patients [ 10.6%]; P = 0.04), and the risk of hip fracture was lower by 38% (41 of 2046 patients [2.0%] vs. 66 of 2047 patients [3.2%]; P = 0.02). Overall adverse events and serious adverse events were balanced between the two groups. During year 1, positively adjudicated serious cardiovascular adverse events were observed more often with romosozumab than with alendronate (50 of 2040 patients [2.5%] vs. 38 of 2014 patients [1.9%]). During the open-label alendronate period, adjudicated events of osteonecrosis of the jaw (1 event each in the romosozumab-to-alendronate and alendronate-to-alendronate groups) and atypical femoral fracture (2 events and 4 events, respectively) were observed. CONCLUSIONS In postmenopausal women with osteoporosis who were at high risk for fracture, romosozumab treatment for 12 months followed by alendronate resulted in a significantly lower risk of fracture than alendronate alone. (Funded by Amgen and others; ARCH ClinicalTrials. gov number, NCT01631214.)	[Saag, Kenneth G.] Univ Alabama Birmingham, Birmingham, AL USA; [Petersen, Jeffrey; Maddox, Judy; Fan, Michelle; Grauer, Andreas] Amgen Inc, Thousand Oaks, CA USA; [Brandi, Maria Luisa] Univ Florence, Florence, Italy; [Karaplis, Andrew C.] McGill Univ, Montreal, PQ, Canada; [Lorentzon, Mattias] Univ Gothenburg, Molndal, Sweden; [Lorentzon, Mattias] Sahlgrens Univ Hosp, Molndal, Sweden; [Thomas, Thierry] CHU St Etienne, St Etienne, France; [Meisner, Paul D.] UCB Pharma, Brussels, Belgium	University of Alabama System; University of Alabama Birmingham; Amgen; University of Florence; McGill University; University of Gothenburg; Sahlgrenska University Hospital; CHU de St Etienne; UCB Pharma SA	Saag, KG (corresponding author), Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Fac Off Tower,Suite 820,510 20th St South, Birmingham, AL 35294 USA.		Lorentzon, Mattias/W-7878-2019	Lorentzon, Mattias/0000-0003-0749-1431; brandi, maria luisa/0000-0002-8741-0592; Blicharski, Tomasz/0000-0001-9747-8817	Amgen	Amgen(Amgen)	Funded by Amgen and others; ARCH ClinicalTrials.gov number, NCT01631214.	Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Brandenburg VM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-219; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Chouinard L, 2016, REGUL TOXICOL PHARM, V81, P212, DOI 10.1016/j.yrtph.2016.08.010; Claes KJ, 2013, J CLIN ENDOCR METAB, V98, P3221, DOI 10.1210/jc.2013-1521; Cosman F, 2016, NEW ENGL J MED, V375, P1532, DOI 10.1056/NEJMoa1607948; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kang JH, 2013, OSTEOPOROSIS INT, V24, P271, DOI 10.1007/s00198-012-2213-5; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; Keaveny TM, 2017, J BONE MINER RES, V32, P1956, DOI 10.1002/jbmr.3176; Kendler D., 2017, C OST OST MUS DIS FL; Kim DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122646; Kramann R, 2013, J BONE MINER RES, V28, P2523, DOI 10.1002/jbmr.1994; Kranenburg G, 2016, ATHEROSCLEROSIS, V252, P106, DOI 10.1016/j.atherosclerosis.2016.06.039; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lu PY, 2011, CLIN THER, V33, P1173, DOI 10.1016/j.clinthera.2011.07.012; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ominsky MS, 2017, J BONE MINER RES, V32, P788, DOI 10.1002/jbmr.3036; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; Rukov JL, 2016, AM J PHYSIOL-RENAL, V310, pF477, DOI 10.1152/ajprenal.00472.2015; van Buchem F, 1976, EXCERPTA MED, P1; Vanhoenacker FM, 2003, SKELETAL RADIOL, V32, P708, DOI 10.1007/s00256-003-0675-4; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	32	568	598	9	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 12	2017	377	15					1417	1427		10.1056/NEJMoa1708322	http://dx.doi.org/10.1056/NEJMoa1708322			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ4ZP	28892457	Green Published, Bronze			2022-12-28	WOS:000412753100006
J	Ference, BA; Kastelein, JJP; Ginsberg, HN; Chapman, J; Nicholls, SJ; Ray, KK; Packard, CJ; Laufs, U; Brook, RD; Oliver-Williams, C; Butterworth, AS; Danesh, J; Smith, GD; Catapano, AL; Sabatine, MS				Ference, Brian A.; Kastelein, John J. P.; Ginsberg, Henry N.; Chapman, John; Nicholls, Stephen J.; Ray, Kausik K.; Packard, Chris J.; Laufs, Ulrich; Brook, Robert D.; Oliver-Williams, Clare; Butterworth, Adam S.; Danesh, John; Smith, George Davey; Catapano, Alberico L.; Sabatine, Marc S.			Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTER TRANSFER PROTEIN; CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL; LDL-CHOLESTEROL; MENDELIAN RANDOMIZATION; VASCULAR-DISEASE; GENOME-WIDE; METAANALYSIS; DISCORDANCE; EVACETRAPIB	IMPORTANCE Some cholesteryl ester transfer protein (CETP) inhibitors lower low-density lipoprotein cholesterol (LDL-C) levels without reducing cardiovascular events, suggesting that the clinical benefit of lowering LDL-C may depend on how LDL-C is lowered. OBJECTIVE To estimate the association between changes in levels of LDL-C (and other lipoproteins) and the risk of cardiovascular events related to variants in the CETP gene, both alone and in combination with variants in the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) gene. DESIGN, SETTING, AND PARTICIPANTS Mendelian randomization analyses evaluating the association between CETP and HMGCR scores, changes in lipid and lipoprotein levels, and the risk of cardiovascular events involving 102 837 participants from 14 cohort or case-control studies conducted in North America or the United Kingdom between 1948 and 2012. The associations with cardiovascular events were externally validated in 189 539 participants from 48 studies conducted between 2011 and 2015. EXPOSURES Differences in mean high-density lipoprotein cholesterol (HDL-C), LDL-C, and apolipoprotein B (apoB) levels in participants with CETP scores at or above vs below the median. MAIN OUTCOMES AND MEASURES Odds ratio (OR) for major cardiovascular events. RESULTS The primary analysis included 102 837 participants (mean age, 59.9 years; 58% women) who experienced 13 821 major cardiovascular events. The validation analyses included 189 539 participants (mean age, 58.5 years; 39% women) with 62 240 cases of coronary heart disease (CHD). Considered alone, the CETP score was associated with higher levels of HDL-C, lower LDL-C, concordantly lower apoB, and a corresponding lower risk of major vascular events (OR, 0.946 [95% CI, 0.921-0.972]) that was similar in magnitude to the association between the HMGCR score and risk of major cardiovascular events per unit change in levels of LDL-C (and apoB). When combined with the HMGCR score, the CETP score was associated with the same reduction in LDL-C levels but an attenuated reduction in apoB levels and a corresponding attenuated nonsignificant risk of major cardiovascular events (OR, 0.985 [95% CI, 0.955-1.015]). In external validation analyses, a genetic score consisting of variants with naturally occurring discordance between levels of LDL-C and apoB was associated with a similar risk of CHD per unit change in apoB level (OR, 0.782 [95% CI, 0.720-0.845] vs 0.793 [95% CI, 0.774-0.812]; P =.79 for difference), but a significantly attenuated risk of CHD per unit change in LDL-C level (OR, 0.916 [95% CI, 0.890-0.943] vs 0.831 [95% CI, 0.816-0.847]; P <.001) compared with a genetic score associated with concordant changes in levels of LDL-C and apoB. CONCLUSIONS AND RELEVANCE Combined exposure to variants in the genes that encode the targets of CETP inhibitors and statins was associated with discordant reductions in LDL-C and apoB levels and a corresponding risk of cardiovascular events that was proportional to the attenuated reduction in apoB but significantly less than expected per unit change in LDL-C. The clinical benefit of lowering LDL-C levels may therefore depend on the corresponding reduction in apoB-containing lipoprotein particles.	[Ference, Brian A.] Wayne State Univ, Sch Med, Div Cardiovasc Med, 4H-34, Detroit, MI 48202 USA; [Ference, Brian A.] Univ Bristol, Inst Adv Studies, Bristol, Avon, England; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Ginsberg, Henry N.] Columbia Univ Coll Phys & Surg, Irving Inst Clin & Translat Res, 630 W 168th St, New York, NY 10032 USA; [Chapman, John] Pitie Salpetriere Univ Hosp, INSERM, Paris, France; [Nicholls, Stephen J.] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Ray, Kausik K.] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London, England; [Packard, Chris J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Laufs, Ulrich] Univ Leipzig, Dept Cardiol, Leipzig, Germany; [Brook, Robert D.] Univ Michigan, Sch Med, Div Cardiovasc Med, Ann Arbor, MI USA; [Oliver-Williams, Clare; Butterworth, Adam S.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Butterworth, Adam S.; Danesh, John] Univ Cambridge, Natl Inst Hlth Res, Blood & Transplant Res Unit Donor Hlth & Genom, Cambridge, England; [Danesh, John] Wellcome Trust Sanger Inst, Hinxton, England; [Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Catapano, Alberico L.] Multimed IRCCS, Milan, Italy; [Sabatine, Marc S.] Harvard Med Sch, Brigham & Womens Hosp, Thrombolysis Myocardial Infarct TIMI Study Grp, Div Cardiovasc Med, Boston, MA USA	Wayne State University; University of Bristol; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; Imperial College London; University of Glasgow; Leipzig University; University of Michigan System; University of Michigan; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Bristol; University of Milan; IRCCS Multimedica; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ference, BA (corresponding author), Wayne State Univ, Sch Med, Div Cardiovasc Med, UHC, 4H-34, Detroit, MI 48202 USA.	bference@med.wayne.edu	Catapano, alberico/AAC-2827-2019; Sabatine, Marc/AAJ-6751-2020; Ray, Kausik/Z-2055-2019; Kastelein, John/AAF-7950-2020; Davey Smith, George/A-7407-2013	Catapano, alberico/0000-0002-7593-2094; Sabatine, Marc/0000-0002-0691-3359; Davey Smith, George/0000-0002-1407-8314; Butterworth, Adam/0000-0002-6915-9015; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nicholls, Stephen/0000-0002-9668-4368	Homerton College, University of Cambridge; European Research Council; Medical Research Council [MC_UU_12013/1]; British Heart Foundation; National Institute for Health Research; University of Bristol; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MC_UU_12013/1, MR/L003120/1] Funding Source: UKRI	Homerton College, University of Cambridge; European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); University of Bristol; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr Oliver-Williams is supported by Homerton College, University of Cambridge. Dr Butterworth is supported by the European Research Council. Dr Danesh is supported by the Medical Research Council, British Heart Foundation, and the National Institute for Health Research. Dr Davey Smith works within the Medical Research Council Integrative Epidemiology Unit at the University of Bristol, which is supported by the Medical Research Council (MC_UU_12013/1) and the University of Bristol.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bloomfield D, 2009, AM HEART J, V157, P352, DOI 10.1016/j.ahj.2008.09.022; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bowman L, 2017, AM HEART J, V187, P182, DOI 10.1016/j.ahj.2017.02.021; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Ference BA, 2018, EUR HEART J, V39, P2540, DOI 10.1093/eurheartj/ehx450; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Hovingh GK, 2015, LANCET, V386, P452, DOI 10.1016/S0140-6736(15)60158-1; Johannsen TH, 2012, J AM COLL CARDIOL, V60, P2041, DOI 10.1016/j.jacc.2012.07.045; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Lincoff AM, 2017, NEW ENGL J MED, V376, P1933, DOI 10.1056/NEJMoa1609581; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Moore C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-363; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pencina MJ, 2015, EUR J PREV CARDIOL, V22, P1321, DOI 10.1177/2047487315569411; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Wilkins JT, 2016, J AM COLL CARDIOL, V67, P193, DOI 10.1016/j.jacc.2015.10.055; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	32	170	172	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					947	956		10.1001/jama.2017.11467	http://dx.doi.org/10.1001/jama.2017.11467			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28846118	Green Published			2022-12-28	WOS:000410487100016
J	Meyer, A				Meyer, Adolf			Progress in Teaching Psychiatry Adolf Meyer, M.D., Baltimore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Meyer Aclolt, 1915, J A M A         0904, P860	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					968	968		10.1001/jama.2017.10486	http://dx.doi.org/10.1001/jama.2017.10486			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG6KJ	28898369				2022-12-28	WOS:000410487100026
J	Mauk, BH; Haggerty, DK; Aranicas, CP; Clark, G; Kollmann, P; Rymer, AM; Bolton, SJ; Levin, SM; Adriani, A; Allegrini, F; Bagenal, F; Bonfond, B; Connerney, JEP; Gladstone, GR; Kurth, WS; McComas, DJ; Valek, P				Mauk, B. H.; Haggerty, D. K.; Aranicas, C. P.; Clark, G.; Kollmann, P.; Rymer, A. M.; Bolton, S. J.; Levin, S. M.; Adriani, A.; Allegrini, F.; Bagenal, F.; Bonfond, B.; Connerney, J. E. P.; Gladstone, G. R.; Kurth, W. S.; McComas, D. J.; Valek, P.			Discrete and broadband electron acceleration in Jupiter's powerful aurora	NATURE			English	Article							MAGNETOSPHERE; OVAL	The most intense auroral emissions from Earth's polar regions, called discrete for their sharply defined spatial configurations, are generated by a process involving coherent acceleration of electrons by slowly evolving, powerful electric fields directed along the magnetic field lines that connect Earth's space environment to its polar regions(1,2). In contrast, Earth's less intense auroras are generally caused by wave scattering of magnetically trapped populations of hot electrons (in the case of diffuse aurora) or by the turbulent or stochastic downward acceleration of electrons along magnetic field lines by waves during transitory periods (in the case of broadband or Alfvenic aurora)(3,4). Jupiter's relatively steady main aurora has a power density that is so much larger than Earth's that it has been taken for granted that it must be generated primarily by the discrete auroral process(5-7). However, preliminary in situ measurements of Jupiter's auroral regions yielded no evidence of such a process(8-10). Here we report observations of distinct, high-energy, downward, discrete electron acceleration in Jupiter's auroral polar regions. We also infer upward magnetic-field-aligned electric potentials of up to 400 kiloelectronvolts, an order of magnitude larger than the largest potentials observed at Earth(11). Despite the magnitude of these upward electric potentials and the expectations from observations at Earth, the downward energy flux from discrete acceleration is less at Jupiter than that caused by broadband or stochastic processes, with broadband and stochastic characteristics that are substantially different from those at Earth.	[Mauk, B. H.; Haggerty, D. K.; Aranicas, C. P.; Clark, G.; Kollmann, P.; Rymer, A. M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21218 USA; [Bolton, S. J.; Allegrini, F.; Gladstone, G. R.; McComas, D. J.; Valek, P.] Southwest Res Inst, San Antonio, TX USA; [Levin, S. M.] Jet Prop Lab, Pasadena, CA USA; [Adriani, A.] Inst Astofis & Planetol Spaziali, Inst Nazl Astrofis, Rome, Italy; [Allegrini, F.] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX USA; [Bagenal, F.] Univ Colorado, Boulder, CO 80309 USA; [Bonfond, B.] Univ Liege, Technol & Astrophys Res Inst, Lab Phys Atmospher & Planetaire, Liege, Belgium; [Connerney, J. E. P.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Kurth, W. S.] Univ Iowa, Iowa City, IA USA; [McComas, D. J.] Princeton Univ, Princeton, NJ 08544 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Southwest Research Institute; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Istituto Nazionale Astrofisica (INAF); University of Texas System; University of Texas at San Antonio (UTSA); University of Colorado System; University of Colorado Boulder; University of Liege; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Iowa; Princeton University	Mauk, BH (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21218 USA.	Barry.Mauk@jhuapl.edu	Mauk, Barry H/E-8420-2017; Haggerty, Dennis K/C-2507-2016; Kurth, William/AAA-7334-2019; Rymer, Abigail/I-6206-2016; Bolton, Scott/M-4392-2019; Paranicas, Christopher/B-1470-2016; Clark, George/L-6433-2015; Kollmann, Peter/C-2583-2016	Mauk, Barry H/0000-0001-9789-3797; Haggerty, Dennis K/0000-0001-6395-8943; Kurth, William/0000-0002-5471-6202; Rymer, Abigail/0000-0002-4879-0748; Paranicas, Christopher/0000-0002-4391-8255; Kollmann, Peter/0000-0002-4274-9760; Allegrini, Frederic/0000-0003-0696-4380; Adriani, Alberto/0000-0003-4998-8008; bolton, scott/0000-0002-9115-0789; Levin, Steven/0000-0003-2242-5459	NASA's New Frontiers Program; Southwest Research Institute	NASA's New Frontiers Program; Southwest Research Institute	We are grateful to NASA and contributing institutions that helped to make the Juno mission possible. This work was funded by NASA's New Frontiers Program for Juno via subcontract with the Southwest Research Institute.	Allegrini F, 2017, GEOPHYS RES LETT, V44, P7131, DOI 10.1002/2017GL073180; Arnoldy R. L., 1981, PHYSICS AURORAL ARC, P56; Bonfond B, 2017, GEOPHYS RES LETT, V44, P4463, DOI 10.1002/2017GL073114; Bonnell J, 2002, SPACE SCI REV, V103, P93, DOI [DOI 10.1023/A:1023082700768, 10.1023/A:1023082700768]; Carlson CW, 1998, GEOPHYS RES LETT, V25, P2013, DOI 10.1029/98GL01592; Chaston CC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.175003; Connerney JEP, 2017, SCIENCE, V356, P826, DOI 10.1126/science.aam5928; Connerney J. E. P., 2017, SPACE SCI REV; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; Cowley SWH, 2001, PLANET SPACE SCI, V49, P1067, DOI 10.1016/S0032-0633(00)00167-7; Ergun RE, 1998, GEOPHYS RES LETT, V25, P2025, DOI 10.1029/98GL00635; Gerard JC, 2014, J GEOPHYS RES-SPACE, V119, P9072, DOI 10.1002/2014JA020514; Gladstone G. R., 2014, SPACE SCI REV; Grodent D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010017; Gustin J, 2016, ICARUS, V268, P215, DOI 10.1016/j.icarus.2015.12.048; Hess SLG, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016262; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Janhunen P, 2006, SPACE SCI REV, V122, P89, DOI 10.1007/s11214-006-7017-5; Krall N. A., 1973, PRINCIPLES PLASMA PH; Mauk BH, 2017, GEOPHYS RES LETT, V44, P4410, DOI 10.1002/2016GL072286; Mauk B. H., 2013, SPACE SCI REV; McComas D. J., 2013, SPACE SCI REV; Ray LC, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015423; Tao C, 2016, J GEOPHYS RES-SPACE, V121, P4055, DOI 10.1002/2015JA021272	24	67	68	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					66	+		10.1038/nature23648	http://dx.doi.org/10.1038/nature23648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880294	Green Published			2022-12-28	WOS:000409388700033
J	Mandelker, D; Zhang, LY; Kemel, Y; Stadler, ZK; Joseph, V; Zehir, A; Pradhan, N; Arnold, A; Walsh, MF; Li, YR; Balakrishnan, AR; Syed, A; Prasad, M; Nafa, K; Carlo, MI; Cadoo, KA; Sheehan, M; Fleischut, MH; Salo-Mullen, E; Trottier, M; Lipkin, SM; Lincoln, A; Mukherjee, S; Ravichandran, V; Cambria, R; Galle, J; Abida, W; Arcila, ME; Benayed, R; Shah, R; Yu, K; Bajorin, DF; Coleman, JA; Leach, SD; Lowery, MA; Garcia-Aguilar, J; Kantoff, PW; Sawyers, CL; Dickler, MN; Saltz, L; Motzer, RJ; O'Reilly, EM; Scher, HI; Baselga, J; Klimstra, DS; Solit, DB; Hyman, DM; Berger, MF; Ladanyi, M; Robson, ME; Offit, K				Mandelker, Diana; Zhang, Liying; Kemel, Yelena; Stadler, Zsofia K.; Joseph, Vijai; Zehir, Ahmet; Pradhan, Nisha; Arnold, Angela; Walsh, Michael F.; Li, Yirong; Balakrishnan, Anoop R.; Syed, Aijazuddin; Prasad, Meera; Nafa, Khedoudja; Carlo, Maria I.; Cadoo, Karen A.; Sheehan, Meg; Fleischut, Megan H.; Salo-Mullen, Erin; Trottier, Magan; Lipkin, Steven M.; Lincoln, Anne; Mukherjee, Semanti; Ravichandran, Vignesh; Cambria, Roy; Galle, Jesse; Abida, Wassim; Arcila, Marcia E.; Benayed, Ryma; Shah, Ronak; Yu, Kenneth; Bajorin, Dean F.; Coleman, Jonathan A.; Leach, Steven D.; Lowery, Maeve A.; Garcia-Aguilar, Julio; Kantoff, Philip W.; Sawyers, Charles L.; Dickler, Maura N.; Saltz, Leonard; Motzer, Robert J.; O'Reilly, Eileen M.; Scher, Howard I.; Baselga, Jose; Klimstra, David S.; Solit, David B.; Hyman, David M.; Berger, Michael F.; Ladanyi, Marc; Robson, Mark E.; Offit, Kenneth			Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL GENETICS; AMERICAN-COLLEGE; ASSOCIATION; VARIANTS; GENOMICS	IMPORTANCE Guidelines for cancer genetic testing based on family history may miss clinically actionable genetic changes with established implications for cancer screening or prevention. OBJECTIVE To determine the proportion and potential clinical implications of inherited variants detected using simultaneous sequencing of the tumor and normal tissue ("tumor-normal sequencing") compared with genetic test results based on current guidelines. DESIGN, SETTING, AND PARTICIPANTS From January 2014 until May 2016 at Memorial Sloan Kettering Cancer Center, 10 336 patients consented to tumor DNA sequencing. Since May 2015, 1040 of these patients with advanced cancer were referred by their oncologists for germline analysis of 76 cancer predisposition genes. Patients with clinically actionable inherited mutations whose genetic test results would not have been predicted by published decision rules were identified. Follow-up for potential clinical implications of mutation detection was through May 2017. EXPOSURE Tumor and germline sequencing compared with the predicted yield of targeted germline sequencing based on clinical guidelines. MAIN OUTCOMES AND MEASURES Proportion of clinically actionable germline mutations detected by universal tumor-normal sequencing that would not have been detected by guideline-directed testing. RESULTS Of 1040 patients, the median age was 58 years (interquartile range, 50.5-66 years), 65.3% were male, and 81.3% had stage IV disease at the time of genomic analysis, with prostate, renal, pancreatic, breast, and colon cancer as the most common diagnoses. Of the 1040 patients, 182 (17.5%; 95% CI, 15.3%-19.9%) had clinically actionable mutations conferring cancer susceptibility, including 149 with moderate-to high-penetrance mutations; 101 patients tested (9.7%; 95% CI, 8.1%-11.7%) would not have had these mutations detected using clinical guidelines, including 65 with moderate-to high-penetrance mutations. Frequency of inherited mutations was related to case mix, stage, and founder mutations. Germline findings led to discussion or initiation of change to targeted therapy in 38 patients tested (3.7%) and predictive testing in the families of 13 individuals (1.3%), including 6 for whom genetic evaluation would not have been initiated by guideline-based testing. CONCLUSIONS AND RELEVANCE In this referral population with selected advanced cancers, universal sequencing of a broad panel of cancer-related genes in paired germline and tumor DNA samples was associated with increased detection of individuals with potentially clinically significant heritable mutations over the predicted yield of targeted germline testing based on current clinical guidelines. Knowledge of these additional mutations can help guide therapeutic and preventive interventions, but whether all of these interventions would improve outcomes for patients with cancer or their family members requires further study.	[Mandelker, Diana; Zhang, Liying; Kemel, Yelena; Stadler, Zsofia K.; Joseph, Vijai; Zehir, Ahmet; Pradhan, Nisha; Arnold, Angela; Walsh, Michael F.; Li, Yirong; Balakrishnan, Anoop R.; Syed, Aijazuddin; Prasad, Meera; Nafa, Khedoudja; Carlo, Maria I.; Cadoo, Karen A.; Sheehan, Meg; Fleischut, Megan H.; Salo-Mullen, Erin; Trottier, Magan; Lincoln, Anne; Mukherjee, Semanti; Ravichandran, Vignesh; Cambria, Roy; Galle, Jesse; Abida, Wassim; Arcila, Marcia E.; Benayed, Ryma; Shah, Ronak; Yu, Kenneth; Bajorin, Dean F.; Coleman, Jonathan A.; Leach, Steven D.; Lowery, Maeve A.; Garcia-Aguilar, Julio; Kantoff, Philip W.; Sawyers, Charles L.; Dickler, Maura N.; Saltz, Leonard; Motzer, Robert J.; O'Reilly, Eileen M.; Scher, Howard I.; Baselga, Jose; Klimstra, David S.; Solit, David B.; Hyman, David M.; Berger, Michael F.; Ladanyi, Marc; Robson, Mark E.; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Kemel, Yelena; Joseph, Vijai; Mukherjee, Semanti; Shah, Ronak; Garcia-Aguilar, Julio; Sawyers, Charles L.; Scher, Howard I.; Baselga, Jose; Solit, David B.; Berger, Michael F.; Ladanyi, Marc; Offit, Kenneth] Sloan Kettering Inst, New York, NY USA; [Stadler, Zsofia K.; Joseph, Vijai; Walsh, Michael F.; Carlo, Maria I.; Cadoo, Karen A.; Lipkin, Steven M.; Abida, Wassim; Yu, Kenneth; Bajorin, Dean F.; Coleman, Jonathan A.; Leach, Steven D.; Lowery, Maeve A.; Garcia-Aguilar, Julio; Kantoff, Philip W.; Sawyers, Charles L.; Dickler, Maura N.; Saltz, Leonard; Motzer, Robert J.; O'Reilly, Eileen M.; Scher, Howard I.; Baselga, Jose; Klimstra, David S.; Solit, David B.; Hyman, David M.; Berger, Michael F.; Robson, Mark E.; Offit, Kenneth] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, 1275 York Ave, New York, NY 10065 USA.	offitk@mskcc.org	lowery, maeve/AAG-2575-2019; Zehir, Ahmet/ABE-7155-2020; Solit, David B./AAC-5309-2019; Shah, Ronak H/H-9726-2017; Balakrishnan Rema, Anoop/AAE-1889-2022; Lincoln, Anne/ABE-7459-2021; Arcila, Maria/ABE-2235-2021; Ladanyi, Marc/AAG-8585-2019; Joseph, Vijai/J-9158-2013	lowery, maeve/0000-0003-1354-7606; Zehir, Ahmet/0000-0001-5406-4104; Shah, Ronak H/0000-0001-9042-6213; Balakrishnan Rema, Anoop/0000-0001-6104-5665; Ravichandran, Vignesh/0000-0002-1532-2593; Solit, David/0000-0002-6614-802X; Joseph, Vijai/0000-0002-7933-151X; Lincoln, Anne/0000-0002-6441-1445; O'Reilly, Eileen M./0000-0002-8076-9199; Kemel, Yelena/0000-0002-5042-5651; Coleman, Jonathan/0000-0002-6428-7835; Kantoff, Philip/0000-0001-7275-0597	Robert and Kate Niehaus Center for Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center; Andrew Sabin Family Foundation; Sharon Levine Corzine Research Fund from Memorial Sloan Kettering Cancer Center; Breast Cancer Research Foundation; J. Randall and Kathleen L. MacDonald Renal Cancer Research Fund; David M. Rubenstein Center for Pancreatic Cancer Research; Cancer Center Support Grant from the National Cancer Institute [P30 CA008748-50]; NATIONAL CANCER INSTITUTE [R01CA193837, P30CA008748, P50CA092629, R01CA182587] Funding Source: NIH RePORTER	Robert and Kate Niehaus Center for Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center; Andrew Sabin Family Foundation; Sharon Levine Corzine Research Fund from Memorial Sloan Kettering Cancer Center; Breast Cancer Research Foundation; J. Randall and Kathleen L. MacDonald Renal Cancer Research Fund; David M. Rubenstein Center for Pancreatic Cancer Research; Cancer Center Support Grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Robert and Kate Niehaus Center for Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center, the Andrew Sabin Family Foundation, the Sharon Levine Corzine Research Fund from Memorial Sloan Kettering Cancer Center, the Breast Cancer Research Foundation, Marie-Josee and Henry R. Kravis, the J. Randall and Kathleen L. MacDonald Renal Cancer Research Fund, the David M. Rubenstein Center for Pancreatic Cancer Research, and Cancer Center Support Grant P30 CA008748-50 from the National Cancer Institute.	Abida W, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00029; Bombard Y, 2013, JAMA-J AM MED ASSOC, V310, P795, DOI 10.1001/jama.2013.276573; Cheng DT, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0271-4; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Hampel H, 2015, GENET MED, V17, P70, DOI 10.1038/gim.2014.147; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Meric-Bernstam F, 2016, ANN ONCOL, V27, P795, DOI 10.1093/annonc/mdw018; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; National Comprehensive Cancer Network, 2022, GEN FAM HIGH RISK AS; Ng AJM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005160; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Offit K, 2016, SEMIN ONCOL, V43, P615, DOI 10.1053/j.seminoncol.2016.10.002; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Pilarski R, 2014, GENE CHROMOSOME CANC, V53, P177, DOI 10.1002/gcc.22129; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schrader KA, 2016, JAMA ONCOL, V2, P104, DOI 10.1001/jamaoncol.2015.5208; Seifert BA, 2016, CLIN CANCER RES, V22, P4087, DOI 10.1158/1078-0432.CCR-16-0015; Shen RL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw520; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Wang LL, 2003, J NATL CANCER I, V95, P669, DOI 10.1093/jnci/95.9.669; Wang LL., 1993, GENEREVIEWS; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	29	257	259	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					825	835		10.1001/jama.2017.11137	http://dx.doi.org/10.1001/jama.2017.11137			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873162	Green Accepted			2022-12-28	WOS:000409183700014
J	Phillips, N				Phillips, Nicky			GLOBAL WARMING Legal threat raises stakes on climate forecasts	NATURE			English	News Item																			0	1	1	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					508	509		10.1038/548508a	http://dx.doi.org/10.1038/548508a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858329	Bronze			2022-12-28	WOS:000408703100005
J	Baker, M				Baker, Monya			CHECK YOUR CHEMISTRY	NATURE			English	Editorial Material							DISCOVERY; INHIBITOR											Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Bisson J, 2016, J MED CHEM, V59, P1671, DOI 10.1021/acs.jmedchem.5b01009; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Davis BJ, 2013, BIOORG MED CHEM LETT, V23, P2844, DOI 10.1016/j.bmcl.2013.03.028; Greco GE, 2016, DNA REPAIR, V43, P18, DOI 10.1016/j.dnarep.2016.04.004; Hermann JC, 2013, ACS MED CHEM LETT, V4, P197, DOI 10.1021/ml3003296; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Levinson NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029828; Shortt J, 2014, CELL REP, V7, P1009, DOI 10.1016/j.celrep.2014.04.008; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054	12	11	11	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					485	488		10.1038/548485a	http://dx.doi.org/10.1038/548485a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836600	Bronze			2022-12-28	WOS:000408279000045
J	Gutmann, DH				Gutmann, David H.			The Tropism of Pleiotrophin: Orchestrating Glioma Brain Invasion	CELL			English	Editorial Material							MACROPHAGES; PROGRESSION; GROWTH	The lateral ventricle (LV) is a preferential location for brain tumor spread; however, the instructive cues responsible for this unique tropism were previously unknown. In this issue, Qin et al. elucidate the underlying mechanism, demonstrating that LV-neural progenitors secrete a pleiotrophin (PTN)-containing complex, which attracts glioma cells through ROCK/Rho activation.	[Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Gutmann, DH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	gutmannd@wustl.edu		Gutmann, David/0000-0002-3127-5045	National Institute of Neurological Disorders and Stroke [1-R35-NS097211-01]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	D.H.G. is supported by a Research Program Award from the National Institute of Neurological Disorders and Stroke (1-R35-NS097211-01).	[Anonymous], TITLE ERROR; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Kolonin MG, 2017, CANCER RES, V77, P3144, DOI 10.1158/0008-5472.CAN-16-0708; Pong WW, 2011, ONCOGENE, V30, P1135, DOI 10.1038/onc.2010.519; Pong WW, 2013, ANN NEUROL, V73, P303, DOI 10.1002/ana.23813; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Zhang L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1690	11	3	3	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					821	822		10.1016/j.cell.2017.08.011	http://dx.doi.org/10.1016/j.cell.2017.08.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841413	Bronze			2022-12-28	WOS:000408372400002
J	McGranahan, N; Swanton, C				McGranahan, Nicholas; Swanton, Charles			Cancer Evolution Constrained by the Immune Microenvironment	CELL			English	Editorial Material							CHECKPOINT BLOCKADE	Tumor development is a Darwinian evolutionary process, involving the interplay between cancer subclones and the local immune microenvironment. These complex interactions are highlighted in this issue of Cell by the results from Jimenez-Sanchez et al. of a deep analysis of one patient with advanced serous carcinoma of the ovary.	[McGranahan, Nicholas; Swanton, Charles] UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England; [Swanton, Charles] Francis Crick Inst, Translat Canc Therapeut Lab, 1 Midland Rd, London NW1 1AT, England	Cancer Research UK; University of London; University College London; Francis Crick Institute	Swanton, C (corresponding author), UCL, Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Paul OGorman Bldg,72 Huntley St, London WC1E 6BT, England.; Swanton, C (corresponding author), Francis Crick Inst, Translat Canc Therapeut Lab, 1 Midland Rd, London NW1 1AT, England.	charles.swanton@crick.ac.uk	McGranahan, Nicholas/ABD-6561-2021	McGranahan, Nicholas/0000-0001-9537-4045; Swanton, Charles/0000-0002-4299-3018	Medical Research Council [MR/P014712/1] Funding Source: Medline; MRC [MR/P014712/1] Funding Source: UKRI; Cancer Research UK [17786, 20466, 19310, 23896] Funding Source: researchfish; Rosetrees Trust [M445, M640, M179, M391, M630, M231-CD1] Funding Source: researchfish; The Francis Crick Institute [10172, C60895/A23896, 10467, 10169, 10170, 10359, 10174, VEG 108844, C28575/A25223, A1278, 10485] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute		[Anonymous], 2012, DARWINS GHOSTS SEARC; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	6	441	471	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					825	827		10.1016/j.cell.2017.08.012	http://dx.doi.org/10.1016/j.cell.2017.08.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841415	Green Submitted, Bronze			2022-12-28	WOS:000408372400004
J	Denny, L				Denny, Lynette			Nine-valent human papillomavirus vaccine: great science, but will it save lives?	LANCET			English	Editorial Material							HPV VACCINE; WOMEN; CANCER		[Denny, Lynette] Univ Cape Town, Dept Obstet & Gynaecol, South African Med Res Council, Gynaecol Canc Res Ctr,Fac Hlth Sci, ZA-7925 Cape Town, South Africa	South African Medical Research Council; University of Cape Town	Denny, L (corresponding author), Univ Cape Town, Dept Obstet & Gynaecol, South African Med Res Council, Gynaecol Canc Res Ctr,Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	lynette.denny@uct.ac.za						Alemany L, 2015, INT J CANCER, V136, P98, DOI 10.1002/ijc.28963; [Anonymous], LANCET; Brisson M, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv282; Denny L, 2017, LANCET, V389, P861, DOI 10.1016/S0140-6736(16)31795-0; Iversen OE, 2016, JAMA-J AM MED ASSOC, V316, P2411, DOI 10.1001/jama.2016.17615; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Ladner J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-670; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Serrano B, 2015, EUR J CANCER, V51, P1732, DOI 10.1016/j.ejca.2015.06.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262	10	1	1	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2017	390	10108					2123	2124		10.1016/S0140-6736(17)32144-X	http://dx.doi.org/10.1016/S0140-6736(17)32144-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0CL	28886906				2022-12-28	WOS:000415642200004
J	Weber, J; Mandala, M; Del Vecchio, M; Gogas, HJ; Arance, AM; Cowey, CL; Dalle, S; Schenker, M; Chiarion-Sileni, V; Marquez-Rodas, I; Grob, JJ; Butler, MO; Middleton, MR; Maio, M; Atkinson, V; Queirolo, P; Gonzalez, R; Kudchadkar, RR; Smylie, M; Meyer, N; Mortier, L; Atkins, MB; Long, GV; Bhatia, S; Lebbe, C; Rutkowski, P; Yokota, K; Yamazaki, N; Kim, TM; de Pril, V; Sabater, J; Qureshi, A; Larkin, J; Ascierto, PA				Weber, J.; Mandala, M.; Del Vecchio, M.; Gogas, H. J.; Arance, A. M.; Cowey, C. L.; Dalle, S.; Schenker, M.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Grob, J-J.; Butler, M. O.; Middleton, M. R.; Maio, M.; Atkinson, V.; Queirolo, P.; Gonzalez, R.; Kudchadkar, R. R.; Smylie, M.; Meyer, N.; Mortier, L.; Atkins, M. B.; Long, G. V.; Bhatia, S.; Lebbe, C.; Rutkowski, P.; Yokota, K.; Yamazaki, N.; Kim, T. M.; de Pril, V.; Sabater, J.; Qureshi, A.; Larkin, J.; Ascierto, P. A.		CheckMate 238 Collaborators	Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; PHASE-3 TRIAL; METASTATIC MELANOMA; UNTREATED MELANOMA; PD-L1 EXPRESSION; DOUBLE-BLIND; EORTC 18071; ONCOLOGY; PLACEBO	BACKGROUND Nivolumab and ipilimumab are immune checkpoint inhibitors that have been approved for the treatment of advanced melanoma. In the United States, ipilimumab has also been approved as adjuvant therapy for melanoma on the basis of recurrence- free and overall survival rates that were higher than those with placebo in a phase 3 trial. We wanted to determine the efficacy of nivolumab versus ipilimumab for adjuvant therapy in patients with resected advanced melanoma. METHODS In this randomized, double-blind, phase 3 trial, we randomly assigned 906 patients (>= 15 years of age) who were undergoing complete resection of stage IIIB, IIIC, or IV melanoma to receive an intravenous infusion of either nivolumab at a dose of 3 mg per kilogram of body weight every 2 weeks (453 patients) or ipilimumab at a dose of 10 mg per kilogram every 3 weeks for four doses and then every 12 weeks (453 patients). The patients were treated for a period of up to 1 year or until disease recurrence, a report of unacceptable toxic effects, or withdrawal of consent. The primary end point was recurrence-free survival in the intention-to-treat population. RESULTS At a minimum follow-up of 18 months, the 12-month rate of recurrence-free survival was 70.5% (95% confidence interval [CI], 66.1 to 74.5) in the nivolumab group and 60.8% (95% CI, 56.0 to 65.2) in the ipilimumab group (hazard ratio for disease recurrence or death, 0.65; 97.56% CI, 0.51 to 0.83; P<0.001). Treatment-related grade 3 or 4 adverse events were reported in 14.4% of the patients in the nivolumab group and in 45.9% of those in the ipilimumab group; treatment was discontinued because of any adverse event in 9.7% and 42.6% of the patients, respectively. Two deaths (0.4%) related to toxic effects were reported in the ipilimumab group more than 100 days after treatment. CONCLUSIONS Among patients undergoing resection of stage IIIB, IIIC, or IV melanoma, adjuvant therapy with nivolumab resulted in significantly longer recurrence-free survival and a lower rate of grade 3 or 4 adverse events than adjuvant therapy with ipilimumab.	[Weber, J.] NYU, Perlmutter Canc Ctr, 522 First Ave,1310 Smilow Bldg, New York, NY 10016 USA; [Mandala, M.] Papa Giovanni XXIII Canc Ctr Hosp, Bergamo, Italy; [Del Vecchio, M.] Natl Canc Inst, Med Oncol, Milan, Italy; [Chiarion-Sileni, V.] Veneto Ist Ricovero & Cura Carattere Sci, Inst Oncol, Padua, Italy; [Maio, M.] Univ Hosp Siena, Ist Toscano Tumori, Ctr Immunooncol, Siena, Italy; [Queirolo, P.] Osped Policlin San Martino, Genoa, Italy; [Ascierto, P. A.] Ist Nazl Tumori Fdn Pascale, Naples, Italy; [Gogas, H. J.] Univ Athens, Athens, Greece; [Arance, A. M.] Hosp Clin Barcelona, Barcelona, Spain; [Marquez-Rodas, I.] Gen Univ Hosp Gregorio Maranon, Madrid, Spain; [Cowey, C. L.] Texas Oncol Baylor Canc Ctr, Dallas, TX USA; [Dalle, S.] Hosp Civils Lyon, Pierre Benite, France; [Grob, J-J.] Aix Marseille Univ, Hosp La Timone, Marseille, France; [Meyer, N.] Inst Univ Canc Toulouse, Toulouse, France; [Meyer, N.] Ctr Hosp Univ CHU, Toulouse, France; [Mortier, L.] Univ Lille, CHU Lille, INSERM, Unite 1189, Lille, France; [Cowey, C. L.] Univ Paris Diderot, Hop St Louis, AP HP, Dermatol & Ctr Invest Clin,INSERM,Unite 976, Paris, France; [Schenker, M.] Oncol Ctr Sf Nectarie, Craiova, Romania; [Butler, M. O.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Smylie, M.] Cross Canc Inst, Edmonton, AB, Canada; [Middleton, M. R.] Univ Oxford, Dept Oncol, Oxford, England; [Larkin, J.] Royal Marsden NHS Fdn Trust, London, England; [Atkinson, V.] Gallipoli Med Res Fdn, Brisbane, Qld, Australia; [Atkinson, V.] Univ Queensland, Brisbane, Qld, Australia; [Long, G. V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Long, G. V.] Royal North Shore & Mater Hosp, Sydney, NSW, Australia; [Gonzalez, R.] Univ Colorado, Denver, CO 80202 USA; [Kudchadkar, R. R.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Atkins, M. B.] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA; [Bhatia, S.] Univ Washington, Seattle, WA 98195 USA; [Rutkowski, P.] Maria Sklodowska Curie Inst, Ctr Oncol, Warsaw, Poland; [Yokota, K.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan; [Yamazaki, N.] Natl Canc Ctr, Tokyo, Japan; [Kim, T. M.] Seoul Natl Univ Hosp, Seoul, South Korea; [de Pril, V.; Sabater, J.; Qureshi, A.] Bristol Myers Squibb, Princeton, NJ USA	New York University; ASST Papa Giovanni XXIII; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Istituto Oncologico Veneto (IOV); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena; University Hospital of Siena; IRCCS Fondazione Pascale; National & Kapodistrian University of Athens; University of Barcelona; Hospital Clinic de Barcelona; General University Gregorio Maranon Hospital; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Alberta; University of Oxford; Royal Marsden NHS Foundation Trust; University of Queensland; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital; University of Colorado System; University of Colorado Denver; Emory University; University of Washington; University of Washington Seattle; Maria Sklodowska-Curie National Research Institute of Oncology; Nagoya University; National Cancer Center - Japan; Seoul National University (SNU); Seoul National University Hospital; Bristol-Myers Squibb	Weber, J (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, 522 First Ave,1310 Smilow Bldg, New York, NY 10016 USA.	jeffrey.weber2@nyumc.org	Rutkowski, Piotr/B-3907-2013; Long, Georgina V/C-1771-2013; Marquez-Rodas, Ivan/ABD-5532-2021; mandala, mario/AAB-8637-2022; Atkinson, Victoria G/G-2507-2015; Mandala', Mario/AAA-4258-2019; Ascierto, Paolo A/J-9106-2016; gonzález, rene/W-2081-2019; Daud, Adil/T-3079-2019; Dalle, Stephane/E-4552-2018; Arenberger, Petr/C-7481-2018; sileni, vanna chiarion/B-9042-2018; Schenker, Michael/AAD-6920-2022; Lorigan, Paul/J-6898-2015; Straume, Oddbjorn/C-2186-2017; Ottensmeier, Christian/E-8131-2012	Rutkowski, Piotr/0000-0002-8920-5429; Long, Georgina V/0000-0001-8894-3545; Marquez-Rodas, Ivan/0000-0002-2476-668X; Ascierto, Paolo A/0000-0002-8322-475X; Daud, Adil/0000-0002-6617-8421; Dalle, Stephane/0000-0002-3423-4548; Arenberger, Petr/0000-0002-4800-5877; sileni, vanna chiarion/0000-0001-9191-9124; Schenker, Michael/0000-0003-2645-6391; Lorigan, Paul/0000-0002-8875-2164; Straume, Oddbjorn/0000-0001-8867-3645; Meyer, Nicolas/0000-0003-4519-8666; Weber, Jeffrey/0000-0002-4962-2957; Lutzky, Jose/0000-0002-9503-2130; MORTIER, Laurent/0000-0002-2644-1790; Kruse, Vibeke/0000-0002-8840-3298; Ottensmeier, Christian/0000-0003-3619-1657; Butler, Marcus/0000-0002-9840-7057; Larkin, James/0000-0001-5569-9523; Guidoboni, Massimo/0000-0001-7703-790X; Arance, Ana/0000-0003-2896-1957; Cebon, Jonathan/0000-0002-3898-950X; Melucci, Maria Teresa/0000-0002-1677-3345	Bristol-Myers Squibb; Ono Pharmaceutical; MRC [MR/P024351/1] Funding Source: UKRI; Cancer Research UK [22795, 15951, 20613] Funding Source: researchfish; Medical Research Council [MR/P024351/1] Funding Source: researchfish; Versus Arthritis [18892] Funding Source: researchfish	Bristol-Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	Supported by Bristol-Myers Squibb and Ono Pharmaceutical.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Coens C, 2017, LANCET ONCOL, V18, P393, DOI 10.1016/S1470-2045(17)30015-3; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Gibney GT, 2015, CLIN CANCER RES, V21, P712, DOI 10.1158/1078-0432.CCR-14-2468; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Rimm DL, 2017, JAMA ONCOL, V3, P1051, DOI 10.1001/jamaoncol.2017.0013; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Sosman JA, 2011, CANCER-AM CANCER SOC, V117, P4740, DOI 10.1002/cncr.26111; Sunshine JC, 2017, CLIN CANCER RES, V23, P4938, DOI 10.1158/1078-0432.CCR-16-1821; Tarhini AA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9500; Tarhini AA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0678-7; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	20	1255	1288	2	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2017	377	19					1824	1835		10.1056/NEJMoa1709030	http://dx.doi.org/10.1056/NEJMoa1709030			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM2QW	28891423	Bronze, Green Published			2022-12-28	WOS:000414845700007
J	Ezekowitz, MD; Kent, AP				Ezekowitz, Michael D.; Kent, Anthony P.			The impact of IMPACT-AF	LANCET			English	Editorial Material							VALVULAR HEART-DISEASE; NONVALVULAR ATRIAL-FIBRILLATION; THROMBOEMBOLIC EVENTS; ANTICOAGULANT-THERAPY; RANDOMIZED EVALUATION; WARFARIN; DESIGN; STROKE; REDUCTION; RATIONALE		[Ezekowitz, Michael D.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Ezekowitz, Michael D.] Lankenau Med Ctr, Wynnewood, PA 19096 USA; [Ezekowitz, Michael D.] Bryn Mawr Hosp, Bryn Mawr, PA 19010 USA; [Kent, Anthony P.] Yale New Haven Hlth, Bridgeport Hosp, Bridgeport, CT USA	Jefferson University; Lankenau Medical Center; Yale University	Ezekowitz, MD (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.; Ezekowitz, MD (corresponding author), Lankenau Med Ctr, Wynnewood, PA 19096 USA.; Ezekowitz, MD (corresponding author), Bryn Mawr Hosp, Bryn Mawr, PA 19010 USA.	michael.ezekowitz@comcast.net	Ezekowitz, Michael/AAJ-2543-2021					Avezum A, 2015, CIRCULATION, V132, P624, DOI 10.1161/CIRCULATIONAHA.114.014807; Breithardt G, 2014, EUR HEART J, V35, P3377, DOI 10.1093/eurheartj/ehu305; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; De Caterina R, 2017, J AM COLL CARDIOL, V69, P1372, DOI 10.1016/j.jacc.2016.12.031; Ezekowitz MD, 2016, CIRCULATION, V134, P589, DOI 10.1161/CIRCULATIONAHA.115.020950; Ezekowitz MD, 2009, AM HEART J, V157, P805, DOI 10.1016/j.ahj.2009.02.005; Gross CP, 2003, CLIN THER, V25, P1750, DOI 10.1016/S0149-2918(03)80167-4; Hsu JC, 2016, JAMA CARDIOL, V1, P55, DOI 10.1001/jamacardio.2015.0374; Katz DF, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003476; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Patel MR, 2010, AM HEART J, V159, P340, DOI 10.1016/j.ahj.2009.11.025; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ruff CT, 2010, AM HEART J, V160, P635, DOI 10.1016/j.ahj.2010.06.042; Vinereanu D, 2017, LANCET	14	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1717	1718		10.1016/S0140-6736(17)32248-1	http://dx.doi.org/10.1016/S0140-6736(17)32248-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ6GB	28859948				2022-12-28	WOS:000412853100006
J	Karaiskos, N; Wahle, P; Alles, J; Boltengagen, A; Ayoub, S; Kipar, C; Kocks, C; Rajewsky, N; Zinzen, RP				Karaiskos, Nikos; Wahle, Philipp; Alles, Jonathan; Boltengagen, Anastasiya; Ayoub, Salah; Kipar, Claudia; Kocks, Christine; Rajewsky, Nikolaus; Zinzen, Robert P.			The Drosophila embryo at single-cell transcriptome resolution	SCIENCE			English	Article							GENOME-WIDE EXPRESSION; GENE-EXPRESSION; RNA-SEQ; MELANOGASTER; REVEALS; FATE; EVOLUTION; COMPLEX; TISSUE; YORKIE	By the onset of morphogenesis, Drosophila embryos consist of about 6000 cells that express distinct gene combinations. Here, we used single-cell sequencing of precisely staged embryos and devised DistMap, a computational mapping strategy to reconstruct the embryo and to predict spatial gene expression approaching single-cell resolution. We produced a virtual embryo with about 8000 expressed genes per cell. Our interactive Drosophila Virtual Expression eXplorer (DVEX) database generates three-dimensional virtual in situ hybridizations and computes gene expression gradients. We used DVEX to uncover patterned expression of transcription factors and long noncoding RNAs, as well as signaling pathway components. Spatial regulation of Hippo signaling during early embryogenesis suggests a mechanism for establishing asynchronous cell proliferation. Our approach is suitable to generate transcriptomic blueprints for other complex tissues.	[Karaiskos, Nikos; Alles, Jonathan; Boltengagen, Anastasiya; Ayoub, Salah; Kocks, Christine; Rajewsky, Nikolaus] Helmholtz Assoc MDC, Berlin Max Delbruck Ctr Mol Med, Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany; [Wahle, Philipp; Kipar, Claudia; Zinzen, Robert P.] MDC, Syst Biol Neural Tissue Differentiat, BIMSB, D-13125 Berlin, Germany		Rajewsky, N (corresponding author), Helmholtz Assoc MDC, Berlin Max Delbruck Ctr Mol Med, Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany.; Zinzen, RP (corresponding author), MDC, Syst Biol Neural Tissue Differentiat, BIMSB, D-13125 Berlin, Germany.	nikolaus.rajewsky@mdc-berlin.de; robert.zinzen@mdc-berlin.de	huang, dezhi/ABC-6566-2021; Zinzen, Robert/AAG-2784-2020; Karaiskos, Nikos/AAB-6838-2022; Zinzen, Robert/A-3130-2015	Karaiskos, Nikos/0000-0001-7771-3947; Wahle, Philipp/0000-0002-4728-806X; Rajewsky, Nikolaus/0000-0002-4785-4332; Zinzen, Robert/0000-0002-8638-5102	DZHK [BER 1.2 VD]; Deutsche Forschungsgemeinschaft [SPP 1738, RA 838/8-1, RA 838/5-1]	DZHK; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Biggin and S. Keranen (Lawrence Berkeley National Laboratory) for discussions and unpublished BDTNP data, R. Satija for initial Drop-seq help, S. Ugowski (MDC) for experimental assistance, S. Small (New York University) for a transgenic Drosophila line, A. Stathopoulos (California Institute of Technology, NIH R35GM118146) for sharing unpublished results, J. Zeitlinger (Stowers) for Yorkie antibody, E. Laufer (Columbia) for pMad antibody, N. Friedman (Hebrew University) and members of the Rajewsky and Zinzen laboratories for constructive discussions, the reviewers for valuable comments and suggestions, D. Munteanu (BIMSB/MDC) for information technology support, the DZHK (project number BER 1.2 VD), and the Deutsche Forschungsgemeinschaft (SPP 1738, RA 838/8-1, and RA 838/5-1) for funding. Raw and processed data sets are available from the Gene Expression Omnibus repository (GSE95025). The DistMap R-package is available at https://github.com/rajewsky-lab/distmap. N. R. and R.P.Z. defined strategy, supervised, and procured funding; N.K., P.W., J. A., C.Ko., N. R., and R.P.Z. designed experimental strategy; and P.W. did fly genetics and embryo collections. J. A. set up, C.Ko. supervised, and J. A., S. A., A.B., and C.Ko. performed Drop-seq. A.B., S. A., and P.W. prepared sequencing libraries; N.K. developed and implemented computational analyses/tools, including DistMap and DVEX; P.W. and C.Ki. validated predictions experimentally; and N.K., P.W., C.Ko., N. R., and R. P.Z. analyzed data and wrote the manuscript.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Alles J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0383-5; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; CARROLL SB, 2005, ENDLESS FORMS MOST B; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Davidson EH, 2006, REG GEN GEN REG; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Goff LA, 2015, GENOME RES, V25, P1456, DOI 10.1101/gr.191122.115; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Handley A, 2015, MOL CELL, V58, P621, DOI 10.1016/j.molcel.2015.04.024; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P181; Hartenstein V., 1993, ATLAS DROSOPHILA DEV, V1; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Riparbelli MG, 2003, MECH DEVELOP, V120, P441, DOI 10.1016/S0925-4773(03)00005-4; Sandler JE, 2016, GENETICS, V202, P1575, DOI 10.1534/genetics.116.186783; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schauer T, 2013, CELL REP, V5, P271, DOI 10.1016/j.celrep.2013.09.001; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Simpson P, 2008, ADV GENET, V61, P67, DOI 10.1016/S0065-2660(07)00003-X; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Steiner FA, 2012, GENOME RES, V22, P766, DOI 10.1101/gr.131748.111; Stoeckius M, 2014, EMBO J, V33, P1740, DOI 10.15252/embj.201488117; Stoeckius M, 2014, EMBO J, V33, P1751, DOI 10.15252/embj.201488769; TECHNAU GM, 1985, ROUX ARCH DEV BIOL, V194, P196; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; TREIER M, 1989, EMBO J, V8, P1517, DOI 10.1002/j.1460-2075.1989.tb03536.x; UNDERWOOD EM, 1980, DEV BIOL, V77, P303, DOI 10.1016/0012-1606(80)90476-5; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Zinzen RP, 2006, DEV CELL, V11, P895, DOI 10.1016/j.devcel.2006.10.012	47	191	191	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2017	358	6360					194	199		10.1126/science.aan3235	http://dx.doi.org/10.1126/science.aan3235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6CO	28860209	Green Accepted, Green Submitted			2022-12-28	WOS:000412841500041
J	Vickers, AJ				Vickers, Andrew J.			Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MORTALITY; TRIAL		[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,2nd Floor, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,2nd Floor, New York, NY 10065 USA.	VickersA@mskcc.org			National Institutes of Health/National Cancer Institute Cancer Center Support Grant [P30-CA008748]; Sidney Kimmel Center for Prostate and Urologic Cancers, a Specialized Programs of Research Excellence grant from the National Cancer Institute [P50-CA92629]; NATIONAL CANCER INSTITUTE [P50CA092629, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Cancer Center Support Grant; Sidney Kimmel Center for Prostate and Urologic Cancers, a Specialized Programs of Research Excellence grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	In part by funds from the Sidney Kimmel Center for Prostate and Urologic Cancers, a Specialized Programs of Research Excellence grant (P50-CA92629) from the National Cancer Institute to Dr. Howard Scher, and a National Institutes of Health/National Cancer Institute Cancer Center Support Grant (P30-CA008748) to Memorial Sloan Kettering Cancer Center.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; Carlsson SV, 2016, CANCER-AM CANCER SOC, V122, P3386, DOI 10.1002/cncr.30192; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; (NCCN) NCCN, 2016, NCCN CLIN PRACT GUID; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shoag JE, 2016, NEW ENGL J MED, V374, P1795, DOI 10.1056/NEJMc1515131; Tsodikov A, 2017, ANN INTERN MED, V167, P449, DOI 10.7326/M16-2586; Vickers AJ, 2014, ANN INTERN MED, V161, P441, DOI 10.7326/M14-0151	10	16	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					509	510		10.7326/M17-2012	http://dx.doi.org/10.7326/M17-2012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28869975				2022-12-28	WOS:000411988900014
J							HPS3 TIMI55-REVEAl Collaborative	Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIPID-LEVEL MANAGEMENT; HIGH-RISK; SAFETY; TORCETRAPIB; PARTICIPANTS; METAANALYSIS; CHOLESTEROL; UNDERSTAND; EFFICACY; THERAPY	BACKGROUND Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [ 10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P = 0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo.					Kato, Eri/AAC-6620-2019; Maggioni, Aldo Pietro/AAL-5334-2020; Gislason, Gunnar/B-7561-2009; De+Servi, Stefano/AAT-2631-2021; Meyer, Barbara/AAC-6078-2019; Salzwedel, Annett/H-3384-2019; Laukkanen, Jari/I-4528-2017	Kato, Eri/0000-0001-6484-7743; Maggioni, Aldo Pietro/0000-0003-2764-6779; Gislason, Gunnar/0000-0002-0548-402X; Meyer, Barbara/0000-0001-7962-7890; Salzwedel, Annett/0000-0003-2530-2673; Kiviniemi, Tuomas/0000-0002-0908-3741; Vadmann, Henrik/0000-0001-8551-9271; TRIPPEL, TOBIAS DANIEL/0000-0001-8575-0019; Ballantyne, Christie/0000-0002-6432-1730; Hopewell, Jemma/0000-0002-3870-8018; Iversen, Helle Klingenberg/0000-0002-5880-6352; stender, steen/0000-0003-1037-1158; Cureton, Lucy/0000-0003-0082-8468; Mortensen, Martin Bodtker/0000-0003-2693-4154; Laukkanen, Jari/0000-0002-3738-1586; Mihaylova, Borislava/0000-0002-0951-1304; Emberson, Jonathan/0000-0001-7792-9422; Landray, Martin/0000-0001-6646-827X; Chen, Fang/0000-0003-0374-8519; Klemsdal, Tor Ole/0000-0001-5442-9134; Gray, Alastair/0000-0003-0239-7278; Haynes, Richard/0000-0002-1179-0023; Dinesen, Pia Thisted/0000-0001-8541-3442; strandberg, timo/0000-0001-6299-925X; Wallendszus, Karl/0000-0003-0971-3026; Kober, Lars/0000-0002-6635-1466; Bekfani, Tarek/0000-0002-9714-1752; McDonough, Caitrin/0000-0001-6393-7288; James, Martin/0000-0001-6065-6018; Craig, Martin/0000-0003-4956-4512	Merck; British Heart Foundation [FS/14/55/30806]; Medical Research Council; National Institute for Health Research Clinical Research Network; MRC [MC_U137686861, MC_UU_12026/5, 1935732] Funding Source: UKRI; Medical Research Council [MC_U137686861, MC_UU_12026/5] Funding Source: researchfish; National Institute for Health Research [RC-PG-0407-10054, NF-SI-0508-10299, NF-SI-0513-10139] Funding Source: researchfish; Versus Arthritis [18475, 20639] Funding Source: researchfish	Merck(Merck & Company); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Clinical Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	Supported by Merck, the British Heart Foundation (including direct support for Drs. Collins and Hopewell by grant number FS/14/55/30806), the Medical Research Council (which funds the MRC Population Health Research Unit in a strategic partnership with the University of Oxford), and the National Institute for Health Research Clinical Research Network.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter P, 2009, AM J CARDIOL, V104, p10E, DOI 10.1016/j.amjcard.2009.09.014; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2011, CIRCULATION, V124, P555, DOI 10.1161/CIRCULATIONAHA.111.018259; Bloomfield D, 2009, AM HEART J, V157; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bowman L, 2017, AM HEART J, V187, P182, DOI 10.1016/j.ahj.2017.02.021; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Cuijpers P, 2009, PSYCHIAT RES, V168, P250, DOI 10.1016/j.psychres.2008.05.012; Davidson M, 2013, J LIPID RES, V54, P467, DOI 10.1194/jlr.M032615; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Forrest MJ, 2008, BRIT J PHARMACOL, V154, P1465, DOI 10.1038/bjp.2008.229; Gotto AM, 2014, J CARDIOVASC PHARM T, V19, P543, DOI 10.1177/1074248414529621; Kastelein JJP, 2015, LANCET, V385, P2153, DOI 10.1016/S0140-6736(14)62115-2; Krishna R, 2017, CLIN PHARM THER; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Lincoff AM, 2017, NEW ENGL J MED, V376, P1933, DOI 10.1056/NEJMoa1609581; Nicholls SJ, 2016, ACCELERATE TRIAL IMP; Nomura A, 2017, CIRC RES, V121, P81, DOI 10.1161/CIRCRESAHA.117.311145; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; TALL AR, 1993, J LIPID RES, V34, P1255; Wang Y., 2015, J NANOMATER, V2015, P1, DOI DOI 10.1038/SREP18296; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	30	512	525	4	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 28	2017	377	13					1217	1227		10.1056/NEJMoa1706444	http://dx.doi.org/10.1056/NEJMoa1706444			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI3DU	28847206	Green Published, Bronze			2022-12-28	WOS:000411838100005
J	Sondergaard, L; Kasner, SE; Rhodes, JF; Andersen, G; Iversen, HK; Nielsen-Kudsk, JE; Settergren, M; Sjostrand, C; Roine, RO; Hildick-Smith, D; Spence, JD; Thomassen, L				Sondergaard, Lars; Kasner, Scott E.; Rhodes, John F.; Andersen, Grethe; Iversen, Helle K.; Nielsen-Kudsk, Jens E.; Settergren, Magnus; Sjostrand, Christina; Roine, Risto O.; Hildick-Smith, David; Spence, J. David; Thomassen, Lars		Gore REDUCE Clinical Study Investi	Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE PROFESSIONALS; SILENT BRAIN INFARCTS; MEDICAL THERAPY; RECURRENT STROKE; RISK; PREVENTION; STATEMENT; GUIDELINE	BACKGROUND The efficacy of closure of a patent foramen ovale (PFO) in the prevention of recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO closure combined with antiplatelet therapy versus antiplatelet therapy alone on the risks of recurrent stroke and new brain infarctions. METHODS In this multinational trial involving patients with a PFO who had had a cryptogenic stroke, we randomly assigned patients, in a 2: 1 ratio, to undergo PFO closure plus antiplatelet therapy (PFO closure group) or to receive antiplatelet therapy alone (anti-platelet-only group). Imaging of the brain was performed at the baseline screening and at 24 months. The coprimary end points were freedom from clinical evidence of ischemic stroke (reported here as the percentage of patients who had a recurrence of stroke) through at least 24 months after randomization and the 24-month incidence of new brain infarction, which was a composite of clinical ischemic stroke or silent brain infarction detected on imaging. RESULTS We enrolled 664 patients (mean age, 45.2 years), of whom 81% had moderate or large interatrial shunts. During a median follow-up of 3.2 years, clinical ischemic stroke occurred in 6 of 441 patients (1.4%) in the PFO closure group and in 12 of 223 patients (5.4%) in the antiplatelet-only group (hazard ratio, 0.23; 95% confidence interval [CI], 0.09 to 0.62; P = 0.002). The incidence of new brain infarctions was significantly lower in the PFO closure group than in the antiplatelet-only group (22 patients [5.7%] vs. 20 patients [11.3%]; relative risk, 0.51; 95% CI, 0.29 to 0.91; P = 0.04), but the incidence of silent brain infarction did not differ significantly between the study groups (P = 0.97). Serious adverse events occurred in 23.1% of the patients in the PFO closure group and in 27.8% of the patients in the antiplatelet-only group (P = 0.22). Serious device-related adverse events occurred in 6 patients (1.4%) in the PFO closure group, and atrial fibrillation occurred in 29 patients (6.6%) after PFO closure. CONCLUSIONS Among patients with a PFO who had had a cryptogenic stroke, the risk of subsequent ischemic stroke was lower among those assigned to PFO closure combined with antiplatelet therapy than among those assigned to antiplatelet therapy alone; however, PFO closure was associated with higher rates of device complications and atrial fibrillation.	[Sondergaard, Lars] Univ Copenhagen, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Iversen, Helle K.] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Andersen, Grethe] Aarhus Univ, Dept Neurol, Aarhus, Denmark; [Nielsen-Kudsk, Jens E.] Aarhus Univ, Dept Cardiol, Aarhus, Denmark; [Andersen, Grethe] Aarhus Univ, Fac Hlth, Aarhus, Denmark; [Kasner, Scott E.] Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19014 USA; [Rhodes, John F.] Nicklaus Childrens Hosp, Dept Cardiol, Miami, FL USA; [Settergren, Magnus] Karolinska Univ Hosp, Heart & Vasc Theme, Stockholm, Sweden; [Sjostrand, Christina] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Settergren, Magnus] Karolinska Inst, Dept Med, Stockholm, Sweden; [Sjostrand, Christina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Roine, Risto O.] Turku Univ Hosp, Dept Clin Neurosci, Turku, Finland; [Roine, Risto O.] Univ Turku, Turku, Finland; [Hildick-Smith, David] Brighton & Sussex Univ Hosp, Dept Cardiol, Sussex Cardiac Ctr, Brighton, E Sussex, England; [Spence, J. David] Western Univ, Div Neurol, London, ON, Canada; [Thomassen, Lars] Haukeland Hosp, Dept Neurol, Bergen, Norway	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; Aarhus University; University of Pennsylvania; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Turku; University of Turku; Brighton and Sussex University Hospitals NHS Trust; Western University (University of Western Ontario); University of Bergen; Haukeland University Hospital	Kasner, SE (corresponding author), Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19014 USA.	kasner@mail.med.upenn.edu	Spence, J. David/K-6396-2013; Iversen, Helle Klingenberg/P-5726-2019; Horev, Anat/AAB-4919-2021; Nielsen, Olav Wendelboe/S-4390-2016; Settergren, Magnus/ABT-9898-2022	Spence, J. David/0000-0001-7478-1098; Iversen, Helle Klingenberg/0000-0002-5880-6352; Nielsen, Olav Wendelboe/0000-0003-3532-9431; Clift, Paul/0000-0001-8906-7647; Appleton, Jason/0000-0002-2604-4410; Andersen, Grethe/0000-0001-6807-2500; Roine, Risto/0000-0002-3824-3003; Mehla, Sandhya/0000-0002-0427-7141; Leirgul, Elisabeth/0000-0002-4988-1203; Airaksinen, Juhani/0000-0002-0193-568X; Richardson, Carla/0000-0002-1774-7261; Christensen, Hanne/0000-0002-7472-3194	W.L. Gore and Associates	W.L. Gore and Associates	Funded by W.L. Gore and Associates; Gore REDUCE ClinicalTrials.gov number, NCT00738894.	Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Jones WJ, 2001, STROKE, V32, P2232, DOI 10.1161/hs1001.096191; Kent DM, 2016, J AM COLL CARDIOL, V67, P907, DOI 10.1016/j.jacc.2015.12.023; Kent DM, 2013, NEUROLOGY, V81, P619, DOI 10.1212/WNL.0b013e3182a08d59; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Meller SM, 2014, CATHETER CARDIO INTE, V83, P502, DOI 10.1002/ccd.24904; Messe SR, 2016, NEUROLOGY, V87, P815, DOI 10.1212/WNL.0000000000002961; Messe SR, 2013, NEW ENGL J MED, V368, P1152, DOI 10.1056/NEJMe1301680; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Putaala J, 2011, NEUROLOGY, V76, P1742, DOI 10.1212/WNL.0b013e31821a44ad; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Smith EE, 2017, STROKE, V48, pE44, DOI 10.1161/STR.0000000000000116; Srivastava TN, 1997, NEW ENGL J MED, V337, P681, DOI 10.1056/NEJM199709043371005; Thaler DE, 2014, NEUROLOGY, V83, P221, DOI 10.1212/WNL.0000000000000589; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Zhu YC, 2011, STROKE, V42, P1140, DOI 10.1161/STROKEAHA.110.600114	25	540	569	2	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2017	377	11					1033	1042		10.1056/NEJMoa1707404	http://dx.doi.org/10.1056/NEJMoa1707404			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6YC	28902580	Bronze			2022-12-28	WOS:000410545200006
J	Stilz, P				Stilz, Peter			How glass fronts deceive bats	SCIENCE			English	Editorial Material									[Stilz, Peter] Univ Tubingen, Dept Anim Physiol, Inst Neurobiol, Tubingen, Germany	Eberhard Karls University of Tubingen	Stilz, P (corresponding author), Univ Tubingen, Dept Anim Physiol, Inst Neurobiol, Tubingen, Germany.	peter.stilz@uni-tuebingen.de						Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Greif S, 2017, SCIENCE, V357, P1045, DOI 10.1126/science.aam7817; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Griffin DR, 1958, LISTENING DARK; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Peremans H, 1998, J ACOUST SOC AM, V104, P1101, DOI 10.1121/1.423326; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Simmons JA, 2012, IET RADAR SONAR NAV, V6, P556, DOI 10.1049/iet-rsn.2012.0009; Surlykke A., 2016, BAT BIOACOUSTICS; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620	10	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		977	978		10.1126/science.aao2989	http://dx.doi.org/10.1126/science.aao2989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883063				2022-12-28	WOS:000409455700029
J	Washington, V; DeSalvo, K; Mostashari, F; Blumenthal, D				Washington, Vindell; DeSalvo, Karen; Mostashari, Farzad; Blumenthal, David			The HITECH Era and the Path Forward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Washington, Vindell] Blue Cross & Blue Shield Louisiana, Baton Rouge, LA 70803 USA; [DeSalvo, Karen] Blue Cross & Blue Shield Louisiana, New Orleans, LA 70803 USA; [Mostashari, Farzad] Aledade, Bethesda, MD USA; [Blumenthal, David] Commonwealth Fund, New York, NY USA	Commonwealth Fund	Washington, V (corresponding author), Blue Cross & Blue Shield Louisiana, Baton Rouge, LA 70803 USA.							Department of Health and Human Ser-vices Office of the Assistant Secretary for Health, 2016, PUBL HLTH 3 0 CALL A; Department of Health and Human Ser-vices Office of the National Coordinator for Health Information Technology, 2014, EFF MEAN US FUNCT HL; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI [10.17226/10027, DOI 10.17226/10027]; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600	4	48	48	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					904	906		10.1056/NEJMp1703370	http://dx.doi.org/10.1056/NEJMp1703370			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF9XU	28877013				2022-12-28	WOS:000409373100003
J	White, EA; Munger, K				White, Elizabeth A.; Munger, Karl			Crowd Control: E7 Conservation Is the Key to Cancer	CELL			English	Editorial Material							ONCOPROTEINS; PROTEINS	Several human papillomavirus type 16 (HPV16) oncoproteins contribute to cellular transformation in vitro. In this issue of Cell, Mirabello and colleagues use high-throughput sequencing data to assess the diversity of HPV16 isolates from human patients. These data suggest that the E7 oncoprotein is the fundamental contributor to in vivo carcinogenesis.	[White, Elizabeth A.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA; [Munger, Karl] Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, 150 Harrison Ave, Boston, MA 02111 USA	University of Pennsylvania; Pennsylvania Medicine; Tufts University	White, EA (corresponding author), Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.; Munger, K (corresponding author), Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, 150 Harrison Ave, Boston, MA 02111 USA.	eawhite@mail.med.upenn.edu; karl.munger@tufts.edu		Munger, Karl/0000-0003-3288-9935	NATIONAL CANCER INSTITUTE [R01CA066980] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA066980] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], TITLE ERROR; Cullen M, 2015, PAPILLOMAVIRUS RES, V1, P3, DOI 10.1016/j.pvr.2015.05.004; Dust M., 1983, P NATL ACAD SCI USA, V80, P3812; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munger K, 2015, J VIROL, V89, P4708, DOI 10.1128/JVI.03486-14; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Van Doorslaer K, 2017, NUCLEIC ACIDS RES, V45, pD499, DOI 10.1093/nar/gkw879; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Vieira VC, 2014, MBIO, V5, DOI 10.1128/mBio.02234-14; White EA, 2012, P NATL ACAD SCI USA, V109, pE260, DOI 10.1073/pnas.1116776109	10	9	9	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1057	1059		10.1016/j.cell.2017.08.033	http://dx.doi.org/10.1016/j.cell.2017.08.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886377	Bronze			2022-12-28	WOS:000409536000004
J	Mohammadi, D				Mohammadi, Dara			RESEARCH DISSEMINATION Conference organisers swimming against the tide of Twitter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												hello@daramohammadi.com						American Diabetes Association, PHOT AUD REC POL; Cortez MF, 2016, CAN BUNCH DOCTORS KE; Groves T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3556	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j3966	10.1136/bmj.j3966	http://dx.doi.org/10.1136/bmj.j3966			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EG	28877906				2022-12-28	WOS:000410575400006
J	Chereau, F; Opatowski, L; Tourdjman, M; Vong, S				Chereau, Fanny; Opatowski, Lulla; Tourdjman, Mathieu; Vong, Sirenda			Risk assessment for antibiotic resistance in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STAPHYLOCOCCUS-AUREUS INFECTIONS; ANTIMICROBIAL RESISTANCE; FOOD ANIMALS; HUMAN HEALTH; ENVIRONMENT; COLONIZATION; TRANSMISSION; AGRICULTURE; COMMUNITY; TRENDS		[Chereau, Fanny; Opatowski, Lulla; Vong, Sirenda] World Hlth Org Reg Off South East Asia, New Delhi, India; [Opatowski, Lulla] Inst Pasteur, Paris, France; [Tourdjman, Mathieu] St Louis Univ Hosp, Paris, France	World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Vong, S (corresponding author), World Hlth Org Reg Off South East Asia, New Delhi, India.	vongs@who.int	Opatowski, Lulla/I-3143-2015	Opatowski, Lulla/0000-0001-8348-700X; Chereau, Fanny/0000-0002-5651-9800	UK Department of Health Fleming Fund	UK Department of Health Fleming Fund	We have read and understood BMJ policy on declaration of interests, and declare funding from the UK Department of Health Fleming Fund.	Aarestrup FM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0085; [Anonymous], 2009, EJHP PRACT, V15, P15; Bain R, 2014, TROP MED INT HEALTH, V19, P917, DOI 10.1111/tmi.12334; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Boonyasiri A, 2014, PATHOG GLOB HEALTH, V108, P235, DOI 10.1179/2047773214Y.0000000148; Centers for Disease Control and Prevention, ONE HLTH; Chang QZ, 2015, EVOL APPL, V8, P240, DOI 10.1111/eva.12185; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chuanchuen R, 2014, REV LIT ANTIMICROBIA; Food and Agriculture Organization, 2016, DRIV DYN EP ANT RES; Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881; Gelband H, 2015, CLIN MICROBIOL REV, V28, P443, DOI [10.1128/CMR.00072-14, DOI 10.1128/CMR.00072-14]; Godinho N, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j2742; Goutard FL, 2017, BMJ-BRIT MED J, V358, P36, DOI 10.1136/bmj.j3544; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Holloway KA, 2017, BMJ-BRIT MED J, V358, pj2440; Holloway KA, 2017, BMJ-BRIT MED J, V358, P9, DOI 10.1136/bmj.j2291; Holmes Alison H, 2016, Lancet, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Kakkar M, 2017, BMJ-BRIT MED J, V358, P25, DOI 10.1136/bmj.j2687; Karanika S, 2016, CLIN INFECT DIS, V63, P195, DOI 10.1093/cid/ciw240; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Lawes T, 2015, LANCET INFECT DIS, V15, P1438, DOI 10.1016/S1473-3099(15)00315-1; Ling ML, 2015, CLIN INFECT DIS, V60, P1690, DOI 10.1093/cid/civ095; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lundborg CS, 2017, BMJ-BRIT MED J, V358, P42, DOI 10.1136/bmj.j2440; Majumder M A A, 2013, S E ASIA J PUBLIC HL, V2, p[3, 3], DOI [10.3329/seajph.v2i2.15936., DOI 10.3329/SEAJPH.V2I2.15936]; McCarthy AJ, 2014, GENOME BIOL EVOL, V6, P2697, DOI 10.1093/gbe/evu214; Smith DL, 2005, PLOS MED, V2, P731, DOI 10.1371/journal.pmed.0020232; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; WHO, 2015, GLOB ACT PLAN ANT RE; WHO, 2015, WATER SANITATION HYG; Wieland B, 2011, PREV VET MED, V99, P4, DOI 10.1016/j.prevetmed.2011.01.001; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; World Health Organization, 2015, Worldwide country situation analysis: response to antimicrobial resistance; World Health Organization, 2014, REG FOOD SAF STRAT; World Health Organization, 2015, REG STRAT PAT SAF WH; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; World Health Organization, 2014, SNAPSH DRINK WAT SAN; World Health Organization, 2012, RAP RISK ASS AC PUBL; World Health Organization Regional Office for South-East Asia, 2014, REG M JAIP IND 10 13	45	76	78	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						2	8	j3393	10.1136/bmj.j3393	http://dx.doi.org/10.1136/bmj.j3393			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874338	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000410575100006
J	Uyeki, TM				Uyeki, Timothy M.			Influenza	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GUILLAIN-BARRE-SYNDROME; VACCINE EFFECTIVENESS; OLDER-ADULTS; NEURAMINIDASE INHIBITORS; SPONTANEOUS-ABORTION; RAPID INFLUENZA; REYES-SYNDROME; NURSING-HOMES; UNITED-STATES; FETAL-DEATH		[Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	[Anonymous], GUID CLIN US RT PCR; [Anonymous], SPEC MAN NAT HOSP IN; Beau AB, 2014, BJOG-INT J OBSTET GY, V121, P895, DOI 10.1111/1471-0528.12617; Belay ED, 1999, NEW ENGL J MED, V340, P1377, DOI 10.1056/NEJM199905063401801; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Belongia EA, 2015, VACCINE, V33, P246, DOI 10.1016/j.vaccine.2014.06.052; Blaschke AJ, 2014, J PEDIAT INF DIS SOC, V3, P112, DOI 10.1093/jpids/pit071; Booy R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046509; Bowles SK, 2002, J AM GERIATR SOC, V50, P608, DOI 10.1046/j.1532-5415.2002.50153.x; Bratton KN, 2015, CLIN INFECT DIS, V60, pE11, DOI 10.1093/cid/ciu915; Buchbinder N, 2011, J HOSP INFECT, V79, P155, DOI 10.1016/j.jhin.2011.04.019; Busson L, 2017, DIAGN MICR INFEC DIS, V87, P238, DOI 10.1016/j.diagmicrobio.2016.11.015; *CDCP, INT GUID SPEC COLL P; Centers for disease control and prevention, INFL VIR TEST METH; Centers for Disease Control and Prevention, ALG ASS INT INFL TES; Centers for Disease Control and Prevention, GUID CONS INFL TEST; Centers for Disease Control and Prevention, PREV STRAT SEAS INFL; Darvishian M, 2017, LANCET RESP MED, V5, P200, DOI 10.1016/S2213-2600(17)30043-7; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Dunkle LM, 2017, NEW ENGL J MED, V376, P2427, DOI [10.1056/NEJMoa1608862, 10.1056/nejmoa1608862]; Duval X, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000362; Falsey AR, 2015, INFLUENZA OTHER RESP, V9, P23, DOI 10.1111/irv.12316; Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977; Ferdinands JM, 2017, CLIN INFECT DIS, V64, P544, DOI 10.1093/cid/ciw816; Ferdinands JM, 2014, J INFECT DIS, V210, P674, DOI 10.1093/infdis/jiu185; Flannery B, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4244; Freidl G.S., 2014, EURO SURVEILL; Graner S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j629; Gravenstein S, 2017, LANCET RESP MED; Grijalva CG, 2015, JAMA-J AM MED ASSOC, V314, P1488, DOI 10.1001/jama.2015.12160; Grohskopf LA, 2017, PREVENTION IN PRESS; Havers F, 2016, CLIN INFECT DIS, V63, P1304, DOI 10.1093/cid/ciw512; Jacobs JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107486; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Kharbanda EO, 2017, J PEDIAT; Kirkbride JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001998; Lam PP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1966-4; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Arias LHM, 2015, VACCINE, V33, P3773, DOI 10.1016/j.vaccine.2015.05.013; McMillan M, 2015, VACCINE, V33, P2108, DOI 10.1016/j.vaccine.2015.02.068; Miksic NG, 2015, INFECTION, V43, P73, DOI 10.1007/s15010-014-0703-4; Monto AS, 1999, NEW ENGL J MED, V340, P1423, DOI 10.1056/NEJM199905063401809; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Okoli GN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113633; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Petrie JG, 2016, CLIN INFECT DIS, V63, P1017, DOI 10.1093/cid/ciw432; Polyzos KA, 2015, OBSTET GYNECOL, V126, P1075, DOI 10.1097/AOG.0000000000001068; Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23; Shah SC, 2015, INFECT CONT HOSP EP, V36, P241, DOI 10.1017/ice.2014.64; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shijubo N, 2002, INTERNAL MED, V41, P366, DOI 10.2169/internalmedicine.41.366; Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124; Smith SMS, 2015, RESPIROLOGY, V20, P896, DOI 10.1111/resp.12541; Steinhoff MC, 2017, LANCET INFECT DIS; Tapia MD, 2016, LANCET INFECT DIS, V16, P1026, DOI 10.1016/S1473-3099(16)30054-8; The Joint Commission, INFL VACC LIC IND PR; U.S. Department of Health and Human Services, 2011, FED REGISTER, P51631; Uyeki TM, 2017, LANCET, V389, P2172, DOI 10.1016/S0140-6736(17)31274-6; Venkatesan S, 2017, CLIN INFECT DIS, V64, P1328, DOI 10.1093/cid/cix127; Wong VWY, 2014, EPIDEMIOL INFECT, V142, P922, DOI 10.1017/S095026881400003X; Ye M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011686	66	50	51	3	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					ITC33	ITC48		10.7326/AITC201709050	http://dx.doi.org/10.7326/AITC201709050			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28869984				2022-12-28	WOS:000409120400002
J	Watts, G				Watts, Geoff			Alvar Agusti: bringing systems biology to COPD	LANCET			English	Biographical-Item																			0	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					927	927		10.1016/S0140-6736(17)32242-0	http://dx.doi.org/10.1016/S0140-6736(17)32242-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28872021				2022-12-28	WOS:000408746300012
J	Ball, P				Ball, Philip			PHYSICS Europe's X-ray laser fires up	NATURE			English	News Item																		Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492	1	7	7	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					507	508		10.1038/548507a	http://dx.doi.org/10.1038/548507a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858328	Bronze			2022-12-28	WOS:000408703100004
J	Barres, BA				Barres, Ben A.			Stop blocking postdocs' paths to success	NATURE			English	Editorial Material									[Barres, Ben A.] Stanford Univ, Sch Med, Neurobiol, Stanford, CA 94305 USA	Stanford University	Barres, BA (corresponding author), Stanford Univ, Sch Med, Neurobiol, Stanford, CA 94305 USA.	barres@stanford.edu							0	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					517	519		10.1038/548517a	http://dx.doi.org/10.1038/548517a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2BO	28858323	Bronze			2022-12-28	WOS:000408703100013
J	Lamkanfi, M; Dixit, VM				Lamkanfi, Mohamed; Dixit, Vishva M.			In Retrospect The inflammasome turns 15	NATURE			English	Editorial Material							INTERLEUKIN-1-BETA CONVERTING-ENZYME; GAMMA-INDUCING FACTOR; MACROPHAGE APOPTOSIS; GASDERMIN D; CELL-DEATH; ACTIVATION; CASPASES; BINDING		[Lamkanfi, Mohamed] VIB, VIB UGent Ctr Inflammat Res, B-9052 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Internal Med, Ghent, Belgium; [Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Roche Holding; Genentech	Lamkanfi, M (corresponding author), VIB, VIB UGent Ctr Inflammat Res, B-9052 Ghent, Belgium.; Lamkanfi, M (corresponding author), Univ Ghent, Dept Internal Med, Ghent, Belgium.	mohamed.lamkanfi@irc.vib-ugent.be; dixit.vishva@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2017, N ENGL J MED; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0	20	33	35	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					534	535		10.1038/548534a	http://dx.doi.org/10.1038/548534a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2BO	28858314				2022-12-28	WOS:000408703100027
J	Sessoli, R				Sessoli, Roberta			MATERIALS SCIENCE Magnetic molecules back in the race	NATURE			English	Editorial Material								Single-molecule magnets have potential data-storage applications, but will need to work at a much higher temperature than has been possible. Two studies suggest that this goal could be met in the near future. SEE LETTER P.439	[Sessoli, Roberta] Univ Florence, Dept Chem Ugo Schiff, I-50019 Florence, Italy	University of Florence	Sessoli, R (corresponding author), Univ Florence, Dept Chem Ugo Schiff, I-50019 Florence, Italy.	roberta.sessoli@unifi.it	Sessoli, Roberta/K-5863-2015	Sessoli, Roberta/0000-0003-3783-2700				Donati F, 2016, SCIENCE, V352, P318, DOI 10.1126/science.aad9898; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Goodwin CAP, 2017, NATURE, V548, P439, DOI 10.1038/nature23447; Guo F.-S., 2017, ANGEW CHEM INT; Gupta SK, 2016, CHEM SCI, V7, P5181, DOI 10.1039/c6sc00279j; Lunghi A., 2017, CHEM SCI; Lunghi A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14620; Natterer FD, 2017, NATURE, V543, P226, DOI 10.1038/nature21371; Rinehart JD, 2011, CHEM SCI, V2, P2078, DOI 10.1039/c1sc00513h; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Wackerlin C, 2016, ADV MATER, V28, P5195, DOI [10.1002/adma.201506305, 10.1002/adma.201670180]	11	38	38	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					400	+		10.1038/548400a	http://dx.doi.org/10.1038/548400a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836590				2022-12-28	WOS:000408279000025
J	Warner, KE; Schroeder, S				Warner, Kenneth E.; Schroeder, StevenA.			FDA's Innovative Plan to Address the Enormous Toll of Smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CIGARETTES		[Warner, Kenneth E.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Schroeder, StevenA.] Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 430, San Francisco, CA 94143 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Schroeder, S (corresponding author), Univ Calif San Francisco, Dept Med, 3333 Calif St,Ste 430, San Francisco, CA 94143 USA.	Steve.Schroeder@ucsf.edu		Warner, Kenneth/0000-0002-8214-1776				Giovenco DP, 2018, ADDICT BEHAV, V76, P129, DOI 10.1016/j.addbeh.2017.08.002; Glantz S., 2016, ACCUMULATING EVIDENC; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; Kozlowski Lynn T, 2017, Drug Alcohol Depend, V174, P209, DOI 10.1016/j.drugalcdep.2017.01.001; Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035; Majeed BA, 2017, AM J PREV MED, V52, P331, DOI 10.1016/j.amepre.2016.08.039; Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Soneji S, 2017, JAMA PEDIATR, V171, P788, DOI 10.1001/jamapediatrics.2017.1488; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G	9	10	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 14	2017	318	18					1755	1756		10.1001/jama.2017.14336	http://dx.doi.org/10.1001/jama.2017.14336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN0IE	28885641				2022-12-28	WOS:000415660700009
J	Xiao, YB; Ng, S; Nam, KH; Ke, AL				Xiao, Yibei; Ng, Sherwin; Nam, Ki Hyun; Ke, Ailong			How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration	NATURE			English	Article							CRYSTAL-STRUCTURE; HOST FACTOR; DNA; ACQUISITION; REPEATS; ADAPTATION; SEQUENCES; ELEMENTS; COMPLEX; TARGETS	CRISPR (clustered regularly interspaced short palindromic repeats) and the nearby Cas (CRISPR-associated) operon establish an RNA-based adaptive immunity system in prokaryotes(1-5). Molecular memory is created when a short foreign DNA-derived prespacer is integrated into the CRISPR array as a new spacer(6-9). Whereas the RNA-guided CRISPR interference mechanism varies widely among CRISPR-Cas systems, the spacer integration mechanism is essentially identical(7-9). The conserved Cas1 and Cas2 proteins form an integrase complex consisting of two distal Cas1 dimers bridged by a Cas2 dimer(6,10). The prespacer is bound by Cas1-Cas2 as a dual-forked DNA, and the terminal 3'-OH of each 3' overhang serves as an attacking nucleophile during integration(11-14). The prespacer is preferentially integrated into the leader-proximal region of the CRISPR array(1,7,10,15,) guided by the leader sequence and a pair of inverted repeats inside the CRISPR repeat(7,15-20). Spacer integration in the well-studied Escherichia coli type I-E CRISPR system also relies on the bacterial integration host factor(21,22). In type II-A CRISPR, however, Cas1-Cas2 alone integrates spacers efficiently in vitro(18); other Cas proteins (such as Cas9 and Csn2) have accessory roles in the biogenesis phase of prespacers(17,23). Here we present four structural snapshots from the type II-A system(24) of Enterococcus faecalis Cas1 and Cas2 during spacer integration. Enterococcus faecalis Cas1-Cas2 selectively binds to a splayed 30-base-pair prespacer bearing 4-nucleotide 3' overhangs. Three molecular events take place upon encountering a target: first, the Cas1-Cas2-prespacer complex searches for half-sites stochastically, then it preferentially interacts with the leader-side CRISPR repeat, and finally, it catalyses a nucleophilic attack that connects one strand of the leader-proximal repeat to the prespacer 3' overhang. Recognition of the spacer half-site requires DNA bending and leads to full integration. We derive a mechanistic framework to explain the stepwise spacer integration process and the leader-proximal preference.	[Xiao, Yibei; Ng, Sherwin; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14353 USA; [Nam, Ki Hyun] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Cornell University; Pohang University of Science & Technology (POSTECH)	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14353 USA.	ak425@cornell.edu	Nam, Ki Hyun/N-6812-2019	Nam, Ki Hyun/0000-0003-3268-354X; Ng, Sherwin/0000-0002-4797-1694	NIH/NIGMS [GM118174, GM102543, P41-GM103403, S10-RR029205, GM-103485]; CHESS and MACCHESS; NSF [DMR-1332208]; US Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, P41GM103403, R35GM118174, R01GM116632, R01GM102543] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CHESS and MACCHESS; NSF(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH/NIGMS awards GM118174 and GM102543 to A.K. We thank D. Neau for assistance with data collection, and K. Rajashankar and I. Kriksunov for beamtime allocation. We thank P. Nguyen, R. Battaglia and A. Dolan for technical assistance and discussions. This work is based upon research conducted at NECAT, supported by NIH/NIGMS awards P41-GM103403 and S10-RR029205; and at CHESS and MACCHESS, supported by NSF award DMR-1332208 and NIH/NIGMS award GM-103485. This research used resources of the Advanced Photon Source, a US Department of Energy facility under contract no. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Goren MG, 2016, CELL REP, V16, P2811, DOI 10.1016/j.celrep.2016.08.043; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rollie C, 2015, ELIFE, V4, DOI [10.7554/eLife.08716, 10.7554/eLife.08716.001]; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yoganand KNR, 2017, NUCLEIC ACIDS RES, V45, P367, DOI 10.1093/nar/gkw1151; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	39	74	76	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2017	550	7674					137	+		10.1038/nature24020	http://dx.doi.org/10.1038/nature24020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7XU	28869593	Green Accepted, Green Submitted			2022-12-28	WOS:000412214100061
J	Chen, SY; Zhu, B; Yin, CQ; Liu, W; Han, CP; Chen, BE; Liu, TZ; Li, X; Chen, X; Li, CY; Hu, LM; Zhou, J; Xu, ZX; Gao, XM; Wu, X; Goding, CR; Cui, RT				Chen, Shuyang; Zhu, Bo; Yin, Chengqian; Liu, Wei; Han, Changpeng; Chen, Baoen; Liu, Tongzheng; Li, Xin; Chen, Xiang; Li, Chunying; Hu, Limin; Zhou, Jun; Xu, Zhi-Xiang; Gao, Xiumei; Wu, Xu; Goding, Colin R.; Cui, Rutao			Palmitoylation-dependent activation of MC1R prevents melanomagenesis	NATURE			English	Article							MELANOCORTIN 1 RECEPTOR; DNA-DAMAGE; HUMAN MELANOCYTES; UV EXPOSURE; RISK; METAANALYSIS; ASSOCIATION; POPULATION; REGULATOR; PHENOTYPE	The melanocortin-1 receptor (MC1R), a G-protein-coupled receptor, has a crucial role in human and mouse pigmentation(1-8). Activation of MC1R in melanocytes by alpha-melanocyte-stimulating hormone (alpha-MSH)(9) stimulates cAMP signalling and melanin production and enhances DNA repair after ultraviolet irradiation(10-16). Individuals carrying MC1R variants, especially those associated with red hair colour, fair skin and poor tanning ability (denoted as RHC variants), are associated with higher risk of melanoma(5,17-20). However, how MC1R activity is modulated by ultraviolet irradiation, why individuals with red hair are more prone to developing melanoma, and whether the activity of RHC variants might be restored for therapeutic benefit are unknown. Here we demonstrate a potential MC1R-targeted intervention strategy in mice to rescue loss-of-function MC1R in MC1R RHC variants for therapeutic benefit by activating MC1R protein palmitoylation. MC1R palmitoylation, primarily mediated by the protein-acyl transferase ZDHHC13, is essential for activating MC1R signalling, which triggers increased pigmentation, ultraviolet-B-induced G1-like cell cycle arrest and control of senescence and melanomagenesis in vitro and in vivo. Using C57BL/6J-Mc1r(e/e)J mice, in which endogenous MC1R is prematurely terminated, expressing Mc1r RHC variants, we show that pharmacological activation of palmitoylation rescues the defects of Mc1r RHC variants and prevents melanomagenesis. The results highlight a central role for MC1R palmitoylation in pigmentation and protection against melanoma.	[Chen, Shuyang; Zhu, Bo; Yin, Chengqian; Liu, Wei; Han, Changpeng; Li, Xin; Cui, Rutao] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Chen, Baoen; Wu, Xu] Harvard Med Sch, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Liu, Tongzheng] Jinan Univ, Inst Tumor Pharmacol, Guangzhou 510632, Guangdong, Peoples R China; [Chen, Xiang] Cent S Univ, Xiangya Hosp, Hunan Key Lab Skin Canc & Psoriasis, Dept Dermatol, Changsha 410008, Hunan, Peoples R China; [Li, Chunying] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710000, Shaanxi, Peoples R China; [Hu, Limin; Gao, Xiumei] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China; [Zhou, Jun] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Xu, Zhi-Xiang] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Goding, Colin R.] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England	Boston University; Harvard University; Massachusetts General Hospital; Jinan University; Central South University; Air Force Military Medical University; Tianjin University of Traditional Chinese Medicine; Nankai University; University of Alabama System; University of Alabama Birmingham; Ludwig Institute for Cancer Research; University of Oxford	Cui, RT (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	rutaocui@bu.edu	Yin, Chengqian/AAK-2991-2020; Liu, Wei/E-8826-2018	Liu, Wei/0000-0003-1792-6048; Chen, Shuyang/0000-0002-4760-4106; Li, Xin/0000-0003-2525-9679; Yin, Chengqian/0000-0003-4247-6245; Goding, Colin/0000-0002-1614-3909	National Institutes of Health [R01CA137098, R01CA193913, R01CA196896]; Department of Defense [CA140020]; Melanoma Research Foundation; Hong Kong and Macao Young Scientists of the National Natural Science Foundation of China [81428025]; National Natural Science Foundation of China [81630106]; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA196896, R01CA193913, R01CA137098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Melanoma Research Foundation; Hong Kong and Macao Young Scientists of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank X. Yao, H. Xie and G. Wei for careful reading and suggestions. This work was supported by the National Institutes of Health (R.C.: R01CA137098, R01CA193913 and R01CA196896), Department of Defense (R.C., CA140020), Melanoma Research Foundation Establish Investigator Award (R.C.), Hong Kong and Macao Young Scientists of the National Natural Science Foundation of China (R.C., 81428025), National Natural Science Foundation of China (X.G., 81630106), and the Ludwig Institute for Cancer Research (C.R.G.). R.C. is an American Cancer Society Research Scholar.	Abdel-Malek ZA, 2009, PIGM CELL MELANOMA R, V22, P635, DOI 10.1111/j.1755-148X.2009.00598.x; Abdel-Mallek ZA, 2008, PHOTOCHEM PHOTOBIOL, V84, P501, DOI 10.1111/j.1751-1097.2008.00294.x; Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200; Cao JX, 2013, MOL CELL, V51, P409, DOI 10.1016/j.molcel.2013.08.010; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Cust AE, 2012, INT J CANCER, V131, pE269, DOI 10.1002/ijc.27357; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Robles-Espinoza CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12064; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Diffey BL, 1997, PHOTODERMATOL PHOTO, V13, P64, DOI 10.1111/j.1600-0781.1997.tb00110.x; Dong L, 2010, CANCER RES, V70, P3547, DOI 10.1158/0008-5472.CAN-09-4596; Dunham WR, 1996, J INVEST DERMATOL, V107, P332, DOI 10.1111/1523-1747.ep12363174; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Goldstein AM, 2005, CANCER EPIDEM BIOMAR, V14, P2208, DOI 10.1158/1055-9965.EPI-05-0321; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Horikawa T, 1996, PIGM CELL RES, V9, P58, DOI 10.1111/j.1600-0749.1996.tb00089.x; Jackson IJ, 2007, HUM MOL GENET, V16, P2341, DOI 10.1093/hmg/ddm191; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Olsen CM, 2010, INT J CANCER, V127, P2430, DOI 10.1002/ijc.25243; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458	35	85	93	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					399	+		10.1038/nature23887	http://dx.doi.org/10.1038/nature23887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7PB	28869973	Green Accepted, Green Submitted			2022-12-28	WOS:000411381300038
J	Tarnawsky, SP; Yoder, MC				Tarnawsky, Stefan P.; Yoder, Mervin C.			From embryo mutation to adult degeneration	NATURE			English	Editorial Material							BRAF; VEMURAFENIB; NEOPLASMS		[Tarnawsky, Stefan P.; Yoder, Mervin C.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Yoder, MC (corresponding author), Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	myoder@iu.edu		Yoder, Mervin/0000-0003-4354-7631				Chan RJ, 2013, BLOOD, V121, P4815, DOI 10.1182/blood-2013-05-500090; Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Idbaih A, 2014, NEUROLOGY, V83, P1478, DOI 10.1212/WNL.0000000000000880; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; Palis J, 2016, FEBS LETT, V590, P3965, DOI 10.1002/1873-3468.12459; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Trifa AP, 2012, LEUKEMIA LYMPHOMA, V53, P2496, DOI 10.3109/10428194.2012.668188	12	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					340	342		10.1038/nature23547	http://dx.doi.org/10.1038/nature23547			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7PB	28854170				2022-12-28	WOS:000411381300024
J	Mehrotra, A; Burstin, H; Raphael, C				Mehrotra, Ateev; Burstin, Helen; Raphael, Carol			Raising the Bar in Attribution	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mehrotra, Ateev] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Burstin, Helen] Natl Qual Forum, 1030 15th St NW,Suite 800, Washington, DC 20005 USA; [Raphael, Carol] 11 Riverside Dr,13LW, New York, NY 10023 USA	Harvard University; Harvard Medical School	Mehrotra, A (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mehrotra@hcp.med.harvard.edu	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582				Centers for Medicare & Medicaid Services, 2017, SHAR SAV LOSS ASS ME; Centers for Medicare & Medicaid Services, 2017, BETT CAR SMART SPEND; Mehrotra A, 2010, ANN INTERN MED, V152, P649, DOI 10.7326/0003-4819-152-10-201005180-00005; National Quality Forum, 2017, ATTR PRINC APPR; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979	5	7	7	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					434	+		10.7326/M17-0655	http://dx.doi.org/10.7326/M17-0655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28847009				2022-12-28	WOS:000411009900021
J	Geller, HI; Singh, A; Alexander, KM; Mirto, TM; Falk, RH				Geller, Hallie I.; Singh, Avinainder; Alexander, Kevin M.; Mirto, Tara M.; Falk, Rodney H.			Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEART-FAILURE		[Geller, Hallie I.; Singh, Avinainder; Alexander, Kevin M.; Mirto, Tara M.; Falk, Rodney H.] Brigham & Womens Hosp, Cardiac Amyloidosis Program, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Falk, RH (corresponding author), Brigham & Womens Hosp, Cardiac Amyloidosis Program, 75 Francis St, Boston, MA 02115 USA.	rfalk@bwh.harvard.edu	Singh, Avinainder/AAJ-2920-2020	Singh, Avinainder/0000-0003-1717-005X; Alexander, Kevin/0000-0003-4024-3691	David Shapira Amyloidosis Fellowship; National Institutes of Health [T32HL007604]; Friends of Burt Glazov Cardiac Amyloidosis Fund; Demarest Lloyd Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	David Shapira Amyloidosis Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Burt Glazov Cardiac Amyloidosis Fund; Demarest Lloyd Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the David Shapira Amyloidosis Fellowship (Dr Singh), grant T32HL007604 from the National Institutes of Health (Dr Alexander), the Friends of Burt Glazov Cardiac Amyloidosis Fund (Dr Falk and Mrs Geller), and the Demarest Lloyd Jr. Foundation (Dr Falk and Mrs Geller).	Connors LH, 2016, CIRCULATION, V133, P282, DOI 10.1161/CIRCULATIONAHA.115.018852; Gillmore JD, 2016, CIRCULATION, V133, P2404, DOI 10.1161/CIRCULATIONAHA.116.021612; Gonzalez-Lopez E, 2015, EUR HEART J, V36, P2585, DOI 10.1093/eurheartj/ehv338; Safran MR, 2002, CLIN ORTHOP RELAT R, P275, DOI 10.1097/01.blo.0000026560.55792.02; Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017	5	77	77	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					962	963		10.1001/jama.2017.9236	http://dx.doi.org/10.1001/jama.2017.9236			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898370	Green Published			2022-12-28	WOS:000410487100019
J	Mostaghim, SR; Gagne, JJ; Kesselheim, AS				Mostaghim, Sana R.; Gagne, Joshua J.; Kesselheim, Aaron S.			Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FDA; DEADLINES; POLICY; RISK	OBJECTIVE To determine if drugs approved through the Food and Drug Administration's expedited development and review pathways have different rates of safety related label changes after approval compared with drugs approved through standard non-expedited pathways. DESIGN Retrospective cohort study. SETTING FDA public records, January 1997 to April 2016. PARTICIPANTS 382 FDA approved drugs. MAIN OUTCOME MEASURES The number of times a particular safety section of a label (boxed warning, contraindication, warning, precaution, or adverse reaction) was changed during a drug's time on the market. The relative rate of safety related label changes per year for expedited pathway and non-expedited pathway drugs was compared by forming matched pairs of drugs in the same therapeutic class that were approved within three years of each other. RESULTS Among the 382 eligible new drugs, 135 (35%) were associated with an expedited development or review pathway, and matches were available for 96 (71%). The matched pairs were associated with a total of 1710 safety related label changes during the study period. Expedited pathway drugs were characterized by a rate of 0.94 safety related label changes for each drug per year, compared with 0.68 safety related label changes per year for non-expedited pathway drugs (rate ratio 1.38, 95% confidence interval 1.25 to 1.52). Compared with non-expedited pathway drugs, expedited pathway drugs had a 48% higher rate of changes to boxed warnings and contraindications, the two most clinically important categories of safety warnings (1.48, 95% confidence interval 1.07 to 2.06). A qualitative review of changes to the boxed warning sections revealed that less than 5% (3/67) were changed to describe reduced risks for patients. CONCLUSIONS Expedited development and regulatory review pathways can accelerate the availability of new drugs, but drugs approved through these pathways are associated with increased safety related label changes after approval, particularly for the types of changes representing the highest risk warnings. To inform appropriate policy interventions, additional research should explore the causal factors contributing to these different rates.	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 1620 Tremont St, Boston, MA 02120 USA; Harvard Med Sch, 1620 Tremont St, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 1620 Tremont St, Boston, MA 02120 USA.	akesselheim@bwh.harvard.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Laura and John Arnold Foundation	Laura and John Arnold Foundation	This study was funded by the Laura and John Arnold Foundation. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Arnardottir AH, 2011, BRIT J CLIN PHARMACO, V72, P490, DOI 10.1111/j.1365-2125.2011.03995.x; Begosh A, 2006, NBER WORKING PAPER S, DOI [10.3386/w12803, DOI 10.3386/W12803]; Berndt ER, 2005, NAT REV DRUG DISCOV, V4, P545, DOI 10.1038/nrd1774; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Darrow Jonathan J, 2014, N Engl J Med, V370, pe39, DOI 10.1056/NEJMp1402114; Downing NS, 2017, JAMA-J AM MED ASSOC, V317, P1854, DOI 10.1001/jama.2017.5150; FDA, 2011, REP C SENT IN NAT ST; Food and Drug Administration, 2014, GUID IND EXP PROGR S; Friedman MA, 1999, JAMA-J AM MED ASSOC, V281, P1728, DOI 10.1001/jama.281.18.1728; Grabowski H, 2008, J LAW ECON, V51, P377, DOI 10.1086/589934; Kagan CM, 2015, ACAD MED, V90, P838, DOI 10.1097/ACM.0000000000000747; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V315, P1516, DOI 10.1001/jama.2015.16984; Kesselheim AS, 2016, ANN INTERN MED, V164, P500, DOI 10.7326/M15-1906; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Lexchin J, 2012, ARCH INTERN MED, V172, P1680, DOI 10.1001/archinternmed.2012.4444; Nardinelli C, 2008, NEW ENGL J MED, V359, P95, DOI 10.1056/NEJMc086158; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Olson MK, 2004, J HEALTH ECON, V23, P1135, DOI 10.1016/j.jhealeco.2004.03.007; Olson MK, 2002, J LAW ECON, V45, P615, DOI 10.1086/368006; Reaves N, 2009, DRUG APPROVALS DRUG; Rockoff J, 2016, WALL STREET J; STERN AD, 2015, CIRCULATION S3, V132	22	56	57	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j3837	10.1136/bmj.j3837	http://dx.doi.org/10.1136/bmj.j3837			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG7EM	28882831	Green Published, hybrid			2022-12-28	WOS:000410576200004
J	Shah, AS; Karunaratne, K; Shakya, G; Barreto, I; Khare, S; Paveenkittiporn, W; Wangchuk, S; Tin, HH; Muhsin, MA; Aung, L; Bhatia, R; Srivastava, R; Maryandi, DA				Shah, Aparna Singh; Karunaratne, Kumudu; Shakya, Geeta; Barreto, Ismael; Khare, Shashi; Paveenkittiporn, Wantana; Wangchuk, Sonam; Tin, Htay Htay; Muhsin, Milza Abdul; Aung, Lin; Bhatia, Rajesh; Srivastava, Rahul; Maryandi, Dwi Adi			Strengthening laboratory surveillance of antimicrobial resistance in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shah, Aparna Singh; Aung, Lin; Bhatia, Rajesh; Srivastava, Rahul; Maryandi, Dwi Adi] WHO, Reg Off South East Asia, New Delhi, India; [Karunaratne, Kumudu] Lady Ridgeway Hosp Colombo, Colombo, Sri Lanka; [Shakya, Geeta] Nat Publ Hlth Lab Kathmandu, Kathmandu, Nepal; [Barreto, Ismael] Nat Hlth Lab Dilli, Dilli, Timor-Leste; [Khare, Shashi] Nat Ctr Dis Control, Delhi, India; [Paveenkittiporn, Wantana] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Wangchuk, Sonam] Royal Ctr Dis Control, Thimphu, Bhutan; [Tin, Htay Htay] Nat Hlth Lab Yangon, Yangon, Myanmar; [Muhsin, Milza Abdul] Indira Gandhi Mem Hosp, Male, Maldives	World Health Organization; Ministry of Public Health - Thailand	Shah, AS (corresponding author), WHO, Reg Off South East Asia, New Delhi, India.	shahap@who.int						Antimicrobial Surveillance System, 2015, MAN EARL IMPL; Bala M, 2013, SEX TRANSM INFECT, V89, P28, DOI 10.1136/sextrans-2012-050904; Dissanayake DMBT, 2013, CEYLON MED J, V58, P35, DOI 10.4038/cmj.v58i1.5364; Joshi Sangeeta, 2012, WHO South East Asia J Public Health, V1, P182, DOI 10.4103/2224-3151.206930; Joshi S, 2013, INDIAN J MED RES, V137, P363; Nugent R, 2010, RACE DRUG RESISTANCE; Shakya G, 2012, AFR J MICROBIOL RES, V6, P4233, DOI 10.5897/AJMR11.606; Thamlikitkul V, 2015, J GLOB ANTIMICROB RE, V3, P290, DOI 10.1016/j.jgar.2015.09.003; World Health Organization, 2014, REG WORKSH ANT RES J; World Health Organization, 2011, BI REG WORKSH LAN BA; World Health Organization, 2012, REG WORKSH ANT RES B; World Health Organization, 2010, AS PAC STRAT STRENGT; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; World Health Organization, 2016, WORLDW COUNTR SIT AN; World Health Organization, REG STRAT PREV CONT; World Health Organization, 2013, REG WORKSH LAB BAS S	16	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						56	58	j3474	10.1136/bmj.j3474	http://dx.doi.org/10.1136/bmj.j3474			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874340	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000410575100007
J	Abbasi, J				Abbasi, Jennifer			Medical Students Fall Short on Blood Pressure Check Challenge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP	2017	318	11					991	992		10.1001/jama.2017.11255	http://dx.doi.org/10.1001/jama.2017.11255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7DP	28854304				2022-12-28	WOS:000411343400002
J	Janssens, TVW; Vennestrom, PNR				Janssens, Ton V. W.; Vennestrom, Peter N. R.			A molecular dance to cleaner air	SCIENCE			English	Editorial Material							SELECTIVE CATALYTIC-REDUCTION; TEMPERATURE; AMMONIA; XES		[Janssens, Ton V. W.; Vennestrom, Peter N. R.] Haldor Topsoe Res Labs, Haldor Topsoes Alle 1, DK-2800 Lyngby, Denmark	Haldor Topsoe	Janssens, TVW (corresponding author), Haldor Topsoe Res Labs, Haldor Topsoes Alle 1, DK-2800 Lyngby, Denmark.	tvj@topsoe.com		Janssens, Ton V.W./0000-0002-1225-0942; Vennestrom, Peter/0000-0002-6744-5640				Falsig H, 2016, TOP CATAL, V59, P861, DOI 10.1007/s11244-016-0560-8; Gao F, 2017, J AM CHEM SOC, V139, P4935, DOI 10.1021/jacs.7b01128; Gao F, 2014, J CATAL, V319, P1, DOI 10.1016/j.jcat.2014.08.010; Giordanino F, 2014, J PHYS CHEM LETT, V5, P1552, DOI 10.1021/jz500241m; Janssens TVW, 2015, ACS CATAL, V5, P2832, DOI 10.1021/cs501673g; Lomachenko KA, 2016, J AM CHEM SOC, V138, P12025, DOI 10.1021/jacs.6b06809; Paolucci C, 2017, SCIENCE, V357, P898, DOI 10.1126/science.aan5630; Paolucci C, 2016, J AM CHEM SOC, V138, P6028, DOI 10.1021/jacs.6b02651; Shwan S, 2015, ACS CATAL, V5, P16, DOI 10.1021/cs5015139	9	6	7	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					866	867		10.1126/science.aao2442	http://dx.doi.org/10.1126/science.aao2442			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860368				2022-12-28	WOS:000408734900022
J	Drachman, DE; Dudzinski, DM; Moy, MP; Castillo, CFD; Chen, JH				Drachman, Douglas E.; Dudzinski, David M.; Moy, Matthew P.; Castillo, Carlos Fernandez-del; Chen, Jonathan H.			Case 27-2017: A 32-Year-Old Man with Acute Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AORTIC DISSECTION; HISTORY; DISEASE; PATIENT		[Drachman, Douglas E.; Dudzinski, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Moy, Matthew P.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Chen, Jonathan H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drachman, Douglas E.; Dudzinski, David M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Moy, Matthew P.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Castillo, Carlos Fernandez-del] Harvard Med Sch, Dept Surg, Boston, MA USA; [Chen, Jonathan H.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Drachman, DE (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Drachman, DE (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Castillo, Carlos Fenandez-del/AAO-2602-2020					[Anonymous], 2016, NEW ENGL J MED, V374, P1178; ATTILI AF, 1995, HEPATOLOGY, V21, P656, DOI 10.1002/hep.1840210309; Dudzinski DM, 2012, CURR PROB CARDIOLOGY, V37, P75, DOI 10.1016/j.cpcardiol.2011.10.002; Gilbert N C, 1942, Bull N Y Acad Med, V18, P83; GRACIE WA, 1982, NEW ENGL J MED, V307, P798, DOI 10.1056/NEJM198209233071305; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Horton KM, 2005, RADIOGRAPHICS, V25, P1177, DOI 10.1148/rg.255055001; Klompas M, 2002, JAMA-J AM MED ASSOC, V287, P2262, DOI 10.1001/jama.287.17.2262; Patel N, 2011, JSLS-J SOC LAPAROEND, V15, P105, DOI 10.4293/108680811X13022985131534; Podrid P., 2013, PODRIDS REAL WORLD E; RYAN ET, 1992, ANN INTERN MED, V116, P218, DOI 10.7326/0003-4819-116-3-218; Schwartz BG, 2010, CIRCULATION, V122, P2558, DOI 10.1161/CIRCULATIONAHA.110.940569; Swap CJ, 2005, JAMA-J AM MED ASSOC, V294, P2623, DOI 10.1001/jama.294.20.2623; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Zhou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027390	15	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					874	882		10.1056/NEJMcpc1706111	http://dx.doi.org/10.1056/NEJMcpc1706111			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854089				2022-12-28	WOS:000408626400012
J	Srivastava, R				Srivastava, Ranjana			Abandonment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Srivastava, Ranjana] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia		Srivastava, R (corresponding author), Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					805	807		10.1056/NEJMp1706793	http://dx.doi.org/10.1056/NEJMp1706793			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854084	Bronze			2022-12-28	WOS:000408626400003
J	Dyer, C				Dyer, Clare			GMC appeals decision not to strike off doctor convicted of manslaughter	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2928; Dyer C, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6832; Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1660	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2017	358								j4023	10.1136/bmj.j4023	http://dx.doi.org/10.1136/bmj.j4023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF1SU	28842473				2022-12-28	WOS:000408680000008
J	Silvera, IF; Dias, R				Silvera, Isaac F.; Dias, Ranga			Response to Comment on "Observation of the Wigner-Huntington transition to metallic hydrogen"	SCIENCE			English	Editorial Material							PRESSURE; SAMPLE; CELLS	Liu et al. present negative comments on our observation of the Wigner-Huntington transition to metallic hydrogen (MH). Earlier attempts to produce MH were unsuccessful due to diamond failure before the required pressures were achieved. We produced the highest static pressures (495 gigapascals) ever on hydrogen at low temperatures. Here, we respond to their objections.	[Silvera, Isaac F.; Dias, Ranga] Harvard Univ, Lyman Lab Phys, Cambridge, MA 02138 USA	Harvard University	Silvera, IF (corresponding author), Harvard Univ, Lyman Lab Phys, Cambridge, MA 02138 USA.	silvera@physics.harvard.edu		Silvera, Isaac/0000-0001-8586-8391	NSF [DMR-1308641]; U.S. Department of Energy Stockpile Stewardship Academic Alliance Program [DE-NA0003346]	NSF(National Science Foundation (NSF)); U.S. Department of Energy Stockpile Stewardship Academic Alliance Program(United States Department of Energy (DOE))	This work was supported by NSF grant DMR-1308641 and U.S. Department of Energy Stockpile Stewardship Academic Alliance Program grant DE-NA0003346.	Dias R., 2016, ARXIV160302162; Dias RP, 2017, SCIENCE, V355, P715, DOI 10.1126/science.aal1579; Dias RP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.145501; Eremets MI, 2011, NAT MATER, V10, P927, DOI [10.1038/NMAT3175, 10.1038/nmat3175]; Eremets MI, 2003, J RAMAN SPECTROSC, V34, P515, DOI 10.1002/jrs.1044; Howie RT, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.175501; Liu XD, 2017, SCIENCE, V357, DOI 10.1126/science.aan2286; Orloff J, 2000, REV SCI INSTRUM, V71, P216, DOI 10.1063/1.1150185; RUOFF AL, 1992, REV SCI INSTRUM, V63, P4342, DOI 10.1063/1.1143734; Silvera I. F., 2017, ARXIV170303064; SILVERA IF, 1985, REV SCI INSTRUM, V56, P121, DOI 10.1063/1.1138514; Zha CS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.146402	12	8	8	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353							eaan2671	10.1126/science.aan2671	http://dx.doi.org/10.1126/science.aan2671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839047				2022-12-28	WOS:000408327900004
J	Mostoslavsky, R; Bardeesy, N				Mostoslavsky, Raul; Bardeesy, Nabeel			Reprogramming Enhancers to Drive Metastasis	CELL			English	Editorial Material							PANCREATIC-CANCER; PROGRESSION	Acquired molecular changes can promote the spreading of primary tumor cells to distant tissues. In this issue of Cell, Roe et al. show that metastatic progression of pancreatic cancer involves large-scale enhancer reprogramming by Foxa1, which activates transcriptional program specifying early endodermal stem cells.	[Mostoslavsky, Raul; Bardeesy, Nabeel] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA; [Mostoslavsky, Raul; Bardeesy, Nabeel] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Mostoslavsky, Raul] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA.; Bardeesy, N (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	bardeesy.nabeel@mgh.harvard.edu						Aiello NM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12819; [Anonymous], TITLE ERROR; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kugel S, 2016, CELL, V165, P1401, DOI 10.1016/j.cell.2016.04.033; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048	10	8	8	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					823	825		10.1016/j.cell.2017.08.010	http://dx.doi.org/10.1016/j.cell.2017.08.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841414	Bronze			2022-12-28	WOS:000408372400003
J	Boucher, HW; Murray, BE; Powderly, WG				Boucher, Helen W.; Murray, Barbara E.; Powderly, William G.			Proposed US Funding Cuts Threaten Progress on Antimicrobial Resistance	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Tufts Med Ctr, Boston, MA USA; Univ Texas Houston, Sch Med, Houston, TX USA; Washington Univ, St Louis, MO USA; [Boucher, Helen W.] Tufts Med Ctr, Div Geog Med & Infect Dis, 750 Washington St,Box 238, Boston, MA 02111 USA; [Murray, Barbara E.] Univ Texas Houston, Med Sch, 6431 Fannin St,MSB 2-112, Houston, TX 77030 USA; [Powderly, William G.] Washington Univ, Clayton Ave,Campus Box 8051, St Louis, MO 63110 USA	Tufts Medical Center; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL); Tufts Medical Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL)	Boucher, HW (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, 750 Washington St,Box 238, Boston, MA 02111 USA.	hboucher@tuftsmedicalcenter.org		Powderly, William/0000-0001-7808-3086				CDC, 2013, ANTIBIOTIC RESISTANC; Chambers HF, 2017, CLIN INFECT DIS, V64, pS3, DOI 10.1093/cid/ciw824; G20, 2017, G20 LEAD DECL SHAP I, P1; Review on Antimicrobial Resistance, 2016, TACKL DRUG RES INF G; Sharma A, 2017, LANCET INFECT DIS, V17, P707, DOI 10.1016/S1473-3099(17)30247-5; World Health Organization, 2017, ANT RES REP SECR	6	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 21	2017	167	10					738	+		10.7326/M17-1678	http://dx.doi.org/10.7326/M17-1678			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO2DP	28869976				2022-12-28	WOS:000416584200018
J	Breen, DP; Freeman, CL; De Silva, RN; Derakhshani, S; Stevens, J				Breen, David P.; Freeman, Ciara L.; De Silva, Rajith N.; Derakhshani, Shahram; Stevens, Jane			Soft tissue plasmacytomas in multiple myeloma	LANCET			English	Editorial Material									[Breen, David P.] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada; [Breen, David P.] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada; [Freeman, Ciara L.] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada; [De Silva, Rajith N.] Queens Hosp, Dept Neurol, Romford, Essex, England; [Derakhshani, Shahram] Queens Hosp, Dept Neuroradiol, Romford, Essex, England; [Stevens, Jane] Queens Hosp, Dept Haematol, Romford, Essex, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; British Columbia Cancer Agency	Breen, DP (corresponding author), Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada.; Breen, DP (corresponding author), Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada.	dpbreen1@gmail.com		Stevens, Jane/0000-0001-8188-9160					0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2083	2083		10.1016/S0140-6736(17)31471-X	http://dx.doi.org/10.1016/S0140-6736(17)31471-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FL5DD	28844475				2022-12-28	WOS:000414250800025
J	Jenkins, BJ				Jenkins, Brendan J.			Potential efficacy of interleukin-1 beta inhibition in lung cancer	LANCET			English	Editorial Material							CANAKINUMAB; INFLAMMATION		[Jenkins, Brendan J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia; [Jenkins, Brendan J.] Fac Med Nursing & Hlth Sci, Dept Mol Translat Sci, Clayton, Vic 3168, Australia	Hudson Institute of Medical Research	Jenkins, BJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic 3168, Australia.; Jenkins, BJ (corresponding author), Fac Med Nursing & Hlth Sci, Dept Mol Translat Sci, Clayton, Vic 3168, Australia.	brendan.jenkins@hudson.org.au		Jenkins, Brendan/0000-0002-7552-4656				Calverley PMA, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0633-7; Cavalli G, 2015, RHEUMATOLOGY, V54, P2134, DOI 10.1093/rheumatology/kev269; Church LD, 2009, CURR OPIN MOL THER, V11, P81; Dhimolea E, 2010, MABS-AUSTIN, V2, P3, DOI 10.4161/mabs.2.1.10328; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Milara J, 2012, CURR PHARM DESIGN, V18, P3901, DOI 10.2174/138161212802083743; Peitz J, 2015, OPEN ACCESS RHEUMATO, V7, P23, DOI 10.2147/OARRR.S54215; Ridker PM, 2017, LANCET; Rogliani P, 2015, PULM PHARMACOL THER, V31, P15, DOI 10.1016/j.pupt.2015.01.005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040	12	4	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1813	1814		10.1016/S0140-6736(17)32289-4	http://dx.doi.org/10.1016/S0140-6736(17)32289-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK1LY	28855076				2022-12-28	WOS:000413244500007
J	Ben-Yakov, G; Devika, K; Etzion, O; Koh, C; Heller, T				Ben-Yakov, Gil; Devika, Kapuria; Etzion, Ohad; Koh, Christopher; Heller, Theo			A Misleading Pattern of Serologic Findings During Hepatitis B Virus Infection	ANNALS OF INTERNAL MEDICINE			English	Letter									[Ben-Yakov, Gil; Devika, Kapuria; Etzion, Ohad; Koh, Christopher; Heller, Theo] NIDDK, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ben-Yakov, G (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.		Yakov, Gil Ben/P-9276-2019; etzion, ohad/N-5927-2019	Ben Yakov, Gil/0000-0002-6832-0903; Heller, Theo/0000-0002-2643-6289	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054514] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		FONG TL, 1993, HEPATOLOGY, V18, P1313, DOI 10.1016/0270-9139(93)90217-B; Gogoi D, 2015, VIRAL IMMUNOL, V28, P348, DOI 10.1089/vim.2014.0115; Makvandi M, 2016, WORLD J GASTROENTERO, V22, P8720, DOI 10.3748/wjg.v22.i39.8720; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2017	167	8					603	604		10.7326/L17-0369	http://dx.doi.org/10.7326/L17-0369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ9JM	28847010				2022-12-28	WOS:000413092700028
J	O'Dowd, A				O'Dowd, Adrian			Is lobbying legislation chilling public debate on health? Health campaigners are pressing for changes to a law they claim is gagging them, writes Adrian O'Dowd	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						B, 2011, BBC NEWS; House of Lords Select Committee on Charities, 2017, REP SESS 2016 17 STR; Third Party Campaigning Review, 2016, 3 PART EL CAMP GETT	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2017	358								j4225	10.1136/bmj.j4225	http://dx.doi.org/10.1136/bmj.j4225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH6MX	28899947				2022-12-28	WOS:000411292200007
J	Cahill, TJ; Dayer, M; Prendergast, B; Thornhill, M				Cahill, Thomas J.; Dayer, Mark; Prendergast, Bernard; Thornhill, Martin			UNCERTAINTIES Do patients at risk of infective endocarditis need antibiotics before dental procedures?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VIRIDANS GROUP STREPTOCOCCI; BACTERIAL-ENDOCARDITIS; PREVENTION GUIDELINES; TEMPORAL TRENDS; PROPHYLAXIS; POPULATION; BACTEREMIA; ADULTS; ETIOLOGY; SURGERY		[Cahill, Thomas J.] Oxford Univ Hosp NHS Fdn Trust, Oxford Heart Ctr, Oxford, England; [Dayer, Mark] Taunton & Somerset NHS Fdn Trust, Dept Cardiol, Musgrove Pk, Taunton, Somerset, England; [Prendergast, Bernard] Guys & St Thomas Hosp NHS Fdn, Dept Cardiol, London, England; [Thornhill, Martin] Univ Sheffield, Sch Clin Dent, Dept Oral & Maxillofacial Med Surg & Patho, Sheffield, S Yorkshire, England	Oxford University Hospitals NHS Foundation Trust; Musgrove Park Hospital; Guy's & St Thomas' NHS Foundation Trust; University of Sheffield	Thornhill, M (corresponding author), Univ Sheffield, Sch Clin Dent, Dept Oral & Maxillofacial Med Surg & Patho, Sheffield, S Yorkshire, England.	m.thornhill@sheffield.ac.uk	Dayer, Mark/AAE-4654-2020	Cahill, Thomas/0000-0003-4318-5618; Thornhill, Martin/0000-0003-0681-4083	Edward Lifesciences; Novartis; Bayer; National Institute for Health Research [15/57/32]	Edward Lifesciences; Novartis(Novartis); Bayer(Bayer AG); National Institute for Health Research(National Institute for Health Research (NIHR))	BP does expert medicolegal work that sometimes involves discussions regarding the relationship to dental procedures and the need for antibiotic prophylaxis. BP has received payment for lectures on TAVI valves and has advised AstraZeneca on pharmaceuticals not related to endocarditis or valve disease. BP has an unrestricted educational grant to attend conferences from Edward Lifesciences. MD has advised St Jude Medical on new heart failure products and devices and his department has received funding from Novartis for studies on heart failure and myocardial infarction. MD also has had a relationship with Pfizer-Bristol Myers Squibb, Boehringer-Ingelheim and Biotronik not related to this article. MD has received educational support from Bayer to attend conferences.; The ongoing research mentioned in this paper is independent research funded by the National Institute for Health Research (Health Technology Assessment, 15/57/32 - The Invasive Dentistry-Endocarditis Association Study: The IDEA Study). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bates KE, 2016, CARDIOL YOUNG, V15, P1; Bikdeli B, 2013, J AM COLL CARDIOL, V62, P2217, DOI 10.1016/j.jacc.2013.07.071; Cahill TJ, 2017, HEART, V103, P937, DOI 10.1136/heartjnl-2015-309102; Cahill TJ, 2017, J AM COLL CARDIOL, V69, P325, DOI 10.1016/j.jacc.2016.10.066; Cahill TJ, 2016, LANCET, V387, P882, DOI 10.1016/S0140-6736(15)00067-7; Chen PY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000474; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; DeSimone DC, 2015, MAYO CLIN PROC, V90, P874, DOI 10.1016/j.mayocp.2015.04.019; DeSimone DC, 2012, CIRCULATION, V126, P60, DOI 10.1161/CIRCULATIONAHA.112.095281; Dillon A, 2016, COMMUNICATION; DURACK DT, 1973, J CLIN INVEST, V52, P592, DOI 10.1172/JCI107220; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Franklin M, 2016, CIRCULATION, V134, P1568, DOI 10.1161/CIRCULATIONAHA.116.022047; Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dkl121; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; HORSTKOTTE D, 1987, EUR HEART J, V8, P379, DOI 10.1093/eurheartj/8.suppl_J.379; IMPERIALE TF, 1990, AM J MED, V88, P131, DOI 10.1016/0002-9343(90)90461-L; Keller K, 2017, AM J CARDIOL, V119, P317, DOI 10.1016/j.amjcard.2016.09.035; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; Mackie AS, 2016, CAN J CARDIOL, V32, P942, DOI 10.1016/j.cjca.2015.09.021; Morris CD, 1998, JAMA-J AM MED ASSOC, V279, P599, DOI 10.1001/jama.279.8.599; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Okell CC, 1935, LANCET, V2, P869; Pant S, 2015, J AM COLL CARDIOL, V65, P2070, DOI 10.1016/j.jacc.2015.03.518; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Roberts GJ, 1999, PEDIATR CARDIOL, V20, P317, DOI 10.1007/s002469900477; Salam AMF, 2014, EUR HEART J, V35, P908; Seymour RA, 2000, BRIT DENT J, V189, P610, DOI 10.1038/sj.bdj.4800845a; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Thornhill MH, 2016, BRIT DENT J, V220, P51, DOI 10.1038/sj.bdj.2016.49; Thornhill MH, 2015, J ANTIMICROB CHEMOTH, V70, P2382, DOI 10.1093/jac/dkv115; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Tubiana S, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3776; van den Brink FS, 2017, EUR HEART J-QUAL CAR, V3, P141, DOI 10.1093/ehjqcco/qcw039; VANDERMEER JTM, 1992, LANCET, V339, P135, DOI 10.1016/0140-6736(92)90207-J; VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1869, DOI 10.1001/archinte.152.9.1869; Wannamaker L.W, 1957, CIRCULATION, V15, P154, DOI [10.1161/01.CIR.15.1.154, DOI 10.1161/01.CIR.15.1.154]	41	15	15	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j3942	10.1136/bmj.j3942	http://dx.doi.org/10.1136/bmj.j3942			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EM	28882816	Green Accepted			2022-12-28	WOS:000410576200005
J	Rafi, K				Rafi, Kasra			Maryam Mirzakhani (1977-2017) OBITUARY	NATURE			English	Biographical-Item									[Rafi, Kasra] Univ Toronto, Dept Math, Toronto, ON, Canada	University of Toronto	Rafi, K (corresponding author), Univ Toronto, Dept Math, Toronto, ON, Canada.	rafi@math.toronto.edu						MIRZAKHANI M, PUBLICATION LIST	1	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					32	32		10.1038/549032a	http://dx.doi.org/10.1038/549032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880285	Bronze			2022-12-28	WOS:000409388700022
J	Greenlee, MC; D'Angelo, L; Harms, SR; Kuo, AA; Landry, M; McManus, M; Talente, GM; White, P				Greenlee, M. Carol; D'Angelo, Lawrence; Harms, Stacey R.; Kuo, Alice A.; Landry, Michael; McManus, Margaret; Talente, Gregg M.; White, Patience		Amer Coll Phys Council Subspecial	Enhancing the Role of Internists in the Transition From Pediatric to Adult Health Care RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							VIEWS		[Greenlee, M. Carol] Western Slope Endocrinol, Grand Junction, CO 81501 USA; [D'Angelo, Lawrence] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Harms, Stacey R.] Amer Coll Physicians, Washington, DC USA; [Kuo, Alice A.] Univ Calif Los Angeles, Los Angeles, CA USA; [Landry, Michael] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Landry, Michael] Southeast Louisiana Vet Healthcare Syst, New Orleans, LA USA; [McManus, Margaret] Natl Alliance Adv Adolescent Hlth, Washington, DC USA; [Talente, Gregg M.] Univ South Carolina, Columbia, SC USA; [White, Patience] Natl Alliance Adv Adolescent Hlth, Washington, DC USA; [White, Patience] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	Children's National Health System; American College of Physicians; University of California System; University of California Los Angeles; Tulane University; University of South Carolina System; University of South Carolina Columbia; George Washington University	Greenlee, MC (corresponding author), Western Slope Endocrinol, Grand Junction, CO 81501 USA.							Amer Acad Pediat, 2011, PEDIATRICS, V128, P182, DOI 10.1542/peds.2011-0969; Garvey KC, 2016, DIABETES CARE, V39, P190, DOI 10.2337/dc15-1775; Heath G, 2017, PATIENT EDUC COUNS, V100, P76, DOI 10.1016/j.pec.2016.08.011; Hislop J, 2016, J ADOLESCENT HEALTH, V59, P345, DOI 10.1016/j.jadohealth.2016.04.004; Okumura MJ, 2010, PEDIATRICS, V125, pE748, DOI 10.1542/peds.2008-3451	5	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					363	364		10.7326/L17-0323	http://dx.doi.org/10.7326/L17-0323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28869980				2022-12-28	WOS:000409120400016
J	Singal, AG; Gupta, S; Skinner, CS; Ahn, C; Santini, NO; Agrawal, D; Mayorga, CA; Murphy, C; Tiro, JA; McCallister, K; Sanders, JM; Bishop, WP; Loewen, AC; Halm, EA				Singal, Amit G.; Gupta, Samir; Skinner, Celette Sugg; Ahn, Chul; Santini, Noel O.; Agrawal, Deepak; Mayorga, Christian A.; Murphy, Caitlin; Tiro, Jasmin A.; McCallister, Katharine; Sanders, Joanne M.; Bishop, Wendy Pechero; Loewen, Adam C.; Halm, Ethan A.			Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHARED DECISION-MAKING; OCCULT BLOOD-TEST; FOLLOW-UP; SURVEILLANCE COLONOSCOPY; ADHERENCE; IMPROVE; CARE; POPULATION; PARTICIPATION; PREFERENCES	IMPORTANCE Mailed fecal immunochemical test (FIT) outreach is more effective than colonoscopy outreach for increasing 1-time colorectal cancer (CRC) screening, but long-term effectiveness may need repeat testing and timely follow-up for abnormal results. OBJECTIVE Compare the effectiveness of FIT outreach and colonoscopy outreach to increase completion of the CRC screening process (screening initiation and follow-up) within 3 years. DESIGN, SETTING, AND PARTICIPANTS Pragmatic randomized clinical trial from March 2013 to July 2016 among 5999 participants aged 50 to 64 years who were receiving primary care in Parkland Health and Hospital System and were not up to date with CRC screenings. INTERVENTIONS Random assignment to mailed FIT outreach (n = 2400), mailed colonoscopy outreach (n = 2400), or usual care with clinic-based screening (n = 1199). Outreach included processes to promote repeat annual testing for individuals in the FIT outreach group with normal results and completion of diagnostic and screening colonoscopy for those with an abnormal FIT result or assigned to colonoscopy outreach. MAIN OUTCOMES AND MEASURES Primary outcomewas screening process completion, defined as adherence to colonoscopy completion, annual testing for a normal FIT result, diagnostic colonoscopy for an abnormal FIT result, or treatment evaluation if CRC was detected. Secondary outcomes included detection of any adenoma or advanced neoplasia (including CRC) and screening-related harms (including bleeding or perforation). RESULTS All 5999 participants(medianage, 56 years; women, 61.9%) were included in the intention-to-screen analyses. Screening process completion was 38.4% in the colonoscopy outreach group, 28.0% in the FIT outreach group, and 10.7% in the usual care group. Compared with the usual care group, between-group differences for completion were higher for both outreach groups, and highest in the colonoscopy outreach group. Compared with usual care, the between-group differences in adenoma and advanced neoplasia detection rates were higher for both outreach groups, and highest in the colonoscopy outreach group. There were no screening-related harms in any groups. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among persons aged 50 to 64 years receiving primary care at a safety-net institution, mailed outreach invitations offering FIT or colonoscopy compared with usual care increased the proportion completing CRC screening process within 3 years. The rate of screening process completion was higher with colonoscopy than FIT outreach.	[Singal, Amit G.; Agrawal, Deepak; Mayorga, Christian A.; Halm, Ethan A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Singal, Amit G.; Santini, Noel O.; Halm, Ethan A.] Parkland Hlth & Hosp Syst, Dallas, TX USA; [Singal, Amit G.; Skinner, Celette Sugg; Ahn, Chul; Murphy, Caitlin; Tiro, Jasmin A.; McCallister, Katharine; Sanders, Joanne M.; Bishop, Wendy Pechero; Loewen, Adam C.; Halm, Ethan A.] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Singal, Amit G.; Skinner, Celette Sugg; Ahn, Chul; Tiro, Jasmin A.; Bishop, Wendy Pechero; Halm, Ethan A.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Gupta, Samir] Vet Affairs San Diego Hlth Care Syst, Div Gastroenterol, San Diego, CA USA; [Gupta, Samir] Univ Calif San Diego, Dept Internal Med, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Singal, AG (corresponding author), Univ Texas Southwestern, Div Digest & Liver Dis, 5959 Harry Hines Blvd,Profess Off Bldg 1,Ste 420, Dallas, TX 75390 USA.	amit.singal@utsouthwestern.edu	Agrawal, Deepak/L-6592-2019; Singal, Amit/ABD-5344-2021	Agrawal, Deepak/0000-0001-7224-6921; Singal, Amit/0000-0002-1172-3971; gupta, samir/0000-0003-4192-5002	National Cancer Institute (NCI); National Institutes of Health (NIH) [U54CA163308-01, P30 CA142543]; NCI from NIH; NIH from NIH [UL1TR001105]; Agency for Healthcare Research and Quality (AHRQ) Center for Patient-Centered Outcomes Research [R24 HS022418]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R24HS022418] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA142543, U54CA163308] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI from NIH; NIH from NIH; Agency for Healthcare Research and Quality (AHRQ) Center for Patient-Centered Outcomes Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was conducted as part of the National Cancer Institute (NCI)-funded consortium Population-Based Research Optimizing Screening through Personalized Regiments (PROSPR) with support from grants U54CA163308-01 and P30 CA142543 from the National Institutes of Health (NIH) and NCI and grant NIH UL1TR001105 from the NIH. This work was also supported in part by grant R24 HS022418 the Agency for Healthcare Research and Quality (AHRQ) Center for Patient-Centered Outcomes Research (Dr Halm). Polymedco provided fecal immunochemical test (FIT) kits and reagents.	Baker DW, 2014, JAMA INTERN MED, V174, P1235, DOI 10.1001/jamainternmed.2014.2352; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Cavanagh MF, 2013, CANCER-AM CANCER SOC, V119, P2894, DOI 10.1002/cncr.28156; Chubak J, 2016, CANCER EPIDEM BIOMAR, V25, P344, DOI 10.1158/1055-9965.EPI-15-0470; Cooper GS, 2013, CANCER-AM CANCER SOC, V119, P1800, DOI 10.1002/cncr.27990; Denis B, 2013, DIGEST LIVER DIS, V45, P474, DOI 10.1016/j.dld.2013.01.006; Fedewa SA, 2015, CANCER-AM CANCER SOC, V121, P3272, DOI 10.1002/cncr.29494; Fenton JJ, 2010, ANN FAM MED, V8, P397, DOI 10.1370/afm.1133; Ferrat E, 2013, BRIT J CANCER, V109, P1437, DOI 10.1038/bjc.2013.476; Goebel Melissa, 2015, Curr Gastroenterol Rep, V17, P22, DOI 10.1007/s11894-015-0445-1; Green BB, 2014, J AM BOARD FAM MED, V27, P789, DOI 10.3122/jabfm.2014.06.140125; Gupta S, 2013, JAMA INTERN MED, V173, P1725, DOI 10.1001/jamainternmed.2013.9294; Hawley ST, 2012, CANCER-AM CANCER SOC, V118, P2726, DOI 10.1002/cncr.26551; Heleno B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5334; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Janda M, 2010, J GASTROEN HEPATOL, V25, P1661, DOI 10.1111/j.1440-1746.2010.06405.x; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kahn B, 2015, CANCER CAUSE CONTROL, V26, P1653, DOI 10.1007/s10552-015-0661-x; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Liang PS, 2016, AM J GASTROENTEROL, V111, P105, DOI 10.1038/ajg.2015.367; Liss DT, 2013, J COMMUN HEALTH, V38, P829, DOI 10.1007/s10900-013-9685-x; Martin J, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.07.028; Paszat L, 2007, CAN J GASTROENTEROL, V21, P379, DOI 10.1155/2007/569689; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Singal AG, 2016, CANCER-AM CANCER SOC, V122, P456, DOI 10.1002/cncr.29770; Singh H, 2009, AM J GASTROENTEROL, V104, P942, DOI 10.1038/ajg.2009.55; Stegeman I, 2015, CANCER EPIDEMIOL, V39, P388, DOI 10.1016/j.canep.2015.03.012; Tiro JA, 2014, CANCER EPIDEM BIOMAR, V23, P1147, DOI 10.1158/1055-9965.EPI-13-1217; Wheeler Stephanie B, 2017, Prev Med Rep, V6, P9, DOI 10.1016/j.pmedr.2016.11.019; White A, 2017, MMWR-MORBID MORTAL W, V66, P1, DOI 10.15585/mmwr.mm6608a1; Wilschut JA, 2011, JNCI-J NATL CANCER I, V103, P1741, DOI 10.1093/jnci/djr385; Wilson FA, 2015, J CANCER EDUC, V30, P260, DOI 10.1007/s13187-014-0718-7; Xu YH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0841-0	37	67	69	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					806	815		10.1001/jama.2017.11389	http://dx.doi.org/10.1001/jama.2017.11389			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873161	Green Accepted			2022-12-28	WOS:000409183700012
J	Pieper, K; Tan, J; Piccoli, L; Foglierini, M; Barbieri, S; Chen, YW; Silacci-Fregni, C; Wolf, T; Jarrossay, D; Anderle, M; Abdi, A; Ndungu, FM; Doumbo, OK; Traore, B; Tran, TM; Jongo, S; Zenklusen, I; Crompton, PD; Daubenberger, C; Bull, PC; Allusto, FS; Lanzavecchia, A				Pieper, Kathrin; Tan, Joshua; Piccoli, Luca; Foglierini, Mathilde; Barbieri, Sonia; Chen, Yiwei; Silacci-Fregni, Chiara; Wolf, Tobias; Jarrossay, David; Anderle, Marica; Abdi, Abdirahman; Ndungu, Francis M.; Doumbo, Ogobara K.; Traore, Boubacar; Tran, Tuan M.; Jongo, Said; Zenklusen, Isabelle; Crompton, Peter D.; Daubenberger, Claudia; Bull, Peter C.; Allusto, Federica S.; Lanzavecchia, Antonio			Public antibodies to malaria antigens generated by two LAIR1 insertion modalities	NATURE			English	Article							MONOCLONAL-ANTIBODIES; HUMAN GENOME; RNA-SEQ; B-CELLS; REPAIR; DNA; INFECTION; REGIONS; BREAKS; GENES	In two previously described donors, the extracellular domain of LAIR1, a collagen-binding inhibitory receptor encoded on chromosome 19 (ref. 1), was inserted between the V and DJ segments of an antibody. This insertion generated, through somatic mutations, broadly reactive antibodies against RIFINs, a type of variant antigen expressed on the surface of Plasmodium falciparum-infected erythrocytes(2). To investigate how frequently such antibodies are produced in response to malaria infection, we screened plasma from two large cohorts of individuals living in malaria-endemic regions. Here we report that 5-10% of malaria-exposed individuals, but none of the European blood donors tested, have high levels of LAIR1-containing antibodies that dominate the response to infected erythrocytes without conferring enhanced protection against febrile malaria. By analysing the antibody-producing B cell clones at the protein, cDNA and gDNA levels, we characterized additional LAIR1 insertions between the V and DJ segments and discovered a second insertion modality whereby the LAIR1 exon encoding the extracellular domain and flanking intronic sequences are inserted into the switch region. By exon shuffling, this mechanism leads to the production of bispecific antibodies in which the LAIR1 domain is precisely positioned at the elbow between the VH and CH1 domains. Additionally, in one donor the genomic DNA encoding the VH and CH1 domains was deleted, leading to the production of a camel-like LAIR1-containing antibody. Sequencing of the switch regions of memory B cells from European blood donors revealed frequent templated inserts originating from transcribed genes that, in rare cases, comprised exons with orientations and frames compatible with expression. These results reveal different modalities of LAIR1 insertion that lead to public and dominant antibodies against infected erythrocytes and suggest that insertion of templated DNA represents an additional mechanism of antibody diversification that can be selected in the immune response against pathogens and exploited for B cell engineering.	[Pieper, Kathrin; Tan, Joshua; Piccoli, Luca; Foglierini, Mathilde; Barbieri, Sonia; Chen, Yiwei; Silacci-Fregni, Chiara; Wolf, Tobias; Jarrossay, David; Anderle, Marica; Allusto, Federica S.; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland; [Tan, Joshua] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Foglierini, Mathilde] SIB, CH-1015 Lausanne, Switzerland; [Chen, Yiwei; Wolf, Tobias; Allusto, Federica S.; Lanzavecchia, Antonio] Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland; [Abdi, Abdirahman; Ndungu, Francis M.] CGMRC, KEMRI Wellcome Trust Res Programme, POB 230, Kilifi 80108, Kenya; [Doumbo, Ogobara K.; Traore, Boubacar] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Bamako 91094, Mali; [Tran, Tuan M.] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Jongo, Said] Bagamoyo Clin, Ifakara Hlth Inst, POB 74, Bagamoyo, Tanzania; [Zenklusen, Isabelle; Daubenberger, Claudia] Swiss Trop & Publ Hlth Inst, Clin Immunol Unit, CH-4002 Basel, Switzerland; [Zenklusen, Isabelle; Daubenberger, Claudia] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland; [Crompton, Peter D.] NIAID, Lab Immunogenet, NIH, Rockville, MD 20852 USA; [Bull, Peter C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Universita della Svizzera Italiana; University of Oxford; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Science & Technology of Bamako; Indiana University System; Indiana University Bloomington; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge	Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.; Lanzavecchia, A (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	lanzavecchia@irb.usi.ch	Tran, Tuan M./H-9439-2019; Ndungu, Francis Maina/C-2199-2019	Tran, Tuan M./0000-0002-1928-861X; Ndungu, Francis Maina/0000-0002-8977-0030; de la Rosa (nee Pieper), Kathrin/0000-0003-4809-3157; Abdi, Abdirahman/0000-0001-7989-2125; Daubenberger, Claudia/0000-0001-7136-0642; Chen, Yiwei/0000-0003-3558-9954; Piccoli, Luca/0000-0002-1085-6502; Foglierini, Mathilde/0000-0001-7538-4262; Anderle, Marica/0000-0002-6840-551X	Swiss Vaccine Research Institute; Fondazione Aldo e Cele Dacco; European Research Council [670955 BROADimmune]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Helmut Horten Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI125682, ZIAAI001155] Funding Source: NIH RePORTER	Swiss Vaccine Research Institute; Fondazione Aldo e Cele Dacco; European Research Council(European Research Council (ERC)European Commission); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Helmut Horten Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Nussenzweig and H. Wardemann for reagents for antibody cloning and expression. This work was supported by the Swiss Vaccine Research Institute and by the Fondazione Aldo e Cele Dacco. The work on the healthy European blood donors was supported by the European Research Council (grant no. 670955 BROADimmune). The Mali study was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. A.L. and F.S. are supported by the Helmut Horten Foundation. This paper is published with the permission of the Director of KEMRI.	Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chakraborty A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13049; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; MILLS FC, 1995, J IMMUNOL, V155, P3021; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Mwakasungula S, 2014, INT J MOL EPIDEMIOL, V5, P185; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Onozawa M, 2015, GENOME BIOL EVOL, V7, P960, DOI 10.1093/gbe/evv043; Onozawa M, 2014, P NATL ACAD SCI USA, V111, P7729, DOI 10.1073/pnas.1321889111; Piccoli L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8375; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Robbiani DF, 2015, CELL, V162, P727, DOI 10.1016/j.cell.2015.07.019; Rommel PC, 2017, J EXP MED, V214, P815, DOI 10.1084/jem.20161638; Tan J, 2016, NATURE, V529, P105, DOI 10.1038/nature16450; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174	33	66	68	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					597	+		10.1038/nature23670	http://dx.doi.org/10.1038/nature23670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28847005	Green Accepted, Green Submitted			2022-12-28	WOS:000408703100041
J	Bender, M; Turnbull, BWH; Ambler, BR; Krische, MJ				Bender, Matthias; Turnbull, Ben W. H.; Ambler, Brett R.; Krische, Michael J.			Ruthenium-catalyzed insertion of adjacent diol carbon atoms into C-C bonds: Entry to type II polyketides	SCIENCE			English	Article							TRANSFER HYDROGENATION; SINGLE BOND; SUBSTITUTED PHENOLS; OLEFIN INSERTION; H BONDS; ALKYNES; ACTIVATION; CLEAVAGE; CYCLOBUTENONES; CYCLOADDITION	Current catalytic processes involving carbon-carbon bond activation rely on p-unsaturated coupling partners. Exploiting the concept of transfer hydrogenative coupling, we report a ruthenium(0)-catalyzed cycloaddition of benzocyclobutenones that functionalizes two adjacent saturated diol carbon-hydrogen bonds. These regio- and diastereoselective processes enable convergent construction of type II polyketide substructures.	[Bender, Matthias; Turnbull, Ben W. H.; Ambler, Brett R.; Krische, Michael J.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Krische, MJ (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	mkrische@cm.utexas.edu			Deutsche Forschungsgemeinschaft; Robert A. Welch Foundation [F-0038]; National Institute of General Medical Sciences [RO1-GM093905]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093905] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert A. Welch Foundation(The Welch Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (M.B.), Robert A. Welch Foundation grant F-0038, and National Institute of General Medical Sciences grant RO1-GM093905. Metrical parameters for compounds 3a, 3d, 3e, 3n, and 3q are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC- 1562339, 1562342, 1562341, 1562338, and 1562340, respectively.	Auvinet AL, 2011, ANGEW CHEM INT EDIT, V50, P2769, DOI 10.1002/anie.201007598; BISHOP KC, 1976, CHEM REV, V76, P461, DOI 10.1021/cr60302a003; CASSAR L, 1970, J CHEM SOC CHEM COMM, P1082, DOI 10.1039/c29700001082; CASSAR L, 1970, J AM CHEM SOC, V92, P6366; EVANS JA, 1973, J CHEM SOC CHEM COMM, P158, DOI 10.1039/c39730000158; Fumagalli G, 2017, CHEM REV, V117, P9404, DOI 10.1021/acs.chemrev.6b00599; Geary LM, 2013, J AM CHEM SOC, V135, P3796, DOI 10.1021/ja400691t; Ho KYT, 2012, CHEM-EUR J, V18, P3486, DOI 10.1002/chem.201200167; HUFFMAN MA, 1991, J AM CHEM SOC, V113, P2771, DOI 10.1021/ja00007a072; Ishida N, 2012, ORG LETT, V14, P3898, DOI 10.1021/ol3016447; Johnson TC, 2012, ORG LETT, V14, P5230, DOI 10.1021/ol302354z; Jun CH, 2001, J AM CHEM SOC, V123, P751, DOI 10.1021/ja0033537; Jun CH, 1999, J AM CHEM SOC, V121, P880, DOI 10.1021/ja983197s; Ketcham JM, 2014, ANGEW CHEM INT EDIT, V53, P9142, DOI 10.1002/anie.201403873; Kharel MK, 2012, NAT PROD REP, V29, P264, DOI 10.1039/c1np00068c; Kondo T, 2004, ANGEW CHEM INT EDIT, V43, P5369, DOI 10.1002/anie.200461002; Kondo T, 2000, J AM CHEM SOC, V122, P6319, DOI 10.1021/ja000238n; Kondo T, 2007, TETRAHEDRON LETT, V48, P2837, DOI 10.1016/j.tetlet.2007.02.091; Kumar P, 2012, ORG LETT, V14, P2026, DOI 10.1021/ol300534j; Leung JC, 2012, J AM CHEM SOC, V134, P15700, DOI 10.1021/ja3075049; LIEBESKIND LS, 1980, J AM CHEM SOC, V102, P7397, DOI 10.1021/ja00544a057; LIEBESKIND LS, 1980, J ORGANOMET CHEM, V202, pC73, DOI 10.1016/S0022-328X(00)92686-X; LIEBESKIND LS, 1984, J AM CHEM SOC, V106, P6451, DOI 10.1021/ja00333a075; Matsuda T, 2004, CHEM LETT, V33, P876, DOI 10.1246/cl.2004.876; Murakami M, 2005, J AM CHEM SOC, V127, P6932, DOI 10.1021/ja050674f; Murakami M, 2002, J AM CHEM SOC, V124, P13976, DOI 10.1021/ja021062n; Murakami M, 1996, J AM CHEM SOC, V118, P8285, DOI 10.1021/ja9604525; MURAKAMI M, 1994, NATURE, V370, P540, DOI 10.1038/370540a0; Murakami M, 2016, J AM CHEM SOC, V138, P13759, DOI 10.1021/jacs.6b01656; Nguyen KD, 2016, SCIENCE, V354, DOI 10.1126/science.aah5133; Park BY, 2015, J AM CHEM SOC, V137, P7652, DOI 10.1021/jacs.5b04688; Park BY, 2013, J AM CHEM SOC, V135, P16320, DOI 10.1021/ja4087193; Perez F, 2016, TOPICS CURR CHEM, V374, DOI 10.1007/s41061-016-0028-0; Richter MF, 2017, NATURE, V545, P299, DOI 10.1038/nature22308; SANCHEZDELGADO RA, 1976, J CHEM SOC DALTON, P399, DOI 10.1039/dt9760000399; Sato H, 2016, J AM CHEM SOC, V138, P16244, DOI 10.1021/jacs.6b11746; Souillart L, 2015, CHEM REV, V115, P9410, DOI 10.1021/acs.chemrev.5b00138; Thakur A, 2015, J ORG CHEM, V80, P9951, DOI 10.1021/acs.joc.5b01458; WONG W, 1972, J CHEM SOC CHEM COMM, P672, DOI 10.1039/c39720000672	39	33	33	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					779	781		10.1126/science.aao0453	http://dx.doi.org/10.1126/science.aao0453			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839069	Green Accepted			2022-12-28	WOS:000408327900037
J	Holmes, D				Holmes, David			SAVING LIFE AND LIMB	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					S42	S43		10.1038/548S42a	http://dx.doi.org/10.1038/548S42a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28832558	Bronze			2022-12-28	WOS:000408279000002
J	Jourdan, PM; Lamberton, PHL; Fenwick, A; Addiss, DG				Jourdan, Peter Mark; Lamberton, Poppy H. L.; Fenwick, Alan; Addiss, David G.			Soil-transmitted helminth infections	LANCET			English	Review							NECATOR-AMERICANUS INFECTION; REAL-TIME PCR; TRICHURIS-TRICHIURA; STRONGYLOIDES-STERCORALIS; ASCARIS-LUMBRICOIDES; GASTROINTESTINAL PARASITES; INTERNATIONAL MIGRANTS; INTESTINAL HELMINTHS; GEOSENTINEL CLINICS; POPULATION BIOLOGY	More than a quarter of the world's population is at risk of infection with the soil-transmitted helminths Ascaris lumbricoides, hookworm (Ancylostoma duodenale and Necator americanus), Trichuris trichiura, and Strongyloides stercoralis. Infected children and adults present with a range of medical and surgical conditions, and clinicians should consider the possibility of infection in individuals living in, or returning from, endemic regions. Although safe and effective drugs are donated free to endemic countries, only half of at-risk children received treatment in 2016. This Seminar describes the epidemiology, lifecycles, pathophysiology, clinical diagnosis, management, and public health control of soil-transmitted helminths. Previous work has questioned the effect of population-level deworming; however, it remains beyond doubt that treatment reduces the severe consequences of soil-transmitted helminthiasis. We highlight the need for refined diagnostic tools and effective control options to scale up public health interventions and improve clinical detection and management of these infections.	[Jourdan, Peter Mark; Fenwick, Alan] Imperial Coll London, Schistosomiasis Control Initiat, St Marys Campus, London, England; [Lamberton, Poppy H. L.] Imperial Coll London, Dept Infect Dis Epidemiol, St Marys Campus, London, England; [Jourdan, Peter Mark] Nat Hist Museum, DEWORM3, London, England; [Jourdan, Peter Mark] Oslo Univ Hosp, Norwegian Ctr Imported & Trop Dis, Dept Infect Dis, Oslo, Norway; [Lamberton, Poppy H. L.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Lamberton, Poppy H. L.] Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Addiss, David G.] Task Force Global Hlth, Decatur, GA USA; [Addiss, David G.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Imperial College London; Imperial College London; Natural History Museum London; University of Oslo; University of Glasgow; University of Glasgow; University of Notre Dame	Lamberton, PHL (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland.; Lamberton, PHL (corresponding author), Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland.	poppy.lamberton@glasgow.ac.uk	Lamberton, Poppy/AAR-3591-2020	Lamberton, Poppy/0000-0003-1048-6318	Bill & Melinda Gates Foundation; European Research Council Starting Grant [680088 SCHISTO_PERSIST]; Wellcome Trust Grant [105614/Z/14/Z]; Johnson Johnson; GlaxoSmithKline	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European Research Council Starting Grant(European Research Council (ERC)); Wellcome Trust Grant(Wellcome Trust); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); GlaxoSmithKline(GlaxoSmithKline)	DEWORM3 (PMJ) is funded by the Bill & Melinda Gates Foundation. PHLL is funded by a European Research Council Starting Grant (680088 SCHISTO_PERSIST), a Wellcome Trust Grant (105614/Z/14/Z), and is a Lord Kelvin Adam Smith Leadership Fellow. The Task Force for Global Health (DGA) receives funding from Johnson & Johnson and GlaxoSmithKline to provide technical and programmatic support to the STH Coalition, a broad coalition of public and private partners engaged in global STH control. All other authors declare no competing interests.	Adegnika AA, ASCARIS LUMBRICOIDES; Akuthota P, 2012, CLIN MICROBIOL REV, V25, P649, DOI 10.1128/CMR.00025-12; Akuthota P, 2012, SEMIN HEMATOL, V49, P113, DOI 10.1053/j.seminhematol.2012.01.005; Albarqi MMY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005358; ANDERSON R M, 1991; ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; Andrews JR, 2017, LANCET GLOB HEALTH, V5, pE4, DOI 10.1016/S2214-109X(16)30333-3; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P456; [Anonymous], 2014, ANTIMICROB AGENTS CH, V58, P2535; Aydin R, 2014, J CLIN ULTRASOUND, V42, P227, DOI 10.1002/jcu.22100; Baek Byerong-Kirl, 1998, Korean Journal of Parasitology, V36, P99, DOI 10.3347/kjp.1998.36.2.99; Barnett ED, 2013, CLIN INFECT DIS, V56, P913, DOI 10.1093/cid/cis1015; Bartsch SM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004922; Bergquist R, 2016, LANCET INFECT DIS, V16, P1089, DOI 10.1016/S1473-3099(16)30231-6; Bisanzio D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002992; Bisoffi Z, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002640; Blackwell AD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001218; BRADLEY M, 1992, T ROY SOC TROP MED H, V86, P73, DOI 10.1016/0035-9203(92)90448-L; Briggs N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004944; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Brooker SJ, 2014, MANSONS TROPICAL DIS, V23rd, P766, DOI 10.1016/B978-0-7020-5101-2.00056-X; BUNDY DAP, 1988, PARASITOLOGY, V97, P469, DOI 10.1017/S003118200005887X; BUNDY DAP, 1991, PARASITE IMMUNOL, V13, P629, DOI 10.1111/j.1365-3024.1991.tb00558.x; BUNDY DAP, 1987, EPIDEMIOL INFECT, V98, P65, DOI 10.1017/S0950268800061719; BUNDY DAP, 1985, T ROY SOC TROP MED H, V79, P232, DOI 10.1016/0035-9203(85)90343-8; Bundy DAP, 2004, GLOBAL EPIDEMIOLOGY, P243; BURDEN DJ, 1976, J HYG-CAMBRIDGE, V77, P377, DOI 10.1017/S0022172400055753; Centers for Disease Control and Prevention, 2013, BIOLOGY; Centers for Disease Control and Prevention, 2015, BIOLOGY; Chen KT, 2003, AM J PUBLIC HEALTH, V93, P489, DOI 10.2105/AJPH.93.3.489; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Concha R, 2005, J CLIN GASTROENTEROL, V39, P203, DOI 10.1097/01.mcg.0000152779.68900.33; COOPER ES, 1988, PARASITOL TODAY, V4, P301, DOI 10.1016/0169-4758(88)90110-X; COOPER ES, 1991, LANCET, V338, P1104, DOI 10.1016/0140-6736(91)91964-V; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; Cooper PJ, 2003, T ROY SOC TROP MED H, V97, P519, DOI 10.1016/S0035-9203(03)80013-5; CROLL NA, 1982, T ROY SOC TROP MED H, V76, P187, DOI 10.1016/0035-9203(82)90272-3; Das AK, 2014, J GLOB INFECT DIS, V6, P65, DOI 10.4103/0974-777X.132042; Das CJ, 2007, AUSTRALAS RADIOL, V51, P500, DOI 10.1111/j.1440-1673.2007.01887.x; de Vlas SJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004386; deSilva NR, 1997, TROP MED INT HEALTH, V2, P189, DOI 10.1046/j.1365-3156.1997.d01-241.x; Dige A, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12394; Donadello K, 2013, INT J ANTIMICROB AG, V42, P580, DOI 10.1016/j.ijantimicag.2013.07.015; Easton AV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1314-y; ELKINS DB, 1986, T ROY SOC TROP MED H, V80, P774, DOI 10.1016/0035-9203(86)90384-6; Elsemore DA, 2014, J VET DIAGN INVEST, V26, P404, DOI 10.1177/1040638714528500; Fitzsimmons CM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00061; FORZY G, 1988, JAMA-J AM MED ASSOC, V259, P2546, DOI 10.1001/jama.1988.03720170022024; Fujiwara RT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000399; Gaze S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002520; Geary TG, 2012, CURR OPIN INFECT DIS, V25, P709, DOI 10.1097/QCO.0b013e328359f04a; Geiger SM, 2007, PARASITE IMMUNOL, V29, P347, DOI 10.1111/j.1365-3024.2007.00950.x; Geri G, 2015, INFECTION, V43, P691, DOI 10.1007/s15010-015-0799-1; Ghoshal UC, 2015, INDIAN J GASTROENTER, V34, P463, DOI 10.1007/s12664-015-0611-2; Gordon CA, 2015, INT J PARASITOL, V45, P477, DOI 10.1016/j.ijpara.2015.02.011; Gravitt PE, 2016, J INFECT DIS, V213, P723, DOI 10.1093/infdis/jiv498; Gupta A, 2013, SE ASIAN J TROP MED, V44, P150; Gyorkos Theresa W, 2013, PLoS Negl Trop Dis, V7, pe2397, DOI 10.1371/journal.pntd.0002397; Gyorkos TW, 2011, TROP MED INT HEALTH, V16, P531, DOI 10.1111/j.1365-3156.2011.02727.x; Hamid R, 2015, PEDIATR SURG INT, V31, P1171, DOI 10.1007/s00383-015-3793-x; Hawlader Mohammad D H, 2014, Trop Med Health, V42, P77, DOI 10.2149/tmh.2013-19; Hill DE, 1997, VET PARASITOL, V68, P91, DOI 10.1016/S0304-4017(96)01055-2; Holland CV, 2005, TOPLEY WILSONS MICRO, P713; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hotez PJ, 2016, ANNU REV MED, V67, P405, DOI 10.1146/annurev-med-051214-024241; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Igual-Adell R, 2004, EXPERT OPIN PHARMACO, V5, P2615, DOI 10.1517/14656566.5.12.2615; Inoue K, 2014, ENDOSCOPY, V46, pE117, DOI 10.1055/s-0034-1364887; International Nutritional Anemia Consultative Group WHO United Nations Childrens Fund, 1998, GUIDELINES USE IRON; Iriemenam NC, 2010, PARASITOL INT, V59, P9, DOI 10.1016/j.parint.2009.10.009; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keenan JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002562; Keiser PB, STRONGYLOIDES STERCO; Khuroo MS, 2010, GASTROINTEST ENDOSC, V71, P200, DOI 10.1016/j.gie.2009.08.002; KHUROO MS, 1993, GASTROINTEST ENDOSC, V39, P680, DOI 10.1016/S0016-5107(93)70222-9; KHUROO MS, 1990, LANCET, V335, P1503, DOI 10.1016/0140-6736(90)93037-P; KHUROO MS, 1985, GASTROENTEROLOGY, V88, P418, DOI 10.1016/0016-5085(85)90501-3; Khuroo MS, 1996, GASTROENTEROL CLIN N, V25, P553, DOI 10.1016/S0889-8553(05)70263-6; KHUROO MS, 1992, BRIT J SURG, V79, P1335, DOI 10.1002/bjs.1800791231; Khuroo MS, 2014, BMJ CASE REP, V2014; Khuroo NS, 2010, AM J GASTROENTEROL, V105, P1675, DOI 10.1038/ajg.2010.112; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Kinjo T, 2015, INTERNAL MED, V54, P83, DOI 10.2169/internalmedicine.54.3284; Kinung'hi SM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0864-5; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Kumapley RS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004206; Lal C, 2013, AM J MED SCI, V345, P385, DOI 10.1097/MAJ.0b013e318266e984; Lamberton Poppy H L, 2015, Curr Trop Med Rep, V2, P189; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Loukas A, 2005, FEMS IMMUNOL MED MIC, V43, P115, DOI 10.1016/j.femsim.2004.11.006; Marty FM, 2005, CLIN INFECT DIS, V41, pE5, DOI 10.1086/430827; McCarthy AE, 2013, CLIN INFECT DIS, V56, P925, DOI 10.1093/cid/cis1016; Means AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub4; Andrade AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000655; Mejia R, 2013, AM J TROP MED HYG, V88, P1041, DOI 10.4269/ajtmh.12-0726; Miguel E, 2016, POLICY RES WORK PAP, P7921; Mkhize-Kwitshana ZL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-273; Moser W, 2016, LANCET INFECT DIS, V16, P53, DOI 10.1016/S1473-3099(15)00271-6; Mupfasoni D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005202; Nadir E, 2016, DIAGN MICR INFEC DIS, V84, P197, DOI 10.1016/j.diagmicrobio.2015.11.015; Nag HH, 2013, INDIAN J SURG, V75, pS128, DOI 10.1007/s12262-012-0514-8; Ndibazza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050325; Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; O'Connell AE, 2011, INFECT IMMUN, V79, P2770, DOI 10.1128/IAI.00931-10; Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013; Pawluk SA, 2015, CLIN PHARMACOKINET, V54, P371, DOI 10.1007/s40262-015-0243-9; Pickard L, 2013, GASTROENTEROLOGY, V144, pE11, DOI 10.1053/j.gastro.2012.08.037; Pilotte N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004578; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Rascoe LN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003694; Repetto SA, 2016, ACTA TROP, V157, P169, DOI 10.1016/j.actatropica.2016.02.004; Requena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002; ROCHE M, 1957, J CLIN INVEST, V36, P1183, DOI 10.1172/JCI103514; Sanchez Ana Lourdes, 2015, BMC Res Notes, V8, P55, DOI 10.1186/s13104-015-1019-x; SCHAD GA, 1985, SCIENCE, V228, P1537, DOI 10.1126/science.4012307; Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288; SINNIAH B, 1982, PARASITOLOGY, V84, P167, DOI 10.1017/S0031182000051763; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Speich B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0702-z; Speich B, 2014, NEW ENGL J MED, V370, P610, DOI 10.1056/NEJMoa1301956; Starr MC, 2011, AM J TROP MED HYG, V85, P680, DOI 10.4269/ajtmh.2011.11-0214; Stolk WA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004560; Strunz EC, 2016, TRENDS PARASITOL, V32, P10, DOI 10.1016/j.pt.2015.11.007; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Suleman S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003345; Sykes AM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000955; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub6; Taylor-Robinson D, 2017, LANCET GLOB HEALTH, V5, pE2, DOI 10.1016/S2214-109X(16)30289-3; The Medical Letter, 2013, MED LETT; Toledo R, 2015, ADV PARASIT, V88, P165, DOI 10.1016/bs.apar.2015.02.005; Tovey D, 2016, COCHRANE DB SYST REV, V9; Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006; Truscott JE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1135-4; Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1187-5; Van der Zalm MM, 2016, PEDIATR INFECT DIS J, V35, P622, DOI 10.1097/INF.0000000000001115; Vlaminck J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004532; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; Wang DD, 2013, INT J INFECT DIS, V17, pE1073, DOI 10.1016/j.ijid.2013.02.008; Wang Pu, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P242; Webb EL, 2016, ALLERGY, V71, P1156, DOI 10.1111/all.12867; Welch VA, 2017, LANCET GLOB HEALTH, V5, pE40, DOI 10.1016/S2214-109X(16)30242-X; WHO, 2015, WAT SAN HYG ACC SUST; WHO, SOIL TRANSM HELM EL; Williams-Blangero S, 2012, PHILOS T R SOC B, V367, P887, DOI 10.1098/rstb.2011.0296; World Health Organization, 2015, INV OV GLOB IMP NEGL; Wright VJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000433; Wu X, 2016, IEEE T MED IMAGING, V35, P1741, DOI 10.1109/TMI.2016.2527736; Zhan B, 2014, EXPERT REV VACCINES, V13, P321, DOI 10.1586/14760584.2014.872035	154	282	289	5	101	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	2018	391	10117					252	265		10.1016/S0140-6736(17)31930-X	http://dx.doi.org/10.1016/S0140-6736(17)31930-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU5BI	28882382	Green Accepted			2022-12-28	WOS:000423867000028
J	Giugliano, RP; Pedersen, TR; Park, JG; De Ferrari, GM; Gaciong, ZA; Ceska, R; Toth, K; Gouni-Berthold, I; Lopez-Miranda, J; Schiele, F; Mach, F; Ott, BR; Kanevsky, E; Pineda, AL; Somaratne, R; Wasserman, SM; Keech, AC; Sever, PS; Sabatine, MS				Giugliano, Robert P.; Pedersen, Terje R.; Park, Jeong-Gun; De Ferrari, Gaetano M.; Gaciong, Zbigniew A.; Ceska, Richard; Toth, Kalman; Gouni-Berthold, Ioanna; Lopez-Miranda, Jose; Schiele, Francois; Mach, Francois; Ott, Brian R.; Kanevsky, Estelle; Pineda, Armando Lira; Somaratne, Ransi; Wasserman, Scott M.; Keech, Anthony C.; Sever, Peter S.; Sabatine, Marc S.		FOURIER Investigators	Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial	LANCET			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; COGNITIVE FUNCTION; STATIN; EVENTS; EZETIMIBE; OUTCOMES; METAANALYSIS; ALIROCUMAB; RATIONALE	Background LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower LDL-cholesterol concentrations achieved at 4 weeks and clinical efficacy and safety in the FOURIER trial of evolocumab, a monoclonal antibody to proprotein convertase subtilisin-kexin type 9 (PCSK9). Methods In this prespecified secondary analysis of 25?982 patients from the randomised FOURIER trial, the relationship between achieved LDL-cholesterol concentration at 4 weeks and subsequent cardiovascular outcomes (primary endpoint was the composite of cardiovascular death, myocardial infarction, stroke, coronary revascularisation, or unstable angina; key secondary endpoint was the composite of cardiovascular death, myocardial infarction, or stroke) and ten prespecified safety events of interest was examined over a median of 2.2 years of follow-up. We used multivariable modelling to adjust for baseline factors associated with achieved LDL cholesterol. This trial is registered with ClinicalTrials.gov, number NCT01764633. Findings Between Feb 8, 2013, and June 5, 2015, 27564 patients were randomly assigned a treatment in the FOURIER study. 1025 (4%) patients did not have an LDL cholesterol measured at 4 weeks and 557 (2%) had already had a primary endpoint event or one of the ten prespecified safety events before the week-4 visit. From the remaining 25982 patients (94% of those randomly assigned) 13013 were assigned evolocumab and 12.969 were assigned placebo. 2669 (10%) of 25982 patients achieved LDL-cholesterol concentrations of less than 0.5 mmol/L, 8003 (31%) patients achieved concentrations between 0.5 and less than 1.3 mmol/L, 3444 (13%) patients achieved concentrations between 1.3 and less than 1.8 mmol/L, 7471 (29%) patients achieved concentrations between 1.8 to less than 2.6 mmol/L, and 4395 (17%) patients achieved concentrations of 2.6 mmol/L or higher. There was a highly significant monotonic relationship between low LDL-cholesterol concentrations and lower risk of the primary and secondary efficacy composite endpoints extending to the bottom first percentile (LDL-cholesterol concentrations of less than 0.2 mmol/L; p=0.0012 for the primary endpoint, p=0.0001 for the secondary endpoint). Conversely, no significant association was observed between achieved LDL cholesterol and safety outcomes, either for all serious adverse events or any of the other nine prespecified safety events. Interpretation There was a monotonic relationship between achieved LDL cholesterol and major cardiovascular outcomes down to LDL-cholesterol concentrations of less than 0.2 mmol/L. Conversely, there were no safety concerns with very low LDL-cholesterol concentrations over a median of 2.2 years. These data support further LDL-cholesterol lowering in patients with cardiovascular disease to well below current recommendations.	[Giugliano, Robert P.; Park, Jeong-Gun; Kanevsky, Estelle; Sabatine, Marc S.] Brigham & Womens Hosp, TIM Study Grp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Pedersen, Terje R.] Oslo Univ Hosp, Ulleval, Norway; [Pedersen, Terje R.] Univ Oslo, Med Fac, Oslo, Norway; [De Ferrari, Gaetano M.] Univ Pavia, Dept Mol Med, Pavia, Italy; [De Ferrari, Gaetano M.] IRCCS Fdn Policlin San Matteo, Labs Expt Cardiol, Pavia, Italy; [Gaciong, Zbigniew A.] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland; [Ceska, Richard] Univ Gen Hosp, Dept Internal Med 3, Ctr Prevent Cardiol, Prague, Czech Republic; [Ceska, Richard] 1 Med Fac, Prague, Czech Republic; [Toth, Kalman] Univ Pecs, Dept Med 1, Pecs, Hungary; [Gouni-Berthold, Ioanna] Univ Cologne, Polyclin Endocrinol Diabet & Prevent Med, Cologne, Germany; [Lopez-Miranda, Jose] Univ Cordoba, Lipids & Atherosclerosis Unit, Maimonides Biomed Res Inst Cordoba, Reina Sofia Univ Hosp,CIBEROBN, Cordoba, Spain; [Schiele, Francois] Univ Hosp Ctr Besancon, Besancon, France; [Mach, Francois] Hop Univ Geneva, Hop Cantonal, Geneva, Switzerland; [Ott, Brian R.] Brown Univ, Rhode Isl Hosp, Dept Neurol, Alpert Med Sch, Providence, RI 02903 USA; [Pineda, Armando Lira; Somaratne, Ransi; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA USA; [Keech, Anthony C.] Univ Sydney, Sydney Med Sch, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW, Australia; [Sever, Peter S.] Imperial Coll London, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London, England	Harvard University; Brigham & Women's Hospital; University of Oslo; University of Oslo; University of Pavia; IRCCS Fondazione San Matteo; Medical University of Warsaw; General University Hospital Prague; Charles University Prague; University of Pecs; University of Cologne; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universidad de Cordoba; Universite de Franche-Comte; CHU Besancon; University of Geneva; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Amgen; University of Sydney; Imperial College London	Giugliano, RP (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	rgiugliano@bwh.harvard.edu	Sabatine, Marc/AAJ-6751-2020; Malynovsky, Yaroslav/T-1898-2017; Lopez-Miranda, Jose/Y-8306-2019; De Ferrari, Gaetano Maria/K-5188-2016; Giugliano, Robert/N-7233-2017	Sabatine, Marc/0000-0002-0691-3359; Malynovsky, Yaroslav/0000-0002-9118-1104; Lopez-Miranda, Jose/0000-0002-8844-0718; De Ferrari, Gaetano Maria/0000-0003-4940-0876; Giugliano, Robert/0000-0003-4110-7675	Amgen; National Institute for Health Research [NF-SI-0513-10059] Funding Source: researchfish	Amgen(Amgen); National Institute for Health Research(National Institute for Health Research (NIHR))	Amgen.	Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bays H, 2014, J CLIN LIPIDOL; Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Farias ST, 2008, NEUROPSYCHOLOGY, V22, P531, DOI 10.1037/0894-4105.22.4.531; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Giugliano RP, 2017, NEW ENGL J MED, V377, P633, DOI 10.1056/NEJMoa1701131; Giugliano RP, 2017, JAMA CARDIOL, V2, P547, DOI 10.1001/jamacardio.2017.0083; Giugliano RP, 2017, CLIN CARDIOL, V40, P59, DOI 10.1002/clc.22678; Giugliano RP, 2015, J AM COLL CARDIOL, V65, pA4, DOI 10.1016/s0735-1097(15)60004-3; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jacobson TA, 2015, J CLIN LIPIDOL, V9, pS1, DOI 10.1016/j.jacl.2015.09.002; Koren MJ, 2017, JAMA CARDIOL, V2, P598, DOI 10.1001/jamacardio.2017.0747; Lipinski MJ, 2016, EUR HEART J, V37, P536, DOI 10.1093/eurheartj/ehv563; Maki KC, 2014, J CLIN LIPIDOL, V8, pS17, DOI 10.1016/j.jacl.2014.02.012; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; Orringer CE, 2017, J CLIN LIPIDOL, V11, P880, DOI [10.1016/j.jacl.2017.05.001, 10.1016/j.jac1.2017.05.001]; Pedersen TR, 1994, LANCET; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Ray K, 2016, J AM COLL CARDIOL, V67, P2082, DOI 10.1016/S0735-1097(16)32083-6; Robinson JG, 2017, J AM COLL CARDIOL, V69, P471, DOI 10.1016/j.jacc.2016.11.037; Rosenson RS, 2014, J CLIN LIPIDOL, V8, pS58, DOI 10.1016/j.jacl.2014.03.004; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sabatine MS, 2016, AM HEART J, V173, P94, DOI 10.1016/j.ahj.2015.11.015; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wiviott SD, 2005, J AM COLL CARDIOL, V46, P1411, DOI 10.1016/j.jacc.2005.04.064	30	334	353	3	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2017	390	10106					1962	1971		10.1016/S0140-6736(17)32290-0	http://dx.doi.org/10.1016/S0140-6736(17)32290-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK9HW	28859947	Green Submitted			2022-12-28	WOS:000413823200032
J	Merckx, J; Wali, R; Schiller, I; Caya, C; Gore, GC; Chartrand, C; Dendukuri, N; Papenburg, J				Merckx, Joanna; Wali, Rehab; Schiller, Ian; Caya, Chelsea; Gore, Genevieve C.; Chartrand, Caroline; Dendukuri, Nandini; Papenburg, Jesse			Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							REAL-TIME PCR; A H1N1 VIRUS; ANTIGEN-DETECTION TESTS; DIRECTIGEN EZ FLU; PLUS B TEST; RESPIRATORY SYNCYTIAL VIRUS; RT-PCR; SEASONAL INFLUENZA; VIRAL CULTURE; A/H1N1 2009	Background: Rapid and accurate influenza diagnostics can im-prove patient care. Purpose: To summarize and compare accuracy of traditional rapid influenza diagnostic tests (RIDTs), digital immunoassays (DIAs), and rapid nucleic acid amplification tests (NAATs) in children and adults with suspected influenza. Data Sources: 6 databases from their inception through May 2017. Study Selection: Studies in English, French, or Spanish comparing commercialized rapid tests (that is, providing results in <30 minutes) with reverse transcriptase polymerase chain reaction reference standard for influenza diagnosis. Data Extraction: Data were extracted using a standardized form; quality was assessed using QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2) criteria. Data Synthesis: 162 studies were included (130 of RIDTs, 19 of DIAs, and 13 of NAATs). Pooled sensitivities for detecting influenza A from Bayesian bivariate random-effects models were 54.4% (95% credible interval [CrI], 48.9% to 59.8%) for RIDTs, 80.0% (CrI, 73.4% to 85.6%) for DIAs, and 91.6% (CrI, 84.9% to 95.9%) for NAATs. Those for detecting influenza B were 53.2% (CrI, 41.7% to 64.4%) for RIDTs, 76.8% (CrI, 65.4% to 85.4%) for DIAs, and 95.4% (CrI, 87.3% to 98.7%) for NAATs. Pooled specificities were uniformly high (>98%). Forty-six influenza A and 24 influenza B studies presented pediatric-specific data; 35 influenza A and 16 influenza B studies presented adult-specific data. Pooled sensitivities were higher in children by 12.1 to 31.8 percentage points, except for influenza A by rapid NAATs (2.7 percentage points). Pooled sensitivities favored industry-sponsored studies by 6.2 to 34.0 percentage points. Incomplete reporting frequently led to unclear risk of bias. Limitations: Underreporting of clinical variables limited exploration of heterogeneity. Few NAAT studies reported adultspecific data, and none evaluated point-of-care testing. Many studies had unclear risk of bias. Conclusion: Novel DIAs and rapid NAATs had markedly higher sensitivities for influenza A and B in both children and adults than did traditional RIDTs, with equally high specificities.	[Merckx, Joanna] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ H3A 1A2, Canada; [Caya, Chelsea] McGill Univ, Hlth Ctr, Res Inst, EM3-3509,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada; [Papenburg, Jesse] McGill Univ, Hlth Ctr, E05-1905,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada; [Chartrand, Caroline] Ctr Hosp Univ St Justine, Dept Pediat, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Montreal, PQ, Canada; Royal Coll Surgeons Ireland, Dublin, Ireland; [Wali, Rehab] 3 Tullyhall Way, Dublin K78 TH73, Ireland; [Schiller, Ian; Dendukuri, Nandini] Ctr Outcomes Res & Evaluat, 5252 Blvd Maisonneuve,Bur 3C07, Montreal, PQ H4A 3S5, Canada; [Gore, Genevieve C.] Schulich Lib Phys Sci Life Sci & Engn, Macdonald Stewart Lib Bldg,809 Sherbrooke St West, Montreal, PQ H3A 0C1, Canada	McGill University; McGill University; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Royal College of Surgeons - Ireland	Papenburg, J (corresponding author), McGill Univ, Hlth Ctr, E05-1905,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	jesse.papenburg@mail.mcgill.ca	Papenburg, Jesse/I-7847-2019; Merckx, Joanna/AHI-1372-2022; Gore, Genevieve/CAF-4925-2022	Papenburg, Jesse/0000-0003-4232-871X; Merckx, Joanna/0000-0001-9426-8259; Gore, Genevieve/0000-0003-1072-2683	Quebec Health Research Fund; BD Diagnostic Systems	Quebec Health Research Fund(Fonds de la Recherche en Sante du Quebec); BD Diagnostic Systems	Quebec Health Research Fund and BD Diagnostic Systems.	Agoritsas K, 2006, J CLIN MICROBIOL, V44, P2638, DOI 10.1128/JCM.02644-05; Al Johani S M, 2011, J Infect Public Health, V4, P7, DOI 10.1016/j.jiph.2010.10.004; Alexander R, 2005, COMMUN DIS INTELL, V29, P272; Alhetheel AF, 2014, J PURE APPL MICROBIO, V8, P2265; Angoulvant F, 2011, EMERG MED J, V28, P924, DOI 10.1136/emj.2010.098533; [Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18360; [Anonymous], GUID CLIN US RT PCR; Avril E, 2016, DIAGN MICR INFEC DIS, V85, P334, DOI 10.1016/j.diagmicrobio.2016.03.015; Beckmann C, 2015, J CLIN VIROL, V67, P43, DOI 10.1016/j.jcv.2015.03.024; Bell JJ, 2014, J CLIN MICROBIOL, V52, P3992, DOI 10.1128/JCM.01639-14; Bellmann-Weiler R, 2011, CLIN MICROBIOL INFEC, V17, P235, DOI 10.1111/j.1469-0691.2010.03235.x; Benito-Fernandez J, 2006, PEDIATR INFECT DIS J, V25, P1153, DOI 10.1097/01.inf.0000246826.93142.b0; Berthod D, 2015, TRAVEL MED INFECT DI, V13, P394, DOI 10.1016/j.tmaid.2015.08.001; Biggs C, 2010, EMERG MED J, V27, P5, DOI 10.1136/emj.2009.078683; Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P2353, DOI 10.1128/JCM.00791-15; BinSaeed AA, 2014, SAUDI MED J, V35, P277; Blaschke AJ, 2014, J PEDIAT INF DIS SOC, V3, P112, DOI 10.1093/jpids/pit071; Boivin G, 2004, J CLIN MICROBIOL, V42, P45, DOI 10.1128/JCM.42.1.45-51.2004; Boivin G, 2001, J CLIN MICROBIOL, V39, P730, DOI 10.1128/JCM.39.2.730-732.2001; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Boyanton BL, 2014, DIAGN MICR INFEC DIS, V78, P360, DOI 10.1016/j.diagmicrobio.2013.10.009; Brendish NJ, 2015, J INFECTION, V71, P501, DOI 10.1016/j.jinf.2015.07.008; Bruning AHL, 2017, CLIN INFECT DIS, V65, P1026, DOI 10.1093/cid/cix461; Bruning AHL, 2014, DIAGN MICR INFEC DIS, V80, P292, DOI 10.1016/j.diagmicrobio.2014.08.010; Busson L, 2017, DIAGN MICR INFEC DIS, V87, P238, DOI 10.1016/j.diagmicrobio.2016.11.015; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Hurtado JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0775-5; Chiarella FC, 2016, J MED MICROBIOL, V65, P456, DOI 10.1099/jmm.0.000249; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Chartrand C, 2015, J CLIN MICROBIOL, V53, P3738, DOI 10.1128/JCM.01816-15; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Chen L, 2015, EUR J MICROBIOL IMMU, V5, P236, DOI 10.1556/1886.2015.00046; Chen M, 2010, LABMEDICINE, V41, P731, DOI 10.1309/LM1SH48AEBLVMJUQ; Cheng XD, 2011, J CLIN VIROL, V50, P153, DOI 10.1016/j.jcv.2010.10.002; Choi YJ, 2010, J MICROBIOL BIOTECHN, V20, P1450, DOI 10.4014/jmb.1004.04039; Choi YJ, 2010, J CLIN MICROBIOL, V48, P2260, DOI 10.1128/JCM.02392-09; Ciblak MA, 2010, SCAND J INFECT DIS, V42, P902, DOI 10.3109/00365548.2010.502903; Crum-Cianflone NF, 2009, CLIN INFECT DIS, V49, P1801, DOI 10.1086/648508; Cruz AT, 2010, PEDIATRICS, V125, pE645, DOI 10.1542/peds.2009-3060; Cruz-Canete M, 2007, ENFERM INFEC MICR CL, V25, P177, DOI 10.1157/13099369; D'Heilly SJ, 2008, J CLIN VIROL, V42, P124, DOI 10.1016/j.jcv.2007.12.014; Dendukuri N, 2012, BIOMETRICS, V68, P1285, DOI 10.1111/j.1541-0420.2012.01773.x; DiMaio MA, 2012, J VIROL METHODS, V186, P137, DOI 10.1016/j.jviromet.2012.07.023; Dunn JJ, 2015, J CLIN MICROBIOL, V53, P1790, DOI 10.1128/JCM.02739-14; Dunn J, 2014, DIAGN MICR INFEC DIS, V79, P10, DOI 10.1016/j.diagmicrobio.2014.01.018; Eggers M, 2012, EUR J CLIN MICROBIOL, V31, P1257, DOI 10.1007/s10096-011-1437-1; Eggers M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127070; Esposito S, 2003, ARCH DIS CHILD, V88, P525, DOI 10.1136/adc.88.6.525; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Foo H, 2009, J CLIN VIROL, V46, P384, DOI 10.1016/j.jcv.2009.09.019; Fuenzalida L, 2010, CLIN MICROBIOL INFEC, V16, P1574, DOI [10.1111/j.1469-0691.2009.03160.x, 10.1111/j.1469-0691.2010.03160.x]; Ganzenmueller T, 2010, J MED MICROBIOL, V59, P713, DOI 10.1099/jmm.0.017244-0; Gao FX, 2012, INFLUENZA OTHER RESP, V6, pe30, DOI 10.1111/j.1750-2659.2011.00313.x; Ghebremedhin B, 2009, J MED MICROBIOL, V58, P365, DOI 10.1099/jmm.0.004358-0; Gimeno C, 2010, DIAGN MICR INFEC DIS, V68, P456, DOI 10.1016/j.diagmicrobio.2010.07.010; Gomez-Vinales C, 2013, ENF INFEC MICROBIOL, V33, P26; Gonzalez-Canudas J, 2011, REV PANAM SALUD PUBL, V29, P1; Gooskens J, 2008, J CLIN VIROL, V41, P7, DOI 10.1016/j.jcv.2007.10.023; Gordon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007907; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hassan F, 2014, J CLIN MICROBIOL, V52, P906, DOI 10.1128/JCM.02484-13; Hatano B, 2011, J MED VIROL, V83, P568, DOI 10.1002/jmv.22031; Hawkes M, 2010, PEDIATRICS, V125, pE639, DOI 10.1542/peds.2009-2669; Hazelton B, 2015, INFLUENZA OTHER RESP, V9, P151, DOI 10.1111/irv.12303; Hazelton B, 2015, J MED VIROL, V87, P35, DOI 10.1002/jmv.23976; Herrmann B, 2001, J CLIN MICROBIOL, V39, P134, DOI 10.1128/JCM.39.1.134-138.2001; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Iyer SB, 2006, ACAD EMERG MED, V13, P1259, DOI 10.1111/j.1553-2712.2006.tb00287.x; Jang JW, 2015, J CLIN VIROL, V73, P42, DOI 10.1016/j.jcv.2015.10.014; Karre T, 2010, J CLIN MICROBIOL, V48, P343, DOI 10.1128/JCM.02063-09; Kawachi S, 2011, J CLIN VIROL, V51, P68, DOI 10.1016/j.jcv.2011.01.007; Kenmoe S, 2014, INFLUENZA OTHER RESP, V8, P131, DOI 10.1111/irv.12210; Kim YK, 2010, J CLIN VIROL, V49, P69, DOI 10.1016/j.jcv.2010.06.012; Klungthong C, 2010, J CLIN VIROL, V48, P91, DOI 10.1016/j.jcv.2010.03.012; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Koul PA, 2015, INDIAN J MED MICROBI, V33, pS26, DOI 10.4103/0255-0857.148831; Landry ML, 2008, J CLIN VIROL, V43, P148, DOI 10.1016/j.jcv.2008.06.006; Lee GC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-244; Lee HM, 2011, SCAND J INFECT DIS, V43, P43, DOI 10.3109/00365548.2010.508463; Leeflang MMG, 2014, CLIN MICROBIOL INFEC, V20, P105, DOI 10.1111/1469-0691.12474; Leonardi GP, 2015, J CLIN MICROBIOL, V53, P1345, DOI 10.1128/JCM.03441-14; Lewandrowski K, 2013, AM J CLIN PATHOL, V139, P684, DOI 10.1309/AJCP7ZTLJCP3LLMA; Li TJ, 2015, ANN INTERN MED, V162, P287, DOI 10.7326/M14-1603; Li XH, 2011, CLIN CHEM LAB MED, V49, P1533, DOI 10.1515/CCLM.2011.235; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loeb M, 2012, J INFECT DIS, V206, P1078, DOI 10.1093/infdis/jis450; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lucas PM, 2011, CLIN INFECT DIS, V52, pS116, DOI 10.1093/cid/ciq027; Macaskill P, 2010, COCHRANE HDB SYSTEMA; Melchers WJG, 2017, J MED VIROL, V89, P1382, DOI 10.1002/jmv.24796; Mese S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1811-9; Miarka M, 2014, ACTA BIOCHIM POL, V61, P485; Microbiology Devices, 2017, RECL INFL VIR ANT DE; Mitamura K, 2013, J INFECT CHEMOTHER, V19, P633, DOI 10.1007/s10156-012-0533-1; Mizuike R, 2011, CLIN VACCINE IMMUNOL, V18, P494, DOI 10.1128/CVI.00269-10; Moesker FM, 2016, J CLIN VIROL, V79, P12, DOI 10.1016/j.jcv.2016.03.022; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Monto AS, 2002, AM J MED, V112, p4S; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Ndegwa LK, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2131-9; Ng S, 2016, PEDIATR INFECT DIS J, V35, P583, DOI 10.1097/INF.0000000000001083; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nilsson AC, 2008, INFECT CONT HOSP EP, V29, P177, DOI 10.1086/526446; Nitsch-Osuch A, 2012, POSTEP HIG MED DOSW, V66, P752, DOI 10.5604/17322693.1015040; Noel G, 2011, ARCH PEDIATRIE, V18, P497, DOI 10.1016/j.arcped.2011.02.017; Noh JY, 2015, DIAGN MICR INFEC DIS, V83, P130, DOI 10.1016/j.diagmicrobio.2015.05.016; Nolte FS, 2016, J CLIN MICROBIOL, V54, P2763, DOI 10.1128/JCM.01586-16; Nougairede A, 2010, CLIN MICROBIOL INFEC, V16, P322, DOI 10.1111/j.1469-0691.2010.03168.x; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009215; Noyola DE, 2000, PEDIATR INFECT DIS J, V19, P303, DOI 10.1097/00006454-200004000-00008; de la Tabla VO, 2010, CLIN MICROBIOL INFEC, V16, P1358, DOI 10.1111/j.1469-0691.2010.03159.x; Peci A, 2014, J CLIN MICROBIOL, V52, P4309, DOI 10.1128/JCM.02024-14; Peng YP, 2013, BRAZ J INFECT DIS, V17, P247, DOI 10.1016/j.bjid.2012.09.014; Poehling KA, 2002, PEDIATRICS, V110, P83, DOI 10.1542/peds.110.1.83; Poeppl W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028089; Pongthanapisith V, 2011, INFECTION, V39, P105, DOI 10.1007/s15010-011-0092-x; Rahman M, 2008, DIAGN MICR INFEC DIS, V62, P162, DOI 10.1016/j.diagmicrobio.2007.10.012; Rashid H, 2008, Emerg Health Threats J, V1, pe2, DOI 10.3134/ehtj.08.002; Rashid H, 2008, CLIN MICROBIOL INFEC, V14, P569, DOI 10.1111/j.1469-0691.2008.01987.x; Rashid Harunor, 2007, Travel Med Infect Dis, V5, P310, DOI 10.1016/j.tmaid.2007.07.006; Rath B, 2012, J CLIN VIROL, V55, P329, DOI 10.1016/j.jcv.2012.08.002; Reina J, 2010, ENFERM INFEC MICR CL, V28, P95, DOI 10.1016/j.eimc.2008.11.021; Renaud C, 2016, CLIN MICROBIOLOGY PR; Reynders M, 2012, ACTA CLIN BELG, V67, P94, DOI 10.2143/ACB.67.2.2062638; Rouleau I, 2009, J CLIN MICROBIOL, V47, P2699, DOI 10.1128/JCM.00762-09; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Ryu SW, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22234; Salez N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130378; Sambol AR, 2010, J CLIN VIROL, V47, P229, DOI 10.1016/j.jcv.2009.12.015; Sandora TJ, 2010, PEDIATR INFECT DIS J, V29, P261, DOI 10.1097/INF.0b013e3181be9f9c; Sasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050670; Schiller I, 2015, HSROC R PACKAGE BAYE, P1; Selim HS, 2014, J EGYPT PUBLIC HEAL, V89, P96, DOI 10.1097/01.EPX.0000452224.96616.42; Selove W, 2016, J INVEST MED, V64, P905, DOI 10.1136/jim-2016-000055; Shi WX, 2014, CLIN LAB, V60, P297, DOI 10.7754/Clin.Lab.2013.121134; Sinclair A, 2013, J CLIN MICROBIOL, V51, P2303, DOI 10.1128/JCM.00137-13; Somerville LK, 2015, PATHOLOGY, V47, P243, DOI 10.1097/PAT.0000000000000240; Spiegelhalter DJ, 2007, WINBUGS VERSION 1 4; Stebbins S, 2011, INFLUENZA OTHER RESP, V5, P104, DOI 10.1111/j.1750-2659.2010.00171.x; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Suntarattiwong P, 2010, PEDIATR INFECT DIS J, V29, P366, DOI 10.1097/INF.0b013e3181c6f05c; Talbot HK, 2010, INFECT CONT HOSP EP, V31, P683, DOI 10.1086/653202; Tenorio-Abreu A, 2012, ACTA PEDIAT ESP, V70, P251; Tuttle R, 2015, DIAGN MICR INFEC DIS, V81, P171, DOI 10.1016/j.diagmicrobio.2014.11.013; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Van JCN, 2016, DIAGN MICR INFEC DIS, V85, P19, DOI 10.1016/j.diagmicrobio.2015.11.012; Velasco JMS, 2010, J CLIN VIROL, V48, P120, DOI 10.1016/j.jcv.2010.03.010; Watanabe M, 2011, PEDIATR INT, V53, P1097, DOI 10.1111/j.1442-200X.2011.03489.x; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yang JH, 2012, J MICROBIOL IMMUNOL, V45, P102, DOI 10.1016/j.jmii.2011.09.027; Zazueta-Garcia R, 2014, J INFECT DEV COUNTR, V8, P331, DOI 10.3855/jidc.3726; Zetti Z R, 2010, Med J Malaysia, V65, P27	156	156	163	1	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					394	+		10.7326/M17-0848	http://dx.doi.org/10.7326/M17-0848			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28869986				2022-12-28	WOS:000411009900016
J	Kits, KD; Sedlacek, CJ; Lebedeva, EV; Han, P; Bulaev, A; Pjevac, P; Daebeler, A; Romano, S; Albertsen, M; Stein, LY; Daims, H; Wagner, M				Kits, K. Dimitri; Sedlacek, Christopher J.; Lebedeva, Elena V.; Han, Ping; Bulaev, Alexandr; Pjevac, Petra; Daebeler, Anne; Romano, Stefano; Albertsen, Mads; Stein, Lisa Y.; Daims, Holger; Wagner, Michael			Kinetic analysis of a complete nitrifier reveals an oligotrophic lifestyle	NATURE			English	Article							AMMONIA-OXIDIZING ARCHAEON; OXIDATION-KINETICS; NITRITE OXIDATION; NITROSOSPHAERA-VIENNENSIS; COMPLETE NITRIFICATION; NITROSOMONAS-EUROPAEA; BACTERIA; WATER; SOIL; COMMUNITIES	Nitrification, the oxidation of ammonia (NH3) via nitrite (NO2-) to nitrate (NO3-), is a key process of the biogeochemical nitrogen cycle. For decades, ammonia and nitrite oxidation were thought to be separately catalysed by ammonia-oxidizing bacteria (AOB) and archaea (AOA), and by nitrite-oxidizing bacteria (NOB). The recent discovery of complete ammonia oxidizers (comammox) in the NOB genus Nitrospira(1,2), which alone convert ammonia to nitrate, raised questions about the ecological niches in which comammox Nitrospira successfully compete with canonical nitrifiers. Here we isolate a pure culture of a comammox bacterium, Nitrospira inopinata, and show that it is adapted to slow growth in oligotrophic and dynamic habitats on the basis of a high affinity for ammonia, low maximum rate of ammonia oxidation, high growth yield compared to canonical nitrifiers, and genomic potential for alternative metabolisms. The nitrification kinetics of four AOA from soil and hot springs were determined for comparison. Their surprisingly poor substrate affinities and lower growth yields reveal that, in contrast to earlier assumptions, AOA are not necessarily the most competitive ammonia oxidizers present in strongly oligotrophic environments and that N. inopinata has the highest substrate affinity of all analysed ammonia oxidizer isolates except the marine AOA Nitrosopumilus maritimus SCM1 (ref. 3). These results suggest a role for comammox organisms in nitrification under oligotrophic and dynamic conditions.	[Kits, K. Dimitri; Sedlacek, Christopher J.; Han, Ping; Pjevac, Petra; Daebeler, Anne; Romano, Stefano; Daims, Holger; Wagner, Michael] Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, Res Network Chem Meets Microbiol, Althanstr 14, A-1090 Vienna, Austria; [Lebedeva, Elena V.; Bulaev, Alexandr] Russian Acad Sci, Biotechnol Res Ctr, Winogradsky Inst Microbiol, Leninsky Ave 33,Bld 2, Moscow 119071, Russia; [Albertsen, Mads] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark; [Stein, Lisa Y.] Univ Alberta, Dept Biol Sci, CW405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada	University of Vienna; Research Center of Biotechnology RAS; Russian Academy of Sciences; Aalborg University; University of Alberta	Daims, H (corresponding author), Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, Res Network Chem Meets Microbiol, Althanstr 14, A-1090 Vienna, Austria.	daims@microbial-ecology.net	Han, Ping/P-5401-2019; Bulaev, Aleksandr/O-2455-2013; Pjevac, Petra/AAW-8737-2020; Daims, Holger/I-8410-2012; Daebeler, Anne/AAP-1274-2021; Pjevac, Petra/ABE-9919-2021; Wagner, Michael/A-7801-2011; Han, Ping/F-2360-2017; Albertsen, Mads/T-7358-2018; Romano, Stefano/J-3756-2013	Han, Ping/0000-0001-6025-1651; Bulaev, Aleksandr/0000-0001-7914-9817; Pjevac, Petra/0000-0001-7344-302X; Daims, Holger/0000-0002-4195-0913; Pjevac, Petra/0000-0001-7344-302X; Wagner, Michael/0000-0002-9778-7684; Han, Ping/0000-0001-6025-1651; Albertsen, Mads/0000-0002-6151-190X; Daebeler, Anne/0000-0001-8026-3297; Valeeva, Aygul V./0000-0002-9968-9586; Sedlacek, Christopher/0000-0002-6002-4982; Kits, K. Dimitri/0000-0002-5288-4616; Romano, Stefano/0000-0002-7600-1953	European Research Council Advanced Grant project [NITRICARE 294343]; Austrian Science Fund (FWF) [P27319-B21]; FWF [P25231-B21]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03745]; VILLUM FONDEN [15510]; Villum Fonden [00015510] Funding Source: researchfish	European Research Council Advanced Grant project(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); VILLUM FONDEN(Villum Fonden); Villum Fonden(Villum Fonden)	We thank A. Mueller for assistance with the cultivation of AOA strain 5A, M. Palatinszky for assistance with the cultivation of N. uzonensis, J. Vierheilig for help with molecular analyses and the cultivation of N. inopinata, and D. Gruber, N. Cyran, A. Klocker and S. A. Eichorst for assistance with sample preparation for electron microscopy. K.D.K., C.J.S., P.H., S.R. and M.W. were supported by the European Research Council Advanced Grant project NITRICARE 294343 (to M.W.). P.P. and H.D. were supported by the Austrian Science Fund (FWF) project P27319-B21, and A.D. and H.D. were supported by FWF project P25231-B21. K.D.K. and L.Y.S. were supported by the Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-03745). M.A. was supported by research grant 15510 from the VILLUM FONDEN.	Bartelme RP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00101; BELSER LW, 1980, FEMS MICROBIOL LETT, V7, P213, DOI 10.1111/j.1574-6941.1980.tb01628.x; Bollmann A, 2005, APPL ENVIRON MICROB, V71, P1276, DOI 10.1128/AEM.71.3.1276-1282.2005; BOON B, 1962, BIOCHEM J, V85, P440, DOI 10.1042/bj0850440; BOTH GJ, 1992, ARCH MICROBIOL, V157, P436, DOI 10.1007/BF00249101; Button DK, 1998, MICROBIOL MOL BIOL R, V62, P636, DOI 10.1128/MMBR.62.3.636-645.1998; BUTTON DK, 1991, APPL ENVIRON MICROB, V57, P2033, DOI 10.1128/AEM.57.7.2033-2038.1991; CLEGG SL, 1995, GEOCHIM COSMOCHIM AC, V59, P2403, DOI 10.1016/0016-7037(95)00135-2; Costa E, 2006, TRENDS MICROBIOL, V14, P213, DOI 10.1016/j.tim.2006.03.006; Daims H, 2001, APPL ENVIRON MICROB, V67, P5273, DOI 10.1128/AEM.67.11.5273-5284.2001; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Daims H, 2016, TRENDS MICROBIOL, V24, P699, DOI 10.1016/j.tim.2016.05.004; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Hayatsu M, 2017, ISME J, V11, P1130, DOI 10.1038/ismej.2016.191; Hood-Nowotny R, 2010, SOIL SCI SOC AM J, V74, P1018, DOI 10.2136/sssaj2009.0389; HUNIK JH, 1993, APPL MICROBIOL BIOT, V40, P442, DOI 10.1007/BF00170408; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Karst S, 2016, MMGENOME TOOLBOX REP, DOI [10.1101/059121, DOI 10.1101/059121]; Koch H, 2014, SCIENCE, V345, P1052, DOI 10.1126/science.1256985; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; LAANBROEK HJ, 1994, ARCH MICROBIOL, V161, P156, DOI 10.1007/BF00276477; Lebedeva EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080835; Lehtovirta-Morley LE, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw057; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nowka B, 2015, APPL ENVIRON MICROB, V81, P745, DOI 10.1128/AEM.02734-14; Palatinszky M, 2015, NATURE, V524, P105, DOI 10.1038/nature14856; Palomo A, 2016, ISME J, V10, P2569, DOI 10.1038/ismej.2016.63; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pinto AJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00054-15; Pjevac P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01508; Prosser JI, 2012, TRENDS MICROBIOL, V20, P523, DOI 10.1016/j.tim.2012.08.001; Prosser JI, 2011, NITRIFICATION, P347; Schleper C, 2010, ISME J, V4, P1092, DOI 10.1038/ismej.2010.111; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Sedlacek CJ, 2016, APPL ENVIRON MICROB, V82, P4776, DOI 10.1128/AEM.01171-16; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Stark JM, 1996, SOIL BIOL BIOCHEM, V28, P1307, DOI 10.1016/S0038-0717(96)00133-2; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Stein LY, 2011, NITRIFICATION, P95; Stieglmeier M, 2014, INT J SYST EVOL MICR, V64, P2738, DOI 10.1099/ijs.0.063172-0; SUWA Y, 1994, WATER RES, V28, P1523, DOI 10.1016/0043-1354(94)90218-6; SUZUKI I, 1974, J BACTERIOL, V120, P556, DOI 10.1128/JB.120.1.556-558.1974; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Ushiki N, 2017, J BIOSCI BIOENG, V123, P581, DOI 10.1016/j.jbiosc.2016.12.016; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459; VERHAGEN FJM, 1991, APPL ENVIRON MICROB, V57, P3255, DOI 10.1128/AEM.57.11.3255-3263.1991; Wang YL, 2017, WATER RES, V116, P332, DOI 10.1016/j.watres.2017.03.042; WARD BB, 1987, ARCH MICROBIOL, V147, P126, DOI 10.1007/BF00415273; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2	55	354	394	80	769	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					269	+		10.1038/nature23679	http://dx.doi.org/10.1038/nature23679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28847001	Green Accepted, Green Submitted			2022-12-28	WOS:000410555900045
J	Hawkes, N				Hawkes, Nigel			A brief history of post-truth in medicine From antivaccine conspiracy theories to climate change denial to obfuscation of the truth about the harms of smoking, post-truth is nothing new, finds Nigel Hawkes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	3	3	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2017	358								j4193	10.1136/bmj.j4193	http://dx.doi.org/10.1136/bmj.j4193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH6MW	28893829				2022-12-28	WOS:000411292100004
J	Solis, GP; Bilousov, O; Koval, A; Luchtenborg, AM; Lin, C; Katanaev, VL				Solis, Gonzalo P.; Bilousov, Oleksii; Koval, Alexey; Luchtenborg, Anne-Marie; Lin, Chen; Katanaev, Vladimir L.			Golgi-Resident Gao Promotes Protrusive Membrane Dynamics (vol 170, pg 939, 2017)	CELL			English	Correction												gonzalo.solis@unil.ch; vladimir.katanaev@unil.ch	Koval, Alexey/AAU-4766-2020; Katanaev, Vladimir/F-9480-2014	Katanaev, Vladimir/0000-0002-7909-5617				Solis GP, 2017, CELL, V170, P939, DOI 10.1016/j.cell.2017.07.015	1	4	4	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1258	1258		10.1016/j.cell.2017.08.045	http://dx.doi.org/10.1016/j.cell.2017.08.045			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886387	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000409536000021
J	Woznica, A; Gerdt, JP; Hulett, RE; Clardy, J; King, N				Woznica, Arielle; Gerdt, Joseph P.; Hulett, Ryan E.; Clardy, Jon; King, Nicole			Mating in the Closest Living Relatives of Animals Is Induced by a Bacterial Chondroitinase	CELL			English	Article							CHOANOFLAGELLATE SALPINGOECA-ROSETTA; QUORUM-SENSING SYSTEMS; VIBRIO-FISCHERI; MARINE-INVERTEBRATES; ACTIVE-SITE; URONIC-ACID; PHEROMONE; SULFATE; BEHAVIOR; LYASES	We serendipitously discovered that the marine bacterium Vibrio fischeri induces sexual reproduction in one of the closest living relatives of animals, the choanoflagellate Salpingoeca rosetta. Although bacteria influence everything from nutrition and metabolism to cell biology and development in eukaryotes, bacterial regulation of eukaryotic mating was unexpected. Here, we show that a single V. fischeri protein, the previously uncharacterized EroS, fully recapitulates the aphrodisiac-like activity of live V. fischeri. EroS is a chondroitin lyase; although its substrate, chondroitin sulfate, was previously thought to be an animal synapomorphy, we demonstrate that S. rosetta produces chondroitin sulfate and thus extend the ancestry of this important glycosaminoglycan to the premetazoan era. Finally, we show that V. fischeri, purified EroS, and other bacterial chondroitin lyases induce S. rosetta mating at environmentally relevant concentrations, suggesting that bacteria likely regulate choanoflagellate mating in nature.	[Woznica, Arielle; Hulett, Ryan E.; King, Nicole] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Woznica, Arielle; Hulett, Ryan E.; King, Nicole] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Gerdt, Joseph P.; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Harvard Medical School	King, N (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; King, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Clardy, J (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; nking@berkeley.edu	Gerdt, Joseph/AAD-2437-2020	Gerdt, Joseph/0000-0002-0375-4110; Woznica, Arielle/0000-0002-3920-1737	NIH [S10 RR025622, P41GM103390, GM099533]; NIH; National Center for Complementary & Integrative Health [R01AT009874] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099533, F32GM116205, P41GM103390] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Visick for V. fischeri syp deletion mutants, N. Ruby for V. fischeri quorum sensing deletion mutants, and Y. Boucher for diverse species of Vibrio bacteria. We thank M. Abedin, D. Booth, and B. Larson for helpful discussions and critical reading of the manuscript and B.L. Azpeitia for technical assistance. This work used the Vincent J. Coates Proteomics/Mass Spectrometry Laboratory at UC Berkeley, supported in part by the NIH (S10 RR025622), and the Complex Carbohydrate Research Center, supported by the NIH-funded Research Resource for Integrated Glycotechnology (P41GM103390). J.P.G. is supported by a Ruth L. Kirchstein Postdoctoral Fellowship from the NIH. This work was funded by the NIH (GM099533).	Ahn MY, 1998, CAN J MICROBIOL, V44, P423, DOI 10.1139/cjm-44-5-423; AVERY MI, 1984, IBIS, V126, P177; BABCOCK R, 1992, INVERTEBR REPROD DEV, V22, P213, DOI 10.1080/07924259.1992.9672274; BartelsHardege HD, 1996, J EXP MAR BIOL ECOL, V201, P275, DOI 10.1016/0022-0981(96)00009-3; Beemelmanns C, 2014, J AM CHEM SOC, V136, P10210, DOI 10.1021/ja5046692; Bell G., 1988, SEX DEATH PROTOZOA H; Buskey EJ, 1998, J MARINE SYST, V15, P13, DOI 10.1016/S0924-7963(97)00045-6; Cantley AM, 2016, J AM CHEM SOC, V138, P4326, DOI 10.1021/jacs.6b01190; Dayel MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095577; Dayel MJ, 2011, DEV BIOL, V357, P73, DOI 10.1016/j.ydbio.2011.06.003; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; Dini Fernando, 1993, Advances in Microbial Ecology, V13, P85; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Fairclough SR, 2010, CURR BIOL, V20, pR875, DOI 10.1016/j.cub.2010.09.014; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; GIESE AC, 1959, ANNU REV PHYSIOL, V21, P547, DOI 10.1146/annurev.ph.21.030159.002555; Goodenough U, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016154; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hong SW, 2002, EUR J BIOCHEM, V269, P2934, DOI 10.1046/j.1432-1033.2002.02967.x; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Jones BW, 2007, MICROB ECOL, V54, P314, DOI 10.1007/s00248-006-9204-z; Kartika T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141799; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kochert G., 2012, SEXUAL INTERACTIONS, P73; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Leadbeater BSC, 2015, CHOANOFLAGELLATES: EVOLUTION, BIOLOGY AND ECOLOGY, P1, DOI 10.1017/CBO9781139051125; Levin TC, 2014, ELIFE, V3, DOI 10.7554/eLife.04070; Levin TC, 2013, CURR BIOL, V23, P2176, DOI 10.1016/j.cub.2013.08.061; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Lupp C, 2005, J BACTERIOL, V187, P3620, DOI 10.1128/JB.187.11.3620-3629.2005; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; McFall-Ngai M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001783; Mengerink KJ, 2001, GLYCOBIOLOGY, V11, p37R, DOI 10.1093/glycob/11.4.37R; MILLER DJ, 1990, MOL REPROD DEV, V26, P184, DOI 10.1002/mrd.1080260213; ODAY DH, 1979, CAN J MICROBIOL, V25, P1416, DOI 10.1139/m79-221; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; Painter SD, 1998, BIOL BULL-US, V194, P120, DOI 10.2307/1543042; Ram JL, 1999, FASEB J, V13, P945, DOI 10.1096/fasebj.13.8.945; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shibata S, 2012, J BACTERIOL, V194, P6736, DOI 10.1128/JB.00707-12; SMITH JR, 1983, INT J INVER REP DEV, V6, P129, DOI 10.1080/01651269.1983.10510032; Sorensen PW, 2015, FISH PHEROMONES AND RELATED CUES, P1; STARR M, 1992, MAR ECOL PROG SER, V79, P275; STARR M, 1990, SCIENCE, V247, P1071, DOI 10.1126/science.247.4946.1071; Thompson FL, 2006, BIOLOGY OF VIBRIOS, P1; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Wang WS, 2015, J BIOL CHEM, V290, P7823, DOI 10.1074/jbc.M114.629154; Watson GJ, 2003, J EXP MAR BIOL ECOL, V294, P169, DOI 10.1016/S0022-0981(03)00264-8; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329; Woznica A, 2016, P NATL ACAD SCI USA, V113, P7894, DOI 10.1073/pnas.1605015113; Yamada Shuhei, 2011, Commun Integr Biol, V4, P150, DOI 10.4161/cib.4.2.14547; Zhang F, 2010, HDB GLYCOMICS, P59, DOI DOI 10.1016/B978-0-12-373600-0.00003-2	59	56	56	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1175	1183		10.1016/j.cell.2017.08.005	http://dx.doi.org/10.1016/j.cell.2017.08.005			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28867285	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000409536000014
J	Xu, YG; Wang, Q; Shen, C; Lin, QH; Wang, PC; Lu, M				Xu, Yuangang; Wang, Qian; Shen, Cheng; Lin, Qiuhan; Wang, Pengcheng; Lu, Ming			A series of energetic metal pentazolate hydrates	NATURE			English	Article							EINES KLASSISCHEN PROBLEMS; ELECTRON-DENSITY ANALYSIS; 1ST GENERATION; ANION; NITROGEN; CYCLO-N-5(-); STABILITY; CHEMISTRY; ORBITALS; SYSTEMS	Singly or doubly bonded polynitrogen compounds can decompose to dinitrogen (N-2) with an extremely large energy release. This makes them attractive as potential explosives or propellants(1-3), but also challenging to produce in a stable form. Polynitrogen materials containing nitrogen as the only element exist in the form of high-pressure polymeric phases(4-6), but under ambient conditions even metastability is realized only in the presence of other elements that provide stabilization. An early example is the molecule phenylpentazole, with a five-membered all-nitrogen ring, which was first reported in the 1900s(7) and characterized in the 1950s(8,9). Salts containing the azide anion (N-3(-))(10-12) or pentazenium cation (N-5(+))(13) are also known, with compounds containing the pentazole anion, cyclo-N-5(-), a more recent addition(14-16). Very recently, a bulk material containing this species was reported(17) and then used to prepare the first example of a solid-state metal-N-5 complex(18). Here we report the synthesis and characterization of five metal pentazolate hydrate complexes [Na(H2O)(N-5)]center dot 2H(2)O, [M(H2O)(4)(N-5)(2)]center dot 4H(2)O (M = Mn, Fe and Co) and [Mg(H2O)(6)(N-5)(2)]center dot 4H(2)O that, with the exception of the Co complex, exhibit good thermal stability with onset decomposition temperatures greater than 100 degrees C. For this series we find that the N-5(-) ion can coordinate to the metal cation through either ionic or covalent interactions, and is stabilized through hydrogen-bonding interactions with water. Given their energetic properties and stability, pentazole-metal complexes might potentially serve as a new class of high-energy density materials(19) or enable the development of such materials containing only nitrogen(20-23). We also anticipate that the adaptability of the N-5(-) ion in terms of its bonding interactions will enable the exploration of inorganic nitrogen analogues of metallocenes(24) and other unusual polynitrogen complexes.	[Xu, Yuangang; Wang, Qian; Shen, Cheng; Lin, Qiuhan; Wang, Pengcheng; Lu, Ming] Nanjing Univ Sci & Technol, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Wang, PC; Lu, M (corresponding author), Nanjing Univ Sci & Technol, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.	alexwpch@mail.njust.edu.cn; luming@mail.njust.edu.cn	王, 鹏程/E-4908-2016; xu, yuangang/P-1314-2019; Wang, Pengcheng/T-7518-2019	王, 鹏程/0000-0002-5282-236X; xu, yuangang/0000-0002-6504-4405; Wang, Pengcheng/0000-0002-5282-236X	NSAF [U1530101]; National Natural Science Foundation of China [51374131]	NSAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the NSAF (U1530101) and the National Natural Science Foundation of China (51374131). We thank C. Zhang and B. Hu for co-exploring the rupture of C-N bonds in phenylpentazole at the beginning of the project, Z. Zhang for analysis of the crystal structures, L. Lu for analysis of Raman and NMR spectra, and L. Cheng for DSC measurements of decomposition kinetics.	[Anonymous], 2009, SAINT V7 68A; Bazanov B, 2016, ANGEW CHEM INT EDIT, V55, P13233, DOI 10.1002/anie.201605400; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bianchi R, 2000, INORG CHEM, V39, P2360, DOI 10.1021/ic991316e; Bruker AXS, 2008, SADABS V2008 1; Burke LA, 2001, J CHEM SOC PERK T 2, P1679, DOI 10.1039/b103852b; Butler RN, 2003, CHEM COMMUN, P1016, DOI 10.1039/b301491f; Choi C, 2016, J PHYS CHEM A, V120, P4249, DOI 10.1021/acs.jpca.6b04226; Christe KO, 2007, PROPELL EXPLOS PYROT, V32, P194, DOI 10.1002/prep.200700020; Christe KO, 1999, ANGEW CHEM INT EDIT, V38, P2004, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2004::AID-ANIE2004>3.0.CO;2-7; Crawford MJ, 2005, ANGEW CHEM INT EDIT, V44, P7874, DOI 10.1002/anie.200502484; Crawford MJ, 2005, INORG CHEM, V44, P8481, DOI 10.1021/ic050409v; CREMER D, 1984, ANGEW CHEM INT EDIT, V23, P627, DOI 10.1002/anie.198406271; Curtius T, 1916, BER DTSCH CHEM GES, V48, P1614; Eremets MI, 2004, NAT MATER, V3, P558, DOI 10.1038/nmat1146; Fehlhammer WP, 2013, Z ANORG ALLG CHEM, V639, P1053, DOI 10.1002/zaac.201300162; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Haiges R, 2003, ANGEW CHEM INT EDIT, V42, P5847, DOI 10.1002/anie.200352680; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448800, 10.1063/1.448799]; Hirshberg B, 2014, NAT CHEM, V6, P52, DOI [10.1038/NCHEM.1818, 10.1038/nchem.1818]; HUISGEN R, 1957, CHEM BER-RECL, V90, P2914, DOI 10.1002/cber.19570901230; HUISGEN R, 1956, ANGEW CHEM INT EDIT, V68, P705, DOI 10.1002/ange.19560682212; Klapotke T. M., 2008, COMPREHENSIVE HETERO, P739; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Malar EJP, 2003, INORG CHEM, V42, P3873, DOI 10.1021/ic0340027; Ostmark H, 2003, CHEM PHYS LETT, V379, P539, DOI 10.1016/j.cplett.2003.08.081; Perera SA, 2009, J PHYS CHEM A, V113, P3197, DOI 10.1021/jp809267y; Schroer T, 2005, CHEM COMMUN, P1607, DOI 10.1039/b417010e; Sheldrick G. M., 2014, SHELXL 2014 7; Steele BA, 2017, CHEM MATER, V29, P735, DOI 10.1021/acs.chemmater.6b04538; Steele BA, 2016, CHEM PHYS LETT, V643, P21, DOI 10.1016/j.cplett.2015.11.008; Stowasser R, 1999, J AM CHEM SOC, V121, P3414, DOI 10.1021/ja9826892; Tsipis AC, 2004, INORG CHEM, V43, P1273, DOI 10.1021/ic035112g; Vij A, 2002, ANGEW CHEM INT EDIT, V41, P3051, DOI 10.1002/1521-3773(20020816)41:16<3051::AID-ANIE3051>3.0.CO;2-T; Zhang C, 2017, ANGEW CHEM INT EDIT, V56, P4512, DOI 10.1002/anie.201701070; Zhang C, 2017, SCIENCE, V355, P374, DOI 10.1126/science.aah3840; Zhang C, 2016, J ENERG MATER, V34, P103, DOI 10.1080/07370652.2014.1001918; Zhang XL, 2015, RSC ADV, V5, P21823, DOI 10.1039/c5ra00818b	39	249	273	33	380	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					78	+		10.1038/nature23662	http://dx.doi.org/10.1038/nature23662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28847006				2022-12-28	WOS:000409388700036
J	Liang, J; Balachandra, S; Ngo, S; O'Brien, LE				Liang, Jackson; Balachandra, Shruthi; Ngo, Sang; O'Brien, Lucy Erin			Feedback regulation of steady-state epithelial turnover and organ size	NATURE			English	Article							INTESTINAL STEM-CELL; ADULT DROSOPHILA MIDGUT; E-CADHERIN; TISSUE HOMEOSTASIS; ACTIVATION; DIVISION; DIFFERENTIATION; PROLIFERATION; REGENERATION; MAINTENANCE	Epithelial organs undergo steady-state turnover throughout adult life, with old cells being continually replaced by the progeny of stem cell divisions(1). To avoid hyperplasia or atrophy, organ turnover demands strict equilibration of cell production and loss(2-4). However, the mechanistic basis of this equilibrium is unknown. Here we show that robustly precise turnover of the adult Drosophila intestine(5) arises through a coupling mechanism in which enterocyte apoptosis breaks feedback inhibition of stem cell division. Healthy enterocytes inhibit stem cell division through E-cadherin, which prevents secretion of mitogenic epidermal growth factors (EGFs) by repressing transcription of the EGF maturation factor rhomboid. Individual apoptotic enterocytes promote divisions by loss of E-cadherin, which releases cadherin-associated beta-catenin (Armadillo in Drosophila) and p120-catenin to induce rhomboid. Induction of rhomboid in the dying enterocyte triggers activation of the EGF receptor (Egfr) in stem cells within a discrete radius. When we blocked apoptosis, E-cadherin-controlled feedback suppressed divisions, and the organ retained the same number of cells. When we disrupted feedback, apoptosis and divisions were uncoupled, and the organ developed either hyperplasia or atrophy. Together, our results show that robust cellular balance hinges on the obligate coupling of divisions to apoptosis, which limits the proliferative potential of a stem cell to the precise time and place at which a replacement cell is needed. In this way, localized cell-cell communication gives rise to tissue-level homeostatic equilibrium and constant organ size.	[Liang, Jackson; Balachandra, Shruthi; Ngo, Sang; O'Brien, Lucy Erin] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	O'Brien, LE (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	lucye@stanford.edu			NSF [GRFP DGE-114747]; NIH [T32GM007276, R03DK104027, R01GM116000-01A1]; Bloomington Drosophila Stock Center [NIH P40OD018537]; TRiP at Harvard Medical School [NIH/NIGMS R01-GM084947]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK104027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276, R01GM116000, R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloomington Drosophila Stock Center; TRiP at Harvard Medical School; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.L. was supported by NSF GRFP DGE-114747 and NIH T32GM007276. This work was supported by NIH R03DK104027 and R01GM116000-01A1 to L.E.O. Confocal microscopy was performed at the Stanford Beckman Cell Sciences Imaging Facility (NIH 1S10OD01058001A1). We thank D. Bilder for the Caspase-3 antibody; the Developmental Studies Hybridoma Bank for other antibodies; D. Bilder, B. Edgar, M. Fuller, H. Jiang, B. Ohlstein, C. Thummel, A. Orian, the Bloomington Drosophila Stock Center (NIH P40OD018537), the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) and the Vienna Drosophila Resource Center (http://stockcenter.vdrc.at/control/main) for fly stocks; J. Axelrod, M. Goodman, M. Fuller, W. J. Nelson, R. Nusse, M. Krasnow, T. Nystul and D. Fox for comments on the manuscript; and M. Mirvis, B. Benham-Pyle, N. Pierce and D. Gordon for helpful discussions.	Apidianakis Y, 2017, ADV INSECT PHYSIOL, V52, P139, DOI 10.1016/bs.aiip.2017.03.002; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Chen HY, 2014, CELL, V159, P829, DOI 10.1016/j.cell.2014.10.028; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kolahgar G, 2015, DEV CELL, V34, P297, DOI 10.1016/j.devcel.2015.06.010; LEBLOND CP, 1948, ANAT REC, V100, P357, DOI 10.1002/ar.1091000306; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Maeda K, 2008, GENES CELLS, V13, P1219, DOI 10.1111/j.1365-2443.2008.01239.x; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; McCrea PD, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.3; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; O'Brien LE, 2013, ANNU REV CELL DEV BI, V29, P107, DOI 10.1146/annurev-cellbio-101512-122319; O'Brien LE, 2013, CELL STEM CELL, V13, P375, DOI 10.1016/j.stem.2013.09.008; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Osman D, 2012, J CELL SCI, V125, P5944, DOI 10.1242/jcs.113100; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; Shilo BZ, 2016, SEMIN CELL DEV BIOL, V60, P5, DOI 10.1016/j.semcdb.2016.07.014; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Strand M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080608; Takeishi A, 2013, CELL REP, V3, P919, DOI 10.1016/j.celrep.2013.02.022; Zhang TY, 2015, DEV BIOL, V407, P246, DOI 10.1016/j.ydbio.2015.09.011; Zhou F, 2013, DEV BIOL, V373, P383, DOI 10.1016/j.ydbio.2012.10.023	34	75	75	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					588	+		10.1038/nature23678	http://dx.doi.org/10.1038/nature23678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28847000	Green Accepted, Green Submitted			2022-12-28	WOS:000408703100039
J	Hurley, R				Hurley, Richard			HUMANITARIAN AID On a mission to relieve the global epidemic of untreated pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						International Narcotics Control Board, 2015, AV INT CONTR DRUGS E; Pettus K, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j309	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2017	358								j4022	10.1136/bmj.j4022	http://dx.doi.org/10.1136/bmj.j4022			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CK	28851682				2022-12-28	WOS:000409386400008
J	Rapoport, AB; Rowley, CF				Rapoport, Alison B.; Rowley, Christopher F.			Stretching the Scope - Becoming Frontline Addiction-Medicine Providers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rapoport, Alison B.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rapoport, AB (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.							[Anonymous], 2016, OP OV UND EP; Henry J., KAISER FAMILY FDN ST; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; U.S. Department of Health and Human Services (HHS), 2016, OFF SURG GEN FAC ADD	4	25	25	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					705	707		10.1056/NEJMp1706492	http://dx.doi.org/10.1056/NEJMp1706492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28834479	Bronze			2022-12-28	WOS:000413090000001
J	Angiolillo, DJ				Angiolillo, Dominick J.			Dual antiplatelet therapy guided by platelet function testing	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; REACTIVITY		[Angiolillo, Dominick J.] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA	State University System of Florida; University of Florida	Angiolillo, DJ (corresponding author), Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA.	dominick.angiolillo@jax.ufl.edu			Scott R MacKenzie Foundation; NIH/NCATS [UL1 TR000064, NIH/NHGRI U01 HG007269]	Scott R MacKenzie Foundation; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	I have received payments as an individual for consulting and honorarium from Amgen, Aralez, AstraZeneca, Bayer, Biosensors, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Janssen, Merck, PLx Pharma, Pfizer, Sanofi, and The Medicines Company for cangrelor (which no longer belongs to this maker); for participation in review activities from CeloNova and St Jude Medical; and institutional payments for grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Janssen, Matsutani Chemical Industry Co, Merck, Novartis, Osprey Medical, and Renal Guard Solutions, all outside of the area of work discussed here. In addition, I have recieved funding from the Scott R MacKenzie Foundation and the NIH/NCATS Clinical and Translational Science Award to the University of Florida UL1 TR000064 and NIH/NHGRI U01 HG007269.	Cayla G, 2016, LANCET, V388, P2015, DOI 10.1016/S0140-6736(16)31323-X; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cuisset T, 2017, EUR HEART J, DOI [10.1093/eurheartj/ehx175., DOI 10.1093/EURHEARTJ/EHX175.]; De Luca L, 2017, EUROINTERVENTION, V13, P459, DOI 10.4244/EIJ-D-17-00092; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Franchi Francesco, 2014, Curr Treat Options Cardiovasc Med, V16, P300, DOI 10.1007/s11936-014-0300-y; Moon JY, 2018, EXPERT REV CLIN PHAR, V11, P151, DOI 10.1080/17512433.2017.1353909; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Rollini F, 2016, NAT REV CARDIOL, V13, P11, DOI 10.1038/nrcardio.2015.113; Sibbing D, 2017, LANCET; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026	12	33	34	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1718	1720		10.1016/S0140-6736(17)32279-1	http://dx.doi.org/10.1016/S0140-6736(17)32279-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ6GB	28855079				2022-12-28	WOS:000412853100007
J	Gremer, L; Scholzel, D; Schenk, C; Reinartz, E; Labahn, J; Ravelli, RBG; Tusche, M; Lopez-Iglesias, C; Hoyer, W; Heise, H; Willbold, D; Schroder, GF				Gremer, Lothar; Schoelzel, Daniel; Schenk, Carla; Reinartz, Elke; Labahn, Joerg; Ravelli, Raimond B. G.; Tusche, Markus; Lopez-Iglesias, Carmen; Hoyer, Wolfgang; Heise, Henrike; Willbold, Dieter; Schroeder, Gunnar F.			Fibril structure of amyloid-beta(1-42) by cryo-electron microscopy	SCIENCE			English	Article							ATOMIC-RESOLUTION STRUCTURE; AMYLOID-BETA FIBRILS; ALZHEIMERS-DISEASE; POLYMORPHISM; DIMER	Amyloids are implicated in neurodegenerative diseases. Fibrillar aggregates of the amyloid-beta protein (A beta) are the main component of the senile plaques found in brains of Alzheimer's disease patients. We present the structure of an A beta(1-42) fibril composed of two intertwined protofilaments determined by cryo-electron microscopy (cryo-EM) to 4.0-angstrom resolution, complemented by solid-state nuclear magnetic resonance experiments. The backbone of all 42 residues and nearly all side chains are well resolved in the EM density map, including the entire N terminus, which is part of the cross-beta structure resulting in an overall "LS"-shaped topology of individual subunits. The dimer interface protects the hydrophobic C termini from the solvent. The characteristic staggering of the nonplanar subunits results in markedly different fibril ends, termed "groove" and "ridge," leading to different binding pathways on both fibril ends, which has implications for fibril growth.	[Gremer, Lothar; Schoelzel, Daniel; Schenk, Carla; Labahn, Joerg; Tusche, Markus; Hoyer, Wolfgang; Heise, Henrike; Willbold, Dieter; Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Gremer, Lothar; Schoelzel, Daniel; Reinartz, Elke; Labahn, Joerg; Hoyer, Wolfgang; Heise, Henrike; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Labahn, Joerg] DESY, CSSB, D-22607 Hamburg, Germany; [Ravelli, Raimond B. G.; Lopez-Iglesias, Carmen] Maastricht Univ, Maastricht Multimodal Mol Imaging Inst, Univ Singel 50, NL-6229 ER Maastricht, Netherlands; [Schroeder, Gunnar F.] Heinrich Heine Univ Dusseldorf, Phys Dept, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; Maastricht University; Heinrich Heine University Dusseldorf	Willbold, D; Schroder, GF (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Willbold, D (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.; Schroder, GF (corresponding author), Heinrich Heine Univ Dusseldorf, Phys Dept, D-40225 Dusseldorf, Germany.	d.willbold@fz-juelich.de; gu.schroeder@fz-juelich.de	Gremer, Lothar/H-9128-2013; Willbold, Dieter/A-6280-2013; Heise, Henrike/A-7703-2010; Schröder, Gunnar F/H-5261-2013; Hoyer, Wolfgang/H-6193-2013; Labahn, Jorg/G-9593-2013	Gremer, Lothar/0000-0001-7065-5027; Willbold, Dieter/0000-0002-0065-7366; Heise, Henrike/0000-0002-9081-3894; Schröder, Gunnar F/0000-0003-1803-5431; Hoyer, Wolfgang/0000-0003-4301-5416; Labahn, Jorg/0000-0002-0648-8145; Ravelli, Raimond/0000-0001-6056-5888	M4I Division of Nanoscopy of Maastricht University; Portfolio Technology and Medicine of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; Portfolio Drug Design of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; Deutsche Forschungsgemeinschaft (DFG) [HE 3243/4-1]; European Research Council (ERC) Consolidator Grant [726368]	M4I Division of Nanoscopy of Maastricht University; Portfolio Technology and Medicine of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; Portfolio Drug Design of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council (ERC) Consolidator Grant(European Research Council (ERC))	The authors gratefully acknowledge the continued support of D. Riesner and G. Buldt. We thank P. J. Peters for advice and helpful discussions, H. Duimel for help with sample preparation, and the M4I Division of Nanoscopy of Maastricht University for microscope access and support. The authors gratefully acknowledge the computing time granted by the Julich Aachen Research Alliance High-Peformance Computing (JARA-HPC) Vergabegremium and VSR commission on the supercomputer JURECA at Forschungszentrum Julich. Computational support and infrastructure was provided by the Center for Information and Media Technology (ZIM) at the University of Dusseldorf (Germany). The authors acknowledge access to the Julich-Dusseldorf Biomolecular NMR Center. D.W. was supported by grants from the Portfolio Technology and Medicine, the Portfolio Drug Design, and the Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft. D.W. is a paid scientific advisor for the Institut de Biologie Structurale (IBS), CEA, DSV, IBS, 38027 Grenoble (France). H.H. was supported by the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf and by the Deutsche Forschungsgemeinschaft (DFG) (HE 3243/4-1). Support from an European Research Council (ERC) Consolidator Grant (grant agreement no. 726368) to W.H. is acknowledged. The 4.0-angstrom EM density map of the A beta(1-42) fibril has been deposited in the Electron Microscopy Data Bank with accession code EMD-3851; the coordinates of the atomic model have been deposited in the Protein Data Bank under accession code 5OQV. The NMR data have been deposited in the Biological Magnetic Resonance Data Bank (BMRB) under accession number 27212. The authors declare no competing financial interests.	Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Fandrich M, 2009, PRION, V3, P89; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Inoue Y, 2001, J BIOL CHEM, V276, P35227, DOI 10.1074/jbc.C100304200; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Lopez del Amo JM, 2012, ANGEW CHEM INT EDIT, V51, P6136, DOI 10.1002/anie.201200965; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	20	506	511	16	293	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2017	358	6359					116	+		10.1126/science.aao2825	http://dx.doi.org/10.1126/science.aao2825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WF	28882996	Green Accepted, Green Published			2022-12-28	WOS:000412359600065
J	Stephenson, T				Stephenson, Terence			On revalidation the GMC is listening to you The GMC is often the misguided target for the ire of those frustrated by the burden of regulation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stephenson, Terence] Gen Med Council, London, England		Stephenson, T (corresponding author), Gen Med Council, London, England.	chair@gmc-uk.org		Stephenson, Terence/0000-0001-8871-7847				Pearson K., 2017, BMJ	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2017	358								j4215	10.1136/bmj.j4215	http://dx.doi.org/10.1136/bmj.j4215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH6MX	28899905	Green Submitted			2022-12-28	WOS:000411292200004
J	Stephenson, R; Gonsalves, L; Askew, I; Say, L				Stephenson, Rob; Gonsalves, Lianne; Askew, Ian; Say, Lale		WHO Working Grp	Detangling and detailing sexual health in the SDG era	LANCET			English	Editorial Material									[Stephenson, Rob] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Stephenson, Rob] Univ Michigan, Ctr Sexual & Hlth Dispar, Ann Arbor, MI 48109 USA; [Gonsalves, Lianne; Askew, Ian; Say, Lale] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; World Health Organization	Say, L (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	sayl@who.int	, lalesay/AAG-1912-2021	Gonsalves, Lianne/0000-0003-2409-5043	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Department for Economic and Social Information and Policy Analysis, 1994, INT C POP DEV; Hawkes S, 2014, LANCET GLOB HEALTH, V2, pE377, DOI 10.1016/S2214-109X(14)70036-1; WHO, 2002, DEF SEX HLTH REP TEC, P28; World Health Organization, 2015, OPERATIONAL FRAMEWOR; World Health Organization, 2010, DEV SEX HLTH PROGR F; World Health Organization, 2017, SEX HLTH ITS LINK RE; World Health Organization, 2004, REPR HLTH STRAT ACC	7	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1014	1015		10.1016/S0140-6736(17)32294-8	http://dx.doi.org/10.1016/S0140-6736(17)32294-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28877852				2022-12-28	WOS:000409528600009
J	Bohn, JL; Rey, AM; Ye, J				Bohn, John L.; Rey, Ana Maria; Ye, Jun			Cold molecules: Progress in quantum engineering of chemistry and quantum matter	SCIENCE			English	Review							BOSE-EINSTEIN CONDENSATION; MANY-BODY PHYSICS; POLAR-MOLECULES; OPTICAL LATTICE; STATISTICAL-MECHANICS; INELASTIC-COLLISIONS; DIPOLAR COLLISIONS; CHEMICAL-REACTIONS; DIATOMIC MOLECULE; ULTRACOLD GASES	Cooling atoms to ultralow temperatures has produced a wealth of opportunities in fundamental physics, precision metrology, and quantum science. The more recent application of sophisticated cooling techniques to molecules, which has been more challenging to implement owing to the complexity of molecular structures, has now opened the door to the longstanding goal of precisely controlling molecular internal and external degrees of freedom and the resulting interaction processes. This line of research can leverage fundamental insights into how molecules interact and evolve to enable the control of reaction chemistry and the design and realization of a range of advanced quantum materials.	[Bohn, John L.; Rey, Ana Maria; Ye, Jun] NIST, JILA, Boulder, CO 80309 USA; Univ Colorado Boulder, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Bohn, JL; Rey, AM; Ye, J (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	bohn@murphy.colorado.edu; arey@jilau1.colorado.edu; ye@jila.colorado.edu	Ye, Jun/C-3312-2011	Ye, Jun/0000-0003-0076-2112; YE, JUN/0000-0003-3702-7445	Army Research Office Multidisciplinary University Research Initiative (MURI); Air Force Office of Scientific Research MURI; Gordon and Betty Moore Foundation; National Institute of Standards and Technology; NSF [PHY-1734006, PHY-1521080]	Army Research Office Multidisciplinary University Research Initiative (MURI)(MURI); Air Force Office of Scientific Research MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NSF(National Science Foundation (NSF))	We gratefully acknowledge many of our colleagues, both in and out of JILA, for their collaborations, discussions, and suggestions. We thank D. Reens, J. Bollinger, and R. Nandkishore for their comments on the paper. We acknowledge funding support for the work from the Army Research Office Multidisciplinary University Research Initiative (MURI), the Air Force Office of Scientific Research MURI, the Gordon and Betty Moore Foundation, the National Institute of Standards and Technology, NSF cooperative agreement PHY-1734006 supporting the JILA Physics Frontiers Center, and NSF grant PHY-1521080.	Anderegg L., 2017, ARXIV170510288PHYSIC; Baier S, 2016, SCIENCE, V352, P201, DOI 10.1126/science.aac9812; Balakrishnan N, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4964096; Balakrishnan N, 2004, J CHEM PHYS, V121, P5563, DOI 10.1063/1.1799571; Balakrishnan N, 2001, CHEM PHYS LETT, V341, P652, DOI 10.1016/S0009-2614(01)00515-2; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Baranov MA, 2008, PHYS REP, V464, P71, DOI 10.1016/j.physrep.2008.04.007; Baranov MA, 2012, CHEM REV, V112, P5012, DOI 10.1021/cr2003568; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Bjork BJ, 2016, SCIENCE, V354, P444, DOI 10.1126/science.aag1862; Bloch I, 2005, NAT PHYS, V1, P23, DOI 10.1038/nphys138; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Byrd JN, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032711; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; CHAO KA, 1977, J PHYS C SOLID STATE, V10, pL271, DOI 10.1088/0022-3719/10/10/002; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Chiu CK, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035005; Chotia A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.080405; Covey JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11279; Cui J, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073202; D'Alessio L, 2016, ADV PHYS, V65, P239, DOI 10.1080/00018732.2016.1198134; Dalfovo F, 1999, REV MOD PHYS, V71, P463, DOI 10.1103/RevModPhys.71.463; Dalibard J, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1523; Danzl JG, 2010, NAT PHYS, V6, P265, DOI 10.1038/NPHYS1533; de Miranda MHG, 2011, NAT PHYS, V7, P502, DOI [10.1038/NPHYS1939, 10.1038/nphys1939]; de Paz A, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.021603; de Paz A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185305; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Devlin JA, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/12/123017; Di Rosa MD, 2004, EUR PHYS J D, V31, P395, DOI 10.1140/epjd/e2004-00167-2; Fabrikant MI, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.033418; Fleisher AJ, 2014, J PHYS CHEM LETT, V5, P2241, DOI 10.1021/jz5008559; Gadway B, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/152002; Gilijamse JJ, 2006, SCIENCE, V313, P1617, DOI 10.1126/science.1131867; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Goldman N, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/12/126401; Gorshkov AV, 2013, MOL PHYS, V111, P1908, DOI 10.1080/00268976.2013.800604; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115301; Guo MY, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.205303; Hazzard KRA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.195302; Hemmerling B, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/17/174001; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Hoekstra S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.063408; Hummon MT, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.143001; Hutzler NR, 2012, CHEM REV, V112, P4803, DOI 10.1021/cr200362u; Janssen LMC, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3268920; Kim JB, 2015, SCIENCE, V349, P510, DOI 10.1126/science.aac6939; Klein A, 2017, NAT PHYS, V13, P35, DOI [10.1038/nphys3904, 10.1038/NPHYS3904]; Kleinpoppen H., 2013, SPRINGER SERIES ATOM; Krems R V, 2009, COLD MOL THEORY EXPT; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lavert-Ofir E, 2014, NAT CHEM, V6, P332, DOI [10.1038/NCHEM.1857, 10.1038/nchem.1857]; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lemeshko M, 2013, MOL PHYS, V111, P1648, DOI 10.1080/00268976.2013.813595; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Lin JJ, 2003, REV SCI INSTRUM, V74, P2495, DOI 10.1063/1.1561604; Low R, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/11/113001; Manmana SR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.081106; Mayle M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012709; Micheli A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043604; Micheli A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.073202; Molony PK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.255301; Moses SA, 2017, NAT PHYS, V13, P13, DOI 10.1038/nphys3985; Moses SA, 2015, SCIENCE, V350, P659, DOI 10.1126/science.aac6400; Mukherjee N, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3599711; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Neyenhuis B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.230403; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ni KK, 2010, NATURE, V464, P1324, DOI 10.1038/nature08953; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; Park J. W., 2016, ARXIV160604184V1COND; Park JW, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.205302; Peter D, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.053617; Prehn A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.063005; Pupillo G., 2009, COLD MOL THEORY EXPT, P421; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Quemener G, 2012, CHEM REV, V112, P4949, DOI 10.1021/cr300092g; Quemener G, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.012705; Randeria M, 2014, ANNU REV CONDEN MA P, V5, P209, DOI 10.1146/annurev-conmatphys-031113-133829; Reens D., 2017, ARXIV170602806PHYSIC; Reichsollner L, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.073201; Rieger T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.173002; Safavi-Naini A, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.063416; Sawyer BC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253002; Sawyer BC, 2011, PHYS CHEM CHEM PHYS, V13, P19059, DOI 10.1039/c1cp21203f; Sawyer BC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203203; Scoles G., 1988, ATOMIC MOL BEAM METH, V1; Shapiro M., 2012, QUANTUM CONTROL MOL; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Simbotin I, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/6/065003; Singh V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.203201; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Stuhl BK, 2012, NATURE, V492, P396, DOI 10.1038/nature11718; Stuhl BK, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243002; Syzranov SV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13543; Syzranov SV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6391; Takekoshi T, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032506; Teslja A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2354466; Truppe S., 2017, ARXIV170300580PHYSIC; Tscherbul TV, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.023201; Van De Meerakker SYT, 2008, NAT PHYS, V4, P595, DOI 10.1038/nphys1031; von Zastrow A, 2014, NAT CHEM, V6, P216, DOI [10.1038/nchem.1860, 10.1038/NCHEM.1860]; Wall M. L., 2014, ATOMIC MESOSCALE, P3; Will SA, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.225306; Willitsch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043203; Yan B, 2013, NATURE, V501, P521, DOI 10.1038/nature12483; Yao NY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.266804; Yao N. Y., 2015, ARXIV151006403CONDMA; Zhai H, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/2/026001; Zhu B, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.070404; Zuchowski PS, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.060703	114	225	227	9	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1002	1010		10.1126/science.aam6299	http://dx.doi.org/10.1126/science.aam6299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883071	Green Submitted			2022-12-28	WOS:000409455700038
J	DeMeo, F				DeMeo, Francesca			Meet the primordial asteroid family	SCIENCE			English	Editorial Material									[DeMeo, Francesca] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	DeMeo, F (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	fdemeo@mit.edu			National Aeronautics and Space Administration [NNX12AL26G]	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	F.D. is supported by the National Aeronautics and Space Administration under grant no. NNX12AL26G issued through the Planetary Astronomy Program.	Bottke WF, 2005, ICARUS, V175, P111, DOI 10.1016/j.icarus.2004.10.026; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; Delbo M, 2017, SCIENCE, V357, P1026, DOI 10.1126/science.aam6036; Hirayama K., 1918, ASTRON J, V31, P185, DOI [10.1086/104299, DOI 10.1086/104299]; Johansen A, 2007, NATURE, V448, P1022, DOI 10.1038/nature06086; Johansen A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500109; Klahr H., 2016, IAU S, V318, P1; Kruijer TS, 2017, P NATL ACAD SCI USA, V114, P6712, DOI 10.1073/pnas.1704461114; Nesvorny D., 2015, ASTEROIDS; Simon JB, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/1/55	11	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		972	973		10.1126/science.aao1141	http://dx.doi.org/10.1126/science.aao1141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883059				2022-12-28	WOS:000409455700025
J	DeMille, D; Doyle, JM; Sushkov, AO				DeMille, David; Doyle, John M.; Sushkov, Alexander O.			Probing the frontiers of particle physics with tabletop-scale experiments	SCIENCE			English	Review							DARK-MATTER; CONSTRAINTS; CONSTANT; LIMIT	The field of particle physics is in a peculiar state. The standard model of particle theory successfully describes every fundamental particle and force observed in laboratories, yet fails to explain properties of the universe such as the existence of dark matter, the amount of dark energy, and the preponderance of matter over antimatter. Huge experiments, of increasing scale and cost, continue to search for new particles and forces that might explain these phenomena. However, these frontiers also are explored in certain smaller, laboratory-scale "tabletop" experiments. This approach uses precision measurement techniques and devices from atomic, quantum, and condensed-matter physics to detect tiny signals due to new particles or forces. Discoveries in fundamental physics may well come first from small-scale experiments of this type.	[DeMille, David] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Doyle, John M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Sushkov, Alexander O.] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Sushkov, Alexander O.] Boston Univ, Photon Ctr, 8 St Marys St, Boston, MA 02215 USA	Yale University; Harvard University; Boston University; Boston University	DeMille, D (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.; Doyle, JM (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Sushkov, AO (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.; Sushkov, AO (corresponding author), Boston Univ, Photon Ctr, 8 St Marys St, Boston, MA 02215 USA.	david.demille@yale.edu; doyle@physics.harvard.edu; asu@bu.edu	Sushkov, Alexander/AAJ-1720-2021		NSF [PHY1404146]; John Templeton Foundation [58468]; Heising-Simons Foundation [2016-035]; Alfred P. Sloan Foundation [FG-2016-6728]	NSF(National Science Foundation (NSF)); John Templeton Foundation; Heising-Simons Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	D.D. acknowledges support by NSF grant PHY1404146, the John Templeton Foundation grant 58468, and the Heising-Simons Foundation grant 2016-035. J.M.D. acknowledges support by NSF grant PHY1404146. A.O.S. acknowledges support by the Heising-Simons Foundation grant 2015-039 and the Alfred P. Sloan Foundation grant FG-2016-6728.	Akerib DS, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.021303; Anastassopoulos V, 2017, NAT PHYS, V13, P584, DOI [10.1038/NPHYS4109, 10.1038/nphys4109]; Baak M, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2205-9; Baron J, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa708e; BARR SM, 1993, INT J MOD PHYS A, V8, P209, DOI 10.1142/S0217751X93000096; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Berengut JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120801; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Bishof M, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.025501; Brubaker BM, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.061302; Budker D, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021030; Cairncross W. B., 2017, ARXIV170407928PHYSIC; Caldwell RR, 2009, ANNU REV NUCL PART S, V59, P397, DOI 10.1146/annurev-nucl-010709-151330; Canetti L, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/095012; Carosi G., 2017, 13 PATR WORKSH AX WM; Chung DJH, 2005, PHYS REP, V407, P1, DOI 10.1016/j.physrep.2004.08.032; Cingoz A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.040801; DeMille D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043202; Derevianko A, 2014, NAT PHYS, V10, P933, DOI 10.1038/NPHYS3137; Dine M, 2004, REV MOD PHYS, V76, P1, DOI 10.1103/RevModPhys.76.1; Ehret K, 2010, PHYS LETT B, V689, P149, DOI 10.1016/j.physletb.2010.04.066; Engel J, 2013, PROG PART NUCL PHYS, V71, P21, DOI 10.1016/j.ppnp.2013.03.003; Feng JL, 2013, ANNU REV NUCL PART S, V63, P351, DOI 10.1146/annurev-nucl-102010-130447; Flambaum VV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.092502; Flambaum VV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150801; Frieman JA, 2008, ANNU REV ASTRON ASTR, V46, P385, DOI 10.1146/annurev.astro.46.060407.145243; Gabrielse G, 2013, PHYS TODAY, V66, P64, DOI 10.1063/PT.3.2223; Graham PW, 2015, ANNU REV NUCL PART S, V65, P485, DOI 10.1146/annurev-nucl-102014-022120; Graner B, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.161601; Hamilton P, 2015, SCIENCE, V349, P849, DOI 10.1126/science.aaa8883; Hosten O, 2016, NATURE, V529, P505, DOI 10.1038/nature16176; Huntemann N, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.210802; Joyce A, 2015, PHYS REP, V568, P1, DOI 10.1016/j.physrep.2014.12.002; Kanekar N, 2015, MON NOT R ASTRON SOC, V448, pL104, DOI 10.1093/mnrasl/slu206; Khachatryan V, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.021802; Leefer N, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.271601; Liu JL, 2017, NAT PHYS, V13, P212, DOI 10.1038/nphys4039; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Morrissey DE, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/125003; Murphy MT, 2016, MON NOT R ASTRON SOC, V461, P2461, DOI 10.1093/mnras/stw1482; Nakai Y, 2017, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2017)031; Nisati A., 2017, DISCOVERY H BOSON, P103; Peik E, 2003, EUROPHYS LETT, V61, P181, DOI 10.1209/epl/i2003-00210-x; RAMSEY NF, 1958, PHYS REV, V109, P225, DOI 10.1103/PhysRev.109.225; SAKHAROV AD, 1967, JETP LETT-USSR, V5, P24; Sikivie P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.131301; SIKIVIE P, 1983, PHYS REV LETT, V51, P1415, DOI 10.1103/PhysRevLett.51.1415; Svrcek P., 2006, J HIGH ENERGY PHYS, V06, P051; Tarbutt MR, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/053034; Uzan JP, 2011, LIVING REV RELATIV, V14, DOI 10.12942/lrr-2011-2; WEINBERG S, 1989, REV MOD PHYS, V61, P1, DOI 10.1103/RevModPhys.61.1; WEINBERG S, 1978, PHYS REV LETT, V40, P223, DOI 10.1103/PhysRevLett.40.223; WILCZEK F, 1978, PHYS REV LETT, V40, P279, DOI 10.1103/PhysRevLett.40.279; Zelevinsky T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043201	56	85	86	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		990	994		10.1126/science.aal3003	http://dx.doi.org/10.1126/science.aal3003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883069				2022-12-28	WOS:000409455700036
J	McCormick, S; Simmens, SJ; Glicksman, RL; Paddock, L; Kim, D; Whited, B; Davies, W				McCormick, Sabrina; Simmens, Samuel J.; Glicksman, Robert L.; Paddock, Leroy; Kim, Daniel; Whited, Brittany; Davies, William			Science in litigation, the third branch of US climate policy	SCIENCE			English	Editorial Material									[McCormick, Sabrina; Simmens, Samuel J.; Whited, Brittany] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA; [Glicksman, Robert L.; Paddock, Leroy; Davies, William] George Washington Univ, Sch Law, Washington, DC 20052 USA; [Kim, Daniel] George Washington Univ, Trachtenberg Sch Publ Policy & Publ Adm, Washington, DC 20052 USA	George Washington University; George Washington University; George Washington University	McCormick, S (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC 20052 USA.	sabmc@gwu.edu		Simmens, Samuel/0000-0001-7830-8003				Abate R. S., 2014, WM MARY ENV L POLICY, V33, P121; [Anonymous], 2011, GREATER YELLOWSTONE; [Anonymous], 2007, GREEN MOUNTAIN CHR S; Bach T., 2016, VT LAW REV, V40, P1; Banda M. L., 2017, ENV LAW I, V2, P10121; Colombo E. J., 2017, ENVIRON LAW, V35, P98; Mank B. C., 2009, J ENVIRON LAW, V34, P513; MARKELL D., 2012, FLA LAW REV, V64, P15; Najafi MR, 2016, CLIMATIC CHANGE, V136, P571, DOI 10.1007/s10584-016-1632-2; Rodgers Jr W. H, 2016, WASH J ENV LAW POLIC, V6, P533; Verheyen R, 2015, INT J GLOBAL WARM, V8, P158, DOI 10.1504/IJGW.2015.071968; Wilensky M., 2015, DUKE ENVTL L POL F, P131	12	10	10	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		979	980		10.1126/science.aao0412	http://dx.doi.org/10.1126/science.aao0412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883064				2022-12-28	WOS:000409455700030
J	Voosen, P				Voosen, Paul			SPACE POLICY Oklahoma politician picked to lead NASA back to the moon	SCIENCE			English	News Item																			0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		957	957		10.1126/science.357.6355.957	http://dx.doi.org/10.1126/science.357.6355.957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883054				2022-12-28	WOS:000409455700012
J	Liew, HM; Chong, JH				Liew, Hui Min; Chong, Jin Ho			CASE REVIEW Peri-orificial rash in an infant	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Liew, Hui Min; Chong, Jin Ho] KK Womens & Childrens Hosp, Dermatol, Singapore, Singapore	KK Women's & Children's Hospital	Liew, HM (corresponding author), KK Womens & Childrens Hosp, Dermatol, Singapore, Singapore.	liew.hui.min@singhealth.com.sg						Choua G, 2014, INT J CHILD HEALTH N, V3, P48, DOI 10.6000/1929-4247.2014.03.01.6; Corbo MD, 2013, J AM ACAD DERMATOL, V69, P616, DOI 10.1016/j.jaad.2013.04.028; Eichenfield LF, 2016, NEONATAL INFANT DERM; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Jen M, 2010, CLIN DERMATOL, V28, P669, DOI 10.1016/j.clindermatol.2010.03.029; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Maverakis E, 2007, J AM ACAD DERMATOL, V56, P116, DOI 10.1016/j.jaad.2006.08.015	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j3606	10.1136/bmj.j3606	http://dx.doi.org/10.1136/bmj.j3606			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EM	28882982				2022-12-28	WOS:000410576200002
J	Kakkar, M; Sharma, A; Vong, S				Kakkar, Manish; Sharma, Anuj; Vong, Sirenda			Developing a situation analysis tool to assess containment of antimicrobial resistance in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kakkar, Manish; Sharma, Anuj; Vong, Sirenda] WHO, Off South East Asia Reg, New Delhi, India	World Health Organization	Vong, S (corresponding author), WHO, Off South East Asia Reg, New Delhi, India.	vongs@who.int						Chereau F, 2017, BMJ-BRIT MED J, V358, P2, DOI 10.1136/bmj.j3393; Global Health Security Agenda, 2014, ACT PACK; IHR Monitoring and Evaluation Framework, 2005, JOINT EXT EV TOOL, P2016; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; ONeill J., 2014, REV ANTIMICROB RESIS; Ulin PR, 2005, QUALITATIVE METHODS; Vong S, 2016, B WORLD HEALTH ORGAN, V94, P913, DOI 10.2471/BLT.16.174441; Wallace, 2005, FMHI PUBLICATION, V231; WHO, 2005, INT HLTH REG, V3rd; WHO, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2016, NAT ACT PLANS NAP; World Health Organization, EM SPREAD ANT RES DR; World Health Organization, 2015, WORLDW COUNTR AN RES; World Health Organization, 2005, TECHN CONS MON EV FU	15	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						14	19	j3760	10.1136/bmj.j3760	http://dx.doi.org/10.1136/bmj.j3760			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874347	Green Published, hybrid			2022-12-28	WOS:000410575100011
J	Makri, A				Makri, Anita			Research Focus Robert Koch Institut: towards digital epidemiology	LANCET			English	Editorial Material																			0	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					833	833		10.1016/S0140-6736(17)32278-X	http://dx.doi.org/10.1016/S0140-6736(17)32278-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28850035				2022-12-28	WOS:000408330700009
J	Cross, R				Cross, Ryan			The inside story on 20,000 vertebrates	SCIENCE			English	News Item																			0	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					742	743		10.1126/science.357.6353.742	http://dx.doi.org/10.1126/science.357.6353.742			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839053				2022-12-28	WOS:000408327900017
J	Letourneau, AR; Price, MC; Azar, MM				Letourneau, Alyssa R.; Price, Melissa C.; Azar, Marwan M.			Case 26-2017: A 63-Year-Old Woman with Fever, Hypotension, and Hypoxemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORGAN-TRANSPLANT RECIPIENTS; INFECTION		[Letourneau, Alyssa R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Price, Melissa C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Azar, Marwan M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Letourneau, Alyssa R.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Price, Melissa C.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Azar, Marwan M.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Letourneau, AR (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Azar, Marwan/AAE-9784-2020					de Maar E F, 2003, Transpl Infect Dis, V5, P112, DOI 10.1034/j.1399-3062.2003.00023.x; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Humar A, 1999, TRANSPLANTATION, V68, P1305, DOI 10.1097/00007890-199911150-00015; Kelesidis T, 2011, INT J INFECT DIS, V15, pE2, DOI 10.1016/j.ijid.2010.03.025; Koo S, 2010, INFECT DIS CLIN N AM, V24, P285, DOI 10.1016/j.idc.2010.01.006; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Liao TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153217; Razonable RR, 2002, J CLIN MICROBIOL, V40, P746, DOI 10.1128/JCM.40.3.746-752.2002	9	0	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					770	778		10.1056/NEJMcpc1616402	http://dx.doi.org/10.1056/NEJMcpc1616402			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28834480				2022-12-28	WOS:000413090000011
J	Ridker, PM; MacFadyen, JG; Thuren, T; Everett, BM; Libby, P; Glynn, RJ				Ridker, Paul M.; MacFadyen, Jean G.; Thuren, Tom; Everett, Brendan M.; Libby, Peter; Glynn, Robert J.		CANTOS Trial Grp	Effect of interleukin-1 beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							C-REACTIVE PROTEIN; TUMOR INVASIVENESS; ANTAGONIST GENE; INFLAMMATION; RISK; PREVENTION; POLYMORPHISMS; RECEPTOR; DISEASE; IL-1	Background Inflammation in the tumour microenvironment mediated by interleukin 1 beta is hypothesised to have a major role in cancer invasiveness, progression, and metastases. We did an additional analysis in the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS), a randomised trial of the role of interleukin-1 beta inhibition in atherosclerosis, with the aim of establishing whether inhibition of a major product of the Nod-like receptor protein 3 (NLRP3) inflammasome with canakinumab might alter cancer incidence. Methods We did a randomised, double-blind, placebo-controlled trial of canakinumab in 10 061 patients with atherosclerosis who had had a myocardial infarction, were free of previously diagnosed cancer, and had concentrations of high-sensitivity C-reactive protein (hsCRP) of 2 mg/L or greater. To assess dose-response effects, patients were randomly assigned by computer-generated codes to three canakinumab doses (50 mg, 150 mg, and 300 mg, subcutaneously every 3 months) or placebo. Participants were followed up for incident cancer diagnoses, which were adjudicated by an oncology endpoint committee masked to drug or dose allocation. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, NCT01327846. The trial is closed (the last patient visit was in June, 2017). Findings Baseline concentrations of hsCRP (median 6.0 mg/L vs 4 . 2 mg/L; p<0.0001) and interleukin 6 (3.2 vs 2.6 ng/L; p<0.0001) were significantly higher among participants subsequently diagnosed with lung cancer than among those not diagnosed with cancer. During median follow-up of 3.7 years, compared with placebo, canakinumab was associated with dose-dependent reductions in concentrations of hsCRP of 26-41% and of interleukin 6 of 25-43% (p<0.0001 for all comparisons). Total cancer mortality (n=196) was significantly lower in the pooled canakinumab group than in the placebo group (p=0.0007 for trend across groups), but was significantly lower than placebo only in the 300 mg group individually (hazard ratio [HR] 0.49 [95% CI 0.31-0.75]; p=0.0009). Incident lung cancer (n=129) was significantly less frequent in the 150 mg (HR 0.61 [95% CI 0.39-0.97]; p=0.034) and 300 mg groups (HR 0.33 [95% CI 0.18-0.59]; p<0.0001; p<0.0001 for trend across groups). Lung cancer mortality was significantly less common in the canakinumab 300 mg group than in the placebo group (HR 0.23 [95% CI 0.10-0.54]; p=0.0002) and in the pooled canakinumab population than in the placebo group (p=0.0002 for trend across groups). Fatal infections or sepsis were significantly more common in the canakinumab groups than in the placebo group. All-cause mortality did not differ significantly between the canakinumab and placebo groups (HR 0.94 [95% CI 0.83-1.06]; p=0.31). Interpretation Our hypothesis-generating data suggest the possibility that anti-inflammatory therapy with canakinumab targeting the interleukin-1 beta innate immunity pathway could significantly reduce incident lung cancer and lung cancer mortality. Replication of these data in formal settings of cancer screening and treatment is required.	[Ridker, Paul M.; MacFadyen, Jean G.; Everett, Brendan M.; Glynn, Robert J.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA USA; [Ridker, Paul M.; Everett, Brendan M.; Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA; [Thuren, Tom] Novartis Pharmaceut, E Hanover, NJ USA; [Thuren, Tom] Novartis Pharmaceut, Basel, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Novartis	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	pridker@partners.org	Nicolau, Jose C/E-1487-2012; Libby, Peter/AAY-6404-2021; cornel, jan hein/Y-7065-2019; Khromtsova, Oksana M./F-4530-2018; Urina-Triana, Miguel A/H-2605-2016; Cioffi, Angela/Q-4622-2016	Nicolau, Jose C/0000-0002-9680-3689; Libby, Peter/0000-0002-1502-502X; cornel, jan hein/0000-0002-1006-2112; Khromtsova, Oksana M./0000-0003-0763-0542; Urina-Triana, Miguel A/0000-0001-6003-4622; Hwang, Juey-Jen/0000-0001-6437-0455; Sinnaeve, Peter/0000-0003-4716-5892; Cheng, Susan/0000-0002-4977-036X; Cioffi, Angela/0000-0001-8290-6815; Pella, Daniel/0000-0001-9999-6271; Shimokawa, Hiroaki/0000-0001-7534-4826; Ballantyne, Christie/0000-0002-6432-1730; Koenig, Wolfgang/0000-0002-2064-9603; Costa Duarte Barbosa, Eduardo/0000-0002-4361-936X	Novartis Pharmaceuticals; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS073806] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Novartis Pharmaceuticals.	Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bhat IA, 2014, META GENE, V2, P123, DOI 10.1016/j.mgene.2013.12.002; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Chaturvedi AK, 2010, J CLIN ONCOL, V28, P2719, DOI 10.1200/JCO.2009.27.0454; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hong DS, 2014, LANCET ONCOL, V15, P656, DOI 10.1016/S1470-2045(14)70155-X; Hu ZB, 2006, CANCER LETT, V236, P269, DOI 10.1016/j.canlet.2005.05.015; Lee JM, 2008, CRIT REV ONCOL HEMAT, V66, P208, DOI 10.1016/j.critrevonc.2008.01.004; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Lind H, 2005, LUNG CANCER, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, N ENGL J ME IN PRESS; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Zienolddiny S, 2004, INT J CANCER, V109, P353, DOI 10.1002/ijc.11695	33	655	678	6	158	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1833	1842		10.1016/S0140-6736(17)32247-X	http://dx.doi.org/10.1016/S0140-6736(17)32247-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK1LY	28855077	Green Accepted			2022-12-28	WOS:000413244500024
J	Sibbing, D; Aradi, D; Jacobshagen, C; Gross, L; Trenk, D; Geisler, T; Orban, M; Hadamitzky, M; Merkely, B; Kiss, RG; Komocsi, A; Dezsi, CA; Holdt, L; Felix, SB; Parma, R; Klopotowski, M; Schwinger, RHG; Rieber, J; Huber, K; Neumann, FJ; Koltowski, L; Mehilli, J; Huczek, Z; Massberg, S; Investigators, TA				Sibbing, Dirk; Aradi, Daniel; Jacobshagen, Claudius; Gross, Lisa; Trenk, Dietmar; Geisler, Tobias; Orban, Martin; Hadamitzky, Martin; Merkely, Bela; Kiss, Robert Gabor; Komocsi, Andras; Dezsi, Csaba A.; Holdt, Lesca; Felix, Stephan B.; Parma, Radoslaw; Klopotowski, Mariusz; Schwinger, Robert H. G.; Rieber, Johannes; Huber, Kurt; Neumann, Franz-Josef; Koltowski, Lukasz; Mehilli, Julinda; Huczek, Zenon; Massberg, Steffen; Investigators, TROPICAL-ACS			Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial	LANCET			English	Article							DIPHOSPHATE RECEPTOR INHIBITOR; MYOCARDIAL-INFARCTION PATIENTS; PLATELET REACTIVITY; ELUTING STENTS; TREATMENT PATTERNS; CLOPIDOGREL; PRASUGREL; TICAGRELOR; OUTCOMES; THERAPY	Background Current guidelines recommend potent platelet inhibition with prasugrel or ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous coronary intervention (PCI). However, the greatest anti-ischaemic benefit of potent antiplatelet drugs over the less potent clopidogrel occurs early, while most excess bleeding events arise during chronic treatment. Hence, a stage-adapted treatment with potent platelet inhibition in the acute phase and de-escalation to clopidogrel in the maintenance phase could be an alternative approach. We aimed to investigate the safety and efficacy of early de-escalation of antiplatelet treatment from prasugrel to clopidogrel guided by platelet function testing (PFT). Methods In this investigator-initiated, randomised, open-label, assessor-blinded, multicentre trial (TROPICAL-ACS) done at 33 sites in Europe, patients were enrolled if they had biomarker-positive acute coronary syndrome with successful PCI and a planned duration of dual antiplatelet treatment of 12 months. Enrolled patients were randomly assigned (1:1) using an internet-based randomisation procedure with a computer-generated block randomisation with stratification across study sites to either standard treatment with prasugrel for 12 months (control group) or a step-down regimen (1 week prasugrel followed by 1 week clopidogrel and PFT-guided maintenance therapy with clopidogrel or prasugrel from day 14 after hospital discharge; guided de-escalation group). The assessors were masked to the treatment allocation. The primary endpoint was net clinical benefit (cardiovascular death, myocardial infarction, stroke or bleeding grade 2 or higher according to Bleeding Academic Research Consortium [BARC]) criteria) 1 year after randomisation (non-inferiority hypothesis; margin of 30%). Analysis was intention to treat. This study is registered with ClinicalTrials. gov, number NCT01959451, and EudraCT, 2013-001636-22. Findings Between Dec 2, 2013, and May 20, 2016, 2610 patients were assigned to study groups; 1304 to the guided de-escalation group and 1306 to the control group. The primary endpoint occurred in 95 patients (7%) in the guided deescalation group and in 118 patients (9%) in the control group (p non-inferiority = 0.0004; hazard ratio [HR] 0.81 [95% CI 0.62-1.06], p superiority = 0.12). Despite early de-escalation, there was no increase in the combined risk of cardiovascular death, myocardial infarction, or stroke in the de-escalation group (32 patients [3%]) versus in the control group (42 patients [3%]; p non-inferiority = 0.0115). There were 64 BARC 2 or higher bleeding events (5%) in the de-escalation group versus 79 events (6%) in the control group (HR 0.82 [95% CI 0.59-1.13]; p=0.23). Interpretation Guided de-escalation of antiplatelet treatment was non-inferior to standard treatment with prasugrel at 1 year after PCI in terms of net clinical benefit. Our trial shows that early de-escalation of antiplatelet treatment can be considered as an alternative approach in patients with acute coronary syndrome managed with PCI.	[Sibbing, Dirk; Gross, Lisa; Orban, Martin; Massberg, Steffen] LMU Munchen, Dept Cardiol, Marchioninistr 15, D-81377 Munich, Germany; [Sibbing, Dirk; Mehilli, Julinda; Massberg, Steffen] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Aradi, Daniel] Semmelweis Univ, Heart Ctr Balatonfured, Budapest, Hungary; [Aradi, Daniel] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Jacobshagen, Claudius] Georg August Univ Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Trenk, Dietmar; Neumann, Franz-Josef] Univ Heart Ctr Freiburg, Dept Cardiol & Angiol 2, Bad Krozingen, Germany; [Geisler, Tobias] Univ Hosp Tubingen, Dept Cardiol & Cardiovasc Dis, Tubingen, Germany; [Hadamitzky, Martin] Deutsch Herzzentrum Munich, Dept Radiol, Munich, Germany; [Merkely, Bela] Univ Semmelweis, Heart & Vasc Ctr, Budapest, Hungary; [Kiss, Robert Gabor] Mil Hosp, Dept Cardiol, Budapest, Hungary; [Komocsi, Andras] Univ Pecs, Heart Inst, Dept Intervent Cardiol, Pecs, Hungary; [Dezsi, Csaba A.] Petz Aladar Cty Teaching Hosp, Dept Cardiol, Gyor, Hungary; [Holdt, Lesca] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Lab Med, Munich, Germany; [Felix, Stephan B.] Univ Med, Dept Internal Med B, Greifswald, Germany; [Felix, Stephan B.] DZHK, Greifswald, Germany; [Parma, Radoslaw] Med Univ Silesia, Dept Cardiol 3, Katowice, Poland; [Klopotowski, Mariusz] Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland; [Schwinger, Robert H. G.] Kliniken Nordoberpfalz AG, Klinikum Weiden, Med Klin II, Weiden, Germany; [Rieber, Johannes] Heart Ctr Munich Bogenhausen, Dept Cardiol & Intens Care Med, Munich, Germany; [Huber, Kurt] Cardiol & Intens Care Med, Med Dept 3, Vienna, Austria; [Huber, Kurt] Sigmund Freud Private Univ, Med Sch, Vienna, Austria; [Koltowski, Lukasz; Huczek, Zenon] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Semmelweis University; Semmelweis University; University of Gottingen; Universitats Herzzentrum Freiburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; German Heart Centre Munich; Semmelweis University; University of Pecs; University of Munich; German Centre for Cardiovascular Research; Medical University Silesia; Institute of Cardiology - Poland; German Heart Centre Munich; Medical University of Warsaw	Sibbing, D (corresponding author), LMU Munchen, Dept Cardiol, Marchioninistr 15, D-81377 Munich, Germany.	dirk.sibbing@med.uni-muenchen.de	Sattler, Stefan/S-9288-2019; Orban, Martin/AAE-6902-2020; Maier, Lars/AAQ-8313-2021; Geisler, Tobias/AAO-4472-2020; Massberg, Steffen/AAN-6054-2021; Munzel, Thomas/A-2912-2014; Parma, Radoslaw/W-6411-2019	Sattler, Stefan/0000-0003-3558-8329; Orban, Martin/0000-0001-9830-1941; Maier, Lars/0000-0001-9915-4429; Munzel, Thomas/0000-0001-5503-4150; Parma, Radoslaw/0000-0002-7304-7315; Merkely, Bela/0000-0001-6514-0723; Malek, Lukasz/0000-0002-9586-0163; Sossalla, Samuel/0000-0001-8034-2673; Haller, Paul/0000-0002-7714-4446; ruzsa, zoltan/0000-0002-2474-5723; Huczek, Zenon/0000-0002-5912-2649	Klinikum der Universitat Munchen; Roche Diagnostics; Eli Lilly; Daiichi Sankyo	Klinikum der Universitat Munchen; Roche Diagnostics; Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited)	Klinikum der Universitat Munchen, Roche Diagnostics, Eli Lilly, and Daiichi Sankyo.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Aradi D, 2015, EUR HEART J, V36, P1762, DOI 10.1093/eurheartj/ehv104; Aradi D, 2014, J AM COLL CARDIOL, V63, P1061, DOI 10.1016/j.jacc.2013.12.023; Bagai A, 2014, CIRC-CARDIOVASC INTE, V7, P585, DOI 10.1161/CIRCINTERVENTIONS.114.001555; Becker RC, 2011, EUR HEART J, V32, P2933, DOI 10.1093/eurheartj/ehr422; Cayla G, 2016, LANCET, V388, P2015, DOI 10.1016/S0140-6736(16)31323-X; Collet JP, 2012, N ENGL J MED; Cuisset T, 2017, EUR HEART J, V38, P3070, DOI 10.1093/eurheartj/ehx175; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Cutlip DE, 2015, JACC-CARDIOVASC INTE, V8, P404, DOI 10.1016/j.jcin.2014.10.017; Czarny MJ, 2014, CLIN CARDIOL, V37, P505, DOI 10.1002/clc.22289; De Luca L, 2017, EUROINTERVENTION, V13, P459, DOI 10.4244/EIJ-D-17-00092; Dery JP, 2016, AM HEART J, V181, P26, DOI 10.1016/j.ahj.2016.07.014; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Karve AM, 2015, AM J CARDIOL, V115, P1502, DOI 10.1016/j.amjcard.2015.02.049; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Montalescot G, PRASUGREL COMPARED C; Motovska Z, 2016, CIRCULATION, V134, P1603, DOI 10.1161/CIRCULATIONAHA.116.024823; Ndrepepa G, 2012, CIRCULATION, V125, P1424, DOI 10.1161/CIRCULATIONAHA.111.060871; Ndrepepa G, 2009, CARDIOLOGY, V113, P198, DOI 10.1159/000201273; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Rezaei SS, 2017, INT J CARDIOL, V235, P61, DOI 10.1016/j.ijcard.2017.02.096; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rollini F, 2016, EUR HEART J, V37, P2722, DOI 10.1093/eurheartj/ehv744; Rollini F, 2016, NAT REV CARDIOL, V13, P11, DOI 10.1038/nrcardio.2015.113; Sibbing D, 2017, THROMB HAEMOSTASIS, V117, P188, DOI 10.1160/TH16-07-0557; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Stone GW, 2009, LANCET, V373, P695, DOI 10.1016/S0140-6736(09)60413-X; Straub N, 2014, THROMB HAEMOSTASIS, V111, P290, DOI 10.1160/TH13-08-0679; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Zettler ME, 2017, AM HEART J, V183, P62, DOI 10.1016/j.ahj.2016.10.006	38	334	354	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1747	1757		10.1016/S0140-6736(17)32155-4	http://dx.doi.org/10.1016/S0140-6736(17)32155-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ6GB	28855078	Green Accepted			2022-12-28	WOS:000412853100027
J	Tsodikov, A; Gulati, R; Heijnsdijk, EAM; Pinsky, PF; Moss, SM; Qiu, S; de Carvalho, TM; Hugosson, J; Berg, CD; Auvinen, A; Andriole, GL; Roobol, MJ; Crawford, ED; Nelen, V; Kwiatkowski, M; Zappa, M; Lujan, M; Villers, A; Feuer, EJ; de Koning, HJ; Mariotto, AB; Etzioni, R				Tsodikov, Alex; Gulati, Roman; Heijnsdijk, Eveline A. M.; Pinsky, Paul F.; Moss, Sue M.; Qiu, Sheng; de Carvalho, Tiago M.; Hugosson, Jonas; Berg, Christine D.; Auvinen, Anssi; Andriole, Gerald L.; Roobol, Monique J.; Crawford, E. David; Nelen, Vera; Kwiatkowski, Maciej; Zappa, Marco; Lujan, Marcos; Villers, Arnauld; Feuer, Eric J.; de Koning, Harry J.; Mariotto, Angela B.; Etzioni, Ruth			Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials	ANNALS OF INTERNAL MEDICINE			English	Article							FOLLOW-UP; RANDOMIZED PROSTATE; LUNG; RECOMMENDATIONS; SURVIVAL; CONTEXT	Background: The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial) found no reduction. Objective: To evaluate whether effects of screening on prostate cancer mortality relative to no screening differed between the ERSPC and PLCO. Design: Cox regression of prostate cancer death in each trial group, adjusted for age and trial. Extended analyses accounted for increased incidence due to screening and diagnostic work-up in each group via mean lead times (MLTs), which were estimated empirically and using analytic or microsimulation models. Setting: Randomized controlled trials in Europe and the United States. Participants: Men aged 55 to 69 (ERSPC) or 55 to 74 (PLCO) years at randomization. Intervention: Prostate cancer screening. Measurements: Prostate cancer incidence and survival from randomization; prostate cancer incidence in the United States before screening began. Results: Estimated MLTs were similar in the ERSPC and PLCO intervention groups but were longer in the PLCO control group than the ERSPC control group. Extended analyses found no evidence that effects of screening differed between trials (P = 0.37 to 0.47 [range across MLT estimation approaches]) but strong evidence that benefit increased with MLT (P = 0.0027 to 0.0032). Screening was estimated to confer a 7% to 9% reduction in the risk for prostate cancer death per year of MLT. This translated into estimates of 25% to 31% and 27% to 32% lower risk for prostate cancer death with screening as performed in the ERSPC and PLCO intervention groups, respectively, compared with no screening. Limitation: The MLT is a simple metric of screening and diagnostic work-up. Conclusion: After differences in implementation and settings are accounted for, the ERSPC and PLCO provide compatible evidence that screening reduces prostate cancer mortality.	[Gulati, Roman; Etzioni, Ruth] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA; [Tsodikov, Alex; Qiu, Sheng] Univ Michigan, Dept Biostat, 1415 Washington Hts, Ann Arbor, MI 48109 USA; [Heijnsdijk, Eveline A. M.; de Carvalho, Tiago M.; de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Pinsky, Paul F.] NCI, Canc Prevent Div, 9609 Med Ctr Dr, Bethesda, MD 20892 USA; [Moss, Sue M.] Queen Mary Univ London, Wolfson Inst, Charterhouse Sq, London EC1M 6BQ, England; [Hugosson, Jonas] Sahlgrens Univ Hosp, Dept Urol, Bla Straket 5, S-41345 Gothenburg, Sweden; [Berg, Christine D.] Johns Hopkins Med, Dept Radiat Oncol & Mol Radiat Sci, 401 North Broadway, Baltimore, MD 21231 USA; [Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, PL-10033014 Tampere, Finland; [Andriole, Gerald L.] Washington Univ, Sch Med, Dept Surg, Div Urol Surg, 4921 Parkview Pl, St Louis, MO USA; [Roobol, Monique J.] Erasmus MC, Dept Urol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Crawford, E. David] Univ Colorado, Urol Oncol, 1665 Aurora Court, Aurora, CO 80045 USA; [Nelen, Vera] Provinciaal Inst Hyg, Kronenburg Str 45, B-2000 Antwerp, Belgium; [Kwiatkowski, Maciej] Kantonsspital Aarau, Dept Urol, CH-5001 Aarau, Switzerland; [Zappa, Marco] Inst Canc Prevent, Unit Epidemiol, Via Oblate 2, I-50141 Florence, Italy; [Lujan, Marcos] Univ Complutense Madrid, Hosp Univ Infanta Cristina, Serv Urol, Ave Nueve Junio 2, Madrid 28981, Spain; [Villers, Arnauld] Univ Lille, CHU Lille, Dept Urol, F-59000 Lille, France; [Feuer, Eric J.; Mariotto, Angela B.] NCI, Div Canc Control & Populat Sci, 9609 Med Ctr Dr, Bethesda, MD 20892 USA	Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Queen Mary University London; Sahlgrenska University Hospital; Johns Hopkins University; Johns Hopkins Medicine; Tampere University; Washington University (WUSTL); Erasmus University Rotterdam; Erasmus MC; University of Colorado System; University of Colorado Anschutz Medical Campus; Kantonsspital Aarau AG (KSA); Complutense University of Madrid; Universite de Lille - ISITE; CHU Lille; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Etzioni, R (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave North,M2-B230,POB 19024, Seattle, WA 98109 USA.	tsodikov@umich.edu; rgulati@fredhutch.org; e.heijnsdijk@erasmusmc.nl; s.moss@qmul.ac.uk; retzioni@fredhutch.org	Auvinen, Anssi/AAD-9311-2020; Gulati, Roman/AAE-4298-2019; Auvinen, Anssi/AAL-2111-2020; zappa, marco/AAB-3294-2019; de+Koning, Harry/AAF-9062-2019; VILLERS, Arnauld/K-6629-2016	Gulati, Roman/0000-0002-7592-6567; Auvinen, Anssi/0000-0003-1125-4818; zappa, marco/0000-0002-6606-9786; de+Koning, Harry/0000-0003-4682-3646; VILLERS, Arnauld/0000-0002-6298-7758	National Cancer Institute Award [U01CA157224]; NATIONAL CANCER INSTITUTE [UM1CA182883, U10CA180834, U01CA157224, U01CA199338] Funding Source: NIH RePORTER	National Cancer Institute Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By National Cancer Institute Award number U01CA157224.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Berg CD, 2011, ACTA ONCOL, V50, P12, DOI 10.3109/0284186X.2010.531283; De Koning HJ, 2003, BJU INT, V92, P112, DOI 10.1111/j.1464-410X.2003.4410x.x; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Gulati R, 2012, CANCER CAUSE CONTROL, V23, P827, DOI 10.1007/s10552-012-9951-8; Jemal A, 2016, JAMA ONCOL, V2, P1657, DOI 10.1001/jamaoncol.2016.2667; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Melnikow J, 2013, MED CARE, V51, P301, DOI 10.1097/MLR.0b013e31828a67d3; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Pinsky PF, 2007, AM J EPIDEMIOL, V165, P874, DOI 10.1093/aje/kwk075; Pinsky PF, 2017, CANCER-AM CANCER SOC, V123, P592, DOI 10.1002/cncr.30474; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Sasieni P, 2017, BIOMETRICS, V73, P473, DOI 10.1111/biom.12578; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208	18	124	129	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					449	+		10.7326/M16-2586	http://dx.doi.org/10.7326/M16-2586			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28869989	Green Accepted			2022-12-28	WOS:000411988900005
J	Mueller, J; Szep, G; Nemethova, M; de Vries, I; Lieber, AD; Winkler, C; Kruse, K; Small, JV; Schmeiser, C; Keren, K; Hauschild, R; Sixt, M				Mueller, Jan; Szep, Gregory; Nemethova, Maria; de Vries, Ingrid; Lieber, Arnon D.; Winkler, Christoph; Kruse, Karsten; Small, J. Victor; Schmeiser, Christian; Keren, Kinneret; Hauschild, Robert; Sixt, Michael			Load Adaptation of Lamellipodial Actin Networks	CELL			English	Article							MEMBRANE TENSION; SELF-ORGANIZATION; ARP2/3 COMPLEX; LEADING-EDGE; MOTILE CELLS; FORCE; PROTRUSION; SHAPE; POLYMERIZATION; MECHANISM	Actin filaments polymerizing against membranes power endocytosis, vesicular traffic, and cell motility. In vitro reconstitution studies suggest that the structure and the dynamics of actin networks respond to mechanical forces. We demonstrate that lamellipodial actin of migrating cells responds to mechanical load when membrane tension is modulated. In a steady state, migrating cell filaments assume the canonical dendritic geometry, defined by Arp2/3-generated 70 degrees branch points. Increased tension triggers a dense network with a broadened range of angles, whereas decreased tension causes a shift to a sparse configuration dominated by filaments growing perpendicularly to the plasma membrane. We show that these responses emerge from the geometry of branched actin: when load per filament decreases, elongation speed increases and perpendicular filaments gradually outcompete others because they polymerize the shortest distance to the membrane, where they are protected from capping. This network-intrinsic geometrical adaptation mechanism tunes protrusive force in response to mechanical load.	[Mueller, Jan; Szep, Gregory; Nemethova, Maria; de Vries, Ingrid; Hauschild, Robert; Sixt, Michael] IST Austria, Campus 1, A-3400 Klosterneuburg, Austria; [Lieber, Arnon D.; Keren, Kinneret] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Lieber, Arnon D.; Keren, Kinneret] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Winkler, Christoph; Schmeiser, Christian] Austrian Acad Sci, RICAM, Apostelgasse 23, A-1030 Vienna, Austria; [Winkler, Christoph; Schmeiser, Christian] Univ Vienna, Fac Math, Oskar Morgenstern Pl 1, A-1090 Vienna, Austria; [Kruse, Karsten] Univ Geneva, Dept Biochem, NCCR Chem Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland; [Kruse, Karsten] Univ Geneva, Dept Theoret Phys, NCCR Chem Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland; [Small, J. Victor] Inst Mol Biotechnol GmbH IMBA, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Keren, Kinneret] Technion Israel Inst Technol, Network Biol Res Labs, IL-32000 Haifa, Israel	Institute of Science & Technology - Austria; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Austrian Academy of Sciences; University of Vienna; University of Geneva; University of Geneva; Technion Israel Institute of Technology	Sixt, M (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	sixt@ist.ac.at	Szep, Grisha/AGK-3747-2022; Kruse, Karsten/GOG-8298-2022	Szep, Grisha/0000-0001-7680-8178; Kruse, Karsten/0000-0001-8665-2349; Keren, Kinneret/0000-0002-2962-6977; Sixt, Michael/0000-0002-6620-9179	European Research Council [ERC StG 281556]; Austrian Science Foundation (FWF); Vienna Science and Technology Fund (WWTF) [LS13-029]; United States-Israel Binational Science Foundation [2013275]; EPSRC [1961111] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Vienna Science and Technology Fund (WWTF); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the scientific support facilities of IST Austria and Biocenter Vienna for technical support and CP Heisenberg for fish lines. This work was supported by the European Research Council (ERC StG 281556), a grant from the Austrian Science Foundation (FWF) (to M.S.), and a grant from Vienna Science and Technology Fund (WWTF) (No. LS13-029 to C.S. and M.S.). Research in the lab of K. Keren was supported by a grant from the United States-Israel Binational Science Foundation (No. 2013275 with Alex Mogilner).	Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bieling P, 2016, CELL, V164, P115, DOI 10.1016/j.cell.2015.11.057; Carlsson AE, 2010, ANNU REV BIOPHYS, V39, P91, DOI 10.1146/annurev.biophys.093008.131207; Demoulin D, 2014, P NATL ACAD SCI USA, V111, P17845, DOI 10.1073/pnas.1414184111; Dickinson RB, 2009, J MATH BIOL, V58, P81, DOI 10.1007/s00285-008-0200-4; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Graziano BR, 2014, CURR OPIN CELL BIOL, V30, P60, DOI 10.1016/j.ceb.2014.06.007; Heinemann F, 2011, BIOPHYS J, V100, P1420, DOI 10.1016/j.bpj.2011.01.063; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lee CT, 2001, J THEOR BIOL, V210, P201, DOI 10.1006/jtbi.2000.2287; Lee K, 2015, CELL SYST, V1, P37, DOI 10.1016/j.cels.2015.07.001; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Lou SS, 2015, J CELL BIOL, V209, P275, DOI 10.1083/jcb.201409001; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; Manhart A, 2015, J THEOR BIOL, V382, P244, DOI 10.1016/j.jtbi.2015.06.044; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Narita A, 2012, J MOL BIOL, V419, P359, DOI 10.1016/j.jmb.2012.03.015; Parekh SH, 2005, NAT CELL BIOL, V7, P1219, DOI 10.1038/ncb1336; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Schaus TE, 2007, P NATL ACAD SCI USA, V104, P7086, DOI 10.1073/pnas.0701943104; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sens P, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/27/273103; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Weichsel J, 2010, P NATL ACAD SCI USA, V107, P6304, DOI 10.1073/pnas.0913730107; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Winkler C, 2012, J STRUCT BIOL, V178, P19, DOI 10.1016/j.jsb.2012.02.011; Ydenberg CA, 2013, CURR BIOL, V23, P1037, DOI 10.1016/j.cub.2013.04.058; Ydenberg CA, 2011, CYTOSKELETON, V68, P596, DOI 10.1002/cm.20543	52	107	108	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					188	+		10.1016/j.cell.2017.07.051	http://dx.doi.org/10.1016/j.cell.2017.07.051			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28867286	Bronze, Green Published			2022-12-28	WOS:000411331800020
J	Madigan, CA; Cambier, CJ; Kelly-Scumpia, KM; Scumpia, PO; Cheng, TY; Zailaa, J; Bloom, BR; Moody, DB; Smale, ST; Sagasti, A; Modlin, RL; Ramakrishnan, L				Madigan, Cressida A.; Cambier, C. J.; Kelly-Scumpia, Kindra M.; Scumpia, Philip O.; Cheng, Tan-Yun; Zailaa, Joseph; Bloom, Barry R.; Moody, D. Branch; Smale, Stephen T.; Sagasti, Alvaro; Modlin, Robert L.; Ramakrishnan, Lalita			A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy	CELL			English	Article							MARINUM INFECTION; REACTIVE OXYGEN; ZEBRAFISH; GRANULOMA; MICROGLIA; SYSTEM; VISUALIZATION; DEMYELINATION; PATHOGENESIS; MYELINATION	Mycobacterium leprae causes leprosy and is unique among mycobacterial diseases in producing peripheral neuropathy. This debilitating morbidity is attributed to axon demyelination resulting from direct interaction of the M. leprae-specific phenolic glycolipid 1 (PGL-1) with myelinating glia and their subsequent infection. Here, we use transparent zebrafish larvae to visualize the earliest events of M. leprae-induced nerve damage. We find that demyelination and axonal damage are not directly initiated by M. leprae but by infected macrophages that patrol axons; demyelination occurs in areas of intimate contact. PGL-1 confers this neurotoxic response on macrophages: macrophages infected with M. marinum-expressing PGL-1 also damage axons. PGL-1 induces nitric oxide synthase in infected macrophages, and the resultant increase in reactive nitrogen species damages axons by injuring their mitochondria and inducing demyelination. Our findings implicate the response of innate macrophages to M. leprae PGL-1 in initiating nerve damage in leprosy.	[Madigan, Cressida A.; Kelly-Scumpia, Kindra M.; Scumpia, Philip O.; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA; [Madigan, Cressida A.; Zailaa, Joseph; Smale, Stephen T.; Modlin, Robert L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Madigan, Cressida A.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Cambier, C. J.; Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Cheng, Tan-Yun; Moody, D. Branch] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Bloom, Barry R.] Harvard Sch Publ Hlth, Boston, MA 02115 USA; [Sagasti, Alvaro] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Cambridge, Dept Med, Mol Immun Unit, MRC,Lab Mol Biol, Cambridge CB2 OQH, England; [Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Cambier, C. J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; University of Cambridge; University of California System; University of California Los Angeles; Stanford University	Madigan, CA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90095 USA.; Madigan, CA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Madigan, CA; Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Ramakrishnan, L (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Ramakrishnan, L (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Ramakrishnan, L (corresponding author), Univ Cambridge, Dept Med, Mol Immun Unit, MRC,Lab Mol Biol, Cambridge CB2 OQH, England.	cmadigan@ucla.edu; lr404@cam.ac.uk	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X; Zailaa, Joseph/0000-0001-9103-190X; Ramakrishnan, Lalita/0000-0003-0692-5533	A.P. Giannini Foundation Postdoctoral Fellowship; NIH training grant [T32 AI1007411, T32 AI55396]; NIH NRSA Postdoctoral Fellowship [AI104240]; NSF Pre-doctoral Fellowship; UCLA Clinical Translational Science Institute grant [UL1TR001881]; NIH grant [R01AR064582]; NIH Director's Pioneer Award; NIH MERIT award [R37AI054503]; Wellcome Trust Principal Research Fellowship;  [K08AR066545];  [U19AI111224];  [R01AI049313]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503, R21AI121779, R01AI049313, R01AI022553, F32AI104240, U19AI111224, T32AI055396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020, R01AR064582, K08AR066545, R01AR040312] Funding Source: NIH RePORTER	A.P. Giannini Foundation Postdoctoral Fellowship; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Pre-doctoral Fellowship(National Science Foundation (NSF)); UCLA Clinical Translational Science Institute grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MERIT award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Principal Research Fellowship(Wellcome Trust); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	L.R. dedicates this paper to Stanley Falkow. M. leprae was supplied by R. Lahiri and J. Krahenbuhl at the National Hansen's Disease Program through the support of the American Leprosy Missions and Society of St. Lazarus of Jerusalem. We thank S. Falkow and P. Edelstein for reading and editing the manuscript; D. Raible, W. Talbot, and P. Edelstein for discussions and advice; P. Edelstein for help with statistics; A. Pagan for advice and help with the macrophage depletion experiments; A. Rambukkana for suggesting TEM; Y. Dong and J. Cameron for zebrafish husbandry; W. Talbot, J. Rasmussen, and C. Guilhot for reagents; E. Layre for development of PGL-1 mass spectrometry methods; F. Ciampi for assistance with movies; and M. Cilluffo at the BRI Electron Microscopy Core for assistance with electron microscopy studies. Confocal imaging was performed at the CNSI Advanced Light Microscopy/Spectroscopy Facility at UCLA. This work was supported by an A.P. Giannini Foundation Postdoctoral Fellowship, an NIH training grant (T32 AI1007411), and an NIH NRSA Postdoctoral Fellowship (AI104240) to C.A.M.; an NSF Pre-doctoral Fellowship and NIH training grant T32 AI55396 to C.J.C.; a UCLA Clinical Translational Science Institute grant (UL1TR001881 to K.K.S.); K08AR066545 to P.O.S.; U19AI111224 and R01AI049313 to D.B.M.; an NIH grant (R01AR064582) to A.S.; the NIH Director's Pioneer Award, an NIH MERIT award (R37AI054503), and a Wellcome Trust Principal Research Fellowship to L.R.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bierman W, 1936, J AMER MED ASSOC, V106, P1158; Bogie JFJ, 2014, ACTA NEUROPATHOL, V128, P191, DOI 10.1007/s00401-014-1310-2; Brannon MK, 2009, CELL MICROBIOL, V11, P755, DOI 10.1111/j.1462-5822.2009.01288.x; Cambier CJ, 2017, IMMUNITY, V47, P552, DOI 10.1016/j.immuni.2017.08.003; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cosma Christine L, 2006, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/0471729256.mc10b02s3; Czopka T, 2016, GLIA, V64, P333, DOI 10.1002/glia.22897; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; De Freitas MRG, 2013, HAND CLINIC, V115, P499, DOI 10.1016/B978-0-444-52902-2.00028-X; DRUTZ DJ, 1972, NEW ENGL J MED, V287, P159, DOI 10.1056/NEJM197207272870402; Elks PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100928; GANAPATI R, 1972, International Journal of Leprosy and Other Mycobacterial Diseases, V40, P281; Ganapati R, 1976, Lepr India, V48, P42; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; JOB CK, 1973, J NEUROL SCI, V20, P25, DOI 10.1016/0022-510X(73)90115-9; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Klein D, 2016, BRAIN RES, V1641, P130, DOI 10.1016/j.brainres.2015.11.033; KONG EY, 2016, INT J MOL SCI, V17; Lahiri R, 2005, INT J LEPROSY, V73, P194; Lane JE, 2006, CLIN EXP DERMATOL, V31, P469, DOI 10.1111/j.1365-2230.2006.02075.x; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Levy L, 2006, LEPROSY REV, V77, P5; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Lockwood DNJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001327; Madigan C. A., 2017, J INFECT DIS; Manca C, 2012, J INTERF CYTOK RES, V32, P27, DOI 10.1089/jir.2011.0044; Marques MAM, 2001, J MED MICROBIOL, V50, P23, DOI 10.1099/0022-2615-50-1-23; Martini R, 2016, GLIA, V64, P475, DOI 10.1002/glia.22899; Medeiros RCA, 2016, J BIOL CHEM, V291, P24803, DOI 10.1074/jbc.A116.725283; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Morell P, 1999, BASIC NEUROCHEMISTRY, P56; Muller M, 2010, J PERIPHER NERV SYST, V15, P357, DOI 10.1111/j.1529-8027.2010.00295.x; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Noordeen SK, 1994, LEPROSY, P29; O'Donnell KC, 2013, J NEUROSCI, V33, P14778, DOI 10.1523/JNEUROSCI.1331-13.2013; Pagan AJ, 2015, CELL HOST MICROBE, V18, P15, DOI 10.1016/j.chom.2015.06.008; PANDYA NJ, 1974, LEPROSY REV, V45, P145; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Ramakrishnan L, 2004, CURR SCI INDIA, V86, P82; Rambukkana A, 2000, TRENDS MICROBIOL, V8, P23, DOI 10.1016/S0966-842X(99)01647-9; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Renault C. A., 2015, MANDELL DOUGLAS BENN, P2819; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Schon T, 2004, BRIT J DERMATOL, V150, P570, DOI 10.1046/j.1365-2133.2004.05764.x; Scollard DM, 2008, LEPROSY REV, V79, P242; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Shetty V P, 1996, Indian J Lepr, V68, P105; SHETTY VP, 1988, J NEUROL SCI, V88, P115, DOI 10.1016/0022-510X(88)90210-9; Siamwala JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00679; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Tabouret G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001159; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Thompson KK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030504; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Truman RW, 2014, ILAR J, V54, P304, DOI 10.1093/ilar/ilt050; Truman RW, 2001, INT J LEPROSY, V69, P1; Van Brakel WH, 2005, LEPROSY REV, V76, P14; Van Brakel WH, 2003, LEPROSY REV, V74, P300; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Wen Y, 2013, AM J TROP MED HYG, V88, P918, DOI 10.4269/ajtmh.11-0253; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009	75	71	72	8	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					973	+	985.e10	10.1016/j.cell.2017.07.030	http://dx.doi.org/10.1016/j.cell.2017.07.030			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841420	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000408372400015
J	Torkamani, A; Andersen, KG; Steinhubl, SR; Topol, EJ				Torkamani, Ali; Andersen, Kristian G.; Steinhubl, Steven R.; Topol, Eric J.			High-Definition Medicine	CELL			English	Review							PLURIPOTENT STEM-CELLS; RANDOMIZED CLINICAL-TRIAL; GENOME-WIDE ASSOCIATION; USUAL BLOOD-PRESSURE; FAMILY-HISTORY; MEDICATION ADHERENCE; GENETIC RISK; DISEASE; CANCER; HEALTH	The foundation for a new era of data-driven medicine has been set by recent technological advances that enable the assessment and management of human health at an unprecedented level of resolution-what we refer to as high-definition medicine. Our ability to assess human health in high definition is enabled, in part, by advances in DNA sequencing, physiological and environmental monitoring, advanced imaging, and behavioral tracking. Our ability to understand and act upon these observations at equally high precision is driven by advances in genome editing, cellular reprogramming, tissue engineering, and information technologies, especially artificial intelligence. In this review, we will examine the core disciplines that enable high-definition medicine and project how these technologies will alter the future of medicine.	[Torkamani, Ali; Andersen, Kristian G.; Steinhubl, Steven R.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Steinhubl, Steven R.; Topol, Eric J.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Torkamani, A (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	atorkama@scripps.edu		Torkamani, Ali/0000-0003-0232-8053	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025774] Funding Source: Medline; NHGRI NIH HHS [U01 HG006476] Funding Source: Medline; NIGMS NIH HHS [U54 GM114833] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SMI, 2016, HOTMOBILE'16: PROCEEDINGS OF THE 17TH INTERNATIONAL WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS, P21, DOI 10.1145/2873587.2873590; Ampofo WK, 2015, VACCINE, V33, P4368, DOI 10.1016/j.vaccine.2015.06.090; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bartlett MS, 2014, CURR BIOL, V24, P738, DOI 10.1016/j.cub.2014.02.009; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Brinkmann F, 2015, SCI REP-UK, V5, DOI 10.1038/srep15342; Burbelo PD, 2014, CURR OPIN RHEUMATOL, V26, P717, DOI 10.1097/BOR.0000000000000107; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Campbell IM, 2015, TRENDS GENET, V31, P382, DOI 10.1016/j.tig.2015.03.013; Castellani B, 2016, COMPLEXITY, V21, P160, DOI 10.1002/cplx.21728; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chan AHY, 2013, J ALLER CL IMM-PRACT, V1, P446, DOI 10.1016/j.jaip.2013.06.015; Chan FKL, 2002, LANCET, V359, P9, DOI 10.1016/S0140-6736(02)07272-0; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Checchi KD, 2014, JAMA-J AM MED ASSOC, V312, P1237, DOI 10.1001/jama.2014.10059; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Cheng Q, 2016, TELEMED E-HEALTH, V22, P132, DOI 10.1089/tmj.2015.0040; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Choudhry NK, 2017, JAMA INTERN MED, V177, P624, DOI 10.1001/jamainternmed.2016.9627; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; De Vlaminck I, 2015, P NATL ACAD SCI USA, V112, P13336, DOI 10.1073/pnas.1517494112; Delaney SK, 2016, EXPERT REV MOL DIAGN, V16, P521, DOI 10.1586/14737159.2016.1146593; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Eggington JM, 2014, CLIN GENET, V86, P229, DOI 10.1111/cge.12315; Engelbart D. C., 1992, HIGH PERFORMANCE ORG; Erikson GA, 2016, CELL, V165, P1002, DOI 10.1016/j.cell.2016.03.022; Esteki MZ, 2015, AM J HUM GENET, V96, P894, DOI 10.1016/j.ajhg.2015.04.011; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Faurholt-Jepsen M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.123; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Forsberg LA, 2017, NAT REV GENET, V18, P128, DOI 10.1038/nrg.2016.145; Fourati S, 2015, VIRUSES-BASEL, V7, P6346, DOI 10.3390/v7122941; Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Grieves M., 2017, TRANSDISCIPLINARY PE, P85, DOI [10.1007/978-3-319-38756-7_4, DOI 10.1007/978-3-319-38756-74]; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haggstrom M., 2014, WIKIJOURNAL MED, V1; Harrington J, 2013, SLEEP BREATH, V17, P1071, DOI 10.1007/s11325-013-0804-9; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hockemeyer D, 2016, CELL STEM CELL, V18, P573, DOI 10.1016/j.stem.2016.04.013; Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790; Honkoop PJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013935; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hughes D, 2015, NAT REV GENET, V16, P459, DOI 10.1038/nrg3922; Hughes V., 2015, BUZZFEED NEWS; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Jakicic JM, 2016, JAMA-J AM MED ASSOC, V316, P1161, DOI 10.1001/jama.2016.12858; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Johannesson B, 2015, EMBO J, V34, P841, DOI 10.15252/embj.201490685; Vaquero JJ, 2015, ANNU REV BIOMED ENG, V17, P385, DOI 10.1146/annurev-bioeng-071114-040723; June CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3643; Koser CU, 2014, TRENDS GENET, V30, P401, DOI 10.1016/j.tig.2014.07.003; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Kramer ADI, 2014, P NATL ACAD SCI USA, V111, P8788, DOI 10.1073/pnas.1320040111; Lefterova MI, 2015, J MOL DIAGN, V17, P623, DOI 10.1016/j.jmoldx.2015.07.004; Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Lu KH, 2014, J CLIN ONCOL, V32, P833, DOI 10.1200/JCO.2013.50.9257; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manyika J., 2011, ANALYTICS, V15, P1; Maor E., 2016, CIRCULATION, V134; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Maxson T, 2016, TETRAHEDRON, V72, P3609, DOI 10.1016/j.tet.2015.09.069; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Mendell JR, 2016, CELL RES, V26, P513, DOI 10.1038/cr.2016.28; Mone G, 2015, COMMUN ACM, V58, P15, DOI 10.1145/2800498; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Myers A, 2015, IEEE I CONF COMP VIS, P1233, DOI 10.1109/ICCV.2015.146; Nakhleh MK, 2017, ACS NANO, V11, P112, DOI 10.1021/acsnano.6b04930; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Philips EJ, 2010, PHARMACOGENOMICS, V11, P973, DOI 10.2217/PGS.10.77; Pilz S, 2016, NAT REV CARDIOL, V13, P404, DOI 10.1038/nrcardio.2016.73; Piwek L, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001953; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Quinn JF, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27495; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; Rodbard D, 2016, DIABETES TECHNOL THE, V18, P3, DOI 10.1089/dia.2015.0417; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Sands TT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0694-x; Scalbert A, 2014, AM J CLIN NUTR, V99, P1286, DOI 10.3945/ajcn.113.076133; Scheuner MT, 1997, AM J MED GENET, V71, P315, DOI 10.1002/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N; Sciences N. A. o. and Medicine N. A. o, 2017, HUM GEN ED SCI ETH G; Seibert T. M., 2016, BIORXIV; Sharp P., 2016, CONVERGENCE FUTURE H; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Sheridan C, 2017, NAT BIOTECHNOL, V35, P101, DOI 10.1038/nbt0217-101; Shulman LM, 2008, MOVEMENT DISORD, V23, P790, DOI 10.1002/mds.21879; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Swan M, 2012, J SENS ACTUAR NETW, V1, P217, DOI 10.3390/jsan1030217; Taylor-Phillips S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010002; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Walsh JA, 2014, CIRCULATION, V130, P573, DOI 10.1161/CIRCULATIONAHA.114.009024; Woodsworth DJ, 2013, GENOME MED, V5, DOI 10.1186/gm502; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Xu GB, 2014, SENSORS-BASEL, V14, P16932, DOI 10.3390/s140916932; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Yong E, 2014, NATURE, V511, P524, DOI 10.1038/511524a; Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009; Zhou KX, 2013, ANNU REV PHARMACOL, V53, P299, DOI 10.1146/annurev-pharmtox-011112-140237; Zmora N, 2016, CELL HOST MICROBE, V19, P12, DOI 10.1016/j.chom.2015.12.016; Zola SM, 2013, AM J ALZHEIMERS DIS, V28, P179, DOI 10.1177/1533317512470484; Zuo J., 2016, SENSORS, V16, pE1692	130	111	119	1	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					828	843		10.1016/j.cell.2017.08.007	http://dx.doi.org/10.1016/j.cell.2017.08.007			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841416	Green Accepted, Bronze			2022-12-28	WOS:000408372400005
J	Mintz, GS; Guagliumi, G				Mintz, Gary S.; Guagliumi, Giulio			Intravascular imaging in coronary artery disease	LANCET			English	Review							OPTICAL COHERENCE TOMOGRAPHY; DRUG-ELUTING STENT; FRACTIONAL FLOW RESERVE; THIN-CAP FIBROATHEROMA; PERIPROCEDURAL MYOCARDIAL-INFARCTION; ULTRASOUND ANALYSIS; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; CULPRIT LESION; YELLOW PLAQUE	Although it is the method used by most interventional cardiologists to assess the severity of coronary artery disease and guide treatment, coronary angiography has many known limitations, particularly the fact that it is a lumenogram depicting foreshortened, shadowgraph, planar projections of the contrast-filled lumen rather than imaging the diseased vessel itself. Intravascular imaging-intravascular ultrasound and more recently optical coherence tomography-provide a tomographical or cross-sectional image of the coronary arteries. These techniques are clinically useful to answer questions such as whether the stenosis is clinically relevant; the identification of the culprit lesion; or whether the plaque (or patient) is at high risk of future adverse events. They can also be used to optimise stent implantation to minimise stent-related adverse events, provide answers to the likelihood of distal embolisation or peri-procedural myocardial infarction during stent implantation, and provide reasons for stent thrombosis or restenosis. This review considers the usefulness of intravascular imaging in day-to-day practice.	[Mintz, Gary S.] Cardiovasc Res Fdn, New York, NY 10019 USA; [Guagliumi, Giulio] ASST Osped Papa Giovanni XXIII, Bergamo, Italy	Cardiovascular Research Foundation (CRF); ASST Papa Giovanni XXIII	Mintz, GS (corresponding author), Cardiovasc Res Fdn, New York, NY 10019 USA.	gmntz@crf.org	Guagliumi, Giulio/K-8006-2016		Boston Scientific; Volcano; St Jude Medical; Abbott Vascular	Boston Scientific(Boston Scientific); Volcano; St Jude Medical(St. Jude Medical); Abbott Vascular(Abbott Laboratories)	GSM is a consultant or receives honoraria from Boston Scientific, Volcano, ACIST, and Infraredx. His institution receives grant or fellowship support from Boston Scientific, Volcano, and St Jude Medical. GG is a consultant for Boston Scientific and St Jude Medical. His institution receives grant support from Abbott Vascular, Boston Scientific, and St Jude Medical.	Adriaenssens T, 2017, CIRCULATION, V136, P1007, DOI 10.1161/CIRCULATIONAHA.117.026788; Alberti A, 2016, EUR J HEALTH ECON, V17, P185, DOI 10.1007/s10198-015-0670-4; Ali ZA, 2016, LANCET, V388, P2618, DOI 10.1016/S0140-6736(16)31922-5; Ali ZA, 2016, EUR HEART J, V37, P3090, DOI 10.1093/eurheartj/ehw078; Ali ZA, 2013, CIRC-CARDIOVASC INTE, V6, P507, DOI 10.1161/CIRCINTERVENTIONS.112.000248; Bavishi C, 2017, AM HEART J, V185, P26, DOI 10.1016/j.ahj.2016.10.008; Bayturan O, 2009, JACC-CARDIOVASC INTE, V2, P672, DOI 10.1016/j.jcin.2009.05.007; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; Bourantas CV, 2017, EUR HEART J, V38, P400, DOI 10.1093/eurheartj/ehw097; Brown AJ, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003487; Bryniarski KL, 2017, EUROINTERVENTION, V12, pE2204, DOI 10.4244/EIJ-D-16-00679; Calvert PA, 2011, JACC-CARDIOVASC IMAG, V4, P894, DOI 10.1016/j.jcmg.2011.05.005; Cheng JM, 2014, EUR HEART J, V35, P639, DOI 10.1093/eurheartj/eht484; D'Ascenzo F, 2015, AM HEART J, V169, P663, DOI 10.1016/j.ahj.2015.01.013; Dato I, 2016, INT J CARDIOL, V220, P726, DOI 10.1016/j.ijcard.2016.06.260; Davies JE, 2017, NEW ENGL J MED, V376, P1824, DOI 10.1056/NEJMoa1700445; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Hernandez JMD, 2011, J AM COLL CARDIOL, V58, P351, DOI 10.1016/j.jacc.2011.02.064; Di Vito L, 2017, EUROINTERVENTION, V13, P303, DOI 10.4244/EIJ-D-16-00317; Elgendy IY, OUTCOMES INTRAVASCUL; Erlinge D, 2015, J INTERN MED, V278, P110, DOI 10.1111/joim.12381; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Fujino Y, 2013, CATHETER CARDIO INTE, V82, pE173, DOI 10.1002/ccd.24843; Galassi AR, 2016, JACC-CARDIOVASC INTE, V9, P1979, DOI 10.1016/j.jcin.2016.06.057; Gerbaud E, 2016, EUR HEART J-CARD IMG, V17, P756, DOI 10.1093/ehjci/jev229; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gotberg M, 2017, NEW ENGL J MED, V376, P1813, DOI 10.1056/NEJMoa1616540; Guagliumi G, 2012, JACC-CARDIOVASC INTE, V5, P12, DOI 10.1016/j.jcin.2011.09.018; Guagliumi G, 2011, CIRCULATION, V123, P274, DOI 10.1161/CIRCULATIONAHA.110.963181; Guo N, 2010, CIRCULATION, V122, P1077, DOI 10.1161/CIRCULATIONAHA.109.906040; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; Hata R, 2017, EUR HEART J, V38, P1613, DOI 10.1093/eurheartj/ehw511; Higo T, 2009, JACC-CARDIOVASC IMAG, V2, P616, DOI 10.1016/j.jcmg.2008.12.026; Hong MK, 2000, AM HEART J, V140, P395, DOI 10.1067/mhj.2000.108829; Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454; Im E, 2014, CIRC-CARDIOVASC INTE, V7, P88, DOI 10.1161/CIRCINTERVENTIONS.113.000797; Ino Y, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004231; Jasti V, 2004, CIRCULATION, V110, P2831, DOI 10.1161/01.CIR.0000146338.62813.E7; Jia HB, 2017, EUR HEART J, V38, P792, DOI 10.1093/eurheartj/ehw381; Karanasos A, 2015, CIRC-CARDIOVASC INTE, V8, DOI DOI 10.1161/CIRCINTERVENTIONS.114.002369; Kataoka Y, 2012, J AM COLL CARDIOL, V59, P1592, DOI 10.1016/j.jacc.2012.03.012; Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299; Kerensky RA, 2002, J AM COLL CARDIOL, V39, P1456, DOI 10.1016/S0735-1097(02)01770-9; Kim BK, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002592; Kini AS, 2015, JACC-CARDIOVASC INTE, V8, P937, DOI 10.1016/j.jcin.2015.03.016; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Kubo T, 2015, JACC-CARDIOVASC IMAG, V8, P1228, DOI 10.1016/j.jcmg.2014.11.012; Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014; Kubo T, 2008, JACC-CARDIOVASC INTE, V1, P74, DOI 10.1016/j.jcin.2007.11.001; Kume T, 2011, EUROINTERVENTION, V6, P768, DOI 10.4244/EIJV6I6A130; Kuroda M, 2016, EUROINTERVENTION, V12, pE1366, DOI 10.4244/EIJY15M12_05; Lowe HC, 2011, JACC-CARDIOVASC INTE, V4, P1257, DOI 10.1016/j.jcin.2011.08.015; Maehara A, 2015, JACC-CARDIOVASC INTE, V8, P1704, DOI 10.1016/j.jcin.2015.07.024; Mariani J, 2014, JACC-CARDIOVASC INTE, V7, P1287, DOI 10.1016/j.jcin.2014.05.024; Meneveau N, 2016, CIRCULATION, V134, P906, DOI 10.1161/CIRCULATIONAHA.116.024393; Mintz GS, 2017, CORONARY ARTERY DIS, V28, P346, DOI 10.1097/MCA.0000000000000483; Mintz GS, 2015, JACC-CARDIOVASC IMAG, V8, P461, DOI 10.1016/j.jcmg.2015.02.003; Mintz GS, 2014, J AM COLL CARDIOL, V64, P207, DOI 10.1016/j.jacc.2014.01.015; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; MINTZ GS, 1995, J AM COLL CARDIOL, V25, P1479, DOI 10.1016/0735-1097(95)00088-L; Mintz GS., INTRAVASCULAR ULTRAS; Mintz GS, 2005, INTRACORONARY ULTRAS, P126; Nakano M, 2016, JACC-CARDIOVASC IMAG, V9, P163, DOI 10.1016/j.jcmg.2015.07.011; Onuma Yoshinobu, 2015, EuroIntervention, V11 Suppl V, pV71, DOI 10.4244/EIJV11SVA15; Ozaki Y, 2015, CIRC J, V79, P808, DOI 10.1253/circj.CJ-14-0758; Park SJ, 2014, JACC-CARDIOVASC INTE, V7, P868, DOI 10.1016/j.jcin.2014.02.015; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Prail F, 2015, JACC-CARDIOVASC IMAG, V8, P1297, DOI 10.1016/j.jcmg.2015.08.013; Prati F, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003726; Prati F, 2015, AM HEART J, V169, P249, DOI 10.1016/j.ahj.2014.11.012; Prati F, 2013, JACC-CARDIOVASC IMAG, V6, P283, DOI 10.1016/j.jcmg.2012.12.007; Prati F, 2012, EUROINTERVENTION, V8, P823, DOI 10.4244/EIJV8I7A125; Raber L, 2015, J AM COLL CARDIOL, V66, P1901, DOI 10.1016/j.jacc.2015.08.853; Romagnoli E, 2017, CATHETER CARDIO INTE, V90, P566, DOI 10.1002/ccd.26974; Sano K, 2006, J AM COLL CARDIOL, V47, P734, DOI 10.1016/j.jacc.2005.09.061; Sawada T, 2008, EUR HEART J, V29, P1136, DOI 10.1093/eurheartj/ehn132; Serruys PW, 2016, J AM COLL CARDIOL, V67, P766, DOI 10.1016/j.jacc.2015.11.060; Shimamura K, 2015, EUR HEART J-CARD IMG, V16, P23, DOI 10.1093/ehjci/jeu174; Shin DH, 2016, JACC-CARDIOVASC INTE, V9, P2232, DOI 10.1016/j.jcin.2016.07.021; Shin ES, 2015, JACC-CARDIOVASC IMAG, V8, P1059, DOI 10.1016/j.jcmg.2015.03.010; Soeda T, 2015, CIRCULATION, V132, P1020, DOI 10.1161/CIRCULATIONAHA.114.014704; Souteyrand G, 2016, EUR HEART J, V37, P1208, DOI 10.1093/eurheartj/ehv711; Steinberg DH, 2010, JACC-CARDIOVASC INTE, V3, P486, DOI 10.1016/j.jcin.2010.03.007; Steinvil A, 2016, INT J CARDIOL, V216, P133, DOI 10.1016/j.ijcard.2016.04.154; Stone GW, 2015, JACC-CARDIOVASC INTE, V8, P927, DOI 10.1016/j.jcin.2015.01.032; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Taniwaki M, 2016, CIRCULATION, V133, P650, DOI 10.1161/CIRCULATIONAHA.115.019071; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tian JW, 2014, J AM COLL CARDIOL, V63, P2209, DOI 10.1016/j.jacc.2014.01.061; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Ueda Y, 2015, JACC-CARDIOVASC INTE, V8, P814, DOI 10.1016/j.jcin.2014.12.239; Uemura S, 2012, EUR HEART J, V33, P78, DOI 10.1093/eurheartj/ehr284; van der Hoeven BL, 2008, JACC-CARDIOVASC INTE, V1, P192, DOI 10.1016/j.jcin.2008.02.003; Wang B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004438; Xie Y, 2014, JACC-CARDIOVASC IMAG, V7, P397, DOI 10.1016/j.jcmg.2013.10.010; Xu YJ, 2012, CIRCULATION, V126, P537, DOI 10.1161/CIRCULATIONAHA.111.055004; Yamagishi M, 2000, J AM COLL CARDIOL, V35, P106, DOI 10.1016/S0735-1097(99)00533-1; Yamamoto M, 2009, CIRC J, V73, P497, DOI 10.1253/circj.CJ-08-0762; Zhang YJ, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0144-8	100	66	68	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					793	809		10.1016/S0140-6736(17)31957-8	http://dx.doi.org/10.1016/S0140-6736(17)31957-8			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28831995				2022-12-28	WOS:000407858900023
J	Terakawa, T; Bisht, S; Eeftens, JM; Dekker, C; Haering, CH; Greene, EC				Terakawa, Tsuyoshi; Bisht, Shveta; Eeftens, Jorine M.; Dekker, Cees; Haering, Christian H.; Greene, Eric C.			The condensin complex is a mechanochemical motor that translocates along DNA	SCIENCE			English	Article							SMC FAMILY; ORGANIZATION; ARCHITECTURE; CHROMOSOMES; COMPACTION; MECHANISM; BINDING; MITOSIS; COHESIN; GENOME	Condensin plays crucial roles in chromosome organization and compaction, but the mechanistic basis for its functions remains obscure. We used single-molecule imaging to demonstrate that Saccharomyces cerevisiae condensin is a molecular motor capable of adenosine triphosphate hydrolysis-dependent translocation along double-stranded DNA. Condensin's translocation activity is rapid and highly processive, with individual complexes traveling an average distance of >= 10 kilobases at a velocity of similar to 60 base pairs per second. Our results suggest that condensin may take steps comparable in length to its similar to 50-nanometer coiled-coil subunits, indicative of a translocation mechanism that is distinct from any reported for a DNA motor protein. The finding that condensin is a mechanochemical motor has important implications for understanding the mechanisms of chromosome organization and condensation.	[Terakawa, Tsuyoshi; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Bisht, Shveta; Haering, Christian H.] EMBL, Cell Biol & Biophys Unit, Struct & Computat Unit, Heidelberg, Germany; [Eeftens, Jorine M.; Dekker, Cees] Delft Univ Technol, Dept Bionanosci, Kavi Inst Nanosci, Delft, Netherlands	Columbia University; European Molecular Biology Laboratory (EMBL); Delft University of Technology	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.; Haering, CH (corresponding author), EMBL, Cell Biol & Biophys Unit, Struct & Computat Unit, Heidelberg, Germany.; Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavi Inst Nanosci, Delft, Netherlands.	c.dekker@tudelft.nl; christian.haering@embl.de; ecg2108@cumc.columbia.edu		Dekker, Cees/0000-0001-6273-071X; Bisht, Shveta/0000-0002-5566-3472; Haering, Christian/0000-0001-8301-1722; Eeftens, Jorine/0000-0001-6784-9955	MIRA (Maximizing Investigators' Research Award) grant from the National Institutes of Health [R35GM118026]; EMBL; European Research Council (ERC) Consolidator Grant CondStruct [ERC-2015-CoG 681365]; ERC Advanced Grant SynDiv [ERC-ADG-2014 669598]; Netherlands Organization for Scientific Research (NWO/OCW) (as part of the Frontiers of Nanoscience program); Japan Society for the Promotion of Science; Uehara Memorial Foundation; EIPOD (EMBL Interdisciplinary Postdocs) fellowship under Marie Curie Actions (COFUND); European Molecular Biology Organization short-term fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	MIRA (Maximizing Investigators' Research Award) grant from the National Institutes of Health; EMBL; European Research Council (ERC) Consolidator Grant CondStruct; ERC Advanced Grant SynDiv; Netherlands Organization for Scientific Research (NWO/OCW) (as part of the Frontiers of Nanoscience program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); EIPOD (EMBL Interdisciplinary Postdocs) fellowship under Marie Curie Actions (COFUND); European Molecular Biology Organization short-term fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Marinova for assistance with the construction of condensin expression constructs; D. D'Amours (University of Montreal) for plasmids and yeast strains; members of the Haering, Greene, and Dekker laboratories for comments on the manuscript; and the EMBL Electron Microscopy Facility and Proteomics Core Facility for support. E.C.G. was funded by a MIRA (Maximizing Investigators' Research Award) grant from the National Institutes of Health (R35GM118026). C.H.H. was supported by EMBL and the European Research Council (ERC) Consolidator Grant CondStruct (ERC-2015-CoG 681365). C.D. was supported by the ERC Advanced Grant SynDiv (ERC-ADG-2014 669598) and the Netherlands Organization for Scientific Research (NWO/OCW) (as part of the Frontiers of Nanoscience program). T.T was supported by fellowships from the Japan Society for the Promotion of Science and the Uehara Memorial Foundation. S.B. was supported by an EIPOD (EMBL Interdisciplinary Postdocs) fellowship under Marie Curie Actions (COFUND). J.M.E was supported by a European Molecular Biology Organization short-term fellowship. Data described in this manuscript are archived in the Greene laboratory at Columbia University and wilI be provided on request. Author contributions: T.T. designed and conducted single-molecule experiments and data analysis. S.B. purified condensin complexes and conducted bulk biochemical measurements and electron microscopy analysis. J.M.E. designed and implemented singlemolecule experiments. All authors discussed the experimental findings and cowrote the manuscript.	Aipour E., 2012, NUCLEIC ACIDS RES, V40, P11202; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Burmann F, 2017, MOL CELL, V65, P861, DOI 10.1016/j.molcel.2017.01.026; Cheng TMK, 2015, ELIFE, V4, DOI 10.7554/eLife.05565; Davidson IF, 2016, EMBO J, V35, P2671, DOI 10.15252/embj.201695402; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Eeftens J. M., 2017, BIORXIV; Eeftens JM, 2016, CELL REP, V14, P1813, DOI 10.1016/j.celrep.2016.01.063; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; GUACCI V, 1993, COLD SPRING HARB SYM, V58, P677, DOI 10.1101/SQB.1993.058.01.075; Haering CH, 2016, CELL, V164, P326, DOI 10.1016/j.cell.2015.12.026; Hauk G, 2016, CURR OPIN STRUC BIOL, V36, P85, DOI 10.1016/j.sbi.2016.01.006; HIRANO T, 1995, CURR OPIN CELL BIOL, V7, P329, DOI 10.1016/0955-0674(95)80087-5; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Kimura K, 2000, P NATL ACAD SCI USA, V97, P11972, DOI 10.1073/pnas.220326097; Minnen A, 2016, CELL REP, V14, P2003, DOI 10.1016/j.celrep.2016.01.066; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; PETERSON CL, 1994, CELL, V79, P389, DOI 10.1016/0092-8674(94)90247-X; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; RIGGS AD, 1990, PHILOS T R SOC B, V326, P285, DOI 10.1098/rstb.1990.0012; Seidel R, 2008, EMBO J, V27, P1388, DOI 10.1038/emboj.2008.69; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Yang W, 2010, ANNU REV BIOPHYS, V39, P367, DOI 10.1146/annurev.biophys.093008.131415	39	170	171	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2017	358	6363					672	676		10.1126/science.aan6516	http://dx.doi.org/10.1126/science.aan6516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4ZP	28882993	Green Submitted, Green Accepted			2022-12-28	WOS:000414240500043
J	Beddhu, S; Rocco, MV; Toto, R; Craven, TE; Greene, T; Bhatt, U; Cheung, AK; Cohen, D; Freedman, BI; Hawfield, AT; Killeen, AA; Kimmel, PL; Lash, J; Papademetriou, V; Rahman, M; Rastogi, A; Servilla, K; Townsend, RR; Wall, B; Whelton, PK				Beddhu, Srinivasan; Rocco, Michael V.; Toto, Robert; Craven, Timothy E.; Greene, Tom; Bhatt, Udayan; Cheung, Alfred K.; Cohen, Debbie; Freedman, Barry I.; Hawfield, Amret T.; Killeen, Anthony A.; Kimmel, Paul L.; Lash, James; Papademetriou, Vasilios; Rahman, Mahboob; Rastogi, Anjay; Servilla, Karen; Townsend, Raymond R.; Wall, Barry; Whelton, Paul K.		SPRINT Res Grp	Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease A Secondary Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; LOSARTAN; RISKS; DIET	Background: The public health significance of the reported higher incidence of chronic kidney disease (CKD) with intensive systolic blood pressure (SBP) lowering is unclear. Objective: To examine the effects of intensive SBP lowering on kidney and cardiovascular outcomes and contrast its apparent beneficial and adverse effects. Design: Subgroup analyses of SPRINT (Systolic Blood Pressure Intervention Trial). (ClinicalTrials. gov: NCT01206062) Setting: Adults with high blood pressure and elevated cardiovascular risk. Participants: 6662 participants with a baseline estimated glomerular filtration rate (eGFR) of at least 60 mL/min/1.73 m(2). Intervention: Random assignment to an intensive or standard SBP goal (120 or 140 mm Hg, respectively). Measurements: Differences in mean eGFR during follow-up (estimated with a linear mixed-effects model), prespecified incident CKD (defined as a >30% decrease in eGFR to a value < 60 mL/min/1.73 m(2)), and a composite of all-cause death or cardiovascular event, with surveillance every 3 months. Results: The difference in adjusted mean eGFR between the intensive and standard groups was -3.32 mL/min/1.73 m(2) (95% CI, -3.90 to -2.74 mL/min/1.73 m2) at 6 months, was -4.50 mL/min/1.73 m(2) (CI, -5.16 to -3.85 mL/min/1.73 m(2)) at 18 months, and remained relatively stable thereafter. An incident CKD event occurred in 3.7% of participants in the intensive group and 1.0% in the standard group at 3-year follow-up, with a hazard ratio of 3.54 (CI, 2.50 to 5.02). The corresponding percentages for the composite of death or cardiovascular event were 4.9% and 7.1% at 3-year follow-up, with a hazard ratio of 0.71 (CI, 0.59 to 0.86). Limitation: Long-term data were lacking. Conclusion: Intensive SBP lowering increased risk for incident CKD events, but this was outweighed by cardiovascular and allcause mortality benefits.	[Beddhu, Srinivasan; Greene, Tom; Cheung, Alfred K.] Univ Utah, Sch Med, Div Nephrol & Hypertens, 295 Chipeta Way,Suite 4000, Salt Lake City, UT 84108 USA; [Rocco, Michael V.; Freedman, Barry I.; Hawfield, Amret T.] Wake Forest Sch Med, Sect Nephrol, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA; [Craven, Timothy E.] Wake Forest Sch Med, Dept Biostat Sci, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA; [Toto, Robert] Univ Texas Southwestern Med Ctr Dallas, Med, 5623 Harry Hines Blvd, Dallas, TX 75390 USA; [Toto, Robert] Univ Texas Southwestern Med Ctr Dallas, Clin & Translat Res, 5623 Harry Hines Blvd, Dallas, TX 75390 USA; [Bhatt, Udayan] Ohio State Univ, Ground Floor,395 West 12th Ave, Columbus, OH 43210 USA; [Cohen, Debbie] Univ Penn, Renal Electrolyte & Hypertens Div, 1 Founders Bldg,3400 Spruce St, Philadelphia, PA 19104 USA; [Townsend, Raymond R.] Univ Penn, Nephrol & Hypertens, 122 Founders Bldg,3400 Spruce St, Philadelphia, PA 19104 USA; [Killeen, Anthony A.] Univ Minnesota, Dept Lab Med & Pathol, Clin Affairs, 420 Delaware St SE,MMC 609, Minneapolis, MN 55455 USA; [Kimmel, Paul L.] NIDDK, NIH, 6707 Democracy Blvd, Bethesda, MD 20892 USA; [Lash, James] Univ Illinois, Div Nephrol, 820 South Wood St,M-C 793, Chicago, IL 60612 USA; [Papademetriou, Vasilios] VA Med Ctr, 50 Irving St NW,Room 1D137, Washington, DC 20422 USA; [Rahman, Mahboob] Case Western Reserve Univ, 11100 Euclid Ave, Cleveland, OH 44196 USA; [Rastogi, Anjay] Univ Calif Los Angeles, Div Nephrol, 10630 Santa Monica Blvd, Los Angeles, CA 90025 USA; VA Med Ctr, Albuquerque, NM USA; [Wall, Barry] VA Med Ctr, Div Nephrol, 1030 Jefferson Ave, Memphis, TN 38104 USA; [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol 8318, 1440 Canal St,Room 2018, New Orleans, LA 70112 USA; [Servilla, Karen] New Mexico Vet Adm Hlth Care Syst, Renal Sect, Med Serv, 120 San Pedro SE, Albuquerque, NM 87108 USA	Utah System of Higher Education; University of Utah; Wake Forest University; Wake Forest University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Case Western Reserve University; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Tulane University	Beddhu, S (corresponding author), Univ Utah, Sch Med, Div Nephrol & Hypertens, 295 Chipeta Way,Suite 4000, Salt Lake City, UT 84108 USA.	Srinivasan.beddhu@hsc.utah.edu		Greene, Tom/0000-0002-3706-7570	National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091437, R21DK106574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health.	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; [Anonymous], 2012, SYST BLOOD PRESS INT; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Holtkamp FA, 2011, KIDNEY INT, V80, P282, DOI 10.1038/ki.2011.79; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levey AS, 1996, J AM SOC NEPHROL, V7, P2097; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ortman J. M., 2014, AGING NATION OLDER P, P25; Palmer BF, 2002, NEW ENGL J MED, V347, P1256, DOI 10.1056/NEJMra020676; Peralta CA, 2016, CIRCULATION, V133, P584, DOI 10.1161/CIRCULATIONAHA.115.019657; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; TOTO RD, 1991, ANN INTERN MED, V115, P513, DOI 10.7326/0003-4819-115-7-513; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981	26	68	68	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					375	+		10.7326/M16-2966	http://dx.doi.org/10.7326/M16-2966			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28869987	Green Accepted			2022-12-28	WOS:000411009900014
J	Ison, MG				Ison, Michael G.			Contemporary Influenza Diagnostics: Renewed Focus on Testing Patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NEURAMINIDASE INHIBITOR TREATMENT; METAANALYSIS; IMPACT		[Ison, Michael G.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ison, MG (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Infect Dis, 645 North Michigan Ave,Suite 900, Chicago, IL 60611 USA.; Ison, MG (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Organ Transplantat, 645 North Michigan Ave,Suite 900, Chicago, IL 60611 USA.	mgison@northwestern.edu						Appiah GD, 2017, CLIN INFECT DIS, V64, P364, DOI 10.1093/cid/ciw745; Dugas A., 2015, OPEN FORUM INFECT DI, V2, P102, DOI [10.1093/ofid/ofv131.22, DOI 10.1093/OFID/OFV131.22]; Havers F, 2014, CLIN INFECT DIS, V59, P774, DOI 10.1093/cid/ciu422; Hurt AC, 2016, EMERG INFECT DIS, V22, P949, DOI 10.3201/eid2206.151037; Ison MG, 2014, CLIN INFECT DIS, V59, P783, DOI 10.1093/cid/ciu425; Lee N, 2012, CLIN INFECT DIS, V55, P1205, DOI 10.1093/cid/cis642; Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Venkatesan S, 2017, CLIN INFECT DIS, V64, P1328, DOI 10.1093/cid/cix127	9	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					438	439		10.7326/M17-2235	http://dx.doi.org/10.7326/M17-2235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28869977				2022-12-28	WOS:000411009900023
J	Zhang, CX; Chen, YS; Sun, BF; Wang, L; Yang, Y; Ma, DY; Lv, JH; Heng, J; Ding, YY; Xue, YY; Lu, XY; Xiao, W; Yang, YG; Liu, F				Zhang, Chunxia; Chen, Yusheng; Sun, Baofa; Wang, Lu; Yang, Ying; Ma, Dongyuan; Lv, Junhua; Heng, Jian; Ding, Yanyan; Xue, Yuanyuan; Lu, Xinyan; Xiao, Wen; Yang, Yun-Gui; Liu, Feng			m(6)A modulates haematopoietic stem and progenitor cell specification	NATURE			English	Article							RNA-METHYLATION; AORTIC ENDOTHELIUM; HITS-CLIP; REVEALS; MICRORNAS; EMERGENCE	N-6-methyladenosine (m(6)A) has been identified as the most abundant modification on eukaryote messenger RNA (mRNA)(1). Although the rapid development of high-throughput sequencing technologies has enabled insight into the biological functions of m(6)A modification(2-13), the function of m(6)A during vertebrate embryogenesis remains poorly understood. Here we show that m(6)A determines cell fate during the endothelial-to-haematopoietic transition (EHT) to specify the earliest haematopoietic stem/progenitor cells (HSPCs) during zebrafish embryogenesis. m(6)A-specific methylated RNA immunoprecipitation combined with high-throughput sequencing (MeRIP-seq) and m(6)A individual-nucleotide-resolution cross-linking and immunoprecipitation with sequencing (miCLIP-seq) analyses reveal conserved features on zebrafish m(6)A methylome and preferential distribution of m(6)A peaks near the stop codon with a consensus RRACH motif. In mettl3-deficient embryos, levels of m(6)A are significantly decreased and emergence of HSPCs is blocked. Mechanistically, we identify that the delayed YTHDF2-mediated mRNA decay of the arterial endothelial genes notch1a and rhoca contributes to this deleterious effect. The continuous activation of Notch signalling in arterial endothelial cells of mettl3-deficient embryos blocks EHT, thereby repressing the generation of the earliest HSPCs. Furthermore, knockdown of Mettl3 in mice confers a similar phenotype. Collectively, our findings demonstrate the critical function of m(6)A modification in the fate determination of HSPCs during vertebrate embryogenesis.	[Zhang, Chunxia; Wang, Lu; Ma, Dongyuan; Lv, Junhua; Heng, Jian; Ding, Yanyan; Xue, Yuanyuan; Lu, Xinyan; Liu, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China; [Zhang, Chunxia; Chen, Yusheng; Lv, Junhua; Heng, Jian; Ding, Yanyan; Xue, Yuanyuan; Lu, Xinyan; Yang, Yun-Gui; Liu, Feng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Chen, Yusheng; Sun, Baofa; Yang, Ying; Xiao, Wen; Yang, Yun-Gui] Chinese Acad Sci, CAS Key Lab Genom & Precis Med, Collaborat Innovat Ctr Genet & Dev,Beijing Inst G, CAS Ctr Excellence Mol Cell Sci,Coll Future Techn, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Liu, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.; Yang, YG; Liu, F (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Yang, YG (corresponding author), Chinese Acad Sci, CAS Key Lab Genom & Precis Med, Collaborat Innovat Ctr Genet & Dev,Beijing Inst G, CAS Ctr Excellence Mol Cell Sci,Coll Future Techn, Beijing 100101, Peoples R China.	ygyang@big.ac.cn; liuf@ioz.ac.cn	Xiao, Wen/AAB-7222-2021; Yang, Yungui/ABF-2507-2021; Chen, Yusheng/HGB-6545-2022; Liu, Feng/B-9985-2015; ding, yy/HHS-9589-2022	Xiao, Wen/0000-0001-6559-3036; Liu, Feng/0000-0003-3228-0943; Yang, Yun-Gui/0000-0002-2821-8541; Zhang, Chunxia/0000-0003-0063-9181	National Natural Science Foundation of China [31425016, 81530004, 31625016]; Ministry of Science and Technology of China [2016YFA0100500, 2016YFC0900300]; Strategic Priority Research Program of the Chinese Academy of Sciences, China [XDA01010110, QYZDY-SSW-SMC027, XDB14030300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of the Chinese Academy of Sciences, China	We thank F. C. Tang and L. Yang for cell sorting and bioinformatics analysis, D. Liu and J.W. Xiong for reagents, H.L. Wang and W.Y. Lai for the UHPLC-MRM-MS/MS analysis. This work was supported by the National Natural Science Foundation of China (31425016 and 81530004 to F. L., and 31625016 to Y.Y.), the Ministry of Science and Technology of China (2016YFA0100500 to F. L. and 2016YFC0900300 to Y.Y.) and the Strategic Priority Research Program of the Chinese Academy of Sciences, China (XDA01010110 to F. L.; QYZDY-SSW-SMC027 and XDB14030300 to Y.Y.).	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gama-Norton L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9510; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Lizama CO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8739; Lv JH, 2017, J EXP MED, V214, P529, DOI 10.1084/jem.20150906; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shah A, 2017, BIOINFORMATICS, V33, P566, DOI 10.1093/bioinformatics/btw653; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001; Wei YL, 2014, BLOOD, V124, P1578, DOI 10.1182/blood-2013-11-541391; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Zhang CX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4431; Zhang PP, 2015, CELL RES, V25, P1093, DOI 10.1038/cr.2015.109; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2017, NUCLEIC ACIDS RES, V45, pD18, DOI 10.1093/nar/gkw1060; Zhao BXS, 2017, NATURE, V542, P475, DOI 10.1038/nature21355; Zhao BS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0609-1; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	52	299	324	12	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					273	+		10.1038/nature23883	http://dx.doi.org/10.1038/nature23883			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28869969				2022-12-28	WOS:000410555900046
J	Acree, M; Davis, AM				Acree, Mary; Davis, Andrew M.			Acute Diarrheal Infections in Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Acree, Mary] Univ Chicago, 4124 N LeClaire Ave, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Davis, AM (corresponding author), Univ Chicago, Gen Internal Med Sect, 4124 N LeClaire Ave, Chicago, IL 60637 USA.	adavis@medicine.bsd.uchicago.edu						Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; DuPont HL, 2016, JAMA-J AM MED ASSOC, V315, P2712, DOI 10.1001/jama.2016.7833; DuPont HL, 2014, NEW ENGL J MED, V370, P1532, DOI 10.1056/NEJMra1301069; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Riddle MS, 2008, CLIN INFECT DIS, V47, P1007, DOI 10.1086/591703; Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006; Trivedi TK, 2012, JAMA-J AM MED ASSOC, V308, P1668, DOI 10.1001/jama.2012.14023	7	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					957	958		10.1001/jama.2017.8485	http://dx.doi.org/10.1001/jama.2017.8485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898366				2022-12-28	WOS:000410487100017
J	Gupta, A; Johnson, DH; Nagalla, S				Gupta, Arjun; Johnson, David H.; Nagalla, Srikanth			Antiphospholipid Antibodies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LUPUS ANTICOAGULANTS; CLASSIFICATION; THROMBOSIS; UPDATE; RISK		[Gupta, Arjun; Johnson, David H.; Nagalla, Srikanth] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Nagalla, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	srikanth.nagalla@utsouthwestern.edu	Johnson, David/AHI-8369-2022					Abo SM, 2007, ANN CLIN LAB SCI, V37, P3; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Centers for Medicare and Medicaid Services, 2016, CMS CLIN LAB FEE SCH; De Groot PG, 2005, J THROMB HAEMOST, V3, P1993, DOI 10.1111/j.1538-7836.2005.01485.x; Galli M, 2003, BLOOD, V101, P1827, DOI 10.1182/blood-2002-02-0441; Gomez-Puerta JA, 2014, J AUTOIMMUN, V48-49, P20, DOI 10.1016/j.jaut.2014.01.006; Krilis SA, 2014, HEMATOL-AM SOC HEMAT, P321, DOI 10.1182/asheducation-2014.1.321; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x	9	1	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					959	960		10.1001/jama.2017.4854	http://dx.doi.org/10.1001/jama.2017.4854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898362				2022-12-28	WOS:000410487100018
J	Manson, JE; Aragaki, AK; Rossouw, JE; Anderson, GL; Prentice, RL; LaCroix, AZ; Chlebowski, RT; Howard, BV; Thomson, CA; Margolis, KL; Lewis, CE; Stefanick, ML; Jackson, RD; Johnson, KC; Martin, L; Shumaker, SA; Espeland, MA; Wactawski-Wende, J				Manson, Joann E.; Aragaki, Aaron K.; Rossouw, Jacques E.; Anderson, Garnet L.; Prentice, Ross L.; LaCroix, Andrea Z.; Chlebowski, Rowan T.; Howard, Barbara V.; Thomson, Cynthia A.; Margolis, Karen L.; Lewis, Cora E.; Stefanick, Marcia L.; Jackson, Rebecca D.; Johnson, Karen C.; Martin, Lisaw.; Shumaker, Sally A.; Espeland, Mark A.; Wactawski-Wende, Jean		WHI Investigators	Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality The Women's Health Initiative Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; MILD COGNITIVE IMPAIRMENT; POSTMENOPAUSAL WOMEN; BREAST-CANCER; REPLACEMENT THERAPY; CLINICAL-PRACTICE; FOLLOW-UP; HYSTERECTOMY; DEMENTIA	IMPORTANCE Health outcomes from the Women's Health Initiative Estrogen Plus Progestin and Estrogen-Alone Trials have been reported, but previous publications have generally not focused on all-cause and cause-specific mortality. OBJECTIVE To examine total and cause-specific cumulative mortality, including during the intervention and extended postintervention follow-up, of the 2 Women's Health Initiative hormone therapy trials. DESIGN, SETTING, AND PARTICIPANTS Observational follow-up of US multiethnic postmenopausal women aged 50 to 79 years enrolled in 2 randomized clinical trials between 1993 and 1998 and followed up through December 31, 2014. INTERVENTIONS Conjugated equine estrogens (CEE, 0.625mg/d) plus medroxyprogesterone acetate (MPA, 2.5mg/d) (n = 8506) vs placebo (n = 8102) for 5.6 years (median) or CEE alone (n = 5310) vs placebo (n = 5429) for 7.2 years (median). MAIN OUTCOMES AND MEASURES All-cause mortality (primary outcome) and cause-specific mortality (cardiovascular disease mortality, cancer mortality, and other major causes of mortality) in the 2 trials pooled and in each trial individually, with prespecified analyses by 10-year age group based on age at time of randomization. RESULTS Among 27 347 women who were randomized (baseline mean [SD] age, 63.4 [7.2] years; 80.6% white), mortality follow-up was available for more than 98%. During the cumulative 18-year follow-up, 7489 deaths occurred (1088 deaths during the intervention phase and 6401 deaths during postintervention follow-up). All-cause mortality was 27.1% in the hormone therapy group vs 27.6% in the placebo group (hazard ratio [HR], 0.99 [95% CI, 0.94-1.03]) in the overall pooled cohort; with CEE plus MPA, the HR was 1.02 (95% CI, 0.96-1.08); and with CEE alone, the HR was 0.94 (95% CI, 0.88-1.01). In the pooled cohort for cardiovascular mortality, the HR was 1.00 (95% CI, 0.92-1.08 [8.9% with hormone therapy vs 9.0% with placebo]); for total cancer mortality, the HR was 1.03 (95% CI, 0.95-1.12 [8.2% with hormone therapy vs 8.0% with placebo]); and for other causes, the HR was 0.95 (95% CI, 0.88-1.02 [10.0% with hormone therapy vs 10.7% with placebo]), and results did not differ significantly between trials. When examined by 10-year age groups comparing younger women (aged 50-59 years) to older women (aged 70-79 years) in the pooled cohort, the ratio of nominal HRs for all-cause mortality was 0.61 (95% CI, 0.43-0.87) during the intervention phase and the ratio was 0.87 (95% CI, 0.76-1.00) during cumulative 18-year follow-up, without significant heterogeneity between trials. CONCLUSIONS AND RELEVANCE Among postmenopausal women, hormone therapy with CEE plus MPA for a median of 5.6 years or with CEE alone for a median of 7.2 years was not associated with risk of all-cause, cardiovascular, or cancer mortality during a cumulative follow-up of 18 years.	[Manson, Joann E.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave,3rd Flr, Boston, MA 02115 USA; [Aragaki, Aaron K.; Anderson, Garnet L.; Prentice, Ross L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Rossouw, Jacques E.] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [LaCroix, Andrea Z.] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Chlebowski, Rowan T.] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Howard, Barbara V.] MedStar Hlth Res Inst, Washington, DC USA; [Howard, Barbara V.] Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC USA; [Thomson, Cynthia A.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, Tucson, AZ USA; [Margolis, Karen L.] HealthPartners Inst Educ & Res, Minneapolis, MN USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Stefanick, Marcia L.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA USA; [Jackson, Rebecca D.] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Martin, Lisaw.] George Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC USA; [Shumaker, Sally A.] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Wactawski-Wende, Jean] Univ Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; City of Hope; MedStar Health Research Institute; University of Arizona; University of Alabama System; University of Alabama Birmingham; Stanford University; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Health Science Center; George Washington University; Wake Forest University; Wake Forest University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave,3rd Flr, Boston, MA 02115 USA.	jmanson@rics.bwh.harvard.edu	Wactawski-Wende, Jean/AGH-5457-2022	Wactawski-Wende, Jean/0000-0003-3096-9595; Margolis, Karen/0000-0003-1862-7402	NHLBI, NIH; US Department of Health and Human Services [HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001409] Funding Source: NIH RePORTER	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Women's Health Initiative is funded by the NHLBI, NIH, and the US Department of Health and Human Services through contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C. Wyeth Ayerst donated the study drugs.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Archer DF, 2009, CLIMACTERIC, V12, P368, DOI 10.1080/13697130903195606; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; BUSH TL, 1983, JAMA-J AM MED ASSOC, V249, P903, DOI 10.1001/jama.249.7.903; Chlebowski RT, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv350; Chlebowski RT, 2015, JAMA ONCOL, V1, P296, DOI 10.1001/jamaoncol.2015.0494; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; FOLSOM AR, 1995, AM J PUBLIC HEALTH, V85, P1128, DOI 10.2105/AJPH.85.8_Pt_1.1128; Goodman NF, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S6.1; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Manson JE, 2016, JAMA-J AM MED ASSOC, V315, P2273, DOI 10.1001/jama.2016.3676; Manson JE, 2016, NEW ENGL J MED, V374, P803, DOI 10.1056/NEJMp1514242; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; [National Center for Health Statistics Centers for Disease Control and Prevention US Department of Health and Human Services], NATL VITAL STAT REPO, V64; Reijmer YD, 2011, DIABETES-METAB RES, V27, P195, DOI 10.1002/dmrr.1163; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Sarrel P, 2015, MENOPAUSE, V22, P260, DOI [10.1097/GME.0000000000000320, 10.1097/gme.0000000000000320]; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236	38	291	302	2	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					927	938		10.1001/jama.2017.11217	http://dx.doi.org/10.1001/jama.2017.11217			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898378	Green Accepted			2022-12-28	WOS:000410487100014
J	Oliver, D				Oliver, David			David Oliver: What GPs told me about how they see the future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Davidoliver372@googlemail.com						[Anonymous], 2017, BMJ, V357, pj3059, DOI 10.1136/bmj.j3059; Campbell D, 2017, GUARDIAN; King's Fund, 2016, UND PRESS GEN PRACT; MAJEED A, 2017, BMJ-BRIT MED J, V358, P94250, DOI DOI 10.1136/BMJ.J3191; MCCARTNEY M, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3457; OLIVER D, 2017, BMJ BRIT MED J, V357; Royal College of General Practitioners, 2016, GEN PRACT FORW VIEW	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2017	358								j3976	10.1136/bmj.j3976	http://dx.doi.org/10.1136/bmj.j3976			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH6MX	28899849	Green Published, Bronze			2022-12-28	WOS:000411292200001
J	Hainmueller, J; Lawrence, D; Marten, L; Black, B; Figueroa, L; Hotard, M; Jimenez, TR; Mendoza, F; Rodriguez, MI; Swartz, JJ; Laitin, DD				Hainmueller, Jens; Lawrence, Duncan; Marten, Linna; Black, Bernard; Figueroa, Lucila; Hotard, Michael; Jimenez, Tomas R.; Mendoza, Fernando; Rodriguez, Maria I.; Swartz, Jonas J.; Laitin, David D.			Protecting unauthorized immigrant mothers improves their children's mental health	SCIENCE			English	Article							REGRESSION-DISCONTINUITY DESIGNS; LABOR-MARKET; UNITED-STATES; LEGAL STATUS; ADOLESCENCE; DEPRESSION; DISORDERS; ANXIETY; CARE	The United States is embroiled in a debate about whether to protect or deport its estimated 11 million unauthorized immigrants, but the fact that these immigrants are also parents to more than 4 million U.S.-born children is often overlooked. We provide causal evidence of the impact of parents' unauthorized immigration status on the health of their U.S. citizen children. The Deferred Action for Childhood Arrivals (DACA) program granted temporary protection from deportation to more than 780,000 unauthorized immigrants. We used Medicaid claims data from Oregon and exploited the quasi-random assignment of DACA eligibility among mothers with birthdates close to the DACA age qualification cutoff. Mothers' DACA eligibility significantly decreased adjustment and anxiety disorder diagnoses among their children. Parents' unauthorized status is thus a substantial barrier to normal child development and perpetuates health inequalities through the intergenerational transmission of disadvantage.	[Hainmueller, Jens; Laitin, David D.] Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA; [Hainmueller, Jens; Lawrence, Duncan; Marten, Linna; Figueroa, Lucila; Hotard, Michael; Laitin, David D.] Stanford Univ, Immigrat Policy Lab, Stanford, CA 94305 USA; [Hainmueller, Jens] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Marten, Linna] Uppsala Univ, Uppsala Ctr Labor Studies, S-75120 Uppsala, Sweden; [Black, Bernard] Northwestern Univ, Pritzker Law Sch, Chicago, IL 60611 USA; [Black, Bernard] Northwestern Univ, Kellogg Sch Management, Chicago, IL 60611 USA; [Figueroa, Lucila] Univ Virginia, Dept Polit, Charlottesville, VA 22903 USA; [Jimenez, Tomas R.] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Mendoza, Fernando] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Rodriguez, Maria I.; Swartz, Jonas J.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA	Stanford University; Stanford University; Stanford University; Uppsala University; Northwestern University; Northwestern University; University of Virginia; Stanford University; Stanford University; Oregon Health & Science University	Hainmueller, J (corresponding author), Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA.; Hainmueller, J (corresponding author), Stanford Univ, Immigrat Policy Lab, Stanford, CA 94305 USA.; Hainmueller, J (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	jhain@stanford.edu		Black, Bernard/0000-0002-6499-0600; Laitin, David/0000-0002-7911-7089; Hainmueller, Jens/0000-0001-8214-9041; Mendoza, Fernando/0000-0001-5516-4588; Marten, Linna/0000-0002-0368-1716; Rodriguez, Maria Isabel/0000-0002-3127-2581; Swartz, Jonas/0000-0002-9726-965X	Russell Sage Foundation [93-16-12]; Ford Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD085809] Funding Source: NIH RePORTER	Russell Sage Foundation; Ford Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by a grant from the Russell Sage Foundation (grant no. 93-16-12). We also acknowledge funding from the Ford Foundation for operational support of the Stanford Immigration Policy Lab. For helpful advice, we thank K. Bansak, V. G. Carrion, A. Hainmueller, and J. Wang. Replication code is available through Harvard Dataverse (https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/8EEDAP). A preregistered analysis plan is available at the Evidence and Governance in Politics website under study ID 20170227AC (http://egap.org/designregistrations). The analysis plan is also reprinted in the supplementary materials. The Institutional Review Boards at Stanford University (protocol 40907) and Oregon Health & Science University (protocol 15633) approved this research.	Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Amuedo-Dorantes C, 2017, J POPUL ECON, V30, P339, DOI 10.1007/s00148-016-0606-z; Bean F. D., 2015, PARENTS PAPERS PROGR; Bean FD, 2011, INT MIGR REV, V45, P348, DOI 10.1111/j.1747-7379.2011.00851.x; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Berk R, 2010, J EXP CRIMINOL, V6, P191, DOI 10.1007/s11292-010-9095-3; C. H. C. Foundation, 2013, MED FACTS FIG PROGR; Caballero TM, 2017, CLIN PEDIATR, V56, P648, DOI 10.1177/0009922816679509; Calonico S, 2014, ECONOMETRICA, V82, P2295, DOI 10.3982/ECTA11757; Capps R., 2016, PROFILE US CHILDREN; Cook TD, 2008, J POLICY ANAL MANAG, V27, P724, DOI 10.1002/pam.20375; Currie J, 2010, J HUM RESOUR, V45, P517; Derose KP, 2007, HEALTH AFFAIR, V26, P1258, DOI 10.1377/hlthaff.26.5.1258; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1085, DOI 10.1001/jama.297.10.1085; Gonzales RG, 2014, AM BEHAV SCI, V58, P1852, DOI 10.1177/0002764214550288; Hyman S.L., 2007, PEDIAT CLIN ADVISOR, P369; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Oropesa RS, 2015, SOC SCI MED, V138, P57, DOI 10.1016/j.socscimed.2015.05.038; Orrenius P. M., 2012, CATO J, V32, P85; Passel J.S., 2014, GROWTH STALLS UNAUTH; Patler C, 2018, SOC SCI MED, V199, P39, DOI 10.1016/j.socscimed.2017.03.009; Pope NG, 2016, J PUBLIC ECON, V143, P98, DOI 10.1016/j.jpubeco.2016.08.014; Potochnick SR, 2010, J NERV MENT DIS, V198, P470, DOI 10.1097/NMD.0b013e3181e4ce24; Rivera-Batiz FL, 1999, J POPUL ECON, V12, P91, DOI 10.1007/s001480050092; Schatzberg A. F., 2015, DIAGNOSTIC STAT MANU; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Skoufias E., 2004, EVALUATION PERFORMAN; Smith JP, 2006, J LABOR ECON, V24, P203, DOI 10.1086/499971; Suarez-Orozco C, 2011, HARVARD EDUC REV, V81, P438, DOI 10.17763/haer.81.3.g23x203763783m75; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; U. S. Government Accountability Office U. S. Labor Force Statistics, 2009, GAO1099; Van Hook J, 2015, DEMOGRAPHY, V52, P329, DOI 10.1007/s13524-014-0358-x; Venkataramani AS, 2017, LANCET PUBLIC HEALTH, V2, pE175, DOI 10.1016/S2468-2667(17)30047-6; Waters M. C., 2015, INTEGRATION IMMIGRAN; Yoshikawa H, 2017, J RES ADOLESCENCE, V27, P4, DOI 10.1111/jora.12272; Yoshikawa H, 2011, CHILD DEV PERSPECT, V5, P291, DOI 10.1111/j.1750-8606.2011.00204.x; Yun K, 2013, MATERN CHILD HLTH J, V17, P1913, DOI 10.1007/s10995-012-1217-2	38	76	75	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1041	1044		10.1126/science.aan5893	http://dx.doi.org/10.1126/science.aan5893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28860206	Bronze, Green Accepted			2022-12-28	WOS:000409455700045
J	Cerrato, E; Varbella, F				Cerrato, Enrico; Varbella, Ferdinando			Left Ventricular Free-Wall Rupture	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cerrato, Enrico; Varbella, Ferdinando] Infermi Rivoli & San Luigi Gonzaga Univ Hosp, Turin, Italy	Azienda Ospedaliero-Universitaria San Luigi Gonzaga	Cerrato, E (corresponding author), Infermi Rivoli & San Luigi Gonzaga Univ Hosp, Turin, Italy.	enrico.cerrato@gmail.com	Cerrato, Enrico/AAO-6799-2020; VARBELLA, FERDINANDO/AAA-9428-2019	Cerrato, Enrico/0000-0002-1260-7534; VARBELLA, FERDINANDO/0000-0002-8213-359X					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					E13	E13		10.1056/NEJMicm1613367	http://dx.doi.org/10.1056/NEJMicm1613367			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF9XU	28877028				2022-12-28	WOS:000409373100001
J	Stewart, E; Federico, SM; Chen, X; Shelat, AA; Bradley, C; Gordon, B; Karlstrom, A; Twarog, NR; Clay, MR; Bahrami, A; Freeman, BB; Xu, BS; Zhou, X; Wu, JR; Honnell, V; Ocarz, M; Blankenship, K; Dapper, J; Mardis, ER; Wilson, RK; Downing, J; Zhang, JH; Easton, J; Pappo, A; Dyer, MA				Stewart, Elizabeth; Federico, Sara M.; Chen, Xiang; Shelat, Anang A.; Bradley, Cori; Gordon, Brittney; Karlstrom, Asa; Twarog, Nathaniel R.; Clay, Michael R.; Bahrami, Armita; Freeman, Burgess B., III; Xu, Beisi; Zhou, Xin; Wu, Jianrong; Honnell, Victoria; Ocarz, Monica; Blankenship, Kaley; Dapper, Jason; Mardis, Elaine R.; Wilson, Richard K.; Downing, James; Zhang, Jinghui; Easton, John; Pappo, Alberto; Dyer, Michael A.			Orthotopic patient-derived xenografts of paediatric solid tumours	NATURE			English	Article							PANOBINOSTAT LBH589; GENOMIC LANDSCAPE; MULTIPLE-MYELOMA; CANCER; DISCOVERY; HETEROGENEITY; BORTEZOMIB; INHIBITOR; BIOBANK; MODELS	Paediatric solid tumours arise from endodermal, ectodermal, or mesodermal lineages(1). Although the overall survival of children with solid tumours is 75%, that of children with recurrent disease is below 30%(2). To capture the complexity and diversity of paediatric solid tumours and establish new models of recurrent disease, here we develop a protocol to produce orthotopic patient-derived xenografts at diagnosis, recurrence, and autopsy. Tumour specimens were received from 168 patients, and 67 orthotopic patient-derived xenografts were established for 12 types of cancer. The origins of the patient-derived xenograft tumours were reflected in their gene-expression profiles and epigenomes. Genomic profiling of the tumours, including detailed clonal analysis, was performed to determine whether the clonal population in the xenograft recapitulated the patient's tumour. We identified several drug vulnerabilities and showed that the combination of a WEE1 inhibitor (AZD1775), irinotecan, and vincristine can lead to complete response in multiple rhabdomyosarcoma orthotopic patient-derived xenografts tumours in vivo.	[Stewart, Elizabeth; Federico, Sara M.; Ocarz, Monica; Blankenship, Kaley; Pappo, Alberto] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Stewart, Elizabeth; Bradley, Cori; Gordon, Brittney; Karlstrom, Asa; Honnell, Victoria; Dapper, Jason; Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chen, Xiang; Xu, Beisi; Zhou, Xin; Zhang, Jinghui; Easton, John] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Shelat, Anang A.; Twarog, Nathaniel R.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gordon, Brittney] St Jude Childrens Res Hosp, Dept Small Anim Imaging, 332 N Lauderdale St, Memphis, TN 38105 USA; [Clay, Michael R.; Bahrami, Armita; Downing, James] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Freeman, Burgess B., III] St Jude Childrens Res Hosp, Dept Preclin Pharmacokinet Shared Resource, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wu, Jianrong] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO 63108 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO 63108 USA; [Mardis, Elaine R.] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Med, St Louis, MO 63108 USA; [Dyer, Michael A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Dyer, Michael A.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Siteman Cancer Center; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Howard Hughes Medical Institute; University of Tennessee System; University of Tennessee Health Science Center	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Dyer, MA (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Dyer, MA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Federico, Sara/N-8159-2018; Karlström, Åsa/A-8448-2015; Chen, Xiang/N-2524-2018; Clay, Michael R/N-3866-2018; Shelat, Anang/J-4995-2013; Dyer, Michael/N-8134-2018; Wilson, Richard K./AAF-4139-2019; Xu, Beisi/C-8560-2009; Zhang, Jing/GWZ-7332-2022; Mardis, Elaine/W-2202-2019; Bahrami, Armita/N-3262-2018	Karlström, Åsa/0000-0003-3847-7309; Chen, Xiang/0000-0002-2499-8261; Clay, Michael R/0000-0003-1659-8927; Shelat, Anang/0000-0002-6266-2910; Wilson, Richard K./0000-0002-1992-1358; Xu, Beisi/0000-0003-0099-858X; Bahrami, Armita/0000-0002-8515-2649; Easton, John/0000-0003-4503-6608	Cancer Center Support from the National Institutes of Health [CA21765, EY014867, EY018599, CA168875]; American Lebanese Syrian Associated Charities; Howard Hughes Medical Institute; Alex Lemonade Stand; Tully Family Foundation; Peterson Foundation; St. Baldrick's Foundation; National Pediatric Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA219686, R01CA168875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014867, R01EY018599] Funding Source: NIH RePORTER	Cancer Center Support from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alex Lemonade Stand; Tully Family Foundation; Peterson Foundation; St. Baldrick's Foundation; National Pediatric Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank A. McArthur for editing the manuscript. This work was supported by Cancer Center Support (CA21765), grants to M.A.D. from the National Institutes of Health (EY014867, EY018599, and CA168875), and American Lebanese Syrian Associated Charities. M.A.D. was also supported by the Howard Hughes Medical Institute, Alex Lemonade Stand, Tully Family and Peterson Foundations. E.S. was supported by the St. Baldrick's Foundation and the National Pediatric Cancer Foundation.	Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bruna A, 2016, CELL, V167, P260, DOI 10.1016/j.cell.2016.08.041; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Chen X, 2015, ONCOGENE, V34, P5207, DOI 10.1038/onc.2014.474; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Langenau DM, 2015, CANCER RES, V75, P5176, DOI 10.1158/0008-5472.CAN-15-1308; Liang XR, 2011, BIOANALYSIS, V3, P1923, DOI [10.4155/bio.11.181, 10.4155/BIO.11.181]; Ocio EM, 2010, HAEMATOL-HEMATOL J, V95, P794, DOI 10.3324/haematol.2009.015495; Pinto EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7302; R Core Team, 2012, R LANG ENV STAT COMP; Reece DE, 2011, CANCER CHEMOTH PHARM, V67, P57, DOI 10.1007/s00280-010-1283-3; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Ritz C, 2005, J STAT SOFTW, V12, P1; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Stewart E, 2016, DEV BIOL, V411, P287, DOI 10.1016/j.ydbio.2015.03.001; Stewart E, 2014, CELL REP, V9, P829, DOI 10.1016/j.celrep.2014.09.028; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Townsend EC, 2016, CANCER CELL, V30, P183, DOI 10.1016/j.ccell.2016.06.008; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Xie CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079106; Zarzosa P, 2017, CLIN TRANSL ONCOL, V19, P44, DOI 10.1007/s12094-016-1557-2	30	148	153	1	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					96	+		10.1038/nature23647	http://dx.doi.org/10.1038/nature23647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28854174	Green Accepted			2022-12-28	WOS:000409388700040
J	Zhou, Y; Zhong, N; Li, XC; Chen, S; Zheng, J; Zhao, D; Yao, W; Zhi, R; Wei, L; He, B; Zhang, X; Yang, C; Li, Y; Li, F; Du, J; Gui, J; Hu, B; Bai, C; Huang, P; Chen, G; Xu, Y; Wang, C; Liang, B; Li, YH; Hu, G; Tan, H; Ye, X; Ma, X; Chen, Y; Hu, X; Tian, J; Zhu, X; Shi, Z; Du, X; Li, M; Liu, S; Yu, R; Zhao, J; Ma, Q; Xie, C; Li, XB; Chen, T; Lin, Y; Zeng, LZ; Ye, C; Ye, W; Luo, X; Zeng, LS; Yu, S; Guan, W; Ran, P				Zhou, Y.; Zhong, N.; Li, Xiaochen; Chen, S.; Zheng, J.; Zhao, D.; Yao, W.; Zhi, R.; Wei, L.; He, B.; Zhang, X.; Yang, C.; Li, Ying; Li, F.; Du, J.; Gui, J.; Hu, B.; Bai, C.; Huang, P.; Chen, G.; Xu, Y.; Wang, C.; Liang, B.; Li, Yinhuan; Hu, G.; Tan, H.; Ye, X.; Ma, X.; Chen, Y.; Hu, X.; Tian, J.; Zhu, X.; Shi, Z.; Du, X.; Li, M.; Liu, S.; Yu, R.; Zhao, J.; Ma, Q.; Xie, C.; Li, Xiongbin; Chen, T.; Lin, Y.; Zeng, Lizhen; Ye, C.; Ye, W.; Luo, X.; Zeng, Lingshan; Yu, S.; Guan, W.; Ran, P.			Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG-FUNCTION DECLINE; COPD; CHINA; EXACERBATIONS; PREVALENCE; DIAGNOSIS; BURDEN	BACKGROUND Patients with mild or moderate chronic obstructive pulmonary disease (COPD) rarely receive medications, because they have few symptoms. We hypothesized that long-term use of tiotropium would improve lung function and ameliorate the decline in lung function in patients with mild or moderate COPD. METHODS In a multicenter, randomized, double-blind, placebo-controlled trial that was conducted in China, we randomly assigned 841 patients with COPD of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 1 (mild) or 2 (moderate) severity to receive a once-daily inhaled dose (18 mu g) of tiotropium (419 patients) or matching placebo (422) for 2 years. The primary end point was the between-group difference in the change from baseline to 24 months in the forced expiratory volume in 1 second (FEV 1) before bronchodilator use. Secondary end points included the between-group difference in the change from baseline to 24 months in the FEV 1 after bronchodilator use and the between-group difference in the annual decline in the FEV 1 before and after bronchodilator use from day 30 to month 24. RESULTS Of 841 patients who underwent randomization, 388 patients in the tiotropium group and 383 in the placebo group were included in the full analysis set. The FEV 1 in patients who received tiotropium was higher than in those who received placebo throughout the trial (ranges of mean differences, 127 to 169 ml before bronchodilator use and 71 to 133 ml after bronchodilator use; P<0.001 for all comparisons). There was no significant amelioration of the mean (+/- SE) annual decline in the FEV 1 before bronchodilator use: the decline was 38 +/- 6 ml per year in the tiotropium group and 53 +/- 6 ml per year in the placebo group (difference, 15 ml per year; 95% confidence interval [CI], -1 to 31; P = 0.06). In contrast, the annual decline in the FEV 1 after bronchodilator use was significantly less in the tiotropium group than in the placebo group (29 +/- 5 ml per year vs. 51 +/- 6 ml per year; difference, 22 ml per year [95% CI, 6 to 37]; P = 0.006). The incidence of adverse events was generally similar in the two groups. CONCLUSIONS Tiotropium resulted in a higher FEV 1 than placebo at 24 months and ameliorated the annual decline in the FEV 1 after bronchodilator use in patients with COPD of GOLD stage 1 or 2. (Funded by Boehringer Ingelheim and others; Tie-COPD ClinicalTrials.gov number, NCT01455129.)	[Zhou, Y.; Zhong, N.; Li, Xiaochen; Chen, S.; Zheng, J.; Zhao, D.; Yao, W.; Ran, P.] First Affiliated Hosp, Guangzhou Inst Resp Dis, Natl Ctr Resp Dis, State Key Lab Resp Dis, Wenzhou, Peoples R China; [Li, F.; Chen, Y.] Liwan Hosp, Guangzhou, Guangdong, Peoples R China; [Zhi, R.; Li, Yinhuan] Guangzhou Med Univ, Guangzhou Panyu Ctr Hosp, Guangzhou, Guangdong, Peoples R China; [Xie, C.] Natl Sun Yat Sen Univ, Affiliated Hosp 1, Kaohsiung, Taiwan; Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [He, B.; Tan, H.] Chenzhou 1 Peoples Hosp, Chenzhou, Peoples R China; [Zhang, X.; Ye, X.] Guizhou Prov Peoples Hosp, Guiyang, Guizhou, Peoples R China; [Yang, C.; Zeng, Lizhen; Ye, C.] Wengyuan Cty Peoples Hosp, Shaoguan, Peoples R China; [Chen, T.] Shaoguan Iron & Steel Grp Co Ltd Hosp, Shaoguan, Peoples R China; [Li, Ying; Ma, X.] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Du, J.; Hu, X.] Affiliated Hosp, GuiYang Med Coll, Guiyang, Guizhou, Peoples R China; [Gui, J.; Tian, J.] Second Peoples Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Hu, B.; Shi, Z.] Huizhou First Hosp, Huizhou, Peoples R China; Fudan Univ, Affiliated Zhongshan, Shanghai, Peoples R China; [Yu, R.] Shanghai Xuhui Cent Hosp, Shanghai, Peoples R China; [Huang, P.; Du, X.] Shenzhen Sixth Peoples Hosp, Shenzhen, Peoples R China; [Chen, G.; Li, M.] First Peoples Hosp Foshan, Foshan, Peoples R China; [Xu, Y.; Zhao, J.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wang, C.; Ma, Q.] Xinqiao Hosp, Chongqing, Peoples R China; [Yao, W.; Liang, B.] Guangdong Med Univ, Affiliated Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Xiongbin] Second Peoples Hosp Zhanjiang, Zhanjiang, Peoples R China; [Lin, Y.] Beijing Chao Yang Hosp, Beijing, Peoples R China; [Ye, W.; Luo, X.; Zeng, Lingshan; Yu, S.] Lianping Cty Peoples Hosp, Heyuan, Peoples R China	Guangzhou Medical University; National Sun Yat Sen University; Jinan University; Zhengzhou University; Guizhou Medical University; Fudan University; Huazhong University of Science & Technology; Army Medical University; Guangdong Medical University; Capital Medical University	Ran, P (corresponding author), 151 Yanjiang Xi Rd, Guangzhou 510120, Guangdong, Peoples R China.	pxran@gzhmu.edu.cn	Guan, Wei-jie/K-8257-2019	Zhao, Jianping/0000-0003-3057-5617; Bai, Chunxue/0000-0001-5798-3130; Ma, Qianli/0000-0003-4504-1933; Zhao, Dongxing/0000-0002-4080-4754; Ran, Pixin/0000-0001-6651-634X; xie, canmao/0000-0002-3134-7416	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Funded by Boehringer Ingelheim and others; Tie-COPD ClinicalTrials.gov number, NCT01455129.	[Anonymous], 2017, GLOB IN CHRON OBSTR; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bhatt SP, 2016, AM J RESP CRIT CARE, V194, P178, DOI 10.1164/rccm.201511-2219OC; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Guan WJ, 2016, LANCET, V388, P1939, DOI 10.1016/S0140-6736(16)31597-5; Johansson Gunnar, 2008, Prim Care Respir J, V17, P169, DOI 10.3132/pcrj.2008.00037; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Lee HY, 2015, INT J CHRONIC OBSTR, V10, P2185, DOI 10.2147/COPD.S91901; Li XC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003991; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mapel DW, 2011, INT J CHRONIC OBSTR, V6, P573, DOI 10.2147/COPD.S16975; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Tantucci C, 2012, INT J CHRONIC OBSTR, V7, P95, DOI 10.2147/COPD.S27480; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tashkin DP, 2012, COPD, V9, P289, DOI 10.3109/15412555.2012.656211; Troosters T, 2010, EUR RESPIR J, V36, P65, DOI 10.1183/09031936.00127809; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Welte T, 2015, INT J CLIN PRACT, V69, P336, DOI 10.1111/ijcp.12522; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou YM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001621	26	137	178	7	266	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					923	935		10.1056/NEJMoa1700228	http://dx.doi.org/10.1056/NEJMoa1700228			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF9XU	28877027	Bronze			2022-12-28	WOS:000409373100006
J	Hampton, T				Hampton, Tracy			Organoids Reveal Clues to Gut-Brain Communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	7	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					787	788		10.1001/jama.2017.11545	http://dx.doi.org/10.1001/jama.2017.11545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873141				2022-12-28	WOS:000409183700002
J	Voelker, R				Voelker, Rebecca			MRI for Neonates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					790	790		10.1001/jama.2017.10934	http://dx.doi.org/10.1001/jama.2017.10934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NC	28873146				2022-12-28	WOS:000426800500001
J	Kimmelman, J; Carlisle, B; Gonen, M				Kimmelman, Jonathan; Carlisle, Benjamin; Gonen, Mithat			Drug Development at the Portfolio Level Is Important for Policy, Care Decisions and Human Protections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kimmelman, Jonathan; Carlisle, Benjamin] McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, 3647 Rue Peel, Montreal, PQ H3A 1X1, Canada; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	McGill University; Memorial Sloan Kettering Cancer Center	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Studies Translat Eth & Med STREAM, 3647 Rue Peel, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca	Carlisle, Benjamin/AAD-6332-2020; Gonen, Mithat/E-4826-2012	Carlisle, Benjamin/0000-0001-8975-0649; Gonen, Mithat/0000-0001-8683-8477	Canadian Institutes of Health Research [EOG111391]; National Institutes of Health [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Canadian Institutes of Health Research (EOG111391) and National Institutes of Health (P30 CA008748).	BAUER P, 1991, STAT MED, V10, P871, DOI 10.1002/sim.4780100609; Brawley L., 20 AGENTS 803 TRIALS; Carlisle B, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv292; EFRON B, 1977, SCI AM, V236, P119, DOI 10.1038/scientificamerican0577-119; Grignani G, 2012, ANN ONCOL, V23, P508, DOI 10.1093/annonc/mdr151; James W, 1960, P 4 BERKELEY SYMPO S, V1, P361, DOI DOI 10.1007/978-1-4612-0919-5; Lipsky AM, 2010, ANN EMERG MED, V55, P544, DOI [10.1016/j.annemergmed.2009.08.010, 10.1016/j.annemergmed.2010.01.002]; Mattina J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000487; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602	9	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP	2017	318	11					1003	1004		10.1001/jama.2017.11502	http://dx.doi.org/10.1001/jama.2017.11502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7DP	28837722				2022-12-28	WOS:000411343400008
J	Sorigue, D; Legeret, B; Cuine, S; Blangy, S; Moulin, S; Billon, E; Richaud, P; Brugiere, S; Coute, Y; Nurizzo, D; Muller, P; Brettel, K; Pignol, D; Arnoux, P; Li-Beisson, Y; Peltier, G; Beisson, F				Sorigue, Damien; Legeret, Bertrand; Cuine, Stephan; Blangy, Stephanie; Moulin, Solene; Billon, Emmanuelle; Richaud, Pierre; Brugiere, Sabine; Coute, Yohann; Nurizzo, Didier; Mueller, Pavel; Brettel, Klaus; Pignol, David; Arnoux, Pascal; Li-Beisson, Yonghua; Peltier, Gilles; Beisson, Fred			An algal photoenzyme converts fatty acids to hydrocarbons	SCIENCE			English	Article							MICROBIAL BIOSYNTHESIS; DNA-REPAIR; MECHANISMS; PHOTORECEPTORS; PROTEINS	Although many organisms capture or respond to sunlight, few enzymes are known to be driven by light. Among these are DNA photolyases and the photosynthetic reaction centers. Here, we show that the microalga Chlorella variabilis NC64A harbors a photoenzyme that acts in lipid metabolism. This enzyme belongs to an algae-specific clade of the glucose-methanol-choline oxidoreductase family and catalyzes the decarboxylation of free fatty acids to n-alkanes or -alkenes in response to blue light. Crystal structure of the protein reveals a fatty acid-binding site in a hydrophobic tunnel leading to the light-capturing flavin adenine dinucleotide ( FAD) cofactor. The decarboxylation is initiated through electron abstraction from the fatty acid by the photoexcited FAD with a quantum yield >80%. This photoenzyme, which we name fatty acid photodecarboxylase, may be useful in light-driven, bio-based production of hydrocarbons.	[Sorigue, Damien; Legeret, Bertrand; Cuine, Stephan; Blangy, Stephanie; Moulin, Solene; Billon, Emmanuelle; Richaud, Pierre; Li-Beisson, Yonghua; Peltier, Gilles; Beisson, Fred] Commissariat Energie Atom & Energies Alternat CEA, CNRS, Biosci & Biotechnol Inst Aix Marseille BIAM, F-13108 St Paul Les Durance, France; [Sorigue, Damien; Legeret, Bertrand; Cuine, Stephan; Blangy, Stephanie; Moulin, Solene; Billon, Emmanuelle; Richaud, Pierre; Li-Beisson, Yonghua; Peltier, Gilles; Beisson, Fred] Aix Marseille Univ, UMR 7265 LB3M, CEA Cadarache, F-13108 St Paul Les Durance, France; [Brugiere, Sabine; Coute, Yohann] Univ Grenoble Alpes, CEA, F-38000 Grenoble, France; [Brugiere, Sabine; Coute, Yohann] INSERM, BIG BGE, F-38000 Grenoble, France; [Nurizzo, Didier] European Synchrotron Radiat Facil, 71 Ave Martyrs,CS 40220, F-38043 Grenoble, France; [Mueller, Pavel; Brettel, Klaus] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, F-91198 Gif Sur Yvette, France; [Pignol, David; Arnoux, Pascal] CEA, CNRS, BIAM, F-13108 St Paul Les Durance, France; [Pignol, David; Arnoux, Pascal] Aix Marseille Univ, UMR LBC 7265, CEA Cadarache, F-13108 St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Aix-Marseille Universite; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); European Synchrotron Radiation Facility (ESRF); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Aix-Marseille Universite	Beisson, F (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, CNRS, Biosci & Biotechnol Inst Aix Marseille BIAM, F-13108 St Paul Les Durance, France.; Beisson, F (corresponding author), Aix Marseille Univ, UMR 7265 LB3M, CEA Cadarache, F-13108 St Paul Les Durance, France.	frederic.beisson@cea.fr	PELTIER, Gilles/ABD-4484-2021; Couté, Yohann/G-2695-2015; Beisson, Frederic/AAX-9165-2021; Moulin, Solène/E-9538-2019; Müller, Pavel/I-8299-2012; Li-Beisson, Yonghua/C-7047-2011; Sorigué, Damien/AAU-2750-2021	PELTIER, Gilles/0000-0002-2226-3931; Couté, Yohann/0000-0003-3896-6196; Moulin, Solène/0000-0002-7347-1247; Müller, Pavel/0000-0002-3245-0810; Li-Beisson, Yonghua/0000-0003-1064-1816; Sorigué, Damien/0000-0003-1149-0757; Billon, Emmanuelle/0000-0001-7278-456X; ARNOUX, Pascal/0000-0003-4609-4893; Sabine, BRUGIERE/0000-0002-0757-0968; PIGNOL, David/0000-0002-8070-0319; Beisson, Frederic/0000-0001-9995-7387	L'Agence Nationale de la Recherche (ANR) [MUSCA ANR-13-JSV5-0005, A*MIDEX ANR-11-IDEX-0001-02]; European Union (EU) (Sun2Chem project of ERASynBio); French Infrastructure for Integrated Structural Biology [ANR-10-INSB-05-01]; Proteomics French Infrastructure [ANR-10-INBS-08-01]; HelioBiotec platform - EU; region Provence-Alpes-Cote-d'Azur (PACA); French Ministry of Research; CEA; region PACA; Ecole Normale Superieure Paris	L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Union (EU) (Sun2Chem project of ERASynBio); French Infrastructure for Integrated Structural Biology; Proteomics French Infrastructure; HelioBiotec platform - EU; region Provence-Alpes-Cote-d'Azur (PACA)(Region Provence-Alpes-Cote d'Azur); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CEA(French Atomic Energy Commission); region PACA(Region Provence-Alpes-Cote d'Azur); Ecole Normale Superieure Paris	We thank J. Ohlrogge for critical reading of the manuscript. Thanks are also due to V. Cardettini, A. Beyly, I. Te, P. Auroy, A. Beynel, J. Alric, C. Sahut, D. Lemaire, and F. Carriere for technical help or discussions. This work was supported by grants from L'Agence Nationale de la Recherche (ANR) (MUSCA ANR-13-JSV5-0005 to Y.L-B. and A*MIDEX ANR-11-IDEX-0001-02 to G.P.), the European Union (EU) (Sun2Chem project of ERASynBio), the French Infrastructure for Integrated Structural Biology (ANR-10-INSB-05-01), the Proteomics French Infrastructure (ANR-10-INBS-08-01), and the HelioBiotec platform funded by the EU, the region Provence-Alpes-Cote-d'Azur (PACA), the French Ministry of Research, and the CEA. PhD studentships were provided by the region PACA and the CEA (D.S.) and the Ecole Normale Superieure Paris (S.M.). F.B. conceived the project. P. A., D.N., and D. P. acquired x-ray data and resolved the protein structure. S.B. and Y.C. performed the proteomic analysis. P.M. and K.B. performed measurements and analyzed data of time-resolved spectrometry. D.S. executed other experiments and analyzed data with the help of all other authors. F.B., D.S., K.B., P.M., and P. A wrote the paper with contributions from G.P., D. P., Y.C., B.L., P.R., and Y.B.-L. The coding sequence of the C. variabilis FAP has been deposited in GenBank under accession no. KY511411. Atomic coordinates and structure factors have been deposited in the Protein Data Bank (PDB) under accession no. 5NCC. All other data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials. D.S., F.B., B.L., S.C., S.B., and G.P. are inventors on patent application EPA 16305583 submitted by CEA and CNRS that covers "New fatty acid decarboxylase and its uses."	BEGLEY TP, 1994, ACCOUNTS CHEM RES, V27, P394, DOI 10.1021/ar00048a002; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Bjorn L. O., 2015, PHOTOBIOLOGY SCI LIG, P139; Bornscheuer UT, 2016, NATURE, V540, P345, DOI 10.1038/540345a; Brettel K, 2010, CURR OPIN STRUC BIOL, V20, P693, DOI 10.1016/j.sbi.2010.07.003; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; DENNIS M, 1992, P NATL ACAD SCI USA, V89, P5306, DOI 10.1073/pnas.89.12.5306; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Emmanuel MA, 2016, NATURE, V540, P414, DOI 10.1038/nature20569; FULLER KK, 2015, CURR GENET, V61, P275, DOI DOI 10.1007/s00294-014-0451-0; Gabruk M, 2015, BIOCHEMISTRY-US, V54, P5255, DOI 10.1021/acs.biochem.5b00704; Greenham K, 2015, NAT REV GENET, V16, P598, DOI 10.1038/nrg3976; HEELIS PF, 1982, CHEM SOC REV, V11, P15, DOI 10.1039/cs9821100015; Ho MY, 2016, SCIENCE, V353, DOI 10.1126/science.aaf9178; KRAEUTLER B, 1978, J AM CHEM SOC, V100, P2239, DOI 10.1021/ja00475a049; Macheroux P., 1999, FLAVOPROTEIN PROTOCO; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Melkozernov AN, 2006, BIOCHEMISTRY-US, V45, P331, DOI 10.1021/bi051932o; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Rui Z, 2014, P NATL ACAD SCI USA, V111, P18237, DOI 10.1073/pnas.1419701112; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Sorigue D, 2016, PLANT PHYSIOL, V171, P2393, DOI 10.1104/pp.16.00462; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Yoshii T, 2015, J NEUROSCI, V35, P6131, DOI 10.1523/JNEUROSCI.0070-15.2015; Zhang K, 2015, TRENDS BIOTECHNOL, V33, P92, DOI 10.1016/j.tibtech.2014.11.007; Zhong DP, 2007, CURR OPIN CHEM BIOL, V11, P174, DOI 10.1016/j.cbpa.2007.02.034; Zhong DP, 2015, ANNU REV PHYS CHEM, V66, P691, DOI 10.1146/annurev-physchem-040513-103631	32	197	204	26	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					903	907		10.1126/science.aan6349	http://dx.doi.org/10.1126/science.aan6349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860382	Green Submitted			2022-12-28	WOS:000408734900039
J	Nayak, AK; Kumar, V; Ma, TP; Werner, P; Pippel, E; Sahoo, R; Damay, F; Rossler, UK; Felser, C; Parkin, SSP				Nayak, Ajaya K.; Kumar, Vivek; Ma, Tianping; Werner, Peter; Pippel, Eckhard; Sahoo, Roshnee; Damay, Francoise; Roessler, Ulrich K.; Felser, Claudia; Parkin, Stuart S. P.			Magnetic antiskyrmions above room temperature in tetragonal Heusler materials	NATURE			English	Article							REAL-SPACE OBSERVATION; SKYRMION LATTICE; CHIRAL MAGNET; DRIVEN	Magnetic skyrmions are topologically stable, vortex-like objects surrounded by chiral boundaries that separate a region of reversed magnetization from the surrounding magnetized material(1-3). They are closely related to nanoscopic chiral magnetic domain walls, which could be used as memory and logic elements for conventional and neuromorphic computing applications that go beyond Moore's law. Of particular interest is 'racetrack memory', which is composed of vertical magnetic nanowires, each accommodating of the order of 100 domain walls, and that shows promise as a solid state, nonvolatile memory with exceptional capacity and performance(4,5). Its performance is derived from the very high speeds (up to one kilometre per second) at which chiral domain walls can be moved with nanosecond current pulses in synthetic antiferromagnet racetracks. Because skyrmions are essentially composed of a pair of chiral domain walls closed in on themselves, but are, in principle, more stable to perturbations than the component domain walls themselves, they are attractive for use in spintronic applications, notably racetrack memory. Stabilization of skyrmions has generally been achieved in systems with broken inversion symmetry, in which the asymmetric Dzyaloshinskii-Moriya interaction modifies the uniform magnetic state to a swirling state(6,7). Depending on the crystal symmetry, two distinct types of skyrmions have been observed experimentally, namely, Bloch(7,8) and Neel skyrmions(9). Here we present the experimental manifestation of another type of skyrmion-the magnetic antiskyrmion-in acentric tetragonal Heusler compounds with D-2d crystal symmetry. Antiskyrmions are characterized by boundary walls that have alternating Bloch and Neel type as one traces around the boundary. A spiral magnetic ground-state, which propagates in the tetragonal basal plane, is transformed into an antiskyrmion lattice state under magnetic fields applied along the tetragonal axis over a wide range of temperatures. Direct imaging by Lorentz transmission electron microscopy shows field-stabilized antiskyrmion lattices and isolated antiskyrmions from 100 kelvin to well beyond room temperature, and zero-field metastable antiskyrmions at low temperatures. These results enlarge the family of magnetic skyrmions and pave the way to the engineering of complex bespoke designed skyrmionic structures.	[Nayak, Ajaya K.; Ma, Tianping; Werner, Peter; Pippel, Eckhard; Parkin, Stuart S. P.] Max Planck Inst Microstruct Phys, Weinberg 2, D-06120 Halle, Germany; [Kumar, Vivek; Sahoo, Roshnee; Felser, Claudia] Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany; [Damay, Francoise] CEA Saclay, CNRS, Lab Leon Brillouin, CEA, F-91191 Gif Sur Yvette, France; [Roessler, Ulrich K.] IFW Dresden, POB 270116, D-01171 Dresden, Germany; [Nayak, Ajaya K.] NISER, Sch Phys Sci, Bhubaneswar 752050, Jatni, India	Max Planck Society; Max Planck Society; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institute for Integrative Nanosciences (IIN); Leibniz Institute for Solid State & Materials Research Dresden; National Institute of Science Education & Research (NISER)	Parkin, SSP (corresponding author), Max Planck Inst Microstruct Phys, Weinberg 2, D-06120 Halle, Germany.	stuart.parkin@mpi-halle.mpg.de	Parkin, Stuart/D-2521-2012; Felser, Claudia/A-5779-2009	Parkin, Stuart/0000-0003-4702-6139; Felser, Claudia/0000-0002-8200-2063	ERC [670166, 291472]	ERC(European Research Council (ERC)European Commission)	We thank H. Blumtritt and N. Schammelt for their help in preparing TEM lamellae for this study. This work was financially supported by the ERC Advanced Grant No. 670166 "SORBET" and the ERC Advanced Grant No. 291472 "Idea Heusler".	Barker J, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.147203; Beleggia M, 2003, ULTRAMICROSCOPY, V96, P93, DOI 10.1016/S0304-3991(02)00402-3; Beleggia M, 2003, APPL PHYS LETT, V83, P1435, DOI 10.1063/1.1603355; Bogdanov AN, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.214410; BOGDANOV AN, 1989, ZH EKSP TEOR FIZ+, V95, P178; Boulle O, 2016, NAT NANOTECHNOL, V11, P449, DOI 10.1038/nnano.2015.315; CHAPMAN JN, 1984, J PHYS D APPL PHYS, V17, P623, DOI 10.1088/0022-3727/17/4/003; Donahue M. J., 1999, 6376 NISTIR; Fert A, 2013, NAT NANOTECHNOL, V8, P152, DOI 10.1038/nnano.2013.29; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/NPHYS2045, 10.1038/nphys2045]; Jeong J., 2016, NAT COMMUN, V7; Jiang WJ, 2015, SCIENCE, V349, P283, DOI 10.1126/science.aaa1442; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Karube K, 2016, NAT MATER, V15, P1237, DOI [10.1038/nmat4752, 10.1038/NMAT4752]; Kezsmarki I, 2015, NAT MATER, V14, P1116, DOI [10.1038/NMAT4402, 10.1038/nmat4402]; Koshibae W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10542; Li YF, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.117202; Meshcheriakova O, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.087203; Milde P, 2013, SCIENCE, V340, P1076, DOI 10.1126/science.1234657; Moreau-Luchaire C, 2016, NAT NANOTECHNOL, V11, P444, DOI 10.1038/nnano.2015.313; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nayak AK, 2015, NAT MATER, V14, P679, DOI [10.1038/nmat4248, 10.1038/NMAT4248]; Oike H, 2016, NAT PHYS, V12, P62, DOI [10.1038/NPHYS3506, 10.1038/nphys3506]; Parkin S, 2015, NAT NANOTECHNOL, V10, P195, DOI 10.1038/nnano.2015.41; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Rohart S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184422; Schulz T, 2012, NAT PHYS, V8, P301, DOI [10.1038/NPHYS2231, 10.1038/nphys2231]; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Tanigaki T, 2015, NANO LETT, V15, P5438, DOI 10.1021/acs.nanolett.5b02653; Tokunaga Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8638; Walton SK, 2013, IEEE T MAGN, V49, P4795, DOI 10.1109/TMAG.2013.2247410; Woo S, 2016, NAT MATER, V15, P501, DOI [10.1038/NMAT4593, 10.1038/nmat4593]; Yang SH, 2015, NAT NANOTECHNOL, V10, P221, DOI [10.1038/NNANO.2014.324, 10.1038/nnano.2014.324]; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Zhang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31248	36	396	399	28	434	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					561	+		10.1038/nature23466	http://dx.doi.org/10.1038/nature23466			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28846999	Green Submitted			2022-12-28	WOS:000408703100034
J	Sridhar, D; Winters, J; Strong, E				Sridhar, Devi; Winters, Janelle; Strong, Eleanor			World Bank's financing, priorities, and lending structures for global health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sridhar, Devi; Winters, Janelle; Strong, Eleanor] Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland	University of Edinburgh	Sridhar, D (corresponding author), Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland.	devi.sridhar@ed.ac.uk		Winters, Janelle/0000-0002-3450-7673	Wellcome Trust [106635/Z/14/Z]	Wellcome Trust(Wellcome Trust)	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. This work was supported by Wellcome Trust [106635/Z/14/Z]. A senior member of the World Bank is on our project's advisory board.	Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; Abbasi K, 1999, BRIT MED J, V318, P865, DOI 10.1136/bmj.318.7187.865; Alliance GAVI, 2014, ANN FIN REP 2013; Ayres RL, 1983, BANKING POOR WORLD B; Clift C., 2013, WHO WORLD BANK UNIVE; Clinton C, 2017, GOVERNING GLOBAL HLT; CRANE BB, 1981, WORLD POLIT, V33, P516, DOI 10.2307/2010134; Fair M., 2008, POPULATION LENDING H; Farmer P, 2013, CALIF SER PUB ANTHR, V26, P1; Fernandes G, 2017, BMJ-BRIT MED J, V358, pj3995; Global Fund to Fight AIDS Tuberculosis and Malaria, 2014, ANN FIN REP 2013; Harman Sophie, 2010, WORLD BANK HIV AIDS; Horton R, 2014, LANCET, V384, P840, DOI 10.1016/S0140-6736(14)61458-6; Institute for Health Metrics and Evaluation (IHME), 2016, FIN GLOB HLTH VIS; Ruger JP, 2005, AM J PUBLIC HEALTH, V95, P60, DOI 10.2105/AJPH.2004.042002; Sridhar D, 2010, VERTICAL FUNDS HLTH; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; Sridhar D, 2011, HEALTH POLICY PLANN, V26, P12, DOI 10.1093/heapol/czq016; Stein F, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3397; Storeng KT, 2014, GLOB PUBLIC HEALTH, V9, P865, DOI 10.1080/17441692.2014.940362; Tichenor M, 2017, BMJ-BRIT MED J, V358, pj3347; Winters J, 2017, BMJ-BRIT MED J, V358, pj3394; Woods N., 2003, HEGEMONY INT ORG, DOI [10.1093/0199261431.003.0005, DOI 10.1093/0199261431.003.0005]; World Bank, 2013, COMMUNICATION; World Bank, 2007, AFR MULT AIDS PROGR; World Bank, 2014, WORLD BANK ANN REP 2; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Bank, 2017, NEW IBRD IDA HNP SEC; World Bank, 2016, PROJ OP; World Bank, 2017, COMMUNICATION; World Bank, 2016, WORLD BANK LEND SECT; World Bank Group, 2013, 2013 TRUST FUND ANN; World Bank Group Finances, 2017, PAID CONTR IBRD IDA; World Health Organization, 2014, FIN REP AUD FIN STAT	34	6	6	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3339	10.1136/bmj.j3339	http://dx.doi.org/10.1136/bmj.j3339			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG0CQ	28860129	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000409387000002
J	Silvera, I; Dias, R				Silvera, Isaac; Dias, Ranga			Response to Comment on "Observation of the Wigner-Huntington transition to metallic hydrogen"	SCIENCE			English	Editorial Material								Goncharov and Struzhkin present comments on our observation of metallic hydrogen. We show that most of their comments are unfounded and that our observation of a transition to a shiny, high-reflectance phase remains as evidence that hydrogen has transformed to the metallic phase.	[Silvera, Isaac; Dias, Ranga] Harvard Univ, Lyman Lab Phys, Cambridge, MA 02138 USA	Harvard University	Silvera, I (corresponding author), Harvard Univ, Lyman Lab Phys, Cambridge, MA 02138 USA.	silvera@physics.harvard.edu		Silvera, Isaac/0000-0001-8586-8391				Akahama Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012195; Dias R., 2016, ARXIV160302162CONDMA; Dias RP, 2017, SCIENCE, V357; Dias RP, 2017, SCIENCE, V355, P715, DOI 10.1126/science.aal1579; Eremets MI, 2003, J RAMAN SPECTROSC, V34, P515, DOI 10.1002/jrs.1044; Gamboa E J, 2017, SLACPUB16488; Goncharov AF, 2017, SCIENCE, V357, DOI 10.1126/science.aam9736; Knudson MD, 2015, SCIENCE, V348, P1455, DOI 10.1126/science.aaa7471; Loubeyre P, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.144115; Vohra Y. K., 1992, AIRAPT RECENT TRENDS, P349; Zha CS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.146402	11	12	12	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353							eaan1215	10.1126/science.aan1215	http://dx.doi.org/10.1126/science.aan1215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839044				2022-12-28	WOS:000408327900002
J	Siwy, Z; Fornasiero, F				Siwy, Zuzanna; Fornasiero, Francesco			Improving on aquaporins	SCIENCE			English	Editorial Material							CARBON NANOTUBES; MEMBRANES; TRANSPORT		[Siwy, Zuzanna] Univ Calif Irvine, Irvine, CA 92697 USA; [Fornasiero, Francesco] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Irvine; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Siwy, Z (corresponding author), Univ Calif Irvine, Irvine, CA 92697 USA.	zsiwy@uci.edu		Fornasiero, Francesco/0000-0002-3505-5867				Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Geng J, 2014, NATURE, V514, P612, DOI 10.1038/nature13817; Guo SR, 2015, ADV MATER, V27, P5726, DOI 10.1002/adma.201500372; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Tang CY, 2013, DESALINATION, V308, P34, DOI 10.1016/j.desal.2012.07.007; Tunuguntla RH, 2017, SCIENCE, V357, P792, DOI 10.1126/science.aan2438; Werber JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.18	11	18	18	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					753	753		10.1126/science.aao2440	http://dx.doi.org/10.1126/science.aao2440			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839059	Green Submitted			2022-12-28	WOS:000408327900023
J	Wright, A				Wright, Alex			Maryam Mirzakhani (1977-2017)	SCIENCE			English	Biographical-Item									[Wright, Alex] Stanford Univ, Dept Math, Stanford, CA 94305 USA	Stanford University	Wright, A (corresponding author), Stanford Univ, Dept Math, Stanford, CA 94305 USA.	amwright@stanford.edu	Khan, Sameen/K-6146-2013	Khan, Sameen/0000-0003-1264-2302					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					758	758		10.1126/science.aao6074	http://dx.doi.org/10.1126/science.aao6074			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839063				2022-12-28	WOS:000408327900027
J	Holmes, D				Holmes, David			CRITICAL LIMB ISCHAEMIA: ARTERY REPAIR	NATURE			English	Editorial Material																		Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037	1	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					S41	S41		10.1038/548S41a	http://dx.doi.org/10.1038/548S41a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28832559	Bronze			2022-12-28	WOS:000408279000001
J	Arie, S				Arie, Sophie			QUALITY IMPROVEMENT Can we save the NHS by reducing unwarranted variation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Arie S., 2017, BMJ-BRIT MED J, V358, pj3701, DOI [10.1136/bmj.j3701, DOI 10.1136/BMJ.J3701]; Briggs T., 2015, NATL REV ADULT ORTHO; Timmins N., 2017, TACKLING VARIATIONS	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2017	358								j3952	10.1136/bmj.j3952	http://dx.doi.org/10.1136/bmj.j3952			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF1SR	28835468				2022-12-28	WOS:000408679700003
J	Li, JY; Ivan, D; Patel, AB				Li, Janet Y.; Ivan, Doina; Patel, Anisha B.			Acral retiform purpura	LANCET			English	Editorial Material									[Li, Janet Y.; Patel, Anisha B.] MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA; [Ivan, Doina] MD Anderson Canc Ctr, Dept Dermatol, Houston, TX USA; [Patel, Anisha B.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Li, JY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA.	janetylimd@gmail.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2382	2382		10.1016/S0140-6736(17)31362-4	http://dx.doi.org/10.1016/S0140-6736(17)31362-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN6IX	28890159				2022-12-28	WOS:000416118700023
J	Hovingh, GK; Boekholdt, SM; Stroes, ES				Hovingh, G. Kees; Boekholdt, S. Matthijs; Stroes, Erik S.			Very low LDL-cholesterol concentrations achieved: which target is next?	LANCET			English	Editorial Material									[Hovingh, G. Kees; Stroes, Erik S.] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; [Boekholdt, S. Matthijs] Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hovingh, GK (corresponding author), Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands.	g.k.hovingh@amc.uva.nl		Boekholdt, Matthijs/0000-0002-0861-0765	Amgen; Sanofi-Aventis; Regeneron; Pfizer; Akcea; Chiesi	Amgen(Amgen); Sanofi-Aventis(Sanofi-Aventis); Regeneron(Regeneron); Pfizer(Pfizer); Akcea; Chiesi(Chiesi Pharmaceuticals Inc)	GKH has participated in advisory boards for and has received lecture fees (for lectures about lipid-lowering therapy in general) from Amgen, Sanofi-Aventis, Regeneron; and has received lecture fees (for lectures about lipid-lowering therapy in general) from Pfizer. SMB has participated in advisory boards for Pfizer and Sanofi-Aventis about lipid-lowering therapy in general. ESS has participated in advisory boards for and has received lecture fees (for lectures about lipid-lowering therapy in general) from Amgen, Sanofi-Aventis, and Akcea; and has received lecture fees (for lectures about lipid-lowering therapy in general) from Chiesi.	Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Giugliano RP, 2017, NEW ENGL J MED, V377, P633, DOI 10.1056/NEJMoa1701131; Giugliano RP, 2017, LANCET; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2017	390	10106					1930	1931		10.1016/S0140-6736(17)32292-4	http://dx.doi.org/10.1016/S0140-6736(17)32292-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK9HW	28859941				2022-12-28	WOS:000413823200014
J	Cannon, CP; Bhatt, DL; Oldgren, J; Lip, GYH; Ellis, SG; Kimura, T; Maeng, M; Merkely, B; Zeymer, U; Gropper, S; Nordaby, M; Kleine, E; Harper, R; Manassie, J; Januzzi, JL; ten Berg, JM; Steg, G; Hohnloser, SH				Cannon, Christopher P.; Bhatt, Deepak L.; Oldgren, Jonas; Lip, Gregory Y. H.; Ellis, Stephen G.; Kimura, Takeshi; Maeng, Michael; Merkely, Bela; Zeymer, Uwe; Gropper, Savion; Nordaby, Matias; Kleine, Eva; Harper, Ruth; Manassie, Jenny; Januzzi, James L.; ten Berg, Jurrien M.; Steg, Gabriel; Hohnloser, Stefan H.		RE-DUAL PCI Steering Comm	Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TRIPLE THERAPY; ORAL ANTICOAGULATION; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CONSENSUS DOCUMENT; WARFARIN; ASSOCIATION; RIVAROXABAN; STRATEGIES	BACKGROUND Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, but this therapy is associated with a high risk of bleeding. METHODS In this multicenter trial, we randomly assigned 2725 patients with atrial fibrillation who had undergone PCI to triple therapy with warfarin plus a P2Y(12) inhibitor (clopidogrel or ticagrelor) and aspirin (for 1 to 3 months) (triple-therapy group) or dual therapy with dabigatran (110 mg or 150 mg twice daily) plus a P2Y(12) inhibitor (clopidogrel or ticagrelor) and no aspirin (110-mg and 150-mg dual-therapy groups). Outside the United States, elderly patients (>= 80 years of age; >= 70 years of age in Japan) were randomly assigned to the 110-mg dual-therapy group or the triple-therapy group. The primary end point was a major or clinically relevant nonmajor bleeding event during follow-up (mean follow-up, 14 months). The trial also tested for the noninferiority of dual therapy with dabigatran (both doses combined) to triple therapy with warfarin with respect to the incidence of a composite efficacy end point of thromboembolic events (myocardial infarction, stroke, or systemic embolism), death, or unplanned revascularization. RESULTS The incidence of the primary end point was 15.4% in the 110-mg dual-therapy group as compared with 26.9% in the triple-therapy group (hazard ratio, 0.52; 95% confidence interval [CI], 0.42 to 0.63; P<0.001 for noninferiority; P<0.001 for superiority) and 20.2% in the 150-mg dual-therapy group as compared with 25.7% in the corresponding triple-therapy group, which did not include elderly patients outside the United States (hazard ratio, 0.72; 95% CI, 0.58 to 0.88; P<0.001 for noninferiority). The incidence of the composite efficacy end point was 13.7% in the two dual-therapy groups combined as compared with 13.4% in the triple-therapy group (hazard ratio, 1.04; 95% CI, 0.84 to 1.29; P=0.005 for noninferiority). The rate of serious adverse events did not differ significantly among the groups. CONCLUSIONS Among patients with atrial fibrillation who had undergone PCI, the risk of bleeding was lower among those who received dual therapy with dabigatran and a P2Y(12) inhibitor than among those who received triple therapy with warfarin, a P2Y(12) inhibitor, and aspirin. Dual therapy was noninferior to triple therapy with respect to the risk of thromboembolic events.	[Cannon, Christopher P.; Januzzi, James L.] Baim Inst Clin Res, 930 Commonwealth Ave, Boston, MA 02215 USA; [Cannon, Christopher P.; Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Cannon, Christopher P.; Bhatt, Deepak L.; Januzzi, James L.] Harvard Med Sch, Boston, MA USA; [Januzzi, James L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Oldgren, Jonas] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Oldgren, Jonas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England; [Harper, Ruth; Manassie, Jenny] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England; [Steg, Gabriel] Imperial Coll, London, England; [Ellis, Stephen G.] Cleveland Clin, Cleveland, OH 44106 USA; [Kimura, Takeshi] Kyoto Univ, Dept Cardiovasc Med, Kyoto, Japan; [Maeng, Michael] Aarhus Univ Hosp, Skejby, Denmark; [Merkely, Bela] Univ Heart & Vasc Ctr, Budapest, Hungary; [Zeymer, Uwe] Klinikum Stadt Ludwigshafen Rhein, Med Klin B, Ludwigshafen, Germany; [Gropper, Savion; Nordaby, Matias; Kleine, Eva] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Dept Med, Div Cardiol, Frankfurt, Germany; [ten Berg, Jurrien M.] St Antonius Hosp, Nieuwegein, Netherlands; [Steg, Gabriel] Univ Paris Diderot, French Alliance Cardiovasc Trials, F CRIN Network, DHU FIRE,INSERM,Unite 1148, Paris, France; [Steg, Gabriel] Hop Bichat Assistance Publ, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Uppsala University; Uppsala University; University of Birmingham; Boehringer Ingelheim; Imperial College London; Cleveland Clinic Foundation; Kyoto University; Aarhus University; Semmelweis University; Ludwigshafen Hospital; Boehringer Ingelheim; Goethe University Frankfurt; St. Antonius Hospital Utrecht; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Cannon, CP (corresponding author), Baim Inst Clin Res, 930 Commonwealth Ave, Boston, MA 02215 USA.	christopher.cannon@baiminstitute.org	Senni, Michele/J-9380-2018; Marchev, Sotir/AAH-6529-2020; Frey, Norbert/A-9695-2010; Cannon, Christopher P/AAY-7644-2020; Duerschmied, D./K-8182-2015; Januzzi, James/Y-2436-2019; Khasanov, Niiaz/W-7678-2019; MELEK, MEHMET/ABI-1308-2020; Pinto, Fausto/G-9363-2015; Brusich, Sandro/S-3072-2018; SILVAIN, Johanne/C-7521-2016	Senni, Michele/0000-0001-5502-7882; Marchev, Sotir/0000-0001-9250-510X; Cannon, Christopher P/0000-0003-4596-2791; Duerschmied, D./0000-0001-5249-4012; Khasanov, Niiaz/0000-0002-7760-0763; Pinto, Fausto/0000-0002-8034-4529; Brusich, Sandro/0000-0001-7394-6698; Lanas, Fernando/0000-0003-3595-9759; A. Samad, Bassem/0000-0001-9440-5073; Westermann, Dirk/0000-0002-7542-1956; Airaksinen, Juhani/0000-0002-0193-568X; Tan, Ru San/0000-0003-2086-6517; Rha, Seung-Woon/0000-0001-9456-9852; Mahon, Niall/0000-0002-2872-2297; CARRIE, didier/0000-0003-2479-8144; Opolski, Grzegorz/0000-0003-4744-2554; Merkely, Bela/0000-0001-6514-0723; SILVAIN, Johanne/0000-0002-1901-2808; Wachter, Rolf/0000-0003-2231-2200; Wongcharoen, Wanwarang/0000-0002-2418-329X; Rumoroso, Jose Ramon/0000-0003-1613-1374; Van de Werf, Frans/0000-0001-9479-7767	Boehringer Ingelheim; Arisaph Pharmaceuticals; Takeda Pharmaceuticals; Bristol-Myers Squibb; Amgen; Merck; Janssen; Daiichi Sankyo; LipimetiX; Pfizer; Sanofi; Regeneron; Kowa; Alnylam; Amarin; GlaxoSmith-Kline; AstraZeneca; Eisai; Ethicon; Medtronic; Sanofi-Aventis; Medicines Company; Roche; Forest Laboratories-AstraZeneca; Ischemix; Lilly; Chiesi; Ironwood Pharmaceuticals; Elsevier; Medscape Cardiology; Regado Biosciences; Cardax; WebMD; Bayer; Bayer-Janssen; Biotronik; Bristol-Myers Squibb-Pfizer; Microlife; Boston Scientific; Terumo; Novartis; Prevencio; Siemens; Singulex; Eli Lilly; Accumetrics; ZonMw; CSL Behring; Merck Sharpe Dohme; Bayer Healthcare; Zoll	Boehringer Ingelheim(Boehringer Ingelheim); Arisaph Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Bristol-Myers Squibb(Bristol-Myers Squibb); Amgen(Amgen); Merck(Merck & Company); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Daiichi Sankyo(Daiichi Sankyo Company Limited); LipimetiX; Pfizer(Pfizer); Sanofi; Regeneron(Regeneron); Kowa; Alnylam; Amarin; GlaxoSmith-Kline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Eisai(Eisai Co Ltd); Ethicon; Medtronic(Medtronic); Sanofi-Aventis(Sanofi-Aventis); Medicines Company; Roche(Roche Holding); Forest Laboratories-AstraZeneca; Ischemix; Lilly(Eli Lilly); Chiesi(Chiesi Pharmaceuticals Inc); Ironwood Pharmaceuticals; Elsevier; Medscape Cardiology; Regado Biosciences; Cardax; WebMD; Bayer(Bayer AG); Bayer-Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech IncBayer AG); Biotronik; Bristol-Myers Squibb-Pfizer(Bristol-Myers SquibbPfizer); Microlife; Boston Scientific(Boston Scientific); Terumo; Novartis(Novartis); Prevencio; Siemens(Siemens AG); Singulex; Eli Lilly(Eli Lilly); Accumetrics; ZonMw(Netherlands Organization for Health Research and Development); CSL Behring; Merck Sharpe Dohme(Merck & Company); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Zoll	Supported by Boehringer Ingelheim.; Dr. Cannon reports receiving research support and consulting fees from Arisaph Pharmaceuticals, Takeda Pharmaceuticals, Bristol-Myers Squibb, Amgen, and Merck, research support from Janssen and Daiichi Sankyo, and consulting fees from LipimetiX, Pfizer, Sanofi, Regeneron, Kowa, Alnylam, Amarin, GlaxoSmith-Kline, AstraZeneca, and Eisai; Dr. Bhatt, receiving research support from Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, Sanofi-Aventis, The Medicines Company, Roche, Pfizer, Forest Laboratories-AstraZeneca, Ischemix, Amgen, Lilly, Chiesi, and Ironwood Pharmaceuticals, fees for serving on data and safety monitoring committees and a clinical trial steering committee from Population Health Research Institute, advisory board fees from Elsevier, Medscape Cardiology, Regado Biosciences, and Cardax, fees for serving on CME steering committees from WebMD, fees for serving as site co-investigator for Biotronik and Boston Scientific, fees for serving on data and safety monitoring committees from Icahn School of Medicine at Mount Sinai, and fees for serving in various editorial roles (editor-in-chief of the Harvard Heart Letter for Belvoir Publications, chief medical editor of Cardiology Today's Intervention for Slack Publications, editor-in-chief of the Journal of Invasive Cardiology from HMP Communications, and deputy editor of Clinical Cardiology), and participating in an unfunded research collaboration with FlowCo, PLx Pharma, Takeda, and Merck; Dr. Oldgren, receiving lecture fees and consulting fees, paid to his institution, from Bayer, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, and Sanofi; Dr. Lip, receiving lecture fees from Bayer and Roche, consulting fees from Bayer-Janssen and Biotronik, and lecture fees and consulting fees from Bristol-Myers Squibb-Pfizer, Medtronic, Boehringer Ingelheim, Microlife, and Daiichi Sankyo; Dr. Maeng, receiving advisory board fees from Bayer and AstraZeneca; Dr. Merkely, receiving grant support from Boston Scientific and Biotronik, and lecture fees from Medtronic and Terumo; Dr. Zeymer, receiving lecture fees from Novartis and Sanofi, lecture fees and consulting fees from The Medicines Company and Amgen, and grant support, lecture fees, and consulting fees from AstraZeneca; Dr. Gropper, Dr. Nordaby, Ms. Kleine, Dr. Harper, and Ms. Manassie, being employed by Boehringer Ingelheim; Dr. Januzzi, receiving grant support and consulting fees from Roche, grant support from Prevencio, Siemens, and Singulex, fees for serving on data and safety monitoring boards for Amgen, grant support and fees for serving on a clinical end-point adjudication committee for Novartis, consulting fees and fees for serving on a clinical end-point adjudication committee for Janssen, fees for serving on clinical end-point adjudication committees for Pfizer, AbbVie, and Bayer; Dr. ten Berg, receiving grant support, advisory board fees, consulting fees, and lecture fees from AstraZeneca, advisory board fees, consulting fees, and lectures fees from Eli Lilly, Daiichi Sankyo, The Medicines Company, Accumetrics, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, and Bayer, and grant support from ZonMw; Dr.; Steg, receiving fees for serving on a steering committee from Amarin, Janssen, and CSL Behring, fees for serving on a steering committee and lecture fees from AstraZeneca, lecture fees and consulting fees from Bayer and Bristol-Myers Squibb, fees for preparation of educational material from Boehringer Ingelheim, consulting fees and fees for serving on a data and safety monitoring board from Lilly and Merck Sharpe & Dohme, consulting fees from Novartis and Regeneron, fees for serving on a critical event committee from Pfizer, grant support, fees for serving on a steering committee, and consulting fees from Sanofi, and grant support, fees for serving on a steering committee, consulting fees, and fees for serving on a data and safety monitoring board from Servier; and Dr. Hohnloser, receiving consulting fees and fees for serving on a speaker bureau from Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb, Daiichi Sankyo, Pfizer, Medtronic, and Zoll. No other potential conflict of interest relevant to this article was reported.	Andrade JG, 2013, CAN J CARDIOL, V29, P204, DOI 10.1016/j.cjca.2012.06.012; Angiolillo DJ, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004395; Bhatt DL, 2017, CIRCULATION, V135, P334, DOI 10.1161/CIRCULATIONAHA.116.025923; Cannon CP, 2016, CLIN CARDIOL, V39, P555, DOI 10.1002/clc.22572; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Depta JP, 2009, AM J CARDIOL, V104, P1171, DOI 10.1016/j.amjcard.2009.06.027; Dewilde WJM, 2014, J AM COLL CARDIOL, V64, P1270, DOI 10.1016/j.jacc.2014.06.1193; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Faxon DP, 2011, THROMB HAEMOSTASIS, V106, P572, DOI 10.1160/TH11-04-0262; Fiedler KA, 2015, J AM COLL CARDIOL, V65, P1619, DOI 10.1016/j.jacc.2015.02.050; Gibson CM, 2017, CIRCULATION, V135, P323, DOI 10.1161/CIRCULATIONAHA.116.025783; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Jackson K, 2008, AM HEART J, V155, P829, DOI 10.1016/j.ahj.2008.01.023; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lamberts M, 2013, J AM COLL CARDIOL, V62, P981, DOI 10.1016/j.jacc.2013.05.029; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Lemesle G, 2017, CLIN CARDIOL; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Steg PG, 2017, EUR HEART J-ACUTE CA, V6, P93, DOI 10.1177/2048872615610868; Vardi M, 2014, CLIN CARDIOL, V37, P103, DOI 10.1002/clc.22226; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	29	824	855	2	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2017	377	16					1513	1524		10.1056/NEJMoa1708454	http://dx.doi.org/10.1056/NEJMoa1708454			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK1LU	28844193	Green Published, Bronze			2022-12-28	WOS:000413243900005
J	Varmus, H				Varmus, Harold			A Prize for Cancer Prevention	CELL			English	Editorial Material							VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS TYPE-16; L1; VACCINE; YEAST	This year's Lasker-DeBakey Prize for Clinical Research to Douglas Lowy and John Schiller celebrates the science behind one of the greatest advances in the history of cancer research: the development of vaccines that prevent infection and thus prevent tumor induction by pathogenic strains of human papilloma virus (HPV).	[Varmus, Harold] Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA	Cornell University	Varmus, H (corresponding author), Weill Cornell Med, Meyer Canc Ctr, New York, NY 10065 USA.	varmus@med.cornell.edu						BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Harro CD, 2001, JNCI-J NATL CANCER I, V93, P284, DOI 10.1093/jnci/93.4.284; Jemal A., 2017, J NAT CANC I, V109; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Pytynia KB, 2014, ORAL ONCOL, V50, P380, DOI 10.1016/j.oraloncology.2013.12.019; ROGERS S, 1951, J EXP MED, V93, P459, DOI 10.1084/jem.93.5.459; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schiller JT, 2011, HISTORY OF VACCINE DEVELOPMENT, P265, DOI 10.1007/978-1-4419-1339-5_27; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4	18	1	1	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					14	17		10.1016/j.cell.2017.08.020	http://dx.doi.org/10.1016/j.cell.2017.08.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28888324	hybrid			2022-12-28	WOS:000411331800004
J	Giuliano, AE; Ballman, KV; McCall, L; Beitsch, PD; Brennan, MB; Kelemen, PR; Ollila, DW; Hansen, NM; Whitworth, PW; Blumencranz, PW; Leitch, AM; Saha, S; Hunt, KK; Morrow, M				Giuliano, Armando E.; Ballman, Karla V.; McCall, Linda; Beitsch, Peter D.; Brennan, Meghan B.; Kelemen, Pond R.; Ollila, David W.; Hansen, Nora M.; Whitworth, Pat W.; Blumencranz, Peter W.; Leitch, A. Marilyn; Saha, Sukamal; Hunt, Kelly K.; Morrow, Monica			Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis The ACOSOG Z0011 (Alliance) Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOCOREGIONAL RECURRENCE; AMERICAN-COLLEGE; SURGERY; IRRADIATION; CRITERIA; THERAPY; IMPACT	IMPORTANCE The results of the American College of Surgeons Oncology Group Z0011 (ACOSOG Z0011) trial were first reported in 2005 with a median follow-up of 6.3 years. Longer follow-up was necessary because the majority of the patients had estrogen receptor-positive tumors that may recur later in the disease course (the ACOSOG is now part of the Alliance for Clinical Trials in Oncology). OBJECTIVE To determine whether the 10-year overall survival of patients with sentinel lymph node metastases treated with breast-conserving therapy and sentinel lymph node dissection (SLND) alone without axillary lymph node dissection (ALND) is noninferior to that of women treated with axillary dissection. DESIGN, SETTING, AND PARTICIPANTS The ACOSOG Z0011 phase 3 randomized clinical trial enrolled patients from May 1999 to December 2004 at 115 sites (both academic and community medical centers). The last date of follow-up was September 29, 2015, in the ACOSOG Z0011 (Alliance) trial. Eligible patients were women with clinical T1 or T2 invasive breast cancer, no palpable axillary adenopathy, and 1 or 2 sentinel lymph nodes containing metastases. INTERVENTIONS All patients had planned lumpectomy, planned tangential whole-breast irradiation, and adjuvant systemic therapy. Third-field radiation was prohibited. MAIN OUTCOMES AND MEASURES The primary outcome was overall survival with a noninferiority hazard ratio (HR) margin of 1.3. The secondary outcome was disease-free survival. RESULTS Among 891 women who were randomized (median age, 55 years), 856 (96%) completed the trial (446 in the SLND alone group and 445 in the ALND group). At a median follow-up of 9.3 years (interquartile range, 6.93-10.34 years), the 10-year overall survival was 86.3% in the SLND alone group and 83.6% in the ALND group (HR, 0.85 [1-sided 95% CI, 0-1.16]; noninferiority P =.02). The 10-year disease-free survival was 80.2% in the SLND alone group and 78.2% in the ALND group (HR, 0.85 [95% CI, 0.62-1.17]; P =.32). Between year 5 and year 10, 1 regional recurrence was seen in the SLND alone group vs none in the ALND group. Ten-year regional recurrence did not differ significantly between the 2 groups. CONCLUSIONS AND RELEVANCE Among women with T1 or T2 invasive primary breast cancer, no palpable axillary adenopathy, and 1 or 2 sentinel lymph nodes containing metastases, 10-year overall survival for patients treated with sentinel lymph node dissection alone was noninferior to overall survival for those treated with axillary lymph node dissection. These findings do not support routine use of axillary lymph node dissection in this patient population based on 10-year outcomes.	[Giuliano, Armando E.] Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Ballman, Karla V.] New York Presbyterian Hosp, Weill Cornell Med, Alliance Stat & Data Ctr, New York, NY USA; [McCall, Linda] Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA; [Beitsch, Peter D.] Dallas Surg Grp, Dallas, TX USA; [Brennan, Meghan B.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Clin Res Unit, TRIO US Network, Los Angeles, CA 90024 USA; [Kelemen, Pond R.] Dobbs Ferry, Ashikari Breast Ctr, New York, NY USA; [Ollila, David W.] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Hansen, Nora M.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Whitworth, Pat W.] Nashville Breast Ctr, Nashville, TN USA; [Blumencranz, Peter W.] Morton Plant Hosp, Clearwater, FL USA; [Leitch, A. Marilyn] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Saha, Sukamal] Michigan State Univ, MacLaren Reg Med Ctr, Flint, MI USA; [Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA	Cedars Sinai Medical Center; Cornell University; NewYork-Presbyterian Hospital; Duke University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Michigan State University; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center	Giuliano, AE (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	armando.giuliano@cshs.org			National Cancer Institute [U10CA180821, U10CA180882, U10CA047559, U10CA077651, U10CA180791, U10CA180838, U10CA180858, U10CA180870]; NATIONAL CANCER INSTITUTE [U10CA047559, U10CA077651, U10CA180858, U10CA180791, P30CA016086, U10CA180821, U10CA180870, U10CA180838, UG1CA233329, U10CA180882] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants U10CA180821 and U10CA180882 (awarded to the Alliance), U10CA047559, U10CA077651, U10CA180791, U10CA180838, U10CA180858, and U10CA180870 from the National Cancer Institute.	Chung A, 2015, ANN SURG ONCOL, V22, P1128, DOI 10.1245/s10434-014-4090-y; Colleoni M, 2016, J CLIN ONCOL, V34, P3400, DOI 10.1200/JCO.2015.65.6595; Colleoni M, 2016, J CLIN ONCOL, V34, P927, DOI 10.1200/JCO.2015.62.3504; GAIL MH, 1981, BIOMETRIKA, V68, P703, DOI 10.1093/biomet/68.3.703; Giuliano AE, 1997, J CLIN ONCOL, V15, P2345, DOI 10.1200/JCO.1997.15.6.2345; Giuliano AE, 2016, ANN SURG, V264, P413, DOI 10.1097/SLA.0000000000001863; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goyal A, 2015, CLIN ONCOL-UK, V27, P692, DOI 10.1016/j.clon.2015.07.005; Guth U, 2012, EJSO-EUR J SURG ONC, V38, P645, DOI 10.1016/j.ejso.2012.04.018; Halsted W S, 1898, Ann Surg, V28, P557; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Jagsi R, 2014, J CLIN ONCOL, V32, P3600, DOI 10.1200/JCO.2014.56.5838; Lowery AJ, 2012, BREAST CANCER RES TR, V133, P831, DOI 10.1007/s10549-011-1891-6; Lucci A, 2007, J CLIN ONCOL, V25, P3657, DOI 10.1200/JCO.2006.07.4062; Mamtani A, 2016, ANN SURG ONCOL, V23, P3481, DOI 10.1245/s10434-016-5259-3; Pan HC, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.505; Poortmans PM, 2015, NEW ENGL J MED, V373, P317, DOI 10.1056/NEJMoa1415369; Poortmans PMP, 2016, JAMA ONCOL, V2, P989, DOI 10.1001/jamaoncol.2016.0183; Rescigno J, 2009, ANN SURG ONCOL, V16, P687, DOI 10.1245/s10434-008-0195-5; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tsao MW, 2016, ANN SURG ONCOL, V23, P3354, DOI 10.1245/s10434-016-5310-4; Verheuvel NC, 2016, EJSO-EUR J SURG ONC, V42, P1162, DOI 10.1016/j.ejso.2016.05.007; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Whelan TJ, 2015, NEW ENGL J MED, V373, P307, DOI 10.1056/NEJMoa1415340; Yao K, 2015, J AM COLL SURGEONS, V221, P71, DOI 10.1016/j.jamcollsurg.2015.02.035	26	704	752	12	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					918	926		10.1001/jama.2017.11470	http://dx.doi.org/10.1001/jama.2017.11470			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898379	Green Accepted			2022-12-28	WOS:000410487100013
J	Simeonov, DR; Gowen, BG; Boontanrart, M; Roth, TL; Gagnon, JD; Mumbach, MR; Satpathy, AT; Lee, YJ; Bray, NL; Chan, AY; Lituiev, DS; Nguyen, ML; Gate, RE; Subramaniam, M; Li, ZM; Woo, JM; Mitros, T; Ray, GJ; Curie, GL; Naddaf, N; Chu, JS; Ma, H; Boyer, E; Van Gool, F; Huang, HL; Liu, RZ; Tobin, VR; Schumann, K; Daly, MJ; Farh, KK; Ansel, KM; Ye, CJ; Greenleaf, WJ; Anderson, MS; Bluestone, JA; Chang, HY; Corn, JE; Marson, A				Simeonov, Dimitre R.; Gowen, Benjamin G.; Boontanrart, Mandy; Roth, Theodore L.; Gagnon, John D.; Mumbach, Maxwell R.; Satpathy, Ansuman T.; Lee, Youjin; Bray, Nicolas L.; Chan, Alice Y.; Lituiev, Dmytro S.; Nguyen, Michelle L.; Gate, Rachel E.; Subramaniam, Meena; Li, Zhongmei; Woo, Jonathan M.; Mitros, Therese; Ray, Graham J.; Curie, Gemma L.; Naddaf, Nicki; Chu, Julia S.; Ma, Hong; Boyer, Eric; Van Gool, Frederic; Huang, Hailiang; Liu, Ruize; Tobin, Victoria R.; Schumann, Kathrin; Daly, Mark J.; Farh, Kyle K.; Ansel, K. Mark; Ye, Chun J.; Greenleaf, William J.; Anderson, Mark S.; Bluestone, Jeffrey A.; Chang, Howard Y.; Corn, Jacob E.; Marson, Alexander			Discovery of stimulation-responsive immune enhancers with CRISPR activation	NATURE			English	Article							INTERLEUKIN-2; GENE; EXPRESSION; AUTOIMMUNE; ANTIBODIES; LOCI	The majority of genetic variants associated with common human diseases map to enhancers, non-coding elements that shape cell-type-specific transcriptional programs and responses to extracellular cues(1-3). Systematic mapping of functional enhancers and their biological contexts is required to understand the mechanisms by which variation in non-coding genetic sequences contributes to disease. Functional enhancers can be mapped by genomic sequence disruption(4-6), but this approach is limited to the subset of enhancers that are necessary in the particular cellular context being studied. We hypothesized that recruitment of a strong transcriptional activator to an enhancer would be sufficient to drive target gene expression, even if that enhancer was not currently active in the assayed cells. Here we describe a discovery platform that can identify stimulus-responsive enhancers for a target gene independent of stimulus exposure. We used tiled CRISPR activation (CRISPRa)(7) to synthetically recruit a transcriptional activator to sites across large genomic regions (more than 100 kilobases) surrounding two key autoimmunity risk loci, CD69 and IL2RA. We identified several CRISPRa-responsive elements with chromatin features of stimulus-responsive enhancers, including an IL2RA enhancer that harbours an autoimmunity risk variant. Using engineered mouse models, we found that sequence perturbation of the disease-associated Il2ra enhancer did not entirely block Il2ra expression, but rather delayed the timing of gene activation in response to specific extracellular signals. Enhancer deletion skewed polarization of naive T cells towards a pro-inflammatory T helper (T(H)17) cell state and away from a regulatory T cell state. This integrated approach identifies functional enhancers and reveals how non-coding variation associated with human immune dysfunction alters context-specific gene programs.	[Simeonov, Dimitre R.; Roth, Theodore L.; Gagnon, John D.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Roth, Theodore L.; Gagnon, John D.; Lee, Youjin; Nguyen, Michelle L.; Li, Zhongmei; Woo, Jonathan M.; Tobin, Victoria R.; Schumann, Kathrin; Ansel, K. Mark; Marson, Alexander] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Roth, Theodore L.; Lee, Youjin; Chan, Alice Y.; Nguyen, Michelle L.; Li, Zhongmei; Woo, Jonathan M.; Boyer, Eric; Van Gool, Frederic; Tobin, Victoria R.; Schumann, Kathrin; Anderson, Mark S.; Bluestone, Jeffrey A.; Marson, Alexander] Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA; [Simeonov, Dimitre R.; Gowen, Benjamin G.; Boontanrart, Mandy; Roth, Theodore L.; Lee, Youjin; Bray, Nicolas L.; Nguyen, Michelle L.; Li, Zhongmei; Woo, Jonathan M.; Mitros, Therese; Ray, Graham J.; Curie, Gemma L.; Naddaf, Nicki; Chu, Julia S.; Ma, Hong; Boyer, Eric; Tobin, Victoria R.; Schumann, Kathrin; Corn, Jacob E.; Marson, Alexander] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Gowen, Benjamin G.; Boontanrart, Mandy; Bray, Nicolas L.; Mitros, Therese; Ray, Graham J.; Curie, Gemma L.; Naddaf, Nicki; Chu, Julia S.; Ma, Hong; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Gagnon, John D.; Ansel, K. Mark] Univ Calif San Francisco, Sandler Asthma Basic Res Ctr, San Francisco, CA 94143 USA; [Mumbach, Maxwell R.; Satpathy, Ansuman T.; Chang, Howard Y.] Stanford Univ, Sch Med, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Mumbach, Maxwell R.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Mumbach, Maxwell R.; Satpathy, Ansuman T.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Chan, Alice Y.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Lituiev, Dmytro S.; Gate, Rachel E.; Subramaniam, Meena; Ye, Chun J.] Univ Calif San Francisco, IHG, Dept Bioengn & Therapeut Sci, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gate, Rachel E.; Subramaniam, Meena] Univ Calif San Francisco, Biol & Med Informat Grad Program, San Francisco, CA 94158 USA; [Huang, Hailiang; Liu, Ruize; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huang, Hailiang; Liu, Ruize; Daly, Mark J.] Harvard Med Sch, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Farh, Kyle K.] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94025 USA; [Greenleaf, William J.; Marson, Alexander] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Anderson, Mark S.; Marson, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Marson, Alexander] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Illumina; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Marson, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Diabet Ctr, San Francisco, CA 94143 USA.; Corn, JE; Marson, A (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Marson, A (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Marson, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Marson, A (corresponding author), Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	jcorn@berkeley.edu; alexander.marson@ucsf.edu	Ye, Chun/AAK-4868-2021; Daly, Mark J/B-2453-2017; Van Gool, Frederic/V-4638-2019; Schumann, Kathrin/HHZ-8041-2022	Ye, Chun/0000-0001-6560-3783; Daly, Mark J/0000-0002-0949-8752; Satpathy, Ansuman/0000-0002-5167-537X; Tobin, Victoria/0000-0002-2195-639X; Mumbach, Maxwell/0000-0002-5570-6663; Ray, Graham/0000-0002-1245-8428; Schumann, Kathrin/0000-0002-0993-3910; Gagnon, John/0000-0001-6208-5781; Roth, Theodore/0000-0002-3970-9573; Naddaf, Nicki/0000-0001-9651-4070	NIH [DP3DK111914-01, R01HG0081410-01, R01HL109102, P50-HG007735]; Scleroderma Research Foundation; UCSF Sandler Fellowship; National Multiple Sclerosis Society grant [CA 1074-A-21]; Marcus Program in Precision Medicine Innovation; Career Award for Medical Scientists from the Burroughs Wellcome Fund; Li Ka Shing Foundation; IGI-AstraZeneca Postdoctoral Fellowship; DFG Postdoctoral Fellowship; NIH S10 Instrumentation Grants [S10RR029668, S10RR027303]; Diabetes Research Center [NIH P30 DK063720]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008140, P50HG007735, T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, T32DK007418, K01DK114379, DP3DK111914, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, T32GM007232, T32GM067547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; UCSF Sandler Fellowship; National Multiple Sclerosis Society grant(National Multiple Sclerosis Society); Marcus Program in Precision Medicine Innovation; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Li Ka Shing Foundation; IGI-AstraZeneca Postdoctoral Fellowship; DFG Postdoctoral Fellowship(German Research Foundation (DFG)); NIH S10 Instrumentation Grants; Diabetes Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of Marson and Corn laboratories, as well as A. Abbas, S. Qi, L. Gilbert, J. Hiatt, M. Lee, V. Nguyen, J. Weissman, J. Roose, M. Gavin and W. Leonard for suggestions and technical assistance. This research was supported by NIH grants DP3DK111914-01 (A. M., M. S. A., C.Y.), R01HG0081410-01 (A. M, W.G.), R01HL109102 (K.M.A., A. M.), P50-HG007735 (H.Y.C., W.J.G.), Scleroderma Research Foundation (H.Y.C.), the UCSF Sandler Fellowship (A. M.), a gift from Jake Aronov (A. M.), a National Multiple Sclerosis Society grant (A. M.; CA 1074-A-21), and the Marcus Program in Precision Medicine Innovation (A. M.). A. M. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and is a Chan Zuckerberg Biohub Investigator. J.E.C. is supported by the Li Ka Shing Foundation. B.G.G. is supported by the IGI-AstraZeneca Postdoctoral Fellowship. K.M.A. is a Leukemia & Lymphoma Society Scholar. J.D.G. is a National Science Foundation Predoctoral Fellow. K.S. is supported by a DFG Postdoctoral Fellowship. We thank Jackson Laboratories for generating the SNP and EDEL mice and Agilent for generating oligo pools for cloning of the CRISPRa gRNA library. We thank UC Berkeley High Throughput Screening Facility and Flow Cytometry Facility. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by NIH S10 Instrumentation Grants S10RR029668 and S10RR027303. We also relied on the Flow Cytometry Core at UCSF, supported by the Diabetes Research Center grant NIH P30 DK063720.	Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goudy K, 2013, CLIN IMMUNOL, V146, P248, DOI 10.1016/j.clim.2013.01.004; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Horlbeck M. A., 2016, ELIFE, V5, P2767; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Kuhn C, 2016, IMMUNOTHERAPY-UK, V8, P889, DOI 10.2217/imt-2016-0049; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Laguna T, 2015, MOL IMMUNOL, V66, P171, DOI 10.1016/j.molimm.2015.02.031; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; LEONARD WJ, 1985, P NATL ACAD SCI USA, V82, P6281, DOI 10.1073/pnas.82.18.6281; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pimentel H. J., 2016, PREPRINT; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Sinha R., 2017, PREPRINT; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	38	149	154	4	59	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					111	+		10.1038/nature23875	http://dx.doi.org/10.1038/nature23875			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28854172	Green Accepted			2022-12-28	WOS:000409388700043
J	Tubiana, S; Blotiere, PO; Hoen, B; Lesclous, P; Millot, S; Rudant, J; Weill, A; Coste, J; Alla, F; Duval, X				Tubiana, Sarah; Blotiere, Pierre-Olivier; Hoen, Bruno; Lesclous, Philippe; Millot, Sarah; Rudant, Jeremie; Weill, Alain; Coste, Joel; Alla, Francois; Duval, Xavier			Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTIVE ENDOCARDITIS; TEMPORAL TRENDS; PREVENTION; GUIDELINES; RISK; BACTEREMIA; DIAGNOSIS; ADULTS	OBJECTIVE To assess the relation between invasive dental procedures and infective endocarditis associated with oral streptococci among people with prosthetic heart valves. DESIGN Nationwide population based cohort and a case crossover study. SETTING French national health insurance administrative data linked with the national hospital discharge database. PARTICIPANTS All adults aged more than 18 years, living in France, with medical procedure codes for positioning or replacement of prosthetic heart valves between July 2008 and July 2014. MAIN OUTCOME MEASURES Oral streptococcal infective endocarditis was identified using primary discharge diagnosis codes. In the cohort study, Poisson regression models were performed to estimate the rate of oral streptococcal infective endocarditis during the three month period after invasive dental procedures compared with non-exposure periods. In the case crossover study, conditional logistic regression models calculated the odds ratio and 95% confidence intervals comparing exposure to invasive dental procedures during the three month period preceding oral streptococcal infective endocarditis (case period) with three earlier control periods. RESULTS The cohort included 138 876 adults with prosthetic heart valves (285 034 person years); 69 303 (49.9%) underwent at least one dental procedure. Among the 396 615 dental procedures performed, 103 463 (26.0%) were invasive and therefore presented an indication for antibiotic prophylaxis, which was performed in 52 280 (50.1%). With a median follow-up of 1.7 years, 267 people developed infective endocarditis associated with oral streptococci (incidence rate 93.7 per 100 000 person years, 95% confidence interval 82.4 to 104.9). Compared with non-exposure periods, no statistically significant increased rate of oral streptococcal infective endocarditis was observed during the three months after an invasive dental procedure (relative rate 1.25, 95% confidence interval 0.82 to 1.82; P=0.26) and after an invasive dental procedure without antibiotic prophylaxis (1.57, 0.90 to 2.53; P=0.08). In the case crossover analysis, exposure to invasive dental procedures was more frequent during case periods than during matched control periods (5.1% v 3.2%; odds ratio 1.66, 95% confidence interval 1.05 to 2.63; P=0.03). CONCLUSION Invasive dental procedures may contribute to the development of infective endocarditis in adults with prosthetic heart valves.	[Tubiana, Sarah; Duval, Xavier] INSERM, UMR 1137, IAME, Paris, France; [Tubiana, Sarah; Duval, Xavier] Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, Paris, France; [Tubiana, Sarah; Duval, Xavier] Hop Bichat Claude Bernard, AP HP, INSERM CIC 1425, Paris, France; [Tubiana, Sarah; Blotiere, Pierre-Olivier; Rudant, Jeremie; Weill, Alain; Coste, Joel; Alla, Francois] French Natl Hlth Insurance, Dept Studies Publ Hlth, Paris 20, France; [Hoen, Bruno] Ctr Hosp Univ Pointe A Pitre, Serv Malad Infect & Trop, Pointe a Pitre, Guadeloupe, France; [Hoen, Bruno] Ctr Hosp Univ Pointe A Pitre, Inserm CIC 1424, Pointe a Pitre, Guadeloupe, France; [Hoen, Bruno] Univ Antilles Guyane, Fac Med Hyacinthe Bastaraud, Pointe a Pitre, Guadeloupe, France; [Lesclous, Philippe] RMeS, U1229, INSERM, Nantes, France; [Lesclous, Philippe] Univ Nantes, UFR Odontol, Nantes, France; [Lesclous, Philippe] CHU Hotel Dieu, Nantes, France; [Millot, Sarah] CHRU Univ Montpellier, Dept Odontol, Montpellier, France; [Millot, Sarah] Univ Paris Diderot, INSERM, CRI, UMR 1149, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Guadeloupe; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Universite des Antilles; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Tubiana, S (corresponding author), INSERM, UMR 1137, IAME, Paris, France.; Tubiana, S (corresponding author), Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, Paris, France.; Tubiana, S (corresponding author), Hop Bichat Claude Bernard, AP HP, INSERM CIC 1425, Paris, France.; Tubiana, S (corresponding author), French Natl Hlth Insurance, Dept Studies Publ Hlth, Paris 20, France.	sarah.tubiana@aphp.fr	Lesclous, Philippe/P-6255-2014; Blotière, Pierre-Olivier/AAH-2024-2021; alla, francois/D-2295-2014	alla, francois/0000-0002-5793-7190; Millot, Sarah/0000-0002-7532-8006; Weill, Alain/0000-0001-8687-9092; lesclous, Philippe/0000-0002-9840-4542	French National Health Insurance Fund (CNAMTS); Universite Paris Diderot, France	French National Health Insurance Fund (CNAMTS); Universite Paris Diderot, France	This research was funded by the French National Health Insurance Fund (CNAMTS) and Universite Paris Diderot, France. The present paper represents the opinions of the authors and does not necessarily reflect the position of their employers.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Baddour LM, 2007, INT J ANTIMICROB AG, V30, pS37, DOI 10.1016/j.ijantimicag.2007.06.033; Ben-Amy DP, 2009, EUR J CLIN MICROBIOL, V28, P269, DOI 10.1007/s10096-008-0622-3; Bikdeli B, 2013, J AM COLL CARDIOL, V62, P2217, DOI 10.1016/j.jacc.2013.07.071; Cahill TJ, 2017, HEART, V103, P937, DOI 10.1136/heartjnl-2015-309102; Chen PY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000474; Cloitre A, 2013, ANTIBIOPROPHYLAXIE E; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; DeSimone DC, 2012, CIRCULATION, V126, P60, DOI 10.1161/CIRCULATIONAHA.112.095281; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Duval X, 2008, LANCET INFECT DIS, V8, P225, DOI 10.1016/S1473-3099(08)70064-1; Duval X, 2017, CLIN INFECT DIS, V64, P1678, DOI 10.1093/cid/cix237; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Glenny AM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003813.pub4; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; IMPERIALE TF, 1990, AM J MED, V88, P131, DOI 10.1016/0002-9343(90)90461-L; Keller K, 2017, AM J CARDIOL, V119, P317, DOI 10.1016/j.amjcard.2016.09.035; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; N'Guyen Y, 2017, ANN MED, V49, P117, DOI 10.1080/07853890.2016.1235282; Pant S, 2015, J AM COLL CARDIOL, V65, P2070, DOI 10.1016/j.jacc.2015.03.518; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Roberts GJ, 1999, PEDIATR CARDIOL, V20, P317, DOI 10.1007/s002469900477; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Thornhill MH, 2016, BRIT DENT J, V221, P112, DOI 10.1038/sj.bdj.2016.554; Toyoda N, 2017, JAMA-J AM MED ASSOC, V317, P1652, DOI 10.1001/jama.2017.4287; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; VANDERMEER JTM, 1992, LANCET, V339, P135, DOI 10.1016/0140-6736(92)90207-J; Veloso TR, 2011, INFECT IMMUN, V79, P2006, DOI 10.1128/IAI.01208-10; Verhagen DWM, 2009, CLIN INFECT DIS, V48, P1559, DOI 10.1086/598930; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Zhang W, 2013, J CLIN PERIODONTOL, V40, P41, DOI 10.1111/jcpe.12029	38	57	58	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j3776	10.1136/bmj.j3776	http://dx.doi.org/10.1136/bmj.j3776			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EM	28882817	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000410576200003
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Nuclear weapons do harm, even if never used	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Fullfact, 2016, MUCH DOES TRID COST; Semple I., 2017, GUARDIAN	2	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j3978	10.1136/bmj.j3978	http://dx.doi.org/10.1136/bmj.j3978			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EG	28877901	Green Published, Bronze			2022-12-28	WOS:000410575400007
J	Rimmer, A				Rimmer, Abi			The impact of the junior doctor contract-one year on	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						BMA, 2016, CONTR IMPL TIM; Rimmer A., 2017, BMJ CAREERS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j4125	10.1136/bmj.j4125	http://dx.doi.org/10.1136/bmj.j4125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EG	28877904				2022-12-28	WOS:000410575400013
J	Mittal, S; Bjornevik, K; Im, DS; Flierl, A; Dong, XJ; Locascio, JJ; Abo, KM; Long, E; Jin, M; Xu, B; Xiang, YK; Rochet, JC; Engeland, A; Rizzu, P; Heutink, P; Bartels, T; Selkoe, DJ; Caldarone, BJ; Glicksman, MA; Khurana, V; Schule, B; Park, DS; Riise, T; Scherzer, CR				Mittal, Shuchi; Bjornevik, Kjetil; Im, Doo Soon; Flierl, Adrian; Dong, Xianjun; Locascio, Joseph J.; Abo, Kristine M.; Long, Elizabeth; Jin, Ming; Xu, Bing; Xiang, Yang K.; Rochet, Jean-Christophe; Engeland, Anders; Rizzu, Patrizia; Heutink, Peter; Bartels, Tim; Selkoe, Dennis J.; Caldarone, Barbara J.; Glicksman, Marcie A.; Khurana, Vikram; Schule, Birgitt; Park, David S.; Riise, Trond; Scherzer, Clemens R.			beta(2)-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease	SCIENCE			English	Article							EXPRESSION; CLENBUTEROL; TOXICITY; PATHWAY; ACID	Copy number mutations implicate excess production of a-synuclein as a possibly causative factor in Parkinson's disease (PD). Using an unbiased screen targeting endogenous gene expression, we discovered that the beta 2-adrenoreceptor (beta 2AR) is a regulator of the a-synuclein gene (SNCA). beta 2AR ligands modulate SNCA transcription through histone 3 lysine 27 acetylation of its promoter and enhancers. Over 11 years of follow-up in 4 million Norwegians, the beta 2AR agonist salbutamol, a brain-penetrant asthma medication, was associated with reduced risk of developing PD (rate ratio, 0.66; 95% confidence interval, 0.58 to 0.76). Conversely, a beta 2AR antagonist correlated with increased risk. beta 2AR activation protected model mice and patient-derived cells. Thus, beta 2AR is linked to transcription of a-synuclein and risk of PD in a ligand-specific fashion and constitutes a potential target for therapies.	[Mittal, Shuchi; Dong, Xianjun; Locascio, Joseph J.; Abo, Kristine M.; Long, Elizabeth; Scherzer, Clemens R.] Harvard Med Sch, Neurogen Lab, Boston, MA 02115 USA; [Mittal, Shuchi; Dong, Xianjun; Locascio, Joseph J.; Abo, Kristine M.; Long, Elizabeth; Scherzer, Clemens R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mittal, Shuchi; Dong, Xianjun; Jin, Ming; Bartels, Tim; Selkoe, Dennis J.; Khurana, Vikram; Scherzer, Clemens R.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Mittal, Shuchi; Dong, Xianjun; Jin, Ming; Bartels, Tim; Selkoe, Dennis J.; Khurana, Vikram; Scherzer, Clemens R.] Harvard Med Sch, Boston, MA 02115 USA; [Mittal, Shuchi; Dong, Xianjun; Jin, Ming; Bartels, Tim; Selkoe, Dennis J.; Caldarone, Barbara J.; Khurana, Vikram; Scherzer, Clemens R.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Bjornevik, Kjetil; Engeland, Anders; Riise, Trond] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Bjornevik, Kjetil; Riise, Trond] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, Bergen, Norway; [Im, Doo Soon; Park, David S.] Univ Ottawa, Brain & Mind Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Flierl, Adrian; Schule, Birgitt] Parkinsons Inst & Clin Ctr, Sunnyvale, CA 94085 USA; [Locascio, Joseph J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Xu, Bing; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Engeland, Anders] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Oslo, Norway; [Rizzu, Patrizia; Heutink, Peter] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Caldarone, Barbara J.; Glicksman, Marcie A.] Harvard Med Sch, Harvard NeuroDiscovery Ctr, Boston, MA 02115 USA; [Khurana, Vikram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Ottawa; Harvard University; Massachusetts General Hospital; University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Norwegian Institute of Public Health (NIPH); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Harvard University; Harvard Medical School; Harvard University	Scherzer, CR (corresponding author), Harvard Med Sch, Neurogen Lab, Boston, MA 02115 USA.; Scherzer, CR (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.; Scherzer, CR (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA.	cscherzer@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021; Engeland, Anders/AAG-7437-2021; Riise, Trond/H-1390-2018; Flierl, Adrian/W-3453-2019; Dong, Xianjun/N-3867-2014; Bjornevik, Kjetil/J-8888-2019	Riise, Trond/0000-0001-9644-5140; Dong, Xianjun/0000-0002-8052-9320; Bjornevik, Kjetil/0000-0002-2892-6986; Heutink, Peter/0000-0001-5218-1737; Flierl, Adrian/0000-0003-0933-2493; Im, Doo Soon/0000-0001-5713-3849; Scherzer, Clemens/0000-0002-0567-9193; Schuele, Birgitt/0000-0002-9952-5776; Khurana, Vikram/0000-0002-4018-5527; Park, David/0000-0002-4490-3784; Bartels, Tim/0000-0002-4071-5612; Rochet, Jean-Christophe/0000-0002-6484-1541	Michael J. Fox Foundation; National Institute of Neurological Disorders and Stroke [U01 NS082157, U01NS095736, R01 NS083845]; U.S. Department of Defense; M.E.M.O. Hoffman Foundation; Prinses Beatrix Spier Fonds; American Parkinson's Disease Association; Parkinson's Disease Foundation; Branfman Family Foundation; Canadian Institute of Health Research; Brain Canada/Krembil Foundation; Heart and Stroke Foundation of Canada; Multiple System Atrophy Coalition; Harvard NeuroDiscovery Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845, RF1NS083845, U01NS095736, U01NS082157] Funding Source: NIH RePORTER	Michael J. Fox Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Department of Defense(United States Department of Defense); M.E.M.O. Hoffman Foundation; Prinses Beatrix Spier Fonds; American Parkinson's Disease Association; Parkinson's Disease Foundation; Branfman Family Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada/Krembil Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Multiple System Atrophy Coalition; Harvard NeuroDiscovery Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. B. Concannon, K. Seyb, Paul J. Lorello, K. J. Shankaran, J. B. Sanderson, R. Passas, S. Aziz, and A. J. Scherzer (Brigham and Women's Hospital); V. Mishra (Purdue University); and P. C. Marcogliese (University of Ottawa) for invaluable technical assistance. Funding was provided by the Michael J. Fox Foundation (to C. R. S.), the National Institute of Neurological Disorders and Stroke (grants U01 NS082157 and U01NS095736 to C. R. S. and grant R01 NS083845 to D.J.S.), the U.S. Department of Defense (to C. R. S.), the M.E.M.O. Hoffman Foundation (to C. R. S.), Prinses Beatrix Spier Fonds (to P.H.), the American Parkinson's Disease Association (to T.B.), the Parkinson's Disease Foundation (to T.B.), the Branfman Family Foundation (to J. C. R.), the Canadian Institute of Health Research (to D.S.P.), Brain Canada/Krembil Foundation (to D.S.P.), the Heart and Stroke Foundation of Canada (to D.S.P.), the Multiple System Atrophy Coalition (to V. K.), and Harvard NeuroDiscovery Center (to V. K.). B.W.H. has applied for a related U.S. patent. C. R. S. is named as inventor on patent application 62487541 submitted by Brigham and Women's Hospital that relates to modifications and combinations of beta-adrenoreceptor agonists as potential therapeutics for Parkinson's disease. NorPD data are accessible by application at http://norpd.no.	Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bezard E, 1997, EXP NEUROL, V148, P288, DOI 10.1006/exnr.1997.6648; Carbone M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-38; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Flierl A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112413; Gleeson LC, 2010, BRAIN BEHAV IMMUN, V24, P1354, DOI 10.1016/j.bbi.2010.06.015; Hasegawa E, 1997, ARCH BIOCHEM BIOPHYS, V337, P69, DOI 10.1006/abbi.1996.9726; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Lund M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/835080; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; Norwegian Institute of Public Health, NORW PRESCR DAT; ODonnell JM, 1997, PHARMACOL BIOCHEM BE, V58, P813, DOI 10.1016/S0091-3057(97)00038-5; Pihlstrom L, 2011, NEUROGENETICS, V12, P283, DOI 10.1007/s10048-011-0292-7; Qian L, 2011, J IMMUNOL, V186, P4443, DOI 10.4049/jimmunol.1002449; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Ritz B, 2007, ARCH NEUROL-CHICAGO, V64, P990, DOI 10.1001/archneur.64.7.990; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	34	236	247	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					891	897		10.1126/science.aaf3934	http://dx.doi.org/10.1126/science.aaf3934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860381	Green Accepted			2022-12-28	WOS:000408734900037
J	Shomura, Y; Taketa, M; Nakashima, H; Tai, H; Nakagawa, H; Ikeda, Y; Ishii, M; Igarashi, Y; Nishihara, H; Yoon, KS; Ogo, S; Hirota, S; Higuchi, Y				Shomura, Y.; Taketa, M.; Nakashima, H.; Tai, H.; Nakagawa, H.; Ikeda, Y.; Ishii, M.; Igarashi, Y.; Nishihara, H.; Yoon, K-S.; Ogo, S.; Hirota, S.; Higuchi, Y.			Structural basis of the redox switches in the NAD(+)-reducing soluble [NiFe]-hydrogenase	SCIENCE			English	Article							NAD-REDUCING HYDROGENASE; RESPIRATORY COMPLEX-I; ACTIVE-SITE; RALSTONIA; OPERON; FTIR; EPR; FMN; NICKEL; STATE	NAD(+) (oxidized form of NAD: nicotinamide adenine dinucleotide)-reducing soluble [ NiFe]hydrogenase (SH) is phylogenetically related to NADH (reduced form of NAD(+)): quinone oxidoreductase (complex I), but the geometrical arrangements of the subunits and Fe-S clusters are unclear. Here, we describe the crystal structures of SH in the oxidized and reduced states. The cluster arrangement is similar to that of complex I, but the subunits orientation is not, which supports the hypothesis that subunits evolved as prebuilt modules. The oxidized active site includes a six-coordinate Ni, which is unprecedented for hydrogenases, whose coordination geometry would prevent O-2 from approaching. In the reduced state showing the normal active site structure without a physiological electron acceptor, the flavin mononucleotide cofactor is dissociated, which may be caused by the oxidation state change of nearby Fe-S clusters and may suppress production of reactive oxygen species.	[Shomura, Y.] Ibaraki Univ, Grad Sch Sci & Engn, Inst Quantum Beam Sci, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan; [Taketa, M.; Nakashima, H.; Nakagawa, H.; Ikeda, Y.; Higuchi, Y.] Univ Hyogo, Grad Sch Life Sci, Dept Picobiol, 3-2-1 Koto,Kamigori Cho, Kobe, Hyogo 6781297, Japan; [Taketa, M.; Tai, H.; Hirota, S.; Higuchi, Y.] Japan & Sci Technol Agcy, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Tai, H.; Hirota, S.] Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama Cho, Ikoma, Nara 6300192, Japan; [Ishii, M.; Igarashi, Y.] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Nishihara, H.] Ibaraki Univ, Coll Agr, Dept Bioresource Sci, 3-21-1 Chu Ou, Ami, Ibaraki 3000393, Japan; [Yoon, K-S.; Ogo, S.] Kyushu Univ, World Premier Int Res Ctr Initiative, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan; [Yoon, K-S.; Ogo, S.] Kyushu Univ, Dept Chem & Biochem, Grad Sch Engn, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan; [Higuchi, Y.] RIKEN, SPring Ctr 8, 1-1-1 Koto, Sayo, Hyogo 6795148, Japan	Ibaraki University; University of Hyogo; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology; University of Tokyo; Ibaraki University; Kyushu University; Kyushu University; RIKEN	Shomura, Y (corresponding author), Ibaraki Univ, Grad Sch Sci & Engn, Inst Quantum Beam Sci, 4-12-1 Nakanarusawa, Hitachi, Ibaraki 3168511, Japan.	yasuhito.shomura.s@vc.ibaraki.ac.jp; hig@sci.u-hyogo.ac.jp	Tai, Hulin/G-8770-2018; Hirota, Shun/AAD-2651-2021	Tai, Hulin/0000-0003-0844-1022; Hirota, Shun/0000-0003-3227-8376; Higuchi, Yoshiki/0000-0001-8284-5709	Japan Science and Technology Agency CREST, Japan [JPMJCR12M4]; Japan Society for the Promotion of Science [JP25291038]; Challenging Exploratory Research [JP24657077]; Scientific Research on Innovative Areas [JP15H00945]; Specially Promoted Research [26000008]; Young Scientists B [JP16K17936]; Mitsubishi Foundation; ENEOS Hydrogen Trust Fund; Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) [1243]; Academia Sinica; National Synchrotron Radiation Research Center (Taiwan, ROC); Grants-in-Aid for Scientific Research [26000008] Funding Source: KAKEN	Japan Science and Technology Agency CREST, Japan(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Challenging Exploratory Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Specially Promoted Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Young Scientists B(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; ENEOS Hydrogen Trust Fund; Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan, ROC); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency CREST grant JPMJCR12M4, Japan (Y.H. and S.H.), Japan Society for the Promotion of Science [Category B, grant JP25291038 (Y.H.); Challenging Exploratory Research, grant JP24657077 (Y.H.); Scientific Research on Innovative Areas, grant JP15H00945 (S.H.); Specially Promoted Research, grant 26000008 (S.O.); and Young Scientists B, grant JP16K17936 (H.T.)], and by research grants from The Mitsubishi Foundation (Y.H.) and ENEOS Hydrogen Trust Fund (Y.H.). We thank M. Habukawa, K. Hataguchi, and K. Matsumoto for their support with enzyme preparation. The synchrotron radiation experiments were performed at the BL38B1 (proposals 21013 and 25476), BL41XU (proposal 22996), BL44XU (proposals 21817, 23301, 24798, and 26479), and BL32XU [Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) (project 1243)]. The charge-coupled device detector MX225-HE (Rayonix) at BL44XU was financially supported by Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan, ROC). Coordinates and structure factors for the x-ray crystal structures of SH in the air-oxidized and H<INF>2</INF>-reduced states have been deposited in the Protein Data Bank (PDB) with accession codes of 5XF9 and 5XFA, respectively.	ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; Burgdorf T, 2002, J BACTERIOL, V184, P6280, DOI 10.1128/JB.184.22.6280-6288.2002; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Foerster S, 2005, J BIOL INORG CHEM, V10, P51, DOI 10.1007/s00775-004-0613-5; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; GOTO E, 1977, AGR BIOL CHEM TOKYO, V41, P685, DOI 10.1080/00021369.1977.10862562; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Holt PJ, 2016, BBA-BIOENERGETICS, V1857, P1777, DOI 10.1016/j.bbabio.2016.08.008; Horch M, 2012, FEBS LETT, V586, P545, DOI 10.1016/j.febslet.2011.10.010; Horch M, 2010, ANGEW CHEM INT EDIT, V49, P8026, DOI 10.1002/anie.201002197; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; MALKI S, 1995, J BACTERIOL, V177, P2628, DOI 10.1128/jb.177.10.2628-2636.1995; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Ohki Y, 2008, P NATL ACAD SCI USA, V105, P7652, DOI 10.1073/pnas.0800538105; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; SCHNEIDER K, 1976, BIOCHIM BIOPHYS ACTA, V452, P66, DOI 10.1016/0005-2744(76)90058-9; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; Shomura Y, 2013, REV INORG CHEM, V33, P173, DOI 10.1515/revic-2013-0005; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; van der Linden E, 2004, EUR J BIOCHEM, V271, P801, DOI 10.1111/j.1432-1033.2004.03984.x; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r	28	28	29	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					928	931		10.1126/science.aan4497	http://dx.doi.org/10.1126/science.aan4497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860386				2022-12-28	WOS:000408734900045
J	Vogel, G; Kupferschmidt, K				Vogel, Gretchen; Kupferschmidt, Kai			Germany seeks 'big flip' in publishing model	SCIENCE			English	News Item																			0	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					744	745		10.1126/science.357.6353.744	http://dx.doi.org/10.1126/science.357.6353.744			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839054				2022-12-28	WOS:000408327900018
J	Farr, WM; Tevenson, SS; Miller, MC; Mandel, I; Farr, B; Vecchio, A				Farr, Will M.; Tevenson, Simon S.; Miller, M. Coleman; Mandel, Ilya; Farr, Ben; Vecchio, Alberto			Distinguishing spin-aligned and isotropic black hole populations with gravitational waves	NATURE			English	Article							EVOLUTION; MISALIGNMENT; MASS	The direct detection of gravitational waves(1-4) from merging binary black holes opens up a window into the environments in which binary black holes form. One signature of such environments is the angular distribution of the black hole spins. Binary systems that formed through dynamical interactions between already-compact objects are expected to have isotropic spin orientations(5-9) (that is, the spins of the black holes are randomly oriented with respect to the orbit of the binary system), whereas those that formed from pairs of stars born together are more likely to have spins that are preferentially aligned with the orbit(10-14). The best-measured combination of spin parameters(3,4) for each of the four likely binary black hole detections GW150914, LVT151012, GW151226 and GW170104 is the 'effective' spin. Here we report that, if the magnitudes of the black hole spins are allowed to extend to high values, the effective spins for these systems indicate a 0.015 odds ratio against an aligned angular distribution compared to an isotropic one. When considering the effect of ten additional detections(15), this odds ratio decreases to 2.9 x 10(-7) against alignment. The existing preference for either an isotropic spin distribution or low spin magnitudes for the observed systems will be confirmed (or overturned) confidently in the near future.	[Farr, Will M.; Tevenson, Simon S.; Mandel, Ilya; Vecchio, Alberto] Univ Birmingham, Birmingham Inst Gravitat Wave Astron, Birmingham B15 2TT, W Midlands, England; [Farr, Will M.; Tevenson, Simon S.; Mandel, Ilya; Vecchio, Alberto] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Tevenson, Simon S.; Mandel, Ilya] Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Miller, M. Coleman] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Miller, M. Coleman] Univ Maryland, Joint Space Sci Inst, College Pk, MD 20742 USA; [Farr, Ben] Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Farr, Ben] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA	University of Birmingham; University of Birmingham; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Chicago; University of Chicago	Farr, WM (corresponding author), Univ Birmingham, Birmingham Inst Gravitat Wave Astron, Birmingham B15 2TT, W Midlands, England.; Farr, WM (corresponding author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.	w.farr@bham.ac.uk	Farr, Ben/ABH-6964-2020; Stevenson, Simon/AAA-5870-2021; Vecchio, Alberto/F-8310-2015	Farr, Ben/0000-0002-2916-9200; Stevenson, Simon/0000-0002-6100-537X; Vecchio, Alberto/0000-0002-6254-1617; Miller, Cole/0000-0002-2666-728X	STFC; University of Birmingham Institute for Advanced Study Distinguished Visiting Fellows programme; National Science Foundation [NSF PHY11-25915]; Science and Technology Facilities Council [ST/N000633/1] Funding Source: researchfish; STFC [ST/N000072/1, ST/N000633/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); University of Birmingham Institute for Advanced Study Distinguished Visiting Fellows programme; National Science Foundation(National Science Foundation (NSF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank R. O'Shaughnessy, C. Berry, D. Gerosa and S. Vitale for discussions and comments on this work. W.M.F., S. S., I.M. and A.V. were supported in part by the STFC. M.C.M. acknowledges support of the University of Birmingham Institute for Advanced Study Distinguished Visiting Fellows programme. S. S. and I. M. acknowledge support from the National Science Foundation under grant number NSF PHY11-25915.	Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241103; Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241102; Abbott BP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.221101; Abbott BP, 2017, CLASSICAL QUANT GRAV, V34, DOI 10.1088/1361-6382/aa6854; Abbott BP, 2016, ASTROPHYS J LETT, V833, DOI 10.3847/2041-8205/833/1/L1; Abbott BP, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041015; Abbott BP, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.064035; Abbott BP, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.122003; Abbott B.P., 2016, PHYS REV LETT, V116; Albrecht S, 2009, NATURE, V461, P373, DOI 10.1038/nature08408; Belczynski K, 2016, NATURE, V534, P512, DOI 10.1038/nature18322; Bezanson J., 2012, PREPRINT; Bogdanovic T, 2007, ASTROPHYS J, V661, pL147, DOI 10.1086/518769; Farr WM, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/81; Fishbach M, 2017, ASTROPHYS J LETT, V840, DOI 10.3847/2041-8213/aa7045; Fragos T, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/17; Gerosa D, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.124046; Gerosa D, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.064016; Hogg DW, 2010, ASTROPHYS J, V725, P2166, DOI 10.1088/0004-637X/725/2/2166; Hotokezaka K, 2017, ASTROPHYS J, V842, DOI 10.3847/1538-4357/aa6f61; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones E., 2001, SCIPY OPEN SOURCE SC; Kalogera V, 2000, ASTROPHYS J, V541, P319, DOI 10.1086/309400; King AR, 1999, MON NOT R ASTRON SOC, V305, P654, DOI 10.1046/j.1365-8711.1999.02482.x; Kollmeier J. A., 2017, PREPRINT; Kushnir D, 2016, MON NOT R ASTRON SOC, V462, P844, DOI 10.1093/mnras/stw1684; Mandel I., 2017, MON NOT R ASTRON SOC; Mandel I, 2016, MON NOT R ASTRON SOC, V458, P2634, DOI 10.1093/mnras/stw379; Mandel I, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.084029; Marchant P, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201628133; Martin RG, 2008, MON NOT R ASTRON SOC, V391, pL15, DOI 10.1111/j.1745-3933.2008.00545.x; Miller MC, 2015, PHYS REP, V548, P1, DOI 10.1016/j.physrep.2014.09.003; Morningstar WR, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L33; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Rodriguez CL, 2016, ASTROPHYS J LETT, V832, DOI 10.3847/2041-8205/832/1/L2; Rodriguez CL, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.051101; Schnittman JD, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.124020; SIGURDSSON S, 1993, NATURE, V364, P423, DOI 10.1038/364423a0; Stevenson S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14906; Stone NC, 2017, MON NOT R ASTRON SOC, V464, P946, DOI 10.1093/mnras/stw2260; TUTUKOV AV, 1993, MON NOT R ASTRON SOC, V260, P675, DOI 10.1093/mnras/260.3.675; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Veitch J, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.042003; Vitale S, 2017, CLASSICAL QUANT GRAV, V34, DOI 10.1088/1361-6382/aa552e; Zwart SFP, 2000, ASTROPHYS J, V528, pL17, DOI 10.1086/312422	45	172	172	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					426	+		10.1038/nature23453	http://dx.doi.org/10.1038/nature23453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28836595	Green Published, Green Submitted			2022-12-28	WOS:000408279000032
J	Hopcroft, P				Hopcroft, Peter			ATMOSPHERIC SCIENCE Ancient ice and the global methane cycle	NATURE			English	Editorial Material							CH4; EMISSIONS; CLIMATE	An analysis of 12,000-year-old Antarctic ice revises our understanding of natural methane emissions to the atmosphere, and constrains estimates of the sensitivity of natural methane sources to abrupt climate-warming events. SEE LETTER P.443	[Hopcroft, Peter] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	University of Bristol	Hopcroft, P (corresponding author), Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England.	peter.hopcroft@bristol.ac.uk	Hopcroft, Peter/O-5535-2019; Hopcroft, Peter/H-4957-2016	Hopcroft, Peter/0000-0003-3694-9181				CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Etiope G, 2008, GLOBAL PLANET CHANGE, V61, P79, DOI 10.1016/j.gloplacha.2007.08.008; Kindler P, 2014, CLIM PAST, V10, P887, DOI 10.5194/cp-10-887-2014; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; O'Connor FM, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000326; Petrenko VV, 2017, NATURE, V548, P443, DOI 10.1038/nature23316; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Saunois M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/120207; Schwietzke S, 2016, NATURE, V538, P88, DOI 10.1038/nature19797; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013	16	3	3	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					403	404		10.1038/548403a	http://dx.doi.org/10.1038/548403a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836592				2022-12-28	WOS:000408279000027
J	Jinatongthai, P; Kongwatcharapong, J; Foo, CY; Phrommintikul, A; Nathisuwan, S; Thakkinstian, A; Reid, CM; Chaiyakunapruk, N				Jinatongthai, Peerawat; Kongwatcharapong, Junporn; Foo, Chee Yoong; Phrommintikul, Arintaya; Nathisuwan, Surakit; Thakkinstian, Ammarin; Reid, Christopher M.; Chaiyakunapruk, Nathorn			Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis	LANCET			English	Review							TISSUE-PLASMINOGEN-ACTIVATOR; PERCUTANEOUS CORONARY INTERVENTION; EARLY INTRAVENOUS HEPARIN; LEFT-VENTRICULAR FUNCTION; THROMBOLYTIC THERAPY; BLEEDING COMPLICATIONS; DOSE RETEPLASE; STREPTOKINASE; ALTEPLASE; TRIAL	Background Fibrinolytic therapy offers an alternative to mechanical reperfusion for ST-segment elevation myocardial infarction (STEMI) in settings where health-care resources are scarce. Comprehensive evidence comparing different agents is still unavailable. In this study, we examined the effects of various fibrinolytic drugs on clinical outcomes. Methods We did a network meta-analysis based on a systematic review of randomised controlled trials comparing fibrinolytic drugs in patients with STEMI. Several databases were searched from inception up to Feb 28, 2017. We included only randomised controlled trials that compared fibrinolytic agents as a reperfusion therapy in adult patients with STEMI, whether given alone or in combination with adjunctive antithrombotic therapy, against other fibrinolytic agents, a placebo, or no treatment. Only trials investigating agents with an approved indication of reperfusion therapy in STEMI (streptokinase, tenecteplase, alteplase, and reteplase) were included. The primary efficacy outcome was all-cause mortality within 30-35 days and the primary safety outcome was major bleeding. This study is registered with PROSPERO (CRD42016042131). Findings A total of 40 eligible studies involving 128 071 patients treated with 12 different fibrinolytic regimens were assessed. Compared with accelerated infusion of alteplase with parenteral anticoagulants as background therapy, streptokinase and non-accelerated infusion of alteplase were significantly associated with an increased risk of allcause mortality (risk ratio [RR] 1.14 [95% CI 1.05-1.24] for streptokinase plus parenteral anticoagulants; RR 1.26 [1.10-1.45] for non-accelerated alteplase plus parenteral anticoagulants). No significant difference in mortality risk was recorded between accelerated infusion of alteplase, tenecteplase, and reteplase with parenteral anticoagulants as background therapy. For major bleeding, a tenecteplase-based regimen tended to be associated with lower risk of bleeding compared with other regimens (RR 0.79 [95% CI 0.63-1.00]). The addition of glycoprotein IIb or IIIa inhibitors to fibrinolytic therapy increased the risk of major bleeding by 1.27-8.82-times compared with accelerated infusion alteplase plus parenteral anticoagulants (RR 1.47 [95% CI 1.10-1.98] for tenecteplase plus parenteral anticoagulants plus glycoprotein inhibitors; RR 1.88 [1.24-2.86] for reteplase plus parenteral anticoagulants plus glycoprotein inhibitors). Interpretation Significant differences exist among various fibrinolytic regimens as reperfusion therapy in STEMI and alteplase (accelerated infusion), tenecteplase, and reteplase should be considered over streptokinase and non-accelerated infusion of alteplase. The addition of glycoprotein IIb or IIIa inhibitors to fibrinolytic therapy should be discouraged.	[Jinatongthai, Peerawat] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Div Pharm Practice, Ubon Ratchathani, Thailand; [Kongwatcharapong, Junporn] Mahidol Univ, Siriraj Hosp, Dept Pharm, Bangkok, Thailand; [Foo, Chee Yoong] Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Foo, Chee Yoong; Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia; [Phrommintikul, Arintaya] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Cardiol, Chiang Mai, Thailand; [Nathisuwan, Surakit] Mahidol Univ, Fac Pharm, Dept Pharm, Pharm Div, Bangkok, Thailand; [Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Sect Clin Epidemiol & Biostat, Bangkok, Thailand; [Reid, Christopher M.] Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Reid, Christopher M.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, CPOR, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Global Asia 21st Century GA21 Platform, Hlth & Well Being Cluster, Asian Ctr Evidence Synth Populat Implementat & Cl, Bandar Sunway, Selangor, Malaysia	Ubon Ratchathani University; Mahidol University; Monash University; Monash University Sunway; Chiang Mai University; Mahidol University; Mahidol University; Monash University; Curtin University; Naresuan University; University of Wisconsin System; University of Wisconsin Madison; Monash University; Monash University Sunway	Chaiyakunapruk, N (corresponding author), Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia.	nathorn.chaiyakunapruk@monash.edu	Foo, C Y/AAC-8637-2019; Reid, Christopher M/AAP-8135-2021; Nathisuwan, Surakit/AAJ-5622-2020; Thakkinstian, Ammarin/J-4788-2019; Phrommintikul, Arintaya/X-1881-2019	Foo, C Y/0000-0002-1833-4290; Nathisuwan, Surakit/0000-0003-4828-4412; Phrommintikul, Arintaya/0000-0003-3986-1951; Reid, Christopher/0000-0001-9173-3944; Chaiyakunapruk, Nathorn/0000-0003-4572-8794; Jinatongthai, Peerawat/0000-0002-7954-2480				Antman EM, 2000, EUR HEART J, V21, P1944, DOI 10.1053/euhj.2000.2243; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Antman EM, 2002, CIRCULATION, V105, P1642, DOI 10.1161/01.CIR.0000013402.34759.46; Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bazzino O, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.07.029; Binbrek AS, 2004, AM J CARDIOL, V93, P1465, DOI 10.1016/j.amjcard.2004.03.004; BLEICH SD, 1990, AM J CARDIOL, V66, P1412, DOI 10.1016/0002-9149(90)90525-6; Bode C, 1996, CIRCULATION, V94, P891, DOI 10.1161/01.CIR.94.5.891; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Brener SJ, 2002, J AM COLL CARDIOL, V39, P377, DOI 10.1016/S0735-1097(01)01758-2; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cannon CP, 1998, CIRCULATION, V98, P2805, DOI 10.1161/01.CIR.98.25.2805; CARNEY RJ, 1992, J AM COLL CARDIOL, V20, P17, DOI 10.1016/0735-1097(92)90131-6; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chatterjee S, 2014, JAMA-J AM MED ASSOC, V311, P2414, DOI 10.1001/jama.2014.5990; CHERNG WJ, 1992, AM HEART J, V123, P841, DOI 10.1016/0002-8703(92)90685-O; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; DEBONO DP, 1992, BRIT HEART J, V67, P122; Dechartres A, 2014, JAMA-J AM MED ASSOC, V312, P623, DOI 10.1001/jama.2014.8166; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dundar Y, 2003, QJM-INT J MED, V96, P103, DOI 10.1093/qjmed/hcg016; Feruglio GA, 1990, LANCET, V336, P652; Gershlick AH, 2013, LANCET, V382, P624, DOI 10.1016/S0140-6736(13)61454-3; Giugliano RP, 2003, J AM COLL CARDIOL, V41, P1251, DOI 10.1016/S0735-1097(03)00123-2; Global Atlas on Cardiovascular Disease Prevention and Control, 2011, WHO COLL WORLD HEART; Guiltermini A, 2016, ARCH MED SCI, V12, P1181, DOI 10.5114/aoms.2016.58929; HAMPTON J, 1993, LANCET, V342, P759; HAMPTON JR, 1995, LANCET, V346, P329; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; James SK, 2013, LANCET, V382, P576, DOI 10.1016/S0140-6736(13)61716-X; Janousek S, 1988, Vnitr Lek, V34, P1145; Jinatongthai P, 2016, COMP EFFICACY SAFETY; KENNEDY JW, 1988, CIRCULATION, V77, P345, DOI 10.1161/01.CIR.77.2.345; Kikkert WJ, 2014, J AM COLL CARDIOL, V63, P1866, DOI 10.1016/j.jacc.2014.01.069; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald F., 2016, 80 DATA CHINESE CLIN; MAGNANI B, 1989, J AM COLL CARDIOL, V13, P19, DOI 10.1016/0735-1097(89)90543-3; McCaul M, 2014, COCHRANE DB SYST REV, V9; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta RH, 2012, AM J CARDIOL, V109, P320, DOI 10.1016/j.amjcard.2011.09.012; Multiple treatments meta-analysis, US STATA NETW MET; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ohman EM, 1997, CIRCULATION, V95, P846; OROURKE M, 1988, CIRCULATION, V77, P1311, DOI 10.1161/01.CIR.77.6.1311; Puhan MA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3326; Rashid MK, 2016, JACC-CARDIOVASC INTE, V9, P2014, DOI 10.1016/j.jcin.2016.07.004; Ronner E, 2000, EUR HEART J, V21, P1530, DOI 10.1053/euhj.1999.2035; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sarullo F M, 2001, Ital Heart J, V2, P605; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; Shimony A, 2014, AM J CARDIOL, V113, P793, DOI 10.1016/j.amjcard.2013.11.024; Sim DS, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003508; Simoons ML, 2002, EUR HEART J, V23, P1282, DOI 10.1053/euhj.2001.3083; Sinno MCN, 2007, AM HEART J, V153, P579, DOI 10.1016/j.ahj.2006.12.024; Siontis KC, 2016, AM J CARDIOL, V117, P1904, DOI 10.1016/j.amjcard.2016.03.036; SMALLING RW, 1995, CIRCULATION, V91, P2725, DOI 10.1161/01.CIR.91.11.2725; Squire IB, 1999, EUR HEART J, V20, P1245, DOI 10.1053/euhj.1999.1528; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; TAYLOR GJ, 1993, AM J CARDIOL, V72, P1010, DOI 10.1016/0002-9149(93)90854-6; THOMPSON PL, 1988, LANCET, V1, P203; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TOPOL EJ, 1989, CIRCULATION, V79, P281, DOI 10.1161/01.CIR.79.2.281; Topol EJ, 2000, CIRCULATION, V101, P2788; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Topol EJ, 2001, LANCET, V357, P1905; Van de Werf F, 1988, BMJ-BRIT MED J, V297, P13742; Van de Werf F, LANCET; Van De Werf FJ, EFFICACY SAFETY TENE; VANDEWERF F, 1990, LANCET, V336, P71; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vranckx P, 2014, EUR HEART J, V35, P2524, DOI 10.1093/eurheartj/ehu161; WEAVER WD, 1993, JAMA-J AM MED ASSOC, V270, P1211, DOI 10.1001/jama.270.10.1211; WHITE HD, 1987, NEW ENGL J MED, V317, P850, DOI 10.1056/NEJM198710013171402; White HD, 2001, LANCET, V358, P1855; WHITE HD, 1989, NEW ENGL J MED, V320, P817, DOI 10.1056/NEJM198903303201301	81	31	32	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					747	759		10.1016/S0140-6736(17)31441-1	http://dx.doi.org/10.1016/S0140-6736(17)31441-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28831992				2022-12-28	WOS:000407858900019
J	Spiering, W; Williams, B; Van der Heyden, J; van Kleef, M; Lo, R; Versmissen, J; Moelker, A; Kroon, A; Reuter, H; Ansel, G; Stone, GW; Bates, M				Spiering, Wilko; Williams, Bryan; Van der Heyden, Jan; van Kleef, Monique; Lo, Rob; Versmissen, Jorie; Moelker, Adriaan; Kroon, Abraham; Reuter, Hannes; Ansel, Gary; Stone, Gregg W.; Bates, Mark		CALM-FIM EUR Investigators	Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study	LANCET			English	Article							RENAL DENERVATION; BLOOD-PRESSURE; DOUBLE-BLIND; TRIAL; STIMULATION; PLACEBO; DISEASE	Background Carotid baroreflex activation lowers blood pressure and might have potential application for the treatment of resistant hypertension. We did a proof-of-principle trial with a novel endovascular baroreceptor amplification device, MobiusHD (Vascular Dynamics, Mountain View, CA, USA), in patients with resistant hypertension. Methods CALM-FIM_EUR was a prospective, first-in-human, open-label study done at six European centres. Eligible patients were adults with resistant hypertension (office systolic blood pressure >= 160 mm Hg despite taking at least three antihypertensive agents, including a diuretic). MobiusHD devices were implanted unilaterally in the internal carotid artery. The primary endpoint was the incidence of serious adverse events at 6 months. Secondary endpoints included changes in office and 24 h ambulatory blood pressure. This trial is registered with ClinicalTrials.gov, number NCT01911897. Findings Between December, 2013, and February, 2016, 30 patients were enrolled and underwent successful implantation. Mean age was 52 years (SD 12), 15 patients (50%) were men, and mean antihypertensive use was 4.4 drugs (1.4). Mean office blood pressure was 184/109 mm Hg (18/14) at baseline and was reduced by 24/12 mm Hg (13-34/6-18) at 6 months (p=0.0003 for systolic and p=0.0001 diastolic blood pressure). Mean baseline 24 h ambulatory blood pressure was 166/100 mm Hg (17/14) at baseline and was reduced by 21/12 mm Hg (14-29/7-16) at 6 months (p< 0.0001 for systolic and diastolic blood pressure). Five serious adverse events had occurred in four patients (13%) at 6 months: hypotension (n=2), worsening hypertension (n=1), intermittent claudication (n=1) and wound infection (n=1). Interpretation In patients with resistant hypertension, endovascular baroreceptor amplification with the MobiusHD device substantially lowered blood pressure with an acceptable safety profile. Randomised, double-blind, sham-controlled trials are warranted to investigate the use of this treatment further.	[Spiering, Wilko; van Kleef, Monique] Univ Utrecht, Dept Vasc Med, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Lo, Rob] Univ Utrecht, Dept Radiol, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Williams, Bryan] UCL, Inst Cardiovasc Sci, London, England; [Williams, Bryan] UCL Hosp, Biomed Res Ctr, NIHR, London, England; [Van der Heyden, Jan] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Versmissen, Jorie] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Moelker, Adriaan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Kroon, Abraham] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Reuter, Hannes] Univ Cologne, Dept Cardiol, Heart Ctr, Cologne, Germany; [Ansel, Gary] OhioHlth Res Inst, Columbus, OH USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Bates, Mark] CAMC Res Inst, Charleston, WV USA; [Bates, Mark] West Virginia Univ, Charleston, WV 25304 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London; St. Antonius Hospital Utrecht; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; University of Cologne; Columbia University; Cardiovascular Research Foundation (CRF)	Spiering, W (corresponding author), Dept Vasc Med, HP F02-126 Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	W.Spiering@umcutrecht.nl		Kroon, Abraham/0000-0001-7750-8249; Williams, Bryan/0000-0002-8094-1841	Vascular Dynamics; Medical Research Council [MC_PC_13090] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10222, NF-SI-0514-10011] Funding Source: researchfish; MRC [MC_PC_13090] Funding Source: UKRI	Vascular Dynamics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Vascular Dynamics.	Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Billingham SAM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-104; Bisognano JD, 2011, J AM COLL CARDIOL, V58, P765, DOI 10.1016/j.jacc.2011.06.008; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; de Jager RL, 2017, HYPERTENSION, V69, P678, DOI 10.1161/HYPERTENSIONAHA.116.08818; de Leeuw PW, 2015, HYPERTENSION, V65, P187, DOI 10.1161/HYPERTENSIONAHA.114.04492; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Freeman R, 2008, NEW ENGL J MED, V358, P615, DOI 10.1056/NEJMcp074189; Heusser K, 2016, HYPERTENSION, V67, P585, DOI 10.1161/HYPERTENSIONAHA.115.06486; Heusser K, 2010, HYPERTENSION, V55, P619, DOI 10.1161/HYPERTENSIONAHA.109.140665; Irvin MR, 2014, J AM SOC HYPERTENS, V8, P405, DOI 10.1016/j.jash.2014.03.003; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Muntner P, 2014, HYPERTENSION, V64, P1012, DOI 10.1161/HYPERTENSIONAHA.114.03850; Peter DA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006339; Tomaszewski M, 2014, HEART, V100, P855, DOI 10.1136/heartjnl-2013-305063; WHO Collaborating Centre for Drug Statistics Methodology, 2016, GUID ATC CLASS DDD A; Williams B, 2015, LANCET, V386, P2059, DOI 10.1016/S0140-6736(15)00257-3; Yoruk A, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0702-9	19	62	68	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2017	390	10113					2655	2661		10.1016/S0140-6736(17)32337-1	http://dx.doi.org/10.1016/S0140-6736(17)32337-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ1FF	28870716	Green Submitted, Green Published			2022-12-28	WOS:000418101000026
J	Lindholt, JS; Sogaard, R				Lindholt, Jes S.; Sogaard, Rikke			Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial	LANCET			English	Article							ABDOMINAL AORTIC-ANEURYSM; BREAST-CANCER; MORTALITY; HARMS; LIFE	Background Abdominal aortic aneurysm is the only cardiovascular disease targeted by population screening. In this study, we test the effect of screening and subsequent intervention for abdominal aortic aneurysm, peripheral arterial disease, and hypertension combined. Methods In this randomised controlled trial, we randomly allocated (1:1) all men aged 65-74 years living in the Central Denmark Region to screening for abdominal aortic aneurysm, peripheral arterial disease, and hypertension, or to no screening. We based allocation on computer-generated random numbers from 1 to 100 in blocks of 1067 to 4392, stratified by 19 municipalities. Only the non-screening group and the investigator assessing outcomes were masked. We invited participants who were found to have abdominal aortic aneurysm or peripheral arterial disease back for confirmation and eventual initiation of relevant pharmacological therapy. We further offered participants with abdominal aortic aneurysm annual control or surgical repair. We referred participants with suspected hypertension to their general practitioner. The primary outcome was all-cause mortality, assessed 5 years after randomisation, analysed in all randomly allocated participants except for those who had incorrect person identification numbers. This trial is registered at ClinicalTrials.gov, number NCT00662480. Findings Between Oct 8, 2008, and Jan 11, 2011, we randomly allocated 50 156 participants, with 25 078 (50%) each in the screening and non-screening groups. Four (<1%) participants in the screening group were lost to follow-up. After a median follow-up of 4.4 years (IQR 3.9-4.8), 2566 (10.2%) of 25 074 participants in the screening group and 2715 (10.8%) of 25 078 in the non-screening group had died. This finding resulted in a significant hazard ratio of 0.93 (95% CI 0.88-0.98; p=0.01), an absolute risk reduction of 0.006 (0.001-0.011), and a number needed to invite of 169 (89-1811). Incidences of diabetes (3995 per 100 000 person-years in the screening group vs 4129 per 100 000 person-years in the non-screening group), intracerebral haemorrhage (146 vs 140), renal failure (612 vs 649), cancer (3578 vs 3719), or 30 day mortality after cardiovascular surgery (44.57 vs 39.33) did not differ between groups. Interpretation The observed reduction of mortality risk from abdominal aortic aneurysm, peripheral arterial disease, and hypertension has never been seen before in the population screening literature and can be linked primarily to initiation of pharmacological therapy. Health policy makers should consider implementing combined screening whether no screening or isolated abdominal aortic aneurysm screening is currently offered.	[Lindholt, Jes S.] Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-5000 Odense C, Denmark; [Lindholt, Jes S.] Viborg Hosp, Vasc Res Unit, Viborg, Denmark; [Sogaard, Rikke] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Sogaard, Rikke] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	University of Southern Denmark; Odense University Hospital; Aarhus University; Aarhus University; Aarhus University	Lindholt, JS (corresponding author), Odense Univ Hosp, Dept Cardiothorac & Vasc Surg, DK-5000 Odense C, Denmark.	jes.sanddal.lindholt@rsyd.dk	; Lindholt, Jes/J-2907-2014	Sogaard, Rikke/0000-0003-3557-8550; Lindholt, Jes/0000-0001-9536-4488	7th European Framework Programme, Central Denmark Region, Viborg Hospital; Danish Council for Independent Research	7th European Framework Programme, Central Denmark Region, Viborg Hospital; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The 7th European Framework Programme, Central Denmark Region, Viborg Hospital, and the Danish Council for Independent Research.	Alahdab F, 2015, J VASC SURG, V61, p42S, DOI 10.1016/j.jvs.2014.12.008; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Betteridge DJ, 2016, NAT REV ENDOCRINOL, V12, P99, DOI 10.1038/nrendo.2015.194; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Carter JL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7773; Carter SM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h869; Forbes JF, 1998, LANCET, V352, P1656; Grondal N, 2015, BRIT J SURG, V102, P902, DOI 10.1002/bjs.9825; Grondal N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-67; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Jacomelli J, 2016, BRIT J SURG, V103, P1125, DOI 10.1002/bjs.10173; Johansson M, 2016, LANCET, V387, P308, DOI 10.1016/S0140-6736(15)00472-9; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Laustsen J, 2004, EUR J VASC ENDOVASC, V27, P216, DOI 10.1016/j.ejvs.2003.11.011; Lindholt JS, 2007, EUR J VASC ENDOVASC, V33, P94, DOI 10.1016/j.ejvs.2006.06.007; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P235, DOI 10.1053/ejvs.2001.1329; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Orrapin S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub3; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Wanhainen A, 2016, CIRCULATION, V134, P1141, DOI 10.1161/CIRCULATIONAHA.116.022305; Wilson JMG, 1968, PRINCIPLES PRACTICE; Wittrup-Jensen KU, 2009, SCAND J PUBLIC HEALT, V37, P459, DOI 10.1177/1403494809105287; World Health Organization, CARDIOVASCULAR DIS; Zastepa E, 2014, NEUROLOGY, V82, P1193, DOI [10.1212/WNL.0000000000000329, 10.1212/01.wnl.0000445976.98849.b1]	30	104	105	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2256	2265		10.1016/S0140-6736(17)32250-X	http://dx.doi.org/10.1016/S0140-6736(17)32250-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN0DH	28859943				2022-12-28	WOS:000415645700024
J	Erlinge, D; Omerovic, E; Frobert, O; Linder, R; Danielewicz, M; Hamid, M; Swahn, E; Henareh, L; Wagner, H; Hardhammar, P; Sjogren, I; Stewart, J; Grimfjard, P; Jensen, J; Aasa, M; Robertsson, L; Lindroos, P; Haupt, J; Wikstrom, H; Ulvenstam, A; Bhiladvala, P; Lindvall, B; Lundin, A; Todt, T; Ioanes, D; Ramunddal, T; Kellerth, T; Zagozdzon, L; Gotberg, M; Andersson, J; Angeras, O; Ostlund, O; Lagerqvist, B; Held, C; Wallentin, L; Schersten, F; Eriksson, P; Koul, S; James, S				Erlinge, D.; Omerovic, E.; Frobert, O.; Linder, R.; Danielewicz, M.; Hamid, M.; Swahn, E.; Henareh, L.; Wagner, H.; Hardhammar, P.; Sjogren, I.; Stewart, J.; Grimfjard, P.; Jensen, J.; Aasa, M.; Robertsson, L.; Lindroos, P.; Haupt, J.; Wikstrom, H.; Ulvenstam, A.; Bhiladvala, P.; Lindvall, B.; Lundin, A.; Todt, T.; Ioanes, D.; Ramunddal, T.; Kellerth, T.; Zagozdzon, L.; Gotberg, M.; Andersson, J.; Angeras, O.; Ostlund, O.; Lagerqvist, B.; Held, C.; Wallentin, L.; Schersten, F.; Eriksson, P.; Koul, S.; James, S.			Bivalirudin versus Heparin Monotherapy in Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; UNFRACTIONATED HEPARIN; STENT THROMBOSIS; NON-ST; CLOPIDOGREL; INHIBITION; PRASUGREL; REGISTRY; TRIAL; PCI	BACKGROUND The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) according to current practice, which includes the use of radial-artery access for PCI and administration of potent P2Y 12 inhibitors without the planned use of glycoprotein IIb/IIIa inhibitors. METHODS In this multicenter, randomized, registry-based, open-label clinical trial, we enrolled patients with either ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) who were undergoing PCI and receiving treatment with a potent P2Y(12) inhibitor (ticagrelor, prasugrel, or cangrelor) without the planned use of glycoprotein IIb/IIIa inhibitors. The patients were randomly assigned to receive bivalirudin or heparin during PCI, which was performed predominantly with the use of radial-artery access. The primary end point was a composite of death from any cause, myocardial infarction, or major bleeding during 180 days of follow-up. RESULTS A total of 6006 patients (3005 with STEMI and 3001 with NSTEMI) were enrolled in the trial. At 180 days, a primary end-point event had occurred in 12.3% of the patients (369 of 3004) in the bivalirudin group and in 12.8% (383 of 3002) in the heparin group (hazard ratio, 0.96; 95% confidence interval [CI], 0.83 to 1.10; P = 0.54). The results were consistent between patients with STEMI and those with NSTEMI and across other major subgroups. Myocardial infarction occurred in 2.0% of the patients in the bivalirudin group and in 2.4% in the heparin group (hazard ratio, 0.84; 95% CI, 0.60 to 1.19; P = 0.33), major bleeding in 8.6% and 8.6%, respectively (hazard ratio, 1.00; 95% CI, 0.84 to 1.19; P = 0.98), definite stent thrombosis in 0.4% and 0.7%, respectively (hazard ratio, 0.54; 95% CI, 0.27 to 1.10; P = 0.09), and death in 2.9% and 2.8%, respectively (hazard ratio, 1.05; 95% CI, 0.78 to 1.41; P = 0.76). CONCLUSIONS Among patients undergoing PCI for myocardial infarction, the rate of the composite of death from any cause, myocardial infarction, or major bleeding was not lower among those who received bivalirudin than among those who received heparin monotherapy. (Funded by the Swedish Heart-Lung Foundation and others;	[Erlinge, D.; Bhiladvala, P.; Lundin, A.; Todt, T.; Gotberg, M.; Schersten, F.; Koul, S.] Lund Univ, Dept Cardiol Clin Sci, Lund, Sweden; [Omerovic, E.; Ioanes, D.; Ramunddal, T.; Angeras, O.] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Frobert, O.; Kellerth, T.; Zagozdzon, L.] Rebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden; [Linder, R.] Danderyd Hosp, Dept Cardiol, Danderyd, Sweden; [Henareh, L.] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Jensen, J.; Lindroos, P.] Karolinska Inst, Capio St Gorans Hosp, Dept Cardiol, Stockholm, Sweden; [Aasa, M.] Sodersjukhuset AB, Dept Cardiol, Stockholm, Sweden; [Danielewicz, M.] Karlstad Hosp, PCI Unit, Karlstad, Sweden; [Hamid, M.] Malarsjukhuset, Dept Cardiol, Eskilstuna, Sweden; [Swahn, E.] Linkoping Univ Hosp, Dept Cardiol, Linkoping, Sweden; [Wagner, H.] Helsingborg Lasarett, Dept Cardiol, Helsingborg, Sweden; [Hardhammar, P.] Halmstad Cty Hosp, Dept Cardiol, Halmstad, Sweden; [Sjogren, I.] Falun Cent Hosp, Dept Cardiol, Falun, Sweden; [Stewart, J.] Skaraborgs Hosp, Dept Cardiol, Skovde, Sweden; [Grimfjard, P.] Vastmanlands Sjukhus, Dept Internal Med, Vasteras, Sweden; [Robertsson, L.] Sodra Alvsborgs Sjukhus, Dept Cardiol, Boras, Sweden; [Haupt, J.] Sunderby Sjukhus, Dept Cardiol, Lulea, Sweden; [Wikstrom, H.] Kristianstad Hosp, Dept Cardiol, Kristianstad, Sweden; [Ulvenstam, A.] Ostersund Hosp, Dept Cardiol, Ostersund, Sweden; [Lindvall, B.] Sundsvall Hosp, Dept Cardiol, Sundsvall, Sweden; [Andersson, J.; Eriksson, P.] Umea Univ, Dept Cardiol, Umea, Sweden; [Ostlund, O.; Lagerqvist, B.; Held, C.; Wallentin, L.; James, S.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ostlund, O.; Lagerqvist, B.; Held, C.; Wallentin, L.; James, S.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Lund University; Sahlgrenska University Hospital; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Saint Goran's Hospital; Linkoping University; Helsingborgs Hospital; Falun Hospital; Sunderby Hospital; Umea University; Uppsala University; Uppsala University	Erlinge, D (corresponding author), Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, S-22185 Lund, Sweden.	david.erlinge@med.lu.se	Demchuk, Andrew M/E-1103-2012; James, Stefan K/J-4554-2014; Held, Claes/AAA-3973-2021	Demchuk, Andrew M/0000-0002-4930-7789; Held, Claes/0000-0001-9402-7404; Frobert, Ole/0000-0002-5846-345X; Ostlund, Ollie/0000-0001-8028-2308; Gotberg, Matthias/0000-0002-0912-7927	Swedish Heart-Lung Foundation; Swedish Research Council; AstraZeneca; Medicines Company; Swedish Foundation for Strategic Research (as part of the TOTAL-AMI project)	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); AstraZeneca(AstraZeneca); Medicines Company; Swedish Foundation for Strategic Research (as part of the TOTAL-AMI project)	Supported by the Swedish Heart-Lung Foundation, the Swedish Research Council, unrestricted grants from AstraZeneca and the Medicines Company, and the Swedish Foundation for Strategic Research (as part of the TOTAL-AMI project).	Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Clemmensen P, 2015, JACC-CARDIOVASC INTE, V8, P214, DOI 10.1016/j.jcin.2014.11.002; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Erlinge D, 2016, AM HEART J, V175, P36, DOI 10.1016/j.ahj.2016.02.007; Han YL, 2015, JAMA-J AM MED ASSOC, V313, P1336, DOI 10.1001/jama.2015.2323; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Koutouzis M, 2011, HEART, V97, P1484, DOI 10.1136/hrt.2011.224709; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Montalescot G, 2011, LANCET, V378, P693, DOI 10.1016/S0140-6736(11)60876-3; Schulz S, 2014, EUR HEART J, V35, P2285, DOI 10.1093/eurheartj/ehu182; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Valgimigli M, 2015, NEW ENGL J MED, V373, P997, DOI 10.1056/NEJMoa1507854; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Zeymer U, 2014, EUR HEART J, V35, P2460, DOI 10.1093/eurheartj/ehu214	21	167	173	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2017	377	12					1132	1142		10.1056/NEJMoa1706443	http://dx.doi.org/10.1056/NEJMoa1706443			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7FF	28844201	Green Published, Bronze			2022-12-28	WOS:000411348500007
J	Cohen, JT; Neumann, PJ; Wong, JB				Cohen, Joshua T.; Neumann, Peter J.; Wong, John B.			A Call for Open-Source Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Cohen, Joshua T.; Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, 800 Washington St,Box 063, Boston, MA 02111 USA; [Wong, John B.] Tufts Med Ctr, Dept Med, Div Clin Decis Making, 800 Washington St,Box 302, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center	Cohen, JT (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, 800 Washington St,Box 063, Boston, MA 02111 USA.	jcohen@TuftsMedicalCenter.org		Wong, John/0000-0003-4203-9010	Bill and Melinda Gates Foundation [OPP1171680]; National Institutes of Health (NIH) [U01NS086294]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086294] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This manuscript was funded in part by the Bill and Melinda Gates Foundation, "Increasing use of health economic information for global health," Investment ID OPP1171680, and by the National Institutes of Health (NIH), ''Personalized Risk Information in Cost Effectiveness Studies (PRICES)," NIH Grant Award U01NS086294.	Bailey Ronald, 2016, REASON; Bertagnolli MM, 2017, NEW ENGL J MED, V376, P1178, DOI 10.1056/NEJMsb1702054; Hanson B, 2011, SCIENCE, V331, P649, DOI 10.1126/science.1203354; Hough J., 2017, BARRONS         0415; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Stodden V, 2016, SCIENCE, V354, P1240, DOI 10.1126/science.aah6168; Taichman DB, 2016, ANN INTERN MED, V164, P505, DOI 10.7326/M15-2928; Teerawattananon Y, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0156-6; Vandewalle P, 2012, COMPUT SCI ENG, V14, P42, DOI 10.1109/MCSE.2012.63	10	32	20	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					432	+		10.7326/M17-1153	http://dx.doi.org/10.7326/M17-1153			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH2YU	28847014	Green Accepted			2022-12-28	WOS:000411009900020
J	Pennisi, E; Malakoff, D				Pennisi, Elizabeth; Malakoff, David			MARINE SCIENCE Record storm puts gulf resilience to the test	SCIENCE			English	News Item																			0	1	1	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		954	954		10.1126/science.357.6355.954	http://dx.doi.org/10.1126/science.357.6355.954			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883051				2022-12-28	WOS:000409455700009
J	Haanen, JBAG				Haanen, John B. A. G.			Converting Cold into Hot Tumors by Combining Immunotherapies	CELL			English	Editorial Material								In a small phase Ib study in this issue of Cell, Ribas et al. report that the combination of intralesional injection of a modified human herpes simplex virus and systemic anti-PD-1 treatment resulted in a 62% response rate in patients with metastatic melanoma, accompanied by enhanced T cell infiltration in virus-injected lesions.	[Haanen, John B. A. G.] Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Haanen, JBAG (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.haanen@nki.nl	Haanen, John/AAD-8534-2022; Haanen, John/AAD-8578-2022	Haanen, John/0000-0001-5884-7704; 				Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954	8	141	145	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1055	1056		10.1016/j.cell.2017.08.031	http://dx.doi.org/10.1016/j.cell.2017.08.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886376	Bronze			2022-12-28	WOS:000409536000003
J	Bagla, P				Bagla, Pallava			India's dark matter quest	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					857	857						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860364				2022-12-28	WOS:000408734900018
J	Fernandes, VM; Chen, ZQ; Rossi, AM; Zipfel, J; Desplan, C				Fernandes, Vilaiwan M.; Chen, Zhenqing; Rossi, Anthony M.; Zipfel, Jaqueline; Desplan, Claude			Glia relay differentiation cues to coordinate neuronal development in Drosophila	SCIENCE			English	Article							INSULIN-LIKE PEPTIDES; VISUAL-SYSTEM; RETINAL AXONS; GROWTH-CONTROL; STEM-CELLS; EYE; RECEPTOR; TARGET; NEUROGENESIS; CARTRIDGE	Neuronal birth and specification must be coordinated across the developing brain to generate the neurons that constitute neural circuits. We used the Drosophila visual system to investigate how development is coordinated to establish retinotopy, a feature of all visual systems. Photoreceptors achieve retinotopy by inducing their target field in the optic lobe, the lamina neurons, with a secreted differentiation cue, epidermal growth factor (EGF). We find that communication between photoreceptors and lamina cells requires a signaling relay through glia. In response to photoreceptor-EGF, glia produce insulin-like peptides, which induce lamina neuronal differentiation. Our study identifies a role for glia in coordinating neuronal development across distinct brain regions, thus reconciling the timing of column assembly with that of delayed differentiation, as well as the spatiotemporal pattern of lamina neuron differentiation.	[Fernandes, Vilaiwan M.; Chen, Zhenqing; Rossi, Anthony M.; Zipfel, Jaqueline; Desplan, Claude] NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA; [Chen, Zhenqing] Univ Illinois, Carl R Woese Inst Genom Biol, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Zipfel, Jaqueline] Inst Neuro & Verhaltensbiol, Badestr 9, D-48149 Munster, Germany	New York University; University of Illinois System; University of Illinois Urbana-Champaign	Fernandes, VM (corresponding author), NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.	vilaiwan@nyu.edu	Fernandes, Vil/ABE-3183-2021	Fernandes, Vil/0000-0002-1991-7252; Chen, Zhenqing/0000-0002-9214-9480; Rossi, Anthony/0000-0001-9345-7939; Desplan, Claude/0000-0002-6914-1413	NIH [EY13012]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research-Banting postdoctoral fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013012, P30EY013079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research-Banting postdoctoral fellowships(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Amoyel, G. Odell, K. Menon, S. Kunes, and current and former laboratory members for insightful comments and suggestions. We thank B. Shilo, L. Partridge, E. Hafen, P. Leopold, Y. N. Jan, and E. Bach for reagents. This work was supported by NIH grant EY13012 to C. D.; V.M.F. was supported by Natural Sciences and Engineering Research Council of Canada and Canadian Institutes of Health Research-Banting postdoctoral fellowships. The supplementary materials contain additional data.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Edwards TN, 2012, J COMP NEUROL, V520, P2067, DOI 10.1002/cne.23071; Franzdottir SR, 2009, NATURE, V460, P758, DOI 10.1038/nature08167; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Ma ZG, 2016, NATURE, V539, P428, DOI 10.1038/nature20145; Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Pecot MY, 2014, NEURON, V82, P320, DOI 10.1016/j.neuron.2014.02.045; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Silies M, 2010, FLY, V4, P71, DOI 10.4161/fly.4.1.11312; Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Sopko R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009050; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sugie A, 2010, DEVELOPMENT, V137, P3303, DOI 10.1242/dev.047332; Umetsu D, 2006, DEVELOPMENT, V133, P791, DOI 10.1242/dev.02253; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Yogev S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000505	31	40	41	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					886	+		10.1126/science.aan3174	http://dx.doi.org/10.1126/science.aan3174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860380	Green Submitted, Green Accepted			2022-12-28	WOS:000408734900036
J	Hey, SP; Cohen, IG; Adashi, EY; Kesselheim, AS				Hey, Spencer Phillips; Cohen, I. Glenn; Adashi, Eli Y.; Kesselheim, Aaron S.			Influence, integrity, and the FDA: An ethical framework	SCIENCE			English	Editorial Material							TRANSPARENCY; LEGAL		[Hey, Spencer Phillips; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, Boston, MA 02120 USA; [Hey, Spencer Phillips; Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA 02120 USA; [Hey, Spencer Phillips; Kesselheim, Aaron S.] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA; [Cohen, I. Glenn] Harvard Law Sch, Petrie Flom Ctr, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brown University	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, Boston, MA 02120 USA.; Kesselheim, AS (corresponding author), Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA.	akesselheim@bwh.harvard.edu						Carpenter D, 2014, PREVENTING REGULATORY CAPTURE: SPECIAL INTEREST INFLUENCE AND HOW TO LIMIT IT, P1; Carpenter D., 2014, REPUTATION POWER ORG; Charo R. Alta, 2015, FDA 21 CENTURY CHALL, P263; Darrow JJ, 2015, NEW ENGL J MED, V372, P279, DOI 10.1056/NEJMhle1409465; Food and Drug Administration, 2016, DEV EV STAND FRAM SA; Food and Drug Administration, 2017, OFF GLOB REG OP POL; Gellad WF, 2015, JAMA-J AM MED ASSOC, V314, P869, DOI 10.1001/jama.2015.8405; Gottlieb S., FDA ANNOUNCES NEW ST; Hey SP, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4435; Hey SP, 2017, HASTINGS CENT REP, V47, P16, DOI 10.1002/hast.685; Hey SP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001978; Hilts P, 2003, PROTECTING AM HLTH F; Sarpatwari A, 2015, NEW ENGL J MED, V372, P2380, DOI 10.1056/NEJMp1504672; Servick K, 2014, SCIENCE, V344, P1329, DOI 10.1126/science.344.6190.1329; Weil D, 2013, SCIENCE, V340, P1410, DOI 10.1126/science.1233480	15	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					876	877		10.1126/science.aao1056	http://dx.doi.org/10.1126/science.aao1056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860375				2022-12-28	WOS:000408734900029
J	Stone, R				Stone, Richard			ATOMIC BONDING	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					862	865		10.1126/science.357.6354.862	http://dx.doi.org/10.1126/science.357.6354.862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860367				2022-12-28	WOS:000408734900021
J	Kathiresan, S				Kathiresan, Sekar			HEART DISEASE Putative medicines that mimic mutations	NATURE			English	Editorial Material							CARDIOVASCULAR-DISEASE; ANGPTL3; PCSK9; HYPERCHOLESTEROLEMIA; PROTECTION		[Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Kathiresan, Sekar] Broad Inst, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Kathiresan, S (corresponding author), Broad Inst, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA.	sekar@broadinstitute.org						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Graham MJ, 2017, NEW ENGL J MED, V377, P222, DOI 10.1056/NEJMoa1701329; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Khera AV, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2016.160; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Musunuru K, 2016, CIRC RES, V118, P579, DOI 10.1161/CIRCRESAHA.115.306398; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	16	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					530	531		10.1038/nature23544	http://dx.doi.org/10.1038/nature23544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2BO	28847003				2022-12-28	WOS:000408703100024
J	Vaishya, R; Agarwal, AK; Singh, SK; Vijay, V; Sardana, R				Vaishya, Raju; Agarwal, Amit Kumar; Singh, Sujeet Kumar; Vijay, Vipul; Sardana, Raman			Polyarthralgia in a young woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHIKUNGUNYA		[Vaishya, Raju; Agarwal, Amit Kumar; Vijay, Vipul] Indraprastha Apollo Hosp, Orthopaed, New Delhi, India; [Sardana, Raman] Indraprastha Apollo Hosp, Microbiol, New Delhi, India; [Singh, Sujeet Kumar] Govt India, Minist Hlth & Family Welf, Nirman Bhawan, New Delhi, India		Agarwal, AK (corresponding author), Indraprastha Apollo Hosp, Orthopaed, New Delhi, India.	amitorthopgi@yahoo.co.in	VAISHYA, RAJU/I-3726-2015	VAISHYA, RAJU/0000-0002-9577-9533				Arroyo-Avila M, 2015, P R HEALTH SCI J, V34, P71; Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Hannu T, 2006, BEST PRACT RES CL RH, V20, P419, DOI 10.1016/j.berh.2006.02.003; Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019; Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3561	10.1136/bmj.j3561	http://dx.doi.org/10.1136/bmj.j3561			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CQ	28860110				2022-12-28	WOS:000409387000007
J	Yang, K; Blanco, DB; Neale, G; Vogel, P; Avila, J; Clish, CB; Wu, C; Shrestha, S; Rankin, S; Long, LY; Anil, KC; Chi, HB				Yang, Kai; Blanco, Daniel Bastardo; Neale, Geoffrey; Vogel, Peter; Avila, Julian; Clish, Clary B.; Wu, Chuan; Shrestha, Sharad; Rankin, Sherri; Long, Lingyun; Anil, K. C.; Chi, Hongbo			Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling	NATURE			English	Article							REGULATORY T-CELLS; ACTIVATION; RESPONSES; PD-1; BETA; OX40; DIFFERENTIATION; COSTIMULATION; INFLAMMATION; SURVIVAL	Regulatory T cells (T-reg cells) have a pivotal role in the establishment and maintenance of immunological self-tolerance and homeostasis(1,2). Transcriptional programming of regulatory mechanisms facilitates the functional activation of T-reg cells in the prevention of diverse types of inflammatory responses(3,4). It remains unclear how T-reg cells orchestrate their homeostasis and interplay with environmental signals. Here we show that liver kinase B1 (LKB1) programs the metabolic and functional fitness of T-reg cells in the control of immune tolerance and homeostasis. Mice with a T-reg-specific deletion of LKB1 developed a fatal inflammatory disease characterized by excessive T(H)2-type-dominant responses. LKB1 deficiency disrupted T-reg cell survival and mitochondrial fitness and metabolism, but also induced aberrant expression of immune regulatory molecules including the negative co-receptor PD-1 and the TNF receptor superfamily proteins GITR and OX40. Unexpectedly, LKB1 function in T-reg cells was independent of conventional AMPK signalling or the mTORC1-HIF-1 alpha axis, but contributed to the activation of beta-catenin signalling for the control of PD-1 and TNF receptor proteins. Blockade of PD-1 activity reinvigorated the ability of LKB1-deficient T-reg cells to suppress T(H)2 responses and the interplay with dendritic cells primed by thymic stromal lymphopoietin. Thus, T-reg cells use LKB1 signalling to coordinate their metabolic and immunological homeostasis and to prevent apoptotic and functional exhaustion, thereby orchestrating the balance between immunity and tolerance.	[Yang, Kai; Blanco, Daniel Bastardo; Shrestha, Sharad; Rankin, Sherri; Long, Lingyun; Anil, K. C.; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Neale, Geoffrey] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Avila, Julian; Clish, Clary B.] Broad Inst & Harvard Univ, Metabol Platform, Cambridge, MA 02142 USA; [Wu, Chuan] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; Clish, Clary B/ABB-9374-2021; Blanco, Daniel Bastardo/AAI-7919-2020; Long, Lingyun/C-2455-2019; Vogel, Peter/N-2490-2018; Clish, Clary/AAB-7124-2019	Chi, Hongbo/0000-0002-9997-2496; Clish, Clary B/0000-0001-8259-9245; Long, Lingyun/0000-0002-8565-4948; Vogel, Peter/0000-0002-7535-0545; Bastardo Blanco, Daniel/0000-0001-8232-7522; Avila, Julian/0000-0001-9388-3946	NIH [AI105887, AI101407, CA176624, NS064599]; American Asthma Foundation; NATIONAL CANCER INSTITUTE [R01CA221290, R01CA176624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101407, R01AI105887, R37AI105887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge A. Rudensky for Foxp<SUP>3YFP-cre</SUP> and Foxp3<SUP>cre-ERT2</SUP> mice, Y. Wang for editing of the manuscript, Y. Dhungana and Y. Li for advice on bioinformatics analyses, and St Jude Immunology FACS core facility for cell sorting. This work was supported by NIH AI105887, AI101407, CA176624 and NS064599, and American Asthma Foundation (to H.C.).	Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Chae WJ, 2016, IMMUNITY, V44, P246, DOI 10.1016/j.immuni.2016.01.008; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Tamaka K, 2015, EXP DERMATOL, V24, P280, DOI 10.1111/exd.12644; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; Valzasina B, 2005, BLOOD, V105, P2845, DOI 10.1182/blood-2004-07-2959; van der Veeken J, 2013, COLD SH Q B, V78, P215, DOI 10.1101/sqb.2013.78.020289; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zheng Y, 2011, METHODS MOL BIOL, V707, P71, DOI 10.1007/978-1-61737-979-6_6; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	38	114	119	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					602	+		10.1038/nature23665	http://dx.doi.org/10.1038/nature23665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28847007	Green Accepted, Green Submitted			2022-12-28	WOS:000408703100042
J	Grill, SW				Grill, Stephan W.			The mechanics of positioning skin follicles	SCIENCE			English	Editorial Material							INDUCTION		[Grill, Stephan W.] Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01309 Dresden, Germany; [Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 108, D-01307 Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Grill, SW (corresponding author), Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01309 Dresden, Germany.; Grill, SW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 108, D-01307 Dresden, Germany.	stephan.grill@tu-dresden.de						Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; CLAXTON JH, 1964, J THEOR BIOL, V7, P302, DOI 10.1016/0022-5193(64)90074-8; Fernandez-Sanchez ME, 2015, NATURE, V523, P92, DOI 10.1038/nature14329; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Michon F, 2008, DEVELOPMENT, V135, P2797, DOI 10.1242/dev.018341; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; Shyer AE, 2017, SCIENCE, V357, P811, DOI 10.1126/science.aai7868; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wigglesworth VB, 1940, J EXP BIOL, V17, P180	9	0	0	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					750	751		10.1126/science.aao2587	http://dx.doi.org/10.1126/science.aao2587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839057				2022-12-28	WOS:000408327900021
J	Tunuguntla, RH; Henley, RY; Yao, YC; Pham, TA; Wanunu, M; Noy, A				Tunuguntla, Ramya H.; Henley, Robert Y.; Yao, Yun-Chiao; Tuan Anh Pham; Wanunu, Meni; Noy, Aleksandr			Enhanced water permeability and tunable ion selectivity in subnanometer carbon nanotube porins	SCIENCE			English	Article							MEMBRANES; CHANNELS; PERMEATION; FLOW; DESALINATION; AQUAPORIN-1; DIFFUSION; TRANSPORT	Fast water transport through carbon nanotube pores has raised the possibility to use them in the next generation of water treatment technologies. We report that water permeability in 0.8-nanometer-diameter carbon nanotube porins (CNTPs), which confine water down to a single-file chain, exceeds that of biological water transporters and of wider CNT pores by an order of magnitude. Intermolecular hydrogen-bond rearrangement, required for entry into the nanotube, dominates the energy barrier and can be manipulated to enhance water transport rates. CNTPs block anion transport, even at salinities that exceed seawater levels, and their ion selectivity can be tuned to configure them into switchable ionic diodes. These properties make CNTPs a promising material for developing membrane separation technologies.	[Tunuguntla, Ramya H.; Henley, Robert Y.; Yao, Yun-Chiao; Noy, Aleksandr] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA; [Henley, Robert Y.; Wanunu, Meni] Northeastern Univ, Phys Dept, Boston, MA 02115 USA; [Yao, Yun-Chiao; Noy, Aleksandr] Univ Calif Merced, Sch Nat Sci, Merced, CA 94343 USA; [Tuan Anh Pham] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Mat Sci Div, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Northeastern University; University of California System; University of California Merced; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Noy, A (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Biol & Biotechnol Div, Livermore, CA 94550 USA.; Noy, A (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 94343 USA.	noy1@llnl.gov	McCoy, Tina/P-3402-2019	Yao, Yun-Chiao/0000-0003-3156-811X; Noy, Aleksandr/0000-0003-4924-2652	Lawrence Fellowship Program; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering; U.S. Department of Energy [DE-AC52-07NA27344]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation [EFMA-1542707]	Lawrence Fellowship Program; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	We thank P. Waduge, Northeastern University, for fabrication of the solid-state nanopore chips; Y. Zhang, Lawrence Livermore National Laboratory (LLNL) for help with graphics used in Figs. 1 and 3; and V. Freger, Technion, Israel, for helpful discussions. T.A.P acknowledges support from the Lawrence Fellowship Program. Computational resources were provided by the LLNL Institutional Computing Grand Challenge Program. This work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering. Work at LLNL was performed under the auspices of the U.S. Department of Energy under contract DE-AC52-07NA27344. Work at the Molecular Foundry at Lawrence Berkeley National Laboratory was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. Solid-state nanopore fabrication at Northeastern was funded by National Science Foundation (grant EFMA-1542707). A.N. is an inventor on U.S. Patent Application Ser. No. 15/503,983, submitted by Lawrence Livermore National Security, LLC, which covers carbon nanotube porins. A.N. holds shares in Porifera, Inc., a company that commercializes carbon nanotube membrane technology.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Amiri H, 2017, NANO LETT, V17, P1204, DOI 10.1021/acs.nanolett.6b04967; Barboiu M, 2013, ACCOUNTS CHEM RES, V46, P2814, DOI 10.1021/ar400025e; Biesheuvel PM, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.050601; Corry B, 2008, J PHYS CHEM B, V112, P1427, DOI 10.1021/jp709845u; Corry B, 2011, ENERG ENVIRON SCI, V4, P751, DOI 10.1039/c0ee00481b; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Geng J, 2014, NATURE, V514, P612, DOI 10.1038/nature13817; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Horner A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400083; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Joseph S, 2008, NANO LETT, V8, P452, DOI 10.1021/nl072385q; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Mekonnen MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500323; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; MILON A, 1986, BIOCHIM BIOPHYS ACTA, V859, P1, DOI 10.1016/0005-2736(86)90311-1; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nelson PH, 2002, J CHEM PHYS, V117, P11396, DOI 10.1063/1.1522709; Ramirez P, 2016, RSC ADV, V6, P54742, DOI 10.1039/c6ra08277g; Schwegler E, 2004, J CHEM PHYS, V121, P5400, DOI 10.1063/1.1782074; Secchi E, 2016, NATURE, V537, P210, DOI 10.1038/nature19315; Secchi E, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.154501; Shen YX, 2015, P NATL ACAD SCI USA, V112, P9810, DOI 10.1073/pnas.1508575112; Shen YX, 2014, J MEMBRANE SCI, V454, P359, DOI 10.1016/j.memsci.2013.12.019; Soveral G, 2011, BIOL CELL, V103, P35, DOI 10.1042/BC20100102; Tang CY, 2013, DESALINATION, V308, P34, DOI 10.1016/j.desal.2012.07.007; Tobias DJ, 2008, SCIENCE, V319, P1197, DOI 10.1126/science.1152799; Uedaira H, 2001, CELL MOL BIOL, V47, P823; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wu J, 2012, CHEM COMMUN, V48, P7979, DOI 10.1039/c2cc33355d; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhu FQ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.224501	33	415	424	56	527	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					792	796		10.1126/science.aan2438	http://dx.doi.org/10.1126/science.aan2438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839070				2022-12-28	WOS:000408327900041
J	Garg, SK; Henry, RR; Banks, P; Buse, JB; Davies, MJ; Fulcher, GR; Pozzilli, P; Gesty-Palmer, D; Lapuerta, P; Simo, R; Danne, T; McGuire, DK; Kushner, JA; Peters, A; Strumph, P				Garg, Satish K.; Henry, Robert R.; Banks, Phillip; Buse, John B.; Davies, Melanie J.; Fulcher, Gregory R.; Pozzilli, Paolo; Gesty-Palmer, Diane; Lapuerta, Pablo; Simo, Rafael; Danne, Thomas; McGuire, Darren K.; Kushner, Jake A.; Peters, Anne; Strumph, Paul			Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; DUAL SGLT1/SGLT2 INHIBITOR; DOUBLE-BLIND; GLYCEMIC CONTROL; SGLT2 INHIBITOR; RANDOMIZED-TRIAL; DELIVERY-SYSTEM; ADULT PATIENTS; T1D EXCHANGE; KETOACIDOSIS	BACKGROUND In most patients with type 1 diabetes, adequate glycemic control is not achieved with insulin therapy alone. We evaluated the safety and efficacy of sotagliflozin, an oral inhibitor of sodium-glucose cotransporters 1 and 2, in combination with insulin treatment in patients with type 1 diabetes. METHODS In this phase 3, double-blind trial, which was conducted at 133 centers worldwide, we randomly assigned 1402 patients with type 1 diabetes who were receiving treatment with any insulin therapy (pump or injections) to receive sotagliflozin (400 mg per day) or placebo for 24 weeks. The primary end point was a glycated hemoglobin level lower than 7.0% at week 24, with no episodes of severe hypoglycemia or diabetic ketoacidosis after randomization. Secondary end points included the change from baseline in glycated hemoglobin level, weight, systolic blood pressure, and mean daily bolus dose of insulin. RESULTS A significantly larger proportion of patients in the sotagliflozin group than in the placebo group achieved the primary end point (200 of 699 patients [28.6%] vs. 107 of 703 [15.2%], P<0.001). The least-squares mean change from baseline was significantly greater in the sotagliflozin group than in the placebo group for glycated hemoglobin (difference, -0.46 percentage points), weight (-2.98 kg), systolic blood pressure (-3.5 mm Hg), and mean daily bolus dose of insulin (-2.8 units per day) (P <= 0.002 for all comparisons). The rate of severe hypoglycemia was similar in the sotagliflozin group and the placebo group (3.0% [21 patients] and 2.4% [17], respectively). The rate of documented hypoglycemia with a blood glucose level of 55 mg per deciliter (3.1 mmol per liter) or below was significantly lower in the sotagliflozin group than in the placebo group. The rate of diabetic ketoacidosis was higher in the sotagliflozin group than in the placebo group (3.0% [21 patients] and 0.6% [4], respectively). CONCLUSIONS Among patients with type 1 diabetes who were receiving insulin, the proportion of patients who achieved a glycated hemoglobin level lower than 7.0% with no severe hypoglycemia or diabetic ketoacidosis was larger in the group that received sotagliflozin than in the placebo group. However, the rate of diabetic ketoacidosis was higher in the sotagliflozin group.	[Garg, Satish K.] Univ Colorado Denver, Aurora, CO 80045 USA; [Henry, Robert R.] Univ Calif San Diego, San Diego, CA USA; [Banks, Phillip; Gesty-Palmer, Diane; Lapuerta, Pablo; Strumph, Paul] Lexicon Pharmaceut, Woodlands, Dallas, TX USA; [McGuire, Darren K.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Kushner, Jake A.] Baylor Coll Med, Houston, TX 77030 USA; [Kushner, Jake A.] Texas Childrens Hosp, Houston, TX 77030 USA; [Buse, John B.] Univ N Carolina, Sch Med, Diabet Res Ctr, Chapel Hill, NC 27515 USA; [Davies, Melanie J.] Univ Leicester, Leicester, Leics, England; [Davies, Melanie J.] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Fulcher, Gregory R.] Univ Sydney, Sydney, NSW, Australia; [Pozzilli, Paolo] Univ Campus Biomed Rome, Rome, Italy; [Simo, Rafael] Vall dHebron Res Inst, Barcelona, Spain; [Simo, Rafael] CIBERDEM Inst Salud Carlos III, Madrid, Spain; [Danne, Thomas] Hannover Med Sch, Diabet Ctr Auf der Bult, Hannover, Germany; [Peters, Anne] Univ Southern Calif, Los Angeles, CA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Diego; Lexicon Pharmaceuticals; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Sydney; University Campus Bio-Medico - Rome Italy; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hannover Medical School; University of Southern California	Garg, SK (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Diabet, 1775 Aurora Court,Rm M20-1323, Aurora, CO 80045 USA.	satish.garg@ucdenver.edu	Buse, John Bernard/J-9742-2019; Kushner, Jake A/AAF-5049-2022; McGuire, Darren K./AAL-4172-2021; Kushner, Jake A/AFJ-8198-2022	Buse, John Bernard/0000-0002-9723-3876; Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Simo Canonge, Rafael/0000-0003-0475-3096; Davies, Melanie/0000-0002-9987-9371; Pozzilli, Paolo/0000-0001-5090-636X	Lexicon Pharmaceuticals	Lexicon Pharmaceuticals	Funded by Lexicon Pharmaceuticals;	American Diabetes Association, 2017, Diabetes Care, V40, pS64; [Anonymous], 2014, NUMB EM DEP VIS THOU; Benstetter M, 2016, SGLT2 INH PRAC MAK R; Bergenstal RM, 2016, JAMA-J AM MED ASSOC, V316, P1407, DOI 10.1001/jama.2016.11708; Bode BW, 2016, ENDOCR PRACT, V22, P220, DOI 10.4158/EP15869.RA; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Cryer PE, 2013, NEW ENGL J MED, V369, P362, DOI 10.1056/NEJMra1215228; Dobbins RL, 2015, AM J PHYSIOL-GASTR L, V308, pG946, DOI 10.1152/ajpgi.00286.2014; Einarson TR, 2014, DIABETES OBES METAB, V16, P492, DOI 10.1111/dom.12226; Ellis SL, 2011, DIABETIC MED, V28, P1176, DOI 10.1111/j.1464-5491.2011.03331.x; Erondu N, 2015, DIABETES CARE, V38, P1680, DOI 10.2337/dc15-1251; Fralick M, 2017, NEW ENGL J MED, V376, P2300, DOI 10.1056/NEJMc1701990; Garg SK, 2017, DIABETES TECHNOL THE, V19, P155, DOI 10.1089/dia.2016.0421; Garg SK, 2013, ENDOCR PRACT, V19, P19, DOI 10.4158/EP12100.OR; Handelsman Y, 2016, ENDOCR PRACT, V22, P753, DOI 10.4158/EP161292.PS; Hayami T, 2015, J DIABETES INVEST, V6, P587, DOI 10.1111/jdi.12330; Heller S, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21200; Henry RR, 2015, DIABETES CARE, V38, P2258, DOI 10.2337/dc15-1730; Henry RR, 2015, DIABETES CARE, V38, P412, DOI 10.2337/dc13-2955; Hine J, 2015, LANCET DIABETES ENDO, V3, P503, DOI 10.1016/S2213-8587(15)00204-1; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; International Diabetes Federation, 2015, DIABETES ATLAS, V7th; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Lapuerta P, 2015, DIABETES VASC DIS RE, V12, P101, DOI 10.1177/1479164114563304; Lyons SK, 2017, DIABETES CARE; Mathieu C, 2016, DIABETES CARE, V39, P1702, DOI 10.2337/dc16-0691; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Ogawa W, 2016, J DIABETES INVEST, V7, P135, DOI 10.1111/jdi.12401; Peters AL, 2015, DIABETES CARE, V38, P1687, DOI 10.2337/dc15-0843; Petrie JR, 2017, LANCET DIABETES ENDO, V5, P597, DOI 10.1016/S2213-8587(17)30194-8; Pieber TR, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12494; Realsen J, 2012, DIABETES TECHNOL THE, V14, P1149, DOI 10.1089/dia.2012.0161; Sands AT, 2015, DIABETES CARE, V38, P1181, DOI 10.2337/dc14-2806; Taylor SI, 2015, J CLIN ENDOCR METAB, V100, P2849, DOI 10.1210/jc.2015-1884; Weinstock RS, 2016, DIABETES RES CLIN PR, V122, P28, DOI 10.1016/j.diabres.2016.09.024; Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079; Zambrowicz B, 2012, CLIN PHARMACOL THER, V92, P158, DOI 10.1038/clpt.2012.58; Zambrowicz B, 2013, CLIN THER, V35, P273, DOI 10.1016/j.clinthera.2013.01.010	39	231	243	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2337	2348		10.1056/NEJMoa1708337	http://dx.doi.org/10.1056/NEJMoa1708337			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	28899222	Green Published, Bronze			2022-12-28	WOS:000417923600006
J	Townsend, RR; Mahfoud, F; Kandzari, DE; Kario, K; Pocock, S; Weber, MA; Ewen, S; Tsioufis, K; Tousoulis, D; Sharp, ASP; Watkinson, AF; Schmieder, RE; Schmid, A; Choi, JW; East, C; Walton, A; Hopper, I; Cohen, DL; Wilensky, R; Lee, DP; Ma, A; Devireddy, CM; Lea, JP; Lurz, PC; Fengler, K; Davies, J; Chapman, N; Cohen, SA; DeBruin, V; Fahy, M; Jones, DE; Rothman, M; Bohm, M				Townsend, Raymond R.; Mahfoud, Felix; Kandzari, David E.; Kario, Kazuomi; Pocock, Stuart; Weber, Michael A.; Ewen, Sebastian; Tsioufis, Konstantinos; Tousoulis, Dimitrios; Sharp, Andrew S. P.; Watkinson, Anthony F.; Schmieder, Roland E.; Schmid, Axel; Choi, James W.; East, Cara; Walton, Anthony; Hopper, Ingrid; Cohen, Debbie L.; Wilensky, Robert; Lee, David P.; Ma, Adrian; Devireddy, Chandan M.; Lea, Janice P.; Lurz, Philipp C.; Fengler, Karl; Davies, Justin; Chapman, Neil; Cohen, Sidney A.; DeBruin, Vanessa; Fahy, Martin; Jones, Denise E.; Rothman, Martin; Boehm, Michael		SPYRAL HTN-OFF MED Trial	Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial	LANCET			English	Article							TREATMENT-RESISTANT HYPERTENSION; BLOOD-PRESSURE; SYMPATHETIC DENERVATION; SYMPLICITY HTN-3; DRUG; ADHERENCE; MORTALITY; DESIGN; IMPACT	Background Previous randomised renal denervation studies did not show consistent efficacy in reducing blood pressure. The objective of our study was to evaluate the effect of renal denervation on blood pressure in the absence of antihypertensive medications. Methods SPYRAL HTN-OFF MED was a multicentre, international, single-blind, randomised, sham-controlled, proofof- concept trial. Patients were enrolled at 21 centres in the USA, Europe, Japan, and Australia. Eligible patients were drug-naive or discontinued their antihypertensive medications. Patients with an office systolic blood pressure (SBP) of 150 mm Hg or greater and less than 180 mm Hg, office diastolic blood pressure (DBP) of 90 mm Hg or greater, and a mean 24-h ambulatory SBP of 140 mm Hg or greater and less than 170 mm Hg at second screening underwent renal angiography and were randomly assigned to renal denervation or sham control. Patients, caregivers, and those assessing blood pressure were blinded to randomisation assignments. The primary endpoint, change in 24-h blood pressure at 3 months, was compared between groups. Drug surveillance was done to ensure patient compliance with absence of antihypertensive medication. The primary analysis was done in the intention-to-treat population. Safety events were assessed at 3 months. This study is registered with ClinicalTrials. gov, number NCT02439749. Findings Between June 25, 2015, and Jan 30, 2017, 353 patients were screened. 80 patients were randomly assigned to renal denervation (n=38) or sham control (n=42) and followed up for 3 months. Office and 24-h ambulatory blood pressure decreased significantly from baseline to 3 months in the renal denervation group: 24-h SBP -5.5 mm Hg (95% CI -9.1 to -2 . 0; p=0 . 0031), 24-h DBP -4.8 mm Hg (-7.0 to -2.6; p<0.0001), office SBP -10.0 mm Hg (-15.1 to -4.9; p=0.0004), and office DBP -5.3 mm Hg (-7.8 to -2. 7; p=0.0002). No significant changes were seen in the sham-control group: 24-h SBP -0.5 mm Hg (95% CI -3.9 to 2 .9; p=0.7644), 24-h DBP -0.4 mm Hg (-2.2 to 1.4; p=0 .6448), office SBP -2.3 mm Hg (-6.1 to 1.6; p=0.2381), and office DBP -0.3 mm Hg (-2.9 to 2.2; p=0.8052). The mean difference between the groups favoured renal denervation for 3-month change in both office and 24-h blood pressure from baseline: 24-h SBP -5.0 mm Hg (95% CI -9. 9 to -0.2; p=0.0414), 24-h DBP -4.4 mm Hg (-7.2 to -1.6; p=0.0024), office SBP -7.7 mm Hg (-14.0 to -1.5; p=0.0155), and office DBP -4.9 mm Hg (-8.5 to -1. 4; p=0.0077). Baseline-adjusted analyses showed similar findings. There were no major adverse events in either group. Interpretation Results from SPYRAL HTN-OFF MED provide biological proof of principle for the blood-pressurelowering efficacy of renal denervation.	[Townsend, Raymond R.; Cohen, Debbie L.; Wilensky, Robert] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mahfoud, Felix; Ewen, Sebastian; Boehm, Michael] Saarland Univ, Univ Hosp Saarland, Dept Internal Med 3, Homburg, Germany; [Mahfoud, Felix] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA USA; [Kario, Kazuomi] Jichi Med Univ, Sch Med, Shimotsuke, Tochigi, Japan; [Pocock, Stuart] London Sch Hyg & Trop Med, London, England; [Weber, Michael A.] SUNY Downstate Coll Med, Brooklyn, NY USA; [Tsioufis, Konstantinos; Tousoulis, Dimitrios] Univ Athens, Hippocrat Hosp, Athens, Greece; [Sharp, Andrew S. P.; Watkinson, Anthony F.] Royal Devon & Exeter Hosp, Exeter, Devon, England; [Schmieder, Roland E.; Schmid, Axel] Univ Hosp Erlangen, Erlangen, Germany; [Choi, James W.; East, Cara] Baylor Jack & Jane Hamilton Heart & Vasc Hosp, Dallas, TX USA; [Walton, Anthony; Hopper, Ingrid] Alfred Hosp, Melbourne, Vic, Australia; [Walton, Anthony] Monash Univ, Melbourne, Vic, Australia; [Lee, David P.; Ma, Adrian] Stanford Hosp & Clin, Stanford, CA USA; [Devireddy, Chandan M.; Lea, Janice P.] Emory Univ, Sch Med, Atlanta, GA USA; [Lurz, Philipp C.; Fengler, Karl] Univ Leipzig, Ctr Heart, Leipzig, Germany; [Davies, Justin; Chapman, Neil] Imperial Coll, London, England; [Davies, Justin; Chapman, Neil] Imperial, Hammersmith Hosp, London, England; [Cohen, Sidney A.; DeBruin, Vanessa; Fahy, Martin; Jones, Denise E.; Rothman, Martin] Medtronic PLC, Santa Rosa, CA USA; [Rothman, Martin] Barts Hlth Trust, London, England	University of Pennsylvania; Pennsylvania Medicine; Universitatsklinikum des Saarlandes; Massachusetts Institute of Technology (MIT); Piedmont Heart Institute; Jichi Medical University; University of London; London School of Hygiene & Tropical Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; National & Kapodistrian University of Athens; University of Exeter; University of Erlangen Nuremberg; Florey Institute of Neuroscience & Mental Health; Monash University; Stanford University; Emory University; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Imperial College London; Imperial College London; Medtronic; Barts Health NHS Trust	Townsend, RR (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	townsend@upenn.edu	Böhm, Michael/C-3638-2011; Lurz, Philipp C/B-6558-2009; Mahfoud, Felix/D-7707-2011	Lurz, Philipp C/0000-0002-5993-4487; Hopper, Ingrid/0000-0002-8805-370X	Medtronic	Medtronic(Medtronic)	Medtronic.	Azizi M, 2016, CIRCULATION, V134, P847, DOI 10.1161/CIRCULATIONAHA.116.022922; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Brinker S, 2014, J AM COLL CARDIOL, V63, P834, DOI 10.1016/j.jacc.2013.10.067; Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421; de Jager RL, 2017, HYPERTENSION, V69, P678, DOI 10.1161/HYPERTENSIONAHA.116.08818; De Jager RL, 2016, CLIN RES CARDIOL, V105, P755, DOI 10.1007/s00392-016-0984-y; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Elmula FEMF, 2017, BLOOD PRESSURE, V26, P195, DOI 10.1080/08037051.2017.1311769; ESLER M, 1988, HYPERTENSION, V11, P3, DOI 10.1161/01.HYP.11.1.3; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Ewen S, 2015, CLIN RES CARDIOL; Helfer AG, 2015, ANAL CHIM ACTA, V891, P221, DOI 10.1016/j.aca.2015.08.018; Howard JP, 2014, INT J CARDIOL, V172, P29, DOI 10.1016/j.ijcard.2013.12.183; James KE, 1996, STAT MED, V15, P1421; Jung O, 2013, J HYPERTENS, V31, P766, DOI 10.1097/HJH.0b013e32835e2286; Kaltenbach B, 2013, CATHETER CARDIO INTE, V81, P335, DOI 10.1002/ccd.24557; Kandzari DE, 2016, AM HEART J, V171, P82, DOI 10.1016/j.ahj.2015.08.021; Kandzari DE, 2015, EUR HEART J, V36, P219, DOI 10.1093/eurheartj/ehu441; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Linicus Y, 2015, INT J CARDIOL, V179, P125, DOI 10.1016/j.ijcard.2014.10.162; Mahfoud F, 2017, EUR HEART J, V38, P93, DOI 10.1093/eurheartj/ehw325; Mahfoud F, 2015, J AM COLL CARDIOL, V66, P1766, DOI 10.1016/j.jacc.2015.08.018; Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192; Mancia G, 2006, HYPERTENSION, V47, P846, DOI 10.1161/01.HYP.0000215363.69793.bb; Mompeo B, 2016, CLIN ANAT, V29, P660, DOI 10.1002/ca.22720; Ott C, 2016, J HYPERTENS, V34, P2475, DOI 10.1097/HJH.0000000000001110; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Tomaszewski M, 2014, HEART; Weber MA, 2015, J CLIN HYPERTENS, V17, P743, DOI 10.1111/jch.12590; White WB, 2014, J AM SOC HYPERTENS, V8, P743, DOI 10.1016/j.jash.2014.06.005; Zannad F, 2015, HYPERTENSION, V65, P5, DOI 10.1161/HYPERTENSIONAHA.114.04057	35	444	470	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2017	390	10108					2160	2170		10.1016/S0140-6736(17)32281-X	http://dx.doi.org/10.1016/S0140-6736(17)32281-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN0CL	28859944	Green Accepted			2022-12-28	WOS:000415642200021
J	Mohammadi, D				Mohammadi, Dara			The dangers of unregulated stem-cell marketing	LANCET			English	Editorial Material																			0	10	11	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1823	1824		10.1016/S0140-6736(17)32358-9	http://dx.doi.org/10.1016/S0140-6736(17)32358-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK1LY	28870714				2022-12-28	WOS:000413244500014
J	Mass, E; Jacome-Galarza, CE; Blank, T; Lazarov, T; Durham, BH; Ozkaya, N; Pastore, A; Schwabenland, M; Chung, YR; Rosenblum, MK; Prinz, M; Abdel-Wahab, O; Geissmann, F				Mass, Elvira; Jacome-Galarza, Christian E.; Blank, Thomas; Lazarov, Tomi; Durham, Benjamin H.; Ozkaya, Neval; Pastore, Alessandro; Schwabenland, Marius; Chung, Young Rock; Rosenblum, Marc K.; Prinz, Marco; Abdel-Wahab, Omar; Geissmann, Frederic			A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease	NATURE			English	Article							LANGERHANS CELL HISTIOCYTOSIS; ERDHEIM-CHESTER-DISEASE; DENDRITIC CELLS; MICE; EXPRESSION; PATTERN; KINASE	The pathophysiology of neurodegenerative diseases is poorly understood and there are few therapeutic options. Neurodegenerative diseases are characterized by progressive neuronal dysfunction and loss, and chronic glial activation(1). Whether microglial activation, which is generally viewed as a secondary process, is harmful or protective in neurodegeneration remains unclear(1-8). Late-onset neurodegenerative disease observed in patients with histiocytoses(9-12), which are clonal myeloid diseases associated with somatic mutations in the RAS-MEK-ERK pathway such as BRAF(V600E)(13-17), suggests a possible role of somatic mutations in myeloid cells in neurodegeneration. Yet the expression of BRAF(V600E) in the haematopoietic stem cell lineage causes leukaemic and tumoural diseases but not neurodegenerative disease(18,19). Microglia belong to a lineage of adult tissue-resident myeloid cells that develop during organogenesis from yolk-sac erythro-myeloid progenitors (EMPs) distinct from haematopoietic stem cells(20-23). We therefore hypothesized that a somatic BRAF(V600E) mutation in the EMP lineage may cause neurodegeneration. Here we show that mosaic expression of BRAF(V600E) in mouse EMPs results in clonal expansion of tissue-resident macrophages and a severe late-onset neurodegenerative disorder. This is associated with accumulation of ERK-activated amoeboid microglia in mice, and is also observed in human patients with histiocytoses. In the mouse model, neurobehavioural signs, astrogliosis, deposition of amyloid precursor protein, synaptic loss and neuronal death were driven by ERK-activated microglia and were preventable by BRAF inhibition. These results identify the fetal precursors of tissue-resident macrophages as a potential cell-of-origin for histiocytoses and demonstrate that a somatic mutation in the EMP lineage in mice can drive late-onset neurodegeneration. Moreover, these data identify activation of the MAP kinase pathway in microglia as a cause of neurodegeneration and this offers opportunities for therapeutic intervention aimed at the prevention of neuronal death in neurodegenerative diseases.	[Mass, Elvira; Jacome-Galarza, Christian E.; Lazarov, Tomi; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA; [Blank, Thomas; Schwabenland, Marius; Prinz, Marco] Univ Freiburg, Inst Neuropathol, BIOSS Ctr Biol Signalling Studies, Fac Med, D-79104 Freiburg, Germany; [Durham, Benjamin H.; Pastore, Alessandro; Chung, Young Rock; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, Leukemia Serv, New York, NY 10065 USA; [Ozkaya, Neval; Rosenblum, Marc K.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Geissmann, Frederic] Kings Coll London, CMCBI, London SE1 1UL, England	Memorial Sloan Kettering Cancer Center; University of Freiburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of London; King's College London	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA.; Geissmann, F (corresponding author), Kings Coll London, CMCBI, London SE1 1UL, England.	geissmaf@mskcc.org	Schwabenland, Marius/AAF-4348-2021; Mass, Elvira/AAH-3805-2019	Schwabenland, Marius/0000-0003-2205-5427; Mass, Elvira/0000-0003-2318-2356; Durham, Benjamin/0000-0001-8090-5448; Blank, Thomas/0000-0002-3969-405X; Chung, Young Rock/0000-0001-5752-8322	NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; National Cancer Institute of the US National Institutes of Health [P30CA008748]; MSKCC core grant; Artemis Association/Histio (UK)/A.G. Leventis Foundation; Ludwig Institute for Cancer Research; NIH/NIAID [1R01AI130345-01]; EMBO [ALTF 530-2015]; Deutsche Krebshilfe e.V. [111354]; American Society of Hematology; Histiocytosis Association; Erdheim-Chester Disease Global Alliance; Pershing Square Sohn Cancer Foundation; Leuekmia and Lymphoma Society; NIH/NCI [R01 CA201247-01]; BMBF; Sobek-Foundation; DFG [SFB 992, SFB1140, SFB/TRR167]; Ministry of Science, Research and Arts, Baden-Wuerttemberg; NATIONAL CANCER INSTITUTE [R01CA201247, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130345] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant (CCSG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSKCC core grant; Artemis Association/Histio (UK)/A.G. Leventis Foundation; Ludwig Institute for Cancer Research; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); American Society of Hematology; Histiocytosis Association; Erdheim-Chester Disease Global Alliance; Pershing Square Sohn Cancer Foundation(Pershing Square Sohn Cancer Research Alliance); Leuekmia and Lymphoma Society(Leukemia and Lymphoma Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BMBF(Federal Ministry of Education & Research (BMBF)); Sobek-Foundation; DFG(German Research Foundation (DFG)); Ministry of Science, Research and Arts, Baden-Wuerttemberg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Donadieu and the Histiocytosis Study Group (Paris, France) for discussions during the course of this project, and C. Pritchard (University of Leicester, UK) for the Braf<SUP>LSL-V600E</SUP> strain and J. Pollard, (University of Edinburgh, UK) for Csf1r<SUP>MerCreMer</SUP> strain, Plexxikon Inc. for the gift of PLX-4720-impregnated and control chow, the Molecular Cytology Facility at MSKCC for tissue processing and histological staining. We acknowledge the use of the Integrated Genomics Operation Core, funded by the NCI Cancer Center Support Grant (CCSG, P30 CA08748), Cycle for Survival and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. This work was supported by National Cancer Institute of the US National Institutes of Health (P30CA008748) MSKCC core grant and grants from the Artemis Association/Histio (UK)/A.G. Leventis Foundation, Ludwig Institute for Cancer Research and NIH/NIAID 1R01AI130345-01 to F.G. E.M. was supported by an EMBO long-term Fellowship (ALTF 530-2015). A.P. is a Mildred-Scheel Postdoctoral Research Fellow of the Deutsche Krebshilfe e.V. (number 111354). B.H.D. is supported by the American Society of Hematology Research Training Award for Fellows. O.A.-W. is supported by grants from the Histiocytosis Association, the Erdheim-Chester Disease Global Alliance, the Pershing Square Sohn Cancer Foundation, a Leuekmia and Lymphoma Society Scholar award and NIH/NCI R01 CA201247-01. M.P. is supported by the BMBF-funded competence network of multiple sclerosis (KKNMS), the Sobek-Foundation, the DFG (SFB 992, SFB1140, SFB/TRR167, Reinhart-Koselleck-Grant) and the Ministry of Science, Research and Arts, Baden-Wuerttemberg (Sonderlinie "Neuroinflammation").	Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Bittner S, 2014, JOVE-J VIS EXP, DOI 10.3791/51275; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carter RJ, 1999, J NEUROSCI, V19, P3248; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Diamond EL, 2014, BLOOD, V124, P483, DOI 10.1182/blood-2014-03-561381; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Heritier S, 2016, J CLIN ONCOL, V34, P3023, DOI 10.1200/JCO.2015.65.9508; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lachenal F, 2006, J NEUROL, V253, P1267, DOI 10.1007/s00415-006-0160-9; Laurencikas E, 2011, PEDIATR BLOOD CANCER, V56, P250, DOI 10.1002/pbc.22791; LOVE MI, 2014, GENOME, V15, DOI DOI 10.1186/S13059-014-0550-8; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Rigaud C, 2016, BRIT J HAEMATOL, V174, P887, DOI 10.1111/bjh.14140; Satoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033891; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Waisman A, 2015, ACTA NEUROPATHOL, V129, P625, DOI 10.1007/s00401-015-1402-7; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wnorowski M, 2008, J PEDIATR-US, V153, P127, DOI 10.1016/j.jpeds.2007.12.042; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	41	101	110	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					389	+		10.1038/nature23672	http://dx.doi.org/10.1038/nature23672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7PB	28854169	Green Accepted			2022-12-28	WOS:000411381300036
J	Lan, XY; Jorg, DJ; Cavalli, FMG; Richards, LM; Nguyen, LV; Vanner, RJ; Guilhamon, P; Lee, L; Kushida, MM; Pellacani, D; Park, NI; Coutinho, FJ; Whetstone, H; Selvadurai, HJ; Che, C; Luu, B; Carles, A; Moksa, M; Rastegar, N; Head, R; Dolma, S; Prinos, P; Cusimano, MD; Das, S; Bernstein, M; Arrowsmith, CH; Mungall, AJ; Moore, RA; Ma, Y; Gallo, M; Lupien, M; Pugh, TJ; Taylor, MD; Hirst, M; Eaves, CJ; Simons, BD; Dirks, PB				Lan, Xiaoyang; Jorg, David J.; Cavalli, Florence M. G.; Richards, Laura M.; Nguyen, Long V.; Vanner, Robert J.; Guilhamon, Paul; Lee, Lilian; Kushida, Michelle M.; Pellacani, Davide; Park, Nicole I.; Coutinho, Fiona J.; Whetstone, Heather; Selvadurai, Hayden J.; Che, Clare; Luu, Betty; Carles, Annaick; Moksa, Michelle; Rastegar, Naghmeh; Head, Renee; Dolma, Sonam; Prinos, Panagiotis; Cusimano, Michael D.; Das, Sunit; Bernstein, Mark; Arrowsmith, Cheryl H.; Mungall, Andrew J.; Moore, Richard A.; Ma, Yussanne; Gallo, Marco; Lupien, Mathieu; Pugh, Trevor J.; Taylor, Michael D.; Hirst, Martin; Eaves, Connie J.; Simons, Benjamin D.; Dirks, Peter B.			Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy	NATURE			English	Article							CLONAL DYNAMICS; READ ALIGNMENT; DIVERSE GROWTH; COPY NUMBER; CANCER; MODEL; HETEROGENEITY; IDENTIFICATION; MUTATIONS; EVOLUTION	Human glioblastomas harbour a subpopulation of glioblastoma stem cells that drive tumorigenesis. However, the origin of intratumoural functional heterogeneity between glioblastoma cells remains poorly understood. Here we study the clonal evolution of barcoded glioblastoma cells in an unbiased way following serial xenotransplantation to define their individual fate behaviours. Independent of an evolving mutational signature, we show that the growth of glioblastoma clones in vivo is consistent with a remarkably neutral process involving a conserved proliferative hierarchy rooted in glioblastoma stem cells. In this model, slow-cycling stem-like cells give rise to a more rapidly cycling progenitor population with extensive self-maintenance capacity, which in turn generates non-proliferative cells. We also identify rare 'outlier' clones that deviate from these dynamics, and further show that chemotherapy facilitates the expansion of pre-existing drug-resistant glioblastoma stem cells. Finally, we show that functionally distinct glioblastoma stem cells can be separately targeted using epigenetic compounds, suggesting new avenues for glioblastoma-targeted therapy.	[Lan, Xiaoyang; Cavalli, Florence M. G.; Vanner, Robert J.; Lee, Lilian; Kushida, Michelle M.; Park, Nicole I.; Coutinho, Fiona J.; Whetstone, Heather; Selvadurai, Hayden J.; Che, Clare; Luu, Betty; Rastegar, Naghmeh; Head, Renee; Dolma, Sonam; Taylor, Michael D.; Dirks, Peter B.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Lan, Xiaoyang; Cavalli, Florence M. G.; Vanner, Robert J.; Lee, Lilian; Kushida, Michelle M.; Park, Nicole I.; Coutinho, Fiona J.; Whetstone, Heather; Selvadurai, Hayden J.; Che, Clare; Luu, Betty; Rastegar, Naghmeh; Head, Renee; Dolma, Sonam; Taylor, Michael D.; Dirks, Peter B.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 0A4, Canada; [Lan, Xiaoyang; Vanner, Robert J.; Park, Nicole I.; Coutinho, Fiona J.; Dirks, Peter B.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Jorg, David J.; Simons, Benjamin D.] Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England; [Jorg, David J.; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Richards, Laura M.; Guilhamon, Paul; Lupien, Mathieu; Pugh, Trevor J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Richards, Laura M.; Guilhamon, Paul; Prinos, Panagiotis; Arrowsmith, Cheryl H.; Lupien, Mathieu; Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Nguyen, Long V.; Pellacani, Davide; Eaves, Connie J.] BC Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Guilhamon, Paul; Lupien, Mathieu] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Pellacani, Davide; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Carles, Annaick; Moksa, Michelle; Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Dolma, Sonam; Taylor, Michael D.; Dirks, Peter B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 0A4, Canada; [Prinos, Panagiotis; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Cusimano, Michael D.; Das, Sunit] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.; Das, Sunit; Bernstein, Mark; Taylor, Michael D.; Dirks, Peter B.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5S 1A8, Canada; [Bernstein, Mark] Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Mungall, Andrew J.; Moore, Richard A.; Ma, Yussanne; Hirst, Martin] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Gallo, Marco] Univ Calgary, Arnie Charbonneau Canc Inst, Alberta Childrens Hosp Res Inst, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Gallo, Marco] Univ Calgary, Arnie Charbonneau Canc Inst, Alberta Childrens Hosp Res Inst, Dept Biochem, Calgary, AB T2N 4N1, Canada; [Gallo, Marco] Univ Calgary, Arnie Charbonneau Canc Inst, Alberta Childrens Hosp Res Inst, Dept Mol Biol, Calgary, AB T2N 4N1, Canada; [Taylor, Michael D.; Dirks, Peter B.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5S 3E1, Canada; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Cambridge; University of Cambridge; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; British Columbia Cancer Agency; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; British Columbia Cancer Agency; University of Calgary; University of Calgary; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge	Dirks, PB (corresponding author), Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 0A4, Canada.; Dirks, PB (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 0A4, Canada.; Dirks, PB (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Simons, BD (corresponding author), Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.; Simons, BD (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.; Dirks, PB (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 0A4, Canada.; Dirks, PB (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5S 1A8, Canada.; Dirks, PB (corresponding author), Hosp Sick Children, Div Neurosurg, Toronto, ON M5S 3E1, Canada.; Simons, BD (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England.	bds10@cam.ac.uk; peter.dirks@sickkids.ca	Lan, Xiaoyang/AAK-9523-2020; Mungall, Andrew J./U-7067-2018; Simons, Benjamin/AAY-8920-2020; Cusimano, Michael/GWR-1025-2022; Pugh, Trevor/Y-2535-2019; Cusimano, Michael/X-4059-2019; Jorg, David/I-3905-2012	Mungall, Andrew J./0000-0002-0905-2742; Simons, Benjamin/0000-0002-3875-7071; Pugh, Trevor/0000-0002-8073-5888; Richards, Laura/0000-0003-3414-7628; Arrowsmith, Cheryl/0000-0002-4971-3250; Eaves, Connie/0000-0002-3452-1926; Nguyen, Long/0000-0002-3347-438X; Prinos, Panagiotis/0000-0001-8785-7856; Gallo, Marco/0000-0002-8451-8207; Cavalli, Florence M. G./0000-0002-4409-9642; Lan, Xiaoyang/0000-0002-1453-5001; Vanner, Robert/0000-0003-1169-1778; Guilhamon, Paul/0000-0001-8276-5987; Jorg, David/0000-0001-5960-0260; Taylor, Michael/0000-0001-7009-3466	Canadian Institutes of Health Research [142434]; Ontario Institute for Cancer Research through Government of Ontario; Stand Up To Cancer (SU2C) Canada; Terry Fox Research Institute; Canadian Cancer Society; Hospital for Sick Children Foundation; Jessica's Footprint Foundation; Hopeful Minds Foundation; Bresler family; B.R.A.I.N. Child; Wellcome Trust [098357/Z/12/Z]; Terry Fox Run; SU2C Canada Cancer Stem Cell Dream Team Research Funding by Government of Canada through Genome Canada [SU2C-AACR-DT-19-15]; Canadian Institutes of Health Research; American Association for Cancer Research International - Canada; AbbVie; Bayer; Boehringer Ingelheim; GSK; Genome Canada; Ontario Genomics Institute; Janssen; Lilly; Merck; Novartis; government of Ontario; Pfizer; Takeda; Wellcome Trust; Medical Research Council [MC_PC_12009] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research through Government of Ontario; Stand Up To Cancer (SU2C) Canada; Terry Fox Research Institute; Canadian Cancer Society(Canadian Cancer Society (CCS)); Hospital for Sick Children Foundation; Jessica's Footprint Foundation; Hopeful Minds Foundation; Bresler family; B.R.A.I.N. Child; Wellcome Trust(Wellcome TrustEuropean Commission); Terry Fox Run; SU2C Canada Cancer Stem Cell Dream Team Research Funding by Government of Canada through Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Association for Cancer Research International - Canada; AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); GSK(GlaxoSmithKline); Genome Canada(Genome Canada); Ontario Genomics Institute; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly(Eli Lilly); Merck(Merck & Company); Novartis(Novartis); government of Ontario; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. D. Corbett, P. Plettner, N. Khuu and G. Edin for technical advice, the SickKids-UHN Flow Cytometry Facility for assistance with fluorescence-activated cell sorting, SickKids Laboratory Animal Services for animal housing and veterinary support, and The Centre for Applied Genomics, Princess Margaret Genomics Centre, and Canada's Michael Smith Genome Sciences Centre for sequencing and bioinformatics support. This study was supported by the Canadian Institutes of Health Research (funding reference number 142434), the Ontario Institute for Cancer Research through funding provided by the Government of Ontario, and Stand Up To Cancer (SU2C) Canada. P.B.D. is also supported by the Terry Fox Research Institute, the Canadian Cancer Society, the Hospital for Sick Children Foundation, Jessica's Footprint Foundation, the Hopeful Minds Foundation, the Bresler family, and B.R.A.I.N. Child. P.B.D. holds a Garron Family Chair in Childhood Cancer Research at The Hospital for Sick Children. B.D.S. acknowledges the support of the Wellcome Trust (grant number 098357/Z/12/Z). C.J.E. acknowledges grant support from the Canadian Cancer Society and the Terry Fox Run. Research was supported by SU2C Canada Cancer Stem Cell Dream Team Research Funding (SU2C-AACR-DT-19-15) provided by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research, with supplementary support from the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. Stand Up To Cancer Canada is a program of the Entertainment Industry Foundation Canada. Research funding is administered by the American Association for Cancer Research International - Canada, the scientific partner of SU2C Canada. The Structural Genomics Consortium is funded by AbbVie, Bayer, Boehringer Ingelheim, GSK, Genome Canada, Ontario Genomics Institute, Janssen, Lilly, Merck, Novartis, the government of Ontario, Pfizer, Takeda, and the Wellcome Trust.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bailey, 1990, ELEMENTS STOCHASTIC; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Borkin D, 2015, CANCER CELL, V27, P589, DOI 10.1016/j.ccell.2015.02.016; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Crisman TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164649; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Funato K, 2014, SCIENCE, V346, P1529, DOI 10.1126/science.1253799; Gallo M, 2015, CANCER CELL, V28, P715, DOI 10.1016/j.ccell.2015.10.005; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Nguyen LV, 2015, NATURE, V528, P267, DOI 10.1038/nature15742; Nguyen LV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6871; Nguyen LV, 2014, CELL STEM CELL, V14, P253, DOI 10.1016/j.stem.2013.12.011; Palmisano WA, 2000, CANCER RES, V60, P5954; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Piccirillo SGM, 2015, STEM CELL REP, V4, P7, DOI 10.1016/j.stemcr.2014.11.003; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rendeiro AF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11938; Rulands S, 2016, CURR OPIN CELL BIOL, V43, P38, DOI 10.1016/j.ceb.2016.07.001; Sanchez-Danes A, 2016, NATURE, V536, P298, DOI 10.1038/nature19069; Schuffler Peter J, 2013, J Pathol Inform, V4, pS2, DOI 10.4103/2153-3539.109804; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simons BD, 2016, P NATL ACAD SCI USA, V113, P128, DOI 10.1073/pnas.1516123113; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Thielecke L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43249; Tirosh I, 2016, NATURE, V539, P309, DOI 10.1038/nature20123; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waclaw B, 2015, NATURE, V525, P261, DOI 10.1038/nature14971; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	63	204	206	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					227	+		10.1038/nature23666	http://dx.doi.org/10.1038/nature23666			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28854171	Green Accepted, Green Submitted			2022-12-28	WOS:000410555900036
J	Mervis, J				Mervis, Jeffrey			US POLICY Panel urges steps to boost evidence-based policy	SCIENCE			English	News Item																			0	2	2	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		959	959		10.1126/science.357.6355.959	http://dx.doi.org/10.1126/science.357.6355.959			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883056				2022-12-28	WOS:000409455700014
J	Szewczak, L				Szewczak, Lara			Seeing DNA Where It Lives	CELL			English	Editorial Material							GENOME											Beagrie RA, 2017, NATURE, V543, P519, DOI 10.1038/nature21411; Nozaki T, 2017, MOL CELL, V67, P282, DOI 10.1016/j.molcel.2017.06.018; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Zhu P, 2016, CURR OPIN STRUC BIOL, V36, P106, DOI 10.1016/j.sbi.2016.01.013	4	0	0	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1045	+		10.1016/j.cell.2017.08.039	http://dx.doi.org/10.1016/j.cell.2017.08.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886374	Bronze			2022-12-28	WOS:000409536000001
J	Dhanvanthari, S; Riccardi, G; Shah, R; Shetty, V; Ng, H				Dhanvanthari, Sonya; Riccardi, Gina; Shah, Rohit; Shetty, Varun; Ng, Henry			Enhancing the Role of Internists in the Transition From Pediatric to Adult Health Care	ANNALS OF INTERNAL MEDICINE			English	Letter									[Dhanvanthari, Sonya] MetroHlth Med Ctr, Cleveland, OH USA; CWRU Sch Med, Cleveland, OH USA	MetroHealth System; Case Western Reserve University	Dhanvanthari, S (corresponding author), MetroHlth Med Ctr, Cleveland, OH USA.		Ng, Henry/AFM-1288-2022	Ng, Henry/0000-0003-4552-8880				Accreditation Council of Graduate Medical Education, 2017, REQ COMB PROGR MED P; Amer Acad Pediat, 2011, PEDIATRICS, V128, P182, DOI 10.1542/peds.2011-0969; American Academy of Pediatrics, 2017, AAP SECT MED PEDS; Greenlee MC, 2017, ANN INTERN MED, V166, P299, DOI 10.7326/M16-0514	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2017	167	5					362	363		10.7326/L17-0322	http://dx.doi.org/10.7326/L17-0322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF6LC	28869979				2022-12-28	WOS:000409120400015
J	Holloway, KA; Batmanabane, G; Puri, M; Tisocki, K				Holloway, Kathleen Anne; Batmanabane, Gitanjali; Puri, Monika; Tisocki, Klara			Antibiotic use in South East Asia and policies to promote appropriate use: reports from country situational analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIMICROBIAL RESISTANCE; NEW-DELHI; MEDICINES		[Holloway, Kathleen Anne] Int Inst Hlth Management Res, Jaipur, Rajasthan, India; [Holloway, Kathleen Anne] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Holloway, Kathleen Anne] Univ Delhi, Vallabhbhai Patel Chest Inst, New Delhi, India; [Batmanabane, Gitanjali] All India Inst Med Sci, Bhubaneswar, Orissa, India; [Puri, Monika; Tisocki, Klara] WHO Reg Off South East Asia, New Delhi, India	University of Sussex; University of Delhi; All India Institute of Medical Sciences (AIIMS) Bhubaneswar	Holloway, KA (corresponding author), Int Inst Hlth Management Res, Jaipur, Rajasthan, India.; Holloway, KA (corresponding author), Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England.; Holloway, KA (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, New Delhi, India.	kaholloway54@gmail.com	Kotwani, Anita/ABF-6201-2021	Kotwani, Anita/0000-0003-3182-5155	WHO/SEARO	WHO/SEARO(World Health Organization)	We have read and understood BMJ policy on declaration of interests, and declare that all five authors were recruited by WHO to facilitate one or more country situational analyses and one or more of the meetings described in the manuscript. KAH is a former regional adviser in essential drugs and other medicines at WHO/SEARO. WHO/SEARO funded all the situational analyses.	[Anonymous], 2006, WHOTCM20062; Bigdeli M, 2014, MED HLTH SYSTEMS ADV, P18; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Holloway K., 2011, WORLD MED SITUATION; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Holloway K. A., 2011, Regional Health Forum, V15, P122; Holloway KA, 2003, CLIN INFECT DIS   S1, V36, pS11; Holloway KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152020; Holloway KA, 2015, PAEDIATR INT CHILD H, V35, P5, DOI 10.1179/2046905514Y.0000000115; Holloway KA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001724; Holloway Kathleen Anne, 2011, Expert Rev Clin Pharmacol, V4, P335, DOI 10.1586/ecp.11.14; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2012, VALUE HEALTH, V15, pS116, DOI 10.1016/j.jval.2011.11.008; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Sumpradit N, 2017, BMJ-BRIT MED J, V358, P20, DOI 10.1136/bmj.j2423; Sumpradit N, 2012, B WORLD HEALTH ORGAN, V90, P905, DOI 10.2471/BLT.12.105445; WHO, 2001, WHO GLOB STRAT CONT; World Health Organisation, 2009, MED US PRIM HLTH CAR; World Health Organization, 2015, A6820 WHO; World Health Organization, 2007, WHO OP PACK ASS MON; World Health Organization, 2010, WHOEMPMPC20101; World Health Organization Regional Office for South-East Asia, 2011, INT M NEW DELH IND 1; World Health Organization Regional Office for South-East Asia, 2013, EFF MAN MED REP S E	23	51	51	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						9	13	j2291	10.1136/bmj.j2291	http://dx.doi.org/10.1136/bmj.j2291			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874360	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000410575100001
J	Vong, S; Anciaux, A; Hulth, A; Stelling, J; Thamlikitkul, V; Gupta, S; Fuks, JM; Walia, K; Rattanumpawan, P; Eremin, S; Tisocki, K; Sedai, TR; Sharma, A				Vong, Sirenda; Anciaux, Amaury; Hulth, Anette; Stelling, John; Thamlikitkul, Visanu; Gupta, Sunil; Fuks, Jonas M.; Walia, Kamini; Rattanumpawan, Pinyo; Eremin, Sergey; Tisocki, Klara; Sedai, Tika R.; Sharma, Anuj			Using information technology to improve surveillance of antimicrobial resistance in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vong, Sirenda] WHO, Off South East Asia Reg, New Delhi, India; Publ Hlth Agcy, Unit Antibiot & Infect Control, Stockholm, Sweden; WHO, Collaborating Ctr AMR Containment, Stockholm, Sweden; Harvard Med Sch, Brigham & Womens Hosp, WHO, Collaborating Ctr Surveillance Antimicrobial Resi, Boston, MA USA; Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med, Bangkok, Thailand; Indias Minist Hlth & Family Welf, Natl Ctr Dis Control, New Delhi, India; Indian Council Med Res, Div Epidemiol & Communicable Dis, New Delhi, India; WHO, AMR Secretariat, Geneva, Switzerland; WHO, Off South East Asia Reg, Essential Drugs & Med, New Delhi, India; WHO, Off South East Asia Reg, Hlth Emergencies Dept, New Delhi, India	World Health Organization; Public Health Agency of Sweden; World Health Organization; Harvard University; Brigham & Women's Hospital; Harvard Medical School; World Health Organization; Mahidol University; National Centre for Disease Control (NCDC); Indian Council of Medical Research (ICMR); World Health Organization; World Health Organization; World Health Organization	Vong, S (corresponding author), WHO, Off South East Asia Reg, New Delhi, India.	vongs@who.int	Hulth, Anette/E-2162-2017; Fuks, Jonas/I-9921-2016	Hulth, Anette/0000-0002-3132-808X; Fuks, Jonas/0000-0002-4719-0097; Eremin, Sergey/0000-0002-0486-3255	NATIONAL CANCER INSTITUTE [U01CA207167] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antimicrobial Resistance Standing Committee, 2013, NAT SURV REP ANT RES; European Centre for Disease Prevention and Control, 2013, ANT RES SURV EUR 201; JANIS-Japan Nosocomial Infections Surveillance, AB JAN; Morikane K, 2012, J EPIDEMIOL, V22, P86, DOI 10.2188/jea.JE20110085; Soderblom T, 2014, EUR C CLIN MICR INF; Stelling J., 2016, MOL MICROBIOLOGY DIA, P692, DOI [DOI 10.1128/9781555819071.CH48, 10.1128/9781555819071.ch48.]; SWEDRES-SVARM, 2013, FOC SVEB SWED SURV A, P75; Tanihara S, 2016, EPIDEMIOL INFECT, V144, P2260, DOI 10.1017/S0950268816000674; WHO, 2015, GLOB ANT RES SURV SY; WHO, 2015, GLOB ACT PLAN ANT RE; World Bank, 2017, POP EST PROJ; World Health Organization, 2016, UN HIGH LEV M ANT RE; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; World Health Organization, 2017, WHON SOFTW; World Health Organization Regional Office for the Western Pacific, 2016, M TOK JAP	15	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						51	55	j3781	10.1136/bmj.j3781	http://dx.doi.org/10.1136/bmj.j3781			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874344	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000410575100013
J	Moberly, T				Moberly, Tom			Accountable care systems and accountable care organisations in the NHS: progress or route to privatisation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tmoberly@bmj.com						El-Gingihy Y., 2017, INDEPENDENT; Shortell S, 2014, ACCOUNTABLE CARE ORG; Vize R, 2016, BMJ-BRIT MED J, V352, DOI [10.1136/bmj.i1811, 10.1136/bmj.i1611]	3	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2017	358								j4105	10.1136/bmj.j4105	http://dx.doi.org/10.1136/bmj.j4105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4XK	28871038				2022-12-28	WOS:000426830300002
J	Leslie, M				Leslie, Mitch			THE CASE OF THE MACHO CROCS	SCIENCE			English	Editorial Material																			0	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					859	861		10.1126/science.357.6354.859	http://dx.doi.org/10.1126/science.357.6354.859			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860366				2022-12-28	WOS:000408734900020
J	Rimmer, A				Rimmer, Abi			Junior doctors are threatened with GMC referral for refusing locum work	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2017, LOC CLAUS LOC PROC A	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2017	358								j4037	10.1136/bmj.j4037	http://dx.doi.org/10.1136/bmj.j4037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CK	28851685				2022-12-28	WOS:000409386400009
J	Geisler, S				Geisler, Sarah			Cultivating Beauty and Good Taste	CELL			English	Editorial Material							EMISSION; PETUNIA; GENE											Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; Fenske MP, 2015, P NATL ACAD SCI USA, V112, P9775, DOI 10.1073/pnas.1422875112; Ma XL, 2016, MOL PLANT, V9, P961, DOI 10.1016/j.molp.2016.04.009; Soyk S, 2017, CELL, V169, P1142, DOI 10.1016/j.cell.2017.04.032; Tieman D, 2017, SCIENCE, V355, P391, DOI 10.1126/science.aal1556; Widhalm JR, 2015, TRENDS PLANT SCI, V20, P545, DOI 10.1016/j.tplants.2015.06.009	6	0	0	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					817	819		10.1016/j.cell.2017.08.013	http://dx.doi.org/10.1016/j.cell.2017.08.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841412	Bronze			2022-12-28	WOS:000408372400001
J	Sigurdsson, S				Sigurdsson, Steinn			GRAVITATIONAL WAVES History of black holes revealed by their spin	NATURE			English	Editorial Material								Four probable detections of gravitational waves have so far been reported, each associated with the merger of two black holes. Analysis of the signals allows formation theories of such black-hole systems to be tested. SEE LETTER P.426	[Sigurdsson, Steinn] Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sigurdsson, S (corresponding author), Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA.	steinn@astro.psu.edu						Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.061102; Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241103; Abbott BP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.221101; Abbott BP, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041015; Belczynski K, 2016, NATURE, V534, P512, DOI 10.1038/nature18322; Bird S, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.201301; Farr WM, 2017, NATURE, V548, P426, DOI 10.1038/nature23453; Kaplinghat M., 2017, PREPRINT; Miller MC, 2015, PHYS REP, V548, P1, DOI 10.1016/j.physrep.2014.09.003; Rodriguez CL, 2016, ASTROPHYS J LETT, V824, DOI 10.3847/2041-8205/824/1/L8	10	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					397	398		10.1038/548397a	http://dx.doi.org/10.1038/548397a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836587				2022-12-28	WOS:000408279000023
J	Walensky, RP; Borre, ED; Bekker, LG; Hyle, EP; Gonsalves, GS; Wood, R; Eholie, SP; Weinstein, MC; Anglaret, X; Freedberg, KA; Paltiel, AD				Walensky, Rochelle P.; Borre, Ethan D.; Bekker, Linda-Gail; Hyle, Emily P.; Gonsalves, Gregg S.; Wood, Robin; Eholie, Serge P.; Weinstein, Milton C.; Anglaret, Xavier; Freedberg, Kenneth A.; Paltiel, A. David			Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid	ANNALS OF INTERNAL MEDICINE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; COST-EFFECTIVENESS; COTE-DIVOIRE; VIRAL LOAD; CD4 COUNT; PREVENTION; INFECTION; IMPACT	Background: Resource-limited nations must consider their response to potential contractions in international support for HIV programs. Objective: To evaluate the clinical, epidemiologic, and budgetary consequences of alternative HIV program scale-back strategies in 2 recipient nations, the Republic of South Africa (RSA) and Cote d'Ivoire (CI). Design: Model-based comparison between current standard (CD4 count at presentation of 0.260 x 10(9) cells/L, universal antiretroviral therapy [ART] eligibility, and 5-year retention rate of 84%) and scale-back alternatives, including reduced HIV detection, no ART or delayed initiation (when CD4 count is < 0.350 x 10(9) cells/L), reduced investment in retention, and no viral load monitoring or second-line ART. Data Sources: Published RSA-and CI-specific estimates of the HIV care continuum, ART efficacy, and HIV-related costs. Target Population: HIV-infected persons, including future incident cases. Time Horizon: 5 and 10 years. Perspective: Modified societal perspective, excluding time and productivity costs. Outcome Measures: HIV transmissions and deaths, years of life, and budgetary outlays (2015 U. S. dollars). Results of Base-Case Analysis: At 10 years, scale-back strategies increase projected HIV transmissions by 0.5% to 19.4% and deaths by 0.6% to 39.1%. Strategies can produce budgetary savings of up to 30% but no more. Compared with the current standard, nearly every scale-back strategy produces proportionally more HIV deaths (and transmissions, in RSA) than savings. When the least harmful and most efficient alternatives for achieving budget cuts of 10% to 20% are applied, every year of life lost will save roughly (sic)900 in HIV-related outlays in RSA and (sic)600 to (sic)900 in CI. Results of Sensitivity Analysis: Scale-back programs, when combined, may result in clinical and budgetary synergies and offsets. Limitation: The magnitude and details of budget cuts are not yet known, nor is the degree to which other international partners might step in to restore budget shortfalls. Conclusion: Scaling back international aid to HIV programs will have severe adverse clinical consequences; for similar economic savings, certain programmatic scale-back choices result in less harm than others. Primary Funding Source: National Institutes of Health and Steve and Deborah Gorlin MGH Research Scholars Award. Annals.org	[Walensky, Rochelle P.; Borre, Ethan D.; Hyle, Emily P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; [Weinstein, Milton C.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, Cape Town, South Africa; [Eholie, Serge P.] Ctr Hosp Univ Treichville, Abidjan 1, Cote Ivoire; [Anglaret, Xavier] Ctr Hosp Univ Treichville, Programme PACCI, 18 BP 1954, Abidjan 18, Cote Ivoire; Treichville Univ Hosp, Abidjan, Cote Ivoire; Univ Bordeaux, Bordeaux, France; [Gonsalves, Gregg S.; Paltiel, A. David] Yale Sch Publ Hlth, 60 Coll St, New Haven, CT 06510 USA; [Bekker, Linda-Gail; Wood, Robin] Desmond Tutu HIV Fdn, POB 13801, ZA-7705 Cape Town, South Africa	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; University of Cape Town; UDICE-French Research Universities; Universite de Bordeaux; Yale University	Walensky, RP (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	rwalensky@mgh.harvard.edu	Anglaret, Xavier/T-2757-2019; Eholie, Serge/T-6008-2019; Bekker, Linda-Gail/AAZ-8929-2020; Anglaret, Xavier/F-7333-2013	Gonsalves, Gregg/0000-0002-5789-9841; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Borre, Ethan/0000-0002-8666-5382; Anglaret, Xavier/0000-0003-3319-8423	National Institutes of Health; Steve and Deborah Gorlin MGH Research Scholars Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL123349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI093269, R01AI058736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Steve and Deborah Gorlin MGH Research Scholars Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health and Steve and Deborah Gorlin MGH Research Scholars Award.	aids2031 Costs and Financing Working Group, 2010, LONG RUN FIN HIV AID; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2017, WORLD DEV IND; Antillean Media Group, 2017, US PULLS HIV FUND HA; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Birn AE, 2009, GLOB PUBLIC HEALTH, V4, P50, DOI 10.1080/17441690802017797; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Burrows D, 2016, TRANSITIONS DONAR FU; CLEARY S, 2004, COST EFFECTIVENESS A; Clinton Health Access Initiative, 2015, ARV MARK REP STAT AN; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Daschle T., 2015, CASE STRATEGIC HLTH; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; Departement de Prise en Charge; Programme National de Lutte Contre le Sida, 2015, DIR NAT PEC AD AD 20; Department of Health South Africa, 2015, NAT CONS GUID PREV M; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gonsalves G., 2011, WASHINGTON POST; Granich R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002253; Hakim AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125218; Halperin D., 2008, NY TIMES; Harris Gardiner, 2017, NY TIMES; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Joint United Nations Programme on HIV/ AIDS, 2014, 90 90 90 AMB TREATM; Kranzer K, 2013, JAIDS-J ACQ IMM DEF, V63, P498, DOI 10.1097/QAI.0b013e318293ae48; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Messou E, 2010, AIDS, V24, P93, DOI 10.1097/QAD.0b013e32832ec1c3; Meyer-Rath G, 2012, JAIDS-J ACQ IMM DEF, V61, pE25, DOI 10.1097/QAI.0b013e31826cc575; Mossong J, 2013, AIDS, V27, P2471, DOI 10.1097/01.aids.0000432475.14992.da; Nattrass N., 2009, EC BACKLASH AIDS SPE; Novitsky V, 2012, CURR OPIN HIV AIDS, V7, P117, DOI 10.1097/COH.0b013e32834fe8ff; Office of Management and Budget; The White House, 2017, NEW FDN AM GREATN BU; Office of Management and Budget; The White House, 2017, AM 1 BUDG BLUEPR MAK; Ouattara EN, 2016, CLIN INFECT DIS, V62, P1454, DOI 10.1093/cid/ciw117; Packard R.M., 2016, HIST GLOBAL HLTH INT; Schneider Kammerle, 2009, Philos Ethics Humanit Med, V4, P1, DOI 10.1186/1747-5341-4-1; Schneider MT, 2016, AIDS, V30, P1475, DOI 10.1097/QAD.0000000000001081; Shisana O, 2014, S AFRICAN NATL HIV P; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; The United States President's Emergency Plan for AIDS Relief, 2017, FISC YEAR 2004 2007; The United States President's Emergency Plan for AIDS Relief, 2016, COT DIV COUNTR OP PL; The United States President's Plan for Emergency AIDS Relief, 2017, 2017 ANN REP C WASH; U.S. President's Emergency Plan for AIDS Relief, 2016, S AFR COUNTR OP PLAN; United Nations Department of Economic and Social Affairs, 2015, POP DIV YOUTH POP TR; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; Walensky RP, 2016, ANN INTERN MED, V165, P325, DOI 10.7326/M16-0799; Walensky RP, 2013, NEW ENGL J MED, V369, P1715, DOI 10.1056/NEJMsa1214720; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHO, 2010, ANT THER HIV INF AD; Williams BG, 2016, LANCET HIV, V3, pE409, DOI 10.1016/S2352-3018(16)30116-3; World Health Organization, 2015, GUID START ANT THER; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	58	13	13	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2017	167	9					618	+		10.7326/M17-1358	http://dx.doi.org/10.7326/M17-1358			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM1DV	28847013	Green Accepted			2022-12-28	WOS:000414714700003
J	Vinereanu, D; Lopes, RD; Bahit, MC; Xavier, D; Jiang, J; Al-Khalidi, HR; He, WS; Xian, Y; Ciobanu, AO; Kamath, DY; Fox, KA; Rao, MP; Pokorney, SD; Berwanger, O; Tajer, C; de Barros e Silva, PGM; Roettig, ML; Huo, Y; Granger, CB				Vinereanu, Dragos; Lopes, Renato D.; Cecilia Bahit, M.; Xavier, Denis; Jiang, Jie; Al-Khalidi, Hussein R.; He, Wensheng; Xian, Ying; Ciobanu, Andrea O.; Kamath, Deepak Y.; Fox, Kathleen A.; Rao, Meena P.; Pokorney, Sean D.; Berwanger, Otavio; Tajer, Carlos; de Barros e Silva, Pedro G. M.; Roettig, Mayme L.; Huo, Yong; Granger, Christopher B.		IMPACT-AF Investigators	A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial	LANCET			English	Article							ANTITHROMBOTIC TREATMENT; REGIONAL DIFFERENCES; STROKE; THERAPY; PREVENTION; KNOWLEDGE; REGISTRY	Background Oral anticoagulation is underused in patients with atrial fibrillation. We assessed the impact of a multifaceted educational intervention, versus usual care, on oral anticoagulant use in patients with atrial fibrillation. Methods This study was a two-arm, prospective, international, cluster-randomised, controlled trial. Patients were included who had atrial fibrillation and an indication for oral anticoagulation. Clusters were randomised (1:1) to receive a quality improvement educational intervention (intervention group) or usual care (control group). Randomisation was carried out centrally, using the eClinicalOS electronic data capture system. The intervention involved education of providers and patients, with regular monitoring and feedback. The primary outcome was the change in the proportion of patients treated with oral anticoagulants from baseline assessment to evaluation at 1 year. The trial is registered at ClinicalTrials. gov, number NCT02082548. Findings 2281 patients from five countries (Argentina, n=343; Brazil, n=360; China, n=586; India, n=493; and Romania, n=499) were enrolled from 48 clusters between June 11, 2014, and Nov 13, 2016. Follow-up was at a median of 12.0 months (IQR 11.8-12.2). Oral anticoagulant use increased in the intervention group from 68% (804 of 1184 patients) at baseline to 80% (943 of 1184 patients) at 1 year (difference 12%), whereas in the control group it increased from 64% (703 of 1092 patients) at baseline to 67% (732 of 1092 patients) at 1 year (difference 3%). Absolute difference in the change between groups was 9.1% (95% CI 3.8-14.4); odds ratio of change in the use of oral anticoagulation between groups was 3.28 (95% CI 1.67-6.44; adjusted p value=0.0002). Kaplan-Meier estimates showed a reduction in the secondary outcome of stroke in the intervention versus control groups (HR 0.48, 95% CI 0.23-0.99; log-rank p value=0.0434). Interpretation A multifaceted and multilevel educational intervention, aimed to improve use of oral anticoagulation in patients with atrial fibrillation and at risk for stroke, resulted in a significant increase in the proportion of patients treated with oral anticoagulants. Such an intervention has the potential to improve stroke prevention around the world for patients with atrial fibrillation.	[Vinereanu, Dragos; Ciobanu, Andrea O.] Univ Med & Pharm Carol Davila, Univ & Emergency Hosp, Bucharest, Romania; [Lopes, Renato D.; Al-Khalidi, Hussein R.; He, Wensheng; Xian, Ying; Fox, Kathleen A.; Rao, Meena P.; Pokorney, Sean D.; Roettig, Mayme L.; Granger, Christopher B.] Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA; [Lopes, Renato D.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Lopes, Renato D.; Berwanger, Otavio; de Barros e Silva, Pedro G. M.] BCRI, Sao Paulo, Brazil; [Cecilia Bahit, M.] INECO Neurociencias, Rosario, Santa Fe, Argentina; [Cecilia Bahit, M.] ACRG, Rosario, Santa Fe, Argentina; [Xavier, Denis; Kamath, Deepak Y.] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Jiang, Jie; Huo, Yong] Peking Univ, Hosp 1, Beijing, Peoples R China; [Xian, Ying] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27705 USA; [Berwanger, Otavio; de Barros e Silva, Pedro G. M.] Hosp Coracao, Heart Hosp, Res Inst HCor, Sao Paulo, SP, Brazil; [Tajer, Carlos] Hosp El Cruce, Buenos Aires, DF, Argentina	Carol Davila University of Medicine & Pharmacy; Duke University; Universidade Federal de Sao Paulo (UNIFESP); St. John's National Academy of Health Sciences; St. John's Medical College; Peking University; Duke University; Hospital do Coracao - HCor; Universidade de Sao Paulo	Granger, CB (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	christopher.granger@duke.edu	chioncel, ovidiu/K-8425-2019; Nakazone, Marcelo Arruda/H-2719-2012; Sinescu, Crina Julieta/AAA-8793-2021; de Barros e Silva, Pedro G M/U-5183-2017; Chioncel, Ovidiu/R-7556-2017; Xian, Ying/O-1956-2019; Desai, Soaham/I-6857-2013	Nakazone, Marcelo Arruda/0000-0002-0449-7056; Sinescu, Crina Julieta/0000-0001-5933-8549; de Barros e Silva, Pedro G M/0000-0003-1940-4470; Chioncel, Ovidiu/0000-0002-3197-3628; Desai, Soaham/0000-0003-0378-1888; dhakal, dr mona/0000-0002-1118-3717; kamath, deepak/0000-0002-8044-7747; Tajer, Carlos/0000-0002-6787-6651; Xian, Ying/0000-0002-1237-1162	Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Pfizer	Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Pfizer(Pfizer)	Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and Pfizer.	Amara W, 2016, EUROPACE, V18, P151, DOI 10.1093/europace/euv317; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Camm AJ, 2017, HEART, V103, P307, DOI 10.1136/heartjnl-2016-309832; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Clarkesmith DE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008600.pub3; Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Frankel DS, 2015, J STROKE CEREBROVASC, V24, P1691, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.026; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Glauser TA, 2016, AM J MED QUAL, V31, P38, DOI 10.1177/1062860614547363; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hendriks JML, 2012, EUR HEART J, V33, P2692, DOI 10.1093/eurheartj/ehs071; Madrid AH, 2016, EUROPACE, V18, P463, DOI 10.1093/europace/euv448; Huisman MV, 2017, J AM COLL CARDIOL, V69, P777, DOI 10.1016/j.jacc.2016.11.061; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lip GYH, 2015, EUROPACE, V17, P194, DOI 10.1093/europace/euu201; Maikranz V, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0588-2; Montalescot G., 2016, CIRCULATION, V134; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Rao MP, 2016, AM HEART J, V176, P107, DOI 10.1016/j.ahj.2016.03.011; van Riet EES, 2016, INT J CARDIOL, V217, P174, DOI 10.1016/j.ijcard.2016.04.171; Vinereanu D, 2017, AM HEART J, V192, P38, DOI 10.1016/j.ahj.2017.07.004; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xavier D, 2016, LANCET DIABETES ENDO, V4, P244, DOI 10.1016/S2213-8587(15)00480-5; Xian Y, 2017, JAMA-J AM MED ASSOC, V317, P1057, DOI 10.1001/jama.2017.1371	30	113	116	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1737	1746		10.1016/S0140-6736(17)32165-7	http://dx.doi.org/10.1016/S0140-6736(17)32165-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ6GB	28859942				2022-12-28	WOS:000412853100026
J	Zhong, T; Kindem, JM; Bartholomew, JG; Rochman, J; Craiciu, I; Miyazono, E; Bettinelli, M; Cavalli, E; Verma, V; Nam, SW; Marsili, F; Shaw, MD; Beyer, AD; Faraon, A				Zhong, Tian; Kindem, Jonathan M.; Bartholomew, John G.; Rochman, Jake; Craiciu, Ioana; Miyazono, Evan; Bettinelli, Marco; Cavalli, Enrico; Verma, Varun; Nam, Sae Woo; Marsili, Francesco; Shaw, Matthew D.; Beyer, Andrew D.; Faraon, Andrei			Nanophotonic rare-earth quantum memory with optically controlled retrieval	SCIENCE			English	Article							PHOTONIC QUBITS; ENSEMBLES; LIGHT	Optical quantum memories are essential elements in quantum networks for long-distance distribution of quantum entanglement. Scalable development of quantum network nodes requires on-chip qubit storage functionality with control of the readout time. We demonstrate a high-fidelity nanophotonic quantum memory based on a mesoscopic neodymium ensemble coupled to a photonic crystal cavity. The nanocavity enables > 95% spin polarization for efficient initialization of the atomic frequency comb memory and time bin-selective readout through an enhanced optical Stark shift of the comb frequencies. Our solid-state memory is integrable with other chip-scale photon source and detector devices for multiplexed quantum and classical information processing at the network nodes.	[Zhong, Tian; Kindem, Jonathan M.; Bartholomew, John G.; Rochman, Jake; Craiciu, Ioana; Miyazono, Evan; Faraon, Andrei] CALTECH, TJ Watson Lab Appl Phys, 1200 East Calif Blvd, Pasadena, CA 91125 USA; [Bettinelli, Marco] Univ Verona, Lab Mat Luminescenti, Str Grazie 15, I-37134 Verona, Italy; [Cavalli, Enrico] Univ Parma, Dipartimento Sci Chim Vita & Sostenibilita Ambien, Parco Area Sci 17-a, I-43124 Parma, Italy; [Verma, Varun; Nam, Sae Woo] NIST, 325 Broadway,MC 815-04, Boulder, CO 80305 USA; [Marsili, Francesco; Shaw, Matthew D.; Beyer, Andrew D.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA	California Institute of Technology; University of Verona; University of Parma; National Institute of Standards & Technology (NIST) - USA; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Faraon, A (corresponding author), CALTECH, TJ Watson Lab Appl Phys, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	faraon@caltech.edu	Bettinelli, Marco/A-2616-2008	Bettinelli, Marco/0000-0002-1271-4241; Zhong, Tian/0000-0003-3884-7453; Miyazono, Evan/0000-0003-2176-0335; Faraon, Andrei/0000-0002-8141-391X; Cavalli, Enrico/0000-0003-2802-6328	National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) award [1454607]; Air Force Office of Scientific Research (AFOSR) Young Investigator Award [FA9550-15-1-0252]; AFOSR Quantum Transduction Multidisciplinary University Research Initiative [FA9550-15-1-002]; Defense Advanced Research Projects Agency Quiness program [W31P4Q-15-1-0012]; Moore Foundation; American Australian Association's Northrop Grumman Fellowship; Institute of Quantum Information and Matter, an NSF Physics Frontiers Center; Directorate For Engineering [1454607] Funding Source: National Science Foundation	National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) award(National Science Foundation (NSF)); Air Force Office of Scientific Research (AFOSR) Young Investigator Award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); AFOSR Quantum Transduction Multidisciplinary University Research Initiative; Defense Advanced Research Projects Agency Quiness program; Moore Foundation(Gordon and Betty Moore Foundation); American Australian Association's Northrop Grumman Fellowship; Institute of Quantum Information and Matter, an NSF Physics Frontiers Center(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) award (1454607), an Air Force Office of Scientific Research (AFOSR) Young Investigator Award (FA9550-15-1-0252), the AFOSR Quantum Transduction Multidisciplinary University Research Initiative (FA9550-15-1-002), and the Defense Advanced Research Projects Agency Quiness program (W31P4Q-15-1-0012). Equipment funding was also provided by the Institute of Quantum Information and Matter, an NSF Physics Frontiers Center with support from the Moore Foundation. The device nanofabrication was performed in the Kavli Nanoscience Institute at the California Institute of Technology. J.G.B. acknowledges the support of the American Australian Association's Northrop Grumman Fellowship. We thank A. Ferrier and P. Goldner for providing Nd: YSO crystals for initial quantum memory experiments. Part of the research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	Afzelius M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022310; Afzelius M, 2010, J LUMIN, V130, P1566, DOI 10.1016/j.jlumin.2009.12.026; Afzelius M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040503; Corrielli G, 2016, PHYS REV APPL, V5, DOI 10.1103/PhysRevApplied.5.054013; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; Hedges MP, 2010, NATURE, V465, P1052, DOI 10.1038/nature09081; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kolesov R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2034; Lauritzen B, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.043402; Longdell JJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032307; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; Marzban S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.013601; McAuslan DL, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.062307; Moiseev SA, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022311; O'Brien C, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.043807; O'Brien C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.063603; Sabooni M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133604; Saglamyurek E, 2011, NATURE, V469, P512, DOI 10.1038/nature09719; Sinclair N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13454; Sinclair N, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053603; Sun Y, 2002, J LUMIN, V98, P281, DOI 10.1016/S0022-2313(02)00281-8; Thiel CW, 2011, J LUMIN, V131, P353, DOI 10.1016/j.jlumin.2010.12.015; Tittel W, 2010, LASER PHOTONICS REV, V4, P244, DOI 10.1002/lpor.200810056; Wolfowicz G, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.170503; Zhong T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14107; Zhong T, 2016, OPT EXPRESS, V24, P536, DOI 10.1364/OE.24.000536; Zhong T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9206; Zhou ZQ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.190505	31	154	153	7	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 29	2017	357	6358					1392	1395		10.1126/science.aan5959	http://dx.doi.org/10.1126/science.aan5959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI3QH	28860208				2022-12-28	WOS:000411880800045
J	Ridker, PM; Everett, BM; Thuren, T; MacFadyen, JG; Chang, WH; Ballantyne, C; Fonseca, F; Nicolau, J; Koenig, W; Anker, SD; Kastelein, JJP; Cornel, JH; Pais, P; Pella, D; Genest, J; Cifkova, R; Lorenzatti, A; Forster, T; Kobalava, Z; Vida-Simiti, L; Flather, M; Shimokawa, H; Ogawa, H; Dellborg, M; Rossi, PRF; Troquay, RPT; Libby, P; Glynn, RJ				Ridker, P. M.; Everett, B. M.; Thuren, T.; MacFadyen, J. G.; Chang, W. H.; Ballantyne, C.; Fonseca, F.; Nicolau, J.; Koenig, W.; Anker, S. D.; Kastelein, J. J. P.; Cornel, J. H.; Pais, P.; Pella, D.; Genest, J.; Cifkova, R.; Lorenzatti, A.; Forster, T.; Kobalava, Z.; Vida-Simiti, L.; Flather, M.; Shimokawa, H.; Ogawa, H.; Dellborg, M.; Rossi, P. R. F.; Troquay, R. P. T.; Libby, P.; Glynn, R. J.		CANTOS Trial Grp	Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; STATIN THERAPY; INTERLEUKIN-1-BETA INHIBITION; MYOCARDIAL-INFARCTION; CLONAL HEMATOPOIESIS; HEART-DISEASE; INFLAMMATION; RISK	BACKGROUND Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. METHODS We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1 beta, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). CONCLUSIONS Antiinflammatory therapy targeting the interleukin-1 beta innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering.	[Ridker, P. M.; Everett, B. M.; MacFadyen, J. G.; Glynn, R. J.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA USA; [Ridker, P. M.; Everett, B. M.; Libby, P.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA; [Thuren, T.; Chang, W. H.] Novartis, E Hanover, NJ USA; [Thuren, T.; Chang, W. H.] Novartis, Basel, Switzerland; [Ballantyne, C.] Baylor Coll Med, Houston, TX 77030 USA; [Fonseca, F.] Univ Fed Sao Paulo, Sao Paulo, SP, Brazil; [Nicolau, J.] Univ Sao Paulo, Heart Inst InCor, Med Sch, Sao Paulo, SP, Brazil; [Rossi, P. R. F.] Fac Evangel Med Parana, Curitiba, Parana, Brazil; [Koenig, W.] Tech Univ Munich, Deutsch Herzzentrum Munchen, German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Anker, S. D.] Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Cardiol, Berlin, Germany; [Anker, S. D.] Univ Med Berlin, Charite Campus Virchow Klinikum, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Kastelein, J. J. P.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Cornel, J. H.] Alkmaar Med Ctr, Alkmaar, Netherlands; [Troquay, R. P. T.] VieCuri Med Ctr Northern Limburg, Venlo, Netherlands; [Pais, P.] St Johns Res Inst, Manipal Hosp, Bangalore, Karnataka, India; [Pella, D.] Pavol Jozef Safarik Univ, Kosice, Slovakia; [Genest, J.] McGill Univ, Montreal, PQ, Canada; [Cifkova, R.] First Fac Med, Prague, Czech Republic; [Cifkova, R.] Thomayer Hosp, Prague, Czech Republic; [Lorenzatti, A.] Cordoba Hosp, Cordoba, Argentina; [Forster, T.] Univ Szeged, Szeged, Hungary; [Kobalava, Z.] RUDN Univ, City Hosp 64, Med Inst, Moscow, Russia; [Vida-Simiti, L.] Iuliu Hatieganu Univ Med & Pharm, Cluj Napoca, Romania; [Flather, M.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Shimokawa, H.] Tohoku Univ Hosp, Sendai, Miyagi, Japan; [Ogawa, H.] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan; [Dellborg, M.] Univ Gothenburg, Sahlgrenska Univ Hosp, Gothenburg, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Baylor College of Medicine; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; German Centre for Cardiovascular Research; German Heart Centre Munich; Munich Heart Alliance; Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Of Alkmaar; VieCuri Medical Center; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Pavol Jozef Safarik Kosice; McGill University; Charles University Prague; Thomayer Hospital; Szeged University; Peoples Friendship University of Russia; Iuliu Hatieganu University of Medicine & Pharmacy; University of East Anglia; Tohoku University; National Cerebral & Cardiovascular Center - Japan; Sahlgrenska University Hospital; University of Gothenburg	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	pridker@partners.org	YILMAZ, Mehmet Birhan/Y-1372-2019; Vozzhaev, Alexander V/A-9466-2017; Shvarts, Yury Григорьевич/AAB-4929-2022; Kastelein, John/AAF-7950-2020; Casoinic, Florin Eugen/AAB-7101-2022; Forster, Tamas/AAV-9037-2020; Senni, Michele/J-9380-2018; sharma, kamal/AAG-7271-2019; Zirlik, Andreas/A-6400-2011; Iannopollo, Gianmarco/AAB-8447-2022; Piskorz, Daniel/AAJ-8751-2020; Libov, Igor/GRN-8152-2022; Renda, Giulia/AIB-5091-2022; Gapon, Lyudmila/GLT-8521-2022; Malik, Jan/K-8681-2019; Ballantyne, Christie/A-6599-2008; Lembo, Giuseppe/AAE-8096-2020; Berk, Michael/M-3585-2019; De Rosa, Salvatore/J-6350-2012; Libby, Peter/AAY-6404-2021; Nicolau, Jose C/E-1487-2012; Malik, Jan/C-4826-2008; Fitilev, Sergey/AAG-2814-2021; Berk, Michael/M-7891-2013; Racca, Vittorio/F-3374-2013; Urina-Triana, Miguel A/H-2605-2016; Edgeworth, Cathrine/AAB-7428-2020; Khromtsova, Oksana M./F-4530-2018; Fitilev, Sergey Borisovich/C-3173-2017; Kasala, Latheef/AAU-1077-2021; tekten, tarkan/AAA-3197-2022; cornel, jan hein/Y-7065-2019; Podoleanu, Cristian/E-2850-2010; Manyari, Dante/AFL-5565-2022; vardas, panos/ABF-7144-2020; Reis, Gilmar/I-4500-2013; Barbarash, Olga/A-4834-2017; Yakushin, Sergey/N-4165-2013; Repin, Alexey/J-6150-2017; Schultz, Carl/G-3557-2011; Cioffi, Angela/Q-4622-2016; Mannucci, Edoardo/K-6749-2016; Moreira, Luiz Felipe P./F-9882-2012	YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Vozzhaev, Alexander V/0000-0002-2687-5986; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Senni, Michele/0000-0001-5502-7882; sharma, kamal/0000-0001-5866-2566; Zirlik, Andreas/0000-0001-6290-3297; Piskorz, Daniel/0000-0002-8615-5446; Renda, Giulia/0000-0002-4770-8386; Gapon, Lyudmila/0000-0003-1795-9595; Malik, Jan/0000-0002-2386-3293; Lembo, Giuseppe/0000-0002-3510-223X; Berk, Michael/0000-0002-5554-6946; De Rosa, Salvatore/0000-0001-5388-942X; Libby, Peter/0000-0002-1502-502X; Nicolau, Jose C/0000-0002-9680-3689; Malik, Jan/0000-0002-2386-3293; Fitilev, Sergey/0000-0001-8395-419X; Berk, Michael/0000-0002-5554-6946; Racca, Vittorio/0000-0002-4465-3789; Urina-Triana, Miguel A/0000-0001-6003-4622; Edgeworth, Cathrine/0000-0002-5190-9711; Khromtsova, Oksana M./0000-0003-0763-0542; Kasala, Latheef/0000-0002-4212-9756; cornel, jan hein/0000-0002-1006-2112; Podoleanu, Cristian/0000-0001-9987-2519; Gupta, Anish Kumar/0000-0002-8701-4063; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Visseren, Frank/0000-0003-3951-5223; Sinnaeve, Peter/0000-0003-4716-5892; Cheng, Susan/0000-0002-4977-036X; Reis, Gilmar/0000-0002-4847-1034; Birdane, Alparslan/0000-0001-7028-9370; Townend, Jonathan/0000-0002-5881-5806; Klemsdal, Tor Ole/0000-0001-5442-9134; Cadeddu, Christian/0000-0002-2823-1797; Barbarash, Olga/0000-0002-4642-3610; Yakushin, Sergey/0000-0001-7202-742X; Singh, Kanwarpal/0000-0002-6884-8089; Shimokawa, Hiroaki/0000-0001-7534-4826; Vesga, Boris/0000-0001-6258-1195; Kosmacheva, Elena/0000-0001-8600-0199; Repin, Alexey/0000-0001-7123-0645; solinas, emilia/0000-0003-3532-1317; Kietselaer, Bas/0000-0002-0096-8594; Chen, Yung Chih/0000-0002-5387-5818; Costa Duarte Barbosa, Eduardo/0000-0002-4361-936X; Schultz, Carl/0000-0002-0847-4361; Kok, Marc/0000-0003-2394-6926; Brouwer, Marc/0000-0001-8617-7672; Pella, Daniel/0000-0001-9999-6271; Marino, Paolo/0000-0002-8192-412X; Ballantyne, Christie/0000-0002-6432-1730; Cioffi, Angela/0000-0001-8290-6815; Alexey, Panov/0000-0003-3356-3873; Parmon, Elena/0000-0002-0852-631X; Koenig, Wolfgang/0000-0002-2064-9603; Apostolovic, Svetlana/0000-0001-9015-297X; Yang, Ke/0000-0002-1870-1134; Fox, Brian/0000-0001-6620-3853; Lozhkina, Natalya/0000-0002-4832-3197; Yamamoto, Takayuki/0000-0001-7551-5568; Kirkland, Susan/0000-0002-8182-2369; Echeverria, Luis Eduardo/0000-0001-5784-3859; Mannucci, Edoardo/0000-0001-9759-9408; Antonicelli, Roberto/0000-0002-5921-1828; Yuan, Zuyi/0000-0002-4141-0298; Moreira, Luiz Felipe P./0000-0003-0179-4976	Novartis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS073806] Funding Source: NIH RePORTER	Novartis(Novartis); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by Novartis.	Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bohula EA, 2015, CIRCULATION, V132, P1224, DOI 10.1161/CIRCULATIONAHA.115.018381; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Folco EJ, 2014, CIRC RES, V115, P875, DOI 10.1161/CIRCRESAHA.115.304437; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; LIBBY P, 1986, AM J PATHOL, V124, P179; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Morton AC, 2015, EUR HEART J, V36, P377, DOI 10.1093/eurheartj/ehu272; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ridker PM, 2017, NEW ENGL J MED, V376, P1527, DOI 10.1056/NEJMoa1701488; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2016, EUR HEART J, V37, P1720, DOI 10.1093/eurheartj/ehw024; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ridker PM, LANCET IN PRESS; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruperto N, 2012, NEW ENGL J MED, V367, P2396, DOI 10.1056/NEJMoa1205099; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sager HB, 2015, CIRCULATION, V132, P1880, DOI 10.1161/CIRCULATIONAHA.115.016160; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Van Tassell BW, 2013, CIRCULATION, V128, P1910, DOI 10.1161/CIRCULATIONAHA.113.003199; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714	39	4377	4535	24	455	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2017	377	12					1119	1131		10.1056/NEJMoa1707914	http://dx.doi.org/10.1056/NEJMoa1707914			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7FF	28845751	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000411348500006
J	Maret-Ouda, J; Wahlin, K; El-Serag, HB; Lagergren, J				Maret-Ouda, John; Wahlin, Karl; El-Serag, Hashem B.; Lagergren, Jesper			Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION-BASED COHORT; PUMP INHIBITOR THERAPY; LONG-TERM OUTCOMES; DEATH CERTIFICATES; CO-MORBIDITY; DISEASE; FUNDOPLICATION; SYMPTOMS; RISK; METAANALYSIS	IMPORTANCE Cohort studies, mainly based on questionnaires and interviews, have reported high rates of reflux recurrence after antireflux surgery, which may have contributed to a decline in its use. Reflux recurrence after laparoscopic antireflux surgery has not been assessed in a long-term population-based study of unselected patients. OBJECTIVES To determine the risk of reflux recurrence after laparoscopic antireflux surgery and to identify risk factors for recurrence. DESIGN AND SETTING Nationwide population-based retrospective cohort study in Sweden between January 1, 2005, and December 31, 2014, based on all Swedish health care and including 2655 patients who underwent laparoscopic antireflux surgery according to the Swedish Patient Registry. Their records were linked to the Swedish Causes of Death Registry and Prescribed Drug Registry. EXPOSURES Primary laparoscopic antireflux surgery due to gastroesophageal reflux disease in adults (> 18 years). MAIN OUTCOMES AND MEASURES The outcome was recurrence of reflux, defined as use of antireflux medication (proton pump inhibitors or histamine(2) receptor antagonists for > 6 months) or secondary antireflux surgery. Multivariable Cox regression was used to assess risk factors for reflux recurrence. RESULTS Among all 2655 patients who underwent antireflux surgery (median age, 51.0 years; interquartile range, 40.0-61.0 years; 1354 men [51.0%]) and were followed up for a median of 5.6 years, 470 patients (17.7%) had reflux recurrence; 393 (83.6%) received long-term antireflux medication and 77 (16.4%) underwent secondary antireflux surgery. Risk factors for reflux recurrence included female sex (hazard ratio [HR], 1.57 [95% CI, 1.29-1.90]; 286 of 1301 women [22.0%] and 184 of 1354 men [13.6%] had recurrence of reflux), older age (HR, 1.41 [95% CI, 1.10-1.81] for age >= 61 years compared with <= 45 years; recurrence among 156 of 715 patients and 133 of 989 patients, respectively), and comorbidity (HR, 1.36 [95% CI, 1.13-1.65] for Charlson comorbidity index score >= 1 compared with 0; recurrence among 180 of 804 patients and 290 of 1851 patients, respectively). Hospital volume of antireflux surgery was not associated with risk of reflux recurrence (HR, 1.09 [95% CI, 0.77-1.53] for hospital volume <= 24 surgeries compared with >= 76 surgeries; recurrence among 38 of 266 patients [14.3%] and 271 of 1526 patients [17.8%], respectively). CONCLUSIONS AND RELEVANCE Among patients who underwent primary laparoscopic antireflux surgery, 17.7% experienced recurrent gastroesophageal reflux requiring long-term medication use or secondary antireflux surgery. Risk factors for recurrence were older age, female sex, and comorbidity. Laparoscopic antireflux surgery was associated with a relatively high rate of recurrent gastroesophageal reflux disease requiring treatment, diminishing some of the benefits of the operation.	[Maret-Ouda, John; Wahlin, Karl; Lagergren, Jesper] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, S-17176 Stockholm, Sweden; [El-Serag, Hashem B.] Baylor Coll Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA; [El-Serag, Hashem B.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Lagergren, Jesper] Kings Coll London, Sch Canc Sci, London, England	Karolinska Institutet; Karolinska University Hospital; Baylor College of Medicine; Baylor College of Medicine; University of London; King's College London	Maret-Ouda, J (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, S-17176 Stockholm, Sweden.	john.maret.ouda@ki.se			Swedish Research Council [D0547801]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Research Council (grant D0547801).	[Anonymous], 2011, AM J GASTROENTEROL, V106, P1209; [Anonymous], 2007, DIGEST DIS SCI, V52, P267; Anvari M, 2011, SURG ENDOSC, V25, P2547, DOI 10.1007/s00464-011-1585-5; Armitage JN, 2010, BRIT J SURG, V97, P772, DOI 10.1002/bjs.6930; Brusselaers N, 2014, GUT, V63, P1393, DOI 10.1136/gutjnl-2013-306074; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ciovica R, 2009, SURG ENDOSC, V23, P1938, DOI 10.1007/s00464-008-0271-8; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; Fei L, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S13; Gawron AJ, 2014, PHARMACOECONOMICS, V32, P745, DOI 10.1007/s40273-014-0164-8; Gee DW, 2008, ARCH SURG-CHICAGO, V143, P482, DOI 10.1001/archsurg.143.5.482; Giuliano C, 2012, EXPERT REV CLIN PHAR, V5, P337, DOI [10.1586/ECP.12.20, 10.1586/ecp.12.20]; Godtman R, 2011, SCAND J UROL NEPHROL, V45, P226, DOI 10.3109/00365599.2011.559950; Grant AM, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17220; Harnik IG, 2015, ANN INTERN MED, V163, DOI 10.7326/AITC201507070; Jackson PG, 2001, AM J SURG, V181, P231, DOI 10.1016/S0002-9610(01)00553-0; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Kaufman JA, 2006, SURG ENDOSC, V20, P1824, DOI 10.1007/s00464-005-0329-9; Khajanchee YS, 2002, ARCH SURG-CHICAGO, V137, P1008, DOI 10.1001/archsurg.137.9.1008; Lagergren J, 2017, LANCET, V22, P31462; Lin M, 2004, AM J GASTROENTEROL, V99, P1442, DOI 10.1111/j.1572-0241.2004.04147.x; Liu CJ, 2015, CANCER-AM CANCER SOC, V121, P2782, DOI 10.1002/cncr.29356; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lundell L, 2008, GUT, V57, P1207, DOI 10.1136/gut.2008.148833; Maret-Ouda J, 2017, AM J SURG, V213, P1160, DOI 10.1016/j.amjsurg.2016.09.034; Maret-Ouda J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3169; Morgenthal CB, 2007, SURG ENDOSC, V21, P1978, DOI 10.1007/s00464-007-9490-7; National Board of Health and Welfare, SWED PRESCR DRUG REG; Ness-Jensen E, 2012, GUT, V61, P1390, DOI 10.1136/gutjnl-2011-300715; Niebisch S, 2012, J AM COLL SURGEONS, V215, P61, DOI 10.1016/j.jamcollsurg.2012.03.022; Papasavas PK, 2003, SURG ENDOSC, V17, P1200, DOI 10.1007/s00464-002-8910-y; Patti MG, 2015, JAMA SURG, V150, P585, DOI 10.1001/jamasurg.2014.3859; Richter JE, 2013, CLIN GASTROENTEROL H, V11, P465, DOI 10.1016/j.cgh.2012.12.006; van Beek DB, 2011, SURG ENDOSC, V25, P706, DOI 10.1007/s00464-010-1254-0; Wijnhoven BPL, 2008, J GASTROINTEST SURG, V12, P510, DOI 10.1007/s11605-007-0443-1; World Health Organization Collaborating Centre for Drug Statistics Methodology, DEF DAIL DOS DEF GEN; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	38	60	63	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					939	946		10.1001/jama.2017.10981	http://dx.doi.org/10.1001/jama.2017.10981			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898377	Green Published			2022-12-28	WOS:000410487100015
J	Horton, R				Horton, Richard			Offline: North Korea-the case for health diplomacy	LANCET			English	Editorial Material												richard.horton@lancet.com							0	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1016	1016		10.1016/S0140-6736(17)32381-4	http://dx.doi.org/10.1016/S0140-6736(17)32381-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28901926	Bronze			2022-12-28	WOS:000409528600010
J	Stajic, J; Hand, E; Yeston, J				Stajic, Jelena; Hand, Eric; Yeston, Jake			MANIPULATING ULTRACOLD MATTER	SCIENCE			English	Editorial Material																			0	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		984	+		10.1126/science.357.6355.984	http://dx.doi.org/10.1126/science.357.6355.984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883067				2022-12-28	WOS:000409455700034
J	Choudhry, NK				Choudhry, Niteesh K.			Randomized, Controlled Trials in Health Insurance Systems	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INFORMED-CONSENT; MYOCARDIAL-INFARCTION; CLINICAL-RESEARCH; PRAGMATIC TRIAL; RATIONALE; ADHERENCE; OUTCOMES; DESIGN; INTERVENTION; ACCURACY		[Choudhry, Niteesh K.] Brigham & Womens Hosp, Ctr Healthcare Delivery Sci, 75 Francis St, Boston, MA 02115 USA; [Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol, 75 Francis St, Boston, MA 02115 USA; [Choudhry, Niteesh K.] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	nkchoudhry@bwh.harvard.edu						Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], 2011, NEW ENGL J MED, V364, P1685; [Anonymous], 2014, DEV APPR COND RAND T; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Centers for Disease Control and Prevention, NAT DEATH IND; Choudhry NK, 2017, JAMA INTERN MED, V177, P624, DOI 10.1001/jamainternmed.2016.9627; Choudhry NK, 2016, AM HEART J, V180, P90, DOI 10.1016/j.ahj.2016.07.017; Choudhry NK, 2015, CONTEMP CLIN TRIALS, V43, P53, DOI 10.1016/j.cct.2015.05.006; Choudhry NK, 2013, J CLIN EPIDEMIOL, V66, pS5, DOI 10.1016/j.jclinepi.2013.03.022; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Faden R, 2013, MED CARE, V51, pS53, DOI 10.1097/MLR.0b013e31829b1e4b; Hlatky MA, 2014, CIRC-CARDIOVASC QUAL, V7, P157, DOI 10.1161/CIRCOUTCOMES.113.000373; Hlatky MA, 2009, CIRCULATION, V120, P2550, DOI 10.1161/CIRCULATIONAHA.109.912709; Hynes D, 1999, MED CARE, V37, pAS27, DOI 10.1097/00005650-199904002-00005; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; Koppenaal T, 2011, J CLIN EPIDEMIOL, V64, P1095, DOI 10.1016/j.jclinepi.2010.11.020; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Lauffenburger JC, 2017, CONTEMP CLIN TRIALS, V59, P57, DOI 10.1016/j.cct.2017.05.014; Love Denise, 2010, Issue Brief (Commonw Fund), V99, P1; Milkman KL, 2011, P NATL ACAD SCI USA, V108, P10415, DOI 10.1073/pnas.1103170108; Nayak RK, 2015, ANN INTERN MED, V163, P356, DOI 10.7326/M15-0817; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Peter WLS, 2008, AM J KIDNEY DIS, V51, P445, DOI 10.1053/j.ajkd.2007.12.002; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Petrou S, 2002, INT J TECHNOL ASSESS, V18, P705, DOI 10.1017/S026646230200051X; Schneeweiss S, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-180; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Seeger JD, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-171; Seidl H, 2016, J EVAL CLIN PRACT, V22, P446, DOI 10.1111/jep.12506; Solomon DH, 2012, ARCH INTERN MED, V172, P477, DOI 10.1001/archinternmed.2011.1977; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7; Zwarenstein M, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0486-3; Zwarenstein M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-87; Zwarenstein M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-37	42	30	32	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					957	964		10.1056/NEJMra1510058	http://dx.doi.org/10.1056/NEJMra1510058			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF9XU	28877014	Bronze			2022-12-28	WOS:000409373100009
J	Jonas, DE; Amick, HR; Wallace, IF; Feltner, C; Vander Schaaf, EB; Brown, CL; Baker, C				Jonas, Daniel E.; Amick, Halle R.; Wallace, Ina F.; Feltner, Cynthia; Vander Schaaf, Emily B.; Brown, Callie L.; Baker, Claire			Vision Screening in Children Aged 6 Months to 5 Years Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PEDIATRIC-EYE-DISEASE; 3-YEAR-OLD KINDERGARTEN-CHILDREN; AUSTRALIAN PRESCHOOL-CHILDREN; AMBLYOPIA TREATMENT OUTCOMES; RANDOMIZED CONTROLLED-TRIAL; VISUAL-ACUITY MEASUREMENTS; AMBLYOGENIC FACTORS; MTI PHOTOSCREENER; RISK-FACTORS; NONCYCLOPLEGIC RETINOSCOPY	IMPORTANCE Preschool vision screening could allow detection and treatment of vision abnormalities during a critical developmental stage, preserving function and quality of life. OBJECTIVE To review the evidence on screening for and treatment of amblyopia, its risk factors, and refractive error in children aged 6 months to 5 years to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, Cochrane Library, CINAHL, and trial registries through June 2016; references; and experts, with surveillance of the literature through June 7, 2017. STUDY SELECTION English-language randomized clinical trials (RCTs) or prospective cohort studies that evaluated screening, studies evaluating test accuracy, RCTs of treatment vs inactive controls, and cohort studies or case-control studies assessing harms. DATA EXTRACTION AND SYNTHESIS Dual review of abstracts, full-text articles, and study quality; qualitative synthesis of findings. Studies were not quantitatively pooled because of clinical and methodological heterogeneity. MAIN OUTCOMES AND MEASURES Visual acuity, amblyopia, school performance, functioning, quality of life, test accuracy, testability, and harms. ); 34 evaluated test accuracy. No RCTs compared screening with no screening, and no studies evaluate RESULTS Forty studies were included (N = 34 709d school performance, function, or quality of life. Studies directly assessing earlier or more intensive screening were limited by high attrition. Positive likelihood ratios were between 5 and 10 for amblyopia risk factors or nonamblyogenic refractive error in most studies of test accuracy and were greater than 10 in most studies evaluating combinations of clinical tests. Inability to cooperate may limit use of some tests in children younger than 3 years. Studies with low prevalence (<10%) of vision abnormalities showed high false-positive rates (usually >75%). Among children with amblyopia risk factors (eg, strabismus or anisometropia), patching improved visual acuity of the amblyopic eye by a mean of less than 1 line on a standard chart after 5 to 12 weeks for children pretreated with glasses (2 RCTs, 240 participants); more children treated with patching than with no patching experienced improvement of at least 2 lines (45% vs 21%; P=.003; 1 RCT, 180 participants). Patching plus glasses improved visual acuity by about 1 line after 1 year (0.11 logMAR [95% CI, 0.05-0.17]) for children not pretreated with glasses (1 RCT, 177 participants). Glasses alone improved visual acuity by less than 1 line after 1 year (0.08 logMAR [95% CI, 0.02-0.15], 1 RCT, 177 participants). CONCLUSIONS AND RELEVANCE Studies directly evaluating the effectiveness of screening were limited and do not establish whether vision screening in preschool children is better than no screening. Indirect evidence supports the utility of multiple screening tests for identifying preschool children at higher risk for vision problems and the effectiveness of some treatments for improving visual acuity outcomes.	[Jonas, Daniel E.; Wallace, Ina F.; Feltner, Cynthia; Baker, Claire] Univ North Carolina Chapel Hill, Evidence Based Practice Ctr RTI UNC EPC, RTI Int, Chapel Hill, NC USA; [Jonas, Daniel E.; Feltner, Cynthia] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Jonas, Daniel E.; Feltner, Cynthia; Baker, Claire] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Amick, Halle R.] Venebio Grp, Richmond, VA USA; [Wallace, Ina F.] RTI Int, Res Triangle Pk, NC USA; [Vander Schaaf, Emily B.] Univ North Carolina Chapel Hill, Dept Pediat, Chapel Hill, NC USA; [Brown, Callie L.] Wake Forest Univ, Dept Pediat, Winston Salem, NC 27109 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University	Jonas, DE (corresponding author), Univ North Carolina Chapel Hill, 5034 Old Clin Bldg, Chapel Hill, NC 27599 USA.	daniel_jonas@med.unc.edu	; Brown, Callie/J-8198-2015	Wallace, Ina/0000-0002-0194-4041; , Emily/0000-0002-1408-7413; Brown, Callie/0000-0003-3060-5652	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Afsari S, 2013, BRIT J OPHTHALMOL, V97, P308, DOI 10.1136/bjophthalmol-2012-302192; American Academy of Ophthalmology (AAO) Pediatric Ophthalmology/Strabismus Panel, 2012, PREF PRACT PATT GUID; Arnold RW, 2013, J PEDIAT OPHTH STRAB, V50, P213, DOI 10.3928/01913913-20130326-01; Arthur BW, 2009, J AAPOS, V13, P51, DOI 10.1016/j.jaapos.2008.08.016; Awan M, 2005, INVEST OPHTH VIS SCI, V46, P1435, DOI 10.1167/iovs.04-0971; Barry JC, 2003, BRIT J OPHTHALMOL, V87, P909, DOI 10.1136/bjo.87.7.909; Barry JC, 2001, BRIT J OPHTHALMOL, V85, P1179, DOI 10.1136/bjo.85.10.1179; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Bertuzzi F, 2006, ACTA OPHTHALMOL SCAN, V84, P807, DOI 10.1111/j.1600-0420.2006.00668.x; Carlton J, 2008, Health Technol Assess, V12, pxi; Carlton J, 2008, HEALTH TECHNOL ASSES, V12, pxi; Choong YF, 2006, AM J OPHTHALMOL, V142, P68, DOI 10.1016/j.ajo.2006.01.084; Chou R, 2011, SCREENING VISUAL IMP; Chui L, 2004, J AAPOS, V8, P566, DOI 10.1016/j.jaapos.2004.08.011; Ciner EB, 1998, OPTOMETRY VISION SCI, V75, P571, DOI 10.1097/00006324-199808000-00022; Ciner E, 2006, J AAPOS, V10, P507, DOI 10.1016/j.jaapos.2006.08.019; Ciner E, 2011, OPTOMETRY VISION SCI, V88, P830, DOI 10.1097/OPX.0b013e3182192658; Clarke MP, 2003, BMJ-BRIT MED J, V327, P1251; Cogen M S, 1992, Ala Med, V62, P16; Cotter SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P22, DOI 10.1001/archophthalmol.2008.520; Cyert L, 2004, OPTOMETRY VISION SCI, V81, P678, DOI 10.1097/01.opx.0000144746.80718.67; Cyert L, 2010, OPTOMETRY VISION SCI, V87, P87, DOI 10.1097/OPX.0b013e3181c750b1; Dahlmann-Noor AH, 2009, BRIT J OPHTHALMOL, V93, P342, DOI 10.1136/bjo.2008.138115; Dahlmann-Noor AH, 2009, BRIT J OPHTHALMOL, V93, P346, DOI 10.1136/bjo.2008.138123; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Donahue SP, 2013, J AAPOS, V17, P4, DOI 10.1016/j.jaapos.2012.09.012; Donahue SP, 2006, J AAPOS, V10, P44, DOI 10.1016/j.jaapos.2005.08.007; Donahue SP, 2004, J AAPOS, V8, P224, DOI 10.1016/j.jaapos.2004.05.004; Donahue SP, 2002, J AAPOS, V6, P86, DOI 10.1067/mpa.2002.121168; Donahue SP, 2000, OPHTHALMOLOGY, V107, P1637, DOI 10.1016/S0161-6420(00)00298-0; Doshi NR, 2007, AM FAM PHYSICIAN, V75, P361; EPELBAUM M, 1993, OPHTHALMOLOGY, V100, P323; Flynn J T, 1998, Trans Am Ophthalmol Soc, V96, P431; Freedman H, 2006, OPHTHALMOLOGY, V113, P1248, DOI 10.1016/j.ophtha.2006.04.007; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Glaser SR, 2002, ARCH OPHTHALMOL-CHIC, V120, P268; Griffith JF, 2016, AM J OPHTHALMOL, V163, P108, DOI 10.1016/j.ajo.2015.11.026; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harvey EM, 2009, J AAPOS, V13, P466, DOI 10.1016/j.jaapos.2009.08.013; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Holmes JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1345; HOPE C, 1990, AUST NZ J OPHTHALMOL, V18, P319, DOI 10.1111/j.1442-9071.1990.tb00627.x; Horwood J, 2005, INVEST OPHTH VIS SCI, V46, P1177, DOI 10.1167/iovs.04-0597; Hrisos S, 2004, OPHTHALMOLOGY, V111, P1550, DOI 10.1016/j.ophtha.2003.12.059; Huang JY, 2013, OPTOMETRY VISION SCI, V90, P1128, DOI 10.1097/OPX.0000000000000025; Jaeschke R, 2002, USERS GUIDES MED LIT, P121; Jost RM, 2015, J AAPOS, V19, P521, DOI 10.1016/j.jaapos.2015.09.004; Kemper AR, 2005, ARCH PEDIAT ADOL MED, V159, P435, DOI 10.1001/archpedi.159.5.435; KENNEDY R, 1995, CAN J OPHTHALMOL, V30, P193; Kennedy RA, 2000, CAN J OPHTHALMOL, V35, P258, DOI 10.1016/S0008-4182(00)80075-7; KENNEDY RA, 1989, CAN J OPHTHALMOL, V24, P259; Kulp MT, 2014, INVEST OPHTH VIS SCI, V55, P1378, DOI 10.1167/iovs.13-13433; Leat SJ, 2001, J PEDIAT OPHTH STRAB, V38, P284; Leone JF, 2012, EYE, V26, P925, DOI 10.1038/eye.2012.60; Manny RE, 2003, INVEST OPHTH VIS SCI, V44, P3294, DOI 10.1167/iovs.02-1199; Matta NS, 2008, J AAPOS, V12, P490, DOI 10.1016/j.jaapos.2008.04.004; McGraw PV, 2000, OPHTHAL PHYSL OPT, V20, P173, DOI 10.1016/S0275-5408(99)00054-X; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Mehravaran S, 2016, J AAPOS, V20, P63, DOI 10.1016/j.jaapos.2015.10.018; Miller JM, 1999, J AAPOS, V3, P160, DOI 10.1016/S1091-8531(99)70062-5; Miller JM, 2001, INVEST OPHTH VIS SCI, V42, P917; Miller JM, 2012, PEDIATRICS, V130, P983, DOI 10.1542/peds.2012-2548; MORGAN KS, 1987, ARCH OPHTHALMOL-CHIC, V105, P1528; OTTAR WL, 1995, J PEDIATR OPHTHALMOL, V32, P289; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Pai ASI, 2012, OPHTHALMOLOGY, V119, P138, DOI 10.1016/j.ophtha.2011.06.024; Pai ASI, 2011, OPHTHALMOLOGY, V118, P1495, DOI 10.1016/j.ophtha.2011.01.027; Pascual M, 2014, OPHTHALMOLOGY, V121, P622, DOI 10.1016/j.ophtha.2013.08.040; Pediat Eye Dis Investigator Grp, 2003, ARCH OPHTHALMOL-CHIC, V121, P603; Rahi JS, 2002, LANCET, V360, P597, DOI 10.1016/S0140-6736(02)09782-9; Repka MS, 2004, OPHTHALMOLOGY, V111, P2076, DOI 10.1016/j.ophtha.2004.04.032; Repka MX, 2005, ARCH OPHTHALMOL-CHIC, V123, P149; Rogers DL, 2008, J AAPOS, V12, P77, DOI 10.1016/j.jaapos.2007.09.004; Rosser DA, 2003, INVEST OPHTH VIS SCI, V44, P3278, DOI 10.1167/iovs.02-1100; Rosser DA, 2003, EYE, V17, P701, DOI 10.1038/sj.eye.6700496; Schmidt P, 2005, INVEST OPHTH VIS SCI, V46, P2639, DOI 10.1167/iovs.05-0141; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Shallo-Hoffmann Josephine, 2004, Strabismus, V12, P65, DOI 10.1080/09273970490515874; Stewart CE, 2007, BMJ-BRIT MED J, V335, P707, DOI 10.1136/bmj.39301.460150.55; Stewart CE, 2003, BRIT J OPHTHALMOL, V87, P1229, DOI 10.1136/bjo.87.10.1229; Sunness JS, 2010, OPHTHALMOLOGY, V117, P1442, DOI 10.1016/j.ophtha.2009.11.017; Tarczy-Hornoch K, 2013, OPHTHALMOLOGY, V120, P1220, DOI 10.1016/j.ophtha.2012.12.029; TOMMILA V, 1981, BRIT J OPHTHALMOL, V65, P575, DOI 10.1136/bjo.65.8.575; Tong PY, 2000, OPHTHALMOLOGY, V107, P1623, DOI 10.1016/S0161-6420(00)00293-1; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; van Leeuwen R, 2007, BRIT J OPHTHALMOL, V91, P1450, DOI 10.1136/bjo.2006.113670; Varma R, 2009, OPHTHALMOLOGY, V116, P1990, DOI 10.1016/j.ophtha.2009.03.027; Wallace DK, 2006, OPHTHALMOLOGY, V113, P904, DOI 10.1016/j.ophtha.2006.01.069; Webber Ann L, 2005, Clin Exp Optom, V88, P365; Weinand F, 1998, GRAEF ARCH CLIN EXP, V236, P801, DOI 10.1007/s004170050163; Williams C, 2006, BRIT J OPHTHALMOL, V90, P670, DOI 10.1136/bjo.2006.091082; Williams C, 2003, BRIT J OPHTHALMOL, V87, P988, DOI 10.1136/bjo.87.8.988; Williams C, 2002, BMJ-BRIT MED J, V324, P1549, DOI 10.1136/bmj.324.7353.1549; Williams C, 2001, Ophthalmic Epidemiol, V8, P279; Williams C, 2000, INVEST OPHTH VIS SCI, V41, P1031; Ying GS, 2014, OPHTHALMOLOGY, V121, P630, DOI 10.1016/j.ophtha.2013.09.036; Ying GS, 2013, OPHTHALMOLOGY, V120, P495, DOI 10.1016/j.ophtha.2012.08.014; Ying GS, 2011, INVEST OPHTH VIS SCI, V52, P9658, DOI 10.1167/iovs.11-8559	98	44	48	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					845	858		10.1001/jama.2017.9900	http://dx.doi.org/10.1001/jama.2017.9900			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873167				2022-12-28	WOS:000409183700016
J	Rosen, J				Rosen, Julia			How an ocean climate cycle favored Harvey	SCIENCE			English	News Item																			0	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					853	854		10.1126/science.357.6354.853	http://dx.doi.org/10.1126/science.357.6354.853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860359				2022-12-28	WOS:000408734900013
J	Whittaker, RJ; Fernandez-Palacios, JM; Matthews, TJ; Borregaard, MK; Triantis, KA				Whittaker, Robert J.; Maria Fernandez-Palacios, Jose; Matthews, Thomas J.; Borregaard, Michael K.; Triantis, Kostas A.			Island biogeography: Taking the long view of nature's laboratories	SCIENCE			English	Review							SPECIES-AREA RELATIONSHIPS; GENERAL DYNAMIC-MODEL; ADAPTIVE RADIATION; OCEANIC ISLANDS; EVOLUTION; DIVERSIFICATION; DIVERSITY; EQUILIBRIUM; DISPERSAL; ENDEMICS	Islands provide classic model biological systems. We review how growing appreciation of geoenvironmental dynamics of marine islands has led to advances in island biogeographic theory accommodating both evolutionary and ecological phenomena. Recognition of distinct island geodynamics permits general models to be developed and modified to account for patterns of diversity, diversification, lineage development, and trait evolution within and across island archipelagos. Emergent patterns of diversity include predictable variation in island species-area relationships, progression rule colonization from older to younger land masses, and syndromes including loss of dispersability and secondary woodiness in herbaceous plant lineages. Further developments in Earth system science, molecular biology, and trait data for islands hold continued promise for unlocking many of the unresolved questions in evolutionary biology and biogeography.	[Whittaker, Robert J.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Whittaker, Robert J.; Borregaard, Michael K.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Copenhagen, Denmark; [Maria Fernandez-Palacios, Jose] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Isl Ecol & Biogeog Res Grp, Tenerife 38206, Canary Islands, Spain; [Matthews, Thomas J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Matthews, Thomas J.] CE3C, Azorean Biodivers Grp, PT-9700042 Angra Do Heroismo, Acores, Portugal; [Matthews, Thomas J.] Univ Acores, Dept Ciencias Agr Engn Ambiente, PT-9700042 Angra Do Heroismo, Acores, Portugal; [Triantis, Kostas A.] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Ecol & Taxon, GR-15784 Athens, Greece	University of Oxford; University of Copenhagen; Universidad de la Laguna; University of Birmingham; Universidade dos Acores; National & Kapodistrian University of Athens	Whittaker, RJ (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England.; Whittaker, RJ (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Copenhagen, Denmark.	robert.whittaker@ouce.ox.ac.uk	Fernández-Palacios, José María/H-2054-2015; Whittaker, Robert/H-1548-2015; Borregaard, Michael/B-8442-2008	Fernández-Palacios, José María/0000-0001-9741-6878; Whittaker, Robert/0000-0001-7775-3383; Triantis, Kostas/0000-0003-2737-8890; Borregaard, Michael/0000-0002-8146-8435; Matthews, Thomas/0000-0002-7624-244X	Special Account for Research Grants; National and Kapodistrian University of Athens	Special Account for Research Grants; National and Kapodistrian University of Athens	We thank J. Crisci, L. Heaney, L. Katinas, J. Patino, L. Valente, and two anonymous reviewers for comments and A. Pool for assistance with figures. K.A.T. acknowledges support from the Special Account for Research Grants and National and Kapodistrian University of Athens.	Agnarsson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086780; Ali JR, 2017, J BIOGEOGR, V44, P984, DOI 10.1111/jbi.12872; Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Bennett GM, 2013, J BIOGEOGR, V40, P1512, DOI 10.1111/jbi.12099; Bess EC, 2014, J BIOGEOGR, V41, P158, DOI 10.1111/jbi.12191; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borregaard MK, 2017, BIOL REV, V92, P830, DOI 10.1111/brv.12256; Borregaard MK, 2016, GLOBAL ECOL BIOGEOGR, V25, P805, DOI 10.1111/geb.12348; Carvajal-Endara S, 2017, ECOL LETT, V20, P495, DOI 10.1111/ele.12753; Caujape-Castells J, 2017, PERSPECT PLANT ECOL, V27, P9, DOI 10.1016/j.ppees.2017.03.003; Crawford DJ, 2017, J SYST EVOL, V55, P1, DOI 10.1111/jse.12234; Dawson MN, 2016, GLOBAL ECOL BIOGEOGR, V25, P831, DOI 10.1111/geb.12314; Ding ZF, 2013, J ANIM ECOL, V82, P781, DOI 10.1111/1365-2656.12046; Duncan RP, 2013, P NATL ACAD SCI USA, V110, P6436, DOI 10.1073/pnas.1216511110; Fattorini S, 2017, J BIOGEOGR, V44, P1018, DOI 10.1111/jbi.12874; Fernandez-Palacios J. M., 2015, FRONT BIOGEOGR, V7, P1; Fjeldsa Jon, 2013, Chinese Birds, V4, P132; Garcia-Olivares V, 2017, J BIOGEOGR, V44, P1053, DOI 10.1111/jbi.12961; Gillespie RG, 2013, CURR BIOL, V23, pR71, DOI 10.1016/j.cub.2012.11.052; Gillespie RG, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P358; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Graham Natalie R., 2017, Environmental Conservation, V44, P323; Grehan JR, 2017, AUST SYST BOT, V29, P447, DOI 10.1071/SB16051; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Heads M, 2018, CLADISTICS, V34, P292, DOI 10.1111/cla.12204; Heaney L.R., 2013, FRONT BIOGEOGR, V5, P249, DOI DOI 10.21425/F5FBG18991; Heaney LR, 2000, GLOBAL ECOL BIOGEOGR, V9, P59, DOI 10.1046/j.1365-2699.2000.00163.x; Heleno R, 2015, GLOBAL ECOL BIOGEOGR, V24, P518, DOI 10.1111/geb.12273; Helmus MR, 2014, NATURE, V513, P543, DOI 10.1038/nature13739; Hooker JD., 1853, INTRO ESSAY FLORA NZ; Itescu Y, 2014, GLOBAL ECOL BIOGEOGR, V23, P689, DOI 10.1111/geb.12149; IUCN, 2021, WIKIPEDIA; Johnson CN, 2017, SCIENCE, V356, P270, DOI 10.1126/science.aam9317; Katinas L, 2013, PERSPECT PLANT ECOL, V15, P269, DOI 10.1016/j.ppees.2013.07.003; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Knope ML, 2012, J BIOGEOGR, V39, P1206, DOI 10.1111/j.1365-2699.2012.02687.x; Kvile KO, 2014, BIOL CONSERV, V173, P108, DOI 10.1016/j.biocon.2013.10.002; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Lapoint RT, 2013, MOL PHYLOGENET EVOL, V69, P95, DOI 10.1016/j.ympev.2013.04.032; Le Roux JJ, 2014, NEW PHYTOL, V204, P230, DOI 10.1111/nph.12900; Lens F, 2013, INT J PLANT SCI, V174, P992, DOI 10.1086/670259; Lenzner B, 2017, J BIOGEOGR, V44, P1029, DOI 10.1111/jbi.12906; Lomolino MV, 2013, J BIOGEOGR, V40, P1427, DOI 10.1111/jbi.12096; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Fernandez-Palacios JM, 2016, GLOBAL ECOL BIOGEOGR, V25, P817, DOI 10.1111/geb.12320; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Matthews TJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P607, DOI 10.1111/geb.12439; Matthews TJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P847, DOI 10.1111/geb.12269; McCall RA, 1998, EVOL ECOL, V12, P569, DOI 10.1023/A:1006508826501; Mortimer N., 2017, GSA TODAY, V27, P27, DOI [10.1130/GSATG321A.1, DOI 10.1130/GSATG321A.1]; Moyle RG, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12709; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; Musgrave RJ, 2013, J GEOPHYS RES-SOL EA, V118, P2670, DOI 10.1002/jgrb.50153; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nicholson KE, 2005, J BIOGEOGR, V32, P929, DOI 10.1111/j.1365-2699.2004.01222.x; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Padilla DP, 2012, J ECOL, V100, P416, DOI 10.1111/j.1365-2745.2011.01924.x; Patino J, 2017, J BIOGEOGR, V44, P963, DOI 10.1111/jbi.12986; Patino J, 2015, SYST BIOL, V64, P579, DOI 10.1093/sysbio/syv013; Presgraves DC, 2010, CURR BIOL, V20, pR440, DOI 10.1016/j.cub.2010.03.032; Ramalho RS, 2017, GEOL SOC AM BULL, V129, P372, DOI 10.1130/B31538.1; Rosenblad KC, 2017, ECOGRAPHY, V40, P1040, DOI 10.1111/ecog.02652; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2011, ECOL LETT, V14, P552, DOI 10.1111/j.1461-0248.2011.01617.x; Shaw KL, 2016, P NATL ACAD SCI USA, V113, P7986, DOI 10.1073/pnas.1601078113; Si XF, 2016, J ANIM ECOL, V85, P409, DOI 10.1111/1365-2656.12478; Storch D, 2016, J VEG SCI, V27, P880, DOI 10.1111/jvs.12428; Tershy BR, 2015, BIOSCIENCE, V65, P592, DOI 10.1093/biosci/biv031; Torres-Carvajal O, 2014, J BIOGEOGR, V41, P1883, DOI 10.1111/jbi.12375; Triantis K. A., 2016, FRONT BIOGEOGR, V8, P29605; Triantis KA, 2008, ECOGRAPHY, V31, P401, DOI 10.1111/j.0906-7590.2007.05323.x; Triantis KA, 2015, GLOBAL ECOL BIOGEOGR, V24, P594, DOI 10.1111/geb.12301; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Valente L, 2017, CURR BIOL, V27, P1660, DOI 10.1016/j.cub.2017.04.053; Valente LM, 2015, ECOL LETT, V18, P844, DOI 10.1111/ele.12461; van Leeuwen CHA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032292; Vargas P, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv073; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; Wallace A. R., 1902, ISLAND LIFE; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Weigelt P, 2016, NATURE, V532, P99, DOI 10.1038/nature17443; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; WILSON EO, 1969, BROOKHAVEN SYM BIOL, P38; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174; Wood J. R., 2017, ENV CONSERV, V1-11, DOI 10.1017/S037689291700039X; World Conservation Monitoring Centre, 1992, GLOBAL BIODIVERSITY; Wright NA, 2016, P NATL ACAD SCI USA, V113, P4765, DOI 10.1073/pnas.1522931113	94	217	223	39	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					885	+	eaam8326	10.1126/science.aam8326	http://dx.doi.org/10.1126/science.aam8326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860356	Green Submitted			2022-12-28	WOS:000408734900035
J	Fernandes, G; Sridhar, D				Fernandes, Genevie; Sridhar, Devi			World Bank and the Global Financing Facility	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fernandes, Genevie; Sridhar, Devi] Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland	University of Edinburgh	Fernandes, G (corresponding author), Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland.	genevie.fernandes@ed.ac.uk			Wellcome Trust [106635/Z/14/Z]	Wellcome Trust(Wellcome Trust)	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. This work was supported by Wellcome Trust [106635/Z/14/Z]. A senior member of the World Bank is on our project's advisory board.	Bauhoff S., HLTH RESULTS INNOVAT; Claeson M, 2017, LANCET, V389, P1588, DOI 10.1016/S0140-6736(17)31000-0; Evans T., 2014, GLOBAL FINANCING FAC; GFF Civil Society Organizations (CSO) coordinating group, 2017, CIV SOC ENG STRAT; Global Financing Facility, 2015, GOV DOC GLOB FIN FAC; Global Financing Facility, 2016, PARTN; Global Financing Facility, 2017, GLOB FIN FAC 2016 20; Global Financing Facility, 2015, GFF INV GROUP MEMB A; Health Nutrition Population Division, 2000, POP WORLD BANK AD CH; Health Nutrition Population Division, 1999, SAF MOTH WORLD BANK; Igoe M., 2017, J KIM THINKS MORE DO; Kandpal E., 2016, COMPLETED IMPACT EVA; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; Martinez J, 2012, EVALUATION HLTH RESU; Measham A, 1996, INDIAS FAMILY WELFAR; The Partnership for Maternal Newborn and Child Health, GFF INV GROUP APPR C; Usher AD, 2015, LANCET, V386, P1809, DOI 10.1016/S0140-6736(15)00813-2; World Bank, 2016, GLOB FIN FAC COUNTR; World Bank, 2015, GLOB FIN FAC SUPP EV; World Bank, 2017, HLTH RES INN TRUST F	20	9	9	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3395	10.1136/bmj.j3395	http://dx.doi.org/10.1136/bmj.j3395			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CQ	28860141	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000409387000005
J	Liu, K; Kim, J; Kim, DW; Zhang, YS; Bao, H; Denaxa, M; Lim, SA; Kim, E; Liu, C; Wickersham, IR; Pachinis, V; Hattar, S; Song, J; Brown, SP; Blackshaw, S				Liu, Kai; Kim, Juhyun; Kim, Dong Won; Zhang, Yi Stephanie; Bao, Hechen; Denaxa, Myrto; Lim, Szu-Aun; Kim, Eileen; Liu, Chang; Wickersham, Ian R.; Pachinis, Vassilis; Hattar, Samer; Song, Juan; Brown, Solange P.; Blackshaw, Seth			Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep	NATURE			English	Article							GABAERGIC NEURONS; GENE-EXPRESSION; MOUSE-BRAIN; CORTEX; OREXIN; MICE; SPECIFICATION; SUBTYPES; SYSTEM; ATLAS	Multiple populations of wake-promoting neurons have been characterized in mammals, but few sleep-promoting neurons have been identified(1). Wake-promoting cell types include hypocretin and GABA (gamma-aminobutyric-acid)-releasing neurons of the lateral hypothalamus, which promote the transition to wakefulness from non-rapid eye movement (NREM) and rapid eye movement (REM) sleep(2,3). Here we show that a subset of GABAergic neurons in the mouse ventral zona incerta, which express the LIM homeodomain factor Lhx6 and are activated by sleep pressure, both directly inhibit wake-active hypocretin and GABAergic cells in the lateral hypothalamus and receive inputs from multiple sleep-wake-regulating neurons. Conditional deletion of Lhx6 from the developing diencephalon leads to decreases in both NREM and REM sleep. Furthermore, selective activation and inhibition of Lhx6-positive neurons in the ventral zona incerta bidirectionally regulate sleep time in adult mice, in part through hypocretin-dependent mechanisms. These studies identify a GABAergic subpopulation of neurons in the ventral zona incerta that promote sleep.	[Liu, Kai; Kim, Juhyun; Kim, Dong Won; Zhang, Yi Stephanie; Liu, Chang; Brown, Solange P.; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Bao, Hechen; Lim, Szu-Aun; Song, Juan] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Denaxa, Myrto; Pachinis, Vassilis] Francis Crick Inst, London, England; [Kim, Eileen] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Wickersham, Ian R.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hattar, Samer] NIMH, Bethesda, MD 20892 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Francis Crick Institute; Johns Hopkins University; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Blackshaw, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	sblack@jhmi.edu	Hattar, Samer/W-6927-2019; Bao, Hechen/AAE-6646-2019; Kim, Juhyun/AAD-6817-2019; Core, Vector/CAF-4832-2022; Liu, Chang/ABG-6992-2021	Kim, Juhyun/0000-0002-3098-5010; Pachnis, Vassilis/0000-0001-9733-7686; Liu, Chang/0000-0003-2544-7215; Kim, Dong Won/0000-0001-8624-0168	Johns Hopkins Discovery Fund award; Klingenstein-Simons Foundation Fellowship in the Neurosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002964, R01MH111773, R21MH106939] Funding Source: NIH RePORTER	Johns Hopkins Discovery Fund award; Klingenstein-Simons Foundation Fellowship in the Neurosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. de Lecea and A. Gittis for providing mice; M. Pletnikov for help with behavioural analysis; and M. Wu, V. Mongrain, R. Kuruvila, D. Lee, J. Bedont and W. Yap for comments on the manuscript. This work was supported by a Johns Hopkins Discovery Fund award to S.B. and S.H. S.P.B. is supported by a Klingenstein-Simons Foundation Fellowship in the Neurosciences.	Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chung S, 2017, NATURE, V545, P477, DOI 10.1038/nature22350; Cox CD, 2010, J MED CHEM, V53, P5320, DOI 10.1021/jm100541c; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hoyer D, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00235; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jurkowlaniec E, 1990, Acta Physiol Pol, V41, P85; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Kim J, 2014, J NEUROSCI, V34, P9656, DOI 10.1523/JNEUROSCI.1325-14.2014; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Liu J, 2015, ELIFE, V4, DOI 10.7554/eLife.09215; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Paxinos G., 2012, MOUSE BRAIN STEROTAX; Peron SP, 2015, NEURON, V86, P783, DOI 10.1016/j.neuron.2015.03.027; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Saito YC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00192; Salvatierra J, 2014, J NEUROSCI, V34, P16809, DOI 10.1523/JNEUROSCI.1711-14.2014; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Skeldon AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103877; Subach FV, 2011, NAT METHODS, V8, P1019, DOI [10.1038/nmeth.1776, 10.1038/NMETH.1776]; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thompson CL, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00165; Urbain N, 2007, NEURON, V56, P714, DOI 10.1016/j.neuron.2007.10.023; Veasey SC, 2004, SLEEP, V27, P388, DOI 10.1093/sleep/27.3.388; Venner A, 2016, CURR BIOL, V26, P2137, DOI 10.1016/j.cub.2016.05.078; Weber F, 2016, NATURE, V538, P51, DOI 10.1038/nature19773; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham Ian R, 2015, Cold Spring Harb Protoc, V2015, P375, DOI 10.1101/pdb.prot072389; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248	42	89	91	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					582	+		10.1038/nature23663	http://dx.doi.org/10.1038/nature23663			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28847002	Green Accepted, Green Submitted			2022-12-28	WOS:000408703100038
J	Reck, M; Rabe, KF				Reck, Martin; Rabe, Klaus F.			Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; PLATINUM-BASED CHEMOTHERAPY; OPEN-LABEL; EGFR MUTATIONS; 1ST-LINE TREATMENT; DOUBLE-BLIND; 8TH EDITION; PHASE-III; MULTICENTER; CRIZOTINIB		[Reck, Martin; Rabe, Klaus F.] LungenClin Grosshansdorf, Grosshansdorf, Germany; [Reck, Martin; Rabe, Klaus F.] Airway Res Ctr North, Grosshansdorf, Germany; [Reck, Martin; Rabe, Klaus F.] German Ctr Lung Res, Giessen, Germany; [Reck, Martin] Univ Lubeck, Lubeck, Germany; [Rabe, Klaus F.] Christian Albrechts Univ Kiel, Kiel, Germany	Grosshansdorf Hospital; University of Lubeck; University of Kiel	Reck, M (corresponding author), LungenClin Grosshansdorf, Dept Thorac Oncol, Woehrendamm 80, D-22927 Grosshansdorf, Germany.	m.reck@lungenclinic.de	Reck, Martin/ABF-5721-2020; Rabe, Klaus F./AAW-6296-2021	Reck, Martin/0000-0002-5348-4462; Rabe, Klaus F./0000-0002-7020-1401				[Anonymous], 2016, GUID NONS CELL LUNG; [Anonymous], 2013, GLOBOCAN 2012 V1 0 C; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Cortot AB, 2016, J CLIN ONCOL S, V34; Cortot AB, 2014, EUR RESPIR REV, V23, P356, DOI 10.1183/09059180.00004614; Dagogo-Jack I, 2016, ANN ONCOL, V27, P42, DOI 10.1093/annonc/mdw305; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Detterbeck FC, 2017, CHEST, V151, P193, DOI 10.1016/j.chest.2016.10.010; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Folch E, 2015, TRANSL LUNG CANCER R, V4, P392, DOI 10.3978/j.issn.2218-6751.2015.08.02; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Hirsch FR, 2016, LANCET, V388, P1012, DOI 10.1016/S0140-6736(16)31473-8; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Islam S, 2013, CANCER J, V19, P208, DOI 10.1097/PPO.0b013e318295185f; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Janne PA, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw435.46; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langer CJ, 2016, J THORAC ONCOL, V11, P2066, DOI 10.1016/j.jtho.2016.08.138; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Lee CK, 2015, J CLIN ONCOL, V33, P1958, DOI 10.1200/JCO.2014.58.1736; Lee KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091893; Li M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037229; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Navani N, 2015, LANCET RESP MED, V3, P282, DOI 10.1016/S2213-2600(15)00029-6; Nokihara H, 2016, J CLIN ONCOL S, V34; Novello S, 2016, ANN ONCOL, V27, pv1, DOI 10.1093/annonc/mdw326; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paz-Ares L, 2016, ANN ONCOL, V27, P1573, DOI 10.1093/annonc/mdw214; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Rimm DL, 2017, JAMA ONCOL; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rivera GA, 2016, ADV EXP MED BIOL, V893, P43, DOI 10.1007/978-3-319-24223-1_3; Sahgal A, 2015, INT J RADIAT ONCOL, V91, P710, DOI 10.1016/j.ijrobp.2014.10.024; Schwartz AG, 2016, ADV EXP MED BIOL, V893, P21, DOI 10.1007/978-3-319-24223-1_2; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Silvestri GA, 2017, CHEST S, V143; Socinski M, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw435.39; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Soria JC, 2017, LANCET, V389, P917, DOI 10.1016/S0140-6736(17)30123-X; Soria JC, 2015, LANCET ONCOL, V16, P897, DOI 10.1016/S1470-2045(15)00006-6; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Vilmann P, 2015, ENDOSCOPY, V47, P546, DOI 10.1055/s-0034-1392040; Yang JCH, 2015, LANCET ONCOL, V16, P830, DOI 10.1016/S1470-2045(15)00026-1; Yi CA, 2008, RADIOLOGY, V248, P632, DOI 10.1148/radiol.2482071822; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhou CC, 2015, J CLIN ONCOL, V33, P2197, DOI 10.1200/JCO.2014.59.4424	68	427	446	2	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					849	861		10.1056/NEJMra1703413	http://dx.doi.org/10.1056/NEJMra1703413			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28854088				2022-12-28	WOS:000408626400008
J	Goncharov, AF; Struzhkin, VV				Goncharov, Alexander F.; Struzhkin, Viktor V.			Comment on "Observation of the Wigner-Huntington transition to metallic hydrogen"	SCIENCE			English	Editorial Material							PHASE	Dias and Silvera (Research Article, 17 February 2017, p. 715) report on the observation of the Wigner-Huntington transition to metallic hydrogen at 495 gigapascals at 5.5 and 83 kelvin. Here, we show that the claim of metallic behavior is not supported by the presented data, which are scarce, contradictory, and do not prove the presence of hydrogen in the high-pressure cavity.	[Goncharov, Alexander F.] Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei, Anhui, Peoples R China; [Goncharov, Alexander F.; Struzhkin, Viktor V.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Carnegie Institution for Science	Goncharov, AF (corresponding author), Chinese Acad Sci, Inst Solid State Phys, Key Lab Mat Phys, Hefei, Anhui, Peoples R China.; Goncharov, AF; Struzhkin, VV (corresponding author), Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA.	agoncharov@carnegiescience.edu; vstruzhkin@carnegiescience.edu	Goncharov, Alexander F./AAX-9943-2020; Struzhkin, Viktor V/J-9847-2013	Goncharov, Alexander F./0000-0002-6422-8819; Struzhkin, Viktor V/0000-0002-3468-0548	U.S. Department of Energy, Basic Energy Sciences [DE-FG02-99ER45775]; NSF [EAR1520648]; U.S. Army Research Office	U.S. Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); U.S. Army Research Office	We thank Z. Geballe for useful comments on the manuscript. V.V.S. acknowledges support from the U.S. Department of Energy, Basic Energy Sciences, under contract DE-FG02-99ER45775. A.F.G. acknowledges support from NSF EAR1520648 and the U.S. Army Research Office.	Babaev E, 2004, NATURE, V431, P666, DOI 10.1038/nature02910; Brazhkin VV, 2004, NAT MATER, V3, P497, DOI 10.1038/nmat1186; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3064; Dalladay-Simpson P, 2016, NATURE, V529, P63, DOI 10.1038/nature16164; Dias RP, 2017, SCIENCE, V355, P715, DOI 10.1126/science.aal1579; Eremets M. I., 2016, ARXIV160104479CONDMA; Goncharov AF, 2001, P NATL ACAD SCI USA, V98, P14234, DOI 10.1073/pnas.201528198; Hemley RJ, 1997, SCIENCE, V276, P1242, DOI 10.1126/science.276.5316.1242; Knudson MD, 2015, SCIENCE, V348, P1455, DOI 10.1126/science.aaa7471; Vohra Y.K, 1991, P 13 AIRAPT INT C HI	11	31	34	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353							eaam9736	10.1126/science.aam9736	http://dx.doi.org/10.1126/science.aam9736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839048	Green Submitted, Bronze			2022-12-28	WOS:000408327900001
J	Lithgow, GJ; Driscoll, M; Phillips, P				Lithgow, Gordon J.; Driscoll, Monica; Phillips, Patrick			A long journey to reproducible results	NATURE			English	Editorial Material							EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS		[Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA 94945 USA; [Driscoll, Monica] Rutgers State Univ, Piscataway, NJ USA; [Phillips, Patrick] Univ Oregon, Eugene, OR 97403 USA	Buck Institute for Research on Aging; Rutgers State University New Brunswick; University of Oregon	Lithgow, GJ (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	glithgow@buckinstitute.org			NATIONAL INSTITUTE ON AGING [U01AG045864, R01AG029631, U01AG045829, U24AG056052] Funding Source: NIH RePORTER; NIA NIH HHS [U01 AG045829, U24 AG056052, U01 AG045864, R01 AG029631] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrows NJ, 2010, J BIOMOL SCREEN, V15, P735, DOI 10.1177/1087057110374994; Cutter AD, 2013, MOL ECOL, V22, P2074, DOI 10.1111/mec.12281; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hines WC, 2014, CELL REP, V6, P779, DOI 10.1016/j.celrep.2014.02.021; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Klionsky DJ, 2016, MOL BIOL CELL, V27, P733, DOI 10.1091/mbc.E15-09-0618; Lucanic M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14256; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062	10	66	68	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					387	388		10.1038/548387a	http://dx.doi.org/10.1038/548387a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836615	Green Accepted, Bronze			2022-12-28	WOS:000408279000013
J	Praz, F; Spargias, K; Chrissoheris, M; Bullesfeld, L; Nickenig, G; Deuschl, F; Schueler, R; Fam, NP; Moss, R; Makar, M; Boone, R; Edwards, J; Moschovitis, A; Kar, S; Webb, J; Schafer, U; Feldman, T; Windecker, S				Praz, Fabien; Spargias, Konstantinos; Chrissoheris, Michael; Bullesfeld, Lutz; Nickenig, Georg; Deuschl, Florian; Schueler, Robert; Fam, Neil P.; Moss, Robert; Makar, Moody; Boone, Robert; Edwards, Jeremy; Moschovitis, Aris; Kar, Saibal; Webb, John; Schafer, Ulrich; Feldman, Ted; Windecker, Stephan			Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study	LANCET			English	Article							END-POINT DEFINITIONS; NATIVE VALVULAR REGURGITATION; TRIAL DESIGN PRINCIPLES; CONSENSUS DOCUMENT; OUTCOMES; RECOMMENDATIONS; IMPLANTATION; SURGERY	Background Severe mitral regurgitation is associated with impaired prognosis if left untreated. Using the devices currently available, transcatheter mitral valve repair (TMVr) remains challenging in complex anatomical situations. We report the procedural and 30-day results of the first-in-man study of the Edwards PASCAL TMVr system. Methods In this multicentre, prospective, observational, first-in-man study, we collected data from seven tertiary care hospitals in five countries that had a compassionate use programme in which patients underwent transcatheter mitral valve repair using the Edwards PASCAL TMVr system. Eligible patients were those with symptomatic, severe functional, degenerative, or mixed mitral regurgitation deemed at high risk or inoperable. Safety and efficacy of the procedure were prospectively assessed at device implantation, discharge, and 30 days after device implantation. The key study endpoints were technical success assessed at the end of the procedure and device success 30 days after implantation using the Mitral Valve Academic Research Consortium definitions. Findings Between Sept 1, 2016, and March 31, 2017, 23 patients (median age 75 years [IQR 61-82]) had treatment for moderate-to-severe (grade 3+) or severe (grade 4+) mitral regurgitation using the Edwards PASCAL TMVr system. At baseline, the median EuroScore II score was 7 1% (IQR 3.6-12.8) and the median Society of Thoracic Surgeons predicted risk of mortality for mitral valve repair was 4.8% (2.1-9.0) and 6.8% (2.9-10.1) for mitral valve replacement. 22 (96%) of 23 patients were New York Heart Association (NYHA) class III or IV at baseline. The implantation of at least one device was successful in all patients, resulting in procedural residual mitral regurgitation of grade 2+ or less in 22 (96%) patients. Six (26%) of 23 patients had two implants. Periprocedural complications occurred in two (9%) of 23 patients (one minor bleeding event and one transient ischaemic attack). Despite the anatomical complexity of mitral regurgitation in the patients in this compassionate use cohort, technical success was achieved in 22 (96%) of 23 patients, and device success at 30 days was achieved in 18 (78%) patients. Three patients (13%) died during the 30 day follow-up. 19 (95%) of 20 patients alive 30 days after implantation were NYHA class I or II. Interpretation This study establishes feasibility of the Edwards PASCAL TMVr system with a high rate of technical success and reduction of mitral regurgitation severity. Further research is needed on procedural and long-term clinical outcomes.	[Praz, Fabien; Moschovitis, Aris; Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Spargias, Konstantinos; Chrissoheris, Michael] Hygeia Hosp, Dept Transcatheter Heart Valves, Athens, Greece; [Bullesfeld, Lutz] GFO Hosp Bonn, Dept Internal Med & Cardiol, Bonn, Germany; [Nickenig, Georg; Schueler, Robert] Univ Hosp Bonn, Heart Ctr Bonn, Dept Med 2, Bonn, Germany; [Deuschl, Florian; Schafer, Ulrich] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Fam, Neil P.; Edwards, Jeremy] Univ Toronto, Div Cardiol, St Michaels Hosp, Toronto, ON, Canada; [Moss, Robert; Boone, Robert; Webb, John] Univ British Columbia, St Pauls Hosp, Vancouver, BC, Canada; [Makar, Moody; Kar, Saibal] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Feldman, Ted] NorthShore Univ Hlth Syst, Evanston Hosp, Dept Cardiol, Evanston, IL USA	University of Bern; University Hospital of Bern; Hygeia Hospital; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Cedars Sinai Medical Center; NorthShore University Health System	Windecker, S (corresponding author), Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	stephan.windecker@insel.ch	Buellesfeld, Lutz/AAE-6635-2021; Schueler, Robert/Z-1059-2019	Praz, Fabien/0000-0001-5416-165X; Makar, Moody/0000-0003-4994-5796				Altiok E, 2012, CIRC-CARDIOVASC IMAG, V5, P748, DOI 10.1161/CIRCIMAGING.112.974691; Andalib A, 2014, EUROINTERVENTION, V9, P1225, DOI 10.4244/EIJV9I10A205; Biaggi P, 2013, CIRC-CARDIOVASC IMAG, V6, P1032, DOI 10.1161/CIRCIMAGING.113.000620; Feldman T, 2015, J AM COLL CARDIOL, V66, P2844, DOI 10.1016/j.jacc.2015.10.018; Goldstein D, 2016, NEW ENGL J MED, V374, P344, DOI 10.1056/NEJMoa1512913; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Lesevic H, 2017, AM J CARDIOL, V119, P1255, DOI 10.1016/j.amjcard.2016.12.027; Magne J, 2007, CIRCULATION, V115, P782, DOI 10.1161/CIRCULATIONAHA.106.649236; Maisano F, 2013, J AM COLL CARDIOL, V62, P1052, DOI 10.1016/j.jacc.2013.02.094; Mirabel M, 2007, EUR HEART J, V28, P1358, DOI 10.1093/eurheartj/ehm001; Nickenig G, 2014, J AM COLL CARDIOL, V64, P875, DOI 10.1016/j.jacc.2014.06.1166; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Puls M, 2016, EUR HEART J, V37, P703, DOI 10.1093/eurheartj/ehv627; Serri K, 2006, J THORAC CARDIOV SUR, V131, P565, DOI 10.1016/j.jtcvs.2005.09.037; Stone GW, 2015, J AM COLL CARDIOL, V66, P278, DOI 10.1016/j.jacc.2015.05.046; Stone GW, 2015, J AM COLL CARDIOL, V66, P308, DOI 10.1016/j.jacc.2015.05.049; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	18	138	179	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					773	780		10.1016/S0140-6736(17)31600-8	http://dx.doi.org/10.1016/S0140-6736(17)31600-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28831993				2022-12-28	WOS:000407858900021
J	Ayoub, C; Murad, MH				Ayoub, Chadi; Murad, M. Hassan			Population-based screening for vascular disease	LANCET			English	Editorial Material							ABDOMINAL AORTIC-ANEURYSM; RANDOMIZED CONTROLLED-TRIAL; PERIPHERAL ARTERY-DISEASE; TASK-FORCE; GUIDELINES; MORTALITY; PROGRAM; IMPACT		[Ayoub, Chadi; Murad, M. Hassan] Mayo Clin, Mayo Clin Evidence Based Practice Ctr, Rochester, MN 55905 USA; [Ayoub, Chadi] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Murad, MH (corresponding author), Mayo Clin, Mayo Clin Evidence Based Practice Ctr, Rochester, MN 55905 USA.	murad.mohammad@mayo.edu	Murad, M. Hassan/AAW-4367-2020	Murad, Mohammad Hassan/0000-0001-5502-5975				Alahdab F, 2015, J VASC SURG, V61, p42S, DOI 10.1016/j.jvs.2014.12.008; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, P1465, DOI 10.1016/j.jacc.2016.11.008; Jacomelli J, 2016, BRIT J SURG, V103, P1125, DOI 10.1002/bjs.10173; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Lindholt JS, 2017, LANCET; Moyer VA, 2013, ANN INTERN MED, V159, P342, DOI 10.7326/0003-4819-159-5-201309030-00008; National Institute of Drug Addiction, 2012, PER ART DIS DIAGN MA, P11; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Wanhainen A, 2016, CIRCULATION, V134, P1141, DOI 10.1161/CIRCULATIONAHA.116.022305; Wilson JMG, 1968, PRINCIPLES PRACTICE	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2017	390	10109					2218	2220		10.1016/S0140-6736(17)32291-2	http://dx.doi.org/10.1016/S0140-6736(17)32291-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN0DH	28859946				2022-12-28	WOS:000415645700005
J	Gallant, J; Lazzarin, A; Mills, A; Orkin, C; Podzamczer, D; Tebas, P; Girard, PM; Brar, I; Daar, ES; Wohl, D; Rockstroh, J; Wei, XL; Custodio, J; White, K; Martin, H; Cheng, A; Quirk, E				Gallant, Joel; Lazzarin, Adriano; Mills, Anthony; Orkin, Chloe; Podzamczer, Daniel; Tebas, Pablo; Girard, Pierre-Marie; Brar, Indira; Daar, Eric S.; Wohl, David; Rockstroh, Juergen; Wei, Xuelian; Custodio, Joseph; White, Kirsten; Martin, Hal; Cheng, Andrew; Quirk, Erin			Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial	LANCET			English	Article							STRAND TRANSFER INHIBITOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; COHORT COLLABORATION; ANTIVIRAL ACTIVITY; DATA-COLLECTION; ADVERSE EVENTS; RISK; REGIMENS; INDIVIDUALS	Background Integrase strand transfer inhibitors (INSTIs) are recommended components of initial antiretroviral therapy with two nucleoside reverse transcriptase inhibitors. Bictegravir is a novel, potent INSTI with a high in-vitro barrier to resistance and low potential as a perpetrator or victim of clinically relevant drug-drug interactions. We aimed to assess the efficacy and safety of bictegravir coformulated with emtricitabine and tenofovir alafenamide as a fixed-dose combination versus coformulated dolutegravir, abacavir, and lamivudine. Methods We did this double-blind, multicentre, active-controlled, randomised controlled non-inferiority trial at 122 outpatient centres in nine countries in Europe, Latin America, and North America. We enrolled HIV-1 infected adults (aged >= 18 years) who were previously untreated (HIV-1 RNA >= 500 copies per mL); HLA-B* 5701-negative; had no hepatitis B virus infection; screening genotypes showing sensitivity to emtricitabine, tenofovir, lamivudine, and abacavir; and an estimated glomerular filtration rate of 50 mL/min or more. Participants were randomly assigned (1:1), via a computer-generated allocation sequence (block size of four), to receive coformulated bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg or coformulated dolutegravir 50 mg, abacavir 600 mg, and lamivudine 300 mg, with matching placebo, once daily for 144 weeks. Randomisation was stratified by HIV-1 RNA (<= 100 000 copies per mL, >100 000 to <= 400 000 copies per mL, or >400 000 copies per mL), CD4 count (<50 cells per mu L, 50-199 cells per mu L, or >= 200 cells per mu L), and region (USA or ex-USA). Investigators, participants, and study staff giving treatment, assessing outcomes, and collecting data were masked to group assignment. The primary endpoint was the proportion of participants with plasma HIV-1 RNA less than 50 copies per mL at week 48, as defined by the US Food and Drug Administration snapshot algorithm, with a prespecified non-inferiority margin of -12%. All participants who received one dose of study drug were included in primary efficacy and safety analyses. This trial is registered with ClinicalTrials. gov, number NCT02607930. Findings Between Nov 13, 2015, and July 14, 2016, we randomly assigned 631 participants to receive coformulated bictegravir, emtricitabine, and tenofovir alafenamide (n=316) or coformulated dolutegravir, abacavir, and lamivudine (n=315), of whom 314 and 315 patients, respectively, received at least one dose of study drug. At week 48, HIV-1 RNA less than 50 copies per mL was achieved in 92.4% of patients (n=290 of 314) in the bictegravir, emtricitabine, and tenofovir alafenamide group and 93.0% of patients (n=293 of 315) in the dolutegravir, abacavir, and lamivudine group (difference -0.6%, 95.002% CI -4.8 to 3.6; p=0.78), demonstrating non-inferiority of bictegravir, emtricitabine, and tenofovir alafenamide to dolutegravir, abacavir, and lamivudine. No individual developed treatment-emergent resistance to any study drug. Incidence and severity of adverse events was mostly similar between groups except for nausea, which occurred less frequently in patients given bictegravir, emtricitabine, and tenofovir alafenamide than in those given dolutegravir, abacavir, and lamivudine (10% [n=32] vs 23% [n=72]; p<0.0001). Adverse events related to study drug were less common with bictegravir, emtricitabine, and tenofovir alafenamide than with dolutegravir, abacavir, and lamivudine (26% [n=82] vs 40% [n=127]), the difference being driven by a higher incidence of drug-related nausea in the dolutegravir, abacavir, and lamivudine group (5% [n=17] vs 17% [n=55]; p<0.0001). Interpretation At 48 weeks, coformulated bictegravir, emtricitabine, and tenofovir alafenamide achieved virological suppression in 92% of previously untreated adults and was non-inferior to coformulated dolutegravir, abacavir, and lamivudine, with no treatment-emergent resistance. Bictegravir, emtricitabine, and tenofovir alafenamide was safe and well tolerated with better gastrointestinal tolerability than dolutegravir, abacavir, and lamivudine. Because coformulated bictegravir, emtricitabine, and tenofovir alafenamide does not require HLA B*5701 testing and provides guideline-recommended treatment for individuals co-infected with HIV and hepatitis B, this regimen might lend itself to rapid or same-day initiation of therapy in the clinical setting.	[Gallant, Joel] Southwest CARE Ctr, Santa Fe, NM USA; [Lazzarin, Adriano] IRCCS Osped San Raffaele SrL, Milan, Italy; [Mills, Anthony] Southern Calif Mens Med Grp, Los Angeles, CA USA; [Orkin, Chloe] Royal London Hosp, Grahame Hayton Unit, London, England; [Podzamczer, Daniel] Hosp Univ Bellvitge, Barcelona, Spain; [Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA; [Girard, Pierre-Marie] Hop St Antoine, Paris, France; [Brar, Indira] Henry Ford Hosp, Detroit, MI 48202 USA; [Daar, Eric S.] UCLA Med Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA USA; [Wohl, David] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Rockstroh, Juergen] Univ Hosp Bonn, Bonn, Germany; [Wei, Xuelian; Custodio, Joseph; White, Kirsten; Martin, Hal; Cheng, Andrew; Quirk, Erin] Gilead Sci, Foster City, CA 94404 USA	Barts Health NHS Trust; Royal London Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Pennsylvania; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Bonn; Gilead Sciences	Martin, H (corresponding author), Gilead Sci, Foster City, CA 94404 USA.	hal.martin@gilead.com	; LAZZARIN, Adriano/K-3607-2018	cheng, andrew/0000-0002-1121-8051; LAZZARIN, Adriano/0000-0003-2551-7754	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	Cahn P, 2016, RALTEGRAVIR RAL 120; de Boer MGJ, 2016, AIDS, V30, P2831, DOI 10.1097/QAD.0000000000001279; European AIDS Clinical Society, 2015, GUID VERS 8 0; Fettiplace A, 2017, JAIDS-J ACQ IMM DEF, V74, P423, DOI 10.1097/qai.0000000000001269; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Fulcher JA, C RETR OPP INF SEATT; GALLANT JE, J ACQUIR IMMUNE DEFI, V75, P61; Gilead Sciences, 2016, GENV ELV COB EMTR TE; Gilead Sciences, 2016, VIR TEN DIS FUM HIGH; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Hoffmann C, 2017, HIV MED, V18, P56, DOI 10.1111/hiv.12468; Jiang JJ, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0115-x; Lazerwith SE, 2016, DISCOVERY GS 9883 HI, P414; Lepik KJ, 2017, AIDS, V31, P1425, DOI 10.1097/QAD.0000000000001494; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V71, P413, DOI 10.1097/QAI.0000000000000881; Min S, 2011, AIDS, V25, P1737, DOI 10.1097/QAD.0b013e32834a1dd9; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sabin CA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0588-4; Sax PE, 2017, LANCET HIV, V4, pE154, DOI 10.1016/S2352-3018(17)30016-4; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Sax PE, 9 INT AIDS SOC IAS C; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Tsiang M, 2016, ANTIMICROB AGENTS CH, V60, P7086, DOI 10.1128/AAC.01474-16; US Food and Drug Administration, 2015, HUM IMM VIR 1 INF DE; ViiV Healthcare-GlaxoSmithKline, 2016, HIGHL PRESCR INF; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Young J, 2015, JAIDS-J ACQ IMM DEF, V69, P413, DOI 10.1097/QAI.0000000000000662; Zhang H, C RETR OPP INF SEATT, P40; Zhang H, 9 INT AIDS SOC IAS C	30	173	183	0	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2063	2072		10.1016/S0140-6736(17)32299-7	http://dx.doi.org/10.1016/S0140-6736(17)32299-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FL5DD	28867497	Green Published			2022-12-28	WOS:000414250800023
J	Burbulla, LF; Song, PP; Mazzulli, JR; Zampese, E; Wong, YC; Jeon, S; Santos, DP; Blanz, J; Obermaier, CD; Strojny, C; Savas, JN; Kiskinis, E; Zhuang, XX; Kruger, R; Surmeier, DJ; Krainc, D				Burbulla, Lena F.; Song, Pingping; Mazzulli, Joseph R.; Zampese, Enrico; Wong, Yvette C.; Jeon, Sohee; Santos, David P.; Blanz, Judith; Obermaier, Carolin D.; Strojny, Chelsee; Savas, Jeffrey N.; Kiskinis, Evangelos; Zhuang, Xiaoxi; Kruger, Rejko; Surmeier, D. James; Krainc, Dimitri			Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease	SCIENCE			English	Article							ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; GLUCOCEREBROSIDASE; DJ-1; PACEMAKING	Mitochondrial and lysosomal dysfunction have been implicated in substantia nigra dopaminergic neurodegeneration in Parkinson's disease (PD), but how these pathways are linked in human neurons remains unclear. Here we studied dopaminergic neurons derived from patients with idiopathic and familial PD. We identified a time-dependent pathological cascade beginning with mitochondrial oxidant stress leading to oxidized dopamine accumulation and ultimately resulting in reduced glucocerebrosidase enzymatic activity, lysosomal dysfunction, and a-synuclein accumulation. This toxic cascade was observed in human, but not in mouse, PD neurons at least in part because of species-specific differences in dopamine metabolism. Increasing dopamine synthesis or a-synuclein amounts in mouse midbrain neurons recapitulated pathological phenotypes observed in human neurons. Thus, dopamine oxidation represents an important link between mitochondrial and lysosomal dysfunction in PD pathogenesis.	[Burbulla, Lena F.; Song, Pingping; Mazzulli, Joseph R.; Wong, Yvette C.; Jeon, Sohee; Santos, David P.; Blanz, Judith; Strojny, Chelsee; Savas, Jeffrey N.; Kiskinis, Evangelos; Krainc, Dimitri] Northwestern Univ Feinberg, Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Burbulla, Lena F.; Mazzulli, Joseph R.; Krainc, Dimitri] Harvard Med Sch, MassGen Inst Neurodegenerat, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Zampese, Enrico] Northwestern Univ Feinberg, Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Obermaier, Carolin D.; Kruger, Rejko] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Obermaier, Carolin D.; Kruger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, DZNE, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Obermaier, Carolin D.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Obermaier, Carolin D.; Kruger, Rejko] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Clin & Expt Neurosci, Luxembourg, Luxembourg; [Zhuang, Xiaoxi] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Kruger, Rejko] Ctr Hosp Luxembourg, Luxembourg, Luxembourg	Northwestern University; Feinberg School of Medicine; Harvard University; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; University of Luxembourg; University of Chicago; Luxembourg Hospital Center	Krainc, D (corresponding author), Northwestern Univ Feinberg, Sch Med, Dept Neurol, Chicago, IL 60611 USA.; Krainc, D (corresponding author), Harvard Med Sch, MassGen Inst Neurodegenerat, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA.	dkrainc@nm.org	Mazzulli, joseph/AAS-4480-2020	Krueger, Rejko/0000-0003-4258-6241; Zampese, Enrico/0000-0002-8851-2566	NIH [R01NS076054, NS047085, R01NS092823, R00DC013805-02, T32NS041234, F32NS101778]; JPB Foundation; Michael J. Fox Foundation; IDP Foundation; German Academic Exchange Service; Les Turner ALS Foundation; Target ALS; MDA; German Research Council [KR2119/8-1]; Fond National de Recherche PEARL program [FNR/P13/6682797];  [P30 NS081774]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS101778, R01NS076054, R01NS096240, T32NS041234, R01NS092823, P30NS081774, P50NS047085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R00DC013805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Michael J. Fox Foundation; IDP Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Les Turner ALS Foundation; Target ALS; MDA(Muscular Dystrophy Association); German Research Council(German Research Foundation (DFG)); Fond National de Recherche PEARL program; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to D. Sulzer, E. V. Mosharov, J. W. Shim, G. Caraveo, and J. Zheng for helpful discussions and suggestions. We thank the Northwestern Stem Cell Core Facility for the generation of mouse iPSC lines (supported by P30 NS081774). We are grateful to K. Hamada as well as M. K. V. Suresh for technical assistance and C. Leong for help with the assessment of off-target gene editing in the CRISPR-edited lines. The mito-roGFP construct was a gift from P. Schumacker (Northwestern University). This work was supported by NIH (grants R01NS076054 to D.K., NS047085 to D.J.S., R01NS092823 to J.R.M., R00DC013805-02 to J.N.S., and T32NS041234 and F32NS101778 to Y.C.W.); The JPB Foundation and The Michael J. Fox and IDP Foundations to D.J.S.; German Academic Exchange Service to L.F.B.; Les Turner ALS Foundation, Target ALS, and MDA to E.K.; and the German Research Council grant KR2119/8-1 and the Fond National de Recherche PEARL program grant FNR/P13/6682797 to R.K. All data necessary to support this paper's conclusions are available in the supplementary materials.	Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Caraveo G, 2014, P NATL ACAD SCI USA, V111, pE3544, DOI 10.1073/pnas.1413201111; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gegg ME, 2016, NEUROBIOL DIS, V90, P43, DOI 10.1016/j.nbd.2015.09.006; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Mazzulli JR, 2016, J NEUROSCI, V36, P7693, DOI 10.1523/JNEUROSCI.0628-16.2016; Mazzulli JR, 2016, ANAL CHEM, V88, P2399, DOI 10.1021/acs.analchem.5b04420; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Plum S, 2016, SCI REP-UK, V6, DOI 10.1038/srep37139; Simuni T, 2013, MOVEMENT DISORD, V28, P1823, DOI 10.1002/mds.25639; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Taipa R, 2016, BRAIN, V139, P1680, DOI 10.1093/brain/aww080; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105	24	407	425	9	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2017	357	6357					1255	+		10.1126/science.aam9080	http://dx.doi.org/10.1126/science.aam9080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7BX	28882997	Green Accepted			2022-12-28	WOS:000411337700037
J	Cohen, LJ; Esterhazy, D; Kim, SH; Lemetre, C; Aguilar, RR; Gordon, EA; Pickard, AJ; Cross, JR; Emiliano, AB; Han, SM; Chu, J; Vila-Farres, X; Kaplitt, J; Rogoz, A; Calle, PY; Hunter, C; Bitok, JK; Brady, SF				Cohen, Louis J.; Esterhazy, Daria; Kim, Seong-Hwan; Lemetre, Christophe; Aguilar, Rhiannon R.; Gordon, Emma A.; Pickard, Amanda J.; Cross, Justin R.; Emiliano, Ana B.; Han, Sun M.; Chu, John; Vila-Farres, Xavier; Kaplitt, Jeremy; Rogoz, Aneta; Calle, Paula Y.; Hunter, Craig; Bitok, J. Kipchirchir; Brady, Sean F.			Commensal bacteria make GPCR ligands that mimic human signalling molecules	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; GPR119 AGONIST; ACTIVATION; G2A; OLEOYLETHANOLAMIDE; MICROBIOTA; DIVERSITY; SECRETION	Commensal bacteria are believed to have important roles in human health. The mechanisms by which they affect mammalian physiology remain poorly understood, but bacterial metabolites are likely to be key components of host interactions. Here we use bioinformatics and synthetic biology to mine the human microbiota for N-acyl amides that interact with G-protein-coupled receptors (GPCRs). We found that N-acyl amide synthase genes are enriched in gastrointestinal bacteria and the lipids that they encode interact with GPCRs that regulate gastrointestinal tract physiology. Mouse and cell-based models demonstrate that commensal GPR119 agonists regulate metabolic hormones and glucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiological role in humans. Our results suggest that chemical mimicry of eukaryotic signalling molecules may be common among commensal bacteria and that manipulation of microbiota genes encoding metabolites that elicit host cellular responses represents a possible small-molecule therapeutic modality (microbiome-biosynthetic gene therapy).	[Cohen, Louis J.; Kim, Seong-Hwan; Lemetre, Christophe; Aguilar, Rhiannon R.; Gordon, Emma A.; Han, Sun M.; Chu, John; Vila-Farres, Xavier; Kaplitt, Jeremy; Calle, Paula Y.; Bitok, J. Kipchirchir; Brady, Sean F.] Rockefeller Univ, Lab Genetically Encoded Small Mol, New York, NY 10065 USA; [Cohen, Louis J.] Icahn Sch Med Mt Sinai, Dept Med, Div Gastroenterol, New York, NY 10029 USA; [Esterhazy, Daria; Rogoz, Aneta] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Pickard, Amanda J.; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Emiliano, Ana B.] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Hunter, Craig] Rockefeller Univ, Comparat Biosci Ctr, New York, NY 10065 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai; Rockefeller University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Rockefeller University	Brady, SF (corresponding author), Rockefeller Univ, Lab Genetically Encoded Small Mol, New York, NY 10065 USA.	sbrady@rockefeller.edu		Chu, John/0000-0002-7033-7229; Pickard, Amanda/0000-0001-8376-1355; Aguilar, Rhiannon/0000-0001-5723-608X	Robertson Foundation; Center for Basic and Translational Research on Disorders of the Digestive System; Leona M. and Harry B. Helmsley Charitable Trust; Rainin Foundation [U01 GM110714-1A1, GM122559-01]; Crohn's and Colitis Foundation Career Development Award; NIDDK [K08 DK109287-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007792, K08DK109287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122559, U01GM110714] Funding Source: NIH RePORTER	Robertson Foundation; Center for Basic and Translational Research on Disorders of the Digestive System; Leona M. and Harry B. Helmsley Charitable Trust; Rainin Foundation; Crohn's and Colitis Foundation Career Development Award; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the High-Throughput and Spectroscopy Resource Center, Center for Clinical and Translational Science and the Comparative Bioscience Center at Rockefeller University for the use of their facilities; members of the Mangelsdorf laboratory at UT Southwestern and D. Drucker at Mount Sinai Hospital, Toronto for the use of the GLUTag cell line; A. Milshteyn, A. Estrela and J. Craig for their critical review of the manuscript. This work was supported in part by a grant from the Robertson Foundation, the Center for Basic and Translational Research on Disorders of the Digestive System, the Leona M. and Harry B. Helmsley Charitable Trust, Rainin Foundation, U01 GM110714-1A1 (S.F.B.), GM122559-01 (S.F.B.), the Crohn's and Colitis Foundation Career Development Award (L.J.C.) and NIDDK K08 DK109287-01 (L.J.C.).	Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211; Chen YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24253; Chen ZY, 2014, J CLIN INVEST, V124, P3391, DOI 10.1172/JCI72517; Cheng J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-113; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; Cohen LJ, 2015, P NATL ACAD SCI USA, V112, pE4825, DOI 10.1073/pnas.1508737112; Flock G, 2011, ENDOCRINOLOGY, V152, P374, DOI 10.1210/en.2010-1047; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Ha TY, 2014, ARCH PHARM RES, V37, P671, DOI 10.1007/s12272-013-0209-0; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Hla T, 2005, PROSTAG OTH LIPID M, V77, P197, DOI 10.1016/j.prostaglandins.2005.06.008; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Katz LB, 2012, DIABETES OBES METAB, V14, P709, DOI 10.1111/j.1463-1326.2012.01587.x; Khan SY, 2010, BIOCHEM J, V432, P35, DOI 10.1042/BJ20091087; Konya V., PHARM THER, V138, P485; Koppel N, 2016, CELL CHEM BIOL, V23, P18, DOI 10.1016/j.chembiol.2015.12.008; Lan H, 2009, J ENDOCRINOL, V201, P219, DOI 10.1677/JOE-08-0453; Lauffer L, 2008, ENDOCRINOLOGY, V149, P2035, DOI 10.1210/en.2008-0182; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Lovejoy DA, 2014, J MOL ENDOCRINOL, V52, pT43, DOI 10.1530/JME-13-0238; Manieri NA, 2015, J CLIN INVEST, V125, P3606, DOI 10.1172/JCI81423; Meinwald J, 2008, P NATL ACAD SCI USA, V105, P4539, DOI 10.1073/pnas.0800649105; Mimee M, 2015, CELL SYST, V1, P62, DOI 10.1016/j.cels.2015.06.001; Moore EK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00637; Nunez DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092494; Ou GW, 2009, AM J GASTROENTEROL, V104, P3058, DOI 10.1038/ajg.2009.524; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Pacher P, 2013, FEBS J, V280, P1918, DOI 10.1111/febs.12260; Peterson SN, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00108; Rimmerman N, 2008, MOL PHARMACOL, V74, P213, DOI 10.1124/mol.108.045997; Ritter K, 2016, J MED CHEM, V59, P3579, DOI 10.1021/acs.jmedchem.5b01198; Schulze T, 2011, FASEB J, V25, P4024, DOI 10.1096/fj.10-179028; Serrano A, 2011, NEUROPHARMACOLOGY, V60, P593, DOI 10.1016/j.neuropharm.2010.12.007; Tang Y, 2007, ANAL BIOCHEM, V360, P303, DOI 10.1016/j.ab.2006.04.051; Van Wagoner RM, 2006, STRUCTURE, V14, P1425, DOI 10.1016/j.str.2006.07.005; Vaudry H, 2014, J MOL ENDOCRINOL, V52, pE1, DOI 10.1530/JME-14-0103; Zhang X, 2009, J AM SOC MASS SPECTR, V20, P198, DOI 10.1016/j.jasms.2008.08.017	44	229	235	9	178	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					48	+		10.1038/nature23874	http://dx.doi.org/10.1038/nature23874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28854168	Green Accepted			2022-12-28	WOS:000409388700030
J	Perkel, JM				Perkel, Jeffrey M.			PLOT A COURSE THROUGH THE GENOME	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					117	118		10.1038/549117a	http://dx.doi.org/10.1038/549117a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880304	Bronze			2022-12-28	WOS:000409388700044
J	Nolan, MB; Warner, DO				Nolan, Margaret B.; Warner, David O.			Perioperative tobacco use treatments: putting them into practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREOPERATIVE SMOKING-CESSATION; NICOTINE REPLACEMENT THERAPY; CLINICAL-PRACTICE GUIDELINE; POSTOPERATIVE COMPLICATIONS; IMPLEMENTATION RESEARCH; DELIVERY-SYSTEMS; PULMONARY COMPLICATIONS; HOSPITALIZED-PATIENTS; RESPIRATORY EVENTS; PROVIDER FEEDBACK	Treatment for tobacco use is efficacious and beneficial to health. Although guidelines recommend that all patients who use tobacco are offered treatment as a part of their clinical care, implementing treatment has proven challenging. In the case of surgical patients, this lack of treatment is particularly unfortunate, as the benefits of abstinence from tobacco are immediate in terms of reducing the risk of surgical complications, including cardiovascular, respiratory, and wound related complications. Surgery also presents an opportunity for patients to quit for good and reduce the long term health risk. This review examines the principles of tobacco use treatment, the rationale for tobacco use treatment in the perioperative period, and how treatment can be incorporated into the routine care of surgical patients. The discipline of implementation science helps to frame these efforts by seeking to better understand how changes in clinical practice occur, and it has the potential to guide an evidence based approach to embedding tobacco treatment into the routine clinical care of surgical patients. This review uses the consolidated framework for implementation research, which includes five major domains, as a representative conceptual framework. A basic understanding of factors potentially important to successful implementation can help to guide clinicians who accept the challenge of implementing tobacco use treatment in surgical care.	[Nolan, Margaret B.] Mayo Clin, Dept Anesthesia, Rochester, MN 55905 USA; [Nolan, Margaret B.] Mayo Clin, Nicotine Dependence Ctr, Rochester, MN 55905 USA; [Warner, David O.] Mayo Clin, Coll Med & Sci, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Warner, DO (corresponding author), Mayo Clin, Coll Med & Sci, Dept Anesthesiol & Perioperat Med, Rochester, MN 55905 USA.	Warner.David@mayo.edu		Nolan, Margaret/0000-0001-5214-3992				Andrews JO, 2001, PREV MED, V33, P415, DOI 10.1006/pmed.2001.0907; Babb S, 2017, MMWR-MORBID MORTAL W, V65, P1457, DOI 10.15585/mmwr.mm6552a1; Barrera R, 2005, CHEST, V127, P1977, DOI 10.1378/chest.127.6.1977; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Bentz CJ, 2007, NICOTINE TOB RES, V9, P341, DOI 10.1080/14622200701188828; Bentz CJ, 2006, AM J PREV MED, V30, P31, DOI 10.1016/j.amepre.2005.08.043; Bottorff JL, 2015, CAN FAM PHYSICIAN, V61, pE562; Bottorff JL, 2016, J PRIM CARE COMMUNIT, V7, P16, DOI 10.1177/2150131915604827; British Thoracic Society, 2016, UK HOSP FAIL MEET NA; Burke MV, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001903; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Canadian Action Network for the Advancement Dissemination and Adoption of Practice-informed Tobacco Treatment (CAN-ADAPTT), 2012, CAN SMOK CESS CLIN P; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chase EC, 2007, NICOTINE TOB RES, V9, P1095, DOI 10.1080/14622200701666344; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; Cropley M, 2008, NICOTINE TOB RES, V10, P407, DOI 10.1080/14622200801888996; Damschroder LJ, 2011, PSYCHOL ADDICT BEHAV, V25, P194, DOI 10.1037/a0022284; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Denny JT, 2016, EXP THER MED, V12, P1599, DOI 10.3892/etm.2016.3496; DePue JD, 2002, TOB CONTROL, V11, P329, DOI 10.1136/tc.11.4.329; Easton A, 2001, WOMEN HEALTH, V34, P15, DOI 10.1300/J013v34n04_02; Ebbert JO, 2007, J AM DENT ASSOC, V138, P595, DOI 10.14219/jada.archive.2007.0229; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-71; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Fellows JL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-129; Ferketich AK, 2006, PREV MED, V43, P472, DOI 10.1016/j.ypmed.2006.07.009; Ferketich AK, 2014, NICOTINE TOB RES, V16, P786, DOI 10.1093/ntr/ntt221; Fiore MC, 2008, AM J PREV MED, V35, P158, DOI 10.1016/j.amepre.2008.04.009; Fiore MC, 2012, NEW ENGL J MED, V366, P1172, DOI 10.1056/NEJMp1115176; Ford CL, 2005, MAYO CLIN PROC, V80, P652, DOI 10.4065/80.5.652; France EK, 2001, PREV MED, V32, P376, DOI 10.1006/pmed.2000.0824; Freund M, 2009, NICOTINE TOB RES, V11, P650, DOI 10.1093/ntr/ntp056; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Garg A, 2007, CLIN PEDIATR, V46, P252, DOI 10.1177/0009922806290694; Gaskill CE, 2017, J SURG RES, V215, P183, DOI 10.1016/j.jss.2017.03.067; Gillies MA, 2012, INTENS CARE MED, V38, P1683, DOI 10.1007/s00134-012-2604-2; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gordon JS, 2007, TOB CONTROL, V16, P285, DOI 10.1136/tc.2007.020271; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gronkjaer M, 2014, ANN SURG, V259, P52, DOI 10.1097/SLA.0b013e3182911913; Hajjar WM, 2016, ANN THORAC MED, V11, P132, DOI 10.4103/1817-1737.180021; Hejblum G, 2009, CHEST, V135, P477, DOI 10.1378/chest.08-0897; Helfrich CD, 2007, MED CARE RES REV, V64, P279, DOI 10.1177/1077558707299887; Houghton CS, 2008, NURS RES, V57, P123, DOI 10.1097/01.NNR.0000313481.39755.ea; Jamal A, 2012, MMWR-MORBID M      S, V61, P38; Jamal A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140529; Joseph AM, 2004, MED CARE, V42, P1100, DOI 10.1097/00005650-200411000-00009; Kadimpati S, 2015, MAYO CLIN PROC, V90, P71, DOI 10.1016/j.mayocp.2014.11.005; Kai T, 2008, BRIT J ANAESTH, V100, P404, DOI 10.1093/bja/aem400; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kasza KA, 2017, NEW ENGL J MED, V376, P342, DOI 10.1056/NEJMsa1607538; Katz DA, 2004, JNCI-J NATL CANCER I, V96, P594, DOI 10.1093/jnci/djh103; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Klesges LM, 2005, ANN BEHAV MED, V29, P66, DOI 10.1207/s15324796abm2902s_10; Kunzel B, 2012, UROLOGY, V80, P104, DOI 10.1016/j.urology.2012.04.024; Kuri M, 2005, ANESTHESIOLOGY, V102, P892, DOI 10.1097/00000542-200505000-00005; Lakshmipathy N, 1996, ANESTH ANALG, V82, P724, DOI 10.1097/00000539-199604000-00008; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lee A, 2015, ANN SURG, V261, P297, DOI 10.1097/SLA.0000000000000544; Lee SM, 2015, ANESTH ANALG, V120, P582, DOI 10.1213/ANE.0000000000000555; Lee SM, 2013, ANESTH ANALG, V117, P605, DOI 10.1213/ANE.0b013e318298a6b0; Manfredi C, 2008, NICOTINE TOB RES, V10, P1597, DOI 10.1080/14622200802410006; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; McAfee T, 2015, NEW ENGL J MED, V372, P5, DOI 10.1056/NEJMp1411437; McRobbie Hayden, 2014, Cochrane Database Syst Rev, pCD010216, DOI 10.1002/14651858.CD010216.pub2; Miech R, 2017, TOB CONTROL, DOI [10.1136/tobarcocontrol-2016-053291 pmid:28167683, DOI 10.1136/TOBARCOCONTROL-2016-053291]; Mills E, 2011, AM J MED, V124, P144, DOI 10.1016/j.amjmed.2010.09.013; Milne B, 2007, J PAEDIATR CHILD H, V43, P464, DOI 10.1111/j.1440-1754.2007.01112.x; Moller A, 2005, COCHRANE DB SYST REV, V3; Mullen KA, 2017, TOB CONTROL, V26, P293, DOI 10.1136/tobaccocontrol-2015-052728; Musallam KM, 2013, JAMA SURG, V148, P755, DOI 10.1001/jamasurg.2013.2360; Myers K, 2011, ARCH INTERN MED, V171, P983, DOI 10.1001/archinternmed.2011.97; Nakagawa M, 2001, CHEST, V120, P705, DOI 10.1378/chest.120.3.705; Nasell H, 2010, J BONE JOINT SURG AM, V92A, P1335, DOI 10.2106/JBJS.I.00627; National Institute for Health and Care Excellence, 2013, PUBL HLTH GUID 48 SM; Nayan S, 2013, OTOLARYNG HEAD NECK, V149, P200, DOI 10.1177/0194599813490886; New Zealand Ministry of Health, 2014, NZ GUID HELP PEOPL S; Nolan M, 2016, NICOTINE TOB RES, V18, P1757, DOI 10.1093/ntr/ntw003; Nolan MB, 2017, JAMA SURG, V152, P476, DOI 10.1001/jamasurg.2016.5704; Nolan MB, 2015, MAYO CLIN PROC, V90, P1553, DOI 10.1016/j.mayocp.2015.08.003; Ozturk O, 2012, HIPPOKRATIA, V16, P124; Pbert L, 2000, TOB CONTROL, V9, P372, DOI 10.1136/tc.9.4.372; Pechacek TF, 2016, NICOTINE TOB RES, V18, P1989, DOI 10.1093/ntr/ntw102; Pokhrel P, 2014, ADDICT BEHAV, V39, P1869, DOI 10.1016/j.addbeh.2014.07.034; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Rabin BA, 2008, J PUBLIC HEALTH MAN, V14, P117, DOI 10.1097/01.PHH.0000311888.06252.bb; Ramsay PP, 2016, AM J PREV MED, V50, P328, DOI 10.1016/j.amepre.2015.07.005; Reid RD, 2010, NICOTINE TOB RES, V12, P11, DOI 10.1093/ntr/ntp165; Rigotti NA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub2; Rigotti NA, 2016, AM J PREV MED, V51, P549, DOI 10.1016/j.amepre.2016.07.012; Rogers, 2003, DIFFUSION INNOVATION; Rycroft-Malone J, 2002, QUAL SAF HEALTH CARE, V11, P174, DOI 10.1136/qhc.11.2.174; Sachs R, 2012, CAN J ANESTH, V59, P662, DOI 10.1007/s12630-012-9716-6; Saxony J, 2017, J SURG RES, V212, P33, DOI 10.1016/j.jss.2016.11.056; Schroeder SA, 2005, JAMA-J AM MED ASSOC, V294, P482, DOI 10.1001/jama.294.4.482; Shannon-Cain Janice, 2002, AANA J, V70, P33; Shi Y, 2011, ANESTH ANALG, V113, P1348, DOI 10.1213/ANE.0b013e31822d6798; Shi Y, 2010, ANESTHESIOLOGY, V112, P338, DOI 10.1097/ALN.0b013e3181c91ee7; Shi Y, 2010, ANESTHESIOLOGY, V112, P102, DOI 10.1097/ALN.0b013e3181c61cf9; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Skolnick ET, 1998, ANESTHESIOLOGY, V88, P1144, DOI 10.1097/00000542-199805000-00003; Slattery C, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0390-x; Spohr SA, 2015, J SUBST ABUSE TREAT, V56, P1, DOI 10.1016/j.jsat.2015.01.011; Stead LF, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000165.PUB3; Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3; Svanstrom H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7176; Taylor CB, 2005, NICOTINE TOB RES, V7, P129, DOI 10.1080/14622200412331328420; Thomas KH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1109; Thomsen T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002294.pub3; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Vick CC, 2011, TRANSL BEHAV MED, V1, P604, DOI 10.1007/s13142-011-0096-1; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; von Ungern-Sternberg BS, 2010, LANCET, V376, P773, DOI 10.1016/S0140-6736(10)61193-2; Walker AE, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-22; Warner DO, 2016, AM J PREV MED, V51, P473, DOI 10.1016/j.amepre.2016.03.005; Warner DO, 2015, ANESTHESIOLOGY, V123, P18, DOI 10.1097/ALN.0000000000000704; Warner DO, 2014, JAMA SURG, V149, P259, DOI 10.1001/jamasurg.2013.5009; Warner DO, 2011, ANESTHESIOLOGY, V114, P847, DOI 10.1097/ALN.0b013e31820d868d; Warner DO, 2009, ANESTHESIOLOGY, V110, P1223, DOI 10.1097/ALN.0b013e3181a5d03e; Warner DO, 2008, AM J PREV MED, V35, pS486, DOI 10.1016/j.amepre.2008.08.032; Warner DO, 2006, ANESTHESIOLOGY, V104, P356, DOI 10.1097/00000542-200602000-00023; Warner DO, 2005, ANESTHESIOLOGY, V102, P1138, DOI 10.1097/00000542-200506000-00013; Warner DO, 2004, ANESTH ANALG, V99, P1766, DOI 10.1213/01.ANE.0000136773.40216.87; Webb A, 2017, ANAESTH INTENS CARE, V45, P52, DOI 10.1177/0310057X1704500108; Webb AR, 2013, ANZ J SURG, V83, P753, DOI 10.1111/ans.12096; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6; Woehlck HJ, 1999, ANESTH ANALG, V89, P856, DOI 10.1097/00000539-199910000-00008; Wolfenden L, 2005, PREV MED, V41, P284, DOI 10.1016/j.ypmed.2004.11.011; Wolfenden L, 2008, HEALTH PROMOT J AUST, V19, P158, DOI 10.1071/HE08158; Wolfenden L, 2008, NICOTINE TOB RES, V10, P1105, DOI 10.1080/14622200802097472; Wong J, 2017, ANESTH ANALG, V17, P17; 于春华, 2010, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V30, P129; Zaballos M, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0036-6; Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660	140	25	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j3340	10.1136/bmj.j3340	http://dx.doi.org/10.1136/bmj.j3340			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG7EG	28877905				2022-12-28	WOS:000410575400001
J	Agusti, A; Celli, B; Faner, R				Agusti, Alvar; Celli, Bartolome; Faner, Rosa			What does endotyping mean for treatment in chronic obstructive pulmonary disease?	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; AIR-FLOW OBSTRUCTION; SHORT-TERM RESPONSE; SYSTEMS BIOLOGY; ALPHA1-ANTITRYPSIN DEFICIENCY; PERSONALIZED MEDICINE; SPUTUM-EOSINOPHILIA; NETWORK MEDICINE; RESPIRATORY SYMPTOMS	Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, both at the clinical and biological level. However, COPD is still diagnosed and treated according to simple clinical measures (level of airflow limitation, symptoms, and frequency of previous exacerbations). To address this clinical and biological complexity and to move towards precision medicine in COPD, we need to integrate (bioinformatics) and interpret (clinical science) the vast amount of high-throughput information that existing technology provides (systems biology and network medicine) so diagnosis, stratification, and treatment of patients with COPD can occur on the basis of their pathobiological mechanism (ie, endotypes). Therefore, this Series paper discusses a possible new taxonomy of COPD, the role of endotypes and associated biomarkers and phenotypes, the gaps (and opportunities) in existing knowledge of COPD pathobiology, how systems biology and network medicine can improve understanding of the disease and help to identify relevant endotypes and their specific biomarkers, and how endotypes and their biomarkers can improve the precision, effectiveness, and safety of the treatment of patients with COPD.	[Agusti, Alvar] Univ Barcelona, Resp Inst, Hosp Clin, Barcelona, Spain; [Agusti, Alvar; Faner, Rosa] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Agusti, Alvar; Faner, Rosa] CIBER Enfermedades Resp, Madrid, Spain; [Celli, Bartolome] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Agusti, A (corresponding author), Hosp Clin Barcelona, Resp Inst, Barcelona 08036, Spain.	AAGUSTI@clinic.cat		Faner, Rosa/0000-0002-8159-0115	Instituto de Salud Carlos III (ISCiii) FEDER FIS [PI15/00799, CP16/00096]; Instituto de Salud Carlos III (ISCiii) FEDER FIS (COPD research programme of CIBERES); SEPAR [PI065/2013, PI068/2015]; AstraZeneca	Instituto de Salud Carlos III (ISCiii) FEDER FIS; Instituto de Salud Carlos III (ISCiii) FEDER FIS (COPD research programme of CIBERES); SEPAR; AstraZeneca(AstraZeneca)	We acknowledge the comments and criticisms of the three anonymous reviewers of this paper who greatly contributed to its improvement. This paper is supported, in part, by Instituto de Salud Carlos III (ISCiii) FEDER FIS (PI15/00799; CP16/00096 and the COPD research programme of CIBERES), SEPAR (PI065/2013 & PI068/2015), and AstraZeneca (2016 COPD young researcher award to RF). RF also has a Miguel Servet research contract from ISCiii, Spain.	Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Agusti A, 2016, EUR RESPIR J, V47, P410, DOI 10.1183/13993003.01359-2015; Agusti A, 2016, RESPIROLOGY, V21, P24, DOI 10.1111/resp.12585; Agusti A, 2015, AM J RESP CRIT CARE, V191, P391, DOI 10.1164/rccm.201410-1935PP; Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Agusti A, 2013, THORAX, V68, P687, DOI 10.1136/thoraxjnl-2012-202772; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barabasi AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beghe B, 2013, EUR RESPIR J, V41, P993, DOI 10.1183/09031936.00180812; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2005, THORAX, V60, P193, DOI 10.1136/thx.2004.032516; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Bush A, 2016, ANN AM THORAC SOC, V13, pS438, DOI 10.1513/AnnalsATS.201602-112AW; Cesario A, 2014, CURR PHARM DESIGN, V20, P5945, DOI 10.2174/1381612820666140314130449; Chapman KR, 2015, LANCET, V386, P360, DOI 10.1016/S0140-6736(15)60860-1; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Diez D, 2014, AM J RESP CRIT CARE, V190, P981, DOI 10.1164/rccm.201403-0421PP; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fabbri LM, 2016, NEW ENGL J MED, V374, P1885, DOI 10.1056/NEJMe1515508; Faner R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02086-2016; Faner R, 2016, ANN AM THORAC SOC, V13, pS466, DOI 10.1513/AnnalsATS.201605-372AW; Faner R, 2016, AM J RESP CRIT CARE, V193, P1242, DOI 10.1164/rccm.201507-1311OC; Faner R, 2015, EUR RESPIR J, V46, P1001, DOI 10.1183/13993003.00763-2015; Faner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097491; Faner R, 2013, EXPERT REV CLIN IMMU, V9, P821, DOI 10.1586/1744666X.2013.828875; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; GANROT PO, 1967, SCAND J CLIN LAB INV, V19, P205, DOI 10.3109/00365516709090627; Ghiassian SD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004120; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gomez-Cabrero D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1291-3; Grosdidier S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0111-4; Gustafsson M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0082-6; Han MLK, 2014, AM J RESP CRIT CARE, V189, P1503, DOI 10.1164/rccm.201402-0207OC; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hofmann-Apitius M, 2015, NAT REV DRUG DISCOV, V14, P75, DOI 10.1038/nrd4537; Holgate S, 2015, NAT REV DRUG DISCOV, V14, P367, DOI 10.1038/nrd4645; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Jensen AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5022; Jobe AH, 2016, FETAL NEONATAL LUNG; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2001, FDN SYSTEMS BIOL; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92; Kola I, 2011, NAT REV DRUG DISCOV, V10, P641, DOI 10.1038/nrd3534; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; LAURELL CB, 1971, SCAND J CLIN LAB INV, V28, P1, DOI 10.3109/00365517109090655; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; McDonald VM, 2013, THORAX; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Menche J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S8; Morrow JD, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-014-0072-y; Obeidat M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0558-1; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pavord ID, 2017, LANCET IN PRESS; Polverino F, 2015, AM J RESP CRIT CARE, V192, P695, DOI 10.1164/rccm.201501-0107OC; Rodriguez-Roisin R, 2017, AM J RESP CRIT CARE, V195, P17, DOI 10.1164/rccm.201607-1376PP; Rosenbaum L, 2017, NEW ENGL J MED, V376, P2201, DOI 10.1056/NEJMp1704482; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; SCADDING JG, 1988, J MED ETHICS, V14, P118, DOI 10.1136/jme.14.3.118; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Sharma A, 2015, HUM MOL GENET, V24, P3005, DOI 10.1093/hmg/ddv001; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; TURINO GM, 1969, SCIENCE, V165, P709, DOI 10.1126/science.165.3894.709; Vanfleteren LEGW, 2014, THORAX, V69, P72, DOI 10.1136/thoraxjnl-2013-203602; Vogelmeier C, 2017, GLOBAL STRATEGY DIAG; Vrijheid M, 2014, THORAX, V69, P876, DOI 10.1136/thoraxjnl-2013-204949; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Wild CP, 2012, INT J EPIDEMIOL, V41, P24, DOI 10.1093/ije/dyr236; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6; Woodruff PG, 2014, EUR RESPIR J, V43, P295, DOI 10.1183/09031936.00140613	92	58	59	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					980	987		10.1016/S0140-6736(17)32136-0	http://dx.doi.org/10.1016/S0140-6736(17)32136-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2SE	28872030				2022-12-28	WOS:000408746300027
J	Juraschek, DM; Spaldin, NA				Juraschek, Dominik M.; Spaldin, Nicola A.			Sounding out optical phonons	SCIENCE			English	Editorial Material									[Juraschek, Dominik M.; Spaldin, Nicola A.] ETH, Mat Theory, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Spaldin, NA (corresponding author), ETH, Mat Theory, CH-8093 Zurich, Switzerland.	nicola.spaldin@mat.ethz.ch	Juraschek, Dominik M./AAN-3258-2021; Spaldin, Nicola A/A-1017-2010	Juraschek, Dominik M./0000-0002-7210-8411; Spaldin, Nicola A/0000-0003-0709-9499				Bliokh KY, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174302; De Silvestri S., 2008, COHERENT VIBRATIONAL; Juraschek DM, 2017, PHYS REV MATER, V1, DOI 10.1103/PhysRevMaterials.1.014401; Korenev VL, 2016, NAT PHYS, V12, P85, DOI [10.1038/NPHYS3497, 10.1038/nphys3497]; Li NB, 2012, REV MOD PHYS, V84, P1045, DOI 10.1103/RevModPhys.84.1045; Maldovan M, 2013, NATURE, V503, P209, DOI 10.1038/nature12608; Nicoletti D, 2016, ADV OPT PHOTONICS, V8, P401, DOI 10.1364/AOP.8.000401; Nova TF, 2017, NAT PHYS, V13, P132, DOI [10.1038/NPHYS3925, 10.1038/nphys3925]; Strohm C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155901; THALMEIER P, 1978, Z PHYS B CON MAT, V29, P299, DOI 10.1007/BF01324026; Zhang LF, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.085503	12	10	10	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					873	+		10.1126/science.aao2446	http://dx.doi.org/10.1126/science.aao2446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860373				2022-12-28	WOS:000408734900027
J	Farland, LV; Eliassen, AH; Tamimi, RM; Spiegelman, D; Michels, KB; Missmer, SA				Farland, Leslie V.; Eliassen, A. Heather; Tamimi, Rulla M.; Spiegelman, Donna; Michels, Karin B.; Missmer, Stacey A.			History of breast feeding and risk of incident endometriosis: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LACTATION; LIFE	OBJECTIVE To investigate the association between lifetime breast feeding, exclusive breast feeding, postpartum amenorrhea, and incidence of endometriosis among parous women. DESIGN Prospective cohort study. SETTING Nurses' Health Study II, 1989-2011. PARTICIPANTS 72 394women who reported having one or more pregnancies that lasted at least six months, 3296 of whom had laparoscopically confirmed endometriosis. For each pregnancy, women reported duration of total breast feeding, exclusive breast feeding, and postpartum amenorrhea. MAIN OUTCOME MEASURES Incident self reported laparoscopically confirmed endometriosis (96% concordance with medical record) in parous women. Multivariable Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals for diagnosis of endometriosis. RESULTS Duration of total and exclusive breast feeding was significantly associated with decreased risk of endometriosis. Among women who reported a lifetime total length of breast feeding of less than one month, there were 453 endometriosis cases/100 000 person years compared with 184 cases/100 000 person years in women who reported a lifetime total of >= 36 months of breast feeding. For every additional three months of total breast feeding per pregnancy, women experienced an 8% lower risk of endometriosis (hazard ratio 0.92, 95% confidence interval 0.90 to 0.94; P<0.001 for trend) and a 14% lower risk for every additional three months of exclusive breast feeding per pregnancy (0.86, 0.81 to 0.90; P<0.001 for trend). Women who breastfed for >= 36 months in total across their reproductive lifetime had a 40% reduced risk of endometriosis compared with women who never breast fed (0.60, 0.50 to 0.72). The protective association with breast feeding was strongest among women who gave birth within the past five years (P=0.04 for interaction). The association with total breast feeding and exclusive breast feeding on endometriosis was partially influenced by postpartum amenorrhea (% mediated was 34% (95% confidence interval 15% to 59%) for total breast feeding and 57% (27% to 82%) for exclusive breast feeding). CONCLUSION Among women who experienced at least one pregnancy that lasted at least six months, breast feeding was inversely associated with risk of incident endometriosis. This association was partially, but not fully, influenced by postpartum amenorrhea, suggesting that breast feeding could influence the risk of endometriosis both through amenorrhea and other mechanisms. Given the chronic and incurable nature of endometriosis, breast feeding should be further investigated as an important modifiable behavior to mitigate risk for pregnant women.	[Farland, Leslie V.; Eliassen, A. Heather; Tamimi, Rulla M.; Spiegelman, Donna; Michels, Karin B.; Missmer, Stacey A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Farland, Leslie V.] Harvard Med Sch, Ctr Infertil & Reprod Surg, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Eliassen, A. Heather; Tamimi, Rulla M.; Spiegelman, Donna] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Eliassen, A. Heather; Tamimi, Rulla M.; Spiegelman, Donna; Missmer, Stacey A.] Harvard Med Sch, Boston, MA 02115 USA; [Michels, Karin B.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Missmer, Stacey A.] Boston Childrens Hosp, Dept Med, Div Adolescent & Young Adult Med, Boston, MA 02115 USA; [Missmer, Stacey A.] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital; Michigan State University; Michigan State University College of Human Medicine	Farland, LV (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Farland, LV (corresponding author), Harvard Med Sch, Ctr Infertil & Reprod Surg, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Boston, MA 02115 USA.	lfarland@mail.harvard.edu		Farland, Leslie/0000-0001-7455-8531; Eliassen, A Heather/0000-0002-3961-6609	National Institutes of Health, National Cancer Institute [UM1 CA176726, 3R25CA057711]; National Institute of Child Health and Human Development [HD57210, T32HD060454]; Dana Farber and Harvard Cancer Center	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Dana Farber and Harvard Cancer Center	This work was supported by National Institutes of Health, National Cancer Institute (UM1 CA176726, 3R25CA057711 to LVF), National Institute of Child Health and Human Development (HD57210, T32HD060454 to LVF), and the Dana Farber and Harvard Cancer Center Mazzone Award. The NIHR had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the funding agencies.	American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, pe86, DOI 10.1097/AOG.0000000000001318; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; HALME J, 1984, OBSTET GYNECOL, V64, P151; Heilier JF, 2007, ENVIRON RES, V103, P121, DOI 10.1016/j.envres.2006.04.004; Hertzmark E, 2012, SAS MEDIATE MACRO; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jerome FS, 2004, YEN JAFFES REPROD EN; Jun HJ, 2010, CANCER CAUSE CONTROL, V21, P1817, DOI 10.1007/s10552-010-9609-3; KARK JD, 1984, J EPIDEMIOL COMMUN H, V38, P218, DOI 10.1136/jech.38.3.218; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Lin DY, 1997, STAT MED, V16, P1515, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.3.CO;2-T; Louis GMB, 2011, FERTIL STERIL, V96, P360, DOI 10.1016/j.fertnstert.2011.05.087; McNeilly AS, 2001, REPROD FERT DEVELOP, V13, P583, DOI 10.1071/RD01056; Missmer SA, 2004, OBSTET GYNECOL, V104, P965, DOI 10.1097/01.AOG.0000142714.54857.f8; Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275; Missmer Stacey A, 2003, Obstet Gynecol Clin North Am, V30, P1, DOI 10.1016/S0889-8545(02)00050-5; Nnoaham KE, 2012, FERTIL STERIL, V98, P702, DOI 10.1016/j.fertnstert.2012.05.035; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sampson JA, 1927, AM J PATHOL, V3, P93; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Signorello LB, 1997, ANN EPIDEMIOL, V7, P267, DOI 10.1016/S1047-2797(97)00017-3; Stuebe AM, 2009, ARCH INTERN MED, V169, P1364, DOI 10.1001/archinternmed.2009.231; Stuebe AM, 2005, JAMA-J AM MED ASSOC, V294, P2601, DOI 10.1001/jama.294.20.2601; Vekemans M, 1997, Eur J Contracept Reprod Health Care, V2, P105	30	16	17	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2017	358								j3778	10.1136/bmj.j3778	http://dx.doi.org/10.1136/bmj.j3778			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CK	28851765	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000409386400001
J	Hunger, J; Parekh, SH				Hunger, Johannes; Parekh, Sapun H.			A water window on surface chemistry	SCIENCE			English	Editorial Material							2ND-HARMONIC GENERATION		[Hunger, Johannes; Parekh, Sapun H.] Max Planck Inst Polymer Res, Dept Mol Spect, Mainz, Germany	Max Planck Society	Hunger, J (corresponding author), Max Planck Inst Polymer Res, Dept Mol Spect, Mainz, Germany.	hunger@mpip-mainz.mpg.de; parekh@mpip-mainz.mpg.de	Hunger, Johannes/G-3242-2010	Hunger, Johannes/0000-0002-4419-5220				De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; Higgins DA, 2015, ANNU REV ANAL CHEM, V8, P193, DOI 10.1146/annurev-anchem-071114-040153; Kriech MA, 2004, J OPT SOC AM B, V21, P1013, DOI 10.1364/JOSAB.21.001013; Lim D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528656; Lis D, 2014, SCIENCE, V344, P1138, DOI 10.1126/science.1253793; Macias-Romero C, 2017, SCIENCE, V357, P784, DOI 10.1126/science.aal4346; Montalti M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14427; Peterson MD, 2011, OPT MATER EXPRESS, V1, P57, DOI 10.1364/OME.1.000057; Zhuravlev LT, 2000, COLLOID SURFACE A, V173, P1, DOI 10.1016/S0927-7757(00)00556-2	9	1	2	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					755	756		10.1126/science.aao1257	http://dx.doi.org/10.1126/science.aao1257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839061				2022-12-28	WOS:000408327900025
J	Maiato, H; Ferras, C				Maiato, Helder; Ferras, Cristina			Actin divides to conquer	SCIENCE			English	Editorial Material							CRANE-FLY SPERMATOCYTES; SPINDLE MICROTUBULE ORGANIZATION; CHROMOSOME CONGRESSION; PTK1 CELLS; FILAMENTS; ANAPHASE; CLASP1		[Maiato, Helder; Ferras, Cristina] Univ Porto, Inst Biol Mol & Celular, Oporto, Portugal; [Maiato, Helder; Ferras, Cristina] Univ Porto, i3S, Oporto, Portugal; [Maiato, Helder] Univ Porto, Dept Biomed, Fac Med, Oporto, Portugal; [Maiato, Helder] Marine Biol Lab, Whitman Ctr, Woods Hole, MA 02543 USA	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Marine Biological Laboratory - Woods Hole	Maiato, H (corresponding author), Univ Porto, Inst Biol Mol & Celular, Oporto, Portugal.; Maiato, H (corresponding author), Univ Porto, i3S, Oporto, Portugal.; Maiato, H (corresponding author), Univ Porto, Dept Biomed, Fac Med, Oporto, Portugal.; Maiato, H (corresponding author), Marine Biol Lab, Whitman Ctr, Woods Hole, MA 02543 USA.	maiato@i3s.up.pt	Ferrás, Cristina/I-1820-2013; Maiato, Helder/J-9466-2013	Ferras, cristina/0000-0003-1134-7387; Maiato, Helder/0000-0002-6200-9997				Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Forer A, 2003, CELL MOTIL CYTOSKEL, V56, P173, DOI 10.1002/cm.10144; FORER A, 1988, J CELL SCI, V91, P449; Forer A, 1998, CHROMOSOME RES, V6, P533, DOI 10.1023/A:1009224322399; LAFOUNTAIN JR, 1992, CHROMOSOMA, V101, P425, DOI 10.1007/BF00582837; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2010, CELL MOL LIFE SCI, V67, P2251, DOI 10.1007/s00018-010-0327-5; Mogessie B, 2017, SCIENCE, V357, DOI 10.1126/science.aal1647; SNYDER JA, 1995, CELL MOTIL CYTOSKEL, V32, P245, DOI 10.1002/cm.970320402; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Wrench GA, 1997, CELL MOTIL CYTOSKEL, V36, P112, DOI 10.1002/(SICI)1097-0169(1997)36:2<112::AID-CM2>3.0.CO;2-B	12	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					756	757		10.1126/science.aao2461	http://dx.doi.org/10.1126/science.aao2461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839062	Green Accepted			2022-12-28	WOS:000408327900026
J	Laland, KN				Laland, Kevin N.			Patrick Bateson (1938-2017) OBITUARY	NATURE			English	Biographical-Item									[Laland, Kevin N.] Univ St Andrews, Behav & Evolutionary Biol, St Andrews, Fife, Scotland	University of St Andrews	Laland, KN (corresponding author), Univ St Andrews, Behav & Evolutionary Biol, St Andrews, Fife, Scotland.	knl1@st-andrews.ac.uk		Laland, Kevin/0000-0002-2457-0900				BATESON P, PUBLICATION LIST	1	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					394	394		10.1038/548394a	http://dx.doi.org/10.1038/548394a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28836598	Bronze			2022-12-28	WOS:000408279000021
J	van Vugt, VA; van der Horst, HE; Payne, RA; Maarsingh, OR				van Vugt, Vincent A.; van der Horst, Henriette E.; Payne, Rupert A.; Maarsingh, Otto R.			CHANGE Chronic vertigo: treat with exercise, not drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATIENT		[van Vugt, Vincent A.; van der Horst, Henriette E.; Maarsingh, Otto R.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, NL-1081 BT Amsterdam, Netherlands; [Payne, Rupert A.] Univ Bristol, Ctr Acad Primary Care, Bristol, Avon, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bristol	van Vugt, VA (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, NL-1081 BT Amsterdam, Netherlands.	v.vanvugt@vumc.nl	Maarsingh, Otto/AAD-1553-2022	Maarsingh, Otto/0000-0002-3747-9217				Adrion C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6816; Agus S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00048; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Brandt T, 2010, RESTOR NEUROL NEUROS, V28, P69, DOI 10.3233/RNN-2010-0504; Bronstein AM, 2010, RESTOR NEUROL NEUROS, V28, P83, DOI 10.3233/RNN-2010-0530; Eguale T, 2012, ARCH INTERN MED, V172, P781, DOI 10.1001/archinternmed.2012.340; Fishman JM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008607.pub2; Geraghty AWA, 2017, ANN FAM MED, V15, P209, DOI 10.1370/afm.2070; Gijsen R, 2009, PHARMACOEPIDEM DR S, V18, P84, DOI 10.1002/pds.1689; Goebel JA, 2000, OTOLARYNG CLIN N AM, V33, P483, DOI 10.1016/S0030-6665(05)70222-X; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Harcourt J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i46; Hilton MP, 2014, COCHRANE DB SYST REV, V358; James AL., 2001, COCHRANE DB SYST REV, V2001, pCD001873, DOI [10.1002/14651858.CD001873, DOI 10.1002/14651858.CD001873, 10.1002/14651858.cd001873]; Jayarajan V, 2003, J LARYNGOL OTOL, V117, P599, DOI 10.1258/002221503768199915; Jeck-Thole S, 2006, DRUG SAFETY, V29, P1049, DOI 10.2165/00002018-200629110-00004; Kaski D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5809; Lacour M, 2016, J NEUROL, V263, pS54, DOI 10.1007/s00415-015-7903-4; Lempert T, 2013, SEMIN NEUROL, V33, P212, DOI 10.1055/s-0033-1354596; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Ludman H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g283; Fernandez MM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010600.pub2; McDonnell MN, 2015, COCHRANE DB SYST REV, V358; Murdin L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010696.pub2; National Institute for Health and Care Excellence, 2011, CLIN KNOWL SUMM VES; Neuhauser HK, 2009, SEMIN NEUROL, V29, P473, DOI 10.1055/s-0029-1241043; Obermann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00257; Phillips JS, 2008, BRIT J CLIN PHARMACO, V65, P470, DOI 10.1111/j.1365-2125.2007.03079.x; Reinink H, 2014, OTOLARYNG HEAD NECK, V151, P399, DOI 10.1177/0194599814536530; Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005; Strupp M, 2015, ANN NY ACAD SCI, V1343, P27, DOI 10.1111/nyas.12774; Vugt VA, 2017, SCAND J PRIM HEALTH, V35, P19, DOI 10.1080/02813432.2017.1288683; van Vugt VA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015479; Yardley L, 1998, CLIN OTOLARYNGOL, V23, P442, DOI 10.1046/j.1365-2273.1998.00179.x; Yardley L, 2004, ANN INTERN MED, V141, P598, DOI 10.7326/0003-4819-141-8-200410190-00007; Yardley L, 2006, PSYCHOSOM MED, V68, P762, DOI 10.1097/01.psy.0000232269.17906.92; Yardley Lucy, 2012, BMJ, V344, pe2237, DOI 10.1136/bmj.e2237	37	14	14	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 23	2017	358								j3727	10.1136/bmj.j3727	http://dx.doi.org/10.1136/bmj.j3727			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF1SR	28835412	Green Published			2022-12-28	WOS:000408679700001
J	Fidler, MM; Hawkins, MM				Fidler, Miranda M.; Hawkins, Michael M.			Childhood cancer: the long-term costs of cure	LANCET			English	Editorial Material							YOUNG-ADULT SURVIVORS; 5-YEAR SURVIVORS; LATE MORTALITY; ADOLESCENT		[Fidler, Miranda M.] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France; [Hawkins, Michael M.] Univ Birmingham, Ctr Childhood Canc Survivor Studies, Birmingham, W Midlands, England	World Health Organization; International Agency for Research on Cancer (IARC); University of Birmingham	Fidler, MM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	fidlerm@fellows.iarc.fr		Fidler-Benaoudia, Miranda/0000-0001-9594-9881				Armstrong GT, 2016, NEW ENGL J MED, V374, P833, DOI 10.1056/NEJMoa1510795; Bhakta N, 2017, LANCET; Bhakta N, 2016, LANCET ONCOL, V17, P1325, DOI 10.1016/S1470-2045(16)30215-7; Howlader NNA, 2020, SEER CANC STAT REV; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Nathan PC, 2013, J CANCER SURVIV, V7, P275, DOI 10.1007/s11764-013-0271-0; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Sutradhar R, 2015, CANCER-AM CANCER SOC, V121, P4389, DOI 10.1002/cncr.29679; Turcotte LM, 2017, JAMA-J AM MED ASSOC, V317, P814, DOI 10.1001/jama.2017.0693; Wallace WHB, 2001, BRIT MED J, V323, P271, DOI 10.1136/bmj.323.7307.271	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2530	2531		10.1016/S0140-6736(17)31755-5	http://dx.doi.org/10.1016/S0140-6736(17)31755-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FP3BI	28890158				2022-12-28	WOS:000417493300006
J	Kandzari, DE; Mauri, L; Koolen, JJ; Massaro, JM; Doros, G; Garcia-Garcia, HM; Bennett, J; Roguin, A; Gharib, EG; Cutlip, DE; Waksman, R				Kandzari, David E.; Mauri, Laura; Koolen, Jacques J.; Massaro, Joseph M.; Doros, Gheorghe; Garcia-Garcia, Hector M.; Bennett, Johan; Roguin, Ariel; Gharib, Elie G.; Cutlip, Donald E.; Waksman, Ron		BIOFLOW V Investigator	Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial	LANCET			English	Article							NON-INFERIORITY TRIAL; COMPREHENSIVE NETWORK METAANALYSIS; OPTICAL COHERENCE TOMOGRAPHY; BARE-METAL; BIODEGRADABLE POLYMER; ARTERY-DISEASE; ANGIOGRAPHIC OUTCOMES; FOLLOW-UP; THROMBOSIS; IMPLANTATION	Background The development of coronary drug-eluting stents has included use of new metal alloys, changes in stent architecture, and use of bioresorbable polymers. Whether these advancements improve clinical safety and efficacy has not been shown in previous randomised trials. We aimed to examine the clinical outcomes of a bioresorbable polymer sirolimus-eluting stent compared with a durable polymer everolimus-eluting stent in a broad patient population undergoing percutaneous coronary intervention. Methods BIOFLOW V was an international, randomised trial done in patients undergoing elective and urgent percutaneous coronary intervention in 90 hospitals in 13 countries (Australia, Belgium, Canada, Denmark, Germany, Hungary, Israel, the Netherlands, New Zealand, South Korea, Spain, Switzerland, and the USA). Eligible patients were those aged 18 years or older with ischaemic heart disease undergoing planned stent implantation in de-novo, native coronary lesions. Patients were randomly assigned (2: 1) to either an ultrathin strut (60 mu m) bioresorbable polymer sirolimus-eluting stent or to a durable polymer everolimus-eluting stent. Randomisation was via a central web-based data capture system (mixed blocks of 3 and 6), and stratified by study site. The primary endpoint was 12-month target lesion failure. The primary non-inferiority comparison combined these data from two additional randomised trials of bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent with Bayesian methods. Analysis was by intention to treat. The trial is registered with ClinicalTrials. gov, number NCT02389946. Findings Between May 8, 2015, and March 31, 2016, 4772 patients were recruited into the study. 1334 patients met inclusion criteria and were randomly assigned to treatment with bioresorbable polymer sirolimus-eluting stents (n=884) or durable polymer everolimus-eluting stents (n=450). 52 (6%) of 883 patients in the bioresorbable polymer sirolimus-eluting stent group and 41 (10%) of 427 patients in the durable polymer everolimus-eluting stent group met the 12-month primary endpoint of target lesion failure (95% CI -6.84 to -0.29, p=0.0399), with differences in target vessel myocardial infarction (39 [5%] of 831 patients vs 35 [8%] of 424 patients, p=0.0155). The posterior probability that the bioresorbable polymer sirolimus-eluting stent is non-inferior to the durable polymer everolimus-eluting stent was 100% (Bayesian analysis, difference in target lesion failure frequency -2.6% [95% credible interval -5.5 to 0.1], non-inferiority margin 3.85%, n=2208). Interpretation The outperformance of the ultrathin, bioresorbable polymer sirolimus-eluting stent over the durable polymer everolimus-eluting stent in a complex patient population undergoing percutaneous coronary intervention suggests a new direction in improving next generation drug-eluting stent technology.	[Kandzari, David E.] Piedmont Heart Inst, Atlanta, GA 30309 USA; [Mauri, Laura] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Koolen, Jacques J.] Catharina Hosp, Eindhoven, Netherlands; [Massaro, Joseph M.; Doros, Gheorghe] Boston Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Boston, MA USA; [Doros, Gheorghe] Baim Inst Clin Res, Boston, MA USA; [Garcia-Garcia, Hector M.; Waksman, Ron] MedStar Washington Hosp Ctr, Div Intervent Cardiol, MedStar Cardiovasc Res Network, Washington, DC USA; [Bennett, Johan] Univ Hosp Leuven, Dept Cardiovasc Med, Leuven, Belgium; [Roguin, Ariel] Rambam Med Ctr, Dept Cardiol, Haifa, Israel; [Gharib, Elie G.] Charleston Area Med Ctr, Charleston, WV USA; [Cutlip, Donald E.] Beth Israel Deaconess Med Ctr, Baim Inst Clin Res, Boston, MA 02215 USA	Piedmont Heart Institute; Harvard University; Brigham & Women's Hospital; Catharina Hospital; Boston University; MedStar Washington Hospital Center; Rambam Health Care Campus; Technion Israel Institute of Technology; Harvard University; Beth Israel Deaconess Medical Center	Kandzari, DE (corresponding author), Piedmont Heart Inst, Atlanta, GA 30309 USA.	david.kandzari@piedmont.org	Bennett, Johan/HHS-5451-2022; Garcia-Garcia, Hector Manuel/AAG-7471-2020; mauri, laura/GPS-4868-2022	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; , Gheorghe/0000-0001-5524-4721	BIOTRONIK	BIOTRONIK	BIOTRONIK.	Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Byrne RA, 2010, J AM COLL CARDIOL, V55, P2536, DOI 10.1016/j.jacc.2010.03.020; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; De Jong WH, 2005, BIOMATERIALS, V26, P1781, DOI 10.1016/j.biomaterials.2004.06.026; Doros G, AM HEART J IN PRESS; Eberhart RC, 2003, J BIOMAT SCI-POLYM E, V14, P299, DOI 10.1163/156856203321478838; Guagliumi G, 2012, JACC-CARDIOVASC INTE, V5, P12, DOI 10.1016/j.jcin.2011.09.018; Jensen LO, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003610; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kandzari DE, 2013, JACC-CARDIOVASC INTE, V6, P504, DOI 10.1016/j.jcin.2012.12.125; Kastrati A, 2001, CIRCULATION, V103, P2816; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Koppara T, 2012, THROMB HAEMOSTASIS, V107, P1161, DOI 10.1160/TH12-01-0043; Kuriyama N, 2011, JACC-CARDIOVASC INTE, V4, P123, DOI 10.1016/j.jcin.2010.09.013; Leon MB, 2010, J AM COLL CARDIOL, V55, P543, DOI 10.1016/j.jacc.2009.08.067; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Otsuka F, 2015, EUR HEART J, V36, P2147, DOI 10.1093/eurheartj/ehv205; Otsuka F, 2015, CIRCULATION, V131, P322, DOI 10.1161/CIRCULATIONAHA.114.012658; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Pache J, 2003, J AM COLL CARDIOL, V41, P1283, DOI 10.1016/S0735-1097(03)00119-0; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Raber L, 2011, CIRCULATION, V123, P2819, DOI 10.1161/CIRCULATIONAHA.110.004762; Saito S., 2017, 81 ANN SCI M JAP CIR; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Soucy NV, 2010, EUROINTERVENTION, V6, P630, DOI 10.4244/EIJV6I5A105; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; van Elteren PH, 1960, B INTERNAT STATISTIQ, V37, P351; vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001441	42	186	188	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 21	2017	390	10105					1843	1852		10.1016/S0140-6736(17)32249-3	http://dx.doi.org/10.1016/S0140-6736(17)32249-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK1LY	28851504				2022-12-28	WOS:000413244500025
J	Diaz, KM; Howard, VJ; Hutto, B; Colabianchi, N; Vena, JE; Safford, MM; Blair, SN; Hooker, SP				Diaz, Keith M.; Howard, Virginia J.; Hutto, Brent; Colabianchi, Natalie; Vena, John E.; Safford, Monika M.; Blair, Steven N.; Hooker, Steven P.			Patterns of Sedentary Behavior and Mortality in US Middle-Aged and Older Adults A National Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICAL-ACTIVITY; ALL-CAUSE; CARDIOVASCULAR-DISEASE; DOSE-RESPONSE; TIME; ASSOCIATION; STROKE; RELIABILITY; BIOMARKERS; BREAKING	Background: Excessive sedentary time is ubiquitous in Western societies. Previous studies have relied on self-reporting to evaluate the total volume of sedentary time as a prognostic risk factor for mortality and have not examined whether the manner in which sedentary time is accrued (in short or long bouts) carries prognostic relevance. Objective: To examine the association between objectively measured sedentary behavior (its total volume and accrual in prolonged, uninterrupted bouts) and all-cause mortality. Design: Prospective cohort study. Setting: Contiguous United States. Participants: 7985 black and white adults aged 45 years or older. Measurements: Sedentary time was measured using a hip-mounted accelerometer. Prolonged, uninterrupted sedentariness was expressed as mean sedentary bout length. Hazard ratios (HRs) were calculated comparing quartiles 2 through 4 to quartile 1 for each exposure (quartile cut points: 689.7, 746.5, and 799.4 min/d for total sedentary time; 7.7, 9.6, and 12.4 min/bout for sedentary bout duration) in models that included moderate to vigorous physical activity. Results: Over a median follow-up of 4.0 years, 340 participants died. In multivariable-adjusted models, greater total sedentary time (HR, 1.22 [95% CI, 0.74 to 2.02]; HR, 1.61 [CI, 0.99 to 2.63]; and HR, 2.63 [CI, 1.60 to 4.30]; P for trend < 0.001) and longer sedentary bout duration (HR, 1.03 [CI, 0.67 to 1.60]; HR, 1.22 [CI, 0.80 to 1.85]; and HR, 1.96 [CI, 1.31 to 2.93]; P for trend < 0.001) were both associated with a higher risk for all-cause mortality. Evaluation of their joint association showed that participants classified as high for both sedentary characteristics (high sedentary time [>= 12.5 h/d] and high bout duration [>= 10 min/bout]) had the greatest risk for death. Limitation: Participants may not be representative of the general U.S. population. Conclusion: Both the total volume of sedentary time and its accrual in prolonged, uninterrupted bouts are associated with all-cause mortality, suggesting that physical activity guidelines should target reducing and interrupting sedentary time to reduce risk for death.	[Diaz, Keith M.] Columbia Univ, Med Ctr, 622 West 168th St,PH9-301, New York, NY 10032 USA; [Safford, Monika M.] Weill Cornell Med Ctr, Dept Med, 1300 York Ave, New York, NY 10021 USA; [Howard, Virginia J.] Univ Alabama Birmingham, Dept Epidemiol, Sch Publ Hlth, 1720 2nd Ave South, Birmingham, AL 35294 USA; [Hutto, Brent] Univ South Carolina, Arnold Sch Publ Hlth, Prevent Res Ctr, 921 Assembly St, Columbia, SC 29208 USA; [Blair, Steven N.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, 921 Assembly St, Columbia, SC 29208 USA; [Colabianchi, Natalie] Univ Michigan, Sch Kinesiol, OBL 1145,1402 Washington Hts, Ann Arbor, MI 48109 USA; [Vena, John E.] Med Univ South Carolina, Dept Publ Hlth Sci, 135 Cannon St,Suite 303,MSC 835, Charleston, SC 29425 USA; [Hooker, Steven P.] Arizona State Univ, Coll Hlth Solut, 550 North 3rd St, Phoenix, AZ 85004 USA	Columbia University; Cornell University; University of Alabama System; University of Alabama Birmingham; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan; Medical University of South Carolina; Arizona State University; Arizona State University-Downtown Phoenix	Diaz, KM (corresponding author), Columbia Univ, Med Ctr, 622 West 168th St,PH9-301, New York, NY 10032 USA.	kd2442@columbia.edu	Colabianchi, Natalie/AAX-4395-2020	Hooker, Steven/0000-0001-9969-6244; Diaz, Keith/0000-0003-0190-0548; Colabianchi, Natalie/0000-0002-7951-9475	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588, R01NS061846, R01NS041588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health.	Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Atlas SJ, 2001, J GEN INTERN MED, V16, P120, DOI 10.1111/j.1525-1497.2001.91141.x; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Diaz KM, 2016, MED SCI SPORT EXER, V48, P430, DOI 10.1249/MSS.0000000000000792; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Esliger DW, 2006, MED SCI SPORT EXER, V38, P2173, DOI 10.1249/01.mss.0000239394.55461.08; Evenson KR, 2016, AM J EPIDEMIOL, V184, P621, DOI 10.1093/aje/kww070; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gerstacker D., 2016, HUFFINGTON POST; Gibbs BB, 2015, MED SCI SPORT EXER, V47, P1295, DOI 10.1249/MSS.0000000000000517; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hooker SP, 2011, J PHYS ACT HEALTH, V8, P372, DOI 10.1123/jpah.8.3.372; Howard BJ, 2013, MED SCI SPORT EXER, V45, P1285, DOI 10.1249/MSS.0b013e318285f57e; Howard G, 1997, STROKE, V28, P936, DOI 10.1161/01.STR.28.5.936; Howard VJ, 2015, MED SCI SPORT EXER, V47, P1531, DOI 10.1249/MSS.0000000000000549; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Hutto B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-120; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; LANSKA DJ, 1995, STROKE, V26, P1145, DOI 10.1161/01.STR.26.7.1145; Li R, 2011, SAS GTPHCURV8 MARCO; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Loprinzi PD, 2016, PREV MED, V90, P47, DOI 10.1016/j.ypmed.2016.06.026; Loprinzi PD, 2016, PREV MED, V86, P55, DOI 10.1016/j.ypmed.2016.01.023; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pandey A, 2016, JAMA CARDIOL, V1, P575, DOI 10.1001/jamacardio.2016.1567; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Qi QB, 2015, CIRCULATION, V132, P1560, DOI 10.1161/CIRCULATIONAHA.115.016938; Schmid D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119591; Sturt D., 2016, FORBES; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Yeager S., 2016, SITTING IS NEW SMOKI	44	261	266	7	68	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					465	+		10.7326/M17-0212	http://dx.doi.org/10.7326/M17-0212			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28892811	Green Accepted			2022-12-28	WOS:000411988900007
J	Jackson, IJ; Patton, EE				Jackson, Ian J.; Patton, E. Elizabeth			Red alert about lipid's role in skin cancer	NATURE			English	Editorial Material							HUMAN MELANOCYTES; MC1R; VARIANTS; MELANOMA; ALLELES; GENE; CARCINOGENESIS; PIGMENTATION; HAIR; RISK		[Jackson, Ian J.; Patton, E. Elizabeth] Univ Edinburgh, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Jackson, IJ (corresponding author), Univ Edinburgh, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	ian.jackson@igmm.ed.ac.uk; liz.patton@igmm.ed.ac.uk		Jackson, Ian/0000-0001-6526-0688	Medical Research Council [MC_PC_U127527200, MC_PC_U127585840, MC_PC_U127561112] Funding Source: Medline; MRC [MC_PC_U127585840, MC_PC_U127561112, MC_PC_U127527200] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219; Chen SY, 2017, NATURE, V549, P399, DOI 10.1038/nature23887; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Hauser JE, 2006, PIGM CELL RES, V19, P303, DOI 10.1111/j.1600-0749.2006.00315.x; Jeon S, 2009, EXP MOL MED, V41, P517, DOI 10.3858/emm.2009.41.7.057; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Perez CJ, 2015, J INVEST DERMATOL, V135, P3133, DOI 10.1038/jid.2015.314; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; Tagliabue E, 2015, BRIT J CANCER, V113, P354, DOI 10.1038/bjc.2015.231; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wendt J, 2016, JAMA DERMATOL, V152, P776, DOI 10.1001/jamadermatol.2016.0050	16	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					337	339		10.1038/nature23550	http://dx.doi.org/10.1038/nature23550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH7PB	28869972	Green Submitted			2022-12-28	WOS:000411381300022
J	Giles, S; Xu, GH; Near, TJ; Friedman, M				Giles, Sam; Xu, Guang-Hui; Near, Thomas J.; Friedman, Matt			Early members of 'living fossil' lineage imply later origin of modern ray-finned fishes	NATURE			English	Article							ACTINOPTERYGII; DIVERSIFICATION; PHYLOGENY; INTERRELATIONSHIPS; LEPISOSTEIFORMES; SCANILEPIFORM; POLYPTERUS; EVOLUTION; INFERENCE; CHINA	Modern ray-finned fishes (Actinopterygii) comprise half of extant vertebrate species and are widely thought to have originated before or near the end of the Middle Devonian epoch (around 385 million years ago)(1-4). Polypterids (bichirs and ropefish) represent the earliest-diverging lineage of living actinopterygians, with almost all Palaeozoic taxa interpreted as more closely related to other extant actinopterygians than to polypterids(5-10). By contrast, the earliest material assigned to the polypterid lineage is mid-Cretaceous in age (around 100 million years old)(11), implying a quarter-of-a-billion-year palaeontological gap. Here we show that scanilepiforms, a widely distributed radiation from the Triassic period (around 252-201 million years ago), are stem polypterids. Importantly, these fossils break the long polypterid branch and expose many supposedly primitive features of extant polypterids as reversals. This shifts numerous Palaeozoic ray-fins to the actinopterygian stem, reducing the minimum age for the crown lineage by roughly 45 million years. Recalibration of molecular clocks to exclude phylogenetically reassigned Palaeozoic taxa results in estimates that the actinopterygian crown lineage is about 20-40 million years younger than was indicated by previous molecular analyses(1-4). These new dates are broadly consistent with our revised palaeontological timescale and coincident with an interval of conspicuous morphological and taxonomic diversification among ray-fins centred on the Devonian-Carboniferous boundary(12-14). A shifting timescale, combined with ambiguity in the relationships of late Palaeozoic actinopterygians, highlights this part of the fossil record as a major frontier in understanding the evolutionary assembly of modern vertebrate diversity.	[Giles, Sam; Friedman, Matt] Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England; [Xu, Guang-Hui] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Near, Thomas J.] Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06520 USA; [Near, Thomas J.] Yale Univ, Peabody Museum Nat Hist, 165 Prospect St, New Haven, CT 06520 USA; [Friedman, Matt] Univ Michigan, Museum Paleontol, 1109 Geddes Ave, Ann Arbor, MI 48109 USA; [Friedman, Matt] Univ Michigan, Dept Earth & Environm Sci, 1109 Geddes Ave, Ann Arbor, MI 48109 USA	University of Oxford; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Yale University; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Giles, S (corresponding author), Univ Oxford, Dept Earth Sci, South Parks Rd, Oxford OX1 3AN, England.	sam.giles@earth.ox.ac.uk		Xu, Guang-Hui/0000-0003-3720-0674; Near, Thomas/0000-0002-7398-6670; Giles, Sam/0000-0001-9267-4392	Junior Research Fellowship from Christ Church, Oxford; L'Oreal-UNESCO For Women in Science Fellowship; National Natural Science Foundation of China [41672001]; National Science Foundation [ANT-134166]; Bingham Oceanographic Fund from the Peabody Museum of Natural History, Yale University; Philip Leverhulme Prize [PLP-2012-130]; Leverhulme Trust Project Grant [RPG-2012-65A]	Junior Research Fellowship from Christ Church, Oxford; L'Oreal-UNESCO For Women in Science Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); Bingham Oceanographic Fund from the Peabody Museum of Natural History, Yale University; Philip Leverhulme Prize; Leverhulme Trust Project Grant	Y.-M. Hou, D. Sykes and R. Summerfield assisted with CT scanning. C. Healy, Z. Johanson and M. M. Smith provided scans of Erpetoichthys. L. Sallan provided helpful discussion. N. Brocklehurst helped with R, and L. Parry assisted with R and MrBayes. S.G. was supported by a Junior Research Fellowship from Christ Church, Oxford, and a L'Oreal-UNESCO For Women in Science Fellowship. G.-H.X. was supported by the National Natural Science Foundation of China (41672001). T.J.N was supported by the National Science Foundation (ANT-134166) and the Bingham Oceanographic Fund from the Peabody Museum of Natural History, Yale University. M.F. was supported by a Philip Leverhulme Prize (PLP-2012-130) and Leverhulme Trust Project Grant (RPG-2012-65A).	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Allis EP, 1922, J ANAT, V56, P189; [Anonymous], 2021, LANG ENV STAT COMP; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Britz R., 2011, ZOOL J LINN SOC-LOND, V138, P495; Broughton R.E., 2013, PLOS CURR; Claeson KM, 2007, J MORPHOL, V268, P1021, DOI 10.1002/jmor.10567; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; Coates MI, 1999, PHILOS T R SOC B, V354, P435, DOI 10.1098/rstb.1999.0396; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dutheil DB, 1999, J VERTEBR PALEONTOL, V19, P243, DOI 10.1080/02724634.1999.10011138; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Friedman M, 2015, PALAEONTOLOGY, V58, P213, DOI 10.1111/pala.12150; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; Gayet M, 2002, PALAEONTOLOGY, V45, P361, DOI 10.1111/1475-4983.00241; Giles S., 2017, FUKANGICHTHYS CT SCA; Giles S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1485; Goodrich E. S., 1928, Palaeobiologica Wien I/I, V1928, P87; Grande L, 2010, COPEIA, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Jessen H. L, 1973, INTERRELATIONSHIPS F, P63; JOLLIE M, 1984, J ZOOL, V204, P469; Lloyd GT., 2015, CLADDIS R PACKAGE PE; Mark A. Bell, 2015, R PACKAGE VERSION 2; Mickle KE, 2009, GEODIVERSITAS, V31, P623, DOI 10.5252/g2009n3a6; Near TJ, 2014, EVOLUTION, V68, P1014, DOI 10.1111/evo.12323; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PATTERSON C, 1982, AM ZOOL, V22, P241; Rambaut A., 2014, TRACER V 1 6; Sallan L. C., 2011, P R SOC B; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; Sallan LC, 2013, ZOOL J LINN SOC-LOND, V169, P156, DOI 10.1111/zoj.12054; Selezneva A.A., 1985, PALEONTOL J+, V19, P1; Swofford D. L., PAUP PHYLOGENETIC AN, V4; Sytchevskaya Eugenia K., 1999, P445; Wilkinson M, 1995, SYST BIOL, V44, P501, DOI 10.1093/sysbio/44.4.501; Xu GH, 2014, J VERTEBR PALEONTOL, V34, P747, DOI 10.1080/02724634.2014.837053; Xu GH, 2011, ZOOL J LINN SOC-LOND, V161, P595, DOI 10.1111/j.1096-3642.2010.00645.x	43	59	61	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					265	+		10.1038/nature23654	http://dx.doi.org/10.1038/nature23654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28854173	Green Submitted			2022-12-28	WOS:000410555900044
J	Voosen, P				Voosen, Paul			OCEANOGRAPHY Billionaire's gift pushes ocean sensors deeper	SCIENCE			English	News Item																			0	1	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		956	957		10.1126/science.357.6355.956	http://dx.doi.org/10.1126/science.357.6355.956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883053				2022-12-28	WOS:000409455700011
J	Kuznetsov, L; Dworzynski, K; Davies, M; Overton, C				Kuznetsov, Laura; Dworzynski, Katharina; Davies, Melanie; Overton, Caroline		Guideline Comm	GUIDELINES Diagnosis and management of endometriosis: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DELAY; WOMEN		[Kuznetsov, Laura; Dworzynski, Katharina; Davies, Melanie] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London NW1 4RG, England; [Davies, Melanie] Univ Coll London Hosp, London, England; [Overton, Caroline] St Michaels Univ Hosp, Bristol, Avon, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Davies, M (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London NW1 4RG, England.	MDaviesmdavies@rcog.org.uk		Davies, Melanie/0000-0001-6907-5527	National Institute for Health; Care Excellence; MRC [G0601458] Funding Source: UKRI; Medical Research Council [G0601458] Funding Source: researchfish; National Institute for Health Research [13/52/04] Funding Source: researchfish; Wellbeing of Women [RG1436] Funding Source: researchfish; Chief Scientist Office [CZH/4/688] Funding Source: researchfish	National Institute for Health; Care Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW)); Chief Scientist Office	The National Guideline Alliance was commissioned and funded by the National Institute for Health and Care Excellence to develop this guideline and write this BMJ summary.	Ballard K, 2006, FERTIL STERIL, V86, P1296, DOI 10.1016/j.fertnstert.2006.04.054; Culley L, 2013, ENDOMETRIOSIS IMPROV; D'Hooghe TM, 2002, HUM REPROD UPDATE, V8, P84, DOI 10.1093/humupd/8.1.84; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Greene R, 2009, FERTIL STERIL, V91, P32, DOI 10.1016/j.fertnstert.2007.11.020; Hudelist G, 2012, HUM REPROD, V27, P3412, DOI 10.1093/humrep/des316; National Institute for Health and Care Excellence, 2017, END DIAGN MAN NICE G; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Royal College of Obstetricians and Gynaecologists, 2017, DIAGN LAP CONS ADV N	9	42	49	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j3935	10.1136/bmj.j3935	http://dx.doi.org/10.1136/bmj.j3935			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EG	28877898	Green Published			2022-12-28	WOS:000410575400005
J	Kakkar, M; Walia, K; Vong, S; Chatterjee, P; Sharma, A				Kakkar, Manish; Walia, Kamini; Vong, Sirenda; Chatterjee, Pranab; Sharma, Anuj			Antibiotic resistance and its containment in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METALLO-BETA-LACTAMASE; STEWARDSHIP; PROFILES; PROGRAM; TRENDS		[Kakkar, Manish; Chatterjee, Pranab] Publ Hlth Fdn India, Delhi, India; [Walia, Kamini] Indian Council Med Res, New Delhi, India; [Vong, Sirenda] World Hlth Org Reg Off South East Asia, New Delhi, India; [Sharma, Anuj] World Hlth Org Country Off India, New Delhi, India	Public Health Foundation of India; Indian Council of Medical Research (ICMR); World Health Organization; World Health Organization	Sharma, A (corresponding author), World Hlth Org Country Off India, New Delhi, India.	sharmaan@who.int	Chatterjee, Pranab/P-6272-2017	Chatterjee, Pranab/0000-0001-6443-608X	WHO SEARO	WHO SEARO(World Health Organization)	This article is one of a series commissioned by The BMJ based on an idea from WHO SEARO. The BMJ retained full editorial control over external peer review, editing, and publication. Open access fees are funded by the WHO SEARO.	[Anonymous], 2011, NAT POL CONT ANT RES; [Anonymous], 2017, TREATM GUID ANT US C; [Anonymous], 2017, NAT ACT PLAN ANT RES; [Anonymous], 2016, ANT US RES FOOD AN C; [Anonymous], 2015, HOSP INF PREV CONTR; Bhattacharyya D, 2016, MICROB DRUG RESIST, V22, P675, DOI 10.1089/mdr.2015.0330; Center for Disease Dynamics, EC POL RES; Center for Disease Dynamics Economics and Policy, RES MAP; Centers for Disease Control and Prevention, ONE HLTH; Chandy SJ, 2014, INDIAN J MED RES, V139, P226; Dhanarani TS, 2009, POULTRY SCI, V88, P1381, DOI 10.3382/ps.2008-00327; Farooqui H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129191; Food and Drug Administration, 2015, ANT SOLD DISTR US FO; Food Safety and Standards Authority of India, 2015, FOOD SAFETY STANDARD; Ghatak S, 2013, TRANSBOUND EMERG DIS, V60, P385, DOI 10.1111/tbed.12119; Gouf LC, 2017, BMJ-BRIT MED J, V358, pj3544; Hazra A, 2014, INDIAN J PHARMACOL, V46, P361, DOI 10.4103/0253-7613.135945; Indian Council of Medical Research, 2013, ANN REP 2012 13; Indian Council of Medical Research, HOSP INF CONTR GUID; International Vaccine Access Center (IVAC) Johns Hopkins Bloomberg School of Public Health, 2016, PNEUM DIARRH PROGR R; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Kotwani A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-99; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Kumar R, 2009, FOODBORNE PATHOG DIS, V6, P621, DOI 10.1089/fpd.2008.0252; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Panda S, 2017, BMJ-BRIT MED J, V358, P67, DOI 10.1136/bmj.j3545; Patel V, 2005, J Postgrad Med, V51, P9; Samanta I, 2014, J APPL POULTRY RES, V23, P536, DOI 10.3382/japr.2013-00929; Shuo, 2016, GUID PREV TREATM OPP, V27, P298; So AD, 2014, MED HLTH SYSTEMS ADV, P63; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Travasso C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1202; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Walia K., ANTIMICROBIAL RESIST; Walia K, 2015, INDIAN J MED RES, V142, P130, DOI 10.4103/0971-5916.164228; WHO, 2015, GLOB ACT PLAN ANT RE; World Health Organization, HLTH STAT INF SYST D	41	37	38	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						25	29	j2687	10.1136/bmj.j2687	http://dx.doi.org/10.1136/bmj.j2687			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874365				2022-12-28	WOS:000410575100004
J	Gilbert, L; Revil, T; Meunier, C; Jardon, K; Zeng, X; Martins, C; Arseneau, J; Fu, LL; North, K; Schiavi, A; Ehrensperger, E; Artho, G; Lee, T; Morris, D; Ragoussis, J				Gilbert, Lucy; Revil, Timothee; Meunier, Charles; Jardon, Kris; Zeng, Xing; Martins, Claudia; Arseneau, Jocelyne; Fu, Lili; North, Krystle; Schiavi, Alicia; Ehrensperger, Eric; Artho, Giovanni; Lee, Todd; Morris, David; Ragoussis, Jiannis			The empress of subterfuge: cancer of the fallopian tube presenting with malapropism	LANCET			English	Editorial Material							OVARIAN		[Gilbert, Lucy; Jardon, Kris; Zeng, Xing; Martins, Claudia; North, Krystle; Schiavi, Alicia] McGill Univ, Hlth Ctr, Div Gynaecol Oncol, Dept Obstet & Gynaecol, Montreal, PQ, Canada; [Arseneau, Jocelyne; Fu, Lili] McGill Univ, Hlth Ctr, Dept Pathol, Montreal, PQ, Canada; [Ehrensperger, Eric] McGill Univ, Hlth Ctr, Div Neurol, Montreal, PQ, Canada; [Artho, Giovanni] McGill Univ, Hlth Ctr, Dept Radiol, Montreal, PQ, Canada; [Lee, Todd; Morris, David] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada; [Revil, Timothee; Meunier, Charles; Ragoussis, Jiannis] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Revil, Timothee; Meunier, Charles; Ragoussis, Jiannis] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Gilbert, L (corresponding author), McGill Univ, Hlth Ctr, Cedars Canc Ctr, Div Gynaecol Oncol, Montreal H4A 3J1, PQ, Canada.	lucy.gilbert@mcgill.ca	Ragoussis, Ioannis/AAD-9790-2022; Gilbert, Lucy/M-6879-2019	Gilbert, Lucy/0000-0001-8605-5472; Lee, Todd/0000-0002-2267-4239; Ragoussis, Ioannis/0000-0002-8515-0934				Barlin JN, 2012, GYNECOL ONCOL, V125, P621, DOI 10.1016/j.ygyno.2012.03.027; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Crum CP, 2013, J PATHOL, V231, P402, DOI 10.1002/path.4263; Gilbert L, 2012, LANCET ONCOL, V13, P285, DOI 10.1016/S1470-2045(11)70333-3; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952	5	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					1003	1004		10.1016/S0140-6736(17)31586-6	http://dx.doi.org/10.1016/S0140-6736(17)31586-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28872014				2022-12-28	WOS:000408746300029
J	Desai, S; Glasier, C				Desai, Shivang; Glasier, Charles			Sturge-Weber Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Desai, Shivang; Glasier, Charles] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Desai, S (corresponding author), Univ Arkansas Med Sci, Little Rock, AR 72205 USA.	sdesai@uams.edu	Desai, Shivang/AAL-7033-2021						0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9								10.1056/NEJMicm1700538	http://dx.doi.org/10.1056/NEJMicm1700538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854093				2022-12-28	WOS:000408626400011
J	Mann, JFE; Orsted, DD; Brown-Frandsen, K; Marso, SP; Poulter, NR; Rasmussen, S; Tornoe, K; Zinman, B; Buse, JB				Mann, Johannes F. E.; Orsted, David D.; Brown-Frandsen, Kirstine; Marso, Steven P.; Poulter, Neil R.; Rasmussen, Soren; Tornoe, Karen; Zinman, Bernard; Buse, John B.		LEADER Steering Comm Investigators	Liraglutide and Renal Outcomes in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE GLUCOSE CONTROL; CARDIOVASCULAR OUTCOMES; KIDNEY-FUNCTION; ALBUMINURIA; MORTALITY; DISEASE; RISK; EMPAGLIFLOZIN; NEPHROPATHY; DEATH	BACKGROUND In a randomized, controlled trial that compared liraglutide, a glucagon-like peptide 1 analogue, with placebo in patients with type 2 diabetes and high cardiovascular risk who were receiving usual care, we found that liraglutide resulted in lower risks of the primary end point (nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes) and death. However, the long-term effects of liraglutide on renal outcomes in patients with type 2 diabetes are unknown. METHODS We report the prespecified secondary renal outcomes of that randomized, controlled trial in which patients were assigned to receive liraglutide or placebo. The secondary renal outcome was a composite of new-onset persistent macroalbuminuria, persistent doubling of the serum creatinine level, end-stage renal disease, or death due to renal disease. The risk of renal outcomes was determined with the use of time-to-event analyses with an intention-to-treat approach. Changes in the estimated glomerular filtration rate and albuminuria were also analyzed. RESULTS A total of 9340 patients underwent randomization, and the median follow-up of the patients was 3.84 years. The renal outcome occurred in fewer participants in the liraglutide group than in the placebo group (268 of 4668 patients vs. 337 of 4672; hazard ratio, 0.78; 95% confidence interval [CI], 0.67 to 0.92; P = 0.003). This result was driven primarily by the new onset of persistent macroalbuminuria, which occurred in fewer participants in the liraglutide group than in the placebo group (161 vs. 215 patients; hazard ratio, 0.74; 95% CI, 0.60 to 0.91; P = 0.004). The rates of renal adverse events were similar in the liraglutide group and the placebo group (15.1 events and 16.5 events per 1000 patient-years), including the rate of acute kidney injury (7.1 and 6.2 events per 1000 patient-years, respectively). CONCLUSIONS This prespecified secondary analysis shows that, when added to usual care, liraglutide resulted in lower rates of the development and progression of diabetic kidney disease than placebo. (Funded by Novo Nordisk and the National Institutes of Health; LEADER ClinicalTrials.gov number, NCT01179048.)	[Mann, Johannes F. E.] KfH Kidney Ctr, 15 Isoldenstr, D-80804 Munich, Germany; [Mann, Johannes F. E.] Friedrich Alexander Univ Erlangen, Erlangen, Germany; [Orsted, David D.; Brown-Frandsen, Kirstine; Rasmussen, Soren; Tornoe, Karen] Novo Nordisk, Bagsvaerd, Denmark; [Marso, Steven P.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Poulter, Neil R.] Imperial Coll London, London, England; [Zinman, Bernard] Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA	University of Erlangen Nuremberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; Imperial College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mann, JFE (corresponding author), KfH Kidney Ctr, 15 Isoldenstr, D-80804 Munich, Germany.	prof.j.mann@gmail.com	Zinman, Bernard/E-7266-2013; Geloneze, Bruno/F-4231-2010; Dagdelen, Selcuk/A-9432-2017; Hramiak, Irene/G-3305-2011; Tack, Cees J/A-2368-2014; Ozdem, Sadi S/C-1140-2016; Gogas Yavuz, Dilek/GPX-2330-2022; Camafort-Babkowski, Miguel/H-6310-2014; Lyudmila, Suplotova A/J-3596-2014; Strelkova, Alexandra/AAE-2917-2019; Vladu, Mihaela Ionela/AAA-6254-2021; Uygur, Meliha Melin/AAJ-5766-2021; Canani, Luis H/G-9686-2012; Stavropoulos, Konstantinos/H-8910-2019; Harbers, Veroniek/G-5470-2017; cavdar, umit/GSI-8283-2022; Gerchman, Fernando/K-1936-2017; Gogas Yavuz, Dilek/AAC-3697-2020; Iyidir, Ozlem/K-7904-2019; Buse, John Bernard/J-9742-2019; Gunasekaran, Prasad/AAW-4107-2021; Buscemi, Silvio/K-9662-2016; mathieu, chantal/ABD-5505-2021; Lacolley, Patrick/G-3118-2013; Mann, Johannes/AAI-8803-2020; Gogas Yavuz, Dilek/GRR-7277-2022; Tamer, Ismet/AAR-6115-2020; Ataoğlu, Hayriye Esra/AAD-5627-2019; Mehr, Ali Poyan/P-9665-2019; Bogdański, Paweł/ABB-2938-2020; Prozesky, Hans Walter/ABE-6956-2020; BALCI, Mustafa Kemal/C-2979-2016; Regnault, Veronique/H-9138-2016; Mattina, Alessandro/F-6020-2019; Charchar, Fadi/I-6656-2017; Saravanan, Ponnusamy/M-6142-2016	Geloneze, Bruno/0000-0002-0557-4578; Dagdelen, Selcuk/0000-0002-0513-1750; Ozdem, Sadi S/0000-0003-4325-5209; Gogas Yavuz, Dilek/0000-0002-0075-6313; Camafort-Babkowski, Miguel/0000-0002-8669-6410; Lyudmila, Suplotova A/0000-0001-9253-8075; Strelkova, Alexandra/0000-0002-9077-889X; Vladu, Mihaela Ionela/0000-0002-6133-4341; Uygur, Meliha Melin/0000-0002-6569-8142; Canani, Luis H/0000-0002-1813-4491; Stavropoulos, Konstantinos/0000-0002-5549-7048; Gerchman, Fernando/0000-0001-5873-9498; Gogas Yavuz, Dilek/0000-0002-0075-6313; Iyidir, Ozlem/0000-0001-5305-6807; Buse, John Bernard/0000-0002-9723-3876; Gunasekaran, Prasad/0000-0002-6852-528X; Buscemi, Silvio/0000-0003-0730-7649; mathieu, chantal/0000-0002-4055-5233; Gogas Yavuz, Dilek/0000-0002-0075-6313; Tamer, Ismet/0000-0001-9596-7203; Ataoğlu, Hayriye Esra/0000-0002-6559-2575; Mehr, Ali Poyan/0000-0001-5610-2979; Bogdański, Paweł/0000-0002-0563-1624; Prozesky, Hans Walter/0000-0001-9715-3449; BALCI, Mustafa Kemal/0000-0002-6494-3249; Mattina, Alessandro/0000-0003-3458-0894; Gram, Jeppe/0000-0003-2584-1132; S, Paramesh/0000-0002-0693-4483; Hernandez Salazar, Eduardo/0000-0002-2087-6849; Lindsay, Robert/0000-0002-9868-5217; ENGIN, ISMAIL/0000-0002-6493-9194; Lin, Shu-Fu/0000-0001-8877-9685; Kiseleva, Tatiana/0000-0001-8959-093X; Sgarbi, Jose/0000-0001-7187-984X; Harbers, Veroniek/0000-0002-0428-3242; Milicic, Tanja/0000-0001-7300-916X; Charchar, Fadi/0000-0002-6164-9941; Valeeva, Farida/0000-0001-6000-8002; MARANGHI, MARIANNA/0000-0002-3117-7488; Gilfillan, Christopher/0000-0002-8193-8994; Zurawska-Klis, Monika/0000-0002-2962-762X; Saravanan, Ponnusamy/0000-0002-9566-2626; Piya, Milan/0000-0002-2783-1168; Kunecki, Marcin/0000-0003-4077-7378; Scofield, Robert Hal/0000-0003-1015-5850; Vuksanovic, Miljanka/0000-0002-1512-479X; Cederberg, Henna/0000-0003-2901-9373; Montenegro Junior, Renan/0000-0001-7287-8726; O'Connell, Jean/0000-0001-7241-8025; DINCER, IREM/0000-0002-3650-7060; Pieber, Thomas/0000-0003-3554-0405; Reyes-Garcia, Rebeca/0000-0003-1729-4431	Novo Nordisk; National Institutes of Health; LEADER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER	Novo Nordisk(Novo Nordisk); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LEADER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Novo Nordisk and the National Institutes of Health; LEADER ClinicalTrials.gov number, NCT01179048.	Alegre-Diaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368; Clase CM, 2017, KIDNEY INT, V91, P683, DOI 10.1016/j.kint.2016.09.038; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Marso SP, 2013, AM HEART J, V166, P823, DOI 10.1016/j.ahj.2013.07.012; Molitch ME, 2015, KIDNEY INT, V87, P20, DOI 10.1038/ki.2014.128; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Skov J, 2016, DIABETES OBES METAB, V18, P581, DOI 10.1111/dom.12651; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; von Scholten BJ, 2015, DIABETIC MED, V32, P343, DOI 10.1111/dme.12594; von Scholten BJ, 2017, DIABETES OBES METAB, V19, P901, DOI 10.1111/dom.12884; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zeisberg M, 2015, KIDNEY INT, V88, P429, DOI 10.1038/ki.2015.175; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoungas S, 2014, DIABETOLOGIA, V57, P2465, DOI 10.1007/s00125-014-3369-7	31	626	651	7	133	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					839	848		10.1056/NEJMoa1616011	http://dx.doi.org/10.1056/NEJMoa1616011			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28854085	Green Published, Green Accepted			2022-12-28	WOS:000408626400007
J	Stein, F; Sridhar, D				Stein, Felix; Sridhar, Devi			Health as a "global public good": creating a market for pandemic risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EBOLA		[Stein, Felix; Sridhar, Devi] Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland	University of Edinburgh	Stein, F (corresponding author), Univ Edinburgh, Med Sch, Edinburgh, Midlothian, Scotland.	felix.stein@ed.ac.uk		Stein, Felix/0000-0002-0123-9895	Wellcome Trust [106635/Z/14/Z]	Wellcome Trust(Wellcome Trust)	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. This work was supported by Wellcome Trust [106635/Z/14/Z]. A senior member of the World Bank is on our project's advisory board.	Clinton C, 2017, GOVERNING GLOBAL HLT; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR, P59; Erikson SL, 2015, FINANCIALIZATION EBO; Erikson SL, 2015, CURR ANTHROPOL, V56, pS306, DOI 10.1086/683271; Ferguson J., 1990, ANTIPOLITICS MACHINE; Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; International Working Group on Financing Preparedness, 2017, PAN NEGL INV HLTH SE; Johnson L, 2015, ENVIRON PLANN A, V47, P2503, DOI 10.1177/0308518X15594800; Jonas, 2013, PANDEMIC RISK; Kaul I, 1999, PUBLIC GOODS INT COO, DOI [10.1093/0195130529.001.0001, DOI 10.1093/0195130529.001.0001]; Kikwete JM, 2016, HIGH LEVEL PANEL GLO; Kim JY, 2016, COMMUNICATION; Lewis M., 2007, NY TIMES; Mankiw GN, 2012, PRINCIPLES EC, P219; Medecins Sans Frontieres, 2016, PUSH LIM; Moon S, 2017, HEALTH ECON POLICY L, V12, P195, DOI [10.1017/S1744133116000451, 10.1017/s1744133116000451]; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Save the Children, 2015, WAK UP CALL LESS EB; Tyson J., 2016, DEVEX; WHO, 2015, REP EB INT ASS PAN; World Bank Group, 1993, DEV REP 1993 INV HLT; World Bank Group, 2017, PAND EM FIN FAC GLOB; World Bank Group, 2007, GLOB PUBL GOODS FRAM; World Bank Group, 2016, ANN REPORT; World Economic Forum, 2015, MAN RISK IMP FUT EP; World Health Organisation, 2015, FACT CONTR UND SPREA; World Health Organization, 2007, INT HLTH REG 2005	28	18	18	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3397	10.1136/bmj.j3397	http://dx.doi.org/10.1136/bmj.j3397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CQ	28860109	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000409387000006
J	Palmer, J				Palmer, Jane			CREEPING CATASTROPHES	NATURE			English	News Item																		Lacroix P, 2014, GEOPHYS RES LETT, V41, P6676, DOI 10.1002/2014GL061170; Lacroix P, 2015, REMOTE SENS ENVIRON, V165, P148, DOI 10.1016/j.rse.2015.05.010; Roering JJ, 2015, GEOMORPHOLOGY, V236, P109, DOI 10.1016/j.geomorph.2015.02.013; Schulz WH, 2017, GEOMORPHOLOGY, V285, P121, DOI 10.1016/j.geomorph.2017.02.011	4	30	32	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					384	386		10.1038/548384a	http://dx.doi.org/10.1038/548384a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE5VI	28836610				2022-12-28	WOS:000408279000012
J	Vatankhah-Varnosfaderani, M; Daniel, WFM; Everhart, MH; Pandya, AA; Liang, HY; Matyjaszewski, K; Dobrynin, AV; Sheiko, SS				Vatankhah-Varnosfaderani, Mohammad; Daniel, William F. M.; Everhart, Matthew H.; Pandya, Ashish A.; Liang, Heyi; Matyjaszewski, Krzysztof; Dobrynin, Andrey V.; Sheiko, Sergei S.			Mimicking biological stress-strain behaviour with synthetic elastomers	NATURE			English	Article							MECHANICAL-PROPERTIES; NETWORKS; BIOMATERIALS; ELECTRONICS; ELASTICITY; COPOLYMERS; SUPERSOFT; POLYMERS; RHEOLOGY; DESIGN	Despite the versatility of synthetic chemistry, certain combinations of mechanical softness, strength, and toughness can be difficult to achieve in a single material. These combinations are, however, commonplace in biological tissues, and are therefore needed for applications such as medical implants, tissue engineering, soft robotics, and wearable electronics(1-9). Present materials synthesis strategies are predominantly Edisonian, involving the empirical mixing of assorted monomers, crosslinking schemes, and occluded swelling agents, but this approach yields limited property control(2,10-16). Here we present a general strategy for mimicking the mechanical behaviour of biological materials by precisely encoding their stress-strain curves in solventfree brush-and comb-like polymer networks (elastomers). The code consists of three independent architectural parameters-network strand length, side-chain length and grafting density. Using prototypical poly(dimethylsiloxane) elastomers, we illustrate how this parametric triplet enables the replication of the strain-stiffening characteristics of jellyfish, lung, and arterial tissues.	[Vatankhah-Varnosfaderani, Mohammad; Daniel, William F. M.; Everhart, Matthew H.; Pandya, Ashish A.; Sheiko, Sergei S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Liang, Heyi; Dobrynin, Andrey V.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA; [Matyjaszewski, Krzysztof] Carnegie Mellon Univ, Dept Chem, 4400 Fifth Ave, Pittsburgh, PA 15213 USA	University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Akron; Carnegie Mellon University	Sheiko, SS (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.; Dobrynin, AV (corresponding author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.	adobrynin@uakron.edu; sergei@email.unc.edu	Matyjaszewski, Krzysztof/A-2508-2008	Matyjaszewski, Krzysztof/0000-0003-1960-3402; Liang, Heyi/0000-0002-8308-3547	National Science Foundation [DMR 1436201, DMR 1407645, DMR 1624569]; Division Of Materials Research [1407645] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the National Science Foundation for funding (grants DMR 1436201, DMR 1407645 and DMR 1624569). We thank M. Rubinstein for discussions; and E. T. Samulski, G. R. Newkome and K. A. Sheyko for reviewing the paper prior to submission.	Akbari M, 2014, ADV FUNCT MATER, V24, P4060, DOI 10.1002/adfm.201303655; Bolton J, 2014, MACROMOLECULES, V47, P2864, DOI 10.1021/ma500625k; Carrillo JMY, 2013, MACROMOLECULES, V46, P3679, DOI 10.1021/ma400478f; Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003; Daniel WFM, 2017, MACROMOLECULES, V50, P2103, DOI 10.1021/acs.macromol.7b00030; Daniel WFM, 2016, NAT MATER, V15, P183, DOI [10.1038/NMAT4508, 10.1038/nmat4508]; Daniels DR, 2001, MACROMOLECULES, V34, P7025, DOI 10.1021/ma010712p; Fetters LJ, 2002, MACROMOLECULES, V35, P10096, DOI 10.1021/ma025659z; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; GOUINLOCK EV, 1977, POLYM ENG SCI, V17, P535, DOI 10.1002/pen.760170809; Green JJ, 2016, NATURE, V540, P386, DOI 10.1038/nature21005; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Grindy SC, 2015, NAT MATER, V14, P1210, DOI [10.1038/nmat4401, 10.1038/NMAT4401]; Kapnistos M, 2005, MACROMOLECULES, V38, P7852, DOI 10.1021/ma050644x; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Luo YD, 2015, MACROMOLECULES, V48, P3422, DOI 10.1021/acs.macromol.5b00518; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; Majidi C, 2014, SOFT ROBOT, V1, P5, DOI 10.1089/soro.2013.0001; Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Pakula T, 2006, POLYMER, V47, P7198, DOI 10.1016/j.polymer.2006.05.064; PATEL SK, 1992, MACROMOLECULES, V25, P5241, DOI 10.1021/ma00046a021; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Takano A, 2005, MACROMOLECULES, V38, P9718, DOI 10.1021/ma050712f; Vatankhah-Varnoosfaderani M, 2017, ADV MATER, V29, DOI 10.1002/adma.201604209; Xia Y, 2009, J AM CHEM SOC, V131, P18525, DOI 10.1021/ja908379q; Yu B, 2016, NAT MATER, V15, P911, DOI [10.1038/NMAT4635, 10.1038/nmat4635]; Zhang JY, 2016, MACROMOLECULES, V49, P9108, DOI 10.1021/acs.macromol.6b02033; Zhong MJ, 2016, SCIENCE, V353, P1264, DOI 10.1126/science.aag0184	30	204	204	23	362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 28	2017	549	7673					497	501		10.1038/nature23673	http://dx.doi.org/10.1038/nature23673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI4GT	28869962				2022-12-28	WOS:000411930000045
J	Shlezinger, N; Irmer, H; Dhingra, S; Beattie, SR; Cramer, RA; Braus, GH; Sharon, A; Hohl, TM				Shlezinger, Neta; Irmer, Henriette; Dhingra, Sourabh; Beattie, Sarah R.; Cramer, Robert A.; Braus, Gerhard H.; Sharon, Amir; Hohl, Tobias M.			Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death	SCIENCE			English	Article							INFECTION; SURVIVIN; ASPERGILLOSIS; INHIBITOR; FAMILY; GENES	Humans inhale mold conidia daily and typically experience lifelong asymptomatic clearance. Conidial germination into tissue-invasive hyphae can occur in individuals with defects in myeloid function, although the mechanism of myeloid cell-mediated immune surveillance remains unclear. By monitoring fungal physiology in vivo, we demonstrate that lung neutrophils trigger programmed cell death with apoptosis-like features in Aspergillus fumigatus conidia, the most prevalent human mold pathogen. An antiapoptotic protein, AfBIR1, opposes this process by inhibiting fungal caspase activation and DNA fragmentation in the murine lung. Genetic and pharmacologic studies indicate that AfBIR1 expression and activity underlie conidial susceptibility to NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase-dependent killing and, in turn, host susceptibility to invasive aspergillosis. Immune surveillance exploits a fungal apoptosis-like programmed cell death pathway to maintain sterilizing immunity in the lung.	[Shlezinger, Neta; Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10065 USA; [Irmer, Henriette; Braus, Gerhard H.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany; [Irmer, Henriette; Braus, Gerhard H.] Univ Gottingen, Gottingen Ctr Mol Biosci, D-37077 Gottingen, Germany; [Dhingra, Sourabh; Beattie, Sarah R.; Cramer, Robert A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Sharon, Amir] Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel; [Hohl, Tobias M.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; University of Gottingen; University of Gottingen; Dartmouth College; Tel Aviv University; Memorial Sloan Kettering Cancer Center	Hohl, TM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10065 USA.; Sharon, A (corresponding author), Tel Aviv Univ, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.; Hohl, TM (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA.	amirsh@tauex.tau.ac.il; hohlt@mskcc.org	Braus, Gerhard/ABC-6293-2021; Braus, Gerhard H/G-3999-2012; shlezinger, neta/ABG-2882-2021	Braus, Gerhard/0000-0002-3117-5626; Braus, Gerhard H/0000-0002-3117-5626; Cramer, Robert/0000-0001-5503-5006; Hohl, Tobias/0000-0002-9097-5412	NIH [RO1 AI093808, R21 AI105617, RO1 AI081838, T32 GM008704, P30 CA008748, P30GM106394]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Awards; Israel Science Foundation [835/13]; Deutsche Forschungsgemeinschaft [BR1502/11-2]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093808, R01AI081838, R21AI105617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394, T32GM008704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Awards; Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Pamer, M. Li, S. Kasahara, B. Zhai, and L. Heung for discussions and critical reading of the manuscript; the Memorial Sloan Kettering Cancer Center Cytology Facility, C. Franqui, and I. Leiner for technical assistance; S. Knoblaugh (Ohio State University) for histopathology; and D. Askew (University of Cincinnati) for expertise on fungal strains. This research was supported by NIH grants RO1 AI093808 (T.M.H.), R21 AI105617 (T.M.H.), RO1 AI081838 (R.A.C.), T32 GM008704 (S.R.B.), P30 CA008748 (to MSKCC), and P30GM106394 (B. Stanton, principal investigator; R.A.C., Pilot Project); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Awards (T.M.H. and R.A.C.); Israel Science Foundation grant 835/13 (A.S.); and Deutsche Forschungsgemeinschaft grant BR1502/11-2 (G.H.B.). All data and code to understand and address the conclusions of this research are available in the main text and supplementary materials.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Berezov A, 2012, ONCOGENE, V31, P1938, DOI 10.1038/onc.2011.377; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Espinosa V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003940; GERSON SL, 1984, ANN INTERN MED, V100, P345, DOI 10.7326/0003-4819-100-3-345; Hein KZ, 2015, P NATL ACAD SCI USA, V112, P13039, DOI 10.1073/pnas.1511197112; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Jhingran A, 2012, CELL REP, V2, P1762, DOI 10.1016/j.celrep.2012.10.026; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; Nagata S, 2017, NAT REV IMMUNOL, V17, P333, DOI 10.1038/nri.2016.153; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sharon A, 2009, FEMS MICROBIOL REV, V33, P833, DOI 10.1111/j.1574-6976.2009.00180.x; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shlezinger N, 2011, BIOCHEM SOC T, V39, P1493, DOI 10.1042/BST0391493; Shlezinger N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002185; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550	21	57	58	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1037	+		10.1126/science.aan0365	http://dx.doi.org/10.1126/science.aan0365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883073	Green Accepted			2022-12-28	WOS:000409455700044
J	Nakamura, J; Fujitani, T; Kuld, S; Helveg, S; Chorkendorff, I; Sehested, J				Nakamura, Junji; Fujitani, Tadahiro; Kuld, Sebastian; Helveg, Stig; Chorkendorff, Ib; Sehested, Jens			Comment on "Active sites for CO2 hydrogenation to methanol on Cu/ZnO catalysts"	SCIENCE			English	Editorial Material							SURFACE; KINETICS; COPPER; MODEL; ZNO	Kattel et al. (Reports, 24 March 2017, p. 1296) report that a zinc on copper (Zn/Cu) surface undergoes oxidation to zinc oxide/copper (ZnO/Cu) during carbon dioxide (CO2) hydrogenation to methanol and conclude that the Cu-ZnO interface is the active site for methanol synthesis. Similar experiments conducted two decades ago by Fujitani and Nakamura et al. demonstrated that Zn is attached to formate rather than being fully oxidized.	[Nakamura, Junji] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058573, Japan; [Fujitani, Tadahiro] Natl Inst Adv Ind Sci & Technol, Interdisciplinary Res Ctr Catalyt Chem, Higashi 1-1-1, Tsukuba, Ibaraki 3058565, Japan; [Kuld, Sebastian; Helveg, Stig; Sehested, Jens] Haldor Topsoe Res Labs, Haldor Topsoes Alle 1, DK-2800 Lyngby, Denmark; [Chorkendorff, Ib] Tech Univ Denmark, Dept Phys, Bldg 312, DK-2800 Lyngby, Denmark	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Haldor Topsoe; Technical University of Denmark	Nakamura, J (corresponding author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba Res Ctr Interdisciplinary Mat Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058573, Japan.; Sehested, J (corresponding author), Haldor Topsoe Res Labs, Haldor Topsoes Alle 1, DK-2800 Lyngby, Denmark.; Chorkendorff, I (corresponding author), Tech Univ Denmark, Dept Phys, Bldg 312, DK-2800 Lyngby, Denmark.	nakamura@ims.tsukuba.ac.jp; ibchork@fysik.dtu.dk; jss@topsoe.dk	Chorkendorff, Ib/C-7282-2008; Nakamura, Junji/ABG-3290-2021; Helveg, Stig/O-7513-2018; Fujitani, Tadahiro/H-9114-2018; Helveg, Stig/AAD-8603-2021	Chorkendorff, Ib/0000-0003-2738-0325; Nakamura, Junji/0000-0002-2837-0535; Fujitani, Tadahiro/0000-0002-1225-3246; Helveg, Stig/0000-0002-0328-8295	Japan Science and Technology Agency ACT-C grant [JPMJCR12YU]; Villum Fonden [9455]	Japan Science and Technology Agency ACT-C grant; Villum Fonden(Villum Fonden)	J.N. acknowledges funding from Japan Science and Technology Agency ACT-C grant JPMJCR12YU. I.C. is supported by research grant 9455 from Villum Fonden.	Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; Fujitani T, 1997, SURF SCI, V383, P285, DOI 10.1016/S0039-6028(97)00192-1; Holse C, 2015, J PHYS CHEM C, V119, P2804, DOI 10.1021/jp510015v; Kattel S, 2017, SCIENCE, V355, P1296, DOI 10.1126/science.aal3573; Kuld S, 2016, SCIENCE, V352, P969, DOI 10.1126/science.aaf0718; Kuld S, 2014, ANGEW CHEM INT EDIT, V53, P5941, DOI 10.1002/anie.201311073; Nakamura J, 2003, TOP CATAL, V22, P277, DOI 10.1023/A:1023588322846; Nakamura J, 1996, STUD SURF SCI CATAL, V101, P1389; Nakamura J, 1996, J CATAL, V160, P65, DOI 10.1006/jcat.1996.0124; RASMUSSEN PB, 1994, SURF SCI, V318, P267, DOI 10.1016/0039-6028(94)90101-5; Schott V, 2013, ANGEW CHEM INT EDIT, V52, P11925, DOI 10.1002/anie.201302315; Yoshihara J, 1996, J CATAL, V161, P776, DOI 10.1006/jcat.1996.0240	12	52	53	22	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354							eaan8074	10.1126/science.aan8074	http://dx.doi.org/10.1126/science.aan8074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860354				2022-12-28	WOS:000408734900001
J	Shara, MM; Ilkiewicz, K; Mikolajewska, J; Pagnotta, A; Bode, MF; Crause, LA; Drozd, K; Faherty, J; Fuentes-Morales, I; Grindlay, JE; Moffat, AFJ; Pretorius, ML; Schmidtobreick, L; Stephenson, FR; Tappert, C; Zurek, D				Shara, M. M.; Ilkiewicz, K.; Mikolajewska, J.; Pagnotta, A.; Bode, M. F.; Crause, L. A.; Drozd, K.; Faherty, J.; Fuentes-Morales, I.; Grindlay, J. E.; Moffat, A. F. J.; Pretorius, M. L.; Schmidtobreick, L.; Stephenson, F. R.; Tappert, C.; Zurek, D.			Proper-motion age dating of the progeny of Nova Scorpii ad 1437	NATURE			English	Article							DWARF NOVA; SHELL; SPACE; SPECTROSCOPY; EVOLUTION; REMNANT; MODELS; STARS	'Cataclysmic variables' are binary star systems in which one star of the pair is a white dwarf, and which often generate bright and energetic stellar outbursts. Classical novae are one type of outburst: when the white dwarf accretes enough matter from its companion, the resulting hydrogen-rich atmospheric envelope can host a runaway thermonuclear reaction that generates a rapid brightening(1-4). Achieving peak luminosities of up to one million times that of the Sun(5), all classical novae are recurrent, on timescales of months(6) to millennia(7). During the century before and after an eruption, the 'novalike' binary systems that give rise to classical novae exhibit high rates of mass transfer to their white dwarfs(8). Another type of outburst is the dwarf nova: these occur in binaries that have stellar masses and periods indistinguishable from those of novalikes(9) but much lower mass-transfer rates(10), when accretion-disk instabilities(11) drop matter onto the white dwarfs. The coexistence at the same orbital period of novalike binaries and dwarf novae-which are identical but for their widely varying accretion rates-has been a longstanding puzzle(9). Here we report the recovery of the binary star underlying the classical nova eruption of 11 March ad 1437 (refs 12, 13), and independently confirm its age by proper-motion dating. We show that, almost 500 years after a classical-nova event, the system exhibited dwarf-nova eruptions. The three other oldest recovered classical novae(14-16) display nova shells, but lack firm post-eruption ages(17,18), and are also dwarf novae at present. We conclude that many old novae become dwarf novae for part of the millennia between successive nova eruptions(19,20).	[Shara, M. M.; Pagnotta, A.; Faherty, J.; Zurek, D.] Amer Museum Nat Hist, Dept Astrophys, Cent Pk West & 79th St, New York, NY 10024 USA; [Shara, M. M.] Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Ilkiewicz, K.; Mikolajewska, J.; Drozd, K.] Polish Acad Sci, N Copernicus Astron Ctr, Bartycka 18, PL-00716 Warsaw, Poland; [Bode, M. F.] Liverpool John Moores Univ, Astrophys Res Inst, IC2 Liverpool Sci Pk, Liverpool L3 5RF, Merseyside, England; [Crause, L. A.; Pretorius, M. L.] South African Astron Observ, POB 9, ZA-7935 Cape Town, South Africa; [Fuentes-Morales, I.; Tappert, C.] Univ Valparaiso, Inst Fis & Astron, Ave Gran Bretana 1111, Valparaiso 2360102, Chile; [Grindlay, J. E.] Harvard Smithsonian Ctr Astrophys, Inst Theory & Computat, 60 Garden St, Cambridge, MA 02138 USA; [Moffat, A. F. J.] Univ Montreal, Dept Phys, CP 6128 Succ C-V, Montreal, PQ H3C 3J7, Canada; [Moffat, A. F. J.] Univ Montreal, CRAQ, CP 6128 Succ C-V, Montreal, PQ H3C 3J7, Canada; [Pretorius, M. L.] Univ Capetown, Dept Astron, Private Bag X3, ZA-7701 Rondebosch, South Africa; [Schmidtobreick, L.] European Southern Observ, Alonso de Cordova 3107, Santiago 7630355, Chile; [Stephenson, F. R.] Univ Durham, Dept Phys, South Rd, Durham DH1 3LE, England	American Museum of Natural History (AMNH); University of Cambridge; Polish Academy of Sciences; Liverpool John Moores University; National Research Foundation - South Africa; South African Astronomical Observatory; Universidad de Valparaiso; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Universite de Montreal; Universite de Montreal; University of Cape Town; European Southern Observatory; Durham University	Shara, MM (corresponding author), Amer Museum Nat Hist, Dept Astrophys, Cent Pk West & 79th St, New York, NY 10024 USA.; Shara, MM (corresponding author), Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	mshara@amnh.org		Ilkiewicz, Krystian/0000-0002-4005-5095; Mikolajewska, Joanna/0000-0003-3457-0020; Schmidtobreick, Linda/0000-0002-6713-4754; Pretorius, Magaretha/0000-0001-6017-9522	Polish Narodowe Centrum Nauki [DEC-2013/10/M/ST9/00086]; National Sciences and Engineering Research Council of Canada; Fonds de Recherche Nature et Technologies (Quebec); AMNH's Kathryn W. Davis Postdoctoral Scholar program - New York State Education Department; National Science Foundation (NSF) [DRL-1119444, DUE-1340006]; NSF [AST-0407380, AST-0909073, AST-1313370];  [MNiSW DIR/WK/2016/07]; Science and Technology Facilities Council [ST/H002391/1, ST/M000966/1, PP/E001149/1, ST/F007159/1, ST/J001465/1, ST/L00061X/1] Funding Source: researchfish; STFC [ST/F007159/1, ST/J001465/1, ST/L00061X/1, ST/H002391/1, PP/E001149/1] Funding Source: UKRI	Polish Narodowe Centrum Nauki; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche Nature et Technologies (Quebec); AMNH's Kathryn W. Davis Postdoctoral Scholar program - New York State Education Department; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); ; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	J.M., K.I., K.D. and M.M.S. acknowledge support by the Polish Narodowe Centrum Nauki (grant DEC-2013/10/M/ST9/00086). M.M.S. acknowledges the late P. Newman and the Newman's Own Foundation, whose support made the participation of the American Museum of Natural History (AMNH) in the South African Large Telescope (SALT) possible. A.F.J.M. thanks the National Sciences and Engineering Research Council of Canada and the Fonds de Recherche Nature et Technologies (Quebec) for financial support. A.P. acknowledges support from the AMNH's Kathryn W. Davis Postdoctoral Scholar program, which is supported in part by the New York State Education Department and by the National Science Foundation (NSF) under grant numbers DRL-1119444 and DUE-1340006. M.M.S. acknowledges the hospitality of the Institute of Astronomy at the University of Cambridge. Some of the observations reported here were obtained with the SALT under programme 2016-1-SCI-044, and with the South African Astronomical Observatory's 1.9-metre and 1.0-metre telescopes. Polish participation in SALT is funded by grant no. MNiSW DIR/WK/2016/07. We thank the Harvard-Smithsonian Center for Astrophysics team for making DASCH data available to the astronomical community. The DASCH project at Harvard is partially supported from NSF grants AST-0407380, AST-0909073 and AST-1313370. The Image Reduction and Analysis Facility (IRAF) is distributed by the National Optical Astronomy Observatories, which is operated by the Association of Universities for Research in Astronomy under a cooperative agreement with the NSF. This research has made use of data obtained from the Chandra Data Archive and software provided by the Chandra X-ray Center in application packages CIAO, ChIPS and Sherpa. All authors thank the referees for thoughtful and constructive suggestions.	BATH GT, 1978, MON NOT R ASTRON SOC, V183, P515, DOI 10.1093/mnras/183.3.515; Beuermann K, 2008, ASTRON ASTROPHYS, V480, P199, DOI 10.1051/0004-6361:20079010; Black DTR, 2008, ASTR SOC P, V401, P351; Buckley D. A. H., 2006, P SOC PHOTO-OPT INS, V6267, P62670; Burgh EB, 2003, P SOC PHOTO-OPT INS, V4841, P1463, DOI 10.1117/12.460312; Clark D. H., 1977, GALACTIC SUPERNOVAE; Collazzi AC, 2009, ASTRON J, V138, P1846, DOI 10.1088/0004-6256/138/6/1846; Coppejans R, 2013, PUBL ASTRON SOC PAC, V125, P976, DOI 10.1086/672156; Crawford S. M, 2010, SPIE C SER, V7737, P25; Darnley MJ, 2014, ASTRON ASTROPHYS, V563, DOI 10.1051/0004-6361/201423411; DUERBECK HW, 1987, ASTROPHYS SPACE SCI, V131, P461, DOI 10.1007/BF00668126; Fang H. L., 1966, ASTRONOMICAL CHAPTER; Frew DJ, 2013, MON NOT R ASTRON SOC, V431, P2, DOI 10.1093/mnras/sts393; Fruscione A, 2006, PROC SPIE, V6270, DOI 10.1117/12.671760; Garmire GP, 2003, PROC SPIE, V4851, P28, DOI 10.1117/12.461599; Grindlay J, 2009, ASTR SOC P, V410, P101; Henden Arne A., 2012, Electronic Journal of the AAVSO, V40; Kalberla PMW, 2015, ASTRON ASTROPHYS, V578, DOI 10.1051/0004-6361/201525859; Kiang T., 1972, MEM R ASTRON SOC, V76, P27; Kniazev AY, 2008, MON NOT R ASTRON SOC, V384, P1045, DOI 10.1111/j.1365-2966.2007.12540.x; Knigge C, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/28; Kobulnicky HA, 2003, P SOC PHOTO-OPT INS, V4841, P1634, DOI 10.1117/12.460315; KRAFT RP, 1964, ASTROPHYS J, V139, P457, DOI 10.1086/147776; Krzeminski W., 1971, Acta Astronomica, V21, P133; Lenz P., 2005, COAST, V146, P53, DOI [10.1553/cia146s53, DOI 10.1553/CIA146S53]; Masetti N, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201322026; Miszalski B, 2016, MON NOT R ASTRON SOC, V456, P633, DOI 10.1093/mnras/stv2689; O'Donoghue D, 2006, MON NOT R ASTRON SOC, V372, P151, DOI 10.1111/j.1365-2966.2006.10834.x; OSAKI Y, 1974, PUBL ASTRON SOC JPN, V26, P429; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; PRIALNIK D, 1978, ASTRON ASTROPHYS, V62, P339; Schaefer BE, 2012, NATURE, V481, P164, DOI 10.1038/nature10692; Shara M. M., 1990, PHYS CLASSICAL NOVAE, V369, P57; Shara MM, 2007, NATURE, V446, P159, DOI 10.1038/nature05576; Shara MM, 2017, MON NOT R ASTRON SOC, V465, P739, DOI 10.1093/mnras/stw2753; Shara MM, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/121; Shara MM, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/107; SHARA MM, 1986, ASTROPHYS J, V311, P163, DOI 10.1086/164762; STARRFIELD S, 1972, ASTROPHYS J, V176, P169, DOI 10.1086/151619; STELLINGWERF RF, 1978, ASTROPHYS J, V224, P953, DOI 10.1086/156444; Vogt N., 1982, ASTRON GESELL, V57, P79; Warner B., 1995, CAMBRIDGE ASTROPHYS, V28; Yaron O, 2005, ASTROPHYS J, V623, P398, DOI 10.1086/428435	43	36	36	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					558	+		10.1038/nature23644	http://dx.doi.org/10.1038/nature23644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858302	Green Submitted, Green Accepted			2022-12-28	WOS:000408703100033
J	Jasny, BR; Wigginton, N; McNutt, M; Bubela, T; Buck, S; Cook-Deegan, R; Gardner, T; Hanson, B; Hustad, C; Kiermer, V; Lazer, D; Lupia, A; Manrai, A; McConnell, L; Noonan, K; Phimister, E; Simon, B; Strandburg, K; Summers, Z; Watts, D				Jasny, B. R.; Wigginton, N.; McNutt, M.; Bubela, T.; Buck, S.; Cook-Deegan, R.; Gardner, T.; Hanson, B.; Hustad, C.; Kiermer, V.; Lazer, D.; Lupia, A.; Manrai, A.; McConnell, L.; Noonan, K.; Phimister, E.; Simon, B.; Strandburg, K.; Summers, Z.; Watts, D.			Fostering reproducibility in industry-academia research	SCIENCE			English	Editorial Material									[Jasny, B. R.] Science, Washington, DC 20005 USA; [Wigginton, N.; Lupia, A.] Univ Michigan, Ann Arbor, MI 48109 USA; [McNutt, M.] Natl Acad Sci, Washington, DC 20001 USA; [Bubela, T.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Buck, S.] Laura & John Arnold Fdn, Houston, TX 77056 USA; [Cook-Deegan, R.] Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC 20009 USA; [Gardner, T.] Riffyn Inc, Oakland, CA 94612 USA; [Hanson, B.] Amer Geophys Union, Washington, DC 20009 USA; [Hustad, C.] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Kiermer, V.] Publ Lib Sci PLOS, San Francisco, CA 94111 USA; [Lazer, D.] Northeastern Univ, Boston, MA 02115 USA; [Manrai, A.] Harvard Med Sch, Boston, MA 02115 USA; [McConnell, L.] Bayer US, Res Triangle Pk, NC 27709 USA; [Noonan, K.] McDonnell Boehnen Hulbert & Berghoff LLP, Chicago, IL 60606 USA; [Phimister, E.] New England Journal Med, Boston, MA 02115 USA; [Simon, B.] Thomas Jefferson Sch Law, San Diego, CA 92101 USA; [Strandburg, K.] NYU, Sch Law, New York, NY 10012 USA; [Summers, Z.] ExxonMobil Res & Engn Co, Annandale, NJ 08801 USA; [Watts, D.] Microsoft Res, New York, NY 10003 USA	University of Michigan System; University of Michigan; National Academies of Sciences, Engineering & Medicine; Simon Fraser University; Arizona State University; Merck & Company; Northeastern University; Harvard University; Harvard Medical School; New York University; Exxon Mobil Corporation; Microsoft	McNutt, M (corresponding author), Natl Acad Sci, Washington, DC 20001 USA.	naspresident@nas.edu	McConnell, Laura Lee/HCI-9681-2022; McConnell, Laura Lee/AAN-4481-2020; Bubela, Tania/F-4860-2014; Wigginton, Nicholas/F-1747-2011	McConnell, Laura Lee/0000-0001-6142-0656; Hanson, R. Brooks/0000-0001-6230-7145; Cook-Deegan, Robert/0000-0002-8251-4237; McNutt, Marcia/0000-0003-0117-7716; Manrai, Arjun/0000-0001-9657-9800; Bubela, Tania/0000-0002-0807-2899; Kiermer, Veronique/0000-0001-8771-7239; Buck, Stuart/0000-0002-8111-3239; Wigginton, Nicholas/0000-0001-9161-6131	Laura and John Arnold Foundation	Laura and John Arnold Foundation	We thank participants of a workshop on this topic held in Washington, DC, on 24 to 25 October 2016 and supported by a grant from the Laura and John Arnold Foundation to the American Association for the Advancement of Science. Views expressed herein represent those of the authors and do not necessarily reflect views of their employers or sponsor. The authors had no input into the handling of the paper after submission or supervisory authority over anyone at the journal.	Bakshy E, 2015, SCIENCE, V348, P1130, DOI 10.1126/science.aaa1160; Besley JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175643; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Kasenda B, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002046; Low Eric, 2016, Ecancermedicalscience, V10, ped57, DOI 10.3332/ecancer.2016.ed57; Markoff J., 2012, TROVES PERSONAL DATA; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; National Council of University Research Administrators (NCURA), 2006, GUID PRINC U IND END; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Rodriguez LL, 2013, SCIENCE, V339, P275, DOI 10.1126/science.1234593; Rosenblatt M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5003; University Industry Demonstration Partnership (UIDP), 2012, RES GUID	13	21	21	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					759	761		10.1126/science.aan4906	http://dx.doi.org/10.1126/science.aan4906			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839064				2022-12-28	WOS:000408327900028
J	Smits, SA; Leach, J; Sonnenburg, ED; Gonzalez, CG; Lichtman, JS; Reid, G; Knight, R; Manjurano, A; Changalucha, J; Elias, JE; Dominguez-Bello, MG; Sonnenburg, JL				Smits, Samuel A.; Leach, Jeff; Sonnenburg, Erica D.; Gonzalez, Carlos G.; Lichtman, Joshua S.; Reid, Gregor; Knight, Rob; Manjurano, Alphaxard; Changalucha, John; Elias, Joshua E.; Dominguez-Bello, Maria Gloria; Sonnenburg, Justin L.			Seasonal cycling in the gut microbiome of the Hadza hunter-gatherers of Tanzania	SCIENCE			English	Article							BACTERIAL SYMBIONT; DIET; DIVERSITY	Although humans have cospeciated with their gut-resident microbes, it is difficult to infer features of our ancestral microbiome. Here, we examine the microbiome profile of 350 stool samples collected longitudinally for more than a year from the Hadza hunter-gatherers of Tanzania. The data reveal annual cyclic reconfiguration of the microbiome, in which some taxa become undetectable only to reappear in a subsequent season. Comparison of the Hadza data set with data collected from 18 populations in 16 countries with varying lifestyles reveals that gut community membership corresponds to modernization: Notably, the taxa within the Hadza that are the most seasonally volatile similarly differentiate industrialized and traditional populations. These data indicate that some dynamic lineages of microbes have decreased in prevalence and abundance in modernized populations.	[Smits, Samuel A.; Sonnenburg, Erica D.; Sonnenburg, Justin L.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Leach, Jeff] Human Food Project, 53600 Highway 118, Terlingua, TX 79852 USA; [Leach, Jeff] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, Lambeth Palace Rd, London SE1 7EH, England; [Gonzalez, Carlos G.; Lichtman, Joshua S.; Elias, Joshua E.] Stanford Univ, Stanford Sch Med, Dept Chem & Syst Biol, Stanford, CA 94025 USA; [Reid, Gregor] Lawson Hlth Res Inst, London, ON N6A 4V2, Canada; [Reid, Gregor] Western Univ, London, ON N6A 4V2, Canada; [Knight, Rob] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, San Diego, CA 92093 USA; [Manjurano, Alphaxard; Changalucha, John] Natl Inst Med Res, Mwanza 11101, Tanzania; [Dominguez-Bello, Maria Gloria] NYU, Sch Med, New York, NY USA; [Dominguez-Bello, Maria Gloria] NYU, Dept Anthropol, New York, NY 10003 USA	Stanford University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Stanford University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; New York University; New York University	Sonnenburg, JL (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu	Reid, Gregor/ABE-8327-2020	Reid, Gregor/0000-0001-9658-5696; Elias, Joshua/0000-0002-8063-3259; Knight, Rob/0000-0002-0975-9019; Gonzalez, Carlos/0000-0002-4673-4048	Emch Family Foundation; Forrest & Frances Lattner Foundation; CD Research Fund; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK085025, R01-DK090989]; Discovery Innovation Fund Awards; NSF Graduate Fellowship; Smith Stanford Graduate Fellowship;  [PRJNA392012];  [PRJNA392180]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085025, R01DK090989] Funding Source: NIH RePORTER	Emch Family Foundation; Forrest & Frances Lattner Foundation; CD Research Fund; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Discovery Innovation Fund Awards; NSF Graduate Fellowship(National Science Foundation (NSF)); Smith Stanford Graduate Fellowship; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to the participants in this study. We thank T. Williams, G. Grymes, A. Omar, B. Bonnen, M. Anyawire, and S. Ward for assistance in collecting samples. D. Peterson (Dorobo Safaris) and Chris and Nani (Kisema Ngeda) provided logistical support during fieldwork. We also thank D. Schneider and S. Holmes for their insights that led to novel data analyses. This work was funded by grants from the Emch Family Foundation and Forrest & Frances Lattner Foundation, C&D Research Fund, grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK085025 to J.L.S.; R01-DK090989 to M.G.D.-B.), two Discovery Innovation Fund Awards (J.L.S. and J.E.E.), NSF Graduate Fellowship (S.A.S., C.G.G., and J.S.L.), and a Smith Stanford Graduate Fellowship (S.A.S.). A material transfer agreement with the National Institute for Medical Research in Tanzania ensures that stool samples collected are used solely for academic purposes. Permission for the study was obtained from the National Institute of Medical Research (MR/53i100/83, NIMR/HQ/R.8a/Vol.IX/1542) and the Tanzania Commission for Science and Technology. We obtained verbal consent from the Hadza after having described the study's intent and scope. The 16S rRNA amplicon sequence data and shotgun metagenomic data have been deposited in the Sequence Read Archive (SRA) under the project IDs PRJNA392012, PRJNA392180 (www.ncbi.nlm.nih.gov/sra). Metabolomics data have been uploaded to Global Natural Products Social Molecular Networking (31) (http://gnps.ucsd.edu), accession number MSV000081199.	Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Diaconis P, 2008, ANN APPL STAT, V2, P777, DOI 10.1214/08-AOAS165; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; JONES NGB, 1992, AM J PHYS ANTHROPOL, V89, P159, DOI 10.1002/ajpa.1330890204; Lichtman JS, 2016, CELL REP, V14, P1049, DOI 10.1016/j.celrep.2016.01.009; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; Marlowe F. W., 2010, HADZA HUNTER GATHERE, V3; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Suzuki TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1037; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	31	398	409	10	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					802	+		10.1126/science.aan4834	http://dx.doi.org/10.1126/science.aan4834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839072	Green Accepted			2022-12-28	WOS:000408327900043
J	Degn, SE; van der Poel, CE; Firl, DJ; Ayoglu, B; Al Qureshah, FA; Bajic, G; Mesin, L; Reynaud, CA; Weill, JC; Utz, PJ; Victora, GD; Carroll, MC				Degn, Soren E.; van der Poel, Cees E.; Firl, Daniel J.; Ayoglu, Burcu; Al Qureshah, Fahd A.; Bajic, Goran; Mesin, Luka; Reynaud, Claude-Agnes; Weill, Jean-Claude; Utz, Paul J.; Victora, Gabriel D.; Carroll, Michael C.			Clonal Evolution of Autoreactive Germinal Centers	CELL			English	Article							B-CELL TOLERANCE; SOMATIC HYPERMUTATION; ANTIGEN; AUTOANTIBODIES; MEMORY; REDEMPTION; ACTIVATION; MECHANISMS; ANTIBODIES; APOPTOSIS	Germinal centers (GCs) are the primary sites of clonal B cell expansion and affinity maturation, directing the production of high-affinity antibodies. This response is a central driver of pathogenesis in autoimmune diseases, such as systemic lupus erythematosus (SLE), but the natural history of autoreactive GCs remains unclear. Here, we present a novel mouse model where the presence of a single autoreactive B cell clone drives the TLR7-dependent activation, expansion, and differentiation of other autoreactive B cells in spontaneous GCs. Once tolerance was broken for one self-antigen, autoreactive GCs generated B cells targeting other self-antigens. GCs became independent of the initial clone and evolved toward dominance of individual clonal lineages, indicating affinity maturation. This process produced serum autoantibodies to a breadth of self-antigens, leading to antibody deposition in the kidneys. Our data provide insight into the maturation of the self-reactive B cell response, contextualizing the epitope spreading observed in autoimmune disease.	[Degn, Soren E.; van der Poel, Cees E.; Firl, Daniel J.; Al Qureshah, Fahd A.; Carroll, Michael C.] Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Degn, Soren E.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Firl, Daniel J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ayoglu, Burcu; Utz, Paul J.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Al Qureshah, Fahd A.] King Abdulaziz City Sci & Technol, Riyadh 11442, Saudi Arabia; [Bajic, Goran] Harvard Med Sch, Boston Childrens Hosp, Lab Mol Med, Boston, MA 02115 USA; [Mesin, Luka; Victora, Gabriel D.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Reynaud, Claude-Agnes; Weill, Jean-Claude] Univ Paris 05, Sorbonne Paris Cite, CNRS UMS 8253, Inst Necker Enfants Malad,INSERM U1151, F-75993 Paris 14, France; [Mesin, Luka; Victora, Gabriel D.] Rockefeller Univ, New York, NY 10065 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Aarhus University; Howard Hughes Medical Institute; Stanford University; King Abdulaziz City for Science & Technology; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University	Degn, SE; Carroll, MC (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Degn, SE (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.	sdegn@biomed.au.dk; michael.carroll@childrens.harvard.edu	Firl, Daniel James/I-7264-2019; Degn, Søren E/G-7936-2017	Firl, Daniel James/0000-0001-7993-6167; Degn, Søren E/0000-0001-5409-045X; /0000-0001-7843-2960; Al Qureshah, Fahd/0000-0002-5022-9917; Bajic, Goran/0000-0003-0480-4324; Victora, Gabriel/0000-0001-8807-348X	Benzon Foundation; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [PIOF-GA-2012-330134]; GSK; HHMI Medical Research Fellows Program; Knut and Alice Wallenberg Foundation Postdoctoral Scholarship Program [KAW 2014.0412]; NIH grants [R01AI039246, R21AI117737, R01AI119006, U19AI110491, UM1AI110498, R01 AI125197]; Donald E. and Delia B. Baxter Foundation (Career Development Award); Henry Gustav Floren Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117737, R01AI119006, R01AI039246, R01AI130307, R37AI054636, R01AI125197, U19AI110491] Funding Source: NIH RePORTER	Benzon Foundation; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; GSK(GlaxoSmithKline); HHMI Medical Research Fellows Program; Knut and Alice Wallenberg Foundation Postdoctoral Scholarship Program; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald E. and Delia B. Baxter Foundation (Career Development Award); Henry Gustav Floren Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Leung of the Optical Microscopy Core and N. Barteneva and K. Ketman of the Flow and Imaging Cytometry Resource at the PCMM for technical assistance. We also thank the SciLifeLab Autoimmunity Profiling Facility for access to FlexMap3D instrument. We are grateful to E. Alicot for technical assistance, D. Weseman for helpful discussion of the topic, and C. Usher for help editing the manuscript. F. Alt provided the attenuated DTA strain and A. Sharpe the UBC-Cre<SUP>ERT2</SUP> line. S.E.D. was supported by the Benzon Foundation and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-330134). C.E.v.d.P. was supported by a fellowship from GSK. D.J.F. was supported by the HHMI Medical Research Fellows Program. B.A. was supported by the Knut and Alice Wallenberg Foundation Postdoctoral Scholarship Program (KAW 2014.0412). This research was supported by NIH grants R01AI039246, R21AI117737 (M.C.C.), R01AI119006 (G.D.V.), U19AI110491, UM1AI110498, and R01 AI125197 (P.J.U.), by the Donald E. and Delia B. Baxter Foundation (Career Development Award to P.J.U.), the Henry Gustav Floren Trust (gift to P.J.U.), and a gift from Elizabeth F. Adler (to P.J.U.).	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Ayoglu B, 2016, P NATL ACAD SCI USA, V113, P2188, DOI 10.1073/pnas.1518553113; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Cappellano G, 2012, AM J CLIN EXP IMMUNO, V1, P136; Chatterjee P, 2013, EUR J IMMUNOL, V43, P2441, DOI 10.1002/eji.201343412; Cornaby C, 2015, IMMUNOL LETT, V163, P56, DOI 10.1016/j.imlet.2014.11.001; Das A, 2017, IMMUNITY, V46, P106, DOI 10.1016/j.immuni.2016.12.014; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; GAVALCHIN J, 1987, J IMMUNOL, V138, P128; Green NM, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383000; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Hershberg U, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0239; Kepler Thomas B, 2013, F1000Res, V2, P103, DOI 10.12688/f1000research.2-103.v1; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Prak ETL, 2011, ANN NY ACAD SCI, V1217, P96, DOI 10.1111/j.1749-6632.2010.05877.x; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Reed JH, 2016, J EXP MED, V213, P1255, DOI 10.1084/jem.20151978; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Team RC., 2022, LANG ENV STAT COMP; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Yau IW, 2013, J IMMUNOL, V191, P1082, DOI 10.4049/jimmunol.1201569; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yusuf I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102791	41	60	63	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					913	+	926.e19	10.1016/j.cell.2017.07.026	http://dx.doi.org/10.1016/j.cell.2017.07.026			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841417	Green Accepted, Bronze			2022-12-28	WOS:000408372400011
J	Jimenez-Sanchez, A; Memon, D; Pourpe, S; Veeraraghavan, H; Li, YY; Vargas, HA; Gill, MB; Park, KJ; Zivanovic, O; Konner, J; Ricca, J; Zamarin, D; Walther, T; Aghajanian, C; Wolchok, JD; Sala, E; Merghoub, T; Snyder, A; Miller, ML				Jimenez-Sanchez, Alejandro; Memon, Danish; Pourpe, Stephane; Veeraraghavan, Harini; Li, Yanyun; Vargas, Hebert Alberto; Gill, Michael B.; Park, Kay J.; Zivanovic, Oliver; Konner, Jason; Ricca, Jacob; Zamarin, Dmitriy; Walther, Tyler; Aghajanian, Carol; Wolchok, Jedd D.; Sala, Evis; Merghoub, Taha; Snyder, Alexandra; Miller, Martin L.			Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient	CELL			English	Article							T-CELL; INTRATUMOR HETEROGENEITY; ACQUIRED-RESISTANCE; EXPRESSION; GENE; GENERATION; PREDICTION; MUTATIONS; EVOLUTION; RESPONSES	We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases were infiltrated by CD8(+) and CD4(+) T cells and exhibited oligoclonal expansion of specific T cell subsets. We also detected CD8(+) T cell reactivity against predicted neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were resected. These findings suggest that multiple distinct tumor immune microenvironments co-exist within a single individual and may explain in part the heterogeneous fates of metastatic lesions often observed in the clinic post-therapy.	[Jimenez-Sanchez, Alejandro; Memon, Danish; Gill, Michael B.; Miller, Martin L.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England; [Memon, Danish] EMBL, European Bioinformat Inst, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Veeraraghavan, Harini] Mem Sloan Kettering Canc Ctr, Dept Med Phys, 1275 York Ave, New York, NY 10065 USA; [Li, Yanyun; Ricca, Jacob; Zamarin, Dmitriy; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Swim Amer Lab, 1275 York Ave, New York, NY 10065 USA; [Vargas, Hebert Alberto; Sala, Evis] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA; [Park, Kay J.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA; [Zivanovic, Oliver] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, 1275 York Ave, New York, NY 10065 USA; [Konner, Jason; Aghajanian, Carol] Mem Sloan Kettering Canc Ctr, Dept Med, Gynecol Med Oncol Serv, 1275 York Ave, New York, NY 10065 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, 1275 York Ave, New York, NY 10065 USA; [Pourpe, Stephane; Zamarin, Dmitriy; Walther, Tyler; Wolchok, Jedd D.; Snyder, Alexandra] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA; [Wolchok, Jedd D.; Snyder, Alexandra] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Wolchok, Jedd D.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Programs, New York, NY 10065 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Miller, ML (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.; Snyder, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.; Snyder, A (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	snyderca@mskcc.org; martin.miller@cruk.cam.ac.uk	Zamarin, Dmitriy/L-9774-2019; Veeraraghavan, Harini/M-1986-2018; Zivanovic, Oliver/AAK-9955-2021; Memon, Danish/S-9092-2019; Sala, Evis/AAD-7265-2019; Merghoub, Taha/ABD-8362-2021; Memon, Danish/ABE-1094-2021; Pourpe, Stephane/K-8976-2015	Veeraraghavan, Harini/0000-0002-4054-5529; Memon, Danish/0000-0002-1365-0710; Miller, Martin L/0000-0003-3161-8690	Marsha Rivkin Organization; Society of Memorial Sloan Kettering, Translational and Integrative Medicine Research Fund (MSKCC); Kaleidoscope of Hope; MSKCC core grant [P30 CA008748]; Cancer Research UK core grant [C14303/A17197]; Cancer Research UK Cambridge Institute; Mexican National Council of Science and Technology (CONACyT); Versus Arthritis [21141] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Marsha Rivkin Organization; Society of Memorial Sloan Kettering, Translational and Integrative Medicine Research Fund (MSKCC); Kaleidoscope of Hope; MSKCC core grant; Cancer Research UK core grant; Cancer Research UK Cambridge Institute; Mexican National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr. Duncan Odom and Dr. Tobias Janowitz (CRUK CI) for their insightful comments on the manuscript. We also thank Ron Gejman (MSKCC) for the HLA typing prediction of TCGA ovarian samples, Leon Chlon (CRUK CI) for his help on the CIBERSORT analysis, and Dr. David Ochoa for his advice in the ssGSEA analysis. A.S. was supported by grants from the Marsha Rivkin Organization, Society of Memorial Sloan Kettering, Translational and Integrative Medicine Research Fund (MSKCC), Kaleidoscope of Hope, and MSKCC core grant (P30 CA008748). M.L.M. was supported by Cancer Research UK core grant (C14303/A17197). A.J.S. was supported by a doctoral fellowship from the Cancer Research UK Cambridge Institute and the Mexican National Council of Science and Technology (CONACyT). D.M. is a fellow of the joint EMBL-EBI & NIHR Cambridge Biomedical Research Centre Postdoctoral (EBPOD) program.	ASCIERTO ML, 2017, CLIN CANC RES, V23; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Brabletz T, 2013, NAT MED, V19, P1104, DOI 10.1038/nm.3327; Bronger H, 2016, BRIT J CANCER, V115, P553, DOI 10.1038/bjc.2016.172; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davoli T, 2017, SCIENCE, V355, DOI 10.1126/science.aaf8399; De Mattos-Arruda L, 2014, MOL ONCOL, V8, P150, DOI 10.1016/j.molonc.2013.10.006; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Gavalas NG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/791603; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Homicsko K, 2015, J CLIN ONCOL, V33, P3987, DOI 10.1200/JCO.2015.63.7785; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kuilman T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0617-1; Lee JY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1077-4; Li H, 2014, BIOFACTORS, V40, P226, DOI 10.1002/biof.1155; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Melero I, 2014, CANCER DISCOV, V4, P522, DOI 10.1158/2159-8290.CD-13-0985; Miao D, 2016, CURR OPIN IMMUNOL, V41, P32, DOI 10.1016/j.coi.2016.05.010; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Pfirschke C, 2016, IMMUNITY, V44, P343, DOI 10.1016/j.immuni.2015.11.024; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Rainczuk A, 2012, REPRODUCTION, V144, P303, DOI 10.1530/REP-12-0153; Reuben A, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0013-8; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sala E, 2012, RADIOLOGY, V263, P149, DOI 10.1148/radiol.11110175; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Senbabaoglu Y, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1092-z; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Sridharan V, 2016, CANCER IMMUNOL RES, V4, P679, DOI 10.1158/2326-6066.CIR-16-0031; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Teng MWL, 2015, J CLIN INVEST, V125, P3338, DOI 10.1172/JCI80004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	97	279	285	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					927	+	938.e20	10.1016/j.cell.2017.07.025	http://dx.doi.org/10.1016/j.cell.2017.07.025			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841418	hybrid, Green Published			2022-12-28	WOS:000408372400012
J	Simpkin, AL; Vyas, JM; Armstrong, KA				Simpkin, Arabella L.; Vyas, Jatin M.; Armstrong, Katrina A.			Diagnostic Reasoning: An Endangered Competency in Internal Medicine Training	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNCERTAINTY; ERRORS		[Simpkin, Arabella L.] Massachusetts Gen Hosp, Dept Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA; [Vyas, Jatin M.; Armstrong, Katrina A.] Massachusetts Gen Hosp, Dept Med, Grey Bigelow 7th Floor,55 Fruit St, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Simpkin, AL (corresponding author), Massachusetts Gen Hosp, Dept Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	asimpkin@partners.org	Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565				Balogh EP, 2015, IMPROVING DIAGNOSIS; Cooke S, 2017, ACAD MED, V92, P746, DOI 10.1097/ACM.0000000000001559; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Internal Medicine Milestone Group, 2015, INT MED MIL PROJ; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Norman GR, 2017, ACAD MED, V92, P23, DOI 10.1097/ACM.0000000000001421; Schmidt HG, 2015, MED EDUC, V49, P961, DOI 10.1111/medu.12775; Simpkin AL, 2016, NEW ENGL J MED, V375, P1713, DOI 10.1056/NEJMp1606402	9	19	19	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					507	+		10.7326/M17-0163	http://dx.doi.org/10.7326/M17-0163			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28892818				2022-12-28	WOS:000411988900013
J	Lee, JH; Tammela, T; Hofree, M; Choi, J; Marjanovic, ND; Han, S; Canner, D; Wu, K; Paschini, M; Bhang, DH; Jacks, T; Regev, A; Kim, CF				Lee, Joo-Hyeon; Tammela, Tuomas; Hofree, Matan; Choi, Jinwook; Marjanovic, Nemanja Despot; Han, Seungmin; Canner, David; Wu, Katherine; Paschini, Margherita; Bhang, Dong Ha; Jacks, Tyler; Regev, Aviv; Kim, Carla F.			Anatomically and Functionally Distinct Lung Mesenchymal Populations Marked by Lgr5 and Lgr6	CELL			English	Article							STEM-CELLS; MOUSE LUNG; HAIR FOLLICLE; SELF-RENEWAL; IN-VITRO; WNT; REGENERATION; REPAIR; DIFFERENTIATION; MORPHOGENESIS	The diversity of mesenchymal cell types in the lung that influence epithelial homeostasis and regeneration is poorly defined. We used genetic lineage tracing, single-cell RNA sequencing, and organoid culture approaches to show that Lgr5 and Lgr6, well-known markers of stem cells in epithelial tissues, are markers of mesenchymal cells in the adult lung. Lgr6(+) cells comprise a subpopulation of smooth muscle cells surrounding airway epithelia and promote airway differentiation of epithelial progenitors via Wnt-Fgf10 cooperation. Genetic ablation of Lgr6(+) cells impairs airway injury repair in vivo. Distinct Lgr5(+) cells are located in alveolar compartments and are sufficient to promote alveolar differentiation of epithelial progenitors through Wnt activation. Modulating Wnt activity altered differentiation outcomes specified by mesenchymal cells. This identification of region-and lineage-specific crosstalk between epithelium and their neighboring mesenchymal partners provides new understanding of how different cell types are maintained in the adult lung.	[Lee, Joo-Hyeon; Paschini, Margherita; Kim, Carla F.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Lee, Joo-Hyeon; Paschini, Margherita; Kim, Carla F.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Lee, Joo-Hyeon; Paschini, Margherita; Kim, Carla F.] Boston Childrens Hosp, Div Pulm & Resp Dis, Boston, MA 02115 USA; [Lee, Joo-Hyeon; Paschini, Margherita; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lee, Joo-Hyeon; Paschini, Margherita; Kim, Carla F.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Lee, Joo-Hyeon; Choi, Jinwook; Han, Seungmin] Univ Cambridge, Wellcome Trust, MRC, Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England; [Lee, Joo-Hyeon] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Tammela, Tuomas; Marjanovic, Nemanja Despot; Canner, David; Wu, Katherine; Jacks, Tyler; Regev, Aviv] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Hofree, Matan; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Han, Seungmin] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Bhang, Dong Ha] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Jacks, Tyler; Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lee, JH; Kim, CF (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.; Lee, JH; Kim, CF (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Lee, JH; Kim, CF (corresponding author), Boston Childrens Hosp, Div Pulm & Resp Dis, Boston, MA 02115 USA.; Lee, JH; Kim, CF (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Lee, JH; Kim, CF (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Lee, JH (corresponding author), Univ Cambridge, Wellcome Trust, MRC, Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England.; Lee, JH (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England.	jhl62@cam.ac.uk; carla.kim@childrens.harvard.edu	Lee, Joo-Hyeon/AAM-2777-2020	Lee, Joo-Hyeon/0000-0002-7364-6422; /0000-0003-3675-6961; Wu, Katherine/0000-0002-0472-0166; Hofree, Matan/0000-0001-8368-0299	Wellcome Trust; Royal Society [107633/Z/15/Z]; European Research Council [679411]; Cambridge Stem Cell Institute from Wellcome Trust [07922/Z/11/Z]; Medical Research Council; Hope Funds for Cancer Research; American Lung Association [400553]; Howard Hughes Medical Institute; Klarman Cell Observatory; NCI [1U24CA180922]; Koch Institute from the NCI [P30-CA14051]; National Cancer Institute [K99 CA187317]; Sigrid Juselius Foundation; Harvard Stem Cell Institute; CFMS Fund;  [R01 HL090136];  [R01 HL132266];  [R01 HL125821];  [U01 HL100402]; Medical Research Council [MC_PC_12009] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K99CA187317, U24CA180922, P30CA014051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125821, R01HL132266, U01HL100402, R01HL090136] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); Cambridge Stem Cell Institute from Wellcome Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hope Funds for Cancer Research; American Lung Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Koch Institute from the NCI; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Harvard Stem Cell Institute; CFMS Fund; ; ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the CSCI, BCH, and KI core facilities for technical assistance, members of the Kim lab and Lee lab for helpful discussions, and the Morrisey lab for sharing unpublished data. This work was supported by (J.-H.L. and J.C.) Wellcome Trust and the Royal Society (107633/Z/15/Z), European Research Council Starting Grant (679411), and the Cambridge Stem Cell Institute Core grant (07922/Z/11/Z) from Wellcome Trust and Medical Research Council; (J.-H.L.) the Hope Funds for Cancer Research; (M.P.) American Lung Association (400553); (A.R.) Howard Hughes Medical Institute, the Klarman Cell Observatory, and NCI grant 1U24CA180922; (A.R., T.T., and T.J.) the Koch Institute Core grant P30-CA14051 from the NCI; (T.T.) the National Cancer Institute K99 CA187317, the Sigrid Juselius Foundation, the Hope Funds for Cancer Research; (T.J.) a Howard Hughes Medical Institute Investigator, a David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar; and (C.F.K.) R01 HL090136, R01 HL132266, R01 HL125821, U01 HL100402, Harvard Stem Cell Institute, Alfred and Gilda Slifka, Gail and Adam Slifka, and the CFMS Fund. A.R. is an SAB member for ThermoFisher Scientific, Syros Pharmaceuticals, and Driver Group; T.J. is a co-founder of Dragonfly Therapeutics.	Abler LL, 2009, DEV DYNAM, V238, P1999, DOI 10.1002/dvdy.22032; [Anonymous], 2000, NON TRADITIONAL REF; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; El Agha E, 2014, DEVELOPMENT, V141, P296, DOI 10.1242/dev.099747; Frank DB, 2016, CELL REP, V17, P2312, DOI 10.1016/j.celrep.2016.11.001; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kumar ME, 2014, SCIENCE, V346, P827, DOI 10.1126/science.1258810; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li CG, 2015, STEM CELLS, V33, P999, DOI 10.1002/stem.1911; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; McCulley D, 2015, CURR OPIN GENET DEV, V32, P98, DOI 10.1016/j.gde.2015.01.011; Moiseenko A, 2017, STEM CELLS, V35, P1566, DOI 10.1002/stem.2615; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Peng T, 2015, NATURE, V526, P578, DOI 10.1038/nature14984; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Volckaert T, 2015, DEV DYNAM, V244, P342, DOI 10.1002/dvdy.24234; Volckaert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071426; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170	33	195	199	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1149	1163		10.1016/j.cell.2017.07.028	http://dx.doi.org/10.1016/j.cell.2017.07.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886383	Green Published, hybrid			2022-12-28	WOS:000409536000012
J	Ocana, OH; Coskun, H; Minguillon, C; Murawala, P; Tanaka, EM; Galceran, J; Munoz-Chapuli, R; Nieto, MA				Ocana, Oscar H.; Coskun, Hakan; Minguillon, Carolina; Murawala, Prayag; Tanaka, Elly M.; Galceran, Joan; Munoz-Chapuli, Ramn; Angela Nieto, M.			A right-handed signalling pathway drives heart looping in vertebrates	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; SITU HYBRIDIZATION ANALYSIS; 2ND HEART; TRANSCRIPTION FACTORS; CHICK-EMBRYOS; WHOLE-MOUNT; ZEBRAFISH; SNAIL; EXPRESSION; GENES	Most animals show external bilateral symmetry, which hinders the observation of multiple internal left-right (L/R) asymmetries that are fundamental to organ packaging and function(1,2). In vertebrates, left identity is mediated by the left-specific Nodal-Pitx2 axis that is repressed on the right-hand side by the epithelial-mesenchymal transition (EMT) inducer Snail1 (refs 3, 4). Despite some existing evidence(3,5), it remains unclear whether an equivalent instructive pathway provides right-hand-specific information to the embryo. Here we show that, in zebrafish, BMP mediates the L/R asymmetric activation of another EMT inducer, Prrx1a, in the lateral plate mesoderm with higher levels on the right. Prrx1a drives L/R differential cell movements towards the midline, leading to a leftward displacement of the cardiac posterior pole through an actomyosin-dependent mechanism. Downregulation of Prrx1a prevents heart looping and leads to mesocardia. Two parallel and mutually repressed pathways, respectively driven by Nodal and BMP on the left and right lateral plate mesoderm, converge on the asymmetric activation of the transcription factors Pitx2 and Prrx1, which integrate left and right information to govern heart morphogenesis. This mechanism is conserved in the chicken embryo, and in the mouse SNAIL1 acts in a similar manner to Prrx1a in zebrafish and PRRX1 in the chick. Thus, a differential L/R EMT produces asymmetric cell movements and forces, more prominent from the right, that drive heart laterality in vertebrates.	[Ocana, Oscar H.; Coskun, Hakan; Galceran, Joan; Angela Nieto, M.] Inst Neurociencias CSIC UMH, Ave Ramon & Cajal S-N, Alicante, Spain; [Minguillon, Carolina] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Murawala, Prayag; Tanaka, Elly M.] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, Fetscherstr 105, Dresden, Germany; [Munoz-Chapuli, Ramn] Univ Malaga, Dept Anim Biol, E-29071 Malaga, Spain; [Munoz-Chapuli, Ramn] Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga, Spain; [Minguillon, Carolina] Pasqual Maragall Fdn, Barcelonasseta Brain Res Ctr, Barcelona, Spain; [Murawala, Prayag; Tanaka, Elly M.] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Technische Universitat Dresden; Universidad de Malaga; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nieto, MA (corresponding author), Inst Neurociencias CSIC UMH, Ave Ramon & Cajal S-N, Alicante, Spain.	anieto@umh.es	Nieto, M. Angela/A-6531-2008; Ocaña, Oscar/K-6843-2014; Murawala, Prayag/W-2027-2018; Galceran, Juan/K-6744-2014	Nieto, M. Angela/0000-0002-3538-840X; Ocaña, Oscar/0000-0001-9274-0089; Murawala, Prayag/0000-0002-0607-1059; Galceran, Juan/0000-0002-5247-2726; Tanaka, Elly/0000-0003-4240-2158; Coskun, Hakan/0000-0002-7581-3060	Spanish Ministry of Economy and Competitiveness - European Regional Development Fund, ERDF [BFU2008-01042, BFU2014-53128-R]; Generalitat Valenciana [PROMETEOII/2013/002]; European Research Council [ERC AdG 322694, BFU2014-52299-P]; Instituto de Salud Carlos III-TERCEL network [RD12/0019-0022]; Junta de Andalucia [P11-CTS-07564]; AEI, through the 'Severo Ochoa' Programme for Centres of Excellence in RD [SEV-2013-0317]	Spanish Ministry of Economy and Competitiveness - European Regional Development Fund, ERDF(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Research Council(European Research Council (ERC)European Commission); Instituto de Salud Carlos III-TERCEL network; Junta de Andalucia(Junta de Andalucia); AEI, through the 'Severo Ochoa' Programme for Centres of Excellence in RD	We thank members of M.A.N. laboratory for continuous and helpful discussions, J.M. Mingot (IN) for the purification of Cas9 protein, B. Alsina (Universitat Pompeu Fabra) for the myl12.1-mCherry transgenic line (originally from C. P. Heisenberg's laboratory<SUP>22</SUP>), L. M. Gutierrez (IN) for the LifeAct construct, J. Exposito (IN) for her technical advice with confocal microscopy, J. F. Lopez Tellez (BIONAND) for the semithin histological sections and S. Ingham (IN) for his help with the graphics. This work was supported by the Spanish Ministry of Economy and Competitiveness (BFU2008-01042; BFU2014-53128-R co-financed by the European Regional Development Fund, ERDF), Generalitat Valenciana (PROMETEOII/2013/002) and European Research Council (ERC AdG 322694) to M.A.N., and BFU2014-52299-P, Instituto de Salud Carlos III-TERCEL network (RD12/0019-0022) and Junta de Andalucia (P11-CTS-07564) to R.M.-C. M.A.N. acknowledges financial support from the AEI, through the 'Severo Ochoa' Programme for Centres of Excellence in R&D (SEV-2013-0317) to Instituto de Neurociencias (IN).	Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; Acloque H, 2017, DEVELOPMENT, V144, P649, DOI 10.1242/dev.142562; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bakkers J, 2009, DEV BIOL, V330, P213, DOI 10.1016/j.ydbio.2009.04.011; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Bayraktar M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00112; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bergwerff M, 2000, VIRCHOWS ARCH, V436, P12, DOI 10.1007/PL00008193; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Bressan M, 2013, SCIENCE, V340, P744, DOI 10.1126/science.1232877; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chang H, 2000, DEV BIOL, V219, P71, DOI 10.1006/dbio.1999.9594; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Dominguez JN, 2012, CIRC RES, V111, P1323, DOI 10.1161/CIRCRESAHA.112.271247; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Gurung R, 2016, BIOCHEM J, V473, P383, DOI 10.1042/BJ20151050; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ITASAKI N, 1991, ANAT EMBRYOL, V183, P29; Kelly RG, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015750; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lin AE, 2014, AM J MED GENET A, V164, P2581, DOI 10.1002/ajmg.a.36695; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Lombardo V. A., 2012, JOVE-J VIS EXP, V67, P4350; Lopez-Gracia ML, 2007, ADV ANAT EMBRYOL CEL, V188, P1; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Morales AV, 2007, EMBO REP, V8, P104, DOI 10.1038/sj.embor.7400867; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Naganathan SR, 2016, CURR OPIN CELL BIOL, V38, P24, DOI 10.1016/j.ceb.2016.01.004; Najm P, 2014, CELL ADHES MIGR, V8, P29, DOI 10.4161/cam.28024; Nasevicius A, 2001, CURR OPIN MOL THER, V3, P224; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Noel ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3754; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; Patel K, 1999, CURR BIOL, V9, P609, DOI 10.1016/S0960-9822(99)80267-X; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Schlueter J, 2009, P NATL ACAD SCI USA, V106, P7485, DOI 10.1073/pnas.0811944106; Sefton M, 1998, DEVELOPMENT, V125, P3111; Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623; Taber LA, 2010, ANN NY ACAD SCI, V1188, P103, DOI 10.1111/j.1749-6632.2009.05089.x; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Veerkamp J, 2013, DEV CELL, V24, P660, DOI 10.1016/j.devcel.2013.01.026; Xie LL, 2012, DEV CELL, V23, P280, DOI 10.1016/j.devcel.2012.06.006	56	59	60	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					86	+		10.1038/nature23454	http://dx.doi.org/10.1038/nature23454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880281	Green Accepted, Green Submitted			2022-12-28	WOS:000409388700038
J	Yan, LH; Li, L; Chen, JS				Yan, Lin-Hai; Li, Li; Chen, Jian-Si			SPOT DIAGNOSIS Abnormalities on computed tomography of the pancreas	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Yan, Lin-Hai; Chen, Jian-Si] Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China; [Li, Li] Guangxi Med Univ, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Yan, LH (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Guangxi, Peoples R China.	yanlinhai000@163.com			National Science Foundation for Young Scholars of China [81502120]	National Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC))	We acknowledge National Science Foundation for Young Scholars of China (No. 81502120) and the Guangxi Medical University Training Program for Distinguished Young Scholars.	Conwell DL, 2014, PANCREAS, V43, P1143, DOI 10.1097/MPA.0000000000000237; Li JN, 2011, CHINESE MED J-PEKING, V124, P3556, DOI 10.3760/cma.j.issn.0366-6999.2011.21.022; Majumder S, 2016, LANCET, V387, P1957, DOI 10.1016/S0140-6736(16)00097-0; Stevens T, 2004, AM J GASTROENTEROL, V99, P2256, DOI 10.1111/j.1572-0241.2004.40694.x; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yadav D, 2011, AM J GASTROENTEROL, V106, P2192, DOI 10.1038/ajg.2011.328	6	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j3979	10.1136/bmj.j3979	http://dx.doi.org/10.1136/bmj.j3979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EM	28882845				2022-12-28	WOS:000410576200006
J	Das, B; Chaudhuri, S; Nair, GB; Ramamurthy, T				Das, Bhabatosh; Chaudhuri, Susmita; Nair, G. Balakrish; Ramamurthy, Thandavarayan			Fostering research into antimicrobial resistance in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MOLECULAR-MECHANISMS; ANTIBIOTIC-RESISTANCE; STEWARDSHIP; PROGRAM		[Das, Bhabatosh; Chaudhuri, Susmita] Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, Faridabad, India; [Nair, G. Balakrish; Ramamurthy, Thandavarayan] WHO, Reg Off South East Asia, New Delhi, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); World Health Organization	Das, B (corresponding author), Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, Faridabad, India.	bhabatosh@thsti.res.in		Das, Bhabatosh/0000-0002-2447-5380				Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Ali A, 2015, J BUSINESS CHEM, V12, P105; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brink AJ, 2016, LANCET INFECT DIS, V16, P1017, DOI 10.1016/S1473-3099(16)30012-3; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Donia MS, 2014, CELL, V158, P1402, DOI 10.1016/j.cell.2014.08.032; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; Holloway KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152020; Holmes Alison H, 2016, Lancet, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Indian Council of Medical Research (ICMR), 2015, ANN REP 2014 15, P1; Lakshminarayanan S, 2011, J FAM COMMUNITY MED, V18, P26, DOI 10.4103/1319-1683.78635; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Lesho EP, 2014, CLIN INFECT DIS, V59, P390, DOI 10.1093/cid/ciu319; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Pena MM, 2013, REV ESC ENFERM USP, V47, P1227, DOI 10.1590/S0080-623420130000500030; Ratcliff WC, 2011, SCIENCE, V332, P547, DOI 10.1126/science.1205970; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Walia K, 2015, INDIAN J MED RES, V142, P130, DOI 10.4103/0971-5916.164228; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh CT, 2014, J ANTIBIOT, V67, P7, DOI 10.1038/ja.2013.49; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Willemsen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141765; Woolhouse MEJ, 2013, SCIENCE, V341, P1460, DOI 10.1126/science.1243444; World Health Organization (WHO), 2015, ANT RES DRAFT GLOB A; Xiao Y, 2015, AMR CONTROL, P46; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556	30	12	12	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2017	358								j3535	10.1136/bmj.j3535	http://dx.doi.org/10.1136/bmj.j3535			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EG	28877874	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000410575400002
J	Swaminathan, S; Prasad, J; Dhariwal, AC; Guleria, R; Misra, MC; Malhotra, R; Mathur, P; Walia, K; Gupta, S; Sharma, A; Ohri, V; Jain, S; Gupta, N; Laserson, K; Malpiedi, P; Velayudhan, A; Park, B; Srikantiah, P				Swaminathan, Soumya; Prasad, Jagdish; Dhariwal, Akshay C.; Guleria, Randeep; Misra, Mahesh C.; Malhotra, Rajesh; Mathur, Purva; Walia, Kamini; Gupta, Sunil; Sharma, Aditya; Ohri, Vinod; Jain, Sarika; Gupta, Neil; Laserson, Kayla; Malpiedi, Paul; Velayudhan, Anoop; Park, Benjamin; Srikantiah, Padmini			Strengthening infection prevention and control and systematic surveillance of healthcare associated infections in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTIDIMENSIONAL APPROACH; KLEBSIELLA-PNEUMONIAE; DEVELOPING-COUNTRIES; RESISTANT PATHOGENS; UNITS; IMPACT; CITIES		[Swaminathan, Soumya; Ohri, Vinod] Minist Hlth & Family Welf, Indian Council Med Res, New Delhi, India; [Prasad, Jagdish] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, New Delhi, India; [Dhariwal, Akshay C.; Jain, Sarika] Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Natl Ctr Dis Control, Delhi, India; [Guleria, Randeep; Misra, Mahesh C.; Malhotra, Rajesh; Mathur, Purva] All India Inst Med Sci, New Delhi, India; [Malhotra, Rajesh; Mathur, Purva] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, New Delhi, India; [Sharma, Aditya; Gupta, Neil; Malpiedi, Paul; Park, Benjamin] US Ctr Dis Control & Prevent, Int Infect Control Program, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Laserson, Kayla; Velayudhan, Anoop; Srikantiah, Padmini] US Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA; [Laserson, Kayla; Velayudhan, Anoop; Srikantiah, Padmini] Ctr Dis Control & Prevent, India Off, Global Dis Detect Program, New Delhi, India	Indian Council of Medical Research (ICMR); National Centre for Disease Control (NCDC); All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Jai Prakash Narayan Apex Trauma Center; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Srikantiah, P (corresponding author), US Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA.; Srikantiah, P (corresponding author), Ctr Dis Control & Prevent, India Off, Global Dis Detect Program, New Delhi, India.	pks6@cdc.gov			WHO SEARO	WHO SEARO(World Health Organization)	This article is one of a series commissioned by The BMJ based on an idea from WHO SEARO. The BMJ retained full editorial control over external peer review, editing, and publication. Open access fees are funded by the WHO SEARO.	Aiken AM, 2014, LANCET INFECT DIS, V14, P550, DOI 10.1016/S1473-3099(14)70709-1; Allegranzi B, 2007, INFECT CONT HOSP EP, V28, P1323, DOI 10.1086/521656; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Biswal M, 2015, J HOSP INFECT, V90, P12, DOI 10.1016/j.jhin.2014.12.011; Cardoso T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1304-2; Rosenthal VD, 2016, AM J INFECT CONTROL, V44, pE81, DOI 10.1016/j.ajic.2016.01.005; Gupta A, 2011, J HOSP INFECT, V78, P323, DOI 10.1016/j.jhin.2011.04.015; Holmes Alison H, 2016, Lancet, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Indian Council of Medical Research, ICMR ANN REP 2012 20; Indian Council of Medical Research, 2016, HOSP INF CONTR GUID; Jaggi N, 2013, INT J INFECT DIS, V17, pE1218, DOI 10.1016/j.ijid.2013.07.007; Kamath S, 2010, INDIAN J PEDIATR, V77, P37, DOI 10.1007/s12098-010-0005-5; Kumar A, 2014, J HOSP INFECT, V86, P272, DOI 10.1016/j.jhin.2013.12.010; LAXMINARAYAN R, 2012, BMJ-BRIT MED J, V344, DOI [10.1136/bmj.e1567, DOI 10.1136/BMJ.E1567]; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Mehrad B, 2015, CHEST, V147, P1413, DOI 10.1378/chest.14-2171; Mehta Y, 2013, EPIDEMIOL INFECT, V141, P2483, DOI 10.1017/S0950268813000381; Mehta Y, 2016, INFECT CONT HOSP EP, V37, P172; Ministry of Health and Family Welfare (MoHFW) Government of Bangladesh, 2017, NATL ACTION PLAN ANT; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; National Centre for Disease Control India, 2014, ANT RES SURV LAB NET; National Health Mission, 2015, CLEAN HOSP IN; National Health Systems Resource Centre, 2016, NAT QUAL ASS STAND A; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Singh AK, 2015, J RES PHARM PRACT, V4, P153, DOI 10.4103/2279-042X.162363; Sodhi J, 2016, INDIAN J MED RES, V143, P502, DOI 10.4103/0971-5916.184306; The Review on Antimicrobial Resistance, 2016, INF PREV CONTR SURV; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; Walia K, 2015, INDIAN J MED RES, V142, P130, DOI 10.4103/0971-5916.164228; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; Weiner Lindsey M, 2016, MMWR Morb Mortal Wkly Rep, V65, P235, DOI 10.15585/mmwr.mm6509e1; World Health Organization, 2011, COR COMP INF PREV CO; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	35	23	23	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						59	62	j3768	10.1136/bmj.j3768	http://dx.doi.org/10.1136/bmj.j3768			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874366	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000410575100012
J	Watson, T				Watson, Traci			PALAEONTOLOGY Roosting dinosaurs are a fossil first	NATURE			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					510	510		10.1038/nature.2017.22508	http://dx.doi.org/10.1038/nature.2017.22508			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858326	Bronze			2022-12-28	WOS:000408703100007
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Why GPs are always running late	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2017	358								j3955	10.1136/bmj.j3955	http://dx.doi.org/10.1136/bmj.j3955			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CK	28851686	Bronze, Green Published			2022-12-28	WOS:000409386400002
J	Bhakta, N; Liu, Q; Ness, KK; Baassiri, M; Eissa, H; Yeo, F; Chemaitilly, W; Ehrhardt, MJ; Bass, J; Bishop, MW; Shelton, K; Lu, L; Huang, SJ; Li, ZH; Caron, E; Lanctot, J; Howell, C; Folse, T; Joshi, V; Green, DM; Mulrooney, DA; Armstrong, GT; Krull, KR; Brinkman, TM; Khan, RB; Srivastava, DK; Hudson, MM; Yasui, Y; Robison, LL				Bhakta, Nickhill; Liu, Qi; Ness, Kirsten K.; Baassiri, Malek; Eissa, Hesham; Yeo, Frederick; Chemaitilly, Wassim; Ehrhardt, Matthew J.; Bass, Johnnie; Bishop, Michael W.; Shelton, Kyla; Lu, Lu; Huang, Sujuan; Li, Zhenghong; Caron, Eric; Lanctot, Jennifer; Howell, Carrie; Folse, Timothy; Joshi, Vijaya; Green, Daniel M.; Mulrooney, Daniel A.; Armstrong, Gregory T.; Krull, Kevin R.; Brinkman, Tara M.; Khan, Raja B.; Srivastava, Deo K.; Hudson, Melissa M.; Yasui, Yutaka; Robison, Leslie L.			The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)	LANCET			English	Article							LONG-TERM SURVIVORS; 5-YEAR SURVIVORS; ADULT SURVIVORS; HEALTH OUTCOMES; CARE; ADOLESCENT; EVENTS; RISKS	Background Survivors of childhood cancer develop early and severe chronic health conditions (CHCs). A quantitative landscape of morbidity of survivors, however, has not been described. We aimed to describe the cumulative burden of curative cancer therapy in a clinically assessed ageing population of long-term survivors of childhood cancer. Methods The St Jude Lifetime Cohort Study (SJLIFE) retrospectively collected data on CHCs in all patients treated for childhood cancer at the St Jude Children's Research Hospital who survived 10 years or longer from initial diagnosis and were 18 years or older as of June 30, 2015. Age-matched and sex-frequency-matched community controls were used for comparison. 21 treatment exposure variables were included in the analysis, with data abstracted from medical records. 168 CHCs for all participants were graded for severity using a modified Common Terminology Criteria of Adverse Events. Multiple imputation with predictive mean matching was used for missing occurrences and grades of CHCs in the survivors who were not clinically evaluable. Mean cumulative count was used for descriptive cumulative burden analysis and marked-point-process regression was used for inferential cumulative burden analysis. Findings Of 5522 patients treated for childhood cancer at St Jude Children's Research Hospital who had complete records, survived 10 years or longer, and were 18 years or older at time of study, 3010 (54.5%) were alive, had enrolled, and had had prospective clinical assessment. 2512 (45.5%) of the 5522 patients were not clinically evaluable. The cumulative incidence of CHCs at age 50 years was 99.9% (95% CI 99.9-99.9) for grade 1-5 CHCs and 96.0% (95% CI 95.3-96.8%) for grade 3-5 CHCs. By age 50 years, a survivor had experienced, on average, 17.1 (95% CI 16.2-18.1) CHCs of any grade, of which 4.7 (4.6-4.9) were CHCs of grade 3-5. The cumulative burden in matched community controls of grade 1-5 CHCs was 9.2 (95% CI 7.9-10.6; p<0.0001 vs total study population) and of grade 3-5 CHCs was 2.3 (1.9-2.7, p<0.0001 vs total study population). Second neoplasms, spinal disorders, and pulmonary disease were major contributors to the excess total cumulative burden. Notable heterogeneity in the distribution of CHC burden in survivors with differing primary cancer diagnoses was observed. The cumulative burden of grade 1-5 CHCs at age 50 years was highest in survivors of CNS malignancies (24.2 [95% CI 20.9-27.5]) and lowest in survivors of germ cell tumours (14.0 [11.5-16.6]). Multivariable analyses showed that older age at diagnosis, treatment era, and higher doses of brain and chest radiation are significantly associated with a greater cumulative burden and severity of CHCs. Interpretation The burden of CHCs in survivors of childhood cancer is substantial and highly variable. Our assessment of total cumulative burden in survivors of paediatric cancer, with detailed characterisation of long-term CHCs, provide data to better inform future clinical guidelines, research investigations, and health services planning for this vulnerable, medically complex population.	[Bhakta, Nickhill] St Jude Childrens Res Hosp, Dept Global Pediat Med, Memphis, TN 38105 USA; [Bhakta, Nickhill; Ness, Kirsten K.; Chemaitilly, Wassim; Ehrhardt, Matthew J.; Shelton, Kyla; Lu, Lu; Huang, Sujuan; Li, Zhenghong; Caron, Eric; Lanctot, Jennifer; Howell, Carrie; Folse, Timothy; Green, Daniel M.; Mulrooney, Daniel A.; Armstrong, Gregory T.; Krull, Kevin R.; Brinkman, Tara M.; Hudson, Melissa M.; Yasui, Yutaka; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Bhakta, Nickhill; Baassiri, Malek; Eissa, Hesham; Yeo, Frederick; Ehrhardt, Matthew J.; Bishop, Michael W.; Folse, Timothy; Mulrooney, Daniel A.; Armstrong, Gregory T.; Hudson, Melissa M.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Bass, Johnnie] St Jude Childrens Res Hosp, Rehabil Serv, Memphis, TN 38105 USA; [Chemaitilly, Wassim; Khan, Raja B.] St Jude Childrens Res Hosp, Dept Pediat Med, Memphis, TN 38105 USA; [Krull, Kevin R.; Brinkman, Tara M.] St Jude Childrens Res Hosp, Dept Psychol, Memphis, TN 38105 USA; [Srivastava, Deo K.] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Liu, Qi] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Chemaitilly, Wassim; Joshi, Vijaya] Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Alberta; University of Tennessee System; University of Tennessee Health Science Center	Bhakta, N (corresponding author), St Jude Childrens Res Hosp, Dept Global Pediat Med, Memphis, TN 38105 USA.	nickhill.bhakta@stjude.org	Ness, Kirsten K/N-2550-2018; Brinkman, Tara M/N-8171-2018; Robison, Leslie/N-8122-2018; Khan, Raja B/N-8150-2018; Bhakta, Nickhill/N-8142-2018; Yasui, Yutaka/E-2564-2015; Chemaitilly, Wassim/N-8178-2018; Hudson, Melissa M/N-4441-2018; Ehrhardt, Matt/N-3105-2018; Chemaitilly, Wassim/AAQ-3397-2021; Krull, Kevin R/N-3882-2018; Armstrong, Gregory/N-8096-2018; Bishop, Michael W./N-8133-2018; Srivastava, Deo Kumar/P-2435-2017; Howell, Carrie/G-8787-2018	Ness, Kirsten K/0000-0002-2084-1507; Brinkman, Tara M/0000-0002-4250-6160; Khan, Raja B/0000-0003-3702-7250; Bhakta, Nickhill/0000-0001-5282-7833; Yasui, Yutaka/0000-0002-7717-8638; Hudson, Melissa M/0000-0001-6984-2407; Ehrhardt, Matt/0000-0003-2781-9983; Krull, Kevin R/0000-0002-0476-7001; Bishop, Michael W./0000-0003-3926-1446; Srivastava, Deo Kumar/0000-0001-6693-8120; Bass, Johnnie/0000-0001-7432-3863; Howell, Carrie/0000-0002-6554-6237	US National Cancer Institute; St Baldrick's Foundation; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA216354, P30CA021765, U01CA195547] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St Baldrick's Foundation; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The US National Cancer Institute, St Baldrick's Foundation, and the American Lebanese Syrian Associated Charities.	Armstrong GT, 2016, NEW ENGL J MED, V374, P833, DOI 10.1056/NEJMoa1510795; Aznar MC, 2016, LANCET ONCOL, V17, P1189, DOI 10.1016/S1470-2045(16)30283-2; Berridge DM, 1996, STAT MED, V15, P2751; Bhakta N, 2016, LANCET ONCOL, V17, P1325, DOI 10.1016/S1470-2045(16)30215-7; Bhatia S, 2015, J CLIN ONCOL, V33, P3055, DOI 10.1200/JCO.2014.59.8052; Brewster DH, 2014, BRIT J CANCER, V110, P1342, DOI 10.1038/bjc.2013.788; Dale SB, 2016, NEW ENGL J MED, V374, P2345, DOI 10.1056/NEJMsa1414953; Dong HR, 2015, AM J EPIDEMIOL, V181, P532, DOI 10.1093/aje/kwu289; Fidler MM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4351; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Geskus RB, 2011, BIOMETRICS, V67, P39, DOI 10.1111/j.1541-0420.2010.01420.x; Howlader N, 2017, SEER CANC STAT REV C; Hudson MM, 2017, CANCER EPIDEM BIOMAR, V26, P666, DOI 10.1158/1055-9965.EPI-16-0812; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Krull KR, 2016, J CLIN ONCOL, V34, P2644, DOI 10.1200/JCO.2015.65.4574; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Little R., 2014, BAYES MULTIPLE IMPUT, P200, DOI [10.1002/9781119013563.ch10, DOI 10.1002/9781119013563.CH10]; Molenberghs G, 2015, HDB MISSING DATA MET, P233; Oeffinger KC, 2006, J CLIN ONCOL, V24, P5117, DOI 10.1200/JCO.2006.07.0474; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Pappas G, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302022; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Sieswerda E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159518; Suh E, 2014, ANN INTERN MED, V160, P11, DOI 10.7326/M13-1941; Winther JF, 2015, ACTA ONCOL, V54, P655, DOI 10.3109/0284186X.2015.1008648	30	346	348	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2017	390	10112					2569	2582		10.1016/S0140-6736(17)31610-0	http://dx.doi.org/10.1016/S0140-6736(17)31610-0			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP3BI	28890157	Green Accepted			2022-12-28	WOS:000417493300025
J	Dehghan, M; Mente, A; Zhang, XH; Swaminathan, S; Li, W; Mohan, V; Iqbal, R; Kumar, R; Wentzel-Viljoen, E; Rosengren, A; Amma, LI; Avezum, A; Chifamba, J; Diaz, R; Khatib, R; Lear, S; Lopez-Jaramillo, P; Liu, XY; Gupta, R; Mohammadifard, N; Gao, N; Oguz, A; Ramli, AS; Seron, P; Sun, Y; Szuba, A; Tsolekile, L; Wielgosz, A; Yusuf, R; Yusufali, AH; Teo, KK; Rangarajan, S; Dagenais, G; Bangdiwala, SI; Islam, S; Anand, SS; Yusuf, S				Dehghan, Mahshid; Mente, Andrew; Zhang, Xiaohe; Swaminathan, Sumathi; Li, Wei; Mohan, Viswanathan; Iqbal, Romaina; Kumar, Rajesh; Wentzel-Viljoen, Edelweiss; Rosengren, Annika; Amma, Leela Itty; Avezum, Alvaro; Chifamba, Jephat; Diaz, Rafael; Khatib, Rasha; Lear, Scott; Lopez-Jaramillo, Patricio; Liu, Xiaoyun; Gupta, Rajeev; Mohammadifard, Noushin; Gao, Nan; Oguz, Aytekin; Ramli, Anis Safura; Seron, Pamela; Sun, Yi; Szuba, Andrzej; Tsolekile, Lungiswa; Wielgosz, Andreas; Yusuf, Rita; Yusufali, Afzal Hussein; Teo, Koon K.; Rangarajan, Sumathy; Dagenais, Gilles; Bangdiwala, Shrikant I.; Islam, Shofiqul; Anand, Sonia S.; Yusuf, Salim		PURE Study Investigators	Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study	LANCET			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; ASSESS DIETARY-INTAKE; ALL-CAUSE MORTALITY; SATURATED FATS; SECONDARY PREVENTION; PROSPECTIVE URBAN; GLYCEMIC LOAD; HIGH-INCOME; HIGH-RISK	Background The relationship between macronutrients and cardiovascular disease and mortality is controversial. Most available data are from European and North American populations where nutrition excess is more likely, so their applicability to other populations is unclear. Methods The Prospective Urban Rural Epidemiology (PURE) study is a large, epidemiological cohort study of individuals aged 35-70 years (enrolled between Jan 1, 2003, and March 31, 2013) in 18 countries with a median followup of 7.4 years (IQR 5.3-9.3). Dietary intake of 135 335 individuals was recorded using validated food frequency questionnaires. The primary outcomes were total mortality and major cardiovascular events (fatal cardiovascular disease, non-fatal myocardial infarction, stroke, and heart failure). Secondary outcomes were all myocardial infarctions, stroke, cardiovascular disease mortality, and non-cardiovascular disease mortality. Participants were categorised into quintiles of nutrient intake (carbohydrate, fats, and protein) based on percentage of energy provided by nutrients. We assessed the associations between consumption of carbohydrate, total fat, and each type of fat with cardiovascular disease and total mortality. We calculated hazard ratios (HRs) using a multivariable Cox frailty model with random intercepts to account for centre clustering. Findings During follow-up, we documented 5796 deaths and 4784 major cardiovascular disease events. Higher carbohydrate intake was associated with an increased risk of total mortality (highest [quintile 5] vs lowest quintile [quintile 1] category, HR 1.28 [95% CI 1.12-1.46], p(trend) = 0.0001) but not with the risk of cardiovascular disease or cardiovascular disease mortality. Intake of total fat and each type of fat was associated with lower risk of total mortality (quintile 5 vs quintile 1, total fat: HR 0.77 [95% CI 0.67-0.87], p(trend) < 0.0001; saturated fat, HR 0.86 [0.76-0.99], p(trend) = 0.0088; monounsaturated fat: HR 0.81 [0.71-0.92], p(trend) < 0.0001; and polyunsaturated fat: HR 0.80 [0.71-0.89], p(trend) < 0.0001). Higher saturated fat intake was associated with lower risk of stroke (quintile 5 vs quintile 1, HR 0.79 [95% CI 0.64-0.98], p(trend) = 0.0498). Total fat and saturated and unsaturated fats were not significantly associated with risk of myocardial infarction or cardiovascular disease mortality. Interpretation High carbohydrate intake was associated with higher risk of total mortality, whereas total fat and individual types of fat were related to lower total mortality. Total fat and types of fat were not associated with cardiovascular disease, myocardial infarction, or cardiovascular disease mortality, whereas saturated fat had an inverse association with stroke. Global dietary guidelines should be reconsidered in light of these findings.	[Dehghan, Mahshid; Mente, Andrew; Zhang, Xiaohe; Teo, Koon K.; Rangarajan, Sumathy; Bangdiwala, Shrikant I.; Islam, Shofiqul; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Mente, Andrew] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Swaminathan, Sumathi] St Johns Natl Acad Hlth, St Johns Res Inst, Sarjapur Rd, Bangalore, Karnataka, India; [Li, Wei; Liu, Xiaoyun; Gao, Nan; Sun, Yi] Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Lab Cardiovasc Dis, Beijing, Peoples R China; [Li, Wei; Liu, Xiaoyun; Gao, Nan; Sun, Yi] Chinese Acad Med Sci, Beijing, Peoples R China; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, Romaina] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Kumar, Rajesh] PGIMER Sch Publ Hlth, Chandigarh, India; [Wentzel-Viljoen, Edelweiss] North West Univ, Fac Hlth Sci, Ctr Excellence Nutr, Potchefstroom, South Africa; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Amma, Leela Itty] Hlth Act People TC 1 1706, Med Coll PO, Trivandrum, Kerala, India; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Diaz, Rafael] ECLA, Rosario, Santa Fe, Argentina; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Lear, Scott] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Fac Hlth Sci, Burnaby, BC, Canada; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Floridablanca Santander, Colombia; [Lopez-Jaramillo, Patricio] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Oguz, Aytekin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Ramli, Anis Safura] Univ Teknol MARA, Fac Med, Selangor, Malaysia; [Seron, Pamela] Univ La Frontera, Temuco, Araucania, Chile; [Szuba, Andrzej] Wroclaw Med Univ, Div Angiol, Wroclaw, Poland; [Tsolekile, Lungiswa] Univ Western Cape, Cape Town, Western Provinc, South Africa; [Wielgosz, Andreas] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Yusuf, Rita] Independent Univ, Dhaka, Bangladesh; [Yusufali, Afzal Hussein] Dubai Med Univ, Dubai Med, Dubai Hlth Author, Dubai, U Arab Emirates; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol, Ville De Quebec, PQ, Canada; [Anand, Sonia S.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University; St. John's National Academy of Health Sciences; St. John's Research Institute; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Madras Diabetes Research Foundation; Aga Khan University; Aga Khan University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; North West University - South Africa; University of Gothenburg; Instituto Dante Pazzanese de Cardiologia; University of Zimbabwe; Birzeit University; Simon Fraser University; Eternal Heart Care Centre & Research Institute; Isfahan University Medical Science; Istanbul Medeniyet University; Universiti Teknologi MARA; Universidad de La Frontera; Wroclaw Medical University; University of the Western Cape; University of Ottawa; Independent University Bangladesh (IUB); Laval University; McMaster University	Dehghan, M (corresponding author), McMaster Univ, DBCVS Res Inst, Populat Hlth Res Inst, Room C1-102,237 Barton St East, Hamilton, ON L8L 2X2, Canada.	mahshid.dehghan@phri.ca	Mohammadifard, Noushin/M-2244-2018; Suraya, Abdul-Razak/AAG-1206-2020; Khatib, Rasha/GXV-8883-2022; Seron, Pamela/AAN-3304-2021; Kelishadi, Roya/E-6154-2012; Swaminathan, Sumathi/AGI-7678-2022; Szuba, Andrzej/AAY-1162-2020; Chifamba, Jephat/AHE-4535-2022; Ramli, Anis Safura/U-3548-2018; Ramli, Anis Safura/K-3322-2014; Tsolekile, Lungiswa/AAB-8949-2020; Schutte, Aletta E/E-5126-2018; Avezum, Alvaro/AAP-7687-2020; Rahman, Omar/E-1329-2019; Heidari, Hadi/K-5853-2015; Mattos, Antonio/AAC-8318-2020; Oguz, Aytekin/AAJ-2732-2021; Ariffin, Farnaza/H-9725-2014; Mohd Tamil, Azmi/E-5259-2017; Igumbor, Ehimario/B-2652-2012; Swart, Elizabeth/O-9619-2014; Gomez-Arbelaez, Diego/K-1883-2013; Kamalasanan, Ajayan/F-8785-2013; Rozanska, Dorota/S-5239-2018	Mohammadifard, Noushin/0000-0003-1776-1060; Suraya, Abdul-Razak/0000-0001-5376-2509; Seron, Pamela/0000-0003-0190-8988; Kelishadi, Roya/0000-0001-7455-1495; Chifamba, Jephat/0000-0001-8166-1182; Ramli, Anis Safura/0000-0002-9517-1413; Ramli, Anis Safura/0000-0002-9517-1413; Schutte, Aletta E/0000-0001-9217-4937; Rahman, Omar/0000-0002-0606-2507; Heidari, Hadi/0000-0001-8412-8164; Mattos, Antonio/0000-0001-8420-098X; Oguz, Aytekin/0000-0002-2595-5167; Bangdiwala, Shrikant/0000-0002-3111-0689; Ariffin, Farnaza/0000-0002-7755-9289; Rabbani, Khondkar/0000-0002-5642-4975; Mohd Tamil, Azmi/0000-0002-1657-3351; Ismail, Noor Hassim/0000-0003-1547-7904; Choudhury, Tarzia/0000-0003-2472-9210; Teo, Koon/0000-0002-3731-0956; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Yusuf, Salim/0000-0003-4776-5601; Tsolekile, Lungiswa/0000-0001-8597-141X; Camacho, Paul Anthony/0000-0002-6233-9582; Jerling, Johann/0000-0003-2600-3536; Igumbor, Ehimario/0000-0002-6313-6031; Swart, Elizabeth/0000-0002-7786-3117; Gulec, Sadi/0000-0002-2685-2522; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Achilova, Diyora/0000-0002-7645-9497; Zatonska, Katarzyna/0000-0002-3772-5588; Lanas, Fernando/0000-0003-3595-9759; Levitt, Naomi/0000-0001-6480-8066; AVEZUM, ALVARO/0000-0002-3073-6890; Peer, Nasheeta/0000-0003-2131-8344; Yusufali, Afzalhussein/0000-0003-3378-2646; Kamalasanan, Ajayan/0000-0003-2389-250X; Regulska-Ilow, Bozena/0000-0002-5941-1715; Patro, Binod Kumar/0000-0003-0019-4522; Wolyniec, Maria/0000-0003-2054-1691; Dehghan, Mahshid/0000-0003-2149-847X; Ali, Mohammed/0000-0001-7266-2503; Szuba, Andrzej/0000-0002-7555-6201; Rozanska, Dorota/0000-0002-0561-2749	Heart and Stroke Foundation/Marion W Burke Chair in Cardiovascular Disease; Population Health Research Institute; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario from CIHR's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care; AstraZeneca [Canada]; Sanofi-Aventis [France]; Sanofi-Aventis [Canada]; Boehringer Ingelheim [Germany]; Boehringer Ingelheim [Canada]; Servier; GlaxoSmithKline; Novartis; King Pharma; Argentina: Fundacion ECLA; Bangladesh: Independent University; Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias [6566-04-18062]; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21[13/2007], 07-05-IFN-BPH 010]; Malaysia: Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3[2/2011]]; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), International Development Research Centre, Canada; Poland: Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Poland: Wroclaw Medical University; South Africa: The North-West University; South Africa: SANPAD (SA and Netherlands Programme for Alternative Development); South Africa: National Research Foundation; South Africa: Medical Research Council of South Africa; South Africa: South Africa Sugar Association; South Africa: Faculty of Community and Health Sciences; Sweden: Swedish State; Sweden: Swedish Heart and Lung Foundation; Sweden: Swedish Research Council; Sweden: Swedish Council for Health, Working Life and Welfare; Sweden: King Gustaf V's and Queen Victoria Freemasons Foundation; Sweden: AFA Insurance; Sweden: Swedish Council for Working Life and Social Research; Sweden: Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Sweden: Vastra Gotaland Region; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca, Turkey; Turkey: Sanofi Aventis, Turkey; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Dubai Health Authority, Dubai; Swedish State	Heart and Stroke Foundation/Marion W Burke Chair in Cardiovascular Disease; Population Health Research Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario from CIHR's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); AstraZeneca [Canada](AstraZeneca); Sanofi-Aventis [France](Sanofi-Aventis); Sanofi-Aventis [Canada](Sanofi-Aventis); Boehringer Ingelheim [Germany](Boehringer Ingelheim); Boehringer Ingelheim [Canada](Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Argentina: Fundacion ECLA; Bangladesh: Independent University; Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias; India: Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Malaysia: Ministry of Science, Technology and Innovation of Malaysia; Malaysia: Ministry of Higher Education of Malaysia; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia; occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), International Development Research Centre, Canada; Poland: Polish Ministry of Science and Higher Education; Poland: Wroclaw Medical University; South Africa: The North-West University; South Africa: SANPAD (SA and Netherlands Programme for Alternative Development); South Africa: National Research Foundation(National Research Foundation - South Africa); South Africa: Medical Research Council of South Africa; South Africa: South Africa Sugar Association; South Africa: Faculty of Community and Health Sciences; Sweden: Swedish State; Sweden: Swedish Heart and Lung Foundation; Sweden: Swedish Research Council; Sweden: Swedish Council for Health, Working Life and Welfare; Sweden: King Gustaf V's and Queen Victoria Freemasons Foundation; Sweden: AFA Insurance; Sweden: Swedish Council for Working Life and Social Research; Sweden: Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Sweden: Vastra Gotaland Region; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca, Turkey; Turkey: Sanofi Aventis, Turkey; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Dubai Health Authority, Dubai; Swedish State	We are grateful to Russell de Souza who provided valuable feedback throughout the preparation of the manuscript. Our sincere thanks also go to Dipika Desai who critically reviewed the nutrient database data. SY is supported by the Heart and Stroke Foundation/Marion W Burke Chair in Cardiovascular Disease. The PURE Study is an investigator-initiated study that is funded by the Population Health Research Institute, the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Ontario, support from CIHR's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi-Aventis [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, and GlaxoSmithKline), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include: Argentina: Fundacion ECLA; Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias (grant number 6566-04-18062); India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant numbers 100-IRDC/BIOTEK 16/6/21[13/2007] and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number 600-RMI/LRGS/5/3[2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), International Development Research Centre, Canada; Poland: Polish Ministry of Science and Higher Education (grant number 290/W-PURE/2008/0), Wroclaw Medical University; South Africa: The North-West University, SANPAD (SA and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences; Sweden: grants from the Swedish State under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V's and Queen Victoria Freemasons Foundation, AFA Insurance, Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, grant from the Swedish State under (LakarUtbildningsAvtalet) Agreement, grant from the Vastra Gotaland Region; Turkey: Metabolic Syndrome Society, AstraZeneca, Turkey, Sanofi Aventis, Turkey; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Dubai Health Authority, Dubai.	Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; Bharathi AV, 2008, ASIA PAC J CLIN NUTR, V17, P178; Burger KNJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025955; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Dehghan M, 2013, PUBLIC HEALTH NUTR, V16, P1782, DOI 10.1017/S1368980012004107; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Dehghan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037958; Dehghan M, 2012, J NUTR EDUC BEHAV, V44, P609, DOI 10.1016/j.jneb.2010.10.001; Dehghan M, 2009, SAUDI MED J, V30, P159; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052182; Grasgruber P, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.31694; Guasch-Ferre M, 2015, AM J CLIN NUTR, V102, P1563, DOI 10.3945/ajcn.115.116046; Gunes FE, 2015, J PAK MED ASSOC, V65, P756; Hamley S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0254-5; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; Hooper L, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD011737, 10.1002/14651858.CD011583.pub2]; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Iqbal R, 2009, PUBLIC HEALTH NUTR, V12, P12, DOI 10.1017/S1368980008001845; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Keys A., 1980, MULTIVARIATE ANAL DE; Li YP, 2015, J AM COLL CARDIOL, V66, P1538, DOI 10.1016/j.jacc.2015.07.055; Mahajan R, 2013, NATL MED J INDIA, V26, P266; Mani I, 2016, INDIAN J MED RES, V144, P507, DOI 10.4103/0971-5916.200904; Mente A, 2017, LANCET DIABETES ENDO; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Merchant AT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-2; Miller V, 2017, LANCET; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nagata C, 2012, J NUTR, V142, P1713, DOI 10.3945/jn.112.161661; O'Donnell M, 2014, NEW ENGL J MED, V371, P2137, DOI 10.1056/NEJMc1412113; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Oh K, 2005, AM J EPIDEMIOL, V161, P161, DOI 10.1093/aje/kwi026; Parish S, 2012, CIRCULATION, V125, P2469, DOI 10.1161/CIRCULATIONAHA.111.073684; Praagman J, 2016, ARTERIOSCL THROM VAS, V36, P2011, DOI 10.1161/ATVBAHA.116.307578; Praagman J, 2016, AM J CLIN NUTR, V103, P356, DOI 10.3945/ajcn.115.122671; Puska P, 2009, ANN NUTR METAB, V54, P33, DOI 10.1159/000220825; Ramsden CE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1246; Schwingshackl L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004487; Siri-Tarino PW, 2015, ANNU REV NUTR, V35, P517, DOI 10.1146/annurev-nutr-071714-034449; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043; Yu DX, 2013, AM J EPIDEMIOL, V178, P1542, DOI 10.1093/aje/kwt178; Yu E, 2016, AM J PUBLIC HEALTH, V106, P1616, DOI 10.2105/AJPH.2016.303316; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	53	576	605	14	265	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2050	2062		10.1016/S0140-6736(17)32252-3	http://dx.doi.org/10.1016/S0140-6736(17)32252-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FL5DD	28864332				2022-12-28	WOS:000414250800022
J	Li, HJ; Liefke, R; Jiang, JY; Kurland, JV; Tian, W; Deng, PJ; Zhang, WD; He, Q; Patel, DJ; Bulyk, ML; Shi, Y; Wang, ZX				Li, Haojie; Liefke, Robert; Jiang, Junyi; Kurland, Jesse Vigoda; Tian, Wei; Deng, Pujuan; Zhang, Weidi; He, Qian; Patel, Dinshaw J.; Bulyk, Martha L.; Shi, Yang; Wang, Zhanxin			Polycomb-like proteins link the PRC2 complex to CpG islands	NATURE			English	Article							HISTONE H3; TUDOR DOMAIN; TRANSCRIPTION; METHYLATION; GENE; TRIMETHYLATION; RECOGNITION; MICROARRAYS; COMPONENTS; H3K36ME3	The Polycomb repressive complex 2 (PRC2) mainly mediates transcriptional repression(1,2) and has essential roles in various biological processes including the maintenance of cell identity and proper differentiation. Polycomb-like (PCL) proteins, such as PHF1, MTF2 and PHF19, are PRC2-associated factors that form subcomplexes with PRC2 core components(3), and have been proposed to modulate the enzymatic activity of PRC2 or the recruitment of PRC2 to specific genomic loci(4-13). Mammalian PRC2-binding sites are enriched in CG content, which correlates with CpG islands that display a low level of DNA methylation(14). However, the mechanism of PRC2 recruitment to CpG islands is not fully understood. Here we solve the crystal structures of the N-terminal domains of PHF1 and MTF2 with bound CpG-containing DNAs in the presence of H3K36me3-containing histone peptides. We show that the extended homologous regions of both proteins fold into a winged-helix structure, which specifically binds to the unmethylated CpG motif but in a completely different manner from the canonical wingedhelix DNA recognition motif. We also show that the PCL extended homologous domains are required for efficient recruitment of PRC2 to CpG island-containing promoters in mouse embryonic stem cells. Our research provides the first, to our knowledge, direct evidence to demonstrate that PCL proteins are crucial for PRC2 recruitment to CpG islands, and further clarifies the roles of these proteins in transcriptional regulation in vivo.	[Li, Haojie; Jiang, Junyi; Tian, Wei; Deng, Pujuan; Zhang, Weidi; He, Qian; Wang, Zhanxin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China; [Liefke, Robert; Shi, Yang] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Liefke, Robert; Shi, Yang] Boston Childrens Hosp, Dept Med, Epigenet Program, Boston, MA 02115 USA; [Liefke, Robert; Shi, Yang] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Kurland, Jesse Vigoda; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Kurland, Jesse Vigoda; Bulyk, Martha L.] Harvard Med Sch, Boston, MA 02115 USA; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Beijing Normal University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital	Wang, ZX (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.	wangz@bnu.edu.cn	Liefke, Robert/AAF-6842-2021; jiang, jun/GWC-9329-2022	Liefke, Robert/0000-0002-8549-637X; Jiang, Junyi/0000-0002-4080-069X	National Natural Science Foundation of China [31370719, 31570729]; Beijing Natural Science Foundation [5152015]; Fundamental Research Funds for the Central Universities [2014KJJCA09, 2017EYT19]; Leukemia and Lymphoma Society; Memorial Sloan-Kettering Cancer Center Core Grant [P30 CA008748]; German Research Foundation (DFG) [LI 2057/1-1]; NIH/NHGRI R01 grant [HG003985]; National Cancer Institute [R01 CA118487]; Boston Children's Hospital; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA118487] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Memorial Sloan-Kettering Cancer Center Core Grant; German Research Foundation (DFG)(German Research Foundation (DFG)); NIH/NHGRI R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Boston Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the staff from the BL17U1, BL18U1 and BL19U1 beamlines of National Facility for Protein Science in Shanghai (NFPS) at Shanghai Synchrotron Radiation Facility (SSRF) in China for assistance during data collection, and C. Yun for help in data collection in the United States. We thank G. Jiang for help with ITC studies. We thank A. Jambhekar for critical reading of the manuscript. This work was supported by the National Natural Science Foundation of China (31370719 and 31570729), Beijing Natural Science Foundation (5152015) and the Fundamental Research Funds for the Central Universities (2014KJJCA09 and 2017EYT19) to Z.W. Early research on PCL protein expression undertaken by Z.W. in the laboratory of D.J.P. was supported by the Leukemia and Lymphoma Society and by the Memorial Sloan-Kettering Cancer Center Core Grant (P30 CA008748). Research on PCL proteins was supported by the German Research Foundation (DFG, LI 2057/1-1) to R.L, NIH/NHGRI R01 grant HG003985 to M.L.B., and the National Cancer Institute (R01 CA118487) and funds from Boston Children's Hospital to Y.S. Y.S. is an American Cancer Society Research Professor.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Ballare C, 2012, NAT STRUCT MOL BIOL, V19, P1257, DOI 10.1038/nsmb.2434; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Boulay G, 2011, BIOCHEM J, V434, P333, DOI 10.1042/BJ20100944; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Cai L, 2013, MOL CELL, V49, P571, DOI 10.1016/j.molcel.2012.11.026; Callebaut I, 2012, BIOCHIMIE, V94, P2006, DOI 10.1016/j.biochi.2012.05.025; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Casanova M, 2011, DEVELOPMENT, V138, P1471, DOI 10.1242/dev.053652; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hauri S, 2016, CELL REP, V17, P583, DOI 10.1016/j.celrep.2016.08.096; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hunkapiller J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002576; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Kloet SL, 2016, NAT STRUCT MOL BIOL, V23, P682, DOI 10.1038/nsmb.3248; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kycia I, 2014, J MOL BIOL, V426, P1651, DOI 10.1016/j.jmb.2013.08.009; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li XZ, 2011, MOL CELL BIOL, V31, P351, DOI 10.1128/MCB.00259-10; Liefke R, 2016, MOL CELL, V64, P659, DOI 10.1016/j.molcel.2016.10.019; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1266, DOI 10.1038/nsmb.2435; Qin S, 2013, BIOCHEM BIOPH RES CO, V430, P547, DOI 10.1016/j.bbrc.2012.11.116; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Xiao S, 2012, CELL, V149, P1381, DOI 10.1016/j.cell.2012.04.029; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237	41	159	160	7	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					287	+		10.1038/nature23881	http://dx.doi.org/10.1038/nature23881			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG7AE	28869966	Green Submitted, Green Accepted			2022-12-28	WOS:000410555900049
J	[Anonymous]				[Anonymous]			Challenges in HCV Elimination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					899	899		10.1001/jama.2017.11457	http://dx.doi.org/10.1001/jama.2017.11457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898385				2022-12-28	WOS:000410487100004
J	Bellin, MD; Beilman, GJ				Bellin, Melena D.; Beilman, Gregory J.			Surgical trials for chronic pancreatitis	LANCET			English	Editorial Material							PYLORUS-PRESERVING PANCREATICODUODENECTOMY; QUALITY-OF-LIFE; RANDOMIZED-TRIAL; HEAD RESECTION; DRAINAGE		[Bellin, Melena D.] Univ Minnesota, Med Ctr, Dept Pediat, Minneapolis, MN 55454 USA; [Bellin, Melena D.; Beilman, Gregory J.] Univ Minnesota, Med Ctr, Dept Surg, Minneapolis, MN 55454 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bellin, MD (corresponding author), Univ Minnesota, Med Ctr, Dept Pediat, Minneapolis, MN 55454 USA.; Bellin, MD (corresponding author), Univ Minnesota, Med Ctr, Dept Surg, Minneapolis, MN 55454 USA.	bell0130@umn.edu						Ali UA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007884.pub3; Amann ST, 2013, PANCREAS, V42, P293, DOI 10.1097/MPA.0b013e31826532e7; Bouwense SAW, 2015, WORLD J GASTROENTERO, V21, P47, DOI 10.3748/wjg.v21.i1.47; BUCHLER MW, 1995, AM J SURG, V169, P65, DOI 10.1016/S0002-9610(99)80111-1; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Diener MK, 2017, LANCET, V390, P1027, DOI 10.1016/S0140-6736(17)31960-8; Farkas G, 2006, LANGENBECK ARCH SURG, V391, P338, DOI 10.1007/s00423-006-0051-7; Hall TC, 2014, J EVAL CLIN PRACT, V20, P203, DOI 10.1111/jep.12117; Izbicki JR, 1998, ANN SURG, V228, P771, DOI 10.1097/00000658-199812000-00008; Keck T, 2012, SURGERY, V152, pS95, DOI 10.1016/j.surg.2012.05.016; KLEMPA I, 1995, CHIRURG, V66, P350; Schmidt CM, 2010, ARCH SURG-CHICAGO, V145, P634, DOI 10.1001/archsurg.2010.118; Ting J, 2016, J PEDIATR GASTR NUTR, V62, P443, DOI 10.1097/MPG.0000000000001057	13	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1007	1008		10.1016/S0140-6736(17)32338-3	http://dx.doi.org/10.1016/S0140-6736(17)32338-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28901924				2022-12-28	WOS:000409528600005
J	Diener, MK; Huttner, FJ; Kieser, M; Knebel, P; Dorr-Harim, C; Distler, M; Grutzmann, R; Wittel, UA; Schirren, R; Hau, HM; Kleespies, A; Heidecke, CD; Tomazic, A; Halloran, CM; Wilhelm, TJ; Bahra, M; Beckurts, T; Borner, T; Glanemann, M; Steger, U; Treitschke, F; Staib, L; Thelen, K; Bruckner, T; Mihaljevic, AL; Werner, J; Ulrich, A; Hackert, T; Buchler, MW				Diener, Markus K.; Huettner, Felix J.; Kieser, Meinhard; Knebel, Phillip; Doerr-Harim, Colette; Distler, Marius; Gruetzmann, Robert; Wittel, Uwe A.; Schirren, Rebekka; Hau, Hans-Michael; Kleespies, Axel; Heidecke, Claus-Dieter; Tomazic, Ales; Halloran, Christopher M.; Wilhelm, Torsten J.; Bahra, Marcus; Beckurts, Tobias; Boerner, Thomas; Glanemann, Matthias; Steger, Ulrich; Treitschke, Frank; Staib, Ludger; Thelen, Karsten; Brueckner, Thomas; Mihaljevic, Andre L.; Werner, Jens; Ulrich, Alexis; Hackert, Thilo; Buechler, Markus W.		ChroPac Trial Grp	Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial	LANCET			English	Article							QUALITY-OF-LIFE; INTERNATIONAL STUDY-GROUP; INTENTION-TO-TREAT; WHIPPLE PROCEDURE; FOLLOW-UP; DRAINAGE; SURGERY; QLQ-C30; EXCISION; BEGER	Background There is substantial uncertainty regarding the optimal surgical treatment for chronic pancreatitis. Short-term outcomes have been found to be better after duodenum-preserving pancreatic head resection (DPPHR) than after partial pancreatoduodenectomy. Therefore, we designed the multicentre ChroPac trial to investigate the long-term outcomes of patients with chronic pancreatitis within 24 months after surgery. Methods This randomised, controlled, double-blind, parallel-group, superiority trial was done in 18 hospitals across Europe. Patients with chronic pancreatitis who were planned for elective surgical treatment were randomly assigned to DPPHR or partial pancreatoduodenectomy with a central web-based randomisation tool. The primary endpoint was mean quality of life within 24 months after surgery, measured with the physical functioning scale of the European Organisation for Research and Treatment of Cancer QLQ-C30 questionnaire. Primary analysis included all patients who underwent one of the assigned procedures; safety analysis included all patients who underwent surgical intervention (categorised into groups as treated). Patients and outcome assessors were masked to group assignment. The trial was registered, ISRCTN38973832. Recruitment was completed on Sept 3, 2013. Findings Between Sept 10, 2009, and Sept 3, 2013, 250 patients were randomly assigned to DPPHR (n=125) or partial pancreatoduodenectomy (n=125), of whom 226 patients (115 in the DPPHR group and 111 in the partial pancreatoduodenectomy group) were analysed. No difference in quality of life was seen between the groups within 24 months after surgery (75.3 [SD 16.4] for partial pancreatoduodenectomy vs 73.0 [16.4] for DPPHR; mean difference -2.3, 95% CI -6.6 to 2.0; p=0.284). The incidence and severity of serious adverse events did not differ between the groups. 70 (64%) of 109 patients in the DPPHR group and 61 (52%) of 117 patients in the partial pancreatoduodenectomy group had at least one serious adverse event, with the most common being reoperations (for reasons other than chronic pancreatitis), gastrointestinal problems, and other surgical morbidity. Interpretation No differences in quality of life after surgery for chronic pancreatitis were seen between the interventions. Results from single-centre trials showing superiority for DPPHR were not confirmed in the multicentre setting.	[Diener, Markus K.; Huettner, Felix J.; Knebel, Phillip; Mihaljevic, Andre L.; Ulrich, Alexis; Hackert, Thilo; Buechler, Markus W.] Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany; [Diener, Markus K.; Huettner, Felix J.; Doerr-Harim, Colette] Heidelberg Univ, German Surg Soc, Study Ctr, Heidelberg, Germany; [Kieser, Meinhard; Brueckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Mihaljevic, Andre L.] Heidelberg Univ, Surg Trial Network CHIR Net, Heidelberg, Germany; [Distler, Marius] Tech Univ Dresden, Univ Hosp Dresden, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Gruetzmann, Robert] Friedrich Alexander Univ Erlangen Nurnberg, Dept Surg, Erlangen, Germany; [Wittel, Uwe A.] Univ Freiburg, Dept Gen & Visceral Surg, Med Ctr, Freiburg, Germany; [Schirren, Rebekka] Tech Univ Munich, Univ Hosp Rechts Isar, Dept Surg, Munich, Germany; [Hau, Hans-Michael] Univ Hosp Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany; [Kleespies, Axel; Werner, Jens] Univ Munich, Dept Gen Visceral Vasc & Transplantat Surg, Munich, Germany; [Heidecke, Claus-Dieter] Univ Med Greifswald, Dept Gen Visceral Thorac & Vasc Surg, Greifswald, Germany; [Tomazic, Ales] Univ Med Ctr, Dept Abdominal Surg, Ljubljana, Slovenia; [Halloran, Christopher M.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, NIHR Pancreas Biomed Res Unit, Liverpool, Merseyside, England; [Wilhelm, Torsten J.] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim UMM, Dept Surg, Mannheim, Germany; [Bahra, Marcus] CCM CVK Berlin, Dept Surg, Charite, Berlin, Germany; [Beckurts, Tobias] Krankenhaus Augustinerinnen, Dept Gen Visceral Thorac & Trauma Surg, Cologne, Germany; [Boerner, Thomas] Univ Med Ctr Regensburg, Dept Surg, Regensburg, Germany; [Glanemann, Matthias] Saarland Univ Hosp, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany; [Glanemann, Matthias] Saarland Univ, Fac Med, Homburg, Germany; [Steger, Ulrich] Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany; [Treitschke, Frank] Red Cross Hosp Munich, Dept Gen & Visceral Surg, Munich, Germany; [Staib, Ludger] Klinikum Esslingen, Dept Gen & Visceral Surg, Esslingen, Germany; [Thelen, Karsten] Univ Hosp Heidelberg, Coordinat Ctr Clin Trials KKS, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Erlangen Nuremberg; University of Freiburg; Technical University of Munich; Leipzig University; University of Munich; Greifswald Medical School; University Medical Centre Ljubljana; University of Liverpool; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; University of Wurzburg; Ruprecht Karls University Heidelberg	Buchler, MW (corresponding author), Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany.	markus.buechler@med.uni-heidelberg.de	Lerch, Markus M./E-2206-2016; Seiler, Christoph/AAG-7056-2021; Reim, Daniel/J-3115-2013; Hau, Hans-Michael/AAJ-1005-2021	Lerch, Markus M./0000-0002-9643-8263; Reim, Daniel/0000-0001-9736-3307; Halloran, Christopher/0000-0002-5471-4178; di sebastiano, pierluigi/0000-0002-9386-8241; Neoptolemos, John/0000-0002-6201-7399; Keck, Tobias/0000-0001-7651-6183; Mihaljevic, Andre/0000-0003-1902-657X; Boerner, Thomas/0000-0001-7030-1325	German Research Foundation (DFG); Cancer Research UK [16791] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK)	German Research Foundation (DFG).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abraha I, 2017, J CLIN EPIDEMIOL, V84, P37, DOI 10.1016/j.jclinepi.2016.11.012; ABT K, 1987, METHOD INFORM MED, V26, P77; Ali UA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007884.pub3; Ali UA, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-49; Ali UA, 2012, ARCH SURG-CHICAGO, V147, P925, DOI 10.1001/archsurg.2012.1094; [Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Bachmann K, 2013, ANN SURG, V258, P815, DOI 10.1097/SLA.0b013e3182a655a8; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; BEGER HG, 1984, LANGENBECK ARCH CHIR, V362, P229, DOI 10.1007/BF01254649; BEGER HG, 1980, CHIRURG, V51, P303; Belina F, 2005, PANCREATOLOGY, V5, P547, DOI 10.1159/000087496; BUCHLER MW, 1995, AM J SURG, V169, P65, DOI 10.1016/S0002-9610(99)80111-1; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Diener MK, 2008, ANN SURG, V247, P950, DOI 10.1097/SLA.0b013e3181724ee7; Diener MK, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-47; Dite P, 2003, ENDOSCOPY, V35, P553; Farkas G, 2006, LANGENBECK ARCH SURG, V391, P338, DOI 10.1007/s00423-006-0051-7; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Fitzsimmons D, 2005, AM J GASTROENTEROL, V100, P918, DOI 10.1111/j.1572-0241.2005.40859.x; Fitzsimmons D, 1999, EUR J CANCER, V35, P939, DOI 10.1016/S0959-8049(99)00047-7; FREY CF, 1987, PANCREAS, V2, P701, DOI 10.1097/00006676-198711000-00014; Gloor B, 2001, DIGEST SURG, V18, P21, DOI 10.1159/000050092; Gurusamy KS, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011521.pub2; Izbicki JR, 1998, ANN SURG, V228, P771, DOI 10.1097/00000658-199812000-00008; Keck T, 2012, SURGERY, V152, pS95, DOI 10.1016/j.surg.2012.05.016; Kleeff J, 2016, DTSCH ARZTEBL INT, V113, P489, DOI 10.3238/arztebl.2016.0489; KLEMPA I, 1995, CHIRURG, V66, P350; Laramee P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003676; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Majumder S, 2016, LANCET, V387, P1957, DOI 10.1016/S0140-6736(16)00097-0; Makowiec F, 2004, GASTROENTEROLOGY, V126, pA802; McClaine RJ, 2009, HPB, V11, P677, DOI 10.1111/j.1477-2574.2009.00118.x; Montedori A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-58; Muller MW, 2008, BRIT J SURG, V95, P350, DOI 10.1002/bjs.5960; NEALON WH, 1993, ANN SURG, V217, P458, DOI 10.1097/00000658-199305010-00005; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Rubin DB, 1987, MULTIPLE IMPUTATION; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Strate T, 2008, GASTROENTEROLOGY, V134, P1406, DOI 10.1053/j.gastro.2008.02.056; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005	43	71	81	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1027	1037		10.1016/S0140-6736(17)31960-8	http://dx.doi.org/10.1016/S0140-6736(17)31960-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG1BW	28901935				2022-12-28	WOS:000409528600021
J	Tam, PKH; Davenport, M; Chan, IHY; Numanoglu, A; Hoebeke, P; Diamond, DA				Tam, Paul K. H.; Davenport, Mark; Chan, Ivy H. Y.; Numanoglu, Alp; Hoebeke, Piet; Diamond, David A.			Long-term implications and global impact of paediatric surgery	LANCET			English	Editorial Material							ANORECTAL-MALFORMATIONS; CLINICAL-PRACTICE; CARE; TRANSITION; DISORDERS; EDUCATION; CHILDREN; UROLOGY		[Tam, Paul K. H.; Chan, Ivy H. Y.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Davenport, Mark] Kings Coll Hosp London, Dept Paediat Surg, London, England; [Numanoglu, Alp] Univ Cape Town, Red Cross War Mem Childrens Hosp, Div Paediat Surg, Cape Town, South Africa; [Hoebeke, Piet] Univ Ghent, Ghent Univ Hosp, Dept Urol, Ghent, Belgium; [Diamond, David A.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA	University of Hong Kong; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Cape Town; Ghent University; Ghent University Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	Tam, PKH (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	paultam@hku.hk	Davenport, Mark/AAZ-5775-2020; /C-4405-2009	/0000-0001-6231-3035; Numanoglu, Alp/0000-0003-2026-6423; Hoebeke, Piet/0000-0002-9883-7647; Davenport, Mark/0000-0002-0938-2717				Castellan M, 2007, J UROLOGY, V178, P1771, DOI 10.1016/j.juro.2007.05.100; Davenport M, 2004, LANCET; Davenport M, 2015, J PEDIATR SURG, V50, P240, DOI 10.1016/j.jpedsurg.2014.11.008; Davidson A, 2017, PEDIATR ANESTH, V27, P336, DOI 10.1111/pan.13122; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; Diamond DA, 2016, J UROLOGY, V196, P305, DOI 10.1016/j.juro.2016.05.080; Giuliani S, 2016, J PEDIATR SURG, V51, P1450, DOI 10.1016/j.jpedsurg.2016.03.011; Hamid R, 2009, BJU INT, V104, P392, DOI 10.1111/j.1464-410X.2009.08401.x; Hazebroek FWJ, 2014, SEMIN PEDIATR SURG, V23, P309, DOI 10.1053/j.sempedsurg.2014.09.013; Kabagambe SK, 2017, MINERVA PEDIATR, V69, P59, DOI 10.23736/S0026-4946.16.04811-8; Kelleher K, 2015, SEMIN PEDIATR SURG, V24, P61, DOI 10.1053/j.sempedsurg.2015.01.001; Kyrklund K, 2016, J UROLOGY, V196, P1741, DOI 10.1016/j.juro.2016.08.079; Langer R, 2016, J PEDIATR SURG, V51, P8, DOI 10.1016/j.jpedsurg.2015.10.022; Loveland J, 2012, SEMIN PEDIATR SURG, V21, P160, DOI 10.1053/j.sempedsurg.2012.01.008; McCracken KA, 2015, SEMIN PEDIATR SURG, V24, P88, DOI 10.1053/j.sempedsurg.2015.01.009; Minto CL, 2003, LANCET, V361, P1252, DOI 10.1016/S0140-6736(03)12980-7; Ohashi T, 2013, J GASTROEN HEPATOL, V28, P243, DOI 10.1111/j.1440-1746.2012.07260.x; Ozgediz D, 2016, SEMIN PEDIATR SURG, V25, P3, DOI 10.1053/j.sempedsurg.2015.09.002; Partridge EA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15112; Polaner DM, 2017, LANCET, V389, P2174, DOI 10.1016/S0140-6736(17)31506-4; Schober J, 2012, J PEDIATR UROL, V8, P616, DOI 10.1016/j.jpurol.2012.08.005; Springford LR, 2016, DIS COLON RECTUM, V59, P570, DOI 10.1097/DCR.0000000000000576; Tam PKH, 2017, LANCET, V390, P1072, DOI 10.1016/S0140-6736(17)32284-5; Tam PKH, 2013, PEDIATR SURG INT, V29, P1053, DOI 10.1007/s00383-013-3407-4; van den Hondel D, 2016, ACTA PAEDIATR, V105, pE77, DOI 10.1111/apa.13154; Wood D, 2017, CURR OPIN UROL, V27, P7, DOI 10.1097/MOU.0000000000000354	26	2	2	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1012	1014		10.1016/S0140-6736(17)32341-3	http://dx.doi.org/10.1016/S0140-6736(17)32341-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG1BW	28901925	Green Submitted			2022-12-28	WOS:000409528600008
J	Laird, DW; Naus, CC; Lampe, PD				Laird, Dale W.; Naus, Christian C.; Lampe, Paul D.			SnapShot: Connexins and Disease	CELL			English	Editorial Material							HEARING-LOSS; MECHANISMS; MUTATIONS		[Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Western University (University of Western Ontario); University of British Columbia; Fred Hutchinson Cancer Center	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.		Laird, Dale W/AAL-2407-2020	Laird, Dale W/0000-0002-4568-3285	Canadian Institutes of Health Research [123228, 130530, 148630, 148584]; National Institutes of Health [GM55632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Eric Press for constructing the topographical models. Related work in the authors' laboratories was supported by Canadian Institutes of Health Research 123228, 130530, 148630, and 148584 to D.W.L. and National Institutes of Health GM55632 to P.D.L. D.W.L. and C.C.N. hold Canada Research Chair positions.	Bai DL, 2014, FEBS LETT, V588, P1238, DOI 10.1016/j.febslet.2014.02.064; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Kelly JJ, 2015, CELL TISSUE RES, V360, P701, DOI 10.1007/s00441-014-2024-4; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lilly E, 2016, SEMIN CELL DEV BIOL, V50, P4, DOI 10.1016/j.semcdb.2015.11.018; Lubkemeier I, 2015, CIRC-CARDIOVASC GENE, V8, P21, DOI 10.1161/CIRCGENETICS.114.000793; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Srinivas M, 2017, AM J HUM GENET	9	34	38	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6							1260.e1	10.1016/j.cell.2017.08.034	http://dx.doi.org/10.1016/j.cell.2017.08.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5CW	28886388	Bronze			2022-12-28	WOS:000424595900001
J	Crisp, N				Crisp, Nigel			What would a sustainable health and care system look like?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.crisp@zen.co.uk		Crisp, Nigel/0000-0002-9452-095X				All Party Parliamentary Group on Global Health, 2016, UKS CONTR HLTH GLOB; British Heart Foundation, 2016, HLTH WORK EC EV REP; Buckner L., 2015, VALUING CARERS 2015; Calouste Gulbenkian Foundation, 2014, FUT HLTH PORT 2014; Commonwealth Fund, MIRR MIRR WALL 2014; Crisp N., 24 HOURS SAVE NHS CH; Crisp N, 2016, LANCET, V388, pE24, DOI 10.1016/S0140-6736(16)31801-3; Crisp N, 2014, NEW ENGL J MED, V370, P950, DOI 10.1056/NEJMra1111610; Department of Health, 2012, LONG TERM CONDITIONS; Johnstone R., 2016, KINGS FUND HIGHLIGHT; National Audit Office, FIN SUST NHS; National Voices, 2016, 6 PRINC ENG PEOPL CO; NHS, 2016, DEL FORW VIEW HNS PL; NHS, 2014, NHS 5 YEAR FORW VIEW; OECD, 2013, WHAT FUT HLTH SPEND; OECD, 2017, HLTH STAT; Royal College of Psychiatrists, 2006, OLD PROBL NEW SOL IM; World Health Organization, 1978, DECL ALM AT, DOI DOI 10.1016/S0140-6736(79)90622-6	18	14	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2017	358								j3895	10.1136/bmj.j3895	http://dx.doi.org/10.1136/bmj.j3895			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EB	28870886				2022-12-28	WOS:000410574800001
J	Hasselmo, M; Stern, C				Hasselmo, Michael; Stern, Chantal			Howard Eichenbaum (1947-2017)	SCIENCE			English	Biographical-Item									[Hasselmo, Michael] Boston Univ, Ctr Memory & Brain, Dept Psychol & Brain Sci, Boston, MA 02215 USA; Boston Univ, Ctr Syst Neurosci, Boston, MA 02215 USA	Boston University; Boston University	Hasselmo, M (corresponding author), Boston Univ, Ctr Memory & Brain, Dept Psychol & Brain Sci, Boston, MA 02215 USA.	hasselmo@bu.edu; chantal@bu.edu							0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					875	875		10.1126/science.aao6751	http://dx.doi.org/10.1126/science.aao6751			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860374				2022-12-28	WOS:000408734900028
J	Normile, D				Normile, Dennis			Science suffers as China plugs holes in Great Firewall	SCIENCE			English	News Item																			0	3	3	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					856	856		10.1126/science.357.6354.856	http://dx.doi.org/10.1126/science.357.6354.856			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860362				2022-12-28	WOS:000408734900016
J	Bissell, DM; Anderson, KE; Bonkovsky, HL				Bissell, D. Montgomery; Anderson, Karl E.; Bonkovsky, Herbert L.			Porphyria	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE INTERMITTENT PORPHYRIA; ACUTE HEPATIC PORPHYRIA; CONGENITAL ERYTHROPOIETIC PORPHYRIA; PORPHOBILINOGEN DEAMINASE GENE; DELTA-AMINOLEVULINIC-ACID; CUTANEA-TARDA; LIVER-TRANSPLANTATION; KIDNEY-DISEASE; CLINICAL-TRIAL; ACUTE ATTACKS		[Bissell, D. Montgomery] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA; [Bissell, D. Montgomery] Univ Calif San Francisco, Porphyria Ctr, San Francisco, CA 94143 USA; [Anderson, Karl E.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Anderson, Karl E.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Bonkovsky, Herbert L.] Wake Forest Sch Med, Dept Gastroenterol, Winston Salem, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Wake Forest University	Bissell, DM (corresponding author), Univ Calif San Francisco, 513 Parnassus Ave,Box 0538, San Francisco, CA 94143 USA.	montgomery.bissell@ucsf.edu	Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230; Anderson, Karl/0000-0002-6499-8573	Clinuvel Pharmaceuticals; Alnylam Pharmaceuticals; Recordati Rare Diseases; Mitsubishi Tanabe Pharma	Clinuvel Pharmaceuticals; Alnylam Pharmaceuticals; Recordati Rare Diseases; Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation)	Dr. Bissell reports receiving fees for participating in clinical trials from Clinuvel Pharmaceuticals and Alnylam Pharmaceuticals and receiving consulting fees from Recordati Rare Diseases and Mitsubishi Tanabe Pharma; Dr. Anderson, receiving grant support from Clinuvel Pharmaceuticals, Alnylam Pharmaceuticals, and Recordati Rare Diseases; and Dr. Bonkovsky, receiving grant support and consulting fees from Clinuvel Pharmaceuticals, Alnylam Pharmaceuticals, Recordati Rare Diseases, and Mitsubishi Tanabe Pharma. No other potential conflict of interest relevant to this article was reported.	Anderson KE, 2006, ANN INTERN MED, V144, P537, DOI 10.7326/0003-4819-144-7-200604040-00023; Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Andersson C, 2000, SCAND J CLIN LAB INV, V60, P643; ASHTON RE, 1984, BRIT J DERMATOL, V111, P609, DOI 10.1111/j.1365-2133.1984.tb06632.x; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Berry AA, 2005, ARCH DERMATOL, V141, P1575, DOI 10.1001/archderm.141.12.1575; Biessen EAL, 1999, BIOCHEM J, V340, P783, DOI 10.1042/0264-6021:3400783; Biolcati G, 2015, BRIT J DERMATOL, V172, P1601, DOI 10.1111/bjd.13598; Bissell DM, 2015, AM J MED, V128, P313, DOI 10.1016/j.amjmed.2014.10.026; BISSELL DM, 1988, J HEPATOL, V6, P1, DOI 10.1016/S0168-8278(88)80456-2; Bonkovsky HL, 2008, NEW ENGL J MED, V358, P2813, DOI 10.1056/NEJMcpc0803190; Bonkovsky HL, 2014, AM J MED, V127, P1233, DOI 10.1016/j.amjmed.2014.06.036; Bonkovsky HL, 1998, HEPATOLOGY, V27, P1661, DOI 10.1002/hep.510270627; Bosio GN, 2013, J AM CHEM SOC, V135, P272, DOI 10.1021/ja308930a; Bossi K, 2015, EUR J CLIN INVEST, V45, P1032, DOI 10.1111/eci.12503; Brancaleoni V, 2016, CLIN GENET, V89, P20, DOI 10.1111/cge.12562; BRENNAN MJW, 1979, NATURE, V280, P514, DOI 10.1038/280514a0; Bulaj ZJ, 2000, J LAB CLIN MED, V136, P482, DOI 10.1067/mlc.2000.111024; Chan A, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.36; Chen B, 2016, HUM MUTAT, V37, P1215, DOI 10.1002/humu.23067; Cox TM, 1998, SEMIN LIVER DIS, V18, P85, DOI 10.1055/s-2007-1007144; D'Avola D, 2016, J HEPATOL, V65, P776, DOI 10.1016/j.jhep.2016.05.012; Dowman JK, 2012, LIVER TRANSPLANT, V18, P195, DOI 10.1002/lt.22345; Elder G, 2013, J INHERIT METAB DIS, V36, P849, DOI 10.1007/s10545-012-9544-4; Emanuelli T, 2001, NEUROCHEM RES, V26, P101, DOI 10.1023/A:1011034409814; GLUECK R, 1983, BLOOD, V61, P243; GOETSCH CA, 1986, NEW ENGL J MED, V315, P235, DOI 10.1056/NEJM198607243150406; Gorchein A, 1999, HEPATOLOGY, V29, P995, DOI 10.1002/hep.510290314; Gou EW, 2015, CLIN CHEM, V61, P1453, DOI 10.1373/clinchem.2015.245456; Gross U, 1998, CLIN CHEM, V44, P1892; Holme SA, 2006, BRIT J DERMATOL, V155, P574, DOI 10.1111/j.1365-2133.2006.07472.x; Innala E, 2010, ACTA OBSTET GYN SCAN, V89, P95, DOI 10.3109/00016340903390729; IPPEN H, 1977, SEMIN HEMATOL, V14, P253; Jalil S, 2010, CLIN GASTROENTEROL H, V8, P297, DOI 10.1016/j.cgh.2009.11.017; Jeans JB, 1996, AM J MED GENET, V65, P269, DOI 10.1002/(SICI)1096-8628(19961111)65:4<269::AID-AJMG4>3.0.CO;2-K; KAUPPINEN R, 1992, MEDICINE, V71, P1; Labbe RF, 1999, CLIN CHEM, V45, P2060; LaDuca JR, 2002, J CUTAN MED SURG, V6, P320, DOI 10.1007/s10227-001-0051-8; Langendonk JG, 2015, NEW ENGL J MED, V373, P48, DOI 10.1056/NEJMoa1411481; Liu LU, 2016, GENE REV; Liu YP, 2005, AM J EMERG MED, V23, P164, DOI 10.1016/j.ajem.2004.03.013; MAGNUSSEN CR, 1975, NEUROLOGY, V25, P1121, DOI 10.1212/WNL.25.12.1121; Marmor MF, 2011, OPHTHALMOLOGY, V118, P415, DOI 10.1016/j.ophtha.2010.11.017; Marsden JT, 2008, CLIN NEPHROL, V69, P339; Marsden JT, 2010, J INHERIT METAB DIS, V33, P591, DOI 10.1007/s10545-010-9142-2; Mattern SET, 1999, AM J MED, V107, P621, DOI 10.1016/S0002-9343(99)00305-8; McGuire BM, 2005, LIVER TRANSPLANT, V11, P1590, DOI 10.1002/lt.20620; Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139; Naik H, 2016, MOL GENET METAB, V119, P278, DOI 10.1016/j.ymgme.2016.08.006; Nakano H, 2006, J INVEST DERMATOL, V126, P2717, DOI 10.1038/sj.jid.5700456; Nordmann Y, 1997, J INTERN MED, V242, P213, DOI 10.1046/j.1365-2796.1997.00189.x; Pallet N, 2015, KIDNEY INT, V88, P386, DOI 10.1038/ki.2015.97; Pandya AG, 2012, ARCH DERMATOL, V148, P898, DOI 10.1001/archdermatol.2012.807; Phillips JD, 2007, P NATL ACAD SCI USA, V104, P5079, DOI 10.1073/pnas.0700547104; POHFITZPATRICK MB, 1980, ARCH DERMATOL, V116, P543, DOI 10.1001/archderm.116.5.543; Reichheld JH, 1999, TRANSPLANTATION, V67, P922, DOI 10.1097/00007890-199903270-00023; Sardh E, 2013, J INHERIT METAB DIS, V36, P1063, DOI 10.1007/s10545-012-9576-9; Sheikh MY, 1998, DIGEST DIS SCI, V43, P529, DOI 10.1023/A:1018854906444; Sinclair PR, 2000, TOXICOL APPL PHARM, V162, P60, DOI 10.1006/taap.1999.8832; Singal AK, 2014, HEPATOLOGY, V60, P1082, DOI 10.1002/hep.27086; Singal AK, 2012, CLIN GASTROENTEROL H, V10, P1402, DOI 10.1016/j.cgh.2012.08.038; Spelt JMC, 2010, J INHERIT METAB DIS, V33, pS1, DOI 10.1007/s10545-008-1037-0; Tchernitchko D, 2017, J AM SOC NEPHROL, V28, P1924, DOI 10.1681/ASN.2016080918; Tishler PV, 2014, J AM ACAD DERMATOL, V70, P391, DOI 10.1016/j.jaad.2013.10.011; Usalan C, 1996, CLIN NEPHROL, V45, P418; WENT LN, 1984, ANN HUM GENET, V48, P105, DOI 10.1111/j.1469-1809.1984.tb01006.x; Whatley SD, 2013, GENEREVIEWS; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Wickliffe JK, 2011, MOL MED, V17, P241, DOI 10.2119/molmed.2010.00130; Willandt B, 2016, JIMD REP, V25, P77, DOI 10.1007/8904_2015_458; XU WM, 1995, J CLIN INVEST, V95, P905, DOI 10.1172/JCI117742; Yasuda M, 2014, P NATL ACAD SCI USA, V111, P7777, DOI 10.1073/pnas.1406228111; Yasuda M, 2010, MOL THER, V18, P17, DOI 10.1038/mt.2009.250	73	180	188	12	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					862	872		10.1056/NEJMra1608634	http://dx.doi.org/10.1056/NEJMra1608634			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28854095				2022-12-28	WOS:000408626400009
J	Gutjahr, M; Ridgwell, A; Sexton, PF; Anagnostou, E; Pearson, PN; Palike, H; Norris, RD; Thomas, E; Foster, GL				Gutjahr, Marcus; Ridgwell, Andy; Sexton, Philip F.; Anagnostou, Eleni; Pearson, Paul N.; Paelike, Heiko; Norris, Richard D.; Thomas, Ellen; Foster, Gavin L.			Very large release of mostly volcanic carbon during the Palaeocene-Eocene Thermal Maximum	NATURE			English	Article							BORON ISOTOPIC COMPOSITION; ATMOSPHERIC CO2; PH; CONSTRAINTS; SEAWATER; METHANE; FORAMINIFERA; EXCURSION; CLIMATE; EVENTS	The Palaeocene-Eocene Thermal Maximum(1,2) (PETM) was a global warming event that occurred about 56 million years ago, and is commonly thought to have been driven primarily by the destabilization of carbon from surface sedimentary reservoirs such as methane hydrates(3). However, it remains controversial whether such reservoirs were indeed the source of the carbon that drove the warming(1,3-5). Resolving this issue is key to understanding the proximal cause of the warming, and to quantifying the roles of triggers versus feedbacks. Here we present boron isotope data-a proxy for seawater pH-that show that the ocean surface pH was persistently low during the PETM. We combine our pH data with a paired carbon isotope record in an Earth system model in order to reconstruct the unfolding carbon-cycle dynamics during the event(6,7). We find strong evidence for a much larger (more than 10,000 petagrams)-and, on average, isotopically heavier-carbon source than considered previously(8,9). This leads us to identify volcanism associated with the North Atlantic Igneous Province(10,11), rather than carbon from a surface reservoir, as the main driver of the PETM. This finding implies that climate-driven amplification of organic carbon feedbacks probably played only a minor part in driving the event. However, we find that enhanced burial of organic matter seems to have been important in eventually sequestering the released carbon and accelerating the recovery of the Earth system(12).	[Gutjahr, Marcus; Anagnostou, Eleni; Foster, Gavin L.] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton SO17 1BJ, Hants, England; [Gutjahr, Marcus] GEOMAR Helmholtz Ctr Ocean Res Kiel, Wischhofstr 1-3, D-24148 Kiel, Germany; [Ridgwell, Andy] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Ridgwell, Andy] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Sexton, Philip F.] Open Univ, Sch Environm Earth & Ecosyst Sci, Milton Keynes MK7 6AA, Bucks, England; [Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Paelike, Heiko] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Norris, Richard D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Thomas, Ellen] Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA; [Thomas, Ellen] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA	NERC National Oceanography Centre; University of Southampton; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bristol; University of California System; University of California Riverside; Open University - UK; Cardiff University; University of Bremen; University of California System; University of California San Diego; Scripps Institution of Oceanography; Yale University; Wesleyan University	Gutjahr, M (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton SO17 1BJ, Hants, England.; Gutjahr, M (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Wischhofstr 1-3, D-24148 Kiel, Germany.	mgutjahr@geomar.de	Foster, Gavin/CAF-4654-2022; Gutjahr, Marcus/ABC-2674-2020; Ridgwell, Andy/AAD-9487-2021; Foster, Gavin/W-5968-2019; Palike, Heiko/A-6560-2008; Gutjahr, Marcus/L-9158-2013; anagnostou, eleni/AAH-2618-2021; Thomas, Ellen/E-5573-2011	Foster, Gavin/0000-0003-3688-9668; Gutjahr, Marcus/0000-0003-2556-2619; Ridgwell, Andy/0000-0003-2333-0128; Palike, Heiko/0000-0003-3386-0923; Gutjahr, Marcus/0000-0003-2556-2619; Anagnostou, Eleni/0000-0002-7200-4794; Thomas, Ellen/0000-0002-7141-9904	UK Ocean Acidification Research Program NERC/DEFRA/DECC grant [NE/H017518/1]; Heising-Simons Foundation award; EU [ERC 2013-CoG-617313]; National Science Foundation Division of Ocean Sciences [NSF OCE 1536611]; ERC [2013-CoG-617462]; NERC [NE/D00876X/2, NE/H017356/1, NE/H017518/1, NE/I005595/1] Funding Source: UKRI; Natural Environment Research Council [NE/H017518/1, NE/I005595/1, NE/H017356/1, NE/D00876X/2] Funding Source: researchfish	UK Ocean Acidification Research Program NERC/DEFRA/DECC grant; Heising-Simons Foundation award; EU(European Commission); National Science Foundation Division of Ocean Sciences(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by a UK Ocean Acidification Research Program NERC/DEFRA/DECC grant (NE/H017518/1) to P.N.P., G.L.F. and P.F.S. (also supporting M.G.). A.R. was supported by a Heising-Simons Foundation award, and by EU grant ERC 2013-CoG-617313. E.T. was in part supported by the National Science Foundation Division of Ocean Sciences (grant no. NSF OCE 1536611). H.P. was in part supported by ERC grant 2013-CoG-617462. This study used samples provided by the International Ocean Discovery Program. We thank A. Milton at the University of Southampton for maintaining the mass spectrometers used in this study, and M. Davies at The Open University for assistance with sample preparation. We thank L. Haxhiaj and D. Nurnberg at GEOMAR Kiel and H. Kuhnert at MARUM Bremen for their help with carbon and oxygen isotope analyses.	Anagnostou E, 2016, NATURE, V533, P380, DOI 10.1038/nature17423; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Bornemann A, 2014, EARTH PLANET SC LETT, V394, P70, DOI 10.1016/j.epsl.2014.03.017; Bowen GJ, 2010, NAT GEOSCI, V3, P866, DOI 10.1038/NGEO1014; BRADY PV, 1991, J GEOPHYS RES-SOL EA, V96, P18101, DOI 10.1029/91JB01898; Cao L, 2009, BIOGEOSCIENCES, V6, P375, DOI 10.5194/bg-6-375-2009; Charles AJ, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003426; Colbourn G, 2015, GLOBAL BIOGEOCHEM CY, V29, P583, DOI 10.1002/2014GB005054; Cui Y, 2015, EARTH-SCI REV, V149, P5, DOI 10.1016/j.earscirev.2014.04.007; Cui Y, 2011, NAT GEOSCI, V4, P481, DOI [10.1038/ngeo1179, 10.1038/NGEO1179]; DeConto RM, 2012, NATURE, V484, P87, DOI 10.1038/nature10929; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickson AJ, 2012, GEOLOGY, V40, P639, DOI 10.1130/G32977.1; Dunkley Jones T, 2013, EARTH-SCI REV, V125, P123, DOI 10.1016/j.earscirev.2013.07.004; Edwards N, 2005, CLIM DYNAM, V24, P415, DOI 10.1007/s00382-004-0508-8; Evans D, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002315; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Foster GL, 2008, EARTH PLANET SC LETT, V271, P254, DOI 10.1016/j.epsl.2008.04.015; Foster GL, 2016, ANNU REV EARTH PL SC, V44, P207, DOI 10.1146/annurev-earth-060115-012226; Foster GL, 2013, CHEM GEOL, V358, P1, DOI 10.1016/j.chemgeo.2013.08.027; Frieling J, 2016, P NATL ACAD SCI USA, V113, P12059, DOI 10.1073/pnas.1603348113; Gibbs SJ, 2016, GEOLOGY, V44, P59, DOI 10.1130/G37273.1; Giusberti L, 2007, GEOL SOC AM BULL, V119, P391, DOI 10.1130/B25994.1; Henehan MJ, 2016, EARTH PLANET SC LETT, V454, P282, DOI 10.1016/j.epsl.2016.09.024; Henehan MJ, 2013, EARTH PLANET SC LETT, V364, P111, DOI 10.1016/j.epsl.2012.12.029; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Honisch B, 2003, MAR MICROPALEONTOL, V49, P87, DOI 10.1016/S0377-8398(03)00030-6; IPCC, 2013, CLIMATE CHANGE 2022; JENKYNS HC, 1980, J GEOL SOC LONDON, V137, P171, DOI 10.1144/gsjgs.137.2.0171; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Klochko K, 2006, EARTH PLANET SC LETT, V248, P276, DOI 10.1016/j.epsl.2006.05.034; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Lemarchand D, 2002, CHEM GEOL, V190, P123, DOI 10.1016/S0009-2541(02)00114-6; Lord NS, 2016, GLOBAL BIOGEOCHEM CY, V30, P2, DOI 10.1002/2014GB005074; Ma ZW, 2014, NAT GEOSCI, V7, P382, DOI [10.1038/ngeo2139, 10.1038/NGEO2139]; Martinez-Boti MA, 2015, NATURE, V518, P219, DOI 10.1038/nature14155; McInerney FA, 2011, ANNU REV EARTH PL SC, V39, P489, DOI 10.1146/annurev-earth-040610-133431; Nunes F, 2006, NATURE, V439, P60, DOI 10.1038/nature04386; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Pardo A, 1997, MAR MICROPALEONTOL, V29, P129, DOI 10.1016/S0377-8398(96)00035-7; Payne JL, 2010, P NATL ACAD SCI USA, V107, P8543, DOI 10.1073/pnas.0914065107; Pearson PN, 2015, CLIM PAST, V11, P95, DOI 10.5194/cp-11-95-2015; Pearson PN, 2014, P NATL ACAD SCI USA, V111, pE1064, DOI 10.1073/pnas.1322077111; Penman DE, 2016, NAT GEOSCI, V9, P575, DOI [10.1038/ngeo2757, 10.1038/NGEO2757]; Penman DE, 2014, PALEOCEANOGRAPHY, V29, P357, DOI 10.1002/2014PA002621; Rampino MR, 2013, B VOLCANOL, V75, DOI 10.1007/s00445-012-0678-x; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P87, DOI 10.5194/bg-4-87-2007; Ridgwell A. J., 2001, THESIS; Ridgwell A, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002764; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Sanyal A, 2001, PALEOCEANOGRAPHY, V16, P515, DOI 10.1029/2000PA000547; Saunders AD, 2016, GEOL MAG, V153, P201, DOI 10.1017/S0016756815000175; Schaller MF, 2016, SCIENCE, V354, P225, DOI 10.1126/science.aaf5466; Schubert BA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2659; Sexton PF, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001291; SPIVACK AJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1033, DOI 10.1016/0016-7037(87)90198-0; Stassen P, 2014, P NATL ACAD SCI USA, V111, pE1066, DOI 10.1073/pnas.1321839111; Storey M, 2007, SCIENCE, V316, P587, DOI 10.1126/science.1135274; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Svensen H, 2010, J GEOL SOC LONDON, V167, P433, DOI 10.1144/0016-76492009-125; Tindall J, 2010, EARTH PLANET SC LETT, V292, P265, DOI 10.1016/j.epsl.2009.12.049; Turner SK, 2016, EARTH PLANET SC LETT, V435, P1, DOI 10.1016/j.epsl.2015.11.027; Turner SK, 2014, NAT GEOSCI, V7, P748, DOI [10.1038/NGEO2240, 10.1038/ngeo2240]; Wieczorek R, 2013, GEOCHIM COSMOCHIM AC, V119, P391, DOI 10.1016/j.gca.2013.06.005; Wright JD, 2014, P NATL ACAD SCI USA, V111, pE1068, DOI 10.1073/pnas.1321876111; Wright JD, 2013, P NATL ACAD SCI USA, V110, P15908, DOI 10.1073/pnas.1309188110; Zeebe RE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000881; Zeebe RE, 2016, NAT GEOSCI, V9, P325, DOI 10.1038/NGEO2681; Zeebe RE, 2014, P NATL ACAD SCI USA, V111, pE1062, DOI 10.1073/pnas.1321177111; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578	74	165	171	15	186	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					573	+		10.1038/nature23646	http://dx.doi.org/10.1038/nature23646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858305	Green Accepted, Green Submitted			2022-12-28	WOS:000408703100036
J	Hezaveh, YD; Levasseur, LP; Marshall, PJ				Hezaveh, Yashar D.; Levasseur, Laurence Perreault; Marshall, Philip J.			Fast automated analysis of strong gravitational lenses with convolutional neural networks	NATURE			English	Article								Quantifying image distortions caused by strong gravitational lensing-the formation of multiple images of distant sources due to the deflection of their light by the gravity of intervening structures-and estimating the corresponding matter distribution of these structures (the 'gravitational lens') has primarily been performed using maximum likelihood modelling of observations. This procedure is typically time-and resource-consuming, requiring sophisticated lensing codes, several data preparation steps, and finding the maximum likelihood model parameters in a computationally expensive process with downhill optimizers(1). Accurate analysis of a single gravitational lens can take up to a few weeks and requires expert knowledge of the physical processes and methods involved. Tens of thousands of new lenses are expected to be discovered with the upcoming generation of ground and space surveys(2,3). Here we report the use of deep convolutional neural networks to estimate lensing parameters in an extremely fast and automated way, circumventing the difficulties that are faced by maximum likelihood methods. We also show that the removal of lens light can be made fast and automated using independent component analysis(4) of multi-filter imaging data. Our networks can recover the parameters of the 'singular isothermal ellipsoid' density profile(5), which is commonly used to model strong lensing systems, with an accuracy comparable to the uncertainties of sophisticated models but about ten million times faster: 100 systems in approximately one second on a single graphics processing unit. These networks can provide a way for non-experts to obtain estimates of lensing parameters for large samples of data.	[Hezaveh, Yashar D.; Levasseur, Laurence Perreault; Marshall, Philip J.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Hezaveh, Yashar D.; Levasseur, Laurence Perreault; Marshall, Philip J.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Hezaveh, YD; Levasseur, LP (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA.; Hezaveh, YD; Levasseur, LP (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.	hezaveh@stanford.edu; lplevass@stanford.edu		Perreault-Levasseur, Laurence/0000-0003-3544-3939	NASA through Hubble Fellowship - Space Telescope Science Institute [HST-HF2-51358.001-A]; NASA [NAS 5-26555]; US Department of Energy [DE-AC02-76SF00515]	NASA through Hubble Fellowship - Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); US Department of Energy(United States Department of Energy (DOE))	We thank R. Keisler, G. Holder, R. Blandford, R. Wechsler and W. Morningstar for discussions and comments on the manuscript. We also thank G. P. Maher and A. Dwaraknath for comments about neural networks, leading to improved performance. We thank Stanford Research Computing Center and their staff for providing computational resources (Sherlock Cluster) and support. Support for this work was provided by NASA through Hubble Fellowship grant HST-HF2-51358.001-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. P.J.M. acknowledges support from the US Department of Energy under contract number DE-AC02-76SF00515. Y.D.H. is a Hubble Fellow.	Baldassi Carlo, 2016, Proc Natl Acad Sci U S A, V113, pE7655; Bolton AS, 2008, ASTROPHYS J, V682, P964, DOI 10.1086/589327; Collett TE, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/1/20; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Gal Y., 2016, ICLR WORK, V1506, P02158; Gal Y, 2016, PR MACH LEARN RES, V48; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jacobs C, 2017, MON NOT R ASTRON SOC, V471, P167, DOI 10.1093/mnras/stx1492; Johnson TL, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/48; KORMANN R, 1994, ASTRON ASTROPHYS, V284, P285; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lanusse F., 2017, CMU DEEPLENS DEEP LE; Lefor AT, 2013, NEW ASTRON REV, V57, P1, DOI 10.1016/j.newar.2013.05.001; LSST Science Collaboration, 2009, LSST SCI BOOK VERS 2; Mandelbaum R, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/5; Petrillo C. E., 2017, FINDING STRONG GRAVI; Ravanbakhsh S, 2017, AAAI CONF ARTIF INTE, P1488; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sermanet P., 2014, OVERFEAT INTEGRATED; Sonnenfeld A, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/2/94; Sonnenfeld A, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/97; Suyu SH, 2006, MON NOT R ASTRON SOC, V371, P983, DOI 10.1111/j.1365-2966.2006.10733.x; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Warren SJ, 2003, ASTROPHYS J, V590, P673, DOI 10.1086/375132; Willett KW, 2017, MON NOT R ASTRON SOC, V464, P4176, DOI 10.1093/mnras/stw2568	25	133	134	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					555	+		10.1038/nature23463	http://dx.doi.org/10.1038/nature23463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858317	Green Submitted			2022-12-28	WOS:000408703100032
J	Ren, YH; Dai, HP				Ren, Yanhong; Dai, Huaping			Eosinophilic Bronchitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ren, Yanhong; Dai, Huaping] China Japan Friendship Hosp, Beijing, Peoples R China	China-Japan Friendship Hospital	Dai, HP (corresponding author), China Japan Friendship Hosp, Beijing, Peoples R China.	daihuaping@sina.com							0	0	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					873	873		10.1056/NEJMicm1616156	http://dx.doi.org/10.1056/NEJMicm1616156			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854083				2022-12-28	WOS:000408626400010
J	Tielemans, SMAJ; de Melker, HE; Hahne, SJM; Boef, AGC; van der Klis, FRM; Sanders, EAM; van der Sande, MAB; Knol, MJ				Tielemans, Susanne M. A. J.; de Melker, Hester E.; Hahne, Susan J. M.; Boef, Anna G. C.; van der Klis, Fiona R. M.; Sanders, Elisabeth A. M.; van der Sande, Marianne A. B.; Knol, Mirjam J.			Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILD SURVIVAL; GUINEA-BISSAU; ROUTINE VACCINATIONS; HOSPITAL ADMISSIONS; BCG VACCINATION; MALE MORTALITY; RURAL AREA; VACCINES; IMMUNIZATION; COVERAGE	OBJECTIVES To investigate whether measles, mumps, and rubella (MMR) vaccine has positive non-specific effects in a high income setting and to compare rates of hospital admissions for infections between children aged <= 2 years who received live MMR vaccine and those who received an inactivated vaccine against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) as their most recent vaccination. DESIGN Nationwide population based cohort study. SETTING In the Netherlands, DTaP-IPV-Hib+pneumococcal vaccination (PCV) is recommended at ages 2, 3, 4, and 11 months and MMR + meningococcal C (MenC) vaccination at age 14 months. Data from the national vaccine register were linked to hospital admission data. PARTICIPANTS 1 096 594 children born in 2005-11 who received the first four DTaP-IPV-Hib+PCV vaccines. MAIN OUTCOME MEASURES Hazard ratio for admission to hospital for infection in children with MMR+MenC compared with the fourth DTaP-IPV-Hib+PCV as their most recent vaccination. Cox regression was performed with most recent vaccination as time dependent variable, adjusted for potential confounders. Analyses were repeated with admission for injuries or poisoning as a negative control outcome. In addition, rate of admission for infection was compared between the fourth and third DTaP-IPV-Hib+PCVas most recent vaccination. RESULTS Having had MMR+MenC as the most recent vaccination was associated with a hazard ratio of 0.62 (95% confidence interval 0.57 to 0.67) for admission to hospital for infection and 0.84 (0.73 to 0.96) for injuries or poisoning, compared with the fourth DTaP-IPV-Hib+PCV as most recent vaccination. The fourth DTaP-IPV-Hib+PCV as most recent vaccination was associated with a hazard ratio of 0.69 (0.63 to 0.76) for admission to hospital for infection, compared with the third DTaP-IPV-Hib+PCV as most recent vaccination. CONCLUSIONS Healthy vaccinee bias could at least partly explain the observed lower rate of admission to hospital with infection after MMR vaccination. The lower rate is associated with receipt of any additional vaccine, not specifically MMR vaccine. This emphasises the caution required in the interpretation of findings from observational studies on non-specific effects of vaccination.	[Tielemans, Susanne M. A. J.; de Melker, Hester E.; Hahne, Susan J. M.; Boef, Anna G. C.; van der Klis, Fiona R. M.; Sanders, Elisabeth A. M.; van der Sande, Marianne A. B.; Knol, Mirjam J.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Knol, MJ (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	mirjam.knol@rivm.nl	van der Sande, Marianne/AAQ-3573-2021	van der Sande, Marianne AB/0000-0002-4778-6739	Dutch Ministry of Health	Dutch Ministry of Health	This research was funded by the Dutch Ministry of Health, and was carried out in the framework of RIVM Strategic Programme (SPR), in which expertise and innovative projects prepare RIVM to respond to future issues in health and sustainability. The views expressed in this publication are those of the authors and not necessarily those of the funding agencies.	AABY P, 1993, AM J EPIDEMIOL, V138, P746, DOI 10.1093/oxfordjournals.aje.a116912; Aaby P, 2004, INT J EPIDEMIOL, V33, P374, DOI 10.1093/ije/dyh005; AABY P, 1990, J INFECT DIS, V162, P1043, DOI 10.1093/infdis/162.5.1043; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 2002, VACCINE, V21, P15, DOI 10.1016/S0264-410X(02)00441-3; AABY P, 1984, J TROP PEDIATRICS, V30, P164, DOI 10.1093/tropej/30.3.164; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2007, VACCINE, V25, P1265, DOI 10.1016/j.vaccine.2006.10.007; Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Aaby P, 2015, T ROY SOC TROP MED H, V109, P77, DOI 10.1093/trstmh/tru186; Aaby P, 2012, ARCH DIS CHILD, V97, P685, DOI 10.1136/archdischild-2011-300646; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Benn CS, 2003, INT J EPIDEMIOL, V32, P822, DOI 10.1093/ije/dyg208; Blok BA, 2015, J LEUKOCYTE BIOL, V98, P347, DOI 10.1189/jlb.5RI0315-096R; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; Bruin de A, 2009, METHODE BIJSCHATTEN; Documentatierapporten LMR, 2005, DOC REP NAT MED REG; Farrington CP, 2009, TROP MED INT HEALTH, V14, P977, DOI 10.1111/j.1365-3156.2009.02302.x; Fisker AB, 2014, LANCET GLOB HEALTH, V2, pE478, DOI 10.1016/S2214-109X(14)70274-8; Fisker AB, 2014, VACCINE, V32, P598, DOI 10.1016/j.vaccine.2013.11.074; Flanagan KL, 2013, CLIN INFECT DIS, V57, P283, DOI 10.1093/cid/cit209; George K, 1998, TROP MED INT HEALTH, V3, P751, DOI 10.1046/j.1365-3156.1998.00295.x; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; HARTFIELD J, 1963, J HYG-CAMBRIDGE, V61, P143, DOI 10.1017/S0022172400020817; Higgins JPT, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5170; Hirve S, 2012, VACCINE, V30, P7300, DOI 10.1016/j.vaccine.2012.09.035; HOLT EA, 1990, PEDIATRICS, V85, P188; Kabir Z, 2003, B WORLD HEALTH ORGAN, V81, P244; Kjaergaard J, 2016, PEDIATR RES, V80, P681, DOI 10.1038/pr.2016.142; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lehmann D, 2005, INT J EPIDEMIOL, V34, P138, DOI 10.1093/ije/dyh262; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Moulton LH, 2005, TROP MED INT HEALTH, V10, P947, DOI 10.1111/j.1365-3156.2005.01434.x; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; Sorup S, 2016, VACCINE, V34, P6172, DOI 10.1016/j.vaccine.2016.11.005; Sorup S, 2015, VACCINE, V33, P237, DOI 10.1016/j.vaccine.2014.07.110; Sorup S, 2014, JAMA-J AM MED ASSOC, V311, P826, DOI 10.1001/jama.2014.470; Stensballe LG, 2017, ARCH DIS CHILD, V102, P224, DOI 10.1136/archdischild-2016-310760; van Lier A, 2012, EUROSURVEILLANCE, V17, P11; van Wijhe M, 2016, LANCET INFECT DIS, V16, P592, DOI 10.1016/S1473-3099(16)00027-X; VANBALEN H, 1981, LANCET, V1, P764; Vaugelade J, 2004, BRIT MED J, V329, P1309, DOI 10.1136/bmj.38261.496366.82; VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474	48	27	27	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2017	358								j3862	10.1136/bmj.j3862	http://dx.doi.org/10.1136/bmj.j3862			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CN	28855159	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000409386700003
J	Chachra, D				Chachra, Debbie			To reduce gender biases, acknowledge them	NATURE			English	Editorial Material									[Chachra, Debbie] Olin Coll Engn, Needham, MA 02492 USA	Franklin W. Olin College of Engineering	Chachra, D (corresponding author), Olin Coll Engn, Needham, MA 02492 USA.	debbie.chachra@olin.edu							0	11	11	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2017	548	7668					373	373		10.1038/548373a	http://dx.doi.org/10.1038/548373a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE5VI	28836614	Bronze			2022-12-28	WOS:000408279000005
J	Pavord, ID; Chanez, P; Criner, GJ; Kerstjens, HAM; Korn, S; Lugogo, N; Martinot, JB; Sagara, H; Albers, FC; Bradford, ES; Harris, SS; Mayer, B; Rubin, DB; Yancey, SW; Sciurba, FC				Pavord, I. D.; Chanez, P.; Criner, G. J.; Kerstjens, H. A. M.; Korn, S.; Lugogo, N.; Martinot, J. -B.; Sagara, H.; Albers, F. C.; Bradford, E. S.; Harris, S. S.; Mayer, B.; Rubin, D. B.; Yancey, S. W.; Sciurba, F. C.			Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED FLUTICASONE FUROATE; DOUBLE-BLIND; BLOOD EOSINOPHILS; PARALLEL-GROUP; SPUTUM EOSINOPHILIA; SECONDARY ANALYSIS; PNEUMONIA RISK; COPD; EXACERBATIONS; ASTHMA	BACKGROUND Patients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5. METHODS We performed two phase 3, randomized, placebo-controlled, double-blind, parallel-group trials comparing mepolizumab (100 mg in METREX, 100 or 300 mg in METREO) with placebo, given as a subcutaneous injection every 4 weeks for 52 weeks in patients with COPD who had a history of moderate or severe exacerbations while taking inhaled glucocorticoid-based triple maintenance therapy. In METREX, unselected patients in the modified intention-to-treat population with an eosinophilic phenotype were stratified according to blood eosinophil count (>= 150 per cubic millimeter at screening or >= 300 per cubic millimeter during the previous year). In METREO, all patients had a blood eosinophil count of at least 150 per cubic millimeter at screening or at least 300 per cubic millimeter during the previous year. The primary end point was the annual rate of moderate or severe exacerbations. Safety was also assessed. RESULTS In METREX, the mean annual rate of moderate or severe exacerbations in the modified intention-to-treat population with an eosinophilic phenotype (462 patients) was 1.40 per year in the mepolizumab group versus 1.71 per year in the placebo group (rate ratio, 0.82; 95% confidence interval [CI], 0.68 to 0.98; adjusted P = 0.04); no significant between-group differences were found in the overall modified intention-to-treat population (836 patients) (rate ratio, 0.98; 95% CI, 0.85 to 1.12; adjusted P>0.99). In METREO, the mean annual rate of moderate or severe exacerbations was 1.19 per year in the 100-mg mepolizumab group, 1.27 per year in the 300-mg mepolizumab group, and 1.49 per year in the placebo group. The rate ratios for exacerbations in the 100-mg and 300-mg mepolizumab groups versus the placebo group were 0.80 (95% CI, 0.65 to 0.98; adjusted P = 0.07) and 0.86 (95% CI, 0.70 to 1.05; adjusted P = 0.14), respectively. A greater effect of mepolizumab, as compared with placebo, on the annual rate of moderate or severe exacerbations was found among patients with higher blood eosinophil counts at screening. The safety profile of mepolizumab was similar to that of placebo. CONCLUSIONS Mepolizumab at a dose of 100 mg was associated with a lower annual rate of moderate or severe exacerbations than placebo among patients with COPD and an eosinophilic phenotype. This finding suggests that eosinophilic airway inflammation contributes to COPD exacerbations.	[Pavord, I. D.] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England; [Pavord, I. D.] Univ Oxford, Nuffield Dept Med, Oxford Resp Biomed Res Ctr, Oxford, England; [Mayer, B.] GlaxoSmithKline, Clin Stat, Uxbridge, Middx, England; [Chanez, P.] Aix Marseille Univ, Dept Resp Med, Marseille, France; [Chanez, P.] Aix Marseille Univ, CIC Nord, Marseille, France; [Criner, G. J.] Temple Univ, Lewis Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA; [Kerstjens, H. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, Groningen, Netherlands; [Korn, S.] Mainz Univ Hosp, Pulm Dept, Mainz, Germany; [Lugogo, N.] Duke Univ, Div Pulm Allergy & Crit Care Med, Durham, NC 27706 USA; [Albers, F. C.] GlaxoSmithKline, Resp Med Franchise, Res Triangle Pk, NC USA; [Bradford, E. S.; Harris, S. S.; Rubin, D. B.; Yancey, S. W.] GlaxoSmithKline, Resp Therapeut Area, Res Triangle Pk, NC USA; [Martinot, J. -B.] Catholic Univ Louvain, Ctr Hosp Univ, Dept Pneumol, Namur, Belgium; [Sagara, H.] Showa Univ, Sch Med, Div Allergol & Resp Med, Tokyo, Japan; [Sciurba, F. C.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA	University of Oxford; University of Oxford; GlaxoSmithKline; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Groningen; University Hospital Mainz; Duke University; GlaxoSmithKline; GlaxoSmithKline; Universite Catholique Louvain; Showa University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sciurba, FC (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, 3471 Fifth Ave,Suite 1211, Pittsburgh, PA 15213 USA.	sciurbafc@upmc.edu	Kerstjens, Huib/N-4754-2017; Sciurba, Frank/AAZ-9339-2021	Kerstjens, Huib/0000-0001-7705-7927; sciurba, frank/0000-0001-7468-2225; Martinot, Jean-Benoit/0000-0001-8536-7300; chanez, pascal/0000-0003-4059-0917	GlaxoSmithKline; METREX; METREO [NCT02105948, NCT02105961]; National Institute for Health Research [NF-SI-0510-10157] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); METREX; METREO; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by GlaxoSmithKline; METREX and METREO ClinicalTrials.gov numbers, NCT02105948 and NCT02105961.	Bafadhel M, 2014, EUR RESPIR J, V44, P789, DOI 10.1183/09031936.00062614; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2014, LANCET RESP MED, V2, P891, DOI 10.1016/S2213-2600(14)70187-0; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chupp GL, 2017, LANCET RESP MED, V5, P390, DOI 10.1016/S2213-2600(17)30125-X; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Global Initiative for Chronic Obstructive Lung Disease, 2017, GLOB IN CHRON OBSTR; Hart TK, 2001, J ALLERGY CLIN IMMUN, V108, P250, DOI 10.1067/mai.2001.116576; Jones P., 2012, ST GEORGES RESP QUES; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Jones PW, 2012, RESP MED, V106, pS86, DOI 10.1016/S0954-6111(12)70017-3; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Keene ON, 2014, PHARM STAT, V13, P258, DOI 10.1002/pst.1624; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Mullerova H, 2017, AM J RESP CRIT CARE, V195; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pascoe S, 2015, LANCET RESP MED, V3, P435, DOI 10.1016/S2213-2600(15)00106-X; Pavord ID, 2016, LANCET RESP MED, V4, P731, DOI 10.1016/S2213-2600(16)30148-5; Pavord ID, 2016, THORAX, V71, P118, DOI 10.1136/thoraxjnl-2015-207021; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Siddiqui SH, 2015, AM J RESP CRIT CARE, V192, P523, DOI 10.1164/rccm.201502-0235LE; Singh D, 2014, EUR RESPIR J, V44, P1697, DOI 10.1183/09031936.00162414; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Varricchi G, 2016, CURR OPIN ALLERGY CL, V16, P186, DOI 10.1097/ACI.0000000000000251; Vestbo J, 2017, LANCET, V389, P1919, DOI 10.1016/S0140-6736(17)30188-5; Yancey S, 2017, AM J RESP CRIT CARE, V195	31	300	313	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2017	377	17					1613	1629		10.1056/NEJMoa1708208	http://dx.doi.org/10.1056/NEJMoa1708208			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK7MV	28893134	Green Published			2022-12-28	WOS:000413691900004
J	Blenis, J				Blenis, John			TOR, the Gateway to Cellular Metabolism, Cell Growth, and Disease	CELL			English	Editorial Material							KINASE; ACTIVATION; RAPAMYCIN; AKT/PKB	Michael N. Hall is this year's recipient of the Lasker Basic Medical Research Award for the identification of the target of rapamycin, TOR. TOR is a master regulator of the cell's growth and metabolic state, and its dysregulation contributes to a variety of diseases, including diabetes, obesity, neuro-degenerative disorders, aging, and cancer, making the TOR pathway an attractive therapeutic target.	[Blenis, John] Weill Cornell Med, Meyer Canc Ctr, 413 East 69th St, New York, NY 10021 USA; [Blenis, John] Weill Cornell Med, Dept Pharmacol, 413 East 69th St, New York, NY 10021 USA	Cornell University; Cornell University	Blenis, J (corresponding author), Weill Cornell Med, Meyer Canc Ctr, 413 East 69th St, New York, NY 10021 USA.; Blenis, J (corresponding author), Weill Cornell Med, Dept Pharmacol, 413 East 69th St, New York, NY 10021 USA.	jblenis@med.cornell.edu						Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	14	50	54	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2017	171	1					10	13		10.1016/j.cell.2017.08.019	http://dx.doi.org/10.1016/j.cell.2017.08.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH7AA	28888322	hybrid			2022-12-28	WOS:000411331800003
J	Krumholz, HM; Wang, K; Lin, ZQ; Dharmarajan, K; Horwitz, LI; Ross, JS; Drye, EE; Bernheim, SM; Normand, SLT				Krumholz, Harlan M.; Wang, Kun; Lin, Zhenqiu; Dharmarajan, Kumar; Horwitz, Leora I.; Ross, Joseph S.; Drye, Elizabeth E.; Bernheim, Susannah M.; Normand, Sharon-Lise T.			Hospital- Readmission Risk - Isolating Hospital Effects from Patient Effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADMINISTRATIVE CLAIMS MEASURE; ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; SOCIOECONOMIC-STATUS; REDUCTION PROGRAM; RATES; PERFORMANCE; OUTCOMES; CARE; QUALITY	BACKGROUND To isolate hospital effects on risk-standardized hospital-readmission rates, we examined readmission outcomes among patients who had multiple admissions for a similar diagnosis at more than one hospital within a given year. METHODS We divided the Centers for Medicare and Medicaid Services hospital-wide readmission measure cohort from July 2014 through June 2015 into two random samples. All the patients in the cohort were Medicare recipients who were at least 65 years of age. We used the first sample to calculate the risk-standardized readmission rate within 30 days for each hospital, and we classified hospitals into performance quartiles, with a lower readmission rate indicating better performance (performance-classification sample). The study sample (identified from the second sample) included patients who had two admissions for similar diagnoses at different hospitals that occurred more than 1 month and less than 1 year apart, and we compared the observed readmission rates among patients who had been admitted to hospitals in different performance quartiles. RESULTS In the performance-classification sample, the median risk-standardized readmission rate was 15.5% (interquartile range, 15.3 to 15.8). The study sample included 37,508 patients who had two admissions for similar diagnoses at a total of 4272 different hospitals. The observed readmission rate was consistently higher among patients admitted to hospitals in a worse-performing quartile than among those admitted to hospitals in a better-performing quartile, but the only significant difference was observed when the patients were admitted to hospitals in which one was in the best-performing quartile and the other was in the worst-performing quartile (absolute difference in readmission rate, 2.0 percentage points; 95% confidence interval, 0.4 to 3.5; P = 0.001). CONCLUSIONS When the same patients were admitted with similar diagnoses to hospitals in the best-performing quartile as compared with the worst-performing quartile of hospital readmission performance, there was a significant difference in rates of readmission within 30 days. The findings suggest that hospital quality contributes in part to readmission rates independent of factors involving patients.	[Krumholz, Harlan M.; Wang, Kun; Dharmarajan, Kumar] Yale Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Ross, Joseph S.; Bernheim, Susannah M.] Yale Sch Med, Gen Internal Med Sect, New Haven, CT USA; [Ross, Joseph S.; Bernheim, Susannah M.] Yale Sch Med, Natl Clinician Scholars Program, New Haven, CT USA; [Drye, Elizabeth E.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Drye, Elizabeth E.] Yale Sch Med, Dept Pediat, New Haven, CT USA; [Krumholz, Harlan M.; Wang, Kun; Lin, Zhenqiu; Dharmarajan, Kumar; Ross, Joseph S.; Drye, Elizabeth E.; Bernheim, Susannah M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Dharmarajan, Kumar] Clover Hlth, Jersey City, NJ USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Populat Hlth, Div Healthcare Delivery Sci, New York, NY USA; [Horwitz, Leora I.] NYU, Sch Med, Dept Med, Div Gen Internal Med & Clin Innovat, New York, NY USA; [Horwitz, Leora I.] NYU Langone Hlth, Ctr Healthcare Innovat & Delivery Sci, New York, NY USA; [Normand, Sharon-Lise T.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; New York University; New York University; NYU Langone Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Krumholz, HM (corresponding author), 1 Church St,Suite 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	Horwitz, Leora/ABD-1292-2020; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Yale-New Haven Hospital Center for Outcomes Research and Evaluation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Yale-New Haven Hospital Center for Outcomes Research and Evaluation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Yale-New Haven Hospital Center for Outcomes Research and Evaluation and others.	Bernheim SM, 2016, HEALTH AFFAIR, V35, P1461, DOI 10.1377/hlthaff.2015.0394; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Blum AB, 2014, CIRC-CARDIOVASC QUAL, V7, P391, DOI 10.1161/CIRCOUTCOMES.113.000520; Bonito AJ, 2008, AHRQ PUBLICATION, P38; Census Bureau, 2010, 2010 CENS SUMM FIL 1, P619; Conover M., 2012, HOSP WIDE ALL CAUSE; Desai NR, 2016, JAMA-J AM MED ASSOC, V316, P2647, DOI 10.1001/jama.2016.18533; Gerhardt G, 2013, MED MED RES REV, V3; Glance LG, 2016, ANN SURG, V263, P698, DOI 10.1097/SLA.0000000000001363; Horwitz LI, 2015, J HOSP MED, V10, P670, DOI 10.1002/jhm.2416; Horwitz LI, 2014, ANN INTERN MED, V161, pS66, DOI 10.7326/M13-3000; Joynt KE, 2017, NEW ENGL J MED, V376, P510, DOI 10.1056/NEJMp1616278; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Konstam MA, 2016, JACC-HEART FAIL, V4, P21, DOI 10.1016/j.jchf.2015.10.002; Krumholz HM, 2016, JACC-HEART FAIL, V4, P12, DOI 10.1016/j.jchf.2015.07.017; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lipstein SH, 2014, ANN INTERN MED, V161, P594, DOI 10.7326/M14-1601; Rahimi AR, 2007, JAMA-J AM MED ASSOC, V297, P1063, DOI 10.1001/jama.297.10.1063; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Wasfy JH, 2017, ANN INTERN MED, V166, P324, DOI 10.7326/M16-0185; Yale New Haven Health Services Corporation Center for Outcomes Research and Evaluation, 2016, 2016 MEAS UPD SPEC R; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	25	73	73	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2017	377	11					1055	1064		10.1056/NEJMsa1702321	http://dx.doi.org/10.1056/NEJMsa1702321			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6YC	28902587	Green Accepted, Bronze			2022-12-28	WOS:000410545200008
J	Tam, PKH; Chung, PHY; St Peter, SD; Gayer, CP; Ford, HR; Tam, GCH; Wong, KKY; Pakarinen, MP; Davenport, M				Tam, Paul K. H.; Chung, Patrick H. Y.; St Peter, Shawn D.; Gayer, Christopher P.; Ford, Henri R.; Tam, Greta C. H.; Wong, Kenneth K. Y.; Pakarinen, Mikko P.; Davenport, Mark			Advances in paediatric gastroenterology	LANCET			English	Article							DONOR LIVER-TRANSPLANTATION; BILIARY ATRESIA; ESOPHAGEAL ATRESIA; LONG-TERM; NECROTIZING ENTEROCOLITIS; TRACHEOESOPHAGEAL FISTULA; KASAI PORTOENTEROSTOMY; PERITONEAL DRAINAGE; PULL-THROUGH; LAPAROSCOPIC PYLOROMYOTOMY	Recent developments in paediatric gastrointestinal surgery have focused on minimally invasive surgery, the accumulation of high-quality clinical evidence, and scientific research. The benefits of minimally invasive surgery for common disorders like appendicitis and hypertrophic pyloric stenosis are all supported by good clinical evidence. Although minimally invasive surgery has been extended to neonatal surgery, it is difficult to establish its role for neonatal disorders such as oesophageal atresia and biliary atresia through clinical trials because of the rarity of these disorders. Advances in treatments for biliary atresia and necrotising enterocolitis have been achieved through specialisation, multidisciplinary management, and multicentre collaboration in research; similarly robust clinical evidence for other rare gastrointestinal disorders is needed. As more neonates with gastrointestinal diseases survive into adulthood, their long-term sequelae will also need evidence-based multidisciplinary care. Identifying cures for long-term problems of a complex developmental anomaly such as Hirschsprung's disease will rely on unravelling its pathogenesis through genetics and the development of stem-cell therapy.	[Tam, Paul K. H.; Chung, Patrick H. Y.; Wong, Kenneth K. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [St Peter, Shawn D.] Univ Missouri, Sch Med, Childrens Mercy Hosp & Clin, Dept Gen & Thorac Surg, Kansas City, MO 64108 USA; [Gayer, Christopher P.; Ford, Henri R.] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Surg, Los Angeles, CA 90033 USA; [Tam, Greta C. H.] Chinese Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Pakarinen, Mikko P.] Univ Helsinki, Paediat Surg & Paediat Liver & Gut Res Grp, Childrens Hosp, Helsinki, Finland; [Pakarinen, Mikko P.] Helsinki Univ Hosp, Helsinki, Finland; [Davenport, Mark] Kings Coll Hosp London, Dept Paediat Surg, London, England	University of Hong Kong; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Children's Hospital Los Angeles; University of Southern California; Chinese University of Hong Kong; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Tam, PKH (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	paultam@hku.hk	Davenport, Mark/AAZ-5775-2020; Pakarinen, Mikko/AAD-8834-2019; Wong, Kenneth K. Y./B-9920-2008; /C-4405-2009	Davenport, Mark/0000-0002-0938-2717; CHUNG, Patrick Ho Yu/0000-0003-2382-5681; /0000-0001-6231-3035; Tam, Greta/0000-0003-4354-4705	Research Grants Council, Hong Kong [T12C-747/14, HKU171195/14]	Research Grants Council, Hong Kong(Hong Kong Research Grants Council)	PKHT's work on Hirschsprung's disease is supported by the Research Grants Council, Hong Kong T12C-747/14, HKU171195/14.	Adibe OO, 2014, J PEDIATR SURG, V49, P129, DOI 10.1016/j.jpedsurg.2013.09.044; Alexopoulos SP, 2017, LIVER TRANSPLANT, V23, P221, DOI 10.1002/lt.24675; AlFaleh K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005496.pub4; Allin B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41149; Asai A, 2015, NAT REV GASTRO HEPAT, V12, P342, DOI 10.1038/nrgastro.2015.74; Aworanti O, 2014, EUR J PEDIATR SURG, V24, P365, DOI 10.1055/s-0034-1370780; Bairdain S, 2016, J AM COLL SURGEONS, V222, P1001, DOI 10.1016/j.jamcollsurg.2015.12.001; Benabbas R, 2017, ACAD EMERG MED, V24, P523, DOI 10.1111/acem.13181; Bhangu A, 2015, LANCET, V386, P1278, DOI 10.1016/S0140-6736(15)00275-5; Bijl EJ, 2013, NETH J MED, V71, P170; Bishay M, 2013, ANN SURG, V258, P895, DOI 10.1097/SLA.0b013e31828fab55; Bjornland K, 2017, J PEDIATR SURG, V52, P1458, DOI 10.1016/j.jpedsurg.2017.01.001; Blakely ML, 2006, PEDIATRICS, V117, pE680, DOI 10.1542/peds.2005-1273; Bradshaw CJ, 2016, J PEDIATR SURG, V51, P1268, DOI 10.1016/j.jpedsurg.2016.02.001; Burns AJ, 2016, DEV BIOL, V417, P229, DOI 10.1016/j.ydbio.2016.04.001; Chen CL, 2012, LAB INVEST, V92, P331, DOI 10.1038/labinvest.2011.167; Chen Y, 2015, J PEDIATR SURG, V50, P1590, DOI 10.1016/j.jpedsurg.2015.05.016; Cheng G, 2013, J HEPATOL, V59, P1285, DOI 10.1016/j.jhep.2013.07.021; Chung PHY, 2015, J PEDIATR SURG, V50, P2134, DOI 10.1016/j.jpedsurg.2015.08.042; Chung PHY, 2015, J PEDIATR SURG, V50, P293, DOI 10.1016/j.jpedsurg.2014.11.015; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Dalton BGA, 2016, J PEDIATR SURG, V51, P1279, DOI 10.1016/j.jpedsurg.2016.01.013; Davenport M, 2008, ANN SURG, V247, P694, DOI 10.1097/SLA.0b013e3181638627; Davenport M, 2006, J PEDIATR-US, V149, P393, DOI 10.1016/j.jpeds.2006.05.030; Davenport M, 2011, J PEDIATR SURG, V46, P1689, DOI 10.1016/j.jpedsurg.2011.04.013; De La Torre L, 2010, SEMIN PEDIAT SURG, V19, P96, DOI 10.1053/j.sempedsurg.2009.11.016; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Georgiou R, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3003; Good M, 2015, MUCOSAL IMMUNOL, V8, P1166, DOI 10.1038/mi.2015.30; Gosain A, 2015, CURR OPIN PEDIATR, V27, P364, DOI 10.1097/MOP.0000000000000210; Gui HS, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1174-6; Hall NJ, 2017, LANCET GASTROENTEROL, V2, P253, DOI 10.1016/S2468-1253(16)30243-6; Hall NJ, 2014, J PEDIATR SURG, V49, P1083, DOI 10.1016/j.jpedsurg.2013.10.014; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Holcomb GW, 2017, PEDIATR SURG INT, V33, P475, DOI 10.1007/s00383-016-4049-0; Huang EY, 2013, ANN SURG, V257, P371, DOI 10.1097/SLA.0b013e31827ee976; Hull MA, 2014, J AM COLL SURGEONS, V218, P1148, DOI 10.1016/j.jamcollsurg.2013.11.015; Hussain MH, 2017, J PEDIATR SURG, V52, P264, DOI 10.1016/j.jpedsurg.2016.11.022; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; Juang D, 2012, EUR J PEDIATR SURG, V22, P409, DOI 10.1055/s-0032-1315809; Kasahara M, 2013, AM J TRANSPLANT, V13, P1830, DOI 10.1111/ajt.12276; Keckler SJ, 2007, PEDIATR SURG INT, V23, P309, DOI 10.1007/s00383-007-1891-0; Koivusalo AI, 2017, J PEDIAT SURG, DOI 10.1016/j.jpedsurg.2017.04.021; Konidis SV, 2015, PAED CHILD HEALT-CAN, V20, P189, DOI 10.1093/pch/20.4.189; Krogh C, 2012, PEDIATRICS, V130, pE943, DOI 10.1542/peds.2011-2785; Krogh C, 2012, AM J EPIDEMIOL, V176, P24, DOI 10.1093/aje/kwr493; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lai FPL, 2017, GASTROENTEROLOGY, V153, P139, DOI 10.1053/j.gastro.2017.03.014; Lal D, 2013, J LAPAROENDOSC ADV S, V23, P635, DOI 10.1089/lap.2013.0210; Lal DR, 2018, J PEDIATR SURG, V53, P1267, DOI 10.1016/j.jpedsurg.2017.05.024; Lal DR, 2017, J PEDIATR SURG, V52, P1245, DOI 10.1016/j.jpedsurg.2016.11.046; Lampela H, 2012, SCAND J GASTROENTERO, V47, P99, DOI 10.3109/00365521.2011.627446; Lelonge Y, 2016, SURG ENDOSC, V30, P1662, DOI 10.1007/s00464-015-4352-1; Markar SR, 2012, J GASTROINTEST SURG, V16, P1993, DOI 10.1007/s11605-012-1962-y; McAteer JP, 2013, JAMA PEDIATR, V167, P1143, DOI 10.1001/jamapediatrics.2013.2857; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Mortellaro VE, 2011, EUR J PEDIATR SURG, V21, P386, DOI 10.1055/s-0031-1291269; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Nadalin S, 2016, HEPATOBIL SURG NUTR, V5, P159, DOI 10.3978/j.issn.2304-3881.2015.10.04; Nakamura H, 2016, PEDIATR SURG INT, V32, P109, DOI 10.1007/s00383-015-3820-y; Neuvonen MI, 2017, ANN SURG, V265, P622, DOI 10.1097/SLA.0000000000001695; Ng VL, 2014, J PEDIATR-US, V165, P539, DOI 10.1016/j.jpeds.2014.05.038; Nino DF, 2016, NAT REV GASTRO HEPAT, V13, P590, DOI 10.1038/nrgastro.2016.119; Nio M, 2015, SURG TODAY, V45, P813, DOI 10.1007/s00595-014-1024-z; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Oomen MWN, 2012, SURG ENDOSC, V26, P2104, DOI 10.1007/s00464-012-2174-y; Ostlie DJ, 2004, SURGERY, V136, P827, DOI 10.1016/j.surg.2004.06.020; Pammi M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0248-8; Pergialiotis V, 2016, INFLAMM RES, V65, P847, DOI 10.1007/s00011-016-0963-9; Rees CM, 2008, ANN SURG, V248, P44, DOI 10.1097/SLA.0b013e318176bf81; Rintala RJ, 2013, EUR J PEDIATR SURG, V23, P219, DOI 10.1055/s-0033-1347912; Rogers William, 2015, Evid Based Med, V20, P3, DOI 10.1136/ebmed-2014-110075; Sadiq J, 2015, HEPATOLOGY, V62, p820A; Scheller RL, 2016, ACAD EMERG MED, V23, P610, DOI 10.1111/acem.12916; Schurink M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121336; Shin JH, 2011, J KOREAN SURG SOC, V80, P355, DOI 10.4174/jkss.2011.80.5.355; Shinkai M, 2009, J PEDIATR GASTR NUTR, V48, P443, DOI 10.1097/MPG.0b013e318189f2d5; Simillis C, 2010, SURGERY, V147, P818, DOI 10.1016/j.surg.2009.11.013; Sistonen SJ, 2010, ANN SURG, V251, P1167, DOI 10.1097/SLA.0b013e3181c9b613; St Peter SD, 2016, J LAPAROENDOSC ADV S, V26, P305, DOI 10.1089/lap.2015.0566; Sulkowski JP, 2014, J PEDIATR SURG, V49, P1619, DOI 10.1016/j.jpedsurg.2014.06.002; Sun X, 2016, J PEDIATR SURG, V51, P374, DOI 10.1016/j.jpedsurg.2015.10.045; Svensson JF, 2015, ANN SURG, V261, P67, DOI 10.1097/SLA.0000000000000835; Tam PKH, 2016, J PEDIATR SURG, V51, P18, DOI 10.1016/j.jpedsurg.2015.10.021; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; Taylor ACF, 2007, CLIN GASTROENTEROL H, V5, P702, DOI 10.1016/j.cgh.2007.03.012; van der Zee DC, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00063; Tran VQ, 2016, J PEDIATR SURG, V51, P2005, DOI 10.1016/j.jpedsurg.2016.09.027; Vongbhavit K, 2016, CLIN THER, V38, P716, DOI 10.1016/j.clinthera.2016.01.006; Wang J, 2016, J IMMUNOL, V196, P5130, DOI 10.4049/jimmunol.1502135; Wang PL, 2016, DIGEST LIVER DIS, V48, P347, DOI 10.1016/j.dld.2015.11.021; Ward DV, 2016, CELL REP, V14, P2912, DOI 10.1016/j.celrep.2016.03.015; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233; Yang YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004428; Zani A, 2015, J PEDIATR SURG, V50, P1739, DOI 10.1016/j.jpedsurg.2015.03.001; Zani A, 2014, EUR J PEDIATR SURG, V24, P3, DOI 10.1055/s-0033-1350058; Zimmer J, 2016, PEDIATR SURG INT, V32, P743, DOI 10.1007/s00383-016-3908-z	100	39	50	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 9	2017	390	10099					1072	1082		10.1016/S0140-6736(17)32284-5	http://dx.doi.org/10.1016/S0140-6736(17)32284-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG1BW	28901937	Green Submitted			2022-12-28	WOS:000409528600025
J	Greif, S; Zsebok, S; Schmieder, D; Siemers, BM				Greif, Stefan; Zsebok, Sandor; Schmieder, Daniela; Siemers, Bjorn M.			Acoustic mirrors as sensory traps for bats	SCIENCE			English	Article							EVOLUTIONARY TRAPS; ECHOLOCATING BATS; ECOLOGICAL TRAPS; EPTESICUS-FUSCUS; LIGHT POLLUTION; FLIGHT	Sensory traps pose a considerable and often fatal risk for animals, leading them to misinterpret their environment. Bats predominantly rely on their echolocation system to forage, orientate, and navigate. We found that bats can mistake smooth, vertical surfaces as clear flight paths, repeatedly colliding with them, likely as a result of their acoustic mirror properties. The probability of collision is influenced by the number of echolocation calls and by the amount of time spent in front of the surface. The echolocation call analysis corroborates that bats perceive smooth, vertical surfaces as open flyways. Reporting on occurrences with different species in the wild, we argue that it is necessary to more closely monitor potentially dangerous locations with acoustic mirror properties (such as glass fronts) to assess the true frequency of fatalities around these sensory traps.	[Greif, Stefan; Zsebok, Sandor; Schmieder, Daniela; Siemers, Bjorn M.] Max Planck Inst Ornithol, Sensory Ecol Grp, D-82319 Seewiesen, Germany; [Greif, Stefan] Tel Aviv Univ, Dept Zool, IL-6997801 Tel Aviv, Israel; [Zsebok, Sandor] Eotvos Lorand Univ, Behav Ecol Res Grp, H-1117 Budapest, Hungary; [Schmieder, Daniela] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland	Max Planck Society; Tel Aviv University; Eotvos Lorand University; University of Bern	Greif, S (corresponding author), Max Planck Inst Ornithol, Sensory Ecol Grp, D-82319 Seewiesen, Germany.; Greif, S (corresponding author), Tel Aviv Univ, Dept Zool, IL-6997801 Tel Aviv, Israel.	stefan.greif@gmail.com	Zsebők, Sándor/H-4768-2015	Zsebők, Sándor/0000-0003-4463-4753; Greif, Stefan/0000-0002-0139-2435	Human Frontier Science Program grant [RGP0062/2009]; National Research, Development and Innovation Office, Hungary (NKFIH) [PD-115730]; Minerva Foundation; Max Planck Society	Human Frontier Science Program grant(Human Frontier Science Program); National Research, Development and Innovation Office, Hungary (NKFIH); Minerva Foundation; Max Planck Society(Max Planck Society)	All experiments were carried out under license of the Bulgarian authorities [Bulgarian Ministry of Environment and Water, and Regional Inspectorate (RIOSV) Ruse, permits 193/01.04.2009 and 205/29.05.2009] and the Hungarian authorities [National Inspectorate for Environment, Nature and Water (OKTVF) permit 14/5969/3/2011]. Supported by Human Frontier Science Program grant RGP0062/2009 (B.M.S.); National Research, Development and Innovation Office, Hungary (NKFIH) grant PD-115730 (S.Z.); the Minerva Foundation (S.G.); and the Max Planck Society. The authors report no conflict of interest. All data used in statistics are archived at the Edmond Data Repository (http://edmond.mpdl.mpg.de/imeji/collection/1nwmhPuiGddSJ4Xd).	CRAWFORD RL, 1981, J MAMMAL, V62, P651, DOI 10.2307/1380421; Danilovich S, 2015, CURR BIOL, V25, pR1124, DOI 10.1016/j.cub.2015.11.003; DAVIS WH, 1965, AM MIDL NAT, V74, P497, DOI 10.2307/2423278; Fletcher RJ, 2012, P ROY SOC B-BIOL SCI, V279, P2546, DOI 10.1098/rspb.2012.0139; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Halfwerk W, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1051; Hoffmann S, 2015, J NEUROPHYSIOL, V113, P1135, DOI 10.1152/jn.00263.2014; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Howard RW, 1995, AURITUS NATURAL HIST; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Madliger CL, 2012, BIODIVERS CONSERV, V21, P3277, DOI 10.1007/s10531-012-0363-6; McGuire LP, 2010, ACTA CHIROPTEROL, V12, P247, DOI 10.3161/150811010X504734; Melcon ML, 2009, J COMP PHYSIOL A, V195, P69, DOI 10.1007/s00359-008-0383-6; Moss CF, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00033; Petrites AE, 2009, J COMP PHYSIOL A, V195, P603, DOI 10.1007/s00359-009-0435-6; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Surlykke A, 2009, P ROY SOC B-BIOL SCI, V276, P853, DOI 10.1098/rspb.2008.1505; Timm R.M., 1989, Bulletin of the Chicago Academy of Sciences, V14, P1; Van Gelder R. G., 1956, Transactions of the Kansas Academy of Science, V59, P220	26	13	14	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1045	+		10.1126/science.aam7817	http://dx.doi.org/10.1126/science.aam7817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883074				2022-12-28	WOS:000409455700046
J	Callaway, E				Callaway, Ewen			Stolen skeleton is one of the oldest in the Americas	NATURE			English	News Item																			0	1	1	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					14	15		10.1038/nature.2017.22521	http://dx.doi.org/10.1038/nature.2017.22521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880302	Bronze			2022-12-28	WOS:000409388700007
J	Guo, RY; Zong, S; Wu, M; Gu, JK; Yang, MJ				Guo, Runyu; Zong, Shuai; Wu, Meng; Gu, Jinke; Yang, Maojun			Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2	CELL			English	Article							CYTOCHROME-C-OXIDASE; BEAM-INDUCED MOTION; CRYSTAL-STRUCTURE; COMPLEX-III; ELECTRON-TRANSPORT; CHAIN; SUPERCOMPLEX; PROTEIN; RESPIRASOME; STABILIZES	The respiratory megacomplex represents the highest-order assembly of respiratory chain complexes, and it allows mitochondria to respond to energy-requiring conditions. To understand its architecture, we examined the human respiratory chain mega-complex-I2III2IV2 (MCI2III2IV2) with 140 subunits and a subset of associated cofactors using cryo-electron microscopy. The MCI2III2IV2 forms a circular structure with the dimeric CIII located in the center, where it is surrounded by two copies each of CI and CIV. Two cytochrome c (Cyt.c) molecules are positioned to accept electrons on the surface of the c(1) state CIII dimer. Analyses indicate that CII could insert into the gaps between CI and CIV to form a closed ring, which we termed the electron transport chain supercomplex. The structure not only reveals the precise assignment of individual subunits of human CI and CIII, but also enables future in-depth analysis of the electron transport chain as a whole.	[Guo, Runyu; Zong, Shuai; Wu, Meng; Gu, Jinke; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci,Tsinghua Peking Join, Beijing 100084, Peoples R China	Tsinghua University	Yang, MJ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Adv Innovat Ctr Struct Biol, Minist Educ,Key Lab Prot Sci,Tsinghua Peking Join, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn	Zong, Shuai/GNH-2196-2022; Zong, Shuai/AAH-7911-2020	Zong, Shuai/0000-0002-7067-6757; Yang, Maojun/0000-0002-6798-3094; Gu, Jinke/0000-0001-5942-480X	National Key R&D Program of China [2017YFA0504600, 2016YFA0501100]; National Science Fund for Distinguished Young Scholars [31625008]; National Natural Science Foundation of China [21532004, 31570733]	National Key R&D Program of China; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the "Explorer 100" cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the National Key R&D Program of China (2017YFA0504600 and 2016YFA0501100), the National Science Fund for Distinguished Young Scholars (31625008), and the National Natural Science Foundation of China (21532004 and 31570733).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Bakthavachalam P, 2017, J NEUROL SCI, V375, P417, DOI 10.1016/j.jns.2017.02.043; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brandt U, 2011, BBA-BIOENERGETICS, V1807, P1364, DOI 10.1016/j.bbabio.2011.04.006; Bultema JB, 2009, BBA-BIOENERGETICS, V1787, P60, DOI 10.1016/j.bbabio.2008.10.010; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cohen RD, 2017, PROTEIN SCI, V26, P403, DOI 10.1002/pro.3092; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Vizarra E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00134; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Guo RY, 2016, PROTEIN CELL, V7, P854, DOI 10.1007/s13238-016-0329-7; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jiang X, 2016, MOL CELL, V63, P229, DOI 10.1016/j.molcel.2016.06.016; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; KUONEN DR, 1986, ANAL BIOCHEM, V153, P221, DOI 10.1016/0003-2697(86)90084-9; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lenaz G, 2016, BBA-BIOENERGETICS, V1857, P991, DOI 10.1016/j.bbabio.2016.01.013; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Melber A, 2016, CELL, V167, P1450, DOI 10.1016/j.cell.2016.11.025; Menezes MJ, 2014, BBA-GEN SUBJECTS, V1840, P1368, DOI 10.1016/j.bbagen.2013.12.025; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rak M, 2016, CLIN SCI, V130, P393, DOI 10.1042/CS20150707; Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012; Sanchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schon EA, 2009, CELL METAB, V9, P1, DOI 10.1016/j.cmet.2008.12.011; Shimada S, 2017, EMBO J, V36, P291, DOI 10.15252/embj.201695021; Shinzawa-Itoh K, 2016, J BIOL CHEM, V291, P4178, DOI 10.1074/jbc.M115.680553; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Sousa JS, 2016, ELIFE, V5, DOI [10.7554/eLife.21290, 10.7554/e.Life.21290]; Sousa PMF, 2013, ARCH BIOCHEM BIOPHYS, V537, P153, DOI 10.1016/j.abb.2013.07.012; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tan AS, 2014, BBA-GEN SUBJECTS, V1840, P1454, DOI 10.1016/j.bbagen.2013.10.016; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	72	236	249	3	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1247	1257		10.1016/j.cell.2017.07.050	http://dx.doi.org/10.1016/j.cell.2017.07.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28844695	Bronze			2022-12-28	WOS:000409536000020
J	Poliakoff, M; Perutz, R				Poliakoff, Martyn; Perutz, Robin			Fertile mind that led to unexpected places	NATURE			English	Letter									[Poliakoff, Martyn] Univ Nottingham, Nottingham, England; [Perutz, Robin] Univ York, York, N Yorkshire, England	University of Nottingham; University of York - UK	Poliakoff, M (corresponding author), Univ Nottingham, Nottingham, England.	martyn@poliakoff.org.uk							0	0	0	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					31	31		10.1038/549031d	http://dx.doi.org/10.1038/549031d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880290	Green Accepted, Green Submitted			2022-12-28	WOS:000409388700021
J	Ribas, A; Dummer, R; Puzanov, I; VanderWalde, A; Andtbacka, RHI; Michielin, O; Olszanski, AJ; Malvehy, J; Cebon, J; Fernandez, E; Kirkwood, JM; Gajewski, TF; Chen, L; Gorski, KS; Anderson, AA; Diede, SJ; Lassman, ME; Gansert, J; Hodi, FS; Long, GV				Ribas, Antoni; Dummer, Reinhard; Puzanov, Igor; VanderWalde, Ari; Andtbacka, Robert H. I.; Michielin, Olivier; Olszanski, Anthony J.; Malvehy, Josep; Cebon, Jonathan; Fernandez, Eugenio; Kirkwood, John M.; Gajewski, Thomas F.; Chen, Lisa; Gorski, Kevin S.; Anderson, Abraham A.; Diede, Scott J.; Lassman, Michael E.; Gansert, Jennifer; Hodi, F. Stephen; Long, Georgina V.			Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy	CELL			English	Article							TALIMOGENE LAHERPAREPVEC; PEMBROLIZUMAB; IPILIMUMAB; ANTIBODY; RESISTANCE; BLOCKADE	Here we report a phase 1b clinical trial testing the impact of oncolytic virotherapy with talimogene laherparepvec on cytotoxic T cell infiltration and therapeutic efficacy of the anti-PD-1 antibody pembrolizumab. Twenty-one patients with advanced melanoma were treated with talimogene laherparepvec followed by combination therapy with pembrolizumab. Therapy was generally well tolerated, with fatigue, fevers, and chills as the most common adverse events. No dose-limiting toxicities occurred. Confirmed objective response rate was 62%, with a complete response rate of 33% per immune-related response criteria. Patients who responded to combination therapy had increased CD8(+) T cells, elevated PD-L1 protein expression, as well as IFN-gamma gene expression on several cell subsets in tumors after talimogene laherparepvec treatment. Response to combination therapy did not appear to be associated with baseline CD8(+) T cell infiltration or baseline IFN-gamma signature. These findings suggest that oncolytic virotherapy may improve the efficacy of anti-PD-1 therapy by changing the tumor microenvironment.	[Ribas, Antoni] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Dummer, Reinhard] Univ Hosp Zurich, Zurich, Switzerland; [Puzanov, Igor] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [VanderWalde, Ari] West Clin, Memphis, TN USA; [Andtbacka, Robert H. I.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Michielin, Olivier] CHU Vaudois, Lausanne, Switzerland; [Olszanski, Anthony J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Malvehy, Josep] Hosp Clin Barcelona, Barcelona, Spain; [Cebon, Jonathan] La Trobe Univ, Olivia Newton John Canc Res Inst, Austin Hlth, Sch Canc Med, Heidelberg, Vic, Australia; [Fernandez, Eugenio] Hop Univ Geneve, Geneva, Switzerland; [Kirkwood, John M.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Kirkwood, John M.] Univ Pittsburgh, Hillman UPMC Canc Ctr, Pittsburgh, PA USA; [Gajewski, Thomas F.] Univ Chicago, Sch Med, Chicago, IL 60637 USA; [Chen, Lisa; Anderson, Abraham A.; Gansert, Jennifer] Amgen Inc, Thousand Oaks, CA 91320 USA; [Gorski, Kevin S.] Amgen Inc, San Francisco, CA USA; [Diede, Scott J.; Lassman, Michael E.] Merck & Co Inc, Kenilworth, NJ USA; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of Zurich; University Zurich Hospital; Roswell Park Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Fox Chase Cancer Center; University of Barcelona; Hospital Clinic de Barcelona; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; Amgen; Amgen; Merck & Company; Harvard University; Dana-Farber Cancer Institute; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital	Ribas, A (corresponding author), Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.	aribas@mednet.ucla.edu	Chen, Lisa/GXN-0315-2022; Michielin, Olivier/ABE-7924-2020; PUZANOV, IGOR/AAP-2966-2020; Long, Georgina V/C-1771-2013; Olszanski, Anthony/AAF-8560-2019; Diede, Scott/G-2288-2012	PUZANOV, IGOR/0000-0002-9803-3497; Long, Georgina V/0000-0001-8894-3545; Diede, Scott/0000-0001-5422-549X; Cebon, Jonathan/0000-0002-3898-950X; Olszanski, Anthony/0000-0001-5276-5898	NIH [R35 CA197633, P20CA016056]; Australian NHMRC [APP1119059]; Medical Foundation, University of Sydney [K8625]; Amgen Inc.; Merck; Bristol-Myers Squibb; Astra-Zeneca; Takara; Provectus; Takeda; Kyowa; Immunocore; EMD Serono; Incyte; Eli Lilly; Advaxis; Mirati; Ignyta; Novartis; Pfizer; Kura; G1 therapeutics; Kyowa Hakko Kirin; Almirall; Roche; GlaxoSmithKline; Pierre Fabre; Leo Pharma; CSL; Amgen, Inc.; Prometheus; Green Peptide; Solaran RX; Checkmate Pharmaceuticals; Roche/Genentech; Ono; Seattle Genetics; Celldex; Genentech; Array; Merck Sharp Dohme	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Foundation, University of Sydney(University of Sydney); Amgen Inc.(Amgen); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Astra-Zeneca(AstraZeneca); Takara; Provectus; Takeda(Takeda Pharmaceutical Company Ltd); Kyowa; Immunocore; EMD Serono; Incyte; Eli Lilly(Eli Lilly); Advaxis; Mirati; Ignyta; Novartis(Novartis); Pfizer(Pfizer); Kura; G1 therapeutics; Kyowa Hakko Kirin(Kyowa Kirin Ltd); Almirall(Almirall); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); Pierre Fabre; Leo Pharma(LEO Pharma); CSL; Amgen, Inc.(Amgen); Prometheus; Green Peptide; Solaran RX; Checkmate Pharmaceuticals; Roche/Genentech(Roche HoldingGenentech); Ono; Seattle Genetics; Celldex; Genentech(Roche HoldingGenentech); Array; Merck Sharp Dohme(Merck & Company)	The authors thank the following individuals: Richard Scolyer, Robyn Saw, Andrew Spillane, Kenneth Lee, and Omgo Neiwig of the Melanoma Institute Australia for tumor excision biopsies to maximize tissue acquisition; Hajime Hiraragi (Amgen Inc.) for peer review of tumor biopsy analyses, Jessica Stern (Amgen Inc.) for flow cytometry peer review and organization of IHC image galleries for preparation of figures, David Kaufman and Christine Gause from Merck & Co for many hours of designing the study and the statistical plan for both the phase 1b and 3 portions, and with special acknowledgment to Jeffrey Chou, MD, PhD, for his medical and scientific contributions to the design and execution of this study during his tenure as the Amgen medical monitor. A.R. is supported by the NIH grant R35 CA197633. I.P. is supported by NIH grant P20CA016056 to Roswell Park Cancer Institute. G.V.L. is supported by an Australian NHMRC fellowship (APP1119059) and the Medical Foundation K8625, University of Sydney. Lastly, we wish to thank Meghan Johnson, PhD (Complete Healthcare Communications, LLC, West Chester, PA), whose work was funded by Amgen Inc., Emily Plummer, PhD (Amgen Inc.), and Mee Rhan Kim, PhD (Amgen Inc.) for assistance in the preparation of this manuscript. The study was funded by Amgen Inc.; A.R. has received consulting fees from Amgen Inc. and Merck. R.D. has intermittent, project-focused consulting and/or advisory relationships with Novartis, Merck Sharp & Dohme, Bristol-Myers Squibb, Roche, Amgen Inc., Takeda, and Pierre Fabre outside the submitted work. I.P. has received consulting fees and honoraria from Amgen Inc. A.VW. has received research grants from Amgen Inc. and consulting fees from Bristol-Myers Squibb, Astra-Zeneca, and Amgen Inc. R.H.I. A. has received consulting fees from Amgen Inc., Merck, Takara, and Provectus. O.M. has previously served on advisory boards for Bristol-Myers Squibb, Merck Sharp & Dohme, Roche, Novartis, and Amgen Inc. and has received travel assistance from Bristol-Myers Squibb, Merck Sharp & Dohme, and Amgen Inc. A.J.O. has received research grants from Takeda, Bristol-Myers Squibb, Kyowa, Immunocore, EMD Serono, Amgen Inc., Incyte, Eli Lilly, Advaxis, Mirati, Ignyta, Novartis, Pfizer, and Kura and has received consulting fees from Merck, Takeda, Bristol-Myers Squibb, G1 therapeutics, and Kyowa Hakko Kirin. J.M. has received research grants from Almirall, Amgen Inc., Roche, GlaxoSmithKline, and Bristol-Myers Squibb; has received consulting fees from Almirall, Amgen Inc., Pierre Fabre, and Leo Pharma; and has served on speakers' bureaus for Amgen Inc., Almirall, Novartis, and Isdin. J.C. has received honoraria from GlaxoSmithKline, Bristol-Myers Squibb, Novartis, Merck Sharp & Dohme, and Amgen Inc.; has served in a non-remunerative position of influence for Austin Health Oncology Information System project Control Group, Olivia Newton-John Cancer & Wellness Centre Executive Committee, and Olivia Newton-John Cancer and Wellness Centre MRI Advisory Committee; has served as a consultant/advisor for Amgen Inc., Bionomics, Bristol-Meyers Squibb, Merck Sharp & Dohme, and Novartis; has received research funding to his institution from GlaxoSmithKline and CSL; has patents/intellectual property at GlaxoSmithKline, Bristol-Meyers Squibb, and Novartis; and is an employee of the Olivia Newton-John Cancer Research Institute. E.F. has received consulting fees from Amgen, Inc. J.M.K. has received research grants from Merck and Prometheus and has received consulting fees from Bristol-Myers Squibb, Green Peptide, Roche, Solaran RX, Checkmate Pharmaceuticals, and Novartis. T.F.G. has received research funding from Amgen Inc., Bristol-Myers Squibb, Merck, Roche/Genentech, Ono, Incyte, and Seattle Genetics; has served on advisory board or as a consultant for Merck, Roche/Genentech, Bayer, Abbvie, Aduro, and Jounce; and owns stock in Jounce. L.C., K.S.G., A.A.A., and J.G. are employees of, and own stock in, Amgen Inc. S.J.D. and M.L. are employees of, and own stock in, Merck. F.S.H. has received research funding from Bristol-Myers Squibb; has received consulting fees from Amgen Inc., Merck, Bristol-Myers Squibb, Novartis, EMD Serono, Celldex, and Genentech; and has received royalties to his institution (per institutional policy) from MICA; related disorders patent pending. G.V.L. has received consulting fees from Amgen Inc., Array, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Roche, and Pierre Fabre.	Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Andtbacka RHI, 2016, ANN SURG ONCOL, V23, P4169, DOI 10.1245/s10434-016-5286-0; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Chesney J, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw379.4; Chesney JA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9509; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Gerdes MJ, 2013, P NATL ACAD SCI USA, V110, P11982, DOI 10.1073/pnas.1300136110; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hoffner B, 2016, ONCOL NURS FORUM, V43, P219, DOI 10.1188/16.ONF.219-226; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; Moesta A. K., 2017, CLIN CANC RES; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529; RIBAS A, 2015, J CLIN ONCOL S, V33; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Ribas A, 2015, CANCER DISCOV, V5, P915, DOI 10.1158/2159-8290.CD-15-0563; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	25	811	847	14	213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1109	1119		10.1016/j.cell.2017.08.027	http://dx.doi.org/10.1016/j.cell.2017.08.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886381	Bronze, Green Accepted			2022-12-28	WOS:000409536000009
J	Medema, JP				Medema, Jan Paul			Targeting the Colorectal Cancer Stem Cell	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLON-CANCER		[Medema, Jan Paul] Acad Med Ctr, Canc Ctr Amsterdam, Lab Expt Oncol & Radiobiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Medema, JP (corresponding author), Acad Med Ctr, Canc Ctr Amsterdam, Lab Expt Oncol & Radiobiol, Amsterdam, Netherlands.			Medema, Jan Paul/0000-0003-3045-2924				Melo FDE, 2017, NATURE, V543, P676, DOI 10.1038/nature21713; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nassar D, 2016, ANNU REV PATHOL-MECH, V11, P47, DOI 10.1146/annurev-pathol-012615-044438; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081	5	38	41	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					888	890		10.1056/NEJMcibr1706541	http://dx.doi.org/10.1056/NEJMcibr1706541			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF0YG	28854096				2022-12-28	WOS:000408626400016
J	Tichenor, M; Sridhar, D				Tichenor, Marlee; Sridhar, Devi			Universal health coverage, health systems strengthening, and the World Bank	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tichenor, Marlee] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Sridhar, Devi] Univ Edinburgh, Global Publ Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Tichenor, M (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	Marlee.Tichenor@ed.ac.uk		Tichenor, Marlee/0000-0001-6434-9795	Wellcome Trust [106635/Z/14/Z]	Wellcome Trust(Wellcome Trust)	We have read and understood BMJ policy on declaration of interests and have no relevant interests to declare. This work was supported by the Wellcome Trust [106635/Z/14/Z]. A senior member of the World Bank is on our project's advisory board.	Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; [Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P646, DOI 10.2471/BLT.10.020910; Bump JB, 2010, LONG ROAD UNIVERSAL; George S., 2016, GUARDIAN; Ghebreysus TA, 2017, PRESS C TRANSCRIPT; Independent Evaluation Group, 2009, DO HLTH SECT WID APP; Independent Evaluation Group, 2016, PROGR FOR RES EARL S; Institute for Health Metrics and Evaluation, 2017, DEV ASS HLTH DAT 199; Johnston T, 1999, INVESTING HLTH DEV E; Marriott A, 2014, INVESTING FEW IFCS H; Ridde V, 2008, SOC SCI MED, V66, P1368, DOI 10.1016/j.socscimed.2007.10.026; Sridhar D, 2015, INT J HEALTH SERV, V45, P495, DOI 10.1177/0020731415584554; Tichenor M., 2017, MED ANTHROPOL, P1; Welch C, HLTH POST 2015 DEV A; WHO, 2016, WORLD HLTH STAT 2016; Winters J, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3394; World Bank, 2013, COMMUNICATION; World Bank, 1970, APPR POP PROJ JAM; World Bank, 1986, FIN HLTH SERV DEV CO; World Bank Group Finances, PAID CONTR IBRD IDA; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2007, GLOB FUND STRAT APPR	22	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2017	358								j3347	10.1136/bmj.j3347	http://dx.doi.org/10.1136/bmj.j3347			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CQ	28860138	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000409387000003
J	Kim, SH; Haines, CS; Li, N; Kim, KJ; Mun, TJ; Choi, C; Di, JT; Oh, YJ; Oviedo, JP; Bykova, J; Fang, SL; Jiang, N; Liu, ZF; Wang, R; Kumar, P; Qiao, R; Priya, S; Cho, K; Kim, M; Lucas, MS; Drummy, LF; Maruyama, B; Lee, DY; Lepro, X; Gao, EL; Albarq, D; Ovalle-Robles, R; Kim, SJ; Baughman, RH				Kim, Shi Hyeong; Haines, Carter S.; Li, Na; Kim, Keon Jung; Mun, Tae Jin; Choi, Changsoon; Di, Jiangtao; Oh, Young Jun; Oviedo, Juan Pablo; Bykova, Julia; Fang, Shaoli; Jiang, Nan; Liu, Zunfeng; Wang, Run; Kumar, Prashant; Qiao, Rui; Priya, Shashank; Cho, Kyeongjae; Kim, Moon; Lucas, Matthew Steven; Drummy, Lawrence F.; Maruyama, Benji; Lee, Dong Youn; Lepro, Xavier; Gao, Enlai; Albarq, Dawood; Ovalle-Robles, Raquel; Kim, Seon Jeong; Baughman, Ray H.			Harvesting electrical energy from carbon nanotube yarn twist	SCIENCE			English	Article							DIFFERENTIAL CAPACITANCE; MECHANICAL ENERGY; SYSTEM; DRIVEN	Mechanical energy harvesters are needed for diverse applications, including self-powered wireless sensors, structural and human health monitoring systems, and the extraction of energy from ocean waves. We report carbon nanotube yarn harvesters that electrochemically convert tensile or torsional mechanical energy into electrical energy without requiring an external bias voltage. Stretching coiled yarns generated 250 watts per kilogram of peak electrical power when cycled up to 30 hertz, as well as up to 41.2 joules per kilogram of electrical energy per mechanical cycle, when normalized to harvester yarn weight. These energy harvesters were used in the ocean to harvest wave energy, combined with thermally driven artificial muscles to convert temperature fluctuations to electrical energy, sewn into textiles for use as self-powered respiration sensors, and used to power a light-emitting diode and to charge a storage capacitor.	[Kim, Shi Hyeong; Kim, Keon Jung; Mun, Tae Jin; Choi, Changsoon; Lee, Dong Youn; Kim, Seon Jeong] Hanyang Univ, Dept Biomed Engn, Ctr Self Powered Actuat, Seoul 04763, South Korea; [Haines, Carter S.; Li, Na; Di, Jiangtao; Fang, Shaoli; Lepro, Xavier; Gao, Enlai; Albarq, Dawood; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75080 USA; [Oh, Young Jun; Oviedo, Juan Pablo; Cho, Kyeongjae; Kim, Moon] Univ Texas Dallas, Dept Mat Sci & Engn, Richardson, TX 75080 USA; [Bykova, Julia; Ovalle-Robles, Raquel] Lintec Amer, Nanosci & Technol Ctr, Richardson, TX 75081 USA; [Jiang, Nan; Liu, Zunfeng; Wang, Run] Jiangnan Graphene Res Inst, Changzhou 213149, Peoples R China; [Liu, Zunfeng; Wang, Run] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Kumar, Prashant; Qiao, Rui; Priya, Shashank] Virginia Polytech Inst & State Univ, Dept Mech Engn, Blacksburg, VA 24061 USA; [Lucas, Matthew Steven; Drummy, Lawrence F.; Maruyama, Benji] Air Force Res Lab, Mat & Mfg Directorate, Dayton, OH 45433 USA	Hanyang University; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; LINTEC Corporation; Nankai University; Virginia Polytechnic Institute & State University	Kim, SJ (corresponding author), Hanyang Univ, Dept Biomed Engn, Ctr Self Powered Actuat, Seoul 04763, South Korea.; Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75080 USA.	sjk@hanyang.ac.kr; ray.baughman@utdallas.edu	Kim, Seon Jeong/AAR-8127-2021; Gao, Enlai/F-6317-2019; Priya, S/GQH-7176-2022; Maruyama, Benji/AAI-3434-2020; Qiao, Rui/B-2350-2009; Di, Jiangtao/C-3241-2017; Kim, Moon J/A-2297-2010; Choi, Changsoon/T-1024-2017; Kumar, Prashant/ABB-3582-2021; Baughman, Ray/A-8628-2018; Gao, Enlai/AAH-8453-2020; Bykova, Julia/H-4020-2014; Lepro, Xavier/G-1021-2012; Li, Na/M-9852-2015	Kim, Seon Jeong/0000-0002-2867-6737; Gao, Enlai/0000-0003-1960-0260; Maruyama, Benji/0000-0002-3832-628X; Qiao, Rui/0000-0001-5219-5530; Di, Jiangtao/0000-0002-5152-0765; Baughman, Ray/0000-0001-5845-5137; Gao, Enlai/0000-0003-1960-0260; Bykova, Julia/0000-0002-0815-2661; Priya, Shashank/0000-0003-1367-3434; Lepro, Xavier/0000-0002-0166-3127; Oviedo, Juan Pablo/0000-0002-4954-9374; Li, Na/0000-0002-1909-6378	Creative Research Initiative Center for Self-Powered Actuation of the National Research Foundation of Korea; Ministry of Science, ICT & Future Planning; Korea-U.S. Air Force Cooperation Program [2013K1A3A1A32035592]; Ministry of Knowledge Economy [20168510011350]; Air Force Office of Scientific Research [FA9550-15-1-0089, FA9550-12-1-0035]; Air Force grant [AOARD-FA2386-13-4119]; NASA [NNX15CS05C]; Robert A. Welch Foundation [AT-0029]; Office of Naval Research [N00014-14-1-0158]	Creative Research Initiative Center for Self-Powered Actuation of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea-U.S. Air Force Cooperation Program; Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force grant(United States Department of DefenseUS Air Force Research Laboratory); NASA(National Aeronautics & Space Administration (NASA)); Robert A. Welch Foundation(The Welch Foundation); Office of Naval Research(Office of Naval Research)	We thank B. Buckenham, A. M. Baughman, and N. K. Mayo for preparing samples and performing measurements. This work was supported in Korea by the Creative Research Initiative Center for Self-Powered Actuation of the National Research Foundation of Korea and the Ministry of Science, ICT & Future Planning, the Korea-U.S. Air Force Cooperation Program (grant 2013K1A3A1A32035592), and a KETEP grant (20168510011350) grant of the Ministry of Knowledge Economy. In the United States, this work was supported by Air Force Office of Scientific Research grants (FA9550-15-1-0089 and FA9550-12-1-0035), an Air Force grant (AOARD-FA2386-13-4119), a NASA project (NNX15CS05C), a Robert A. Welch Foundation grant (AT-0029), and an Office of Naval Research grant (N00014-14-1-0158). S.H.K., C.S.H., N.L., S.F., J.D., K.J.K., T.J.M., C.C., S.J.K., and R.H.B. are the inventors of provisional U.S. patent application no. 62/526,188, submitted jointly by the Board of Regents, the University of Texas System (for the University of Texas at Dallas), and the Industry-University Cooperation Foundation of Hanyang University, that covers the design, fabrication, performance, and applications of twistron mechanical energy harvesters.	Aureli M, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/1/015003; Barisci JN, 2003, J ELECTROCHEM SOC, V150, pE409, DOI 10.1149/1.1593045; Beeby SP, 2009, ENERGY HARVESTING TECHNOLOGIES, P129, DOI 10.1007/978-0-387-76464-1_5; Chiba S, 2008, PROC SPIE, V6927, DOI 10.1117/12.778345; Chmiola J, 2006, SCIENCE, V313, P1760, DOI [10.1126/science.1132195, 10.1126/science/1132195]; Ghosh S, 2003, SCIENCE, V299, P1042, DOI 10.1126/science.1079080; Haines CS, 2016, P NATL ACAD SCI USA, V113, P11709, DOI 10.1073/pnas.1605273113; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; Heinzelman WR., 2000, PROC 33 ANN HAWAII I, V1, P10, DOI [10.1109/HICSS.2000.926982, DOI 10.1109/HICSS.2000.926982]; Kim S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10146; Kim SH, 2015, ENERG ENVIRON SCI, V8, P3336, DOI 10.1039/c5ee02219c; Kosmulski M, 2009, J COLLOID INTERF SCI, V337, P439, DOI 10.1016/j.jcis.2009.04.072; Krupenkin T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1454; Lepro X, 2012, ADV FUNCT MATER, V22, P1069, DOI 10.1002/adfm.201102114; Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Liu JW, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710776; McCafferty E, 2010, ELECTROCHIM ACTA, V55, P1630, DOI 10.1016/j.electacta.2009.10.040; Mirfakhrai T, 2009, ADV SCI TECH, V61, P65; Moon JK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2485; Motta M, 2007, ADV MATER, V19, P3721, DOI 10.1002/adma.200700516; Niu SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9975; Park T, 2013, ENERG ENVIRON SCI, V6, P788, DOI 10.1039/c3ee23729j; Pelrine R, 2001, PROC SPIE, V4329, P148, DOI 10.1117/12.432640; Persano L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2639; Priya Shashank, 2017, Energy Harvesting and Systems (Materials, Mechanisms, Circuits and Storage), V4, P3, DOI 10.1515/ehs-2016-0028; RANDIN JP, 1971, J ELECTROCHEM SOC, V118, P711, DOI 10.1149/1.2408151; RANDIN JP, 1972, J ELECTROANAL CHEM, V36, P257, DOI 10.1016/0368-1874(72)80089-3; Shao LH, 2010, PHYS CHEM CHEM PHYS, V12, P7580, DOI 10.1039/b916331j; Tanaka Y, 2009, ANGEW CHEM INT EDIT, V48, P7655, DOI 10.1002/anie.200902468; Tang W, 2015, ACS NANO, V9, P7867, DOI 10.1021/acsnano.5b03567; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005; Yin J, 2014, NAT NANOTECHNOL, V9, P378, DOI [10.1038/nnano.2014.56, 10.1038/NNANO.2014.56]; Yu MF, 2001, J APPL PHYS, V89, P4554, DOI 10.1063/1.1356437; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhu G, 2014, ADV MATER, V26, P3788, DOI 10.1002/adma.201400021; Zi YL, 2016, ACS NANO, V10, P4797, DOI 10.1021/acsnano.6b01569	38	232	241	53	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					773	778		10.1126/science.aam8771	http://dx.doi.org/10.1126/science.aam8771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6OD	28839068				2022-12-28	WOS:000408327900036
J	Miller, V; Mente, A; Dehghan, M; Rangarajan, S; Zhang, XH; Swaminathan, S; Dagenais, G; Gupta, R; Mohan, V; Lear, S; Bangdiwala, SI; Schutte, AE; Wentzel-Viljoen, E; Avezum, A; Altuntas, Y; Yusoff, K; Ismail, N; Peer, N; Chifamba, J; Diaz, R; Rahman, O; Mohammadifard, N; Lana, F; Zatonska, K; Wielgosz, A; Yusufali, A; Iqbal, R; Lopez-Jaramillo, P; Khatib, R; Rosengren, A; Kutty, VR; Li, W; Liu, JK; Liu, XY; Yin, L; Teo, K; Anand, S; Yusuf, S				Miller, Victoria; Mente, Andrew; Dehghan, Mahshid; Rangarajan, Sumathy; Zhang, Xiaohe; Swaminathan, Sumathi; Dagenais, Gilles; Gupta, Rajeev; Mohan, Viswanathan; Lear, Scott; Bangdiwala, Shrikant I.; Schutte, Aletta E.; Wentzel-Viljoen, Edelweiss; Avezum, Alvaro; Altuntas, Yuksel; Yusoff, Khalid; Ismail, Noorhassim; Peer, Nasheeta; Chifamba, Jephat; Diaz, Rafael; Rahman, Omar; Mohammadifard, Noushin; Lana, Fernando; Zatonska, Katarzyna; Wielgosz, Andreas; Yusufali, Afzalhussein; Iqbal, Romaina; Lopez-Jaramillo, Patricio; Khatib, Rasha; Rosengren, Annika; Kutty, V. Raman; Li, Wei; Liu, Jiankang; Liu, Xiaoyun; Yin, Lu; Teo, Koon; Anand, Sonia; Yusuf, Salim		PURE Study Investigators	Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study	LANCET			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ASSESS DIETARY-INTAKE; PROSPECTIVE URBAN; BLOOD-PRESSURE; ANTIOXIDANT VITAMINS; HIGH-INCOME; CONSUMPTION; RISK; PREVENTION; MORTALITY	Background The association between intake of fruits, vegetables, and legumes with cardiovascular disease and deaths has been investigated extensively in Europe, the USA, Japan, and China, but little or no data are available from the Middle East, South America, Africa, or south Asia. Methods We did a prospective cohort study (Prospective Urban Rural Epidemiology [PURE] in 135 335 individuals aged 35 to 70 years without cardiovascular disease from 613 communities in 18 low-income, middle-income, and high-income countries in seven geographical regions: North America and Europe, South America, the Middle East, south Asia, China, southeast Asia, and Africa. We documented their diet using country-specific food frequency questionnaires at baseline. Standardised questionnaires were used to collect information about demographic factors, socioeconomic status (education, income, and employment), lifestyle (smoking, physical activity, and alcohol intake), health history and medication use, and family history of cardiovascular disease. The follow-up period varied based on the date when recruitment began at each site or country. The main clinical outcomes were major cardiovascular disease (defined as death from cardiovascular causes and non-fatal myocardial infarction, stroke, and heart failure), fatal and non-fatal myocardial infarction, fatal and non-fatal strokes, cardiovascular mortality, non-cardiovascular mortality, and total mortality. Cox frailty models with random effects were used to assess associations between fruit, vegetable, and legume consumption with risk of cardiovascular disease events and mortality. Findings Participants were enrolled into the study between Jan 1, 2003, and March 31, 2013. For the current analysis, we included all unrefuted outcome events in the PURE study database through March 31, 2017. Overall, combined mean fruit, vegetable and legume intake was 3.91 (SD 2.77) servings per day. During a median 7.4 years (5.5-9.3) of follow-up, 4784 major cardiovascular disease events, 1649 cardiovascular deaths, and 5796 total deaths were documented. Higher total fruit, vegetable, and legume intake was inversely associated with major cardiovascular disease, myocardial infarction, cardiovascular mortality, non-cardiovascular mortality, and total mortality in the models adjusted for age, sex, and centre (random effect). The estimates were substantially attenuated in the multivariable adjusted models for major cardiovascular disease (hazard ratio [HR] 0.90, 95% CI 0.74-1.10, p(trend) = 0.1301), myocardial infarction (0.99, 0.74-1.31;p(trend) = 0.2033), stroke (0.92, 0.67-1.25;p(trend) = 0.7092), cardiovascular mortality (0.73, 0.53-1.02; p(trend) = 0.0568), non-cardiovascular mortality (0.84, 0.68-1.04; p trend = 0.0038), and total mortality (0.81, 0.68-0.96; p(trend) < 0.0001). The HR for total mortality was lowest for three to four servings per day (0.78, 95% CI 0.69-0.88) compared with the reference group, with no further apparent decrease in HR with higher consumption. When examined separately, fruit intake was associated with lower risk of cardiovascular, non-cardiovascular, and total mortality, while legume intake was inversely associated with non-cardiovascular death and total mortality (in fully adjusted models). For vegetables, raw vegetable intake was strongly associated with a lower risk of total mortality, whereas cooked vegetable intake showed a modest benefit against mortality. Interpretation Higher fruit, vegetable, and legume consumption was associated with a lower risk of non-cardiovascular, and total mortality. Benefits appear to be maximum for both non-cardiovascular mortality and total mortality at three to four servings per day (equivalent to 375-500 g/day).	[Miller, Victoria; Mente, Andrew; Dehghan, Mahshid; Rangarajan, Sumathy; Zhang, Xiaohe; Bangdiwala, Shrikant I.; Teo, Koon; Anand, Sonia; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Swaminathan, Sumathi] St Johns Res Inst, Bangalore, Karnataka, India; [Dagenais, Gilles] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Laval, PQ, Canada; [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Dr Mohans Diabet Specialties Ctr, Chennai, Tamil Nadu, India; [Lear, Scott] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Schutte, Aletta E.; Wentzel-Viljoen, Edelweiss] North West Univ, South African Med Res Council, Potchefstroom, South Africa; [Avezum, Alvaro] Univ Santo Amaro, Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Altuntas, Yuksel] Istanbul Sisli Hamidiye Etfal Hlth Training & Res, Istanbul, Turkey; [Yusoff, Khalid] Univ Teknol MARA, Selayang, Selangor, Malaysia; [Yusoff, Khalid] UCSI Univ, Kuala Lumpur, Malaysia; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Fac Med, Dept Community Hlth, Kuala Lumpur, Malaysia; [Peer, Nasheeta] South African Med Res Council, Noncommunicable Dis Res Unit, Durban, South Africa; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Physiol Dept, Harare, Zimbabwe; [Diaz, Rafael] Estudios Clin Latinoamer ECLA, Rosaria, Argentina; [Rahman, Omar] Independent Univ, Dhaka, Bangladesh; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Lana, Fernando] Univ La Frontera, Temuco, Chile; [Zatonska, Katarzyna] Med Univ Wroclaw, Dept Social Med, Wroclaw, Poland; [Wielgosz, Andreas] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Yusufali, Afzalhussein] Dubai Hlth Author, Hatta Hosp, Dubai, U Arab Emirates; [Yusufali, Afzalhussein] Dubai Med Coll, Dubai, U Arab Emirates; [Iqbal, Romaina] Aga Khan Univ, Karachi, Pakistan; [Lopez-Jaramillo, Patricio] FOSCAL, Res Inst, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] UDES, MASIRA Inst, Med Studies, Bucaramanga, Colombia; [Khatib, Rasha] Stritch Sch Med, Publ Hlth Sci, Maywood, IL USA; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Kutty, V. Raman] Hlth Act People, Trivandrum, Kerala, India; [Li, Wei; Liu, Xiaoyun; Yin, Lu] Peking Union Med Coll, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp, Beijing, Peoples R China; [Li, Wei; Liu, Xiaoyun; Yin, Lu] Chinese Acad Med Sci, Beijing, Peoples R China; [Liu, Jiankang] Jianshe Rd Community Hlth Ctr, Chengdu, Sichuan, Peoples R China	McMaster University; Population Health Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; Laval University; Eternal Heart Care Centre & Research Institute; Madras Diabetes Research Foundation; Simon Fraser University; North West University - South Africa; South African Medical Research Council; Instituto Dante Pazzanese de Cardiologia; Universidade de Santo Amaro (UNISA); Istanbul Sisli Hamidiye Etfal Training & Research Hospital; UCSI University; Universiti Kebangsaan Malaysia; South African Medical Research Council; University of Zimbabwe; Independent University Bangladesh (IUB); Isfahan University Medical Science; Universidad de La Frontera; Wroclaw Medical University; University of Ottawa; Aga Khan University; Loyola University Chicago; University of Gothenburg; Sahlgrenska University Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Miller, V (corresponding author), McMaster Univ, DBCVS Res Inst, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	victoria.miller@phri.ca	Avezum, Alvaro/AAP-7687-2020; Seron, Pamela/AAN-3304-2021; Zatońska, Katarzyna/ABD-4236-2021; Lana-Moliner, Fernando/I-8832-2019; Mattos, Antonio/AAC-8318-2020; Suraya, Abdul-Razak/AAG-1206-2020; Kelishadi, Roya/E-6154-2012; Chifamba, Jephat/AHE-4535-2022; Yusoff, Khalid/I-7029-2019; Schutte, Aletta E/E-5126-2018; Khatib, Rasha/GXV-8883-2022; Swaminathan, Sumathi/AGI-7678-2022; Rahman, Omar/E-1329-2019; Mohammadifard, Noushin/M-2244-2018; Igumbor, Ehimario/B-2652-2012; Gomez-Arbelaez, Diego/K-1883-2013; Rozanska, Dorota/S-5239-2018; Ariffin, Farnaza/H-9725-2014; Mohd Tamil, Azmi/E-5259-2017; Kamalasanan, Ajayan/F-8785-2013; Swart, Elizabeth/O-9619-2014	Seron, Pamela/0000-0003-0190-8988; Lana-Moliner, Fernando/0000-0003-0257-7957; Mattos, Antonio/0000-0001-8420-098X; Suraya, Abdul-Razak/0000-0001-5376-2509; Kelishadi, Roya/0000-0001-7455-1495; Chifamba, Jephat/0000-0001-8166-1182; Yusoff, Khalid/0000-0001-5669-5188; Schutte, Aletta E/0000-0001-9217-4937; Rahman, Omar/0000-0002-0606-2507; Mohammadifard, Noushin/0000-0003-1776-1060; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Levitt, Naomi/0000-0001-6480-8066; Teo, Koon/0000-0002-3731-0956; Ismail, Noor Hassim/0000-0003-1547-7904; Bangdiwala, Shrikant/0000-0002-3111-0689; Yusufali, Afzalhussein/0000-0003-3378-2646; Igumbor, Ehimario/0000-0002-6313-6031; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Achilova, Diyora/0000-0002-7645-9497; Jerling, Johann/0000-0003-2600-3536; Choudhury, Tarzia/0000-0003-2472-9210; Rozanska, Dorota/0000-0002-0561-2749; Wolyniec, Maria/0000-0003-2054-1691; Peer, Nasheeta/0000-0003-2131-8344; AVEZUM, ALVARO/0000-0002-3073-6890; Lanas, Fernando/0000-0003-3595-9759; Ali, Mohammed/0000-0001-7266-2503; Regulska-Ilow, Bozena/0000-0002-5941-1715; Ariffin, Farnaza/0000-0002-7755-9289; Miller, Victoria/0000-0003-0509-1549; Mohd Tamil, Azmi/0000-0002-1657-3351; Kamalasanan, Ajayan/0000-0003-2389-250X; Tsolekile, Lungiswa/0000-0001-8597-141X; Zatonska, Katarzyna/0000-0002-3772-5588; Patro, Binod Kumar/0000-0003-0019-4522; Gulec, Sadi/0000-0002-2685-2522; Swart, Elizabeth/0000-0002-7786-3117; Rabbani, Khondkar/0000-0002-5642-4975; Dehghan, Mahshid/0000-0003-2149-847X; Szuba, Andrzej/0000-0002-7555-6201; Yusuf, Salim/0000-0003-4776-5601; Camacho, Paul Anthony/0000-0002-6233-9582	Heart & Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease; Population Health Research Institute; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario from CIHR's Strategy for Patient Oriented Research (SPOR) through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care; AstraZeneca (Canada); Sanofi-Aventis (France); Sanofi-Aventis (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GlaxoSmithkline; Novartis; King Pharma; Argentina: Fundacion ECLA; Bangladesh: Independent University, Bangladesh; Bangladesh: Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada; Canada: Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias [6566-04-18062]; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia [100 - IRDC/BIOTEK 16/6/21 (13/2007), 07-05-IFN-BPH 010]; Malaysia: Ministry of Higher Education of Malaysia [600 - RMI/LRGS/5/3 (2/2011)]; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research Development; Poland: Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Poland: Wroclaw Medical University; Saudi Arabia: the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia [RG-1436-013]; South Africa: the North-West University; South Africa: SANPAD (SA and Netherlands Programme for Alternative Development); South Africa: National Research Foundation; South Africa: Medical Research Council of SA; South Africa: SA Sugar Association (SASA; South Africa: Faculty of Community and Health Sciences (UWC); Sweden: Swedish state; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish Council for Health, Working Life and Welfare; King Gustaf V's and Queen Victoria Freemasons Foundation; AFA Insurance; Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish State; Lakar Utbildnings Avtalet agreement; Vastra Gataland Region; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca, Turkey; Turkey: Sanofi Aventis, Turkey; United Arab Emirates (UAE): Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai UAE	Heart & Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease; Population Health Research Institute; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario from CIHR's Strategy for Patient Oriented Research (SPOR) through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); AstraZeneca (Canada)(AstraZeneca); Sanofi-Aventis (France)(Sanofi-Aventis); Sanofi-Aventis (Canada)(Sanofi-Aventis); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); Servier(Servier); GlaxoSmithkline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Argentina: Fundacion ECLA; Bangladesh: Independent University, Bangladesh; Bangladesh: Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada; Canada: Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias; India: Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Malaysia: Ministry of Science, Technology and Innovation of Malaysia; Malaysia: Ministry of Higher Education of Malaysia; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia; occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada(CGIAR); Philippines: Philippine Council for Health Research Development; Poland: Polish Ministry of Science and Higher Education; Poland: Wroclaw Medical University; Saudi Arabia: the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia; South Africa: the North-West University; South Africa: SANPAD (SA and Netherlands Programme for Alternative Development); South Africa: National Research Foundation(National Research Foundation - South Africa); South Africa: Medical Research Council of SA; South Africa: SA Sugar Association (SASA; South Africa: Faculty of Community and Health Sciences (UWC); Sweden: Swedish state; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Health, Working Life and Welfare; King Gustaf V's and Queen Victoria Freemasons Foundation; AFA Insurance; Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish State; Lakar Utbildnings Avtalet agreement; Vastra Gataland Region; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca, Turkey; Turkey: Sanofi Aventis, Turkey; United Arab Emirates (UAE): Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai UAE	SY is supported by the Heart & Stroke Foundation/Marion W. Burke Chair in Cardiovascular Disease. The PURE Study is an investigatorinitiated study funded by the Population Health Research Institute, the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Ontario, support from CIHR's Strategy for Patient Oriented Research (SPOR) through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithkline, and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries; these include: Argentina: Fundacion ECLA; Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias, grant number 6566-04-18062; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia, grant numbers 100 - IRDC/BIOTEK 16/6/21 (13/2007) and 07-05-IFN-BPH 010, Ministry of Higher Education of Malaysia grant number 600 - RMI/LRGS/5/3 (2/2011), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); occupied Palestinian territory: the UN Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory; International Development Research Centre, Canada; Philippines: Philippine Council for Health Research & Development; Poland: Polish Ministry of Science and Higher Education grant number 290/W-PURE/2008/0, Wroclaw Medical University; Saudi Arabia: the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (research group number RG-1436-013); South Africa: the North-West University, SANPAD (SA and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of SA, The SA Sugar Association (SASA), Faculty of Community and Health Sciences (UWC); Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V's and Queen Victoria Freemasons Foundation, AFA Insurance, Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, grant from the Swedish State under the Lakar Utbildnings Avtalet agreement, and grant from the Vastra Gataland Region; Turkey: Metabolic Syndrome Society, AstraZeneca, Turkey, Sanofi Aventis, Turkey; United Arab Emirates (UAE): Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai UAE.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Agudo A., 2004, MEASURING INTAKE FRU; Akibode S, 2011, GLOBAL REGIONAL TREN; Anderson JW, 2002, BRIT J NUTR, V88, pS263, DOI [10.1079/BJN.2002716, 10.1079/BJN2002716]; ANDERSON JW, 1995, METABOLISM, V44, P848, DOI 10.1016/0026-0495(95)90236-8; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Asplund K, 2002, J INTERN MED, V251, P372, DOI 10.1046/j.1365-2796.2002.00973.x; Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; Bharathi AV, 2008, ASIA PAC J CLIN NUTR, V17, P178; Nguyen B, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0334-5; Buil-Cosiales P, 2016, BRIT J NUTR, V116, P534, DOI 10.1017/S0007114516002099; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Dehghan M, 2013, PUBLIC HEALTH NUTR, V16, P1782, DOI 10.1017/S1368980012004107; Dehghan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037958; Dehghan M, 2012, J NUTR EDUC BEHAV, V44, P609, DOI 10.1016/j.jneb.2010.10.001; Dehghan M, 2009, SAUDI MED J, V30, P159; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Eichholzer M, 2001, INT J VITAM NUTR RES, V71, P5, DOI 10.1024/0300-9831.71.1.5; Gunes FE, 2015, J PAK MED ASSOC, V65, P756; Iqbal R, 2009, PUBLIC HEALTH NUTR, V12, P12, DOI 10.1017/S1368980008001845; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Kabagambe EK, 2005, J NUTR, V135, P1770, DOI 10.1093/jn/135.7.1770; Key TJA, 1996, BMJ-BRIT MED J, V313, P775, DOI 10.1136/bmj.313.7060.775; Larsson SC, 2013, ATHEROSCLEROSIS, V227, P147, DOI 10.1016/j.atherosclerosis.2012.12.022; Leenders M, 2013, AM J EPIDEMIOL, V178, P590, DOI 10.1093/aje/kwt006; LEFER AM, 1990, CIRCULATION, V81, P2013, DOI 10.1161/01.CIR.81.6.2013; Link LB, 2004, CANCER EPIDEM BIOMAR, V13, P1422; Mahajan R, 2013, NATL MED J INDIA, V26, P266; Merchant AT, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-37; Micha R, RED PROCESSED MEAT C; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Miller V, 2016, LANCET GLOB HEALTH, V4, pE695, DOI 10.1016/S2214-109X(16)30186-3; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; National Nutrition Council, 2011, DIET REC IMPR PUBL H; Oude Griep LM, 2011, EUR J CLIN NUTR, V65, P791, DOI 10.1038/ejcn.2011.36; Painter J, 2002, J AM DIET ASSOC, V102, P483, DOI 10.1016/S0002-8223(02)90113-6; RIPSIN CM, 1992, JAMA-J AM MED ASSOC, V267, P3317, DOI 10.1001/jama.267.24.3317; Rock CL, 1998, J NUTR, V128, P913, DOI 10.1093/jn/128.5.913; Sharma S, 2013, J AM COLL NUTR, V32, P151, DOI 10.1080/07315724.2013.791798; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Whelton PK, 1997, JAMA-J AM MED ASSOC, V277, P1624, DOI 10.1001/jama.277.20.1624; WHO, 1990, WHO TECHNICAL REPORT; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang XL, 2011, AM J CLIN NUTR, V94, P240, DOI 10.3945/ajcn.110.009340	50	308	322	11	118	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2037	2049		10.1016/S0140-6736(17)32253-5	http://dx.doi.org/10.1016/S0140-6736(17)32253-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FL5DD	28864331	hybrid, Green Published			2022-12-28	WOS:000414250800021
J	Toledo, E; Martinez-Gonzalez, MA				Toledo, Estefania; Martinez-Gonzalez, Miguel A.			Fruits, vegetables, and legumes: sound prevention tools	LANCET			English	Editorial Material							NUTRITIONAL EPIDEMIOLOGY		[Toledo, Estefania; Martinez-Gonzalez, Miguel A.] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona 31008, Spain; [Toledo, Estefania; Martinez-Gonzalez, Miguel A.] Ctr Invest Biomed Red Area Fisiopatol Obesidad &, Madrid, Spain; [Toledo, Estefania; Martinez-Gonzalez, Miguel A.] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Martinez-Gonzalez, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Harvard University; Harvard T.H. Chan School of Public Health	Toledo, E (corresponding author), Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona 31008, Spain.; Toledo, E (corresponding author), Ctr Invest Biomed Red Area Fisiopatol Obesidad &, Madrid, Spain.; Toledo, E (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.	etoledo@unav.es	Toledo, Estefania/H-6211-2014; Martinez-Gonzalez, Miguel A./AAE-7669-2019	Toledo, Estefania/0000-0002-6263-4434; 				Aune D, 2017, INT J EPIDEMIOL, V46, P1029, DOI 10.1093/ije/dyw319; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Miller V, 2017, LANCET; Satija A, 2017, J AM COLL CARDIOL, V70, P411, DOI 10.1016/j.jacc.2017.05.047; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; World Health Organization, CARDIOVASCULAR DIS	6	6	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2017	2018		10.1016/S0140-6736(17)32251-1	http://dx.doi.org/10.1016/S0140-6736(17)32251-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FL5DD	28864333				2022-12-28	WOS:000414250800004
J	Cardemil, CV; Dahl, RM; James, L; Wannemuehler, K; Gary, HE; Shah, M; Marin, M; Riley, J; Feikin, DR; Patel, M; Quinlisk, P				Cardemil, Cristina V.; Dahl, Rebecca M.; James, Lisa; Wannemuehler, Kathleen; Gary, Howard E.; Shah, Minesh; Marin, Mona; Riley, Jacob; Feikin, Daniel R.; Patel, Manisha; Quinlisk, Patricia			Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RUBELLA VACCINE; UNITED-STATES; MEASLES; PERSISTENCE; UNIVERSITY; POPULATION; ANTIBODIES; STUDENTS; COVERAGE; IMPACT	BACKGROUND The effect of a third dose of the measles-mumps-rubella (MMR) vaccine in stemming a mumps outbreak is unknown. During an outbreak among vaccinated students at the University of Iowa, health officials implemented a widespread MMR vaccine campaign. We evaluated the effectiveness of a third dose for outbreak control and assessed for waning immunity. METHODS Of 20,496 university students who were enrolled during the 2015-2016 academic year, mumps was diagnosed in 259 students. We used Fisher's exact test to compare unadjusted attack rates according to dose status and years since receipt of the second MMR vaccine dose. We used multivariable time-dependent Cox regression models to evaluate vaccine effectiveness, according to dose status (three vs. two doses and two vs. no doses) after adjustment for the number of years since the second dose. RESULTS Before the outbreak, 98.1% of the students had received at least two doses of MMR vaccine. During the outbreak, 4783 received a third dose. The attack rate was lower among the students who had received three doses than among those who had received two doses (6.7 vs. 14.5 cases per 1000 population, P<0.001). Students had more than nine times the risk of mumps if they had received the second MMR dose 13 years or more before the outbreak. At 28 days after vaccination, receipt of the third vaccine dose was associated with a 78.1% lower risk of mumps than receipt of a second dose (adjusted hazard ratio, 0.22; 95% confidence interval, 0.12 to 0.39). The vaccine effectiveness of two doses versus no doses was lower among students with more distant receipt of the second vaccine dose. CONCLUSIONS Students who had received a third dose of MMR vaccine had a lower risk of mumps than did those who had received two doses, after adjustment for the number of years since the second dose. Students who had received a second dose of MMR vaccine 13 years or more before the outbreak had an increased risk of mumps. These findings suggest that the campaign to administer a third dose of MMR vaccine improved mumps outbreak control and that waning immunity probably contributed to propagation of the outbreak. (Funded by the Centers for Disease Control and Prevention.)	[Cardemil, Cristina V.; Wannemuehler, Kathleen; Gary, Howard E.; Shah, Minesh; Marin, Mona; Feikin, Daniel R.; Patel, Manisha] Ctr Dis Control & Prevent, 1600 Clifton Rd NE, Atlanta, GA 30333 USA; [Dahl, Rebecca M.] Maximus Fed, Falls Church, VA USA; [James, Lisa] Univ Iowa, Iowa City, IA 52242 USA; [Riley, Jacob] Johnson Cty Publ Hlth, Iowa City, IA USA; [Quinlisk, Patricia] Iowa Dept Publ Hlth, Des Moines, IA 50319 USA	Centers for Disease Control & Prevention - USA; University of Iowa	Cardemil, CV (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE, Atlanta, GA 30333 USA.	iyk8@cdc.gov		Wannemuehler, Kathleen/0000-0001-9535-6277; Shah, Minesh/0000-0001-9117-5006; Riley, Jacob/0000-0003-3741-1930	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the Centers for Disease Control and Prevention.	Albertson JP, 2016, MMWR-MORBID MORTAL W, V65, P731, DOI 10.15585/mmwr.mm6529a2; [Anonymous], 2011, MMWR-MORBID MORTAL W, V61, P986; Barskey AE, 2012, NEW ENGL J MED, V367, P1704, DOI 10.1056/NEJMoa1202865; Barskey AE, 2009, VACCINE, V27, P6186, DOI 10.1016/j.vaccine.2009.06.109; Cohen C, 2007, EMERG INFECT DIS, V13, P12; Cortese MM, 2008, CLIN INFECT DIS, V46, P1172, DOI 10.1086/529141; Date AA, 2008, J INFECT DIS, V197, P1662, DOI 10.1086/588197; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; Dayan GH, 2008, CLIN INFECT DIS, V47, P1458, DOI 10.1086/591196; Deeks SL, 2011, CAN MED ASSOC J, V183, P1014, DOI 10.1503/cmaj.101371; Fiebelkorn AP, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu094; Fiebelkorn AP, 2012, MANUAL SURVEILLANCE, P1; Harling R, 2005, VACCINE, V23, P4070, DOI 10.1016/j.vaccine.2004.10.020; Kutty PK, 2014, HUM VACC IMMUNOTHER, V10, P1373, DOI 10.4161/hv.28389; LeBaron CW, 2009, J INFECT DIS, V199, P552, DOI 10.1086/596207; Mahamud A, 2012, VACCINE, V30, P6444, DOI 10.1016/j.vaccine.2012.08.001; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Nelson GE, 2013, PEDIATR INFECT DIS J, V32, P374, DOI 10.1097/INF.0b013e318279f593; Ogbuanu IU, 2012, PEDIATRICS, V130, pE1567, DOI 10.1542/peds.2012-0177; Reagan-Steiner S, 2016, MMWR-MORBID MORTAL W, V65, P850, DOI 10.15585/mmwr.mm6533a4; Rubin S, 2016, PEDIATR INFECT DIS J, V35, P799, DOI 10.1097/INF.0000000000001182; Schaffzin JK, 2007, PEDIATRICS, V120, pE862, DOI 10.1542/peds.2006-3451; Shah M, 2016, OPEN FORUM INFECT S1, V3, P1425; Snijders BEP, 2012, VACCINE, V30, P2999, DOI 10.1016/j.vaccine.2012.02.035; Vygen S, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.10.30156	26	104	111	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					947	956		10.1056/NEJMoa1703309	http://dx.doi.org/10.1056/NEJMoa1703309			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF9XU	28877026	Bronze, Green Accepted			2022-12-28	WOS:000409373100008
J	Chomet, P; Martienssen, R				Chomet, Paul; Martienssen, Rob			Barbara McClintock's Final Years as Nobelist and Mentor: A Memoir	CELL			English	Editorial Material							ZEA-MAYS; MAIZE; TRANSPOSITION; CHROMOSOMES; DS	September 2, 2017, marks the 25th year after the passing of Dr. Barbara McClintock, geneticist and recipient of the 1983 Nobel Prize in Physiology or Medicine for her discovery of transposable elements in maize. This memoir focuses on the last years of her life-after the prize-and includes personal recollections of how she mentored young scientists and inspired the age of genetics, epigenetics, and genomics.	[Chomet, Paul] NRGene, 20 South Sarah St, St Louis, MO 63108 USA; [Martienssen, Rob] Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Martienssen, R (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu			NIGMS NIH HHS [R01 GM067014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKAN A, 1991, P NATL ACAD SCI USA, V88, P3502, DOI 10.1073/pnas.88.8.3502; Creighton HB, 1931, P NATL ACAD SCI USA, V17, P492, DOI 10.1073/pnas.17.8.492; FEDOROFF N, 1983, CELL, V35, P235, DOI 10.1016/0092-8674(83)90226-X; KLAR AJS, 1979, P NATL ACAD SCI USA, V76, P4539, DOI 10.1073/pnas.76.9.4539; McClintock B, 1938, GENETICS, V23, P315; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCLINTOCK B, 1948, CARNEGIE I WASH, V47, P155; McClintock B, 1929, SCIENCE, V69, P629, DOI 10.1126/science.69.1798.629; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; McClintock B, 1941, GENETICS, V26, P234; WEIL CF, 1992, GENETICS, V130, P175	11	0	0	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1049	1054		10.1016/j.cell.2017.08.040	http://dx.doi.org/10.1016/j.cell.2017.08.040			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886375	Bronze			2022-12-28	WOS:000409536000002
J	Israel, E; Reddel, HK				Israel, Elliot; Reddel, Helen K.			Severe and Difficult-to-Treat Asthma in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							UNCONTROLLED PERSISTENT ASTHMA; DOUBLE-BLIND; REFRACTORY ASTHMA; CXCR2 ANTAGONIST; CLUSTER-ANALYSIS; PHENOTYPES; SAFETY; MEPOLIZUMAB; EFFICACY; INFLAMMATION		[Israel, Elliot] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Pulm & Crit Care Med Div, 75 Francis St, Boston, MA 02115 USA; [Israel, Elliot] Harvard Med Sch, Boston, MA USA; [Reddel, Helen K.] Univ Sydney, Woolcock Inst Med Res, Clin Management Grp, Sydney, NSW, Australia; [Reddel, Helen K.] Univ Sydney, Woolcock Inst Med Res, Ctr Res Excellence Severe Asthma, Sydney, NSW, Australia	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Woolcock Institute of Medical Research	Israel, E (corresponding author), Brigham & Womens Hosp, Pulm & Crit Care Med Div, 75 Francis St, Boston, MA 02115 USA.	eisrael@partners.org	Reddel, Helen/AAC-3394-2020; Reddel, Helen/ABD-6338-2021	Reddel, Helen/0000-0002-6695-6350; 	AstraZeneca; Cowen Co.; Philips Respironics; Regeneron; Teva Specialty Pharmaceuticals; Bird Rock Bio; Nuvelution Pharmaceutical; Vitaeris; Entrinsic Health Solutions; Merck; Sanofi; Novartis; Genentech; Boehringer Ingelheim; GlaxoSmithKline; Sunovion; Mundipharma; Teva	AstraZeneca(AstraZeneca); Cowen Co.; Philips Respironics; Regeneron(Regeneron); Teva Specialty Pharmaceuticals(Teva Pharmaceutical Industries); Bird Rock Bio; Nuvelution Pharmaceutical(Johnson & Johnson); Vitaeris; Entrinsic Health Solutions; Merck(Merck & Company); Sanofi; Novartis(Novartis); Genentech(Roche HoldingGenentech); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Sunovion; Mundipharma; Teva(Teva Pharmaceutical Industries)	Dr. Israel reports receiving consulting fees from AstraZeneca, Cowen & Co., Philips Respironics, Regeneron, Teva Specialty Pharmaceuticals, Bird Rock Bio, Nuvelution Pharmaceutical, Vitaeris, Entrinsic Health Solutions, Merck, Sanofi, and Novartis; receiving grant support from Genentech, Boehringer Ingelheim, GlaxoSmithKline, Merck, Sunovion and Sanofi; receiving travel support from Teva Specialty Pharmaceuticals; and serving on a data and safety monitoring board for Novartis. Dr. Reddel reports receiving fees from GlaxoSmithKline for serving on a data and safety monitoring board and an advisory board and for independent medical education; receiving grant support, advisory board fees, and study medication, provided to her institution, from GlaxoSmithKline; receiving fees from AstraZeneca for serving on a data and safety monitoring board and an advisory board and for independent medical education; receiving advisory board fees, steering committee fees, fees for independent medical education, grant support, and medical editing and graphics support, paid to her institution, from AstraZeneca; and receiving fees for serving on a data and safety monitoring board from Merck, fees for serving on a data and safety monitoring board and an advisory board from Novartis, fees for participation as symposium chair, paid to her institution, from Novartis, fees for independent medical education and advisory board fees from Boehringer Ingelheim, and fees for independent medical education from Mundipharma and Teva. No other potential conflict of interest relevant to this article was reported.	Amelink M, 2013, ALLERGY, V68, P674, DOI 10.1111/all.12136; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Brusselle GG, 2013, NAT MED, V19, P977, DOI 10.1038/nm.3300; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Canonica GW, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0130-3; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Desai D, 2013, AM J RESP CRIT CARE, V188, P657, DOI 10.1164/rccm.201208-1470OC; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gerald JK, 2015, J ALLER CL IMM-PRACT, V3, P957, DOI 10.1016/j.jaip.2015.06.021; Gibeon D, 2015, CHEST, V148, P870, DOI 10.1378/chest.14-3056; Gibson PG, 2017, LANCET; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042; Hanania NA, 2015, THORAX, V70, P748, DOI 10.1136/thoraxjnl-2014-206719; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Heaney LG, 2003, THORAX, V58, P561, DOI 10.1136/thorax.58.7.561; Hekking PPW, 2015, J ALLERGY CLIN IMMUN, V135, P896, DOI 10.1016/j.jaci.2014.08.042; Hyland ME, 2015, QUAL LIFE RES, V24, P631, DOI 10.1007/s11136-014-0801-x; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kuo CHS, 2017, AM J RESP CRIT CARE, V195, P443, DOI 10.1164/rccm.201512-2452OC; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Loza MJ, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0482-9; McNicholl DM, 2012, AM J RESP CRIT CARE, V186, P1102, DOI 10.1164/rccm.201204-0587OC; Molfino NA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007709; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Newby C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102987; Normansell R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub4; O'Byrne PM, 2016, LANCET RESP MED, V4, P797, DOI 10.1016/S2213-2600(16)30227-2; O'Neill S, 2015, THORAX, V70, P376, DOI 10.1136/thoraxjnl-2013-204114; Ortega HG, 2016, LANCET RESP MED, V4, P549, DOI 10.1016/S2213-2600(16)30031-5; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Radhakrishna N, 2017, J ASTHMA, V54, P294, DOI 10.1080/02770903.2016.1212369; Sadatsafavi M, 2010, CAN RESPIR J, V17, P74, DOI 10.1155/2010/361071; ten Brinke A, 2001, AM J RESP CRIT CARE, V163, P1093, DOI 10.1164/ajrccm.163.5.2004020; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; van der Meer AN, 2016, EUR RESPIR J, V48, P726, DOI 10.1183/13993003.00220-2016; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042	49	247	280	2	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					965	976		10.1056/NEJMra1608969	http://dx.doi.org/10.1056/NEJMra1608969			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF9XU	28877019				2022-12-28	WOS:000409373100010
J	Kesimer, M; Ford, AA; Ceppe, A; Radicioni, G; Cao, R; Davis, CW; Doerschuk, CM; Alexis, NE; Anderson, WH; Henderson, AG; Barr, RG; Bleecker, ER; Christenson, SA; Cooper, CB; Han, MK; Hansel, NN; Hastie, AT; Hoffman, EA; Kanner, RE; Martinez, F; Paine, R; Woodruff, PG; O'Neal, WK; Boucher, RC				Kesimer, Mehmet; Ford, Amina A.; Ceppe, Agathe; Radicioni, Giorgia; Cao, Rui; Davis, C. William; Doerschuk, Claire M.; Alexis, Neil E.; Anderson, Wayne H.; Henderson, Ashley G.; Barr, R. Graham; Bleecker, Eugene R.; Christenson, Stephanie A.; Cooper, Christopher B.; Han, MeiLan K.; Hansel, Nadia N.; Hastie, Annette T.; Hoffman, Eric A.; Kanner, Richard E.; Martinez, Fernando; Paine, Robert, III; Woodruff, Prescott G.; O'Neal, Wanda K.; Boucher, Richard C.			Airway Mucin Concentration as a Marker of Chronic Bronchitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC MUCUS HYPERSECRETION; SMOKING-CESSATION; OSMOTIC-PRESSURE; COPD; SMOKERS; MUC5AC; ASTHMA; PATHOPHYSIOLOGY; INFLAMMATION	BACKGROUND Chronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitic and emphysematous components. In one biophysical model, the concentration of mucin on the airway surfaces is hypothesized to be a key variable that controls mucus transport in healthy persons versus cessation of transport in persons with muco-obstructive lung diseases. Under this model, it is postulated that a high mucin concentration produces the sputum and disease progression that are characteristic of chronic bronchitis. METHODS We characterized the COPD status of 917 participants from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) using questionnaires administered to participants, chest tomography, spirometry, and examination of induced sputum. Total mucin concentrations in sputum were measured with the use of size-exclusion chromatography and refractometry. In 148 of these participants, the respiratory secreted mucins MUC5AC and MUC5B were quantitated by means of mass spectrometry. Data from chronic-bronchitis questionnaires and data on total mucin concentrations in sputum were also analyzed in an independent 94-participant cohort. RESULTS Mean (+/- SE) total mucin concentrations were higher in current or former smokers with severe COPD than in controls who had never smoked (3166 +/- 402 vs. 1515 +/- 152 mu g per milliliter) and were higher in participants with two or more respiratory exacerbations per year than in those with zero exacerbations (4194 +/- 878 vs. 2458 +/- 113 mu g per milliliter). The absolute concentrations of MUC5B and MUC5AC in current or former smokers with severe COPD were approximately 3 times as high and 10 times as high, respectively, as in controls who had never smoked. Receiver-operating-characteristic curve analysis of the association between total mucin concentration and a diagnosis of chronic bronchitis yielded areas under the curve of 0.72 (95% confidence interval [CI], 0.65 to 0.79) for the SPIROMICS cohort and 0.82 (95% CI, 0.73 to 0.92) for the independent cohort. CONCLUSIONS Airway mucin concentrations may quantitate a key component of the chronic bronchitis pathophysiologic cascade that produces sputum and mediates disease severity. Studies designed to explore total mucin concentrations in sputum as a diagnostic biomarker and therapeutic target for chronic bronchitis appear to be warranted. (Funded by the National Heart, Lung, and Blood Institute and others.)	[Kesimer, Mehmet; Ford, Amina A.; Ceppe, Agathe; Radicioni, Giorgia; Cao, Rui; Davis, C. William; Doerschuk, Claire M.; Alexis, Neil E.; Anderson, Wayne H.; Henderson, Ashley G.; O'Neal, Wanda K.; Boucher, Richard C.] Univ North Carolina Chapel Hill, Marsico Lung Inst, Chapel Hill, NC USA; [Bleecker, Eugene R.; Hastie, Annette T.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Barr, R. Graham] Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Martinez, Fernando] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Christenson, Stephanie A.; Woodruff, Prescott G.] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA; [Cooper, Christopher B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Physiol, Los Angeles, CA 90095 USA; [Han, MeiLan K.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Hoffman, Eric A.] Univ Iowa Hosp & Clin, Dept Radiol, Div Physiol Imaging, Iowa City, IA 52242 USA; [Kanner, Richard E.; Paine, Robert, III] Univ Utah, Dept Med, Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Salt Lake City, UT 84112 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Wake Forest University; Columbia University; Columbia University; Cornell University; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; Johns Hopkins University; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Kesimer, M (corresponding author), Univ N Carolina, Cyst Fibrosis Ctr, Marsico Lung Inst, 7111 Marsico Hall, Chapel Hill, NC 27599 USA.	kesimer@med.unc.edu	Facility, Biospecimen Processing/AAC-7837-2022; , Mehmet Kesimer/AHB-9223-2022	Hoffman, Eric/0000-0001-8456-9437	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL120100, K24HL137013, R01HL110906, R01HL103940, P01HL108808, U01HL137880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Heart, Lung, and Blood Institute and others.	Allinson JP, 2016, AM J RESP CRIT CARE, V193, P662, DOI 10.1164/rccm.201511-2210OC; Anderson WH, 2015, AM J RESP CRIT CARE, V192, P182, DOI 10.1164/rccm.201412-2230OC; Bonser LR, 2016, J CLIN INVEST, V126, P2367, DOI 10.1172/JCI84910; Borchers MT, 1998, AM J PHYSIOL-LUNG C, V274, pL573, DOI 10.1152/ajplung.1998.274.4.L573; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Fletcher CM, 1976, NATURAL HIST CHRONIC; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Hoffman Eric A, 2014, Ann Am Thorac Soc, V11, P898, DOI 10.1513/AnnalsATS.201310-364OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Kesimer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138988; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kim V, 2016, ANN AM THORAC SOC, V13, P1016, DOI 10.1513/AnnalsATS.201512-800OC; Kim V, 2015, ANN AM THORAC SOC, V12, P332, DOI 10.1513/AnnalsATS.201411-518OC; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Kirkham S, 2008, AM J RESP CRIT CARE, V178, P1033, DOI 10.1164/rccm.200803-391OC; Kumbhare S, 2016, ANN AM THORAC SOC, V13, P803, DOI 10.1513/AnnalsATS.201508-554OC; Lachowicz-Scroggins ME, 2016, AM J RESP CRIT CARE, V194, P1296; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Livraghi-Butrico A, 2017, MUCOSAL IMMUNOL, V10, P395, DOI 10.1038/mi.2016.63; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Rogers DF, 2007, RESP CARE, V52, P1134; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971	36	194	203	10	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					911	922		10.1056/NEJMoa1701632	http://dx.doi.org/10.1056/NEJMoa1701632			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF9XU	28877023	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000409373100005
J	Snyder, EY				Snyder, Evan Y.			Finding a new purpose for old drugs	SCIENCE			English	Editorial Material							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; PHOSPHORYLATION; DOPAMINE		[Snyder, Evan Y.] Univ Calif San Diego, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Snyder, Evan Y.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Snyder, EY (corresponding author), Univ Calif San Diego, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.; Snyder, EY (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA.	esnyder@sbp.edu						Butler B, 2012, TRANSL NEUROSCI, V3, P249, DOI 10.2478/s13380-012-0036-7; Emamzadeh FN, 2016, J RES MED SCI, V21, P165, DOI 10.4103/1735-1995.181989; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; Farah BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098155; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Mittal S, 2017, SCIENCE, V357, P891, DOI 10.1126/science.aaf3934; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Xu Y, 2015, J NEUROCHEM, V135, P4, DOI 10.1111/jnc.13234	12	5	5	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					869	870		10.1126/science.aao2992	http://dx.doi.org/10.1126/science.aao2992			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2NU	28860370				2022-12-28	WOS:000408734900024
J	Clarke, R				Clarke, Rachel			The professor and the politician	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Aylin P., 2016, WEEKEND GRAVITY WAVE; Craven D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6358; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; Hawking S., 2017, NHS SAVED ME SCI MUS; Nasser T, 2016, EVIDENCE NHS WEEKEND; Slawson N, 2017, JEREMY HUNT ACCUSES	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2017	358								j3972	10.1136/bmj.j3972	http://dx.doi.org/10.1136/bmj.j3972			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF1ST	28838959				2022-12-28	WOS:000408679900001
J	Sax, PE; Pozniak, A; Montes, ML; Koenig, E; DeJesus, E; Stellbrink, HJ; Antinori, A; Workowski, K; Slim, J; Reynes, J; Garner, W; Custodio, J; White, K; SenGupta, D; Cheng, A; Quirk, E				Sax, Paul E.; Pozniak, Anton; Montes, M. Luisa; Koenig, Ellen; DeJesus, Edwin; Stellbrink, Hans-Juergen; Antinori, Andrea; Workowski, Kimberly; Slim, Jihad; Reynes, Jacques; Garner, Will; Custodio, Joseph; White, Kirsten; SenGupta, Devi; Cheng, Andrew; Quirk, Erin			Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial	LANCET			English	Article							STRAND TRANSFER INHIBITOR; ANTIVIRAL ACTIVITY; RESISTANCE; REGIMENS; ADULTS	Background Integra se strand transfer inhibitors (INSTIs) coadministered with two nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs) are recommended as first-line treatment for HIV, and coformulated fixed-dose combinations are preferred to facilitate adherence. We report 48-week results from a study comparing initial HIV-1 treatment with bictegravir-a novel INSTI with a high in-vitro barrier to resistance and low potential as a perpetrator or victim of clinically relevant drug interactions-coformulated with the NRTI combination emtricitabine and tenofovir alafenamide as a fixed-dose combination to dolutegravir administered with coformulated emtricitabine and tenofovir alafenamide. Methods In this randomised, double-blind, multicentre, placebo-controlled, non-inferiority trial, HIV-infected adults were screened and enrolled at 126 outpatient centres in 10 countries in Australia, Europe, Latin America, and North America. Participants were previously untreated adults (HIV-1 RNA >= 500 copies per mL) with estimated glomerular filtration rate of at least 30 mL/min. Chronic hepatitis B virus or hepatitis C co-infection was allowed. We randomly assigned participants (1:1) to receive oral fixed-dose combination bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg or dolutegravir 50 mg with coformulated emtricitabine 200 mg and tenofovir alafenamide 25 mg, with matching placebo, once a day for 144 weeks. Investigators, participants, study staff, and those assessing outcomes were masked to treatment group. All participants who received at least one dose of study drug were included in primary efficacy and safety analyses. The primary endpoint was the proportion of participants with plasma HIV-1 RNA of less than 50 copies per mL at week 48 (US Food and Drug Administration snapshot algorithm), with a prespecified non-inferiority margin of -12%. This study is registered with ClinicalTrials.gov, number NCT02607956. Findings Between Nov 11, 2015, and July 15, 2016, 742 participants were screened for eligibility, of whom 657 were randomly assigned to treatment (327 with bictegravir, emtricitabine, and tenofovir alafenamide fixed-dose combination [bictegravir group] and 330 with dolutegravir plus emtricitabine and tenofovir alafenamide [dolutegravir group]). 320 participants who received the bictegravir regimen and 325 participants who received the dolutegravir regimen were included in the primary efficacy analyses. At week 48, HIV-1 RNA <50 copies per mL was achieved in 286 (89%) of 320 participants in the bictegravir group and 302 (93%) of 325 in the dolutegravir group (difference -3.5%, 95.002% CI -7.9 to 1.0, p=0.12), showing non-inferiority of the bictegravir regimen to the dolutegravir regimen. No treatment-emergent resistance to any study drug was observed. Incidence and severity of adverse events were similar between groups, and few participants discontinued treatment due to adverse events (5 [2%] of 320 in the bictegravir group and 1 [<1%] 325 in the dolutegravir group). Study drug-related adverse events were less common in the bictegravir group than in the dolutegravir group (57 [18%] of 320 vs 83 [26%] of 325, p=0.022). Interpretation At 48 weeks, virological suppression with the bictegravir regimen was achieved and was non-inferior to the dolutegravir regimen in previously untreated adults. There was no emergent resistance to either regimen. The fixed-dose combination of bictegravir, emtricitabine, and tenofovir alafenamide was safe and well tolerated compared with the dolutegravir regimen.	[Sax, Paul E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Pozniak, Anton] Chelsea & Westminster Hosp NHS Fdn Trust, Imperial Coll, London, England; [Montes, M. Luisa] Hosp Univ La Paz, Madrid, Spain; [Koenig, Ellen] IDEV, Santo Domingo, Dominican Rep; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Stellbrink, Hans-Juergen] ICH Study Ctr, Hamburg, Germany; [Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy; [Workowski, Kimberly] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Slim, Jihad] St Michaels Hosp, Newark, NJ USA; [Reynes, Jacques] Montpellier Univ Hosp, Dept Infect Dis, Montpellier, France; [Custodio, Joseph; White, Kirsten; SenGupta, Devi; Cheng, Andrew; Quirk, Erin] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Harvard University; Brigham & Women's Hospital; Imperial College London; Hospital Universitario La Paz; Orlando Immunology Center; IRCCS Lazzaro Spallanzani; Emory University; Universite de Montpellier; CHU de Montpellier; Gilead Sciences	SenGupta, D (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	devi.sengupta@gilead.com	Antinori, Andrea/K-7125-2016; Ramirez, Maria Luisa Montes/H-8065-2017	Antinori, Andrea/0000-0003-2121-4684; Ramirez, Maria Luisa Montes/0000-0003-1748-813X; cheng, andrew/0000-0002-1121-8051	Gilead Sciences Inc.	Gilead Sciences Inc.(Gilead Sciences)	Gilead Sciences Inc.	[Anonymous], 2016, GENVOYA ELV COB EMTR; [Anonymous], 2016, VIVIREAD TEN DIS FUM; [Anonymous], 2016, ASM MICROBE; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; European AIDS Clinical Society, 2015, GUID VERS 8 0; [Food and Drug Administration US Department of Health and Human Services], 1998, GUID IND ICH E9 STAT; Fulcher JA, C RETR OPP INF SEATT; Gallant J, 2017, LANCET; Gallant JE, 2017, JAIDS-J ACQ IMM DEF, V75, P61, DOI [10.1097/QAI.0000000000001306, 10.1097/qai.0000000000001306]; Gunthard HF, 2016, JAMA-J AM MED ASSOC, V316, P191, DOI 10.1001/jama.2016.8900; Jones G, 2016, ASM MICROBE; Lennox JL, 2014, ANN INTERN MED, V161, P461, DOI 10.7326/M14-1084; Lepik KJ, 2017, AIDS, V31, P1425, DOI 10.1097/QAD.0000000000001494; Sax PE, 2017, LANCET HIV, V4, pE154, DOI 10.1016/S2352-3018(17)30016-4; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Squires K, 2016, LANCET HIV, V3, pE410, DOI 10.1016/S2352-3018(16)30016-9; Tsiang M, 2016, ANTIMICROB AGENTS CH, V60, P7086, DOI 10.1128/AAC.01474-16; U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; U.S. Food and Drug Administration (FDA) Guidance, 2015, HUM IMM VIR 1 INF DE; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; White K, 2016, HIV DRUG THERAPY; White KL, C RETR OPPINF SEATTL	22	160	167	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2073	2082		10.1016/S0140-6736(17)32340-1	http://dx.doi.org/10.1016/S0140-6736(17)32340-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FL5DD	28867499				2022-12-28	WOS:000414250800024
J	Shultz, JM; Galea, S				Shultz, James M.; Galea, Sandro			Mitigating the Mental and Physical Health Consequences of Hurricane Harvey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EPIDEMIOLOGY; DISASTERS; KATRINA		[Shultz, James M.] Univ Miami, Miller Sch Med, Donald Soffer Clin Res Ctr, Miami, FL 33136 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA	University of Miami; Boston University	Shultz, JM (corresponding author), Donald Soffer Clin Res Ctr, Rm 926,1120 NW 14 St, Miami, FL 33136 USA.	jshultz1@med.miami.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945				Department of Health, 2013, BETT CAR FUND; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; McLaughlin EC, 2017, CNN WEBSITE; Neria Y, 2012, JAMA-J AM MED ASSOC, V308, P2571, DOI 10.1001/jama.2012.110700; Shultz JM, 2005, EPIDEMIOL REV, V27, P21, DOI 10.1093/epirev/mxi011	8	64	64	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2017	318	15					1437	1438		10.1001/jama.2017.14618	http://dx.doi.org/10.1001/jama.2017.14618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK0RM	28892814				2022-12-28	WOS:000413187300011
J	Reed, DA; Keitz, BK; Oktawiec, J; Mason, JA; Runcevski, T; Xiao, DJ; Darago, LE; Crocella, V; Bordiga, S; Long, JR				Reed, Douglas A.; Keitz, Benjamin K.; Oktawiec, Julia; Mason, Jarad A.; Runcevski, Tomce; Xiao, Dianne J.; Darago, Lucy E.; Crocella, Valentina; Bordiga, Silvia; Long, Jeffrey R.			A spin transition mechanism for cooperative adsorption in metal-organic frameworks	NATURE			English	Article							CO; CROSSOVER; SEPARATIONS; NETWORKS; POLYMERS; BINDING; MN; NI	Cooperative binding, whereby an initial binding event facilitates the uptake of additional substrate molecules, is common in biological systems such as haemoglobin(1,2).It was recently shown that porous solids that exhibit cooperative binding have substantial energetic benefits over traditional adsorbents(3), but few guidelines currently exist for the design of such materials. In principle, metal-organic frameworks that contain coordinatively unsaturated metal centres could act as both selective(4-7) and cooperative adsorbents if guest binding at one site were to trigger an electronic transformation that subsequently altered the binding properties at neighbouring metal sites(8-10). Here we illustrate this concept through the selective adsorption of carbon monoxide (CO) in a series of metal-organic frameworks featuring coordinatively unsaturated iron(ii) sites. Functioning via a mechanism by which neighbouring iron(ii) sites undergo a spin-state transition above a threshold CO pressure, these materials exhibit large CO separation capacities with only small changes in temperature. The very low regeneration energies that result may enable more efficient Fischer-Tropsch conversions and extraction of CO from industrial waste feeds, which currently underutilize this versatile carbon synthon(11). The electronic basis for the cooperative adsorption demonstrated here could provide a general strategy for designing efficient and selective adsorbents suitable for various separations.	[Reed, Douglas A.; Keitz, Benjamin K.; Oktawiec, Julia; Mason, Jarad A.; Runcevski, Tomce; Xiao, Dianne J.; Darago, Lucy E.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Keitz, Benjamin K.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Runcevski, Tomce; Long, Jeffrey R.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Crocella, Valentina; Bordiga, Silvia] Univ Turin, Dept Chem, NIS & INSTM Ctr Reference, Via Quarello 15, I-10135 Turin, Italy; [Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Turin; University of California System; University of California Berkeley	Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Long, JR (corresponding author), Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.; Long, JR (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	jrlong@berkeley.edu	Bordiga, Silvia/M-3875-2014; Crocellà, Valentina/E-5203-2016	Bordiga, Silvia/0000-0003-2371-4156; Crocellà, Valentina/0000-0002-3606-8424; Reed, Douglas/0000-0001-5170-9050; Oktawiec, Julia/0000-0002-2895-3327; Runcevski, Tomce/0000-0003-0886-8464; Darago, Lucy/0000-0001-7515-5558	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001015]; Advanced Photon Source, a DOE Office of Science User Facility [AC02-06CH11357]; National Science Foundation	Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center - US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Advanced Photon Source, a DOE Office of Science User Facility(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This research was supported through the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0001015. Powder X-ray diffraction data were collected at Beamline 11-BM and Beamline 17-BM at the Advanced Photon Source, a DOE Office of Science User Facility, operated by Argonne National Laboratory under contract DE-AC02-06CH11357. We thank P. C. Bunting, R. L. Siegelman and J. E. Bachman for discussions, and H. Z. H. Jiang for experimental assistance. D.A.R., J.O., J.A.M., D.J.X. and L.E.D. thank the National Science Foundation for graduate fellowship support.	Benito-Garagorri D, 2011, DALTON T, V40, P4778, DOI 10.1039/c0dt01636e; Bloch ED, 2014, J AM CHEM SOC, V136, P10752, DOI 10.1021/ja505318p; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Coelho A., 2007, TOPAS ACAD; Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878; Davis R. A., US patent, Patent No. [5,011,670, 5011670]; Denysenko D, 2011, CHEM-EUR J, V17, P1837, DOI 10.1002/chem.201001872; DUTTA NN, 1995, GAS SEP PURIF, V9, P277, DOI 10.1016/0950-4214(95)00011-Y; FOUCHER DA, 1993, ANGEW CHEM INT EDIT, V32, P1709, DOI 10.1002/anie.199317091; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Garcia Y, 2004, TOP CURR CHEM, V233, P229, DOI 10.1007/b95408; Halder GJ, 2002, SCIENCE, V298, P1762, DOI 10.1126/science.1075948; Herm ZR, 2014, CHEM MATER, V26, P323, DOI 10.1021/cm402897c; IEA, 2013, GLOB ACT ADV CARB CA; Kahn O, 1998, SCIENCE, V279, P44, DOI 10.1126/science.279.5347.44; Kerry F. G., 2007, IND GAS HDB GAS SEPA; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Liao PQ, 2015, ENERG ENVIRON SCI, V8, P1011, DOI 10.1039/c4ee02717e; Liao PQ, 2014, CHEM-EUR J, V20, P11303, DOI 10.1002/chem.201403123; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; Niel V, 2001, INORG CHEM, V40, P3838, DOI 10.1021/ic010259y; Peng JJ, 2015, CHEM ENG J, V270, P282, DOI 10.1016/j.cej.2015.01.126; Perrella M, 1999, J BIOL CHEM, V274, P2605, DOI 10.1074/jbc.274.5.2605; Perutz M. F., 1990, MECH COOPERATIVITY A; Reed DA, 2016, J AM CHEM SOC, V138, P5594, DOI 10.1021/jacs.6b00248; Rieth AJ, 2016, J AM CHEM SOC, V138, P9401, DOI 10.1021/jacs.6b05723; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Schneemann A, 2014, CHEM SOC REV, V43, P6062, DOI 10.1039/c4cs00101j; Serre C, 2007, ADV MATER, V19, P2246, DOI 10.1002/adma.200602645; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Walton KS, 2008, J AM CHEM SOC, V130, P406, DOI 10.1021/ja076595g; Xiao DJ, 2016, J AM CHEM SOC, V138, P7161, DOI 10.1021/jacs.6b03680; Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x	33	143	144	14	301	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2017	550	7674					96	+		10.1038/nature23674	http://dx.doi.org/10.1038/nature23674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7XU	28892810				2022-12-28	WOS:000412214100052
J	Wolchok, JD; Chiarion-Sileni, V; Gonzalez, R; Rutkowski, P; Grob, JJ; Cowey, CL; Lao, CD; Wagstaff, J; Schadendorf, D; Ferrucci, PF; Smylie, M; Dummer, R; Hill, A; Hogg, D; Haanen, J; Carlino, MS; Bechter, O; Maio, M; Marquez-Rodas, I; Guidoboni, M; McArthur, G; Lebbe, C; Ascierto, PA; Long, GV; Cebon, J; Sosman, J; Postow, MA; Callahan, MK; Walker, D; Rollin, L; Bhore, R; Hodi, FS; Larkin, J				Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. -J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; Dummer, R.; Hill, A.; Hogg, D.; Haanen, J.; Carlino, M. S.; Bechter, O.; Maio, M.; Marquez-Rodas, I.; Guidoboni, M.; McArthur, G.; Lebbe, C.; Ascierto, P. A.; Long, G. V.; Cebon, J.; Sosman, J.; Postow, M. A.; Callahan, M. K.; Walker, D.; Rollin, L.; Bhore, R.; Hodi, F. S.; Larkin, J.			Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MELANOMA; UNTREATED MELANOMA	BACKGROUND Nivolumab combined with ipilimumab resulted in longer progression-free survival and a higher objective response rate than ipilimumab alone in a phase 3 trial involving patients with advanced melanoma. We now report 3-year overall survival outcomes in this trial. METHODS We randomly assigned, in a 1: 1: 1 ratio, patients with previously untreated advanced melanoma to receive nivolumab at a dose of 1 mg per kilogram of body weight plus ipilimumab at a dose of 3 mg per kilogram every 3 weeks for four doses, followed by nivolumab at a dose of 3 mg per kilogram every 2 weeks; nivolumab at a dose of 3 mg per kilogram every 2 weeks plus placebo; or ipilimumab at a dose of 3 mg per kilogram every 3 weeks for four doses plus placebo, until progression, the occurrence of unacceptable toxic effects, or withdrawal of consent. Randomization was stratified according to programmed death ligand 1 (PD-L1) status, BRAF mutation status, and metastasis stage. The two primary end points were progression-free survival and overall survival in the nivolumab-plus-ipilimumab group and in the nivolumab group versus the ipilimumab group. RESULTS At a minimum follow-up of 36 months, the median overall survival had not been reached in the nivolumab-plus-ipilimumab group and was 37.6 months in the nivolumab group, as compared with 19.9 months in the ipilimumab group (hazard ratio for death with nivolumab plus ipilimumab vs. ipilimumab, 0.55 [P<0.001]; hazard ratio for death with nivolumab vs. ipilimumab, 0.65[P<0.001]). The overall survival rate at 3 years was 58% in the nivolumab-plus-ipilimumab group and 52% in the nivolumab group, as compared with 34% in the ipilimumab group. The safety profile was unchanged from the initial report. Treatment-related adverse events of grade 3 or 4 occurred in 59% of the patients in the nivolumab-plus-ipilimumab group, in 21% of those in the nivolumab group, and in 28% of those in the ipilimumab group. CONCLUSIONS Among patients with advanced melanoma, significantly longer overall survival occurred with combination therapy with nivolumab plus ipilimumab or with nivolumab alone than with ipilimumab alone.	[Wolchok, J. D.; Postow, M. A.; Callahan, M. K.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Wolchok, J. D.; Postow, M. A.; Callahan, M. K.] Weill Cornell Med Coll, New York, NY USA; [Chiarion-Sileni, V.] IRCCS, Oncol Inst Veneto, Padua, Italy; [Ferrucci, P. F.] European Inst Oncol, Milan, Italy; [Maio, M.] Univ Hosp Siena, Ctr Immunooncol, Ist Toscano Tumori, Siena, Italy; [Guidoboni, M.] IRCCS, Ist Sci Romagnolo Studio Cura Tumori, Immunotherapy & Somat Cell Therapy Unit, Meldola, Italy; [Ascierto, P. A.] Fdn Pascale, Ist Nazl Tumori, Naples, Italy; [Gonzalez, R.] Univ Colorado, Denver, CO 80202 USA; [Rutkowski, P.] Oncol Ctr, Maria Sklodowska Curie Inst, Warsaw, Poland; [Grob, J. -J.] Aix Marseille Univ, Hop Timone, Marseille, France; [Lebbe, C.] Univ Paris Diderot, Hop St Louis, AP HP, Dermatol & Ctr Invest Clin,INSERM Unite 976, Paris, France; [Cowey, C. L.] Baylor Canc Ctr, Texas Oncol, Dallas, TX USA; [Lao, C. D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Wagstaff, J.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Larkin, J.] Royal Marsden NHS Fdn Trust, London, England; [Schadendorf, D.] Univ Essen Gesamthsch, Dept Dermatol, Essen, Germany; [Schadendorf, D.] German Canc Consortium, Heidelberg, Germany; [Smylie, M.] Cross Canc Inst, Edmonton, AB, Canada; [Hogg, D.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Dummer, R.] Univ Spital, Zurich, Switzerland; [Hill, A.] Tasman Oncol Res, Southport Gold Coast, Qld, Australia; [Carlino, M. S.] Univ Sydney, Melanoma Inst Australia, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia; [Long, G. V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Long, G. V.] Royal North Shore & Mater Hosp, Sydney, NSW, Australia; [McArthur, G.] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Cebon, J.] Univ Melbourne, Oliivia Newton John Canc Res Inst, Melbourne, Vic, Australia; [Haanen, J.] Netherlands Canc Inst, Amsterdam, Netherlands; [Bechter, O.] Katholieke Univ Leuven, Univ Hosp Leuven, Leuven, Belgium; [Marquez-Rodas, I.] Gen Univ Hosp Gregorio Maranon, Madrid, Spain; [Sosman, J.] Northwestern Univ, Chicago, IL 60611 USA; [Walker, D.; Rollin, L.; Bhore, R.] Bristol Myers Squibb, Princeton, NJ USA; [Hodi, F. S.] Dana Farber Canc Inst, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Cornell University; IRCCS Istituto Oncologico Veneto (IOV); IRCCS European Institute of Oncology (IEO); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena; University Hospital of Siena; IRCCS Meldola (IRST); IRCCS Fondazione Pascale; University of Colorado System; University of Colorado Denver; Maria Sklodowska-Curie National Research Institute of Oncology; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Texas Oncology; University of Michigan System; University of Michigan; Swansea University; Royal Marsden NHS Foundation Trust; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Melanoma Institute Australia; University of Sydney; Melanoma Institute Australia; University of Sydney; Royal North Shore Hospital; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Netherlands Cancer Institute; KU Leuven; University Hospital Leuven; General University Gregorio Maranon Hospital; Northwestern University; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Parker Inst & Ludwig Ctr, Dept Med, 1275 York Ave,Box 340, New York, NY 10065 USA.	wolchokj@mskcc.org	Haanen, John/AAD-8534-2022; Ferrucci, Pier Francesco/AAQ-9002-2020; Rutkowski, Piotr/B-3907-2013; Bechter, Oliver/H-7634-2013; Long, Georgina V/C-1771-2013; Haanen, John/AAD-8578-2022; Ascierto, Paolo A/J-9106-2016; Schadendorf, Dirk/AAE-8206-2019; Marquez-Rodas, Ivan/ABD-5532-2021; sileni, vanna chiarion/B-9042-2018; Carlino, Matteo/GRS-7198-2022; Bechter, Oliver/ABB-5359-2021	Haanen, John/0000-0001-5884-7704; Rutkowski, Piotr/0000-0002-8920-5429; Bechter, Oliver/0000-0003-0667-3284; Long, Georgina V/0000-0001-8894-3545; Ascierto, Paolo A/0000-0002-8322-475X; Marquez-Rodas, Ivan/0000-0002-2476-668X; sileni, vanna chiarion/0000-0001-9191-9124; Bechter, Oliver/0000-0003-0667-3284; Wagstaff, John/0000-0002-1140-5981; Guidoboni, Massimo/0000-0001-7703-790X; Larkin, James/0000-0001-5569-9523; Cebon, Jonathan/0000-0002-3898-950X; Melucci, Maria Teresa/0000-0002-1677-3345; McArthur, Grant/0000-0001-8908-6071; Ferrucci, Pier Francesco/0000-0001-6255-5851; Carlino, Matteo/0000-0002-7861-4104	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Bristol-Myers Squibb and others; CheckMate 067 ClinicalTrials.gov number, NCT01844505.	Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hodi FS, 2016, LANCET ONCOL, V17, P1558, DOI 10.1016/S1470-2045(16)30366-7; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Larkin J, 2017, AM ASS CANC RES ANN; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; Long GV, 2017, ANN ONCOL; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Ribas A, 2017, AM ASS CANC RES ANN; Robert C, 2017, J CLIN ONCOL S, V15, P35, DOI DOI 10.1200/JC0.2017.35.15_; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sznol M, 2015, SOC MEL RES ANN M SA	15	2083	2143	7	151	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2017	377	14					1345	1356		10.1056/NEJMoa1709684	http://dx.doi.org/10.1056/NEJMoa1709684			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ0CB	28889792	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000412375000014
J	Alter, DA				Alter, David A.			Tracking Our Physical Inactivity and Progression to Death: Is This Evolutionary Stagnation?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Alter, David A.] Univ Toronto, Toronto, ON, Canada	University of Toronto	Alter, DA (corresponding author), Univ Hlth Network, Toronto Rehab Inst, 347 Rumsey Rd, Toronto, ON M4G 1R7, Canada.	dalter@ices.on.ca					Dr. Alter is funded by a Chair in Cardiovascular and Metabolic Rehabilitation, University Health Network-Toronto Rehabilitation Institute, University of Toronto. The Institute for Clinical Evaluative Sciences is supported by a grant from the Ontario Ministry of Health and Long-Term Care.		0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					513	514		10.7326/M17-2181	http://dx.doi.org/10.7326/M17-2181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28892823				2022-12-28	WOS:000411988900031
J	Mentzelopoulos, SD; Zakynthinos, SG				Mentzelopoulos, Spyros D.; Zakynthinos, Spyros G.			Research Integrity, Academic Promotion, and Attribution of Authorship and Nonauthor Contributions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mentzelopoulos, Spyros D.; Zakynthinos, Spyros G.] Univ Athens, Sch Med, Dept Intens Care Med 1, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Mentzelopoulos, SD (corresponding author), Evaggelismos Gen Hosp, Dept Intens Care Med, 45-47 Ipsilandou St, GR-10675 Athens, Greece.	sdmentzelopoulos@yahoo.com						All European Academies (ALLEA), EUR COD COND RES INT; Clarivate Analytics Web of Science, THOMPS REUT IMP FACT; International committee of Medical Journal Editors, DEF ROL AUTH CONTR	3	18	19	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2017	318	13					1221	1222		10.1001/jama.2017.11790	http://dx.doi.org/10.1001/jama.2017.11790			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI8CW	28880990				2022-12-28	WOS:000412229600010
J	[Anonymous]				[Anonymous]			Duration of Sedentary Episodes Is Associated With Risk for Death	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					I24	I24		10.7326/P17-9045	http://dx.doi.org/10.7326/P17-9045			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI4ZI	28892830				2022-12-28	WOS:000411988900002
J	Burki, T				Burki, Talha			Lasker foundation announces award winners for 2017	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1479	1480		10.1016/S0140-6736(17)32380-2	http://dx.doi.org/10.1016/S0140-6736(17)32380-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH7BS	28888329				2022-12-28	WOS:000411337100012
J	Acerce, M; Akdogan, EK; Chhowalla, M				Acerce, Muharrem; Akdogan, E. Koray; Chhowalla, Manish			Metallic molybdenum disulfide nanosheet-based electrochemical actuators	NATURE			English	Article							ARTIFICIAL MUSCLES; LARGE-STRAIN; INTERCALATION; POLYPYRROLE; ELASTOMERS; CHEMISTRY; DEVICES; DRIVEN; REDOX; MOS2	Actuators that convert electrical energy to mechanical energy are useful in a wide variety of electromechanical systems and in robotics(1-6), with applications such as steerable catheters(7), adaptive wings for aircraft and drag-reducing wind turbines(8). Actuation systems can be based on various stimuli, such as heat, solvent adsorption/desorption(4,9), or electrochemical action (in systems such as carbon nanotube electrodes(1,10), graphite electrodes(11), polymer electrodes(6,12-14) and metals(15)). Here we demonstrate that the dynamic expansion and contraction of electrode films formed by restacking chemically exfoliated nanosheets of two-dimensional metallic molybdenum disulfide (MoS2) on thin plastic substrates can generate substantial mechanical forces. These films are capable of lifting masses that are more than 150 times that of the electrode over several millimetres and for hundreds of cycles. Specifically, the MoS2 films are able to generate mechanical stresses of about 17 megapascals-higher than mammalian muscle (about 0.3 megapascals) 3 and comparable to ceramic piezoelectric actuators (about 40 megapascals)-and strains of about 0.6 per cent, operating at frequencies up to 1 hertz. The actuation performance is attributed to the high electrical conductivity of the metallic 1T phase of MoS2 nanosheets, the elastic modulus of restacked MoS2 layers (2 to 4 gigapascals) and fast proton diffusion between the nanosheets. These results could lead to new electrochemical actuators for high-strain and high-frequency applications.	[Acerce, Muharrem; Akdogan, E. Koray; Chhowalla, Manish] Rutgers State Univ, Mat Sci & Engn, 607 Taylor Rd, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chhowalla, M (corresponding author), Rutgers State Univ, Mat Sci & Engn, 607 Taylor Rd, Piscataway, NJ 08854 USA.	manish1@soe.rutgers.edu	Acerce, Muharrem/Z-1080-2018	Acerce, Muharrem/0000-0002-9832-9941	Turkish Ministry of Education; NSF [ECCS 1128335]; Rutgers MSE Department	Turkish Ministry of Education(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NSF(National Science Foundation (NSF)); Rutgers MSE Department	M.A. acknowledges the Turkish Ministry of Education for a graduate fellowship. M.C. acknowledges support from NSF grant ECCS 1128335. E.K.A. acknowledges support from Rutgers MSE Department.	Acerce M, 2015, NAT NANOTECHNOL, V10, P313, DOI [10.1038/nnano.2015.40, 10.1038/NNANO.2015.40]; Aliev AE, 2009, SCIENCE, V323, P1575, DOI 10.1126/science.1168312; Bar-Cohen Y., 2004, ELECTROACTIVE POLYM; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Biener J, 2009, NAT MATER, V8, P47, DOI 10.1038/NMAT2335; Brochu P, 2010, MACROMOL RAPID COMM, V31, P10, DOI 10.1002/marc.200900425; Calandra M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.245428; Cheng C, 2015, ACS NANO, V9, P3984, DOI 10.1021/nn507466n; Chin TE, 2006, ELECTROCHEM SOLID ST, V9, pA134, DOI 10.1149/1.2161523; Come J, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502290; Come J, 2015, NANO ENERGY, V17, P27, DOI 10.1016/j.nanoen.2015.07.028; Cooper RC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.035423; Du P, 2010, SENSOR ACTUAT A-PHYS, V163, P240, DOI 10.1016/j.sna.2010.06.002; Eda G, 2011, NANO LETT, V11, P5111, DOI 10.1021/nl201874w; Feng PY, 2005, ACCOUNTS CHEM RES, V38, P293, DOI 10.1021/ar0401754; Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; Ge Y, 2017, ELECTROCHIM ACTA, V235, P348, DOI 10.1016/j.electacta.2017.03.069; Gu G, 2003, NAT MATER, V2, P316, DOI 10.1038/nmat880; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; Ham Ronald, 2009, IEEE Robotics & Automation Magazine, V16, P81, DOI 10.1109/MRA.2009.933629; Hara S, 2004, POLYM J, V36, P151, DOI 10.1295/polymj.36.151; Jia KM, 2009, J MICROELECTROMECH S, V18, P1004, DOI 10.1109/JMEMS.2009.2023838; Jin HJ, 2010, NANO LETT, V10, P187, DOI 10.1021/nl903262b; Klein CA, 2000, J APPL PHYS, V88, P5487, DOI 10.1063/1.1313776; Koyama Y, 2006, ADV FUNCT MATER, V16, P492, DOI 10.1002/adfm.200500633; Lu W, 2002, SCIENCE, V297, P983, DOI 10.1126/science.1072651; Ma MM, 2013, SCIENCE, V339, P186, DOI 10.1126/science.1230262; Mazzoldi A, 2000, PROC SPIE, V3987, P273, DOI 10.1117/12.387786; Mirfakhrai T, 2007, SMART MATER STRUCT, V16, pS243, DOI 10.1088/0964-1726/16/2/S07; Otero TF, 2002, PROC SPIE, V4695, P395, DOI 10.1117/12.475186; PEI QB, 1992, J PHYS CHEM-US, V96, P10507, DOI 10.1021/j100204a071; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; SANDOVAL SJ, 1991, PHYS REV B, V44, P3955, DOI 10.1103/PhysRevB.44.3955; Shahinpoor M, 1998, SMART MATER STRUCT, V7, pR15, DOI 10.1088/0964-1726/7/6/001; Sokolnikoff I. S., 1946, MATH THEORY ELASTICI; Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366; Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021; Timoshenko S., 1951, THEORY ELASTICITY; Weissmuller J, 2003, SCIENCE, V300, P312, DOI 10.1126/science.1081024; Xie XJ, 2011, J MATER CHEM, V21, P2057, DOI 10.1039/c0jm03926h; Yun Y, 2006, NANO LETT, V6, P689, DOI 10.1021/nl052435w; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	43	169	170	19	510	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 21	2017	549	7672					370	+		10.1038/nature23668	http://dx.doi.org/10.1038/nature23668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH7PB	28854166				2022-12-28	WOS:000411381300032
J	Seoane, J				Seoane, Joan			CANCER Division hierarchy leads to cell heterogeneity	NATURE			English	Editorial Material							REVEALS; GROWTH		[Seoane, Joan] Vall dHebron Inst Oncol, Vall dHebron Barcelona Univ Hosp Campus, Barcelona 08035, Spain; [Seoane, Joan] ICREA, Barcelona, Spain	Vall d'Hebron Institut d'Oncologia (VHIO); ICREA	Seoane, J (corresponding author), Vall dHebron Inst Oncol, Vall dHebron Barcelona Univ Hosp Campus, Barcelona 08035, Spain.; Seoane, J (corresponding author), ICREA, Barcelona, Spain.	jseoane@vhio.net	Seoane, Joan/AAG-9173-2019	Seoane, Joan/0000-0002-6541-5974				Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lan XY, 2017, NATURE, V549, P227, DOI 10.1038/nature23666; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854	11	8	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 14	2017	549	7671					164	166		10.1038/nature23546	http://dx.doi.org/10.1038/nature23546			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG7AE	28854167				2022-12-28	WOS:000410555900024
J	Krupic, J				Krupic, Julija			Wire together, fire apart	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; HIPPOCAMPUS		[Krupic, Julija] UCL, Cell & Dev Biol, London, England	University of London; University College London	Krupic, J (corresponding author), UCL, Cell & Dev Biol, London, England.	j.krupic@ucl.ac.uk		Krupic, Julija/0000-0001-6299-1629				Bittner KC, 2017, SCIENCE, V357, P1033, DOI 10.1126/science.aan3846; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Hebb Donald O., 1949, ORG BEHAV; Jeffery KJ, 1997, HIPPOCAMPUS, V7, P95; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1	11	2	2	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		974	975		10.1126/science.aao4159	http://dx.doi.org/10.1126/science.aao4159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883061				2022-12-28	WOS:000409455700027
J	Torres, A; Brandt, J; Lear, K; Liu, JG				Torres, Aurora; Brandt, Jodi; Lear, Kristen; Liu, Jianguo			A looming tragedy of the sand commons	SCIENCE			English	Editorial Material									[Torres, Aurora] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Torres, Aurora] Martin Luther Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany; [Brandt, Jodi] Boise State Univ, Coll Innovat & Design, Human Environm Syst Inst, Boise, ID 83725 USA; [Lear, Kristen] Univ Georgia, Warnell Sch Forestry & Nat Resources, Integrat Conservat, Athens, GA 30602 USA; [Liu, Jianguo] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Martin Luther University Halle Wittenberg; Idaho; Boise State University; University System of Georgia; University of Georgia; Michigan State University	Torres, A (corresponding author), German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany.; Torres, A (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany.	aurora.torres@idiv.de; liuji@msu.edu	Liu, Jianguo/G-5211-2015; Torres, Aurora/AAD-1125-2022	Liu, Jianguo/0000-0001-6344-0087; Torres, Aurora/0000-0001-6019-6648; Lear, Kristen/0000-0002-5649-8560	U.S. National Science Foundation; NASA-MSU Professional Enhancement Awards Program; US-IALE Foreign Scholar Travel Award Program; Dartmouth Neukom Institute; Michigan AgBioResearch; Office of Integrative Activities [1301792] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); NASA-MSU Professional Enhancement Awards Program; US-IALE Foreign Scholar Travel Award Program; Dartmouth Neukom Institute; Michigan AgBioResearch; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank S. Nichols for helpful comments on an earlier version and acknowledge funding from the U.S. National Science Foundation, NASA-MSU Professional Enhancement Awards Program, US-IALE Foreign Scholar Travel Award Program, Dartmouth Neukom Institute, and Michigan AgBioResearch. At the start of this project, A.T. was at the Museo Nacional de Ciencias Naturales, Madrid.	Anthony EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14745; Buzzetti DRC, 2013, REV BRAS ORNITOL, V21, P269; Fraser MW, 2017, ECOL INDIC, V78, P229, DOI 10.1016/j.ecolind.2017.03.026; Krausmann F, 2017, P NATL ACAD SCI USA, V114, P1880, DOI 10.1073/pnas.1613773114; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Lucy FE, 2012, AQUAT INVASIONS, V7, P465, DOI 10.3391/ai.2012.7.4.003; Mazumder MK, 2014, GLOB ECOL CONSERV, V2, P359, DOI 10.1016/j.gecco.2014.09.004; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Peduzzi P., 2014, ENVIRON DEV, V11, P208, DOI DOI 10.1016/J.ENVDEV.2014.04.001; Ratnayake R., 2013, WATER INTEGRITY ACTI; Rege A, 2016, INT J COMP APPL CRIM, V40, P101, DOI 10.1080/01924036.2015.1082486; Schandl H., 2016, GLOBAL MAT FLOWS RES, P30; Soleimani-Ahmadi M, 2013, ASIAN PAC J TROP MED, V6, P510, DOI 10.1016/S1995-7645(13)60087-5; Sutherland WJ, 2017, TRENDS ECOL EVOL, V32, P31, DOI 10.1016/j.tree.2016.11.005	15	166	169	6	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		970	971		10.1126/science.aao0503	http://dx.doi.org/10.1126/science.aao0503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883058				2022-12-28	WOS:000409455700024
J	Mirabello, L; Yeager, M; Yu, K; Clifford, GM; Xiao, YZ; Zhu, B; Cullen, M; Boland, JF; Wentzensen, N; Nelson, CW; Raine-Bennett, T; Chen, ZG; Bass, S; Song, L; Yang, Q; Steinberg, M; Burdett, L; Dean, M; Roberson, D; Mitchell, J; Lorey, T; Franceschi, S; Castle, PE; Walker, J; Zuna, R; Kreimer, AR; Beachler, DC; Hildesheim, A; Gonzalez, P; Porras, C; Burk, RD; Schiffman, M				Mirabello, Lisa; Yeager, Meredith; Yu, Kai; Clifford, Gary M.; Xiao, Yanzi; Zhu, Bin; Cullen, Michael; Boland, Joseph F.; Wentzensen, Nicolas; Nelson, Chase W.; Raine-Bennett, Tina; Chen, Zigui; Bass, Sara; Song, Lei; Yang, Qi; Steinberg, Mia; Burdett, Laurie; Dean, Michael; Roberson, David; Mitchell, Jason; Lorey, Thomas; Franceschi, Silvia; Castle, Philip E.; Walker, Joan; Zuna, Rosemary; Kreimer, Aimee R.; Beachler, Daniel C.; Hildesheim, Allan; Gonzalez, Paula; Porras, Carolina; Burk, Robert D.; Schiffman, Mark			HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis	CELL			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; EARLY END-POINTS; CERVICAL-CANCER; NATURAL-HISTORY; CONTINUOUS EXPRESSION; GENOTYPE ATTRIBUTION; READING FRAMES; BROAD-SPECTRUM; E1 PROTEIN; E6	Although most cervical human papillomavirus type 16 (HPV16) infections become undetectable within 1-2 years, persistent HPV16 causes half of all cervical cancers. We used a novel HPV whole-genome sequencing technique to evaluate an exceptionally large collection of 5,570 HPV16-infected case-control samples to determine whether viral genetic variation influences risk of cervical precancer and cancer. We observed thousands of unique HPV16 genomes; very few women shared the identical HPV16 sequence, which should stimulate a careful re-evaluation of the clinical implications of HPV mutation rates, transmission, clearance, and persistence. In case-control analyses, HPV16 in the controls had significantly more amino acid changing variants throughout the genome. Strikingly, E7 was devoid of variants in precancers/cancers compared to higher levels in the controls; we confirmed this in cancers from around the world. Strict conservation of the 98 amino acids of E7, which disrupts Rb function, is critical for HPV16 carcinogenesis, presenting a highly specific target for etiologic and therapeutic research.	[Mirabello, Lisa; Yeager, Meredith; Yu, Kai; Xiao, Yanzi; Zhu, Bin; Cullen, Michael; Boland, Joseph F.; Wentzensen, Nicolas; Bass, Sara; Song, Lei; Yang, Qi; Steinberg, Mia; Burdett, Laurie; Dean, Michael; Roberson, David; Mitchell, Jason; Kreimer, Aimee R.; Beachler, Daniel C.; Hildesheim, Allan; Schiffman, Mark] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA; [Yeager, Meredith; Cullen, Michael; Boland, Joseph F.; Bass, Sara; Song, Lei; Yang, Qi; Steinberg, Mia; Burdett, Laurie; Roberson, David; Mitchell, Jason] Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick, MD USA; [Clifford, Gary M.; Franceschi, Silvia] Int Agcy Res Canc, Infect & Canc Epidemiol Grp, 150 Cours Albert Thomas, F-69372 Lyon 08, France; [Nelson, Chase W.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Raine-Bennett, Tina] Kaiser Permanente Northern Calif, Womens Hlth Res Inst, Div Res, Oakland, CA USA; [Chen, Zigui] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Lorey, Thomas] Kaiser Permanente Northern Calif, Reg Lab, Oakland, CA USA; [Castle, Philip E.; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Walker, Joan; Zuna, Rosemary] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Beachler, Daniel C.] HealthCore Inc, Safety & Epidemiol, Wilmington, DE USA; [Gonzalez, Paula; Porras, Carolina] Fdn INCIENSA, ACIB, Guanacaste, Costa Rica; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Microbiol & Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Womens Hlth, Bronx, NY 10467 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); American Museum of Natural History (AMNH); Kaiser Permanente; Chinese University of Hong Kong; Kaiser Permanente; Yeshiva University; Albert Einstein College of Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center; HealthCore, Inc; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Mirabello, L (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA.	mirabellol@mail.nih.gov	Schiffman, Mark/B-9766-2015; ZHU, BIN/GLQ-8199-2022; Wentzensen, Nicolas/AAG-8522-2019; franceschi, silvia/M-2452-2014; Yeager, Meredith/AAA-5322-2020; Song, Lei/F-6946-2018; Dean, Michael C/G-8172-2012; Castle, Philip/AAP-6395-2020; Dean, Michael/R-7501-2019; Mirabello, Lisa/H-5594-2018; Chen, Zigui/E-8490-2017	franceschi, silvia/0000-0003-4181-8071; Dean, Michael C/0000-0003-2234-0631; Castle, Philip/0000-0003-1082-6554; Chen, Zigui/0000-0002-8577-1298; Nelson, Chase/0000-0001-6287-1598	Gerstner Family Foundation at the American Museum of Natural History; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH; National Cancer Institute, NIH [HHSN261200800001E]; National Cancer Institute [CA78527]; Einstein Cancer Research Center from the National Cancer Institute [P30CA013330]; Institut National du Cancer (INCa), France [SHSESP 16-006]; NATIONAL CANCER INSTITUTE [P30CA013330, U01CA078527, R01CA078527, ZIACP010228] Funding Source: NIH RePORTER	Gerstner Family Foundation at the American Museum of Natural History; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Cancer Research Center from the National Cancer Institute; Institut National du Cancer (INCa), France(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ayax Perez Gallegos, Albert Einstein College of Medicine, for helpful input on HPV16 E6 protein structure. C.W.N. was supported by a Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History. This study was funded by the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH. This project has been funded in whole or in part with federal funds from the National Cancer Institute, NIH (HHSN261200800001E); and, the National Cancer Institute (CA78527) and the Einstein Cancer Research Center (P30CA013330) from the National Cancer Institute (to R.D.B.). Work at IARC was supported by a grant from the Institut National du Cancer (INCa), France (SHSESP 16-006). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Bergvall M, 2013, VIROLOGY, V445, P35, DOI 10.1016/j.virol.2013.07.020; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Burk RD, 1996, J INFECT DIS, V174, P679, DOI 10.1093/infdis/174.4.679; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Castle PE, 2011, CANCER EPIDEM BIOMAR, V20, P946, DOI 10.1158/1055-9965.EPI-10-1267; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Cooper B, 2003, VIROLOGY, V306, P87, DOI 10.1016/S0042-6822(02)00012-0; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Cullen M, 2015, PAPILLOMAVIRUS RES, V1, P3, DOI 10.1016/j.pvr.2015.05.004; Dalal S, 1996, J VIROL, V70, P683, DOI 10.1128/JVI.70.2.683-688.1996; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DILLNER J, 1990, INT J CANCER, V46, P703, DOI 10.1002/ijc.2910460426; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dunn ST, 2007, J VIROL METHODS, V143, P45, DOI 10.1016/j.jviromet.2007.02.006; Egawa N, 2012, J VIROL, V86, P3276, DOI 10.1128/JVI.06450-11; ESCHLE D, 1992, J GEN VIROL, V73, P1829, DOI 10.1099/0022-1317-73-7-1829; Flores ER, 2000, J VIROL, V74, P6622, DOI 10.1128/JVI.74.14.6622-6631.2000; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Harden ME, 2017, MBIO, V8, DOI 10.1128/mBio.02170-16; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; Herrero R, 2011, CANCER DISCOV, V1, P408, DOI 10.1158/2159-8290.CD-11-0131; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Holmes E., 2009, EVOLUTION EMERGENCE; Hughes AL, 2005, VIRUS RES, V113, P81, DOI 10.1016/j.virusres.2005.03.030; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jabbar SF, 2012, CANCER RES, V72, P4008, DOI 10.1158/0008-5472.CAN-11-3085; Jabbar SF, 2009, CANCER RES, V69, P4407, DOI 10.1158/0008-5472.CAN-09-0023; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Kim K, 2002, VIROLOGY, V293, P10, DOI 10.1006/viro.2001.1305; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kleter B, 1999, J CLIN MICROBIOL, V37, P2508, DOI 10.1128/JCM.37.8.2508-2517.1999; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LAMBERT PF, 1993, P NATL ACAD SCI USA, V90, P5583, DOI 10.1073/pnas.90.12.5583; LEHTINEN M, 1995, BIOCHEM BIOPH RES CO, V209, P541, DOI 10.1006/bbrc.1995.1535; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mirabello L, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw100; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Nelson CW, 2015, BIOINFORMATICS, V31, P3709, DOI 10.1093/bioinformatics/btv449; Nelson CW, 2015, INFECT GENET EVOL, V30, P1, DOI 10.1016/j.meegid.2014.11.026; Riley RR, 2003, CANCER RES, V63, P4862; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Safaeian M, 2010, ARCH VIROL, V155, P367, DOI 10.1007/s00705-009-0579-2; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86; Schiffman M, 2016, INT J CANCER, V139, P2606, DOI 10.1002/ijc.30375; Schiffman M, 2015, CANCER EPIDEM BIOMAR, V24, P1304, DOI 10.1158/1055-9965.EPI-14-1353; Serrano B, 2015, EUR J CANCER, V51, P1732, DOI 10.1016/j.ejca.2015.06.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taylor S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1633-9; van Doorn LJ, 2006, J CLIN MICROBIOL, V44, P3292, DOI 10.1128/JCM.00539-06; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang SS, 2009, CANCER EPIDEM BIOMAR, V18, P113, DOI 10.1158/1055-9965.EPI-08-0591; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Wentzensen N, 2009, INT J CANCER, V124, P964, DOI 10.1002/ijc.23969; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934	76	154	163	3	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1164	1174		10.1016/j.cell.2017.08.001	http://dx.doi.org/10.1016/j.cell.2017.08.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886384	Green Accepted, Bronze			2022-12-28	WOS:000409536000013
J	Nguyen, S; Choi, C				Nguyen, Sabine; Choi, Chester			Neobladder Stone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nguyen, Sabine; Choi, Chester] St Mary Med Ctr Long Beach, Long Beach, CA 90813 USA		Nguyen, S (corresponding author), St Mary Med Ctr Long Beach, Long Beach, CA 90813 USA.	sabine.nguyen@dignityhealth.org							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2017	377	10					977	977		10.1056/NEJMicm1611578	http://dx.doi.org/10.1056/NEJMicm1611578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF9XU	28877017				2022-12-28	WOS:000409373100011
J	Zepp, JA; Zacharias, WJ; Frank, DB; Cavanaugh, CA; Zhou, S; Morley, MP; Morrisey, EE				Zepp, Jarod A.; Zacharias, William J.; Frank, David B.; Cavanaugh, Christina A.; Zhou, Su; Morley, Michael P.; Morrisey, Edward E.			Distinct Mesenchymal Lineages and Niches Promote Epithelial Self-Renewal and Myofibrogenesis in the Lung	CELL			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; KERATINOCYTE GROWTH-FACTOR; ALVEOLAR PROGENITOR; WNT/BETA-CATENIN; STEM-CELLS; ADULT LUNG; II CELLS; MICE; ACTIVATION; SURVIVAL	The lung is an architecturally complex organ comprising a heterogeneous mixture of various epithelial and mesenchymal lineages. We use single-cell RNA sequencing and signaling lineage reporters to generate a spatial and transcriptional map of the lung mesenchyme. We find that each mesenchymal lineage has a distinct spatial address and transcriptional profile leading to unique niche regulatory functions. The mesenchymal alveolar niche cell is Wnt responsive, expresses Pdgfr alpha, and is critical for alveolar epithelial cell growth and self-renewal. In contrast, the Axin2+ myofibrogenic progenitor cell preferentially generates pathologically deleterious myofibroblasts after injury. Analysis of the secretome and receptome of the alveolar niche reveals functional pathways that mediate growth and self-renewal of alveolar type 2 progenitor cells, including IL-6/Stat3, Bmp, and Fgf signaling. These studies define the cellular and molecular framework of lung mesenchymal niches and reveal the functional importance of developmental pathways in promoting self-renewal versus a pathological response to tissue injury.	[Zepp, Jarod A.; Zacharias, William J.; Cavanaugh, Christina A.; Morley, Michael P.; Morrisey, Edward E.] Childrens Hosp Philadelphia, Dept Med, Div Pediat Cardiol, Philadelphia, PA 19104 USA; [Frank, David B.] Childrens Hosp Philadelphia, Dept Pediat, Div Pediat Cardiol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Zepp, Jarod A.; Zacharias, William J.; Frank, David B.; Cavanaugh, Christina A.; Morley, Michael P.; Morrisey, Edward E.] Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA; [Zepp, Jarod A.; Zhou, Su; Morrisey, Edward E.] Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Penn Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Childrens Hosp Philadelphia, Dept Med, Div Pediat Cardiol, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Ctr Pulm Biol, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.; Morrisey, EE (corresponding author), Univ Penn, Penn Inst Regenerat Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu		Morley, Michael/0000-0002-0958-7376; Zacharias, William/0000-0002-2643-0610	NIH [R01-HL132999, R01-HL132349, R01-HL087825, U01-HL134745, U01-HL110942, T32-HL007843, T32-HL007586, T32-HL007915, K12-HD043245]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132349, U01HL134745, R01HL087825, R01HL132999, U01HL110942, T32HL007843, T32HL007915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by funding from the NIH (R01-HL132999, R01-HL132349, R01-HL087825, U01-HL134745, and U01-HL110942 to E.E.M.; T32-HL007843 to J.A.Z.; T32-HL007586 to W.J.Z; T32-HL007915, K12-HD043245 to D.B.F.). The authors would like acknowledge Florin Tuluc and his staff at the Flow Cytometry Core Laboratory of Children's Hospital of Philadelphia for their assistance with FACS and Collin Stabler and Renata Pellegrino and her staff at the Center for Applied Genomics at Children's Hospital of Philadelphia for their assistance with single-cell RNA sequencing. The authors are also grateful for the technical assistance provided by the Penn Cardiovascular Histology Core for their histological services, as well as the Next Generation Sequencing Core and the University of Pennsylvania for the RNA sequencing.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Bellusci S, 1996, DEVELOPMENT, V122, P1693; Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035; Cardoso WV, 1997, DEV DYNAM, V208, P398, DOI 10.1002/(SICI)1097-0177(199703)208:3<398::AID-AJA10>3.0.CO;2-X; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Frank DB, 2016, CELL REP, V17, P2312, DOI 10.1016/j.celrep.2016.11.001; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hsia LT, 2016, P NATL ACAD SCI USA, V113, pE2162, DOI 10.1073/pnas.1603534113; KAPANCI Y, 1992, J HISTOCHEM CYTOCHEM, V40, P1955, DOI 10.1177/40.12.1333502; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee JH, 2017, CELL, V170, P1149, DOI 10.1016/j.cell.2017.07.028; Liang JR, 2016, NAT MED, V22, P1285, DOI 10.1038/nm.4192; Liu YR, 2015, AM J RESP CELL MOL, V53, P113, DOI 10.1165/rcmb.2013-0497OC; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; PANOS RJ, 1993, J CLIN INVEST, V92, P969, DOI 10.1172/JCI116673; Peng T, 2015, NATURE, V526, P578, DOI 10.1038/nature14984; Peng T, 2013, NATURE, V500, P589, DOI 10.1038/nature12358; Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Volckaert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071426; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Wang YY, 2014, DEVELOPMENT, V141, P307, DOI 10.1242/dev.096107; Weaver M, 2000, DEVELOPMENT, V127, P2695; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176	39	255	261	8	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1134	1148		10.1016/j.cell.2017.07.034	http://dx.doi.org/10.1016/j.cell.2017.07.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886382	Green Accepted, Bronze			2022-12-28	WOS:000409536000011
J	[Anonymous]				[Anonymous]			"Found: A One Day Cure for Syphilis" (Reprinted from JAMA, vol 1201, pg 48-49, 1942)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		2017, JAMA, V318, P871	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					871	871		10.1001/jama.2017.10226	http://dx.doi.org/10.1001/jama.2017.10226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873151				2022-12-28	WOS:000409183700028
J	Couzin-Frankel, J				Couzin-Frankel, Jennifer			Anti-inflammatory prevents heart attacks	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					855	855		10.1126/science.357.6354.855	http://dx.doi.org/10.1126/science.357.6354.855			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860361				2022-12-28	WOS:000408734900015
J	Wang, YH; Kuang, Z; Yu, XF; Ruhn, KA; Kubo, M; Hooper, LV				Wang, Yuhao; Kuang, Zheng; Yu, Xiaofei; Ruhn, Kelly A.; Kubo, Masato; Hooper, Lora V.			The intestinal microbiota regulates body composition through NFIL3 and the circadian clock	SCIENCE			English	Article							ROR-GAMMA-T; DENDRITIC CELLS; PROMOTES; OBESITY; HOST; DIFFERENTIATION; HOMEOSTASIS; EPITHELIUM	The intestinal microbiota has been identified as an environmental factor that markedly affects energy storage and body-fat accumulation in mammals, yet the underlying mechanisms remain unclear. Here we show that the microbiota regulates body composition through the circadian transcription factor NFIL3. Nfil3 transcription oscillates diurnally in intestinal epithelial cells, and the amplitude of the circadian oscillation is controlled by the microbiota through group 3 innate lymphoid cells, STAT3 (signal transducer and activator of transcription 3), and the epithelial cell circadian clock. NFIL3 controls expression of a circadian lipid metabolic program and regulates lipid absorption and export in intestinal epithelial cells. These findings provide mechanistic insight into how the intestinal microbiota regulates body composition and establish NFIL3 as an essential molecular link among the microbiota, the circadian clock, and host metabolism.	[Wang, Yuhao; Kuang, Zheng; Yu, Xiaofei; Ruhn, Kelly A.; Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kubo, Masato] RIKEN, Yokohama Inst, Ctr Integrat Med Sci, Lab Cytokine Regulat, Suehiro Cho 1-7-22, Yokohama, Kanagawa 2300045, Japan; [Kubo, Masato] Tokyo Sci Univ, Res Inst Biomed Sci, Div Mol Pathol, 2669 Yamazaki, Chiba 2780022, Japan; [Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yu, Xiaofei] Rockefeller Univ, Lab Mol Genet, New York, NY 10065 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; RIKEN; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rockefeller University	Hooper, LV (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Hooper, LV (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Yu, Xiaofei/J-9245-2017; Kuang, Zheng/ABG-3667-2021	Yu, Xiaofei/0000-0002-1712-331X; 	NIH [R01 DK070855]; Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases Award; Welch Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases Award; Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. L. Behrendt-Boyd, T. Leal, and B. Hassell for assistance with mouse experiments and other members of the Hooper laboratory for discussions and critical reading of the manuscript. This work was supported by NIH grant R01 DK070855 (L. V. H.), a Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Diseases Award (L. V. H.), the Welch Foundation (L. V. H.), and the Howard Hughes Medical Institute (L. V. H.). All data and code to understand and assess the conclusions of this research are available in the main text, supplementary materials, and via the Gene Expression Omnibus repository with accession number GSE100339.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Cai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036785; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Douris N, 2011, CURR BIOL, V21, P1347, DOI 10.1016/j.cub.2011.07.018; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zong HH, 2012, AM J PHYSIOL-ENDOC M, V302, pE532, DOI 10.1152/ajpendo.00258.2011	31	214	232	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					913	+		10.1126/science.aan0677	http://dx.doi.org/10.1126/science.aan0677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860383	Green Accepted			2022-12-28	WOS:000408734900041
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Caveats about collaborative health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Dixon A., 2013, DELIVERING BETTER SE; GODLEE F, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3257; Millenson ML, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3048	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2017	358								j3965	10.1136/bmj.j3965	http://dx.doi.org/10.1136/bmj.j3965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG0CK	28851701	Bronze, Green Published			2022-12-28	WOS:000409386400003
J	Berlowitz, DR; Foy, CG; Kazis, LE; Bolin, LP; Conroy, MB; Fitzpatrick, P; Gure, TR; Kimmel, PL; Kirchner, K; Morisky, DE; Newman, J; Olney, C; Oparil, S; Pajewski, NM; Powell, J; Ramsey, T; Simmons, DL; Snyder, J; Supiano, MA; Weiner, DE; Whittle, J				Berlowitz, Dan R.; Foy, Capri G.; Kazis, Lewis E.; Bolin, Linda P.; Conroy, Molly B.; Fitzpatrick, Peter; Gure, Tanya R.; Kimmel, Paul L.; Kirchner, Kent; Morisky, Donald E.; Newman, Jill; Olney, Christine; Oparil, Suzanne; Pajewski, Nicholas M.; Powell, James; Ramsey, Thomas; Simmons, Debra L.; Snyder, Joni; Supiano, Mark A.; Weiner, Daniel E.; Whittle, Jeff		SPRINT Res Grp	Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; AGED 60 YEARS; HEALTH OUTCOMES; DEPRESSION; OLDER; HYPERTENSION; SPRINT; RISK; ASSOCIATION; POPULATION	BACKGROUND The previously published results of the Systolic Blood Pressure Intervention Trial showed that among participants with hypertension and an increased cardiovascular risk, but without diabetes, the rates of cardiovascular events were lower among those who were assigned to a target systolic blood pressure of less than 120 mm Hg (intensive treatment) than among those who were assigned to a target of less than 140 mm Hg (standard treatment). Whether such intensive treatment affected patient-reported outcomes was uncertain; those results from the trial are reported here. METHODS We randomly assigned 9361 participants with hypertension to a systolic blood-pressure target of less than 120 mm Hg or a target of less than 140 mm Hg. Patient-reported outcome measures included the scores on the Physical Component Summary (PCS) and Mental Component Summary (MCS) of the Veterans RAND 12-Item Health Survey, the Patient Health Questionnaire 9-item depression scale (PHQ-9), patient-reported satisfaction with their blood-pressure care and blood-pressure medications, and adherence to blood-pressure medications. We compared the scores in the intensive-treatment group with those in the standard-treatment group among all participants and among participants stratified according to physical and cognitive function. RESULTS Participants who received intensive treatment received an average of one additional antihypertensive medication, and the systolic blood pressure was 14.8 mm Hg (95% confidence interval, 14.3 to 15.4) lower in the group that received intensive treatment than in the group that received standard treatment. Mean PCS, MCS, and PHQ-9 scores were relatively stable over a median of 3 years of follow-up, with no significant differences between the two treatment groups. No significant differences between the treatment groups were noted when participants were stratified according to baseline measures of physical or cognitive function. Satisfaction with blood-pressure care was high in both treatment groups, and we found no significant difference in adherence to blood-pressure medications. CONCLUSIONS Patient-reported outcomes among participants who received intensive treatment, which targeted a systolic blood pressure of less than 120 mm Hg, were similar to those among participants who received standard treatment, including among participants with decreased physical or cognitive function.	[Berlowitz, Dan R.; Kazis, Lewis E.] Bedford Vet Affairs VA Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Berlowitz, Dan R.; Kazis, Lewis E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Berlowitz, Dan R.; Kazis, Lewis E.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Weiner, Daniel E.] Tufts Med Ctr, Boston, MA USA; [Foy, Capri G.; Newman, Jill; Pajewski, Nicholas M.] Wake Forest Sch Med, Winston Salem, NC USA; [Bolin, Linda P.] East Carolina Univ Coll Nursing, Greenville, NC USA; [Powell, James] East Carolina Univ, Brody Sch Med, Greenville, NC USA; [Conroy, Molly B.] Univ Pittsburgh, Pittsburgh, PA USA; [Fitzpatrick, Peter] Mayo Clin Florida, Jacksonville, FL USA; [Gure, Tanya R.] Ohio State Wexner Med Ctr, Columbus, OH USA; [Kimmel, Paul L.] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA; [Snyder, Joni] NHLBI, Bldg 10, Bethesda, MD 20892 USA; GV Sonny Montgomery VA Med Ctr, Jackson, MS USA; [Morisky, Donald E.] UCLA Fielding Sch Publ Hlth, Los Angeles, CA USA; [Olney, Christine] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Oparil, Suzanne; Ramsey, Thomas] Univ Alabama Birmingham, Birmingham, AL USA; [Simmons, Debra L.; Supiano, Mark A.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Supiano, Mark A.] VA Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA; [Whittle, Jeff] Clement J Zablocki VA Med Ctr, Milwaukee, WI USA	Boston University; Boston University; Tufts Medical Center; Wake Forest University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center	Berlowitz, DR (corresponding author), Bedford VA Hosp, 200 Springs Rd, Bedford, MA 01730 USA.	dan.berlowitz@va.gov	Pajewski, Nicholas/J-1096-2019; Gure, Tanya R/J-8546-2012; Morisky, Donald/AAU-4679-2021; Dwyer, Jamie/A-4799-2015	Rahbari-Oskoui, Frederic/0000-0001-8933-4880; Berlowitz, Dan/0000-0002-8783-5611; Supiano, Mark/0000-0002-5438-5087; Bolin, Linda/0000-0002-2889-3459; Dwyer, Jamie/0000-0002-8402-8961; Kostis, William/0000-0002-0543-9798; Weiner, Daniel/0000-0002-8775-394X; Whittle, Jeff/0000-0002-9544-838X; Ramsey, Thomas M./0000-0002-8182-038X	NIH [HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, HHSN268200900049C, A-HL-13-002-001]; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Institute of Neurological Disorders and Stroke; Clinical and Translational Science Awards - National Center for Advancing Translational Sciences of the NIH [UL1TR000439, UL1RR025755, UL1RR024134, UL1TR000003, UL1RR025771, UL1TR000093, UL1RR025752, UL1TR000073, UL1TR001064, UL1TR000050, UL1 TR000005, 9U54TR000017-06, UL1TR000105-05, UL1 TR000445, UL1TR000075, UL1TR000002, UL1TR000064, UL1TR000433, P30GM103337]; Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433, UL1TR000005, ZIATR000017, UL1TR001064, UL1TR000439, UL1TR000445, UL1TR000003, UL1TR000105, UL1TR002240, UL1TR001427, UL1TR000073, UL1TR000075, UL1TR000093, UL1TR000002, UL1TR000064, UL1TR000050] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755, UL1RR024134, UL1RR025752, UL1RR025771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Clinical and Translational Science Awards - National Center for Advancing Translational Sciences of the NIH; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by contracts (HHSN268200900040C, HHSN268200900046C, HHSN268200900047C, HHSN268200900048C, and HHSN268200900049C) and an interagency agreement (A-HL-13-002-001) from the NIH, including the National Heart, Lung, and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke. Several trial sites were supported by Clinical and Translational Science Awards funded by the National Center for Advancing Translational Sciences of the NIH (Case Western Reserve University: UL1TR000439; Ohio State University: UL1RR025755; University of Pennsylvania: UL1RR024134 and UL1TR000003; Boston University: UL1RR025771; Stanford University: UL1TR000093; Tufts University: UL1RR025752, UL1TR000073, and UL1TR001064; University of Illinois: UL1TR000050; University of Pittsburgh: UL1 TR000005; University of Texas Southwestern: 9U54TR000017-06; University of Utah: UL1TR000105-05; Vanderbilt University: UL1 TR000445; George Washington University: UL1TR000075; University of California, Davis: UL1TR000002; University of Florida: UL1TR000064; University of Michigan: UL1TR000433; and Tulane University: P30GM103337 COBRE Award NIGMS). The trial was also supported in part with respect to resources and the use of facilities by the Department of Veterans Affairs.	Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; Bress AP, 2016, J AM COLL CARDIOL, V67, P463, DOI 10.1016/j.jacc.2015.10.037; Chobanian AV, 2015, NEW ENGL J MED, V373, P2093, DOI 10.1056/NEJMp1513290; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; Gangavati A, 2011, J AM GERIATR SOC, V59, P383, DOI 10.1111/j.1532-5415.2011.03317.x; Grimm RH, 1997, ARCH INTERN MED, V157, P638, DOI 10.1001/archinte.157.6.638; Hildrum B, 2007, J EPIDEMIOL COMMUN H, V61, P53, DOI 10.1136/jech.2005.044966; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lipsitz LA, 2015, HYPERTENSION, V66, P183, DOI 10.1161/HYPERTENSIONAHA.115.05513; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Moonen JEF, 2015, JAMA INTERN MED, V175, P1622, DOI 10.1001/jamainternmed.2015.4103; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Moser Marvin, 2006, J Clin Hypertens (Greenwich), V8, P313, DOI 10.1111/j.1524-6175.2005.05153.x; Muntner P, 2011, ANN PHARMACOTHER, V45, P569, DOI 10.1345/aph.1P677; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Connor PJ, 2012, DIABETES CARE, V35, P1479, DOI 10.2337/dc11-1868; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Ortiz E, 2016, ANN INTERN MED, V165, P889, DOI 10.7326/L16-0442; Pajewski NM, 2016, J GERONTOL A-BIOL, V71, P649, DOI 10.1093/gerona/glv228; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; R Development Core Team, 2011, R FDN STAT COMP; Sabayan B, 2013, STROKE, V44, P15, DOI 10.1161/STROKEAHA.112.663062; Saper CB, 2015, ANN NEUROL, V78, P665, DOI 10.1002/ana.24530; Schiffrin EL, 2016, AM J HYPERTENS, V29, P2, DOI 10.1093/ajh/hpv190; Selim AJ, 2010, HEALTH SERV RES, V45, P376, DOI 10.1111/j.1475-6773.2009.01068.x; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Tryambake D, 2013, HYPERTENSION, V61, P1309, DOI 10.1161/HYPERTENSIONAHA.112.200972; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Wright JT, 2014, ANN INTERN MED, V160, P499, DOI 10.7326/M13-2981	34	112	113	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					733	744		10.1056/NEJMoa1611179	http://dx.doi.org/10.1056/NEJMoa1611179			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28834483	Green Accepted, Bronze			2022-12-28	WOS:000413090000006
J	Krem, MM				Krem, Maxwell M.			Man versus Nature - Also Sprach Zarathustra and an End-of-Life House Call	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Krem, Maxwell M.] Univ Louisville, Sch Med, Div Blood & Bone Marrow Transplantat, Louisville, KY 40292 USA	University of Louisville	Krem, MM (corresponding author), Univ Louisville, Sch Med, Div Blood & Bone Marrow Transplantat, Louisville, KY 40292 USA.							Meltzer K., 2013, JUNE 2013 DISTANT WO	1	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					709	711		10.1056/NEJMp1705492	http://dx.doi.org/10.1056/NEJMp1705492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28834470				2022-12-28	WOS:000413090000003
J	Long, GV; Hauschild, A; Santinami, M; Atkinson, V; Mandala, M; Chiarion-Sileni, V; Larkin, J; Nyakas, M; Dutriaux, C; Haydon, A; Robert, C; Mortier, L; Schachter, J; Schadendorf, D; Lesimple, T; Plummer, R; Ji, R; Zhang, P; Mookerjee, B; Legos, J; Kefford, R; Dummer, R; Kirkwood, JM				Long, G. V.; Hauschild, A.; Santinami, M.; Atkinson, V.; Mandala, M.; Chiarion-Sileni, V.; Larkin, J.; Nyakas, M.; Dutriaux, C.; Haydon, A.; Robert, C.; Mortier, L.; Schachter, J.; Schadendorf, D.; Lesimple, T.; Plummer, R.; Ji, R.; Zhang, P.; Mookerjee, B.; Legos, J.; Kefford, R.; Dummer, R.; Kirkwood, J. M.			Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-RISK MELANOMA; PHASE-III; MEK INHIBITION; DOUBLE-BLIND; SURVIVAL; IPILIMUMAB; THERAPY; INTERFERON-ALPHA-2B; PLACEBO; HAZARD	BACKGROUND Combination therapy with the BRAF inhibitor dabrafenib plus the MEK inhibitor trametinib improved survival in patients with advanced melanoma with BRAF V600 mutations. We sought to determine whether adjuvant dabrafenib plus trametinib would improve outcomes in patients with resected, stage III melanoma with BRAF V600 mutations. METHODS In this double-blind, placebo-controlled, phase 3 trial, we randomly assigned 870 patients with completely resected, stage III melanoma with BRAF V600E or V600K mutations to receive oral dabrafenib at a dose of 150 mg twice daily plus trametinib at a dose of 2 mg once daily (combination therapy, 438 patients) or two matched placebo tablets (432 patients) for 12 months. The primary end point was relapse-free survival. Secondary end points included overall survival, distant metastasis-free survival, freedom from relapse, and safety. RESULTS At a median follow-up of 2.8 years, the estimated 3-year rate of relapse-free survival was 58% in the combination-therapy group and 39% in the placebo group (hazard ratio for relapse or death, 0.47; 95% confidence interval [CI], 0.39 to 0.58; P<0.001). The 3-year overall survival rate was 86% in the combination-therapy group and 77% in the placebo group (hazard ratio for death, 0.57; 95% CI, 0.42 to 0.79; P = 0.0006), but this level of improvement did not cross the prespecified interim analysis boundary of P=0.000019. Rates of distant metastasis-free survival and freedom from relapse were also higher in the combination-therapy group than in the placebo group. The safety profile of dabrafenib plus trametinib was consistent with that observed with the combination in patients with metastatic melanoma. CONCLUSIONS Adjuvant use of combination therapy with dabrafenib plus trametinib resulted in a significantly lower risk of recurrence in patients with stage III melanoma with BRAF V600E or V600K mutations than the adjuvant use of placebo and was not associated with new toxic effects.	[Long, G. V.] Univ Sydney, Royal North Shore & Mater Hosp, Melanoma Inst Australia, Sydney, NSW, Australia; [Kefford, R.] Univ Sydney, Macquarie Univ, Melanoma Inst Australia, Sydney, NSW, Australia; [Kefford, R.] Westmead Hosp, Sydney, NSW, Australia; [Atkinson, V.] Univ Queensland, Princess Alexandra Hosp, Gallipoli Med Res Fdn, Brisbane, Qld, Australia; [Haydon, A.] Alfred Hosp, Melbourne, Vic, Australia; [Hauschild, A.] Univ Hosp Schleswig Holstein, Kiel, Germany; [Schadendorf, D.] Univ Hosp Essen, Essen, Germany; [Schadendorf, D.] German Canc Consortium, Heidelberg, Germany; [Santinami, M.] Fdn Ist Nazl Tumori, Milan, Italy; [Mandala, M.] Papa Giovanni XXIII Canc Ctr Hosp, Bergamo, Italy; [Chiarion-Sileni, V.] Veneto Oncol Inst, Melanoma Oncol Unit, Padua, Italy; [Nyakas, M.] Radiumhosp, Rikshosp, Oslo, Norway; [Dutriaux, C.] Hop St Andre, Ctr Hosp Univ Bordeaux, Bordeaux, France; [Robert, C.] Inst Gustave Roussy, Paris, France; [Mortier, L.] Univ Lille, Ctr Hosp Reg Univ Lille, INSERM, Unite 1189, Lille, France; [Lesimple, T.] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France; [Schachter, J.] Sheba Med Ctr, Ella Inst Melanoma, Tel Hashomer, Israel; [Larkin, J.] Royal Marsden NHS Fdn Trust, London, England; [Plummer, R.] Freeman Rd Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England; [Ji, R.; Zhang, P.; Mookerjee, B.; Legos, J.] Novartis Pharmaceut, E Hanover, NJ USA; [Dummer, R.] Univ Hosp Zurich Skin Canc Ctr, Zurich, Switzerland; [Kirkwood, J. M.] Univ Pittsburgh, Hillman UPMC Canc Ctr, Melanoma Program, Pittsburgh, PA USA	Melanoma Institute Australia; Royal North Shore Hospital; University of Sydney; Macquarie University; Melanoma Institute Australia; University of Sydney; University of Sydney; University of Queensland; Florey Institute of Neuroscience & Mental Health; University of Kiel; Schleswig Holstein University Hospital; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Fondazione IRCCS Istituto Nazionale Tumori Milan; ASST Papa Giovanni XXIII; IRCCS Istituto Oncologico Veneto (IOV); University of Oslo; National Hospital Norway; CHU Bordeaux; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; UNICANCER; Centre Eugene Marquis; Chaim Sheba Medical Center; Royal Marsden NHS Foundation Trust; Newcastle Freeman Hospital; Newcastle University - UK; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Long, GV (corresponding author), Univ Sydney, Melanoma Inst Australia, 40 Rocklands Rd, Sydney, NSW 2060, Australia.	georgina.long@sydney.edu.au	mandala, mario/AAB-8637-2022; Atkinson, Victoria G/G-2507-2015; Robert, Caroline/G-6157-2018; Schadendorf, Dirk/AAE-8206-2019; sileni, vanna chiarion/B-9042-2018; Santinami, Mario/I-3795-2017; Long, Georgina V/C-1771-2013; Mandala', Mario/AAA-4258-2019	Robert, Caroline/0000-0002-9493-0238; sileni, vanna chiarion/0000-0001-9191-9124; Santinami, Mario/0000-0001-8436-4757; Long, Georgina V/0000-0001-8894-3545; Larkin, James/0000-0001-5569-9523; Kefford, Richard/0000-0001-9251-9229; MORTIER, Laurent/0000-0002-2644-1790	GlaxoSmithKline; Novartis; National Institute for Health Research Biomedical Research Centre at the Royal Marsden NHS Foundation Trust; Institute of Cancer Research; Australian National Health and Medical Research Council fellowship; University of Sydney Medical Foundation; Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Sharp Dohme; Pierre Fabre; Roche; Merck; Provectus; Merck Serono; Philogen; Regeneron; OncoSec; Pfizer; Eisai; Kymab; Roche/Genentech; Secarna; EUSA Pharma; Sysmex; Boehringer Ingelheim; Novartis/GlaxoSmithKline; Teva; Takeda; Prometheus; Genentech; EMD Serono	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); National Institute for Health Research Biomedical Research Centre at the Royal Marsden NHS Foundation Trust; Institute of Cancer Research; Australian National Health and Medical Research Council fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Medical Foundation(University of Sydney); Amgen(Amgen); Array BioPharma(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); Pierre Fabre; Roche(Roche Holding); Merck(Merck & Company); Provectus; Merck Serono(Merck & Company); Philogen; Regeneron(Regeneron); OncoSec; Pfizer(Pfizer); Eisai(Eisai Co Ltd); Kymab; Roche/Genentech(Roche HoldingGenentech); Secarna; EUSA Pharma; Sysmex; Boehringer Ingelheim(Boehringer Ingelheim); Novartis/GlaxoSmithKline; Teva(Teva Pharmaceutical Industries); Takeda(Takeda Pharmaceutical Company Ltd); Prometheus; Genentech(Roche HoldingGenentech); EMD Serono	Supported by GlaxoSmithKline and Novartis. Dr. Larkin is supported by the National Institute for Health Research Biomedical Research Centre at the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research. Dr. Long is supported by an Australian National Health and Medical Research Council fellowship and the University of Sydney Medical Foundation.; Dr. Long reports receiving consulting fees from Amgen, Array BioPharma, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Pierre Fabre, and Roche; Dr. Hauschild, receiving grant support, lecture fees, and consulting fees from Amgen, Bristol-Myers Squibb, Merck, Pierre Fabre, Provectus, and Roche, grant support and consulting fees from Merck Serono, Philogen, and Regeneron, and consulting fees from OncoSec; Dr. Atkinson, receiving travel support, advisory board fees, and lecture fees from Merck Sharp & Dohme, Bristol-Myers Squibb, and Novartis, lecture fees from Roche, and advisory board fees from Pierre Fabre; Dr. Mandala, receiving grant support, advisory board fees, and lecture fees from Roche and advisory board fees and lecture fees from Novartis, Merck Sharp & Dohme, and Bristol-Myers Squibb; Dr. Chiarion-Sileni, receiving advisory board fees from Bristol-Myers Squibb, Merck Sharp & Dohme, Roche, Novartis, and Merck Serono; Dr. Larkin, receiving grant support, paid to his institution, and consulting fees from Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, and Novartis and consulting fees from Eisai, GlaxoSmithKline, Kymab, Roche/Genentech, Secarna, Pierre Fabre, and EUSA Pharma; Dr. Mortier, receiving fees for serving on a medical board from Roche; Dr. Schadendorf, receiving grant support, consulting fees, lecture fees, and fees for serving on speakers bureaus from Novartis and Bristol-Myers Squibb, consulting fees, lecture fees, and fees for serving on speakers bureaus from Merck, Amgen, and GlaxoSmithKline, and consulting fees from Sysmex and Boehringer Ingelheim; Dr. Lesimple, receiving advisory board fees from Novartis, advisory board fees, travel support, and drugs from Roche, and advisory board fees and travel support from Merck Sharp & Dohme; Dr. Plummer, receiving clinical trial support, paid to her institution, and consulting fees from Novartis/GlaxoSmithKline; Dr. Ji, being employed by Novartis; Dr. Zhang, being employed by Novartis; Dr. Mookerjee, being employed by and having stock options in Novartis and GlaxoSmithKline; Dr. Legos, being employed by and being a shareholder in Novartis; Dr. Kefford, receiving advisory board fees and fees for conference reporting, paid to his institution, from Bristol-Myers Squibb, and advisory board fees, paid to his institution, from Merck, Amgen, and Teva; Dr. Dummer, receiving consulting fees from Novartis, Merck Sharp & Dohme, Roche, Takeda, and Pierre Fabre and grant support and consulting fees from Bristol-Myers Squibb and Amgen; and Dr. Kirkwood, receiving grant support, paid to his institution, from Merck and Prometheus and advisory board fees from Bristol-Myers Squibb, Novartis, Roche, Genentech, EMD Serono, and Array BioPharma. No other potential conflict of interest relevant to this article was reported.	Amin MB, 2016, AJCC CANC STAGING MA; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; BERNSTEIN L, 1981, BIOMETRICS, V37, P513, DOI 10.2307/2530564; BERRY G, 1991, STAT MED, V10, P749, DOI 10.1002/sim.4780100510; Edge SB, 2010, AJCC CANC STAGING MA; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gershenwald JE, CA CANC J C IN PRESS; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2016, J CLIN ONCOL, V34, P871, DOI 10.1200/JCO.2015.62.9345; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Long GV, 2017, ANN ONCOL; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Mocellin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008955.pub2; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; National Comprehensive Cancer Network, 2017, CLIN PRACT GUID ONC; Robert C, 2015, EUR J CANCER, V51, pS663, DOI 10.1016/S0959-8049(16)31820-2; Robert C, 2016, ANN ONCOL, V6, P27, DOI DOI 10.1093/ANNONC/MDW335.03; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tarhini AA, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9500; Weber J, 2015, J IMMUNOTHER CANCER, V2, P3	26	800	811	3	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2017	377	19					1813	1823		10.1056/NEJMoa1708539	http://dx.doi.org/10.1056/NEJMoa1708539			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM2QW	28891408	Green Accepted, Green Published			2022-12-28	WOS:000414845700006
J	Sun, EC; Jena, AB				Sun, Eric C.; Jena, Anupam B.			Distribution of Prescription Opioid Use Among Privately Insured Adults Without Cancer: United States, 2001 to 2013	ANNALS OF INTERNAL MEDICINE			English	Letter									[Sun, Eric C.] Stanford Univ, Stanford, CA 94305 USA; [Jena, Anupam B.] Harvard Med Sch, Boston, MA USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Stanford University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sun, EC (corresponding author), Stanford Univ, Stanford, CA 94305 USA.		Sun, Eric/K-3900-2019		K08 award; National Institute on Drug Abuse [K08DA042314-01]; National Institutes of Health Early Independence Award; Office of the Director, National Institutes of Health [1DP5OD017897-01]; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA042314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	K08 award; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Sun is supported by a K08 award and grant K08DA042314-01 from the National Institute on Drug Abuse. Dr. Jena is supported by the National Institutes of Health Early Independence Award and grant 1DP5OD017897-01 from the Office of the Director, National Institutes of Health.	Aizcorbe Ana, 2012, Stat J IAOS, V28, P43, DOI 10.3233/SJI-2012-0743; American Pain Society, 2008, PRINC AN US TREATM A; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Lipari R.N., 2016, PRESCRIPTION DRUG US; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433	5	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2017	167	9					684	686		10.7326/M17-1408	http://dx.doi.org/10.7326/M17-1408			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM1DV	28892817	Green Accepted			2022-12-28	WOS:000414714700015
J	Agarwal, N; Freakley, SJ; McVicker, RU; Althahban, SM; Dimitratos, N; He, Q; Morgan, DJ; Jenkins, RL; Willock, DJ; Taylor, SH; Kiely, CJ; Hutchings, GJ				Agarwal, Nishtha; Freakley, Simon J.; McVicker, Rebecca U.; Althahban, Sultan M.; Dimitratos, Nikolaos; He, Qian; Morgan, David J.; Jenkins, Robert L.; Willock, David J.; Taylor, Stuart H.; Kiely, Christopher J.; Hutchings, Graham J.			Aqueous Au-Pd colloids catalyze selective CH4 oxidation to CH3OH with O-2 under mild conditions	SCIENCE			English	Article							LOW-TEMPERATURE OXIDATION; HYDROGEN-PEROXIDE; ALLOY NANOPARTICLES; SOL IMMOBILIZATION; METHANE; CONVERSION; ALKANES; SURFACE; ETHANE; SYSTEM	The selective oxidation of methane, the primary component of natural gas, remains an important challenge in catalysis. We used colloidal gold-palladium nanoparticles, rather than the same nanoparticles supported on titanium oxide, to oxidize methane to methanol with high selectivity (92%) in aqueous solution at mild temperatures. Then, using isotopically labeled oxygen (O-2) as an oxidant in the presence of hydrogen peroxide (H2O2), we demonstrated that the resulting methanol incorporated a substantial fraction (70%) of gas-phase O-2. More oxygenated products were formed than the amount of H2O2 consumed, suggesting that the controlled breakdown of H2O2 activates methane, which subsequently incorporates molecular oxygen through a radical process. If a source of methyl radicals can be established, then the selective oxidation of methane to methanol using molecular oxygen is possible.	[Agarwal, Nishtha; Freakley, Simon J.; McVicker, Rebecca U.; Dimitratos, Nikolaos; He, Qian; Morgan, David J.; Jenkins, Robert L.; Willock, David J.; Taylor, Stuart H.; Kiely, Christopher J.; Hutchings, Graham J.] Cardiff Univ, Cardiff Catalysis Inst, Sch Chem, Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales; [Althahban, Sultan M.; Kiely, Christopher J.] Lehigh Univ, Dept Mat Sci & Engn, 5 East Packer Ave, Bethlehem, PA 18015 USA	Cardiff University; Lehigh University	Hutchings, GJ (corresponding author), Cardiff Univ, Cardiff Catalysis Inst, Sch Chem, Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	hutch@cardiff.ac.uk	Willock, David J/A-2819-2011; Dimitratos, Nikolaos/O-1699-2019; He, Qian/U-1329-2019; Morgan, David John/F-6285-2010; agarwal, nishtha/AAL-5128-2020; He, Qian/AAK-8732-2020; Dimitratos, Nikolaos/B-8787-2008; Taylor, Stuart/A-3125-2011	Willock, David J/0000-0002-8893-1090; Morgan, David John/0000-0002-6571-5731; agarwal, nishtha/0000-0002-6747-2876; He, Qian/0000-0003-4891-3581; Dimitratos, Nikolaos/0000-0002-6620-4335; Taylor, Stuart/0000-0002-1933-4874; Freakley, Simon/0000-0002-6395-6646; Hutchings, Graham/0000-0001-8885-1560; Althahban, sultan/0000-0003-2228-1184; Kiely, Christopher/0000-0001-5412-0970	MAXNET Energy Consortium; NSF Major Research Instrumentation program [MRI/DMR-1040229]; Saudi Arabian government	MAXNET Energy Consortium; NSF Major Research Instrumentation program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Saudi Arabian government	We acknowledge Cardiff University for financial support as part of the MAXNET Energy Consortium. C.J.K. acknowledges funding from the NSF Major Research Instrumentation program (grant MRI/DMR-1040229). S.M.A. thanks the Saudi Arabian government for his Ph.D. scholarship. All results are reported in the main text and supplementary materials.	Ab Rahim MH, 2013, ANGEW CHEM INT EDIT, V52, P1280, DOI 10.1002/anie.201207717; Antcliff KL, 2003, PHYS CHEM CHEM PHYS, V5, P4306, DOI 10.1039/b306398b; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; Conley BL, 2006, J MOL CATAL A-CHEM, V251, P8, DOI 10.1016/j.molcata.2006.02.035; FRESE KW, 1991, LANGMUIR, V7, P13, DOI 10.1021/la00049a004; GESSER HD, 1985, CHEM REV, V85, P235, DOI 10.1021/cr00068a001; Gondal MA, 2003, APPL CATAL A-GEN, V243, P165, DOI 10.1016/S0926-860X(02)00562-8; Groothaert MH, 2005, J AM CHEM SOC, V127, P1394, DOI 10.1021/ja047158u; Hammond C, 2012, ANGEW CHEM INT EDIT, V51, P5129, DOI 10.1002/anie.201108706; IEA, 2013, RES RES 2013; Jones CJ, 2004, ANGEW CHEM, V116, P4726; KAO LC, 1991, J AM CHEM SOC, V113, P700, DOI 10.1021/ja00002a063; Kesavan L, 2011, SCIENCE, V331, P195, DOI 10.1126/science.1198458; Lopez-Sanchez JA, 2008, PHYS CHEM CHEM PHYS, V10, P1921, DOI 10.1039/b719345a; Minasyan V. T., 1998, OXID COMMUN, V11, P87; Nizova GV, 1997, CHEM COMMUN, P397, DOI 10.1039/a607765j; Noceti RP, 1997, CATAL TODAY, V33, P199, DOI 10.1016/S0920-5861(96)00155-1; Oliver-Meseguer J, 2012, SCIENCE, V338, P1452, DOI 10.1126/science.1227813; OLIVERA PP, 1995, SURF SCI, V327, P330, DOI 10.1016/0039-6028(94)00847-7; Palkovits R, 2009, ANGEW CHEM INT EDIT, V48, P6909, DOI 10.1002/anie.200902009; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; PERIANA RA, 1993, SCIENCE, V259, P340, DOI 10.1126/science.259.5093.340; Pritchard J, 2013, CATAL SCI TECHNOL, V3, P308, DOI 10.1039/c2cy20234d; Sheppard T, 2014, CHEM COMMUN, V50, P11053, DOI 10.1039/c4cc02832e; Shul'pin GB, 2004, ADV SYNTH CATAL, V346, P317, DOI 10.1002/adsc.200303147; SOBOLEV VI, 1995, CATAL TODAY, V24, P251, DOI 10.1016/0920-5861(95)00035-E; Starokon EV, 2013, J CATAL, V300, P47, DOI 10.1016/j.jcat.2012.12.030; Sushkevich VL, 2017, SCIENCE, V356, P523, DOI 10.1126/science.aam9035; Thetford A, 2011, P ROY SOC A-MATH PHY, V467, P1885, DOI 10.1098/rspa.2010.0561; Tomita A, 2008, ANGEW CHEM INT EDIT, V47, P1462, DOI 10.1002/anie.200703928; Xie J, 2016, ANGEW CHEM INT EDIT, V55, P9416, DOI 10.1002/anie.201602347; Yuan Q, 2007, ADV SYNTH CATAL, V349, P1199, DOI 10.1002/adsc.200600438	32	320	343	46	772	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2017	358	6360					223	226		10.1126/science.aan6515	http://dx.doi.org/10.1126/science.aan6515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ6CO	28882995	Green Submitted, Green Accepted			2022-12-28	WOS:000412841500048
J	Chen, H; Ye, F; Tang, WT; He, JJ; Yin, MS; Wang, YB; Xie, FX; Bi, EB; Yang, XD; Gratzel, M; Han, LY				Chen, Han; Ye, Fei; Tang, Wentao; He, Jinjin; Yin, Maoshu; Wang, Yanbo; Xie, Fengxian; Bi, Enbing; Yang, Xudong; Gratzel, Michael; Han, Liyuan			A solvent- and vacuum-free route to large-area perovskite films for efficient solar modules	NATURE			English	Article							HALIDE PEROVSKITES; THIN-FILMS; CELLS; PERFORMANCE; DEPOSITION; METHYLAMINE; CH3NH3PBI3; STABILITY; ADSORPTION; LAYERS	Recent advances in the use of organic-inorganic hybrid perovskites for optoelectronics have been rapid, with reported power conversion efficiencies of up to 22 per cent for perovskite solar cells1-9. Improvements in stability have also enabled testing over a timescale of thousands of hours(10-14). However, large-scale deployment of such cells will also require the ability to produce large-area, uniformly high-quality perovskite films. A key challenge is to overcome the substantial reduction in power conversion efficiency when a small device is scaled up: a reduction from over 20 per cent to about 10 per cent is found(15-21) when a common aperture area of about 0.1 square centimetres is increased to more than 25 square centimetres. Here we report a new deposition route for methyl ammonium lead halide perovskite films that does not rely on use of a common solvent(1,2,4-15) or vacuum3: rather, it relies on the rapid conversion of amine complex precursors to perovskite films, followed by a pressure application step. The deposited perovskite films were free of pin-holes and highly uniform. Importantly, the new deposition approach can be performed in air at low temperatures, facilitating fabrication of large-area perovskite devices. We reached a certified power conversion efficiency of 12.1 per cent with an aperture area of 36.1 square centimetres for a mesoporous TiO2-based perovskite solar module architecture.	[Chen, Han; Ye, Fei; Tang, Wentao; He, Jinjin; Yin, Maoshu; Wang, Yanbo; Yang, Xudong; Han, Liyuan] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China; [Xie, Fengxian; Han, Liyuan] Natl Inst Mat Sci, Res Network & Facil Serv Div, Tsukuba, Ibaraki 3050047, Japan; [Bi, Enbing] Suzhou Liyuan New Energy Technol Co, M1,2 Peiyuan Rd, Suzhou, Peoples R China; [Gratzel, Michael] Swiss Fed Inst Technol, Inst Chem & Engn Sci, Lab Photon & Interfaces, Stn 6, CH-1015 Lausanne, Switzerland	Shanghai Jiao Tong University; National Institute for Materials Science; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Yang, XD; Han, LY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China.; Han, LY (corresponding author), Natl Inst Mat Sci, Res Network & Facil Serv Div, Tsukuba, Ibaraki 3050047, Japan.	yang.xudong@sjtu.edu.cn; han.liyuan@nims.go.jp	Han, Liyuan/O-2856-2019; Ye, Fei/F-2605-2012; Nazeeruddin, Mohammad K/B-1323-2008; Wang, Yanbo/AAY-3761-2021; Wang, Yanbo/HFZ-8018-2022; Yang, Xudong/S-4750-2017; Chen, Han/S-4723-2017	Han, Liyuan/0000-0001-9766-9015; Ye, Fei/0000-0001-9132-3283; Nazeeruddin, Mohammad K/0000-0001-5955-4786; Yang, Xudong/0000-0002-3877-7830; Chen, Han/0000-0002-3727-6823; Wang, Yanbo/0000-0002-6061-7577	National Natural Science Foundation of China [11574199, 11674219]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Natural Science Foundation of Shanghai [17ZR1414800]; European Research Council (ERC); Mesolight Advanced Research Grant (ARF)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); European Research Council (ERC)(European Research Council (ERC)); Mesolight Advanced Research Grant (ARF)	This work was supported by the National Natural Science Foundation of China (grant nos 11574199 and 11674219), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Natural Science Foundation of Shanghai (17ZR1414800). We thank B. Dai from Instrumental Analysis Center of SJTU and G. Lu from Shanghai Institute of Organic Chemistry for NMR measurements, and Y. Wu for discussions. M.G. thanks the European Research Council (ERC) for support of this work under a Proof of Concept project associated with his Mesolight Advanced Research Grant (ARF).	Bella F, 2016, SCIENCE, V354, P203, DOI 10.1126/science.aah4046; Bi DQ, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.142, 10.1038/nenergy.2016.142]; Bi EB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15330; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chen W, 2015, SCIENCE, V350, P944, DOI 10.1126/science.aad1015; Gardner KL, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600386; Green MA, 2017, PROG PHOTOVOLTAICS, V25, P3, DOI 10.1002/pip.2855; Hu Y, 2017, SOL RRL, V1, DOI 10.1002/solr.201600019; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Li X, 2016, SCIENCE, V353, P58, DOI 10.1126/science.aaf8060; Li X, 2015, NAT CHEM, V7, P703, DOI [10.1038/nchem.2324, 10.1038/NCHEM.2324]; Liao LF, 2001, J PHYS CHEM B, V105, P5928, DOI 10.1021/jp004285d; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Matteocci F, 2014, PHYS CHEM CHEM PHYS, V16, P3918, DOI 10.1039/c3cp55313b; Matteocci F, 2016, PROG PHOTOVOLTAICS, V24, P436, DOI 10.1002/pip.2557; Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763; Nunney TS, 1999, SURF SCI, V427-28, P282, DOI 10.1016/S0039-6028(99)00280-0; Patel JB, 2016, J PHYS CHEM LETT, V7, P96, DOI 10.1021/acs.jpclett.5b02495; Qiu W, 2016, ENERG ENVIRON SCI, V9, P484, DOI 10.1039/c5ee03703d; Razza S, 2015, J POWER SOURCES, V277, P286, DOI 10.1016/j.jpowsour.2014.12.008; Rosales BA, 2016, CHEM MATER, V28, P6848, DOI 10.1021/acs.chemmater.6b01874; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Xiao ZG, 2014, ADV MATER, V26, P6503, DOI 10.1002/adma.201401685; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Ye F, 2016, ENERG ENVIRON SCI, V9, P2295, DOI 10.1039/c6ee01411a; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Zhou ZM, 2015, ANGEW CHEM INT EDIT, V54, P9705, DOI 10.1002/anie.201504379	30	528	543	51	1040	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 5	2017	550	7674					92	+		10.1038/nature23877	http://dx.doi.org/10.1038/nature23877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7XU	28869967				2022-12-28	WOS:000412214100051
J	Kahan, S; Manson, JE				Kahan, Scott; Manson, Joann E.			Nutrition Counseling in Clinical Practice How Clinicians Can Do Better	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kahan, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Kahan, Scott] George Washington Univ, Sch Med, Washington, DC USA; [Manson, Joann E.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Manson, Joann E.] Harvard Med Sch, Boston, MA 02215 USA; [Manson, Joann E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,Third Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu		Kahan, Scott/0000-0002-3080-0661				Adams KM, 2010, ACAD MED, V85, P1537, DOI 10.1097/ACM.0b013e3181eab71b; [Anonymous], HLTH PEOPL 2020; Batsis JA, 2016, OBESITY, V24, P1983, DOI 10.1002/oby.21578; Kahan S, 2014, HLTH BEHAV CHANGE PO; Kolasa KM, 2010, NUTR CLIN PRACT, V25, P502, DOI 10.1177/0884533610380057; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; Paxton AE, 2011, AM J PREV MED, V40, P67, DOI 10.1016/j.amepre.2010.10.009; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Williams MJA, 1999, J AM COLL CARDIOL, V33, P1050, DOI 10.1016/S0735-1097(98)00681-0	10	49	51	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2017	318	12					1101	1102		10.1001/jama.2017.10434	http://dx.doi.org/10.1001/jama.2017.10434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI2LE	28880975				2022-12-28	WOS:000411769300011
J	Gostin, LO				Gostin, Lawrence O.			"America's Health First": A Misnomer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA; [Gostin, Lawrence O.] World Hlth Org, Collaborating Ctr Publ Hlth Law & Human Rights, Washington, DC 20057 USA	Georgetown University; World Health Organization	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA.; Gostin, LO (corresponding author), World Hlth Org, Collaborating Ctr Publ Hlth Law & Human Rights, Washington, DC 20057 USA.	gostin@law.georgetown.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					896	897		10.1001/jama.2017.11239	http://dx.doi.org/10.1001/jama.2017.11239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898368	Green Published			2022-12-28	WOS:000410487100002
J	Andersen, PR; Tirian, L; Vunjak, M; Rennecke, JB				Andersen, Peter Refsing; Tirian, Laszlo; Vunjak, Milica; Rennecke, Julius B.			A heterochromatin-dependent transcription machinery drives piRNA expression	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; TBP-LIKE FACTOR; SMALL RNAS; CRYSTAL-STRUCTURE; MICE LACKING; POL II; TFIIA; TRF2; COMPLEX; CHROMATIN	Nuclear small RNA pathways safeguard genome integrity by establishing transcription-repressing heterochromatin at transposable elements. This inevitably also targets the transposon-rich source loci of the small RNAs themselves. How small RNA source loci are efficiently transcribed while transposon promoters are potently silenced is not understood. Here we show that, in Drosophila, transcription of PIWI-interacting RNA (piRNA) clusters-small RNA source loci in animal gonads-is enforced through RNA polymerase II pre-initiation complex formation within repressive heterochromatin. This is accomplished through Moonshiner, a paralogue of a basal transcription factor IIA (TFIIA) subunit, which is recruited to piRNA clusters via the heterochromatin protein-1 variant Rhino. Moonshiner triggers transcription initiation within piRNA clusters by recruiting the TATA-box binding protein (TBP)-related factor TRF2, an animal TFIID core variant. Thus, transcription of heterochromatic small RNA source loci relies on direct recruitment of the core transcriptional machinery to DNA via histone marks rather than sequence motifs, a concept that we argue is a recurring theme in evolution.	[Andersen, Peter Refsing; Tirian, Laszlo; Vunjak, Milica; Rennecke, Julius B.] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Andersen, PR; Rennecke, JB (corresponding author), Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	peter.andersen@imba.oeaw.ac.at; julius.brennecke@imba.oeaw.ac.at	Brennecke, Julius/T-5883-2019; Brennecke, Julius/C-1626-2015	Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; Vunjak, Milica/0000-0001-6330-363X; Andersen, Peter Ebert/0000-0001-5815-4860	Austrian Academy of Sciences; European Community (ERC) [260711EU, ERC-2015-CoG-682181]; Alfred Benzon Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0009189] Funding Source: researchfish	Austrian Academy of Sciences; European Community (ERC)(European CommissionEuropean Research Council (ERC)); Alfred Benzon Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank K. Meixner for experimental support, D. Handler and D. Jurczak for bioinformatics help, P. Duchek and J. Gokcezade for generating CRISPR-edited and transgenic flies, K. Mechtler and his team for mass spectrometry, T. Lendl for RNA FISH quantification, A. Schleiffer and M. Novatchkova for Moonshiner phylogenetic analysis, the Vienna Biocenter Core Facilities Next Generation Sequencing unit for deep sequencing, M. Elmaghraby for the Deadlock antigen, the Max F. Perutz Laboratories monoclonal facility for the Deadlock antibody, and the Vienna Drosophila RNAi Center, TRiP, and Bloomington stock centers for flies. We thank A. Ordonez, D. Handler, F. Mohn, F. Muerdter, M. Buhler, and especially O. Wueseke (Impulse Science) and Life Science Editors for comments on the manuscript. This work was supported by the Austrian Academy of Sciences and the European Community (ERC grant 260711EU and ERC-2015-CoG-682181). P.R.A. is supported by fellowships from the Alfred Benzon Foundation and the Novo Nordisk Foundation.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2021, LANG ENV STAT COMP; Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; BOLSTAD BM, PREPROCESSCORE COLLE; Brancorsini S, 2008, CELL CYCLE, V7, P1415, DOI 10.4161/cc.7.10.5835; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen YCA, 2016, MOL CELL, V63, P97, DOI 10.1016/j.molcel.2016.05.010; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Duttke SHC, 2014, GENE DEV, V28, P2071, DOI 10.1101/gad.250563.114; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Gokcezade J, 2014, G3-GENES GENOM GENET, V4, P2279, DOI 10.1534/g3.114.014126; Goriaux C, 2014, EMBO REP, V15, P411, DOI 10.1002/embr.201337898; Gu WF, 2012, CELL, V151, P1488, DOI 10.1016/j.cell.2012.11.023; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hur JK, 2016, GENE DEV, V30, P840, DOI 10.1101/gad.276030.115; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Kopytova DV, 2006, MOL CELL BIOL, V26, P7492, DOI 10.1128/MCB.00349-06; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Le Thomas A, 2014, GENE DEV, V28, P1667, DOI 10.1101/gad.245514.114; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Maggert Keith A., 2008, V420, P155, DOI 10.1007/978-1-59745-583-1_9; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Martianov I, 2002, DEVELOPMENT, V129, P945; Martianov I, 2016, SCI REP-UK, V6, DOI 10.1038/srep32069; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Muller F, 2001, CURR BIOL, V11, P282, DOI 10.1016/S0960-9822(01)00076-8; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Oyama T, 2013, DEV CELL, V27, P188, DOI 10.1016/j.devcel.2013.09.025; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; PURNELL BA, 1994, GENE DEV, V8, P830, DOI 10.1101/gad.8.7.830; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Stampfel G, 2015, NATURE, V528, P147, DOI 10.1038/nature15545; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wickham H., SCALES SCALE FUNCTIO; Wickham H, 2016, PROGRAMMING GGPLOT2, DOI 10.1007/978-3-319-24277-4_12; Wickham H, 2007, J STAT SOFTW, V21, P1; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; YOKOMORI K, 1994, GENE DEV, V8, P2313, DOI 10.1101/gad.8.19.2313; Zeidler MP, 1996, GENE DEV, V10, P50, DOI 10.1101/gad.10.1.50; Zhai JX, 2015, CELL, V163, P445, DOI 10.1016/j.cell.2015.09.032; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030	81	124	130	0	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					54	+		10.1038/nature23482	http://dx.doi.org/10.1038/nature23482			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28847004	Green Accepted			2022-12-28	WOS:000409388700031
J	Antebi, YE; Linton, JM; Klumpe, H; Bintu, B; Gong, M; Su, C; McCardell, R; Elowitz, MB				Antebi, Yaron E.; Linton, James M.; Klumpe, Heidi; Bintu, Bogdan; Gong, Mengsha; Su, Christina; McCardell, Reed; Elowitz, Michael B.			Combinatorial Signal Perception in the BMP Pathway	CELL			English	Article							BONE MORPHOGENETIC PROTEINS; SERINE/THREONINE KINASE RECEPTORS; PRIMORDIAL GERM-CELLS; EXTRACELLULAR REGULATION; SYNERGISTIC ACTION; MAMMALIAN-CELLS; FAMILY-MEMBERS; SMAD PROTEINS; ACTIVIN-A; IN-VITRO	The bone morphogenetic protein (BMP) signaling pathway comprises multiple ligands and receptors that interact promiscuously with one another and typically appear in combinations. This feature is often explained in terms of redundancy and regulatory flexibility, but it has remained unclear what signal-processing capabilities it provides. Here, we show that the BMP pathway processes multi-ligand inputs using a specific repertoire of computations, including ratiometric sensing, balance detection, and imbalance detection. These computations operate on the relative levels of different ligands and can arise directly from competitive receptor-ligand interactions. Furthermore, cells can select different computations to perform on the same ligand combination through expression of alternative sets of receptor variants. These results provide a direct signal-processing role for promiscuous receptor-ligand interactions and establish operational principles for quantitatively controlling cells with BMP ligands. Similar principles could apply to other promiscuous signaling pathways.	[Antebi, Yaron E.; Linton, James M.; Klumpe, Heidi; Bintu, Bogdan; Gong, Mengsha; Su, Christina; McCardell, Reed; Elowitz, Michael B.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Klumpe, Heidi] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.; Elowitz, MB (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Antebi, Yaron/0000-0002-5771-6814; Su, Christina/0000-0002-9223-9777	Gordon and Betty Moore Foundation [GBMF2809]; Human Frontiers Science Program [RGP0020]; NIH [R01 HD75335A]; Defense Advanced Research Projects Agency [HR0011-16-0138]; Institute for Collaborative Biotechnologies from the US Army Research Office [W911NF-09-0001]; National Science Foundation [DGE-1144469]; NIH (National Institute of General Medical Sciences) [T32 GM008042]; David Geffen Medical Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Human Frontiers Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Institute for Collaborative Biotechnologies from the US Army Research Office; National Science Foundation(National Science Foundation (NSF)); NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); David Geffen Medical Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Uri Alon, James Briscoe, Marcelo Ehrlich, Jordi Garcia-Ojalvo, Lea Goentoro, Roy Kishony, Vicki Rosen, Boris Shraiman, Ned Wingreen, and members of the Elowitz lab for helpful discussions and feedback. We thank the Caltech Flow Cytometry Facility and the Millard and Muriel Jacobs Genetics and Genomics Laboratory at Caltech for technical assistance. This work was supported by the Gordon and Betty Moore Foundation (grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative), the Human Frontiers Science Program (grant RGP0020), the NIH (grant R01 HD75335A), the Defense Advanced Research Projects Agency (contract HR0011-16-0138), and the Institute for Collaborative Biotechnologies (grant W911NF-09-0001 from the US Army Research Office). This work does not necessarily reflect the position or policy of the US Government, and no official endorsement should be inferred. H.K. is supported by a National Science Foundation graduate research fellowship (grant DGE-1144469). C.S. is supported by the NIH (National Institute of General Medical Sciences training grant T32 GM008042) and by a David Geffen Medical Scholarship. Y.E.A., J.M.L., and M.B.E. filed a provisional patent application relating to this work.	Acil Y, 2014, J CRANIO MAXILL SURG, V42, P2002, DOI 10.1016/j.jcms.2014.09.006; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Cheifetz S, 1999, CRIT REV ORAL BIOL M, V10, P182, DOI 10.1177/10454411990100020501; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dudley AT, 1997, DEV DYNAM, V208, P349; Edson MA, 2010, MOL ENDOCRINOL, V24, P1251, DOI 10.1210/me.2009-0461; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Escalante-Chong R, 2015, P NATL ACAD SCI USA, V112, P1636, DOI 10.1073/pnas.1418058112; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Hart Y, 2015, NAT METHODS, V12, P233, DOI [10.1038/NMETH.3254, 10.1038/nmeth.3254]; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Heggebo J, 2014, ORTHOP REV, V6, P65, DOI 10.4081/or.2014.5242; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619; Klammert U, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0183-8; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Li XF, 2003, J ORTHOP RES, V21, P908, DOI 10.1016/S0736-0266(03)00008-1; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23670; Llimargas M, 2001, P NATL ACAD SCI USA, V98, P14487, DOI 10.1073/pnas.251304398; Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877; Lorda-Diez CI, 2014, J BONE MINER RES, V29, P735, DOI 10.1002/jbmr.2077; Lowery JW, 2015, J CELL SCI, V128, P1308, DOI 10.1242/jcs.156737; MADL JE, 1979, GENETICS, V93, P393; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Neugebauer JM, 2015, P NATL ACAD SCI USA, V112, pE2307, DOI 10.1073/pnas.1501449112; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nicklas D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0363; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Olsen OE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0104-z; Piek E, 1999, J CELL SCI, V112, P4557; Piscione TD, 1997, AM J PHYSIOL-RENAL, V273, pF961, DOI 10.1152/ajprenal.1997.273.6.F961; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Storm EE, 1996, DEVELOPMENT, V122, P3969; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tendler A, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0149-z; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798; Zakin L, 2010, CURR BIOL, V20, pR89, DOI 10.1016/j.cub.2009.11.021; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063	69	109	111	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1184	1196		10.1016/j.cell.2017.08.015	http://dx.doi.org/10.1016/j.cell.2017.08.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28886385	Green Accepted, Bronze			2022-12-28	WOS:000409536000015
J	Harrington, LB; Doxzen, KW; Ma, E; Liu, JJ; Knott, GJ; Edraki, A; Garcia, B; Amrani, N; Chen, JS; Cofsky, JC; Kranzusch, PJ; Sontheimer, EJ; Davidson, AR; Maxwell, KL; Doudna, JA				Harrington, Lucas B.; Doxzen, Kevin W.; Ma, Enbo; Liu, Jun-Jie; Knott, Gavin J.; Edraki, Alireza; Garcia, Bianca; Amrani, Nadia; Chen, Janice S.; Cofsky, Joshua C.; Kranzusch, Philip J.; Sontheimer, Erik J.; Davidson, Alan R.; Maxwell, Karen L.; Doudna, Jennifer A.			A Broad-Spectrum Inhibitor of CRISPR-Cas9	CELL			English	Article							QUORUM SENSING CONTROLS; ADAPTIVE IMMUNITY; PROGRAM PACKAGE; DNA CLEAVAGE; DUAL-RNA; CAS9; DIVERSITY; SYSTEM; CLASSIFICATION; BACTERIOPHAGE	CRISPR-Cas9 proteins function within bacterial immune systems to target and destroy invasive DNA and have been harnessed as a robust technology for genome editing. Small bacteriophage-encoded anti-CRISPR proteins (Acrs) can inactivate Cas9, providing an efficient off switch for Cas9-based applications. Here, we show that two Acrs, AcrIIC1 and AcrIIC3, inhibit Cas9 by distinct strategies. AcrIIC1 is a broad-spectrum Cas9 inhibitor that prevents DNA cutting by multiple divergent Cas9 orthologs through direct binding to the conserved HNH catalytic domain of Cas9. A crystal structure of an AcrIIC1-Cas9 HNH domain complex shows how AcrIIC1 traps Cas9 in a DNA-bound but catalytically inactive state. By contrast, AcrIIC3 blocks activity of a single Cas9 ortholog and induces Cas9 dimerization while preventing binding to the target DNA. These two orthogonal mechanisms allow for separate control of Cas9 target binding and cleavage and suggest applications to allow DNA binding while preventing DNA cutting by Cas9.	[Harrington, Lucas B.; Ma, Enbo; Liu, Jun-Jie; Knott, Gavin J.; Chen, Janice S.; Cofsky, Joshua C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doxzen, Kevin W.; Doudna, Jennifer A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Liu, Jun-Jie; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Edraki, Alireza; Amrani, Nadia; Sontheimer, Erik J.] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Program Mol Med, Worcester, MA 01605 USA; [Garcia, Bianca; Davidson, Alan R.; Maxwell, Karen L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Kranzusch, Philip J.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Kranzusch, Philip J.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02115 USA; [Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Toronto; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Amrani, Nadia/AAG-7474-2021	Amrani, Nadia/0000-0001-6871-7962; Maxwell, Karen/0000-0002-0211-5480; Liu, Jun-Jie/0000-0002-8982-107X; Chen, Janice/0000-0003-4797-3056; Edraki, Alireza/0000-0003-0849-4888; Edraki, Alireza/0000-0003-3113-1233; Doxzen, Kevin/0000-0002-3616-6569; Knott, Gavin J./0000-0002-9007-6273	UC Office of the President, Multicampus Research Programs and Initiatives [MR-15-328599]; Sandler Foundation; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; National Science Foundation [MCB-1244557]; NIH [GM115911]; Canadian Institutes of Health Research [MOP-130482, MOP-136845]; US National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115911, P01GM051487, T32GM008295] Funding Source: NIH RePORTER	UC Office of the President, Multicampus Research Programs and Initiatives; Sandler Foundation; Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Meigs and the 8.3.1 beamline staff at the Advanced Light Source for assistance with data collection and members of the Doudna laboratory for comments and discussions. The 8.3.1 beamline is supported by UC Office of the President, Multicampus Research Programs and Initiatives grant MR-15-328599 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. J.A.D. is an Investigator of the Howard Hughes Medical Institute. This research was supported in part by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group, the National Science Foundation (MCB-1244557 to J.A.D.), the NIH (GM115911 to E.J.S.), and the Canadian Institutes of Health Research (MOP-130482 to A.R.D. and MOP-136845 to K.L.M.). L.B.H., K.W.D., and J.S.C. are supported by US National Science Foundation graduate research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Burstein D, 2017, NATURE, V542, P237, DOI 10.1038/nature21059; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Dagdas Y, 2017, BIORXIV; Dong D, 2017, NATURE, V546, P436, DOI 10.1038/nature22377; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Franzosa EA, 2011, P NATL ACAD SCI USA, V108, P10538, DOI 10.1073/pnas.1101440108; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Harrington L., 2017, BIORXIV; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hoyland-Kroghsbo NM, 2017, P NATL ACAD SCI USA, V114, P131, DOI 10.1073/pnas.1617415113; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim EH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14964; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu JJ, 2014, NAT STRUCT MOL BIOL, V21, P95, DOI 10.1038/nsmb.2736; Ma EB, 2015, MOL CELL, V60, P398, DOI 10.1016/j.molcel.2015.10.030; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mekler V, 2017, P NATL ACAD SCI USA, V114, P5443, DOI 10.1073/pnas.1619926114; Morgan G. J., 2002, BACTERIO PHAGE MU GE; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Patterson AG, 2017, CURR OPIN MICROBIOL, V37, P1, DOI 10.1016/j.mib.2017.02.004; Patterson AG, 2016, MOL CELL, V64, P1102, DOI 10.1016/j.molcel.2016.11.012; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rauch BJ, 2017, CELL, V168, P150, DOI 10.1016/j.cell.2016.12.009; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; van Houte S, 2016, NATURE, V532, P385, DOI 10.1038/nature17436; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020	58	133	144	8	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2017	170	6					1224	1233		10.1016/j.cell.2017.07.037	http://dx.doi.org/10.1016/j.cell.2017.07.037			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FG1ED	28844692	Green Accepted, Bronze			2022-12-28	WOS:000409536000018
J	Pfisterer, JHK; Liang, YC; Schneider, O; Bandarenka, AS				Pfisterer, Jonas H. K.; Liang, Yunchang; Schneider, Oliver; Bandarenka, Aliaksandr S.			Direct instrumental identification of catalytically active surface sites	NATURE			English	Article							OXYGEN REDUCTION REACTION; SCANNING-TUNNELING-MICROSCOPY; HYDROGEN EVOLUTION REACTION; SINGLE-CRYSTAL ELECTRODES; HIGH-INDEX PLANES; PLATINUM; REACTIVITY; ELECTROCATALYSIS; DEPOSITION; CATALYSIS	The activity of heterogeneous catalysts-which are involved in some 80 per cent of processes in the chemical and energy industries-is determined by the electronic structure of specific surface sites that offer optimal binding of reaction intermediates. Directly identifying and monitoring these sites during a reaction should therefore provide insight that might aid the targeted development of heterogeneous catalysts and electrocatalysts (those that participate in electrochemical reactions) for practical applications. The invention of the scanning tunnelling microscope (STM)(1,2) and the electrochemical STM3,4 promised to deliver such imaging capabilities, and both have indeed contributed greatly to our atomistic understanding of heterogeneous catalysis(5-8). But although the STM has been used to probe and initiate surface reactions(9,10), and has even enabled local measurements of reactivity in some systems(11-13), it is not generally thought to be suited to the direct identification of catalytically active surface sites under reaction conditions. Here we demonstrate, however, that common STMs can readily map the catalytic activity of surfaces with high spatial resolution: we show that by monitoring relative changes in the tunnelling current noise, active sites can be distinguished in an almost quantitative fashion according to their ability to catalyse the hydrogen-evolution reaction or the oxygen-reduction reaction. These data allow us to evaluate directly the importance and relative contribution to overall catalyst activity of different defects and sites at the boundaries between two materials. With its ability to deliver such information and its ready applicability to different systems, we anticipate that our method will aid the rational design of heterogeneous catalysts.	[Pfisterer, Jonas H. K.; Liang, Yunchang; Bandarenka, Aliaksandr S.] Tech Univ Munich, Phys Energy Convers & Storage, Phys Dept, James Franck Str 1, D-85748 Garching, Germany; [Liang, Yunchang; Schneider, Oliver] Tech Univ Munich, Inst Informat 6, Schleissheimerstr 90a, D-85748 Garching, Germany; [Liang, Yunchang; Bandarenka, Aliaksandr S.] NIM, Schellingstr 4, D-80799 Munich, Germany; [Bandarenka, Aliaksandr S.] TUM, Catalysis Res Ctr, Ernst Otto Fischer Str 1, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Bandarenka, AS (corresponding author), Tech Univ Munich, Phys Energy Convers & Storage, Phys Dept, James Franck Str 1, D-85748 Garching, Germany.; Bandarenka, AS (corresponding author), NIM, Schellingstr 4, D-80799 Munich, Germany.; Bandarenka, AS (corresponding author), TUM, Catalysis Res Ctr, Ernst Otto Fischer Str 1, D-85748 Garching, Germany.	bandarenka@ph.tum.de	Liang, Yunchang/ABB-2483-2020; Bandarenka, Aliaksandr/AAO-1553-2021	Liang, Yunchang/0000-0003-4004-3315; 	Deutsche Forschungsgemeinschaft (DFG) [BA 5795/3-1]; cluster of excellence Nanosystems Initiative Munich (NIM); Toyota Motor Europe	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); cluster of excellence Nanosystems Initiative Munich (NIM); Toyota Motor Europe	We thank the Deutsche Forschungsgemeinschaft (DFG; project BA 5795/3-1) and the cluster of excellence Nanosystems Initiative Munich (NIM) for financial support. O.S. acknowledges funding from Toyota Motor Europe.	Bandarenka AS, 2014, PHYS CHEM CHEM PHYS, V16, P13625, DOI 10.1039/c4cp00260a; BATTINO R, 1981, OXYGEN OZONE SOLUBIL, V7; Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Bjorketun ME, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045407; Brankovic SR, 2001, SURF SCI, V474, pL173, DOI 10.1016/S0039-6028(00)01103-1; Calle-Vallejo F, 2015, SCIENCE, V350, P185, DOI 10.1126/science.aab3501; Chorkendorff I., 2006, CONCEPTS MODERN CATA; Colic V, 2015, CHEMELECTROCHEM, V2, P143, DOI 10.1002/celc.201402295; Hahn JR, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.166102, 10.1103/PhysRevLett.87.196102]; Hernandez F, 2007, J SOLID STATE ELECTR, V11, P877, DOI 10.1007/s10008-007-0308-2; Hitotsuyanagi A, 2012, ELECTROCHIM ACTA, V82, P512, DOI 10.1016/j.electacta.2012.03.133; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hugelmann M, 2003, SURF SCI, V541, pL643, DOI 10.1016/S0039-6028(03)00923-3; ITAYA K, 1988, SURF SCI, V201, pL507, DOI 10.1016/0039-6028(88)90489-X; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kibler LA, 2000, J ELECTROANAL CHEM, V484, P73, DOI 10.1016/S0022-0728(00)00065-6; Kibler LA, 2006, CHEMPHYSCHEM, V7, P985, DOI 10.1002/cphc.200500646; Koper MTM, 2011, NANOSCALE, V3, P2054, DOI 10.1039/c0nr00857e; Kuzume A, 2007, J ELECTROANAL CHEM, V599, P333, DOI 10.1016/j.jelechem.2006.05.006; LIU HY, 1986, J AM CHEM SOC, V108, P3838, DOI 10.1021/ja00273a054; Liu YH, 2012, SCIENCE, V338, P1327, DOI 10.1126/science.1228925; Meier J, 2002, FARADAY DISCUSS, V121, P365, DOI 10.1039/b200014h; MOLLER R, 1989, APPL PHYS LETT, V55, P2360, DOI 10.1063/1.102018; Norskov JK, 2001, NATURE, V414, P405, DOI 10.1038/35106674; Pandelov S, 2007, ELECTROCHIM ACTA, V52, P5548, DOI 10.1016/j.electacta.2007.02.043; Perez J, 1998, J PHYS CHEM B, V102, P10931, DOI 10.1021/jp9831987; REISS G, 1990, APPL PHYS LETT, V57, P867, DOI 10.1063/1.103390; Rurigaki T, 2014, J ELECTROANAL CHEM, V716, P58, DOI 10.1016/j.jelechem.2013.12.008; Stephens IEL, 2012, ENERG ENVIRON SCI, V5, P6744, DOI 10.1039/c2ee03590a; Takesue Y, 2014, PHYS CHEM CHEM PHYS, V16, P13774, DOI 10.1039/c4cp00243a; Thomas J. M., 2014, PRINCIPLES PRACTICE; TRASATTI S, 1991, PURE APPL CHEM, V63, P711, DOI 10.1351/pac199163050711; Tymoczko J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10990; Wolfschmidt H, 2010, CHEMPHYSCHEM, V11, P1533, DOI 10.1002/cphc.201000148; Zambelli T, 1996, SCIENCE, V273, P1688, DOI 10.1126/science.273.5282.1688; Zhang LJ, 2006, LANGMUIR, V22, P8109, DOI 10.1021/la060859f	38	131	133	19	405	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2017	549	7670					74	+		10.1038/nature23661	http://dx.doi.org/10.1038/nature23661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0DH	28880284				2022-12-28	WOS:000409388700035
J	Godinho, N; Bezbaruah, S; Nayyar, S; Gautam, J; Sachdeva, S; Behara, I; Vong, S				Godinho, Natasha; Bezbaruah, Supriya; Nayyar, Shikha; Gautam, Juhi; Sachdeva, Stuti; Behara, Indira; Vong, Sirenda			Antimicrobial resistance communication activities in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIBIOTICS		[Godinho, Natasha; Bezbaruah, Supriya; Nayyar, Shikha; Gautam, Juhi; Sachdeva, Stuti; Behara, Indira] Global Hlth Strategies, New Delhi, India; [Vong, Sirenda] World Hlth Org Reg Off South East Asia, New Delhi, India	World Health Organization	Godinho, N (corresponding author), Global Hlth Strategies, New Delhi, India.	ngodinho@globalhealthstrategies.com						[Anonymous], 2016, HLTH MINISTER INAUGU; Bangladesh: UNICEF, 2008, WRIT COMM STRAT DEV; Bernhardt JM, 2004, AM J PUBLIC HEALTH, V94, P2051, DOI 10.2105/AJPH.94.12.2051; Eugene Bell Foundation, 2016, N KOR TUB REL APPR; Federation of Asian Pharmaceutical Associations, 2015, 4 FRAM COM COMP; Fresle DA, 1997, PUBLIC ED RATIONAL D; Ghafur A, 2013, INDIAN J CANCER, V50, P71, DOI 10.4103/0019-509X.104065; Hsuliyang, 2015, ANTIBIOTIC TEACHING; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Larson CP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000175; Maldives Customs Service, 2015, AW SESS ANT RES HELD; Markovingian, 2015, SMART US ANT SUA IND; Nurbiyanti N, 2014, CIVAS 8 ANN SEM GLOB; Obregon R, 2009, B WORLD HEALTH ORGAN, V87, P624, DOI 10.2471/BLT.08.060863; Rahman M, 2014, BANGLADESH J PHARM, V9; Ron AR, 2016, REV ANTIMICROBIAL RE; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Sumpradit N, 2012, B WORLD HEALTH ORGAN, V90, P905, DOI 10.2471/BLT.12.105445; WHO, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2015, Worldwide country situation analysis: response to antimicrobial resistance; World Health Organization, 2010, REG STRAT PREV CONT; World Health Organization South East Asia Regional Office, 2015, TIM LEST GEARS COMB; World Veterinary Association, 2012, WORLD VET DAY 2012; Yewale VN, 2014, INDIAN PEDIATR, V51, P171, DOI 10.1007/s13312-014-0374-3	24	3	3	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358								j2742	10.1136/bmj.j2742	http://dx.doi.org/10.1136/bmj.j2742			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874342	Green Published, hybrid			2022-12-28	WOS:000410575100005
J	Goutard, FL; Bordier, M; Calba, C; Erlacher-Vindel, E; Gochez, D; de Balogh, K; Benigno, C; Kalpravidh, W; Roger, F; Vong, S				Goutard, Flavie Luce; Bordier, Marion; Calba, Clementine; Erlacher-Vindel, Elisabeth; Gochez, Delfy; de Balogh, Katinka; Benigno, Carolyn; Kalpravidh, Wantanee; Roger, Francois; Vong, Sirenda			Antimicrobial policy interventions in food animal production in South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANCE		[Goutard, Flavie Luce; Bordier, Marion; Calba, Clementine; Roger, Francois] CIRAD, UMR ASTRE, F-34398 Montpellier, France; [Goutard, Flavie Luce; Roger, Francois] Kasetsart Univ, Bangkok 10900, Thailand; [Erlacher-Vindel, Elisabeth; Gochez, Delfy] World Org Anim Hlth OIE, Paris, France; [de Balogh, Katinka; Benigno, Carolyn; Kalpravidh, Wantanee] Food & Agr Org United Nations, Reg Off Asia & Pacif, Bangkok, Thailand; [Vong, Sirenda] WHO, Reg Off South East Asia, New Delhi, India	CIRAD; Kasetsart University; Food & Agriculture Organization of the United Nations (FAO); World Health Organization	Goutard, FL (corresponding author), CIRAD, UMR ASTRE, F-34398 Montpellier, France.; Goutard, FL (corresponding author), Kasetsart Univ, Bangkok 10900, Thailand.	flavie.goutard@cirad.fr		goutard, flavie luce/0000-0002-8618-4132; ROGER, FRANCOIS/0000-0002-1573-6833				Archawakulathep A, 2014, THAI J VET MED, V44, P5; Chuanchuen R, 2014, THAILAND FAO REGIONA; Codex Alimentarius Commission, 2016, JOINT FAO WHO FOOD S; Dar OA, 2016, LANCET, V387, P285, DOI 10.1016/S0140-6736(15)00520-6; Dey M. M., 2005, Aquaculture Economics & Management, V9, P217, DOI 10.1080/13657300590967450; FAO, 2012, P INT WORKSH US ANT; FAO / WHO Codex Alimentarius, 2015, COD TEXTS FOODB ANT; Food and Agriculture Organisation World Health Organization World Organisation for Animal Health (OIE), 2008, JOINT FAO WHO OIE EX; Founou LL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01881; Grace D, 2015, REV EVIDENCE ANTIMIC; Hao Haihong, 2014, Front Microbiol, V5, P288, DOI 10.3389/fmicb.2014.00288; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Kirkpatrick C, 2004, PUBLIC ADMIN DEVELOP, V24, P333, DOI 10.1002/pad.310; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Leger D, 2017, BMJ-BRIT MED J, V358, pj3544; OIE, RISKS ASS US ANT AN; Queenan K, 2016, INT J ANTIMICROB AG, V48, P422, DOI 10.1016/j.ijantimicag.2016.06.014; Thamlikitkul V., 2015, THAILAND AMR CONTAIN; United Nations News Centre, 2016, UN GLOB LEAD COMM AC; WHO, 2015, GLOB ACT PLAN ANT RE; World Bank Group, 2016, DRUG RES INF THREAT; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; World Organisation for Animal Health (OIE), 2017, ANT OIE	23	44	44	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						36	41	j3544	10.1136/bmj.j3544	http://dx.doi.org/10.1136/bmj.j3544			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874351	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000410575100008
J	Voelker, R				Voelker, Rebecca			Combination Drug for HCV Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					790	790		10.1001/jama.2017.10930	http://dx.doi.org/10.1001/jama.2017.10930			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4NC	28873145				2022-12-28	WOS:000426800500003
J	Green, A				Green, Andrew			President of Zambia declares HIV testing mandatory	LANCET			English	Editorial Material																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					925	925		10.1016/S0140-6736(17)32295-X	http://dx.doi.org/10.1016/S0140-6736(17)32295-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28847612				2022-12-28	WOS:000408746300010
J	Kikuchi, T; Morizane, A; Doi, D; Magotani, H; Onoe, H; Hayashi, T; Mizuma, H; Takara, S; Takahashi, R; Inoue, H; Morita, S; Yamamoto, M; Okita, K; Nakagawa, M; Parmar, M; Takahashi, J				Kikuchi, Tetsuhiro; Morizane, Asuka; Doi, Daisuke; Magotani, Hiroaki; Onoe, Hirotaka; Hayashi, Takuya; Mizuma, Hiroshi; Takara, Sayuki; Takahashi, Ryosuke; Inoue, Haruhisa; Morita, Satoshi; Yamamoto, Michio; Okita, Keisuke; Nakagawa, Masato; Parmar, Malin; Takahashi, Jun			Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model	NATURE			English	Article							PLURIPOTENT STEM-CELLS; NEURAL PROGENITORS; MACAQUE MONKEY; BRAIN IMAGES; HUMAN ES; TRANSPLANTATION; EXPRESSION; ROBUST; BLOOD; PET	Induced pluripotent stem cells (iPS cells) are a promising source for a cell-based therapy to treat Parkinson's disease (PD), in which midbrain dopaminergic neurons progressively degenerate(1,2). However, long-term analysis of human iPS cell-derived dopaminergic neurons in primate PD models has never been performed to our knowledge. Here we show that human iPS cell-derived dopaminergic progenitor cells survived and functioned as midbrain dopaminergic neurons in a primate model of PD (Macaca fascicularis) treated with the neurotoxin MPTP. Score-based and video-recording analyses revealed an increase in spontaneous movement of the monkeys after transplantation. Histological studies showed that the mature dopaminergic neurons extended dense neurites into the host striatum; this effect was consistent regardless of whether the cells were derived from patients with PD or from healthy individuals. Cells sorted by the floor plate marker CORIN did not form any tumours in the brains for at least two years. Finally, magnetic resonance imaging and positron emission tomography were used to monitor the survival, expansion and function of the grafted cells as well as the immune response in the host brain. Thus, this preclinical study using a primate model indicates that human iPS cell-derived dopaminergic progenitors are clinically applicable for the treatment of patients with PD.	[Kikuchi, Tetsuhiro; Morizane, Asuka; Doi, Daisuke; Magotani, Hiroaki; Takahashi, Jun] Kyoto Univ, Dept Clin Applicat, Ctr IPS Cell Res & Applicat, Kyoto 6068507, Japan; [Onoe, Hirotaka; Hayashi, Takuya; Mizuma, Hiroshi; Takara, Sayuki] RIKEN Ctr Life Sci Technol, Div Biofunct Dynam Imaging, Kobe, Hyogo 6500047, Japan; [Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan; [Inoue, Haruhisa] Kyoto Univ, Ctr IPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto 6068507, Japan; [Morita, Satoshi; Yamamoto, Michio] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto 6068507, Japan; [Okita, Keisuke; Nakagawa, Masato] Kyoto Univ, Dept Life Sci Frontiers, Ctr IPS Cell Res & Applicat, Kyoto 6068507, Japan; [Parmar, Malin] Lund Univ, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden; [Parmar, Malin] Lund Univ, Lund Stem Cell Ctr, S-22184 Lund, Sweden; [Takahashi, Jun] Kyoto Univ, Grad Sch Med, Clin Neurosci, Dept Neurosurg, Kyoto 6068507, Japan	Kyoto University; RIKEN; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Lund University; Lund University; Kyoto University	Takahashi, J (corresponding author), Kyoto Univ, Dept Clin Applicat, Ctr IPS Cell Res & Applicat, Kyoto 6068507, Japan.; Takahashi, J (corresponding author), Kyoto Univ, Grad Sch Med, Clin Neurosci, Dept Neurosurg, Kyoto 6068507, Japan.	jbtaka@cira.kyoto-u.ac.jp	Hayashi, Takuya/A-1634-2011	Hayashi, Takuya/0000-0001-7639-0197; Inoue, Haruhisa/0000-0003-4736-9537; Kikuchi, Tetsuhiro/0000-0003-2332-4967; Okita, Keisuke/0000-0001-5806-1090; Parmar, Malin/0000-0001-5002-4199; Morizane, Asuka/0000-0001-7411-1828	Highway Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Network Program for Realization of Regenerative Medicine from the Japan Agency for Medical Research and Development (AMED); Program for Intractable Diseases Research using disease-specific iPS cells from AMED; Grants-in-Aid for Scientific Research [15K12779, 15H02540] Funding Source: KAKEN	Highway Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Network Program for Realization of Regenerative Medicine from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Program for Intractable Diseases Research using disease-specific iPS cells from AMED; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Sekiguchi, J. Toga and E. Yagi for providing recombinant LM511-E8, Y. Ono for anti-CORIN and anti-NURR1 antibodies, H. Doi, A. Mawatari, M. Tsuji, K. Takahashi, M. Goto, Y. Wada, A. Yamazaki, T. Kawasaki, C. Takeda, N. Shibata, S. Kurai, A. Igesaka, T. Mori, R. Zochi, E. Hayashinaka, M. Yamano, T. Ose, M. Ohno and K. Onoe for supporting the PET study, H. Ohmori for an electrophysiological study, S. Nolbrant for discussions about gene expression by the donor cells, and Astellas Pharma Inc. for FK506. We also thank P. Karagiannis for reading of the manuscript, K. Kubota, Y. Ishii, Y. Morita and Y. Katano for technical assistance, K. Nishimura, M. Motono, Y. Ioroi, B. Samata, Y. Koshiba, Y. Nakajima and Y. Miyawaki for taking care of the animals, and S. Tsuji, J. Mitsui and S. Morishita for whole-exome analysis of patients with PD. This study was supported by grants from the Highway Project for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Network Program for Realization of Regenerative Medicine from the Japan Agency for Medical Research and Development (AMED) and the Program for Intractable Diseases Research using disease-specific iPS cells from AMED (to H. I.). M.P. is a New York Stem Cell Foundation - Robertson Investigator.	Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; Doi D, 2014, STEM CELL REP, V2, P337, DOI 10.1016/j.stemcr.2014.01.013; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hallett PJ, 2015, CELL STEM CELL, V16, P269, DOI 10.1016/j.stem.2015.01.018; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; Katsukawa M, 2016, STEM CELLS DEV, V25, P815, DOI 10.1089/scd.2015.0394; Kikuchi T, 2017, J NEUROSCI RES, V95, P1829, DOI 10.1002/jnr.24014; Kikuchi T, 2011, J PARKINSON DIS, V1, P395, DOI 10.3233/JPD-2011-11070; Kirkeby A, 2017, CELL STEM CELL, V20, P135, DOI 10.1016/j.stem.2016.09.004; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kurowska Z, 2011, J PARKINSON DIS, V1, P83, DOI 10.3233/JPD-2011-11004; Leroy C, 2007, J NUCL MED, V48, P538, DOI 10.2967/jnumed.106.037283; Li W, 2016, P NATL ACAD SCI USA, V113, P6544, DOI 10.1073/pnas.1605245113; Liechti R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116088; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Redmond DE, 2008, NEUROBIOL DIS, V29, P103, DOI 10.1016/j.nbd.2007.08.008; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Shukuri M, 2011, J NUCL MED, V52, P1094, DOI 10.2967/jnumed.110.084046; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sossi V, 2003, J CEREBR BLOOD F MET, V23, P301, DOI 10.1097/01.WCB.0000050041.22945.3E; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Turkheimer FE, 2007, J NUCL MED, V48, P158; Warschausky S, 2001, ARCH PHYS MED REHAB, V82, P329, DOI 10.1053/apmr.2001.21510; Yin DL, 2009, J NEUROSCI METH, V176, P200, DOI 10.1016/j.jneumeth.2008.08.027; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	46	353	369	16	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2017	548	7669					592	+		10.1038/nature23664	http://dx.doi.org/10.1038/nature23664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2BO	28858313				2022-12-28	WOS:000408703100040
J	Croce, R; van Amerongen, H				Croce, Roberta; van Amerongen, Herbert			The complex that conquered the land	SCIENCE			English	Editorial Material							PHOTOSYSTEM-II; ARABIDOPSIS-THALIANA; ORGANIZATION; RESOLUTION; ANGSTROM		[Croce, Roberta] Vrije Univ Amsterdam, Dept Phys & Astron, Biophys Photosynth Grp, Amsterdam, Netherlands; [van Amerongen, Herbert] Wageningen Univ & Res, Lab Biophys, Wageningen, Netherlands	Vrije Universiteit Amsterdam; Wageningen University & Research	Croce, R (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Biophys Photosynth Grp, Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014; Croce, Roberta/HGU-9554-2022	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X				Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Su XD, 2017, SCIENCE, V357, P816, DOI 10.1126/science.aan0327; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020	9	5	5	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					752	752		10.1126/science.aao4191	http://dx.doi.org/10.1126/science.aao4191			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839058				2022-12-28	WOS:000408327900022
J	Wang, WL				Wang, Wei-Lin			Venous Congestion in Ischemic Bowel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, Wei-Lin] Taipei Med Univ Hosp, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital	Wang, WL (corresponding author), Taipei Med Univ Hosp, Taipei, Taiwan.	luckyweilin@hotmail.com							0	1	1	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					E10	E10		10.1056/NEJMicm1610862	http://dx.doi.org/10.1056/NEJMicm1610862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28834489				2022-12-28	WOS:000413090000010
J	Chan, AW; Pello, A; Kitchen, J; Axentiev, A; Virtanen, JI; Liu, A; Hemminki, E				Chan, An-Wen; Pello, Annukka; Kitchen, Jessica; Axentiev, Anna; Virtanen, Jorma I.; Liu, Annie; Hemminki, Elina			Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chan, An-Wen; Kitchen, Jessica; Axentiev, Anna; Liu, Annie] Univ Toronto, Womens Coll, Res Inst, Toronto, ON, Canada; [Pello, Annukka] Univ Helsinki, Helsinki, Finland; [Virtanen, Jorma I.] Univ Oulu, Oulu, Finland; [Hemminki, Elina] Natl Inst Hlth & Welfare, Helsinki, Finland	University of Toronto; Women's College Research Institute; University of Helsinki; University of Oulu; Finland National Institute for Health & Welfare	Chan, AW (corresponding author), Womens Coll, Res Inst, 76 Grenville St,Room 6416, Toronto, ON M5S 1B2, Canada.	anwen.chan@utoronto.ca	Liu, Annie/GRR-2847-2022; Virtanen, Jorma/AAP-1160-2021	Virtanen, Jorma/0000-0001-6574-9942	Canadian Institutes of Health Research Dissemination Events [MET 117434]; Academy of Finland [28356]	Canadian Institutes of Health Research Dissemination Events(Canadian Institutes of Health Research (CIHR)); Academy of Finland(Academy of Finland)	This project was supported in part by grant MET 117434 from the Canadian Institutes of Health Research Dissemination Events and grant 28356 from the Academy of Finland.	Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	6	40	40	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	2017	318	17					1709	1711		10.1001/jama.2017.13001	http://dx.doi.org/10.1001/jama.2017.13001			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM0CW	28892118	Green Published			2022-12-28	WOS:000414627500024
J	Rosenbaum, L				Rosenbaum, Lisa			Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Buechner J., 2017, CLIN LYMPHOMA MYEL S, V17, pS263; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871	5	75	83	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 5	2017	377	14					1313	1315		10.1056/NEJMp1711886	http://dx.doi.org/10.1056/NEJMp1711886			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ0CB	28902570				2022-12-28	WOS:000412375000010
J	Dalton, JE; Perzynski, AT; Zidar, DA; Rothberg, MB; Coulton, CJ; Milinovich, AT; Einstadter, D; Karichu, JK; Dawson, NV				Dalton, Jarrod E.; Perzynski, Adam T.; Zidar, David A.; Rothberg, Michael B.; Coulton, Claudia J.; Milinovich, Alex T.; Einstadter, Douglas; Karichu, James K.; Dawson, Neal V.			Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; PREVENTIVE THERAPIES; COLLEGE; INEQUALITIES; MORTALITY; MODELS	Background: Inequality in health outcomes in relation to Americans' socioeconomic position is rising. Objective: First, to evaluate the spatial relationship between neighborhood disadvantage and major atherosclerotic cardiovascular disease (ASCVD)-related events; second, to evaluate the relative extent to which neighborhood disadvantage and physiologic risk account for neighborhood-level variation in ASCVD event rates. Design: Observational cohort analysis of geocoded longitudinal electronic health records. Setting: A single academic health center and surrounding neighborhoods in northeastern Ohio. Patients: 109 793 patients from the Cleveland Clinic Health System (CCHS) who had an outpatient lipid panel drawn between 2007 and 2010. The date of the first qualifying lipid panel served as the study baseline. Measurements: Time from baseline to the first occurrence of a major ASCVD event (myocardial infarction, stroke, or cardiovascular death) within 5 years, modeled as a function of a locally derived neighborhood disadvantage index (NDI) and the predicted 5-year ASCVD event rate from the Pooled Cohort Equations Risk Model (PCERM) of the American College of Cardiology and American Heart Association. Outcome data were censored if no CCHS encounters occurred for 2 consecutive years or when state death data were no longer available (that is, from 2014 onward). Results: The PCERM systematically underpredicted ASCVD event risk among patients from disadvantaged communities. Model discrimination was poorer among these patients (concordance index [C], 0.70 [95% CI, 0.67 to 0.74]) than those from the most affluent communities (C, 0.80 [CI, 0.78 to 0.81]). The NDI alone accounted for 32.0% of census tract-level variation in ASCVD event rates, compared with 10.0% accounted for by the PCERM. Limitations: Patients from affluent communities were over-represented. Outcomes of patients who received treatment for cardiovascular disease at Cleveland Clinic were assumed to be independent of whether the patients came from a disadvantaged or an affluent neighborhood. Conclusion: Neighborhood disadvantage may be a powerful regulator of ASCVD event risk. In addition to supplemental risk models and clinical screening criteria, population-based solutions are needed to ameliorate the deleterious effects of neighborhood disadvantage on health outcomes.	[Rothberg, Michael B.] Cleveland Clin, Ctr Value Based Care Res, Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Perzynski, Adam T.] Case Western Reserve Univ, MetroHlth Med Ctr, Ctr Healthcare Res & Policy, 2500 MetroHlth Dr, Cleveland, OH 44109 USA; [Zidar, David A.] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland, Harrington Heart & Vasc Inst,Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA; [Coulton, Claudia J.] Case Western Reserve Univ, Mandel Sch Appl Social Sci, Ctr Urban Poverty & Community Dev, 10900 Euclid Ave, Cleveland, OH 44106 USA; MetroHlth Med Ctr, Cleveland, OH USA; [Dalton, Jarrod E.; Milinovich, Alex T.] Lerner Res Inst, Dept Quantitat Hlth Sci, 9500 Euclid Ave JJN 3, Cleveland, OH 44195 USA; [Karichu, James K.] Roche Mol Syst, 4300 Hacienda Dr, Pleasanton, CA 94588 USA	Cleveland Clinic Foundation; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; MetroHealth System; Cleveland Clinic Foundation; Roche Holding	Dalton, JE (corresponding author), Lerner Res Inst, Dept Quantitat Hlth Sci, 9500 Euclid Ave JJN 3, Cleveland, OH 44195 USA.	daltonj@ccf.org	Perzynski, Adam/AAX-5730-2020; Milinovich, Alex/AAA-7353-2019	Perzynski, Adam/0000-0002-1323-0353; Milinovich, Alex/0000-0003-0585-1480	Clinical and Translational Science Collaborative of Cleveland; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055480] Funding Source: NIH RePORTER	Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Clinical and Translational Science Collaborative of Cleveland and National Institutes of Health.	Ball K, 2009, HEALTH PLACE, V15, P578, DOI 10.1016/j.healthplace.2008.09.010; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V7, P39, DOI [10.1016/j.sste.2013.07.003, 10.1016/j.sste.2012.12.001]; Bosworth B, 2016, LATER RETIREMENT INQ; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; DeFilippis AP, 2017, EUR HEART J, V38, P598, DOI 10.1093/eurheartj/ehw301; Estabrooks PA, 2003, ANN BEHAV MED, V25, P100, DOI 10.1207/S15324796ABM2502_05; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Griffin SF, 2008, HEALTH PROMOT PRACT, V9, P180, DOI 10.1177/1524839906296011; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Lindgren F, 2015, J STAT SOFTW, V63, P1, DOI 10.18637/jss.v063.i19; Lloyd-Jones DM, 2017, CIRCULATION, V135, pE793, DOI 10.1161/CIR.0000000000000467; McCormack GR, 2010, HEALTH PLACE, V16, P712, DOI 10.1016/j.healthplace.2010.03.003; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schulz A.J., 2006, GENDER RACE CLASS HL; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; US Census Bureau, 2016, AM FACTFINDER; US Department of Agriculture Economic Research Service, 2016, FOOD ENV ATL	25	49	49	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 3	2017	167	7					456	+		10.7326/M16-2543	http://dx.doi.org/10.7326/M16-2543			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI4ZI	28847012	Green Accepted			2022-12-28	WOS:000411988900006
J	Eastwood, GL				Eastwood, Gregory L.			What Should I Do When I Hear the Call for Medical Assistance in a Plane?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMERCIAL AIRLINE FLIGHTS; EMERGENCIES		[Eastwood, Gregory L.] SUNY Upstate Med Univ, Ctr Bioeth & Humanities, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Eastwood, GL (corresponding author), SUNY Upstate Med Univ, Ctr Bioeth & Humanities, 750 E Adams St, Syracuse, NY 13210 USA.	eastwood@upstate.edu						Eastwood Gregory L, 2011, Ann Intern Med, V154, P703, DOI 10.7326/0003-4819-154-10-201105170-00015; Gendreau MA, 2002, NEW ENGL J MED, V346, P1067, DOI 10.1056/NEJMra012774; Mattison MLP, 2011, JAMA-J AM MED ASSOC, V305, P2003, DOI 10.1001/jama.2011.618; Nable JV, 2015, NEW ENGL J MED, V373, P939, DOI 10.1056/NEJMra1409213; Peterson DC, 2013, NEW ENGL J MED, V368, P2075, DOI 10.1056/NEJMoa1212052	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2017	318	10					907	908		10.1001/jama.2017.7187	http://dx.doi.org/10.1001/jama.2017.7187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG6KJ	28898382				2022-12-28	WOS:000410487100008
J	Cho, A				Cho, Adrian			TRAPPED IN ORBIT	SCIENCE			English	Editorial Material																			0	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		986	989		10.1126/science.357.6355.986	http://dx.doi.org/10.1126/science.357.6355.986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0OE	28883068				2022-12-28	WOS:000409455700035
J	Jones, SH				Jones, Samantha H.			Choose a program, have a life	SCIENCE			English	Editorial Material									[Jones, Samantha H.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Jones, SH (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	SciCareerEditor@aaas.org							0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2017	357	6355			SI		1058	1058		10.1126/science.357.6355.1058	http://dx.doi.org/10.1126/science.357.6355.1058			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0OE	28883075				2022-12-28	WOS:000409455700048
J	Dyer, C				Dyer, Clare			CLINICAL NEGLIGENCE New settlement procedures: changing the way the NHS resolves negligence claims	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						DYER C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F988; Dyer C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1503; Royal College of Obstetricians and Gynaecologists, 2017, EACH BAB COUNTS 2015	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2017	358								j4134	10.1136/bmj.j4134	http://dx.doi.org/10.1136/bmj.j4134			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7EM	28882838				2022-12-28	WOS:000410576200011
J	Corey, E				Corey, Elizabeth			Delivering Emotions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Corey, Elizabeth] Univ Illinois, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Corey, E (corresponding author), Univ Illinois, Obstet & Gynecol, 820 S Wood St, Chicago, IL 60612 USA.	lizcorey@gmail.com							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					797	798		10.1001/jama.2017.7129	http://dx.doi.org/10.1001/jama.2017.7129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873165				2022-12-28	WOS:000409183700008
J	Lundborg, CS; Tamhankar, A				Lundborg, Cecilia Stalsby; Tamhankar, Ashok			Antibiotic residues in the environment of South East Asia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WATER TREATMENT PLANTS; WASTE-WATER; RESISTANT-BACTERIA; FATE; EFFLUENT; BANGKOK		[Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Tamhankar, Ashok] RD Gardi Med Coll, Dept Environm Med, Ujjain, Madhya Pradesh, India	Karolinska Institutet	Lundborg, CS (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	cecilia.stalsby.lundborg@ki.se		Stalsby Lundborg, Cecilia/0000-0001-6525-1861				Ashbolt NJ, 2013, ENVIRON HEALTH PERSP, V121, P993, DOI 10.1289/ehp.1206316; Bakar M. A., 2013, Bangladesh Journal of Veterinary Medicine, V11, P173; Bengtsson-Palme J, 2016, ENVIRON INT, V86, P140, DOI 10.1016/j.envint.2015.10.015; Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1; Das S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00173-0; Diwan V, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-414; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Holm G, 2013, DRUG SAFETY, V36, P533, DOI 10.1007/s40264-013-0049-3; Hu XG, 2010, ENVIRON POLLUT, V158, P2992, DOI 10.1016/j.envpol.2010.05.023; Impens S, 2003, ANAL CHIM ACTA, V483, P153, DOI 10.1016/S0003-2670(02)01232-1; Koeypudsa W, 2005, AQUAC RES, V36, P570, DOI 10.1111/j.1365-2109.2005.01255.x; Kriebel D, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454986; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Mutiyar PK, 2014, ENVIRON MONIT ASSESS, V186, P541, DOI 10.1007/s10661-013-3398-6; Revannasiddaiah N, 2015, J DRUG DISCOVERY THE, V3, P62; Rico A, 2014, ENVIRON POLLUT, V191, P8, DOI 10.1016/j.envpol.2014.04.002; Shimizu A, 2013, SCI TOTAL ENVIRON, V452, P108, DOI 10.1016/j.scitotenv.2013.02.027; Singh KP, 2014, ENVIRON MONIT ASSESS, V186, P6663, DOI 10.1007/s10661-014-3881-8; Sinthuchai D, 2016, WATER SCI TECHNOL, V73, P182, DOI 10.2166/wst.2015.484; Swapna KM, 2012, INDIAN J GEO-MAR SCI, V41, P344; Tamhankar AJ, ANTIMICROBIOL RESIST, P390; Tewari S, 2013, CHEMOSPHERE, V91, P697, DOI 10.1016/j.chemosphere.2012.12.042; Ur Rehman MS, 2015, CHEMOSPHERE, V138, P1045, DOI 10.1016/j.chemosphere.2013.02.036; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; WHO, 2015, GLOB ACT PLAN ANT RE; WHO, 2012, PHARM DRINK WAT	28	49	51	2	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2017	358						42	45	j2440	10.1136/bmj.j2440	http://dx.doi.org/10.1136/bmj.j2440			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG7ED	28874355	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000410575100003
J	Rat, C; Pogu, C; Le Donne, D; Latour, C; Bianco, G; Nanin, F; Cowppli-Bony, A; Gaultier, A; Nguyen, JM				Rat, Cedric; Pogu, Corinne; Le Donne, Delphine; Latour, Chloe; Bianco, Gaelle; Nanin, France; Cowppli-Bony, Anne; Gaultier, Aurelie; Nguyen, Jean-Michel			Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OCCULT BLOOD-TEST; IMPROVE; GUIDELINES; INCREASES; SUPPORT; GPS	IMPORTANCE Increasing participation in fecal screening tests is a major challenge in countries that have implemented colorectal cancer (CRC) screening programs. OBJECTIVE To determine whether providing general practitioners (GPs) a list of patients who are nonadherent to CRC screening enhances patient participation in fecal immunochemical testing (FIT). DESIGN, SETTING, AND PARTICIPANTS A 3-group, cluster-randomized study was conducted from July 14, 2015, to July 14, 2016, on the west coast of France, with GPs in 801 practices participating and involving adult patients (50-74 years) who were at average risk of CRC and not up-to-date with CRC screening. The final follow-up date was July 14, 2016. INTERVENTIONS General practitioners were randomly assigned to 1 of 3 groups: 496 received a list of patients who had not undergone CRC screening (patient-specific reminders group, 10 476 patients), 495 received a letter describing region-specific CRC screening adherence rates (generic reminders group, 10 606 patients), and 455 did not receive any reminders (usual care group, 10 147 patients). MAIN OUTCOMES AND MEASURES The primary end point was patient participation in CRC screening 1 year after the intervention. RESULTS Among 1482 randomized GPs (mean age, 53.4 years; 576 women [38.9%]), 1446 participated; of the 33 044 patients of these GPs (mean age, 59.7 years; 17 949 women [54.3%]), follow-up at 1 year was available for 31 229 (94.5%). At 1 year, 24.8%(95% CI, 23.4%-26.2%) of patients in the specific reminders group, 21.7%(95% CI, 20.5%-22.8%) in the generic reminders group, and 20.6%(95% CI, 19.3%-21.8%) in the usual care group participated in the FIT screening. The between-group differences were 3.1% (95% CI, 1.3%-5.0%) for the patient-specific reminders group vs the generic reminders group, 4.2% (95% CI, 2.3%-6.2%) for the patient-specific reminders group vs the usual care group, and 1.1% (95% CI, -0.6% to 2.8%) for generic reminders group vs the usual care group. CONCLUSIONS AND RELEVANCE Providing French GPs caring for adults at average risk of CRC with a list of their patients who were not up-to-date with their CRC screening resulted in a small but significant increase in patient participation in FIT screening at 1 year compared with patients who received usual care. Providing GPs with generic reminders about regional rates of CRC screening did not increase screening rates compared with usual care.	[Rat, Cedric; Le Donne, Delphine; Latour, Chloe] Fac Med, Dept Gen Practice, Nantes, France; [Rat, Cedric; Nguyen, Jean-Michel] INSERM U1232 Team 2, French Natl Inst Hlth & Med Res, Nantes, France; [Pogu, Corinne] CAPSANTE 44, Assoc Charge Colorectal Canc Screening Program, Nantes, France; [Bianco, Gaelle] AUDACE, Assoc Charge Colorectal Canc Screening Program, La Roche Sur Yon, France; [Nanin, France] French Hlth Insurance Syst, Div Nantes, Nantes, France; [Cowppli-Bony, Anne] Canc Registry Loire Atlantique & Vendee Geog Area, Nantes, France; [Gaultier, Aurelie; Nguyen, Jean-Michel] Nantes Univ Hosp, Dept Epidemiol & Biostat, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Rat, C (corresponding author), Fac Med Nantes, Dept Gen Practice, 1 Rue Gaston Veil, F-44035 Nantes, France.	cedric.rat@univ-nantes.fr			French National Institute of Cancer	French National Institute of Cancer	Financial support was provided by a grant from the French National Institute of Cancer.	Aubin-Auger I, 2016, EUR J CANCER CARE, V25, P18, DOI 10.1111/ecc.12310; Aubin-Auger I, 2011, FAM PRACT, V28, P670, DOI 10.1093/fampra/cmr020; Birkenfeld S, 2011, J MED SCREEN, V18, P135, DOI 10.1258/jms.2011.010147; Brotons C, 2005, PREV MED, V40, P595, DOI 10.1016/j.ypmed.2004.07.020; Cole SR, 2007, J MED SCREEN, V14, P73, DOI 10.1258/096914107781261927; Cole SR, 2003, J MED SCREEN, V10, P117, DOI 10.1258/096914103769011003; Deding U, 2017, INT J COLORECTAL DIS, V32, P1117, DOI 10.1007/s00384-017-2832-6; Federici A, 2005, J MED SCREEN, V12, P83, DOI 10.1258/0969141053908357; Goebel LJ, 1997, JOINT COMM J QUAL IM, V23, P196, DOI 10.1016/S1070-3241(16)30309-1; Gonzalez EC, 2001, SOUTHERN MED J, V94, P913; Green BB, 2013, ANN INTERN MED, V158, P301, DOI 10.7326/0003-4819-158-5-201303050-00002; Hewitson P, 2011, BRIT J CANCER, V105, P475, DOI 10.1038/bjc.2011.255; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Holme O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009259.pub2; Howlader NA., SEER CANC STAT REV C; Hudson SV, 2007, CANCER DETECT PREV, V31, P417, DOI 10.1016/j.cdp.2007.08.004; Hughes K, 2005, AUST NZ J PUBL HEAL, V29, P358, DOI 10.1111/j.1467-842X.2005.tb00207.x; Hvidberg L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-581; Kiran T, 2014, ANN FAM MED, V12, P317, DOI 10.1370/afm.1664; Lee JK, 2009, J GEN INTERN MED, V24, P1192, DOI 10.1007/s11606-009-1087-5; Levi Z, 2011, INT J CANCER, V128, P2415, DOI 10.1002/ijc.25574; Lieberman D, 2016, JAMA-J AM MED ASSOC, V316, P2135, DOI 10.1001/jama.2016.17418; Hurtado JL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2370-5; MANT D, 1992, BRIT J GEN PRACT, V42, P18; Martos C, 2018, 29089 EUR EN; Piette C, 2017, DIGEST LIVER DIS, V49, P308, DOI 10.1016/j.dld.2016.09.015; Pornet C, 2010, J EPIDEMIOL COMMUN H, V64, P318, DOI 10.1136/jech.2008.081117; Rat C, 2018, EUR J CANCER PREV, V27, P227, DOI 10.1097/CEJ.0000000000000344; Rossi PG, 2011, J MED SCREEN, V18, P121, DOI 10.1258/jms.2011.011009; Sabatino SA, 2012, AM J PREV MED, V43, P97, DOI 10.1016/j.amepre.2012.04.009; Senore C, 2015, GUT, V64, P1158, DOI 10.1136/gutjnl-2014-308081; Sequist TD, 2009, ARCH INTERN MED, V169, P364, DOI 10.1001/archinternmed.2008.564; van der Vlugt M, 2017, BRIT J CANCER, V116, P44, DOI 10.1038/bjc.2016.399; Vinker S, 2002, ISRAEL MED ASSOC J, V4, P424; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; Woodrow C, 2008, HEALTH EXPECT, V11, P16, DOI 10.1111/j.1369-7625.2007.00474.x; Zanetti R, 2015, EUR J CANCER, V51, P1091, DOI 10.1016/j.ejca.2013.11.040	37	30	32	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2017	318	9					816	824		10.1001/jama.2017.11387	http://dx.doi.org/10.1001/jama.2017.11387			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF7GE	28873160	Green Published			2022-12-28	WOS:000409183700013
J	Voosen, P				Voosen, Paul			Hurricane Harvey provides lab for US forecast experiments	SCIENCE			English	News Item																			0	1	1	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2017	357	6354					854	854		10.1126/science.357.6354.854	http://dx.doi.org/10.1126/science.357.6354.854			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF2NU	28860360				2022-12-28	WOS:000408734900014
J	Sinha, G				Sinha, Gunjan			THE ORGANOID ARCHITECT	SCIENCE			English	Editorial Material																			0	4	4	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2017	357	6353					746	749		10.1126/science.357.6353.746	http://dx.doi.org/10.1126/science.357.6353.746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6OD	28839056				2022-12-28	WOS:000408327900020
J	Samwer, M; Schneider, MWG; Hoefler, R; Schmalhorst, PS; Jude, JG; Zuber, J; Gerlich, DW				Samwer, Matthias; Schneider, Maximilian W. G.; Hoefler, Rudolf; Schmalhorst, Philipp S.; Jude, Julian G.; Zuber, Johannes; Gerlich, Daniel W.			DNA Cross-Bridging Shapes a Single Nucleus from a Set of Mitotic Chromosomes	CELL			English	Article							TO-AUTOINTEGRATION FACTOR; ENVELOPE; BARRIER; BAF; EMERIN; CHROMATIN; GENOME; MITOSIS; BINDING; SYSTEM	Eukaryotic cells store their chromosomes in a single nucleus. This is important to maintain genomic integrity, as chromosomes packaged into separate nuclei (micronuclei) are prone to massive DNA damage. During mitosis, higher eukaryotes disassemble their nucleus and release individualized chromosomes for segregation. How numerous chromosomes subsequently reforma single nucleus has remained unclear. Using image-based screening of human cells, we identified barrier-to-autointegration factor (BAF) as a key factor guiding membranes to form a single nucleus. Unexpectedly, nuclear assembly does not require BAF's association with inner nuclear membrane proteins but instead relies on BAF's ability to bridge distant DNA sites. Live-cell imaging and in vitro reconstitution showed that BAF enriches around the mitotic chromosome ensemble to induce a densely cross-bridged chromatin layer that is mechanically stiff and limits membranes to the surface. Our study reveals that BAF-mediated changes in chromosome mechanics underlie nuclear assembly with broad implications for proper genome function.	[Samwer, Matthias; Schneider, Maximilian W. G.; Hoefler, Rudolf; Gerlich, Daniel W.] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Schmalhorst, Philipp S.] IST Austria, A-3400 Klosterneuburg, Austria; [Jude, Julian G.; Zuber, Johannes] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Institute of Science & Technology - Austria; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Gerlich, DW (corresponding author), Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, A-1030 Vienna, Austria.	daniel.gerlich@imba.oeaw.ac.at	Zuber, Johannes/E-7517-2011; Gerlich, Daniel Wolfram W/A-6991-2016	Zuber, Johannes/0000-0001-8810-6835; Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Schneider, Maximilian/0000-0001-7485-0460; Jude, Julian/0000-0002-9091-9867; Samwer, Matthias/0000-0003-4495-8619; Schmalhorst, Philipp/0000-0002-5795-0133	European Community's Seventh Framework Programme FP7 [241548, 258068]; ERC Starting Grant [281198]; Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) [LS14-009]; Austrian Science Fund (FWF) [SFB F34-06]	European Community's Seventh Framework Programme FP7; ERC Starting Grant; Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank O. Wueseke (https://www.impulse-science.org), R. Foisner, D. Handler, and I. Patten for comments on the manuscript, the IMBA/IMP/GMI BioOptics core facility, the Vienna Biocenter Core Facilities GmbH (VBCF) Protein Technologies facility, the IST Austria Bioimaging Facility, and C. Blaukopf for technical support, C. Sommer for statistical advice, B.E. Mierzwa for illustration of the model figure (http://www.beatascienceart.com), and Life Science Editors for editing assistance. D.W.G. has received financial support from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreements 241548 (MitoSys) and 258068 (Systems Microscopy), from an ERC Starting Grant (281198), from the Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF; LS14-009), and from the Austrian Science Fund (FWF; SFB F34-06).	Abrams EW, 2012, CELL, V150, P521, DOI 10.1016/j.cell.2012.05.048; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Cuylen S, 2016, NATURE, V535, P308, DOI 10.1038/nature18610; de Vries AHB, 2007, NANO LETT, V7, P1424, DOI 10.1021/nl070603+; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Furukawa K, 1999, J CELL SCI, V112, P2485; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Harris D, 2000, J BIOL CHEM, V275, P39671, DOI 10.1074/jbc.M002626200; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Hirano Y, 2005, J BIOL CHEM, V280, P39925, DOI 10.1074/jbc.M503214200; Hirano Y, 2009, BIOCHEMISTRY-US, V48, P1636, DOI 10.1021/bi802060v; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; Jamin A, 2015, CURR OPIN CELL BIOL, V34, P61, DOI 10.1016/j.ceb.2015.05.006; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lee KK, 2001, J CELL SCI, V114, P4567; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Liu GJ, 2014, GENE DEV, V28, P1337, DOI 10.1101/gad.240416.114; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Molitor TP, 2014, MOL BIOL CELL, V25, P891, DOI 10.1091/mbc.E13-10-0603; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Otsuka S, 2016, ELIFE, V5, DOI 10.7554/eLife.19071; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; Ungricht R, 2017, NAT REV MOL CELL BIO, V18, P229, DOI 10.1038/nrm.2016.153; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	54	101	103	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2017	170	5					956	+	972.e23	10.1016/j.cell.2017.07.038	http://dx.doi.org/10.1016/j.cell.2017.07.038			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FE7FG	28841419	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000408372400014
J	Cuisset, T; Verheugt, FWA; Mauri, L				Cuisset, Thomas; Verheugt, Freek W. A.; Mauri, Laura			Update on antithrombotic therapy after percutaneous coronary revascularisation	LANCET			English	Review							DUAL-ANTIPLATELET THERAPY; ELUTING STENT IMPLANTATION; ELEVATION MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; SECONDARY PREVENTION; DOUBLE-BLIND; ANTICOAGULANT-THERAPY; PLATELET REACTIVITY; TRIPLE THERAPY; DAPT SCORE	For relief of coronary obstruction, percutaneous coronary intervention has become a standard-of-care procedure over the past 40 years. Nonetheless, optimal outcomes after coronary stenting require careful attention to antithrombotic therapy. This review aims to summarise the current available evidence and discusses how to integrate scientific knowledge into clinical decisions. In recent years, improvement and modifications of drugs and devices have changed the field tremendously, and substantially benefitted patient outcomes. The key challenge of how to provide optimal protection against thrombotic events without excessive increases in bleeding risk has remained the same for decades. Alternative strategies with new drugs, both antiplatelet and anticoagulant agents, and new coronary stents will continue the journey to achieve this ultimate goal.	[Cuisset, Thomas] CHU Timone, Dept Cardiol, F-13005 Marseille, France; [Cuisset, Thomas] Marseille Univ, Fac Med, Marseille, France; [Verheugt, Freek W. A.] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands; [Mauri, Laura] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Mauri, Laura] Baim Inst Clin Res, Boston, MA USA	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Onze Lieve Vrouwe Gasthuis Hospital; Harvard University; Brigham & Women's Hospital	Cuisset, T (corresponding author), CHU Timone, Dept Cardiol, F-13005 Marseille, France.	thomas.cuisset@ap-hm.fr	mauri, laura/GPS-4868-2022		AstraZeneca; Boston Scientific; Biotronik; Eli Lilly; Medtronic; Sanofi-Aventis; Terumo; Cordis; Daiichi Sankyo; Bristol-Myers Squibb; Amgen; Abbott; Boehringer Ingelheim; Corvia; St Jude Medical	AstraZeneca(AstraZeneca); Boston Scientific(Boston Scientific); Biotronik; Eli Lilly(Eli Lilly); Medtronic(Medtronic); Sanofi-Aventis(Sanofi-Aventis); Terumo; Cordis; Daiichi Sankyo(Daiichi Sankyo Company Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); Amgen(Amgen); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Corvia; St Jude Medical(St. Jude Medical)	TC has received personal fees from AstraZeneca, Boston Scientific, Biotronik, Eli Lilly, Medtronic, Sanofi-Aventis, and Terumo. FWAV has received honoraria for consultancies or presentations from Bayer Healthcare, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer, Daiichi Sankyo, and AstraZeneca. LM has received grants from Cordis, Medtronic, Eli Lilly, Daiichi Sankyo, Bristol-Myers Squibb, Sanofi-Aventis, Amgen, Abbott, Boston Scientific, Boehringer Ingelheim, Biotronik, and Corvia; consulting fees from Amgen, St Jude Medical, Eli Lilly, and Medtronic; and honoraria from Daiichi Sankyo and Sanofi. LM is a member of the advisory board for St Jude Medical, and executive steering committee for Corvia and Biotronik; and is principal investigator for ReCor.	Alexander JH, 2014, EUR HEART J, V35, P224, DOI 10.1093/eurheartj/eht445; Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Angiolillo DJ, ANTITHROMBOTIC THERA; [Anonymous], 1988, LANCET, V2, P349; Baber U, 2016, AM HEART J, V182, P125, DOI 10.1016/j.ahj.2016.09.006; Baber U, 2016, J AM COLL CARDIOL, V67, P2224, DOI 10.1016/j.jacc.2016.02.064; Bagai A, 2015, EUR HEART J-ACUTE CA, V4, P499, DOI 10.1177/2048872614564082; BARRAGAN P, 1994, ARCH MAL COEUR VAISS, V87, P1431; Bergmeijer TO, 2014, AM HEART J, V168, P16, DOI 10.1016/j.ahj.2014.03.006; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bonaca MP, 2014, J AM COLL CARDIOL, V64, P2309, DOI 10.1016/j.jacc.2014.09.037; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Cuisset T, 2017, EUR HEART J, V38, P3070, DOI 10.1093/eurheartj/ehx175; Dans AL, CONCOMITANT USE ANTI; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Elmariah S, 2015, LANCET, V385, P792, DOI 10.1016/S0140-6736(14)62052-3; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Fiedler KA, 2015, J AM COLL CARDIOL, V65, P1619, DOI 10.1016/j.jacc.2015.02.050; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Gibson CM, 2013, J AM COLL CARDIOL, V62, P286, DOI 10.1016/j.jacc.2013.03.041; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Giustino G, 2016, J AM COLL CARDIOL, V68, P1851, DOI 10.1016/j.jacc.2016.07.760; Giustino G, 2015, J AM COLL CARDIOL, V65, P1298, DOI 10.1016/j.jacc.2015.01.039; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Helft G, 2016, EUR HEART J, V37, P365, DOI 10.1093/eurheartj/ehv481; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Kereiakes DJ, 2016, J AM COLL CARDIOL, V67, P2492, DOI 10.1016/j.jacc.2016.03.485; Kereiakes DJ, 2015, JACC-CARDIOVASC INTE, V8, P1552, DOI 10.1016/j.jcin.2015.05.026; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lamberts M, 2012, CIRCULATION, V126, P1185, DOI 10.1161/CIRCULATIONAHA.112.114967; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Ohman EM, 2017, LANCET, V389, P1799, DOI 10.1016/S0140-6736(17)30751-1; Oldgren J, 2011, EUR HEART J, V32, P2781, DOI 10.1093/eurheartj/ehr113; Palmerini T, 2017, J AM COLL CARDIOL, V69, P2011, DOI 10.1016/j.jacc.2017.02.029; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Pourdjabbar A, 2017, THROMB HAEMOSTASIS, V117, P303, DOI 10.1160/TH16-04-0340; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Schulz S, 2014, J CARDIOVASC TRANSL, V7, P91, DOI 10.1007/s12265-013-9527-3; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Serruys PW, 2016, LANCET, V388, P2479, DOI 10.1016/S0140-6736(16)32050-5; Sibbing D, 2017, THROMB HAEMOSTASIS, V117, P188, DOI 10.1160/TH16-07-0557; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Vranckx P, 2016, EUROINTERVENTION, V12, P1239, DOI 10.4244/EIJY15M11_07; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wykrzykowska JJ, 2017, NEW ENGL J MED, V376, P2319, DOI 10.1056/NEJMoa1614954; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003; Yusuf S, 2001, NEW ENGL J MED, V345, P494	80	18	18	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2017	390	10096					810	820		10.1016/S0140-6736(17)31936-0	http://dx.doi.org/10.1016/S0140-6736(17)31936-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9RD	28831996				2022-12-28	WOS:000407858900024
